PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nagahashi, M; Kim, EY; Yamada, A; Ramachandran, S; Allegood, JC; Hait, NC; Maceyka, M; Milstien, S; Takabe, K; Spiegel, S				Nagahashi, Masayuki; Kim, Eugene Y.; Yamada, Akimitsu; Ramachandran, Subramaniam; Allegood, Jeremy C.; Hait, Nitai C.; Maceyka, Michael; Milstien, Sheldon; Takabe, Kazuaki; Spiegel, Sarah			Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network	FASEB JOURNAL			English	Article						sphingosine-1-phosphate; lymphocytes	CANCER PROGRESSION; ENDOTHELIAL-CELLS; SPHINGOSINE-1-PHOSPHATE; 1-PHOSPHATE; EGRESS; ORGANS; LYMPHANGIOGENESIS; ZEBRAFISH; EXPORT; MICE	Sphingosine-1-phosphate (S1P), a ligand for 5 specific receptors, is a potent lipid mediator that plays important roles in lymphocyte trafficking and immune responses. S1P is produced inside cells and therefore must be secreted to exert its effects through these receptors. Spinster 2 (Spns2) is one of the cell surface transporters thought to secrete S1P. We have shown that Spns2 can export endogenous S1P from cells and also dihydro-S1P, which is active at all cell surface S1P receptors. Moreover, Spns(2-/-) mice have decreased levels of both of these phosphorylated sphingoid bases in blood, accompanied by increases in very long chain ceramide species, and have defective lymphocyte trafficking. Surprisingly, levels of S1P and dihydro-S1P were increased in lymph from Spns(2-/-) mice as well as in specific tissues, including lymph nodes, and interstitial fluid. Moreover, lymph nodes from Spns(2-/-) mice have aberrant lymphatic sinus that appeared collapsed, with reduced numbers of lymphocytes. Our data suggest that Spns2 is an S1P transporter in vivo that plays a role in regulation not only of blood S1P but also lymph node and lymph S1P levels and consequently influences lymphocyte trafficking and lymphatic vessel network organization.-Nagahashi, M., Kim, E. Y., Yamada, A., Ramachandran, S., Allegood, J. C., Hait, N. C., Maceyka, M., Milstien, S., Takabe, K., Spiegel, S. Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels and the lymphatic network. FASEB J. 27, 1001-1011 (2013). www.fasebj.org	[Nagahashi, Masayuki; Kim, Eugene Y.; Yamada, Akimitsu; Ramachandran, Subramaniam; Allegood, Jeremy C.; Hait, Nitai C.; Maceyka, Michael; Milstien, Sheldon; Takabe, Kazuaki; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Nagahashi, Masayuki; Yamada, Akimitsu; Takabe, Kazuaki] Virginia Commonwealth Univ, Sch Med, Dept Surg, Richmond, VA 23298 USA; [Nagahashi, Masayuki; Kim, Eugene Y.; Yamada, Akimitsu; Ramachandran, Subramaniam; Allegood, Jeremy C.; Hait, Nitai C.; Maceyka, Michael; Milstien, Sheldon; Takabe, Kazuaki; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 1101 E Marshall St,2011 Sanger Hall, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Maceyka, Michael/B-9277-2008; Nagahashi, Masayuki/AAB-4202-2020	Takabe, Kazuaki/0000-0002-6435-4241	U.S. National Institutes of Health (NIH) [R37-GM043880, U19-AI077435, K12-HD055881]; Cure Research Foundation [KG090510]; NIH [T32HL094290, P30CA16059]; Japan Society for the Promotion of Science Postdoctoral Fellow; National Institute of Neurological Disorders and Stroke Center Core [5P30NS047463]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD055881] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA160688] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science Postdoctoral Fellow; National Institute of Neurological Disorders and Stroke Center Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) grants R37-GM043880 and U19-AI077435 (to S. S.) and K12-HD055881 and Susan G. Komen for the Cure Research Foundation Career Catalyst research grant KG090510 (to K. T.). E.Y.K. and J.C.A. were supported by NIH training grant T32HL094290. M.N. is a Japan Society for the Promotion of Science Postdoctoral Fellow. The Flow Cytometry and Confocal Microscopy Shared Resource Cores were supported in part by NIH grant P30CA16059 to the Massey Cancer Center and National Institute of Neurological Disorders and Stroke Center Core grant 5P30NS047463, respectively. M.N. designed and performed the research and assisted in writing the manuscript; E.Y.K., A.Y., S.R., and N.C.H. performed the research and analyzed the data; J.C.A. measured sphingolipids; M. M. and S. M. analyzed the data and assisted in writing the manuscript; K. T. designed experiments, analyzed the data, and assisted in writing the manuscript; and S. S. designed experiments, analyzed data, and wrote the manuscript. The authors declare no conflicts of interest.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Meissner A, 2012, CIRCULATION, V125, P2739, DOI 10.1161/CIRCULATIONAHA.111.047316; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nagahashi M, 2010, WORLD J GASTROENTERO, V16, P4003, DOI 10.3748/wjg.v16.i32.4003; Nijnik A, 2012, J IMMUNOL, V189, P102, DOI 10.4049/jimmunol.1200282; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sensken SC, 2010, J IMMUNOL, V184, P4133, DOI 10.4049/jimmunol.0903358; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wiig H, 2003, AM J PHYSIOL-HEART C, V284, pH416, DOI 10.1152/ajpheart.00327.2002; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	32	116	121	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					1001	1011		10.1096/fj.12-219618	http://dx.doi.org/10.1096/fj.12-219618			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23180825	Green Published			2022-12-25	WOS:000315585200015
J	Berim, A; Gang, DR				Berim, Anna; Gang, David R.			The Roles of a Flavone-6-Hydroxylase and 7-O-Demethylation in the Flavone Biosynthetic Network of Sweet Basil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; OCIMUM-BASILICUM; GLANDULAR HAIRS; O-DEMETHYLATION; ESSENTIAL OIL; CYTOCHROME-P450; AGLYCONES; EXPRESSION; P450S	Lipophilic flavonoids found in the Lamiaceae exhibit unusual 6- and 8-hydroxylations whose enzymatic basis is unknown. We show that crude protein extracts from peltate trichomes of sweet basil (Ocimum basilicum L.) cultivars readily hydroxylate position 6 of 7-O-methylated apigenin but not apigenin itself. The responsible protein was identified as a P450 monooxygenase from the CYP82 family, a family not previously reported to be involved in flavonoid metabolism. This enzyme prefers flavones but also accepts flavanones in vitro and requires a 5-hydroxyl in addition to a 7-methoxyl residue on the substrate. A peppermint (Mentha x piperita L.) homolog displayed identical substrate requirements, suggesting that early 7-O-methylation of flavones might be common in the Lamiaceae. This hypothesis is further substantiated by the pioneering discovery of 2-oxoglutarate-dependent flavone demethylase activity in basil, which explains the accumulation of 7-O-demethylated flavone nevadensin.	[Berim, Anna; Gang, David R.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Washington State University	Gang, DR (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	gangd@wsu.edu			Department of Energy Biological and Environmental Research Program [DE-SC0001728]	Department of Energy Biological and Environmental Research Program(United States Department of Energy (DOE))	This work was supported by Department of Energy Biological and Environmental Research Program Grant DE-SC0001728 (to D. R. G.).	Anzellotti D, 2000, ARCH BIOCHEM BIOPHYS, V382, P161, DOI 10.1006/abbi.2000.2002; Anzellotti Dominique, 2004, BMC Plant Biology, V4, P20, DOI 10.1186/1471-2229-4-20; Berim A, 2012, PLANT PHYSIOL, V160, P1052, DOI 10.1104/pp.112.204164; Bosabalidis A, 1998, PHYTOCHEMISTRY, V49, P1549, DOI 10.1016/S0031-9422(98)00186-1; Bui ML, 2004, BIOCHEM SYST ECOL, V32, P943, DOI 10.1016/j.bse.2004.03.001; Chemler JA, 2008, CURR OPIN BIOTECH, V19, P597, DOI 10.1016/j.copbio.2008.10.011; Facchini PJ, 2012, TRENDS BIOTECHNOL, V30, P127, DOI 10.1016/j.tibtech.2011.10.001; FERRERES F, 1985, PHYTOCHEMISTRY, V24, P1869, DOI 10.1016/S0031-9422(00)82579-0; Fliegmann J, 2010, PHYTOCHEMISTRY, V71, P508, DOI 10.1016/j.phytochem.2010.01.007; Gang DR, 2005, ANNU REV PLANT BIOL, V56, P301, DOI 10.1146/annurev.arplant.56.032604.144128; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; GERSHENZON J, 1992, ANAL BIOCHEM, V200, P130, DOI 10.1016/0003-2697(92)90288-I; Grayer RJ, 1996, PHYTOCHEMISTRY, V43, P1041, DOI 10.1016/S0031-9422(96)00430-X; Grayer RJ, 2001, PHYTOCHEMISTRY, V56, P559, DOI 10.1016/S0031-9422(00)00439-8; Greenham J, 2001, PHYTOCHEMISTRY, V56, P87, DOI 10.1016/S0031-9422(00)00355-1; Hagel JM, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00014; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Halbwirth H, 2004, PLANT SCI, V167, P129, DOI 10.1016/j.plantsci.2004.03.007; Halbwirth H, 2010, INT J MOL SCI, V11, P595, DOI 10.3390/ijms11020595; Ibrahim RK, 2005, CAN J BOT, V83, P433, DOI [10.1139/b05-030, 10.1139/B05-030]; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Kitada C, 2001, PLANT CELL PHYSIOL, V42, P1338, DOI 10.1093/pcp/pce169; Kruse T, 2008, CHEM BIOL, V15, P149, DOI 10.1016/j.chembiol.2008.01.008; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Larbat R, 2007, J BIOL CHEM, V282, P542, DOI 10.1074/jbc.M604762200; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Liu Y, 1998, PHYTOCHEMISTRY, V48, P339, DOI 10.1016/S0031-9422(97)01129-1; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Matsuba Y, 2010, PLANT CELL, V22, P3374, DOI 10.1105/tpc.110.077487; Mau Christopher J. D., 2006, Phytochemistry Reviews, V5, P373, DOI 10.1007/s11101-006-9008-2; OMURA T, 1964, J BIOL CHEM, V239, P2370; PARMAR VS, 1994, PHYTOCHEMISTRY, V36, P507, DOI 10.1016/S0031-9422(00)97104-8; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Pollastri S, 2011, ANN BOT-LONDON, V108, P1225, DOI 10.1093/aob/mcr234; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; RIESEBERG LH, 1987, AM J BOT, V74, P224, DOI 10.2307/2444024; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroder G, 1999, FEBS LETT, V458, P97, DOI 10.1016/S0014-5793(99)01138-2; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Takemura T, 2012, PHYTOCHEMIS IN PRESS; TALAPATR.SK, 1974, PHYTOCHEMISTRY, V13, P284, DOI 10.1016/S0031-9422(00)91316-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Tezuka Y, 2000, CHEM PHARM BULL, V48, P1711, DOI 10.1248/cpb.48.1711; Valant-Vetschera KM, 2003, BIOCHEM SYST ECOL, V31, P1279, DOI 10.1016/S0305-1978(03)00037-1; VANDENBROUCKE CO, 1982, PHYTOCHEMISTRY, V21, P2581, DOI 10.1016/0031-9422(82)85261-8; Veitch NC, 2011, NAT PROD REP, V28, P1626, DOI 10.1039/c1np00044f; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; VOIRIN B, 1992, PHYTOCHEMISTRY, V31, P2299, DOI 10.1016/0031-9422(92)83268-4; Wang YC, 2011, APPL MICROBIOL BIOT, V91, P949, DOI 10.1007/s00253-011-3449-2; WERKER E, 1993, ANN BOT-LONDON, V71, P43, DOI 10.1006/anbo.1993.1005; WOLLENWEBER E, 1981, PHYTOCHEMISTRY, V20, P869, DOI 10.1016/0031-9422(81)83001-4; Wollenweber E, 2003, Z NATURFORSCH C, V58, P771; WOLLENWEBER E, 1972, TETRAHEDRON LETT, P797, DOI 10.1016/S0040-4039(01)84442-7; Wollenweber E, 2008, BIOCHEM SYST ECOL, V36, P481, DOI 10.1016/j.bse.2007.12.004; Yuk HJ, 2011, J AGR FOOD CHEM, V59, P12683, DOI 10.1021/jf203326c; Zhang JA, 2007, PLANT PHYSIOL, V144, P741, DOI 10.1104/pp.106.095018	59	43	45	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1795	1805		10.1074/jbc.M112.420448	http://dx.doi.org/10.1074/jbc.M112.420448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184958	Green Published, hybrid			2022-12-25	WOS:000313751400035
J	Bunker, RD; Bulloch, EMM; Dickson, JMJ; Loomes, KM; Baker, EN				Bunker, Richard D.; Bulloch, Esther M. M.; Dickson, James M. J.; Loomes, Kerry M.; Baker, Edward N.			Structure and Function of Human Xylulokinase, an Enzyme with Important Roles in Carbohydrate Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; RESPONSE ELEMENT; GLYCEROL KINASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ESSENTIAL PENTOSURIA; CRYSTAL-STRUCTURES; DATA QUALITY; GLUCOSE; LIVER	D-Xylulokinase (XK; EC 2.7.1.17) catalyzes the ATP-dependent phosphorylation of D-xylulose (Xu) to produce xylulose 5-phosphate (Xu5P). In mammals, XK is the last enzyme in the glucuronate-xylulose pathway, active in the liver and kidneys, and is linked through its product Xu5P to the pentose-phosphate pathway. XK may play an important role in metabolic disease, given that Xu5P is a key regulator of glucose metabolism and lipogenesis. We have expressed the product of a putative human XK gene and identified it as the authentic human D-xylulokinase (hXK). NMR studies with a variety of sugars showed that hXK acts only on D-xylulose, and a coupled photometric assay established its key kinetic parameters as K-m(Xu) = 24 +/- 3 mu M and k(cat) = 35 +/- 5 s(-1). Crystal structures were determined for hXK, on its own and in complexes with Xu, ADP, and a fluorinated inhibitor. These reveal that hXK has a two-domain fold characteristic of the sugar kinase/hsp70/actin superfamily, with glycerol kinase as its closest relative. Xu binds to domain-I and ADP to domain-II, but in this open form of hXK they are 10 angstrom apart, implying that a large scale conformational change is required for catalysis. Xu binds in its linear keto-form, sandwiched between a Trp side chain and polar side chains that provide exquisite hydrogen bonding recognition. The hXK structure provides a basis for the design of specific inhibitors with which to probe its roles in sugar metabolism and metabolic disease.	[Loomes, Kerry M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand	University of Auckland; University of Auckland	Loomes, KM (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Private Bag 92019, Auckland 1142, New Zealand.	k.loomes@auckland.ac.nz; ted.baker@auckland.ac.nz		Baker, Edward/0000-0003-2456-7661; Bulloch, Esther/0000-0002-4262-1791; Bunker, Richard/0000-0001-8866-5290	Tertiary Education Commission of New Zealand through Maurice Wilkins Centre for Molecular Biodiscovery; University of Auckland; Maurice Wilkins Centre for Molecular Biodiscovery	Tertiary Education Commission of New Zealand through Maurice Wilkins Centre for Molecular Biodiscovery; University of Auckland; Maurice Wilkins Centre for Molecular Biodiscovery	This work was supported by the Tertiary Education Commission of New Zealand through funding of the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by a Doctorate Scholarship from the University of Auckland and by the Maurice Wilkins Centre for Molecular Biodiscovery.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; BAIS R, 1985, BIOCHEM J, V230, P53, DOI 10.1042/bj2300053; Blanc E., 2011, BUSTER VERSION 2 11; BOZIAN RC, 1959, NATURE, V184, P463, DOI 10.1038/184463a0; Bunker RD, 2012, ACTA CRYSTALLOGR F, V68, P1259, DOI 10.1107/S1744309112031181; Bystrom CE, 1999, BIOCHEMISTRY-US, V38, P3508, DOI 10.1021/bi982460z; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONYERS RAJ, 1990, CLIN CHEM, V36, P1717; Di Luccio E, 2007, J MOL BIOL, V365, P783, DOI 10.1016/j.jmb.2006.10.068; DILLS WL, 1994, PROTEIN EXPRES PURIF, V5, P259, DOI 10.1006/prep.1994.1039; Doiron B, 1996, J BIOL CHEM, V271, P5321, DOI 10.1074/jbc.271.10.5321; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engh RA, 2006, INT TABLES CRYSTALLO, VF, P382; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feese MD, 1998, STRUCTURE, V6, P1407, DOI 10.1016/S0969-2126(98)00140-3; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Hadwiger P, 2000, TETRAHEDRON-ASYMMETR, V11, P607, DOI 10.1016/S0957-4166(99)00526-1; Hahn-Hagerdal B, 2001, Adv Biochem Eng Biotechnol, V73, P53; HICKMAN J, 1958, J BIOL CHEM, V232, P737; Holmes RP, 1998, J UROLOGY, V160, P1617, DOI 10.1016/S0022-5347(01)62363-2; Home PD, 2008, DIABETES OBES METAB, V10, P699, DOI 10.1111/j.1463-1326.2007.00761.x; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mao C, 1999, BIOCHEM BIOPH RES CO, V259, P640, DOI 10.1006/bbrc.1999.0816; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MORAVCOVA J, 1994, CARBOHYD RES, V263, P61, DOI 10.1016/0008-6215(94)00165-0; Moreland N, 2005, ACTA CRYSTALLOGR D, V61, P1378, DOI 10.1107/S090744905023590; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richard P, 2000, FEMS MICROBIOL LETT, V190, P39, DOI 10.1016/S0378-1097(00)00312-8; Schnick C, 2009, MOL MICROBIOL, V71, P533, DOI 10.1111/j.1365-2958.2008.06544.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; STEITZ TA, 1981, PHILOS T ROY SOC B, V293, P43, DOI 10.1098/rstb.1981.0058; Stutz A. E., 1976, J MAGN RESON, V21, P337; Tamari M, 1998, CYTOGENET CELL GENET, V82, P101, DOI 10.1159/000015076; TOUSTER O, 1960, FED PROC, V19, P977; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Veech RL, 2003, P NATL ACAD SCI USA, V100, P5578, DOI 10.1073/pnas.1132039100; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VUORINEN T, 1991, CARBOHYD RES, V209, P13, DOI 10.1016/0008-6215(91)80142-A; WU J, 1990, CARBOHYD RES, V206, P1, DOI 10.1016/0008-6215(90)84001-B; Yew WS, 2004, BIOCHEMISTRY-US, V43, P6427, DOI 10.1021/bi049741t	52	18	19	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1643	1652		10.1074/jbc.M112.427997	http://dx.doi.org/10.1074/jbc.M112.427997			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23179721	Green Published, hybrid			2022-12-25	WOS:000313751400020
J	Jaramillo-Lambert, A; Hao, J; Xiao, HJ; Li, YM; Han, ZY; Zhu, WG				Jaramillo-Lambert, Aimee; Hao, Jing; Xiao, Haijie; Li, Yongming; Han, Zhiyong; Zhu, Wenge			Acidic Nucleoplasmic DNA-binding Protein (And-1) Controls Chromosome Congression by Regulating the Assembly of Centromere Protein A (CENP-A) at Centromeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ALPHA; SACCHAROMYCES-CEREVISIAE; HUMAN-CELLS; CHROMATIN; REPLICATION; MAINTENANCE; CHECKPOINT; COMPLEX; DOMAIN; HJURP	The centromere is an epigenetically designated chromatin domain that is essential for the accurate segregation of chromosomes during mitosis. The incorporation of centromere protein A (CENP-A) into chromatin is fundamental in defining the centromeric loci. Newly synthesized CENP-A is loaded at centromeres in early G(1) phase by the CENP-A-specific histone chaperone Holliday junction recognition protein (HJURP) coupled with other chromatin assembly factors. However, it is unknown whether there are additional HJURP-interacting factor(s) involving in this process. Here we identify acidic nucleoplasmic DNA-binding protein 1 (And-1) as a new factor that is required for the assembly of CENP-A nucleosomes. And-1 interacts with both CENP-A and HJURP in a prenucleosomal complex, and the association of And-1 with CENP-A is increased during the cell cycle transition from mitosis to G(1) phase. And-1 down-regulation significantly compromises chromosome congression and the deposition of HJURP-CENP-A complexes at centromeres. Consistently, overexpression of And-1 enhances the assembly of CENP-A at centromeres. We conclude that And-1 is an important factor that functions together with HJURP to facilitate the cell cycle-specific recruitment of CENP-A to centromeres.	[Jaramillo-Lambert, Aimee; Hao, Jing; Xiao, Haijie; Li, Yongming; Han, Zhiyong; Zhu, Wenge] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Zhu, WG (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	wz6812@gwu.edu	li, yong/HDN-3885-2022	Jaramillo-Lambert, Aimee/0000-0001-7697-8580	National Institutes of Health [CA136555]; National Center for Research Resources [S10RR025565-01]; NATIONAL CANCER INSTITUTE [R00CA136555] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136555 (to W. Z).; We thank Dr. Daniel Foltz for CENP-A, HJURP, H3.1, and H4 plasmids. Images collected with the Zeiss 710 microscope were supported by National Center for Research Resources Grant S10RR025565-01.	Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Alexiadis V, 2007, BBA-GENE STRUCT EXPR, V1769, P29, DOI 10.1016/j.bbaexp.2006.11.006; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Li Y, 2012, ONCOGENE, V31, P643, DOI 10.1038/onc.2011.261; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Mamnun YM, 2006, BIOCHEM BIOPH RES CO, V350, P125, DOI 10.1016/j.bbrc.2006.09.024; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Sibani S, 2005, BIOCHEMISTRY-US, V44, P7885, DOI 10.1021/bi047327n; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	36	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1480	1488		10.1074/jbc.M112.429266	http://dx.doi.org/10.1074/jbc.M112.429266			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184928	hybrid, Green Published			2022-12-25	WOS:000313751400006
J	Bazan, S; Mileykovskaya, E; Mallampalli, VKPS; Heacock, P; Sparagna, GC; Dowhan, W				Bazan, Soledad; Mileykovskaya, Eugenia; Mallampalli, Venkata K. P. S.; Heacock, Philip; Sparagna, Genevieve C.; Dowhan, William			Cardiolipin-dependent Reconstitution of Respiratory Supercomplexes from Purified Saccharomyces cerevisiae Complexes III and IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; CHAIN COMPLEXES; SUPRAMOLECULAR ORGANIZATION; YEAST; LIPIDS; PURIFICATION; RESPIRASOME; ARRANGEMENT; COMPONENTS; ENZYMES	Here, we report for the first time in vitro reconstitution of the respiratory supercomplexes from individual complexes III and IV. Complexes III and IV were purified from Saccharomyces cerevisiae mitochondria. Complex III contained eight molecules of cardiolipin, and complex IV contained two molecules of cardiolipin, as determined by electrospray ionization-mass spectrometry. Complex IV also contained Rcf1p. No supercomplexes were formed upon mixing of the purified complexes, and low amounts of the supercomplex trimer III2IV1 were formed after reconstitution into proteoliposomes containing only phosphatidylcholine and phosphatidylethanolamine. Further addition of cardiolipin to the proteoliposome reconstitution mixture resulted in distinct formation of both the III2IV1 supercomplex trimer and III2IV2 supercomplex tetramer. No other anionic phospholipid was as effective as cardiolipin in supporting tetramer formation. Phospholipase treatment of complex IV prevented trimer formation in the absence of cardio-lipin. Both trimer and tetramer formations were restored by cardiolipin. Analysis of the reconstituted tetramer by single particle electron microscopy confirmed native organization of individual complexes within the supercomplex. In conclusion, although some trimerformation ocurred dependent only on tightly bound cardio-lipin, tetramer formation required additional cardiolipin. This is consistent with the high cardiolipin content in the native tetramer. The dependence on cardiolipin for supercomplex formation suggests that changes in cardiolipin levels resulting from changes in physiological conditions may control the equilibrium between individual respiratory complexes and supercomplexes in vivo.	[Bazan, Soledad; Mileykovskaya, Eugenia; Mallampalli, Venkata K. P. S.; Heacock, Philip; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Dowhan, William] Univ Texas Houston, Sch Med, Struct Biol Imaging Ctr, Houston, TX 77030 USA; [Dowhan, William] Univ Texas Houston, Sch Med, Ctr Membrane Biol, Houston, TX 77030 USA; [Sparagna, Genevieve C.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Colorado System; University of Colorado Boulder	Mileykovskaya, E (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St,Ste 6-200, Houston, TX 77030 USA.	Eugenia.Mileykovskaya@uth.tmc.edu; William.Dowhan@uth.tmc.edu	Mallampalli, Venkata KPS/I-3208-2019	Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health [GM-069338, GM R01 56389]; John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338, R01GM056389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Dunn Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Irina Serysheva for use of the Odyssey Infrared Imaging System. We also acknowledge the generous gift of antibodies by Drs. Rosemary Stuart and Bernard Trumpower. We thank Dr. Robert Murphy for the use of the LIPID MAPS mass spectrometry facility at the University of Colorado at Denver, which is supported by National Institutes of Health Large Scale Collaborative Grant GM-069338.; This work was supported, in whole or in part, by National Institutes of Health Grant GM R01 56389 (to W. D.). This work was also supported by the John Dunn Research Foundation (to W.D.).	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Boumans H, 1998, J BIOL CHEM, V273, P4872, DOI 10.1074/jbc.273.9.4872; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Dumas J. F., 2012, BIOCHIMIE IN PRESS; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gomez LA, 2012, SEMIN CELL DEV BIOL, V23, P758, DOI 10.1016/j.semcdb.2012.04.002; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huang ZT, 2008, FREE RADICAL BIO MED, V44, P1935, DOI 10.1016/j.freeradbiomed.2008.02.016; Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; McMillin J. B., 2002, BIOCHIM BIOPHYS ACTA, V1585, P95; Meunier B, 2012, BIOCHEM J, V444, P199, DOI 10.1042/BJ20120116; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Musatov A, 2000, BIOCHEMISTRY-US, V39, P12996, DOI 10.1021/bi000884z; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Palsdottir H., 2003, MEMBRANE PROTEIN PUR, P191; Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Sabar M, 2005, PLANT J, V44, P893, DOI 10.1111/j.1365-313X.2005.02577.x; Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Sedlak E, 2006, BIOCHEMISTRY-US, V45, P746, DOI 10.1021/bi050870z; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; Stuart RA, 2008, J BIOENERG BIOMEMBR, V40, P411, DOI 10.1007/s10863-008-9168-4; TAANMAN JW, 1992, J BIOL CHEM, V267, P22481; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2009, BBA-BIOENERGETICS, V1787, P672, DOI 10.1016/j.bbabio.2008.12.016; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yoshikawa S, 1998, J BIOENERG BIOMEMBR, V30, P7, DOI 10.1023/A:1020595108560; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	54	106	106	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					401	411		10.1074/jbc.M112.425876	http://dx.doi.org/10.1074/jbc.M112.425876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23172229	Green Published, hybrid			2022-12-25	WOS:000313197200041
J	Ghasriani, H; Belcourt, PJF; Sauve, S; Hodgson, DJ; Brochu, D; Gilbert, M; Aubin, Y				Ghasriani, Houman; Belcourt, Pascal J. F.; Sauve, Simon; Hodgson, Derek J.; Brochu, Denis; Gilbert, Michel; Aubin, Yves			A Single N-Acetylgalactosamine Residue at Threonine 106 Modifies the Dynamics and Structure of Interferon alpha 2a around the Glycosylation Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; VISUALIZATION; SPECTROSCOPY; SYSTEM	Enzymatic addition of GalNAc to isotopically labeled IFN alpha 2a produced in Escherichia coli yielded the O-linked glycoprotein GalNAc alpha-[C-13,N-15]IFN alpha 2a. The three-dimensional structure of GalNAc alpha-IFN alpha 2a has been determined in solution by NMR spectroscopy at high resolution. Proton-nitrogen heteronuclear Overhauser enhancement measurements revealed that the addition of a single monosaccharide unit at Thr-106 significantly slowed motions of the glycosylation loop on the nanosecond time scale. Subsequent addition of a Gal unit produced Gal(beta 1,3) GalNAc alpha-[C-13,N-15]IFN alpha 2a. This extension resulted in a further decrease in the dynamics of this loop. The methodology used here allowed the first such description of the structure and dynamics of an O-glycoprotein and opens the way to the study of this class of proteins.	[Ghasriani, Houman; Belcourt, Pascal J. F.; Sauve, Simon; Hodgson, Derek J.; Aubin, Yves] Hlth Canada, Biol & Genet Therapies Directorate, Ctr Vaccine Evaluat, Ottawa, ON K1A 0K9, Canada; [Ghasriani, Houman; Aubin, Yves] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Belcourt, Pascal J. F.; Aubin, Yves] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Brochu, Denis; Gilbert, Michel] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	Health Canada; University of Ottawa; Carleton University; National Research Council Canada	Aubin, Y (corresponding author), Hlth Canada, Biol & Genet Therapies Directorate, Ctr Vaccine Evaluat, 251 Sir Frederick Banting Drwy, Ottawa, ON K1A 0K9, Canada.	yves.aubin@hc-sc.gc.ca		Gilbert, Michel/0000-0002-0204-4408; Ghasriani, Houman/0000-0002-9646-0006	Faculty of Graduate and Postdoctoral Affairs M.S. scholarship; National Science and Engineering Research Council	Faculty of Graduate and Postdoctoral Affairs M.S. scholarship; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Faculty of Graduate and Postdoctoral Affairs M.S. scholarship (to P. J. F. B.) and a National Science and Engineering Research Council Discovery Grant (to Y. A.).	ADOLF GR, 1991, BIOCHEM J, V276, P511, DOI 10.1042/bj2760511; Bernatchez S, 2007, GLYCOBIOLOGY, V17, P1333, DOI 10.1093/glycob/cwm090; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brik A, 2006, CURR OPIN CHEM BIOL, V10, P638, DOI 10.1016/j.cbpa.2006.10.003; Brockausen I., 1999, ESSENTIALS GLYCOBIOL, P115; Coltart DM, 2002, J AM CHEM SOC, V124, P9833, DOI 10.1021/ja020208f; DeFrees S, 2006, GLYCOBIOLOGY, V16, P833, DOI 10.1093/glycob/cwl004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Glue P, 2000, CLIN PHARMACOL THER, V68, P556, DOI 10.1067/mcp.2000.110973; Goddard T. D., 2008, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnston MJW, 2011, PHARM RES-DORDR, V28, P1661, DOI 10.1007/s11095-011-0402-0; Klaus W, 1997, J MOL BIOL, V274, P661, DOI 10.1006/jmbi.1997.1396; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2007, BIOINFORMATICS, V23, P1824, DOI 10.1093/bioinformatics/btm085; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Loris R, 2000, J MOL BIOL, V301, P987, DOI 10.1006/jmbi.2000.4016; Nudelman I, 2011, J AM CHEM SOC, V133, P14755, DOI 10.1021/ja205480v; OHEDA M, 1990, J BIOL CHEM, V265, P11432; Panjwani N, 2010, J PHARM SCI-US, V99, P3334, DOI 10.1002/jps.22105; Parham P, 2005, IMMUNE SYSTEM, P250; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; YAMAMOTO K, 1981, APPL ENVIRON MICROB, V41, P392, DOI 10.1128/AEM.41.2.392-395.1981; Youngster S, 2002, CURR PHARM DESIGN, V8, P2139, DOI 10.2174/1381612023393242; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3	30	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					247	254		10.1074/jbc.M112.413252	http://dx.doi.org/10.1074/jbc.M112.413252			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184955	hybrid, Green Published			2022-12-25	WOS:000313197200024
J	Sun, YY; Selvaraj, S; Varma, A; Derry, S; Sahmoun, AE; Singh, BB				Sun, Yuyang; Selvaraj, Senthil; Varma, Archana; Derry, Susan; Sahmoun, Abe E.; Singh, Brij B.			Increase in Serum Ca2+/Mg2+ Ratio Promotes Proliferation of Prostate Cancer Cells by Activating TRPM7 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; EPITHELIAL-CELLS; CALCIUM; CA2+; MAGNESIUM; MG2+; EXPRESSION; HOMEOSTASIS; RECEPTOR; PROTEIN	TRPM7 is a novel magnesium-nucleotide-regulated metal current (MagNuM) channel that is regulated by serum Mg2+ concentrations. Changes in Mg2+ concentration have been shown to alter cell proliferation in various cells; however, the mechanism and the ion channel(s) involved have not yet been identified. Here we demonstrate that TRPM7 is expressed in control and prostate cancer cells. Supplementation of intracellular Mg-ATP or addition of external 2-aminoethoxydiphenyl borate inhibited MagNuM currents. Furthermore, silencing of TRPM7 inhibited whereas overexpression of TRPM7 increased endogenous MagNuM currents, suggesting that these currents are dependent on TRPM7. Importantly, although an increase in the serum Ca2+/Mg2+ ratio facilitated Ca2+ influx in both control and prostate cancer cells, a significantly higher Ca2+ influx was observed in prostate cancer cells. TRPM7 expression was also increased in cancer cells, but its expression was not dependent on the Ca2+/Mg2+ ratio per se. Additionally, an increase in the extracellular Ca2+/Mg2+ ratio led to a significant increase in cell proliferation of prostate cancer cells when compared with control cells. Consistent with these results, age-matched prostate cancer patients also showed a subsequent increase in the Ca2+/Mg2+ ratio and TRPM7 expression. Altogether, we provide evidence that the TRPM7 channel has an important role in prostate cancer and have identified that the Ca2+/Mg2+ ratio could be essential for the initiation/progression of prostate cancer.	[Sun, Yuyang; Selvaraj, Senthil; Singh, Brij B.] Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA; [Varma, Archana; Derry, Susan; Sahmoun, Abe E.] Univ N Dakota, Sch Med & Hlth Sci, Dept Internal Med, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks	Singh, BB (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Grand Forks, ND 58201 USA.	brij.singh@med.und.edu	Selvaraj, Senthil/P-5766-2019	Selvaraj, Senthil/0000-0002-0185-6033; Singh, Brij/0000-0003-0535-5997	National Institutes of Health [RO1 DE017102, 5P20RR017699, P20RR017699]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DE017102 and 5P20RR017699 (to B. B. S.).; We acknowledge The Edward C. Carlson Imaging and Image Analysis core facility (supported in part by National Institutes of Health Grant P20RR017699) and thank Sarah Abrahamson for technical advice. We also thank Dr. Loren Runnels for providing the HA-TRPM7 construct.	Alexander RT, 2008, J AM SOC NEPHROL, V19, P1451, DOI 10.1681/ASN.2008010098; Anghileri LJ, 2009, MAGNESIUM RES, V22, P247, DOI 10.1684/mrh.2009.0173; BERRIDGE MJ, 1985, J CELL SCI, P187; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Dai Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018237; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Dimke H, 2011, J PHYSIOL-LONDON, V589, P1535, DOI 10.1113/jphysiol.2010.199869; Flourakis M, 2009, BBA-MOL CELL RES, V1793, P1105, DOI 10.1016/j.bbamcr.2009.01.009; GONG YW, 1995, ENDOCRINOLOGY, V136, P2172, DOI 10.1210/en.136.5.2172; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HAZELTON B, 1979, J CELL BIOL, V83, P487, DOI 10.1083/jcb.83.2.487; Ikari A, 2008, BIOCHEM BIOPH RES CO, V369, P1129, DOI 10.1016/j.bbrc.2008.03.002; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; Mishra R, 2009, AM J PHYSIOL-GASTR L, V297, pG687, DOI 10.1152/ajpgi.90683.2008; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Prevarskaya N, 2004, BIOCHEM BIOPH RES CO, V322, P1326, DOI 10.1016/j.bbrc.2004.08.037; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rubin H, 2005, ADV CANCER RES, V93, P1, DOI 10.1016/S0065-230X(05)93001-7; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sahmoun AE, 2010, MED HYPOTHESES, V75, P315, DOI 10.1016/j.mehy.2010.02.037; Schmitz C, 2007, MAGNESIUM RES, V20, P6; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Sun YH, 2006, J ANDROL, V27, P671, DOI 10.2164/jandrol.106.000554; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wang HP, 2007, ASIAN J ANDROL, V9, P634, DOI 10.1111/j.1745-7262.2007.00291.x; WHITFIELD JF, 1979, MOL CELL BIOCHEM, V27, P155, DOI 10.1007/BF00215364; Wissenbach U, 2004, BIOCHEM BIOPH RES CO, V322, P1359, DOI 10.1016/j.bbrc.2004.08.042; Wolf FI, 2004, FRONT BIOSCI-LANDMRK, V9, P2056, DOI 10.2741/1389; Zhang L, 2006, ENDOCR-RELAT CANCER, V13, P27, DOI 10.1677/erc.1.01093	40	85	86	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					255	263		10.1074/jbc.M112.393918	http://dx.doi.org/10.1074/jbc.M112.393918			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23168410	Green Published, hybrid			2022-12-25	WOS:000313197200025
J	Lopez-Hidalgo, M; Salgado-Puga, K; Alvarado-Martinez, R; Medina, AC; Prado-Alcala, RA; Garcia-Colunga, J				Lopez-Hidalgo, Monica; Salgado-Puga, Karla; Alvarado-Martinez, Reynaldo; Cristina Medina, Andrea; Prado-Alcala, Roberto A.; Garcia-Colunga, Jesus			Nicotine Uses Neuron-Glia Communication to Enhance Hippocampal Synaptic Transmission and Long-term Memory	PLOS ONE			English	Article							MOUSE DENTATE GYRUS; D-SERINE; ACETYLCHOLINE-RECEPTORS; IN-VIVO; CA1 REGION; RAT HIPPOCAMPUS; SUBCUTANEOUS NICOTINE; SPREADING DEPRESSION; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION	Nicotine enhances synaptic transmission and facilitates long-term memory. Now it is known that bi-directional glia-neuron interactions play important roles in the physiology of the brain. However, the involvement of glial cells in the effects of nicotine has not been considered until now. In particular, the gliotransmitter D-serine, an endogenous co-agonist of NMDA receptors, enables different types of synaptic plasticity and memory in the hippocampus. Here, we report that hippocampal long-term synaptic plasticity induced by nicotine was annulled by an enzyme that degrades endogenous D-serine, or by an NMDA receptor antagonist that acts at the D-serine binding site. Accordingly, both effects of nicotine: the enhancement of synaptic transmission and facilitation of long-term memory were eliminated by impairing glial cells with fluoroacetate, and were restored with exogenous D-serine. Together, these results show that glial D-serine is essential for the long-term effects of nicotine on synaptic plasticity and memory, and they highlight the roles of glial cells as key participants in brain functions.	[Lopez-Hidalgo, Monica; Salgado-Puga, Karla; Alvarado-Martinez, Reynaldo; Garcia-Colunga, Jesus] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Celular & Mol, Queretaro, Mexico; [Cristina Medina, Andrea; Prado-Alcala, Roberto A.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Conductual & Cognit, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Garcia-Colunga, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Celular & Mol, Campus Juriquilla, Queretaro, Mexico.	garciacolunga@unam.mx	Hidalgo, Mónica López/AAS-2391-2021; Prado-Alcalá, Roberto A./J-8395-2019	Salgado-Puga, Karla/0000-0002-5215-4760; Garcia-Colunga, Jesus/0000-0002-5836-3942; Prado-Alcala, Roberto A./0000-0001-5237-9460	Consejo Nacional de Ciencia y Tecnologia Mexico [81911, 128259]; Direccion General de Asuntos del Personal Academico, U.N.A.M. [IN204809]; CONACyT [213708]	Consejo Nacional de Ciencia y Tecnologia Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, U.N.A.M.(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Grants from Consejo Nacional de Ciencia y Tecnologia Mexico (81911 and 128259) and by a Grant from Direccion General de Asuntos del Personal Academico, U.N.A.M. (IN204809). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Martin Garcia Servin and Angel Mendez for technical assistance. We express our gratitude to Drs. Hugo Merchant, Fernando Pena, and Dorothy Pless for critically reviewing the manuscript. MLH received a scholarship from CONACyT (213708). This paper was part of the Ph.D. thesis of MLH in Doctorado en Ciencias Biomedicas, UNAM.	Achour SB, 2010, NEUROCHEM INT, V57, P440, DOI 10.1016/j.neuint.2010.02.013; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Bacci A, 2002, J NEUROPHYSIOL, V88, P2302, DOI 10.1152/jn.00665.2001; Barros DM, 2004, NEUROSCIENCE, V126, P651, DOI 10.1016/j.neuroscience.2004.03.010; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; BERGJOHNSEN J, 1993, EXP BRAIN RES, V96, P241; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonansco C, 2011, EUR J NEUROSCI, V33, P1483, DOI 10.1111/j.1460-9568.2011.07631.x; Brunzell DH, 2012, NEUROPSYCHOPHARMACOL, V37, P1134, DOI 10.1038/npp.2011.299; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Canals S, 2008, J CEREBR BLOOD F MET, V28, P1835, DOI 10.1038/jcbfm.2008.71; Ciamei A, 2001, PSYCHOPHARMACOLOGY, V154, P126, DOI 10.1007/s002130000584; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; DECKER MW, 1992, BRAIN RES, V572, P281, DOI 10.1016/0006-8993(92)90485-R; Delbro D, 2009, NEUROSCIENCE, V159, P770, DOI 10.1016/j.neuroscience.2009.01.005; Fellin T, 2006, PHYSIOLOGY, V21, P208, DOI 10.1152/physiol.00161.2005; de Sevilla DF, 2010, J NEUROSCI, V30, P11032, DOI 10.1523/JNEUROSCI.1848-10.2010; Fonnum F, 1997, GLIA, V21, P106; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gahring LC, 2004, J COMP NEUROL, V468, P322, DOI 10.1002/cne.10942; Gibbs ME, 2012, NEURON GLIA BIOL, V6, P1; Greenwood SM, 2010, J NEUROCHEM, V113, P1471, DOI 10.1111/j.1471-4159.2010.06737.x; Guizzetti M, 2008, J BIOL CHEM, V283, P31884, DOI 10.1074/jbc.M801316200; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; He J, 2003, ACTA PHARMACOL SIN, V24, P398; Heinrich A, 2012, BRIT J PHARMACOL, V167, P1003, DOI 10.1111/j.1476-5381.2012.01932.x; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hernandez-Morales M, 2009, NEUROPHARMACOLOGY, V56, P975, DOI 10.1016/j.neuropharm.2009.01.024; Ikeda H, 2004, J NEUROSCI, V24, P9888, DOI 10.1523/JNEUROSCI.2608-04.2004; Jia YS, 2009, EUR J NEUROSCI, V29, P1588, DOI 10.1111/j.1460-9568.2009.06706.x; JONES GMM, 1992, PSYCHOPHARMACOLOGY, V108, P485, DOI 10.1007/BF02247426; Kanematsu S, 2006, J NEURAL TRANSM, V113, P1717, DOI 10.1007/s00702-006-0517-3; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; KEYSER DO, 1994, GLIA, V10, P237, DOI 10.1002/glia.440100402; Larrosa B, 2006, NEUROSCIENCE, V141, P1057, DOI 10.1016/j.neuroscience.2006.04.005; Le Magueresse C, 2007, HIPPOCAMPUS, V17, P316, DOI 10.1002/hipo.20271; LEHOUEZEC J, 1994, PSYCHOPHARMACOLOGY, V114, P628, DOI 10.1007/BF02244994; LEVIN ED, 1993, COGNITIVE BRAIN RES, V1, P137, DOI 10.1016/0926-6410(93)90021-V; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Levin ED, 1998, PSYCHOPHARMACOLOGY, V138, P217, DOI 10.1007/s002130050667; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Matsuyama S, 2003, J PHARMACOL SCI, V93, P180, DOI 10.1254/jphs.93.180; Matsuyama S, 2000, EUR J NEUROSCI, V12, P3741, DOI 10.1046/j.1460-9568.2000.00259.x; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mineur YS, 2010, TRENDS PHARMACOL SCI, V31, P580, DOI 10.1016/j.tips.2010.09.004; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Mothet JP, 2006, AGING CELL, V5, P267, DOI 10.1111/j.1474-9726.2006.00216.x; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; MUIR D, 1986, BRAIN RES, V380, P336, DOI 10.1016/0006-8993(86)90231-3; Nakauchi S, 2007, EUR J NEUROSCI, V25, P2666, DOI 10.1111/j.1460-9568.2007.05513.x; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Newhouse P, 2002, AM J GERIAT PSYCHIAT, V10, P483, DOI 10.1176/appi.ajgp.10.4.483; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Oikawa H, 2005, J NEUROSCI RES, V79, P535, DOI 10.1002/jnr.20398; Oliet SHR, 2009, NEUROSCIENCE, V158, P275, DOI 10.1016/j.neuroscience.2008.01.071; OMARA SM, 1995, NEUROPHARMACOLOGY, V34, P983, DOI 10.1016/0028-3908(95)00062-B; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Perea G, 2010, BRAIN RES REV, V63, P93, DOI 10.1016/j.brainresrev.2009.10.005; Placzek AN, 2009, ACTA PHARMACOL SIN, V30, P752, DOI 10.1038/aps.2009.39; Quik M, 2007, TRENDS PHARMACOL SCI, V28, P229, DOI 10.1016/j.tips.2007.03.001; Rangani RJ, 2012, PEPTIDES, V33, P317, DOI 10.1016/j.peptides.2012.01.004; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rezayof A, 2010, LIFE SCI, V86, P260, DOI 10.1016/j.lfs.2009.12.008; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Rosato-Siri M, 2006, J PHYSIOL-LONDON, V576, P361, DOI 10.1113/jphysiol.2006.114587; Rose JE, 2010, P NATL ACAD SCI USA, V107, P5190, DOI 10.1073/pnas.0909184107; Rosenberg D, 2010, FASEB J, V24, P2951, DOI 10.1096/fj.09-147967; SANSONE M, 1991, PHARMACOL BIOCHEM BE, V39, P197, DOI 10.1016/0091-3057(91)90421-W; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shen JX, 2012, J MOL NEUROSCI, V48, P14, DOI 10.1007/s12031-012-9719-3; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; SOCCI DJ, 1995, NEUROBIOL AGING, V16, P857, DOI 10.1016/0197-4580(95)00091-R; Srivareerat M, 2011, NEUROBIOL AGING, V32, P834, DOI 10.1016/j.neurobiolaging.2009.04.015; SWANSON RA, 1994, BRAIN RES, V664, P94, DOI 10.1016/0006-8993(94)91958-5; Szabo SI, 2008, HIPPOCAMPUS, V18, P376, DOI 10.1002/hipo.20401; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Tang JR, 2009, NEURON, V63, P673, DOI 10.1016/j.neuron.2009.07.025; Turpin F, 2012, METHODS MOL BIOL, V794, P299, DOI 10.1007/978-1-61779-331-8_20; Uwechue NM, 2012, J PHYSIOL-LONDON, V590, P2317, DOI 10.1113/jphysiol.2011.226605; Velez-Fort M, 2009, GLIA, V57, P1104, DOI 10.1002/glia.20834; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wang J, 2001, ACTA PHARMACOL SIN, V22, P685; Waniewski RA, 1998, J NEUROSCI, V18, P5225, DOI 10.1523/JNEUROSCI.18-14-05225.1998; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Williams SM, 2006, GLIA, V53, P401, DOI 10.1002/glia.20300; Wolosker H, 2011, BBA-PROTEINS PROTEOM, V1814, P1558, DOI 10.1016/j.bbapap.2011.01.001; Yamazaki Y, 2002, BRAIN RES, V946, P148, DOI 10.1016/S0006-8993(02)02935-9; Yamazaki Y, 2006, EUR J NEUROSCI, V23, P1819, DOI 10.1111/j.1460-9568.2006.04714.x; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang TA, 2010, J NEUROSCI, V30, P6443, DOI 10.1523/JNEUROSCI.0458-10.2010; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	106	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49998	10.1371/journal.pone.0049998	http://dx.doi.org/10.1371/journal.pone.0049998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185511	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000161
J	Orabi, AI; Luo, YH; Ahmad, MU; Shah, AU; Mannan, Z; Wang, D; Sarwar, S; Muili, KA; Shugrue, C; Kolodecik, TR; Singh, VP; Lowe, ME; Thrower, E; Chen, J; Husain, SZ				Orabi, Abrahim I.; Luo, Yuhuan; Ahmad, Mahwish U.; Shah, Ahsan U.; Mannan, Zahir; Wang, Dong; Sarwar, Sheharyar; Muili, Kamaldeen A.; Shugrue, Christine; Kolodecik, Thomas R.; Singh, Vijay P.; Lowe, Mark E.; Thrower, Edwin; Chen, Ju; Husain, Sohail Z.			IP3 Receptor Type 2 Deficiency Is Associated with a Secretory Defect in the Pancreatic Acinar Cell and an Accumulation of Zymogen Granules	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CA2+ RELEASE; REGULATED EXOCYTOSIS; ACTIVATION; SNARE; VAMP8/ENDOBREVIN; SENSITIVITY; INSP(3); VAMP8	Acute pancreatitis is a painful, life-threatening disorder of the pancreas whose etiology is often multi-factorial. It is of great importance to understand the interplay between factors that predispose patients to develop the disease. One such factor is an excessive elevation in pancreatic acinar cell Ca2+. These aberrant Ca2+ elevations are triggered by release of Ca2+ from apical Ca2+ pools that are gated by the inositol 1,4,5-trisphosphate receptor (IP3R) types 2 and 3. In this study, we examined the role of IP3R type 2 (IP3R2) using mice deficient in this Ca2+ release channel (IP3R2(-/-)). Using live acinar cell Ca2+ imaging we found that loss of IP3R2 reduced the amplitude of the apical Ca2+ signal and caused a delay in its initiation. This was associated with a reduction in carbachol-stimulated amylase release and an accumulation of zymogen granules (ZGs). Specifically, there was a 2-fold increase in the number of ZGs (P < 0.05) and an expansion of the ZG pool area within the cell. There was also a 1.6- and 2.6-fold increase in cellular amylase and trypsinogen, respectively. However, the mice did not have evidence of pancreatic injury at baseline, other than an elevated serum amylase level. Further, pancreatitis outcomes using a mild caerulein hyperstimulation model were similar between IP3R2(-/-) and wild type mice. In summary, IP3R2 modulates apical acinar cell Ca2+ signals and pancreatic enzyme secretion. IP3R-deficient acinar cells accumulate ZGs, but the mice do not succumb to pancreatic damage or worse pancreatitis outcomes.	[Orabi, Abrahim I.; Luo, Yuhuan; Ahmad, Mahwish U.; Shah, Ahsan U.; Mannan, Zahir; Wang, Dong; Sarwar, Sheharyar; Muili, Kamaldeen A.; Lowe, Mark E.; Husain, Sohail Z.] Univ Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15260 USA; [Shugrue, Christine; Kolodecik, Thomas R.; Thrower, Edwin] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Singh, Vijay P.] Univ Pittsburgh, Dept Internal Med, Med Ctr, Pittsburgh, PA USA; [Chen, Ju] Univ Calif San Diego, Dept Mol Pathol, San Diego, CA 92103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego	Husain, SZ (corresponding author), Univ Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15260 USA.	sohail.husain@chp.edu	Chen, Ju/E-5579-2011; Wang, Dong/A-6518-2018	Husain, Sohail Z/0000-0003-3012-1308; Singh, Vijay/0000-0001-6611-1908	National Institutes of Health [DK093491, DK083327, HD001401, DK34989]; Children's Digestive Health and Nutrition Young Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083327, P30DK034989, R01DK093491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Digestive Health and Nutrition Young Investigator Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK093491, DK083327, HD001401 (Yale Child Health Research Center), DK34989 (Yale Liver Center), and a Children's Digestive Health and Nutrition Young Investigator Award (to SZH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai HX, 2011, J PEDIATR GASTR NUTR, V53, P423, DOI 10.1097/MPG.0b013e318228574e; Behrendorff N, 2011, J BIOL CHEM, V286, P29627, DOI 10.1074/jbc.M111.265199; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castle AM, 2002, J CELL SCI, V115, P2963; Chaudhuri A, 2005, AM J PHYSIOL-GASTR L, V288, pG235, DOI 10.1152/ajpgi.00334.2004; Chaudhuri A, 2007, AM J PHYSIOL-GASTR L, V292, pG1403, DOI 10.1152/ajpgi.00478.2005; Chung OW, 2004, GASTROENTEROLOGY, V127, P957, DOI 10.1053/j.gastro.2004.05.002; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Cruz LN, 2010, HEPATOLOGY, V52, P327, DOI 10.1002/hep.23625; de Dios I, 1999, J ENDOCRINOL, V163, P199, DOI 10.1677/joe.0.1630199; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gerasimenko JV, 2011, P NATL ACAD SCI USA, V108, P5873, DOI 10.1073/pnas.1016534108; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Hernandez E, 2007, J BIOL CHEM, V282, P10057, DOI 10.1074/jbc.M700746200; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Husain SZ, 2005, P NATL ACAD SCI USA, V102, P14386, DOI 10.1073/pnas.0503215102; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Kern Horst F., 1993, P9; LaRusch J, 2011, CURR OPIN GASTROEN, V27, P467, DOI 10.1097/MOG.0b013e328349e2f8; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Lugea A, 2010, ALCOHOL CLIN EXP RES, V34, P1768, DOI 10.1111/j.1530-0277.2010.01264.x; Lur G., 2011, BIOCH J; MALAISSELAGAE F, 1975, SCIENCE, V190, P795, DOI 10.1126/science.1105788; MROZ EA, 1986, SCIENCE, V232, P871, DOI 10.1126/science.2422756; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Park HS, 2008, J BIOL CHEM; Park HS, 2008, J BIOL CHEM, V283, P26081, DOI 10.1074/jbc.M804184200; Petersen OH, 2005, CELL CALCIUM, V38, P171, DOI 10.1016/j.ceca.2005.06.024; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rahman T, 2012, BIOCHEM SOC T, V40, P325, DOI 10.1042/BST20110772; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V275, P668, DOI 10.1006/bbrc.2000.3355; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wildi S, 2007, GUT, V56, P685, DOI 10.1136/gut.2006.105833; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656, DOI 10.1124/mol.53.4.656	47	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48465	10.1371/journal.pone.0048465	http://dx.doi.org/10.1371/journal.pone.0048465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185258	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000012
J	Sharma, R; Goossens, B; Kun-Rodrigues, C; Teixeira, T; Othman, N; Boone, JQ; Jue, NK; Obergfell, C; O'Neill, RJ; Chikhi, L				Sharma, Reeta; Goossens, Benoit; Kun-Rodrigues, Celia; Teixeira, Tatiana; Othman, Nurzhafarina; Boone, Jason Q.; Jue, Nathaniel K.; Obergfell, Craig; O'Neill, Rachel J.; Chikhi, Lounes			Two Different High Throughput Sequencing Approaches Identify Thousands of De Novo Genomic Markers for the Genetically Depleted Bornean Elephant	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SNP DISCOVERY; MICROSATELLITE MARKERS; COMPUTER-PROGRAM; IDENTIFICATION; LOCI; HYBRIDIZATION; MAP	High throughput sequencing technologies are being applied to an increasing number of model species with a high-quality reference genome. The application and analyses of whole-genome sequence data in non-model species with no prior genomic information are currently under way. Recent sequencing technologies provide new opportunities for gathering genomic data in natural populations, laying the empirical foundation for future research in the field of conservation and population genomics. Here we present the case study of the Bornean elephant, which is the most endangered subspecies of Asian elephant and exhibits very low genetic diversity. We used two different sequencing platforms, the Roche 454 FLX (shotgun) and Illumina, GAIIx (Restriction site associated DNA, RAD) to evaluate the feasibility of the two methodologies for the discovery of de novo markers (single nucleotide polymorphism, SNPs and microsatellites) using low coverage data. Approximately, 6,683 (shotgun) and 14,724 (RAD) SNPs were detected within our elephant sequence dataset. Genotyping of a representative sample of 194 SNPs resulted in a SNP validation rate of similar to 83 to 94% and 17% of the loci were polymorphic with a low diversity (H-o = 0.057). Different numbers of microsatellites were identified through shotgun (27,226) and RAD (868) techniques. Out of all di-, tri-, and tetra-microsatellite loci, 1,706 loci had sufficient flanking regions (shotgun) while only 7 were found with RAD. All microsatellites were monomorphic in the Bornean but polymorphic in another elephant subspecies. Despite using different sample sizes, and the well known differences in the two platforms used regarding sequence length and throughput, the two approaches showed high validation rate. The approaches used here for marker development in a threatened species demonstrate the utility of high throughput sequencing technologies as a starting point for the development of genomic tools in a non-model species and in particular for a species with low genetic diversity.	[Sharma, Reeta; Kun-Rodrigues, Celia; Teixeira, Tatiana; Chikhi, Lounes] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Goossens, Benoit; Othman, Nurzhafarina] Cardiff Univ, Organisms & Environm Div, Sch Biosci, Cardiff, S Glam, Wales; [Goossens, Benoit; Othman, Nurzhafarina] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Boone, Jason Q.] Floragenex Inc, Eugene, OR USA; [Jue, Nathaniel K.; Obergfell, Craig; O'Neill, Rachel J.] Univ Connecticut, Dept Mol & Cell Biol, Ctr Appl Genet & Technol, Storrs, CT USA; [Chikhi, Lounes] Univ Toulouse 3, CNRS, Lab Evolut & Diversite Biol, F-31062 Toulouse, France; [Chikhi, Lounes] Univ Toulouse, Toulouse, France	Instituto Gulbenkian de Ciencia; Cardiff University; University of Connecticut; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse	Sharma, R (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	rsharma@igc.gulbenkian.pt	Goossens, Benoit R/E-8812-2010; Kun-Rodrigues, Celia/AAH-9450-2021	Sharma, Reeta/0000-0001-9862-9218; Chikhi, Lounes/0000-0002-1140-0718; Jue, Nathaniel/0000-0003-3769-5638	Portuguese Science Foundation ("Fundacao para a Ciencia e a Tecnologia" (FCT) [SFRH/BPD/64837/2009]; FCT project [PTDC/BIA-BDE/71299/2006]; "Laboratoire d'Excellence (LABEX)" entitled TULIP [ANR-10-LABX-41]; Darwin Initiative for the Survival of Species [09/016]; Fundação para a Ciência e a Tecnologia [SFRH/BD/136590/2018, PTDC/BIA-BDE/71299/2006] Funding Source: FCT	Portuguese Science Foundation ("Fundacao para a Ciencia e a Tecnologia" (FCT)(Portuguese Foundation for Science and Technology); FCT project(Portuguese Foundation for Science and Technology); "Laboratoire d'Excellence (LABEX)" entitled TULIP; Darwin Initiative for the Survival of Species; Fundação para a Ciência e a Tecnologia	This work was supported by Portuguese Science Foundation ("Fundacao para a Ciencia e a Tecnologia" (FCT)) individual fellowship (ref. SFRH/BPD/64837/2009) to RS and FCT project (ref. PTDC/BIA-BDE/71299/2006) to LC. LC was also supported by the "Laboratoire d'Excellence (LABEX)" entitled TULIP (ANR-10-LABX-41). BG was also supported by a grant from the Darwin Initiative for the Survival of Species (Grant no. 09/016, DEFRA, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Aguilar A, 2008, MOL ECOL RESOUR, V8, P659, DOI 10.1111/j.1471-8286.2007.02038.x; Aitken N, 2004, MOL ECOL, V13, P1423, DOI 10.1111/j.1365-294X.2004.02159.x; Alfred R., 2010, ONLINE J BIOL SCI, V10, P92; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Broders KD, 2011, MOL ECOL RESOUR, V11, P693, DOI 10.1111/j.1755-0998.2011.02998.x; Brumfield RT, 2003, TRENDS ECOLOGY EVOLU, P18; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Chikhi L, 2001, GENETICS, V158, P1347; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Colbourne JK, 2004, MOL ECOL NOTES, V4, P485, DOI 10.1111/j.1471-8286.2004.00721.x; Cranbrook E, 2008, SARAWAK MUSEUM J; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; de Silva G. S., 1968, Sabah Soc J, V3, P169; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Etter PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018561; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fernando P, 2003, PLOS BIOL, V1, P110, DOI 10.1371/journal.pbio.0000006; Gabriel S, 2009, CURRENT PROTOCOLS HU; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garvin MR, 2010, MOL ECOLOGY RESOURCE; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; James MR, 2005, J INVEST DERMATOL, V125, P1252, DOI 10.1111/j.0022-202X.2005.23937.x; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li S, 2009, CONSERV GENET; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Moen T, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-18; Morin PA, 2007, MOL ECOL NOTES, V7, P937, DOI 10.1111/j.1471-8286.2007.01804.x; Morin PA, 2007, MOL ECOL NOTES, V7, P626, DOI 10.1111/j.1471-8286.2006.01654.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; NEI M, 1978, GENETICS, V89, P583; Nicod JC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng019; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; O'Rourke SM, 2011, GENETICS, V189, P767, DOI 10.1534/genetics.111.134031; Ogden R, 2011, MOL ECOL RESOUR, V11, P109, DOI 10.1111/j.1755-0998.2010.02954.x; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Perry JC, 2011, J HERED, V102, P125, DOI 10.1093/jhered/esq099; Renaut S, 2010, MOL ECOL, V19, P115, DOI 10.1111/j.1365-294X.2009.04477.x; Roden SE, 2008, J HEREDITY; Rohland N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000564; Rowe HC, 2011, MOL ECOL, V20, P3499, DOI 10.1111/j.1365-294X.2011.05197.x; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; Salmona J, 2010, CONSERVATION GENETIC; Scaglione D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-3; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Seddon JM, 2005, MOL ECOL, V14, P503, DOI 10.1111/j.1365-294X.2005.02435.x; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Sharma R, 2008, MOL ECOL RESOUR, V8, P1480, DOI 10.1111/j.1755-0998.2008.02292.x; Shim PS, 2003, SABAH SOC J, V20, P7; Slate J, 2009, GENETICA, V136, P97, DOI 10.1007/s10709-008-9317-z; Smith S, 2004, MOL ECOL NOTES, V4, P348, DOI 10.1111/j.1471-8286.2004.00693.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Weber JN, 2010, CONSERV GENET, V11, P1243, DOI 10.1007/s10592-009-9941-x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Williams LM, 2010, BMC GENETICS, P11; Wright S., 1978, EVOLUTION GENETICS P, V4; Xu SH, 2010, MOL ECOL RESOUR, V10, P1085, DOI 10.1111/j.1755-0998.2010.02862.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	75	16	16	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49533	10.1371/journal.pone.0049533	http://dx.doi.org/10.1371/journal.pone.0049533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185354	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000061
J	Wang, Y; Zhang, TY; Xin, J; Li, T; Yu, H; Li, N; Chen, ZY				Wang, Yue; Zhang, Tian-Yi; Xin, Jian; Li, Ting; Yu, Hui; Li, Na; Chen, Zhe-Yu			Differential Involvement of Brain-Derived Neurotrophic Factor in Reconsolidation and Consolidation of Conditioned Taste Aversion Memory	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; RECEPTOR; AMYGDALA; CORTEX	Consolidated memory can re-enter states of transient instability following reactivation, which is referred to as reconsolidation, and the exact molecular mechanisms underlying this process remain unexplored. Brain-derived neurotrophic factor (BDNF) plays a critical role in synaptic plasticity and memory processes. We have recently observed that BDNF signaling in the central nuclei of the amygdala (CeA) and insular cortex (IC) was involved in the consolidation of conditioned taste aversion (CTA) memory. However, whether BDNF in the CeA or IC is required for memory reconsolidation is still unclear. In the present study, using a CTA memory paradigm, we observed increased BDNF expression in the IC but not in the CeA during CTA reconsolidation. We further determined that BDNF synthesis and signaling in the IC but not in the CeA was required for memory reconsolidation. The differential, spatial-specific roles of BDNF in memory consolidation and reconsolidation suggest that dissociative molecular mechanisms underlie reconsolidation and consolidation, which might provide novel targets for manipulating newly encoded and reactivated memories without causing universal amnesia.	[Wang, Yue; Zhang, Tian-Yi; Xin, Jian; Li, Ting; Yu, Hui; Li, Na; Chen, Zhe-Yu] Shandong Univ, Sch Med, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Jinan 250100, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Sch Med, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Jinan 250100, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn			National Natural Science Foundation of China [31130026, 31070991]; National 973 Basic Research Program of China [2012CB911000]; State Program of the National Natural Science Foundation of China for Innovative Research Group [81021001]; Foundation for Excellent Young Scientists of Shandong Province [BS2009SW028, BS2011SW021]; Independent Innovation Foundation of Shandong University (IIFSDU)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); State Program of the National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientists of Shandong Province; Independent Innovation Foundation of Shandong University (IIFSDU)	This study was supported by the National Natural Science Foundation of China (No. 31130026, 31070991), the National 973 Basic Research Program of China (No. 2012CB911000), the State Program of the National Natural Science Foundation of China for Innovative Research Group (No. 81021001), the Foundation for Excellent Young Scientists of Shandong Province (No. BS2009SW028, BS2011SW021) and the Independent Innovation Foundation of Shandong University (IIFSDU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Carim-Todd L, 2009, J NEUROSCI, V29, P678, DOI 10.1523/JNEUROSCI.5060-08.2009; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Gal-Ben-Ari S, 2012, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00087; GARCIA E Y, 1955, J Philipp Med Assoc, V31, P717; Garcia-DeLaTorre P, 2009, LEARN MEMORY, V16, P514, DOI 10.1101/lm.1356509; Kobilo T, 2007, EUR J NEUROSCI, V25, P3417, DOI 10.1111/j.1460-9568.2007.05561.x; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Ma L, 2011, J NEUROSCI, V31, P2079, DOI 10.1523/JNEUROSCI.5348-10.2011; Maroun M, 2009, LEARN MEMORY, V16, P243, DOI 10.1101/lm.1245009; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Musumeci G, 2011, REV NEUROSCIENCE, V22, P303, DOI 10.1515/RNS.2011.031; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ohno M, 2009, NEUROBIOL LEARN MEM, V92, P455, DOI 10.1016/j.nlm.2009.05.001; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schiller D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00024; Spencer JL, 2010, P NATL ACAD SCI USA, V107, P4395, DOI 10.1073/pnas.0915105107; Stehberg J, 2011, NEUROBIOL LEARN MEM, V95, P14, DOI 10.1016/j.nlm.2010.10.002; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; von Hertzen LSJ, 2005, J NEUROSCI, V25, P1935, DOI 10.1523/JNEUROSCI.4707-04.2005; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Yu H, 2009, J NEUROSCI, V29, P4056, DOI 10.1523/JNEUROSCI.5539-08.2009	33	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49942	10.1371/journal.pone.0049942	http://dx.doi.org/10.1371/journal.pone.0049942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185492	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000147
J	Fonseca, MB; Peix, A; de Faria, SM; Mateos, PF; Rivera, LP; Simoes-Araujo, JL; Franca, MGC; Isaias, RMD; Cruz, C; Velazquez, E; Scotti, MR; Sprent, JI; James, EK				Fonseca, Marcia Bacelar; Peix, Alvaro; de Faria, Sergio Miana; Mateos, Pedro F.; Rivera, Lina P.; Simoes-Araujo, Jean L.; Costa Franca, Marcel Giovanni; dos Santos Isaias, Rosy Mary; Cruz, Cristina; Velazquez, Encarna; Scotti, Maria Rita; Sprent, Janet I.; James, Euan K.			Nodulation in Dimorphandra wilsonii Rizz. (Caesalpinioideae), a Threatened Species Native to the Brazilian Cerrado	PLOS ONE			English	Article							ROOT-NODULE SYMBIOSIS; BRADYRHIZOBIUM STRAINS; MAXIMUM-LIKELIHOOD; LEGUME EVOLUTION; MIMOSA SPP.; HOST-RANGE; SP NOV.; DIVERSITY; INFECTION; BACTERIA	The threatened caesalpinioid legume Dimorphandra wilsonii, which is native to the Cerrado biome in Brazil, was examined for its nodulation and N-2-fixing ability, and was compared with another, less-threatened species, D. jorgei. Nodulation and potential N-2 fixation was shown on seedlings that had been inoculated singly with five bradyrhizobial isolates from mature D. wilsonii nodules. The infection of D. wilsonii by two of these strains (Dw10.1, Dw12.5) was followed in detail using light and transmission electron microscopy, and was compared with that of D. jorgei by Bradyrhizobium strain SEMIA6099. The roots of D. wilsonii were infected via small transient root hairs at 42 d after inoculation (dai), and nodules were sufficiently mature at 63 dai to express nitrogenase protein. Similar infection and nodule developmental processes were observed in D. jorgei. The bacteroids in mature Dimorphandra nodules were enclosed in plant cell wall material containing a homogalacturonan (pectic) epitope that was recognized by the monoclonal antibody JIM5. Analysis of sequences of their rrs (16S rRNA) genes and their ITS regions showed that the five D. wilsonii strains, although related to SEMIA6099, may constitute five undescribed species of genus Bradyrhizobium, whilst their nodD and nifH gene sequences showed that they formed clearly separated branches from other rhizobial strains. This is the first study to describe in full the N2-fixing symbiotic interaction between defined rhizobial strains and legumes in the sub-family Caesalpinioideae. This information will hopefully assist in the conservation of the threatened species D. wilsonii.	[Sprent, Janet I.; James, Euan K.] Univ Dundee, James Hutton Inst, Div Plant Sci, Dundee, Scotland; [Fonseca, Marcia Bacelar; Costa Franca, Marcel Giovanni; dos Santos Isaias, Rosy Mary; Scotti, Maria Rita] Univ Fed Minas Gerais, Dept Bot, Belo Horizonte, MG, Brazil; [Peix, Alvaro] Univ Salamanca, CSIC Interacc Planta Microorganismo, Unidad Asociada, Inst Recursos Nat & Agrobiol,IRNASA,CSIC, E-37008 Salamanca, Spain; [de Faria, Sergio Miana; Simoes-Araujo, Jean L.] Embrapa Agrobiol, Rio De Janeiro, Brazil; [Mateos, Pedro F.; Rivera, Lina P.; Velazquez, Encarna] Univ Salamanca, CSIC Interacc Planta Microorganismo, Unidad Asociada, Dept Microbiol & Genet,CIALE, E-37008 Salamanca, Spain; [Cruz, Cristina] Univ Lisbon, Fac Ciencias, CBA, P-1699 Lisbon, Portugal	James Hutton Institute; University of Dundee; Universidade Federal de Minas Gerais; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); University of Salamanca; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Universidade de Lisboa	James, EK (corresponding author), Univ Dundee, James Hutton Inst, Div Plant Sci, Dundee, Scotland.	euan.james@hutton.ac.uk	James, Euan K/K-1135-2012; Peix, Alvaro/A-7196-2010; Cruz, Cristina/F-2643-2011; Velázquez, Encarna/B-3669-2017; Isaias, Rosy MS/C-3736-2013; de Faria, Sergio Miana/C-1405-2013; Cruz, Cristina/H-7026-2019; Mateos, Pedro/L-6001-2014; Scotti, Maria Rita/I-3034-2015	James, Euan K/0000-0001-7969-6570; Peix, Alvaro/0000-0001-5084-1586; Velázquez, Encarna/0000-0002-5946-7241; Isaias, Rosy MS/0000-0001-8500-3320; Cruz, Cristina/0000-0003-3100-463X; Mateos, Pedro/0000-0003-1628-598X; de Faria, Sergio/0000-0001-5066-046X	CAPES [2127/09-1]; CSIC [AGL2008-03360]; JAE-predoc scholarship	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CSIC; JAE-predoc scholarship	This work was partly funded by CAPES grant 2127/09-1 (www.capes.gov.br) and by CSIC grant AGL2008-03360 (www.csic.es), which provided a JAE-predoc scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Binde DR, 2009, APPL MICROBIOL BIOT, V83, P897, DOI 10.1007/s00253-009-1927-6; Bonaldi K, 2011, MOL PLANT MICROBE IN, V24, P1359, DOI 10.1094/MPMI-04-11-0093; Bontemps C, 2010, MOL ECOL, V19, P44, DOI 10.1111/j.1365-294X.2009.04458.x; Chahboune R, 2012, SYST APPL MICROBIOL, V35, P302, DOI 10.1016/j.syapm.2012.06.001; Chang YL, 2011, INT J SYST EVOL MICR, V61, P2496, DOI 10.1099/ijs.0.027110-0; Chen WM, 2005, APPL ENVIRON MICROB, V71, P7461, DOI 10.1128/AEM.71.11.7461-7471.2005; Chen WM, 2003, MOL PLANT MICROBE IN, V16, P1051, DOI 10.1094/MPMI.2003.16.12.1051; de Faria SM, 2010, J EXP BOT, V61, P3119, DOI 10.1093/jxb/erq142; de Lima HC, 2010, JARDIM BOT RIO DE JA; DEFARIA SM, 1987, CAN J BOT, V65, P553, DOI 10.1139/b87-071; Diabate M, 2005, NEW PHYTOL, V166, P231, DOI 10.1111/j.1469-8137.2005.01318.x; dos Reis FB, 2010, NEW PHYTOL, V186, P934, DOI 10.1111/j.1469-8137.2010.03267.x; Doyle JJ, 2011, MOL PLANT MICROBE IN, V24, P1289, DOI 10.1094/MPMI-05-11-0114; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fernandes FM, 2007, RECUPERANDO VERDE CI, P87; Fonseca MB, 2010, ACTA BOT BRAS, V24, P322, DOI 10.1590/S0102-33062010000200003; Franco AA, 1997, SOIL BIOL BIOCHEM, V29, P897, DOI 10.1016/S0038-0717(96)00229-5; Germano MG, 2006, INT J SYST EVOL MICR, V56, P217, DOI 10.1099/ijs.0.02917-0; Gonzalez-Sama A, 2004, NEW PHYTOL, V163, P371, DOI 10.1111/j.1469-8137.2004.01121.x; Graham P. H., 2008, V7, P23; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Gyaneshwar P, 2011, MOL PLANT MICROBE IN, V24, P1276, DOI 10.1094/MPMI-06-11-0172; Han SZ, 2005, SYST APPL MICROBIOL, V28, P265, DOI 10.1016/j.syapm.2004.12.005; Ramirez-Bahena MH, 2009, INT J SYST EVOL MICR, V59, P1929, DOI 10.1099/ijs.0.006320-0; Islam MS, 2008, BIOSCI BIOTECH BIOCH, V72, P1416, DOI 10.1271/bbb.70739; IUCN, 2006, IUCN RED LIST THREAT; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lafay B, 2006, INT J SYST EVOL MICR, V56, P1013, DOI 10.1099/ijs.0.63897-0; Lafay B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000277; Martinez-Romero E, 2009, DNA CELL BIOL, V28, P361, DOI 10.1089/dna.2009.0863; Maunoury N., 2008, V7, P153; Menna P, 2009, INT J SYST EVOL MICR, V59, P2934, DOI 10.1099/ijs.0.009779-0; MOREIRA FMS, 1993, SYST APPL MICROBIOL, V16, P135, DOI 10.1016/S0723-2020(11)80258-4; Moreira FMS, 1998, MOL ECOL, V7, P889, DOI 10.1046/j.1365-294x.1998.00411.x; Moulin L, 2004, MOL PHYLOGENET EVOL, V30, P720, DOI 10.1016/S1055-7903(03)00255-0; NAISBITT T, 1992, NEW PHYTOL, V122, P487, DOI 10.1111/j.1469-8137.1992.tb00077.x; NEWCOMB W, 1979, CAN J BOT, V57, P2603, DOI 10.1139/b79-309; OBrien TP, 1981, STUDY PLANT STRUCTUR; Op den Camp RHM, 2012, MOL PLANT MICROBE IN, V25, P954, DOI 10.1094/MPMI-11-11-0304; Ormeno-Orrillo E, 2012, MICROB ECOL, V63, P822, DOI 10.1007/s00248-011-9974-9; Parker MA, 2000, SYST APPL MICROBIOL, V23, P585, DOI 10.1016/S0723-2020(00)80034-X; Parker MA, 2006, CAN J MICROBIOL, V52, P1148, DOI 10.1139/W06-076; Perrineau MM, 2012, SYMBIOSIS, V56, P87, DOI 10.1007/s13199-012-0163-5; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Rivas R, 2007, LETT APPL MICROBIOL, V44, P181, DOI 10.1111/j.1472-765X.2006.02050.x; Rivas R, 2002, APPL ENVIRON MICROB, V68, P5217, DOI 10.1128/AEM.68.11.5217-5222.2002; RIZZINI CT, 1969, AN ACAD BRAS CIENC, V41, P239; Rizzini CT, 1986, B SOC BRASILEIRA CON, V21, P99; Schrire B, 2005, LEGUMES WORLD; SCOTT KF, 1986, NUCLEIC ACIDS RES, V14, P2905, DOI 10.1093/nar/14.7.2905; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; SMITH CA, 1986, CAN J BOT, V64, P1474, DOI 10.1139/b86-200; Somasegaran P, 1994, METHODS LEGUME RHIZO; Sprent J.I., 2009, LEGUME NODULATION GL; Sprent J.I., 2001, NODULATION LEGUMES; Sprent JI, 2007, PLANT PHYSIOL, V144, P575, DOI 10.1104/pp.107.096156; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Steenkamp ET, 2008, MOL PHYLOGENET EVOL, V48, P1131, DOI 10.1016/j.ympev.2008.04.032; Stepkowski T, 2007, APPL ENVIRON MICROB, V73, P3254, DOI 10.1128/AEM.02125-06; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRINICK MJ, 1979, CAN J MICROBIOL, V25, P565, DOI 10.1139/m79-082; VANDENBOSCH KA, 1989, EMBO J, V8, P335, DOI 10.1002/j.1460-2075.1989.tb03382.x; Vega-Hernandez MC, 2001, NEW PHYTOL, V150, P707, DOI 10.1046/j.1469-8137.2001.00120.x; Velazquez E, 2010, MICROBES FOR LEGUME IMPROVEMENT, P1, DOI 10.1007/978-3-211-99753-6_1; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Willems A, 2003, SYST APPL MICROBIOL, V26, P203, DOI 10.1078/072320203322346056; Zhang Y, 2011, INT J SYST EVOL MICR, V62, P1951	71	25	26	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49520	10.1371/journal.pone.0049520	http://dx.doi.org/10.1371/journal.pone.0049520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185349	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800027
J	Robison, G; Zakharova, T; Fu, S; Jiang, W; Fulper, R; Barrea, R; Marcus, MA; Zheng, W; Pushkar, Y				Robison, Gregory; Zakharova, Taisiya; Fu, Sherleen; Jiang, Wendy; Fulper, Rachael; Barrea, Raul; Marcus, Matthew A.; Zheng, Wei; Pushkar, Yulia			X-Ray Fluorescence Imaging: A New Tool for Studying Manganese Neurotoxicity	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; PARKINSONS-DISEASE; MOUSE-BRAIN; MOLECULAR-MECHANISM; INDUCED APOPTOSIS; BASAL GANGLIA; RISK-FACTORS; PC12 CELLS; EXPOSURE; RATS	The neurotoxic effect of manganese (Mn) establishes itself in a condition known as manganism or Mn induced parkinsonism. While this condition was first diagnosed about 170 years ago, the mechanism of the neurotoxic action of Mn remains unknown. Moreover, the possibility that Mn exposure combined with other genetic and environmental factors can contribute to the development of Parkinson's disease has been discussed in the literature and several epidemiological studies have demonstrated a correlation between Mn exposure and an elevated risk of Parkinson's disease. Here, we introduce X-ray fluorescence imaging as a new quantitative tool for analysis of the Mn distribution in the brain with high spatial resolution. The animal model employed mimics deficits observed in affected human subjects. The obtained maps of Mn distribution in the brain demonstrate the highest Mn content in the globus pallidus, the thalamus, and the substantia nigra pars compacta. To test the hypothesis that Mn transport into/distribution within brain cells mimics that of other biologically relevant metal ions, such as iron, copper, or zinc, their distributions were compared. It was demonstrated that the Mn distribution does not follow the distributions of any of these metals in the brain. The majority of Mn in the brain was shown to occur in the mobile state, confirming the relevance of the chelation therapy currently used to treat Mn intoxication. In cells with accumulated Mn, it can cause neurotoxic action by affecting the mitochondrial respiratory chain. This can result in increased susceptibility of the neurons of the globus pallidus, thalamus, and substantia nigra pars compacta to various environmental or genetic insults. The obtained data is the first demonstration of Mn accumulation in the substantia nigra pars compacta, and thus, can represent a link between Mn exposure and its potential effects for development of Parkinson's disease.	[Robison, Gregory; Zakharova, Taisiya; Fulper, Rachael; Pushkar, Yulia] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Fu, Sherleen; Jiang, Wendy; Zheng, Wei] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Barrea, Raul] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Marcus, Matthew A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Pushkar, Y (corresponding author), Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA.	ypushkar@purdue.edu	marcus, matthew/P-8023-2019; Robison, Gregory/D-7940-2013	Robison, Gregory/0000-0002-6513-4291	Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; U.S. DOE [DE-AC02-06CH11357]; National Institutes of Health (NIH) [RR-08630]; NIH/National Institute of Environmental Health Sciences [R01 ES008146-14]; Purdue start up funds; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Purdue start up funds; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The operations of the Advanced Light Source at Lawrence Berkeley National Laboratory are supported by the Director, Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (DOE) under contract number DE-AC02-05CH11231. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. DOE Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. The Biophysics Collaborative Access Team is a National Institutes of Health (NIH) supported Research Center RR-08630. This study was supported by NIH/National Institute of Environmental Health Sciences Grants Numbers R01 ES008146-14, and by Purdue start up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki I, 2004, NEUROIMAGE, V22, P1046, DOI 10.1016/j.neuroimage.2004.03.031; ASCHNER M, 1994, BRAIN RES BULL, V33, P345, DOI 10.1016/0361-9230(94)90204-6; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; Barrea RA, 2005, PHYS SCRIPTA, VT115, P867; Becker JS, 2010, TRAC-TREND ANAL CHEM, V29, P966, DOI 10.1016/j.trac.2010.06.009; Benedetto A, 2009, CHEM REV, V109, P4862, DOI 10.1021/cr800536y; Bohic S, 2008, ANAL CHEM, V80, P9557, DOI 10.1021/ac801817k; Boxer SG, 2009, ANNU REV BIOPHYS, V38, P53, DOI 10.1146/annurev.biophys.050708.133634; CAMPBELL JL, 1981, NUCL INSTRUM METHODS, V181, P285, DOI 10.1016/0029-554X(81)90622-4; Carmona A, 2010, ACS CHEM NEUROSCI, V1, P194, DOI 10.1021/cn900021z; Cersosimo MG, 2006, NEUROTOXICOLOGY, V27, P340, DOI 10.1016/j.neuro.2005.10.006; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; Cowan DM, 2009, NEUROTOXICOLOGY, V30, P1214, DOI 10.1016/j.neuro.2009.02.005; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Crossgrove JS, 2005, NEUROTOXICOLOGY, V26, P297, DOI 10.1016/j.neuro.2004.09.004; Crossgrove JS, 2003, NEUROTOXICOLOGY, V24, P3, DOI 10.1016/S0161-813X(02)00089-X; Discalzi G, 2000, NEUROTOXICOLOGY, V21, P863; DONALDSON J, 1981, NEUROTOXICOLOGY, V2, P53; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Dydak U, 2011, ENVIRON HEALTH PERSP, V119, P219, DOI 10.1289/ehp.1002192; Finkelstein MM, 2007, ENVIRON RES, V104, P420, DOI 10.1016/j.envres.2007.03.002; Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788; Gavin CE, 1999, NEUROTOXICOLOGY, V20, P445; Gorell JM, 2004, J NEUROL SCI, V217, P169, DOI 10.1016/j.jns.2003.09.014; Gorell JM, 1997, NEUROLOGY, V48, P650, DOI 10.1212/WNL.48.3.650; Gu HY, 2012, TOXICOL LETT, V213, P211, DOI 10.1016/j.toxlet.2012.07.002; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Hare D, 2009, METALLOMICS, V1, P53, DOI 10.1039/b816188g; Hare DJ, 2010, METALLOMICS, V2, P745, DOI 10.1039/c0mt00039f; HAUSER RA, 1994, ANN NEUROL, V36, P871, DOI 10.1002/ana.410360611; Hernandez EH, 2006, NEUROTOXICOLOGY, V27, P333, DOI 10.1016/j.neuro.2005.09.003; Hirata Y, 2002, NEUROTOXICOL TERATOL, V24, P639, DOI 10.1016/S0892-0362(02)00215-5; Jenkins R., 1995, QUANTITATIVE XRAY SP; Joly A, 2011, WATER AIR SOIL POLL, V219, P263, DOI 10.1007/s11270-010-0704-6; Kalia K, 2008, NEUROTOXICOLOGY, V29, P466, DOI 10.1016/j.neuro.2008.02.012; Levin OS, 2005, Z NEVROL PSIKHIATRII, V105, P12; Li GJ, 2006, NEUROTOXICOLOGY, V27, P737, DOI 10.1016/j.neuro.2006.02.003; LLOYD RV, 1995, CHEM RES TOXICOL, V8, P111, DOI 10.1021/tx00043a015; Lucchini RG, 2007, AM J IND MED, V50, P788, DOI 10.1002/ajim.20494; Marcus MA, 2004, J SYNCHROTRON RADIAT, V11, P239, DOI 10.1107/S0909049504005837; Marsh GM, 2006, J OCCUP ENVIRON MED, V48, P1031, DOI 10.1097/01.jom.0000232547.74802.d8; Matusch A, 2010, J AM SOC MASS SPECTR, V21, P161, DOI 10.1016/j.jasms.2009.09.022; McRae R, 2009, CHEM REV, V109, P4780, DOI 10.1021/cr900223a; Migheli R, 1999, J NEUROCHEM, V73, P1155, DOI 10.1046/j.1471-4159.1999.0731155.x; Morello M, 2008, NEUROTOXICOLOGY, V29, P60, DOI 10.1016/j.neuro.2007.09.001; National Research Council Food and Nutrition Board, 1989, REC DIET ALL; PARENTI M, 1988, BRAIN RES, V473, P236, DOI 10.1016/0006-8993(88)90852-9; Park JD, 2007, INHAL TOXICOL, V19, P965, DOI 10.1080/08958370701516108; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Popescu BFG, 2009, PHYS MED BIOL, V54, P651, DOI 10.1088/0031-9155/54/3/012; Prabhakaran K, 2008, BRAIN RES BULL, V76, P361, DOI 10.1016/j.brainresbull.2008.03.004; RABIN O, 1993, J NEUROCHEM, V61, P509; Racette BA, 2005, NEUROLOGY, V64, P230, DOI 10.1212/01.WNL.0000149511.19487.44; Roth JA, 2009, NEUROMOL MED, V11, P281, DOI 10.1007/s12017-009-8088-8; Santamaria AB, 2007, J TOXICOL ENV HEAL B, V10, P417, DOI 10.1080/15287390600975004; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Stepens A, 2008, NEW ENGL J MED, V358, P1009, DOI 10.1056/NEJMoa072488; TAKEDA A, 1994, BRAIN RES, V640, P341, DOI 10.1016/0006-8993(94)91891-0; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Wadghiri YZ, 2004, NMR BIOMED, V17, P613, DOI 10.1002/nbm.932; Watanabe T, 2002, MAGN RESON MED, V48, P852, DOI 10.1002/mrm.10276; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6; Witholt R, 2000, NEUROTOXICOL TERATOL, V22, P851, DOI 10.1016/S0892-0362(00)00108-2; Yokel RA, 2009, NEUROMOL MED, V11, P297, DOI 10.1007/s12017-009-8101-2; Zhang SR, 2003, ENVIRON RES, V93, P149, DOI 10.1016/S0013-9351(03)00109-9; Zheng W, 1998, BRAIN RES, V799, P334, DOI 10.1016/S0006-8993(98)00481-8; Zheng W, 1999, BRAIN RES, V833, P125, DOI 10.1016/S0006-8993(99)01558-9; Zheng W, 2001, BRAIN RES, V897, P175, DOI 10.1016/S0006-8993(01)02049-2; Zheng W, 2009, NEUROTOXICOLOGY, V30, P240, DOI 10.1016/j.neuro.2008.12.007	70	34	38	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48899	10.1371/journal.pone.0048899	http://dx.doi.org/10.1371/journal.pone.0048899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185282	gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800013
J	Sobrova, P; Vyslouzilova, L; Stepankova, O; Ryvolova, M; Anyz, J; Trnkova, L; Adam, V; Hubalek, J; Kizek, R				Sobrova, Pavlina; Vyslouzilova, Lenka; Stepankova, Olga; Ryvolova, Marketa; Anyz, Jiri; Trnkova, Libuse; Adam, Vojtech; Hubalek, Jaromir; Kizek, Rene			Tissue Specific Electrochemical Fingerprinting	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; BRDICKA REACTION; METALLOTHIONEIN; CANCER; VOLTAMMETRY; PHYSIOLOGY; DISEASE; SYSTEM	Background: Proteomics and metalloproteomics are rapidly developing interdisciplinary fields providing enormous amounts of data to be classified, evaluated and interpreted. Approaches offered by bioinformatics and also by biostatistical data analysis and treatment are therefore of extreme interest. Numerous methods are now available as commercial or open source tools for data processing and modelling ready to support the analysis of various datasets. The analysis of scientific data remains a big challenge, because each new task sets its specific requirements and constraints that call for the design of a targeted data pre-processing approach. Methodology/Principal Findings: This study proposes a mathematical approach for evaluating and classifying datasets obtained by electrochemical analysis of metallothionein in rat 9 tissues (brain, heart, kidney, eye, spleen, gonad, blood, liver and femoral muscle). Tissue extracts were heated and then analysed using the differential pulse voltammetry Brdicka reaction. The voltammograms were subsequently processed. Classification models were designed making separate use of two groups of attributes, namely attributes describing local extremes, and derived attributes resulting from the level=5 wavelet transform. Conclusions/Significance: On the basis of our results, we were able to construct a decision tree that makes it possible to distinguish among electrochemical analysis data resulting from measurements of all the considered tissues. In other words, we found a way to classify an unknown rat tissue based on electrochemical analysis of the metallothionein in this tissue.	[Sobrova, Pavlina; Ryvolova, Marketa; Adam, Vojtech; Kizek, Rene] Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, Brno, Czech Republic; [Vyslouzilova, Lenka; Stepankova, Olga; Anyz, Jiri] Czech Tech Univ, Dept Cybernet, Fac Elect Engn, CR-16635 Prague, Czech Republic; [Trnkova, Libuse] Masaryk Univ, Fac Sci, Dept Chem, CS-61137 Brno, Czech Republic; [Ryvolova, Marketa; Trnkova, Libuse; Adam, Vojtech; Hubalek, Jaromir; Kizek, Rene] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic; [Hubalek, Jaromir] Brno Univ Technol, Fac Elect Engn & Commun, Dept Microelect, Brno, Czech Republic	Mendel University in Brno; Czech Technical University Prague; Masaryk University Brno; Brno University of Technology; Brno University of Technology	Kizek, R (corresponding author), Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, Brno, Czech Republic.	kizek@sci.muni.cz	Anýž, Jiří/AAC-5569-2019; Hubalek, Jaromir/D-7753-2012; Stepankova, Olga/ABD-7408-2021; Vysloužilová, Lenka/S-6809-2016; Adam, Vojtech/D-7686-2012; Stepankova, Olga/H-6522-2014; Vaculovicova, Marketa/E-5583-2016; Anyz, Jiri/C-7954-2019	Hubalek, Jaromir/0000-0002-7496-2558; Stepankova, Olga/0000-0002-4384-1868; Vysloužilová, Lenka/0000-0002-5722-6671; Adam, Vojtech/0000-0002-8527-286X; Stepankova, Olga/0000-0002-4384-1868; Kizek, Rene/0000-0002-0467-6169; Vaculovicova, Marketa/0000-0002-6771-1304; Anyz, Jiri/0000-0002-8977-1172	Grant Agency of the Czech Republic [GACR P102/11/1068]; Central European Institute of Technology [CEITEC CZ.1.05/1.1.00/02.0068]; Ministry of Education, Youth and Sports [MSM 6840770038]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Central European Institute of Technology; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	The financial support from the following projects from Grant Agency of the Czech Republic (GACR P102/11/1068), Central European Institute of Technology (CEITEC CZ.1.05/1.1.00/02.0068) and Ministry of Education, Youth and Sports (MSM 6840770038) is greatly acknowledged. The authors wish to express their thanks to Anna Vasatkova for excellent work with rat breeding. The author PS is "Holder of Brno PhD Talent Financial Aid". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011441; Adam V, 2010, TRAC-TREND ANAL CHEM, V29, P409, DOI 10.1016/j.trac.2010.02.004; [Anonymous], 2001, WAVELETS MADE EASY; ANZENBACHER P, 1972, COLLECT CZECH CHEM C, V37, P3209, DOI 10.1135/cccc19723209; Barbas C, 2011, J PHARMACEUT BIOMED, V55, P823, DOI 10.1016/j.jpba.2011.02.001; Bebianno MJ, 1997, MAR POLLUT BULL, V34, P666, DOI 10.1016/S0025-326X(97)00036-2; BERTINI I, 1989, J AM CHEM SOC, V111, P7296, DOI 10.1021/ja00201a002; Brdicka R, 1937, NATURE, V139, P330; Brdicka R., 1937, NATURE, V139, P1020, DOI [10.1038/1391020a0, DOI 10.1038/1391020A0]; Brdicka R., 1933, IBID, V5, P148, DOI 10.1135/cccc19330148; Chui Charles K., 1992, INTRO WAVELETS; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; EBADI M, 1994, GEN PHARMACOL-VASC S, V25, P1297, DOI 10.1016/0306-3623(94)90152-X; Eckschlager T, 2009, CURR PROTEIN PEPT SC, V10, P360, DOI 10.2174/138920309788922243; Fabrik I, 2008, ELECTROANAL, V20, P1521, DOI 10.1002/elan.200704215; Fayyad U.M., 2002, INFORM VISUALIZATION; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Heyrovsky J, 1938, NATURE, V142, P317, DOI 10.1038/142317a0; Heyrovsky M, 2000, ELECTROANAL, V12, P935, DOI 10.1002/1521-4109(200008)12:12<935::AID-ELAN935>3.0.CO;2-F; Hoffman P., 1999, WORKSHOP NEW PARADIG, P9, DOI [10.1145/331770.331775, DOI 10.1145/331770.331775]; Jasani B, 1997, HISTOPATHOLOGY, V31, P211, DOI 10.1046/j.1365-2559.1997.2140848.x; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Klema J, 2008, IEEE T SYST MAN CY C, V38, P3, DOI 10.1109/TSMCC.2007.906055; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mairanovskii S G., 1968, CATALYTIC KINETIC WA; MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064; MASTERS BA, 1994, J NEUROSCI, V14, P5844; Mierswa I, 2009, 12 ACM SIGKDD INT C, P1; Moffatt P, 1998, DNA CELL BIOL, V17, P501, DOI 10.1089/dna.1998.17.501; Novakova L, 2006, CYBERNET SYST, V2, P785; OLAFSON RW, 1991, METHOD ENZYMOL, V205, P205; OLAFSON RW, 1988, BIOELECTROCH BIOENER, V19, P111, DOI 10.1016/0302-4598(88)85010-4; OLAFSON RW, 1979, ANAL BIOCHEM, V100, P343, DOI 10.1016/0003-2697(79)90239-2; Petrlova J, 2006, ELECTROCHIM ACTA, V51, P5112, DOI 10.1016/j.electacta.2006.03.078; Raspor B, 2001, TALANTA, V55, P109, DOI 10.1016/S0039-9140(01)00399-X; Raspor B, 2001, J ELECTROANAL CHEM, V503, P159, DOI 10.1016/S0022-0728(01)00383-7; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Simpkins CO, 2000, CELL MOL BIOL, V46, P465; Thirumoorthy N, 2007, WORLD J GASTROENTERO, V13, P993, DOI 10.3748/wjg.v13.i7.993; Vasatkova A, 2009, NEUROENDOCRINOL LETT, V30, P163; Ward M.O., 2010, INTERACTIVE DATA VIS; Witten IH, 2011, MOR KAUF D, P1	44	10	10	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49654	10.1371/journal.pone.0049654	http://dx.doi.org/10.1371/journal.pone.0049654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185396	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800046
J	Wei, JC; Yuan, YZ; Jin, CZ; Chen, H; Leng, L; He, FC; Wang, J				Wei, Juncheng; Yuan, Yanzhi; Jin, Chaozhi; Chen, Hui; Leng, Ling; He, Fuchu; Wang, Jian			The Ubiquitin Ligase TRAF6 Negatively Regulates the JAK-STAT Signaling Pathway by Binding to STAT3 and Mediating Its Ubiquitination	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; PROTEIN; INTERLEUKIN-6; DOMAIN; TRANSDUCTION; SPECIFICITY; INHIBITOR; FAMILY; CANCER; PIAS3	STAT3 is a key transcription factor that mediates various cellular and organismal processes, such as cell growth, apoptosis, immune response and cancer. However, the molecular mechanisms of STAT3 regulation remain poorly understood. Here, we identified TRAF6 as a new STAT3 interactor. TRAF6 augmented the ubiquitination of STAT3 and deactivated its transcriptional activity induced by IFN alpha stimulation or overexpressed with JAK2. Both the RING domain and the TRAF-type zinc finger domain of TRAF6 were indispensable for STAT3 deactivation. Accordingly, TRAF6 also down-regulated the expression of two known STAT3 target genes, CRP and ACT. Therefore, we showed that TRAF6 is a new regulator of JAK/STAT signaling and provide a new mechanistic explanation for the crosstalk between the NF-kappa B and the JAK-STAT pathways.	[Wei, Juncheng; Yuan, Yanzhi; Jin, Chaozhi; Chen, Hui; Leng, Ling; He, Fuchu; Wang, Jian] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Wei, Juncheng; He, Fuchu] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Wei, Juncheng; He, Fuchu] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Fudan University	He, FC (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	hefc@nic.bmi.ac.cn; wangjian@nic.bmi.ac.cn	Wei, Juncheng/Q-1092-2019; leng, ling/GQH-2273-2022		National High-tech R&D Program of China [2012AA020201]; Special Funds for Major State Basic Research of China [2011CB910600, 2012CB910200]; National International Cooperation Project [2011DFB30370]; Beijing Municipal Natural Science Foundation [5122014]; Beijing NOVA program [2011014]	National High-tech R&D Program of China; Special Funds for Major State Basic Research of China; National International Cooperation Project; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing NOVA program(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the National High-tech R&D Program of China (2012AA020201), the Special Funds for Major State Basic Research of China (2011CB910600, 2012CB910200), the National International Cooperation Project (2011DFB30370), Beijing Municipal Natural Science Foundation (5122014) and Beijing NOVA program (2011014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedel R, 2011, CANCER RES, V71, P1615, DOI 10.1158/0008-5472.CAN-09-4540; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Hawthorne VS, 2009, MOL CANCER RES, V7, P592, DOI 10.1158/1541-7786.MCR-08-0316; He JQ, 2007, J BIOL CHEM, V282, P3688, DOI 10.1074/jbc.M610271200; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lee TL, 2008, BIOCHEM BIOPH RES CO, V375, P326, DOI 10.1016/j.bbrc.2008.07.164; Leong H, 2009, BREAST CANCER RES TR, V117, P505, DOI 10.1007/s10549-008-0196-x; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Megas C, 2011, CELL SIGNAL, V23, P772, DOI 10.1016/j.cellsig.2010.12.004; Mercier P, 2007, PROTEIN SCI, V16, P602, DOI 10.1110/ps.062358007; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Rajendran P, 2011, CLIN CANCER RES, V17, P1425, DOI 10.1158/1078-0432.CCR-10-1123; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Sen B, 2009, CANCER RES, V69, P1958, DOI 10.1158/0008-5472.CAN-08-2944; Stark GR, 2011, CELL RES, V21, P375, DOI 10.1038/cr.2010.174; Takeda K, 1998, J IMMUNOL, V161, P4652; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Wu ZH, 2009, BIOCHEM BIOPH RES CO, V387, P348, DOI 10.1016/j.bbrc.2009.07.023; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Yu Yang, 2010, Zhongguo Fei Ai Za Zhi, V13, P160, DOI 10.3779/j.issn.1009-3419.2010.02.16; Zhang DX, 1996, J BIOL CHEM, V271, P9503, DOI 10.1074/jbc.271.16.9503; Zhang WQ, 2010, MOL BIOL CELL, V21, P2500, DOI 10.1091/mbc.E09-08-0715; Zhang WN, 2012, J BIOL CHEM, V287, P382, DOI 10.1074/jbc.M111.276832; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	42	41	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49567	10.1371/journal.pone.0049567	http://dx.doi.org/10.1371/journal.pone.0049567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185365	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800035
J	Chekroud, K; Guillou, L; Gregoire, S; Ducharme, G; Brun, E; Cazevieille, C; Bretillon, L; Hamel, CP; Brabet, P; Pequignot, MO				Chekroud, Karim; Guillou, Laurent; Gregoire, Stephane; Ducharme, Gilles; Brun, Emilie; Cazevieille, Chantal; Bretillon, Lionel; Hamel, Christian P.; Brabet, Philippe; Pequignot, Marie O.			Fatp1 Deficiency Affects Retinal Light Response and Dark Adaptation, and Induces Age-Related Alterations	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; FATTY-ACID TRANSPORTERS; PIGMENT EPITHELIUM; SKELETAL-MUSCLE; ULTRASTRUCTURAL-CHANGES; BRUCHS MEMBRANE; KNOCKOUT MICE; VISUAL CYCLE; DEGENERATION; OXIDATION	FATP1 is involved in lipid transport into cells and in intracellular lipid metabolism. We showed previously that this protein interacts with and inhibits the limiting-step isomerase of the visual cycle RPE65. Here, we aimed to analyze the effect of Fatp1-deficiency in vivo on the visual cycle, structure and function, and on retinal aging. Among the Fatp family members, we observed that only Fatp1 and 4 are expressed in the control retina, in both the neuroretina and the retinal pigment epithelium. In the neuroretina, Fatp1 is mostly expressed in photoreceptors. In young adult Fatp1(-/-) mice, Fatp4 expression was unchanged in retinal pigment epithelium and reduced two-fold in the neuroretina as compared to Fatp1(+/+) mice. The Fatp1(-/-) mice had a preserved retinal structure but a decreased electroretinogram response to light. These mice also displayed a delayed recovery of the beta-wave amplitude after bleaching, however, visual cycle speed was unchanged, and both retinal pigment epithelium and photoreceptors presented the same fatty acid pattern compared to controls. In 2 year-old Fatp1(-/-) mice, transmission electron microscopy studies showed specific abnormalities in the retinas comprising choroid vascularization anomalies and thickening of the Bruch membrane with material deposits, and sometimes local disorganization of the photoreceptor outer segments. These anomalies lead us to speculate that the absence of FATP1 accelerates the aging process.	[Chekroud, Karim; Guillou, Laurent; Brun, Emilie; Hamel, Christian P.; Brabet, Philippe; Pequignot, Marie O.] CHU St Eloi, INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France; [Gregoire, Stephane; Bretillon, Lionel] INRA, Eye & Nutr Res Grp, F-21034 Dijon, France; [Ducharme, Gilles] CNRS, UMR5149, Inst Math & Modelisat Montpellier, F-75700 Paris, France; [Cazevieille, Chantal] CRIC IURC 641, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI)	Brabet, P (corresponding author), CHU St Eloi, INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France.	philippe.brabet@inserm.fr; marie.pequignot@inserm.fr	Brabet, Philippe/AAO-8522-2020; Pequignot, Marie O/P-1994-2017	Brabet, Philippe/0000-0003-2739-1622; Bretillon, Lionel/0000-0002-6957-100X; Pequignot, Marie/0000-0002-8866-3778	Federation des Aveugles et Handicapes Visuels de France; IRRP; UNADEV; SOS Retinite; University of Montpellier [UM1, UM2]; Region Languedoc Roussillon; French Ministry for National Education and Inserm	Federation des Aveugles et Handicapes Visuels de France; IRRP; UNADEV; SOS Retinite; University of Montpellier; Region Languedoc Roussillon(Region Ile-de-FranceRegion Occitanie); French Ministry for National Education and Inserm	This work was supported by private foundations (Federation des Aveugles et Handicapes Visuels de France, IRRP, UNADEV, SOS Retinite), University of Montpellier (UM1 and UM2), the Region Languedoc Roussillon, the French Ministry for National Education and Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; BUSH RA, 1994, INVEST OPHTH VIS SCI, V35, P91; Chabowski A, 2005, FEBS LETT, V579, P2428, DOI 10.1016/j.febslet.2004.11.118; Chekroud K, 2011, OPHTHALMIC RES, V45, P174, DOI 10.1159/000321118; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gambis A, 2011, DEV BIOL, V351, P128, DOI 10.1016/j.ydbio.2010.12.040; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Guignard TJP, 2010, J BIOL CHEM, V285, P18759, DOI 10.1074/jbc.M109.064329; Guitart M, 2009, MITOCHONDRION, V9, P266, DOI 10.1016/j.mito.2009.03.007; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Holloway GP, 2011, DIABETOLOGIA, V54, P1457, DOI 10.1007/s00125-011-2114-8; Houssier M, 2008, PLOS MED, V5, P323, DOI 10.1371/journal.pmed.0050039; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JOHNSON RA, 2001, APPL MULTIVARIATE ST; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; MORRISON WR, 1964, J LIPID RES, V5, P600; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; Pawlosky RJ, 1997, AM J CLIN NUTR, V65, P465, DOI 10.1093/ajcn/65.2.465; Picard E, 2010, AGING-US, V2, P981, DOI 10.18632/aging.100218; Provost AC, 2009, INVEST OPHTH VIS SCI, V50, P3931, DOI 10.1167/iovs.08-2527; Rudolf M, 2005, BRIT J OPHTHALMOL, V89, P1627, DOI 10.1136/bjo.2005.071183; Sarks S, 2007, INVEST OPHTH VIS SCI, V48, P968, DOI 10.1167/iovs.06-0443; Schmidt-Erfurth U, 2008, INVEST OPHTH VIS SCI, V49, P390, DOI 10.1167/iovs.07-0227; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Sparrrow JR, 2010, CURR MOL MED, V10, P802; SUZUKI T, 1986, VISION RES, V26, P425, DOI 10.1016/0042-6989(86)90185-9; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Xiao QH, 2010, PFLUG ARCH EUR J PHY, V460, P559, DOI 10.1007/s00424-010-0821-5; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50231	10.1371/journal.pone.0050231	http://dx.doi.org/10.1371/journal.pone.0050231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166839	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300095
J	Cherukuri, P; DeCastro, AJ; Balboni, AL; Downey, SL; Liu, JY; Hutchinson, JA; DiRenzo, J				Cherukuri, Pratima; DeCastro, Andrew J.; Balboni, Amanda L.; Downey, Sondra L.; Liu, Jennifer Y.; Hutchinson, Justine A.; DiRenzo, James			Phosphorylation of Delta Np63 alpha via a Novel TGF beta/ALK5 Signaling Mechanism Mediates the Anti-Clonogenic Effects of TGF beta	PLOS ONE			English	Article							P53 HOMOLOG; STEM-CELLS; P63; RECEPTOR; SENESCENCE; CHEMOSENSITIVITY; PROLIFERATION; DEGRADATION; ACTIVATION; PHENOTYPE	Genetic analysis of TP63 implicates Delta Np63 isoforms in preservation of replicative capacity and cellular lifespan within adult stem cells. Delta Np63 alpha is also an oncogene and survival factor that mediates therapeutic resistance in squamous carcinomas. These diverse activities are the result of genetic and functional interactions between TP63 and an array of morphogenic and morphostatic signals that govern tissue and tumor stasis, mitotic polarity, and cell fate; however the cellular signals that account for specific functions of TP63 are incompletely understood. To address this we sought to identify signaling pathways that regulate expression, stability or activity of Delta Np63 alpha. An siRNA-based screen of the human kinome identified the Type 1 TGF beta receptor, ALK5, as the kinase required for phosphorylation of Delta Np63 alpha at Serine 66/68 (S66/68). This activity is TGF beta-dependent and sensitive to either ALK5-directed siRNA or the ALK5 kinase inhibitor A83-01. Mechanistic studies support a model in which ALK5 is proteolytically cleaved at the internal juxtamembrane region resulting in the translocation of the C-terminal ALK5-intracellular kinase domain (ALK5(IKD)). In this study, we demonstrate that ALK5-mediated phosphorylation of Delta Np63 alpha is required for the anti-clonogenic effects of TGF beta and ectopic expression of ALK5(IKD) mimics these effects. Finally, we present evidence that ultraviolet irradiation-mediated phosphorylation of Delta Np63 alpha is sensitive to ALK5 inhibitors. These findings identify a non-canonical TGF beta-signaling pathway that mediates the anti-clonogenic effects of TGF beta and the effects of cellular stress via Delta Np63 alpha phosphorylation.	[Cherukuri, Pratima; DeCastro, Andrew J.; Balboni, Amanda L.; Downey, Sondra L.; Hutchinson, Justine A.; DiRenzo, James] Audrey & Theodor Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [DeCastro, Andrew J.; Balboni, Amanda L.; Downey, Sondra L.; Hutchinson, Justine A.; DiRenzo, James] Audrey & Theodor Geisel Sch Med Dartmouth, Program Expt Mol Med, Hanover, NH USA; [Liu, Jennifer Y.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	DiRenzo, J (corresponding author), Audrey & Theodor Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA.	james.direnzo@dartmouth.edu			National Cancer Institute [5RO1CA108539-05]; United States Department of Defense Breast Cancer Research Program [BC095560]; Prouty Pilot Award from the Friends of the Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA108539] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense Breast Cancer Research Program(United States Department of Defense); Prouty Pilot Award from the Friends of the Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part grants to J.D.R. from the National Cancer Institute (5RO1CA108539-05), the United States Department of Defense Breast Cancer Research Program (BC095560) and a Prouty Pilot Award from the Friends of the Norris Cotton Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; DiRenzo J, 2002, CANCER RES, V62, P89; Feng XH, 1996, J BIOL CHEM, V271, P13123, DOI 10.1074/jbc.271.22.13123; Gambichler T, 2006, J DERMATOL SCI, V44, P56, DOI 10.1016/j.jdermsci.2006.06.004; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Higashikawa K, 2007, CANCER RES, V67, P9207, DOI 10.1158/0008-5472.CAN-07-0932; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Jeon YJ, 2012, J CLIN INVEST, V122, P2622, DOI 10.1172/JCI61762; Jung MS, 2001, ONCOGENE, V20, P5818, DOI 10.1038/sj.onc.1204748; Kent S, 2011, CELL CYCLE, V10; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Komatsu S, 2009, ONCOGENE, V28, P3631, DOI 10.1038/onc.2009.216; Lazzari C, 2011, ONCOGENE, V30, P4802, DOI 10.1038/onc.2011.182; Lee HST, 1997, EXP DERMATOL, V6, P105, DOI 10.1111/j.1600-0625.1997.tb00155.x; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Li N, 2008, STEM CELLS, V26, P1253, DOI 10.1634/stemcells.2007-0691; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Nguyen DH, 2011, CANCER CELL, V19, P640, DOI 10.1016/j.ccr.2011.03.011; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; Reiner JE, 2011, FRONT BIOSCI-LANDMRK, V16, P105, DOI 10.2741/3678; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Stehmeier P, 2009, DNA REPAIR, V8, P491, DOI 10.1016/j.dnarep.2009.01.002; Su X, 2009, EMBO J; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Suzuki D, 2012, J INVEST DERMATOL; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Westfall MD, 2005, CELL CYCLE, V4, P710, DOI 10.4161/cc.4.5.1685; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yin L, 2003, J INVEST DERMATOL, V120, P703, DOI 10.1046/j.1523-1747.2003.12099.x; Yuan M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.15; Zwaagstra JC, 2000, EXP CELL RES, V258, P121, DOI 10.1006/excr.2000.4905	53	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50066	10.1371/journal.pone.0050066	http://dx.doi.org/10.1371/journal.pone.0050066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166821	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300082
J	Ghazi, K; Deng-Pichon, U; Warnet, JM; Rat, P				Ghazi, Kamelia; Deng-Pichon, Uriell; Warnet, Jean-Michel; Rat, Patrice			Hyaluronan Fragments Improve Wound Healing on In Vitro Cutaneous Model through P2X7 Purinoreceptor Basal Activation: Role of Molecular Weight	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; P2X(7) ATP RECEPTOR; DEATH RECEPTOR; CD44; PROLIFERATION; MIGRATION; APOPTOSIS; GROWTH; BETA-DEFENSIN-2; KERATINOCYTES	Background: hyaluronan biopolymer is used in dermatology but the underlying mechanism and the impact of its molecular weight have not yet been investigated in skin wound healing. The aim of our work was to study the role of HA molecular weight in the proliferative phase of wound healing and to understand how this physiological biopolymer acts to promote wound healing on a human keratinocyte in vitro model. Methodology and Findings: wound healing closure was evaluated using scratch test assay, cell proliferation by counting cell with haemocytometer, expression of CD44 and ZO-1 (protein present in tight junctions specific of epithelia) using flow cytometry, and P2X7 receptor activation on living using a cytoflurometric method. Our study showed that medium hyaluronan fragment (MMW-HA, between 100 and 300 kDa) induced a significant increase in wound closure, increased ZO-1 protein expression and induced a slight activation of P2X7 receptor, contrary to high (between 1000 and 1400 kDa) and low (between 5 and 20 kDa) molecular hyaluronan fragments that had no healing effects. Basal activation of P2X7 receptor is already known to stimulate cell proliferation and this activation in our model plays a pivotal role in MMW-HA-induced wound healing. Indeed, we showed that use of BBG, a specific inhibitor of P2X7 receptor, blocked completely the beneficial effects of MMW-HA on wound healing. Conclusion: taken together, our results showed for the first time the relationship between P2X7 receptor and hyaluronan in wound healing, and that topical use of MMW-HA (fragment between 100 and 300 kDa) could represent a new therapeutic strategy to promote healing.	[Ghazi, Kamelia; Deng-Pichon, Uriell; Warnet, Jean-Michel; Rat, Patrice] Univ Paris 05, Fac Pharm, Chim Toxicol Analyt & Cellulaire EA 4463, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Rat, P (corresponding author), Univ Paris 05, Fac Pharm, Chim Toxicol Analyt & Cellulaire EA 4463, Paris, France.	patrice.rat@parisdescartes.fr			ADEBIOPHARM [ER67]	ADEBIOPHARM	The authors would to thank ADEBIOPHARM ER67 for its financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Ballerini P, 1996, NEUROREPORT, V7, P2533, DOI 10.1097/00001756-199611040-00026; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Bianco F, 2006, J NEUROCHEM, V99, P745, DOI 10.1111/j.1471-4159.2006.04101.x; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brandle U, 1998, MOL BRAIN RES, V59, P269, DOI 10.1016/S0169-328X(98)00159-4; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Campo GM, 2010, BIOCHEM PHARMACOL, V80, P480, DOI 10.1016/j.bcp.2010.04.024; Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Dutot M, 2008, MOL VIS, V14, P889; Dutot M, 2006, INVEST OPHTH VIS SCI, V47, P2812, DOI 10.1167/iovs.06-0224; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Foger N, 2001, J CELL SCI, V114, P1169; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fronza M, 2009, J ETHNOPHARMACOL, V126, P463, DOI 10.1016/j.jep.2009.09.014; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gariboldi S, 2008, J IMMUNOL, V181, P2103, DOI 10.4049/jimmunol.181.3.2103; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; Mankus C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028541; Mayo C, 2007, ARVO ANN M, V48, P3476; Mayo C, 2008, INVEST OPHTH VIS SCI, V49, P4384, DOI 10.1167/iovs.08-1688; Meyer K, 1934, J BIOL CHEM, V107, P620; MOCZAR M, 1993, EXP GERONTOL, V28, P59, DOI 10.1016/0531-5565(93)90020-E; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; PAPAKONSTANTINOU E, 1995, P NATL ACAD SCI USA, V92, P9881, DOI 10.1073/pnas.92.21.9881; Pauloin T, 2008, EUR J PHARM SCI, V34, P263, DOI 10.1016/j.ejps.2008.04.006; Pauloin T, 2009, CORNEA, V28, P1032, DOI 10.1097/ICO.0b013e3181a0a3f8; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; RAT P, 1994, CELL BIOL TOXICOL, V10, P329, DOI 10.1007/BF00755779; Russ PK, 1998, INVEST OPHTH VIS SCI, V39, P2479; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Sherman L, 1995, J NEURO-ONCOL, V26, P171, DOI 10.1007/BF01052620; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takenouchi T, 2010, ARCH IMMUNOL THER EX, V58, P91, DOI 10.1007/s00005-010-0069-y; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; TODARO GJ, 1965, J CELL COMPAR PHYSL, V66, P325, DOI 10.1002/jcp.1030660310; Weissman B, 1954, J AM CHEM SOC, V27, P1753	50	66	68	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e48351	10.1371/journal.pone.0048351	http://dx.doi.org/10.1371/journal.pone.0048351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173033	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300003
J	Bruns, AM; Pollpeter, D; Hadizadeh, N; Myong, S; Marko, JF; Horvath, CM				Bruns, Annie M.; Pollpeter, Darja; Hadizadeh, Nastaran; Myong, Sua; Marko, John F.; Horvath, Curt M.			ATP Hydrolysis Enhances RNA Recognition and Antiviral Signal Transduction by the Innate Immune Sensor, Laboratory of Genetics and Physiology 2 (LGP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; STRUCTURAL BASIS; HELICASE; ACTIVATION; MDA5	Laboratory of genetics and physiology 2 (LGP2) is a member of the RIG-I-like receptor family of cytoplasmic pattern recognition receptors that detect molecular signatures of virus infection and initiate antiviral signal transduction cascades. The ATP hydrolysis activity of LGP2 is essential for antiviral signaling, but it has been unclear how the enzymatic properties of LGP2 regulate its biological response. Quantitative analysis of the dsRNA binding and enzymatic activities of LGP2 revealed high dsRNA-independent ATP hydrolysis activity. Biochemical assays and single-molecule analysis of LGP2 and mutant variants that dissociate basal from dsRNA-stimulated ATP hydrolysis demonstrate that LGP2 utilizes basal ATP hydrolysis to enhance and diversify its RNA recognition capacity, enabling the protein to associate with intrinsically poor substrates. This property is required for LGP2 to synergize with another RIG-I-like receptor, MDA5, to potentiate IFN beta transcription in vivo during infection with encephalomyocarditis virus or transfection with poly(I: C). These results demonstrate previously unrecognized properties of LGP2 ATP hydrolysis and RNA interaction and provide a mechanistic basis for a positive regulatory role for LGP2 in antiviral signaling.	[Bruns, Annie M.; Pollpeter, Darja; Marko, John F.; Horvath, Curt M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Hadizadeh, Nastaran; Marko, John F.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Myong, Sua] Univ Illinois, Inst Genom Biol, Champaign, IL 61801 USA	Northwestern University; Northwestern University; University of Illinois System; University of Illinois Urbana-Champaign	Horvath, CM (corresponding author), Pancoe Pavil,Rm 4401,2200 Campus Dr, Evanston, IL 60208 USA.	horvath@northwestern.edu	Marko, John F./AAY-7111-2021	Marko, John F./0000-0003-4151-9530; Horvath, Curt/0000-0003-2449-225X	National Institutes of Health [R01AI073919, U01AI082984]; NU-PS-OC [1U54CA143869-01]; National Science Foundation [MCB-1022117]; Immune Mechanisms of Virus Control Pilot Award; National Institutes of Health Cellular and Molecular Basis of Disease Training Grant [T32GM008061]; Div Of Molecular and Cellular Bioscience [1022117] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073919, U01AI082984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NU-PS-OC; National Science Foundation(National Science Foundation (NSF)); Immune Mechanisms of Virus Control Pilot Award; National Institutes of Health Cellular and Molecular Basis of Disease Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI073919 and U01AI082984 (to C. M. H.) and 1U54CA143869-01 (NU-PS-OC) and National Science Foundation Grant MCB-1022117 (to J. M.), and an Immune Mechanisms of Virus Control Pilot Award (to C. M. H. and S. M.).; Supported in part by a predoctoral fellowship from the National Institutes of Health Cellular and Molecular Basis of Disease Training Grant T32GM008061.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Hwang H, 2011, P NATL ACAD SCI USA, V108, P7414, DOI 10.1073/pnas.1017672108; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Moresco EMY, 2010, P NATL ACAD SCI USA, V107, P1261, DOI 10.1073/pnas.0914011107; Myong S, 2010, CURR OPIN STRUC BIOL, V20, P121, DOI 10.1016/j.sbi.2009.12.008; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Parisien JP, 2009, J VIROL, V83, P7252, DOI 10.1128/JVI.00153-09; Pollpeter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018842; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schmidt A, 2012, EUR J CELL BIOL, V91, P78, DOI 10.1016/j.ejcb.2011.01.015; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	27	66	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					938	946		10.1074/jbc.M112.424416	http://dx.doi.org/10.1074/jbc.M112.424416			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184951	Green Published, hybrid			2022-12-25	WOS:000313570300018
J	Chandrashekarappa, DG; McCartney, RR; Schmidt, MC				Chandrashekarappa, Dakshayini G.; McCartney, Rhonda R.; Schmidt, Martin C.			Ligand Binding to the AMP-activated Protein Kinase Active Site Mediates Protection of the Activation Loop from Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SNF1 KINASE; REGULATES TRANSCRIPTION; CONFORMATIONAL-CHANGES; STRUCTURAL INSIGHT; CRYSTAL-STRUCTURE; SUBUNIT; YEAST; PHOSPHORYLATION; GLUCOSE	The AMP-activated protein kinase (AMPK) is a conserved signaling molecule in a pathway that maintains adenosine triphosphate homeostasis. Recent studies have suggested that low energy adenylate ligands bound to one or more sites in the gamma subunit of AMPK promote the formation of an active, phosphatase-resistant conformation. We propose an alternative model in which the kinase domain association with the heterotrimer core results in activation of the kinase catalytic activity, whereas low energy adenylate ligands bound in the kinase active site promote phosphatase resistance. Purified Snf1 alpha subunit with a conservative, single amino acid substitution in the kinase domain is protected from dephosphorylation by adenosine diphosphate in the complete absence of the beta and gamma subunits. Staurosporine, a compound known to bind to the active site of many protein kinases, mediates strong protection from dephosphorylation to yeast and mammalian AMPK enzymes. The analog-sensitive Snf1-I132G protein but not wild type Snf1 exhibits protection from dephosphorylation when bound by the adenosine analog 2NM-PP1 in vitro and in vivo. These data demonstrate that ligand binding to the Snf1 active site can mediate phosphatase resistance. Finally, Snf1 kinase with an amino acid substitution at the interface of the kinase domain and the heterotrimer core exhibits normal regulation of phosphorylation in vivo but greatly reduced Snf1 kinase activity, supporting a model in which kinase domain association with the heterotrimer core is needed for kinase activation.	[Chandrashekarappa, Dakshayini G.; McCartney, Rhonda R.; Schmidt, Martin C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schmidt, MC (corresponding author), Dept Microbiol & Mol Genet, 450 Technol Dr, Pittsburgh, PA 15219 USA.	mcs2@pitt.edu			National Institutes of Health [GM46443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046443, R01GM046443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46443.	Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Barrett L, 2012, EUKARYOT CELL, V11, P119, DOI 10.1128/EC.05061-11; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; Chandrashekarappa DG, 2011, J BIOL CHEM, V286, P44532, DOI 10.1074/jbc.M111.315895; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; DAVIES SP, 1994, EUR J BIOCHEM, V223, P351, DOI 10.1111/j.1432-1033.1994.tb19001.x; Elbing K, 2006, J BIOL CHEM, V281, P26170, DOI 10.1074/jbc.M603811200; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; Keshwani MM, 2008, J BIOL CHEM, V283, P11972, DOI 10.1074/jbc.M800114200; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Leech A, 2003, EUKARYOT CELL, V2, P265, DOI 10.1128/EC.2.2.265-273.2003; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Littler DR, 2010, ACTA CRYSTALLOGR F, V66, P143, DOI 10.1107/S1744309109052543; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; MEGGIO F, 1995, EUR J BIOCHEM, V234, P317, DOI 10.1111/j.1432-1033.1995.317_c.x; Momcilovic M, 2011, J BIOL CHEM, V286, P23544, DOI 10.1074/jbc.M111.244111; Murray BW, 2001, BIOCHEMISTRY-US, V40, P10243, DOI 10.1021/bi010959e; Nath N, 2002, J BIOL CHEM, V277, P50403, DOI 10.1074/jbc.M207058200; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Oakhill JS, 2009, ACTA PHYSIOL, V196, P3, DOI 10.1111/j.1748-1716.2009.01977.x; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Orlova M, 2008, YEAST, V25, P745, DOI 10.1002/yea.1628; Prade L, 1997, STRUCTURE, V5, P1627, DOI 10.1016/S0969-2126(97)00310-9; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rubenstein EM, 2008, J BIOL CHEM, V283, P222, DOI 10.1074/jbc.M707957200; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Ruiz A, 2012, P NATL ACAD SCI USA, V109, P8652, DOI 10.1073/pnas.1206280109; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaffer J, 2001, BIOCHEMISTRY-US, V40, P11149, DOI 10.1021/bi011029y; Shirra MK, 2008, J BIOL CHEM, V283, P35889, DOI 10.1074/jbc.M805325200; Smith FC, 1999, FEBS LETT, V453, P219, DOI 10.1016/S0014-5793(99)00725-5; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; WOODS A, 1994, J BIOL CHEM, V269, P19509; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Young ET, 2012, J BIOL CHEM, V287, P29021, DOI 10.1074/jbc.M112.380147; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n; [No title captured]	51	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					89	98		10.1074/jbc.M112.422659	http://dx.doi.org/10.1074/jbc.M112.422659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184934	hybrid, Green Published			2022-12-25	WOS:000313197200009
J	Al Abdallah, Q; Choe, SI; Campoli, P; Baptista, S; Gravelat, FN; Lee, MJ; Sheppard, DC				Al Abdallah, Qusai; Choe, Se-In; Campoli, Paolo; Baptista, Stefanie; Gravelat, Fabrice N.; Lee, Mark J.; Sheppard, Donald C.			A Conserved C-Terminal Domain of the Aspergillus fumigatus Developmental Regulator MedA Is Required for Nuclear Localization, Adhesion and Virulence	PLOS ONE			English	Article							STRUCTURE PREDICTION; INVASIVE ASPERGILLOSIS; ASEXUAL DEVELOPMENT; ANTIFUNGAL AGENTS; IMPORTIN ALPHA; NIDULANS; GENES; SIGNALS; PROGRAM; BINDING	MedA is a developmental regulator that is conserved in the genome of most filamentous fungi. In the pathogenic fungus Aspergillus fumigatus MedA regulates conidiogenesis, adherence to host cells, and pathogenicity. The mechanism by which MedA governs these phenotypes remains unknown. Although the nuclear import of MedA orthologues has been reported in other fungi, no nuclear localization signal, DNA-binding domain or other conserved motifs have been identified within MedA. In this work, we performed a deletion analysis of MedA and identified a novel domain within the C-terminal region of the protein, designated MedA(346-557), that is necessary and sufficient for nuclear localization of MedA. We further demonstrate that MedA nuclear localization is required for the function of MedA. Surprisingly, expression of the minimal nuclear localization fragment MedA(346-557) alone was sufficient to restore conidogenesis, biofilm formation and virulence to the medA mutant strain. Collectively these results suggest that MedA functions in the regulation of transcription, and that the MedA(346-557) domain is both necessary and sufficient to mediate MedA function.	[Al Abdallah, Qusai; Choe, Se-In; Campoli, Paolo; Baptista, Stefanie; Gravelat, Fabrice N.; Lee, Mark J.; Sheppard, Donald C.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Sheppard, Donald C.] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University	Sheppard, DC (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	donald.sheppard@mcgill.ca	Sheppard, Donald/B-4637-2008	Sheppard, Donald/0000-0001-8877-880X; Gravelat, Fabrice/0000-0003-2416-9380; Al Abdallah, Qusai/0000-0002-6532-0617	Canadian Institutes of Health Research (CIHR) [MI 199372 CIHR]; CIHR; Fonds du Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds du Recherche en Sante du Quebec	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR), grant number MI 199372 CIHR. DCS was supported by a Clinician Scientist award from the CIHR and a Chercheur-Clinicien award from the Fonds du Recherche en Sante du Quebec. CIHR: http://www.cihr-irsc.gc.ca/FRSQ: http://www.frsq.gouv.qc.ca/en/index. shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; AGUIRRE J, 1993, MOL MICROBIOL, V8, P211, DOI 10.1111/j.1365-2958.1993.tb01565.x; Araujo-Bazan L, 2009, FUNGAL GENET BIOL, V46, P506, DOI 10.1016/j.fgb.2009.03.006; AXELROD DE, 1973, DEV BIOL, V34, P9, DOI 10.1016/0012-1606(73)90335-7; Barnes M, 2003, BIOINFORMATICS GENET; Brakhage AA, 2002, ANNU REV MICROBIOL, V56, P433, DOI 10.1146/annurev.micro.56.012302.160625; BRAKHAGE AA, 1995, J BACTERIOL, V177, P2781, DOI 10.1128/jb.177.10.2781-2788.1995; Busby TM, 1996, GENETICS, V143, P155; Campoli P, 2011, ANTIMICROB AGENTS CH, V55, P5732, DOI 10.1128/AAC.00637-11; Chung DW, 2011, FUNGAL GENET BIOL, V48, P370, DOI 10.1016/j.fgb.2010.12.008; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Etxebeste O, 2010, TRENDS MICROBIOL, V18, P569, DOI 10.1016/j.tim.2010.09.007; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; MARTINELLI SD, 1979, J GEN MICROBIOL, V114, P277, DOI 10.1099/00221287-114-2-277; MILLER KY, 1991, MOL GEN GENET, V227, P285, DOI 10.1007/BF00259682; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Morgan J, 2005, MED MYCOL, V43, pS49, DOI 10.1080/13693780400020113; Mowat E, 2007, J MED MICROBIOL, V56, P1205, DOI 10.1099/jmm.0.47247-0; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nishimura M, 2000, MOL PLANT MICROBE IN, V13, P892, DOI 10.1094/MPMI.2000.13.8.892; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ohara T, 2004, GENETICS, V166, P113, DOI 10.1534/genetics.166.1.113; PITT JI, 1994, J MED VET MYCOL, V32, P17; SHEPPARD D, 1994, AM J RESP CELL MOL, V11, P1; Sheppard DC, 2005, MOL BIOL CELL, V16, P5866, DOI 10.1091/mbc.E05-07-0617; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vanden Bossche H, 1988, ASPERGILLUS ASPERGIL; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229	44	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49959	10.1371/journal.pone.0049959	http://dx.doi.org/10.1371/journal.pone.0049959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185496	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000150
J	Bangerter, A; Krings, F; Mouton, A; Gilles, I; Green, EGT; Clemence, A				Bangerter, Adrian; Krings, Franciska; Mouton, Audrey; Gilles, Ingrid; Green, Eva G. T.; Clemence, Alain			Longitudinal Investigation of Public Trust in Institutions Relative to the 2009 H1N1 Pandemic in Switzerland	PLOS ONE			English	Article							PERCEPTIONS; OUTBREAK; SCIENCE	Background: The 2009 H1N1 pandemic left a legacy of mistrust in the public relative to how outbreaks of emerging infectious diseases are managed. To prepare for future outbreaks, it is crucial to explore the phenomenon of public trust in the institutions responsible for managing disease outbreaks. We investigated the evolution of public trust in institutions during and after the 2009 pandemic in Switzerland. We also explored respondents' perceptions of the prevention campaign and the roles of the government and media. Methodology/Principal Findings: A two-wave longitudinal survey was mailed to 2,400 members of the Swiss public. Wave 1 was in Spring 2009. Wave 2 was in Spring 2010. Six hundred and two participants responded in both waves. Participants indicated moderate to high levels of trust in medical organizations, the WHO, the Swiss government, the pharmaceutical industry, and the EU. On the other hand, trust in the media was low. Moreover, trust in almost all institutions decreased over time. Participants were satisfied with the amount of information received and indicated having followed official recommendations, but widespread concerns about the vaccine were evident. A large majority of participants agreed the vaccine might have unknown or undesirable side effects. Perceptions of the government's and the media's role in handling the outbreak were characterized by a substantial degree of skepticism and mistrust. Conclusions/Significance: Results show clear patterns of skepticism and mistrust on the part of the public relative to various institutions and their actions. Results underscore the importance of systematically investigating trust of the public relative to epidemics. Moreover, studies investigating the evolution of the public's memories of the pandemic over the coming years may be important to understand reactions to future pandemics. A systematic research program on trust can inform public health communication campaigns, enabling tailored communication initiatives.	[Bangerter, Adrian] Univ Neuchatel, Inst Work & Org Psychol, CH-2000 Neuchatel, Switzerland; [Krings, Franciska; Mouton, Audrey] Univ Lausanne, Dept Org Behav, Lausanne, Switzerland; [Gilles, Ingrid; Green, Eva G. T.; Clemence, Alain] Univ Lausanne, Inst Social Sci, Lausanne, Switzerland	University of Neuchatel; University of Lausanne; University of Lausanne	Bangerter, A (corresponding author), Univ Neuchatel, Inst Work & Org Psychol, CH-2000 Neuchatel, Switzerland.	adrian.bangerter@unine.ch			Swiss National Science Foundation [100014_132023/1, 100014_122366/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Research was supported by grants from the Swiss National Science Foundation ((100014_132023/1 and 100014_122366/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CDC MMR REPORT; Chan M, 2010, H1N1 POSTPANDEMIC PE; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; Dupras C, 2012, AM J PUBLIC HEALTH, V102, P591, DOI 10.2105/AJPH.2011.300417; FEINGOLD A, 1994, PSYCHOL BULL, V116, P429, DOI 10.1037/0033-2909.116.3.429; Gilles I, 2011, EUR J EPIDEMIOL, V26, P203, DOI 10.1007/s10654-011-9577-2; Godlee F, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2947; Hardin R., 2002, RUSSELL SAGE FDN SER; Henrich N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018479; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Liao QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017713; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011292; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Siegrist M., 2007, TRUST RISK MANAGEMEN; Singh J, 2007, NAT REV NEUROSCI, V8, P153, DOI 10.1038/nrn2073; Sjoberg L, 2001, RISK ANAL, V21, P189, DOI 10.1111/0272-4332.211101; Specter M., 2009, DENIALISM IRRATIONAL; THOMAS SB, 1991, AM J PUBLIC HEALTH, V81, P1498, DOI 10.2105/AJPH.81.11.1498; Tsfati Y, 2003, J BROADCAST ELECTRON, V47, P157, DOI 10.1207/s15506878jobem4702_1; Verger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041837; Wagner-Egger P, 2011, PUBLIC UNDERST SCI, V20, P461, DOI 10.1177/0963662510393605; Washer Peter, 2010, EMERGING INFECT DIS; Wilson CB, 2001, NAT REV IMMUNOL, V1, P160, DOI 10.1038/35100585	27	53	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49806	10.1371/journal.pone.0049806	http://dx.doi.org/10.1371/journal.pone.0049806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185444	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000114
J	Brylinski, M; Lingam, D				Brylinski, Michal; Lingam, Daswanth			eThread: A Highly Optimized Machine Learning-Based Approach to Meta-Threading and the Modeling of Protein Tertiary Structures	PLOS ONE			English	Article							BINDING SITE PREDICTION; FOLD RECOGNITION; CONTACT PREDICTION; QUALITY ASSESSMENT; SCORING FUNCTION; SEQUENCE; REFINEMENT; ALIGNMENT; ACCURACY; DOCKING	Template-based modeling that employs various meta-threading techniques is currently the most accurate, and consequently the most commonly used, approach for protein structure prediction. Despite the evident progress in this field, accurate structure models cannot be constructed for a significant fraction of gene products, thus the development of new algorithms is required. Here, we describe the development, optimization and large-scale benchmarking of eThread, a highly accurate meta-threading procedure for the identification of structural templates and the construction of corresponding target-to-template alignments. eThread integrates ten state-of-the-art threading/fold recognition algorithms in a local environment and extensively uses various machine learning techniques to carry out fully automated template-based protein structure modeling. Tertiary structure prediction employs two protocols based on widely used modeling algorithms: Modeller and TASSER-Lite. As a part of eThread, we also developed eContact, which is a Bayesian classifier for the prediction of inter-residue contacts and eRank, which effectively ranks generated multiple protein models and provides reliable confidence estimates as structure quality assessment. Excluding closely related templates from the modeling process, eThread generates models, which are correct at the fold level, for >80% of the targets; 40-50% of the constructed models are of a very high quality, which would be considered accurate at the family level. Furthermore, in large-scale benchmarking, we compare the performance of eThread to several alternative methods commonly used in protein structure prediction. Finally, we estimate the upper bound for this type of approach and discuss the directions towards further improvements.	[Brylinski, Michal; Lingam, Daswanth] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Brylinski, Michal] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; [Lingam, Daswanth] Louisiana State Univ, Dept Elect & Comp Engn, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Brylinski, M (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	michal@brylinski.org			Louisiana Board of Regents through the Board of Regents Support Fund [LEQSF(2012-15)-RD-A-05]	Louisiana Board of Regents through the Board of Regents Support Fund	This study was supported by the Louisiana Board of Regents through the Board of Regents Support Fund [contract LEQSF(2012-15)-RD-A-05]. Portions of this research were conducted with high performance computational resources provided by Louisiana State University (HPC@LSU, http://www.hpc.lsu.edu) and the Louisiana Optical Network Institute (LONI, http://www.loni.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Brylinski M, 2010, J COMPUT CHEM, V31, P1093, DOI 10.1002/jcc.21395; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Damm KL, 2006, BIOPHYS J, V90, P4558, DOI 10.1529/biophysj.105.066654; Dominy BN, 2002, J COMPUT CHEM, V23, P147, DOI 10.1002/jcc.10018; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Gao Xin, 2009, BMC Struct Biol, V9, P28, DOI 10.1186/1472-6807-9-28; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Han SJ, 2005, BIOINFORMATICS, V21, P2667, DOI 10.1093/bioinformatics/bti384; Hartshorn MJ, 2002, J COMPUT AID MOL DES, V16, P871, DOI 10.1023/A:1023813504011; Hughey R, 1996, COMPUT APPL BIOSCI, V12, P95; Izarzugaza JMG, 2007, PROTEINS, V69, P152, DOI 10.1002/prot.21637; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; JOACHIMS T., 2006, P 12 ACM SIGKDD INT, DOI DOI 10.1145/1150402.1150429; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kmiecik S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-43; Kosinski J, 2005, PROTEINS, V61, P106, DOI 10.1002/prot.20726; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MR, 2001, J MOL BIOL, V313, P417, DOI 10.1006/jmbi.2001.5032; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lundstrom J, 2001, PROTEIN SCI, V10, P2354, DOI 10.1110/ps.08501; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oh M, 2009, PROTEINS, V77, P152, DOI 10.1002/prot.22572; Pandit SB, 2006, BIOPHYS J, V91, P4180, DOI 10.1529/biophysj.106.084293; Pandit SB, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-531; Peng JA, 2010, BIOINFORMATICS, V26, pi294, DOI 10.1093/bioinformatics/btq192; Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Punta M, 2005, J MOL BIOL, V348, P507, DOI 10.1016/j.jmb.2005.02.068; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Randall A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-52; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Roche DB, 2011, NUCLEIC ACIDS RES, V39, pW171, DOI 10.1093/nar/gkr184; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; Skolnick J, 1997, PROTEIN SCI, V6, P676; Skolnick J, 2012, J PHYS CHEM B, V116, P6654, DOI 10.1021/jp211052j; Skolnick J, 2009, BRIEF BIOINFORM, V10, P378, DOI 10.1093/bib/bbp017; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tovchigrechko A, 2002, PROTEIN SCI, V11, P1888, DOI 10.1110/ps.4730102; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Wallner B, 2007, NUCLEIC ACIDS RES, V35, pW369, DOI 10.1093/nar/gkm319; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang Z, 2011, BIOINFORMATICS, V27, P1715, DOI 10.1093/bioinformatics/btr268; Wass MN, 2009, PROTEINS, V77, P147, DOI 10.1002/prot.22513; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xu D, 2012, PROTEINS; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhang Y, 2004, BIOPHYS J, V87, P2647, DOI 10.1529/biophysj.104.045385; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005; Zhang ZD, 2005, PROTEIN SCI, V14, P431, DOI 10.1110/ps.041035505; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729; Zhou HY, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20732	80	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50200	10.1371/journal.pone.0050200	http://dx.doi.org/10.1371/journal.pone.0050200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185577	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000200
J	English, AC; Richards, S; Han, Y; Wang, M; Vee, V; Qu, JX; Qin, X; Muzny, DM; Reid, JG; Worley, KC; Gibbs, RA				English, Adam C.; Richards, Stephen; Han, Yi; Wang, Min; Vee, Vanesa; Qu, Jiaxin; Qin, Xiang; Muzny, Donna M.; Reid, Jeffrey G.; Worley, Kim C.; Gibbs, Richard A.			Mind the Gap: Upgrading Genomes with Pacific Biosciences RS Long-Read Sequencing Technology	PLOS ONE			English	Article							DROSOPHILA; ASSEMBLER	Many genomes have been sequenced to high-quality draft status using Sanger capillary electrophoresis and/or newer short-read sequence data and whole genome assembly techniques. However, even the best draft genomes contain gaps and other imperfections due to limitations in the input data and the techniques used to build draft assemblies. Sequencing biases, repetitive genomic features, genomic polymorphism, and other complicating factors all come together to make some regions difficult or impossible to assemble. Traditionally, draft genomes were upgraded to "phase 3 finished" status using time-consuming and expensive Sanger-based manual finishing processes. For more facile assembly and automated finishing of draft genomes, we present here an automated approach to finishing using long-reads from the Pacific Biosciences RS (PacBio) platform. Our algorithm and associated software tool, PBJelly, (publicly available at https://sourceforge.net/projects/pb-jelly/) automates the finishing process using long sequence reads in a reference-guided assembly process. PBJelly also provides "lift-over" co-ordinate tables to easily port existing annotations to the upgraded assembly. Using PBJelly and long PacBio reads, we upgraded the draft genome sequences of a simulated Drosophila melanogaster, the version 2 draft Drosophila pseudoobscura, an assembly of the Assemblathon 2.0 budgerigar dataset, and a preliminary assembly of the Sooty mangabey. With 24xmapped coverage of PacBio long-reads, we addressed 99% of gaps and were able to close 69% and improve 12% of all gaps in D. pseudoobscura. With 4xmapped coverage of PacBio long-reads we saw reads address 63% of gaps in our budgerigar assembly, of which 32% were closed and 63% improved. With 6.8xmapped coverage of mangabey PacBio long-reads we addressed 97% of gaps and closed 66% of addressed gaps and improved 19%. The accuracy of gap closure was validated by comparison to Sanger sequencing on gaps from the original D. pseudoobscura draft assembly and shown to be dependent on initial reference quality.	[English, Adam C.; Richards, Stephen; Han, Yi; Wang, Min; Vee, Vanesa; Qu, Jiaxin; Qin, Xiang; Muzny, Donna M.; Reid, Jeffrey G.; Worley, Kim C.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine	English, AC (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	English@bcm.edu		Worley, Kim/0000-0002-0282-1000	NHGRI [NHGRI U54 HG003273]; NCRR [1S10RR026605-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by NHGRI grant NHGRI U54 HG003273 to RAG (www.genome.gov); and NCRR grant # 1S10RR026605-01 to JGR, funding the massive RAM genomic analysis cluster resource which was serviceable to the PBJelly development process. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; DELABASTIDE M, 2007, CURR PROTOC BIOINFOR, pCH11, DOI DOI 10.1002/0471250953.BI1104S17; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Huson D H, 2001, Bioinformatics, V17 Suppl 1, pS132; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koren S, 2012, HYBRID ERROR C UNPUB; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Richards S., 1994, AUTOMATED DNA SEQUEN, P191; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; The_Arabadopsis_Genome_Initiative, 1998, SCIENCE, V282, P2012; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	21	138	161	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e47768	10.1371/journal.pone.0047768	http://dx.doi.org/10.1371/journal.pone.0047768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185243	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000006
J	Land, R; Engler, G; Kral, A; Engel, AK				Land, Ruediger; Engler, Gerhard; Kral, Andrej; Engel, Andreas K.			Auditory Evoked Bursts in Mouse Visual Cortex during Isoflurane Anesthesia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; GENERAL-ANESTHETICS; IN-VIVO; SUPPRESSION ANESTHESIA; NETWORK MECHANISMS; SLOW OSCILLATION; CEREBRAL-CORTEX; LESS-THAN-1 HZ; RAT; HIPPOCAMPAL	General anesthesia is not a uniform state of the brain. Ongoing activity differs between light and deep anesthesia and cortical response properties are modulated in dependence of anesthetic dosage. We investigated how anesthesia level affects cross-modal interactions in primary sensory cortex. To examine this, we continuously measured the effects of visual and auditory stimulation during increasing and decreasing isoflurane level in the mouse visual cortex and the subiculum (from baseline at 0.7 to 2.5 vol % and reverse). Auditory evoked burst activity occurred in visual cortex after a transition during increase of anesthesia level. At the same time, auditory and visual evoked bursts occurred in the subiculum, even though the subiculum was unresponsive to both stimuli previous to the transition. This altered sensory excitability was linked to the presence of burst suppression activity in cortex, and to a regular slow burst suppression rhythm (similar to 0.2 Hz) in the subiculum. The effect disappeared during return to light anesthesia. The results show that pseudo-heteromodal sensory burst responses can appear in brain structures as an effect of an anesthesia induced state change.	[Land, Ruediger; Engler, Gerhard; Kral, Andrej; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Land, Ruediger; Kral, Andrej] Hannover Med Sch, Inst Audioneurotechnol, Dept Expt Otol, D-3000 Hannover, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School	Land, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	land.ruediger@mh-hannover.de	Engel, Andreas K./AAH-6384-2019; Land, Rüdiger/N-3512-2018; Engel, Andreas K/C-7781-2012	Engel, Andreas K./0000-0003-4899-8466; Land, Rüdiger/0000-0003-0264-585X; Engel, Andreas K/0000-0003-4899-8466; Kral, Andrej/0000-0002-7762-4642	German Research Foundation (DFG) [SFB 444/3]; European Union [IST-2000-28127, IST-2005-27268, NEST-Path-043457]; German Research Foundation [SPP 1608 Kr 3370/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union(European Commission); German Research Foundation(German Research Foundation (DFG))	This study was supported by grants from the German Research Foundation (DFG) (SFB 444/3, A. K. E.) and the European Union (IST-2000-28127, IST-2005-27268, NEST-Path-043457, A. K. E.) and supported in part by the German Research Foundation (SPP 1608 Kr 3370/2-1, AK).	Akrawi WP, 1996, J NEUROSURG ANESTH, V8, P40, DOI 10.1097/00008506-199601000-00010; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Butovas S, 2010, ANESTHESIOLOGY, V113, P48, DOI 10.1097/ALN.0b013e3181dc1db7; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; CLARK DL, 1973, ANESTHESIOLOGY, V38, P564, DOI 10.1097/00000542-197306000-00011; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Doi A, 2007, EUR J NEUROSCI, V26, P2565, DOI 10.1111/j.1460-9568.2007.05885.x; Erchova IA, 2002, EUR J NEUROSCI, V15, P744, DOI 10.1046/j.0953-816x.2002.01898.x; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Gao EQ, 2010, J NEUROSCI, V30, P5912, DOI 10.1523/JNEUROSCI.6456-09.2010; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hartikainen K, 1999, ANAESTHESIA, V54, P210, DOI 10.1046/j.1365-2044.1999.00300.x; HARTIKAINEN KM, 1995, ANESTH ANALG, V81, P1223, DOI 10.1097/00000539-199512000-00018; HENRY CE, 1952, ELECTROEN CLIN NEURO, V4, P1, DOI 10.1016/0013-4694(52)90027-8; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Hudetz AG, 2007, ANESTHESIOLOGY, V107, P983, DOI 10.1097/01.anes.0000291471.80659.55; Huotari AM, 2004, BRIT J ANAESTH, V92, P18, DOI 10.1093/bja/aeh022; Imas OA, 2005, ANESTHESIOLOGY, V102, P937, DOI 10.1097/00000542-200505000-00012; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jackson J, 2011, J NEUROSCI, V31, P12104, DOI 10.1523/JNEUROSCI.1370-11.2011; KELLAWAY P, 1966, EXP NEUROL, V14, P281, DOI 10.1016/0014-4886(66)90115-4; Kisley MA, 1999, J NEUROSCI, V19, P10451; Kroeger D, 2007, J NEUROSCI, V27, P10597, DOI 10.1523/JNEUROSCI.3440-07.2007; Laramee ME, 2011, EUR J NEUROSCI, V34, P65, DOI 10.1111/j.1460-9568.2011.07732.x; Larsen DD, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.030.2009; Lukatch HS, 2005, CEREB CORTEX, V15, P1322, DOI 10.1093/cercor/bhi015; MacIver MB, 1996, ANESTHESIOLOGY, V84, P1411, DOI 10.1097/00000542-199606000-00018; Magill PJ, 2006, J NEUROSCI, V26, P6318, DOI 10.1523/jneurosci.0620-06.2006; Naber PA, 1998, J COMP NEUROL, V393, P284; Niedermeyer Ernst, 2009, Am J Electroneurodiagnostic Technol, V49, P333; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; RAMPIL IJ, 1988, ANESTHESIOLOGY, V69, P298, DOI 10.1097/00000542-198809000-00002; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Ruiz-Mejias M, 2011, J NEUROPHYSIOL, V106, P2910, DOI 10.1152/jn.00440.2011; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; STERIADE M, 1994, ELECTROEN CLIN NEURO, V90, P1, DOI 10.1016/0013-4694(94)90108-2; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; SWANK RL, 1949, J NEUROPHYSIOL, V12, P137, DOI 10.1152/jn.1949.12.2.137; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Taxidis J, 2010, BIOL CYBERN, V102, P327, DOI 10.1007/s00422-010-0370-1; TOMODA K, 1993, BRIT J ANAESTH, V71, P383, DOI 10.1093/bja/71.3.383; Wilson DA, 2010, J NEUROPHYSIOL, V104, P3231, DOI 10.1152/jn.00711.2010; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; YLIHANKALA A, 1993, ELECTROEN CLIN NEURO, V87, P215, DOI 10.1016/0013-4694(93)90021-M	57	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49855	10.1371/journal.pone.0049855	http://dx.doi.org/10.1371/journal.pone.0049855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185462	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000125
J	Nagle, AA; Gan, FF; Jones, G; So, CL; Wells, G; Chew, EH				Nagle, Amrita A.; Gan, Fei-Fei; Jones, Gavin; So, Choon-Leng; Wells, Geoffrey; Chew, Eng-Hui			Induction of Tumor Cell Death through Targeting Tubulin and Evoking Dysregulation of Cell Cycle Regulatory Proteins by Multifunctional Cinnamaldehydes	PLOS ONE			English	Article							APOPTOSIS INDUCTION; SPINDLE CHECKPOINT; ANTICANCER AGENTS; CANCER-THERAPY; MICROTUBULES; SURVIVIN; ALPHA; DEGRADATION; ACTIVATION; INHIBITORS	Multifunctional trans-cinnamaldehyde (CA) and its analogs display anti-cancer properties, with 2-benzoyloxycinnamaldehyde (BCA) and 5-fluoro-2-hydroxycinnamaldehyde (FHCA) being identified as the ortho-substituted analogs that possess potent anti-tumor activities. In this study, BCA, FHCA and a novel analog 5-fluoro-2-benzoyloxycinnamaldehyde (FBCA), were demonstrated to decrease growth and colony formation of human colon-derived HCT 116 and mammary-derived MCF-7 carcinoma cells under non-adhesive conditions. The 2-benzoyloxy and 5-fluoro substituents rendered FBCA more potent than BCA and equipotent to FHCA. The cellular events by which these cinnamaldehydes caused G(2)/M phase arrest and halted proliferation of HCT 116 cells were thereby investigated. Lack of significant accumulation of mitosis marker phospho-histone H3 in cinnamaldehyde-treated cells indicated that the analogs arrested cells in G(2) phase. G(2) arrest was brought about partly by cinnamaldehyde-mediated depletion of cell cycle proteins involved in regulating G(2) to M transition and spindle assembly, namely cdk1, cdc25C, mad2, cdc20 and survivin. Cyclin B1 levels were found to be increased, which in the absence of active cdk1, would fail to drive cells into M phase. Concentrations of cinnamaldehydes that brought about dysregulation of levels of cell cycle proteins also caused tubulin aggregation, as evident from immunodetection of dose-dependent tubulin accumulation in the insoluble cell lysate fractions. In a cell-free system, reduced biotin-conjugated iodoacetamide (BIAM) labeling of tubulin protein pretreated with cinnamaldehydes was indicative of drug interaction with the sulfhydryl groups in tubulin. In conclusion, cinnamaldehydes treatment at proapoptotic concentrations caused tubulin aggregation and dysegulation of cell cycle regulatory proteins cdk1 and cdc25C that contributed at least in part to arresting cells at G(2) phase, resulting in apoptotic cell death characterized by emergence of cleaved forms of caspase 3 and poly (ADPribose) polymerase (PARP). Results presented in this study have thus provided further insights into the intricate network of cellular events by which cinnamaldehydes induce tumor cell death.	[Nagle, Amrita A.; Gan, Fei-Fei; So, Choon-Leng; Chew, Eng-Hui] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Jones, Gavin; Wells, Geoffrey] UCL, Sch Pharm, Dept Pharmaceut & Biol Chem, London, England	National University of Singapore; University of London; University College London; University of London School of Pharmacy	Chew, EH (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.	phaceh@nus.edu.sg	Chew, Eng Hui/D-8975-2016	Chew, Eng Hui/0000-0002-2615-8987; Wells, Geoffrey/0000-0002-0253-911X; So, Choon Leng/0000-0003-4161-401X	National University of Singapore [R-148-000-116-112]; School of Pharmacy, University of London	National University of Singapore(National University of Singapore); School of Pharmacy, University of London	This work was supported by the National University of Singapore (Academic Research Fund Tier 1 R-148-000-116-112 to EHC and NUS President Graduate Fellowship to AAN) and the School of Pharmacy, University of London (to GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Chen SM, 2010, EXPERT OPIN INV DRUG, V19, P329, DOI 10.1517/13543780903571631; Chew EH, 2010, FREE RADICAL BIO MED, V48, P98, DOI 10.1016/j.freeradbiomed.2009.10.028; Esteve MA, 2007, CURR CANCER DRUG TAR, V7, P713; Gan FF, 2009, BIOCHEM BIOPH RES CO, V387, P741, DOI 10.1016/j.bbrc.2009.07.104; Ge S, 2009, CELL CYCLE, V8, P167, DOI 10.4161/cc.8.1.7606; Han DC, 2004, J BIOL CHEM, V279, P6911, DOI 10.1074/jbc.M309708200; Hong SH, 2007, BIOCHEM PHARMACOL, V74, P557, DOI 10.1016/j.bcp.2007.05.016; Ishiguro K, 2008, FEBS LETT, V582, P3531, DOI 10.1016/j.febslet.2008.09.027; Jeong HW, 2003, BIOCHEM PHARMACOL, V65, P1343, DOI 10.1016/S0006-2952(03)00038-8; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Ka H, 2003, CANCER LETT, V196, P143, DOI 10.1016/S0304-3835(03)00238-6; Koh WS, 1998, INT J IMMUNOPHARMACO, V20, P643, DOI 10.1016/S0192-0561(98)00064-2; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kwon BM, 1997, BIOORG MED CHEM LETT, V7, P2473, DOI 10.1016/S0960-894X(97)10008-7; Kwon BM, 1998, ARCH PHARM RES, V21, P147, DOI 10.1007/BF02974019; Lee CW, 2007, J PHARMACOL SCI, V104, P19, DOI 10.1254/jphs.FP0061204; Lee CW, 1999, PLANTA MED, V65, P263, DOI 10.1055/s-2006-960772; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liao BC, 2008, TOXICOL APPL PHARM, V229, P161, DOI 10.1016/j.taap.2008.01.021; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Moeller Stephanie J., 2006, V42, P1, DOI 10.1007/b136683; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; MOON KH, 1983, DRUG CHEM TOXICOL, V6, P521, DOI 10.3109/01480548309017807; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; Schaefer KL, 2007, EXPERT OPIN INV DRUG, V16, P923, DOI 10.1517/13543784.16.7.923; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Singh P, 2008, IUBMB LIFE, V60, P368, DOI 10.1002/iub.42; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5	34	27	27	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50125	10.1371/journal.pone.0050125	http://dx.doi.org/10.1371/journal.pone.0050125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185555	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000187
J	van Vuuren, SH; Sol, CM; Broekhuizen, R; Lilien, MR; Oosterveld, MJS; Nguyen, TQ; Goldschmeding, R; de Jong, TPVM				van Vuuren, Stefan H.; Sol, Chalana M.; Broekhuizen, Roel; Lilien, Marc R.; Oosterveld, Michiel J. S.; Nguyen, Tri Q.; Goldschmeding, Roel; de Jong, Tom P. V. M.			Compensatory Growth of Congenital Solitary Kidneys in Pigs Reflects Increased Nephron Numbers Rather Than Hypertrophy	PLOS ONE			English	Article							UNILATERAL RENAL AGENESIS; BLOOD-PRESSURE; HYPERTENSION; VARIANT; CHILDREN; SIZE; DISEASE; WEIGHT; RISK; GENE	Background: Patients with unilateral MultiCystic Kidney Dysplasia (MCKD) or unilateral renal agenesis (URA) have a congenital solitary functioning kidney (CSFK) that is compensatory enlarged. The question whether this enlargement is due to increased nephron numbers and/or to nephron hypertrophy is unresolved. This question is of utmost clinical importance, since hypertrophy is associated with a risk of developing hypertension and proteinuria later in life with consequent development of CKD and cardiovascular disease. Methodology/Principal Findings: In a cohort of 32,000 slaughter pigs, 7 congenital solitary functioning kidneys and 7 control kidneys were identified and harvested. Cortex volume was measured and with a 3-dimensional stereologic technique the number and volume of glomeruli was determined and compared. The mean total cortex volume was increased by more than 80% and the mean number of glomeruli per kidney was 50% higher in CSFKs than in a single control kidney, equaling 75% of the total nephron number in both kidneys of control subjects. The mean total glomerular volume in the CSFKs was not increased relative to the controls. Conclusions/Significance: Thus, in pigs, compensatory enlargement of a CSFK is based on increased nephron numbers. Extrapolation of these findings to the human situation suggests that patients with a CSFK might not be at increased risk for developing hyperfiltration-associated renal and cardiovascular disease in later life due to a lower nephron number.	[de Jong, Tom P. V. M.] Univ Childrens Hosp UMC Utrecht & AMC, Dept Paediat Urol, Amsterdam, Netherlands; [van Vuuren, Stefan H.; Sol, Chalana M.; Broekhuizen, Roel; Nguyen, Tri Q.; Goldschmeding, Roel] Univ Med Ctr, Dept Pathol, Utrecht, Netherlands; [Lilien, Marc R.] Univ Childrens Hosp UMC, Dept Paediat Nephrol, Utrecht, Netherlands; [Oosterveld, Michiel J. S.] Univ Childrens Hosp AMC, Dept Paediat Nephrol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center	de Jong, TPVM (corresponding author), Univ Childrens Hosp UMC Utrecht & AMC, Dept Paediat Urol, Amsterdam, Netherlands.	T.P.V.M.deJong@umcutrecht.nl	Goldschmeding, Roel/I-1723-2014; Nguyen, Tri/A-9508-2009; de Jong, Tom/AAG-5659-2020; Nguyen, Tri Q/AAN-9673-2021; Lilien, Marc/AAE-1452-2020	Nguyen, Tri/0000-0001-6475-0706; Nguyen, Tri Q/0000-0001-6475-0706; de Jong, Tom P.V.M./0000-0002-9091-1099				Amakasu K, 2011, J VET MED SCI, V73, P787, DOI 10.1292/jvms.10-0498; Amakasu K, 2009, COMPARATIVE MED, V59, P249; ARGUESO LR, 1992, PEDIATR NEPHROL, V6, P412, DOI 10.1007/BF00873996; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406, DOI 10.1681/ASN.V132406; El Kares R, 2010, KIDNEY INT, V78, P96, DOI 10.1038/ki.2010.101; GLAZEBROOK KN, 1993, RADIOLOGY, V189, P733, DOI 10.1148/radiology.189.3.8234697; Gonzalez E, 2005, KIDNEY INT, V68, P263, DOI 10.1111/j.1523-1755.2005.00401.x; Hill LM, 2000, ULTRASOUND OBST GYN, V15, P191, DOI 10.1046/j.1469-0705.2000.00064.x; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; KIRKMAN RL, 1989, INT CONGR SER, V880, P125; Maluf NSR, 1997, BRIT J UROL, V79, P836, DOI 10.1046/j.1464-410X.1997.00215.x; MANDELL J, 1993, J UROLOGY, V150, P790, DOI 10.1016/S0022-5347(17)35614-8; Mei-Zahav M, 2001, BLOOD PRESS MONIT, V6, P263, DOI 10.1097/00126097-200110000-00007; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Narchi H, 2005, ARCH DIS CHILD, V90, P921, DOI 10.1136/adc.2005.075333; Quinlan J, 2007, J AM SOC NEPHROL, V18, P1915, DOI 10.1681/ASN.2006101107; Schreuder MF, 2008, J PAEDIATR CHILD H, V44, P363, DOI 10.1111/j.1440-1754.2008.01315.x; Taylor CM, 2006, ARCH DIS CHILD, V91, P277; van Vuuren SH, 2012, ULTRASOUND OBSTET GY; Zhang Z, 2008, J AM SOC NEPHROL, V19, P2027, DOI 10.1681/ASN.2007101098; Zhang Z, 2011, HUM MOL GENET, V20, P4167, DOI 10.1093/hmg/ddr341	27	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49735	10.1371/journal.pone.0049735	http://dx.doi.org/10.1371/journal.pone.0049735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185419	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000095
J	Hollon, J; Eide, M; Gorman, G				Hollon, Justin; Eide, Matilda; Gorman, Gregory			Early Diagnosis of Extrahepatic Biliary Atresia in an Open-Access Medical System	PLOS ONE			English	Article							HEALTH INSURANCE PROGRAM; IDENTIFICATION; EPIDEMIOLOGY; SURVIVAL; JAUNDICE; OUTCOMES; INFANTS; DISEASE; TAIWAN; WOMEN	Introduction: Biliary atresia (BA) is the most common cause of cholestatic jaundice in infancy. Early diagnosis and surgical management, ideally before 60 days of age, result in improved outcomes. We aimed to determine the age at diagnosis of BA in the Military Health System (MHS) and to compare the age at diagnosis by access to care models. We hypothesized that children with BA receiving primary care in military facilities have an earlier age at diagnosis due to decreased economic and access barriers. Methods: Data for all Tricare enrollees born in fiscal years 2004-2008 with a diagnosis of BA were extracted from MHS databases. Non-parametric tests, Kaplan-Meier curves and log rank tests compared differences in age at diagnosis by type of primary care facility, gender, prematurity and presence of additional anomalies. Results: 64 subjects were identified within the five year period. Median age at diagnosis was 40 days [range 1-189], with 67% diagnosed by 60 days and 80% by 90 days. 45 (70%) received civilian primary care within the MHS. There was no difference in the median age at diagnosis between subjects in the MHS with civilian primary care vs. military primary care (37 days [1-188] vs. 46 days [1-189]; p = 0.58). Conclusion: In the MHS, two-thirds of infants with biliary atresia are diagnosed prior to 60 days of life. Gender, prematurity or presence of additional anomalies do not affect the timing of diagnosis. Civilian and military primary care models within the MHS make timely diagnoses of biliary atresia at equivalent rates.	[Hollon, Justin; Eide, Matilda; Gorman, Gregory] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Hollon, Justin] Johns Hopkins Univ, Sch Med, Div Pediat Gastroenterol & Nutr, Baltimore, MD USA; [Gorman, Gregory] Walter Reed Natl Mil Med Ctr, Dept Pediat, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Johns Hopkins University; Walter Reed National Military Medical Center	Hollon, J (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA.	jhollon1@jhmi.edu						[Anonymous], 2008, BIRTH DEFECTS RES A, V82, P831; Bibb S C, 2001, Oncol Nurs Forum, V28, P711; Caton AR, 2004, PAEDIATR PERINAT EP, V18, P97, DOI 10.1111/j.1365-3016.2003.00536.x; Chardot C, 2001, J PEDIATR-US, V138, P224, DOI 10.1067/mpd.2001.111276; Chardot C, 2006, J PEDIATR-US, V148, P432, DOI 10.1016/j.jpeds.2006.01.049; Chen CS, 2005, AM J PUBLIC HEALTH, V95, P305, DOI 10.2105/AJPH.2002.012567; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Farley JH, 2001, CANCER, V91, P869, DOI 10.1002/1097-0142(20010215)91:4<869::AID-CNCR1075>3.0.CO;2-D; Hadzic N, 2003, J PEDIATR GASTR NUTR, V37, P430; Hsiao CH, 2008, HEPATOLOGY, V47, P1233, DOI 10.1002/hep.22182; MATSUI A, 1994, LANCET, V343, P925, DOI 10.1016/S0140-6736(94)90052-3; MIELIVERGANI G, 1989, LANCET, V1, P421; MOWAT AP, 1995, ARCH DIS CHILD, V72, P90, DOI 10.1136/adc.72.1.90; Moyer V, 2004, J PEDIATR GASTR NUTR, V39, P115, DOI 10.1097/00005176-200408000-00001; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Thomas AG, 2001, OBSTET GYNECOL, V98, P1117, DOI 10.1097/00006250-200112000-00022; Wadhwani SI, 2008, PEDIATRICS, V121, pE1438, DOI 10.1542/peds.2007-2709; Yoon PW, 1997, PEDIATRICS, V99, P376, DOI 10.1542/peds.99.3.376	19	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49643	10.1371/journal.pone.0049643	http://dx.doi.org/10.1371/journal.pone.0049643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185392	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700047
J	Li, X; Ren, AZ; Han, R; Yin, LJ; Wei, MY; Gao, YB				Li, Xia; Ren, Anzhi; Han, Rong; Yin, Lijia; Wei, Maoying; Gao, Yubao			Endophyte-Mediated Effects on the Growth and Physiology of Achnatherum sibiricum Are Conditional on Both N and P Availability	PLOS ONE			English	Article							LOLIUM-PERENNE; TALL FESCUE; ROOT SURFACE; NUTRIENT LIMITATION; NITROGEN-FERTILIZER; FESTUCA-ARUNDINACEA; NEOTYPHODIUM-LOLII; MYCORRHIZAL FUNGI; PHOSPHORUS; INFECTION	The interaction of endophyte-grass associations are conditional on nitrogen (N) availability, but the reported responses of these associations to N are inconsistent. We hypothesized that this inconsistency is caused, at least in part, by phosphorus (P) availability. In this experiment, we compared the performance of endophyte-infected (EI) and endophyte-free (EF) Achnatherum sibiricum subjected to four treatments comprising a factorial combination of two levels of N (N+ vs, N-, i.e. N supply vs. N deficiency) and two levels of P (P+ vs. P-, i.e. P supply vs. P deficiency) availability. The results showed that A. sibiricum-Neotyphodium associations were conditional on both N and P availability, but more conditional on N than P. Under N+P- conditions, endophyte infection significantly improved acid phosphatase activity of EI plants, such that the biomass of EI plants was not affected by P deficiency (i.e. similar growth to N+P+ conditions), and resulted in more biomass in EI than EF plants. Under N-P+ conditions, biomass of both EI and EF decreased compared with N+P+; however, EI biomass decreased slowly by decreasing leaf N concentration more rapidly but allocating higher fractions of N to photosynthetic machinery compared with EF plants. This change of N allocation not only improved photosynthetic ability of EI plants but also significantly increased their biomass. Under N-P- conditions, EI plants allocated higher fractions of N to photosynthesis and had greater P concentrations in roots, but there was no significant difference in biomass between EI and EF plants. Our results support the hypothesis that endophyte-grass interactions are dependent on both N and P availability. However, we did not find a clear cost of endophyte infection in A. sibiricum.	[Li, Xia; Ren, Anzhi; Han, Rong; Yin, Lijia; Wei, Maoying; Gao, Yubao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University	Ren, AZ (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	renanzhi@nankai.edu.cn			National Natural Science Foundation [30970460]; Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This research was funded by the National Natural Science Foundation (30970460) and the Scientific Research Foundation for Returned Overseas Chinese Scholars, State Education Ministry (2009-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm JU, 2002, OIKOS, V99, P173, DOI 10.1034/j.1600-0706.2002.990118.x; ALLEN EB, 1995, PLANT SOIL, V170, P47, DOI 10.1007/BF02183054; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bao S, 2000, ANAL METHODS SOIL CH, V3rd ed., P44; Bao YY, 2004, THESIS INNER MONGOLI; BRUEHL GW, 1994, MYCOLOGIA, V86, P773, DOI 10.2307/3760590; CHEPLICK GP, 1988, OIKOS, V52, P309, DOI 10.2307/3565204; CHEPLICK GP, 1989, NEW PHYTOL, V111, P89, DOI 10.1111/j.1469-8137.1989.tb04222.x; Cheplick GP, 2007, ENVIRON EXP BOT, V60, P202, DOI 10.1016/j.envexpbot.2006.10.001; CHUCHOU M, 1992, SOIL BIOL BIOCHEM, V24, P633, DOI 10.1016/0038-0717(92)90041-U; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; ELMI AA, 1995, NEW PHYTOL, V131, P61, DOI 10.1111/j.1469-8137.1995.tb03055.x; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Feng YL, 2008, PLANTA, V228, P383, DOI 10.1007/s00425-008-0732-2; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Fujita Y, 2010, OIKOS, V119, P1665, DOI 10.1111/j.1600-0706.2010.18427.x; Gonzalez AL, 2010, OIKOS, V119, P779, DOI 10.1111/j.1600-0706.2009.18549.x; Hesse U, 2003, GRASS FORAGE SCI, V58, P407, DOI 10.1111/j.1365-2494.2003.00393.x; Hikosaka K, 2004, J PLANT RES, V117, P481, DOI 10.1007/s10265-004-0174-2; Jeyasingh PD, 2009, ECOL LETT, V12, P1229, DOI 10.1111/j.1461-0248.2009.01368.x; Jin XiaoMing, 2010, Pratacultural Science, V27, P7; Kannadan S, 2008, FUNCT ECOL, V22, P706, DOI 10.1111/j.1365-2435.2008.01395.x; KROEHLER CJ, 1988, PLANT SOIL, V105, P3, DOI 10.1007/BF02371136; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; LATCH GCM, 1984, MYCOTAXON, V20, P535; Lewis GC, 2004, ANN APPL BIOL, V144, P53, DOI 10.1111/j.1744-7348.2004.tb00316.x; [李夏 Li Xia], 2010, [微生物学通报, Microbiology], V37, P1395; Lin F.P., 1999, CHIN J PLANT ECOL, V23, P220; Loustau D, 1999, TREE PHYSIOL, V19, P707; Mack KML, 2008, OIKOS, V117, P310, DOI 10.1111/j.2007.0030-1299.15973.x; Malinowski DP, 1999, J AGRON CROP SCI, V183, P53, DOI 10.1046/j.1439-037x.1999.00321.x; Malinowski DP, 1998, PLANT SOIL, V205, P1, DOI 10.1023/A:1004331932018; Malinowski DP, 1998, PLANT SOIL, V198, P53, DOI 10.1023/A:1004279401196; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; MARKS S, 1991, J APPL ECOL, V28, P194, DOI 10.2307/2404125; Marks S, 2007, INT J PLANT SCI, V168, P1269, DOI 10.1086/521834; McCormick MK, 2001, AM J BOT, V88, P903, DOI 10.2307/2657042; MCLACHLAN KD, 1980, AUST J AGR RES, V31, P429, DOI 10.1071/AR9800429; MOHREN GMJ, 1986, PLANT SOIL, V95, P191, DOI 10.1007/BF02375071; Morse LJ, 2007, FUNCT ECOL, V21, P813, DOI 10.1111/j.1365-2435.2007.01285.x; Mulder K, 2007, ECOL MODEL, V202, P427, DOI 10.1016/j.ecolmodel.2006.11.007; Muller CB, 2005, CURR OPIN PLANT BIOL, V8, P450, DOI 10.1016/j.pbi.2005.05.007; Niinemets U, 2003, PLANT CELL ENVIRON, V26, P941, DOI 10.1046/j.1365-3040.2003.01027.x; Niinemets U, 1997, PLANT CELL ENVIRON, V20, P845, DOI 10.1046/j.1365-3040.1997.d01-133.x; Onoda Y, 2004, FUNCT ECOL, V18, P419, DOI 10.1111/j.0269-8463.2004.00847.x; Petroski Richard J., 1992, Natural Toxins, V1, P84, DOI 10.1002/nt.2620010205; Poorter H, 1998, OECOLOGIA, V116, P26, DOI 10.1007/s004420050560; Ravel C, 1997, AGRONOMIE, V17, P173, DOI 10.1051/agro:19970304; Ravel C, 1999, AGRONOMIE, V19, P635, DOI 10.1051/agro:19990707; Ren AZ, 2007, PLANT SOIL ENVIRON, V53, P113, DOI 10.17221/2225-PSE; Ren AZ, 2009, J INTEGR PLANT BIOL, V51, P75, DOI 10.1111/j.1744-7909.2008.00721.x; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; VANDERWOUDE BJ, 1994, J APPL ECOL, V31, P405, DOI 10.2307/2404438; Wasaki J, 2003, PLANT SOIL, V248, P129, DOI 10.1023/A:1022332320384; Wei YK, 2006, GRASS FORAGE SCI, V61, P422, DOI 10.1111/j.1365-2494.2006.00551.x; WU ZL, 1995, ACTA PHYTOTAXONOMICA, V34, P152; Zabalgogeazcoa I, 2006, EUR J AGRON, V24, P374, DOI 10.1016/j.eja.2006.01.003	62	42	45	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48010	10.1371/journal.pone.0048010	http://dx.doi.org/10.1371/journal.pone.0048010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185245	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700005
J	Grujic, J; Rohl, T; Semmann, D; Milinski, M; Traulsen, A				Grujic, Jelena; Roehl, Torsten; Semmann, Dirk; Milinski, Manfred; Traulsen, Arne			Consistent Strategy Updating in Spatial and Non-Spatial Behavioral Experiments Does Not Promote Cooperation in Social Networks	PLOS ONE			English	Article							EVOLUTIONARY GAMES; DYNAMICS; DILEMMAS	The presence of costly cooperation between otherwise selfish actors is not trivial. A prominent mechanism that promotes cooperation is spatial population structure. However, recent experiments with human subjects report substantially lower level of cooperation then predicted by theoretical models. We analyze the data of such an experiment in which a total of 400 players play a Prisoner's Dilemma on a 4 x 4 square lattice in two treatments, either interacting via a fixed square lattice (15 independent groups) or with a population structure changing after each interaction (10 independent groups). We analyze the statistics of individual decisions and infer in which way they can be matched with the typical models of evolutionary game theorists. We find no difference in the strategy updating between the two treatments. However, the strategy updates are distinct from the most popular models which lead to the promotion of cooperation as shown by computer simulations of the strategy updating. This suggests that the promotion of cooperation by population structure is not as straightforward in humans as often envisioned in theoretical models.	[Grujic, Jelena] Univ Carlos III Madrid, Dept Matemat, GISC, Madrid, Spain; [Roehl, Torsten; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany; [Roehl, Torsten; Traulsen, Arne] Courant Res Ctr Evolut Social Behav, Res Grp Evolut Cooperat & Prosocial Behav, Gottingen, Germany; [Milinski, Manfred] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Plon, Germany	Universidad Carlos III de Madrid; Max Planck Society; Max Planck Society	Grujic, J (corresponding author), Univ Carlos III Madrid, Dept Matemat, GISC, Madrid, Spain.	jelenagr@gmail.com; traulsen@evolbio.mpg.de	Traulsen, Arne/A-4955-2009	Traulsen, Arne/0000-0002-0669-5267	German Initiative of Excellence of the German Science Foundation (DFG); Ministerio de Ciencia e Innovacion (MICINN) (Spain) [PRODIEVO, MOSAICO, FPI, EEBB]; Comunidad de Madrid (Spain) [MODELICO-CM]	German Initiative of Excellence of the German Science Foundation (DFG)(German Research Foundation (DFG)); Ministerio de Ciencia e Innovacion (MICINN) (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid)	D.S. acknowledges funding by the German Initiative of Excellence of the German Science Foundation (DFG). J.G.'s work was supported in part by The Ministerio de Ciencia e Innovacion (MICINN) (Spain) through grants PRODIEVO, MOSAICO, FPI, EEBB, and by Comunidad de Madrid (Spain) through grant MODELICO-CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Allen B, 2012, J THEOR BIOL, V299, P97, DOI 10.1016/j.jtbi.2011.03.034; Antal T, 2009, P NATL ACAD SCI USA, V106, P8597, DOI 10.1073/pnas.0902528106; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Darwin C., 1859, ORIGIN SPECIES MEANS; Eshel I, 1998, AM ECON REV, V88, P157; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fisher RA, 1935, DESIGN EXPT; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Gracia-Lazaro C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00325; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2002, INT J BIFURCAT CHAOS, V12, P1531, DOI 10.1142/S0218127402005273; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2010, P NATL ACAD SCI USA, V107, P5265, DOI 10.1073/pnas.1000140107; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030901; Kirchkamp O, 2007, GAME ECON BEHAV, V58, P269, DOI 10.1016/j.geb.2006.04.002; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; NOWAK MA, 1994, INT J BIFURCAT CHAOS, V4, P33, DOI 10.1142/S0218127494000046; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szathmary E, 1995, MAJOR TRANSITIONS EV; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Vukov J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017939; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Zschaler G, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093015	52	44	44	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e47718	10.1371/journal.pone.0047718	http://dx.doi.org/10.1371/journal.pone.0047718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040PB	23185242	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800004
J	Li, SW; Yang, H; Liu, YF; Liao, QR; Du, J; Jin, DC				Li, Shang-Wei; Yang, Hong; Liu, Yue-Feng; Liao, Qi-Rong; Du, Juan; Jin, Dao-Chao			Transcriptome and Gene Expression Analysis of the Rice Leaf Folder, Cnaphalocrosis medinalis	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; MOLECULAR-MECHANISMS; SEX DETERMINATION; LEPIDOPTERA; SILKWORM; CARBOXYLESTERASES; POPULATION; ANNOTATION; PHEROMONE; DYNAMICS	Background: The rice leaf folder (RLF), Cnaphalocrocis medinalis (Guenee) (Lepidoptera: Pyralidae), is one of the most destructive pests affecting rice in Asia. Although several studies have been performed on the ecological and physiological aspects of this species, the molecular mechanisms underlying its developmental regulation, behavior, and insecticide resistance remain largely unknown. Presently, there is a lack of genomic information for RLF; therefore, studies aimed at profiling the RLF transcriptome expression would provide a better understanding of its biological function at the molecular level. Principal Findings: De novo assembly of the RLF transcriptome was performed via the short read sequencing technology (Illumina). In a single run, we produced more than 23 million sequencing reads that were assembled into 44,941 unigenes (mean size = 474 bp) by Trinity. Through a similarity search, 25,281 (56.82%) unigenes matched known proteins in the NCBI Nr protein database. The transcriptome sequences were annotated with gene ontology (GO), cluster of orthologous groups of proteins (COG), and KEGG orthology (KO). Additionally, we profiled gene expression during RLF development using a tag-based digital gene expression (DGE) system. Five DGE libraries were constructed, and variations in gene expression were compared between collected samples: eggs vs. 3 rd instar larvae, 3 rd instar larvae vs. pupae, pupae vs. adults. The results demonstrated that thousands of genes were significantly differentially expressed during various developmental stages. A number of the differentially expressed genes were confirmed by quantitative real-time PCR (qRT-PCR). Conclusions: The RLF transcriptome and DGE data provide a comprehensive and global gene expression profile that would further promote our understanding of the molecular mechanisms underlying various biological characteristics, including development, elevated fecundity, flight, sex differentiation, olfactory behavior, and insecticide resistance in RLF. Therefore, these findings could help elucidate the intrinsic factors involved in the RLF-mediated destruction of rice and offer sustainable insect pest management.	[Li, Shang-Wei; Yang, Hong; Liu, Yue-Feng; Liao, Qi-Rong; Du, Juan; Jin, Dao-Chao] Guizhou Univ, Inst Entomol, Prov Key Lab Agr Pest Management Mt Reg, Guiyang 550003, Peoples R China	Guizhou University	Jin, DC (corresponding author), Guizhou Univ, Inst Entomol, Prov Key Lab Agr Pest Management Mt Reg, Guiyang 550003, Peoples R China.	jindaochao@163.com	, Shangwei/P-4513-2019	, Shangwei/0000-0002-1733-6438	National Basic Research Program of China (973 Program) [2009CB125908]; Provincial Key Project for Agricultural Science and Technology of Guizhou [NY20103064]; Natural Science Research Project of Guizhou Provincial Education Department [2010011]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Provincial Key Project for Agricultural Science and Technology of Guizhou; Natural Science Research Project of Guizhou Provincial Education Department	This work was supported by the National Basic Research Program of China (973 Program, No.2009CB125908) (website: http://program.most.gov.cn), the Provincial Key Project for Agricultural Science and Technology of Guizhou (No.NY20103064) (website: http://kjt.gzst.gov.cn/pages/index.aspx), and the Natural Science Research Project of Guizhou Provincial Education Department (No.2010011) (website: http://www.gzsjyt.gov.cn).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias Z, 2010, PESTIC BIOCHEM PHYS, V98, P94, DOI 10.1016/j.pestbp.2010.05.005; Alvi Shah Muhammad, 2003, International Journal of Agriculture and Biology, V5, P615; Anandan G. K., 2007, Resistant Pest Management Newsletter, V16, P3; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; [包云轩 Bao Yunxuan], 2008, [气象科学, Scientia Meteorologlca Sinica], V28, P184; Chertemps T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-56; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dale D, 1994, BIOL MANAGEMENT RICE, P432; De Kraker J, 2000, INT J PEST MANAGE, V46, P225, DOI 10.1080/096708700415571; Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Heong KL, 1992, RES RICE LEAFFOLDER, P8; Herranz R, 2005, MOL BIOL EVOL, V22, P2231, DOI 10.1093/molbev/msi223; KHAN ZR, 1988, INSECT SCI APPL, V9, P129, DOI 10.1017/S1742758400005919; Kohno S, 2010, SEX DEV, V4, P73, DOI 10.1159/000260374; LEHMAN W, 1975, J GEN PHYSIOL, V66, P1, DOI 10.1085/jgp.66.1.1; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Minakuchi C, 2011, INSECT BIOCHEM MOLEC, V41, P125, DOI 10.1016/j.ibmb.2010.11.004; Moore JR, 1999, J MUSCLE RES CELL M, V20, P797, DOI 10.1023/A:1005607818302; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Niewiadomska-Cimicka A, 2011, BBA-GENE REGUL MECH, V1809, P226, DOI 10.1016/j.bbagrm.2011.02.001; Nongthomba U, 2001, J MUSCLE RES CELL M, V22, P111, DOI 10.1023/A:1010308326890; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Picimbon JF, 1999, INSECT BIOCHEM MOLEC, V29, P973, DOI 10.1016/S0965-1748(99)00073-9; Pieau C, 1996, BIOESSAYS, V18, P19, DOI 10.1002/bies.950180107; SHEPARD BM, 1991, HDB PEST MANAGEMENT, P225; SPOTILA JR, 1994, J EXP ZOOL, V270, P117, DOI 10.1002/jez.1402700113; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tu CW, 1983, SCI AGR SINICA, V6, P76; Vogt R.G., 2005, P753; Vogt RG, 2002, J EXP BIOL, V205, P719; WADA T, 1980, APPL ENTOMOL ZOOL, V15, P81, DOI 10.1303/aez.15.81; Yan SG, 2009, PROTEIN PEPTIDE LETT, V16, P1181; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Zhao Y, 2007, AFR J BIOTECHNOL, V6, P672; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	43	47	54	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e47401	10.1371/journal.pone.0047401	http://dx.doi.org/10.1371/journal.pone.0047401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185238	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800001
J	Murdaugh, DL; Shinkareva, SV; Deshpande, HR; Wang, J; Pennick, MR; Kana, RK				Murdaugh, Donna L.; Shinkareva, Svetlana V.; Deshpande, Hrishikesh R.; Wang, Jing; Pennick, Mark R.; Kana, Rajesh K.			Differential Deactivation during Mentalizing and Classification of Autism Based on Default Mode Network Connectivity	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; FMRI DATA; BRAIN; SELF; MINDS; ABNORMALITIES; ATTRIBUTION; RETRIEVAL; SPECTRUM	The default mode network (DMN) is a collection of brain areas found to be consistently deactivated during task performance. Previous neuroimaging studies of resting state have revealed reduced task-related deactivation of this network in autism. We investigated the DMN in 13 high-functioning adults with autism spectrum disorders (ASD) and 14 typically developing control participants during three fMRI studies (two language tasks and a Theory-of-Mind (ToM) task). Each study had separate blocks of fixation/resting baseline. The data from the task blocks and fixation blocks were collated to examine deactivation and functional connectivity. Deficits in the deactivation of the DMN in individuals with ASD were specific only to the ToM task, with no group differences in deactivation during the language tasks or a combined language and self-other discrimination task. During rest blocks following the ToM task, the ASD group showed less deactivation than the control group in a number of DMN regions, including medial prefrontal cortex (MPFC), anterior cingulate cortex, and posterior cingulate gyrus/precuneus. In addition, we found weaker functional connectivity of the MPFC in individuals with ASD compared to controls. Furthermore, we were able to reliably classify participants into ASD or typically developing control groups based on both the whole-brain and seed-based connectivity patterns with accuracy up to 96.3%. These findings indicate that deactivation and connectivity of the DMN were altered in individuals with ASD. In addition, these findings suggest that the deficits in DMN connectivity could be a neural signature that can be used for classifying an individual as belonging to the ASD group.	[Murdaugh, Donna L.; Deshpande, Hrishikesh R.; Pennick, Mark R.; Kana, Rajesh K.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Shinkareva, Svetlana V.; Wang, Jing] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	University of Alabama System; University of Alabama Birmingham; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Kana, RK (corresponding author), Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA.	rkana@uab.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Murdaugh, Donna/0000-0001-8550-8353; Wang, Jing/0000-0001-6022-8240; Shinkareva, Svetlana/0000-0001-5112-4829	UAB College of Arts and Sciences Faculty Development Grant; McNulty-Civitan Scientist Award	UAB College of Arts and Sciences Faculty Development Grant; McNulty-Civitan Scientist Award	This research was supported by the UAB College of Arts and Sciences Faculty Development Grant and the McNulty-Civitan Scientist Award to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Anderson ML, 2010, COGNITION IN FLUX, P1511; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; DAWSON G, 1984, J AUTISM DEV DISORD, V14, P383, DOI 10.1007/BF02409829; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frith U, 2005, CONSCIOUS COGN, V14, P719, DOI 10.1016/j.concog.2005.04.006; Frith U, 1999, MIND LANG, V14, P1; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Groen WB, 2010, CEREB CORTEX, V20, P1937, DOI 10.1093/cercor/bhp264; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Huijbers W, 2011, NEUROPSYCHOLOGIA, V49, P1730, DOI 10.1016/j.neuropsychologia.2011.02.051; HURLBURT RT, 1994, PSYCHOL MED, V24, P385, DOI 10.1017/S0033291700027367; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2011, NEUROCASE, V17, P201, DOI 10.1080/13554794.2010.509320; Uddin LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003526; Zhao JZ, 2011, NEUROSCI LETT, V487, P27, DOI 10.1016/j.neulet.2010.09.067	52	73	73	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50064	10.1371/journal.pone.0050064	http://dx.doi.org/10.1371/journal.pone.0050064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040PB	23185536	gold, Green Published, Green Submitted			2022-12-25	WOS:000311333800067
J	Abdul, F; Ndeboko, B; Buronfosse, T; Zoulim, F; Kann, M; Nielsen, PE; Cova, L				Abdul, Fabien; Ndeboko, Benedicte; Buronfosse, Thierry; Zoulim, Fabien; Kann, Michael; Nielsen, Peter E.; Cova, Lucyna			Potent Inhibition of Late Stages of Hepadnavirus Replication by a Modified Cell Penetrating Peptide	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; NEUTRALIZING HUMORAL RESPONSE; LARGE ENVELOPE PROTEIN; HERPES-SIMPLEX-VIRUS; CLOSED CIRCULAR DNA; NUCLEIC-ACIDS PNA; ANTI-HSV ACTIVITY; IN-VITRO; REVERSE TRANSCRIPTION; MONOCLONAL-ANTIBODIES	Cationic cell-penetrating peptides (CPPs) and their lipid domain-conjugates (CatLip) are agents for the delivery of (uncharged) biologically active molecules into the cell. Using infection and transfection assays we surprisingly discovered that CatLip peptides were able to inhibit replication of Duck Hepatitis B Virus (DHBV), a reference model for human HBV. Amongst twelve CatLip peptides we identified Deca-(Arg)(8) having a particularly potent antiviral activity, leading to a drastic inhibition of viral particle secretion without detectable toxicity. Inhibition of virion secretion was correlated with a dose-dependent increase in intracellular viral DNA. Deca-(Arg)(8) peptide did neither interfere with DHBV entry, nor with formation of mature nucleocapsids nor with their travelling to the nucleus. Instead, Deca-(Arg)(8) caused envelope protein accumulation in large clusters as revealed by confocal laser scanning microscopy indicating severe structural changes of preS/S. Sucrose gradient analysis of supernatants from Deca-(Arg)(8)-treated cells showed unaffected naked viral nucleocapsids release, which was concomitant with a complete arrest of virion and surface protein-containing subviral particle secretion. This is the first report showing that a CPP is able to drastically block hepadnaviral release from infected cells by altering late stages of viral morphogenesis via interference with enveloped particle formation, without affecting naked nucleocapsid egress, thus giving a view inside the mode of inhibition. Deca-(Arg)(8) may be a useful tool for elucidating the hepadnaviral secretory pathway, which is not yet fully understood. Moreover we provide the first evidence that a modified CPP displays a novel antiviral mechanism targeting another step of viral life cycle compared to what has been so far described for other enveloped viruses.	[Abdul, Fabien; Ndeboko, Benedicte; Buronfosse, Thierry; Zoulim, Fabien; Cova, Lucyna] Univ Lyon 1, F-69365 Lyon, France; [Abdul, Fabien; Ndeboko, Benedicte; Buronfosse, Thierry; Zoulim, Fabien; Cova, Lucyna] CRCL, INSERM, U1052, Lyon, France; [Abdul, Fabien; Ndeboko, Benedicte; Buronfosse, Thierry; Zoulim, Fabien; Cova, Lucyna] Ctr Rech Cancerol Lyon, CNRS, UMR 5286, Lyon, France; [Buronfosse, Thierry] VetAgro Sup, Marcy Letoile, France; [Kann, Michael] Univ Bordeaux, UMR 5234, Bordeaux, France; [Kann, Michael] CNRS, UMR 5234, Bordeaux, France; [Kann, Michael] CHU Bordeaux, Bordeaux, France; [Nielsen, Peter E.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen N, Denmark; [Nielsen, Peter E.] Univ Copenhagen, Dept Drug Design & Pharmacol, Fac Hlth & Med Sci, Panum Inst, Copenhagen N, Denmark	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; University of Copenhagen; University of Copenhagen	Cova, L (corresponding author), Univ Lyon 1, F-69365 Lyon, France.	lucyna.cova@inserm.fr	Zoulim, Fabien/ABD-5594-2021	Zoulim, Fabien/0000-0002-2245-0083; /0000-0001-8771-330X	Agence National de la Recherche contre le SIDA (ANRS); Fondation pour la Recherche Medicale (FRM); INSERM; French National Agency of Research on Aids and Hepatitis B and C (ANRS); ANRS	Agence National de la Recherche contre le SIDA (ANRS)(ANRS); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French National Agency of Research on Aids and Hepatitis B and C (ANRS)(ANRS); ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by grants of the Agence National de la Recherche contre le SIDA (ANRS)(http://www.anrs.fr/) to MK, LC and FA and the Fondation pour la Recherche Medicale (FRM)(http://www.frm.org/) to MK and INSERM to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from French National Agency of Research on Aids and Hepatitis B and C (ANRS). Fabien Abdul was the recipient of a fellowship from ANRS. We thank for expert assistance with animals for PDH preparation.	Andersen JH, 2004, J MED VIROL, V74, P262, DOI 10.1002/jmv.20171; Bardens A, 2011, CELL MICROBIOL, V13, P602, DOI 10.1111/j.1462-5822.2010.01557.x; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Bendifallah N, 2006, BIOCONJUGATE CHEM, V17, P750, DOI 10.1021/bc050283q; Borel C, 2001, HEPATOLOGY, V34, P168, DOI 10.1053/jhep.2001.25637; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Bruss V, 2004, VIRUS RES, V106, P199, DOI 10.1016/j.virusres.2004.08.016; Bruss V, 2007, WORLD J GASTROENTERO, V13, P65, DOI 10.3748/wjg.v13.i1.65; CHASSOT S, 1993, VIROLOGY, V192, P217, DOI 10.1006/viro.1993.1024; CONDREAY LD, 1990, J VIROL, V64, P3249, DOI 10.1128/JVI.64.7.3249-3258.1990; Cova Lucyna, 2004, Methods Mol Med, V96, P261; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Gares SL, 2006, CLIN VACCINE IMMUNOL, V13, P958, DOI 10.1128/CVI.00080-06; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; GONG SS, 1995, J VIROL, V69, P8102, DOI 10.1128/JVI.69.12.8102-8108.1995; Guo JT, 1997, J VIROL, V71, P4829, DOI 10.1128/JVI.71.6.4829-4831.1997; Guterstam P, 2009, BBA-BIOMEMBRANES, V1788, P2509, DOI 10.1016/j.bbamem.2009.09.014; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Holm T, 2006, NAT PROTOC, V1, P1001, DOI 10.1038/nprot.2006.174; HUOVILA APJ, 1992, J CELL BIOL, V118, P1305, DOI 10.1083/jcb.118.6.1305; Jenssen H, 2004, ANTIVIR RES, V61, P101, DOI 10.1016/j.antiviral.2003.09.001; Jenssen H, 2004, ANTIVIR RES, V64, P119, DOI 10.1016/j.antiviral.2004.08.003; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kann M, 2007, WORLD J GASTROENTERO, V13, P39, DOI 10.3748/wjg.v13.i1.39; Khawaja G, 2012, VIROLOGY, V425, P61, DOI 10.1016/j.virol.2012.01.001; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Koppelhus U, 2008, BIOCONJUGATE CHEM, V19, P1526, DOI 10.1021/bc800068h; Lambert C, 2001, J BIOL CHEM, V276, P22265, DOI 10.1074/jbc.M100956200; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Le Guerhier F, 2000, ANTIMICROB AGENTS CH, V44, P111, DOI 10.1128/AAC.44.1.111-122.2000; Lizzi AR, 2009, MINI-REV MED CHEM, V9, P687, DOI 10.2174/138955709788452757; Mabit H, 2000, J VIROL, V74, P11472, DOI 10.1128/JVI.74.24.11472-11478.2000; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; MANDART E, 1984, J VIROL, V49, P782, DOI 10.1128/JVI.49.3.782-792.1984; Marcellin P, 2009, LIVER INT, V29, P1, DOI 10.1111/j.1478-3231.2008.01947.x; Mhamdi M, 2007, HEPATOLOGY, V46, P95, DOI 10.1002/hep.21666; Narayan R, 2006, J GEN VIROL, V87, P3225, DOI 10.1099/vir.0.82170-0; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nielsen PE, 2005, Q REV BIOPHYS, V38, P345, DOI 10.1017/S0033583506004148; NOIVA R, 1992, J BIOL CHEM, V267, P3553; Patient R, 2009, CELL MICROBIOL, V11, P1561, DOI 10.1111/j.1462-5822.2009.01363.x; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Rabe B, 2006, J VIROL, V80, P5465, DOI 10.1128/JVI.02303-05; Rabe B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000563; Ren ST, 2001, J VIROL, V75, P1104, DOI 10.1128/JVI.75.3.1104-1116.2001; Robaczewska M, 2005, J HEPATOL, V42, P180, DOI 10.1016/j.jhep.2004.10.010; Rollier C, 1999, GASTROENTEROLOGY, V116, P658, DOI 10.1016/S0016-5085(99)70188-5; Saade F, 2008, VACCINE, V26, P5159, DOI 10.1016/j.vaccine.2008.03.086; Schmidt N., 2009, FEBS LETT; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shiraishi T, 2011, METHODS MOL BIOL, V751, P209, DOI 10.1007/978-1-61779-151-2_13; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Thermet A, 2004, J VIROL, V78, P1945, DOI 10.1128/JVI.78.4.1945-1953.2004; Tillmann HL, 2007, WORLD J GASTROENTERO, V13, P125, DOI 10.3748/wjg.v13.i1.125; Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968; Villet S, 2009, GASTROENTEROLOGY, V136, P168, DOI 10.1053/j.gastro.2008.09.068; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010; Zoulim F, 1996, ANTIMICROB AGENTS CH, V40, P448, DOI 10.1128/AAC.40.2.448; Zoulim F, 2008, HEPATITIS B VIRUS AN	63	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e48721	10.1371/journal.pone.0048721	http://dx.doi.org/10.1371/journal.pone.0048721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173037	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300007
J	Durand, A; Chauveau, F; Cho, TH; Bolbos, R; Langlois, JB; Hermitte, L; Wiart, M; Berthezene, Y; Nighoghossian, N				Durand, Anne; Chauveau, Fabien; Cho, Tae-Hee; Bolbos, Radu; Langlois, Jean-Baptiste; Hermitte, Laure; Wiart, Marlene; Berthezene, Yves; Nighoghossian, Norbert			Spontaneous Reperfusion after In Situ Thromboembolic Stroke in Mice	PLOS ONE			English	Article							MRI; MODEL; TIME	Injection of thrombin into the middle cerebral artery (MCA) of mice has been proposed as a new model of thromboembolic stroke. The present study used sequential multiparametric Magnetic Resonance Imaging (MRI), including Magnetic Resonance Angiography (MRA), Diffusion-Weighted Imaging (DWI) and Perfusion-Weighted Imaging (PWI), to document MCA occlusion, PWI-DWI mismatch, and lesion development. In the first experiment, complete MCA occlusion and reproducible hypoperfusion were obtained in 85% of animals during the first hour after stroke onset. In the second experiment, 80% of animals showed partial to complete reperfusion during a three-hour follow-up. Spontaneous reperfusion thus contributed to the variability in ischemic volume in this model. The study confirmed the value of the model for evaluating new thrombolytic treatments, but calls for extended MRI follow-up at the acute stage in therapeutic studies.	[Durand, Anne; Chauveau, Fabien; Cho, Tae-Hee; Hermitte, Laure; Wiart, Marlene; Berthezene, Yves; Nighoghossian, Norbert] Univ Lyon 1, Hosp Civils Lyon, CREATIS, CNRS,UMR5220,INSERM,U1044,INSA Lyon, F-69365 Lyon, France; [Bolbos, Radu; Langlois, Jean-Baptiste] Animage, CERMEP Imagerie Vivant, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Nighoghossian, N (corresponding author), Univ Lyon 1, Hosp Civils Lyon, CREATIS, CNRS,UMR5220,INSERM,U1044,INSA Lyon, F-69365 Lyon, France.	norbert.nighoghossian@chu-lyon.fr	Wiart, Marlene/K-3839-2014; Chauveau, Fabien/T-4295-2019; Chauveau, Fabien/I-9722-2014; Nighoghossian, Norbert/H-7492-2014; Cho, Tae-Hee/GOJ-9942-2022; Cho, Tae-Hee/I-5491-2014; Berthezene, yves/I-5689-2014	Wiart, Marlene/0000-0003-0326-7002; Chauveau, Fabien/0000-0002-4177-741X; Chauveau, Fabien/0000-0002-4177-741X; Cho, Tae-Hee/0000-0001-8677-2447; 				Calamante F, 2001, STROKE, V32, P2810, DOI 10.1161/hs1201.099893; Campbell BC, STROKE, V41, P82; Chauveau F, 2011, CURR NEUROVASC RES, V8, P95, DOI 10.2174/156720211795495349; Cho T-H, 2012, INT J STROKE; Dobre MC, 2007, MAGN RESON IMAGING, V25, P733, DOI 10.1016/j.mri.2006.10.020; Donnan GA, 2009, LANCET NEUROL, V8, P261, DOI 10.1016/S1474-4422(09)70041-9; Garcia-Yebenes I, 2011, STROKE, V42, P196, DOI 10.1161/STROKEAHA.110.600452; Gauberti M, 2012, CEREBROVASC DIS, V33, P329, DOI 10.1159/000335309; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Legos JJ, 2008, EXP NEUROL, V212, P53, DOI 10.1016/j.expneurol.2008.03.011; Macrez R, 2011, STROKE, V42, P2315, DOI 10.1161/STROKEAHA.110.606293; Marinescu M, 2012, EUR RADIOL; Meng XJ, 2004, ANN NEUROL, V55, P207, DOI 10.1002/ana.10803; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; Zaro-Weber O, 2010, STROKE, V41, P443, DOI 10.1161/STROKEAHA.109.569889	15	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50083	10.1371/journal.pone.0050083	http://dx.doi.org/10.1371/journal.pone.0050083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166825	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300085
J	Sattar, S; Addo-Quaye, C; Song, Y; Anstead, JA; Sunkar, R; Thompson, GA				Sattar, Sampurna; Addo-Quaye, Charles; Song, Yan; Anstead, James A.; Sunkar, Ramanjulu; Thompson, Gary A.			Expression of Small RNA in Aphis gossypii and Its Potential Role in the Resistance Interaction with Melon	PLOS ONE			English	Article							FEEDING-BEHAVIOR; MICRORNAS; RECOGNITION; PIRNAS; SITE	Background: The regulatory role of small RNAs (sRNAs) in various biological processes is an active area of investigation; however, there has been limited information available on the role of sRNAs in plant-insect interactions. This study was designed to identify sRNAs in cotton-melon aphid (Aphis gossypii) during the Vat-mediated resistance interaction with melon (Cucumis melo). Methodology/Principal Findings: The role of miRNAs was investigated in response to aphid herbivory, during both resistant and susceptible interactions. sRNA libraries made from A. gossypii tissues feeding on Vat(+) and Vat(-) plants revealed an unexpected abundance of 27 nt long sRNA sequences in the aphids feeding on Vat+ plants. Eighty-one conserved microRNAs (miRNAs), twelve aphid-specific miRNAs, and nine novel candidate miRNAs were also identified. Plant miRNAs found in the aphid libraries were most likely ingested during phloem feeding. The presence of novel miRNAs was verified by qPCR experiments in both resistant Vat(+) and susceptible Vat(-) interactions. The comparative analyses revealed that novel miRNAs were differentially regulated during the resistant and susceptible interactions. Gene targets predicted for the miRNAs identified in this study by in silico analyses revealed their involvement in morphogenesis and anatomical structure determination, signal transduction pathways, cell differentiation and catabolic processes. Conclusion/Significance: In this study, conserved and novel miRNAs were reported in A. gossypii. Deep sequencing data showed differences in the abundance of miRNAs and piRNA-like sequences in A. gossypii. Quantitative RT-PCR revealed that A. gossypii miRNAs were differentially regulated during resistant and susceptible interactions. Aphids can also ingest plant miRNAs during phloem feeding that are stable in the insect.	[Sattar, Sampurna; Anstead, James A.; Thompson, Gary A.] Penn State Univ, Coll Agr Sci, University Pk, PA 16802 USA; [Addo-Quaye, Charles] Penn State Univ, Dept Ecosyst Sci & Management, Schatz Ctr Tree Mol Genet, University Pk, PA 16802 USA; [Song, Yan; Sunkar, Ramanjulu] Oklahoma State Univ, Bioinformat Core Facil, Stillwater, OK 74078 USA; [Song, Yan] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Sattar, S (corresponding author), Penn State Univ, Coll Agr Sci, University Pk, PA 16802 USA.	sus56@psu.edu; gat10@psu.edu	Sunkar, Ramanjulu/L-2982-2014; Addo-Quaye, Charles/J-3694-2016	Addo-Quaye, Charles/0000-0003-0598-5980	National Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture [2009-35302-30592]; Schatz Center for Tree Molecular Genetics	National Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture; Schatz Center for Tree Molecular Genetics	This research was supported by National Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture, grant number 2009-35302-30592. CAQ was supported by The Schatz Center for Tree Molecular Genetics. The funding agency had no role in in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BAUMANN P, 1995, APPL ENVIRON MICROB, V61, P1; Behura SK, 2007, INSECT BIOCHEM MOLEC, V37, P3, DOI 10.1016/j.ibmb.2006.10.006; Belles X, 2012, 2 INSECT MICRORNAS M, P30; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bohn G. W., 1972, HortScience, V7, P281; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JQ, 1996, ENTOMOL EXP APPL, V80, P250, DOI 10.1007/BF00194768; Chen Q, 2012, PLOS ONE, P7, DOI [10.1371/journal.-pone.0032860, DOI 10.1371/J0URNAL.-P0NE.0032860]; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; DOGIMONT C, 2008, CUCURBITACEAE 2008; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Foster SP, 2007, ANIM BEHAV, V74, P621, DOI 10.1016/j.anbehav.2006.12.018; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Garzo E, 2002, PHYTOPARASITICA, V30, P129, DOI 10.1007/BF02979695; Gauthier JP, 2007, BIOINFORMATICS, V23, P783, DOI 10.1093/bioinformatics/btl682; Gomez-Orte E, 2009, P NATL ACAD SCI USA, V106, P21678, DOI 10.1073/pnas.0907391106; Gonzalez-Ibeas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-393; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; KENNEDY GG, 1977, J ECON ENTOMOL, V70, P407, DOI 10.1093/jee/70.4.407; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Klingler J, 1998, ENTOMOL EXP APPL, V86, P79, DOI 10.1023/A:1003153410049; Klingler J, 2001, J AM SOC HORTIC SCI, V126, P56, DOI 10.21273/JASHS.126.1.56; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee L, 2005, AM PHYT SOC ANN M AU, P579; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legeai F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-281; Lin HF, 1997, DEVELOPMENT, V124, P2463; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; McCreight J.D., 1992, REP CUCURBIT GENET C, V15, P51; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mishima Y, 2007, CELL, V129, P247, DOI 10.1016/j.cell.2007.04.008; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pauquet J, 2004, PROGR CUCURBIT GENET, P325; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rodriguez-Medina C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-36; Sattar S, 2012, MOL PLANT MICROBE IN, V25, P839, DOI 10.1094/MPMI-09-11-0252; Silver SJ, 2007, P NATL ACAD SCI USA, V104, P18151, DOI 10.1073/pnas.0706673104; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Soria C, 2003, EUPHYTICA, V133, P313, DOI 10.1023/A:1025721329026; Tsurudome K, 2010, NEURON, V68, P879, DOI 10.1016/j.neuron.2010.11.016; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Varkonyi-Gasic E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-159; WALTERS KFA, 1988, ECOL ENTOMOL, V13, P337, DOI 10.1111/j.1365-2311.1988.tb00364.x; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	67	29	30	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e48579	10.1371/journal.pone.0048579	http://dx.doi.org/10.1371/journal.pone.0048579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173035	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885300005
J	Somm, E; Vauthay, DM; Guerardel, A; Toulotte, A; Cettour-Rose, P; Klee, P; Meda, P; Aubert, ML; Huppi, PS; Schwitzgebel, VM				Somm, Emmanuel; Vauthay, Delphine M.; Guerardel, Audrey; Toulotte, Audrey; Cettour-Rose, Philippe; Klee, Philippe; Meda, Paolo; Aubert, Michel L.; Hueppi, Petra S.; Schwitzgebel, Valerie M.			Early Metabolic Defects in Dexamethasone-Exposed and Undernourished Intrauterine Growth Restricted Rats	PLOS ONE			English	Article							CATCH-UP GROWTH; INTERLEUKIN-1 RECEPTOR ANTAGONIST; HEPATIC INSULIN-RESISTANCE; BETA-CELL DEVELOPMENT; GLUCOCORTICOID EXPOSURE; ADIPOSE-TISSUE; PANCREAS DEVELOPMENT; GLUCOSE-INTOLERANCE; PROTEIN RESTRICTION; ENDOCRINE PANCREAS	Poor fetal growth, also known as intrauterine growth restriction (IUGR), is a worldwide health concern. IUGR is commonly associated with both an increased risk in perinatal mortality and a higher prevalence of developing chronic metabolic diseases later in life. Obesity, type 2 diabetes or metabolic syndrome could result from noxious "metabolic programming." In order to better understand early alterations involved in metabolic programming, we modeled IUGR rat pups through either prenatal exposure to synthetic glucocorticoid (dams infused with dexamethasone 100 mg/kg/day, DEX) or prenatal undernutrition (dams feeding restricted to 30% of ad libitum intake, UN). Physiological (glucose and insulin tolerance), morphometric (automated tissue image analysis) and transcriptomic (quantitative PCR) approaches were combined during early life of these IUGR pups with a special focus on their endocrine pancreas and adipose tissue development. In the absence of catch-up growth before weaning, DEX and UN IUGR pups both presented basal hyperglycaemia, decreased glucose tolerance, and pancreatic islet atrophy. Other early metabolic defects were model-specific: DEX pups presented decreased insulin sensitivity whereas UN pups exhibited lowered glucose-induced insulin secretion and more marked alterations in gene expression of pancreatic islet and adipose tissue development regulators. In conclusion, these results show that before any catch-up growth, IUGR rats present early physiologic, morphologic and transcriptomic defects, which can be considered as initial mechanistic basis of metabolic programming.	[Somm, Emmanuel; Vauthay, Delphine M.; Guerardel, Audrey; Toulotte, Audrey; Cettour-Rose, Philippe; Klee, Philippe; Aubert, Michel L.; Hueppi, Petra S.; Schwitzgebel, Valerie M.] Univ Geneva, Sch Med, Dept Paediat, CH-1211 Geneva, Switzerland; [Meda, Paolo] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Somm, E (corresponding author), Univ Geneva, Sch Med, Dept Paediat, CH-1211 Geneva, Switzerland.	emmanuel.somm@unige.ch	Huppi, Petra S./A-4079-2009; Huppi, Petra/A-4079-2009	Huppi, Petra S./0000-0002-7383-6648; Schwitzgebel, Valerie/0000-0002-8015-950X; Huppi, Petra/0000-0002-7063-4215	Swiss National Science Foundation [50, 310030_141162, CR32I3_129987]; Juvenile Diabetes Research Foundation [40-2011-11]; European Union [BETAIMAGE 222980, C2008-T7]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission)	This work was supported by a grant from the Swiss National Science Foundation targeted National Research Program 50 "Endocrine disruptors: relevance to humans, animals and ecosystems" grants to Pr Michel Aubert and Pr Petra Huppi. Pr Paolo Meda is supported by grants from Swiss National Science Foundation (310030_141162, CR32I3_129987), the Juvenile Diabetes Research Foundation (40-2011-11) and the European Union (BETAIMAGE 222980; IMIDIA, C2008-T7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieswal F, 2004, J NUTR, V134, P1493, DOI 10.1093/jn/134.6.1493; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Blondeau B, 2002, DIABETOLOGIA, V45, P394, DOI 10.1007/s00125-001-0767-4; Bol VV, 2008, OBESITY, V16, P2760, DOI 10.1038/oby.2008.417; Briana DD, 2009, EUR J ENDOCRINOL, V160, P337, DOI 10.1530/EJE-08-0621; Buhl ES, 2007, AM J PHYSIOL-ENDOC M, V293, pE1451, DOI 10.1152/ajpendo.00356.2007; Cleasby ME, 2003, ENDOCRINOLOGY, V144, P999, DOI 10.1210/en.2002-220559; Delahaye F, 2010, AM J PHYSIOL-REG I, V299, pR101, DOI 10.1152/ajpregu.00604.2009; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2008, REPROD SCI, V15, P785, DOI 10.1177/1933719108318597; Drake AJ, 2005, AM J PHYSIOL-REG I, V288, pR34, DOI 10.1152/ajpregu.00106.2004; Dumortier O, 2007, DIABETOLOGIA, V50, P2495, DOI 10.1007/s00125-007-0811-0; Ellis-Hutchings RG, 2010, BIRTH DEFECTS RES B, V89, P396, DOI 10.1002/bdrb.20265; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Eriksson JG, 2003, DIABETES CARE, V26, P3006, DOI 10.2337/diacare.26.11.3006; ERIKSSON UJ, 1984, PEDIATR RES, V18, P735, DOI 10.1203/00006450-198408000-00012; Garofano A, 1998, BIOL NEONATE, V73, P89, DOI 10.1159/000013964; Garofano A, 1997, DIABETOLOGIA, V40, P1231, DOI 10.1007/s001250050812; Gesina E, 2006, DIABETOLOGIA, V49, P2939, DOI 10.1007/s00125-006-0449-3; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Holemans K, 1996, J SOC GYNECOL INVEST, V3, P71, DOI 10.1016/1071-5576(95)00046-1; Holness MJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE946, DOI 10.1152/ajpendo.1996.270.6.E946; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Lim K, 2011, PEDIAT RES; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mutel E, 2011, DIABETES, V60, P3121, DOI 10.2337/db11-0571; Nyirenda MJ, 2006, DIABETOLOGIA, V49, P1412, DOI 10.1007/s00125-006-0188-5; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Nyirenda MJ, 2001, J ENDOCRINOL, V170, P653, DOI 10.1677/joe.0.1700653; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Ozanne SE, 1997, AM J PHYSIOL-ENDOC M, V273, pE46, DOI 10.1152/ajpendo.1997.273.1.E46; Pouteau E, 2008, INT J OBESITY, V32, P648, DOI 10.1038/sj.ijo.0803787; Raab EL, 2009, AM J PHYSIOL-REG I, V297, pR1785, DOI 10.1152/ajpregu.00519.2009; Reusens B, 2006, INT J BIOCHEM CELL B, V38, P913, DOI 10.1016/j.biocel.2005.10.012; Schwitzgebel VM, 2009, MOL CELL ENDOCRINOL, V304, P78, DOI 10.1016/j.mce.2009.02.019; Shahkhalili Y, 2010, AM J PHYSIOL-REG I, V298, pR141, DOI 10.1152/ajpregu.00128.2009; Shen CN, 2003, BIOCHEM J, V375, P41, DOI 10.1042/BJ20030140; Slieker LJ, 1996, J BIOL CHEM, V271, P5301, DOI 10.1074/jbc.271.10.5301; Somm E, 2006, DIABETOLOGIA, V49, P387, DOI 10.1007/s00125-005-0046-x; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; Soto N, 2003, J CLIN ENDOCR METAB, V88, P3645, DOI 10.1210/jc.2002-030031; Sugden MC, 2001, EUR J ENDOCRINOL, V145, P529, DOI 10.1530/eje.0.1450529; TAPANAINEN PJ, 1994, PEDIATR RES, V36, P152, DOI 10.1203/00006450-199408000-00004; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005	54	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50131	10.1371/journal.pone.0050131	http://dx.doi.org/10.1371/journal.pone.0050131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166830	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885300086
J	Souza, PM; Elias, ST; Simeoni, LA; de Paula, JE; Gomes, SM; Guerra, ENS; Fonseca, YM; Silva, EC; Silveira, D; Magalhaes, PO				Souza, Paula Monteiro; Elias, Silvia Taveira; Simeoni, Luiz Alberto; de Paula, Jose Elias; Gomes, Sueli Maria; Silva Guerra, Eliete Neves; Fonseca, Yris Maria; Silva, Elton Clementino; Silveira, Damaris; Magalhaes, Perola Oliveira			Plants from Brazilian Cerrado with Potent Tyrosinase Inhibitory Activity	PLOS ONE			English	Article							MUSHROOM TYROSINASE; CONSTITUENTS; MECHANISM; EXTRACTS	The increased amount of melanin leads to skin disorders such as age spots, freckles, melasma and malignant melanoma. Tyrosinase is known to be the key enzyme in melanin production. Plants and their extracts are inexpensive and rich resources of active compounds that can be utilized to inhibit tyrosinase as well as can be used for the treatment of dermatological disorders associated with melanin hyperpigmentation. Using in vitro tyrosinase inhibitory activity assay, extracts from 13 plant species from Brazilian Cerrado were evaluated. The results showed that Pouteria torta and Eugenia dysenterica extracts presented potent in vitro tyrosinase inhibition compared to positive control kojic acid. Ethanol extract of Eugenia dysenterica leaves showed significant (p<0.05) tyrosinase inhibitory activity exhibiting the IC50 value of 11.88 mu g/mL, compared to kojic acid (IC50 value of 13.14 mu g/mL). Pouteria torta aqueous extract leaves also showed significant inhibitory activity with IC50 value of 30.01 mu g/mL. These results indicate that Pouteria torta and Eugenia dysenterica extracts and their isolated constituents are promising agents for skin-whitening or antimelanogenesis formulations.	[Souza, Paula Monteiro; Simeoni, Luiz Alberto; Fonseca, Yris Maria; Silva, Elton Clementino; Silveira, Damaris; Magalhaes, Perola Oliveira] Univ Brasilia, Sch Hlth Sci, Dept Pharmaceut Sci, Brasilia, DF, Brazil; [Elias, Silvia Taveira; Silva Guerra, Eliete Neves] Univ Brasilia, Sch Hlth Sci, Dept Odontol, Brasilia, DF, Brazil; [de Paula, Jose Elias; Gomes, Sueli Maria] Univ Brasilia, Inst Biol Sci, Dept Bot, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Magalhaes, PO (corresponding author), Univ Brasilia, Sch Hlth Sci, Dept Pharmaceut Sci, Campus Darcy Ribeiro, Brasilia, DF, Brazil.	perolamagalhaes@unb.br	Fonseca, Yris M/A-9893-2016; Guerra, Eliete Neves Silva/E-1021-2016; Souza, Paula/AAE-5731-2021; Gomes, Sueli M./J-7147-2012; MAGALHÃES, PÉROLA/P-3378-2018; Simeoni, Luiz Alberto/A-9088-2008; Silveira, Damaris/J-5165-2019; MAGALHÃES, PÉROLA O/P-2521-2017; Silveira, Damaris/A-1942-2008	Fonseca, Yris M/0000-0002-1230-3207; Guerra, Eliete Neves Silva/0000-0002-7622-1550; Gomes, Sueli M./0000-0002-6234-7777; MAGALHÃES, PÉROLA/0000-0001-8011-6940; Simeoni, Luiz Alberto/0000-0003-3401-290X; Silveira, Damaris/0000-0003-1851-5224; MAGALHÃES, PÉROLA O/0000-0001-8011-6940; Silveira, Damaris/0000-0003-1851-5224; Souza, Paula/0000-0003-1824-2211; Elias, Silvia/0000-0001-7309-0877	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF); Fundacao de Empreendimentos Cientificos e Tecnologicos (FINATEC); Conselho Nacional de Pesquisa (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Empreendimentos Cientificos e Tecnologicos (FINATEC); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF), Fundacao de Empreendimentos Cientificos e Tecnologicos (FINATEC), Conselho Nacional de Pesquisa (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The authors are grateful to Universidade de Brasilia (UnB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baurin N, 2002, J ETHNOPHARMACOL, V82, P155, DOI 10.1016/S0378-8741(02)00174-5; Boonclarm D, 2006, ACTA BIOCH BIOPH SIN, V38, P563, DOI 10.1111/j.1745-7270.2006.00196.x; Caramori SS, 2004, BRAZ ARCH BIOL TECHN, V47, P253, DOI 10.1590/S1516-89132004000200013; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Costa TR, 2000, J ETHNOPHARMACOL, V72, P111, DOI 10.1016/S0378-8741(00)00214-2; de Faria RO, 2007, FOOD TECHNOL BIOTECH, V45, P287; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; Falguera V, 2010, FOOD RES INT, V43, P66, DOI 10.1016/j.foodres.2009.08.013; Karioti A, 2007, BIOORGAN MED CHEM, V15, P2708, DOI 10.1016/j.bmc.2007.01.035; Khan SB, 2005, CHEM PHARM BULL, V53, P86, DOI 10.1248/cpb.53.86; Khatib S, 2005, BIOORGAN MED CHEM, V13, P433, DOI 10.1016/j.bmc.2004.10.010; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kim YJ, 2004, BIOMACROMOLECULES, V5, P474, DOI 10.1021/bm034320x; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Kubo I, 2007, MOLECULES, V12, P1045, DOI 10.3390/12051045; Lee K. T., 1997, International Journal of Cosmetic Science, V19, P291, DOI 10.1046/j.1467-2494.1997.171725.x; Lin JW, 2008, J FOOD DRUG ANAL, V16, P1, DOI 10.1097/01.JNR.0000387284.45935.c7; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; MATSUDA H, 1995, BIOL PHARM BULL, V18, P1148, DOI 10.1248/bpb.18.1148; Momtaz S, 2008, J ETHNOPHARMACOL, V119, P507, DOI 10.1016/j.jep.2008.06.006; Momtaz S, 2008, S AFR J BOT, V74, P577, DOI 10.1016/j.sajb.2008.02.005; Nakatsu T, 2000, STUD NAT PROD CHEM, V21, P571; Napolitano DR, 2005, J ETHNOPHARMACOL, V99, P37, DOI 10.1016/j.jep.2005.01.059; No JK, 1999, LIFE SCI, V65, pPL241, DOI 10.1016/S0024-3205(99)00492-0; Ortonne JP, 2005, DERMATOL CLIN, V23, P209, DOI 10.1016/j.det.2005.01.001; Parvez S, 2007, PHYTOTHER RES, V21, P805, DOI 10.1002/ptr.2184; Petit L., 2003, International Journal of Cosmetic Science, V25, P169, DOI 10.1046/j.1467-2494.2003.00182.x; Rebecca MA, 2002, J ETHNOPHARMACOL, V83, P101, DOI 10.1016/S0378-8741(02)00219-2; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Si YX, 2012, J BIOMOL STRUCT DYN, V29, P999, DOI 10.1080/073911012010525028; Silva CAM, 2009, REV BRAS FARMACOGN, V19, P501, DOI 10.1590/S0102-695X2009000300025; Wang H, 2010, J TAIWAN I CHEM ENG	33	54	58	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e48589	10.1371/journal.pone.0048589	http://dx.doi.org/10.1371/journal.pone.0048589			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173036	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300006
J	Wehbe, M; Soudja, SM; Mas, A; Chasson, L; Guinamard, R; de Tenbossche, CP; Verdeil, G; Van den Eynde, B; Schmitt-Verhulst, AM				Wehbe, Maria; Soudja, Saidi M.; Mas, Amandine; Chasson, Lionel; Guinamard, Rodolphe; de Tenbossche, Celine Powis; Verdeil, Gregory; Van den Eynde, Benoit; Schmitt-Verhulst, Anne-Marie			Epithelial-Mesenchymal-Transition-Like and TGF beta Pathways Associated with Autochthonous Inflammatory Melanoma Development in Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; UP-REGULATION; NEURAL CREST; CELL LINES; SNAIL; EXPRESSION; PHOSPHORYLATION; GROWTH; RAS	We compared gene expression signatures of aggressive amelanotic (Amela) melanomas with those of slowly growing pigmented melanomas (Mela), identifying pathways potentially responsible for the aggressive Amela phenotype. Both tumors develop in mice upon conditional deletion in melanocytes of Ink4a/Arf tumor suppressor genes with concomitant expression of oncogene H-Ras(G12V) and a known tumor antigen. We previously showed that only the aggressive Amela tumors were highly infiltrated by leukocytes concomitant with local and systemic inflammation. We report that Amela tumors present a pattern of de-differentiation with reduced expression of genes involved in pigmentation. This correlates with reduced and enhanced expression, respectively, of microphthalmia-associated (Mitf) and Pou3f2/Brn-2 transcription factors. The reduced expression of Mitf-controlled melanocyte differentiation antigens also observed in some human cutaneous melanoma has important implications for immunotherapy protocols that generally target such antigens. Induced Amela tumors also express Epithelial-Mesenchymal-Transition (EMT)-like and TGF beta-pathway signatures. These are correlated with constitutive Smad3 signaling in Amela tumors and melanoma cell lines. Signatures of infiltrating leukocytes and some chemokines such as chemotactic cytokine ligand 2 (Ccl2) that contribute to leukocyte recruitment further characterize Amela tumors. Inhibition of the mitogen-activated protein kinase (MAPK) activation pathway in Amela tumor lines leads to reduced expression of EMT hallmark genes and inhibits both proinflammatory cytokine Ccl2 gene expression and Ccl2 production by the melanoma cells. These results indicate a link between EMT-like processes and alterations of immune functions, both being controlled by the MAPK pathway. They further suggest that targeting the MAPK pathway within tumor cells will impact tumor-intrinsic oncogenic properties as well as the nature of the tumor microenvironment.	[Wehbe, Maria; Soudja, Saidi M.; Mas, Amandine; Chasson, Lionel; Guinamard, Rodolphe; Verdeil, Gregory; Schmitt-Verhulst, Anne-Marie] Aix Marseille Univ, UM2, CIML, Marseille, France; [Wehbe, Maria; Soudja, Saidi M.; Mas, Amandine; Chasson, Lionel; Guinamard, Rodolphe; Verdeil, Gregory; Schmitt-Verhulst, Anne-Marie] INSERM, F-13258 Marseille, France; [Wehbe, Maria; Soudja, Saidi M.; Mas, Amandine; Chasson, Lionel; Guinamard, Rodolphe; Verdeil, Gregory; Schmitt-Verhulst, Anne-Marie] CNRS, Marseille, France; [de Tenbossche, Celine Powis; Van den Eynde, Benoit] UCL, Ludwig Inst Canc Res, Brussels, Belgium; [de Tenbossche, Celine Powis; Van den Eynde, Benoit] UCL, Cellular Genet Unit, Brussels, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Schmitt-Verhulst, AM (corresponding author), Aix Marseille Univ, UM2, CIML, Marseille, France.	verhulst@ciml.univ-mrs.fr	Verdeil, Gregory/GZL-0065-2022; Guinamard, Rodolphe/P-9804-2016	Wehbe, Maria/0000-0003-2900-2811; Guinamard, Rodolphe/0000-0002-7400-582X; Verdeil, Gregory/0000-0001-9445-8474; Schmitt-Verhulst, Anne-Marie/0000-0002-1296-2739	INSERM; CNRS; "Institut National du Cancer" (INCA); INCA PROCAN program; European Communities (Integrated project "Cancerimmunotherapy") [LSHC-CT-2006-518234]; Association pour la Recherche sur le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); "Institut National du Cancer" (INCA)(Institut National du Cancer (INCA) France); INCA PROCAN program; European Communities (Integrated project "Cancerimmunotherapy"); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by institutional funding from INSERM and CNRS, and by grants from the "Institut National du Cancer" (INCA) and the INCA PROCAN program (to AMSV), the European Communities (Integrated project "Cancerimmunotherapy" LSHC-CT-2006-518234 to AMSV and to BVdE) and the "Association pour la Recherche sur le Cancer" (to AMSV). MW and SMS were the recipients of doctoral fellowships from the "Association pour la Recherche sur le Cancer." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Choi BY, 2005, NAT STRUCT MOL BIOL, V12, P699, DOI 10.1038/nsmb960; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Du F, 2010, CANCER RES, V70, P10080, DOI 10.1158/0008-5472.CAN-10-0324; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; Gotzmann J, 2002, J CELL SCI, V115, P1189; Grange M, 2012, CANCER RES, V72, P76, DOI 10.1158/0008-5472.CAN-11-2187; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Herlyn M, 2000, MELANOMA RES, V10, P303, DOI 10.1097/00008390-200008000-00001; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huijbers IJ, 2006, CANCER RES, V66, P3278, DOI 10.1158/0008-5472.CAN-05-3216; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamaraju AK, 2002, J BIOL CHEM, V277, P15132, DOI 10.1074/jbc.M200004200; Kobi D, 2010, PIGM CELL MELANOMA R, V23, P404, DOI 10.1111/j.1755-148X.2010.00697.x; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kuphal S, 2005, MELANOMA RES, V15, P305, DOI 10.1097/00008390-200508000-00012; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Li DX, 1997, J BIOL CHEM, V272, P25062, DOI 10.1074/jbc.272.40.25062; Li G, 2001, CANCER RES, V61, P3819; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nevala WK, 2009, CLIN CANCER RES, V15, P1931, DOI 10.1158/1078-0432.CCR-08-1980; Nielsen C, 2007, CANCER RES, V67, P178, DOI 10.1158/0008-5472.CAN-06-2801; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Salti GI, 2000, CANCER RES, V60, P5012; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shirley SH, 2012, AM J PATHOL, V180, P2479, DOI 10.1016/j.ajpath.2012.02.014; Soudja SM, 2010, CANCER RES, V70, P3515, DOI 10.1158/0008-5472.CAN-09-4354; Stuelten CH, 2007, BIOTECHNIQUES, V43, P289, DOI 10.2144/000112549; Tesseur I, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-15; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WALTER S, 1991, INT J CANCER, V49, P431, DOI 10.1002/ijc.2910490321; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamagata H, 2005, CANCER RES, V65, P157; Yang JM, 2010, J CLIN INVEST, V120, P2563, DOI 10.1172/JCI42358; Zaidi MR, 2012, CANCER RES, V72, P1591, DOI 10.1158/0008-5472.CAN-11-2586; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	64	32	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49419	10.1371/journal.pone.0049419	http://dx.doi.org/10.1371/journal.pone.0049419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173060	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300038
J	Margariti, A; Li, HL; Chen, T; Martin, D; Vizcay-Barrena, G; Alam, S; Karamariti, E; Xiao, QZ; Zampetaki, A; Zhang, ZY; Wang, W; Jiang, ZX; Gao, C; Ma, BY; Chen, YG; Cockerill, G; Hu, YH; Xu, QB; Zeng, LF				Margariti, Andriana; Li, Hongling; Chen, Ting; Martin, Daniel; Vizcay-Barrena, Gema; Alam, Saydul; Karamariti, Eirini; Xiao, Qingzhong; Zampetaki, Anna; Zhang, Zhongyi; Wang, Wen; Jiang, Zhixin; Gao, Chan; Ma, Benyu; Chen, Ye-Guang; Cockerill, Gillian; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang			XBP1 mRNA Splicing Triggers an Autophagic Response in Endothelial Cells through BECLIN-1 Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SMOOTH-MUSCLE-CELLS; ER STRESS; DEATH; ATHEROSCLEROSIS; APOPTOSIS; PATHWAY; ANGIOGENESIS; DEACETYLATION	Sustained activation of X-box-binding protein 1 (XBP1) results in endothelial cell (EC) apoptosis and atherosclerosis development. The present study provides evidence that XBP1 mRNA splicing triggered an autophagic response in ECs by inducing autophagic vesicle formation and markers of autophagy BECLIN-1 and microtubule-associated protein 1 light chain 3 beta (LC3-beta II). Endostatin activated autophagic gene expression through XBP1 mRNA splicing in an inositol-requiring enzyme 1 alpha (IRE1 alpha)-dependent manner. Knockdown of XBP1 or IRE1 alpha by shRNA in ECs ablated endostatin-induced autophagosome formation. Importantly, data from arterial vessels from XBP1 EC conditional knock-out (XBP1eko) mice demonstrated that XBP1 deficiency in ECs reduced the basal level of LC3 beta expression and ablated response to endostatin. Chromatin immunoprecipitation assays further revealed that the spliced XBP1 isoform bound directly to the BECLIN-1 promoter at the region from nt -537 to -755. BECLIN-1 deficiency in ECs abolished the XBP1-induced autophagy response, whereas spliced XBP1 did not induce transcriptional activation of a truncated BECLIN-1 promoter. These results suggest that XBP1 mRNA splicing triggers an autophagic signal pathway through transcriptional regulation of BECLIN-1.	[Margariti, Andriana; Li, Hongling; Martin, Daniel; Alam, Saydul; Karamariti, Eirini; Zampetaki, Anna; Zhang, Zhongyi; Hu, Yanhua; Xu, Qingbo; Zeng, Lingfang] Kings Coll London BHF Ctr, Div Cardiovasc, London SE5 9NU, England; [Chen, Ting] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Vizcay-Barrena, Gema] Kings Coll London, Ctr Ultrastruct Imaging, London WC2R 2LS, England; [Xiao, Qingzhong] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Clin Pharmacol, London EC1M 6BQ, England; [Wang, Wen] Queen Mary Univ London, Sch Engn & Mat Sci, London E1 4NS, England; [Jiang, Zhixin] 305th Hosp Peoples Liberat Army, Ctr Lab, Beijing 100017, Peoples R China; [Gao, Chan; Ma, Benyu; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Cockerill, Gillian] St Georges Univ London, Dept Cardiovasc Sci, London SW17 0RE, England	University of London; King's College London; Zhejiang University; University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; Tsinghua University; St Georges University London	Margariti, A (corresponding author), Kings Coll London BHF Ctr, Div Cardiovasc, 125 Coldharbour Lane, London SE5 9NU, England.	andriani.margariti@kcl.ac.uk; lingfang.zeng@kcl.ac.uk	Margariti, Andriana/AAH-5318-2019; Chen, Ye-Guang/L-6998-2019; Gao, Chan/D-7964-2013	Zeng, Lingfang/0000-0002-0390-4561; Zampetaki, Anna/0000-0002-7257-8624	British Heart Foundation; Oak Foundation; British Heart Foundation [FS/09/044/28007, PG/11/40/28891, PG/12/11/29408, FS/13/18/30207] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Oak Foundation; British Heart Foundation(British Heart Foundation)	This work was supported by Grants from the British Heart Foundation and the Oak Foundation.	Chau YP, 2003, HISTOL HISTOPATHOL, V18, P715, DOI 10.14670/HH-18.715; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Du JH, 2012, AM J PHYSIOL-CELL PH, V302, pC383, DOI 10.1152/ajpcell.00164.2011; Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Ghavami S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.61; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Han Qiao, 2011, Zhonghua Yi Xue Za Zhi, V91, P2216; Hetz C, 2008, P NATL ACAD SCI USA, V105, P757, DOI 10.1073/pnas.0711094105; Hu PF, 2012, INT J MOL MED, V29, P613, DOI 10.3892/ijmm.2012.891; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P422, DOI 10.1111/j.1440-1711.2006.01449.x; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Mitra AK, 2004, CAN J PHYSIOL PHARM, V82, P860, DOI 10.1139/Y04-095; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Razani B, 2012, CELL METAB, V15, P534, DOI 10.1016/j.cmet.2012.02.011; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rovetta F, 2012, EXP CELL RES, V318, P238, DOI 10.1016/j.yexcr.2011.11.008; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Schrijvers DM, 2011, ARTERIOSCL THROM VAS, V31, P2787, DOI 10.1161/ATVBAHA.111.224899; Sirois I, 2012, AUTOPHAGY, V8, P927, DOI 10.4161/auto.19768; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tao R, 2011, CELL RES, V21, P1619, DOI 10.1038/cr.2011.58; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Vidal RL, 2012, AUTOPHAGY, V8, P970, DOI 10.4161/auto.20139; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Wang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010409; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshimori T, 2007, CELL, V128, P833, DOI 10.1016/j.cell.2007.02.023; Yoshimori Tamotsu, 2004, Tanpakushitsu Kakusan Koso, V49, P1029; Younce C, 2012, CELL PHYSIOL BIOCHEM, V30, P307, DOI 10.1159/000339066; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zhang YL, 2010, BIOCHEM BIOPH RES CO, V394, P377, DOI 10.1016/j.bbrc.2010.03.026	58	183	195	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					859	872		10.1074/jbc.M112.412783	http://dx.doi.org/10.1074/jbc.M112.412783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184933	hybrid, Green Published			2022-12-25	WOS:000313570300011
J	Margaron, Y; Fradet, N; Cote, JF				Margaron, Yoran; Fradet, Nadine; Cote, Jean-Francois			ELMO Recruits Actin Cross-linking Family 7 (ACF7) at the Cell Membrane for Microtubule Capture and Stabilization of Cellular Protrusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; INTEGRIN-LINKED KINASE; RAC ACTIVATOR; MYOBLAST CITY; RHO GTPASES; CRKII/DOCK180/RAC PATHWAY; NEUTROPHIL CHEMOTAXIS; COLLECTIVE MIGRATION; SIGNALING PATHWAY; EXCHANGE FACTORS	ELMO and DOCK180 proteins form an evolutionarily conserved module controlling Rac GTPase signaling during cell migration, phagocytosis, and myoblast fusion. Here, we identified the microtubule and actin-binding spectraplakin ACF7 as a novel ELMO-interacting partner. AC-terminal polyproline segment in ELMO and the last spectrin repeat of ACF7 mediate a direct interaction between these proteins. Co-expression of ELMO1 with ACF7 promoted the formation of long membrane protrusions during integrin-mediated cell spreading. Quantification of membrane dynamics established that coupling of ELMO and ACF7 increases the persistence of the protruding activity. Mechanistically, we uncovered a role for ELMO in the recruitment of ACF7 to the membrane to promote microtubule capture and stability. Functionally, these effects of ELMO and ACF7 on cytoskeletal dynamics required the Rac GEF DOCK180. In conclusion, our findings support a role for ELMO in protrusion stability by acting at the interface between the actin cytoskeleton and the microtubule network.	[Margaron, Yoran; Fradet, Nadine; Cote, Jean-Francois] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Cote, Jean-Francois] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Cote, Jean-Francois] McGill Univ, Div Expt Med, Montreal, PQ H3A 1A3, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Cote, JF (corresponding author), Inst Rech Clin Montreal, 110 Ave Pins Ouest, Montreal, PQ H2W 1R7, Canada.	jean-francois.cote@ircm.qc.ca			Canadian Cancer Society [019104]; Canadian Institute of Health Research [MOP 77591]; Fonds de Recherche en Sante du Quebec post-doctoral fellowship; Fonds de Recherche en Sante du Quebec Junior 2 career award	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec post-doctoral fellowship; Fonds de Recherche en Sante du Quebec Junior 2 career award	This work was supported by Operating Grant 019104 from the Canadian Cancer Society and Canadian Institute of Health Research Grant MOP 77591 (to J.-F. C.).; Recipient of a Fonds de Recherche en Sante du Quebec post-doctoral fellowship.; Recipient of a Fonds de Recherche en Sante du Quebec Junior 2 career award. To whom correspondence should be addressed: IRCM, 110 Avenue des Pins Ouest, Montreal, PQ H2W 1R7, Canada. Tel.: 514-987-5647; Fax: 514-987-5624; E-mail: jean-francois.cote@ircm.qc.ca.	Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2009, SCIENCE, V324, P346, DOI 10.1126/science.1173646; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ho E, 2012, MOL BIOL CELL, V23, P492, DOI 10.1091/mbc.E11-07-0596; Ho E, 2009, MOL BIOL CELL, V20, P3033, DOI 10.1091/mbc.E09-01-0050; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Kunisaki Y, 2006, J CELL BIOL, V174, P647, DOI 10.1083/jcb.200602142; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Mitra RD, 1996, GENE, V173, P13, DOI 10.1016/0378-1119(95)00768-7; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parrini MC, 2011, MOL CELL, V42, P650, DOI 10.1016/j.molcel.2011.03.032; Patel M, 2011, J BIOL CHEM, V286, P38969, DOI 10.1074/jbc.M111.274191; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Poukkula M, 2011, J CELL BIOL, V192, P513, DOI 10.1083/jcb.201010003; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Sun YP, 1999, J BIOL CHEM, V274, P33522, DOI 10.1074/jbc.274.47.33522; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	65	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1184	1199		10.1074/jbc.M112.431825	http://dx.doi.org/10.1074/jbc.M112.431825			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184944	Green Published, hybrid			2022-12-25	WOS:000313570300040
J	Tang, J; Majeti, JW; Sudom, A; Xiong, YM; Lu, M; Liu, Q; Higbee, J; Zhang, Y; Wang, Y; Wang, W; Cao, P; Xia, Z; Johnstone, S; Min, XS; Yang, XP; Shao, H; Yu, T; Sharkov, N; Walker, N; Tu, H; Shen, WY; Wang, ZL				Tang, Jie; Majeti, Jiangwen; Sudom, Athena; Xiong, Yumei; Lu, Mei; Liu, Qiang; Higbee, Jared; Zhang, Yi; Wang, Yan; Wang, Wei; Cao, Ping; Xia, Zhen; Johnstone, Sheree; Min, Xiaoshan; Yang, Xiaoping; Shao, Hui; Yu, Timothy; Sharkov, Nik; Walker, Nigel; Tu, Hua; Shen, Wenyan; Wang, Zhulun			An Inhibitory Antibody against Dipeptidyl Peptidase IV Improves Glucose Tolerance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ADENOSINE-DEAMINASE; PROTEASE INHIBITION; 7-36 AMIDE; COMPLEX; POTENT; CD26; VILDAGLIPTIN; MEMBRANE; MOLECULE	Dipeptidyl peptidase IV (DPP-IV) degrades the incretin hormone glucagon-like peptide 1 (GLP-1). Small molecule DPP-IV inhibitors have been used as treatments for type 2 diabetes to improve glucose tolerance. However, each of the marketed small molecule drugs has its own limitation in terms of efficacy and side effects. To search for an alternative strategy of inhibiting DPP-IV activity, we generated a panel of tight binding inhibitory mouse monoclonal antibodies (mAbs) against rat DPP-IV. When tested in vitro, these mAbs partially inhibited the GLP-1 cleavage activity of purified enzyme and rat plasma. To understand the partial inhibition, we solved the co-crystal structure of one of the mAb Fabs (Ab1) in complex with rat DPP-IV. Although Ab1 does not bind at the active site, it partially blocks the side opening, which prevents the large substrates such as GLP-1 from accessing the active site, but not small molecules such as sitagliptin. When Ab1 was tested in vivo, it reduced plasma glucose and increased plasma GLP-1 concentration during an oral glucose tolerance test in rats. Together, we demonstrated the feasibility of using mAbs to inhibit DPP-IV activity and to improve glucose tolerance in a diabetic rat model.	[Tang, Jie; Lu, Mei; Liu, Qiang; Higbee, Jared; Zhang, Yi; Wang, Yan; Wang, Wei; Cao, Ping; Xia, Zhen; Yang, Xiaoping; Shao, Hui; Yu, Timothy; Sharkov, Nik; Shen, Wenyan] Amgen Inc, Dept Biol, 1120 Vet Blvd, San Francisco, CA 94080 USA; [Majeti, Jiangwen; Xiong, Yumei; Tu, Hua] Amgen Inc, Dept Metab Disorders, San Francisco, CA 94080 USA; [Sudom, Athena; Johnstone, Sheree; Min, Xiaoshan; Walker, Nigel; Wang, Zhulun] Amgen Inc, Dept Mol Struct, San Francisco, CA 94080 USA	Amgen; Amgen; Amgen	Tang, J (corresponding author), Amgen Inc, Dept Biol, 1120 Vet Blvd, San Francisco, CA 94080 USA.	jiet@amgen.com; zwang@amgen.com			United States Department of Energy at the Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]	United States Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	The ALS is supported by the United States Department of Energy under Contract DE-AC03-76SF00098 at the Lawrence Berkeley National Laboratory.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Balkan B, 1999, DIABETOLOGIA, V42, P1324, DOI 10.1007/s001250051445; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chahal H, 2007, QJM-INT J MED, V100, P671, DOI 10.1093/qjmed/hcm081; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Che ZW, 1998, J VIROL, V72, P4610, DOI 10.1128/JVI.72.6.4610-4622.1998; Davidson Jaime A, 2009, Cleve Clin J Med, V76 Suppl 5, pS28, DOI 10.3949/ccjm.76.s5.05; Deacon CF, 2011, DIABETES OBES METAB, V13, P7, DOI 10.1111/j.1463-1326.2010.01306.x; Deacon CF, 2004, DIABETES, V53, P2181, DOI 10.2337/diabetes.53.9.2181; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel SS, 2010, INT J CLIN PRACT, V64, P984, DOI 10.1111/j.1742-1241.2010.02382.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gallwitz B, 2011, EXPERT OPIN INV DRUG, V20, P723, DOI 10.1517/13543784.2011.576667; Ganesan R, 2009, STRUCTURE, V17, P1614, DOI 10.1016/j.str.2009.09.014; Garber AJ, 2010, AM J MANAG CARE, V16, pS187; Gorrell MD, 2005, CLIN SCI, V108, P277, DOI 10.1042/CS20040302; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Gupta R, 2009, CURR DRUG TARGETS, V10, P71, DOI 10.2174/138945009787122860; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Keating GM, 2010, DRUGS, V70, P2089, DOI 10.2165/11206370-000000000-00000; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Kirby M, 2010, CLIN SCI, V118, P31, DOI 10.1042/CS20090047; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Ligueros-Saylan M, 2010, DIABETES OBES METAB, V12, P495, DOI 10.1111/j.1463-1326.2010.01214.x; Longenecker KL, 2006, BIOCHEMISTRY-US, V45, P7474, DOI 10.1021/bi060184f; MARGUET D, 1992, J BIOL CHEM, V267, P2200; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; MISUMI Y, 1992, BIOCHIM BIOPHYS ACTA, V1131, P333, DOI 10.1016/0167-4781(92)90036-Y; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Pederson RA, 1998, DIABETES, V47, P1253, DOI 10.2337/diabetes.47.8.1253; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Richter B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006739.pub2; Rosenblum JS, 2003, CURR OPIN CHEM BIOL, V7, P496, DOI 10.1016/S1367-5931(03)00084-X; Sheehan SM, 2007, BIOORG MED CHEM LETT, V17, P1765, DOI 10.1016/j.bmcl.2006.12.074; Sun J, 2003, BIOCHEMISTRY-US, V42, P892, DOI 10.1021/bi026878f; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; Weihofen WA, 2005, J BIOL CHEM, V280, P14911, DOI 10.1074/jbc.M413400200; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Williams-Herman D, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-7; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104	46	5	6	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1307	1316		10.1074/jbc.M112.396317	http://dx.doi.org/10.1074/jbc.M112.396317			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184939	hybrid, Green Published			2022-12-25	WOS:000313570300052
J	Brown, EM; McDougall, GJ; Stewart, D; Pereira-Caro, G; Gonzalez-Barrio, R; Allsopp, P; Magee, P; Crozier, A; Rowland, I; Gill, CIR				Brown, Emma M.; McDougall, Gordon J.; Stewart, Derek; Pereira-Caro, Gema; Gonzalez-Barrio, Rocio; Allsopp, Philip; Magee, Pamela; Crozier, Alan; Rowland, Ian; Gill, Chris I. R.			Persistence of Anticancer Activity in Berry Extracts after Simulated Gastrointestinal Digestion and Colonic Fermentation	PLOS ONE			English	Article							ANTHOCYANIN-RICH EXTRACTS; PHENOLIC-COMPOUNDS; ELLAGIC ACID; FECAL WATER; CANCER; POLYPHENOLS; BIOAVAILABILITY; PHYTOCHEMICALS; INVASION; CELLS	Fruit and vegetable consumption is associated at the population level with a protective effect against colorectal cancer. Phenolic compounds, especially abundant in berries, are of interest due to their putative anticancer activity. After consumption, however, phenolic compounds are subject to digestive conditions within the gastrointestinal tract that alter their structures and potentially their function. However, the majority of phenolic compounds are not efficiently absorbed in the small intestine and a substantial portion pass into the colon. We characterized berry extracts (raspberries, strawberries, blackcurrants) produced by in vitro-simulated upper intestinal tract digestion and subsequent fecal fermentation. These extracts and selected individual colonic metabolites were then evaluated for their putative anticancer activities using in vitro models of colorectal cancer, representing the key stages of initiation, promotion and invasion. Over a physiologically-relevant dose range (0-50 mg/ml gallic acid equivalents), the digested and fermented extracts demonstrated significant anti-genotoxic, anti-mutagenic and anti-invasive activity on colonocytes. This work indicates that phenolic compounds from berries undergo considerable structural modifications during their passage through the gastrointestinal tract but their breakdown products and metabolites retain biological activity and can modulate cellular processes associated with colon cancer.	[Brown, Emma M.; Allsopp, Philip; Magee, Pamela; Gill, Chris I. R.] Univ Ulster, Ctr Mol Biosci, No Ireland Ctr Food & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland; [McDougall, Gordon J.; Stewart, Derek] James Hutton Inst, Environm & Biochem Sci Grp, Dundee, Scotland; [Pereira-Caro, Gema; Gonzalez-Barrio, Rocio; Crozier, Alan] Univ Glasgow, Sch Med, Plant Prod & Human Nutr Grp, Glasgow, Lanark, Scotland; [Rowland, Ian] Univ Reading, Hugh Sinclair Unit Human Nutr, Dept Food & Nutr Sci, Reading, Berks, England; [Stewart, Derek] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland	Ulster University; James Hutton Institute; University of Glasgow; University of Reading; Heriot Watt University	Gill, CIR (corresponding author), Univ Ulster, Ctr Mol Biosci, No Ireland Ctr Food & Hlth, Coleraine BT52 1SA, Londonderry, North Ireland.	C.Gill@ulster.ac.uk	Gonzalez-Barrio, Rocío/F-2180-2018; Crozier, Alan/H-6642-2017	Gonzalez-Barrio, Rocío/0000-0002-6648-5229; Crozier, Alan/0000-0001-7581-6782; Brown, Emma/0000-0002-2762-2489; Magee, Pamela/0000-0002-0479-3314; Pereira Caro, Gema/0000-0003-3162-0432	University of Ulster; N. Ireland Department of Education and Learning; James Hutton Institute; Washington Red Raspberry Commission	University of Ulster; N. Ireland Department of Education and Learning; James Hutton Institute; Washington Red Raspberry Commission	EB was in receipt of a joint PhD studentship scheme between the University of Ulster (an award from the N. Ireland Department of Education and Learning), and the James Hutton Institute. The study was part funded by the Washington Red Raspberry Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LS, 2010, CANCER RES, V70, P3594, DOI 10.1158/0008-5472.CAN-09-3565; Aura Anna-Marja, 2008, Phytochemistry Reviews, V7, P407, DOI 10.1007/s11101-008-9095-3; Bermudez-Soto MJ, 2007, FOOD CHEM, V102, P865, DOI 10.1016/j.foodchem.2006.06.025; Borges G, 2010, J AGR FOOD CHEM, V58, P3901, DOI 10.1021/jf902263n; Boyd LA, 2006, NUTR CANCER, V55, P232, DOI 10.1207/s15327914nc5502_15; Brown EM, 2012, CURR PHARM BIOTECHNO, V13, P200; Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033; Coates Emma M, 2007, J Carcinog, V6, P4, DOI 10.1186/1477-3163-6-4; Duthie SJ, 2007, MOL NUTR FOOD RES, V51, P665, DOI 10.1002/mnfr.200600257; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gil-Izquierdo A, 2002, EUR FOOD RES TECHNOL, V214, P155, DOI 10.1007/s00217-001-0428-3; Gonzalez-Barrio R, 2010, J AGR FOOD CHEM, V58, P3933, DOI 10.1021/jf100315d; Gonzalez-Sarrias A, 2010, BRIT J NUTR, V104, P503, DOI 10.1017/S0007114510000826; Hashim YZHY, 2008, INT J CANCER, V122, P495, DOI 10.1002/ijc.23148; Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003; Jenner AM, 2005, FREE RADICAL BIO MED, V38, P763, DOI 10.1016/j.freeradbiomed.2004.11.020; Johnson IT, 2004, MUTAT RES-FUND MOL M, V551, P9, DOI 10.1016/j.mrfmmm.2004.02.017; Lala G, 2006, NUTR CANCER, V54, P84, DOI 10.1207/s15327914nc5401_10; Macheix JJ, 1990, FRUIT PHENOLICS; Makena PS, 2007, FOOD CHEM TOXICOL, V45, P1899, DOI 10.1016/j.fct.2007.04.007; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; McCann MJ, 2008, MOL NUTR FOOD RES, V52, P567, DOI 10.1002/mnfr.200700052; McDougall G, 2007, ACTA HORTIC, P135, DOI 10.17660/ActaHortic.2007.744.13; McDougall GJ, 2005, J AGR FOOD CHEM, V53, P5896, DOI 10.1021/jf050131p; Nielsen ILF, 2003, J AGR FOOD CHEM, V51, P2813, DOI 10.1021/jf025947u; Parr C, 2000, INT J CANCER, V85, P563, DOI 10.1002/(SICI)1097-0215(20000215)85:4<563::AID-IJC19>3.0.CO;2-D; Pearson JR, 2009, NUTR REV, V67, P509, DOI 10.1111/j.1753-4887.2009.00224.x; Perez-Vicente A, 2002, J AGR FOOD CHEM, V50, P2308, DOI 10.1021/jf0113833; Petermann A, 2009, MOL NUTR FOOD RES, V53, P1245, DOI 10.1002/mnfr.200900110; Ramnani P, 2012, ANAEROBE, V18, P1, DOI 10.1016/j.anaerobe.2011.08.003; Ramos S, 2008, MOL NUTR FOOD RES, V52, P507, DOI 10.1002/mnfr.200700326; Reyes-Zurita FJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-154; Roowi S, 2010, J AGR FOOD CHEM, V58, P1296, DOI 10.1021/jf9032975; SAHASRABUDHE SR, 1991, GENETICS, V129, P981; Seeram NP, 2008, J AGR FOOD CHEM, V56, P630, DOI 10.1021/jf072504n; Sharma M, 2010, J AGR FOOD CHEM, V58, P3965, DOI 10.1021/jf902857v; Shin DY, 2011, ONCOL REP, V25, P567, DOI 10.3892/or.2010.1104; Singh BN, 2009, FOOD CHEM TOXICOL, V47, P1161, DOI 10.1016/j.fct.2009.02.004; Spada PDS, 2008, J MED FOOD, V11, P144, DOI 10.1089/jmf.2007.598; Thomasset S, 2009, CANCER PREV RES, V2, P625, DOI 10.1158/1940-6207.CAPR-08-0201; van Duijnhoven FJB, 2009, AM J CLIN NUTR, V89, P1441, DOI 10.3945/ajcn.2008.27120; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Williamson G, 2010, BRIT J NUTR, V104, pS48, DOI 10.1017/S0007114510003946; Yun JW, 2010, FOOD CHEM TOXICOL, V48, P903, DOI 10.1016/j.fct.2009.12.031; Zhao C, 2004, J AGR FOOD CHEM, V52, P6122, DOI 10.1021/jf049517a	45	54	55	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49740	10.1371/journal.pone.0049740	http://dx.doi.org/10.1371/journal.pone.0049740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185422	Green Accepted, gold, Green Published			2022-12-25	WOS:000311821000098
J	Fujiwara, H; Ito, H; Kodaka, F; Kimura, Y; Takano, H; Suhara, T				Fujiwara, Hironobu; Ito, Hiroshi; Kodaka, Fumitoshi; Kimura, Yasuyuki; Takano, Harumasa; Suhara, Tetsuya			Association between Striatal Subregions and Extrastriatal Regions in Dopamine D-1 Receptor Expression: A Positron Emission Tomography Study	PLOS ONE			English	Article							IN-VIVO; HUMAN BRAIN; SCHIZOPHRENIA; BINDING; SYSTEM; PET; D1; PATHWAYS; PRIMATES; CORTEX	The mesencephalic dopamine (DA) system is the main DA system related to affective and cognitive functions. The system consists of two different cell groups, A9 and A10, which originate from different regions of the midbrain. The striatum is the main input from the midbrain, and is functionally organized into associative, sensorimotor and limbic subdivisions. At present, there have been few studies investigating the associations of DA functions between striatal subdivisions and extrastriatal regions. The aim of this study was to investigate the relationship of DA D-1 receptor (D1R) expression between striatal subdivisions and extrastriatal regions in humans using positron emission tomography (PET) with voxel-by-voxel whole brain analysis. The PET study was performed on 30 healthy subjects using [C-11]SCH23390 to measure D1R expression. Parametric images of binding potentials (BPND) were created using the simplified reference tissue model. Regions of interest were defined for striatal subdivisions. Multiple regression analysis was undertaken to determine extrastriatal regions that were associated with each striatal subdivision in BPND using statistical parametric mapping 5. The BPND values of associative, sensorimotor and limbic subdivisions were similarly correlated with those of multiple brain regions. Regarding the interrelationships among striatal subdivisions, mutual correlations were found among associative, sensorimotor and limbic subdivisions in BPND as well. The relationships in BPND between striatal subdivisions and extra-striatal regions suggest that differential striatal subdivisions and extrastriatal regions have a similar biological basis of D1R expression. Different DA projections from the midbrain did not explain the associations between striatal subdivisions and extrastriatal regions in D1R expression, and the DA-related neural networks among the midbrain, striatum and the other regions would contribute to a similar D1R expression pattern throughout the whole brain.	[Ito, Hiroshi] Natl Inst Radiol Sci, Mol Imaging Ctr, Biophys Program, Chiba 260, Japan; [Fujiwara, Hironobu; Kodaka, Fumitoshi; Kimura, Yasuyuki; Takano, Harumasa; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Neuroimaging Program, Clin Neuroimaging Team, Chiba 260, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology	Ito, H (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Biophys Program, Chiba 260, Japan.	hito@nirs.go.jp	Kimura, Yasuyuki/D-4459-2016; Kimura, Yasuyuki/ABC-5158-2020	Kimura, Yasuyuki/0000-0002-7927-9483; Kimura, Yasuyuki/0000-0002-7927-9483	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a consignment expemse for Molecular Imaging Program on "Research Base for PET Diagnosis" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Carlsson A, 1999, EUR ARCH PSY CLIN N, V249, P37; Cervenka S, 2010, SYNAPSE, V64, P478, DOI 10.1002/syn.20765; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V60, P293, DOI 10.1111/j.1748-1716.1964.tb02891.x; DICARLO FJ, 1973, J RETICULOENDOTH SOC, V14, P387; FELTEN DL, 1983, BRAIN RES BULL, V10, P171, DOI 10.1016/0361-9230(83)90045-X; GASPAR P, 1991, ANN NEUROL, V30, P365, DOI 10.1002/ana.410300308; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Haber SN, 2000, J NEUROSCI, V20, P2369; Haber SN, 1999, ANN NY ACAD SCI, V877, P33, DOI 10.1111/j.1749-6632.1999.tb09259.x; Hurd YL, 2001, J CHEM NEUROANAT, V22, P127, DOI 10.1016/S0891-0618(01)00122-3; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Ito H, 2008, NEUROIMAGE, V39, P555, DOI 10.1016/j.neuroimage.2007.09.011; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; Rieckmann A, 2011, CEREB CORTEX, V21, P2023, DOI 10.1093/cercor/bhq266; Steiner H, 2000, J NEUROSCI, V20, P5449, DOI 10.1523/JNEUROSCI.20-14-05449.2000; Suhara T, 2002, ARCH GEN PSYCHIAT, V59, P25, DOI 10.1001/archpsyc.59.1.25; Summerfield SG, 2008, XENOBIOTICA, V38, P1518, DOI 10.1080/00498250802499459; Takahashi H, 2008, J NEUROSCI, V28, P12032, DOI 10.1523/JNEUROSCI.3446-08.2008; Takahashi H, 2010, J NEUROSCI, V30, P16567, DOI 10.1523/JNEUROSCI.3933-10.2010; WATSON CC, 1996, 3 DIMENSIONAL IMAGE, P255	26	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49775	10.1371/journal.pone.0049775	http://dx.doi.org/10.1371/journal.pone.0049775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185434	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000106
J	Lawrence, BD; Pan, Z; Rosenblatt, MI				Lawrence, Brian D.; Pan, Zhi; Rosenblatt, Mark I.			Silk Film Topography Directs Collective Epithelial Cell Migration	PLOS ONE			English	Article							BASEMENT-MEMBRANE; CONTACT GUIDANCE; NANOSCALE TOPOGRAPHY; CORNEAL FIBROBLASTS; FIBROIN MEMBRANES; HYALURONIC-ACID; IN-VIVO; BIOMATERIAL; PATTERNS; ORGANIZATION	The following study provides new insight into how surface topography dictates directed collective epithelial cell sheet growth through the guidance of individual cell movement. Collective cell behavior of migrating human corneal limbal-epithelial cell sheets were studied on highly biocompatible flat and micro-patterned silk film surfaces. The silk film edge topography guided the migratory direction of individual cells making up the collective epithelial sheet, which resulted in a 75% increase in total culture elongation. This was due to a 3-fold decrease in cell sheet migration rate efficiency for movement perpendicular to the topography edge. Individual cell migration direction is preferred in the parallel approach to the edge topography where localization of cytoskeletal proteins to the topography's edge region is reduced, which results in the directed growth of the collective epithelial sheet. Findings indicate customized biomaterial surfaces may be created to direct both the migration rate and direction of tissue epithelialization.	[Pan, Zhi; Rosenblatt, Mark I.] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Lawrence, Brian D.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University	Rosenblatt, MI (corresponding author), Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA.	mar2058@med.cornell.edu	Lawrence, Brian David/AAI-9088-2020		National Institutes of Health (NIH) [K08EY015829, NIH R21EY019561, NIH R24EY015656]; Research to Prevent Blindness Career Development Award; Tri-Institutional Stem Cell Initiative; NIH P41 Tissue Engineering Resource Center at Tufts University; NATIONAL EYE INSTITUTE [R24EY015656, R21EY019561, K08EY015829] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Career Development Award(Research to Prevent Blindness (RPB)); Tri-Institutional Stem Cell Initiative; NIH P41 Tissue Engineering Resource Center at Tufts University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work was from National Institutes of Health (NIH) K08EY015829, NIH R21EY019561, and NIH R24EY015656, Research to Prevent Blindness Career Development Award, Tri-Institutional Stem Cell Initiative, and the NIH P41 Tissue Engineering Resource Center at Tufts University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Boudreau N, 1996, P NATL ACAD SCI USA, V93, P3509, DOI 10.1073/pnas.93.8.3509; Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1; Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]; Crabb RAB, 2006, TISSUE ENG, V12, P1565, DOI 10.1089/ten.2006.12.1565; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467; DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gov NS, 2007, P NATL ACAD SCI USA, V104, P15970, DOI 10.1073/pnas.0708037104; Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041; Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103; Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kaplan D, 2012, ADV MAT; Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174; Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y; Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f; Lawrence BD, 2012, JOVE-J VIS EXP, DOI 10.3791/3646; Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294; Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744; Lin CC, 2005, BIOMATERIALS, V26, P3655, DOI 10.1016/j.biomaterials.2004.09.051; Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047; MEYLE J, 1994, J MATER SCI-MATER M, V5, P463, DOI 10.1007/BF00058984; Mo C, 2009, VIBRATIONAL SPECTROS; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207; Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Rockwood D., 2011, NATURE PROT IN PRESS; Rolli CG, 2012, BIOMATERIALS, V33, P2409, DOI 10.1016/j.biomaterials.2011.12.012; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180; Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044; Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089; Tocce EJ, 2010, BIOMATERIALS, V31, P4064, DOI 10.1016/j.biomaterials.2010.01.101; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Vrana E, 2008, J BIOMED MATER RES A, V84A, P454, DOI 10.1002/jbm.a.31442; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Whitesides G, 1998, SOFT LITHOGRAPHY	52	33	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50190	10.1371/journal.pone.0050190	http://dx.doi.org/10.1371/journal.pone.0050190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185573	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000197
J	Millet, JK; Kien, F; Cheung, CY; Siu, YL; Chan, WL; Li, HY; Leung, HL; Jaume, M; Bruzzone, R; Peiris, JSM; Altmeyer, RM; Nal, B				Millet, Jean Kaoru; Kien, Francois; Cheung, Chung-Yan; Siu, Yu-Lam; Chan, Wing-Lim; Li, Huiying; Leung, Hiu-Lan; Jaume, Martial; Bruzzone, Roberto; Peiris, Joseph S. Malik; Altmeyer, Ralf Marius; Nal, Beatrice			Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage	PLOS ONE			English	Article							RESPIRATORY-SYNDROME CORONAVIRUS; IMMUNODEFICIENCY-VIRUS TYPE-1; STABLE MICROTUBULE FORMATION; ERM PROTEINS; STRUCTURAL BASIS; IMMUNOLOGICAL SYNAPSE; FUNCTIONAL RECEPTOR; GENE DELIVERY; GLYCOPROTEIN; CELLS	Background: Entry of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and its envelope fusion with host cell membrane are controlled by a series of complex molecular mechanisms, largely dependent on the viral envelope glycoprotein Spike (S). There are still many unknowns on the implication of cellular factors that regulate the entry process. Methodology/Principal Findings: We performed a yeast two-hybrid screen using as bait the carboxy-terminal endodomain of S, which faces the cytosol during and after opening of the fusion pore at early stages of the virus life cycle. Here we show that the ezrin membrane-actin linker interacts with S endodomain through the F1 lobe of its FERM domain and that both the eight carboxy-terminal amino-acids and a membrane-proximal cysteine cluster of S endodomain are important for this interaction in vitro. Interestingly, we found that ezrin is present at the site of entry of S-pseudotyped lentiviral particles in Vero E6 cells. Targeting ezrin function by small interfering RNA increased S-mediated entry of pseudotyped particles in epithelial cells. Furthermore, deletion of the eight carboxy-terminal amino acids of S enhanced S-pseudotyped particles infection. Expression of the ezrin dominant negative FERM domain enhanced cell susceptibility to infection by SARS-CoV and S-pseudotyped particles and potentiated S-dependent membrane fusion. Conclusions/Significance: Ezrin interacts with SARS-CoV S endodomain and limits virus entry and fusion. Our data present a novel mechanism involving a cellular factor in the regulation of S-dependent early events of infection.	[Millet, Jean Kaoru; Kien, Francois; Siu, Yu-Lam; Chan, Wing-Lim; Li, Huiying; Leung, Hiu-Lan; Jaume, Martial; Bruzzone, Roberto; Peiris, Joseph S. Malik; Nal, Beatrice] Univ Hong Kong, Sch Publ Hlth, HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Millet, Jean Kaoru; Nal, Beatrice] Univ Hong Kong, Dept Anat, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Chan, Wing-Lim] Univ Hong Kong, Dept Pathol, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Cheung, Chung-Yan; Leung, Hiu-Lan; Peiris, Joseph S. Malik] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Bruzzone, Roberto] Inst Pasteur, Dept Cell Biol & Infect, Paris, France; [Altmeyer, Ralf Marius] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Nal, B (corresponding author), Brunel Univ, Ctr Infect Immun & Dis Mech, Div Biosci, Sch Hlth Sci & Social Care, Uxbridge UB8 3PH, Middx, England.	beatrice.nal-rogier@brunel.ac.uk	Leung, Nancy Hiu Lan/M-9080-2016; Bruzzone, Roberto/G-9355-2017; Bruzzone, Roberto/C-4719-2009; Millet, Jean Kaoru/V-5479-2018; NAL, Beatrice/GYU-8888-2022; Peiris, Joseph Sriyal Malik/C-4380-2009	Leung, Nancy Hiu Lan/0000-0001-7314-840X; Bruzzone, Roberto/0000-0003-4373-1447; Bruzzone, Roberto/0000-0003-4373-1447; Millet, Jean Kaoru/0000-0001-8373-3688; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Nal, Beatrice/0000-0003-3452-7524	Research Grant Council of Hong Kong (RGC) [760208]; RESPARI project of the International Network of Pasteur Institutes; University of Hong Kong	Research Grant Council of Hong Kong (RGC)(Hong Kong Research Grants Council); RESPARI project of the International Network of Pasteur Institutes; University of Hong Kong(University of Hong Kong)	This work was supported by the Research Grant Council of Hong Kong (RGC#760208); http://www.ugc.edu.hk/eng/rgc/index.htm. the RESPARI project of the International Network of Pasteur Institutes; http://www.hkupasteur.hku.hk/respari/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We warmly thank Dr. Monique Arpin (Institut Curie, Paris, France) for providing the pCB6-ezrin and pCB6-ezrin N-term constructs and the rabbit serum against ezrin protein. We thank Dr. Pierre Charneau (Institut Pasteur, Paris, France), Dr. Garry Golan (Stanford University, USA) and Dr. Debyser (Katholieke Universiteit, Leuven, Belgium) for sharing the pNL4.3.Luc R<SUP>+</SUP> E<SUP>-</SUP>, pCI-VSV G and pCMV-dR8.91 and pcHMWS plasmids, respectively. We acknowledge Dr. Dongjiang Tang and Dr. Peigang Wang (HKU-Pasteur Research Centre) for the data from the screen of the siRNA library. We thank Nadege Lagarde (HKU-Pasteur Research Centre) for treatment of images acquired by TIRFM. We warmly thank Dr. Frederic Tangy and Dr. Pierre-Olivier Vidalain (Institut Pasteur, Paris) for helpful discussions and comments on the manuscript. JM was a Ph.D. student, WLC and HLL were M.Phil. students supported by The University of Hong Kong.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Charrin S, 2006, FRONT BIOSCI-LANDMRK, V11, P1987, DOI 10.2741/1940; Chen A, 2008, J CELL SCI, V121, P3619, DOI 10.1242/jcs.032169; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Das V, 2002, IMMUNOL REV, V189, P123, DOI 10.1034/j.1600-065X.2002.18911.x; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Haedicke J, 2008, J VIROL, V82, P4665, DOI 10.1128/JVI.02403-07; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Howard MW, 2008, J VIROL, V82, P2883, DOI 10.1128/JVI.01805-07; Huang IC, 2006, ADV EXP MED BIOL, V581, P335; Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11; Kam YW, 2007, VACCINE, V25, P729, DOI 10.1016/j.vaccine.2006.08.011; Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870; Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kubo Y, 2008, VIROLOGY, V375, P130, DOI 10.1016/j.virol.2008.01.047; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lau SKP, 2012, J VIROL, V86, P5481, DOI 10.1128/JVI.06927-11; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497; Lontok E, 2004, J VIROL, V78, P5913, DOI 10.1128/JVI.78.11.5913-5922.2004; Ma HL, 2012, J VIROL, V86, P1789, DOI 10.1128/JVI.06003-11; McBride CE, 2007, J VIROL, V81, P2418, DOI 10.1128/JVI.02146-06; McBride CE, 2010, VIROLOGY, V405, P139, DOI 10.1016/j.virol.2010.05.031; Moore MJ, 2004, J VIROL, V78, P10628, DOI 10.1128/JVI.78.19.10628-10635.2004; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Nuesch JPF, 2009, J VIROL, V83, P5854, DOI 10.1128/JVI.00039-09; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Petit CM, 2007, VIROLOGY, V360, P264, DOI 10.1016/j.virol.2006.10.034; Petit CM, 2005, VIROLOGY, V341, P215, DOI 10.1016/j.virol.2005.06.046; Richard JP, 2011, BIOCHEM J, V440, P185, DOI 10.1042/BJ20111243; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Treanor B, 2011, J EXP MED, V208, P1055, DOI 10.1084/jem.20101125; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Wang PG, 2004, BIOCHEM BIOPH RES CO, V315, P439, DOI 10.1016/j.bbrc.2004.01.076; Wise AG, 2006, VIROLOGY, V349, P164, DOI 10.1016/j.virol.2006.01.031; Woo PCY, 2009, VIRUSES-BASEL, V1, P57, DOI 10.3390/v1010057; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	67	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49566	10.1371/journal.pone.0049566	http://dx.doi.org/10.1371/journal.pone.0049566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185364	Green Published, gold			2022-12-25	WOS:000311821000066
J	Grabski, K; Lamalle, L; Sato, M				Grabski, Krystyna; Lamalle, Laurent; Sato, Marc			Somatosensory-Motor Adaptation of Orofacial Actions in Posterior Parietal and Ventral Premotor Cortices	PLOS ONE			English	Article							MIRROR NEURONS; FUNCTIONAL-ORGANIZATION; AUDITORY-FEEDBACK; SPEECH PRODUCTION; MACAQUE MONKEY; BRAIN; FMRI; CORTEX; REPRESENTATION; REPETITION	Recent studies have provided evidence for sensory-motor adaptive changes and action goal coding of visually guided manual action in premotor and posterior parietal cortices. To extend these results to orofacial actions, devoid of auditory and visual feedback, we used a repetition suppression paradigm while measuring neural activity with functional magnetic resonance imaging during repeated intransitive and silent lip, jaw and tongue movements. In the motor domain, this paradigm refers to decreased activity in specific neural populations due to repeated motor acts and has been proposed to reflect sensory-motor adaptation. Orofacial movements activated a set of largely overlapping, common brain areas forming a core neural network classically involved in orofacial motor control. Crucially, suppressed neural responses during repeated orofacial actions were specifically observed in the left ventral premotor cortex, the intraparietal sulcus, the inferior parietal lobule and the superior parietal lobule. Since no visual and auditory feedback were provided during orofacial actions, these results suggest somatosensory-motor adaptive control of intransitive and silent orofacial actions in these premotor and parietal regions.	[Grabski, Krystyna; Sato, Marc] CNRS, UMR 5216, Dept Parole & Cognit, Gipsa Lab, Grenoble, France; [Grabski, Krystyna; Sato, Marc] Grenoble Univ, Grenoble, France; [Lamalle, Laurent] CHU Grenoble, INSERM, Struct Federat Rech RMN Biomed & Neurosci N 1, F-38043 Grenoble, France; [Lamalle, Laurent] CHU Grenoble, Unite IRM 3T, F-38043 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Grabski, K (corresponding author), CNRS, UMR 5216, Dept Parole & Cognit, Gipsa Lab, Grenoble, France.	krystyna.grabski@gipsa-lab.inpg.fr; marc.sato@gipsa-lab.inpg.fr		Lamalle, Laurent/0000-0002-8930-7337	CNRS (Centre National de la Recherche Scientifique); ANR (Agence Nationale de la Recherche, ANR SPIM "Imitation in Speech''); Grenoble-INP (BQR "Modyc: Modelisation dynamique de l'activite cerebrale'')	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche, ANR SPIM "Imitation in Speech'')(French National Research Agency (ANR)); Grenoble-INP (BQR "Modyc: Modelisation dynamique de l'activite cerebrale'')	This study was supported by research grants from CNRS (Centre National de la Recherche Scientifique) and ANR (Agence Nationale de la Recherche, ANR SPIM "Imitation in Speech'') to MS and from Grenoble-INP (BQR "Modyc: Modelisation dynamique de l'activite cerebrale'') to MS and KG Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Birn RM, 1999, HUM BRAIN MAPP, V7, P106, DOI 10.1002/(SICI)1097-0193(1999)7:2<106::AID-HBM4>3.0.CO;2-O; Bonini L, 2011, J NEUROSCI, V31, P5876, DOI 10.1523/JNEUROSCI.5186-10.2011; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Chang SE, 2009, NEUROIMAGE, V47, P314, DOI 10.1016/j.neuroimage.2009.03.032; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Dhanjal NS, 2008, J NEUROSCI, V28, P9969, DOI 10.1523/JNEUROSCI.2607-08.2008; Dinstein I, 2007, J NEUROPHYSIOL, V98, P1415, DOI 10.1152/jn.00238.2007; Dresel C, 2005, NEUROIMAGE, V28, P588, DOI 10.1016/j.neuroimage.2005.06.021; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gardner EP, 2007, J NEUROPHYSIOL, V97, P387, DOI 10.1152/jn.00558.2006; Grabski K, 2012, HUM BRAIN MAPP, V33, P2306, DOI 10.1002/hbm.21363; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; Gracco VL, 1994, J ACOUST SOC AM, V95, P2821; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Grafton ST, 1998, J NEUROPHYSIOL, V79, P1092, DOI 10.1152/jn.1998.79.2.1092; Grell A, 2009, J ACOUST SOC AM, V126, P407, DOI 10.1121/1.3147508; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Guenther FH, 2012, J NEUROLINGUISTICS; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Haaland KY, 2000, BRAIN, V123, P2306, DOI 10.1093/brain/123.11.2306; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hamilton AFD, 2009, HUM BRAIN MAPP, V30, P2898, DOI 10.1002/hbm.20717; Hashimoto Y, 2003, HUM BRAIN MAPP, V20, P22, DOI 10.1002/hbm.10119; Heinks-Maldonado TH, 2006, NEUROREPORT, V17, P1375, DOI 10.1097/01.wnr.0000233102.43526.e9; Hesselmann V, 2004, BRAIN TOPOGR, V16, P159; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Ito T, 2010, J NEUROPHYSIOL, V104, P1230, DOI 10.1152/jn.00199.2010; Ito T, 2009, P NATL ACAD SCI USA, V106, P1245, DOI 10.1073/pnas.0810063106; Jeannerod M, 2005, NEUROPSYCHOLOGIA, V43, P301, DOI 10.1016/j.neuropsychologia.2004.11.016; Jones JA, 2005, CURR BIOL, V15, P1768, DOI 10.1016/j.cub.2005.08.063; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kroliczak G, 2008, J NEUROPHYSIOL, V100, P2627, DOI 10.1152/jn.01376.2007; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Larson CR, 2008, EXP BRAIN RES, V187, P613, DOI 10.1007/s00221-008-1330-z; Liepmann H., 1920, APRAXIA ERGEBN GES M, V1, P516; Lingnau A, 2009, P NATL ACAD SCI USA, V106, P9925, DOI 10.1073/pnas.0902262106; Liu JZ, 2003, J NEUROPHYSIOL, V90, P300, DOI 10.1152/jn.00821.2002; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Noppeney U, 2006, HUM BRAIN MAPP, V27, P411, DOI 10.1002/hbm.20242; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelgrims B, 2009, CEREB CORTEX, V19, P2298, DOI 10.1093/cercor/bhn248; Perkell JS, 2012, J NEUROLINGUISTICS; Price CJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00237; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Takai O, 2010, BRAIN LANG, V113, P39, DOI 10.1016/j.bandl.2010.01.008; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian X, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00166; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Tremblay S, 2003, NATURE, V423, P866, DOI 10.1038/nature01710; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van Duinen H, 2007, NEUROIMAGE, V35, P1438, DOI 10.1016/j.neuroimage.2007.02.008; Watanabe J, 2004, NEUROIMAGE, V21, P1289, DOI 10.1016/j.neuroimage.2003.10.024; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	72	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49117	10.1371/journal.pone.0049117	http://dx.doi.org/10.1371/journal.pone.0049117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185300	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700026
J	Radhika, V; Kost, C; Bonaventure, G; David, A; Boland, W				Radhika, Venkatesan; Kost, Christian; Bonaventure, Gustavo; David, Anja; Boland, Wilhelm			Volatile Emission in Bracken Fern Is Induced by Jasmonates but Not by Spodoptera littoralis or Strongylogaster multifasciata Herbivory	PLOS ONE			English	Article							PTERIDIUM-AQUILINUM; ISOPRENOID BIOSYNTHESIS; ACYCLIC HOMOTERPENES; PHASEOLUS-LUNATUS; INDIRECT DEFENSE; PLANT VOLATILES; ZEA-MAYS; ACID; INDUCTION; STRESS	Jasmonate-mediated regulation of VOC emission has been extensively investigated in higher plants, however, only little is known about VOC production and its regulation in ferns. Here, we investigate whether the emission of VOCs from bracken fern Pteridium aquilinum is triggered by herbivory and if so - whether it is regulated by the octadecanoid signaling pathway. Interestingly, feeding of both generalist (Spodoptera littoralis) and specialist (Strongylogaster multifasciata) herbivores as well as application of singular and continuous mechanical wounding of fronds induced only very low levels of VOC emission. In contrast, treatment with jasmonic acid (JA) led to the emission of a blend of VOCs that was mainly comprised of terpenoids. Likewise, treatment with the JA precursor 12-oxo-phytodienoic acid (OPDA) and alpha-linolenic acid also induced VOC emission, albeit to a lower intesity than the JA treatment. Accumulation of endogenous JA was low in mechanically wounded fronds and these levels were unaffected by the application of oral secretions from both generalist or specialist herbivores. The emission of terpenoids upon JA treatment could be blocked with fosmidomycin and mevinolin, which are inhibitors of the MEP- and MVA pathways, respectively. These results indicate that similar to higher plants, terpenoid VOCs are produced via these pathways in bracken fern and that these pathways are JA-responsive. However, the very low amounts of terpenoids released after herbivory or mechanical damage are in stark contrast to what is known from higher plants. We speculate that S. multifasciata and S. littoralis feeding apparently did not induce the threshold levels of JA required for activating the MEP and MVA pathways and the subsequent volatile emission in bracken fern.	[Radhika, Venkatesan; Kost, Christian; David, Anja; Boland, Wilhelm] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Radhika, Venkatesan] RIKEN Yokohama Inst, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Kost, Christian] Max Planck Inst Chem Ecol, Expt Ecol & Evolut Res Grp, Jena, Germany; [Kost, Christian] Univ Jena, Inst Microbiol, Jena, Germany; [Bonaventure, Gustavo] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany	Max Planck Society; RIKEN; Max Planck Society; Friedrich Schiller University of Jena; Max Planck Society	Boland, W (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany.	boland@ice.mpg.de	Kost, Christian/N-1553-2014; Boland, Wilhelm/K-7762-2012	Kost, Christian/0000-0002-7870-7343; Boland, Wilhelm/0000-0001-6784-2534; Bonaventure, Gustavo/0000-0001-6120-3897	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The project only received financial support of the Max Planck Society. No current external funding sources for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Bak M, 2001, BIOPHYS J, V81, P1684, DOI 10.1016/S0006-3495(01)75822-5; Bartram S, 2006, PHYTOCHEMISTRY, V67, P1661, DOI 10.1016/j.phytochem.2006.02.004; BOLAND W, 1995, ANGEW CHEM INT EDIT, V34, P1600, DOI 10.1002/anie.199516001; BUTTERY RG, 1975, J AGR FOOD CHEM, V23, P516, DOI 10.1021/jf60199a053; COOPERDRIVER GA, 1985, AM J BOT, V72, P921; COOPERDRIVER GA, 1978, ENTOMOL EXP APPL, V24, P310, DOI 10.1007/BF02385079; COOPERDRIVER GA, 1990, ANN MO BOT GARD, V77, P281, DOI 10.2307/2399541; Diaz-Maroto MC, 2007, FLAVOUR FRAG J, V22, P114, DOI 10.1002/ffj.1766; Dicke M, 2003, BASIC APPL ECOL, V4, P27, DOI 10.1078/1439-1791-00131; DICKE M, 1991, SYMP BIOL HUNG, V39, P127; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; DONATH J, 1995, PHYTOCHEMISTRY, V39, P785, DOI 10.1016/0031-9422(95)00082-I; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Engelberth J, 2001, PLANT PHYSIOL, V125, P369, DOI 10.1104/pp.125.1.369; Francis F, 2005, J APPL ENTOMOL, V129, P6, DOI 10.1111/j.1439-0418.2005.00925.x; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Hamann T, 2009, PLANT J, V57, P1015, DOI 10.1111/j.1365-313X.2008.03744.x; Harper J. L., 1977, Population biology of plants.; Holopainen JK, 2004, TRENDS PLANT SCI, V9, P529, DOI 10.1016/j.tplants.2004.09.006; HOPKE J, 1994, FEBS LETT, V352, P146, DOI 10.1016/0014-5793(94)00948-1; Imbiscuso G, 2009, J PLANT INTERACT, V4, P15, DOI 10.1080/17429140802387739; IRVINE JIM, 1987, ANN APPL BIOL, V110, P25, DOI 10.1111/j.1744-7348.1987.tb03229.x; JONES CG, 1978, J CHEM ECOL, V4, P117, DOI 10.1007/BF00988049; Kallenbach M, 2010, PLANT PHYSIOL, V152, P96, DOI 10.1104/pp.109.149013; Kamiya T, 1980, HYDROXYAMINOHYDROCAR; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kishimoto Kyutaro, 2007, Journal of General Plant Pathology, V73, P35, DOI 10.1007/s10327-006-0314-8; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Kost C, 2008, J CHEM ECOL, V34, P2, DOI 10.1007/s10886-007-9404-0; Lauchli R, 2002, PHYTOCHEMISTRY, V61, P807, DOI 10.1016/S0031-9422(02)00397-7; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; LAWTON JH, 1982, J ANIM ECOL, V51, P573, DOI 10.2307/3985; LAWTON JH, 1976, BOT J LINN SOC, V73, P187, DOI 10.1111/j.1095-8339.1976.tb02022.x; Lombard J, 2011, MOL BIOL EVOL, V28, P87, DOI 10.1093/molbev/msq177; LORENZ H, 1957, LARVALSYSTEMATIK BLA; Maischak H, 2007, FEBS LETT, V581, P898, DOI 10.1016/j.febslet.2007.01.067; Marrs RH, 2000, ANN BOT-LONDON, V85, P3, DOI 10.1006/anbo.1999.1054; McAuslane HJ, 1998, J CHEM ECOL, V24, P399, DOI 10.1023/A:1022596812049; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Mumm R, 2003, J CHEM ECOL, V29, P1235, DOI 10.1023/A:1023841909199; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Rodriguez-Saona C, 2001, J CHEM ECOL, V27, P679, DOI 10.1023/A:1010393700918; Rose USR, 2004, PLANTA, V218, P824, DOI 10.1007/s00425-003-1162-9; Schmelz EA, 2003, PLANTA, V216, P665, DOI 10.1007/s00425-002-0898-y; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schnurer J, 1999, FUNGAL GENET BIOL, V27, P209, DOI 10.1006/fgbi.1999.1139; SCHREINER I, 1984, ECOL ENTOMOL, V9, P69, DOI 10.1111/j.1365-2311.1984.tb00699.x; Schuler G, 2004, FEBS LETT, V563, P17, DOI 10.1016/S0014-5793(04)00239-X; Schulze B, 2007, CHEMBIOCHEM, V8, P208, DOI 10.1002/cbic.200600379; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Smith DR, 2005, P ENTOMOL SOC WASH, V107, P273; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Van Den Boom CEM, 2004, J CHEM ECOL, V30, P69, DOI 10.1023/B:JOEC.0000013183.72915.99; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730	60	21	22	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48050	10.1371/journal.pone.0048050	http://dx.doi.org/10.1371/journal.pone.0048050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185246	Green Published, gold			2022-12-25	WOS:000311535700006
J	Lorenzi, M; Sylvi, L; Gerbaud, G; Mileo, E; Halgand, F; Walburger, A; Vezin, H; Belle, V; Guigliarelli, B; Magalon, A				Lorenzi, Magali; Sylvi, Lea; Gerbaud, Guillaume; Mileo, Elisabetta; Halgand, Frederic; Walburger, Anne; Vezin, Herve; Belle, Valerie; Guigliarelli, Bruno; Magalon, Axel			Conformational Selection Underlies Recognition of a Molybdoenzyme by Its Dedicated Chaperone	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; IONIZATION MASS-SPECTROMETRY; SPIN-LABELED PROTEINS; ESCHERICHIA-COLI; T4 LYSOZYME; NITRATE REDUCTASE; EPR SPECTROSCOPY; STRUCTURAL DETERMINANTS; MOLECULAR RECOGNITION; DISTANCE MEASUREMENTS	Molecular recognition is central to all biological processes. Understanding the key role played by dedicated chaperones in metalloprotein folding and assembly requires the knowledge of their conformational ensembles. In this study, the NarJ chaperone dedicated to the assembly of the membrane-bound respiratory nitrate reductase complex NarGHI, a molybdenum-iron containing metalloprotein, was taken as a model of dedicated chaperone. The combination of two techniques ie site-directed spin labeling followed by EPR spectroscopy and ion mobility mass spectrometry, was used to get information about the structure and conformational dynamics of the NarJ chaperone upon binding the N-terminus of the NarG metalloprotein partner. By the study of singly spin-labeled proteins, the E119 residue present in a conserved elongated hydrophobic groove of NarJ was shown to be part of the interaction site. Moreover, doubly spin-labeled proteins studied by pulsed double electron-electron resonance (DEER) spectroscopy revealed a large and composite distribution of inter-label distances that evolves into a single preexisting one upon complex formation. Additionally, ion mobility mass spectrometry experiments fully support these findings by revealing the existence of several conformers in equilibrium through the distinction of different drift time curves and the selection of one of them upon complex formation. Taken together our work provides a detailed view of the structural flexibility of a dedicated chaperone and suggests that the exquisite recognition and binding of the N-terminus of the metalloprotein is governed by a conformational selection mechanism.	[Lorenzi, Magali; Gerbaud, Guillaume; Mileo, Elisabetta; Halgand, Frederic; Belle, Valerie; Guigliarelli, Bruno] CNRS, Inst Microbiol Mediterranee, Unite Bioenerget & Ingn Prot UMR7281, Marseille, France; [Lorenzi, Magali; Sylvi, Lea; Gerbaud, Guillaume; Mileo, Elisabetta; Halgand, Frederic; Walburger, Anne; Belle, Valerie; Guigliarelli, Bruno; Magalon, Axel] Aix Marseille Univ, Marseille, France; [Sylvi, Lea; Walburger, Anne; Magalon, Axel] CNRS, Inst Microbiol Mediterranee, Lab Chim Bacterienne UMR7283, Marseille, France; [Vezin, Herve] Lab Spectrochim Infrarouge & Raman UMR8516, Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Belle, V (corresponding author), CNRS, Inst Microbiol Mediterranee, Unite Bioenerget & Ingn Prot UMR7281, Marseille, France.	belle@imm.cnrs.fr; magalon@imm.cnrs.fr	; Vezin, Herve/I-8004-2015	Magalon, Axel/0000-0002-3375-738X; Gerbaud, Guillaume/0000-0002-7320-9839; Vezin, Herve/0000-0002-7282-2703; Mileo, Elisabetta/0000-0002-0883-6043	Agence Nationale de la Recherche (ANR SPINFOLD) [09-BLAN-0100]; Centre National de la Recherche Scientifique (CNRS) and Aix-Marseille University; Aix-Marseille University EPR center; Conseil Regional of PACA; city of Marseille; University of Provence	Agence Nationale de la Recherche (ANR SPINFOLD)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS) and Aix-Marseille University; Aix-Marseille University EPR center; Conseil Regional of PACA; city of Marseille(Region Provence-Alpes-Cote d'Azur); University of Provence	This work was supported by the Agence Nationale de la Recherche (ANR SPINFOLD no 09-BLAN-0100), the Centre National de la Recherche Scientifique (CNRS) and Aix-Marseille University. The authors are also grateful to the EPR facilities available at the national TGE RPE and the Aix-Marseille University EPR center and, to the Conseil Regional of PACA, the city of Marseille and the University of Provence for financial support in the acquisition of instrumentations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Atmanene C, 2009, ANAL CHEM, V81, P6364, DOI 10.1021/ac9007557; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Breuker K, 2008, P NATL ACAD SCI USA, V105, P18145, DOI 10.1073/pnas.0807005105; Bridges MD, 2010, APPL MAGN RESON, V37, P363, DOI 10.1007/s00723-009-0079-2; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; Coulthurst SJ, 2012, BIOCHEMISTRY-US, V51, P1678, DOI 10.1021/bi201852d; Crane JM, 2010, METHODS MOL BIOL, V619, P173, DOI 10.1007/978-1-60327-412-8_11; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Feng S, 2008, PROTEINS, V71, P844, DOI 10.1002/prot.21744; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; Galiano L, 2009, J PHYS CHEM B, V113, P1673, DOI 10.1021/jp8057788; Genest O, 2008, J BIOL CHEM, V283, P21433, DOI 10.1074/jbc.M802954200; Georgieva ER, 2012, J MAGN RESON, V216, P69, DOI 10.1016/j.jmr.2012.01.004; Ghimire H, 2009, BIOCHEMISTRY-US, V48, P5782, DOI 10.1021/bi900781u; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Guo ZF, 2008, PROTEIN SCI, V17, P228, DOI 10.1110/ps.073174008; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Halgand F, 2001, EUR J MASS SPECTROM, V7, P433, DOI 10.1255/ejms.458; Hilton GR, 2010, J AM SOC MASS SPECTR, V21, P845, DOI 10.1016/j.jasms.2010.01.017; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jenner M, 2011, ANGEW CHEM INT EDIT, V50, P8291, DOI 10.1002/anie.201101077; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jurneczko E, 2012, BIOCHEM SOC T, V40, P1021, DOI 10.1042/BST20120125; Kavalenka A, 2010, BIOPHYS J, V98, P1055, DOI 10.1016/j.bpj.2009.11.036; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kirillova O, 2007, ACTA CRYSTALLOGR D, V63, P348, DOI 10.1107/S0907444906055065; Klare JP, 2009, PHOTOSYNTH RES, V102, P377, DOI 10.1007/s11120-009-9490-7; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Longhi S, 2011, J PEPT SCI, V17, P315, DOI 10.1002/psc.1344; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Magalon A, 2011, COORDIN CHEM REV, V255, P1159, DOI 10.1016/j.ccr.2010.12.031; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Musiani F, 2011, J CHEM INF MODEL, V51, P1513, DOI 10.1021/ci200183n; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Qiu Y, 2008, PROTEINS, V71, P525, DOI 10.1002/prot.21828; Ramasamy SK, 2009, ACTA CRYSTALLOGR F, V65, P746, DOI 10.1107/S1744309109023811; Ranaldi S, 2010, BIOCHEMISTRY-US, V49, P2140, DOI 10.1021/bi901918f; Rand KD, 2009, ANAL CHEM, V81, P10019, DOI 10.1021/ac901897x; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Smith DP, 2009, EUR J MASS SPECTROM, V15, P113, DOI 10.1255/ejms.947; Stevens CM, 2009, J MOL BIOL, V389, P124, DOI 10.1016/j.jmb.2009.03.069; Strancar J, 2005, J CHEM INF MODEL, V45, P394, DOI 10.1021/ci049748h; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; SUCKAU D, 1993, P NATL ACAD SCI USA, V90, P790, DOI 10.1073/pnas.90.3.790; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tranier S, 2003, STRUCTURE, V11, P165, DOI 10.1016/S0969-2126(03)00008-X; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Uetrecht C, 2010, CHEM SOC REV, V39, P1633, DOI 10.1039/b914002f; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Williams JP, 2010, J AM SOC MASS SPECTR, V21, P1097, DOI 10.1016/j.jasms.2010.02.012; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zakian S, 2010, FEBS J, V277, P1886, DOI 10.1111/j.1742-4658.2010.07611.x	74	20	20	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49523	10.1371/journal.pone.0049523	http://dx.doi.org/10.1371/journal.pone.0049523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185350	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800029
J	Van Boeckel, TP; Thanapongtharm, W; Robinson, T; Biradar, CM; Xiao, XM; Gilbert, M				Van Boeckel, Thomas P.; Thanapongtharm, Weerapong; Robinson, Timothy; Biradar, Chandrashekhar M.; Xiao, Xiangming; Gilbert, Marius			Improving Risk Models for Avian Influenza: The Role of Intensive Poultry Farming and Flooded Land during the 2004 Thailand Epidemic	PLOS ONE			English	Article							RICE AGRICULTURE; H5N1 OUTBREAKS; DOMESTIC DUCKS; VIRUS; INFECTION; SPREAD; MAPS; FOOT	Since 1996 when Highly Pathogenic Avian Influenza type H5N1 first emerged in southern China, numerous studies sought risk factors and produced risk maps based on environmental and anthropogenic predictors. However little attention has been paid to the link between the level of intensification of poultry production and the risk of outbreak. This study revised H5N1 risk mapping in Central and Western Thailand during the second wave of the 2004 epidemic. Production structure was quantified using a disaggregation methodology based on the number of poultry per holding. Population densities of extensively-and intensively-raised ducks and chickens were derived both at the sub-district and at the village levels. LandSat images were used to derive another previously neglected potential predictor of HPAI H5N1 risk: the proportion of water in the landscape resulting from floods. We used Monte Carlo simulation of Boosted Regression Trees models of predictor variables to characterize the risk of HPAI H5N1. Maps of mean risk and uncertainty were derived both at the subdistrict and the village levels. The overall accuracy of Boosted Regression Trees models was comparable to that of logistic regression approaches. The proportion of area flooded made the highest contribution to predicting the risk of outbreak, followed by the densities of intensively-raised ducks, extensively-raised ducks and human population. Our results showed that as little as 15% of flooded land in villages is sufficient to reach the maximum level of risk associated with this variable. The spatial pattern of predicted risk is similar to previous work: areas at risk are mainly located along the flood plain of the Chao Phraya river and to the south-east of Bangkok. Using high-resolution village-level poultry census data, rather than subdistrict data, the spatial accuracy of predictions was enhanced to highlight local variations in risk. Such maps provide useful information to guide intervention.	[Van Boeckel, Thomas P.; Gilbert, Marius] Univ Libre Bruxelles, Brussels, Belgium; [Van Boeckel, Thomas P.; Gilbert, Marius] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Thanapongtharm, Weerapong] Dept Livestock Dev, Bangkok, Thailand; [Robinson, Timothy] Food & Agr Org United Nations FAO, Rome, Italy; [Biradar, Chandrashekhar M.; Xiao, Xiangming] Univ Oklahoma, Coll Atmospher & Geog Sci, Ctr Spatial Anal, Norman, OK 73019 USA	Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; Food & Agriculture Organization of the United Nations (FAO); University of Oklahoma System; University of Oklahoma - Norman	Van Boeckel, TP (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	thomas.van.boeckel@gmail.com	xiao, xiang/GWU-6035-2022; Biradar, Chandrashekhar/AAP-1789-2020	Biradar, Chandrashekhar/0000-0002-9532-9452; Thanapongtharm, Weerapong/0000-0002-9957-2011; Gilbert, Marius/0000-0003-3708-3359; Xiao, Xiangming/0000-0003-0956-7428	National Institutes of Health Fogarty International Centre through the The National Science Foundation/National Institute of Health Ecology of Infectious Diseases program [7R01TW007869-04]; Belgian Fond National pour la Recherche Scientifique; FOGARTY INTERNATIONAL CENTER [R01TW007869] Funding Source: NIH RePORTER	National Institutes of Health Fogarty International Centre through the The National Science Foundation/National Institute of Health Ecology of Infectious Diseases program; Belgian Fond National pour la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the National Institutes of Health Fogarty International Centre through the The National Science Foundation/National Institute of Health Ecology of Infectious Diseases program (7R01TW007869-04) and the Belgian Fond National pour la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari D, 2009, CURR SCI INDIA, V97, P73; Ahmed SSU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033938; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; [Anonymous], 2004, LIVESTOCK SECTOR REP; [Anonymous], HIGHLY PATHOGENIC AV; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Busani L, 2009, VET J, V181, P171, DOI 10.1016/j.tvjl.2008.02.013; Cao CX, 2010, CHINESE SCI BULL, V55, P4168, DOI 10.1007/s11434-010-4225-x; CIESIN IPFRI CIAT, 2005, ALPH VERS; Crase B, 2012, ECOGRAPHY, V35, P879, DOI 10.1111/j.1600-0587.2011.07138.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Hastie T, 2001, ELEMENTS STAT LEARNI, V1.8, P371; Heft-Neal S, 2008, RES REPORT; Henning J, 2009, VET RES, V40, DOI 10.1051/vetres:2008053; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Leibler JH, 2009, ECOHEALTH, V6, P58, DOI 10.1007/s10393-009-0226-0; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Loth Leo, 2011, Prev Vet Med, V102, P50, DOI 10.1016/j.prevetmed.2011.06.006; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Otte J., 2006, EVIDENCE BASED POLIC; Otte J., 2007, IND LIVESTOCK PRODUC; Paul M, 2011, ACTA TROP, V118, P209, DOI 10.1016/j.actatropica.2011.03.009; Paul M, 2010, VET RES, V41, DOI 10.1051/vetres/2009076; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Savill NJ, 2006, NATURE, V442, P757, DOI 10.1038/442757a; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Tiensin T, 2009, J INFECT DIS, V199, P1735, DOI 10.1086/599207; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; Walker PGT, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000683; Wallace RG, 2009, ANTIPODE, V41, P916, DOI 10.1111/j.1467-8330.2009.00702.x; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; Xiao XM, 2006, REMOTE SENS ENVIRON, V100, P95, DOI 10.1016/j.rse.2005.10.004	49	33	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49528	10.1371/journal.pone.0049528	http://dx.doi.org/10.1371/journal.pone.0049528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185352	gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800030
J	Aquiloni, L; Giulianini, PG; Mosco, A; Guarnaccia, C; Ferrero, E; Gherardi, F				Aquiloni, Laura; Giulianini, Piero G.; Mosco, Alessandro; Guarnaccia, Corrado; Ferrero, Enrico; Gherardi, Francesca			Crustacean Hyperglycemic Hormone (cHH) as a Modulator of Aggression in Crustacean Decapods	PLOS ONE			English	Article							ORCONECTES-RUSTICUS; AGONISTIC BEHAVIORS; STATUS RECOGNITION; ENDOCRINE-CELLS; CRAYFISH; SEROTONIN; OCTOPAMINE; HEMOLYMPH; ASTACUS; COMMUNICATION	Biogenic amines, particularly serotonin, are recognised to play an important role in controlling the aggression of invertebrates, whereas the effect of neurohormones is still underexplored. The crustacean Hyperglycemic Hormone (cHH) is a multifunctional member of the eyestalk neuropeptide family. We expect that this neuropeptide influences aggression either directly, by controlling its expression, or indirectly, by mobilizing the energetic stores needed for the increased activity of an animal. Our study aims at testing such an influence and the possible reversion of hierarchies in the red swamp crayfish, Procambarus clarkii, as a model organism. Three types of pairs of similarly sized males were formed: (1) 'control pairs' (CP, n = 8): both individuals were injected with a phosphate saline solution (PBS); (2) 'reinforced pairs' (RP, n = 9): the alpha alone was injected with native cHH, and the beta with PBS; (3) 'inverted pairs' (IP, n = 9): the opposite of (2). We found that, independently of the crayfish's prior social experience, cHH injections induced (i) the expression of dominance behaviour, (ii) higher glycemic levels, and (iii) lower time spent motionless. In CP and RP, fight intensity decreased with the establishment of dominance. On the contrary, in IP, betas became increasingly likely to initiate and escalate fights and, consequently, increased their dominance till a temporary reversal of the hierarchy. Our results demonstrate, for the first time, that, similarly to serotonin, cHH enhances individual aggression, up to reverse, although transitorily, the hierarchical rank. New research perspectives are thus opened in our intriguing effort of understanding the role of cHH in the modulation of agonistic behaviour in crustaceans.	[Aquiloni, Laura; Gherardi, Francesca] Univ Florence, Dipartimento Biol Evoluzionist Leo Pardi, Florence, Italy; [Giulianini, Piero G.; Mosco, Alessandro; Ferrero, Enrico] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Guarnaccia, Corrado] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	University of Florence; University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB)	Aquiloni, L (corresponding author), Univ Florence, Dipartimento Biol Evoluzionist Leo Pardi, Florence, Italy.	laura.aquiloni@unifi.it		Giulianini, Piero Giulio/0000-0001-5356-7754; Mosco, Alessandro/0000-0002-4885-3665	Italian Ministry of Education, University and Research [cod. 2008BZFFFY]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by PRIN 2008, Italian Ministry of Education, University and Research (cod. 2008BZFFFY; http://prin.miur.it/index.php?pag=2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio J, 1996, PHARMACOL BIOCHEM BE, V53, P441, DOI 10.1016/0091-3057(95)02015-2; Antonsen BL, 1997, J COMP PHYSIOL A, V181, P501, DOI 10.1007/s003590050134; Aquiloni L, 2008, CURR BIOL, V18, pR462, DOI 10.1016/j.cub.2008.04.006; BAUCHAU AG, 1966, EXPERIENTIA, V22, P238, DOI 10.1007/BF01900932; Bergman DA, 2005, ANIM BEHAV, V70, P311, DOI 10.1016/j.anbehav.2004.10.026; Bergman DA, 2003, BEHAVIOUR, V140, P805, DOI 10.1163/156853903322370689; Bocking D, 2002, CRUSTACEAN NERVOUS SYSTEM, P84; BOVBJERG RV, 1953, PHYSIOL ZOOL, V26, P173, DOI 10.1086/physzool.26.2.30154514; BRUSKI CA, 1987, BEHAVIOUR, V103, P83, DOI 10.1163/156853987X00288; Chang ES, 1999, AM ZOOL, V39, P487; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; De Kleijn DPV, 1998, INVERTEBR REPROD DEV, V33, P263, DOI 10.1080/07924259.1998.9652637; de Kleijn DPV, 1998, J ENDOCRINOL, V156, P291, DOI 10.1677/joe.0.1560291; Edwards D.H., 2005, BIOL AGGRESSION, P38, DOI DOI 10.1093/ACPROF:OSO/9780195168761.003.0003; Escamilla-Chimal EG, 2002, GEN COMP ENDOCR, V125, P283, DOI 10.1006/gcen.2001.7752; Escamllla-Chimal EG, 2001, J EXP BIOL, V204, P1073; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gherardi F, 2004, BEHAV PROCESS, V65, P163, DOI 10.1016/j.beproc.2003.09.002; Gherardi F, 2003, CAN J ZOOL, V81, P1269, DOI 10.1139/Z03-107; Gherardi F, 2010, TREATISE ON ZOOLOGY-ANATOMY, TAXONOMY, BIOLOGY: THE CRUSTACEA, VOL 9, PT A, P269; Giulianini Piero Giulio, 2006, P225; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; HARRISWARRICK RM, 1984, J NEUROSCI, V4, P1976; HEMELRIJK CK, 1997, COM ADAP SY, P511; Hemsworth R, 2007, BIOL BULL-US, V213, P187, DOI 10.2307/25066634; Herberholz J, 2003, J COMP PHYSIOL A, V189, P321, DOI 10.1007/s00359-003-0409-z; Huber R, 1998, J COMP PHYSIOL A, V182, P573, DOI 10.1007/s003590050204; Huber R, 1997, P NATL ACAD SCI USA, V94, P5939, DOI 10.1073/pnas.94.11.5939; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Kravitz EA, 2000, J COMP PHYSIOL A, V186, P221, DOI 10.1007/s003590050423; Lee CY, 2001, PHYSIOL BIOCHEM ZOOL, V74, P376, DOI 10.1086/320430; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Lorenzon S, 2004, J EXP BIOL, V207, P4205, DOI 10.1242/jeb.01264; Lorenzon S, 2004, J EXP ZOOL PART A, V301A, P727, DOI 10.1002/jez.a.59; Lorenzon S, 2000, ARCH ENVIRON CON TOX, V39, P167, DOI 10.1007/s002440010093; Moore PA, 2005, INTEGR COMP BIOL, V45, P650, DOI 10.1093/icb/45.4.650; Mosco A, 2012, PLOS ONE, V7; Quinn D. G. P., 2002, EXPT DESIGN DATA ANA; Santos EA, 1997, PHYSIOL ZOOL, V70, P415, DOI 10.1086/515846; Schneider RAZ, 2001, BEHAVIOUR, V138, P137, DOI 10.1163/15685390151074348; SEDLMEIER D, 1982, GEN COMP ENDOCR, V46, P384; Song CK, 2006, J EXP BIOL, V209, P1355, DOI 10.1242/jeb.02126; STROLENBERG GEC, 1977, CR ACAD SCI D NAT, V284, P57; Tricarico E, 2007, ANIM BEHAV, V74, P1715, DOI 10.1016/j.anbehav.2007.04.015; VANHERP F, 1991, STUD NEUROS, V11, P211; Vye C, 1997, J EXP MAR BIOL ECOL, V217, P19, DOI 10.1016/S0022-0981(97)00004-X; Webster SG, 2000, CELL TISSUE RES, V300, P193; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wilson E.O., 1975, P1; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138; [No title captured]	52	17	18	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50047	10.1371/journal.pone.0050047	http://dx.doi.org/10.1371/journal.pone.0050047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166815	Green Published, gold			2022-12-25	WOS:000311885300079
J	Lunde, HMB; Aae, TF; Indrevag, W; Aarseth, J; Bjorvatn, B; Myhr, KM; Bo, L				Lunde, Hanne Marie Boe; Aae, Tommy F.; Indrevag, William; Aarseth, Jan; Bjorvatn, Bjorn; Myhr, Kjell-Morten; Bo, Lars			Poor Sleep in Patients with Multiple Sclerosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; IMPACT SCALE MSIS-29; DAYTIME SLEEPINESS; NORWEGIAN VERSION; FATIGUE; PAIN; DEPRESSION; DISTURBANCE; PREVALENCE; DISORDERS	Background: Poor sleep is a frequent symptom in patients with multiple sclerosis (MS). Sleep may be influenced by MS-related symptoms and adverse effects from immunotherapy and symptomatic medications. We aimed to study the prevalence of poor sleep and the influence of socio-demographic and clinical factors on sleep quality in MS-patients. Methods: A total of 90 MS patients and 108 sex-and age-matched controls were included in a questionnaire survey. Sleep complaints were evaluated by Pittsburgh Sleep Quality Index (PSQI) and a global PSQI score was used to separate good sleepers (<= 5) from poor sleepers (>5). Excessive daytime sleepiness, the use of immunotherapy and antidepressant drugs, symptoms of pain, depression, fatigue and MS-specific health related quality of life were registered. Results were compared between patients and controls and between good and poor sleepers among MS patients. Results: MS patients reported a higher mean global PSQI score than controls (8.6 vs. 6.3, p = 0.001), and 67.1% of the MS patients compared to 43.9% of the controls (p = 0.002) were poor sleepers. Pain (p = 0.02), fatigue (p = 0.001), depression (p = 0.01) and female gender (p = 0.04) were associated with sleep disturbance. Multivariate analyses showed that female gender (p = 0.02), use of immunotherapy (p = 005) and a high psychological burden of MS (p = 0.001) were associated with poor sleep among MS patients. Conclusions: Poor sleep is common in patients with MS. Early identification and treatment of modifiable risk factors may improve sleep and quality of life in MS.	[Lunde, Hanne Marie Boe; Aae, Tommy F.; Indrevag, William; Aarseth, Jan; Myhr, Kjell-Morten; Bo, Lars] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital	Lunde, HMB (corresponding author), Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway.	hmbl75@gmail.com		Froseth Aae, Tommy/0000-0003-3643-0822				Aasen H, 2001, EMPIRICAL INVESTIGAT; Attarian H, 2009, SLEEP MED, V10, P7, DOI 10.1016/j.sleep.2008.02.002; Bamer AM, 2008, MULT SCLER J, V14, P1127, DOI 10.1177/1352458508092807; Bamer AM, 2010, CLIN EPIDEMIOL, P99; Beiske KK, 2009, SLEEP BREATH, V13, P65, DOI 10.1007/s11325-008-0202-x; Brass SD, 2010, SLEEP MED REV, V14, P121, DOI 10.1016/j.smrv.2009.07.005; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; CLARK CM, 1992, ARCH NEUROL-CHICAGO, V49, P641, DOI 10.1001/archneur.1992.00530300077013; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; Cote I, 2012, MULT SCLER; Crayton H, 2004, NEUROLOGY, V63, pS12, DOI 10.1212/WNL.63.11_suppl_5.S12; Dyken ME, 2012, CHEST, V141, P528, DOI 10.1378/chest.11-0773; Frauscher B, 2005, SLEEP MED, V6, P543, DOI 10.1016/j.sleep.2005.05.001; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Hogl B, 2010, MOVEMENT DISORD, V25, P2704, DOI 10.1002/mds.23190; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hossain JL, 2005, J SLEEP RES, V14, P245, DOI 10.1111/j.1365-2869.2005.00466.x; Janssens ACJW, 2003, ACTA NEUROL SCAND, V108, P389, DOI 10.1034/j.1600-0404.2003.00166.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaminska M, 2011, MULT SCLER; Kane RL, 2005, J CLIN EPIDEMIOL, V58, P618, DOI 10.1016/j.jclinepi.2004.11.017; Kaynak H, 2006, EUR J NEUROL, V13, P1333, DOI 10.1111/j.1468-1331.2006.01499.x; Lobentanz IS, 2004, ACTA NEUROL SCAND, V110, P6, DOI 10.1111/j.1600-0404.2004.00257.x; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Lublin FD, 1996, NEUROLOGY, V46, P12, DOI 10.1212/WNL.46.1.12; Mendozzi L, 2010, MULT SCLER J, V16, P238, DOI 10.1177/1352458509354551; Merkelbach S, 2006, J SLEEP RES, V15, P105, DOI 10.1111/j.1365-2869.2006.00508.x; Merlino G, 2009, SLEEP MED, V10, P26, DOI 10.1016/j.sleep.2007.11.004; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; Nadjar Y, 2011, CLIN NEUROL NEUROSUR, V113, P316, DOI 10.1016/j.clineuro.2010.12.013; Newland PK, 2009, J NEUROSCI NURS, V41, P322, DOI 10.1097/JNN.0b013e3181b6be96; O'Connor AB, 2008, PAIN, V137, P96, DOI 10.1016/j.pain.2007.08.024; Pallesen S, 2005, TIDSSKRIFT NORSK PSY, P714; Paparrigopoulos T, 2010, INT REV PSYCHIATR, V22, P14, DOI 10.3109/09540261003589323; Riemann D, 2001, BIOL PSYCHOL, V57, P67, DOI 10.1016/S0301-0511(01)00090-4; Smedal T, 2010, ACTA NEUROL SCAND, V122, P244, DOI 10.1111/j.1600-0404.2009.01298.x; Stanton BR, 2006, MULT SCLER J, V12, P481, DOI 10.1191/135248506ms1320oa; Stenager E, 1995, ITAL J NEUROL SCI, V16, P629, DOI 10.1007/BF02230913; Svanborg P, 2001, J AFFECT DISORDERS, V64, P203, DOI 10.1016/S0165-0327(00)00242-1; TACHIBANA N, 1994, EUR NEUROL, V34, P320, DOI 10.1159/000117070; Trojan DA, 2012, J NEUROL SCI, V316, P158, DOI 10.1016/j.jns.2011.12.013; Voderholzer U, 2001, EUR ARCH PSY CLIN N, V251, P117, DOI 10.1007/s004060170045; Wright Lance J, 2012, J Clin Psychiatry, V73, pe23, DOI 10.4088/JCP.11093nr1c	45	67	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49996	10.1371/journal.pone.0049996	http://dx.doi.org/10.1371/journal.pone.0049996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166808	Green Published, Green Submitted, gold			2022-12-25	WOS:000311151900211
J	Baron, S; Hoang, A; Vogel, H; Attardi, LD				Baron, Sylvain; Anabel Hoang; Vogel, Hannes; Attardi, Laura D.			Unimpaired Skin Carcinogenesis in Desmoglein 3 Knockout Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; E-CADHERIN EXPRESSION; DESMOSOMAL CADHERINS; P53 MUTATIONS; BETA-CATENIN; ADHESION; CANCER; GENE; TARGET; SPECIFICITY	The contribution of adherens junction inactivation, typically by downregulation or mutation of the transmembrane core component E-cadherin, to cancer progression is well recognized. In contrast, the role of the desmosomal cadherin components of the related cell-cell adhesion junction, the desmosome, in cancer development has not been well explored. Here, we use mouse models to probe the functional role of desmosomal cadherins in carcinogenesis. Because mice lacking the desmosomal cadherin Desmoglein 3 (Dsg3) have revealed a crucial role for Dsg3 in cell-cell adhesion in stratified epithelia, we investigate the consequence of Dsg3 loss in two models of skin carcinogenesis. First, using Dsg3(-/-) keratinocytes, we show that these cells display adhesion defects in vitro and compromised tumor growth in allograft assays, suggesting that Dsg3 enables tumor formation in certain settings. In contrast, using an autochthonous model for SCC development in response to chronic UVB treatment, we discover a surprising lack of enhanced tumorigenesis in Dsg3(-/-) mice relative to controls, unlike mice lacking the desmosomal component Perp. Accordingly, there is no defect in the apoptotic response to UVB or enhanced immune cell infiltration upon Dsg3 loss that could promote tumorigenesis. Thus, Dsg3 does not display a clear function as a tumor suppressor in these mouse skin cancer models. Continued unraveling of the roles of Dsg3 and other desmosomal constituents in carcinogenesis in different contexts will be important for ultimately improving cancer diagnosis, prognostication, and treatment.	[Baron, Sylvain; Anabel Hoang; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Vogel, Hannes] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Attardi, Laura D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Attardi, LD (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	attardi@stanford.edu		Vogel, Otto Hannes/0000-0002-0960-3508	Fondation pour la Recherche Medicale; National Institutes of Health [5 R01 CA093665-10]; NATIONAL CANCER INSTITUTE [R01CA093665] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Fondation pour la Recherche Medicale to SB and the National Institutes of Health (Grant Number 5 R01 CA093665-10) to LDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudry VG, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001168; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chen JL, 2012, MOL CARCINOGEN, V51, P535, DOI 10.1002/mc.20818; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Hanakawa Y, 2002, J INVEST DERMATOL, V119, P27, DOI 10.1046/j.1523-1747.2002.01780.x; Huang CC, 2010, LARYNGOSCOPE, V120, P26, DOI 10.1002/lary.20151; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; KANJILAL S, 1993, CANCER RES, V53, P2961; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Koch PJ, 1998, J CELL SCI, V111, P2529; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Mannan T, 2011, CELL PROLIFERAT, V44, P301, DOI 10.1111/j.1365-2184.2011.00765.x; Marques MR, 2005, CANCER RES, V65, P6551, DOI 10.1158/0008-5472.CAN-05-0366; Nie ZX, 2011, J BIOL CHEM, V286, P2143, DOI 10.1074/jbc.M110.192245; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Rakha EA, 2005, HISTOPATHOLOGY, V46, P685, DOI 10.1111/j.1365-2559.2005.02156.x; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Savci-Heijink CD, 2009, AM J PATHOL, V174, P1629, DOI 10.2353/ajpath.2009.080778; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; Syrigos KN, 1995, INT J CANCER, V64, P367, DOI 10.1002/ijc.2910640603; Tada H, 2000, J CUTAN PATHOL, V27, P24, DOI 10.1034/j.1600-0560.2000.027001024.x; Wang LH, 2007, VIRCHOWS ARCH, V451, P959, DOI 10.1007/s00428-007-0485-5; Wijnhoven BPL, 2005, J SURG ONCOL, V92, P116, DOI 10.1002/jso.20344; Wong MP, 2008, PATHOLOGY, V40, P611, DOI 10.1080/00313020802320614; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005; Zheng Z, 1999, HUM PATHOL, V30, P458, DOI 10.1016/S0046-8177(99)90123-5	43	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50024	10.1371/journal.pone.0050024	http://dx.doi.org/10.1371/journal.pone.0050024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185521	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000167
J	Jasrapuria, S; Specht, CA; Kramer, KJ; Beeman, RW; Muthukrishnan, S				Jasrapuria, Sinu; Specht, Charles A.; Kramer, Karl J.; Beeman, Richard W.; Muthukrishnan, Subbaratnam			Gene Families of Cuticular Proteins Analogous to Peritrophins (CPAPs) in Tribolium castaneum Have Diverse Functions	PLOS ONE			English	Article							RED FLOUR BEETLE; CHITIN-SYNTHASE; EXOSKELETON; DROSOPHILA; MIDGUT; MATRIX; SECRETION; CDNAS	The functional characterization of an entire class of 17 genes from the red flour beetle, Tribolium castaneum, which encode two families of Cuticular Proteins Analogous to Peritrophins (CPAPs) has been carried out. CPAP genes in T. castaneum are expressed exclusively in cuticle-forming tissues and have been classified into two families, CPAP1 and CPAP3, based on whether the proteins contain either one (CPAP1), or three copies (CPAP3) of the chitin-binding domain, ChtBD2, with its six characteristically spaced cysteine residues. Individual members of the TcCPAP1 and TcCPAP3 gene families have distinct developmental patterns of expression. Many of these proteins serve essential and non-redundant functions in maintaining the structural integrity of the cuticle in different parts of the insect anatomy. Three genes of the TcCPAP1 family and five genes of the TcCPAP3 family are essential for insect development, molting, cuticle integrity, proper locomotion or fecundity. RNA interference (RNAi) targeting TcCPAP1-C, TcCPAP1-H, TcCPAP1-J or TcCPAP3-C transcripts resulted in death at the pharate adult stage of development. RNAi for TcCPAP3-A1, TcCPAP3-B, TcCPAP3-D1 or TcCPAP3-D2 genes resulted in different developmental defects, including adult/embryonic mortality, abnormal elytra or hindwings, or an abnormal 'stiff-jointed' gait. These results provide experimental support for specialization in the functions of CPAP proteins in T. castaneum and a biological rationale for the conservation of CPAP orthologs in other orders of insects. This is the first comprehensive functional analysis of an entire class of cuticular proteins with one or more ChtBD2 domains in any insect species.	[Jasrapuria, Sinu; Kramer, Karl J.; Muthukrishnan, Subbaratnam] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Specht, Charles A.] Univ Massachusetts, Dept Med, Worcester, MA 01605 USA; ARS, USDA, Ctr Grain & Anim Hlth Res Ctr, Manhattan, KS USA	Kansas State University; University of Massachusetts System; University of Massachusetts Worcester; United States Department of Agriculture (USDA)	Muthukrishnan, S (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.	smk@ksu.edu			 [NSF-IOS-102227]; Division Of Integrative Organismal Systems [1022227] Funding Source: National Science Foundation	; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF-IOS-102227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arakane Y, 2008, INSECT BIOCHEM MOLEC, V38, P959, DOI 10.1016/j.ibmb.2008.07.006; Arakane Y, 2012, PLOS GENET, V8, P612, DOI 10.1371/journal.pgen.1002682; Barry MK, 1999, INSECT BIOCHEM MOLEC, V29, P319, DOI 10.1016/S0965-1748(99)00004-1; BEEMAN RW, 1990, J ECON ENTOMOL, V83, P1745, DOI 10.1093/jee/83.5.1745; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; Bolognesi R, 2005, INSECT BIOCHEM MOLEC, V35, P1249, DOI 10.1016/j.ibmb.2005.06.006; BOULIGAND Y, 1965, CR HEBD ACAD SCI, V261, P4864; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Dittmer NT, 2012, J PROTEOME RES, V11, P269, DOI 10.1021/pr2009803; Gaines PJ, 2003, INSECT BIOCHEM MOLEC, V33, P1061, DOI 10.1016/S0965-1748(03)00096-1; Jasrapuria S, 2010, INSECT BIOCHEM MOLEC, V40, P214, DOI 10.1016/j.ibmb.2010.01.011; KLEIN U, 1991, J EXP BIOL, V161, P61; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Moreira MF, 2007, INSECT BIOCHEM MOLEC, V37, P1249, DOI 10.1016/j.ibmb.2007.07.017; Moussian B, 2007, MATRIX BIOL, V26, P337, DOI 10.1016/j.matbio.2007.02.001; Muthukrishnan S, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P193, DOI 10.1016/B978-0-12-384747-8.10007-8; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Willis JH, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P134, DOI 10.1016/B978-0-12-384747-8.10005-4; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001	24	74	86	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49844	10.1371/journal.pone.0049844	http://dx.doi.org/10.1371/journal.pone.0049844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185457	Green Published, gold			2022-12-25	WOS:000311821000122
J	Salinas, F; Cubillos, FA; Soto, D; Garcia, V; Bergstrom, A; Warringer, J; Ganga, MA; Louis, EJ; Liti, G; Martinez, C				Salinas, Francisco; Cubillos, Francisco A.; Soto, Daniela; Garcia, Veronica; Bergstroem, Anders; Warringer, Jonas; Ganga, M. Angelica; Louis, Edward J.; Liti, Gianni; Martinez, Claudio			The Genetic Basis of Natural Variation in Oenological Traits in Saccharomyces cerevisiae	PLOS ONE			English	Article							WINE YEAST STRAINS; QUANTITATIVE TRAITS; ADAPTIVE EVOLUTION; MOLECULAR-BASIS; MAJOR ROLE; RESOLUTION; GLUCOSE; FERMENTATION; EPISTASIS; CULTURES	Saccharomyces cerevisiae is the main microorganism responsible for wine alcoholic fermentation. The oenological phenotypes resulting from fermentation, such as the production of acetic acid, glycerol, and residual sugar concentration are regulated by multiple genes and vary quantitatively between different strain backgrounds. With the aim of identifying the quantitative trait loci (QTLs) that regulate oenological phenotypes, we performed linkage analysis using three crosses between highly diverged S. cerevisiae strains. Segregants from each cross were used as starter cultures for 20-day fermentations, in synthetic wine must, to simulate actual winemaking conditions. Linkage analysis on phenotypes of primary industrial importance resulted in the mapping of 18 QTLs. We tested 18 candidate genes, by reciprocal hemizygosity, for their contribution to the observed phenotypic variation, and validated five genes and the chromosome II right subtelomeric region. We observed that genes involved in mitochondrial metabolism, sugar transport, nitrogen metabolism, and the uncharacterized ORF YJR030W explained most of the phenotypic variation in oenological traits. Furthermore, we experimentally validated an exceptionally strong epistatic interaction resulting in high level of succinic acid between the Sake FLX1 allele and the Wine/European MDH2 allele. Overall, our work demonstrates the complex genetic basis underlying wine traits, including natural allelic variation, antagonistic linked QTLs and complex epistatic interactions between alleles from strains with different evolutionary histories.	[Salinas, Francisco; Bergstroem, Anders; Liti, Gianni] Univ Nice Sophia Antipolis, IRCAN, CNRS, UMR 7284,INSERM,U1081, Nice, France; [Salinas, Francisco; Soto, Daniela; Garcia, Veronica; Ganga, M. Angelica; Martinez, Claudio] Univ Santiago Chile USACH, Dept Ciencia & Tecnol Alimentos, Santiago, Chile; [Cubillos, Francisco A.; Louis, Edward J.; Liti, Gianni] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; [Warringer, Jonas] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Martinez, Claudio] Univ Santiago Chile USACH, Ctr Estudios Ciencia & Tecnol Alimentos CECTA, Santiago, Chile	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universidad de Santiago de Chile; University of Nottingham; University of Gothenburg; Universidad de Santiago de Chile	Liti, G (corresponding author), Univ Nice Sophia Antipolis, IRCAN, CNRS, UMR 7284,INSERM,U1081, Nice, France.	gianni.liti@unice.fr; claudio.martinez@usach.cl	Martinez, Claudio/T-2903-2019; Salinas, Francisco/W-3269-2017; Liti, Gianni/I-9929-2014; Ganga, Maria Angelica/S-8176-2019; Salinas, Francisco/AAP-9439-2020; Soto Madrid, Daniela Paz/GSD-5684-2022; Warringer, Jonas/B-8520-2013; García, Verónica/AAM-1175-2021; Louis, Edward/B-7920-2008; Cubillos, Francisco/G-5195-2019	Salinas, Francisco/0000-0002-8391-8145; Salinas, Francisco/0000-0002-8391-8145; Warringer, Jonas/0000-0001-6144-2740; Louis, Edward/0000-0003-1157-3608; Cubillos, Francisco/0000-0003-3022-469X; Liti, Gianni/0000-0002-2318-0775; Martinez, Claudio/0000-0001-8564-9287; Bergstrom, Anders/0000-0002-4096-9268	CNRS; ATIP-Avenir; Biological Sciences Research Council [BBF0152161]; FONDECYT [1100509]; MECESUP UCH [0604]; Becas Chile; Apoyo tesis doctoral [AT-24100036]; CONICYT	CNRS(Centre National de la Recherche Scientifique (CNRS)); ATIP-Avenir; Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); MECESUP UCH; Becas Chile; Apoyo tesis doctoral; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by CNRS and ATIP-Avenir, Biological Sciences Research Council (BBF0152161), FONDECYT 1100509, MECESUP UCH 0604, Becas Chile, Apoyo tesis doctoral AT-24100036 and CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Bisson LF, 1994, FOOD BIOTECHNOL, V18, P63; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; Borneman AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001287; Boulton R. B., 1996, PRINCIPLES PRACTICES, DOI DOI 10.1007/978-1-4615-1781-8; Bradbury JE, 2006, ANTON LEEUW INT J G, V89, P27, DOI 10.1007/s10482-005-9006-1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cambon B, 2006, APPL ENVIRON MICROB, V72, P4688, DOI 10.1128/AEM.02975-05; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; Cocolin L, 2004, FEMS YEAST RES, V5, P237, DOI 10.1016/j.femsyr.2004.08.005; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Cubillos FA, 2009, FEMS YEAST RES, V9, P1217, DOI 10.1111/j.1567-1364.2009.00583.x; Cubillos FA, 2009, FEMS MICROBIOL ECOL, V67, P162, DOI 10.1111/j.1574-6941.2008.00600.x; DAIGNANFORNIER B, 1994, MOL GEN GENET, V243, P575, DOI 10.1007/BF00284206; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000123; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dunn B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-53; Ericson E, 2006, MOL GENET GENOMICS, V275, P605, DOI 10.1007/s00438-006-0112-1; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; FUGELSANG KC, 2007, WIN MICR PRACT APPL, pR15; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson N, 2003, J BIOL CHEM, V278, P25628, DOI 10.1074/jbc.M213231200; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; Infante JJ, 2003, GENETICS, V165, P1745; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Katou T, 2009, J BIOSCI BIOENG, V107, P383, DOI 10.1016/j.jbiosc.2008.12.014; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000659; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Marullo P, 2006, FEMS YEAST RES, V6, P268, DOI 10.1111/j.1567-1364.2006.00034.x; Marullo P, 2004, FEMS YEAST RES, V4, P711, DOI 10.1016/j.femsyr.2004.01.006; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Nissen TL, 1997, MICROBIOL-UK, V143, P203, DOI 10.1099/00221287-143-1-203; Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Querol A, 2003, INT J FOOD MICROBIOL, V86, P3, DOI 10.1016/S0168-1605(03)00244-7; Rossouw D, 2010, APPL ENVIRON MICROB, V76, P3911, DOI 10.1128/AEM.00586-10; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Salinas F, 2010, J APPL MICROBIOL, V108, P1850, DOI 10.1111/j.1365-2672.2010.04689.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Zorgo E, 2012, MOL BIOL EVOL, V29, P1781, DOI 10.1093/molbev/mss019; Zuzuarregui A, 2006, APPL ENVIRON MICROB, V72, P836, DOI 10.1128/AEM.72.1.836-847.2006	61	62	62	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49640	10.1371/journal.pone.0049640	http://dx.doi.org/10.1371/journal.pone.0049640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185390	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000073
J	van der Meer, MH; Hobbs, JPA; Jones, GP; van Herwerden, L				van der Meer, Martin H.; Hobbs, Jean-Paul A.; Jones, Geoffrey P.; van Herwerden, Lynne			Genetic Connectivity among and Self-Replenishment within Island Populations of a Restricted Range Subtropical Reef Fish	PLOS ONE			English	Article							RED THROAT EMPEROR; CORAL-REEF; LARVAL DISPERSAL; MARINE RESERVES; COMPARATIVE PHYLOGEOGRAPHY; MICROSATELLITE MARKERS; MANAGEMENT; DIVERSITY; MIGRATION; PATTERNS	Marine protected areas (MPAs) are increasingly being advocated and implemented to protect biodiversity on coral reefs. Networks of appropriately sized and spaced reserves can capture a high proportion of species diversity, with gene flow among reserves presumed to promote long term resilience of populations to spatially variable threats. However, numerically rare small range species distributed among isolated locations appear to be at particular risk of extinction and the likely benefits of MPA networks are uncertain. Here we use mitochondrial and microsatellite data to infer evolutionary and contemporary gene flow among isolated locations as well as levels of self-replenishment within locations of the endemic anemonefish Amphiprion mccullochi, restricted to three MPA offshore reefs in subtropical East Australia. We infer high levels of gene flow and genetic diversity among locations over evolutionary time, but limited contemporary gene flow amongst locations and high levels of self-replenishment (68 to 84%) within locations over contemporary time. While long distance dispersal explained the species' integrity in the past, high levels of self-replenishment suggest locations are predominantly maintained by local replenishment. Should local extinction occur, contemporary rescue effects through large scale connectivity are unlikely. For isolated islands with large numbers of endemic species, and high local replenishment, there is a high premium on local species-specific management actions.	[van der Meer, Martin H.; van Herwerden, Lynne] James Cook Univ, Mol Ecol & Evolut Lab, Townsville, Qld 4811, Australia; [van der Meer, Martin H.; Jones, Geoffrey P.; van Herwerden, Lynne] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [van der Meer, Martin H.; Jones, Geoffrey P.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Hobbs, Jean-Paul A.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Hobbs, Jean-Paul A.] Australian Inst Marine Sci, Perth, WA, Australia; [van Herwerden, Lynne] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University; University of Western Australia; University of Western Australia; Australian Institute of Marine Science; James Cook University	van der Meer, MH (corresponding author), James Cook Univ, Mol Ecol & Evolut Lab, Townsville, Qld 4811, Australia.	martinhvandermeer@gmail.com	Hobbs, Jean-Paul/I-8743-2012; Jones, Geoffrey P./E-9306-2010; van Herwerden, Lynne/I-1087-2012	Hobbs, Jean-Paul/0000-0003-0331-354X; Jones, Geoffrey P./0000-0002-6244-1245; van Herwerden, Lynne/0000-0001-6717-8995	Lord Howe Island Board; Envirofund Australia (Natural Heritage Trust); Lord Howe Island Marine Park; Australian Department of the Environment and Water Resources	Lord Howe Island Board; Envirofund Australia (Natural Heritage Trust); Lord Howe Island Marine Park; Australian Department of the Environment and Water Resources(Australian Government)	The authors are grateful for the Lord Howe Island Board, Envirofund Australia (Natural Heritage Trust) and the Lord Howe Island Marine Park for financial and logistical support. The authors thank the Australian Department of the Environment and Water Resources for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the valuable support and assistance provided by Sallyann Gudge and Ian Kerr at Lord Howe Island. We thank the Lord Howe Island Board, Envirofund Australia (Natural Heritage Trust) and the Lord Howe Island Marine Park for financial and logistical support. We thank the Australian Department of the Environment and Water Resources for funding and the Capricorn Star for excellent logistical support.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson CS, 2010, CONSERV GENET, V11, P1593, DOI 10.1007/s10592-009-0033-8; Bay LK, 2004, MAR BIOL, V144, P757, DOI 10.1007/s00227-003-1224-3; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bell JJ, 2005, P ROY SOC B-BIOL SCI, V272, P1067, DOI 10.1098/rspb.2005.3051; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berumen ML, 2012, ECOL EVOL, V2, P444, DOI 10.1002/ece3.208; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Burbrink FT, 2010, MOL ECOL, V19, P5321, DOI 10.1111/j.1365-294X.2010.04861.x; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Chapman DD, 2011, J HERED, DOI 101093/jhered/esr098; Choat J. H., 2006, REPORT ECOLOGICAL SU, P65; Ciofi C, 2006, GENETICS, V172, P1727, DOI 10.1534/genetics.105.047860; Coade G, 2010, EUTROPHICATION UNPUB, P30; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2002, P GULF CARIB FISH I, P1; Craig MT, 2010, J BIOGEOGR, V37, P2125, DOI 10.1111/j.1365-2699.2010.02358.x; Drechsler M, 2003, ECOL APPL, V13, P990, DOI 10.1890/1051-0761(2003)13[990:RMERFP]2.0.CO;2; Dudgeon CL, 2000, MAR BIOL, V137, P1059, DOI 10.1007/s002270000403; Eble Jeff A., 2011, Journal of Marine Biology, V2011, P1; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Evans RD, 2010, FISH RES, V102, P16, DOI 10.1016/j.fishres.2009.10.002; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Fautin D.G., 1992, ANEMONE FISHES THEIR; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Froukh T, 2007, THESIS U BREMEN BREM; Froukh T, 2007, MOL ECOL, V16, P1359, DOI 10.1111/j.1365-294X.2007.03236.x; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Gold JR, 2011, N AM J FISH MANAGE, V31, P209, DOI 10.1080/02755947.2011.568864; Gow JL, 2006, MOL ECOL, V15, P739, DOI 10.1111/j.1365-294X.2006.02825.x; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Harris LN, 2010, J EVOLUTION BIOL, V23, P72, DOI 10.1111/j.1420-9101.2009.01858.x; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hattori A, 2002, J ANIM ECOL, V71, P824, DOI 10.1046/j.1365-2656.2002.00649.x; Heath L, 2008, GARNAUT CLIMATE CHAN, P25; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Hill R, 2012, CORAL REEFS, V31, P273, DOI 10.1007/s00338-011-0848-x; Hobbs J., 2009, REPORT LORD HOWE ISL, P37; Hobbs J. P., 2007, MONITORING ECO UNPUB, P37; Hoelzel AR, 2002, J EVOLUTION BIOL, V15, P567, DOI 10.1046/j.1420-9101.2002.00419.x; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; Horne JB, 2011, MOL ECOL, V20, P2291, DOI 10.1111/j.1365-294X.2011.05097.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; James MK, 2002, P ROY SOC B-BIOL SCI, V269, P2079, DOI 10.1098/rspb.2002.2128; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jombart T., 2010, BMC GENET, V11, P1, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94]; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Klanten OS, 2007, MAR BIOL, V150, P659, DOI 10.1007/s00227-006-0372-7; Leis JM, 2011, OCEANOGR MAR BIOL, V49, P193; Liao W, 2009, ANIM CONSERV, V12, P54, DOI 10.1111/j.1469-1795.2008.00220.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Ludt WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038042; McNeely JA, 1990, CON CONSERVING WORLD; Messmer V, 2005, CORAL REEFS, V24, P392, DOI 10.1007/s00338-005-0001-9; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Palstra FP, 2007, MOL ECOL, V16, P4504, DOI 10.1111/j.1365-294X.2007.03541.x; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; Pritchard JK, 2000, GENETICS, V155, P945; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Scascitelli M, 2010, MOL ECOL, V19, P521, DOI 10.1111/j.1365-294X.2009.04504.x; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Shulman MJ, 1998, AUST J ECOL, V23, P216, DOI 10.1111/j.1442-9993.1998.tb00723.x; Smith LD, 2008, CORAL REEFS, V27, P197, DOI 10.1007/s00338-007-0311-1; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Suthers IM, 2011, DEEP-SEA RES PT II, V58, P538, DOI 10.1016/j.dsr2.2010.09.029; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; van der Meer MH, 2012, ECOL EVOL, V2, P1592, DOI 10.1002/ece3.251; van der Meer MH, 2012, CONSERV GENET RESOUR, V4, P247, DOI 10.1007/s12686-011-9517-1; Van Herwerden L, 2000, MOL ECOL, V9, P1929, DOI 10.1046/j.1365-294x.2000.01076-7.x; van Herwerden L, 2006, MOL PHYLOGENET EVOL, V41, P420, DOI 10.1016/j.ympev.2006.04.024; van Herwerden L, 2003, J FISH BIOL, V62, P987, DOI 10.1046/j.1095-8649.2003.00075.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092; Wilson GA, 2003, GENETICS, V163, P1177	96	18	18	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49660	10.1371/journal.pone.0049660	http://dx.doi.org/10.1371/journal.pone.0049660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185398	Green Accepted, gold, Green Published			2022-12-25	WOS:000311821000078
J	Zhang, R; Guo, CD; Sui, SC; Yu, T; Wang, JW; Li, N				Zhang, Ran; Guo, Chengdong; Sui, Shunchao; Yu, Tian; Wang, Jianwu; Li, Ning			Comprehensive Assessment of Milk Composition in Transgenic Cloned Cattle	PLOS ONE			English	Article							PROTEOME ANALYSIS; RISK-ASSESSMENT; ANIMAL CLONING; BOVINE CLONES; PROTEINS; MEAT; EXPRESSION; PRODUCTS; COWS	The development of transgenic cloned animals offers new opportunities for agriculture, biomedicine and environmental science. Expressing recombinant proteins in dairy animals to alter their milk composition is considered beneficial for human health. However, relatively little is known about the expression profile of the proteins in milk derived from transgenic cloned animals. In this study, we compared the proteome and nutrient composition of the colostrum and mature milk from three lines of transgenic cloned (TC) cattle that specifically express human alpha-lactalbumin (TC-LA), lactoferrin (TC-LF) or lysozyme (TC-LZ) in the mammary gland with those from cloned non-transgenic (C) and conventionally bred normal animals (N). Protein expression profile identification was performed, 37 proteins were specifically expressed in the TC animals and 70 protein spots that were classified as 22 proteins with significantly altered expression levels in the TC and C groups compared to N group. Assessment of the relationship of the transgene effect and normal variability in the milk protein profiles in each group indicated that the variation in the endogenous protein profiles of the three TC groups was within the limit of natural variability. More than 50 parameters for the colostrum and mature milk were compared between each TC group and the N controls. The data revealed essentially similar profiles for all groups. This comprehensive study demonstrated that in TC cattle the mean values for the measured milk parameters were all within the normal range, suggesting that the expression of a transgene does not affect the composition of milk.	[Zhang, Ran; Guo, Chengdong; Sui, Shunchao; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Yu, Tian] Wuxi Kingenew Biotechnol Co Ltd, Wuxi, Jiangsu, Peoples R China; [Wang, Jianwu] Beijing GenProt Biotech Co Ltd, Beijing, Peoples R China	China Agricultural University	Li, N (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglcau@cau.edu.cn			"863" High-Tech Research Development Project [2010AA10A105, 2011AA100601]	"863" High-Tech Research Development Project	This project was supported by the "863" High-Tech Research Development Project (project grant numbers 2010AA10A105 and 2011AA100601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; D'Alessandro A, 2011, MOL BIOSYST, V7, P579, DOI 10.1039/c0mb00027b; D'Amato A, 2009, J PROTEOME RES, V8, P3925, DOI 10.1021/pr900221x; Gorg A, 2009, ELECTROPHORESIS, V30, pS122, DOI 10.1002/elps.200900051; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Heyman Y, 2007, THERIOGENOLOGY, V67, P134, DOI 10.1016/j.theriogenology.2006.09.020; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kelly L, 2005, REV SCI TECH OIE, V24, P61, DOI 10.20506/rst.24.1.1553; Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003; Laible G, 2009, COMP IMMUNOL MICROB, V32, P123, DOI 10.1016/j.cimid.2007.11.012; Laible G, 2007, THERIOGENOLOGY, V67, P166, DOI 10.1016/j.theriogenology.2006.09.028; Le A, 2011, J PROTEOME RES, V10, P692, DOI 10.1021/pr100884z; Liao YL, 2011, J PROTEOME RES, V10, P1746, DOI 10.1021/pr101028k; Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Norman HD, 2004, CLONING STEM CELLS, V6, P157, DOI 10.1089/1536230041372346; Palmer DJ, 2006, PROTEOMICS, V6, P2208, DOI 10.1002/pmic.200500558; Pink M, 2010, ELECTROPHORESIS, V31, P593, DOI 10.1002/elps.200900481; Rudenko L, 2007, THERIOGENOLOGY, V67, P198, DOI 10.1016/j.theriogenology.2006.09.033; Rudenko L, 2007, NAT BIOTECHNOL, V25, P39, DOI 10.1038/nbt0107-39; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smolenski G, 2007, J PROTEOME RES, V6, P207, DOI 10.1021/pr0603405; Tian XC, 2005, P NATL ACAD SCI USA, V102, P6261, DOI 10.1073/pnas.0500140102; Walker SC, 2007, THERIOGENOLOGY, V67, P178, DOI 10.1016/j.theriogenology.2006.09.025; Wang J, 2008, J DAIRY SCI, V91, P4466, DOI 10.3168/jds.2008-1189; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yang XZ, 2007, NAT BIOTECHNOL, V25, P77, DOI 10.1038/nbt1276	30	8	9	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49697	10.1371/journal.pone.0049697	http://dx.doi.org/10.1371/journal.pone.0049697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185411	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000089
J	Baker, MR; Baker, SN				Baker, Mark R.; Baker, Stuart N.			Beta-Adrenergic Modulation of Tremor and Corticomuscular Coherence in Humans	PLOS ONE			English	Article							ISOPRENALINE-INDUCED TREMOR; MONKEY MOTOR CORTEX; SKELETAL-MUSCLE; MESSENGER-RNA; PHYSIOLOGICAL TREMOR; OSCILLATORY ACTIVITY; SENSORIMOTOR CORTEX; 40 HZ; SYNCHRONIZATION; TASK	Coherence between the bioelectric activity of sensorimotor cortex and contralateral muscles can be observed around 20 Hz. By contrast, physiological tremor has a dominant frequency around 10 Hz. Although tremor has multiple sources, it is partly central in origin, reflecting a component of motoneuron discharge at this frequency. The motoneuron response to similar to 20 Hz descending input could be altered by non-linear interactions with similar to 10 Hz motoneuron firing. We investigated this further in eight healthy human subjects by testing the effects of the beta-adrenergic agents propranolol (non-selective beta-antagonist) and salbutamol (beta(2)-agonist), which are known to alter the size of physiological tremor. Corticomuscular coherence was assessed during an auxotonic precision grip task; tremor was quantified using accelerometry during index finger extension. Experiments with propranolol used a double-blind, placebo-controlled crossover design. A single oral dose of propranolol (40 mg) significantly increased beta band (15.3-32.2 Hz) corticomuscular coherence compared with placebo, but reduced tremor in the 6.2-11.9 Hz range. Salbutamol (2.5 mg) was administered by inhalation. Whilst salbutamol significantly increased tremor amplitude as expected, it did not change corticomuscular coherence. The opposite direction of the effects of propranolol on corticomuscular coherence and tremor, and the fact that salbutamol enhances tremor but does not affect coherence, implies that the magnitude of corticomuscular coherence is little influenced by non-linear interactions with 10 Hz oscillations in motoneurons or the periphery. Instead, we suggest that propranolol and salbutamol may affect both tremor and corticomuscular coherence partly via a central site of action.	[Baker, Mark R.; Baker, Stuart N.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Baker, SN (corresponding author), Newcastle Univ, Inst Neurosci, Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	stuart.baker@ncl.ac.uk		Baker, Mark/0000-0001-6916-1329; Baker, Stuart/0000-0001-8118-4048	Wellcome Trust; Medical Research Council	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by grants from the Wellcome Trust and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABILA B, 1985, J NEUROL NEUROSUR PS, V48, P1031, DOI 10.1136/jnnp.48.10.1031; ABILA B, 1985, BRIT J CLIN PHARMACO, V20, P369, DOI 10.1111/j.1365-2125.1985.tb05079.x; ALLUM JHJ, 1978, J NEUROPHYSIOL, V41, P557, DOI 10.1152/jn.1978.41.3.557; Baker MR, 2003, J PHYSIOL-LONDON, V546, P931, DOI 10.1113/jphysiol.2002.029553; Baker SN, 2003, J NEUROPHYSIOL, V89, P1941, DOI 10.1152/jn.00832.2002; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Baker SN, 2006, J NEUROPHYSIOL, V95, P3904, DOI 10.1152/jn.01106.2005; Beitzel F, 2004, J APPL PHYSIOL, V96, P1385, DOI 10.1152/japplphysiol.01081.2003; Brown P, 1998, J NEUROPHYSIOL, V80, P2911, DOI 10.1152/jn.1998.80.6.2911; Clark DJ, 1996, EUR J CLIN PHARMACOL, V51, P91, DOI 10.1007/s002280050166; Claustre Y, 2008, NEUROSCIENCE, V156, P353, DOI 10.1016/j.neuroscience.2008.07.011; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; Desaphy JF, 2003, MOL PHARMACOL, V63, P659, DOI 10.1124/mol.63.3.659; Duranti G, 2011, MED SCI SPORT EXER, V43, P2259, DOI 10.1249/MSS.0b013e3182223094; Evans CMB, 2003, EUR J NEUROSCI, V18, P453, DOI 10.1046/j.1460-9568.2003.02751.x; Fisher NI, 1995, STAT ANAL CIRCULAR D; Foppen RJG, 2003, PFLUG ARCH EUR J PHY, V446, P239, DOI 10.1007/s00424-003-1042-y; Gross J, 2000, J PHYSIOL-LONDON, V527, P623, DOI 10.1111/j.1469-7793.2000.00623.x; HAGBARTH KE, 1979, BRAIN, V102, P509, DOI 10.1093/brain/102.3.509; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Halliday DM, 1999, J NEUROPHYSIOL, V82, P664, DOI 10.1152/jn.1999.82.2.664; Hinkle RT, 2002, MUSCLE NERVE, V25, P729, DOI 10.1002/mus.10092; JointFormularyCommittee, 2011, BRIT NAT FORM; Kilner JM, 2000, J NEUROSCI, V20, P8838; Koster B, 1998, NEUROSCI LETT, V241, P135, DOI 10.1016/S0304-3940(98)00015-9; Lakie M, 2004, J NEUROL NEUROSUR PS, V75, P1013, DOI 10.1136/jnnp.2003.022749; LAKIE M, 1986, J NEUROL NEUROSUR PS, V49, P669, DOI 10.1136/jnnp.49.6.669; Levitt David G, 2002, BMC Clin Pharmacol, V2, P5; Lipworth BJ, 1997, THORAX, V52, P1036, DOI 10.1136/thx.52.12.1036; MARSDEN CD, 1967, CLIN SCI, V33, P53; MCAINSH J, 1990, PHARMACOL THERAPEUT, V46, P163, DOI 10.1016/0163-7258(90)90092-G; McAuley JH, 1997, EXP BRAIN RES, V114, P525, DOI 10.1007/PL00005662; Mima T, 2000, CLIN NEUROPHYSIOL, V111, P326, DOI 10.1016/S1388-2457(99)00229-1; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; NICHOLAS AP, 1993, NEUROSCIENCE, V56, P1023, DOI 10.1016/0306-4522(93)90148-9; Nicholson R, 2005, NEUROSCI LETT, V380, P316, DOI 10.1016/j.neulet.2005.01.079; Paschalis A, 2009, NEUROSCI LETT, V458, P84, DOI 10.1016/j.neulet.2009.04.023; Pohja M, 2005, NEUROIMAGE, V26, P764, DOI 10.1016/j.neuroimage.2005.02.031; Raethjen J, 2001, J NEUROL NEUROSUR PS, V70, P78, DOI 10.1136/jnnp.70.1.78; Rankovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027474; Riddle CN, 2006, NEUROIMAGE, V33, P618, DOI 10.1016/j.neuroimage.2006.07.027; Riddle CN, 2005, J PHYSIOL-LONDON, V566, P625, DOI 10.1113/jphysiol.2005.089607; Riddle CN, 2004, NEUROIMAGE, V22, P333, DOI 10.1016/j.neuroimage.2003.12.040; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; SUMMERS RJ, 1995, BRIT J PHARMACOL, V116, P2547, DOI 10.1111/j.1476-5381.1995.tb17205.x; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P1792, DOI 10.1016/S1388-2457(00)00378-3; Williams ER, 2010, P NATL ACAD SCI USA, V107, P11098, DOI 10.1073/pnas.0913373107; Williams ER, 2009, J NEUROSCI, V29, P6616, DOI 10.1523/JNEUROSCI.0272-09.2009; Williams ER, 2009, J NEUROPHYSIOL, V101, P31, DOI 10.1152/jn.90362.2008; Witham CL, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00038; Witham CL, 2011, J PHYSIOL-LONDON, V589, P3789, DOI 10.1113/jphysiol.2011.211045; ZILM DH, 1976, ELECTROEN CLIN NEURO, V41, P310, DOI 10.1016/0013-4694(76)90123-1	54	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49088	10.1371/journal.pone.0049088	http://dx.doi.org/10.1371/journal.pone.0049088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185297	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700024
J	Bower, K; Napier, CE; Cole, SL; Dagg, RA; Lau, LMS; Duncan, EL; Moy, EL; Reddel, RR				Bower, Kylie; Napier, Christine E.; Cole, Sara L.; Dagg, Rebecca A.; Lau, Loretta M. S.; Duncan, Emma L.; Moy, Elsa L.; Reddel, Roger R.			Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres	PLOS ONE			English	Article							IMMORTAL HUMAN-CELLS; COMPLEMENTATION GROUPS; MAINTENANCE MECHANISM; HISTONE CHAPERONE; PROTEIN ATRX; X SYNDROME; MUTATIONS; DAXX; RECOMBINATION; PATHWAY	Alternative Lengthening of Telomeres (ALT) is a non-telomerase mechanism of telomere lengthening that occurs in about 10% of cancers overall and is particularly common in astrocytic brain tumors and specific types of sarcomas. Somatic cell hybridization analyses have previously shown that normal telomerase-negative fibroblasts and telomerase-positive immortalized cell lines contain repressors of ALT activity, indicating that activation of ALT results from loss of one or more unidentified repressors. More recently, ATRX or DAXX was shown to be mutated both in tumors with telomere lengths suggestive of ALT activity and in ALT cell lines. Here, an ALT cell line was separately fused to each of four telomerase-positive cell lines, and four or five independent hybrid lines from each fusion were examined for expression of ATRX and DAXX and for telomere lengthening mechanism. The hybrid lines expressed either telomerase or ALT, with the other mechanism being repressed. DAXX was expressed normally in all parental cell lines and in all of the hybrids. ATRX was expressed normally in each of the four telomerase-positive parental cell lines and in every telomerase-positive hybrid line, and was abnormal in the ALT parental cells and in all but one of the ALT hybrids. This correlation between ALT activity and loss of ATRX expression is consistent with ATRX being a repressor of ALT.	[Bower, Kylie; Napier, Christine E.; Cole, Sara L.; Duncan, Emma L.; Moy, Elsa L.; Reddel, Roger R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia; [Dagg, Rebecca A.; Lau, Loretta M. S.] Childrens Hosp Westmead, Childrens Canc Res Unit, Westmead, NSW, Australia; [Lau, Loretta M. S.; Reddel, Roger R.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Children's Medical Research Institute - Australia; University of Sydney; University of Sydney	Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia.	rreddel@cmri.org.au	Cole, Sara L/GYQ-5700-2022; Lau, Loretta MS/B-1565-2008; Reddel, Roger R/A-6635-2014	Lau, Loretta MS/0000-0002-3172-0970; Reddel, Roger R/0000-0002-6302-6107; Dagg, Rebecca/0000-0002-3023-9616; Pearson, Kylie/0000-0001-5501-1581	Cancer Council NSW [PG11-08]; National Health and Medical Research Council of Australia [1009231]	Cancer Council NSW(Cancer Council New South Wales); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a Cancer Council NSW Program grant (PG11-08) and a National Health and Medical Research Council of Australia Project grant (1009231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentaro A, 2007, P NATL ACAD SCI USA, V104, P11939, DOI 10.1073/pnas.0704057104; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Colgin LM, 1999, CURR OPIN GENET DEV, V9, P97, DOI 10.1016/S0959-437X(99)80014-8; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; DUNCAN EL, 1993, EXP CELL RES, V205, P337, DOI 10.1006/excr.1993.1095; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Grobelny JV, 2001, HUM MOL GENET, V10, P1953, DOI 10.1093/hmg/10.18.1953; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Henson JD, 2005, CLIN CANCER RES, V11, P217; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; HUSCHTSCHA LI, 1983, J CELL SCI, V63, P77; Ishii Y, 1999, MECH AGEING DEV, V110, P175, DOI 10.1016/S0047-6374(99)00054-8; Jiang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017036; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Katoh M, 1998, MOL CARCINOGEN, V21, P17, DOI 10.1002/(SICI)1098-2744(199801)21:1<17::AID-MC4>3.0.CO;2-M; KE Y, 1989, AM J PATHOL, V134, P979; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; OHMURA H, 1995, JPN J CANCER RES, V86, P899, DOI 10.1111/j.1349-7006.1995.tb02998.x; PEREIRASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042, DOI 10.1073/pnas.85.16.6042; Perrem K, 1999, ONCOGENE, V18, P3383, DOI 10.1038/sj.onc.1202752; Perrem K, 2001, MOL CELL BIOL, V21, P3862, DOI 10.1128/MCB.21.12.3862-3875.2001; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Ulaner GA, 2003, CANCER RES, V63, P1759; WHITAKER NJ, 1992, J VIROL, V66, P1202, DOI 10.1128/JVI.66.2.1202-1206.1992; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yeager TR, 1999, CANCER RES, V59, P4175	48	56	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50062	10.1371/journal.pone.0050062	http://dx.doi.org/10.1371/journal.pone.0050062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185534	Green Submitted, Green Published, gold			2022-12-25	WOS:000311535700067
J	Schoewel, V; Marg, A; Kunz, S; Overkamp, T; Carrazedo, RS; Zacharias, U; Daniel, PT; Spuler, S				Schoewel, Verena; Marg, Andreas; Kunz, Severine; Overkamp, Tim; Carrazedo, Romy Siegert; Zacharias, Ute; Daniel, Peter T.; Spuler, Simone			Dysferlin-Peptides Reallocate Mutated Dysferlin Thereby Restoring Function	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GIRDLE MUSCULAR-DYSTROPHY; GLUCOSE-REGULATED PROTEINS; PROTEASOME INHIBITION; MIYOSHI MYOPATHY; MEMBRANE REPAIR; CELLS; GENE; DEGRADATION; ENDOCYTOSIS	Mutations in the dysferlin gene cause the most frequent adult-onset limb girdle muscular dystrophy, LGMD2B. There is no therapy. Dysferlin is a membrane protein comprised of seven, beta-sheet enriched, C2 domains and is involved in Ca2+ dependent sarcolemmal repair after minute wounding. On the protein level, point mutations in DYSF lead to misfolding, aggregation within the endoplasmic reticulum, and amyloidogenesis. We aimed to restore functionality by relocating mutant dysferlin. Therefore, we designed short peptides derived from dysferlin itself and labeled them to the cell penetrating peptide TAT. By tracking fluorescently labeled short peptides we show that these dysferlin-peptides localize in the endoplasmic reticulum. There, they are capable of reducing unfolded protein response stress. We demonstrate that the mutant dysferlin regains function in membrane repair in primary human myotubes derived from patients' myoblasts by the laser wounding assay and a novel technique to investigate membrane repair: the interventional atomic force microscopy. Mutant dysferlin abuts to the sarcolemma after peptide treatment. The peptide-mediated approach has not been taken before in the field of muscular dystrophies. Our results could redirect treatment efforts for this condition.	[Schoewel, Verena; Marg, Andreas; Kunz, Severine; Carrazedo, Romy Siegert; Zacharias, Ute; Spuler, Simone] Expt & Clin Res Ctr, Muscle Res Unit, Berlin, Germany; [Overkamp, Tim; Daniel, Peter T.] Univ Med Ctr Charite, Berlin, Germany; [Schoewel, Verena; Marg, Andreas; Kunz, Severine; Carrazedo, Romy Siegert; Zacharias, Ute; Spuler, Simone] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Spuler, S (corresponding author), Expt & Clin Res Ctr, Muscle Res Unit, Berlin, Germany.	simone.spuler@charite.de	Zacharias, Ute/AAS-4998-2020	Schoewel, Verena/0000-0002-5924-3088; Spuler, Simone/0000-0002-0155-1117	Clinical Education Program (KAP) of the Charite Medical Faculty; Max Delbruck Center for Molecular Medicine, Berlin; German Research Foundation [KFO192, Sp 1152/8-2, GK1631 MyoGrad]; Jain Foundation	Clinical Education Program (KAP) of the Charite Medical Faculty; Max Delbruck Center for Molecular Medicine, Berlin; German Research Foundation(German Research Foundation (DFG)); Jain Foundation	Dr. Verena Schoewel received a stipend from the Clinical Education Program (KAP) of the Charite Medical Faculty and the Max Delbruck Center for Molecular Medicine, Berlin. This work was funded by the German Research Foundation (KFO192, Sp 1152/8-2; GK1631 MyoGrad) and the Jain Foundation (www.jain-foundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LVB, 2000, NEUROMUSCULAR DISORD, V10, P553, DOI 10.1016/S0960-8966(00)00143-7; Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x; Azakir BA, 2012, J BIOL CHEM, V287, P10344, DOI 10.1074/jbc.M111.329078; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bartolini M, 2010, CHEMBIOCHEM, V11, P1018, DOI 10.1002/cbic.200900666; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Belanto JJ, 2010, NEUROMUSCULAR DISORD, V20, P111, DOI 10.1016/j.nmd.2009.12.003; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Cavaletti G, 2007, EXP NEUROL, V204, P317, DOI 10.1016/j.expneurol.2006.11.010; Clemen CS, 2010, BRAIN, V133, P2920, DOI 10.1093/brain/awq222; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Evesson FJ, 2010, J BIOL CHEM, V285, P28529, DOI 10.1074/jbc.M110.111120; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fukai T, 2007, CIRC RES, V101, P859, DOI 10.1161/CIRCRESAHA.107.164020; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Gulow K, 2002, J CELL SCI, V115, P2443; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Herrmann J, 2007, CIRC RES, V101, P865, DOI 10.1161/CIRCRESAHA.107.152959; Jones D, 2010, NAT REV DRUG DISCOV, V9, P825, DOI 10.1038/nrd3316; Jung SH, 2010, EXP MOL MED, V42, P597, DOI 10.3858/emm.2010.42.9.064; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Krahn M, 2009, HUM MUTAT, V30, pE345, DOI 10.1002/humu.20910; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; Ling YH, 2002, MOL CANCER THER, V1, P841; Lioneiti V, 2009, ULTRASOUND MED BIOL, V35, P136, DOI 10.1016/j.ultrasmedbio.2008.07.011; LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Marg A, 2012, TRAFFIC, V13, P1286, DOI 10.1111/j.1600-0854.2012.01386.x; Matsumoto M, 1996, FEBS LETT, V395, P143, DOI 10.1016/0014-5793(96)01016-2; Philippi Susanne, 2012, PLoS Curr, V4, pRRN1298, DOI 10.1371/currents.RRN1298; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; Richardson PG, 2006, J CLIN ONCOL, V24, P3113, DOI 10.1200/JCO.2005.04.7779; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Sawant R, 2010, MOL BIOSYST, V6, P628, DOI 10.1039/b916297f; Selcen D, 2001, NEUROLOGY, V56, P1472, DOI 10.1212/WNL.56.11.1472; Selcen D, 2011, NEUROMUSCULAR DISORD, V21, P161, DOI 10.1016/j.nmd.2010.12.007; Spuler S, 2008, ANN NEUROL, V63, P323, DOI 10.1002/ana.21309; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wenzel Katrin, 2006, Hum Mutat, V27, P599, DOI 10.1002/humu.9424; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; Yum K, 2010, NANOSCALE, V2, P363, DOI 10.1039/b9nr00231f; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	53	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49603	10.1371/journal.pone.0049603	http://dx.doi.org/10.1371/journal.pone.0049603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185377	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000311535700042
J	Jarvandi, S; Yan, Y; Schootman, M				Jarvandi, Soghra; Yan, Yan; Schootman, Mario			Income Disparity and Risk of Death: The Importance of Health Behaviors and Other Mediating Factors	PLOS ONE			English	Article							CUMULATIVE BIOLOGICAL RISK; US ADULTS; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC DISPARITIES; INDIVIDUAL INCOME; PHYSICAL-ACTIVITY; UNITED-STATES; MORTALITY; INEQUALITY; INFLAMMATION	Background: Income disparities in mortality are profound in the United States, but reasons for this remain largely unexplained. The objective of this study was to assess the effects of health behaviors, and other mediating pathways, separately and simultaneously, including health insurance, health status, and inflammation, in the association between income and mortality. Methods: This study used data from 9925 individuals aged 20 years or older who participated in the 1999-2004 National Health and Nutrition Examination Survey (NHANES) and were followed up through December 31, 2006 for mortality. The outcome measures were all-cause and CVD/diabetes mortality. During follow-up 505 persons died, including 196 deaths due to CVD or diabetes. Results: After adjusting for age, sex, education, and race/ethnicity, risk of death was higher in low-income than high-income group for both all-cause mortality (Hazard ratio [HR], 1.98; 95% confidence interval [CI]: 1.37, 2.85) and cardiovascular disease (CVD)/diabetes mortality (HR, 3.68; 95% CI: 1.64, 8.27). The combination of the four pathways attenuated 58% of the association between income and all-cause mortality and 35% of that of CVD/diabetes mortality. Health behaviors attenuated the risk of all-cause and CVD/diabetes mortality by 30% and 21%, respectively, in the low-income group. Health status attenuated 39% of all-cause mortality and 18% of CVD/diabetes mortality, whereas, health insurance and inflammation accounted for only a small portion of the income-associated mortality (<= 6%). Conclusion: Excess mortality associated with lower income can be largely accounted for by poor health status and unhealthy behaviors. Future studies should address behavioral modification, as well as possible strategies to improve health status in low-income people.	[Jarvandi, Soghra; Yan, Yan; Schootman, Mario] Washington Univ, Sch Med, Div Hlth Behav Res, St Louis, MO 63130 USA; [Yan, Yan] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Jarvandi, S (corresponding author), Washington Univ, Sch Med, Div Hlth Behav Res, St Louis, MO 63130 USA.	sjarvand@dom.wustl.edu	Schootman, Mario/AAF-3941-2019	Schootman, Mario/0000-0003-1162-8824; Yan, Yan/0000-0002-5917-1475	Washington University School of Medicine; National Cancer Institute at the National Institutes of Health [CA112159]; NATIONAL CANCER INSTITUTE [R01CA112159] Funding Source: NIH RePORTER	Washington University School of Medicine; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the funding received from Washington University School of Medicine and the National Cancer Institute at the National Institutes of Health (grant number CA112159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003; Avlund K, 1997, AGING CLIN EXP RES, V9, P164, DOI 10.1007/BF03340145; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2003, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention National Center for Health Statistics, 2003, NAT HLTH NUTR EX LAB; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chen HL, 2008, J AM GERIATR SOC, V56, P689, DOI 10.1111/j.1532-5415.2007.01624.x; Duncan PW, 1997, STROKE, V28, P740, DOI 10.1161/01.STR.28.4.740; Efron B, 1993, INTRO BOOTSTRAP, P178; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; Fiscella K, 2000, HEALTH SERV RES, V35, P307; Fisher EB, 1998, AM J PUBLIC HEALTH, V88, P1658, DOI 10.2105/AJPH.88.11.1658; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; George SM, 2010, CANCER EPIDEM BIOMAR, V19, P2220, DOI 10.1158/1055-9965.EPI-10-0464; Giles-Corti B, 2002, SOC SCI MED, V54, P1793, DOI 10.1016/S0277-9536(01)00150-2; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Lantz PM, 2001, SOC SCI MED, V53, P29, DOI 10.1016/S0277-9536(00)00319-1; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Linder SH, 2011, AM J PUBLIC HEALTH, V101, pS74, DOI 10.2105/AJPH.2011.300318; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; Mackenbach JP, 1996, AM J PUBLIC HEALTH, V86, P706, DOI 10.2105/AJPH.86.5.706; Macleod J, 2005, SOC SCI MED, V61, P1916, DOI 10.1016/j.socscimed.2005.04.009; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rask K, 2009, J PUBLIC HEALTH-UK, V31, P231, DOI 10.1093/pubmed/fdp015; Schulz AJ, 2005, ENVIRON HEALTH PERSP, V113, P1817, DOI 10.1289/ehp.7913; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; U.S. Center for Disease Control and Prevention. Health United States, 2010, SPEC FEAT DEATH DYIN; US Department of Health and Human Services, HLTH PEOPL 2020 TOP; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; Wilkinson RG, 2009, ANNU REV SOCIOL, V35, P493, DOI 10.1146/annurev-soc-070308-115926; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	42	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49929	10.1371/journal.pone.0049929	http://dx.doi.org/10.1371/journal.pone.0049929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040PB	23185488	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800061
J	Lopez de Victoria, A; Tamamis, P; Kieslich, CA; Morikis, D				Lopez de Victoria, Aliana; Tamamis, Phanourios; Kieslich, Chris A.; Morikis, Dimitrios			Insights into the Structure, Correlated Motions, and Electrostatic Properties of Two HIV-1 gp120 V3 Loops	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ENVELOPE GLYCOPROTEIN; LIGAND-BINDING; CD4 RECEPTOR; CCR5; CORECEPTOR; PROTEIN; COMPSTATIN; COMPLEX; CONFORMATIONS	The V3 loop of the glycoprotein 120 (gp120) is a contact point for cell entry of HIV-1 leading to infection. Despite sequence variability and lack of specific structure, the highly flexible V3 loop possesses a well-defined role in recognizing and selecting cell-bound coreceptors CCR5 and CXCR4 through a mechanism of charge complementarity. We have performed two independent molecular dynamics (MD) simulations to gain insights into the dynamic character of two V3 loops with slightly different sequences, but significantly different starting crystallographic structures. We have identified highly populated trajectory-specific salt bridges between oppositely charged stem residues Arg9 and Glu25 or Asp29. The two trajectories share nearly identical correlated motions within the simulations, despite their different overall structures. High occupancy salt bridges play a key role in the major cross-correlated motions in both trajectories, and may be responsible for transient structural stability in preparation for coreceptor binding. In addition, the two V3 loops visit conformations with similarities in spatial distributions of electrostatic potentials, despite their inherent flexibility, which may play a role in coreceptor recognition. It is plausible that cooperativity between overall electrostatic potential, charged residue interactions, and correlated motions could be associated with a coreceptor selection and binding.	[Lopez de Victoria, Aliana; Tamamis, Phanourios; Kieslich, Chris A.; Morikis, Dimitrios] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside	Morikis, D (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	dmorikis@ucr.edu	Morikis, Dimitrios/L-8527-2013	Morikis, Dimitrios/0000-0003-0083-4665; Kieslich, Chris/0000-0002-1845-6589; Tamamis, Phanourios/0000-0002-3342-2651				Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baritaki S, 2002, BIOCHEM BIOPH RES CO, V298, P574, DOI 10.1016/S0006-291X(02)02511-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chandramouli B, 2012, J BIOMOL STRUCT DYN, V29, P879; Chocholousova J, 2006, J COMPUT CHEM, V27, P719, DOI 10.1002/jcc.20387; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Da LT, 2011, J CHEM INF MODEL, V51, P359, DOI 10.1021/ci1003448; Dittmar MT, 1997, NATURE, V385, P495, DOI 10.1038/385495a0; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Edo-Matas D, 2011, VIROLOGY, V412, P269, DOI 10.1016/j.virol.2011.01.010; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Falconi M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-73; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Galanakis PA, 2009, BIOPOLYMERS, V92, P94, DOI 10.1002/bip.21127; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gorham RD, 2012, CELL MOL BIOENG, V5, P32, DOI 10.1007/s12195-011-0195-6; Gorham RD, 2011, BIOPOLYMERS, V95, P746, DOI 10.1002/bip.21644; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hakkoymaz H, 2011, MOL INFORM, V30, P733, DOI 10.1002/minf.201100002; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hsu STD, 2004, PROTEINS, V55, P582, DOI 10.1002/prot.20061; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kieslich CA, 2012, AIDS RES HUM R UNPUB; Kieslich CA, 2011, J NON-CRYST SOLIDS, V357, P707, DOI 10.1016/j.jnoncrysol.2010.05.087; Kieslich CA, 2011, BIOTECHNOL PROGR, V27, P316, DOI 10.1002/btpr.541; Krambovitis E, 2004, SCAND J IMMUNOL, V59, P231, DOI 10.1111/j.0300-9475.2004.01377.x; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Liu SQ, 2008, J MOL MODEL, V14, P857, DOI 10.1007/s00894-008-0327-7; Liu SQ, 2007, J MOL GRAPH MODEL, V26, P306, DOI 10.1016/j.jmgm.2006.12.007; Liu SQ, 2003, J MOL MODEL, V9, P329, DOI 10.1007/s00894-003-0154-9; Lobritz MA, 2010, VIRUSES-BASEL, V2, P1069, DOI 10.3390/v2051069; Lopez de Victoria A, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-3; Lukman S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000922; Macias AT, 2005, J COMPUT CHEM, V26, P1452, DOI 10.1002/jcc.20281; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Matter H, 1997, J AM CHEM SOC, V119, P2212, DOI 10.1021/ja962776z; Morikis D, 2007, INT J MOL MED, V19, P343; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Napier KB, 2007, J MOL MODEL, V13, P29, DOI 10.1007/s00894-006-0117-z; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Silla Y, 2011, BIOCHEMISTRY-US, V50, P1396, DOI 10.1021/bi101095g; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Soriano V, 2009, AIDS, V23, P2377, DOI 10.1097/QAD.0b013e328332d32d; Tamamis P, 2012, CHEM BIOL DRUG DES, V79, P703, DOI 10.1111/j.1747-0285.2012.01324.x; Tamamis P, 2011, PROTEINS, V79, P3166, DOI 10.1002/prot.23149; Tamamis P, 2010, PROTEINS, V78, P2655, DOI 10.1002/prot.22780; Teoh TC, 2011, DARU, V19, P469; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tsibris A, 2007, PRN NOTEBOOK, P12; Wang X, 2011, ACTA PHARM SIN B, V1, P80, DOI 10.1016/j.apsb.2011.06.002; Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiao LH, 1998, VIROLOGY, V240, P83, DOI 10.1006/viro.1997.8924; Yokoyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037530	70	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49925	10.1371/journal.pone.0049925	http://dx.doi.org/10.1371/journal.pone.0049925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185486	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800060
J	Gurski, LA; Xu, X; Labrada, LN; Nguyen, NT; Xiao, LX; van Golen, KL; Jia, XQ; Farach-Carson, MC				Gurski, Lisa A.; Xu, Xian; Labrada, Lyana N.; Nguyen, Ngoc T.; Xiao, Longxi; van Golen, Kenneth L.; Jia, Xinqiao; Farach-Carson, Mary C.			Hyaluronan (HA) Interacting Proteins RHAMM and Hyaluronidase Impact Prostate Cancer Cell Behavior and Invadopodia Formation in 3D HA-Based Hydrogels	PLOS ONE			English	Article							BONE-MARROW; IN-VITRO; ACID; PROGRESSION; ACTIVATION; MIGRATION; INVASION; METASTASIS; MATRIX; ASSAYS	To study the individual functions of hyaluronan interacting proteins in prostate cancer (PCa) motility through connective tissues, we developed a novel three-dimensional (3D) hyaluronic acid (HA) hydrogel assay that provides a flexible, quantifiable, and physiologically relevant alternative to current methods. Invasion in this system reflects the prevalence of HA in connective tissues and its role in the promotion of cancer cell motility and tissue invasion, making the system ideal to study invasion through bone marrow or other HA-rich connective tissues. The bio-compatible cross-linking process we used allows for direct encapsulation of cancer cells within the gel where they adopt a distinct, cluster-like morphology. Metastatic PCa cells in these hydrogels develop fingerlike structures, "invadopodia", consistent with their invasive properties. The number of invadopodia, as well as cluster size, shape, and convergence, can provide a quantifiable measure of invasive potential. Among candidate hyaluronan interacting proteins that could be responsible for the behavior we observed, we found that culture in the HA hydrogel triggers invasive PCa cells to differentially express and localize receptor for hyaluronan mediated motility (RHAMM)/CD168 which, in the absence of CD44, appears to contribute to PCa motility and invasion by interacting with the HA hydrogel components. PCa cell invasion through the HA hydrogel also was found to depend on the activity of hyaluronidases. Studies shown here reveal that while hyaluronidase activity is necessary for invadopodia and inter-connecting cluster formation, activity alone is not sufficient for acquisition of invasiveness to occur. We therefore suggest that development of invasive behavior in 3D HA-based systems requires development of additional cellular features, such as activation of motility associated pathways that regulate formation of invadopodia. Thus, we report development of a 3D system amenable to dissection of biological processes associated with cancer cell motility through HA-rich connective tissues.	[Gurski, Lisa A.; Labrada, Lyana N.; Nguyen, Ngoc T.; van Golen, Kenneth L.; Farach-Carson, Mary C.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Xu, Xian; Xiao, Longxi; Jia, Xinqiao] Univ Delaware, Dept Mat Sci & Engn, Newark, DE USA; [Gurski, Lisa A.; Xu, Xian; Labrada, Lyana N.; Nguyen, Ngoc T.; Xiao, Longxi; van Golen, Kenneth L.; Jia, Xinqiao] Univ Delaware, Ctr Translat Canc Res, Newark, DE USA; [Farach-Carson, Mary C.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Farach-Carson, Mary C.] Rice Univ, Dept Bioengn, Houston, TX USA	University of Delaware; University of Delaware; University of Delaware; Rice University; Rice University	Farach-Carson, MC (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	farachca@rice.edu	Xu, Xian/L-2448-2014	Farach-Carson, Mary/0000-0002-4526-3088	National Institutes of Health [P01CA098912, P20RR016458, P20RR017716, R01DC008965]; National Science Foundation [DMR 0643226, IGERT 0221651]; Delaware Health Science Alliance (DHSA); Department of Defense [PCRP W81XWH-05-1-0005, W81XWH-08-1-0356, PCRP W81XWH-11-1-0564]; Center for Translational Cancer Research; NATIONAL CANCER INSTITUTE [P01CA098912] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016458, P20RR017716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Delaware Health Science Alliance (DHSA); Department of Defense(United States Department of Defense); Center for Translational Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by the National Institutes of Health (www.nih.gov) P01CA098912 (MCFC) and P20RR016458, P20RR017716, R01DC008965 (XJ), the National Science Foundation (www.nsf.gov) DMR 0643226 (XJ) and IGERT 0221651 (LG) and Delaware Health Science Alliance (DHSA) (www.delawarehsa.org) (XJ), the Department of Defense (www.defense.gov) PCRP W81XWH-05-1-0005 and W81XWH-08-1-0356 (KLVG) and PCRP W81XWH-11-1-0564 (LG), and the Center for Translational Cancer Research (www.udel.edu/ctcr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Barla F, 2009, BIOSCI BIOTECH BIOCH, V73, P2335, DOI 10.1271/bbb.90365; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; CHEN JL, 1969, J ALLERGY, V43, P89, DOI 10.1016/0021-8707(69)90129-4; Clark BR, 1995, ANN NY ACAD SCI, V770, P70, DOI 10.1111/j.1749-6632.1995.tb31044.x; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Edwards AM, 2000, CLIN EXP ALLERGY, V30, P756; Ekici S, 2004, INT J CANCER, V112, P121, DOI 10.1002/ijc.20368; Gomez CS, 2009, J UROLOGY, V182, P1350, DOI 10.1016/j.juro.2009.06.070; Goueffic Y, 2006, CARDIOVASC RES, V72, P339, DOI 10.1016/j.cardiores.2006.07.017; GUNTENHONER MW, 1992, MATRIX, V12, P388, DOI 10.1016/S0934-8832(11)80035-1; Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Harper K, 2010, CANCER RES, V70, P4634, DOI 10.1158/0008-5472.CAN-09-3813; Harrison GM, 2006, ONCOL REP, V15, P199; HE XY, 1994, PHOTOCHEM PHOTOBIOL, V59, P468, DOI 10.1111/j.1751-1097.1994.tb05066.x; Hofinger ESA, 2008, GLYCOCONJUGATE J, V25, P101, DOI 10.1007/s10719-007-9058-8; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Huxley-Jones J, 2008, DRUG DISCOV TODAY, V13, P685, DOI 10.1016/j.drudis.2008.05.005; Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012; KAKEGAWA H, 1985, CHEM PHARM BULL, V33, P642; Kobayashi T, 2010, MOL ENDOCRINOL, V24, P722, DOI 10.1210/me.2009-0326; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Lokeshwar VB, 1996, CANCER RES, V56, P651; Marshall J, 2011, METHODS MOL BIOL, V769, P97, DOI 10.1007/978-1-61779-207-6_8; MEYER K, 1958, FED PROC, V17, P1075; Mio K, 2002, MATRIX BIOL, V21, P31, DOI 10.1016/S0945-053X(01)00185-8; MIURA RO, 1995, ANAL BIOCHEM, V225, P333, DOI 10.1006/abio.1995.1163; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Reiman T, 2003, BLOOD, V102, p680A; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462; Schade UM, 2006, ACTA HISTOCHEM, V108, P141, DOI 10.1016/j.acthis.2006.03.018; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Shaw MT, 2005, INTRODUCTION TO POLYMER VISCOELASTICITY, 3RD EDITION, P1, DOI 10.1002/0471741833; Society AC, 2012, CANC FACTS FIG 2012; Stern R, 2008, SEMIN CANCER BIOL, V18, P275, DOI 10.1016/j.semcancer.2008.03.017; THALMANN GN, 1994, CANCER RES, V54, P2577; Thalmann GN, 2000, PROSTATE, V44, P91; Thalmann GN, 1999, CLIN CANCER RES, V5, P2271; TURLEY EA, 1991, J CELL BIOL, V112, P1041, DOI 10.1083/jcb.112.5.1041; van Horssen R, 2011, J CELL PHYSIOL, V226, P288, DOI 10.1002/jcp.22330; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Xiao WW, 2012, CLIN EXP METASTAS, V29, P1, DOI 10.1007/s10585-011-9423-7; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zhang C, 2011, PROSTATE, V71, P157, DOI 10.1002/pros.21231; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342	54	42	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50075	10.1371/journal.pone.0050075	http://dx.doi.org/10.1371/journal.pone.0050075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166824	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300084
J	Banfic, H; Bedalov, A; York, JD; Visnjic, D				Banfic, Hrvoje; Bedalov, Antonio; York, John D.; Visnjic, Dora			Inositol Pyrophosphates Modulate S Phase Progression after Pheromone-induced Arrest in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPENSATORY LIVER GROWTH; PHOSPHOLIPASE-C; CELL-CYCLE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOINOSITIDE 3-KINASE; SWISS 3T3-CELLS; TELOMERE LENGTH; PLASMA-MEMBRANE; PROTEIN-KINASE; HL-60 CELLS	Several studies have demonstrated the activation of phosphoinositide-specific phospholipase C (Plc) in nuclei of mammalian cells during synchronous progression through the cell cycle, but the downstream targets of Plc-generated inositol 1,4,5-trisphosphate are poorly described. Phospholipid signaling in the budding yeast Saccharomyces cerevisiae shares similarities with endonuclear phospholipid signaling in mammals, and many recent studies point to a role for inositol phosphates, including InsP(5), InsP(6), and inositol pyrophosphates, in mediating the action of Plc. In this study, we investigated the changes in inositol phosphate levels in alpha-factor-treated S. cerevisiae, which allows cells to progress synchronously through the cell cycle after release from a G(1) block. We found an increase in the activity of Plc1 early after release from the block with a concomitant increase in the levels of InsP(7) and InsP(8). Treatment of cells with the Plc inhibitor U73122 prevented increases in inositol phosphate levels and blocked progression of cells through S phase after pheromone arrest. The enzymatic activity of Kcs1 in vitro and HPLC analysis of [H-3] inositol-labeled kcs1 Delta cells confirmed that Kcs1 is the principal kinase responsible for generation of pyrophosphates in synchronously progressing cells. Analysis of plc1 Delta, kcs1 Delta, and ddp1 Delta yeast mutants further confirmed the role that a Plc1- and Kcs1-mediated increase in pyrophosphates may have in progression through S phase. Our data provide genetic, metabolic, and biochemical evidence that synthesis of inositol pyrophosphates through activation of Plc1 and Kcs1 plays an important role in the signaling response required for cell cycle progression after mating pheromone arrest.	[Banfic, Hrvoje; Visnjic, Dora] Univ Zagreb, Sch Med, Dept Physiol, Zagreb 10000, Croatia; [Banfic, Hrvoje; Visnjic, Dora] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Zagreb 10000, Croatia; [Bedalov, Antonio] Fred Hutchinson Canc Reaserch Ctr, Seattle, WA 98109 USA; [York, John D.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA	University of Zagreb; University of Zagreb; Fred Hutchinson Cancer Center; Vanderbilt University	Banfic, H (corresponding author), Univ Zagreb, Sch Med, Dept Physiol, Salata 3, Zagreb 10000, Croatia.	hrvoje.banfic@zg.t-com.hr			National Institutes of Health [R01-HL55672-15, R01-CA129132]; Ministry of Science, Education, and Sport of the Republic of Croatia [108-1081347-0173, 108-1081347-1448]; Unity through Knowledge Fund [02/07]; University of Zagreb Development Fund [380-181/102-12-21]; NATIONAL CANCER INSTITUTE [R21CA164545, R01CA129132] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Education, and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Unity through Knowledge Fund; University of Zagreb Development Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL55672-15 and R01-CA129132 (to J. Y. and A. B., respectively). This work was also supported by Ministry of Science, Education, and Sport of the Republic of Croatia Grants 108-1081347-0173 (to H. B.) and 108-1081347-1448 (to D. V.); Unity through Knowledge Fund Grant 02/07 (to H. B. and A. B.); and University of Zagreb Development Fund Grant 380-181/102-12-21 (to H. B.).	Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Barker CJ, 2004, BIOCHEM J, V380, P465, DOI 10.1042/BJ20031872; Crljen V, 2004, FEBS LETT, V571, P35, DOI 10.1016/j.febslet.2004.06.051; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Faenza I, 2000, J BIOL CHEM, V275, P30520, DOI 10.1074/jbc.M004630200; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; HUANG KN, 1995, GENETICS, V141, P1275; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lin HY, 2000, MOL CELL BIOL, V20, P3597, DOI 10.1128/MCB.20.10.3597-3607.2000; Lukinovic-Skudar V, 2005, BBA-MOL CELL BIOL L, V1733, P148, DOI 10.1016/j.bbalip.2004.12.009; Lukinovic-Skudar V, 2007, BBA-MOL CELL BIOL L, V1771, P514, DOI 10.1016/j.bbalip.2007.02.002; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; Perera NM, 2004, J BIOL CHEM, V279, P5216, DOI 10.1074/jbc.M305068200; Pesesse X, 2004, J BIOL CHEM, V279, P43378, DOI 10.1074/jbc.C400286200; Safrany ST, 1999, J BIOL CHEM, V274, P21735, DOI 10.1074/jbc.274.31.21735; Saiardi A, 2000, J BIOL CHEM, V275, P24686, DOI 10.1074/jbc.M002750200; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A., 2012, SUBCELL BIOCH, V59, P413; Sindic A, 2001, J BIOL CHEM, V276, P17754, DOI 10.1074/jbc.M006533200; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Stallings JD, 2008, J BIOL CHEM, V283, P13992, DOI 10.1074/jbc.M800752200; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; Visnjic D, 2007, PFLUG ARCH EUR J PHY, V455, P19, DOI 10.1007/s00424-007-0288-1; Yang L, 2008, J BIOL CHEM, V283, P11823, DOI 10.1074/jbc.M800308200; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	40	14	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1717	1725		10.1074/jbc.M112.412288	http://dx.doi.org/10.1074/jbc.M112.412288			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23179856	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000313751400028
J	Mogilenko, DA; Kudriavtsev, IV; Shavva, VS; Dizhe, EB; Vilenskaya, EG; Efremov, AM; Perevozchikov, AP; Orlov, SV				Mogilenko, Denis A.; Kudriavtsev, Igor V.; Shavva, Vladimir S.; Dizhe, Ella B.; Vilenskaya, Ekaterina G.; Efremov, Alexander M.; Perevozchikov, Andrej P.; Orlov, Sergey V.			Peroxisome Proliferator-activated Receptor alpha Positively Regulates Complement C3 Expression but Inhibits Tumor Necrosis Factor alpha-mediated Activation of C3 Gene in Mammalian Hepatic-derived Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYLATION-STIMULATING PROTEIN; PPAR-ALPHA; NUCLEAR RECEPTORS; 3RD COMPONENT; X-RECEPTOR; FACTOR-B; FATTY-ACIDS; KAPPA-B; INFLAMMATION; PATHWAY	Complement C3 is a pivotal component of three cascades of complement activation. The liver is the main source of C3 in circulation and expression and secretion of C3 by hepatocytes is increased during acute inflammation. However, the mechanism of the regulation of the C3 gene in hepatocytes is not well elucidated. We showed that the C3 gene is the direct target for peroxisome proliferator-activated receptor alpha (PPAR alpha) in human hepatoma HepG2 cells and mouse liver. Using PPAR alpha siRNA and synthetic PPAR alpha agonist WY-14643 and antagonist MK886 we showed that activation of PPAR alpha results in up-regulation of C3 gene expression and protein secretion by HepG2 cells. The PPAR response element (PPRE), which is able to bind PPAR alpha in vitro and in vivo, was found in the human C3 promoter. PPRE is conserved between human and mouse, and WY-14643 stimulates mouse C3 expression in the liver. TNF alpha increases C3 gene via NF-kappa B and, to a lesser extent, MEK1/2 signaling pathways, whereas TNF alpha-mediated stimulation of C3 protein secretion depends on activation of MEK1/2, p38, and JNK in HepG2 cells. Activation of PPAR alpha abolishes TNF alpha-mediated up-regulation of C3 gene expression and protein secretion due to interference with NF-kappa B via PPRE-dependent mechanism in HepG2 cells. TNF alpha decreases PPAR alpha protein content via NF-kappa B and MEK1/2 signaling pathways and inhibits PPAR alpha binding with the human C3 promoter in HepG2 cells. These results suggest novel mechanism controlling C3 expression in hepatocytes during acute phase inflammation and demonstrate a crosstalk between PPAR alpha and TNF alpha in the regulation of complement system.	[Mogilenko, Denis A.; Shavva, Vladimir S.; Dizhe, Ella B.; Vilenskaya, Ekaterina G.; Efremov, Alexander M.; Perevozchikov, Andrej P.; Orlov, Sergey V.] Russian Acad Med Sci, Inst Expt Med, Dept Biochem, St Petersburg 197376, Russia; [Kudriavtsev, Igor V.] Russian Acad Med Sci, Inst Expt Med, Dept Immunol, St Petersburg 197376, Russia; [Mogilenko, Denis A.; Shavva, Vladimir S.; Vilenskaya, Ekaterina G.; Perevozchikov, Andrej P.; Orlov, Sergey V.] St Petersburg State Univ, Dept Embryol, St Petersburg 199034, Russia; [Kudriavtsev, Igor V.; Efremov, Alexander M.] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg 199034, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Saint Petersburg State University; Saint Petersburg State University	Mogilenko, DA (corresponding author), Russian Acad Med Sci, Inst Expt Med, Dept Biochem, Acad Pavlov Str 12, St Petersburg 197376, Russia.	denis@iem.sp.ru; serge@iem.sp.ru	Orlov, Sergey V./N-6823-2014; Mogilenko, Denis/H-4436-2013; Dizhe, Ella B./N-6842-2014; Perevozchikov, Andrej/M-9744-2015; Mogilenko, Denis/ABE-9454-2021; Kudryavtsev, Igor/D-2124-2013	Orlov, Sergey V./0000-0002-3134-1989; Mogilenko, Denis/0000-0001-5427-5243; Perevozchikov, Andrej/0000-0001-7049-3224; Kudryavtsev, Igor/0000-0001-7204-7850; Dizhe, Ella/0000-0001-5147-4749; Shavva, Vladimir S./0000-0002-5080-8636	Russian Fund of Basic Research [11-04-02012-a, 12-04-00858-a]	Russian Fund of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Fund of Basic Research Grants 11-04-02012-a and 12-04-00858-a.	Ajjan R, 2005, THROMB HAEMOSTASIS, V94, P1048, DOI 10.1160/TH05-06-0384; ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; Cope Nathan F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5137; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; EINSTEIN LP, 1977, J CLIN INVEST, V60, P963, DOI 10.1172/JCI108876; FALUS A, 1987, J IMMUNOL, V138, P856; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Gervois P, 2001, J BIOL CHEM, V276, P33471, DOI 10.1074/jbc.M102839200; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Huang W, 2010, ARTERIOSCL THROM VAS, V30, P1542, DOI 10.1161/ATVBAHA.109.191189; ISSEMANN I, 1993, BIOCHIMIE, V75, P251, DOI 10.1016/0300-9084(93)90084-6; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LEVISTRAUSS M, 1987, J IMMUNOL, V139, P2361; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Li JL, 2005, J BIOL CHEM, V280, P7427, DOI 10.1074/jbc.M411473200; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Mogilenko DA, 2012, J BIOL CHEM, V287, P5954, DOI 10.1074/jbc.M111.289322; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Muscari A, 2000, EUR HEART J, V21, P1081, DOI 10.1053/euhj.1999.2013; Orlov SV, 2007, FEBS J, V274, P4848, DOI 10.1111/j.1742-4658.2007.06006.x; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; PERLMUTTER DH, 1986, MOL IMMUNOL, V23, P1263, DOI 10.1016/0161-5890(86)90162-8; PERLMUTTER DH, 1986, SCIENCE, V232, P850, DOI 10.1126/science.3010455; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Rodgers JT, 2000, ANAL BIOCHEM, V277, P254, DOI 10.1006/abio.1999.4394; RUDDY S, 1974, NEW ENGL J MED, V290, P1284, DOI 10.1056/NEJM197406062902304; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Shoda J, 2004, J LIPID RES, V45, P1813, DOI 10.1194/jlr.M400132-JLR200; STRUNK RC, 1985, J CLIN INVEST, V76, P985, DOI 10.1172/JCI112099; Van Hermelen V, 1999, J BIOL CHEM, V274, P18243, DOI 10.1074/jbc.274.26.18243; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; VOLANAKIS JE, 1995, ANNU REV IMMUNOL, V13, P277, DOI 10.1146/annurev.immunol.13.1.277; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WARREN HB, 1987, AM J PATHOL, V129, P9; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975	51	33	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1726	1738		10.1074/jbc.M112.437525	http://dx.doi.org/10.1074/jbc.M112.437525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23168409	Green Published, hybrid			2022-12-25	WOS:000313751400029
J	Weiser, BP; Kelz, MB; Eckenhoff, RG				Weiser, Brian P.; Kelz, Max B.; Eckenhoff, Roderic G.			In Vivo Activation of Azipropofol Prolongs Anesthesia and Reveals Synaptic Targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GABA(A) RECEPTOR; BINDING-SITE; TRANSMEMBRANE DOMAIN; GEL-ELECTROPHORESIS; CALCIUM-CHANNELS; ANALOG; MODULATION; ETOMIDATE; SNAP-25; RAT	General anesthetic photolabels have been instrumental in discovering and confirming protein binding partners and binding sites of these promiscuous ligands. We report the in vivo photoactivation of meta-azipropofol, a potent analog of propofol, in Xenopus laevis tadpoles. Covalent adduction of meta-azipropofol in vivo prolongs the primary pharmacologic effect of general anesthetics in a behavioral phenotype we termed "optoanesthesia." Coupling this behavior with a tritiated probe, we performed unbiased, time-resolved gel proteomics to identify neuronal targets of meta-azipropofol in vivo. We have identified synaptic binding partners, such as synaptosomal-associated protein 25, as well as voltage-dependent anion channels as potential facilitators of the general anesthetic state. Pairing behavioral phenotypes elicited by the activation of efficacious photolabels in vivo with time-resolved proteomics provides a novel approach to investigate molecular mechanisms of general anesthetics.	[Weiser, Brian P.; Kelz, Max B.; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesia & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Weiser, Brian P.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kelz, Max B.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kelz, Max B.] Univ Penn, David Mahoney Inst Neurol Sci, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Eckenhoff, RG (corresponding author), Univ Penn, Dept Anesthesia & Crit Care, Perelman Sch Med, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	roderic.eckenhoff@uphs.upenn.edu	Kelz, Max/E-4054-2010	Kelz, Max/0000-0002-2803-6078; Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health [GM055876, NS080519, GM088156]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088156, P01GM055876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS080519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM055876 (to R. G. E.), NS080519 (to B. P. W.), and GM088156 (to M. B. K.).	Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Bunai K, 2005, J CHROMATOGR B, V815, P227, DOI 10.1016/j.jchromb.2004.08.030; BUREAU MH, 1992, J BIOL CHEM, V267, P8679; Chen ZW, 2012, MOL PHARMACOL, V82, P408, DOI 10.1124/mol.112.078410; Chen ZW, 2012, ELECTROPHORESIS, V33, P666, DOI 10.1002/elps.201100434; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Condliffe SB, 2010, J BIOL CHEM, V285, P24968, DOI 10.1074/jbc.M110.145813; Cui TX, 2012, BBA-BIOMEMBRANES, V1818, P617, DOI 10.1016/j.bbamem.2011.11.021; Darbandi-Tonkabon R, 2003, J BIOL CHEM, V278, P13196, DOI 10.1074/jbc.M213168200; Darbandi-Tonkabon R, 2004, J PHARMACOL EXP THER, V308, P502, DOI 10.1124/jpet.103.058123; Das J, 2004, J BIOL CHEM, V279, P37964, DOI 10.1074/jbc.M405137200; Downes H, 1996, J PHARMACOL EXP THER, V278, P284; ECKENHOFF RG, 1993, ANESTHESIOLOGY, V79, P96, DOI 10.1097/00000542-199307000-00015; Eckenhoff RG, 2010, ACS CHEM NEUROSCI, V1, P139, DOI 10.1021/cn900014m; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Garbelli R, 2008, J COMP NEUROL, V506, P373, DOI 10.1002/cne.21505; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herring BE, 2011, J PHYSIOL-LONDON, V589, P1103, DOI 10.1113/jphysiol.2010.200964; Herring BE, 2009, J NEUROPHYSIOL, V102, P1265, DOI 10.1152/jn.00252.2009; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Issaq HJ, 2008, BIOTECHNIQUES, V44, P697, DOI 10.2144/000112823; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Nagele P, 2005, ANESTHESIOLOGY, V103, P768, DOI 10.1097/00000542-200510000-00015; Nguyen HT, 2009, ANESTHESIOLOGY, V110, P326, DOI 10.1097/ALN.0b013e3181942b5b; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; van Swinderen B, 1999, P NATL ACAD SCI USA, V96, P2479, DOI 10.1073/pnas.96.5.2479; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Xi J, 2004, J BIOL CHEM, V279, P19628, DOI 10.1074/jbc.M313864200; Yuki K, 2012, FASEB J, V26, P4408, DOI 10.1096/fj.12-212746; Zhong HJ, 2008, ANESTHESIOLOGY, V108, P103, DOI 10.1097/01.anes.0000296074.33999.52; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	37	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1279	1285		10.1074/jbc.M112.413989	http://dx.doi.org/10.1074/jbc.M112.413989			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184948	Green Published, hybrid			2022-12-25	WOS:000313570300049
J	Zhong, XT; Kieras, E; Sousa, E; D'Antona, A; Baber, JC; He, T; Desharnais, J; Wood, L; Luxenberg, D; Stahl, M; Kriz, R; Lin, L; Somers, W; Fitz, LJ; Wright, JF				Zhong, Xiaotian; Kieras, Elizabeth; Sousa, Eric; D'Antona, Aaron; Baber, J. Christian; He, Tao; Desharnais, Joel; Wood, Lauren; Luxenberg, Deborah; Stahl, Mark; Kriz, Ronald; Lin, Laura; Somers, Will; Fitz, Lori J.; Wright, Jill F.			Pyroglutamate and O-Linked Glycan Determine Functional Production of Anti-IL17A and Anti-IL22 Peptide-Antibody Bispecific Genetic Fusions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO SELECTION; TH17 CELLS; PROTEIN THERAPEUTICS; DISPLAY; LIBRARIES; INFLAMMATION; EXPRESSION; DISEASE; POTENT; IL-22	Protein biosynthesis and extracellular secretion are essential biological processes for therapeutic protein production in mammalian cells, which offer the capacity for correct folding and proper post-translational modifications. In this study, we have generated bispecific therapeutic fusion proteins in mammalian cells by combining a peptide and an antibody into a single open reading frame. A neutralizing peptide directed against interleukin-17A (IL17A) was genetically fused to the N termini of an anti-IL22 antibody, through either the light chain, the heavy chain, or both chains. Although the resulting fusion proteins bound and inhibited IL22 with the same affinity and potency as the unmodified anti-IL22 antibody, the peptide modality in the fusion scaffold was not active in the cell-based assay due to the N-terminal degradation. When a glutamine residue was introduced at the N terminus, which can be cyclized to form pyroglutamate in mammalian cells, the IL17A neutralization activity of the fusion protein was restored. Interestingly, the mass spectroscopic analysis of the purified fusion protein revealed an unexpected O-linked glycosylation modification at threonine 5 of the anti-IL17A peptide. The subsequent removal of this post-translational modification by site-directed mutagenesis drastically enhanced the IL17A binding affinity and neutralization potency for the resulting fusion protein. These results provide direct experimental evidence that post-translational modifications during protein biosynthesis along secretory pathways play critical roles in determining the structure and function of therapeutic proteins produced by mammalian cells. The newly engineered peptide-antibody genetic fusion is promising for therapeutically targeting multiple antigens in a single antibody like molecule.	[Zhong, Xiaotian; Kieras, Elizabeth; Sousa, Eric; D'Antona, Aaron; Baber, J. Christian; He, Tao; Luxenberg, Deborah; Stahl, Mark; Kriz, Ronald; Lin, Laura; Somers, Will; Fitz, Lori J.; Wright, Jill F.] Pfizer BioTherapeut Res & Dev, Cambridge, MA 02140 USA; [Desharnais, Joel; Wood, Lauren] Pfizer CovX Res, San Diego, CA 92121 USA	Pfizer; Pfizer	Zhong, XT (corresponding author), Pfizer BioTherapeut Res & Dev, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	Xiaotian.Zhong@pfizer.com; Lori.Fitz@pfizer.com						Bendele A, 1998, TOXICOL SCI, V42, P152, DOI 10.1093/toxsci/42.2.152; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Bray BL, 2003, NAT REV DRUG DISCOV, V2, P587, DOI 10.1038/nrd1133; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cohn CS, 2009, DRUG TODAY, V45, P175, DOI 10.1358/dot.2009.45.3.1343793; CULL MG, 1992, P NATL ACAD SCI USA, V89, P1865, DOI 10.1073/pnas.89.5.1865; Dick LW, 2007, BIOTECHNOL BIOENG, V97, P544, DOI 10.1002/bit.21260; Doppalapudi VR, 2010, P NATL ACAD SCI USA, V107, P22611, DOI 10.1073/pnas.1016478108; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Ebbinghaus S, 2007, P NATL ACAD SCI USA, V104, P20749, DOI 10.1073/pnas.0709207104; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Gerhardt S, 2009, J MOL BIOL, V394, P905, DOI 10.1016/j.jmb.2009.10.008; Hagemeyer CE, 2009, THROMB HAEMOSTASIS, V101, P1012, DOI 10.1160/TH08-12-0816; Hanisch FG, 2001, ANAL BIOCHEM, V290, P47, DOI 10.1006/abio.2000.4955; Huang BC, 2007, BIOCHEMISTRY-US, V46, P10102, DOI 10.1021/bi700220x; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Hudson PJ, 1999, J IMMUNOL METHODS, V231, P177, DOI 10.1016/S0022-1759(99)00157-X; Kelley WS, 1996, BIO-TECHNOL, V14, P28, DOI 10.1038/nbt0196-28; Kipriyanov SM, 2009, METHODS MOL BIOL, V562, P177, DOI 10.1007/978-1-60327-302-2_14; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Leavy O, 2010, NAT REV IMMUNOL, V10, P297, DOI 10.1038/nri2763; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liu YD, 2011, J BIOL CHEM, V286, P11211, DOI 10.1074/jbc.M110.185041; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Macdougall IC, 2009, NEW ENGL J MED, V361, P1848, DOI 10.1056/NEJMoa074037; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; McGregor DP, 2008, CURR OPIN PHARMACOL, V8, P616, DOI 10.1016/j.coph.2008.06.002; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Odegrip R, 2004, P NATL ACAD SCI USA, V101, P2806, DOI 10.1073/pnas.0400219101; Omasa T, 2010, CURR PHARM BIOTECHNO, V11, P233, DOI 10.2174/138920110791111960; Peschen D, 2004, NAT BIOTECHNOL, V22, P732, DOI 10.1038/nbt970; Rader C, 2003, J MOL BIOL, V332, P889, DOI 10.1016/S0022-2836(03)00992-6; Rink R, 2010, J PHARMACOL TOX MET, V61, P210, DOI 10.1016/j.vascn.2010.02.010; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sonnenberg GF, 2010, ADV IMMUNOL, V107, P1, DOI [10.1016/S0065-2776(10)07008-2, 10.1016/B978-0-12-381300-8.00001-0]; Sroda K, 2005, CELL MOL BIOL LETT, V10, P37; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yonezawa M, 2004, J BIOCHEM, V135, P285, DOI 10.1093/jb/mvh034; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zuraw B, 2010, NAT REV DRUG DISCOV, V9, P189, DOI 10.1038/nrd3125	54	16	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1409	1419		10.1074/jbc.M112.417717	http://dx.doi.org/10.1074/jbc.M112.417717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184956	Green Published, hybrid			2022-12-25	WOS:000313570300061
J	Dennis, MD; Kimball, SR; Jefferson, LS				Dennis, Michael D.; Kimball, Scot R.; Jefferson, Leonard S.			Mechanistic Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation Is Governed by Competition between Substrates for Interaction with Raptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; MAMMALIAN TARGET; SIGNALING PATHWAY; PROTEIN-SYNTHESIS; MTOR; BINDING; 4E-BP1; TRANSLATION; AKT; TOR	In this study, the interaction of mTORC1 with its downstream targets p70S6K1 and 4E-BP1 was evaluated in both mouse liver and mouse embryonic fibroblasts following combined disruption of the genes encoding 4E-BP1 and 4E-BP2. Phosphorylation of p70S6K1 was dramatically elevated in the livers of mice lacking 4E-BP1 and 4E-BP2 following feeding-induced activation of mTORC1. Immunoprecipitation of mTORC1 suggested that elevated phosphorylation was the result of enhanced interaction of p70S6K1 with raptor. These findings were extended to a cell culture system wherein loss of 4E-BP1 and 4E-BP2 resulted in elevated interaction of p70S6K1 with IGF1-induced activation of mTORC1 in conjunction with an enhanced rate of p70S6K1 phosphorylation at Thr-389. Furthermore, co-transfecting HA-p70S6K1 with 4E-BP1, but not 4E-BP1(F114A), reduced recovery of mTORC1 in HA-p70S6K1 immunoprecipitates. Together, these findings support the conclusion that, in the absence of 4E-BP proteins, mTORC1-mediated phosphorylation of p70S6K1 is elevated by a reduction in competition between the two substrates for interaction with raptor.	[Dennis, Michael D.; Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu		Dennis, Michael/0000-0002-0645-6864	National Institutes of Health [DK13499, DK088416]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088416, R37DK013499, R01DK013499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK13499 (to L. S. J.) and DK088416 (to M. D. D.).	Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Dennis MD, 2011, J BIOL CHEM, V286, P34286, DOI 10.1074/jbc.M111.259457; Dennis MD, 2011, J BIOL CHEM, V286, P8287, DOI 10.1074/jbc.M110.209171; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	26	25	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					10	19		10.1074/jbc.M112.402461	http://dx.doi.org/10.1074/jbc.M112.402461			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184952	Green Published, hybrid			2022-12-25	WOS:000313197200002
J	Carro, B; Quintela, M; Ruiz, JM; Barreiro, R				Carro, Belen; Quintela, Maria; Miguel Ruiz, Jose; Barreiro, Rodolfo			AFLPs Reveal Different Population Genetic Structure under Contrasting Environments in the Marine Snail Nucella lapillus L.	PLOS ONE			English	Article							LENGTH POLYMORPHISM AFLP; PROPAGULE DISPERSAL; LARVAL DEVELOPMENT; DOG-WHELK; PROSOBRANCHIA; PATCHINESS; CONNECTIVITY; FLOW; RECRUITMENT; GASTROPODA	Dispersal has received growing attention in marine ecology, particularly since evidence obtained with up-to-date techniques challenged the traditional view. The dogwhelk Nucella lapillus L., a sedentary gastropod with direct development, is a good example: dispersal was traditionally assumed to be limited until studies with microsatellites disputed this idea. To shed some light on this controversy, the genetic structure of dogwhelk populations in northwest Spain was investigated with highly polymorphic AFLP markers giving special attention to the influence of hydrodynamic stress. In agreement with the expectations for a poor disperser, our results show a significant genetic structure at regional (<200 km) and areal scales (<15 km). However, the spatial genetic structure varied with wave-exposure in the present case study: IBD was evident under sheltered conditions but absent from the exposed area where genetic differentiation was stronger. Our results provide evidence that differences in wave-exposure can exert a detectable influence on the genetic structure of coastal organisms, even in species without a planktonic larva.	[Carro, Belen; Quintela, Maria; Miguel Ruiz, Jose; Barreiro, Rodolfo] Univ A Coruna, Fac Sci, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain	Universidade da Coruna	Carro, B (corresponding author), Univ A Coruna, Fac Sci, Dept Anim Biol Plant Biol & Ecol, La Coruna, Spain.	b.carro@udc.es	Barreiro, Rodolfo/B-1005-2008; Ruiz, José M./E-5363-2010	Barreiro, Rodolfo/0000-0002-6049-5215; Ruiz, José M./0000-0002-0893-6175; Carro, Belen/0000-0002-9392-9737	Ministerio de Educacion y Ciencia of Spain [CTM2004-04496/MAR]; FEDER; Fondo Europeo de Desarrollo Regional; Xunta de Galicia [PGIDT05PXIC10302PN]; University of A Coruna and Deputacion da Coruna	Ministerio de Educacion y Ciencia of Spain(Spanish Government); FEDER(European Commission); Fondo Europeo de Desarrollo Regional(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); University of A Coruna and Deputacion da Coruna	Financial support for this work was provided by the Ministerio de Educacion y Ciencia of Spain, grant CTM2004-04496/MAR (partially co-founded by FEDER, Fondo Europeo de Desarrollo Regional); and Xunta de Galicia, grant PGIDT05PXIC10302PN. BC acknowledges fellowships from University of A Coruna and Deputacion da Coruna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Barreiro R, 2006, MAR BIOL, V148, P1051, DOI 10.1007/s00227-005-0139-6; Barreiro R, 1999, MAR ECOL PROG SER, V185, P229, DOI 10.3354/meps185229; Bell JJ, 2008, MAR ECOL PROG SER, V357, P185, DOI 10.3354/meps07301; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Blears MJ, 1998, J IND MICROBIOL BIOT, V21, P99, DOI 10.1038/sj.jim.2900537; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2005, METHOD ENZYMOL, V395, P145, DOI 10.1016/S0076-6879(05)95010-6; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Burrows MT, 2002, MAR ECOL PROG SER, V240, P39, DOI 10.3354/meps240039; Campbell D, 2003, MOL ECOL, V12, P1979, DOI 10.1046/j.1365-294X.2003.01856.x; Chia FS, 1984, REV CANADIENNE ZOOLO, V62; Colson I, 2004, MOL ECOL, V13, P2223, DOI 10.1111/j.1365-294X.2004.02245.x; Colson I, 2006, INTEGR ZOOL, V1, P104, DOI 10.1111/j.1749-4877.2006.00022.x; Colson I, 2007, MAR ECOL PROG SER, V343, P183, DOI 10.3354/meps06879; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CROTHERS J H, 1985, Field Studies, V6, P291; DAY AJ, 1988, MAR BIOL, V99, P93, DOI 10.1007/BF00644981; DAY AJ, 1990, BIOL J LINN SOC, V40, P245, DOI 10.1111/j.1095-8312.1990.tb00538.x; DAY AJ, 1994, BIOL J LINN SOC, V51, P257, DOI 10.1006/bijl.1994.1023; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fretter V, 1985, J MOLLUS STUD, P435; Fretter V, 1994, BRIT PROSOBRANCH MOL, P820; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Gibbs P.E., 1996, P259; GIBBS PE, 1986, J MAR BIOL ASSOC UK, V66, P767, DOI 10.1017/S0025315400048414; Gonzalez-Wanguemert M, 2007, MAR ECOL PROG SER, V334, P237; GOUDET J, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P81; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Guerra-Varela J, 2009, EVOL ECOL, V23, P261, DOI 10.1007/s10682-007-9221-5; Hancock B, 2000, MAR FRESHWATER RES, V51, P679, DOI 10.1071/MF99144; Hellberg Michael E., 2006, P431, DOI 10.1016/B978-012088781-1/50016-9; HIGHSMITH RC, 1985, MAR ECOL PROG SER, V25, P169, DOI 10.3354/meps025169; Hoffman JI, 2011, MAR BIOL, V158, P287, DOI 10.1007/s00227-010-1558-6; Hogan JD, 2010, MAR ECOL PROG SER, V417, P263, DOI 10.3354/meps08793; Hoskin MG, 1997, MAR BIOL, V127, P647, DOI 10.1007/s002270050055; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; JOHNSON MS, 1984, EVOLUTION, V38, P1371, DOI 10.1111/j.1558-5646.1984.tb05658.x; JOHNSON MS, 1982, MAR BIOL, V70, P157, DOI 10.1007/BF00397680; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Labour M. V., 1931, Journal of the Marine Biological Association Plymouth NS, V17, P797; LAMBECK RHD, 1984, NETH J SEA RES, V18, P395, DOI 10.1016/0077-7579(84)90012-7; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; Lester SE, 2007, ECOL LETT, V10, P745, DOI 10.1111/j.1461-0248.2007.01070.x; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; PALMER AR, 1984, MALACOLOGIA, V25, P477; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Palumbi SR, 2003, FRONT ECOL ENVIRON, V1, P73, DOI 10.2307/3868033; Palumbi SR, 2003, ECOL APPL, V13, pS146; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pineira J, 2008, MAR POLLUT BULL, V56, P270, DOI 10.1016/j.marpolbul.2007.10.020; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rolan E, 2004, J MOLLUS STUD, V70, P179, DOI 10.1093/mollus/70.2.179; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shank TM, 2007, MAR ECOL-EVOL PERSP, V28, P25, DOI 10.1111/j.1439-0485.2007.00146.x; Shanks AL, 2003, ECOL APPL, V13, pS159; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sokal R. R., 2012, BIOMETRY; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; TALLMARK B, 1980, MAR ECOL PROG SER, V3, P51, DOI 10.3354/meps003051; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Wood AR, 2007, MAR ECOL PROG SER, V349, P159, DOI 10.3354/meps07110; Yan G, 1999, MOL ECOL, V8, P951, DOI 10.1046/j.1365-294x.1999.00647.x; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	79	3	3	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49776	10.1371/journal.pone.0049776	http://dx.doi.org/10.1371/journal.pone.0049776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185435	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000107
J	Chen, CJ; Sung, WW; Lin, YM; Chen, MK; Lee, CH; Lee, H; Yeh, KT; Ko, JL				Chen, Chih-Jung; Sung, Wen-Wei; Lin, Yueh-Min; Chen, Mu-Kuan; Lee, Ching-Hsiao; Lee, Huei; Yeh, Kun-Tu; Ko, Jiunn-Liang			Gender Difference in the Prognostic Role of Interleukin 6 in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							SERUM INTERLEUKIN-6; CANCER PATIENTS; CLINICAL-SIGNIFICANCE; POTENTIAL BIOMARKERS; COLORECTAL-CANCER; LUNG-CANCER; NECK-CANCER; IN-VIVO; IL-6; EXPRESSION	Background: Interleukin 6 (IL6) plays an important role in immunoregulation and tumorigenesis in human cancers. Oral squamous cell carcinoma (OSCC) is a malignant tumor of the oral cavity with a male predominant tendency and a poor clinical prognosis. Due to the relatively few cases in females, the gender difference of prognostic markers for OSCC is seldom discussed. Methods: In this study, we used immunohistochemical staining methods to investigate the associations between IL6 expression and the clinicopathological characteristics of OSCC. In addition, we collected 74 female and 263 male OSCC patients for evaluation. Results: High IL6 expression in tumor cells was significantly associated OSCC patient characteristics including female gender (P<0.001), high lymph node metastatic rate (P = 0.007), and poor tumor differentiation (P = 0.008). Tumor-expressed IL6 had prognostic role in male OSCC patients as defined by the log-rank test (P = 0.014), but not in female patients (P = 0.959). In male OSCC patients, high IL6 expression in tumor cells was associated with poor prognosis (P = 0.025) and a 1.454-fold higher death risk, as determined by Cox regression. Conclusions: High IL6 expression in tumor cells was therefore significantly associated with aggressive clinical manifestations and might be an independent survival predictor, particularly in male OSCC patients.	[Chen, Chih-Jung; Sung, Wen-Wei; Lee, Huei; Ko, Jiunn-Liang] Chung Shan Med Univ, Inst Med, Taichuang, Taiwan; [Chen, Chih-Jung; Sung, Wen-Wei; Lee, Huei; Ko, Jiunn-Liang] Chung Shan Med Univ, Inst Med & Mol Toxicol, Taichuang, Taiwan; [Chen, Chih-Jung; Lin, Yueh-Min; Yeh, Kun-Tu] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan; [Chen, Chih-Jung; Lin, Yueh-Min; Lee, Ching-Hsiao] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Chen, Chih-Jung; Sung, Wen-Wei; Chen, Mu-Kuan; Yeh, Kun-Tu] Chung Shan Med Univ, Sch Med, Taichuang, Taiwan; [Chen, Mu-Kuan] Changhua Christian Hosp, Dept Otorhinolaryngol Head & Neck Surg, Changhua, Taiwan; [Ko, Jiunn-Liang] Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med, Taichuang, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Lee, H (corresponding author), Chung Shan Med Univ, Inst Med, Taichuang, Taiwan.	hl@csmu.edu.tw; 10159@cch.org.tw; jlko@csmu.edu.tw	Sung, Wen-Wei/P-5053-2019	Sung, Wen-Wei/0000-0002-2375-0029; Ko, Jiunn-Liang/0000-0001-6855-9239	Changhua Christian Hospital [101-CCH-IRP-33]	Changhua Christian Hospital	This study was supported by Changhua Christian Hospital (http://www.cch.org.tw/) under Grant No. 101-CCH-IRP-33 (CJ Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Barnes L., 2005, WHO CLASSIFICATION T; Bayliss TJ, 2011, EXPERT OPIN BIOL TH, V11, P1663, DOI 10.1517/14712598.2011.627850; Chen CJ, 2012, HUM PATHOL, V43, P1119, DOI 10.1016/j.humpath.2011.09.003; Chiang CT, 2011, ENVIRON GEOCHEM HLTH, V33, P469, DOI 10.1007/s10653-010-9346-2; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Gasche JA, 2011, INT J CANCER, V129, P1053, DOI 10.1002/ijc.25764; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hirsch FR, 2011, J CLIN ONCOL, V29, P3567, DOI 10.1200/JCO.2010.34.4929; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; KLEIN SC, 1995, HEMATOL ONCOL, V13, P121, DOI 10.1002/hon.2900130302; Knupfer H, 2010, INT J COLORECTAL DIS, V25, P135, DOI 10.1007/s00384-009-0818-8; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Kurago ZB, 2008, HEAD NECK PATHOL, V2, P1, DOI 10.1007/s12105-007-0038-x; KURZROCK R, 1993, CANCER RES, V53, P2118; Landi S, 2003, CANCER RES, V63, P3560; Lin MT, 2007, INT J CANCER, V120, P2600, DOI 10.1002/ijc.22599; Nagata M, 2003, INT J CANCER, V106, P683, DOI 10.1002/ijc.11283; Nibali L, 2012, ORAL DIS, V18, P236, DOI 10.1111/j.1601-0825.2011.01867.x; Okamoto M, 2000, CANCER, V89, P1966, DOI 10.1002/1097-0142(20001101)89:9<1966::AID-CNCR13>3.0.CO;2-R; Paule B, 2000, J CLIN PATHOL, V53, P388, DOI 10.1136/jcp.53.5.388; Qian YG, 2009, J CANCER RES CLIN, V135, P379, DOI 10.1007/s00432-008-0478-z; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; SahebJamee M, 2008, MED ORAL PATOL ORAL, V13, pE292; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Shinriki S, 2011, J PATHOL, V225, P142, DOI 10.1002/path.2935; Shinriki S, 2009, CLIN CANCER RES, V15, P5426, DOI 10.1158/1078-0432.CCR-09-0287; St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929; Termine N, 2008, ANN ONCOL, V19, P1681, DOI 10.1093/annonc/mdn372; Thiounn N, 1997, IMMUNOL LETT, V58, P121, DOI 10.1016/S0165-2478(97)00036-9; Wang YF, 2002, HEAD NECK-J SCI SPEC, V24, P850, DOI 10.1002/hed.10145; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Yang YY, 2004, JPN J CLIN ONCOL, V34, P176, DOI 10.1093/jjco/hyh037	35	24	25	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50104	10.1371/journal.pone.0050104	http://dx.doi.org/10.1371/journal.pone.0050104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185547	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000182
J	Han, JY; Wang, H; Xie, YT; Li, Y; Zheng, LY; Ruan, Y; Song, AP; Tian, XX; Fang, WG				Han, Ji-Yuan; Wang, Hui; Xie, Yun-Tao; Li, Yan; Zheng, Li-Yuan; Ruan, Yuan; Song, Ai-Ping; Tian, Xin-Xia; Fang, Wei-Gang			Association of Germline Variation in CCNE1 and CDK2 with Breast Cancer Risk, Progression and Survival among Chinese Han Women	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CYCLE CONTROL GENES; OVARIAN-CANCER; LINKAGE DISEQUILIBRIUM; BLADDER-CANCER; HUMAN GENOME; LUNG-CANCER; SUSCEPTIBILITY; POPULATION; VARIANTS	Background: Somatic alterations of cyclin-dependent kinase 2 (CDK2)-cyclin E complex have been shown to contribute to breast cancer (BC) development and progression. This study aimed to explore the effects of single nucleotide polymorphisms (SNPs) in CDK2 and CCNE1 (a gene encoding G1/S specific cyclin E1 protein, formerly called cyclin E) on BC risk, progression and survival in a Chinese Han population. Methodology/Principal Findings: We herein genotyped 6 haplotype-tagging SNPs (htSNPs) of CCNE1 and 2 htSNPs of CDK2 in 1207 BC cases and 1207 age-matched controls among Chinese Han women, and then reconstructed haplotype blocks according to our genotyping data and linkage disequilibrium status of these htSNPs. For CCNE1, the minor allele homozygotes of three htSNPs were associated with BC risk (rs3218035: adjusted odds ratio [aOR] = 3.35, 95% confidence interval [CI] = 1.69-6.67; rs3218038: aOR = 1.81, 95% CI = 1.22-2.70; rs3218042: aOR = 2.64, 95% CI = 1.31-5.34), and these three loci showed a dose-dependent manner in increasing BC risk (P-trend = 0.0001). Moreover, the 5-SNP haplotype CCGTC, which carried none of minor alleles of the 3 at-risk SNPs, was associated with a favorable event-free survival (hazard ratio [HR] = 0.53, 95% CI = 0.32-0.90). Stratified analysis suggested that the minor-allele homozygote carriers of rs3218038 had a worse event-free survival among patients with aggressive tumours (in tumour size >2 cm group: HR = 2.06, 95% CI = 1.06-3.99; in positive lymph node metastasis group: HR = 2.41, 95% CI = 1.15-5.03; in stage II-IV group: HR = 2.03, 95% CI = 1.09-3.79). For CDK2, no significant association was found. Conclusions/Significance: This study indicates that genetic variants in CCNE1 may contribute to BC risk and survival in Chinese Han population. They may become molecular markers for individual evaluation of BC susceptibility and prognosis. Nevertheless, further validation studies are needed.	[Han, Ji-Yuan; Wang, Hui; Li, Yan; Zheng, Li-Yuan; Ruan, Yuan; Song, Ai-Ping; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Dept Pathol, Key Lab Carcinogenesis & Translat Res, Sch Basic Med Sci,Minist Educ,Hlth Sci Ctr, Beijing 100871, Peoples R China; [Xie, Yun-Tao] Peking Univ, Breast Ctr, Sch Oncol, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China	Peking University; Peking University	Tian, XX (corresponding author), Peking Univ, Dept Pathol, Key Lab Carcinogenesis & Translat Res, Sch Basic Med Sci,Minist Educ,Hlth Sci Ctr, Beijing 100871, Peoples R China.	tianxinxia@yahoo.com; wgfang@bjmu.edu.cn			National Natural Science Foundation of China [81171961, 30670805]; Chinese Ministry of Education [108003]; Beijing Municipal Education Commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Beijing Municipal Education Commission(Beijing Municipal Commission of Education)	This study was supported by the National Natural Science Foundation of China (Grant Nos 81171961 and 30670805), the Key Project of the Chinese Ministry of Education (Grant No. 108003) and the Beijing Municipal Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Azzato EM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2100; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Cai H, 2011, AM J EPIDEMIOL, V173, P1263, DOI 10.1093/aje/kwr002; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cunningham JM, 2009, BRIT J CANCER, V101, P1461, DOI 10.1038/sj.bjc.6605284; Ding SL, 2009, CARCINOGENESIS, V30, P43, DOI 10.1093/carcin/bgn233; Driver KE, 2008, CARCINOGENESIS, V29, P333, DOI 10.1093/carcin/bgm284; Ferlay J, 2010, INT J CANC; Gayther SA, 2007, CANCER RES, V67, P3027, DOI 10.1158/0008-5472.CAN-06-3261; Ghoussaini M, 2009, FUTURE ONCOL, V5, P689, DOI [10.2217/fon.09.29, 10.2217/FON.09.29]; Goode EL, 2009, CANCER EPIDEM BIOMAR, V18, P935, DOI 10.1158/1055-9965.EPI-08-0860; Hosgood HD, 2008, CARCINOGENESIS, V29, P1938, DOI 10.1093/carcin/bgn178; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Liang YL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015295, 10.1371/journal.pone.0012860]; Mittendorf EA, 2010, ONCOGENE, V29, P3896, DOI 10.1038/onc.2010.151; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Narod SA, 2011, LANCET ONCOL, V12, P415, DOI 10.1016/S1470-2045(11)70084-5; Olson JE, 2011, BREAST CANCER RES TR, V125, P221, DOI 10.1007/s10549-010-0950-8; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Ruan Y, 2011, J PATHOL, V225, P535, DOI 10.1002/path.2902; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Shaye A, 2009, BREAST CANCER RES TR, V115, P651, DOI 10.1007/s10549-008-0266-0; Song H, 2008, CLIN CANCER RES, V14, P1090, DOI 10.1158/1078-0432.CCR-07-1195; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Varadi V, 2011, BREAST CANCER RES TR, V129, P235, DOI 10.1007/s10549-011-1460-z; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Yasmeen A, 2003, EXPERT REV MOL DIAGN, V3, P617, DOI 10.1586/14737159.3.5.617; Ye YQ, 2008, CANCER-AM CANCER SOC, V112, P2467, DOI 10.1002/cncr.23472; Yin JK, 2011, CARCINOGENESIS, V32, P1867, DOI 10.1093/carcin/bgr217; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636	39	20	20	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49296	10.1371/journal.pone.0049296	http://dx.doi.org/10.1371/journal.pone.0049296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185313	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000038
J	Holten-Andersen, L; Dalsgaard, I; Nylen, J; Lorenzen, N; Buchmann, K				Holten-Andersen, Lars; Dalsgaard, Inger; Nylen, Jorgen; Lorenzen, Niels; Buchmann, Kurt			Determining Vaccination Frequency in Farmed Rainbow Trout Using Vibrio anguillarum O1 Specific Serum Antibody Measurements	PLOS ONE			English	Article							SALMO-GAIRDNERI; ELISA; FISH; PROTECTION	Background: Despite vaccination with a commercial vaccine with a documented protective effect against Vibrio anguillarum O1 disease outbreaks caused by this bacterium have been registered among rainbow trout at Danish fish farms. The present study examined specific serum antibody levels as a valid marker for assessing vaccination status in a fish population. For this purpose a highly sensitive enzyme-linked immunosorbent assay (ELISA) was developed and used to evaluate sera from farmed rainbow trout vaccinated against V. anguillarum O1. Study Design: Immune sera from rainbow trout immunised with an experimental vaccine based on inactivated V. anguillarum O1 bacterin in Freund's incomplete adjuvant were used for ELISA optimisation. Subsequently, sera from farmed rainbow trout vaccinated with a commercial vaccine against V. anguillarum were analysed with the ELISA. The measured serum antibody levels were compared with the vaccine status of the fish (vaccinated/unvaccinated) as evaluated through visual examination. Results: Repeated immunisation with the experimental vaccine lead to increasing levels of specific serum antibodies in the vaccinated rainbow trout. The farmed rainbow trout responded with high antibody levels to a single injection with the commercial vaccine. However, the diversity in responses was more pronounced in the farmed fish. Primary visual examinations for vaccine status in rainbow trout from the commercial farm revealed a large pool of unvaccinated specimens (vaccination failure rate = 20%) among the otherwise vaccinated fish. Through serum analyses using the ELISA in a blinded set-up it was possible to separate samples collected from the farmed rainbow trout into vaccinated and unvaccinated fish. Conclusions: Much attention has been devoted to development of new and more effective vaccines. Here we present a case from a Danish rainbow trout farm indicating that attention should also be directed to the vaccination procedure in order to secure high vaccination frequencies necessary for optimal protection with a reported effective vaccine.	[Holten-Andersen, Lars; Buchmann, Kurt] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Holten-Andersen, Lars; Dalsgaard, Inger] Tech Univ Denmark, Natl Vet Inst, Div Vet Diagnost & Res, Copenhagen, Denmark; [Nylen, Jorgen] MSD Anim Hlth, Aqua Denmark Unit, Ballerup, Denmark; [Lorenzen, Niels] Tech Univ Denmark, Natl Vet Inst, Div Poultry Fish & Anim, Aarhus N, Denmark	University of Copenhagen; Technical University of Denmark; Merck & Company; Intervet International B.V.; Technical University of Denmark	Holten-Andersen, L (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	lhoa@life.ku.dk	; Lorenzen, Niels/L-3967-2017	Dalsgaard, Inger/0000-0003-2066-1060; Lorenzen, Niels/0000-0002-6946-3252; Buchmann, Kurt/0000-0002-2747-237X	Danish Agency for Science, Technology and Innovation (MarinVac) [DSF jnr 09-063102]	Danish Agency for Science, Technology and Innovation (MarinVac)	This work was supported by a grant from the Danish Agency for Science, Technology and Innovation (MarinVac, DSF jnr 09-063102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 1997, DEV BIOLOGICALS, V90, P257; DOUGLAS JT, 1984, INT J LEPROSY, V52, P19; Gudding R, 1999, VET IMMUNOL IMMUNOP, V72, P203, DOI 10.1016/S0165-2427(99)00133-6; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL LW, 1975, AQUACULTURE, V6, P211, DOI 10.1016/0044-8486(75)90041-1; Hastein T, 2005, DEV BIOLOGICALS, V121, P55; Holten-Andersen L, 2004, INFECT IMMUN, V72, P1608, DOI 10.1128/IAI.72.3.1608-1617.2004; Kheyrandish Azarmidokht, 2010, American Journal of Animal and Veterinary Sciences, V5, P8; KORVER K, 1984, J IMMUNOL METHODS, V74, P241, DOI 10.1016/0022-1759(84)90291-6; LARSEN JL, 1988, APPL ENVIRON MICROB, V54, P2264, DOI 10.1128/AEM.54.9.2264-2267.1988; Midtlying PJ, 1996, FISH SHELLFISH IMMUN, V6, P335, DOI 10.1006/fsim.1996.0034; Palm RC, 1998, DIS AQUAT ORGAN, V33, P157, DOI 10.3354/dao033157; Pedersen K, 2008, J FISH DIS, V31, P659, DOI 10.1111/j.1365-2761.2008.00941.x; Plant KP, 2011, DEV COMP IMMUNOL, V35, P1256, DOI 10.1016/j.dci.2011.03.007; Sun Y, 2011, FISH SHELLFISH IMMUN, V31, P595, DOI 10.1016/j.fsi.2011.06.025; THORBURN MA, 1988, DIS AQUAT ORGAN, V5, P171, DOI 10.3354/dao005171; VIELE D, 1980, J FISH BIOL, V17, P379, DOI 10.1111/j.1095-8649.1980.tb02772.x; YORK JJ, 1983, AVIAN DIS, V27, P409, DOI 10.2307/1590167	18	9	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49672	10.1371/journal.pone.0049672	http://dx.doi.org/10.1371/journal.pone.0049672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185402	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000082
J	Howe, EN; Cochrane, DR; Cittelly, DM; Richer, JK				Howe, Erin N.; Cochrane, Dawn R.; Cittelly, Diana M.; Richer, Jennifer K.			miR-200c Targets a NF-kappa B Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FOCAL ADHESION KINASE; NERVE GROWTH-FACTOR; PROTEIN-KINASE; EXTRACELLULAR-MATRIX; TUMOR-GROWTH; E-CADHERIN; TRKB; SURVIVAL; INTEGRIN	Anoikis is apoptosis initiated upon cell detachment from the native extracellular matrix. Since survival upon detachment from basement membrane is required for metastasis, the ability to resist anoikis contributes to the metastatic potential of breast tumors. miR-200c, a potent repressor of epithelial to mesenchymal transition, is expressed in luminal breast cancers, but is lost in more aggressive basal-like, or triple negative breast cancers (TNBC). We previously demonstrated that miR-200c restores anoikis sensitivity to TNBC cells by directly targeting the neurotrophic receptor tyrosine kinase, TrkB. In this study, we identify a TrkB ligand, neurotrophin 3 (NTF3), as capable of activating TrkB to induce anoikis resistance, and show that NTF3 is also a direct target of miR-200c. We present the first evidence that anoikis resistant TNBC cells up-regulate both TrkB and NTF3 when suspended, and show that this up-regulation is necessary for survival in suspension. We further demonstrate that NF-kappa B activity increases 6 fold in suspended TNBC cells, and identify RelA and NF-kappa B1 as the transcription factors responsible for suspension-induced up-regulation of TrkB and NTF3. Consequently, inhibition of NF-kappa B activity represses anoikis resistance. Taken together, our findings define a critical mechanism for transcriptional and post-transcriptional control of suspension-induced up-regulation of TrkB and NTF3 in anoikis resistant breast cancer cells.	[Howe, Erin N.; Richer, Jennifer K.] Univ Colorado, Program Canc Biol, Aurora, CO 80010 USA; [Howe, Erin N.; Cochrane, Dawn R.; Cittelly, Diana M.; Richer, Jennifer K.] Univ Colorado, Dept Pathol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Richer, JK (corresponding author), Univ Colorado, Program Canc Biol, Anschutz Med Campus, Aurora, CO 80010 USA.	Jennifer.Richer@ucdenver.edu		Howe, Erin/0000-0003-0314-6999; Cittelly, Diana/0000-0002-8392-0800	National Institutes of Health NRSA pre-doctoral fellowship [F31CA165668-01]; Cancer League of Colorado; DOD BCRP Idea Award [W81XWH-09-1-0124]; Susan G. Komen Award [KG090415]; AMC Cancer Fund;  [P30CA046934]; NATIONAL CANCER INSTITUTE [F31CA165668, P30CA046934] Funding Source: NIH RePORTER	National Institutes of Health NRSA pre-doctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; DOD BCRP Idea Award; Susan G. Komen Award(Susan G. Komen Breast Cancer Foundation); AMC Cancer Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ENH is supported by a National Institutes of Health NRSA pre-doctoral fellowship F31CA165668-01. This work was supported by a research grant from the Cancer League of Colorado to DRC, DOD BCRP Idea Award W81XWH-09-1-0124, Susan G. Komen Award KG090415 and AMC Cancer Fund gift to JKR. The University of Colorado Cancer Center shared resources are supported by P30CA046934. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Antonov AS, 2011, J CELL PHYSIOL, V226, P469, DOI 10.1002/jcp.22356; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bhatia V, 2009, MOL CANCER RES, V7, P1119, DOI 10.1158/1541-7786.MCR-08-0568; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Campbell I.D., 2011, COLD SPRING HARB PER, V3; Chen J, 2011, MED ONCOLOGY NORTHWO; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Coates JM, 2010, J SURG RES, V164, P301, DOI 10.1016/j.jss.2009.07.011; Cochrane Dawn R., 2010, Hormones & Cancer, V1, P306, DOI 10.1007/s12672-010-0043-5; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Cochrane DR, 2009, MOL CANC THERAPEUTIC; Creedon DJ, 1996, J BIOL CHEM, V271, P20713, DOI 10.1074/jbc.271.34.20713; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Dia VP, 2011, CANCER LETT, V313, P167, DOI 10.1016/j.canlet.2011.09.002; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Ernsberger U, 2009, CELL TISSUE RES, V336, P349, DOI 10.1007/s00441-009-0784-z; Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Gramantieri L, 2009, CLIN CANCER RES, V15, P5073, DOI 10.1158/1078-0432.CCR-09-0092; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Howe EN, 2012, J MAMMARY GLAND BIOL; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Huang YT, 2010, INT J ONCOL, V36, P1469, DOI 10.3892/ijo_00000633; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Ilic D, 1998, J CELL BIOL, V143, P547; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Jin W, 2010, CARCINOGENESIS, V31, P1939, DOI 10.1093/carcin/bgq180; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; KURAMOTO H, 1991, ANN NY ACAD SCI, V622, P402; Lin D-C, 2011, CLIN CANC RES; Lv Xiao-Bin, 2011, Chin J Cancer, V30, P821, DOI 10.5732/cjc.011.10289; Mantovani A, 2008, ADV EXP MED BIOL, V610, P112; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mino K, 2011, CANCER SCI, V102, P1052, DOI 10.1111/j.1349-7006.2011.01901.x; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Neri P, 2011, BLOOD, V117, P6202, DOI 10.1182/blood-2010-06-292243; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Prakash M, 2011, CELL SIGNAL, V23, P1563, DOI 10.1016/j.cellsig.2011.04.009; Sadick MD, 1997, EXP CELL RES, V234, P354, DOI 10.1006/excr.1997.3614; Saldanha-Gama RF, 2010, BBA-MOL CELL RES, V1803, P848, DOI 10.1016/j.bbamcr.2010.03.012; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Shih YW, 2010, CELL BIOCHEM BIOPHYS, V58, P31, DOI 10.1007/s12013-010-9091-2; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siu MKY, 2009, EXPERT OPIN THER TAR, V13, P1169, DOI 10.1517/14728220903196787; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002258; Stoilov P, 2002, BIOCHEM BIOPH RES CO, V290, P1054, DOI 10.1006/bbrc.2001.6301; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Wang XC, 2011, CANCER LETT, V311, P203, DOI 10.1016/j.canlet.2011.07.026; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wright JA, 2010, J MAMMARY GLAND BIOL, V15, P213, DOI 10.1007/s10911-010-9183-z; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Yu X, 2012, STEM CELLS DAYTON OH; Yu XH, 2008, CANCER SCI, V99, P543, DOI 10.1111/j.1349-7006.2007.00722.x; Zanotti S, 2011, EXP CELL RES, V317, P2536, DOI 10.1016/j.yexcr.2011.08.004	85	55	57	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49987	10.1371/journal.pone.0049987	http://dx.doi.org/10.1371/journal.pone.0049987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185507	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000158
J	Johnson, HC; Elfstrom, KM; Edmunds, WJ				Johnson, Helen C.; Elfstrom, K. Miriam; Edmunds, W. John			Inference of Type-Specific HPV Transmissibility, Progression and Clearance Rates: A Mathematical Modelling Approach	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY MODEL; RISK; WOMEN; CANCER; EPIDEMIOLOGY; IMPACT; PREVALENCE; PRECANCER	Quantifying rates governing the clearance of Human Papillomavirus (HPV) and its progression to clinical disease, together with viral transmissibility and the duration of naturally-acquired immunity, is essential in estimating the impact of vaccination programmes and screening or testing regimes. However, the complex natural history of HPV makes this difficult. We infer the viral transmissibility, rate of waning natural immunity and rates of progression and clearance of infection of 13 high-risk and 2 non-oncogenic HPV types, making use of a number of rich datasets from Sweden. Estimates of viral transmissibility, clearance of initial infection and waning immunity were derived in a Bayesian framework by fitting a susceptible-infectious-recovered-susceptible (SIRS) transmission model to age- and type-specific HPV prevalence data from both a cross-sectional study and a randomised controlled trial (RCT) of primary HPV screening. The models fitted well, but over-estimated the prevalence of four high-risk types with respect to the data. Three of these types (HPV-33, -35 and -58) are among the most closely related phylogenetically to the most prevalent HPV-16. The fourth (HPV-45) is the most closely related to HPV-18; the second most prevalent type. We suggest that this may be an indicator of cross-immunity. Rates of progression and clearance of clinical lesions were additionally estimated from longitudinal data gathered as part of the same RCT. Our estimates of progression and clearance rates are consistent with the findings of survival analysis studies and we extend the literature by estimating progression and clearance rates for non-16 and non-18 high-risk types. We anticipate that such type-specific estimates will be useful in the parameterisation of further models and in developing our understanding of HPV natural history.	[Johnson, Helen C.; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Ctr Math Modelling Infect Dis, London WC1, England; [Elfstrom, K. Miriam] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	University of London; London School of Hygiene & Tropical Medicine; Karolinska Institutet	Johnson, HC (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Ctr Math Modelling Infect Dis, London WC1, England.	helen.johnson@lshtm.ac.uk			European Community [242061EU]	European Community(European Commission)	No part of the paper has been presented or published elsewhere. The work was supported by the European Community's Seventh Framework programme (FP7/2007 2013) under grant agreement No. 242061EU (PreHdict). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2011, VACCINE, V29, P1270, DOI 10.1016/j.vaccine.2010.11.082; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Berkhof J, 2006, CANCER EPIDEM BIOMAR, V15, P1268, DOI 10.1158/1055-9965.EPI-05-0764; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Castle PE, 2005, JNCI-J NATL CANCER I, V97, P1066, DOI 10.1093/jnci/dji186; de Velde NV, 2007, AM J EPIDEMIOL, V165, P762, DOI 10.1093/aje/kwk059; Elfgren K, 2005, AM J OBSTET GYNECOL, V193, P650, DOI 10.1016/j.ajog.2005.01.056; Forslund O, 2002, J MED VIROL, V66, P535, DOI 10.1002/jmv.2178; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Goldie SJ, 2003, INT J CANCER, V106, P896, DOI 10.1002/ijc.11334; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Jit M, 2010, MED DECIS MAKING, V30, P84, DOI 10.1177/0272989X09336140; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Kim JJ, 2006, PLOS MED, V3, P587, DOI 10.1371/journal.pmed.0030164; Kohli M, 2007, BRIT J CANCER, V96, P143, DOI 10.1038/sj.bjc.6603501; Kulasingam S, 2008, COST EFFECT RESOUR A, V6, P1; LEWIN B, 2000, SEX SWEDEN SWEDISH S; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; REMMINK AJ, 1995, INT J CANCER, V61, P306, DOI 10.1002/ijc.2910610305; Sanders GD, 2003, EMERG INFECT DIS, V9, P37; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49614	10.1371/journal.pone.0049614	http://dx.doi.org/10.1371/journal.pone.0049614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185383	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000311821000070
J	Kiliszek, M; Burzynska, B; Michalak, M; Gora, M; Winkler, A; Maciejak, A; Leszczynska, A; Gajda, E; Kochanowski, J; Opolski, G				Kiliszek, Marek; Burzynska, Beata; Michalak, Marcin; Gora, Monika; Winkler, Aleksandra; Maciejak, Agata; Leszczynska, Agata; Gajda, Ewa; Kochanowski, Janusz; Opolski, Grzegorz			Altered Gene Expression Pattern in Peripheral Blood Mononuclear Cells in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							EARLY GROWTH RESPONSE-1; ACUTE CORONARY SYNDROME; ST-SEGMENT ELEVATION; FC-GAMMA-RI; SOCS PROTEINS; KNOCKOUT MICE; ATHEROSCLEROSIS; RECEPTOR; INTERLEUKIN-6; MORTALITY	Background: Despite a substantial progress in diagnosis and therapy, acute myocardial infarction (MI) is a major cause of mortality in the general population. A novel insight into the pathophysiology of myocardial infarction obtained by studying gene expression should help to discover novel biomarkers of MI and to suggest novel strategies of therapy. The aim of our study was to establish gene expression patterns in leukocytes from acute myocardial infarction patients. Methods and Results: Twenty-eight patients with ST-segment elevation myocardial infarction (STEMI) were included. The blood was collected on the 1st day of myocardial infarction, after 4-6 days, and after 6 months. Control group comprised 14 patients with stable coronary artery disease, without history of myocardial infarction. Gene expression analysis was performed with Affymetrix Human Gene 1.0 ST microarrays and GCS3000 TG system. Lists of genes showing altered expression levels (fold change >1.5, p<0.05) were submitted to Ingenuity Pathway Analysis. Gene lists from each group were examined for canonical pathways and molecular and cellular functions. Comparing acute phase of MI with the same patients after 6 months (stable phase) and with control group we found 24 genes with changed expression. In canonical analysis three pathways were highlighted: signaling of PPAR (peroxisome proliferator-activated receptor), IL-10 and IL-6 (interleukin 10 and 6). Conclusions: In the acute phase of STEMI, dozens of genes from several pathways linked with lipid/glucose metabolism, platelet function and atherosclerotic plaque stability show altered expression. Up-regulation of SOCS3 and FAM20 genes in the first days of myocardial infarction is observed in the vast majority of patients.	[Kiliszek, Marek; Michalak, Marcin; Winkler, Aleksandra; Gajda, Ewa; Kochanowski, Janusz; Opolski, Grzegorz] Med Univ Warsaw, Chair 1, Warsaw, Poland; [Kiliszek, Marek; Michalak, Marcin; Winkler, Aleksandra; Gajda, Ewa; Kochanowski, Janusz; Opolski, Grzegorz] Med Univ Warsaw, Dept Cardiol, Warsaw, Poland; [Burzynska, Beata; Gora, Monika; Maciejak, Agata; Leszczynska, Agata] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Kiliszek, M (corresponding author), Med Univ Warsaw, Chair 1, Warsaw, Poland.	kiliszek@mp.pl; atka@ibb.waw.pl	Michalak, Marcin/R-9684-2018; Maciejak-Jastrzębska, Agata/ABG-5609-2020; Maciejak, Agata/O-7427-2018; Gora, Monika/AAB-9577-2020; Burzynska, Beata/A-4691-2013	Michalak, Marcin/0000-0003-4220-0855; Maciejak-Jastrzębska, Agata/0000-0002-7654-8414; Maciejak, Agata/0000-0002-7654-8414; Gora, Monika/0000-0002-8554-663X; Burzynska, Beata/0000-0003-1595-0036; Opolski, Grzegorz/0000-0003-4744-2554; Kochanowski, Janusz/0000-0003-2727-5701	National Centre for Research and Development (NCBiR) [R13 0001 06]	National Centre for Research and Development (NCBiR)	This work was supported by grant R13 0001 06 from The National Centre for Research and Development (NCBiR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Asnani S, 2003, METAB SYNDR RELAT D, V1, P23, DOI 10.1089/154041903321648234; Barron HV, 2001, J AM COLL CARDIOL, V38, P1654, DOI 10.1016/S0735-1097(01)01613-8; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Cavusoglu E, 2011, AM J MED, V124, P724, DOI 10.1016/j.amjmed.2011.02.040; Darragh MR, 2008, FRONT BIOSCI-LANDMRK, V13, P528, DOI 10.2741/2698; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Holley CL, 2011, CARDIOVASC DRUG THER, V25, P151, DOI 10.1007/s10557-011-6290-z; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Jandeleit-Dahm KAM, 2009, CURR OPIN LIPIDOL, V20, P24, DOI 10.1097/MOL.0b013e32831f1b18; Kaminski KA, 2009, ATHEROSCLEROSIS, V206, P581, DOI 10.1016/j.atherosclerosis.2009.03.033; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Magni F, 2006, PROTEOMICS, V6, P5637, DOI 10.1002/pmic.200600212; Millonig G, 2002, ATHEROSCLEROSIS, V160, P441, DOI 10.1016/S0021-9150(01)00596-2; Mueller C, 2003, HEART, V89, P389, DOI 10.1136/heart.89.4.389; Nalbant D, 2005, BMC GENOMICS, V27, P6; Ndrepepa G, 2009, CLIN SCI, V116, P651, DOI 10.1042/CS20080298; Oba T, 2012, J AM COLL CARDIOL, V59, P838, DOI 10.1016/j.jacc.2011.10.887; OHTA Y, 1991, CELL, V67, P275, DOI 10.1016/0092-8674(91)90179-3; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potteaux S, 2004, ARTERIOSCL THROM VAS, V24, P1474, DOI 10.1161/01.ATV.0000134378.86443.cd; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tan J, 2009, HEART VESSELS, V24, P329, DOI 10.1007/s00380-008-1128-8; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; VanderLaan PA, 2005, J LIPID RES, V46, P829, DOI 10.1194/jlr.R500003-JLR200; WEIGEL PH, 1994, BIOESSAYS, V16, P519, DOI 10.1002/bies.950160713; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang L, 2004, TRENDS ENDOCRIN MET, V15, P500, DOI 10.1016/j.tem.2004.10.006	38	49	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50054	10.1371/journal.pone.0050054	http://dx.doi.org/10.1371/journal.pone.0050054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185530	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000172
J	Koura, KG; Ouedraogo, S; Cottrell, G; Le Port, A; Massougbodji, A; Garcia, A				Koura, Kobto G.; Ouedraogo, Smaila; Cottrell, Gilles; Le Port, Agnes; Massougbodji, Achille; Garcia, Andre			Maternal Anaemia at Delivery and Haemoglobin Evolution in Children during Their First 18 Months of Life Using Latent Class Analysis	PLOS ONE			English	Article							SICKLE-CELL TRAIT; PLASMODIUM-FALCIPARUM; RISK-FACTOR; DEVELOPMENTAL TRAJECTORIES; IRON-DEFICIENCY; BIRTH-WEIGHT; PREGNANCY; MODELS; PREVALENCE; CHILDHOOD	Background: Anaemia during pregnancy and at delivery is an important public health problem in low-and middle-income countries. Its association with the children's haemoglobin level over time remains unclear. Our goals were to identify distinct haemoglobin level trajectories using latent class analysis and to assess the association between these trajectories and maternal anaemia and other risk factors. Method: A prospective study of children from birth to 18 months of life was conducted in a rural setting in Tori-Bossito, Benin. The main outcome measure was the haemoglobin levels repeatedly measured at 3, 6, 9, 12, 15 and 18 months. Variables were collected from the mothers at delivery and from their children at birth and during the follow-up. The analyses were performed by means of Latent Class Analysis which has never been used for this kind of data. All the analyses were performed with Stata software, version 11.0, using the generalized linear latent and mixed model (GLLAMM) framework. Results: We showed that 33.7% of children followed a low haemoglobin trajectory and 66.3% a high trajectory during the first 18 months of life. Newborn anaemia, placental malaria, malaria attack, sickle cell trait and male gender were significantly associated with a lower children's haemoglobin level over time, whereas maternal age, children living in a polygamous family and with good feeding practices had a higher Hb level in the first18 months. We also showed that maternal anaemia was a predictor for 'low haemoglobin level trajectory' group membership but have no significant effect on children haemoglobin level over time. Conclusion: Latent Class Analyses framework seems well suited to analyse longitudinal data under the hypothesis that different subpopulations of subjects are present in the data, each with its own set of parameters, with distinctive evolutions that themselves may reflect distinctive aetiologies.	[Koura, Kobto G.; Ouedraogo, Smaila; Cottrell, Gilles; Le Port, Agnes; Garcia, Andre] IRD UMR216 Mere & Enfant Face Infect Trop, Paris, France; [Koura, Kobto G.; Ouedraogo, Smaila; Cottrell, Gilles; Le Port, Agnes; Garcia, Andre] Univ Paris 05, Fac Pharm, Paris, France; [Koura, Kobto G.; Ouedraogo, Smaila; Le Port, Agnes] Univ Pierre Marie Curie, Paris, France; [Massougbodji, Achille] Univ Abomey Calavi, Fac Sci Sante, Cotonou, Benin; [Massougbodji, Achille] Paludisme Associe Grossesse & Enfant, Ctr Etud & Rech, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Abomey Calavi	Koura, KG (corresponding author), IRD UMR216 Mere & Enfant Face Infect Trop, Paris, France.	kourakobtoghislain@yahoo.fr	Garcia, Andre/S-2959-2016; KOURA, Kobto K/F-3421-2013; Garcia, Andre/ABA-1820-2020	Garcia, Andre/0000-0002-1808-472X; KOURA, Kobto K/0000-0002-8928-6732; Garcia, Andre/0000-0002-1808-472X; Cottrell, Gilles/0000-0002-7964-8963; Le Port, Agnes/0000-0002-8337-6569	Agence Nationale de la Recherche (ANR), Paris, France [SEST 2006/040/001]	Agence Nationale de la Recherche (ANR), Paris, France(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche (ANR), Paris, France. (Project SEST 2006/040/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; [Anonymous], 2008, WORLDW PREV AN 1993; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; BARRETT JFR, 1994, BRIT MED J, V309, P79, DOI 10.1136/bmj.309.6947.79; Bernat DH, 2008, J ADOLESCENT HEALTH, V43, P334, DOI 10.1016/j.jadohealth.2008.02.014; Broadbent JM, 2008, J DENT RES, V87, P69, DOI 10.1177/154405910808700112; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; EVANS RW, 1945, T ROY SOC TROP MED H, V39, P207, DOI 10.1016/0035-9203(45)90023-X; Gambling L, 2001, BIOCHEM J, V356, P883, DOI 10.1042/0264-6021:3560883; Gong L, 2012, BLOOD, V119, P3808, DOI 10.1182/blood-2011-08-371062; Hagenaars J.A., 2002, APPL LATENT CLASS AN, DOI [10.1017/CBO9780511499531, DOI 10.1017/CBO9780511499531]; Hamalainen H, 2003, CLIN NUTR, V22, P271, DOI 10.1016/S0261-5614(02)00209-1; Hoeve M, 2008, J ABNORM CHILD PSYCH, V36, P223, DOI 10.1007/s10802-007-9172-x; IDJRADINATA P, 1993, LANCET, V341, P1, DOI 10.1016/0140-6736(93)92477-B; Jedidi K, 1997, MARKET SCI, V16, P39, DOI 10.1287/mksc.16.1.39; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Kilbride J, 1999, INT J EPIDEMIOL, V28, P461, DOI 10.1093/ije/28.3.461; Kiryluk K, 2007, KIDNEY INT, V71, P706, DOI 10.1038/sj.ki.5002060; Koura GK, 2012, TROP MED INT HEALTH, V17, P283, DOI 10.1111/j.1365-3156.2011.02932.x; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Le Port A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000342; Levy A, 2005, EUR J OBSTET GYN R B, V122, P182, DOI 10.1016/j.ejogrb.2005.02.015; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; McCutcheon AllanL., 1987, LATENT CLASS ANAL; McElroy PD, 1999, AM J TROP MED HYG, V61, P932, DOI 10.4269/ajtmh.1999.61.932; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Muthen B., 2004, SAGE HDB QUANTITATIV, P345, DOI DOI 10.4135/9781412986311.N19; Nagin D. S., 2009, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 2005, CRIMINOLOGY, V43, P873, DOI 10.1111/j.1745-9125.2005.00026.x; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ostbye T, 2011, INT J EPIDEMIOL, V40, P240, DOI 10.1093/ije/dyq142; Preziosi P, 1997, AM J CLIN NUTR, V66, P1178, DOI 10.1093/ajcn/66.5.1178; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rabe-Hesketh S., 2004, WORKING PAPER SERIES; REDD SC, 1994, AM J TROP MED HYG, V51, P170, DOI 10.4269/ajtmh.1994.51.170; Roeder K, 1997, J AM STAT ASSOC, V92, P894, DOI 10.2307/2965553; SEARS DA, 1978, AM J MED, V64, P1021, DOI 10.1016/0002-9343(78)90458-8; Shobeiri F, 2006, NUTR RES, V26, P209, DOI 10.1016/j.nutres.2006.05.008; Skrondal A., 2004, GEN LATENT VARIABLE; Tsaras G, 2009, AM J MED, V122, P507, DOI 10.1016/j.amjmed.2008.12.020; Van Rheenen PF, 2008, EUR J CLIN NUTR, V62, P1379, DOI 10.1038/sj.ejcn.1602862; WHO/UNICEF, 2010, IND ASS INF YOUNG 2; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; YAMADA M, 1989, AM J TROP MED HYG, V41, P161, DOI 10.4269/ajtmh.1989.41.161	48	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50136	10.1371/journal.pone.0050136	http://dx.doi.org/10.1371/journal.pone.0050136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185556	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000188
J	Li, CG; Yan, Y; Ji, WD; Bao, LL; Qian, HH; Chen, L; Wu, MC; Chen, HZ; Li, ZG; Su, CQ				Li, Chunguang; Yan, Yan; Ji, Weidan; Bao, Longlong; Qian, Haihua; Chen, Lei; Wu, Mengchao; Chen, Hezhong; Li, Zhigang; Su, Changqing			OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LUNG-CANCER; BLADDER-CANCER; BREAST-CANCER; MARKER; PLURIPOTENCY; INHIBITION; RESISTANCE; APOPTOSIS; BIOMARKER	Background: OCT4 and Survivin are important factors for cancer cell proliferation, renewal and dedifferentiation, and correlate with resistance to radiotherapy and chemotherapy in most human cancers, but their regulatory mechanisms are not well known. Methodology/Principal Findings: In this study, 50 patients with esophageal squamous cell carcinoma (ESCC) were retrospectively analyzed. OCT4 was expressed in 13 cases (26%), and survivin was positively expressed in 31 cases (62%), examined by immunochemistry. OCT4 was found to be an independent predictive factor for median survival time, and the patients from the subgroup with both high expression of OCT4 and Survivin had the worst prognosis investigated by log-rank test. To further explore the molecular regulatory mechanism between OCT4 and Survivin, we constructed the specific small hairpin RNA (shRNA)-expressing vectors targeting OCT4 or/and Survivin and manipulated the expression of OCT4 and Survivin. By Western blotting and RT-PCR, we found that OCT4 could up-regulate Survivin expression in the esophageal cancer cell lines Eca109 and TE1. Simultaneously knockdown of OCT4 and Survivin expression induced cell apoptosis and G2-phase decrease of cell cycle by flow cytometry, and finally exerted an enhanced anti-proliferation potency in Eca109 and TE1 cell lines by MTT assay. Conclusions: This study shows that OCT4 and Survivin expression were correlated with poor survival in patients with ESCC. OCT4 and Survivin may be regarded as targets in ESCC biotherapy.	[Li, Chunguang; Chen, Hezhong; Li, Zhigang] Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China; [Li, Chunguang; Yan, Yan; Ji, Weidan; Bao, Longlong; Qian, Haihua; Chen, Lei; Wu, Mengchao; Su, Changqing] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Mol Oncol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Li, ZG (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China.	li_zhi_gang123@163.com; suchangqing@gmail.com		Su, Changqing/0000-0002-3396-7248; Li, Zhigang/0000-0001-5086-5334	National Natural Scientific Foundation of China [30801106, 81172308, 30973469]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (30801106, 81172308, 30973469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MH, 2007, CLIN CANCER RES, V13, P5991, DOI 10.1158/1078-0432.CCR-07-0686; Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Cao M, 2009, CLIN EXP METASTAS, V26, P751, DOI 10.1007/s10585-009-9274-7; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Cheng L, 2007, J PATHOL, V211, P1, DOI 10.1002/path.2105; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Collard JM, 2001, ANN SURG, V234, P25, DOI 10.1097/00000658-200107000-00005; Cosgrave N, 2006, J MOL ENDOCRINOL, V37, P377, DOI 10.1677/jme.1.02118; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; FRIEDRICHS K, 1993, CANCER, V72, P3641, DOI 10.1002/1097-0142(19931215)72:12<3641::AID-CNCR2820721215>3.0.CO;2-8; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Gil J, 2008, J APPL GENET, V49, P193, DOI 10.1007/BF03195612; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guha M, 2009, CELL CYCLE, V8, P2708, DOI 10.4161/cc.8.17.9457; Guo Y, 2008, STEM CELLS, V26, P30, DOI 10.1634/stemcells.2007-0401; Hoffmann AC, 2010, PHARMACOGENOMICS, V11, P341, DOI [10.2217/pgs.09.164, 10.2217/PGS.09.164]; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kato J, 2001, INT J CANCER, V95, P92; Kawakami H, 2005, INT J CANCER, V115, P967, DOI 10.1002/ijc.20954; Kim Ran-Ju, 2011, Lab Anim Res, V27, P147, DOI 10.5625/lar.2011.27.2.147; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu JL, 2010, CHINESE MED J-PEKING, V123, P2901, DOI 10.3760/cma.j.issn.0366-6999.2010.20.028; Liu ZH, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-20; Margulis V, 2008, WORLD J UROL, V26, P59, DOI 10.1007/s00345-007-0219-y; Mega S, 2006, DIS ESOPHAGUS, V19, P355, DOI 10.1111/j.1442-2050.2006.00604.x; Okamoto K, 2012, MOL CANCER THER, V11, P204, DOI 10.1158/1535-7163.MCT-11-0638; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pennati M, 2004, ONCOGENE, V23, P386, DOI 10.1038/sj.onc.1207071; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Prud'Homme GJ, 2012, CURR PHARM DES; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Talbot DC, 2010, CLIN CANCER RES, V16, P6150, DOI 10.1158/1078-0432.CCR-10-1932; Trabulo S, 2011, MOL PHARMACEUT, V8, P1120, DOI 10.1021/mp100426e; Wang Q, 2009, ANTICANCER RES, V29, P1233; Xi Z, 2011, MOL CELLS, V32, P39, DOI 10.1007/s10059-011-2315-5; Yuan FJ, 2010, MOL CELL BIOCHEM, V343, P155, DOI 10.1007/s11010-010-0509-3; Zhao JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021419; Zhao XH, 2011, BIOTECHNOL LETT, V33, P1293, DOI 10.1007/s10529-011-0577-9	43	53	59	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49693	10.1371/journal.pone.0049693	http://dx.doi.org/10.1371/journal.pone.0049693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185410	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000088
J	O'Hagan, S; Knowles, J; Kell, DB				O'Hagan, Steve; Knowles, Joshua; Kell, Douglas B.			Exploiting Genomic Knowledge in Optimising Molecular Breeding Programmes: Algorithms from Evolutionary Computing	PLOS ONE			English	Article							SYSTEMS BIOLOGY; MULTIOBJECTIVE OPTIMIZATION; SYNTHETIC BIOLOGY; GENETIC ALGORITHM; FITNESS LANDSCAPE; ESCHERICHIA-COLI; FOOD SECURITY; CLOSED-LOOP; PROTEIN; DISCOVERY	Comparatively few studies have addressed directly the question of quantifying the benefits to be had from using molecular genetic markers in experimental breeding programmes (e. g. for improved crops and livestock), nor the question of which organisms should be mated with each other to best effect. We argue that this requires in silico modelling, an approach for which there is a large literature in the field of evolutionary computation (EC), but which has not really been applied in this way to experimental breeding programmes. EC seeks to optimise measurable outcomes (phenotypic fitnesses) by optimising in silico the mutation, recombination and selection regimes that are used. We review some of the approaches from EC, and compare experimentally, using a biologically relevant in silico landscape, some algorithms that have knowledge of where they are in the (genotypic) search space (G-algorithms) with some (albeit well-tuned ones) that do not (F-algorithms). For the present kinds of landscapes, F-and G-algorithms were broadly comparable in quality and effectiveness, although we recognise that the G-algorithms were not equipped with any 'prior knowledge' of epistatic pathway interactions. This use of algorithms based on machine learning has important implications for the optimisation of experimental breeding programmes in the post-genomic era when we shall potentially have access to the full genome sequence of every organism in a breeding population. The non-proprietary code that we have used is made freely available (via Supplementary information).	[O'Hagan, Steve; Kell, Douglas B.] Univ Manchester, Sch Chem, Manchester, Lancs, England; [O'Hagan, Steve; Knowles, Joshua; Kell, Douglas B.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Knowles, Joshua] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Kell, DB (corresponding author), Univ Manchester, Sch Chem, Manchester, Lancs, England.	dbk@manchester.ac.uk	; Kell, Douglas/E-8318-2011	Knowles, Joshua/0000-0001-8112-6112; Kell, Douglas/0000-0001-5838-7963; O'Hagan, Steve/0000-0001-6235-5462				Aita T, 2002, BIOPOLYMERS, V64, P95, DOI 10.1002/bip.10126; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Baker M, 2011, NATURE, V473, P403, DOI 10.1038/473403a; Barrett CL, 2006, CURR OPIN BIOTECH, V17, P488, DOI 10.1016/j.copbio.2006.08.001; Becker J, 2011, METAB ENG, V13, P159, DOI 10.1016/j.ymben.2011.01.003; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Birattari M., 2002, P GENETIC EVOLUTIONA, V2, P11; Bloom JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100119; Bongard JC, 2005, IEEE T EVOLUT COMPUT, V9, P361, DOI 10.1109/TEVC.2005.850293; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen VCP, 2006, IIE TRANS, V38, P273, DOI 10.1080/07408170500232495; Coello CAC., 2007, EVOLUTIONARY ALGORIT, V5; Collins RJ, 1991, P 4 INT C GEN ALG, P249; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Corne D, 2003, LECT NOTES COMPUT SC, V2611, P187; Corne D., 1999, NEW IDEAS OPTIMIZATI; Corne DW, 2003, LECT NOTES COMPUT SC, V2632, P327; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crary SB, 2002, ANALOG INTEGR CIRC S, V32, P7, DOI 10.1023/A:1016063422605; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; DASGUPTA P, 1999, MULTIOBJECTIVE HEURI; Deb K., 2008, MULTIOBJECTIVE PROBL; Deb K., 2001, WIL INT S SYS OPT; Eathington SR, 2007, CROP SCI, V47, pS154, DOI 10.2135/cropsci2007.04.0015IPBS; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Emmerich M., 2002, Parallel Problem Solving from Nature - PPSN VII. 7th International Conference. Proceedings (Lecture Notes in Computer Science Vol.2439), P361; Fahrenkrug SC, 2010, J ANIM SCI, V88, P2530, DOI 10.2527/jas.2010-2847; Fan QW, 2003, CANCER RES, V63, P8930; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FELL D, 1996, UNDERSTANDING CONTRO; Fisher P, 2009, METHODS MOL BIOL, V573, P329, DOI 10.1007/978-1-60761-247-6_18; Foresight, 2011, FUT FOOD FARM FIN PR; Fox R, 2005, J THEOR BIOL, V234, P187, DOI 10.1016/j.jtbi.2004.11.031; Fox R, 2003, PROTEIN ENG, V16, P589, DOI 10.1093/protein/gzg077; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Garey M.R., 1979, COMPUTERS INTRACTABI; Gianola D, 2003, GENETICS, V163, P347; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Godfray HCJ, 2010, PHILOS T R SOC B, V365, P2769, DOI 10.1098/rstb.2010.0180; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goldberg D. E., 1987, Genetic Algorithms and their Applications: Proceedings of the Second International Conference on Genetic Algorithms, P41; Goldberg D. E., 1989, GENETIC ALGORITHMS S, DOI DOI 10.1111/J.1365-2486.2009.02080.X; Gordo I, 2001, CURR BIOL, V11, pR684, DOI 10.1016/S0960-9822(01)00408-0; Haupt R., 1998, PRACTICAL GENETIC AL; Hayashi Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000096; Heinemann M, 2006, BIOINFORMATICS, V22, P2790, DOI 10.1093/bioinformatics/btl469; Heinrich R., 1996, REGULATION CELLULAR; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Hill WG, 2005, SCIENCE, V307, P683, DOI 10.1126/science.1105459; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; Holland JH, 1992, ADAPTATION NATURAL A, DOI [10.7551/mitpress/1090.001.0001, DOI 10.7551/MITPRESS/1090.001.0001]; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Horn J, 1994, MULTICRITERION DECIS, P82; Hutter M, 2001, IDSIA0101; Hutter M, 2006, IEEE T EVOLUT COMPUT, V10, P568, DOI 10.1109/TEVC.2005.863127; Ihekwaba AEC, 2005, IEE P SYST BIOL, V152, P153, DOI 10.1049/ip-syb:20050050; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jin Y, 2005, SOFT COMPUT, V9, P3, DOI 10.1007/S00500-003-0328-5; Jin YC, 2002, IEEE T EVOLUT COMPUT, V6, P481, DOI 10.1109/TEVC.2002.800884; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Jourdan L, 2005, LECT NOTES COMPUT SC, V3410, P841; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1989, J THEOR BIOL, V141, P211, DOI 10.1016/S0022-5193(89)80019-0; Kean S, 2010, SCIENCE, V328, P301, DOI 10.1126/science.328.5976.301; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kell DB, 2002, TRENDS GENET, V18, P555, DOI 10.1016/S0168-9525(02)02765-8; KELL DB, 1986, FEMS MICROBIOL LETT, V39, P305, DOI 10.1016/0378-1097(86)90020-0; Kell DB, 2006, FEBS J, V273, P873, DOI 10.1111/j.1742-4658.2006.05136.x; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Kell DB, 2012, PHILOS T R SOC B, V367, P1589, DOI 10.1098/rstb.2011.0244; Kell DB, 2012, BIOESSAYS, V34, P236, DOI 10.1002/bies.201100144; Kell DB, 2011, ANN BOT-LONDON, V108, P407, DOI 10.1093/aob/mcr175; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; King RD, 2009, COMPUTER, V42, P46, DOI 10.1109/MC.2009.270; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Knight CG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn899; Knowles J, 2006, IEEE T EVOLUT COMPUT, V10, P50, DOI 10.1109/TEVC.2005.851274; Knowles J, 2005, LECT NOTES COMPUT SC, V3410, P176; Knowles JD, 2004, RECENT ADV MEMETIC A, P313; Knowles J, 2009, IEEE COMPUT INTELL M, V4, P77, DOI 10.1109/MCI.2009.933095; Knowles J, 2008, LECT NOTES COMPUT SC, V5252, P245, DOI 10.1007/978-3-540-88908-3_10; Lal R, 2010, J PLANT NUTR SOIL SC, V173, P4, DOI 10.1002/jpln.200900290; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Leonard E, 2008, TRENDS BIOTECHNOL, V26, P674, DOI 10.1016/j.tibtech.2008.08.003; Lippman Z, 2001, GENETICS, V158, P413; Llora X, 2003, LECT NOTES COMPUT SC, V2723, P1172; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Maenhout S, 2010, GENETICS, V185, P1463, DOI 10.1534/genetics.110.116426; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Mahfoud S.W., 1995, THESIS U ILLINOIS UR; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mendes P, 1998, BIOINFORMATICS, V14, P869, DOI 10.1093/bioinformatics/14.10.869; Mengshoel OJ, 2008, EVOL COMPUT, V16, P315, DOI 10.1162/evco.2008.16.3.315; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen T, 2010, GENETICS, V185, P623, DOI 10.1534/genetics.110.116590; Michalewicz Z., 2000, SOLVE IT MODERN HEUR; Michalski RS, 2000, MACH LEARN, V38, P9, DOI 10.1023/A:1007677805582; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2005, MOL GENET METAB, V84, P104, DOI 10.1016/j.ymgme.2004.10.006; Moreau L, 2000, CROP SCI, V40, P329, DOI 10.2135/cropsci2000.402329x; Moscato P., 1999, NEW IDEAS OPTIMIZATI, P219; Muhlenbein H, 1993, EVOL COMPUT, V1, P335, DOI 10.1162/evco.1993.1.4.335; Muhlenbein H, 1993, EVOL COMPUT, V1, P25, DOI 10.1162/evco.1993.1.1.25; O'Hagan S, 2005, ANAL CHEM, V77, P290, DOI 10.1021/ac049146x; Odegard J, 2009, GENETICS, V181, P737, DOI 10.1534/genetics.108.098160; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Ostman B, 2012, P ROY SOC B-BIOL SCI, V279, P247, DOI 10.1098/rspb.2011.0870; Park JH, 2008, TRENDS BIOTECHNOL, V26, P404, DOI 10.1016/j.tibtech.2008.05.001; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Pierce NA, 2002, PROTEIN ENG, V15, P779, DOI 10.1093/protein/15.10.779; Pretty J, 2010, INT J AGR SUSTAIN, V8, P219, DOI 10.3763/ijas.2010.0534; Pritchard L, 2000, J THEOR BIOL, V202, P77, DOI 10.1006/jtbi.1999.1043; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Radcliffe NJ, 1995, LECT NOTES COMPUT SC, V1000, P275; REEVES CR, 2002, GENETIC ALGORITHMS P; Rockman MV, 2010, SCIENCE, V330, P372, DOI 10.1126/science.1194208; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rowe W, 2006, IEEE C EV COMP CEC 2, P9849; Rowe W, 2010, BIOINFORMATICS, V26, P2145, DOI 10.1093/bioinformatics/btq353; Rowe W, 2010, J R SOC INTERFACE, V7, P397, DOI 10.1098/rsif.2009.0193; Sasena MJ, 2002, ENG OPTIMIZ, V34, P263, DOI 10.1080/03052150211751; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Schlierkamp-Voosen D, 1994, LECT NOTES COMPUT SC, V866, P199; Shannon CE., 1949, MATH THEORY COMMUNIC; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Skolicki Z., 2005, P 7 ANN C GEN EV COM, P1295, DOI DOI 10.1145/1068009.1068219; SYSWERDA G, 1989, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON GENETIC ALGORITHMS, P2; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Tomassini M, 2005, NAT COMP SER, DOI 10.1007/3-540-29938-6; van Veen JE, 2003, CURR BIOL, V13, pR831, DOI 10.1016/j.cub.2003.10.014; Wedge DC, 2009, J THEOR BIOL, V257, P131, DOI 10.1016/j.jtbi.2008.11.005; WEDGE DC, 2008, GECCO 08, P1315; Wineberg M, 2004, LECT NOTES COMPUT SC, V3103, P318; Wojtusiak J, 2006, PROC INT C TOOLS ART, P523; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P131, DOI 10.1016/S0169-7439(01)00156-3; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Xu SZ, 2003, GENETICS, V163, P789; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; YONEZAWA K, 1977, EUPHYTICA, V26, P413, DOI 10.1007/BF00027003; Yuan B, 2004, LNCS, V3242; Zaccolo M, 1999, J MOL BIOL, V285, P775, DOI 10.1006/jmbi.1998.2262; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; Zitzler E., 1999, EVOLUTIONARY ALGORIT	164	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48862	10.1371/journal.pone.0048862	http://dx.doi.org/10.1371/journal.pone.0048862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185279	Green Published, gold			2022-12-25	WOS:000311821000024
J	Pan, YW; Kuo, CT; Storm, DR; Xia, ZG				Pan, Yung-Wei; Kuo, Chay T.; Storm, Daniel R.; Xia, Zhengui			Inducible and Targeted Deletion of the ERK5 MAP Kinase in Adult Neurogenic Regions Impairs Adult Neurogenesis in the Olfactory Bulb and Several Forms of Olfactory Behavior	PLOS ONE			English	Article							NEWBORN NEURONS; SUBVENTRICULAR ZONE; RAT HIPPOCAMPUS; NERVOUS-SYSTEM; FEMALE MICE; MEMORY; ODOR; MOUSE; FOREBRAIN; TMT	Although adult-born neurons in the subventricular zone (SVZ) and olfactory bulb (OB) have been extensively characterized at the cellular level, their functional impact on olfactory behavior is still highly controversial with many conflicting results reported in the literature. Furthermore, signaling mechanisms regulating adult SVZ/OB neurogenesis are not well defined. Here we report that inducible and targeted deletion of erk5, a MAP kinase selectively expressed in the adult neurogenic regions of the adult brain, impairs adult neurogenesis in the SVZ and OB of transgenic mice. Although erk5 deletion had no effect on olfactory discrimination among discrete odorants in the habituation/dishabituation assay, it reduced short-term olfactory memory as well as detection sensitivity to odorants and pheromones including those evoking aggression and fear. Furthermore, these mice show impaired acquisition of odor-cued associative olfactory learning, a novel phenotype that had not been previously linked to adult neurogenesis. These data suggest that ERK5 MAP kinase is a critical kinase signaling pathway regulating adult neurogenesis in the SVZ/OB, and provide strong evidence supporting a functional role for adult neurogenesis in several distinct forms of olfactory behavior.	[Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Pan, Yung-Wei; Xia, Zhengui] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Kuo, Chay T.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Kuo, Chay T.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Xia, Zhengui] Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Duke University; University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu; zxia@u.washington.edu			National Institutes of Healths [MH095840, DC004156, T32HD007183, F31DC011216]; National Institute of Child Health and Human Development [P30 HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183, P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156, F31DC011216] Funding Source: NIH RePORTER	National Institutes of Healths(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institutes of Healths grants MH095840 to ZX, DC004156 to DRS, T32HD007183 and F31DC011216 to YWP and the National Institute of Child Health and Human Development P30 HD02274. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiraman S, 2011, ZOOL SCI, V28, P600, DOI 10.2108/zsj.28.600; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arenkiel BR, 2010, J NEUROPHYSIOL, V103, P2935, DOI 10.1152/jn.00179.2010; Bardy C, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnnes.2010.00002; Belvindrah R, 2009, REV NEUROSCIENCE, V20, P331, DOI 10.1515/REVNEURO.2009.20.5-6.331; Breton-Provencher V, 2012, BEHAV BRAIN RES, V227, P480, DOI 10.1016/j.bbr.2011.08.001; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Buron G, 2007, BEHAV NEUROSCI, V121, P1063, DOI 10.1037/0735-7044.121.5.1063; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Hacquemand R, 2010, BEHAV BRAIN RES, V215, P58, DOI 10.1016/j.bbr.2010.06.024; Hawkes C, 2006, ADV OTO-RHINO-LARYNG, V63, P133, DOI 10.1159/000093759; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jonasson Z, 2004, HIPPOCAMPUS, V14, P28, DOI 10.1002/hipo.10146; Kageyama R, 2012, BEHAV BRAIN RES, V227, P459, DOI 10.1016/j.bbr.2011.04.038; Kaut KP, 2001, COGN AFFECT BEHAV NE, V1, P270, DOI 10.3758/CABN.1.3.270; Kaut KP, 2003, BEHAV NEUROSCI, V117, P304, DOI 10.1037/0735-7044.117.2.304; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Mak GK, 2010, NAT NEUROSCI, V13, P753, DOI 10.1038/nn.2550; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mechawar N, 2004, P NATL ACAD SCI USA, V101, P9822, DOI 10.1073/pnas.0403361101; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; NOVOTNY M, 1990, EXPERIENTIA, V46, P109, DOI 10.1007/BF01955433; Pan YW, 2012, J BIOL CHEM, V287, P23306, DOI 10.1074/jbc.M112.344762; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sakamoto M, 2011, P NATL ACAD SCI US; Singer BH, 2009, J COMP NEUROL, V514, P567, DOI 10.1002/cne.22052; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	47	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49622	10.1371/journal.pone.0049622	http://dx.doi.org/10.1371/journal.pone.0049622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185386	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000071
J	Peck, JR; Waxman, D; Welch, JJ				Peck, Joel R.; Waxman, David; Welch, John J.			Hidden Epistastic Interactions Can Favour the Evolution of Sex and Recombination	PLOS ONE			English	Article							MUTATION-SELECTION BALANCE; DELETERIOUS MUTATIONS; BENEFICIAL MUTATIONS; ADVANTAGE; LOAD; ACCUMULATION; REPRODUCTION; POPULATIONS; ORGANISMS; FITNESS	Deleterious mutations can have a strong influence on the outcome of evolution. The nature of this influence depends on how mutations combine together to affect fitness. "Negative epistasis" occurs when a new deleterious mutation causes the greatest loss in fitness in a genome that already contains many deleterious mutations. Negative epistasis is a key ingredient for some of the leading hypotheses regarding the evolution of recombination, the evolution of sex, and a variety of other phenomena. In general, laboratory studies have not supported the idea that negative epistasis is ubiquitous, and this has led to doubts about its importance in biological evolution. Here, we show that these experimental results may be misleading, because negative epistasis can produce evolutionary advantages for sex and recombination while simultaneously being almost impossible to detect using current experimental methods. Under asexual reproduction, such hidden epistasis influences evolutionary outcomes only if the fittest individuals are present in substantial numbers, while also forming a very small proportion of the population as a whole. This implies that our results for asexuals will apply only for very large populations, and also limits the extent of the fitness benefits that hidden epistasis can provide. Despite these caveats, our results show that the fitness consequences of sex and recombination cannot always be inferred from observable epistasis alone.	[Peck, Joel R.; Welch, John J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Waxman, David] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China	University of Cambridge; Fudan University	Welch, JJ (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	joel.r.peck@gmail.com		Peck, Joel/0000-0003-0421-8739				Barton NH, 2009, COLD SH Q B, V74, P187, DOI 10.1101/sqb.2009.74.030; Barton NH, 2010, PHILOS T R SOC B, V365, P1281, DOI 10.1098/rstb.2009.0320; Burt A, 2000, EVOLUTION, V54, P337; CHARLESWORTH B, 1990, NATURE, V347, P380, DOI 10.1038/347380a0; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; HAIGH J, 1978, THEOR POPUL BIOL, V14, P251, DOI 10.1016/0040-5809(78)90027-8; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hansen TF, 2001, GENETICS, V158, P477; Keightley PD, 2009, GENETICA, V136, P359, DOI 10.1007/s10709-008-9304-4; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; Laffafian A, 2010, EVOLUTION, V64, P3232, DOI 10.1111/j.1558-5646.2010.01062.x; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2007, GENET RES, V89, P447, DOI 10.1017/S001667230800966X; Peck JR, 2010, EVOLUTION, V64, P3300, DOI 10.1111/j.1558-5646.2010.01074.x; Peck JR, 2000, NATURE, V406, P399, DOI 10.1038/35019055; Peck JR, 1997, GENETICS, V145, P1171; PECK JR, 1994, GENETICS, V137, P597; Rice WR, 1998, GENETICA, V102-3, P71, DOI 10.1023/A:1017055429755; Rivero A, 2003, EVOLUTION, V57, P1698, DOI 10.1111/j.0014-3820.2003.tb00375.x; Rose MR, 1995, EVOLUTIONARY BIOL AG; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; West SA, 1998, GENETICS, V149, P435; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569	31	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48382	10.1371/journal.pone.0048382	http://dx.doi.org/10.1371/journal.pone.0048382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185255	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000011
J	Ramakrishnan, V; Kimlinger, T; Haug, J; Painuly, U; Wellik, L; Halling, T; Rajkumar, SV; Kumar, S				Ramakrishnan, Vijay; Kimlinger, Teresa; Haug, Jessica; Painuly, Utkarsh; Wellik, Linda; Halling, Timothy; Rajkumar, S. Vincent; Kumar, Shaji			Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway	PLOS ONE			English	Article							PROTEIN-KINASE B; MULTIPLE-MYELOMA; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; UP-REGULATION; CELL-LINE; MTOR; PHOSPHORYLATION	The PI3K/Akt/mTOR signal transduction pathway plays a central role in multiple myeloma (MM) disease progression and development of therapeutic resistance. mTORC1 inhibitors have shown limited efficacy in the clinic, largely attributed to the reactivation of Akt due to rapamycin induced mTORC2 activity. Here, we present promising anti-myeloma activity of MK-2206, a novel allosteric pan-Akt inhibitor, in MM cell lines and patient cells. MK-2206 was able to induce cytotoxicity and inhibit proliferation in all MM cell lines tested, albeit with significant heterogeneity that was highly dependent on basal pAkt levels. MK-2206 was able to inhibit proliferation of MM cells even when cultured with marrow stromal cells or tumor promoting cytokines. The induction of cytotoxicity was due to apoptosis, which at least partially was mediated by caspases. MK-2206 inhibited pAkt and its down-stream targets and up-regulated pErk in MM cells. Using MK-2206 in combination with rapamycin (mTORC1 inhibitor), LY294002 (PI3K inhibitor), or U0126 (MEK1/2 inhibitor), we show that Erk- mediated downstream activation of PI3K/Akt pathway results in resistance to Akt inhibition. These provide the basis for clinical evaluation of MK-2206 alone or in combination in MM and potential use of baseline pAkt and pErk as biomarkers for patient selection.	[Ramakrishnan, Vijay; Kimlinger, Teresa; Haug, Jessica; Painuly, Utkarsh; Wellik, Linda; Halling, Timothy; Rajkumar, S. Vincent; Kumar, Shaji] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Kumar, S (corresponding author), Mayo Clin, Div Hematol, Rochester, MN 55905 USA.	kumar.shaji@mayo.edu	Rajkumar, S. Vincent/AAV-1834-2021; Kumar, Shaji K/A-9853-2008	Rajkumar, S. Vincent/0000-0002-5862-1833; Kumar, Shaji K/0000-0001-5392-9284	Hematological Malignancies Program (Mayo Clinic Cancer Center); National Cancer Institute [CA90628]; Celgene; Millennium; Novartis; Merck; Cephalon; Genzyme; Bayer; NATIONAL CANCER INSTITUTE [K12CA090628] Funding Source: NIH RePORTER	Hematological Malignancies Program (Mayo Clinic Cancer Center); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Celgene(Bristol-Myers SquibbCelgene Corporation); Millennium(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Merck(Merck & Company); Cephalon; Genzyme(Sanofi-AventisGenzyme Corporation); Bayer(Bayer AG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by Hematological Malignancies Program (Mayo Clinic Cancer Center) and CA90628 (SK) from National Cancer Institute. SK received research support from Celgene, Millennium, Novartis, Merck, Cephalon, Genzyme and Bayer. MK-2206 was provided by Merck. & Co., Inc. (Whitehouse Station, New Jersey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Baumann P, 2012, ANTI-CANCER DRUG, V23, P131, DOI 10.1097/CAD.0b013e32834c8683; BELLAMY WT, 1991, CANCER RES, V51, P995; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chang H, 2006, LEUKEMIA RES, V30, P262, DOI 10.1016/j.leukres.2005.07.008; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cirstea D, 2010, MOL CANCER THER, V9, P963, DOI 10.1158/1535-7163.MCT-09-0763; DALTON WS, 1986, CANCER RES, V46, P5125; delPeso L, 1997, SCIENCE, V278, P687; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Farag SS, 2009, LEUKEMIA RES, V33, P1475, DOI 10.1016/j.leukres.2009.01.039; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gills JJ, 2009, CURR ONCOL REP, V11, P102, DOI 10.1007/s11912-009-0016-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; Hideshima T, 2007, BRIT J HAEMATOL, V138, P783, DOI 10.1111/j.1365-2141.2007.06714.x; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hu LP, 2003, BLOOD, V101, P3126, DOI 10.1182/blood-2002-08-2640; Ismail SI, 2010, LEUKEMIA RES, V34, P824, DOI 10.1016/j.leukres.2009.11.018; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; KATAGIRI S, 1985, INT J CANCER, V36, P241, DOI 10.1002/ijc.2910360217; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Krett NL, 1997, CLIN CANCER RES, V3, P1781; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Maiso P, 2011, BLOOD, V118, P6860, DOI 10.1182/blood-2011-03-342394; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Moreaux J, 2004, BLOOD, V103, P3148, DOI 10.1182/blood-2003-06-1984; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Ramakrishnan V, 2012, LEUKEMIA, V26, P340, DOI 10.1038/leu.2011.192; Ramakrishnan V, 2010, ONCOGENE, V29, P1190, DOI 10.1038/onc.2009.403; Ramakrishnan V, 2010, AM J HEMATOL, V85, P675, DOI 10.1002/ajh.21785; Richardson PG, 2011, J CLIN ONCOL, V29, P4243, DOI 10.1200/JCO.2010.33.9788; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shi YY, 2002, J BIOL CHEM, V277, P15712, DOI 10.1074/jbc.M200043200; Steinbrunn T, 2011, BLOOD, V117, P1998, DOI 10.1182/blood-2010-05-284422; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	48	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50005	10.1371/journal.pone.0050005	http://dx.doi.org/10.1371/journal.pone.0050005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185517	gold, Green Published			2022-12-25	WOS:000311821000164
J	Rodrigues, HG; Sole, F; Charles, C; Tafforeau, P; Vianey-Liaud, M; Viriot, L				Rodrigues, Helder Gomes; Sole, Floreal; Charles, Cyril; Tafforeau, Paul; Vianey-Liaud, Monique; Viriot, Laurent			Evolutionary and Biological Implications of Dental Mesial Drift in Rodents: The Case of the Ctenodactylidae (Rodentia, Mammalia)	PLOS ONE			English	Article							ROOT RESORPTION; TOOTH ERUPTION; ALVEOLAR BONE; MOUSE; TEETH; ODONTOCLASTS; REPLACEMENT; OSTEOCLASTS; INHIBITION; PHYLOGENY	Dental characters are importantly used for reconstructing the evolutionary history of mammals, because teeth represent the most abundant material available for the fossil species. However, the characteristics of dental renewal are presently poorly used, probably because dental formulae are frequently not properly established, whereas they could be of high interest for evolutionary and developmental issues. One of the oldest rodent families, the Ctenodactylidae, is intriguing in having longstanding disputed dental formulae. Here, we investigated 70 skulls among all extant ctenodactylid genera (Ctenodactylus, Felovia, Massoutiera and Pectinator) by using X-ray conventional and synchrotron microtomography in order to solve and discuss these dental issues. Our study clearly indicates that Massoutiera, Felovia and Ctenodactylus differ from Pectinator not only by a more derived dentition, but also by a more derived eruptive sequence. In addition to molars, their dentition only includes the fourth deciduous premolars, and no longer bears permanent premolars, conversely to Pectinator. Moreover, we found that these premolars are lost during adulthood, because of mesial drift of molars. Mesial drift is a striking mechanism involving migration of teeth allowed by both bone remodeling and dental resorption. This dental innovation is to date poorly known in rodents, since it is only the second report described. Interestingly, we noted that dental drift in rodents is always associated with high-crowned teeth favoring molar size enlargement. It can thus represent another adaptation to withstand high wear, inasmuch as these rodents inhabit desert environments where dust is abundant. A more accurate study of mesial drift in rodents would be very promising from evolutionary, biological and orthodontic points of view.	[Rodrigues, Helder Gomes; Sole, Floreal; Charles, Cyril; Viriot, Laurent] Univ Lyon 1, Ecole Normale Super Lyon, CNRS,UMR 5242, Team Evo Devo Vertebrate Dentit,Inst Genom Fonct, F-69365 Lyon, France; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Vianey-Liaud, Monique] Univ Montpellier 2, CNRS, UMR 5554, Lab Paleontol,Inst Sci Evolut Montpellier, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Rodrigues, HG (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, CNRS,UMR 5242, Team Evo Devo Vertebrate Dentit,Inst Genom Fonct, F-69365 Lyon, France.	helder.gomes.rodrigues@ens-lyon.fr; Laurent.Viriot@ens-lyon.fr	Charles, Cyril/E-7606-2011	Charles, Cyril/0000-0002-6930-039X; Tafforeau, Paul/0000-0002-5962-1683; Viriot, Laurent/0000-0003-2092-588X	ANR "Bouillabaisse" Program; Centre National de la Recherche Scientifique postdoctoral grant; ESRF	ANR "Bouillabaisse" Program(French National Research Agency (ANR)); Centre National de la Recherche Scientifique postdoctoral grant(Centre National de la Recherche Scientifique (CNRS)); ESRF	The ANR "Bouillabaisse" Program, a Centre National de la Recherche Scientifique postdoctoral grant, and ESRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SCANNING MICROSCOPY; Butler PM, 1985, HOMOLOGIES MOLARS CU, P381; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Charles C, 2007, NATURWISSENSCHAFTEN, V94, P71, DOI 10.1007/s00114-006-0161-7; Chlastakova I, 2011, EUR J ORAL SCI, V119, P265, DOI 10.1111/j.1600-0722.2011.00838.x; DOMNING DP, 1984, MAMMALIA, V48, P105, DOI 10.1515/mamm.1984.48.1.105; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Ellerman JR, 1940, FAMILIES GENERA LIVI; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; GEORGE W, 1979, ZOOL J LINN SOC-LOND, V65, P261, DOI 10.1111/j.1096-3642.1979.tb01096.x; Gomes Rodrigues H, 2011, EVOL DEV, V13, P260; Harokopakis-Hajishengallis Evlambia, 2007, J Oral Sci, V49, P1, DOI 10.2334/josnusd.49.1; Jager A, 2008, EUR J ORTHODONT, V30, P336, DOI 10.1093/ejo/cjn012; Jaeger JJ., 1971, NOTES SERV GEOL MARO, V31, P113; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Kilic N, 2010, EUR J ORTHODONT, V32, P154, DOI 10.1093/ejo/cjp083; Lanyon JM, 2006, J ZOOL, V268, P133, DOI 10.1111/j.1469-7998.2005.00004.x; LASFARGUES JJ, 1993, ANAT REC, V237, P458, DOI 10.1002/ar.1092370404; LASFARGUES JJ, 1992, ANAT REC, V234, P310, DOI 10.1002/ar.1092340303; Lataste F., 1885, NATURALISTE, V3, P21; Lavocat R, 1961, NOTES MEMOIRES SERVI, V155, P109; Lavocat R., 1961, NOTES MEM SERV GEOL, V155, P29; Lazzari V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003607; Lentle RG, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P127; Lopez-Antonanzas R, 2011, J SYST PALAEONTOL, V9, P379, DOI 10.1080/14772019.2010.529175; Luckett W.P., 1985, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V92, P227; Marivaux L, 2004, ZOOL J LINN SOC-LOND, V142, P105, DOI 10.1111/j.1096-3642.2004.00131.x; Marks SC, 1996, ANAT RECORD, V245, P374, DOI 10.1002/(SICI)1097-0185(199606)245:2<374::AID-AR18>3.0.CO;2-M; Martin T, 1997, TOOTH ENAMEL MICROSTRUCTURE, P163; Misonne X., 1969, Annales du Musee R de l'Afrique Central, VNo. 172, P1; MONES A, 1982, Palaeontologische Zeitschrift, V56, P107; MOSS JP, 1982, ARCH ORAL BIOL, V27, P273, DOI 10.1016/0003-9969(82)90062-0; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Patterson B., 1982, Bulletin of the Museum of Comparative Zoology, V149, P371; Prochazka J, 2010, P NATL ACAD SCI USA, V107, P15497, DOI 10.1073/pnas.1002784107; Ren YJ, 2004, EUR J ORTHODONT, V26, P483, DOI 10.1093/ejo/26.5.483; Rodrigues HG, 2011, P NATL ACAD SCI USA, V108, P17355, DOI 10.1073/pnas.1109615108; ROUX D, 1994, ARCH ORAL BIOL, V39, P1023, DOI 10.1016/0003-9969(94)90053-1; Saffar JL, 1997, PERIODONTOL 2000, V13, P76, DOI 10.1111/j.1600-0757.1997.tb00096.x; Sanchez S, MICROSCOPY MICROANAL; Sasaki T, 2003, MICROSC RES TECHNIQ, V61, P483, DOI 10.1002/jemt.10370; Schmid-Kittler N, 2006, OLIGOCENE MIOCENE VE, P173; Schrenk F, 1989, COURIER FORSCHUNGSIN, V108, P1; Sicher H., 1944, AM J ORTHOD ORAL SUR, V30, pC109, DOI [10.1016/S0096-6347(44)90257-7, DOI 10.1016/S0096-6347(44)90257-7]; Sikes S.K, 1971, NATURAL HIST AFRICAN; Sringkarnboriboon S, 2003, J DENT RES, V82, P486, DOI 10.1177/154405910308200616; STEHLIN HG, 1951, SCHWEIZ PALEONT ABH, V67, P1; Stromberg CAE, 2011, ANNU REV EARTH PL SC, V39, P517, DOI 10.1146/annurev-earth-040809-152402; Tureckova J, 1996, INT J DEV BIOL, V40, P483; Vianey-Liaud M., 1976, Palaeovertebrata, V7, P1; Vianey-Liaud M, 2010, ZOOL J LINN SOC-LOND, V160, P531, DOI 10.1111/j.1096-3642.2010.00615.x; Vianey-Liaud Monique, 2006, Palaeovertebrata (Montpellier), V34, P111; Viriot L, 2000, INT J DEV BIOL, V44, P233; Viriot L, 2002, CONNECT TISSUE RES, V43, P129, DOI 10.1080/03008200290001168; von Koenigswald W, 2004, PALAEONTOGR ABT A, V270, P95; von Koenigswald W, 2011, PALAEONTOGR ABT A, V294, P63; Wang BY, 1997, B AM MUS NAT HIST, P1; Wang Z, 2011, ORAL DIS, V17, P129, DOI 10.1111/j.1601-0825.2010.01718.x; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509	62	11	11	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50197	10.1371/journal.pone.0050197	http://dx.doi.org/10.1371/journal.pone.0050197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185576	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000199
J	Spitz, J; Trites, AW; Becquet, V; Brind'Amour, A; Cherel, Y; Galois, R; Ridoux, V				Spitz, Jerome; Trites, Andrew W.; Becquet, Vanessa; Brind'Amour, Anik; Cherel, Yves; Galois, Robert; Ridoux, Vincent			Cost of Living Dictates what Whales, Dolphins and Porpoises Eat: The Importance of Prey Quality on Predator Foraging Strategies	PLOS ONE			English	Article							BOTTLE-NOSED-DOLPHIN; BASAL METABOLIC-RATE; STOMACH CONTENTS; BALAENOPTERA-ACUTOROSTRATA; STENELLA-COERULEOALBA; STRIPED DOLPHIN; NUTRITIONAL STRESS; TURSIOPS-TRUNCATUS; NORTHEAST ATLANTIC; ENERGY ALLOCATION	Understanding the mechanisms that drive prey selection is a major challenge in foraging ecology. Most studies of foraging strategies have focused on behavioural costs, and have generally failed to recognize that differences in the quality of prey may be as important to predators as the costs of acquisition. Here, we tested whether there is a relationship between the quality of diets (kJ.g(-1)) consumed by cetaceans in the North Atlantic and their metabolic costs of living as estimated by indicators of muscle performance (mitochondrial density, n = 60, and lipid content, n = 37). We found that the cost of living of 11 cetacean species is tightly coupled with the quality of prey they consume. This relationship between diet quality and cost of living appears to be independent of phylogeny and body size, and runs counter to predictions that stem from the well-known scaling relationships between mass and metabolic rates. Our finding suggests that the quality of prey rather than the sheer quantity of food is a major determinant of foraging strategies employed by predators to meet their specific energy requirements. This predator-specific dependence on food quality appears to reflect the evolution of ecological strategies at a species level, and has implications for risk assessment associated with the consequences of changing the quality and quantities of prey available to top predators in marine ecosystems.	[Spitz, Jerome; Becquet, Vanessa; Galois, Robert; Ridoux, Vincent] Univ La Rochelle, CNRS, UMR 7266, Littoral Environm & Soc, La Rochelle, France; [Trites, Andrew W.] Univ British Columbia, Fisheries Ctr, Marine Mammal Res Unit, Vancouver, BC V5Z 1M9, Canada; [Brind'Amour, Anik] IFREMER, Dept Ecol & Modeles Halieut, Nantes, France; [Cherel, Yves] CNRS, UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France; [Ridoux, Vincent] Univ La Rochelle, CNRS, UMS 3462, Observ PELAGIS Syst Observat Conservat Mammifere, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; University of British Columbia; Ifremer; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Spitz, J (corresponding author), Univ La Rochelle, CNRS, UMR 7266, Littoral Environm & Soc, La Rochelle, France.	jspitz@univ-lr.fr	Trites, Andrew/K-5648-2012	Ridoux, Vincent/0000-0002-9779-9319; Brind'Amour, Anik/0000-0003-4072-2588; SPITZ, Jerome/0000-0003-2729-2413; Trites, Andrew/0000-0003-0342-5322	French Ministry in charge of the Environment; University of La Rochelle; Agence Nationale de la Recherche Technique; CIFRE grant; North Pacific Marine Science Foundation through the North Pacific Universities Marine Mammal Research Consortium	French Ministry in charge of the Environment; University of La Rochelle; Agence Nationale de la Recherche Technique(French National Research Agency (ANR)); CIFRE grant; North Pacific Marine Science Foundation through the North Pacific Universities Marine Mammal Research Consortium	The data collection and analysis was funded by the French Ministry in charge of the Environment and the University of La Rochelle. JS was supported by the Agence Nationale de la Recherche Technique with a CIFRE grant. AWT was supported in part by the North Pacific Marine Science Foundation through the North Pacific Universities Marine Mammal Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berta A, 2008, MARINE MAMMALS EVOLU; Borjesson P, 2003, MAR MAMMAL SCI, V19, P38, DOI 10.1111/j.1748-7692.2003.tb01091.x; Bozinovic F, 2004, COMP BIOCHEM PHYS A, V137, P597, DOI 10.1016/j.cbpb.2003.11.014; Bundle MW, 1999, NATURE, V397, P31, DOI 10.1038/16173; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; CLARKE A, 1985, J MAR BIOL ASSOC UK, V65, P983, DOI 10.1017/S0025315400019457; Cruz-Neto AP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P877, DOI 10.1086/425187; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; du Dot TJ, 2009, COMP BIOCHEM PHYS A, V152, P524, DOI 10.1016/j.cbpa.2008.12.010; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Evans M, 2003, OECOLOGIA, V137, P171, DOI 10.1007/s00442-003-1322-4; Feldhamer GA, 2007, MAMMALOGY ADAPTATION; Fernandez R, 2009, J MAR BIOL ASSOC UK, V89, P873, DOI 10.1017/S0025315409000290; FOLCH J, 1957, J BIOL CHEM, V226, P497; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; GONZALEZ AF, 1994, FISH RES, V21, P179, DOI 10.1016/0165-7836(94)90103-1; GRANT BR, 1989, AM NAT, V133, P377, DOI 10.1086/284924; Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Lieber R.L., 2002, SKELETAL MUSCLE STRU, P13; LOCKYER C, 1986, CAN J FISH AQUAT SCI, V43, P142, DOI 10.1139/f86-015; Lopez A, 2002, THESIS U SANTIAGO CO; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; Meynier L, 2008, MAR ECOL PROG SER, V354, P277, DOI 10.3354/meps07246; Munoz-Garcia A, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1039, DOI 10.1086/432852; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; Olsen Erik, 2001, Journal of Cetacean Research and Management, V3, P179; PERRIN N, 1993, ANNU REV ECOL SYST, V24, P379, DOI 10.1146/annurev.es.24.110193.002115; Perry G, 1997, TRENDS ECOL EVOL, V12, P360, DOI 10.1016/S0169-5347(97)01097-5; Pierce GJ, 2007, J MAR BIOL ASSOC UK, V87, P213, DOI 10.1017/S0025315407055348; Pierce GJ, 2004, J MAR BIOL ASSOC UK, V84, P1241, DOI 10.1017/S0025315404010732h; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Price SA, 2005, BIOL REV, V80, P445, DOI 10.1017/S1464793105006743; R Core Team, 2022, R LANG ENV STAT COMP; Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a; Rosen DAS, 2004, CAN J ZOOL, V82, P1061, DOI 10.1139/Z04-082; Santos MB, 2008, J MAR BIOL ASSOC UK, V88, P1175, DOI 10.1017/S0025315408000155; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P243, DOI 10.1017/S0025315407054380; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; Santos MB, 2006, MAR MAMMAL SCI, V22, P600, DOI 10.1111/j.1748-7692.2006.00038.x; Santos MB, 2001, J MAR BIOL ASSOC UK, V81, P687, DOI 10.1017/S0025315401004386; Santos MB, 2004, MAR MAMMAL SCI, V20, P1, DOI 10.1111/j.1748-7692.2004.tb01138.x; Santos MB, 2002, J MAR BIOL ASSOC UK, V82, P501, DOI 10.1017/S0025315402005787; Santos MB, 2001, J MAR BIOL ASSOC UK, V81, P873, DOI 10.1017/S0025315401004714; Santos MB, 1999, MAR ECOL PROG SER, V183, P281, DOI 10.3354/meps183281; Santos MB, 2004, INTERVENTIONS PSYCHO, V2004, P09; Sheriff MJ, 2009, CAN J ZOOL, V87, P956, DOI 10.1139/Z09-087; Sigurjonsson J, 2000, NAMMCO SCI PUBL, V2, P82, DOI 10.7557/3.2973; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; Silva MA, 1999, J MAR BIOL ASSOC UK, V79, P531, DOI 10.1017/S0025315498000654; Sivertsen SP, 2006, MAR BIOL RES, V2, P89, DOI 10.1080/17451000600670952; Spitz J, 2006, J SEA RES, V55, P309, DOI 10.1016/j.seares.2006.02.001; Spitz J, 2011, DEEP SEA RES 1, pI; Spitz J, 2006, ESTUAR COAST SHELF S, V70, P259, DOI 10.1016/j.ecss.2006.04.020; Spitz J, 2010, J EXP MAR BIOL ECOL, V390, P73, DOI 10.1016/j.jembe.2010.05.010; Spitz J, 2010, ICES J MAR SCI, V67, P909, DOI 10.1093/icesjms/fsq008; Stephens D.W., 1986, pi; Tollit DJ, 1997, CAN J FISH AQUAT SCI, V54, P105, DOI 10.1139/cjfas-54-1-105; Trillmich Fritz, 1996, Advances in the Study of Behavior, V25, P533; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; Vikingsson G.A., 2003, NAMMCO Scientific Publications, V5, P243; Vikingsson Gisli A., 1997, Journal of Northwest Atlantic Fishery Science, V22, P77; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; WURTZ M, 1993, J MAR BIOL ASSOC UK, V73, P571, DOI 10.1017/S0025315400033117; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	72	72	74	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50096	10.1371/journal.pone.0050096	http://dx.doi.org/10.1371/journal.pone.0050096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185542	Green Published, gold			2022-12-25	WOS:000311821000180
J	Wu, WX; Zhang, W; Booth, JL; Metcalf, JP				Wu, Wenxin; Zhang, Wei; Booth, J. Leland; Metcalf, Jordan P.			Influenza A(H1N1)pdm09 Virus Suppresses RIG-I Initiated Innate Antiviral Responses in the Human Lung	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; A VIRUS; IMMUNE-RESPONSE; PANDEMIC INFLUENZA; STRANDED-RNA; NS1 PROTEIN; CYTOKINE RESPONSES; EPITHELIAL-CELLS; DENDRITIC CELLS; NEGATIVE-STRAND	Influenza infection is a major cause of morbidity and mortality. Retinoic acid-inducible gene I (RIG-I) is believed to play an important role in the recognition of, and response to, influenza virus and other RNA viruses. Our study focuses on the hypothesis that pandemic H1N1/09 influenza virus alters the influenza-induced proinflammatory response and suppresses host antiviral activity. We first compared the innate response to a clinical isolate of influenza A(H1N1)pdm09 virus, OK/09, a clinical isolate of seasonal H3N2 virus, OK/06, and to a laboratory adapted seasonal H1N1 virus, PR8, using a unique human lung organ culture model. Exposure of human lung tissue to either pandemic or seasonal influenza virus resulted in infection and replication in alveolar epithelial cells. Pandemic virus induces a diminished RIG-I mRNA and antiviral cytokine response than seasonal virus in human lung. The suppression of antiviral response and RIG-I mRNA expression was confirmed at the protein level by ELISA and western blot. We performed a time course of RIG-I and interferon-beta (IFN-beta) mRNA induction by the two viruses. RIG-I and IFN-beta induction by OK/09 was of lower amplitude and shorter duration than that caused by PR8. In contrast, the pandemic virus OK/09 caused similar induction of proinflammatory cytokines, IL-8 and IL-6, at both the transcriptional and translational level as PR8 in human lung. Differential antiviral responses did not appear to be due to a difference in cellular infectivity as immunohistochemistry showed that both viruses infected alveolar macrophages and epithelial cells. These findings show that influenza A(H1N1) pdm09 virus suppresses anti-viral immune responses in infected human lung through inhibition of viral-mediated induction of the pattern recognition receptor, RIG-I, though proinflammatory cytokine induction was unaltered. This immunosuppression of the host antiviral response by pandemic virus may have contributed to the more serious lung infections that occurred in the H1N1 pandemic of 2009.	[Wu, Wenxin; Zhang, Wei; Booth, J. Leland; Metcalf, Jordan P.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Pulm & Crit Care, Oklahoma City, OK 73104 USA; [Metcalf, Jordan P.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Metcalf, JP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Pulm & Crit Care, Oklahoma City, OK 73104 USA.	jordan-metcalf@ouhsc.edu			Oklahoma Health Research Program from Oklahoma Center for the Advancement of Science Technology; National Institute of Allergy and Infectious Diseases [1U19 AI62629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629] Funding Source: NIH RePORTER	Oklahoma Health Research Program from Oklahoma Center for the Advancement of Science Technology; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described in this work was partially supported by the Oklahoma Health Research Program from Oklahoma Center for the Advancement of Science & Technology (to WW) and by the National Institute of Allergy and Infectious Diseases, project 1U19 AI62629 (to JPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Booth JL, 2004, J VIROL, V78, P4156, DOI 10.1128/JVI.78.8.4156-4164.2004; Bose S, 2003, J INTERF CYTOK RES, V23, P401, DOI 10.1089/107999003322277810; Brydon EWA, 2003, J GEN VIROL, V84, P2389, DOI 10.1099/vir.0.18913-0; Chakrabarty K, 2007, INFECT IMMUN, V75, P3729, DOI 10.1128/IAI.00046-07; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; Hui KPY, 2011, J INFECT DIS, V204, P1866, DOI 10.1093/infdis/jir665; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kang YM, 2011, ARCH VIROL, V156, P759, DOI 10.1007/s00705-010-0914-7; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Kwon D, 2010, J MICROBIOL, V48, P657, DOI 10.1007/s12275-010-0120-z; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Liao HY, 2010, J AM CHEM SOC, V132, P14849, DOI 10.1021/ja104657b; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Morosky SA, 2011, J BIOL CHEM, V286, P28574, DOI 10.1074/jbc.M111.227942; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Ronni T, 1997, J IMMUNOL, V158, P2363; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Wu SH, 2011, CURR OPIN INFECT DIS, V24, P235, DOI 10.1097/QCO.0b013e328344c0e3; Wu WX, 2011, AM J PHYSIOL-LUNG C, V300, pL821, DOI 10.1152/ajplung.00267.2010; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; YANG YP, 1995, P NATL ACAD SCI USA, V92, P7257, DOI 10.1073/pnas.92.16.7257; ZHANG H, 1994, BIOCHEM BIOPH RES CO, V200, P95, DOI 10.1006/bbrc.1994.1419	49	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49856	10.1371/journal.pone.0049856	http://dx.doi.org/10.1371/journal.pone.0049856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185463	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000126
J	Yu, WB; Yin, CY; Zhou, Y; Ye, BC				Yu, Wen-Bang; Yin, Chun-Yun; Zhou, Ying; Ye, Bang-Ce			Prediction of the Mechanism of Action of Fusaricidin on Bacillus subtilis	PLOS ONE			English	Article							GENE-EXPRESSION; STRUCTURE ELUCIDATION; BIOLOGICAL-ACTIVITY; ESCHERICHIA-COLI; POLYMYXA KT-8; AMINO-ACID; ANTIBIOTICS; BIOSYNTHESIS; STRESS; ZINC	Long-term use of antibiotics has engendered a large number of resistant pathogens, which pose a serious threat to human health. Here, we investigated the mechanism of fusaricidin antibacterial activity toward Bacillus subtilis and characterized the pathways responsible for drug resistance. We found that sigma(w), an extracytoplasmic function sigma factor, plays an important role in the resistance to fusaricidins during the initial 5 minutes of drug addition. Approximately 18 genes were induced more than 3-fold, of which 66.7% are known to be regulated by sigma(w). Over the following 3 h, fusaricidins induced 194 genes more than three-fold, and most were associated with classes of antibiotic-responsive stimulons. Moreover, the fusaricidin treatment increased the catabolism of fatty and amino acids but strongly repressed glucose decomposition and gluconeogenesis. In summary, our data provide insight into the mechanism of fusaricidin activity, on which we based our suggested strategies for the development of novel antibiotic agents.	[Yu, Wen-Bang; Yin, Chun-Yun; Zhou, Ying; Ye, Bang-Ce] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China	East China University of Science & Technology	Zhou, Y (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Lab Biosyst & Microanal, Shanghai 200237, Peoples R China.	zhouying@ecust.edu.cn; bcye@ecust.edu.cn			Fundamental Research Funds for the Central Universities [WF1214071]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding was provided by Fundamental Research Funds for the Central Universities (WF1214071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attila C, 2009, APPL MICROBIOL BIOT, V82, P525, DOI 10.1007/s00253-009-1860-8; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Bandow JE, 2003, ANTIMICROB AGENTS CH, V47, P948, DOI 10.1128/AAC.47.3.948-955.2003; Breithaupt H, 1999, NAT BIOTECHNOL, V17, P1165, DOI 10.1038/70705; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Donovan C, 2009, MICROBIOL-SGM, V155, P1786, DOI 10.1099/mic.0.025312-0; Gabriel SE, 2008, J BACTERIOL, V190, P3482, DOI 10.1128/JB.01978-07; Giedroc DP, 2009, MOL MICROBIOL, V73, P1, DOI 10.1111/j.1365-2958.2009.06752.x; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; Kajimura Y, 1997, J ANTIBIOT, V50, P220, DOI 10.7164/antibiotics.50.220; Kajimura Y, 1996, J ANTIBIOT, V49, P129, DOI 10.7164/antibiotics.49.129; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Li J, 2008, CHEM BIOL, V15, P118, DOI 10.1016/j.chembiol.2007.12.014; Ludwig H, 2001, MOL MICROBIOL, V41, P409, DOI 10.1046/j.1365-2958.2001.02523.x; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Miethke M, 2008, J BACTERIOL, V190, P5143, DOI 10.1128/JB.00464-08; Miethke M, 2006, J BACTERIOL, V188, P8655, DOI 10.1128/JB.01049-06; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Nanamiya H, 2004, MOL MICROBIOL, V52, P273, DOI 10.1111/j.1365-2958.2003.03972.x; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; Pietiainen M, 2005, MICROBIOL-SGM, V151, P1577, DOI 10.1099/mic.0.27761-0; Rezacova P, 2008, MOL MICROBIOL, V69, P895, DOI 10.1111/j.1365-2958.2008.06318.x; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Takamatsu H, 2009, J BACTERIOL, V191, P1220, DOI 10.1128/JB.01269-08; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Ye BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007073	33	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50003	10.1371/journal.pone.0050003	http://dx.doi.org/10.1371/journal.pone.0050003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185515	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000163
J	Zhang, X; Cheng, E; Huo, XF; Yu, CH; Zhang, QY; Pham, TH; Wang, DH; Spechler, SJ; Souza, RF				Zhang, Xi; Cheng, Edaire; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Pham, Thai H.; Wang, David H.; Spechler, Stuart J.; Souza, Rhonda F.			Omeprazole Blocks STAT6 Binding to the Eotaxin-3 Promoter in Eosinophilic Esophagitis Cells	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; GENE-EXPRESSION; CONSENSUS RECOMMENDATIONS; EPITHELIAL-CELLS; ACTIVATION; ACIDIFICATION; ASSOCIATION; CHILDREN; ATPASE; ADULTS	Background: Patients who have esophageal eosinophilia without gastroesophageal reflux disease (GERD) nevertheless can respond to proton pump inhibitors (PPIs), which can have anti-inflammatory actions independent of effects on gastric acid secretion. In esophageal cell cultures, omeprazole has been reported to inhibit Th2 cytokine-stimulated expression of eotaxin-3, an eosinophil chemoattractant contributing to esophageal eosinophilia in eosinophilic esophagitis (EoE). The objective of this study was to elucidate molecular mechanisms underlying PPI inhibition of IL-4-stimulated eotaxin-3 production by esophageal cells. Methods/Findings: Telomerase-immortalized and primary cultures of esophageal squamous cells from EoE patients were treated with IL-4 in the presence or absence of acid-activated omeprazole or lansoprazole. We measured eotaxin-3 protein secretion by ELISA, mRNA expression by PCR, STAT6 phosphorylation and nuclear translocation by Western blotting, eotaxin-3 promoter activation by an exogenous reporter construct, and STAT6, RNA polymerase II, and trimethylated H3K4 binding to the endogenous eotaxin-3 promoter by ChIP assay. Omeprazole in concentrations >= 5 mu M significantly decreased IL-4-stimulated eotaxin-3 protein secretion and mRNA expression. Lansoprazole also blocked eotaxin-3 protein secretion. Omeprazole had no effect on eotaxin-3 mRNA stability or on STAT6 phosphorylation and STAT6 nuclear translocation. Rather, omeprazole blocked binding of IL-4-stimulated STAT6, RNA polymerase II, and trimethylated H3K4 to the eotaxin-3 promoter. Conclusions/Significance: PPIs, in concentrations achieved in blood with conventional dosing, significantly inhibit IL-4-stimulated eotaxin-3 expression in EoE esophageal cells and block STAT6 binding to the promoter. These findings elucidate molecular mechanisms whereby patients with Th2 cytokine-driven esophageal eosinophilia can respond to PPIs, independent of effects on gastric acid secretion.	[Zhang, Xi; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Wang, David H.; Spechler, Stuart J.; Souza, Rhonda F.] Vet Affairs N Texas Hlth Care Syst, Dept Internal Med, Dallas, TX 75216 USA; [Zhang, Xi; Cheng, Edaire; Huo, Xiaofang; Yu, Chunhua; Zhang, Qiuyang; Pham, Thai H.; Wang, David H.; Spechler, Stuart J.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Pham, Thai H.] Vet Affairs N Texas Hlth Care Syst, Dept Surg, Dallas, TX USA; [Cheng, Edaire] Childrens Med Ctr, Dept Pediat, Dallas, TX 75235 USA; [Wang, David H.; Souza, Rhonda F.] Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Souza, RF (corresponding author), Vet Affairs N Texas Hlth Care Syst, Dept Internal Med, Dallas, TX 75216 USA.	rhonda.souza@utsouthwestern.edu			Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health [R01-DK63621, R01-CA134571, K12 HD-068369-01]; American Gastroenterological Association Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA134571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063621] Funding Source: NIH RePORTER	Office of Medical Research, Departments of Veterans Affairs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by the Office of Medical Research, Departments of Veterans Affairs (RFS, SJS, DHW); the National Institutes of Health (R01-DK63621 to RFS, R01-CA134571 to RFS and SJS, K12 HD-068369-01 to EC), and the American Gastroenterological Association Institute (Fellow to Faculty Transition Award to EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankers-Fulbright JL, 2004, J CELL SCI, V117, P5749, DOI 10.1242/jcs.01498; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blanchard C, 2005, INT J BIOCHEM CELL B, V37, P2559, DOI 10.1016/j.biocel.2005.06.010; CEDERBERG C, 1992, GASTROENTEROLOGY, V103, P913, DOI 10.1016/0016-5085(92)90025-T; Cheng E, 2012, GUT IN PRESS; Cortes JR, 2009, J ALLERGY CLIN IMMUN, V124, P607, DOI 10.1016/j.jaci.2009.06.023; DUBOS RJ, 1955, LANCET, V2, P1; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Furuta GT, 2007, GASTROENTEROLOGY, V133, P1342, DOI 10.1053/j.gastro.2007.08.017; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Goenka S, 2003, J BIOL CHEM, V278, P50362, DOI 10.1074/jbc.M305854200; Hebenstreit D, 2005, MOL IMMUNOL, V42, P295, DOI 10.1016/j.molimm.2004.09.004; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, P1392, DOI 10.1053/j.gastro.2008.08.044; Kahrilas PJ, 2011, GUT, V60, P1473, DOI 10.1136/gut.2011.241307; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Kurashima K, 1996, LAB INVEST, V75, P689; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Moayyedi P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001960.pub3; Molina-Infante J, 2011, CLIN GASTROENTEROL H, V9, P110, DOI 10.1016/j.cgh.2010.09.019; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ngo P, 2006, AM J GASTROENTEROL, V101, P1666, DOI 10.1111/j.1572-0241.2006.00562.x; Perez M, 2008, MOL IMMUNOL, V45, P3896, DOI 10.1016/j.molimm.2008.06.026; Shin Jai Moo, 2008, Curr Gastroenterol Rep, V10, P528, DOI 10.1007/s11894-008-0098-4; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Spechler SJ, 2007, AM J GASTROENTEROL, V102, P1301, DOI 10.1111/j.1572-0241.2007.01179.x; Tobey NA, 1998, AM J GASTROENTEROL, V93, P2075; WARD TT, 1978, AM J MED, V64, P933, DOI 10.1016/0002-9343(78)90446-1; Zhang HY, 2008, AM J PHYSIOL-GASTR L, V295, pG470, DOI 10.1152/ajpgi.90262.2008	34	118	121	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50037	10.1371/journal.pone.0050037	http://dx.doi.org/10.1371/journal.pone.0050037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185525	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000170
J	Batra, J; Robinson, J; Mehner, C; Hockla, A; Miller, E; Radisky, DC; Radisky, ES				Batra, Jyotica; Robinson, Jessica; Mehner, Christine; Hockla, Alexandra; Miller, Erin; Radisky, Derek C.; Radisky, Evette S.			PEGylation Extends Circulation Half-Life While Preserving In Vitro and In Vivo Activity of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)	PLOS ONE			English	Article							BREAST-CANCER CELLS; MATRIX METALLOPROTEINASES; TERMINAL DOMAIN; COLON-CANCER; TUMOR-CELLS; EXTRACELLULAR-MATRIX; PROTEIN THERAPEUTICS; VASCULAR-DISEASES; MASS-SPECTROMETRY; ESCHERICHIA-COLI	Excess proteolytic activity of matrix metalloproteinases (MMPs) contributes to the development of arthritis, cardiovascular diseases and cancer progression, implicating these enzymes as therapeutic targets. While many small molecule inhibitors of MMPs have been developed, clinical uses have been limited, in part by toxicity and off-target effects. Development of the endogenous tissue inhibitors of metalloproteinases (TIMPs) as recombinant biopharmaceuticals represents an alternative therapeutic approach; however, the short plasma half-life of recombinant TIMPs has restricted their potential in this arena. To overcome this limitation, we have modified recombinant human TIMP-1 (rhTIMP-1) by PEGylation on lysine residues. We analyzed a mixture of mono- and di-PEGylated rhTIMP-1 species modified by attachment of 20 kDa mPEG chains (PEG(20K)-TIMP-1), as confirmed by SELDI-TOF mass spectrometry. This preparation retained complete inhibitory activity toward the MMP-3 catalytic domain and partial inhibitory activity toward full length MMP-9. Pharmacokinetic evaluation showed that PEGylation extended the plasma half-life of rhTIMP-1 in mice from 1.1 h to 28 h. In biological assays, PEG(20K)-TIMP-1 inhibited both MMP-dependent cancer cell invasion and tumor cell associated gelatinase activity. Overall these results suggest that PEGylated TIMP-1 exhibits improved potential for development as an anti-cancer recombinant protein therapeutic, and additionally may offer potential for clinical applications in the treatment of other diseases.	[Batra, Jyotica; Robinson, Jessica; Mehner, Christine; Hockla, Alexandra; Miller, Erin; Radisky, Derek C.; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Radisky, ES (corresponding author), Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Radisky, Evette S/C-8526-2012; Radisky, Derek/B-6569-2018	Radisky, Evette S/0000-0003-3121-109X; Radisky, Derek/0000-0002-1962-8784	Florida Department of Health [08KN12, 09BB17, 1BD01]; National Cancer Institute [R01 CA122086]; Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) [P50 CA116201]; NATIONAL CANCER INSTITUTE [R01CA122086, P50CA116201] Funding Source: NIH RePORTER	Florida Department of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Florida Department of Health grants 08KN12 and 09BB17 (to ESR) and 1BD01 (to JB), National Cancer Institute grant R01 CA122086 (to DCR), and by the Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) grant P50 CA116201 (PI James Ingle). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatan OI, 2008, J AM ASSOC LAB ANIM, V47, P8; ALVAREZ OA, 1990, J NATL CANCER I, V82, P589, DOI 10.1093/jnci/82.7.589; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Bateman KP, 2001, J CHROMATOGR B, V754, P245, DOI 10.1016/S0378-4347(00)00612-5; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Black RA, 1996, BIOCHEM BIOPH RES CO, V225, P400, DOI 10.1006/bbrc.1996.1186; Brand Karsten, 2002, Current Gene Therapy, V2, P255, DOI 10.2174/1566523024605564; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098; Caterina NCM, 1997, J BIOL CHEM, V272, P32141, DOI 10.1074/jbc.272.51.32141; Chaturvedi M, 2012, NEUROPROTECTION TISS; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crombez L, 2005, BIOCHEM BIOPH RES CO, V337, P908, DOI 10.1016/j.bbrc.2005.09.136; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Durschlag M, 1996, PHYSIOL BEHAV, V60, P1565, DOI 10.1016/S0031-9384(96)00307-1; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; GOODSON RJ, 1990, BIO-TECHNOL, V8, P343, DOI 10.1038/nbt0490-343; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; HIMELSTEIN BP, 1994, J CELL SCI, V107, P477; Himelstein BP, 1996, CLIN EXP METASTAS, V14, P197; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086; ITO A, 1995, BRIT J CANCER, V71, P1039, DOI 10.1038/bjc.1995.200; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KOLKENBROCK H, 1995, BIOL CHEM H-S, V376, P495, DOI 10.1515/bchm3.1995.376.8.495; Kumagai K, 1999, J IMMUNOL, V162, P4212; Kunigal S, 2007, INT J CANCER, V121, P2307, DOI 10.1002/ijc.22962; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; KURFURST MM, 1992, ANAL BIOCHEM, V200, P244, DOI 10.1016/0003-2697(92)90460-O; KURSCHAT P, 1995, EUR J BIOCHEM, V234, P485, DOI 10.1111/j.1432-1033.1995.485_b.x; Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399; Lee MS, 2011, J PHARM PHARM SCI, V14, P368, DOI 10.18433/J3H88D; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Muroski ME, 2008, CURR PHARM BIOTECHNO, V9, P34; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Ohtani Y, 2006, ACTA MED OKAYAMA, V60, P257; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Pepinsky RB, 2002, J PHARM SCI, V91, P371, DOI 10.1002/jps.10052; Radisky ES, 2007, REV ENDOCR METAB DIS, V8, P279, DOI 10.1007/s11154-007-9037-1; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Ramachandran P, 2006, J PROTEOME RES, V5, P1493, DOI 10.1021/pr050492k; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4; Sa YL, 2011, NEUROL RES, V33, P433, DOI 10.1179/1743132810Y.0000000012; Saad S, 2000, BREAST CANCER RES TR, V63, P105, DOI 10.1023/A:1006437530169; Safina A, 2008, ONCOGENE, V27, P1198, DOI 10.1038/sj.onc.1210768; Safina A, 2007, ONCOGENE, V26, P2407, DOI 10.1038/sj.onc.1210046; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; SCHULTZ RM, 1988, CANCER RES, V48, P5539; Sela-Passwell NA, 2012, NAT MED, V18, P143, DOI 10.1038/nm.2582; Singer CF, 2002, BREAST CANCER RES TR, V72, P69, DOI 10.1023/A:1014918512569; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Stuelten CH, 2005, J CELL SCI, V118, P2143, DOI 10.1242/jcs.02334; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Szymkowski DE, 2005, CURR OPIN DRUG DISC, V8, P590; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Vandenbroucke RE, 2011, EUR RESPIR J, V38, P1200, DOI 10.1183/09031936.00027411; VANDENSTEEN PE, 2002, MOL BIOL, V37, P375; Vempati P, 2007, J BIOL CHEM, V282, P37585, DOI 10.1074/jbc.M611500200; Veronese FM, 2008, ADV DRUG DELIVER REV, V60, P1, DOI 10.1016/j.addr.2007.08.003; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yamauchi K, 2001, SURG TODAY, V31, P791, DOI 10.1007/s005950170049	76	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50028	10.1371/journal.pone.0050028	http://dx.doi.org/10.1371/journal.pone.0050028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185522	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700063
J	Imrie, HJ; Fowkes, FJI; Migot-Nabias, F; Luty, AJF; Deloron, P; Hajduk, SL; Day, KP				Imrie, Heather J.; Fowkes, Freya J. I.; Migot-Nabias, Florence; Luty, Adrian J. F.; Deloron, Philippe; Hajduk, Stephen L.; Day, Karen P.			Individual Variation in Levels of Haptoglobin-Related Protein in Children from Gabon	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TRYPANOSOME LYTIC FACTOR; UNEQUAL CROSSING-OVER; EVOLUTIONARY PRODUCT; HEMOGLOBIN; MALARIA; BINDING; DENSITY; IDENTIFICATION; LIPOPROTEINS	Background: Haptoglobin related protein (Hpr) is a key component of trypanosome lytic factors (TLF), a subset of high-density lipoproteins (HDL) that form the first line of human defence against African trypanosomes. Hpr, like haptoglobin (Hp) can bind to hemoglobin (Hb) and it is the Hpr-Hb complexes which bind to these parasites allowing uptake of TLF. This unique form of innate immunity is primate-specific. To date, there have been no population studies of plasma levels of Hpr, particularly in relation to hemolysis and a high prevalence of ahaptoglobinemia as found in malaria endemic areas. Methods and Principal Findings: We developed a specific enzyme-linked immunosorbent assay to measure levels of plasma Hpr in Gabonese children sampled during a period of seasonal malaria transmission when acute phase responses (APR), malaria infection and associated hemolysis were prevalent. Median Hpr concentration was 0.28 mg/ml (range 0.03-1.1). This was 5-fold higher than that found in Caucasian children (0.049 mg/ml, range 0.002-0.26) with no evidence of an APR. A general linear model was used to investigate associations between Hpr levels, host polymorphisms, parasitological factors and the acute phase proteins, Hp, C-reactive protein (CRP) and albumin. Levels of Hpr were associated with Hp genotype, decreased with age and were higher in females. Hpr concentration was strongly correlated with that of Hp, but not CRP. Conclusions/Significance: Individual variation in Hpr levels was related to Hp level, Hp genotype, demographics, malaria status and the APR. The strong correlations between plasma levels of Hp and Hpr suggest that they are regulated by similar mechanisms. These population-based observations indicate that a more dynamic view of the relative roles of Hpr and Hpr-Hb complexes needs to be considered in understanding innate immunity to African trypanosomes and possibly other pathogens including the newly discovered Plasmodium spp of humans and primates.	[Fowkes, Freya J. I.; Day, Karen P.] NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA; [Imrie, Heather J.; Fowkes, Freya J. I.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Migot-Nabias, Florence; Luty, Adrian J. F.; Deloron, Philippe] Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Paris, France; [Migot-Nabias, Florence; Luty, Adrian J. F.; Deloron, Philippe] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, France; [Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	New York University; University of Oxford; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University System of Georgia; University of Georgia	Day, KP (corresponding author), NYU, Sch Med, Dept Microbiol, Div Parasitol, New York, NY 10016 USA.	Karen.Day@nyumc.org	Luty, Adrian/CAH-2547-2022; Deloron, Philippe/G-6305-2010; Day, Karen/F-3697-2015	Deloron, Philippe/0000-0003-4705-2484; Day, Karen/0000-0002-6115-6135; Migot-Nabias, Florence/0000-0001-9982-594X; Fowkes, Freya/0000-0001-5832-9464; Luty, Adrian John Frederick/0000-0001-8830-3425	European Community (E.C.) [IC18-CT98-0359]; Wellcome Trust; Research Leave Fellowship from the Wellcome Trust [047069/Z/96/Z]; Wellcome Trust [041354]; National Institutes of Health [AI039099]	European Community (E.C.)(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); Research Leave Fellowship from the Wellcome Trust; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the European Community (E.C. Grant No. IC18-CT98-0359) and the Wellcome Trust. Professor Day was supported by a Research Leave Fellowship from the Wellcome Trust (047069/Z/96/Z). Dr. Imrie and Dr. Fowkes were supported by Programme Grant funding awarded to Professor Day from the Wellcome Trust (041354). The studies on TLF in the Hajduk laboratory were supported by a grant from the National Institutes of Health (AI039099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker C, 2001, MOL BIOCHEM PARASIT, V117, P129, DOI 10.1016/S0166-6851(01)00339-5; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; BOWMAN BH, 1982, ADV HUM GENET, V12, P453; Bullard W, 2012, VIRULENCE, V3, P72, DOI 10.4161/viru.3.1.18295; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Fowkes FJI, 2006, AM J TROP MED HYG, V74, P26, DOI 10.4269/ajtmh.2006.74.26; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; Harmse B, 2010, CARDIOVASC J AFR, V21, P316; Hatada S, 2003, GENE, V319, P55, DOI 10.1016/S0378-1119(03)00791-1; Jahangiri A, 2010, CURR OPIN ENDOCRINOL, V17, P156, DOI 10.1097/MED.0b013e328337278b; Kasvosve I, 2010, ADV CLIN CHEM, V50, P23, DOI 10.1016/S0065-2423(10)50002-7; Kohagne TL, 2010, AFR HEALTH SCI, V10, P341; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KUNITAKE ST, 1994, BIOCHEMISTRY-US, V33, P1988, DOI 10.1021/bi00174a003; Kushner I, 1995, ANN NY ACAD SCI, V762, P102; Lim SK, 2001, REDOX REP, V6, P219, DOI 10.1179/135100001101536364; MAEDA N, 1985, J BIOL CHEM, V260, P6698; MAEDA N, 1986, P NATL ACAD SCI USA, V83, P7395, DOI 10.1073/pnas.83.19.7395; MARLES SL, 1993, HUM GENET, V92, P364, DOI 10.1007/BF01247336; McGuire W, 1996, T ROY SOC TROP MED H, V90, P10, DOI 10.1016/S0035-9203(96)90461-7; McPherson RA, 2007, HENRYS CLIN DIAGNOSI, P237; Morrison JA, 2003, J PEDIATR-US, V142, P637, DOI 10.1067/mpd.2003.246; Muranjan M, 1998, J BIOL CHEM, V273, P3884, DOI 10.1074/jbc.273.7.3884; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Ntoumi F, 2002, IMMUNOL LETT, V84, P9, DOI 10.1016/S0165-2478(02)00131-1; Okazaki T, 1997, CLIN CHEM, V43, P2012; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; Polticelli F, 2008, FEBS J, V275, P5648, DOI 10.1111/j.1742-4658.2008.06690.x; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Ritchie RF, 2000, J CLIN LAB ANAL, V14, P284, DOI 10.1002/1098-2825(20001212)14:6<284::AID-JCLA7>3.0.CO;2-U; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; SPIEKERMAN AM, 1993, CLIN LAB MED, V13, P353, DOI 10.1016/S0272-2712(18)30443-8; TRAIL JCM, 1993, VET PARASITOL, V45, P241, DOI 10.1016/0304-4017(93)90079-3; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P430, DOI 10.1016/0035-9203(85)90053-7; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Wheeler RJ, 2010, TRENDS PARASITOL, V26, P457, DOI 10.1016/j.pt.2010.05.005; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Yano A, 1998, ACTA MED OKAYAMA, V52, P173; Young DP, 2008, J IMMUNOL, V181, P2420, DOI 10.4049/jimmunol.181.4.2420	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49816	10.1371/journal.pone.0049816	http://dx.doi.org/10.1371/journal.pone.0049816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185445	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700052
J	Saito, K; Matsumoto, S; Yasui, H; Devasahayam, N; Subramanian, S; Munasinghe, JP; Patel, V; Gutkind, JS; Mitchell, JB; Krishna, MC				Saito, Keita; Matsumoto, Shingo; Yasui, Hironobu; Devasahayam, Nallathamby; Subramanian, Sankaran; Munasinghe, Jeeva P.; Patel, Vyomesh; Gutkind, J. Silvio; Mitchell, James B.; Krishna, Murali C.			Longitudinal Imaging Studies of Tumor Microenvironment in Mice Treated with the mTOR Inhibitor Rapamycin	PLOS ONE			English	Article							MAMMALIAN TARGET; HYPERBARIC-OXYGEN; PATHWAY; CANCER; HEAD; GROWTH; VASCULATURE; ANGIOGENESIS; IRRADIATION; RESOLUTION	Rapamycin is an allosteric inhibitor of mammalian target of rapamycin, and inhibits tumor growth and angiogenesis. Recent studies suggested a possibility that rapamycin renormalizes aberrant tumor vasculature and improves tumor oxygenation. The longitudinal effects of rapamycin on angiogenesis and tumor oxygenation were evaluated in murine squamous cell carcinoma (SCCVII) by electron paramagnetic resonance imaging (EPRI) and magnetic resonance imaging (MRI) to identify an optimal time after rapamycin treatment for enhanced tumor radioresponse. Rapamycin treatment was initiated on SCCVII solid tumors 8 days after implantation (500-750 mm(3)) and measurements of tumor pO(2) and blood volume were conducted from day 8 to 14 by EPRI/MRI. Microvessel density was evaluated over the same time period by immunohistochemical analysis. Tumor blood volume as measured by MRI significantly decreased 2 days after rapamycin treatment. Tumor pO(2) levels modestly but significantly increased 2 days after rapamycin treatment; whereas, it decreased in non-treated control tumors. Furthermore, the fraction of hypoxic area (pixels with pO(2)<10 mm Hg) in the tumor region decreased 2 days after rapamycin treatments. Immunohistochemical analysis of tumor microvessel density and pericyte coverage revealed that microvessel density decreased 2 days after rapamycin treatment, but pericyte coverage did not change, similar to what was seen with anti-angiogenic agents such as sunitinib which cause vascular renormalization. Collectively, EPRI/MRI co-imaging can provide non-invasive evidence of rapamycin-induced vascular renormalization and resultant transient increase in tumor oxygenation. Improved oxygenation by rapamycin treatment provides a temporal window for anti-cancer therapies to realize enhanced response to radiotherapy.	[Saito, Keita; Matsumoto, Shingo; Yasui, Hironobu; Devasahayam, Nallathamby; Subramanian, Sankaran; Mitchell, James B.; Krishna, Murali C.] NCI, Radiat Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yasui, Hironobu] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Radiat Biol Lab, Sapporo, Hokkaido, Japan; [Munasinghe, Jeeva P.] Natl Inst Neurol Disorder & Stroke, NIH, Bethesda, MD USA; [Patel, Vyomesh; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hokkaido University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Krishna, MC (corresponding author), NCI, Radiat Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	murali@helix.nih.gov	Yasui, Hironobu/E-3794-2010; Gutkind, J. Silvio/J-1201-2016	Yasui, Hironobu/0000-0002-6757-1110; Gutkind, J. Silvio/0000-0002-5150-4482; Matsumoto, Shingo/0000-0003-2698-0839	Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558] Funding Source: NIH RePORTER	Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2008, EXPERT OPIN THER TAR, V12, P209, DOI [10.1517/14728222.12.2.209, 10.1517/14728222.12.2.209 ]; Amornphimoltham P, 2005, CANCER RES, V65, P9953, DOI 10.1158/0008-5472.CAN-05-0921; Amornphimoltham P, 2008, CANCER RES, V68, P1144, DOI 10.1158/0008-5472.CAN-07-1756; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Brader S, 2004, TUMORI J, V90, P2, DOI 10.1177/030089160409000102; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; de Lussanet QG, 2005, RADIOLOGY, V235, P65, DOI 10.1148/radiol.2351040411; Devasahayam N, 2000, J MAGN RESON, V142, P168, DOI 10.1006/jmre.1999.1926; Devasahayam N, 2007, MAGN RESON MED, V57, P776, DOI 10.1002/mrm.21194; Dharmaraj CD, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/528639; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Fokas E, 2012, CANCER RES, V72, P239, DOI 10.1158/0008-5472.CAN-11-2263; FU KK, 1984, INT J RADIAT ONCOL, V10, P1473, DOI 10.1016/0360-3016(84)90371-7; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hansen-Algenstaedt N, 2000, CANCER RES, V60, P4556; Hunter KD, 2005, NAT REV CANCER, V5, P127, DOI 10.1038/nrc1549; Hyodo F, 2009, INT J ONCOL, V35, P797, DOI 10.3892/ijo_00000392; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Lane HA, 2009, CLIN CANCER RES, V15, P1612, DOI 10.1158/1078-0432.CCR-08-2057; Lee CG, 2000, CANCER RES, V60, P5565; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Matsumoto K, 2006, MAGN RESON MED, V55, P1157, DOI 10.1002/mrm.20872; Matsumoto S, 2008, J CLIN INVEST, V118, P1965, DOI 10.1172/JCI34928; Matsumoto S, 2011, CANCER RES, V71, P6350, DOI 10.1158/0008-5472.CAN-11-2025; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Murphy JD, 2009, CLIN CANCER RES, V15, P589, DOI 10.1158/1078-0432.CCR-08-1019; Muruganandham M, 2006, MOL CANCER THER, V5, P1950, DOI 10.1158/1535-7163.MCT-06-0010; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Saito K, 2012, MAGN RESON MED, V67, P801, DOI 10.1002/mrm.23065; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Subramanian S, 2002, MAGNET RESON MED, V48, P370, DOI 10.1002/mrm.10199; SUIT HD, 1981, RADIAT RES, V87, P360, DOI 10.2307/3575590; SUIT HD, 1967, RADIOLOGY, V89, P713, DOI 10.1148/89.4.713; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yasui H, 2010, CANCER RES, V70, P6427, DOI 10.1158/0008-5472.CAN-10-1350; Zhang QB, 2011, MOL CANCER THER, V10, P1173, DOI 10.1158/1535-7163.MCT-11-0008; Zhou QY, 2008, CLIN CANCER RES, V14, P1540, DOI 10.1158/1078-0432.CCR-07-4544	42	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49456	10.1371/journal.pone.0049456	http://dx.doi.org/10.1371/journal.pone.0049456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185335	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700034
J	Van Hiel, MB; Breugelmans, B; Pagel, CN; Williams, AK; Varan, AK; Burke, R; Bowles, VM; Batterham, P				Van Hiel, Matthias B.; Breugelmans, Bert; Pagel, Charles N.; Williams, Adam K.; Varan, Aiden K.; Burke, Richard; Bowles, Vernon M.; Batterham, Philip			The Ovicidal, Larvacidal and Adulticidal Properties of 5,5 '-Dimethyl-2,2 '-Bipyridyl against Drosophila melanogaster	PLOS ONE			English	Article							HEAD LICE; INSECTICIDE RESISTANCE; SPINOSAD RESISTANCE; POPULATION; STRAIN	Insecticide resistance has limited the number of available chemical options for insect pest control. Hence there is a need for new chemistries with novel modes of action. Here we investigate the mode of action for an insecticide that has not yet been released for commercial use. The ovicidal, larvacidal and adulticidal effects of 5,5'-dimethyl-2,2'-dipyridyl (termed Ha44), which is being developed as a treatment for head lice, were evaluated in the Drosophila melanogaster model system. Ha44 demonstrated significant activity against embryos and was capable of arresting development at a number of stages of embryogenesis. The effects of Ha44 on embryos was shown to be reversible following the addition of the metal ions Fe(II) and Fe(III), Cu and Zn. When larvae were exposed to Ha44, lethality was recorded at similar concentrations to those observed for embryos. Using an eYFP reporter system it was shown that Ha44 was able to reduce the levels of both copper and zinc in the digestive tract, confirming the binding of Ha44 to these metals in vivo. Ha44 has further been shown to inhibit a zinc containing metalloproteinase in vitro. Exposure of adult flies to Ha44 resulted in lethality, but at higher concentrations than those observed for embryos and larvae. The median lethal dose in adult flies was shown to be associated with the type of exposure, with an LD-50 of 1.57 mM being recorded following the direct contact of flies with Ha44, while an LD-50 of 12.29 mM was recorded following the ingestion of the compound. The capacity of Ha44 to act on all stages of the life-cycle and potentially via a range of targets suggests that target site resistance is unlikely to evolve.	[Van Hiel, Matthias B.; Breugelmans, Bert; Williams, Adam K.; Varan, Aiden K.; Batterham, Philip] Univ Melbourne, Dept Genet, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Pagel, Charles N.; Bowles, Vernon M.] Univ Melbourne, Ctr Anim Biotechnol, Sch Vet Sci, Melbourne, Vic 3010, Australia; [Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Bowles, Vernon M.] Hatchtech Pty Ltd, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Monash University	Batterham, P (corresponding author), Univ Melbourne, Dept Genet, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.	pbatterham@unimelb.edu.au	Varan, Aiden/A-5354-2019; Batterham, Philip/G-5914-2012; Pagel, Charles N/A-8890-2014	Varan, Aiden/0000-0002-0516-0084; Batterham, Philip/0000-0001-9840-9119; Pagel, Charles N/0000-0002-7844-2242; Bowles, Vern/0000-0002-6296-2358; Burke, Richard/0000-0003-0086-0767; Van Hiel, Boris/0000-0002-6224-1745	Linkage Grant from the Australian Research Council [LP0884047]; Hatchtech Pty Ltd.	Linkage Grant from the Australian Research Council(Australian Research Council); Hatchtech Pty Ltd.	This research was supported through a Linkage Grant from the Australian Research Council (Grant LP0884047) and matching support from Hatchtech Pty Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN P, 1991, FUND CLIN PHARMACOL, V5, P39, DOI 10.1111/j.1472-8206.1991.tb00699.x; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; AULD DS, 1995, METHOD ENZYMOL, V248, P228; Bielza P, 2007, J ECON ENTOMOL, V100, P916, DOI 10.1603/0022-0493(2007)100[916:GOSRIF]2.0.CO;2; Bowles VM, 2008, PARASITOLOGY, V135, P125, DOI 10.1017/S0031182007003587; Breugelmans B, 2011, PEPTIDES, V32, P539, DOI 10.1016/j.peptides.2010.08.006; Casida JE, 2009, CHEM RES TOXICOL, V22, P609, DOI 10.1021/tx8004949; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; Downs AMR, 1999, BRIT J DERMATOL, V141, P508, DOI 10.1046/j.1365-2133.1999.03046.x; Durand R, 2012, CLIN MICROBIOL INFEC, V18, P338, DOI 10.1111/j.1469-0691.2012.03806.x; Durand R, 2011, J MED ENTOMOL, V48, P73, DOI 10.1603/ME10115; FFRENCHCONSTANT RH, 1992, MOL APPROACHES PURE, P1; Ishtiaq M, 2011, J ECON ENTOMOL, V104, P1343, DOI 10.1603/EC10383; Markussen MDK, 2012, PEST MANAG SCI, V68, P75, DOI 10.1002/ps.2223; McKenzie JA, 1998, PHILOS T ROY SOC B, V353, P1729, DOI 10.1098/rstb.1998.0325; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Pu X, 2010, PEST MANAG SCI, V66, P371, DOI 10.1002/ps.1885; Rand MD, 2010, INSECT BIOCHEM MOLEC, V40, P792, DOI 10.1016/j.ibmb.2010.07.007; ROMANS AY, 1978, BIOINORG CHEM, V9, P217, DOI 10.1016/S0006-3061(78)80007-6; Sonnberg S, 2010, OPEN DERMATOLOGY J, V4, P82; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Wang ZY, 2009, PEST MANAG SCI, V65, P1189, DOI 10.1002/ps.1808; Ware GW, 2004, INSECTICIDES PESTICI; Xu Z, 2010, J CHEM ECOL, V36, P526, DOI 10.1007/s10886-010-9785-3; Young AR, 2000, INT J PARASITOL, V30, P925, DOI 10.1016/S0020-7519(00)00073-4	27	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49961	10.1371/journal.pone.0049961	http://dx.doi.org/10.1371/journal.pone.0049961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185497	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700058
J	Wu, F; Sun, YW; Shao, Y; Xu, SJ; Liu, GY; Peng, J; Liu, LL				Wu, Fei; Sun, Yanwei; Shao, Yong; Xu, Shujuan; Liu, Guiying; Peng, Jian; Liu, Lingling			DNA Abasic Site-Selective Enhancement of Sanguinarine Fluorescence with a Large Emission Shift	PLOS ONE			English	Article							SINGLE-BASE BULGES; NUCLEOBASE RECOGNITION; BENZOPHENANTHRIDINE ALKALOIDS; STRONG BINDING; CANCER-CELLS; SEQUENCE; LIGAND; CHELERYTHRINE; DERIVATIVES; OPPOSITE	Small molecules that can specifically bind to a DNA abasic site (AP site) have received much attention due to their importance in DNA lesion identification, drug discovery, and sensor design. Herein, the AP site binding behavior of sanguinarine (SG), a natural alkaloid, was investigated. In aqueous solution, SG has a short-wavelength alkanolamine emission band and a long-wavelength iminium emission band. At pH 8.3, SG experiences a fluorescence quenching for both bands upon binding to fully matched DNAs without the AP site, while the presence of the AP site induces a strong SG binding and the observed fluorescence enhancement for the iminium band are highly dependent on the nucleobases flanking the AP site, while the alkanolamine band is always quenched. The bases opposite the AP site also exert some modifications on the SG's emission behavior. It was found that the observed quenching for DNAs with Gs and Cs flanking the AP site is most likely caused by electron transfer between the AP site-bound excited-state SG and the nearby Gs. However, the flanking As and Ts that are not easily oxidized favor the enhanced emission. This AP site-selective enhancement of SG fluorescence accompanies a band conversion in the dominate emission from the alkanolamine to iminium band thus with a large emission shift of about 170 nm. Absorption spectra, steady-state and transient-state fluorescence, DNA melting, and electrolyte experiments confirm that the AP site binding of SG occurs and the stacking interaction with the nearby base pairs is likely to prevent the converted SG iminium form from contacting with water that is thus emissive when the AP site neighbors are bases other than guanines. We expect that this fluorophore would be developed as a promising AP site binder having a large emission shift.	[Wu, Fei; Shao, Yong; Xu, Shujuan; Liu, Guiying; Peng, Jian; Liu, Lingling] Zhejiang Normal Univ, Inst Phys Chem, Jinhua, Zhejiang, Peoples R China; [Sun, Yanwei] Zhejiang Normal Univ, Chuyang Honors Coll, Jinhua, Zhejiang, Peoples R China	Zhejiang Normal University; Zhejiang Normal University	Shao, Y (corresponding author), Zhejiang Normal Univ, Inst Phys Chem, Jinhua, Zhejiang, Peoples R China.	yshao@zjnu.cn	Shao, Yong/AAL-3300-2021		National Natural Science Foundation of China [21075112]; Zhejiang Provincial Natural Science Foundation of China for Distinguished Young Scholars [LR12B05001]; Foundation of State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry [SKLEAC2010001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China for Distinguished Young Scholars; Foundation of State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry	This work was supported by the National Natural Science Foundation of China (Grant No. 21075112), the Zhejiang Provincial Natural Science Foundation of China for Distinguished Young Scholars (Grant No. LR12B05001), and the Foundation of State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry (Grant No. SKLEAC2010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2000, CLIN CANCER RES, V6, P1524; Alarcon K, 2001, BIOORG MED CHEM LETT, V11, P1855, DOI 10.1016/S0960-894X(01)00310-9; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Atsumi H, 2009, TETRAHEDRON LETT, V50, P2177, DOI 10.1016/j.tetlet.2009.02.152; Bai LP, 2008, CHEMBIOCHEM, V9, P2583, DOI 10.1002/cbic.200800256; Bai LP, 2006, BIOORGAN MED CHEM, V14, P5439, DOI 10.1016/j.bmc.2006.05.012; Bajaj N P, 1990, J Mol Recognit, V3, P48, DOI 10.1002/jmr.300030106; Belmont P, 1999, J MED CHEM, V42, P5153, DOI 10.1021/jm9901428; Benner K, 2007, EUR J ORG CHEM, V2007, P4721, DOI 10.1002/ejoc.200700207; Bowler FR, 2010, ANGEW CHEM INT EDIT, V49, P1809, DOI 10.1002/anie.200905699; Buzzeo MC, 2008, BIOCONJUGATE CHEM, V19, P2110, DOI 10.1021/bc800339y; Chaturvedi MM, 1997, J BIOL CHEM, V272, P30129, DOI 10.1074/jbc.272.48.30129; Dai Q, 2006, ANAL SCI, V22, P201, DOI 10.2116/analsci.22.201; DAS A, 1992, PHOTOCHEM PHOTOBIOL, V56, P311, DOI 10.1111/j.1751-1097.1992.tb02165.x; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Ding ZH, 2002, BIOCHEM PHARMACOL, V63, P1415, DOI 10.1016/S0006-2952(02)00902-4; Fakhari A, 2011, CHEM COMMUN, V47, P4222, DOI 10.1039/c0cc04917d; Giri P, 2007, BBA-GEN SUBJECTS, V1770, P1419, DOI 10.1016/j.bbagen.2007.05.005; Hossain M, 2012, J CHEM THERMODYN, V47, P90, DOI 10.1016/j.jct.2011.09.026; Hossain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018333; Hrbac J, 2005, ELECTROANAL, V17, P2175, DOI 10.1002/elan.200503349; Huh J, 2006, CANCER RES, V66, P3726, DOI 10.1158/0008-5472.CAN-05-4033; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jakobsen U, 2010, J AM CHEM SOC, V132, P10424, DOI 10.1021/ja102797k; Janovska M, 2010, PHYS CHEM CHEM PHYS, V12, P11335, DOI 10.1039/b925828k; Janovska M, 2009, ANAL BIOANAL CHEM, V395, P235, DOI 10.1007/s00216-009-2903-9; KE SH, 1993, NUCLEIC ACIDS RES, V21, P5137, DOI 10.1093/nar/21.22.5137; LATIMER LJP, 1995, BIOCHEM CELL BIOL, V73, P11, DOI 10.1139/o95-002; Lhomme J, 1999, BIOPOLYMERS, V52, P65, DOI 10.1002/1097-0282(1999)52:2<65::AID-BIP1>3.0.CO;2-U; Maiti M, 2002, J BIOMOL STRUCT DYN, V20, P455, DOI 10.1080/07391102.2002.10506864; MAITI M, 1983, PHOTOCHEM PHOTOBIOL, V38, P245, DOI 10.1111/j.1751-1097.1983.tb03869.x; MAITI M, 1984, INDIAN J BIOCHEM BIO, V21, P158; Maiti M, 2007, MED RES REV, V27, P649, DOI 10.1002/med.20087; Maiti Motilal, 2009, Biophys Rev, V1, P119, DOI 10.1007/s12551-009-0014-7; Marnett LJ, 2001, TRENDS GENET, V17, P214, DOI 10.1016/S0168-9525(01)02239-9; NANDI R, 1985, PHOTOCHEM PHOTOBIOL, V42, P497, DOI 10.1111/j.1751-1097.1985.tb01600.x; Sankaran NB, 2009, J PHYS CHEM B, V113, P1522, DOI 10.1021/jp808576t; Seidel CAM, 1996, J PHYS CHEM-US, V100, P5541, DOI 10.1021/jp951507c; SEN A, 1994, BIOCHEM PHARMACOL, V48, P2097, DOI 10.1016/0006-2952(94)90510-X; Wu F, 2012, ORG BIOMOL CHEM, V10, P3300, DOI 10.1039/c2ob00028h; Xu SJ, 2011, ANALYST, V136, P4480, DOI 10.1039/c1an15652g; Ye Z, 2008, CHEM COMMUN, P6588, DOI 10.1039/b816876h; Yoshimoto K, 2003, CHEM COMMUN, P2960, DOI 10.1039/b309229a; Yoshimoto K, 2003, J AM CHEM SOC, V125, P8982, DOI 10.1021/ja029786m; Zeglis BM, 2008, J AM CHEM SOC, V130, P7530, DOI 10.1021/ja801479y; Zeglis BM, 2009, BIOCHEMISTRY-US, V48, P839, DOI 10.1021/bi801885w; Zhao CX, 2006, CHEM COMMUN, P1185, DOI 10.1039/b516575j	47	25	25	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48251	10.1371/journal.pone.0048251	http://dx.doi.org/10.1371/journal.pone.0048251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185252	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700009
J	Coxon, CH; Sadler, AJ; Huo, JD; Campbell, RD				Coxon, Carmen H.; Sadler, Amanda J.; Huo, Jiandong; Campbell, R. Duncan			An Investigation of Hierachical Protein Recruitment to the Inhibitory Platelet Receptor, G6B-b	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; TREM-LIKE TRANSCRIPT-1; TYROSINE-PHOSPHATASE; NATURAL-KILLER; BINDING MOTIFS; IN-VITRO; ACTIVATION; SHP-2; IMMUNORECEPTOR; AGGREGATION	Platelet activation is regulated by both positive and negative signals. G6B-b is an inhibitory platelet receptor with an immunoreceptor tyrosine-based inhibitory motif (ITIM) and an immunoreceptor tyrosine-based switch motif (ITSM). The molecular basis of inhibition by G6B-b is currently unknown but thought to involve the SH2 domain-containing tyrosine phosphatase SHP-1. Here we show that G6B-b also associates with SHP-2, as well as SHP-1, in human platelets. Using a number of biochemical approaches, we found these interactions to be direct and that the tandem SH2 domains of SHP-2 demonstrated a binding affinity for G6B-b 100-fold higher than that of SHP-1. It was also observed that while SHP-1 has an absolute requirement for phosphorylation at both motifs to bind, SHP-2 can associate with G6B-b when only one motif is phosphorylated, with the N-terminal SH2 domain and the ITIM being most important for the interaction. A number of other previously unreported SH2 domain-containing proteins, including Syk and PLC gamma 2, also demonstrated specificity for G6B-b phosphomotifs and may serve to explain the observation that G6B-b remains inhibitory in the absence of both SHP-1 and SHP-2. In addition, the presence of dual phosphorylated G6B-b in washed human platelets can reduce the EC50 for both CRP and collagen.	[Coxon, Carmen H.; Sadler, Amanda J.; Campbell, R. Duncan] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Huo, Jiandong] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Coxon, CH (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	carmen.coxon@dpag.ox.ac.uk; duncan.campbell@dpag.ox.ac.uk	Huo, Jiandong/AAL-5945-2021	Huo, Jiandong/0000-0002-7899-1815	Medical Research Council [G0600681]; EP Abraham Cephalosporin Trust; MRC [G0600681] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EP Abraham Cephalosporin Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council grant number G0600681. The authors would also like to acknowledge the Medical Research Council and the EP Abraham Cephalosporin Trust for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Becker-Hapak M, 2003, CURR PROTOC CELL BIO; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Cicmil M, 2002, BLOOD, V99, P137, DOI 10.1182/blood.V99.1.137; Clarkson NG, 2009, J BIOL CHEM, V284, P24725, DOI 10.1074/jbc.M109.028209; DAERON M, 1995, J CLIN INVEST, V95, P577, DOI 10.1172/JCI117701; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; de Vet ECJM, 2001, J BIOL CHEM, V276, P42070, DOI 10.1074/jbc.M103214200; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Gibbins JM, 2002, TRENDS CARDIOVAS MED, V12, P213, DOI 10.1016/S1050-1738(02)00164-0; Giomarelli B, 2007, THROMB HAEMOSTASIS, V97, P955, DOI 10.1160/TH06-08-0456; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Hassan NJ, 2004, EUR J IMMUNOL, V34, P930, DOI 10.1002/eji.200424856; Henshall TL, 2001, J IMMUNOL, V166, P3098, DOI 10.4049/jimmunol.166.5.3098; Hua CT, 1998, J BIOL CHEM, V273, P28332, DOI 10.1074/jbc.273.43.28332; Hughan SC, 2007, ARTERIOSCL THROM VAS, V27, P422, DOI 10.1161/01.ATV.0000252826.96134.21; Jackson DE, 1997, J BIOL CHEM, V272, P24868, DOI 10.1074/jbc.272.40.24868; Jackson DE, 1997, J BIOL CHEM, V272, P6986, DOI 10.1074/jbc.272.11.6986; Lewandrowski U, 2009, BLOOD, V114, pE10, DOI 10.1182/blood-2009-02-203828; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Moraes LA, 2010, J THROMB HAEMOST; Mori J, 2008, J BIOL CHEM; Newland SA, 2007, BLOOD, V109, P4806, DOI 10.1182/blood-2006-09-047449; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Pumphrey NJ, 1999, FEBS LETT, V450, P77, DOI 10.1016/S0014-5793(99)00446-9; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Tskvitaria-Fuller I, 2007, J IMMUNOL METHODS, V319, P64, DOI 10.1016/j.jim.2006.10.017; Tucker KL, 2009, PROTEOMICS, V9, P4340, DOI 10.1002/pmic.200900024; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; Washington AV, 2009, J CLIN INVEST, V119, P1489, DOI 10.1172/JCI36175	34	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49543	10.1371/journal.pone.0049543	http://dx.doi.org/10.1371/journal.pone.0049543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185356	gold, Green Published, Green Submitted			2022-12-25	WOS:000311333800032
J	Moore, M; Berejikian, BA; Tezak, EP				Moore, Megan; Berejikian, Barry A.; Tezak, Eugene P.			Variation in the Early Marine Survival and Behavior of Natural and Hatchery-Reared Hood Canal Steelhead	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-KISUTCH; COHO SALMON; WILD POPULATIONS; PUGET-SOUND; GROWTH; SMOLTS; MYKISS; RIVER; PACIFIC; SUPPLEMENTATION	Background: Hatchery-induced selection and direct effects of the culture environment can both cause captively bred fish populations to survive at low rates and behave unnaturally in the wild. New approaches to fish rearing in conservation hatcheries seek to reduce hatchery-induced selection, maintain genetic resources, and improve the survival of released fish. Methodology/Principal Findings: This study used acoustic telemetry to compare three years of early marine survival estimates for two wild steelhead populations to survival of two populations raised at two different conservation hatcheries located within the Hood Canal watershed. Steelhead smolts from one conservation hatchery survived with probabilities similar to the two wild populations (freshwater: 95.8-96.9%, early marine: 10.0-15.9%), while smolts from the other conservation hatchery exhibited reduced freshwater and early marine survival (freshwater: 50.2-58.7%, early marine: 2.6-5.1%). Freshwater and marine travel rates did not differ significantly between wild and hatchery individuals from the same stock, though hatchery smolts did display reduced migration ranges within Hood Canal. Between-hatchery differences in rearing density and vessel geometry likely affected survival and behavior after release and contributed to greater variation between hatcheries than between wild populations. Conclusions/Significance: Our results suggest that hatchery-reared smolts can achieve early marine survival rates similar to wild smolt survival rates, and that migration performance of hatchery-reared steelhead can vary substantially depending on the environmental conditions and practices employed during captivity.	[Moore, Megan; Berejikian, Barry A.; Tezak, Eugene P.] Natl Ocean & Atmospher Adm Fisheries, NW Fisheries Sci Ctr, Manchester Res Lab, Washington, DC USA	National Oceanic Atmospheric Admin (NOAA) - USA	Moore, M (corresponding author), Natl Ocean & Atmospher Adm Fisheries, NW Fisheries Sci Ctr, Manchester Res Lab, Washington, DC USA.	megan.moore@noaa.gov		Berejikian, Barry/0000-0003-2933-7806				Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Banks JL, 1990, FNWC187 NOAA NW FISH, V187; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Beckman BR, 1999, T AM FISH SOC, V128, P1125, DOI 10.1577/1548-8659(1999)128&lt;1125:GSASTA&gt;2.0.CO;2; Berejikian BA, 1996, CAN J FISH AQUAT SCI, V53, P2004, DOI 10.1139/cjfas-53-9-2004; Berejikian BA, 2004, PROPAGATED FISH RESO, P253; Berejikian BA, 2012, ENVIRON BIOL FISH, V94, P29, DOI 10.1007/s10641-011-9788-0; Brockmark S, 2010, P ROY SOC B-BIOL SCI, V277, P3035, DOI 10.1098/rspb.2010.0561; Brockmark S, 2010, CAN J FISH AQUAT SCI, V67, P288, DOI 10.1139/F09-185; Burnham K. P., 1998, MODEL SELECTION INFE; Chittenden CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012261; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Duffy EJ, 2011, CAN J FISH AQUAT SCI, V68, P232, DOI 10.1139/F10-144; FISHER JP, 1988, CAN J FISH AQUAT SCI, V45, P1036, DOI 10.1139/f88-127; Flagg TA, 2004, AM FISH S S, V44, P387; FLEMING IA, 1992, AQUACULTURE, V103, P101, DOI 10.1016/0044-8486(92)90405-A; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Hard JJ, 2000, ENVIRON BIOL FISH, V58, P61, DOI 10.1023/A:1007646332666; Hill MS, 2006, CAN J FISH AQUAT SCI, V63, P1627, DOI 10.1139/F06-061; Hulett PL, 2004, AM FISH S S, V44, P253; Johnson SL, 2010, N AM J FISH MANAGE, V30, P55, DOI 10.1577/M08-224.1; Kostow KE, 2004, CAN J FISH AQUAT SCI, V61, P577, DOI [10.1139/f04-019, 10.1139/F04-019]; Laake J., 2022, MARK, P109; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lorenzen K, 2012, BIOL REV, P000; Melnychuk M.C., 2009, THESIS U BRIT COLUMB; Melnychuk MC, 2007, HYDROBIOLOGIA, V582, P55, DOI 10.1007/s10750-006-0541-1; Moore ME, 2010, T AM FISH SOC, V139, P49, DOI 10.1577/T09-012.1; Naish KA, 2008, ADV MAR BIOL, V53, P61, DOI 10.1016/S0065-2881(07)53002-6; Paquet PJ, 2011, FISHERIES, V36, P547, DOI 10.1080/03632415.2011.626661; PARKER RR, 1968, J FISH RES BOARD CAN, V25, P757, DOI 10.1139/f68-068; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Piper R.G., 1982, FISH HATCHERY MANAGE, V1st ed.; Poole WR, 2003, AQUACULTURE, V222, P301, DOI 10.1016/S0044-8486(03)00129-7; Rohlf FJ., 2011, BIOMETRY PRINCIPLES; Scordino J, 1993, SEA LION STEELHEAD C; Scott JB, 2008, ONCHORHYNCHUS MYKISS; SIGHOLT T, 1995, AQUACULTURE, V130, P373, DOI 10.1016/0044-8486(94)00349-S; Small MP, 2009, CAN J FISH AQUAT SCI, V66, P1216, DOI 10.1139/F09-068; SWAIN DP, 1991, CAN J FISH AQUAT SCI, V48, P1783, DOI 10.1139/f91-210; Tackley S, 2008, PINNIPED PREDATION A; Toft JD, 2007, N AM J FISH MANAGE, V27, P465, DOI 10.1577/M05-158.1; Waples RS, 2007, REV-METHODS TECHNOL, V6, P383; WARD BR, 1990, T AM FISH SOC, V119, P492, DOI 10.1577/1548-8659(1990)119<0492:ROPSFR>2.3.CO;2; Welch DW, 2011, P NATL ACAD SCI USA, V108, P8708, DOI 10.1073/pnas.1014044108; Welch DW, 2000, FISH OCEANOGR, V9, P17; Welch DW, 2004, DEEP SEA RES 2, V51, P987; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	50	24	25	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49645	10.1371/journal.pone.0049645	http://dx.doi.org/10.1371/journal.pone.0049645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185393	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800045
J	Zhao, XL; Moloughney, JG; Zhang, S; Komazaki, S; Weisleder, N				Zhao, Xiaoli; Moloughney, Joseph G.; Zhang, Sai; Komazaki, Shinji; Weisleder, Noah			Orai1 Mediates Exacerbated Ca2+ Entry in Dystrophic Skeletal Muscle	PLOS ONE			English	Article							OPERATED CALCIUM-ENTRY; LOW MYOPLASMIC MG2+; SARCOPLASMIC-RETICULUM; MDX MOUSE; LEAK CHANNELS; DEPENDENT PROTEOLYSIS; MUSCULAR-DYSTROPHY; ELEVATED LEVELS; STORE; CALPAIN	There is substantial evidence indicating that disruption of Ca2+ homeostasis and activation of cytosolic proteases play a key role in the pathogenesis and progression of Duchenne Muscular Dystrophy (DMD). However, the exact nature of the Ca2+ deregulation and the Ca2+ signaling pathways that are altered in dystrophic muscles have not yet been resolved. Here we examined the contribution of the store-operated Ca2+ entry (SOCE) for the pathogenesis of DMD. RT-PCR and Western blot found that the expression level of Orai1, the pore-forming unit of SOCE, was significantly elevated in the dystrophic muscles, while parallel increases in SOCE activity and SR Ca2+ storage were detected in adult mdx muscles using Fura-2 fluorescence measurements. High-efficient shRNA probes against Orai1 were delivered into the flexor digitorum brevis muscle in live mice and knockdown of Orai1 eliminated the differences in SOCE activity and SR Ca2+ storage between the mdx and wild type muscle fibers. SOCE activity was repressed by intraperitoneal injection of BTP-2, an Orai1 inhibitor, and cytosolic calpain1 activity in single muscle fibers was measured by a membrane-permeable calpain substrate. We found that BTP-2 injection for 2 weeks significantly reduced the cytosolic calpain1 activity in mdx muscle fibers. Additionally, ultrastructural changes were observed by EM as an increase in the number of triad junctions was identified in dystrophic muscles. Compensatory changes in protein levels of SERCA1, TRP and NCX3 appeared in the mdx muscles, suggesting that comprehensive adaptations occur following altered Ca2+ homeostasis in mdx muscles. Our data indicates that upregulation of the Orai1-mediated SOCE pathway and an overloaded SR Ca2+ store contributes to the disrupted Ca2+ homeostasis in mdx muscles and is linked to elevated proteolytic activity, suggesting that targeting Orai1 activity may be a promising therapeutic approach for the prevention and treatment of muscular dystrophy.	[Zhao, Xiaoli; Moloughney, Joseph G.; Zhang, Sai; Weisleder, Noah] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Zhao, Xiaoli] Ohio State Univ, Coll Pharm, Div Pharmacol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Komazaki, Shinji] Saitama Med Univ, Dept Anat, Saitama, Japan; [Weisleder, Noah] Ohio State Univ, Dept Physiol & Cell Biol, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Ohio; Ohio State University; Saitama Medical University; University System of Ohio; Ohio State University	Zhao, XL (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	zhao.1028@osu.edu; noah.weisleder@osumc.edu	Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088	NIH/NIAMS [AR054793]; American Heart Association National scientist development grant [10SDG2630086]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR054793, K99AR054793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); American Heart Association National scientist development grant(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a NIH/NIAMS grant (AR054793) to NW and an American Heart Association National scientist development grant to XZ (10SDG2630086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Badalamente MA, 2000, MUSCLE NERVE, V23, P106, DOI 10.1002/(SICI)1097-4598(200001)23:1<106::AID-MUS14>3.0.CO;2-D; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Briguet A, 2008, FASEB J, V22, P4190, DOI 10.1096/fj.07-099036; Brinkmeier H, 2011, ADV EXP MED BIOL, V704, P749, DOI 10.1007/978-94-007-0265-3_39; Brotto MAP, 2004, CELL RES, V14, P373, DOI 10.1038/sj.cr.7290237; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Chen M, 2005, BIOCHEM BIOPH RES CO, V330, P714, DOI 10.1016/j.bbrc.2005.03.029; Chen M, 2004, BIOCHEM BIOPH RES CO, V316, P332, DOI 10.1016/j.bbrc.2004.02.052; Collet C, 2004, BIOPHYS J, V87, P268, DOI 10.1529/biophysj.103.039305; Constantin B, 2006, J MUSCLE RES CELL M, V27, P375, DOI 10.1007/s10974-006-9085-2; CULLEN MJ, 1988, ACTA NEUROPATHOL, V77, P69, DOI 10.1007/BF00688245; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Edwards JN, 2010, AM J PHYSIOL-CELL PH, V299, pC42, DOI 10.1152/ajpcell.00524.2009; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; Gailly P, 2007, J PHYSIOL-LONDON, V582, P1261, DOI 10.1113/jphysiol.2007.132191; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Goonasekera SA, J CLIN INVEST; Hoffman E P, 1992, Biotechnology, V24, P457; Hopf F. W., 2007, V45, P429; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JACQUEMOND V, 1992, J GEN PHYSIOL, V100, P115, DOI 10.1085/jgp.100.1.115; JACQUEMOND V, 1992, J GEN PHYSIOL, V100, P137, DOI 10.1085/jgp.100.1.137; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Lynch GS, 2000, AM J PHYSIOL-CELL PH, V279, pC1290, DOI 10.1152/ajpcell.2000.279.4.C1290; Ma JJ, 2003, CELL CALCIUM, V33, P375, DOI 10.1016/S0143-4160(03)00050-2; Ma JJ, 2003, FRONT BIOSCI-LANDMRK, V8, pD242, DOI 10.2741/977; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; Mallouk N, 2002, BIOPHYS J, V82, P3012, DOI 10.1016/S0006-3495(02)75642-7; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Nagaraj RY, 2000, PHYSIOL GENOMICS, V4, P43, DOI 10.1152/physiolgenomics.2000.4.1.43; OBERC MA, 1977, LAB INVEST, V36, P566; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Perronnet C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/849426; Phillips MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004571.pub2; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Robin G, 2012, J GEN PHYSIOL, V139, P209, DOI 10.1085/jgp.201110738; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; TAKAGI A, 1992, J NEUROL SCI, V110, P160, DOI 10.1016/0022-510X(92)90023-E; Thornton AM, 2011, AGING-US, V3, P621, DOI 10.18632/aging.100335; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Touchberry CD, 2011, BIOCHEM BIOPH RES CO, V416, P45, DOI 10.1016/j.bbrc.2011.10.133; Ueyama H, 1998, J NEUROL SCI, V155, P163, DOI 10.1016/S0022-510X(97)00309-2; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wadosky KM, 2011, MUSCLE NERVE, V44, P553, DOI 10.1002/mus.22125; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao XL, 2008, AGING CELL, V7, P561, DOI 10.1111/j.1474-9726.2008.00408.x; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005	73	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49862	10.1371/journal.pone.0049862	http://dx.doi.org/10.1371/journal.pone.0049862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185465	Green Published, gold			2022-12-25	WOS:000311333800057
J	Gehlert, S; Bungartz, G; Willkomm, L; Korkmaz, Y; Pfannkuche, K; Schiffer, T; Bloch, W; Suhr, F				Gehlert, Sebastian; Bungartz, Gerd; Willkomm, Lena; Korkmaz, Yueksel; Pfannkuche, Kurt; Schiffer, Thorsten; Bloch, Wilhelm; Suhr, Frank			Intense Resistance Exercise Induces Early and Transient Increases in Ryanodine Receptor 1 Phosphorylation in Human Skeletal Muscle	PLOS ONE			English	Article							CALCIUM-RELEASE; FATIGUE; FIBERS; RECRUITMENT; ACTIVATION; EXPRESSION; PLASTICITY; VOLUNTARY; RESPONSES; CHANNELS	Background: While ryanodine receptor 1 (RyR1) critically contributes to skeletal muscle contraction abilities by mediating Ca(2+)ion oscillation between sarcoplasmatic and myofibrillar compartments, AMP-activated protein kinase (AMPK) senses contraction-induced energetic stress by phosphorylation at Thr(172). Phosphorylation of RyR1 at serine(2843) (pRyR1Ser(2843)) results in leaky RyR1 channels and impaired Ca2+ homeostasis. Because acute resistance exercise exerts decreased contraction performance in skeletal muscle, preceded by high rates of Ca2+-oscillation and energetic stress, intense myofiber contractions may induce increased RyR1 and AMPK phosphorylation. However, no data are available regarding the time-course and magnitude of early RyR1 and AMPK phosphorylation in human myofibers in response to acute resistance exercise. Purpose: Determine the effects and early time-course of resistance exercise on pRyR1Ser(2843) and pAMPKThr(172) in type I and II myofibers. Methods: 7 male subjects (age 23 +/- 2 years, height: 185 +/- 7 cm, weight: 82 +/- 5 kg) performed 3 sets of 8 repetitions of maximum eccentric knee extensions. Muscle biopsies were taken at rest, 15, 30 and 60 min post exercise. pRyR1Ser(2843) and pAMPKThr(172) levels were determined by western blot and semi-quantitative immunohistochemistry techniques. Results: While total RyR1 and total AMPK levels remained unchanged, RyR1 was significantly more abundant in type II than type I myofibers. pRyR1Ser(2843) increased 15 min and peaked 30 min (p<0.01) post exercise in both myofiber types. Type I fibers showed relatively higher increases in pRyR1Ser(2843) levels than type II myofibers and remained elevated up to 60 min post resistance exercise (p<0.05). pAMPKThr(172) also increased 15 to 30 min post exercise (p<0.01) in type I and II myofibers and in whole skeletal muscle. Conclusion: Resistance exercise induces acutely increased pRyR1Ser(2843) and concomitantly pAMPKThr(172) levels for up to 30 min in resistance exercised myofibers. This provides a time-course by which pRyR1Ser(2843) can mechanistically impact Ca2+ handling properties and consequently induce reduced myofiber contractility beyond immediate fatiguing mechanisms.	[Gehlert, Sebastian; Bungartz, Gerd; Willkomm, Lena; Bloch, Wilhelm; Suhr, Frank] German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Dept Mol & Cellular Sport Med, Cologne, Germany; [Korkmaz, Yueksel] Univ Dusseldorf, Dept Operat Dent Periodont & Endodont, D-40225 Dusseldorf, Germany; [Pfannkuche, Kurt] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany; [Schiffer, Thorsten] German Sport Univ Cologne, Outpatient Clin Sportstraumatol, Cologne, Germany; [Gehlert, Sebastian; Willkomm, Lena; Bloch, Wilhelm; Suhr, Frank] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany	German Sport University Cologne; Heinrich Heine University Dusseldorf; University of Cologne; German Sport University Cologne; German Sport University Cologne	Gehlert, S (corresponding author), German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Dept Mol & Cellular Sport Med, Cologne, Germany.	Gehlert@dshs-koeln.de	Gehlert, Sebastian/AAU-7086-2021; Suhr, Frank/AAU-5080-2021; Gehlert, Sebastian/P-7687-2016	Gehlert, Sebastian/0000-0001-6940-3084; Pfannkuche, Kurt Paul/0000-0002-4284-774X; Suhr, Frank/0000-0002-9013-3944	Federal Institute of Sports Science (BISp) [IIA1-507 070103/09-10]	Federal Institute of Sports Science (BISp)	This investigation was funded by the Federal Institute of Sports Science (BISp) IIA1-507 070103/09-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen DG, 2008, J APPL PHYSIOL, V104, P296, DOI 10.1152/japplphysiol.00908.2007; Altenburg TM, 2007, J APPL PHYSIOL, V103, P1752, DOI 10.1152/japplphysiol.00496.2007; Atherton PJ, 2005, FASEB J, V19, P786, DOI 10.1096/fj.04-2179fje; Baker JS, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/905612; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Beltman JGM, 2004, EUR J APPL PHYSIOL, V92, P485, DOI 10.1007/s00421-004-1105-6; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; BIGLANDRITCHIE B, 1979, EXP NEUROL, V64, P414, DOI 10.1016/0014-4886(79)90280-2; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; BIGLANDRITCHIE B, 1986, ACTA PHYSIOL SCAND, V128, P137; Bruton JD, 1998, ACTA PHYSIOL SCAND, V162, P285, DOI 10.1046/j.1365-201X.1998.0292f.x; CHASIOTIS D, 1983, ACTA PHYSIOL SCAND, P1; Chin ER, 2004, P NUTR SOC, V63, P279, DOI 10.1079/PNS2004335; Choi SJ, 2009, J APPL PHYSIOL, V107, P1156, DOI 10.1152/japplphysiol.00403.2009; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; EDWARDS RHT, 1977, J PHYSIOL-LONDON, V272, P769, DOI 10.1113/jphysiol.1977.sp012072; Gehlert S, 2010, LYMPHAT RES BIOL, V8, P165, DOI 10.1089/lrb.2009.0035; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Godin R, 2010, J PHYSIOL-LONDON, V588, P4073, DOI 10.1113/jphysiol.2010.195925; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Lee-Young RS, 2009, J APPL PHYSIOL, V107, P283, DOI 10.1152/japplphysiol.91208.2008; Munch G, 2001, CIRCULATION, V103, P2739; PLAUGHER G, 1991, J MANIP PHYSIOL THER, V14, P503; Rose AJ, 2006, J PHYSIOL-LONDON, V574, P889, DOI 10.1113/jphysiol.2006.111757; Sahlin K, 1997, AM J PHYSIOL-CELL PH, V273, pC172, DOI 10.1152/ajpcell.1997.273.1.C172; Salanova M, 2008, HISTOCHEM CELL BIOL, V130, P105, DOI 10.1007/s00418-008-0399-6; Serrano AL, 2001, P NATL ACAD SCI USA, V98, P13108, DOI 10.1073/pnas.231148598; Westerblad H, 1997, J GEN PHYSIOL, V109, P385, DOI 10.1085/jgp.109.3.385; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163	36	31	31	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49326	10.1371/journal.pone.0049326	http://dx.doi.org/10.1371/journal.pone.0049326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173055	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300029
J	Glas, MS; Fabricius, KE; de Beer, D; Uthicke, S				Glas, Martin S.; Fabricius, Katharina E.; de Beer, Dirk; Uthicke, Sven			The O-2, pH and Ca2+ Microenvironment of Benthic Foraminifera in a High CO2 World	PLOS ONE			English	Article							DIFFUSIVE BOUNDARY-LAYERS; OCEAN ACIDIFICATION; INORGANIC CARBON; OXYGEN-UPTAKE; SEA-WATER; CALCIFICATION; PHOTOSYNTHESIS; SEAWATER; RESPIRATION; ACQUISITION	Ocean acidification (OA) can have adverse effects on marine calcifiers. Yet, phototrophic marine calcifiers elevate their external oxygen and pH microenvironment in daylight, through the uptake of dissolved inorganic carbon (DIC) by photosynthesis. We studied to which extent pH elevation within their microenvironments in daylight can counteract ambient seawater pH reductions, i.e. OA conditions. We measured the O-2 and pH microenvironment of four photosymbiotic and two symbiont-free benthic tropical foraminiferal species at three different OA treatments (similar to 432, 1141 and 2151 mu atm pCO(2)). The O-2 concentration difference between the seawater and the test surface (Delta O-2) was taken as a measure for the photosynthetic rate. Our results showed that O-2 and pH levels were significantly higher on photosymbiotic foraminiferal surfaces in light than in dark conditions, and than on surfaces of symbiont-free foraminifera. Rates of photosynthesis at saturated light conditions did not change significantly between OA treatments (except in individuals that exhibited symbiont loss, i.e. bleaching, at elevated pCO(2)). The pH at the cell surface decreased during incubations at elevated pCO(2), also during light incubations. Photosynthesis increased the surface pH but this increase was insufficient to compensate for ambient seawater pH decreases. We thus conclude that photosynthesis does only partly protect symbiont bearing foraminifera against OA.	[Glas, Martin S.; de Beer, Dirk] Max Planck Inst Marine Microbiol, Biogeochem Dept, Microsensor Grp, Bremen, Germany; [Glas, Martin S.; Fabricius, Katharina E.; Uthicke, Sven] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Max Planck Society; Australian Institute of Marine Science	Glas, MS (corresponding author), Max Planck Inst Marine Microbiol, Biogeochem Dept, Microsensor Grp, Bremen, Germany.	mglas@mpi-bremen.de	Fabricius, Katharina E/F-1759-2010; de Beer, Dirk/L-4840-2013; Uthicke, Sven/F-1810-2010	Fabricius, Katharina E/0000-0001-7671-4358; de Beer, Dirk/0000-0001-5274-1781; Uthicke, Sven/0000-0002-3476-6595	German BMBF Project BioAcid [03F0608C]; Max Planck Institute for Marine Microbiology (MPI); Australian Institute of Marine Science (AIMS)	German BMBF Project BioAcid(Federal Ministry of Education & Research (BMBF)); Max Planck Institute for Marine Microbiology (MPI); Australian Institute of Marine Science (AIMS)	This project was funded by the German BMBF Project BioAcid (03F0608C), the Max Planck Institute for Marine Microbiology (MPI), and the Australian Institute of Marine Science (AIMS), who are thanked for their continuous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2008, MOL BIOL CELL, P879; Allison N, 2010, CHEM GEOL, V274, P87, DOI 10.1016/j.chemgeo.2010.03.019; AMMANN D, 1987, PFLUG ARCH EUR J PHY, V409, P223, DOI 10.1007/BF00583469; Amoroso G, 1998, PLANT PHYSIOL, V116, P193, DOI 10.1104/pp.116.1.193; ANGELL R W, 1979, Journal of Foraminiferal Research, V9, P341; ANGELL R W, 1980, Journal of Foraminiferal Research, V10, P89; ANGELL RW, 1967, J PROTOZOOL, V14, P566, DOI 10.1111/j.1550-7408.1967.tb02043.x; Bentov S, 2009, P NATL ACAD SCI USA, V106, P21500, DOI 10.1073/pnas.0906636106; BERNER RA, 1975, GEOCHIM COSMOCHIM AC, V39, P489, DOI 10.1016/0016-7037(75)90102-7; BOWES G, 1993, ANNU REV PLANT PHYS, V44, P309, DOI 10.1146/annurev.pp.44.060193.001521; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; Buxton L, 2009, J PHYCOL, V45, P357, DOI 10.1111/j.1529-8817.2009.00659.x; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; de Beer D, 2000, MAR ECOL PROG SER, V194, P75, DOI 10.3354/meps194075; De Beer D, 2001, PLANT CELL ENVIRON, V24, P1209, DOI 10.1046/j.1365-3040.2001.00772.x; De Beer D., 2000, IN SITU MONITORING A, P161; Dias BB, 2010, J GEOL SOC LONDON, V167, P843, DOI 10.1144/0016-76492010-050; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Dissard D, 2010, BIOGEOSCIENCES, V7, P81, DOI 10.5194/bg-7-81-2010; Dolan JR, 1997, MAR GEOL, V139, P109, DOI 10.1016/S0025-3227(96)00106-5; Doney SC, 2007, ANNU REV ENV RESOUR, V32, P31, DOI 10.1146/annurev.energy.32.041706.124700; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Fujita K, 2011, BIOGEOSCIENCES, V8, P2089, DOI 10.5194/bg-8-2089-2011; Gattuso JP, 2000, NATURE, V407, P311, DOI 10.1038/35030280; Glas MS, 2012, J EXP MAR BIOL ECOL, V424, P53, DOI 10.1016/j.jembe.2012.05.006; Glud RN, 1996, MAR ECOL PROG SER, V140, P217, DOI 10.3354/meps140217; Goiran C, 1996, J EXP MAR BIOL ECOL, V199, P207, DOI 10.1016/0022-0981(95)00201-4; Goldstein ST, 1999, MODERN FORAMINIFERA, P37; Gran G, 1952, OCEANOL ACTA, V5, P209; GUNDERSEN JK, 1990, NATURE, V345, P604, DOI 10.1038/345604a0; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Hallock P., 2011, BIOGEOSCIENCES DISCU, V8, P9165, DOI DOI 10.5194/BGD-8-9165-2011; Hallock Pamela, 2006, Anuario do Instituto de Geociencias, V29, P108; Haynert K, 2012, BIOGEOSCIENCES DISCU, V9, P7783; Haynert K, 2011, MAR ECOL PROG SER, V432, P53, DOI 10.3354/meps09138; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Hofmann AF, 2010, MAR CHEM, V121, P246, DOI 10.1016/j.marchem.2010.05.004; Hohenegger J, 2004, J FORAMIN RES, V34, P9, DOI 10.2113/0340009; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jokiel PL, 2011, J EXP MAR BIOL ECOL, V409, P1, DOI 10.1016/j.jembe.2011.10.008; JORGENSEN BB, 1990, LIMNOL OCEANOGR, V35, P1343, DOI 10.4319/lo.1990.35.6.1343; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P111, DOI 10.4319/lo.1985.30.1.0111; Koehler-Rink S, 2005, MARINE BIOL RES, V1, P1745; Kohler-Rink S, 2000, MAR BIOL, V137, P473, DOI 10.1007/s002270000335; Kohn SF, 2008, MAR BIOL, V154, P109, DOI 10.1007/s00227-008-0904-4; Kuhn SF, 2008, PHOTOSYNTH RES, V95, P37, DOI 10.1007/s11120-007-9221-x; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Kuroyanagi A, 2009, MAR MICROPALEONTOL, V73, P190, DOI 10.1016/j.marmicro.2009.09.003; Le Cadre V, 2003, J FORAMIN RES, V33, P1, DOI 10.2113/0330001; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; Nobes K, 2008, RES REPORT; Pierrot D., 2006, ORNLCDIAC105A US DEP; PLUMMER LN, 1974, AM J SCI, V274, P61, DOI 10.2475/ajs.274.1.61; Polerecky L, 2007, ENVIRON MICROBIOL, V9, P2007, DOI 10.1111/j.1462-2920.2007.01317.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Raven JA, 1997, ADV BOT RES, V27, P85; Reisinger A, 2007, IPCC CLIMATE CHANGE, P73; REVSBECH NP, 1986, ADV MICROB ECOL, V9, P293; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rink S, 1998, MAR BIOL, V131, P583, DOI 10.1007/s002270050350; ROSS CA, 1972, J PROTOZOOL, V19, P181, DOI 10.1111/j.1550-7408.1972.tb03433.x; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; ROTTGER R, 1974, MAR BIOL, V26, P5, DOI 10.1007/BF00389081; Ryle V.D., 1981, AIMS OCEANOGRAPHY SE, P24; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schmidt C, 2011, LIMNOL OCEANOGR, V56, P1587, DOI 10.4319/lo.2011.56.5.1587; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; TERKUILE B, 1989, MAR BIOL, V103, P241, DOI 10.1007/BF00543354; TERKUILE B, 1989, MAR BIOL, V103, P253, DOI 10.1007/BF00543355; Uhle ME, 1999, LIMNOL OCEANOGR, V44, P1968, DOI 10.4319/lo.1999.44.8.1968; Uthicke S, 2011, CORAL REEFS, P1; Uthicke S, 2008, ESTUAR COAST SHELF S, V78, P763, DOI 10.1016/j.ecss.2008.02.014; Uthicke S, 2012, GLOBAL CHANGE BIOL, V18, P2781, DOI 10.1111/j.1365-2486.2012.02715.x; Vogel N, 2012, J EXP MAR BIOL ECOL, V424, P15, DOI 10.1016/j.jembe.2012.05.008; WILLIAMS PJL, 1991, J PLANKTON RES, V13, pS153; Wolf-Gladrow DA, 1999, MAR CHEM, V64, P181, DOI 10.1016/S0304-4203(98)00074-7; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Ziegler M, 2011, J EXP MAR BIOL ECOL, V407, P70, DOI 10.1016/j.jembe.2011.07.009	88	37	37	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e50010	10.1371/journal.pone.0050010	http://dx.doi.org/10.1371/journal.pone.0050010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166810	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000311272300082
J	Zhan, Q; Fang, YP; He, YQ; Liu, HX; Fang, JW; Wan, YJY				Zhan, Qi; Fang, Yaping; He, Yuqi; Liu, Hui-Xin; Fang, Jianwen; Wan, Yu-Jui Yvonne			Function Annotation of Hepatic Retinoid x Receptor alpha Based on Genome-Wide DNA Binding and Transcriptome Profiling	PLOS ONE			English	Article							ACTIVATED RECEPTOR; MOUSE-LIVER; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; DEFICIENT MICE; SIGNALING PATHWAYS; GENE-EXPRESSION; GROWTH-FACTOR; TARGET GENE; FATTY-ACID	Background: Retinoid x receptor alpha (RXR alpha) is abundantly expressed in the liver and is essential for the function of other nuclear receptors. Using chromatin immunoprecipitation sequencing and mRNA profiling data generated from wild type and RXR alpha-null mouse livers, the current study identifies the bona-fide hepatic RXR alpha targets and biological pathways. In addition, based on binding and motif analysis, the molecular mechanism by which RXR alpha regulates hepatic genes is elucidated in a high-throughput manner. Principal Findings: Close to 80% of hepatic expressed genes were bound by RXR alpha, while 16% were expressed in an RXR alpha-dependent manner. Motif analysis predicted direct repeat with a spacer of one nucleotide as the most prevalent RXR alpha binding site. Many of the 500 strongest binding motifs overlapped with the binding motif of specific protein 1. Biological functional analysis of RXR alpha-dependent genes revealed that hepatic RXR alpha deficiency mainly resulted in up-regulation of steroid and cholesterol biosynthesis-related genes and down-regulation of translation- as well as anti-apoptosis-related genes. Furthermore, RXR alpha bound to many genes that encode nuclear receptors and their cofactors suggesting the central role of RXR alpha in regulating nuclear receptor-mediated pathways. Conclusions: This study establishes the relationship between RXR alpha DNA binding and hepatic gene expression. RXR alpha binds extensively to the mouse genome. However, DNA binding does not necessarily affect the basal mRNA level. In addition to metabolism, RXR alpha dictates the expression of genes that regulate RNA processing, translation, and protein folding illustrating the novel roles of hepatic RXR alpha in post-transcriptional regulation.	[Zhan, Qi; Wan, Yu-Jui Yvonne] Guangzhou Med Univ, Dept Gastroenterol Hepatol, Guangzhou Municipal Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China; [He, Yuqi; Liu, Hui-Xin; Wan, Yu-Jui Yvonne] Univ Calif Davis, Dept Med Pathol & Lab Med, Davis Hlth Syst, Sacramento, CA 95817 USA; [Fang, Yaping; Fang, Jianwen] Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA	Guangzhou Medical University; University of California System; University of California Davis; University of Kansas	Wan, YJY (corresponding author), Guangzhou Med Univ, Dept Gastroenterol Hepatol, Guangzhou Municipal Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China.	yjywan@ucdavis.edu		Fang, Yaping/0000-0001-6075-0768; Liu, Hui-Xin/0000-0002-8981-9981	National Institutes of Health [DK092100, CA053596]; NATIONAL CANCER INSTITUTE [R29CA053596, R01CA053596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (DK092100 and CA053596 to YYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashibe B, 2009, FEBS J, V276, P6956, DOI 10.1111/j.1742-4658.2009.07404.x; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Buroker NE, 2009, FEBS J, V276, P3247, DOI 10.1111/j.1742-4658.2009.07039.x; Cai Y, 2003, ENDOCRINOLOGY, V144, P2311, DOI 10.1210/en.2002-0129; Costet P, 2000, J BIOL CHEM, V275, P28240; Cui JY, 2010, NUCLEIC ACIDS RES, V38, P7943, DOI 10.1093/nar/gkq654; DE LUCA LM, 1991, FASEB J, V5, P2924; Desai DS, 1999, BIOCHEM BIOPH RES CO, V263, P28, DOI 10.1006/bbrc.1999.1307; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Guo ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-403; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Gyamfi MA, 2006, J PHARMACOL EXP THER, V319, P360, DOI 10.1124/jpet.106.108175; Gyamfi MA, 2009, TOXICOL APPL PHARM, V234, P166, DOI 10.1016/j.taap.2008.09.022; Honkakoski P, 1997, J BIOL CHEM, V272, P14943, DOI 10.1074/jbc.272.23.14943; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence JA, 1998, CANCER EPIDEM BIOMAR, V7, P29; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu BR, 1999, MOL CELL ENDOCRINOL, V148, P11, DOI 10.1016/S0303-7207(98)00242-1; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Magliocco MA, 2006, J AM ACAD DERMATOL, V54, P115, DOI 10.1016/j.jaad.2005.09.012; Mak PA, 2002, J LIPID RES, V43, P2037, DOI 10.1194/jlr.C200014-JLR200; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; Qu LY, 2010, CANCER CHEMOTH PHARM, V65, P201, DOI 10.1007/s00280-009-1140-4; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Shimada J, 2001, MOL ENDOCRINOL, V15, P1677, DOI 10.1210/me.15.10.1677; Shin DJ, 2006, NUCLEIC ACIDS RES, V34, P3853, DOI 10.1093/nar/gkl506; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; SUDO Y, 1994, ENDOCRINOLOGY, V134, P2532, DOI 10.1210/en.134.6.2532; Tata JR, 2002, NAT REV MOL CELL BIO, V3, P702, DOI 10.1038/nrm914; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Wan YJY, 2000, J BIOL CHEM, V275, P28285; Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000; Wan YJY, 2003, ENDOCRINOLOGY, V144, P605, DOI 10.1210/en.2002-221003; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wu CH, 2011, HEPATOLOGY, V54, P1966, DOI 10.1002/hep.24645; Wu Y, 2004, MOL PHARMACOL, V65, P550, DOI 10.1124/mol.65.3.550; XU J, 1993, J BIOL CHEM, V268, P16065; Yang XX, 2010, AM J PATHOL, V176, P733, DOI 10.2353/ajpath.2010.090524; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zierold C, 2003, J CELL BIOCHEM, V88, P234, DOI 10.1002/jcb.10341	50	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e50013	10.1371/journal.pone.0050013	http://dx.doi.org/10.1371/journal.pone.0050013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166811	Green Published, gold, Green Submitted			2022-12-25	WOS:000311272300083
J	Makarava, N; Savtchenko, R; Baskakov, IV				Makarava, Natallia; Savtchenko, Regina; Baskakov, Ilia V.			Selective Amplification of Classical and Atypical Prions Using Modified Protein Misfolding Cyclic Amplification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO GENERATION; AMYLOID FIBRILS; HETEROGENEITY; PRPSC; CONFORMATION; PROPAGATION; ADAPTATION; GLYCOFORMS; MOLECULES; COFACTOR	With the development of protein misfolding cyclic amplification (PMCA), the topic of faithful propagation of prion strain-specific structures has been constantly debated. Here we show that by subjecting brain material of a synthetic strain consisting of a mixture of self-replicating states to PMCAb, selective amplification of PrPSc could be achieved, and that PMCAb mimicked the evolutionary trend observed during serial transmission in animals. On the other hand, using modified PMCAb conditions that employ partially deglycosylated PrPC (dgPMCAb), an alternative transmissible state referred to as atypical protease-resistant form of the prion protein (atypical PrPres) was selectively amplified from a mixture. Surprisingly, when hamster-adapted strains (263K and Hyper) were subjected to dgPMCAb, their proteinase K digestion profile underwent a dramatic transformation, suggesting that a mixture of atypical PrPres and PrPSc might be present in brain-derived materials. However, detailed analysis revealed that the proteinase K-resistant profile of PrPSc changed in response to dgPMCAb. Despite these changes, the 263K strain-specific disease phenotype was preserved after passage through dgPMCAb. This study revealed that the change in PrPSc biochemical phenotype does not always represent an irreversible transformation of a strain, but rather demonstrated the existence of a wide range of variation for strain-specific physical features in response to a change in prion replication environment. The current work introduced a new PMCA technique for amplification of atypical PrPres and raised a number of questions about the need for a clever distinction between actual strain mutation and variation of strain-specific features in response to a change in the replication environment.	Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), 725 W Lombard St, Baltimore, MD 21201 USA.	Baskakov@umaryland.edu			National Institutes of Health [NS045585, NS074998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074998, R56NS074998, R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS045585 and NS074998 (to I. V. B.).	Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Bett C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002522; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Gong BB, 2011, BIOCHEMISTRY-US, V50, P4963, DOI 10.1021/bi102073j; Gonzalez-Montalban N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041210; Gonzalez-Montalban N, 2011, BIOCHEMISTRY-US, V50, P7933, DOI 10.1021/bi200950v; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; Li JL, 2011, EMBO REP, V12, P1243, DOI 10.1038/embor.2011.191; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Monnet C, 2003, EUR J NEUROSCI, V18, P542, DOI 10.1046/j.1460-9568.2003.02777.x; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sajnani G, 2008, J MOL BIOL, V382, P88, DOI 10.1016/j.jmb.2008.06.070; Shashilov V, 2012, J PHYS CHEM B, V116, P7926, DOI 10.1021/jp2122455; Shikiya RA, 2011, J VIROL, V85, P13439, DOI 10.1128/JVI.06134-11; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	45	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					33	41		10.1074/jbc.M112.419531	http://dx.doi.org/10.1074/jbc.M112.419531			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23168413	Green Published, hybrid			2022-12-25	WOS:000313197200004
J	Baio, G; Capone, A; Marcellusi, A; Mennini, FS; Favato, G				Baio, Gianluca; Capone, Alessandro; Marcellusi, Andrea; Mennini, Francesco Saverio; Favato, Giampiero			Economic Burden of Human Papillomavirus-Related Diseases in Italy	PLOS ONE			English	Article							VULVAR INTRAEPITHELIAL NEOPLASIA; INVASIVE CERVICAL-CANCER; COST-EFFECTIVENESS; ANAL CANCER; IN-SITU; HPV; PREVALENCE; INFECTION; MANAGEMENT; CARCINOMA	Introduction: Human papilloma virus (HPV) genotypes 6, 11, 16, and 18 impose a substantial burden of direct costs on the Italian National Health Service that has never been quantified fully. The main objective of the present study was to address this gap: (1) by estimating the total direct medical costs associated with nine major HPV-related diseases, namely invasive cervical cancer, cervical dysplasia, cancer of the vulva, vagina, anus, penis, and head and neck, anogenital warts, and recurrent respiratory papillomatosis, and (2) by providing an aggregate measure of the total economic burden attributable to HPV 6, 11, 16, and 18 infection. Methods: For each of the nine conditions, we used available Italian secondary data to estimate the lifetime cost per case, the number of incident cases of each disease, the total economic burden, and the relative prevalence of HPV types 6, 11, 16, and 18, in order to estimate the aggregate fraction of the total economic burden attributable to HPV infection. Results: The total direct costs (expressed in 2011 Euro) associated with the annual incident cases of the nine HPV-related conditions included in the analysis were estimated to be (sic)528.6 million, with a plausible range of (sic)480.1-686.2 million. The fraction attributable to HPV 6, 11, 16, and 18 was (sic)291.0 (range (sic)274.5-315.7 million), accounting for approximately 55% of the total annual burden of HPV-related disease in Italy. Conclusions: The results provided a plausible estimate of the significant economic burden imposed by the most prevalent HPV-related diseases on the Italian welfare system. The fraction of the total direct lifetime costs attributable to HPV 6, 11, 16, and 18 infections, and the economic burden of noncervical HPV-related diseases carried by men, were found to be cost drivers relevant to the making of informed decisions about future investments in programmes of HPV prevention.	[Capone, Alessandro; Mennini, Francesco Saverio; Favato, Giampiero] Kingston Univ London, Inst Leadership & Management Hlth ILMH, London, England; [Baio, Gianluca] UCL, Dept Stat Sci, London, England; [Baio, Gianluca] Univ Milano Bicocca, Dept Stat, Biostat Unit, Milan, Italy; [Marcellusi, Andrea; Mennini, Francesco Saverio] Univ Roma Tor Vergata, Fac Econ, CEIS Sanita CHEM Ctr Hlth Econ & Management, Rome, Italy	Kingston University; University of London; University College London; University of Milano-Bicocca; University of Rome Tor Vergata	Favato, G (corresponding author), Kingston Univ London, Inst Leadership & Management Hlth ILMH, London, England.	g.favato@kingston.ac.uk	Marcellusi, Andrea/AAL-6573-2020	Favato, Giampiero/0000-0003-3499-2979; Baio, Gianluca/0000-0003-4314-2570; Marcellusi, Andrea/0000-0002-3974-3798				Abramowitz L, 2010, REV EPIDEMIOL SANTE, V58, P331, DOI 10.1016/j.respe.2010.06.165; Acay R, 2008, ORAL MICROBIOL IMMUN, V23, P271, DOI 10.1111/j.1399-302X.2007.00422.x; Agodi A, 2009, INT J GYNECOL CANCER, V19, P1094, DOI 10.1111/IGC.0b013e3181a83c9d; Anaya-Saavedra G, 2008, ARCH MED RES, V39, P189, DOI 10.1016/j.arcmed.2007.08.003; Annemans L, 2009, PHARMACOECONOMICS, V27, P231, DOI 10.2165/00019053-200927030-00006; Armstrong LR, 2000, CLIN INFECT DIS, V31, P107, DOI 10.1086/313914; Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743, DOI 10.1001/archotol.125.7.743; Associazione Italiana di Oncologia Medica (AIOM), LIN GUID; Associazione Italiana per la Ricerca sul Gancro (AIRC), GUID TUM TUM PEN; BECKMANN AM, 1989, INT J CANCER, V43, P1042, DOI 10.1002/ijc.2910430615; Bishai D, 2000, ARCH OTOLARYNGOL, V126, P935, DOI 10.1001/archotol.126.8.935; Bonvicini F, 2005, J MED VIROL, V77, P102, DOI 10.1002/jmv.20420; Carozzi FM, 2010, CANCER EPIDEM BIOMAR, V19, P2389, DOI 10.1158/1055-9965.EPI-10-0131; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Chesson HW, 2008, EMERG INFECT DIS, V14, P244, DOI 10.3201/eid1402.070499; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Costa S, 2011, CURR MED RES OPIN, V27, P569, DOI 10.1185/03007995.2010.546730; Costa S, 2008, EVALUATION EC IMPACT; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Engelman DES, 2003, BRAZ J MED BIOL RES, V36, P1159, DOI 10.1590/S0100-879X2003000900003; Ferrandina G, 2010, GYNECOL ONCOL, V119, P243, DOI 10.1016/j.ygyno.2010.06.025; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Hartwig S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-30; HOLM R, 1994, MODERN PATHOL, V7, P449; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; ISTAT -The Italian National Institute of Statistics, STAT DAT WAR; KOUTSKY LA, 1988, EPIDEMIOL REV, V10, P122, DOI 10.1093/oxfordjournals.epirev.a036020; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; LEE YY, 1994, ONCOGENE, V9, P1655; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; McClay JE., 2008, RECURRENT RESP PAPIL; Mennini FS, 2009, VACCINE, V27, pA54, DOI 10.1016/j.vaccine.2009.02.052; Mennini FS, 2009, GYNECOL ONCOL, V112, P370, DOI 10.1016/j.ygyno.2008.09.031; Merito M, 2008, CURR MED RES OPIN, V24, P3175, DOI [10.1185/03007990802485694, 10.1185/03007990802485694 ]; Ministero della Salute, NOM TAR PREST ASS SP; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Nomenclatore Tariffario Nazionale, 2006, GAZZ UFF; Rassu M, 2005, SCAND J INFECT DIS, V37, P476, DOI 10.1080/00365540510036633; Ricciardi A, 2009, TUMORI J, V95, P146; Ronco Guglielmo, 2006, Epidemiol Prev, V30, P27; Rossi PG, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-71, 10.1186/1471-2407-9-69]; Shykhon M, 2002, CLIN OTOLARYNGOL, V27, P237, DOI 10.1046/j.1365-2273.2002.00555.x; Silverberg MJ, 2003, OBSTET GYNECOL, V101, P645, DOI 10.1016/S0029-7844(02)03081-8; Silvestrini S, 1999, TUMORI EPITELIALI TE; Skapa P, 2007, AM J SURG PATHOL, V31, P1834, DOI 10.1097/PAS.0b013e3180686d10; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Societa' Italiana di Ginecologia e Ostetricia (SIGO), LIN GUID ONC GIN; Suligoi Barbara, 2010, Ig Sanita Pubbl, V66, P733; Tornesello ML, 2008, INT J CANCER, V122, P132, DOI 10.1002/ijc.23062; VITTORI G, 2008, IT J GYNAECOL OBSTET, V20, P33, DOI DOI 10.1016/J.VACCINE.2010.02.080; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), HUM PAP REL CANC IT; Wiley D, 2006, OBSTET GYNECOL SURV, V61, pS3, DOI 10.1097/01.ogx.0000221010.82943.8c	61	38	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49699	10.1371/journal.pone.0049699	http://dx.doi.org/10.1371/journal.pone.0049699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185412	Green Published, gold, Green Accepted			2022-12-25	WOS:000311821000090
J	Balsby, TJS; Momberg, JV; Dabelsteen, T				Balsby, Thorsten J. S.; Momberg, Jane Vestergaard; Dabelsteen, Torben			Vocal Imitation in Parrots Allows Addressing of Specific Individuals in a Dynamic Communication Network	PLOS ONE			English	Article							CONTACT CALLS; GREAT TITS; CONVERGENCE; RESPONSES; SEX; REPERTOIRES; INFORMATION; PLAYBACK; MIMICRY; SIGNAL	Parrots in captivity are known for their ability to vocally imitate humans and recently it has been shown that wild-living orange-fronted conures are able to immediately imitate other individuals' contact calls. The function of this exceptional ability to imitate remains unclear. However, orange-fronted conures live in fission-fusion flocks where they encounter many different individuals every day, and it is possible that their vocal imitation ability is a flexible means to address a specific individual within a flock. We tested this via playback to short-term captive wild conures. Test birds were placed together in pairs in outdoor aviaries to form simple flocks. To simulate imitation of a specific individual these pairs received playback of contact calls that primarily imitate one of the two birds. Overall, individuals that received simulated vocal imitations of its calls responded more frequently and faster than the other individual. This suggests that orange-fronted conures can use imitations of contact calls to address specific individuals of a flock. In the discussion we argue that the fission-fusion flock dynamics of many parrot species has been an important factor in evolving conures' and other parrots' exceptional ability to imitate.	[Balsby, Thorsten J. S.; Momberg, Jane Vestergaard; Dabelsteen, Torben] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Balsby, TJS (corresponding author), Aarhus Univ, Dept Biol Sci, Silkeborg, Denmark.	tjsbalsby@bio.ku.dk	Balsby, Thorsten/J-2854-2013; Dabelsteen, Torben/D-9854-2015	Dabelsteen, Torben/0000-0001-7162-3924; Balsby, Thorsten J. S./0000-0001-6855-4040	Danish Council for Independent Research, Natural Sciences [272-07-0477, 272-06-0272]	Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF))	TD is supported by a framework grant No. 272-07-0477 from The Danish Council for Independent Research, Natural Sciences. TJSB is supported by a Steno-stipend No. 272-06-0272 from The Danish Council for Independent Research, Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Balsby TJS, 2008, P ROY SOC B-BIOL SCI, V275, P2147, DOI 10.1098/rspb.2008.0517; Balsby TJS, 2009, BEHAV PROCESS, V82, P133, DOI 10.1016/j.beproc.2009.05.005; Balsby TJS, 2005, ANIM BEHAV, V69, P161, DOI 10.1016/j.anbehav.2004.01.021; Balsby TJS, CONTACT CALLS UNPUB; Beecher MD, 2000, ANIM BEHAV, V59, P21, DOI 10.1006/anbe.1999.1276; Beecher MD, 1996, ANIM BEHAV, V51, P917, DOI 10.1006/anbe.1996.0095; Bradbury JW, 2001, AUK, V118, P958, DOI 10.1642/0004-8038(2001)118[0958:GVITCC]2.0.CO;2; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Cortopassi KA, 2006, ANIM BEHAV, V71, P1141, DOI 10.1016/j.anbehav.2005.09.011; Cortopassi Kathryn A., 2000, Bioacoustics, V11, P89; Dabelsteen Torben, 1996, P398; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dyrcz A, 2004, IBIS, V146, P269, DOI 10.1046/j.1474-919X.2004.00256.x; FALLS JB, 1982, ANIM BEHAV, V30, P997, DOI 10.1016/S0003-3472(82)80188-7; FALLS JB, 1985, CAN J ZOOL, V63, P2520, DOI 10.1139/z85-373; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hile AG, 2000, ANIM BEHAV, V59, P1209, DOI 10.1006/anbe.1999.1438; HORN AG, 1988, ETHOLOGY, V77, P337; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Janik Vincent M., 1999, Symposia of the Zoological Society of London, V72, P308; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Jarvis Erich D., 2004, P226, DOI 10.1016/B978-012473070-0/50011-6; Juniper T, 1998, PARROTS GUIDE PARROT; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; LEMON RE, 1968, BEHAVIOUR, V32, P158, DOI 10.1163/156853968X00126; MAMMEN DL, 1981, BEHAV ECOL SOCIOBIOL, V9, P179, DOI 10.1007/BF00302935; Marlowe FW, 2005, EVOL ANTHROPOL, V14, P54, DOI 10.1002/evan.20046; Matessi G., 2008, SOCIOBIOLOGY COMMUNI, P33; McGregor Peter K., 1996, P409; MCGREGOR PK, 1992, ANIM BEHAV, V43, P987, DOI 10.1016/0003-3472(92)90012-X; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mennill DJ, 2004, BEHAVIOUR, V141, P125, DOI 10.1163/156853904772746637; MUNDINGER PC, 1970, SCIENCE, V168, P480, DOI 10.1126/science.168.3930.480; NIELSEN BMB, 1995, BEHAV ECOL SOCIOBIOL, V37, P109, DOI 10.1007/BF00164156; Otter KA, 2002, ETHOLOGY, V108, P181, DOI 10.1046/j.1439-0310.2002.00764.x; Patricelli GL, 2008, ANIM BEHAV, V76, P1389, DOI 10.1016/j.anbehav.2008.07.005; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; Peake TM, 2001, P ROY SOC B-BIOL SCI, V268, P1183, DOI 10.1098/rspb.2001.1648; RICHARDS DG, 1984, J COMP PSYCHOL, V98, P10, DOI 10.1037/0735-7036.98.1.10; Scarl JC, 2009, ANIM BEHAV, V77, P1019, DOI 10.1016/j.anbehav.2008.11.024; TYACK P, 1986, BEHAV ECOL SOCIOBIOL, V18, P251, DOI 10.1007/BF00300001; Vehrencamp SL, 2003, ETHOLOGY, V109, P37, DOI 10.1046/j.1439-0310.2003.00850.x; Vehrencamp SL, 2001, P ROY SOC B-BIOL SCI, V268, P1637, DOI 10.1098/rspb.2001.1714; Wanker R, 2005, ANIM BEHAV, V70, P111, DOI 10.1016/j.anbehav.2004.09.022	46	38	39	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49747	10.1371/journal.pone.0049747	http://dx.doi.org/10.1371/journal.pone.0049747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185424	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000099
J	Bors, EK; Rowden, AA; Maas, EW; Clark, MR; Shank, TM				Bors, Eleanor K.; Rowden, Ashley A.; Maas, Elizabeth W.; Clark, Malcolm R.; Shank, Timothy M.			Patterns of Deep-Sea Genetic Connectivity in the New Zealand Region: Implications for Management of Benthic Ecosystems	PLOS ONE			English	Article							MARINE PROTECTED AREAS; MITOCHONDRIAL-DNA; PACIFIC-OCEAN; CHATHAM RISE; POPULATION-GENETICS; SEAMOUNTS; RESERVES; DESIGN; BATHYMODIOLUS; INVERTEBRATES	Patterns of genetic connectivity are increasingly considered in the design of marine protected areas (MPAs) in both shallow and deep water. In the New Zealand Exclusive Economic Zone (EEZ), deep-sea communities at upper bathyal depths (< 2000 m) are vulnerable to anthropogenic disturbance from fishing and potential mining operations. Currently, patterns of genetic connectivity among deep-sea populations throughout New Zealand's EEZ are not well understood. Using the mitochondrial Cytochrome Oxidase I and 16S rRNA genes as genetic markers, this study aimed to elucidate patterns of genetic connectivity among populations of two common benthic invertebrates with contrasting life history strategies. Populations of the squat lobster Munida gracilis and the polychaete Hyalinoecia longibranchiata were sampled from continental slope, seamount, and offshore rise habitats on the Chatham Rise, Hikurangi Margin, and Challenger Plateau. For the polychaete, significant population structure was detected among distinct populations on the Chatham Rise, the Hikurangi Margin, and the Challenger Plateau. Significant genetic differences existed between slope and seamount populations on the Hikurangi Margin, as did evidence of population differentiation between the northeast and southwest parts of the Chatham Rise. In contrast, no significant population structure was detected across the study area for the squat lobster. Patterns of genetic connectivity in Hyalinoecia longibranchiata are likely influenced by a number of factors including current regimes that operate on varying spatial and temporal scales to produce potential barriers to dispersal. The striking difference in population structure between species can be attributed to differences in life history strategies. The results of this study are discussed in the context of existing conservation areas that are intended to manage anthropogenic threats to deep-sea benthic communities in the New Zealand region.	[Bors, Eleanor K.; Shank, Timothy M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Rowden, Ashley A.; Maas, Elizabeth W.; Clark, Malcolm R.] Natl Inst Water & Atmospher Res, Wellington, New Zealand	Woods Hole Oceanographic Institution; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Shank, TM (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	tshank@whoi.edu	Bors, Eleanor/W-1235-2019; Rowden, Ashley/O-9358-2019; Rowden, Ashley/ABG-6010-2020	Rowden, Ashley/0000-0003-2975-2524	Fulbright Fellowship; U.S. Department of State; Land Information New Zealand; New Zealand Ministry of Fisheries; NIWA; Census of Marine Life on Seamounts (CenSeam); Foundation for Research, Science and Technology; New Zealand Ministry of Science and Innovation [CO1X0906]; National Science Foundation [OCE-0647612]; Deep Ocean Exploration Institute	Fulbright Fellowship; U.S. Department of State; Land Information New Zealand; New Zealand Ministry of Fisheries; NIWA; Census of Marine Life on Seamounts (CenSeam); Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); New Zealand Ministry of Science and Innovation; National Science Foundation(National Science Foundation (NSF)); Deep Ocean Exploration Institute	This work was funded in part by a Fulbright Fellowship administered by Fulbright New Zealand and the U.S. Department of State, awarded in 2011 to EKB. Funding and support for research expedition was provided by Land Information New Zealand, New Zealand Ministry of Fisheries, NIWA, Census of Marine Life on Seamounts (CenSeam), and the Foundation for Research, Science and Technology. Other research funding was provided by the New Zealand Ministry of Science and Innovation project "Impacts of resource use on vulnerable deep-sea communities" (FRST contract CO1X0906), the National Science Foundation (OCE-0647612), and the Deep Ocean Exploration Institute (Fellowship support to TMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airame S, 2003, ECOL APPL, V13, pS170; [Anonymous], PERM DAT; Apte S, 2002, MOL ECOL, V11, P1617, DOI 10.1046/j.1365-294X.2002.01554.x; Baba K, 2011, BIOL SQUAT LOBSTERS; Baird SJ., 2011, NZ AQUATIC ENV BIODI; Barange M, 2010, MARINE ECOSYSTEMS AND GLOBAL CHANGE, P1; BARNES EJ, 1985, NEW ZEAL J MAR FRESH, V19, P405, DOI 10.1080/00288330.1985.9516105; Berkenbusch K, 2011, MAR ECOL PROG SER, V425, P79, DOI 10.3354/meps09014; Brodie S., 2003, AQUATIC PROTECTED AR, P664; CARRASCO FD, 1983, J NAT HIST, V17, P87, DOI 10.1080/00222938300770061; Chiswell SM, 1999, MAR ECOL PROG SER, V183, P227, DOI 10.3354/meps183227; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; Christin L, 2008, J AVIAN BIOL, V39, p252_256; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; CRADDOCK C, 1995, MAR BIOL, V124, P137, DOI 10.1007/BF00349155; Crown Minerals, 2010, CROWN MIN; Cryer M, 2002, ECOL APPL, V12, P1824, DOI 10.1890/1051-0761(2002)012[1824:MOMBBT]2.0.CO;2; Department for Environment Food and Rural Affairs United Kingdom, 2011, PB13583 DEP ENV FOOD; Department of Conservation and Ministry for the Environment, 2000, NZ BIOD STRAT; Drummond A., 2011, GENEIOUS V5 5; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO, 2006, FAO FISHERIES REPORT; FAO, 2008, 829 FAO; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Gibbs MT, 2008, ELECT J SUSTAINABLE, V1, P23; GLASBY GP, 1990, MAR MINING, V9, P403; Gordon DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010905; Hayward BW, 2008, GLOBAL PLANET CHANGE, V63, P309, DOI 10.1016/j.gloplacha.2008.07.003; HEATH RA, 1985, NEW ZEAL J MAR FRESH, V19, P79, DOI 10.1080/00288330.1985.9516077; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Helson J, 2010, MAR POLICY, V34, P557, DOI 10.1016/j.marpol.2009.11.002; Henderson JR, 1885, ANN MAGAZINE NATURAL, V16, P407, DOI DOI 10.1080/00222938509459908; Kojima S, 2006, J MAR BIOL ASSOC UK, V86, P1357, DOI 10.1017/S002531540601438X; Lavelle JW, 2010, OCEANOGRAPHY, V23, P90, DOI 10.5670/oceanog.2010.64; Leathwick J, 2008, CONSERV LETT, V1, P91, DOI 10.1111/j.1755-263X.2008.00012.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Machordom A, 2004, MOL PHYLOGENET EVOL, V33, P259, DOI 10.1016/j.ympev.2004.06.001; Mackay KA, 2005, MIWA MISCELLANEOUS C; McIntosh W.C., 1885, ZOOLOGY, V12, P1, DOI DOI 10.5962/BHL.TITLE.6513; McKnight DG, 1997, NEW ZEAL J MAR FRESH, V31, P505, DOI 10.1080/00288330.1997.9516784; Miles EL, 2009, ANNU REV ENV RESOUR, V34, P17, DOI 10.1146/annurev.environ.33.041707.110117; Miller KJ, 2008, CONSERV BIOL, V22, P1245, DOI 10.1111/j.1523-1739.2008.00985.x; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Miller KJ, 1997, MAR ECOL PROG SER, V161, P123, DOI 10.3354/meps161123; Ministry of Fisheries and Department of Conservation, 2008, MARINE PROTECTED ARE, P54; Munasinghe DHN, 2003, J CRUSTACEAN BIOL, V23, P402, DOI 10.1651/0278-0372(2003)023[0402:UOMDSF]2.0.CO;2; New Zealand Ministry of Fisheries, 2010, REP FISH ASS PLEN MA; Nielsen JF, 2005, THESIS U AUCKLAND; Nodder SD, 2012, ELSEV INSIGHT, P763, DOI 10.1016/B978-0-12-385140-6.00056-6; Nodder SD, 2003, DEEP-SEA RES PT I, V50, P959, DOI 10.1016/S0967-0637(03)00094-3; Orensanz J.M., 1990, Antarctic Research Series, V52, P1; Palumbi SR, 2003, ECOL APPL, V13, pS146; Paxton H., 1986, RECORDS AUSTR MUSEUM, V28, P1; Perrin C, 2004, MOL ECOL, V13, P2183, DOI 10.1111/j.1365-294X.2004.02241.x; Plouviez S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-220; Probert P. Keith, 1997, Aquatic Conservation, V7, P27, DOI 10.1002/(SICI)1099-0755(199703)7:1<27::AID-AQC214>3.3.CO;2-0; Probert PK, 1999, AQUAT CONSERV, V9, P601, DOI 10.1002/(SICI)1099-0755(199911/12)9:6<601::AID-AQC365>3.3.CO;2-F; PROBERT PK, 1993, DEEP-SEA RES PT I, V40, P1003, DOI 10.1016/0967-0637(93)90086-I; Ramillien G, 2000, J GEOPHYS RES-SOL EA, V105, P16577, DOI 10.1029/2000JB900099; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Read GB, 1999, NEW ZEAL J ZOOL, V26, P49, DOI 10.1080/03014223.1999.9518177; Rex MA, 2010, J CONCHOL, V40, P287; Ross PM, 2012, ESTUAR COAST, V35, P143, DOI 10.1007/s12237-011-9429-z; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Shank TM, 2010, OCEANOGRAPHY, V23, P108, DOI 10.5670/oceanog.2010.65; Smith PJ, 2004, MAR BIOL, V144, P537, DOI 10.1007/s00227-003-1207-4; Smith PJ, 2004, MAR BIOL, V144, P253, DOI 10.1007/s00227-003-1206-5; Thompson RM, 1991, NZ OCEANOGRAPHIC I M; Van Dover CL, 2012, MAR POLICY, V36, P378, DOI 10.1016/j.marpol.2011.07.002; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Zanol J, 2010, MOL PHYLOGENET EVOL, V55, P660, DOI 10.1016/j.ympev.2009.12.024	76	25	25	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49474	10.1371/journal.pone.0049474	http://dx.doi.org/10.1371/journal.pone.0049474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185341	Green Published, gold			2022-12-25	WOS:000311821000054
J	Heffernan, KS; Manini, TM; Hsu, FC; Blair, SN; Nicklas, BJ; Kritchevsky, SB; Newman, AB; Sutton-Tyrrell, K; Church, TS; Haskell, WL; Fielding, RA				Heffernan, Kevin S.; Manini, Todd M.; Hsu, Fang-Chi; Blair, Steven N.; Nicklas, Barbara J.; Kritchevsky, Stephen B.; Newman, Anne B.; Sutton-Tyrrell, Kim; Church, Timothy S.; Haskell, William L.; Fielding, Roger A.			Relation of Pulse Pressure to Long-Distance Gait Speed in Community-Dwelling Older Adults: Findings from the LIFE-P Study	PLOS ONE			English	Article							BLOOD-PRESSURE; ARTERIAL STIFFNESS; WALKING SPEED; STYLE INTERVENTIONS; PHYSICAL FUNCTION; WAVE REFLECTION; HEART-FAILURE; RISK; DISABILITY; AGE	Background: Reduced gait speed is associated with falls, late-life disability, hospitalization/institutionalization and cardiovascular morbidity and mortality. Aging is also accompanied by a widening of pulse pressure (PP) that contributes to ventricular-vascular uncoupling. The purpose of this study was to test the hypothesis that PP is associated with long-distance gait speed in community-dwelling older adults in the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) study. Methods: Brachial blood pressure and 400-meter gait speed (average speed maintained over a 400-meter walk at "usual" pace) were assessed in 424 older adults between the ages of 70-89 yrs at risk for mobility disability (mean age = 77 yrs; 31% male). PP was calculated as systolic blood pressure (BP) - diastolic BP. Results: Patients with a history of heart failure and stroke (n = 42) were excluded leaving 382 participants for final analysis. When categorized into tertiles of PP, participants within the highest PP tertile had significantly slower gait speed than those within the lowest PP tertile (p < 0.05). Following stepwise multiple regression, PP was significantly and inversely associated with 400-meter gait speed (p < 0.05). Other significant predictors of gait speed included: handgrip strength, body weight, age and history of diabetes mellitus (p < 0.05). Mean arterial pressure, systolic BP and diastolic BP were not predictors of gait speed. Conclusions: Pulse pressure is associated long-distance gait speed in community-dwelling older adults. Vascular senescence and altered ventricular-vascular coupling may be associated with the deterioration of mobility and physical function in older adults.	[Heffernan, Kevin S.] Syracuse Univ, Dept Exercise Sci, Human Performance Lab, Syracuse, NY 13244 USA; [Manini, Todd M.] Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA; [Hsu, Fang-Chi] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA; [Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA; [Nicklas, Barbara J.; Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, J Paul Sticht Ctr Aging, Winston Salem, NC 27103 USA; [Newman, Anne B.; Sutton-Tyrrell, Kim] Univ Pittsburgh, Dept Epidemiol, Ctr Aging & Populat Hlth, Pittsburgh, PA 15261 USA; [Church, Timothy S.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Haskell, William L.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Fielding, Roger A.] Tufts Univ, Nutr Exercise Physiol & Sarcopenia Lab, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Syracuse University; State University System of Florida; University of Florida; Wake Forest University; Wake Forest University School of Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Wake Forest University; Wake Forest Baptist Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Stanford University; Tufts University	Heffernan, KS (corresponding author), Syracuse Univ, Dept Exercise Sci, Human Performance Lab, Syracuse, NY 13244 USA.	ksheffer@syr.edu	Newman, Anne B./C-6408-2013; Nicklas, Barbara/AAA-2781-2020	Newman, Anne B./0000-0002-0106-1150; Heffernan, Kevin/0000-0002-3499-1477; Kritchevsky, Stephen/0000-0003-3336-6781	National Institutes of Health/ National Institute on Aging [U01 AG22376]; National Institute on Aging, National Institutes of Health (NIH); Claude D. Older American Independence Pepper Center [1P30AG21332]; United States Department of Agriculture [58-1950-0-014]; Boston Claude D. Pepper Older Americans Independence Center [1P30AG031679]; Boston Rehabilitation Outcomes Center [HD065688]; Pittsburgh Claude D. Pepper Center [P30 AG024827]; NIH [T32 HL069770-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG022376, P30AG024827, P30AG028740, P30AG031679, P30AG021332] Funding Source: NIH RePORTER	National Institutes of Health/ National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Claude D. Older American Independence Pepper Center; United States Department of Agriculture(United States Department of Agriculture (USDA)); Boston Claude D. Pepper Older Americans Independence Center; Boston Rehabilitation Outcomes Center; Pittsburgh Claude D. Pepper Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) Study was funded by a grant from the National Institutes of Health/ National Institute on Aging (U01 AG22376) and supported in part by the Intramural Research Program, National Institute on Aging, National Institutes of Health (NIH). The Wake Forest University Field Center was partially supported by the Claude D. Older American Independence Pepper Center (1P30AG21332). RF's contribution was partially supported by the United States Department of Agriculture, under agreement No. 58-1950-0-014, the Boston Claude D. Pepper Older Americans Independence Center (1P30AG031679) and the Boston Rehabilitation Outcomes Center (HD065688). The Pittsburgh Field Center was partially supported by the Pittsburgh Claude D. Pepper Center P30 AG024827. KSH was supported by funding from NIH T32 HL069770-06. The protocol of LIFE-P is registered at http://www.ClinicalTrials.gov (registration #NCT00116194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HH, 2007, J GERONTOL A-BIOL, V62, P844, DOI 10.1093/gerona/62.8.844; Brach JS, 2008, PHYS THER, V88, P1365, DOI 10.2522/ptj.20080016; Brewer LC, 2007, ATHEROSCLEROSIS, V191, P384, DOI 10.1016/j.atherosclerosis.2006.03.038; Brunner EJ, 2011, HYPERTENSION, V57, P1003, DOI 10.1161/HYPERTENSIONAHA.110.168864; Cacciatore F, 2004, AGING CLIN EXP RES, V16, P382; Callisaya ML, 2008, J GERONTOL A-BIOL, V63, P165, DOI 10.1093/gerona/63.2.165; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Domanski M, 2001, HYPERTENSION, V38, P793, DOI 10.1161/hy1001.092966; Dumurgier J, 2010, J HYPERTENS, V28, P1506, DOI 10.1097/HJH.0b013e328338bbec; Dumurgier J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4460; Elbaz A, 2005, STROKE, V36, P2198, DOI 10.1161/01.STR.0000181752.16915.5c; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Gardin JM, 1997, HYPERTENSION, V29, P1095, DOI 10.1161/01.HYP.29.5.1095; GURALNIK JM, 1991, AM J PUBLIC HEALTH, V81, P443, DOI 10.2105/AJPH.81.4.443; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hajjar I, 2007, HYPERTENSION, V50, P1026, DOI 10.1161/HYPERTENSIONAHA.107.097667; Hajjar I, 2011, CIRCULATION, V123, P858, DOI 10.1161/CIRCULATIONAHA.110.978114; Hardy SE, 2007, J AM GERIATR SOC, V55, P1727, DOI 10.1111/j.1532-5415.2007.01413.x; Heffernan KS, 2011, J NEUROL SCI, V309, P105, DOI 10.1016/j.jns.2011.07.004; Heffernan KS, 2011, CLIN CARDIOL, V34, P39, DOI 10.1002/clc.20841; Hirvensalo M, 2000, J AM GERIATR SOC, V48, P493, DOI 10.1111/j.1532-5415.2000.tb04994.x; Inzitari M, 2008, J GERONTOL A-BIOL, V63, P1112, DOI 10.1093/gerona/63.10.1112; Katsi V, 2012, INT J CARDIOL, V157, P370, DOI 10.1016/j.ijcard.2010.12.074; Katula JA, 2007, J AM GERIATR SOC, V55, P674, DOI 10.1111/j.1532-5415.2007.01136.x; Kim DH, 2012, ARCH OPHTHALMOL-CHIC, V130, P350, DOI 10.1001/archophthalmol.2011.360; Kingwell BA, 2002, J AM COLL CARDIOL, V40, P773, DOI 10.1016/S0735-1097(02)02009-0; Kuo Chen-Ko, 2009, BMC Geriatr, V9, P49, DOI 10.1186/1471-2318-9-49; Kuvin JT, 2005, J HUM HYPERTENS, V19, P501, DOI 10.1038/sj.jhh.1001844; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; McGinn AP, 2008, STROKE, V39, P1233, DOI 10.1161/STROKEAHA.107.500850; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Mitchell GF, 2010, CIRCULATION, V122, P1379, DOI 10.1161/CIRCULATIONAHA.109.914507; Papaioannou TG, 2008, AM J HYPERTENS, V21, P334, DOI 10.1038/ajh.2007.52; Poole DC, 2010, ADV EXP MED BIOL, V662, P301, DOI 10.1007/978-1-4419-1241-1_43; Rejeski WJ, 2005, CONTEMP CLIN TRIALS, V26, P141, DOI 10.1016/j.cct.2004.12.005; Rosano C, 2011, J AM GERIATR SOC, V59, P390, DOI 10.1111/j.1532-5415.2010.03282.x; SAEKI A, 1995, CIRC RES, V76, P132, DOI 10.1161/01.RES.76.1.132; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Segers P, 2007, HYPERTENSION, V49, P1248, DOI 10.1161/HYPERTENSIONAHA.106.085480; Shrestha I, 2009, HYPERTENS RES, V32, P869, DOI 10.1038/hr.2009.121; Simonsick EM, 2008, J GERONTOL A-BIOL, V63, P841, DOI 10.1093/gerona/63.8.841; Studenski S, 2009, J NUTR HEALTH AGING, V13, P878, DOI 10.1007/s12603-009-0245-0; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Watson NL, 2011, AM J HYPERTENS; Watson NL, 2011, AM J HYPERTENS, V24, P90, DOI 10.1038/ajh.2010.193	49	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49544	10.1371/journal.pone.0049544	http://dx.doi.org/10.1371/journal.pone.0049544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185357	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000062
J	Leigh, SJ; Bradley, RJ; Purssell, CP; Billson, DR; Hutchins, DA				Leigh, Simon J.; Bradley, Robert J.; Purssell, Christopher P.; Billson, Duncan R.; Hutchins, David A.			A Simple, Low-Cost Conductive Composite Material for 3D Printing of Electronic Sensors	PLOS ONE			English	Article							CARBON-BLACK; SILICON	3D printing technology can produce complex objects directly from computer aided digital designs. The technology has traditionally been used by large companies to produce fit and form concept prototypes ('rapid prototyping') before production. In recent years however there has been a move to adopt the technology as full-scale manufacturing solution. The advent of low-cost, desktop 3D printers such as the RepRap and Fab@Home has meant a wider user base are now able to have access to desktop manufacturing platforms enabling them to produce highly customised products for personal use and sale. This uptake in usage has been coupled with a demand for printing technology and materials able to print functional elements such as electronic sensors. Here we present formulation of a simple conductive thermoplastic composite we term 'carbomorph' and demonstrate how it can be used in an unmodified low-cost 3D printer to print electronic sensors able to sense mechanical flexing and capacitance changes. We show how this capability can be used to produce custom sensing devices and user interface devices along with printed objects with embedded sensing capability. This advance in low-cost 3D printing with offer a new paradigm in the 3D printing field with printed sensors and electronics embedded inside 3D printed objects in a single build process without requiring complex or expensive materials incorporating additives such as carbon nanotubes.	[Leigh, Simon J.; Purssell, Christopher P.; Billson, Duncan R.; Hutchins, David A.] Univ Warwick, Sch Engn, Coventry, Warwick, England; [Bradley, Robert J.] GKN Aerosp, Bristol, Avon, England	University of Warwick; GKN	Leigh, SJ (corresponding author), Univ Warwick, Sch Engn, Coventry, Warwick, England.	s.j.leigh@warwick.ac.uk	Leigh, Simon/G-5650-2013	Hutchins, David/0000-0002-1121-531X; Purssell, Chris/0000-0002-1885-8721; Leigh, Simon/0000-0002-2040-0592	EPSRC project: Novel 3D Printing Technologies for Maximising Industrial Impact [30821]; EPSRC UK Research Centre In Nondestructive Evaluation; Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials); Advantage West Midlands (AWM); European Regional Development Fund (ERDF)	EPSRC project: Novel 3D Printing Technologies for Maximising Industrial Impact(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC UK Research Centre In Nondestructive Evaluation(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials); Advantage West Midlands (AWM); European Regional Development Fund (ERDF)(European Commission)	This work was funded by the EPSRC project: Novel 3D Printing Technologies for Maximising Industrial Impact (Subproject # 30821) and by the EPSRC UK Research Centre In Nondestructive Evaluation. The helium pycnometer used in this research was obtained through Birmingham Science City: Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials Project 2), with support from Advantage West Midlands (AWM) and part funded by the European Regional Development Fund (ERDF). The authors acknowledge the contribution of Dr James Bowen (School of Chemical Engineering, University of Birmingham) for carrying out density measurements and Mr Ian Adkins (Bits from Bytes Ltd, Clevedon, UK) for advice and discussions regarding the printing process. We also acknowledge the work of Paul Badger in creating the CapSense library for the Arduino platform which was used in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avramov-Zamurovic S, 2011, IEEE T INSTRUM MEAS, V60, P2730, DOI 10.1109/TIM.2011.2126150; Chen ZH, 1998, IEEE T IND ELECTRON, V45, P886, DOI 10.1109/41.735332; Chua CK, 2010, RAPID PROTOTYPING: PRINCIPLES AND APPLICATIONS, 3RD EDITION, DOI 10.1142/6665; Foulger SH, 1999, J APPL POLYM SCI, V72, P1573, DOI 10.1002/(SICI)1097-4628(19990620)72:12<1573::AID-APP10>3.3.CO;2-Y; Jones R, 2011, ROBOTICA, V29, P177, DOI 10.1017/S026357471000069X; Lee JI, 2009, J MICROELECTROMECH S, V18, P660, DOI 10.1109/JMEMS.2009.2016275; Li X, 2009, MATER LETT, V63, P403, DOI 10.1016/j.matlet.2008.10.065; Lu JR, 2005, ADV FUNCT MATER, V15, P1358, DOI 10.1002/adfm.200400298; Malone E, 2007, RAPID PROTOTYPING J, V13, P245, DOI 10.1108/13552540710776197; MOSSER V, 1991, SENSOR ACTUAT A-PHYS, V28, P113, DOI 10.1016/0924-4247(91)85020-O; Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010; REBOUL JP, 1976, INT J POLYM MATER, V5, P133, DOI 10.1080/00914037608072394; SUMITA M, 1991, POLYM BULL, V25, P265, DOI 10.1007/BF00310802; Terzic E, 2010, ENG APPL ARTIF INTEL, V23, P614, DOI 10.1016/j.engappai.2009.09.014; Upcraft S, 2003, ASSEMBLY AUTOM, V23, P318, DOI 10.1108/01445150310698634; Walters P, 2010, RAPPORT J NORWEGIAN, V1, P12; Wang Y, 2010, SENSOR ACTUAT B-CHEM, V149, P136, DOI 10.1016/j.snb.2010.06.010; Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057; Xiao F, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/7/075005; Yamada T, 2011, NAT NANOTECHNOL, V6, P296, DOI [10.1038/NNANO.2011.36, 10.1038/nnano.2011.36]; Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0; Zhang X, 1999, SENSOR ACTUAT A-PHYS, V77, P149, DOI 10.1016/S0924-4247(99)00189-2	22	507	533	15	542	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49365	10.1371/journal.pone.0049365	http://dx.doi.org/10.1371/journal.pone.0049365			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185319	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000041
J	Mattar, L; Huas, C; Godart, N				Mattar, Lama; Huas, Caroline; Godart, Nathalie		EVHAN Grp	Relationship between Affective Symptoms and Malnutrition Severity in Severe Anorexia Nervosa	PLOS ONE			English	Article							BODY-COMPOSITION; BIOELECTRICAL-IMPEDANCE; EATING-DISORDERS; SOCIAL ANXIETY; LEPTIN; COMORBIDITY; INVENTORY; WEIGHT; MOOD; MASS	Background: Very few studies have investigated the relationship between malnutrition and psychological symptoms in Anorexia Nervosa (AN). They have used only body weight or body mass index (BMI) for the nutritional assessment and did not always report on medication, or if they did, it was not included in the analysis of results, and they did not include confounding factors such as duration of illness, AN subtype or age. The present study investigates this relationship using indicators other than BMI/weight, among which body composition and biological markers, also considering potential confounders related to depression and anxiety. Methods: 155 AN patients, (DSM-IV) were included consecutively upon admission to inpatient treatment. Depression, anxiety, obsessive behaviours and social functioning were measured using various scales. Nutritional status was measured using BMI, severity of weight loss, body composition, and albumin and prealbumin levels. Results: No correlation was found between BMI at inclusion, fat-free mass index, fat mass index, and severity of weight loss and any of the psychometric scores. Age and medication are the only factors that affect the psychological scores. None of the psychological scores were explained by the nutritional indicators with the exception of albumin levels which was negatively linked to the LSAS fear score (p = 0.024; beta = -0.225). Only the use of antidepressants explained the variability in BDI scores (p = 0.029; beta = 0.228) and anxiolytic use explained the variability in HADs depression scores (p = 0.037; beta = 0.216). Conclusion: The present study is a pioneer investigation of various nutritional markers in relation to psychological symptoms in severely malnourished AN patients. The clinical hypothesis that malnutrition partly causes depression and anxiety symptoms in AN in acute phase is not confirmed, and future studies are needed to back up our results.	[Mattar, Lama; Huas, Caroline] INSERM, U669, Paris, France; [Mattar, Lama; Huas, Caroline] Univ Paris Sud, Paris, France; [Mattar, Lama; Huas, Caroline] Univ Paris 05, Paris, France; [Godart, Nathalie] Inst Mutualiste Montsouris 42, Psychiat Unit, Paris, France; [Huas, Caroline] Dept Univ Med Gen, Fac Med Paris Descartes, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; CHU Tours	Mattar, L (corresponding author), INSERM, U669, Paris, France.	lamamattar@gmail.com	Berthoz Landron, Sylvie/M-4517-2018; Mattar, Lama/W-2467-2019; godart, nathalie/I-9553-2014	Mattar, Lama/0000-0002-8813-1798; BENOIT, Jean-Pierre/0000-0002-6178-7199; bioulac, stephanie/0000-0003-2618-4234; Duclos - Lavagne d'Ortigue, Jeanne/0000-0002-7454-0021; godart, nathalie/0000-0002-7233-6991	public Eiffel Scholarship; AP-HP PHRC (Assistance Publique-Hopitaux de Paris, Projet Hospitalier de Recherche Clinique) grant; CNAM-TS (Caisse Nationale de l'Assurance Maladie des Travailleurs Salaries); ANR program jeune chercheur (Agence Nationale de la Recherche)	public Eiffel Scholarship; AP-HP PHRC (Assistance Publique-Hopitaux de Paris, Projet Hospitalier de Recherche Clinique) grant; CNAM-TS (Caisse Nationale de l'Assurance Maladie des Travailleurs Salaries); ANR program jeune chercheur (Agence Nationale de la Recherche)(French National Research Agency (ANR))	The project was granted by the public Eiffel Scholarship, the AP-HP PHRC (Assistance Publique-Hopitaux de Paris, Projet Hospitalier de Recherche Clinique) grant, the CNAM-TS (Caisse Nationale de l'Assurance Maladie des Travailleurs Salaries) and the ANR program jeune chercheur (Agence Nationale de la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric A, 2006, AM J PSYCHIAT, V163, P4; [Anonymous], 2009, Harv Heart Lett, V20, P3; Asakawa A, 2003, J DIABETES COMPLICAT, V17, P105, DOI 10.1016/S1056-8727(02)00185-X; Attia E, 2010, ANNU REV MED, V61, P425, DOI 10.1146/annurev.med.050208.200745; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BOURQUE P, 1982, CAN J BEHAV SCI, V14, P211, DOI 10.1037/h0081254; Brinkworth GD, 2009, ARCH INTERN MED, V169, P1873, DOI 10.1001/archinternmed.2009.329; COOPER Z, 1989, BRIT J PSYCHIAT, V154, P807, DOI 10.1192/bjp.154.6.807; DEURENBERG P, 1991, INT J OBESITY, V15, P17; Forest A, 2009, REV MED INTERNE, V30, P696, DOI 10.1016/j.revmed.2009.03.012; GARNER DM, 1993, LANCET, V341, P1631, DOI 10.1016/0140-6736(93)90768-C; GERNER RH, 1984, AM J PSYCHIAT, V141, P1441; Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023; Godart NT, 2002, INT J EAT DISORDER, V32, P253, DOI 10.1002/eat.10096; Gola E, 1976, G Ital Cardiol, V6, P279; Golden NH, 2008, INT J EAT DISORDER, V41, P301, DOI 10.1002/eat.20503; Hantouche E., 1993, Encephale, V19, P241; Harvey J, 2005, BIOCHEM SOC T, V33, P1029, DOI 10.1042/BST0331029; Hebebrand J, 2007, MOL PSYCHIATR, V12, P23, DOI 10.1038/sj.mp.4001909; Helba M, 2009, PEDIATR RADIOL, V39, P647, DOI 10.1007/s00247-009-1247-0; HODGSON RJ, 1977, BEHAV RES THER, V15, P389, DOI 10.1016/0005-7967(77)90042-0; JEAMMET P, 1992, SCHWEIZ MED WSCHR, V122, P94; Kaye W, 2008, PHYSIOL BEHAV, V94, P121, DOI 10.1016/j.physbeh.2007.11.037; Kaye WH, 2003, INT J EAT DISORDER, V33, P257, DOI 10.1002/eat.10135; Keys A, 1950, BIOL HUMAN STARVATIO; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; LEPINE JP, 1985, ANN MED-PSYCHOL, V143, P175; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; Mattar L, 2010, J AFFECT DISORD; Mattar L, 2011, CLIN NUTR, V30, P746, DOI 10.1016/j.clnu.2011.05.012; Mattar L, 2011, NUTR RES REV, V24, P39, DOI 10.1017/S0954422410000284; Narayanan Vignesh, 2009, Eat Disord, V17, P322, DOI 10.1080/10640260902991202; Nicholls D, 2002, EUR J CLIN NUTR, V56, P857, DOI 10.1038/sj.ejcn.1601403; Organization WH, 1997, COMPOSITE INT DIAGNO; Piccoli A, 2005, JPEN-PARENTER ENTER, V29, P148, DOI 10.1177/0148607105029003148; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Probst M, 2001, AM J CLIN NUTR, V73, P190; Rytwinski NK, 2009, DEPRESS ANXIETY, V26, P34, DOI 10.1002/da.20503; Shiveley L, 2000, KRAUSES FOOD NUTR DI; TAYLOR HL, 1948, AM J PHYSIOL, V152, P141, DOI 10.1152/ajplegacy.1947.152.1.141; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Wells JCK, 2001, ARCH DIS CHILD, V85, P67, DOI 10.1136/adc.85.1.67; Winston AP, 2012, ANN CLIN BIOCHEM, V49, P132, DOI 10.1258/acb.2011.011185; Yao SN, 1999, ENCEPHALE, V25, P429; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49380	10.1371/journal.pone.0049380	http://dx.doi.org/10.1371/journal.pone.0049380			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185320	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000042
J	Wang, PX; Wang, JJ; Lei, YX; Xiao, L; Luo, ZC				Wang, Pei-Xi; Wang, Jia-Ji; Lei, Yi-Xiong; Xiao, Lin; Luo, Zhong-Cheng			Impact of Fetal and Infant Exposure to the Chinese Great Famine on the Risk of Hypertension in Adulthood	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BLOOD-PRESSURE; DUTCH FAMINE; IN-UTERO; PRENATAL EXPOSURE; EARLY-LIFE; OBESITY; CONSEQUENCES; MECHANISMS; HYPOTHESIS	Background: Famine provides quasi-experimental conditions for testing the hypothesis of "programming" health effects by poor nutrition in early life. It remains uncertain whether early life exposure to famine increases the risk of hypertension in adulthood. There is a lack of data on the relative impact of exposure to famine during fetal development versus infancy (, 2 years postnatal). We sought to assess the impact of exposure to the 1959-1961 Chinese Great Famine (the largest in human history) during fetal development and infancy on the risks of hypertension, short stature and obesity in adulthood. Methodology/Principal Findings: We conducted a retrospective cohort study of 12,065 adults (46-53 years of age) born 1957-1964 in the Zhongshan and Nanhai municipalities of Guangdong province, China. Adjusting for socio-demographic and lifestyle characteristics, as compared to subjects who were unexposed to famine, the risk of hypertension was not significantly elevated in subjects exposed to famine during fetal development only overall, but was 1.36-fold higher in those exposed during the first trimester of pregnancy only [adjusted odds ratio (OR) 1.36 (95% confidence intervals 1.03-1.79)], 1.83-fold higher in those exposed during infancy only [adjusted OR 1.83 (1.61-2.08)], and 1.31-fold higher in those exposed during both fetal development and infancy [adjusted OR 1.31 (1.14-1.51)]. Exposure to famine during infancy increased the risk of short stature. Early life exposure to famine did not increase the risk of obesity. Conclusions/Significance: Exposure to the Chinese Great Famine during the first trimester of pregnancy only, or during infancy only, or during both fetal development and infancy increased the risk of hypertension in adulthood, suggesting an important role of changes in exposure to famine during fetal development and from prenatal to early postnatal life in developmental "programming" cardiovascular disease risk.	[Wang, Pei-Xi; Wang, Jia-Ji; Lei, Yi-Xiong] Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China; [Xiao, Lin; Luo, Zhong-Cheng] Univ Montreal, Dept Obstet & Gynecol, CHU St Justine, Montreal, PQ, Canada	Guangzhou Medical University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Wang, PX (corresponding author), Guangzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China.	peixi001@163.com; zc_luo@yahoo.com	WANG, Jia Ji/E-9059-2015; Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	Nanhai Municipal Health Bureau; Zhongshan Municipal Health Bureau, Guangdong province, China	Nanhai Municipal Health Bureau; Zhongshan Municipal Health Bureau, Guangdong province, China	This project was supported by research grants from the Nanhai Municipal Health Bureau and the Zhongshan Municipal Health Bureau, Guangdong province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bateman BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036171; Bol V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012656; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; de Rooij SR, 2007, AM J CLIN NUTR, V86, P1219, DOI 10.1093/ajcn/86.4.1219; Forsen T, 2000, J INTERN MED, V248, P326, DOI 10.1046/j.1365-2796.2000.00747.x; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Huang C, 2010, J NUTR, V140, P1874, DOI 10.3945/jn.110.121293; Hult M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013582; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Li YP, 2011, J HYPERTENS, V29, P1085, DOI 10.1097/HJH.0b013e328345d969; Luo ZC, 2010, WORLD J DIABETES, V1, P89, DOI 10.4239/wjd.v1.i3.89; MACKENZIE HS, 1995, AM J KIDNEY DIS, V26, P91, DOI 10.1016/0272-6386(95)90161-2; Nuyt AM, 2008, CLIN SCI, V114, P1, DOI 10.1042/CS20070113; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Roseboom TJ, 1999, J HYPERTENS, V17, P325, DOI 10.1097/00004872-199917030-00004; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; Smil V, 1999, BMJ-BRIT MED J, V319, P1619, DOI 10.1136/bmj.319.7225.1619; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Stein AD, 2006, EUR J EPIDEMIOL, V21, P759, DOI 10.1007/s10654-006-9065-2; van Abeelen AFM, 2012, AM J CLIN NUTR, V95, P179, DOI 10.3945/ajcn.111.022038; Wang YH, 2010, OBESITY, V18, P588, DOI 10.1038/oby.2009.296; Wlodek ME, 2007, J AM SOC NEPHROL, V18, P1688, DOI 10.1681/ASN.2007010015; Yang DL, 1996, CALAMITY REFORM CHIN, P38	31	106	112	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49720	10.1371/journal.pone.0049720	http://dx.doi.org/10.1371/journal.pone.0049720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185416	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000094
J	Zhou, AM; Zeng, L; Lu, YY; Xu, YJ; Liang, GW				Zhou, Aiming; Zeng, Ling; Lu, Yongyue; Xu, Yijuan; Liang, Guangwen			Fire Ants Protect Mealybugs against Their Natural Enemies by Utilizing the Leaf Shelters Constructed by the Leaf Roller Sylepta derogata	PLOS ONE			English	Article							PHENACOCCUS-SOLENOPSIS; ARGENTINE ANTS; HYMENOPTERA; FORMICIDAE; MUTUALISM; HONEYDEW; INVICTA	The importance of mutualism is receiving more attention in community ecology. In this study, the fire ant Solenopsis invicta was found to take advantage of the shelters constructed by the leaf roller Sylepta derogata to protect mealybugs (Phenacoccus solenopsis) against their natural enemies. This protective effect of fire ant tending on the survival of mealybugs in shelters was observed when enemies and leaf rollers were simultaneously present. Specifically, fire ants moved the mealybugs inside the shelters produced by S. derogata on enemy-infested plants. Compared with that in plants without ants, the survival of mealybugs in shelters in the presence of natural enemies in plants with ants markedly improved. Both the protection of ants and the shelters provided by leaf rollers did not affect the survival of mealybugs in the absence of enemies in plants. Ants and leaf rollers significantly improved the survival of mealybugs in predator-infested plants, whereas no such improvement was observed in parasitoid-infested ones.	[Zhou, Aiming; Zeng, Ling; Lu, Yongyue; Xu, Yijuan; Liang, Guangwen] S China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou, Guangdong, Peoples R China; [Zhou, Aiming] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China	South China Agricultural University; Huazhong Agricultural University	Xu, YJ (corresponding author), S China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou, Guangdong, Peoples R China.	xuyijuan@yahoo.com; gwliang@scau.edu.cn			National Natural Science Foundation of China [31101498]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31101498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop DB, 2001, ANN ENTOMOL SOC AM, V94, P33, DOI 10.1603/0013-8746(2001)094[0033:EOAMAH]2.0.CO;2; Brightwell RJ, 2010, BIOL INVASIONS, V12, P2051, DOI 10.1007/s10530-009-9607-0; Chen Hua-Yan, 2011, Huanjing Kunchong Xuebao, V33, P269; Daane KM, 2007, ECOL ENTOMOL, V32, P583, DOI 10.1111/j.1365-2311.2007.00910.x; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Helms KR, 2003, INSECT SOC, V50, P403, DOI 10.1007/s00040-003-0702-4; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Liu Fang, 2005, Chinese Bulletin of Entomology, V42, P275; [陆永跃 LU Yong-Yue], 2008, [环境昆虫学报, Journal of Environmental Entomology], V30, P386; Michaud JP, 1999, FLA ENTOMOL, V82, P424, DOI 10.2307/3496869; Misra HP, 2002, ANN PLANT PROTECTION, P51; Mittler T. E., 1958, Proceedings of the Royal Entomological Society of London (A), V33, P49; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Renault CK, 2005, ECOL RES, V20, P71, DOI 10.1007/s11284-004-0015-8; Stadler B, 1998, J ANIM ECOL, V67, P454, DOI 10.1046/j.1365-2656.1998.00209.x; Vennila S, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11501; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Xu YJ, 2011, SOCIOBIOLOGY, V58, P119; Zeng L, 2005, MONITOR CONTROL FIRE; [曾玲 Zeng Ling], 2005, [昆虫知识, Entomological  Knowledge], V42, P144; Zhou AM, 2012, SOCIOBIOLOGY, V59, P71; Zhou AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041856	25	13	16	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49982	10.1371/journal.pone.0049982	http://dx.doi.org/10.1371/journal.pone.0049982			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185505	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000156
J	Barrett, E; Fitzgerald, P; Dinan, TG; Cryan, JF; Ross, RP; Quigley, EM; Shanahan, F; Kiely, B; Fitzgerald, GF; O'Toole, PW; Stanton, C				Barrett, Eoin; Fitzgerald, Patrick; Dinan, Timothy G.; Cryan, John F.; Ross, R. Paul; Quigley, Eamonn M.; Shanahan, Fergus; Kiely, Barry; Fitzgerald, Gerald F.; O'Toole, Paul W.; Stanton, Catherine			Bifidobacterium breve with alpha-Linolenic Acid and Linoleic Acid Alters Fatty Acid Metabolism in the Maternal Separation Model of Irritable Bowel Syndrome	PLOS ONE			English	Article							ADIPOSE-TISSUE; DPC 6330; MICROBIOTA; STRESS; CHAIN; PROBIOTICS; BEHAVIOR; INFANTS; RATS; SUPPLEMENTATION	The aim of this study was to compare the impact of dietary supplementation with a Bifidobacterium breve strain together with linoleic acid & alpha-linolenic acid, for 7 weeks, on colonic sensitivity and fatty acid metabolism in rats. Maternally separated and non-maternally separated Sprague Dawley rats (n = 15) were orally gavaged with either B. breve DPC6330 (10(9) microorganisms/day) alone or in combination with 0.5% (w/w) linoleic acid & 0.5% ( w/w) alpha-linolenic acid, daily for 7 weeks and compared with trehalose and bovine serum albumin. Tissue fatty acid composition was assessed by gas-liquid chromatography and visceral hypersensitivity was assessed by colorectal distension. Significant differences in the fatty acid profiles of the non-separated controls and maternally separated controls were observed for alpha-linolenic acid and arachidonic acid in the liver, oleic acid and eicosenoic acid (c11) in adipose tissue, and for palmitoleic acid and docosahexaenoic acid in serum (p<0.05). Administration of B. breve DPC6330 to MS rats significantly increased palmitoleic acid, arachidonic acid and docosahexaenoic acid in the liver, eicosenoic acid (c11) in adipose tissue and palmitoleic acid in the prefrontal cortex (p<0.05), whereas feeding B. breve DPC6330 to non separated rats significantly increased eicosapentaenoic acid and docosapentaenoic acid in serum (p<0.05) compared with the NS un-supplemented controls. Administration of B. breve DPC6330 in combination with linoleic acid and alpha-linolenic acid to maternally separated rats significantly increased docosapentaenoic acid in the serum (p<0.01) and alpha-linolenic acid in adipose tissue (p<0.001), whereas feeding B. breve DPC6330 with fatty acid supplementation to non-separated rats significantly increased liver and serum docosapentaenoic acid (p<0.05), and alpha-linolenic acid in adipose tissue (p<0.001). B. breve DPC6330 influenced host fatty acid metabolism. Administration of B. breve DPC6330 to maternally separated rats significantly modified the palmitoleic acid, arachidonic acid and docosahexaenoic acid contents in tissues. The effect was not observed in non-separated animals.	[Barrett, Eoin; Fitzgerald, Patrick; Dinan, Timothy G.; Cryan, John F.; Ross, R. Paul; Quigley, Eamonn M.; Shanahan, Fergus; Kiely, Barry; Fitzgerald, Gerald F.; O'Toole, Paul W.; Stanton, Catherine] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Alimentary Pharmabiot Ctr, Cork, Ireland; [Barrett, Eoin; Ross, R. Paul; Stanton, Catherine] TEAGASC, Food Res Ctr, Fermoy, Cork, Ireland; [Fitzgerald, Gerald F.; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland	University College Cork; Teagasc; University College Cork	Stanton, C (corresponding author), Natl Univ Ireland Univ Coll Cork, Biosci Inst, Alimentary Pharmabiot Ctr, Cork, Ireland.	catherine.stanton@teagasc.ie	Dinan, Timothy/ABA-8284-2020; O'Toole, Paul W/G-1593-2012; Stanton, Catherine/A-9549-2015; Ross, Paul/A-7584-2015; Cryan, John F./A-6950-2013; Shanahan, Fergus/ABF-2390-2020	O'Toole, Paul W/0000-0001-5377-0824; Stanton, Catherine/0000-0002-6724-7011; Ross, Paul/0000-0003-4876-8839; Cryan, John F./0000-0001-5887-2723; Shanahan, Fergus/0000-0003-0467-0936; Dinan, Timothy/0000-0002-2316-7220	Science Foundation of Ireland; Alimentary Pharmabiotic Centre	Science Foundation of Ireland(Science Foundation Ireland); Alimentary Pharmabiotic Centre(Science Foundation Ireland)	This work was supported by the Science Foundation of Ireland - funded Centre for Science, Engineering and Technology, the Alimentary Pharmabiotic Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allergies PoDPNa, 2009, EFSA J, V1000, P1; Appleton KM, 2008, NUTR RES REV, V21, P13, DOI 10.1017/S0954422408998620; Arebi N, 2008, ALIMENT PHARM THER, V28, P830, DOI 10.1111/j.1365-2036.2008.03801.x; Barreau F, 2007, PEDIATR RES, V62, P240, DOI 10.1203/PDR.0b013e3180db2949; Bassaganya-Riera J, 2002, CLIN NUTR, V21, P451, DOI 10.1054/clnu.2002.0594; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Browning LM, 2003, P NUTR SOC, V62, P447, DOI 10.1079/PNS2003252; Calder PC, 2005, POLYUNSATURATED FATT, P197; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chierici R, 2003, ACTA PAEDIATR, V92, P56; Clarke G, 2012, ALIMENT PHARM THER, V35, P403, DOI 10.1111/j.1365-2036.2011.04965.x; Clarke G, 2010, J LIPID RES, V51, P1186, DOI 10.1194/jlr.P000695; Clarke G, 2009, BEHAV BRAIN RES, V205, P319, DOI 10.1016/j.bbr.2009.07.008; Das UN, 2000, PROSTAG LEUKOTR ESS, V63, P351, DOI 10.1054/plef.2000.0226; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P455, DOI 10.2174/138920106779116810; De Fabiani E, 2011, EUR J LIPID SCI TECH, V113, P809, DOI 10.1002/ejlt.201100187; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Dinan TG, 2008, AM J GASTROENTEROL, V103, P2570, DOI 10.1111/j.1572-0241.2008.01871.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Drossman DA, 1998, PSYCHOSOM MED, V60, P258, DOI 10.1097/00006842-199805000-00007; Dulin WE, 1956, EFFECTS CORTICOSTERO, P253; Eutamene H, 2007, J NUTR, V137, P1901, DOI 10.1093/jn/137.8.1901; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukushima M, 1999, NUTRITION, V15, P373, DOI 10.1016/S0899-9007(99)00030-1; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; Gaullier JM, 2004, AM J CLIN NUTR, V79, P1118; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guinane CM, 2011, J BACTERIOL, V193, P6799, DOI 10.1128/JB.06196-11; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Hennessy AA, 2011, LIPIDS, V46, P105, DOI 10.1007/s11745-010-3501-5; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Ip MM, 2003, J MAMMARY GLAND BIOL, V8, P103, DOI 10.1023/A:1025739506536; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; Kelley DS, 2006, PROSTAG LEUKOTR ESS, V74, P331, DOI 10.1016/j.plefa.2006.02.008; Kirjavainen PV, 2002, GUT, V51, P51, DOI 10.1136/gut.51.1.51; Ladd CO, 1998, LONG TERM BEHAV NEUR, P81; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maekawa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005085; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Mayer EA, 2000, GUT, V47, P861, DOI 10.1136/gut.47.6.861; McKernan DP, 2010, NEUROGASTROENT MOTIL, V22, P1029, DOI 10.1111/j.1365-2982.2010.01520.x; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; O'Flaherty S, 2010, INT DAIRY J, V20, P262, DOI 10.1016/j.idairyj.2009.11.011; O'Mahony S, 2008, NEUROGASTROENT MOTIL, V20, P680, DOI 10.1111/j.1365-2982.2007.01065.x; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; O'Sullivan E, 2011, BENEF MICROBES, V2, P199, DOI 10.3920/BM2011.0015; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rise P, 2002, PROSTAG LEUKOTR ESS, V67, P85, DOI 10.1054/plef.2002.0403; SAAVEDRA JM, 1994, LANCET, V344, P1046, DOI 10.1016/S0140-6736(94)91708-6; Sanders TAB, 2000, AM J CLIN NUTR, V71, p176S, DOI 10.1093/ajcn/71.1.176s; Sauma L, 2006, NUTRITION, V22, P60, DOI 10.1016/j.nut.2005.04.011; Solakivi T, 2011, SCAND J GASTROENTERO, V46, P299, DOI 10.3109/00365521.2010.533380; Thompson WG, 2001, EUR J GASTROEN HEPAT, V13, P1135, DOI 10.1097/00042737-200110000-00001; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Wall R, 2012, AM J CLIN NUTR, V95, P1278, DOI 10.3945/ajcn.111.026435; Wall R, 2010, LIPIDS, V45, P429, DOI 10.1007/s11745-010-3410-7; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wall R, 2009, AM J CLIN NUTR, V89, P1393, DOI 10.3945/ajcn.2008.27023; Welch AA, 2006, AM J CLIN NUTR, V84, P1330, DOI 10.1093/ajcn/84.6.1330; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013	72	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48159	10.1371/journal.pone.0048159	http://dx.doi.org/10.1371/journal.pone.0048159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185248	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700007
J	Sun, PH; Ye, L; Mason, MD; Jiang, WG				Sun, Ping-Hui; Ye, Lin; Mason, Malcolm D.; Jiang, Wen G.			Protein Tyrosine Phosphatase mu (PTP mu or PTPRM), a Negative Regulator of Proliferation and Invasion of Breast Cancer Cells, Is Associated with Disease Prognosis	PLOS ONE			English	Article							E-CADHERIN; IN-VIVO; EXPRESSION; MUTATIONS; MIGRATION; PATHWAY; CARCINOMA; CATENINS; ADHESION; IMPACT	Background: PTPRM has been shown to exhibit homophilic binding and confer cell-cell adhesion in cells including epithelial and cancer cells. The present study investigated the expression of PTPRM in breast cancer and the biological impact of PTPRM on breast cancer cells. Design: Expression of PTPRM protein and gene transcript was examined in a cohort of breast cancer patients. Knockdown of PTPRM in breast cancer cells was performed using a specific anti-PTPRM transgene. The impact of PTPRM knockdown on breast cancer was evaluated using in vitro cell models. Results: A significant decrease of PTPRM transcripts was seen in poorly differentiated and moderately differentiated tumours compared with well differentiated tumours. Patients with lower expression of PTPRM had shorter survival compared with those which had a higher level of PTPRM expression. Knockdown of PTPRM increased proliferation, adhesion, invasion and migration of breast cancer cells. Furthermore, knockdown of PTPRM in MDA-MB-231 cells resulted in increased cell migration and invasion via regulation of the tyrosine phosphorylation of ERK and JNK. Conclusions: Decreased expression of PTPRM in breast cancer is correlated with poor prognosis and inversely correlated with disease free survival. PTPRM coordinated cell migration and invasion through the regulation of tyrosine phosphorylation of ERK and JNK.	[Sun, Ping-Hui; Ye, Lin; Mason, Malcolm D.; Jiang, Wen G.] Cardiff Univ, Sch Med, Inst Canc & Genet, Metastasis & Angiogenesis Res Grp, Cardiff, S Glam, Wales	Cardiff University	Sun, PH (corresponding author), Cardiff Univ, Sch Med, Inst Canc & Genet, Metastasis & Angiogenesis Res Grp, Cardiff, S Glam, Wales.	sunp2@cf.ac.uk	Jiang, Wen G./AAF-1876-2020; Ye, Lin/G-9819-2016; Jiang, Wen G/B-1293-2010; jiang, wen/GYI-9662-2022; Mason, Malcolm D/H-6979-2013	Jiang, Wen G./0000-0002-3283-1111; Ye, Lin/0000-0002-0303-2409; Jiang, Wen G/0000-0002-3283-1111; 	Cancer Research Wales and Breast Cancer Hope Foundation	Cancer Research Wales and Breast Cancer Hope Foundation	The present study was supported by Cancer Research Wales and Breast Cancer Hope Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers-Loustau A, 1999, BIOCHEM CELL BIOL, V77, P493, DOI 10.1139/bcb-77-6-493; Becka S, 2010, CELL COMMUN ADHES, V17, P34, DOI 10.3109/15419061.2010.487957; Blanquart C, 2010, BIOCHEM BIOPH RES CO, V392, P83, DOI 10.1016/j.bbrc.2009.12.176; BRADYKALNAY SM, 1993, J CELL BIOL, V122, P961, DOI 10.1083/jcb.122.4.961; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Freiss G, 2004, CRIT REV ONCOL HEMAT, V52, P9, DOI 10.1016/j.critrevonc.2004.05.004; Giefing M, 2011, GENE CHROMOSOME CANC, V50, P154, DOI 10.1002/gcc.20840; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Halle M, 2007, CELL CYCLE, V6, P2773, DOI 10.4161/cc.6.22.4926; Hellberg CB, 2002, J BIOL CHEM, V277, P11165, DOI 10.1074/jbc.M112157200; Hiscox S, 1998, INT J ONCOL, V13, P1077; Hyun SW, 2011, EXP LUNG RES, V37, P327, DOI 10.3109/01902148.2011.566673; Iuliano R, 2004, ONCOGENE, V23, P8432, DOI 10.1038/sj.onc.1207766; Jiang WG, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-71; Jiang WG, 2005, CLIN CANCER RES, V11, P6012, DOI 10.1158/1078-0432.CCR-05-0275; Jiang WG, 2004, ENDOCR-RELAT CANCER, V11, P781, DOI 10.1677/erc.1.00825; Jiang WG, 1999, CLIN CANCER RES, V5, P3695; JIANG WG, 1995, CANCER RES, V55, P5043; Li W, 2010, BIOL REPROD, V83, P481, DOI 10.1095/biolreprod.109.082578; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Nakamura M, 2003, CANCER RES, V63, P737; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Phillips-Mason PJ, 2011, J CELL BIOCHEM, V112, P39, DOI 10.1002/jcb.22710; Rosdahl JA, 2002, MOL CELL NEUROSCI, V19, P292, DOI 10.1006/mcne.2001.1071; Ruivenkamp C, 2003, ONCOGENE, V22, P3472, DOI 10.1038/sj.onc.1206246; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sarmiento N, 2010, PANCREAS, V39, P639, DOI 10.1097/MPA.0b013e3181c314b3; Schiller KR, 2005, J CELL BIOCHEM, V96, P262, DOI 10.1002/jcb.20515; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Zheng J, 2000, ANTICANCER RES, V20, P11; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50183	10.1371/journal.pone.0050183	http://dx.doi.org/10.1371/journal.pone.0050183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185569	gold, Green Submitted, Green Published			2022-12-25	WOS:000311535700076
J	Szuroczki, D; Richardson, JML				Szuroczki, Dorina; Richardson, Jean M. L.			The Behavioral Response of Larval Amphibians (Ranidae) to Threats from Predators and Parasites	PLOS ONE			English	Article							ANTIPARASITE BEHAVIOR; ECHINOSTOMA-TRIVOLVIS; RANA TADPOLES; CERCARIAE; ANURANS; RISK; ECOLOGY; CONSEQUENCES; ANTIPREDATOR; TRANSMISSION	Organisms are exposed to strong selective pressures from several sources, including predators and pathogens. Response to such interacting selective pressures may vary among species that differ in life history and ecology in predictable ways. We consider the impact of multiple enemies (fish predators and trematode parasites) on the behavior of larvae of three anuran species (Lithobates (= Rana) sylvaticus, L. clamitans and L. catesbeianus). We show that the three ranid species differ in response to the trade-off imposed by the simultaneous presence of fish predators and trematode parasites in the environment. Two more permanent pond breeders (L. clamitans and L. catesbeianus), which commonly encounter parasites and fish, increased activity when in the combined presence of parasites and a fish predator, resulting in a relatively lower parasite encystment rate. In contrast, the temporary pond breeder (L. sylvaticus), which does not commonly encounter fish in the wild, decreased activity in the combined presence of a fish predator and parasites similar to when only the predator was present. For L. sylvaticus, this suggests that the presence of an unknown predator poses a greater threat than parasites. Further, the presence of fish along with parasites increased the susceptibility of both L. sylvaticus and L. clamitans to trematode infection, whereas parasite infection in L. catesbeianus was unaffected by the presence of fish. Unpalatability to fish may allow some species to respond more freely to attacking parasites in the presence of fish. The results from this study highlight the importance of considering multiple selective pressures faced by organisms and how this shapes their behavior.	[Szuroczki, Dorina; Richardson, Jean M. L.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada	Brock University	Szuroczki, D (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	dorina.szuroczki@utoronto.ca	Richardson, Jean/D-2702-2014		National Science and Engineering Council of Canada [261587-03]; Innovation Trust [9369]; Department of Biological Sciences, Brock University	National Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Innovation Trust; Department of Biological Sciences, Brock University	This work was supported by the National Science and Engineering Council of Canada (DG # 261587-03 to JMLR), Innovation Trust (Project # 9369 to JMLR) and the Department of Biological Sciences, Brock University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Baker RL, 1997, OECOLOGIA, V109, P622, DOI 10.1007/s004420050125; Belden LK, 2011, OECOLOGIA, V166, P1077, DOI 10.1007/s00442-011-1946-8; BLUMSTEIN DT, 2000, JWATCHER 0 9 INTRO U; Crawley MJ., 2007, R BOOK; Daly EW, 2011, OECOLOGIA, V165, P1043, DOI 10.1007/s00442-010-1778-y; Decaestecker E, 2002, P NATL ACAD SCI USA, V99, P5481, DOI 10.1073/pnas.082543099; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fried B, 1997, PARASITOL RES, V83, P666, DOI 10.1007/s004360050316; Gosner K. L., 1960, Herpetologica, V16, P183; Harding JH, 2006, AMPHIBIANS REPTILES; Hatcher MJ, 2006, ECOL LETT, V9, P1253, DOI 10.1111/j.1461-0248.2006.00964.x; Huffman J. E., 1990, Advances in Parasitology, V29, P215, DOI 10.1016/S0065-308X(08)60107-4; Johnson PTJ, 2004, ADV PARASIT, V57, P191, DOI 10.1016/S0065-308X(04)57003-3; Johnson PTJ, 2008, BIOL ECHINOSTOMES; Keeler Shamus P., 2009, P61, DOI 10.1007/978-0-387-09577-6_3; Kiesecker JM, 2000, ECOLOGY, V81, P2939, DOI 10.1890/0012-9658(2000)081[2939:COOSBG]2.0.CO;2; Koprivnikar J, 2006, CAN J ZOOL, V84, P1623, DOI 10.1139/Z06-158; Koprivnikar J, 2012, P ROY SOC B-BIOL SCI, V279, P1544, DOI 10.1098/rspb.2011.2156; LAWLER SP, 1989, ANIM BEHAV, V38, P1039, DOI 10.1016/S0003-3472(89)80142-3; LIEM KAREL F., 1961, HERPETOLOGICA, V17, P69; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; NAJARIAN HAIG H., 1955, AMER MIDLAND NAT, V53, P195, DOI 10.2307/2422309; Orlofske SA, 2012, ECOLOGY, V93, P1247, DOI 10.1890/11-1901.1; Prudhoe S, 1982, PLATYHELMINTH PARASI; R Core Team, 2011, R LANG ENV STAT COMP; Raffel TR, 2008, TRENDS ECOL EVOL, V23, P610, DOI 10.1016/j.tree.2008.06.015; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Richardson JML, 2001, BEHAV ECOL, V12, P51, DOI 10.1093/oxfordjournals.beheco.a000378; Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6; Schell S. C., 1970, KNOW TREMATODES; Schotthoefer AM, 2003, J PARASITOL, V89, P475, DOI 10.1645/0022-3395(2003)089[0475:ROTSTL]2.0.CO;2; SEALE DB, 1979, OECOLOGIA, V39, P259, DOI 10.1007/BF00345438; Skelly David K., 2006, P153; Szuroczki D, 2011, HERPETOLOGICA, V67, P213, DOI 10.1655/HERPETOLOGICA-D-10-00059.1; Szuroczki D, 2009, OECOLOGIA, V161, P371, DOI 10.1007/s00442-009-1388-8; Taylor CN, 2004, CAN J ZOOL, V82, P701, DOI [10.1139/z04-037, 10.1139/Z04-037]; Taylor R.J., 1984, PREDATION; Thiemann GW, 2000, BIOL J LINN SOC, V71, P513, DOI [10.1111/j.1095-8312.2000.tb01272.x, 10.1006/bijl.2000.0459]; Thiemann GW, 2000, J ZOOL, V252, P534, DOI 10.1111/j.1469-7998.2000.tb01236.x; Van Buskirk J, 1998, BIOL J LINN SOC, V65, P301, DOI 10.1006/bijl.1998.0249; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2	42	20	20	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49592	10.1371/journal.pone.0049592	http://dx.doi.org/10.1371/journal.pone.0049592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185374	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700040
J	Mu, J; Qureshi, SA; Brady, EJ; Muise, ES; Candelore, MR; Jiang, GQ; Li, ZH; Wu, MS; Yang, XD; Dallas-Yang, Q; Miller, C; Xiong, YS; Langdon, RB; Parmee, ER; Zhang, BB				Mu, James; Qureshi, Sajjad A.; Brady, Edward J.; Muise, Eric S.; Candelore, Mari Rios; Jiang, Guoqiang; Li, Zhihua; Wu, Margaret S.; Yang, Xiaodong; Dallas-Yang, Qing; Miller, Corey; Xiong, Yusheng; Langdon, Ronald B.; Parmee, Emma R.; Zhang, Bei B.			Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist	PLOS ONE			English	Article							GLUCOSE-PRODUCTION; KNOCKOUT MICE; DIABETES-MELLITUS; IN-VIVO; HYPERGLUCAGONEMIA; DISCOVERY; GENE; HYPERGLYCEMIA; EXPRESSION; POTENT	Hyperglucagonemia is implicated in the pathophysiology of hyperglycemia. Antagonism of the glucagon receptor (GCGR) thus represents a potential approach to diabetes treatment. Herein we report the characterization of GRA1, a novel small-molecule GCGR antagonist that blocks glucagon binding to the human GCGR (hGCGR) and antagonizes glucagon-induced intracellular accumulation of cAMP with nanomolar potency. GRA1 inhibited glycogenolysis dose-dependently in primary human hepatocytes and in perfused liver from hGCGR mice, a transgenic line of mouse that expresses the hGCGR instead of the murine GCGR. When administered orally to hGCGR mice and rhesus monkeys, GRA1 blocked hyperglycemic responses to exogenous glucagon. In several murine models of diabetes, acute and chronic dosing with GRA1 significantly reduced blood glucose concentrations and moderately increased plasma glucagon and glucagon-like peptide-1. Combination of GRA1 with a dipeptidyl peptidase-4 inhibitor had an additive antihyperglycemic effect in diabetic mice. Hepatic gene-expression profiling in monkeys treated with GRA1 revealed down-regulation of numerous genes involved in amino acid catabolism, an effect that was paralleled by increased amino acid levels in the circulation. In summary, GRA1 is a potent glucagon receptor antagonist with strong antihyperglycemic efficacy in preclinical models and prominent effects on hepatic gene-expression related to amino acid metabolism.	[Mu, James; Qureshi, Sajjad A.; Brady, Edward J.; Muise, Eric S.; Candelore, Mari Rios; Jiang, Guoqiang; Li, Zhihua; Wu, Margaret S.; Yang, Xiaodong; Dallas-Yang, Qing; Miller, Corey; Xiong, Yusheng; Langdon, Ronald B.; Parmee, Emma R.; Zhang, Bei B.] Merck Sharp & Dohme Corp, Merck Res Labs, Discovery & Preclin Sci, Whitehouse Stn, NJ USA	Merck & Company	Mu, J (corresponding author), Merck Sharp & Dohme Corp, Merck Res Labs, Discovery & Preclin Sci, Whitehouse Stn, NJ USA.	yingjun_mu@merck.com		Mu, James/0000-0001-8081-2401; Muise, Eric/0000-0002-1238-5118				Bagger JI, 2011, DIABETES OBES METAB, V13, P965, DOI 10.1111/j.1463-1326.2011.01427.x; Burcelin R, 1996, DIABETES METAB, V22, P373; Charlton MR, 1996, J CLIN INVEST, V98, P90, DOI 10.1172/JCI118782; Cohen SM, 2006, BIOORGAN MED CHEM, V14, P1506, DOI 10.1016/j.bmc.2005.10.008; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Cryer Philip E, 2008, Endocr Pract, V14, P750; Dallas-Yang Q, 2004, EUR J PHARMACOL, V501, P225, DOI 10.1016/j.ejphar.2004.08.023; Duffy JL, 2005, BIOORG MED CHEM LETT, V15, P1401, DOI 10.1016/j.bmcl.2005.01.003; Eldor R, 2011, CLIN ENDOCRINOL, V74, P593, DOI 10.1111/j.1365-2265.2011.03967.x; Engel SS, 2011, DIABETES, V60, pA85; Engel SS, 2011, EFFICACY SAFETY GLUC; FLAKOLL PJ, 1994, METABOLISM, V43, P1509, DOI 10.1016/0026-0495(94)90009-4; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Hebert SL, 2010, CLIN NUTR, V29, P13, DOI 10.1016/j.clnu.2009.09.001; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kim RM, 2008, BIOORG MED CHEM LETT, V18, P3701, DOI 10.1016/j.bmcl.2008.05.072; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; LOK S, 1994, GENE, V140, P203, DOI 10.1016/0378-1119(94)90545-2; Mang Y, 2004, DIABETES, V53, P410; Mu J, 2011, DIABETOLOGIA, V54, P2381, DOI 10.1007/s00125-011-2217-2; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; Parker JC, 2002, BIOCHEM BIOPH RES CO, V290, P839, DOI 10.1006/bbrc.2001.6265; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Rivera N, 2007, J PHARMACOL EXP THER, V321, P743, DOI 10.1124/jpet.106.115717; Ruddy M, 2011, DIABETES, V60, pA85; Shah P, 2000, J CLIN ENDOCR METAB, V85, P4053, DOI 10.1210/jc.85.11.4053; Shen DM, 2005, BIOORG MED CHEM LETT, V15, P4564, DOI 10.1016/j.bmcl.2005.06.101; Shen DM, 2011, EXPERT OPIN THER PAT, V21, P1211, DOI 10.1517/13543776.2011.587001; Shen DM, 2011, BIOORG MED CHEM LETT, V21, P76, DOI 10.1016/j.bmcl.2010.11.074; Shiao LL, 1999, TRANSGENIC RES, V8, P295, DOI 10.1023/A:1008922521461; Sloop KW, 2005, EXPERT OPIN THER TAR, V9, P593, DOI 10.1517/14728222.9.3.593; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Toft I, 2002, METABOLISM, V51, P1128, DOI 10.1053/meta.2002.34702; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; UNGER RH, 1978, METABOLISM, V27, P1691, DOI 10.1016/0026-0495(78)90291-3; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Winzell MS, 2007, DIABETOLOGIA, V50, P1453, DOI 10.1007/s00125-007-0675-3; Xiong YS, 2012, J MED CHEM, V55, P6137, DOI 10.1021/jm300579z; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009; Yang JX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-281; Zhang BB, 2000, CURR OPIN CHEM BIOL, V4, P461, DOI 10.1016/S1367-5931(00)00103-4; Zhao WQ, 2010, MOL PHARMACOL, V78, P350, DOI 10.1124/mol.110.064980	45	42	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49572	10.1371/journal.pone.0049572	http://dx.doi.org/10.1371/journal.pone.0049572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185367	gold, Green Published, Green Submitted			2022-12-25	WOS:000311333800036
J	Norgren, N; Hellman, U; Ericzon, BG; Olsson, M; Suhr, OB				Norgren, Nina; Hellman, Urban; Ericzon, Bo Goran; Olsson, Malin; Suhr, Ole B.			Allele Specific Expression of the Transthyretin Gene in Swedish Patients with Hereditary Transthyretin Amyloidosis (ATTR V30M) Is Similar between the Two Alleles	PLOS ONE			English	Article							BINDING-SITE; POLYNEUROPATHY; VARIANTS; DISEASE; RISK	Background: Hereditary transthyretin (TTR) amyloidosis (ATTR) is an autosomal dominant disease characterized by extracellular deposits of amyloid fibrils composed of misfolded TTR. The differences in penetrance and age at onset are vast, both between and within populations, with a generally late onset for Swedish carriers. In a recent study the entire TTR gene including the 3' UTR in Swedish, French and Japanese ATTR patients was sequenced. The study disclosed a SNP in the V30M TTR 3' UTR of the Swedish ATTR population that was not present in either the French or the Japanese populations (rs62093482-C > T). This SNP could create a new binding site for miRNA, which would increase degradation of the mutated TTR's mRNA thus decrease variant TTR formation and thereby delay the onset of the disease. The aim of the present study was to disclose differences in allele specific TTR expression among Swedish V30M patients, and to see if selected miRNA had any effect upon the expression. Methodology/Principal Findings: Allele-specific expression was measured on nine liver biopsies from Swedish ATTR patients using SNaPshot Multiplex assay. Luciferase activity was measured on cell lines transfected with constructs containing the TTR 3' UTR. Allele-specific expression measured on liver biopsies from Swedish ATTR patients showed no difference in expression between the two alleles. Neither was there any difference in expression between cell lines co-transfected with two constructs with or without the TTR 3' UTR SNP regardless of added miRNA. Conclusions/Significance: The SNP found in the 3' UTR of the TTR gene has no effect on degrading the variant allele's expression and thus has no impact on the diminished penetrance of the trait in the Swedish population. However, the 3' UTR SNP is unique for patients descending from the Swedish founder, and this SNP could be utilized to identify ATTR patients of Swedish descent.	[Norgren, Nina; Hellman, Urban; Olsson, Malin; Suhr, Ole B.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Ericzon, Bo Goran] Karolinska Inst, Div Transplantat Surg, Stockholm, Sweden	Umea University; Karolinska Institutet	Norgren, N (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	nina.norgren@medicin.umu.se	Ericzon, Bo-Goran/AAH-5328-2020; Hellman, Urban/L-7820-2019	Hellman, Urban/0000-0002-3822-0725; Suhr, Ole/0000-0002-1175-2369; Olsson, Malin/0000-0002-5300-6487	Swedish Heart and Lung Foundation; Central grant; Clinical ALF grant; Vasterbottens county; FAMY/AMYL; Norr- and Vasterbotten	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Central grant; Clinical ALF grant; Vasterbottens county; FAMY/AMYL; Norr- and Vasterbotten	The study was supported by grants from the Swedish Heart and Lung Foundation (http://www.hjart-lungfonden.se/), Central and Clinical ALF grants, Spearhead grant from Vasterbottens county, and research support from the patients' associations FAMY/AMYL, Norr- and Vasterbotten (http://www.famynorrbotten.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2011, EUR HEART J; Coelho TML, 2011, 8 INT S FAM AM POL; Coelho TSO, 2011, 8 INT S FAM AM POL K; Hanes D, 1996, Adv Food Nutr Res, V40, P149, DOI 10.1016/S1043-4526(08)60025-X; Hellman U, 2008, AMYLOID, V15, P181, DOI 10.1080/13506120802193720; HOLMGREN G, 1993, ACTA NEUROL SCAND, V87, P124; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Laguette MJ, 2011, MATRIX BIOL, V30, P338, DOI 10.1016/j.matbio.2011.05.001; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Monia BPAE, 2011, 8 INT S FAM AM POL K; Olsson M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-130; Plante-Bordeneuve V, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.11.e120; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; Ribeiro-Silva C, 2011, AMYLOID, V18, P191, DOI 10.3109/13506129.2011.614295; Sato T, 2007, EMBO J, V26, P2501, DOI 10.1038/sj.emboj.7601685; Soares ML, 2004, EUR J HUM GENET, V12, P225, DOI 10.1038/sj.ejhg.5201095; Suhr O, 1998, EUR J CLIN INVEST, V28, P687; Ueda M, 2009, CLIN CHEM, V55, P1223, DOI 10.1373/clinchem.2008.118505; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021	20	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49981	10.1371/journal.pone.0049981	http://dx.doi.org/10.1371/journal.pone.0049981			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185504	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800064
J	Ahrens, S; Geissler, B; Satchell, KJF				Ahrens, Sebastian; Geissler, Brett; Satchell, Karla J. F.			Identification of a His-Asp-Cys Catalytic Triad Essential for Function of the Rho Inactivation Domain (RID) of Vibrio cholerae MARTX Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING DOMAIN; RTX TOXIN; GENE-CLUSTER; ACTIN; INTESTINE; RESIDUES; DELIVERY	Vibrio cholerae is the causative agent of the severe diarrheal disease cholera. For V. cholerae to colonize the intestinal epithelium, accessory toxins such as the multifunctional autoprocessing repeats-in-toxin (MARTX(Vc)) toxin are required. MARTX toxins are composite toxins comprised of arrayed effector domains that carry out distinct functions inside the host cell. Among the three effector domains of MARTX(Vc) is the Rho inactivation domain (RIDVc) known to cause cell rounding through inactivation of small RhoGTPases. Using alanine scanning mutagenesis in the activity subdomain of RIDVc, four residues, His-2782, Leu-2851, Asp-2854, and Cys-3022, were identified as impacting RIDVc function in depolymerization of the actin cytoskeleton and inactivation of RhoA. Tyr-2807 and Tyr-3015 were identified as important potentially for forming the active structure for substrate contact but are not involved in catalysis or post translational modifications. Finally, V. cholerae strains modified to carry a catalytically inactive RIDVc show that the rate and efficiency of MARTX(Vc) actin cross-linking activity does not depend on a functional RIDVc, demonstrating that these domains function independently in actin depolymerization. Overall, our results indicate a His-Asp-Cys catalytic triad is essential for function of the RID effector domain family shared by MARTX toxins produced by many Gram-negative bacteria.	[Ahrens, Sebastian; Geissler, Brett; Satchell, Karla J. F.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Satchell, KJF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, 320 E Super Ave,Searle 3-525, Chicago, IL 60611 USA.	k-satchell@northwestern.edu	Satchell, Karla/GSN-3100-2022		National Institutes of Health [RO1 AI051490]; Burroughs Wellcome Investigators in Pathogenesis of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigators in Pathogenesis of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI051490 (to K. J. F. S.). This work was also supported by Burroughs Wellcome Investigators in Pathogenesis of Infectious Diseases (to K. J. F. S.).	Ballard JD, 1996, P NATL ACAD SCI USA, V93, P12531, DOI 10.1073/pnas.93.22.12531; Barrett AJ, 2001, BIOL CHEM, V382, P727, DOI 10.1515/BC.2001.088; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Boardman Bethany Kay, 2009, P433; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; Cullinane M, 2008, AUTOPHAGY, V4, P744, DOI 10.4161/auto.6246; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Egerer M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000942; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Geissler B, 2009, MOL MICROBIOL, V73, P858, DOI 10.1111/j.1365-2958.2009.06810.x; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Kwak JS, 2011, P NATL ACAD SCI USA, V108, P1645, DOI 10.1073/pnas.1014339108; Le Roux F, 2011, ENVIRON MICROBIOL, V13, P296, DOI 10.1111/j.1462-2920.2010.02329.x; Li L, 2008, INFECT IMMUN, V76, P2620, DOI 10.1128/IAI.01308-07; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Olivier V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007352; Pei JM, 2009, PROTEINS, V77, P413, DOI 10.1002/prot.22447; Prochazkova K, 2008, J BIOL CHEM, V283, P23656, DOI 10.1074/jbc.M803334200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Queen J, 2012, INFECT IMMUN, V80, P2905, DOI 10.1128/IAI.00356-12; Rasband W., 2006, IMAGEJ; Roig FJ, 2011, APPL ENVIRON MICROB, V77, P657, DOI 10.1128/AEM.01806-10; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Satchell KJF, 2009, TOXINS, V1, P123, DOI 10.3390/toxins1020123; Satchell KJF, 2007, INFECT IMMUN, V75, P5079, DOI 10.1128/IAI.00525-07; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; Shen A, 2009, NAT CHEM BIOL, V5, P469, DOI 10.1038/nchembio.178; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Spyres LM, 2001, INFECT IMMUN, V69, P599, DOI 10.1128/IAI.69.1.599-601.2001	39	27	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1397	1408		10.1074/jbc.M112.396309	http://dx.doi.org/10.1074/jbc.M112.396309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184949	Green Published, hybrid			2022-12-25	WOS:000313570300060
J	Gao, GF; Wieczorek, L; Peachman, KK; Polonis, VR; Alving, CR; Rao, M; Rao, VB				Gao, Guofen; Wieczorek, Lindsay; Peachman, Kristina K.; Polonis, Victoria R.; Alving, Carl R.; Rao, Mangala; Rao, Venigalla B.			Designing a Soluble Near Full-length HIV-1 gp41 Trimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL REGION; BROADLY NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; TYPE-1 ENVELOPE; INTEGRIN ALPHA(4)BETA(7); CONFORMATIONAL-CHANGES; IMMUNODOMINANT DOMAIN; MEMBRANE-FUSION	The HIV-1 envelope spike is a trimer of heterodimers composed of an external glycoprotein gp120 and a transmembrane glycoprotein gp41. gp120 initiates virus entry by binding to host receptors, whereas gp41 mediates fusion between viral and host membranes. Although the basic pathway of HIV-1 entry has been extensively studied, the detailed mechanism is still poorly understood. Design of gp41 recombinants that mimic key intermediates is essential to elucidate the mechanism as well as to develop potent therapeutics and vaccines. Here, using molecular genetics and biochemical approaches, a series of hypotheses was tested to overcome the extreme hydrophobicity of HIV-1 gp41 and design a soluble near full-length gp41 trimer. The two long heptad repeat helices HR1 and HR2 of gp41 ectodomain were mutated to disrupt intramolecular HR1-HR2 interactions but not intermolecular HR1-HR1 interactions. This resulted in reduced aggregation and improved solubility. Attachment of a 27-amino acid foldon at the C terminus and slow refolding channeled gp41 into trimers. The trimers appear to be stabilized in a prehairpin-like structure, as evident from binding of a HR2 peptide to exposed HR1 grooves, lack of binding to hexa-helical bundle specific NC-1 mAb, and inhibition of virus neutralization by broadly neutralizing antibodies 2F5 and 4E10. Fusion to T4 small outer capsid protein, Soc, allowed display of gp41 trimers on the phage nanoparticle. These approaches for the first time led to the design of a soluble gp41 trimer containing both the fusion peptide and the cytoplasmic domain, providing insights into the mechanism of entry and development of gp41-based HIV-1 vaccines.	[Gao, Guofen; Rao, Venigalla B.] Catholic Univ Amer, Dept Biol, Washington, DC 20064 USA; [Wieczorek, Lindsay; Peachman, Kristina K.] Henry M Jackson Fdn Adv Mil Med, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Polonis, Victoria R.; Alving, Carl R.; Rao, Mangala] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA	Catholic University of America; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Rao, VB (corresponding author), Catholic Univ Amer, Dept Biol, 620 Michigan Ave NE, Washington, DC 20064 USA.	rao@cua.edu		Rao, Venigalla/0000-0002-0777-6587	National Institutes of Health [R01AI02725 (NIAID)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R01AI02725 (NIAID).	Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bianchi E, 2010, P NATL ACAD SCI USA, V107, P10655, DOI 10.1073/pnas.1004261107; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Chakrabarti BK, 2011, J VIROL, V85, P8217, DOI 10.1128/JVI.00756-11; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; de Rosny E, 2004, J VIROL, V78, P2627, DOI 10.1128/JVI.78.5.2627-2631.2004; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; GNANN JW, 1987, J VIROL, V61, P2639, DOI 10.1128/JVI.61.8.2639-2641.1987; Greenberg M, 2004, REV MED VIROL, V14, P321, DOI 10.1002/rmv.440; Hager-Braun C, 2006, J IMMUNOL, V176, P7471, DOI 10.4049/jimmunol.176.12.7471; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Kwong P. D., 2012, COLD SPRING HARB PER, V4; Li Q, 2007, J MOL BIOL, V370, P1006, DOI 10.1016/j.jmb.2007.05.008; Li Q, 2006, J MOL BIOL, V363, P577, DOI 10.1016/j.jmb.2006.08.049; Lorizate M, 2006, J MOL BIOL, V360, P45, DOI 10.1016/j.jmb.2006.04.056; Maltez Fernando, 2011, Curr Opin HIV AIDS, V6 Suppl 1, pS21, DOI 10.1097/01.COH.0000410238.80894.81; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; MATHIESEN T, 1989, IMMUNOLOGY, V67, P1; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Meadows DC, 2006, CHEMMEDCHEM, V1, P16, DOI 10.1002/cmdc.200500026; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JK, 2008, IEEE T DIELECT EL IN, V15, P1, DOI 10.1109/T-DEI.2008.4446730; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Peachman KK, 2012, CLIN VACCINE IMMUNOL, V19, P11, DOI 10.1128/CVI.05376-11; Pejchal R, 2010, CURR PHARM DESIGN, V16, P3744, DOI 10.2174/138161210794079173; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Qin L, 2010, J MOL BIOL, V395, P728, DOI 10.1016/j.jmb.2009.10.007; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBINSON WE, 1990, J VIROL, V64, P5301, DOI 10.1128/JVI.64.11.5301-5305.1990; ROBINSON WE, 1991, J VIROL, V65, P4169, DOI 10.1128/JVI.65.8.4169-4176.1991; Sathaliyawala T, 2006, J VIROL, V80, P7688, DOI 10.1128/JVI.00235-06; Scholz C, 2005, J MOL BIOL, V345, P1229, DOI 10.1016/j.jmb.2004.10.091; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; WANG JJG, 1986, P NATL ACAD SCI USA, V83, P6159, DOI 10.1073/pnas.83.16.6159; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	69	17	24	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					234	246		10.1074/jbc.M112.424432	http://dx.doi.org/10.1074/jbc.M112.424432			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184960	Green Published, hybrid			2022-12-25	WOS:000313197200023
J	Lachish, S; Bonsall, MB; Lawson, B; Cunningham, AA; Sheldon, BC				Lachish, Shelly; Bonsall, Michael B.; Lawson, Becki; Cunningham, Andrew A.; Sheldon, Ben C.			Individual and Population-Level Impacts of an Emerging Poxvirus Disease in a Wild Population of Great Tits	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; COWPOX VIRUS-INFECTION; POX-LIKE LESIONS; PARUS-MAJOR; AVIAN POX; MULE DEER; PREVALENCE; SURVIVAL; PREDATION; DYNAMICS	Emerging infectious diseases of wildlife can have severe effects on host populations and constitute a pressing problem for biodiversity conservation. Paridae pox is an unusually severe form of avipoxvirus infection that has recently been identified as an emerging infectious disease particularly affecting an abundant songbird, the great tit (Parus major), in Great Britain. In this study, we study the invasion and establishment of Paridae pox in a long-term monitored population of wild great tits to (i) quantify the impact of this novel pathogen on host fitness and (ii) determine the potential threat it poses to population persistence. We show that Paridae pox significantly reduces the reproductive output of great tits by reducing the ability of parents to fledge young successfully and rear those young to independence. Our results also suggested that pathogen transmission from diseased parents to their offspring was possible, and that disease entails severe mortality costs for affected chicks. Application of multistate mark-recapture modelling showed that Paridae pox causes significant reductions to host survival, with particularly large effects observed for juvenile survival. Using an age-structured population model, we demonstrate that Paridae pox has the potential to reduce population growth rate, primarily through negative impacts on host survival rates. However, at currently observed prevalence, significant disease-induced population decline seems unlikely, although pox prevalence may be underestimated if capture probability of diseased individuals is low. Despite this, because pox-affected model populations exhibited lower average growth rates, this emerging infectious disease has the potential to reduce the resilience of populations to other environmental factors that reduce population size.	[Lachish, Shelly; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England; [Lawson, Becki; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England	University of Oxford; University of Oxford; Zoological Society of London	Lachish, S (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	shelly.lachish@zoo.ox.ac.uk	Cunningham, Andrew A/E-7536-2010; Sheldon, Ben C/A-8056-2010	Sheldon, Ben C/0000-0002-5240-7828; lawson, becki/0000-0003-1706-7140; Bonsall, Michael/0000-0003-0250-0423	Natural Environment Research Council [NE/I028718/1]; European Research Council [AdG250164]; Royal Society Wolfson Research Merit Award; NERC [NE/I028718/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by an Urgency grant from the Natural Environment Research Council (NE/I028718/1), and by a European Research Council Advanced Investigator grant (AdG250164) to BCS. AAC is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, J WILDLIFE DIS, V30, P481, DOI 10.7589/0090-3558-30.4.481; Alley MR, 2010, NEW ZEAL VET J, V58, P218, DOI 10.1080/00480169.2010.68868; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Atkinson CT, 2005, CONDOR, V107, P537, DOI 10.1650/0010-5422(2005)107[0537:POPLAM]2.0.CO;2; Beldomenico PM, 2009, EPIDEMIOL INFECT, V137, P1295, DOI 10.1017/S0950268808001866; Blakey JK, 1999, P 22 INT ORN C DURB, P1364; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bouwhuis S, 2009, P ROY SOC B-BIOL SCI, V276, P2769, DOI 10.1098/rspb.2009.0457; Bouwhuis S, 2012, AM NAT, V179, pE15, DOI 10.1086/663194; Buenestado F, 2004, EPIDEMIOL INFECT, V132, P369, DOI 10.1017/S095026880300178X; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carrete M, 2009, ECOL APPL, V19, P840, DOI 10.1890/07-2134.1; Caswell H, 1989, MATRIX POPULATION MO; CHOQUET R, 2007, E SURGE 1 0 USERS MA; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; CLOBERT J, 1988, J ANIM ECOL, V57, P287, DOI 10.2307/4779; Conner MM, 2008, ANN NY ACAD SCI, V1134, P146, DOI 10.1196/annals.1439.005; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; de Castro F, 2005, ECOL LETT, V8, P117, DOI 10.1111/j.1461-0248.2004.00693.x; Dulberger J, 2010, J WILDLIFE DIS, V46, P1086, DOI 10.7589/0090-3558-46.4.1086; Feore SM, 1997, P ROY SOC B-BIOL SCI, V264, P1457, DOI 10.1098/rspb.1997.0202; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; Gotmark F, 2002, OECOLOGIA, V130, P25, DOI 10.1007/s004420100769; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Jarvi SI, 2008, CONSERV GENET, V9, P339, DOI 10.1007/s10592-007-9346-7; Jennelle CS, 2007, ECOL APPL, V17, P154, DOI 10.1890/1051-0761(2007)017[0154:SDPADP]2.0.CO;2; Kleindorfer S, 2006, J AVIAN BIOL, V37, P69, DOI 10.1111/j.0908-8857.2006.03503.x; Lachish S, 2012, PLOS ONE IN PRESS; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lachish S, 2010, CONSERV BIOL, V24, P841, DOI 10.1111/j.1523-1739.2009.01429.x; Lawson B, 2012, PLOS ONE IN PRESS; Literak I, 2010, EUR J WILDLIFE RES, V56, P529, DOI 10.1007/s10344-009-0345-5; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Parker PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015989; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Perdeck AC, 2000, ARDEA, V88, P99; Perrins C.M., 1979, BRIT TITS; PERRINS CM, 1991, IBIS, V133, P49, DOI 10.1111/j.1474-919X.1991.tb07668.x; Pioz M, 2008, OECOLOGIA, V155, P691, DOI 10.1007/s00442-007-0942-5; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Ritchie B.W., 1995, AVIAN VIRUSES FUNCTI, P285; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; Rohani P, 2010, TRENDS ECOL EVOL, V25, P611, DOI 10.1016/j.tree.2010.07.010; Ryan MJ, 2008, BIOL CONSERV, V141, P1636, DOI 10.1016/j.biocon.2008.04.014; Senar J. C., 2004, Animal Biodiversity and Conservation, V27, P133; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Svensson L., 1992, IDENTIFICATION GUIDE; TATNER P, 1993, J ZOOL, V231, P215, DOI 10.1111/j.1469-7998.1993.tb01913.x; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Tompkins D.M., 2002, P45; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; van Oers K, 2010, J ORNITHOL, V151, P69, DOI 10.1007/s10336-009-0427-x; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; van Riper Charles III, 2007, P131, DOI 10.1002/9780470344668.ch6; VanderWerf EA, 2001, STUD AVIAN BIOL-SER, P247; Vanderwerf EA, 2009, J WILDLIFE MANAGE, V73, P737, DOI 10.2193/2008-284; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wikelski M, 2004, ECOL SOC, V9; Wild MA, 2011, J WILDLIFE DIS, V47, P78, DOI 10.7589/0090-3558-47.1.78; Wilkin TA, 2006, J ANIM ECOL, V75, P604, DOI 10.1111/j.1365-2656.2006.01078.x; Young LC, 2008, J FIELD ORNITHOL, V79, P93, DOI 10.1111/j.1557-9263.2008.00149.x	74	21	21	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48545	10.1371/journal.pone.0048545	http://dx.doi.org/10.1371/journal.pone.0048545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185263	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000015
J	Lai, CH; Huang, SF; Chen, IH; Liao, CT; Wang, HM; Hsieh, LL				Lai, Chih-Hsiung; Huang, Shiang-Fu; Chen, I-How; Liao, Chun-Ta; Wang, Hung-Ming; Hsieh, Ling-Ling			The Mitochondrial DNA Northeast Asia CZD Haplogroup Is Associated with Good Disease-Free Survival among Male Oral Squamous Cell Carcinoma Patients	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; INVASIVE BREAST-CANCER; G10398A POLYMORPHISM; GENETIC RISK; NECK-CANCER; MUTATIONS; LONGEVITY; CHINESE; GENOME; MOUNTAIN	Reprogramming of energy metabolism in cancer cells has been directly/indirectly linked to mitochondria and mitochondrial functional defects and these changes seem to contribute to the development and progression of cancer. Studies have indicated that mitochondrial DNA haplogroups are associated with risk in relation to various diseases including cancer. However, few studies have examined the effect of haplogroups on cancer prognosis outcome. In order to explore the role of haplogroups on oral squamous cell carcinoma (OSCC) prognosis, the mitochondrial genomes of 300 male OSCC patients were comprehensively analyzed by direct sequencing. They were then haplotyped and grouped into four major geographic haplogroups, namely the East Asia AN, Southeast Asia RBF, East Asia MGE and Northeast Asia CZD groups. The Kaplan-Meier plot analysis indicated that individuals who were members of the CZD haplogroup showed a significant association with better disease-free survival (DFS) than the other three haplogroups and this phenomenon still existed after adjusting for tumor stage, differentiation and age at diagnosis (hazard ratio = 0.55; 95% CI = 0.36-0.84). In addition, an interaction between membership of the RBF haplogroup and radiotherapy/chemo-radiotherapy in DFS was also identified. The results strongly support the hypothesis that an individual's haplogroup, by defining their genomic background, plays an important role in tumor behavior and mitochondrially-targeted anticancer drugs are promising future therapeutic approaches.	[Hsieh, Ling-Ling] Chang Gung Univ, Dept Publ Hlth, Tao Yuan, Taiwan; [Lai, Chih-Hsiung] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Huang, Shiang-Fu; Chen, I-How; Liao, Chun-Ta] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Wang, Hung-Ming] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Hsieh, LL (corresponding author), Chang Gung Univ, Dept Publ Hlth, Tao Yuan, Taiwan.	llhsieh@mail.cgu.edu.tw			National Science Council, Executive Yuan, Taiwan [NSC95-2314-B-182-049-MY3, NSC98-2314-B-182-046-MY3]	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Grant NSC95-2314-B-182-049-MY3 and NSC98-2314-B-182-046-MY3 from the National Science Council, Executive Yuan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aikhionbare FO, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-32; Alexe G, 2007, HUM GENET, V121, P347, DOI 10.1007/s00439-007-0330-6; Bailey DM, 2009, J PHYSIOL-LONDON, V587, P73, DOI 10.1113/jphysiol.2008.159855; Balliet RM, 2011, CELL CYCLE, V10, P4065, DOI 10.4161/cc.10.23.18254; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cai XY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006423; Canter JA, 2005, CANCER RES, V65, P8028, DOI 10.1158/0008-5472.CAN-05-1428; Carvalho AL, 2005, INT J CANCER, V114, P806, DOI 10.1002/ijc.20740; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Department of Health, 2011, CANC REG ANN REP 200; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh LL, 2003, CANCER EPIDEM BIOMAR, V12, P439; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022116; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Jin Y, 2012, GENET TEST MOL BIOMA; Juo SHH, 2010, MITOCHONDRION, V10, P294, DOI 10.1016/j.mito.2010.01.001; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Komandur S, 2011, GENET TEST MOL BIOMA, V15, P361, DOI 10.1089/gtmb.2010.0205; Ladiges W, 2010, AGING CELL, V9, P462, DOI 10.1111/j.1474-9726.2010.00579.x; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Li FX, 2011, MITOCHONDRION, V11, P553, DOI 10.1016/j.mito.2011.02.003; Li XY, 2011, MITOCHONDRION, V11, P27, DOI 10.1016/j.mito.2010.06.005; Liao CT, 2006, ORAL ONCOL, V42, P800, DOI 10.1016/j.oraloncology.2005.11.020; Liu SM, 2007, DIABETES RES CLIN PR, V76, P425, DOI 10.1016/j.diabres.2006.09.032; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Massano J, 2006, ORAL SURG ORAL MED O, V102, P67, DOI 10.1016/j.tripleo.2005.07.038; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Mims MP, 2006, CANCER RES, V66, P1880, DOI 10.1158/0008-5472.CAN-05-3774; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mizutani S, 2009, CANCER SCI, V100, P1680, DOI 10.1111/j.1349-7006.2009.01238.x; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; Murakami H, 2002, JPN J PHYSIOL, V52, P247, DOI 10.2170/jjphysiol.52.247; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nishigaki Y, 2007, MITOCHONDRION, V7, P72, DOI 10.1016/j.mito.2006.11.002; Nishigaki Y, 2010, GERIATR GERONTOL INT, V10, pS221, DOI 10.1111/j.1447-0594.2010.00599.x; Sawabe M, 2011, J ATHEROSCLER THROMB, V18, P166, DOI 10.5551/jat.6742; Shen LJ, 2010, ANN NY ACAD SCI, V1201, P26, DOI 10.1111/j.1749-6632.2010.05635.x; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Singh Keshav K., 2009, V471, P291, DOI 10.1007/978-1-59745-416-2_15; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taddei M.L., 2012, J SIGNAL TRANSDUCT; Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008; Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002; Tanaka M, 2000, MECH AGEING DEV, V116, P65, DOI 10.1016/S0047-6374(00)00149-4; Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105; Umetsu Kazuo, 2005, Legal Medicine, V7, P259, DOI 10.1016/j.legalmed.2005.01.005; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Verma Mukesh, 2007, Cancer Res, V67, P437, DOI 10.1158/0008-5472.CAN-06-4119; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang D, 2001, EXP CLIN ENDOCR DIAB, V109, P361, DOI 10.1055/s-2001-17407; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Wang L, 2007, CANCER EPIDEM BIOMAR, V16, P1455, DOI 10.1158/1055-9965.EPI-07-0119; Webb E, 2008, BRIT J CANCER, V99, P2088, DOI 10.1038/sj.bjc.6604805; Wong LJC, 2002, CLIN CHEM, V48, P1901; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zarbo RJ, 2000, HUM PATHOL, V31, P1191; Zhang RX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-155; Zheng SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031322	67	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49684	10.1371/journal.pone.0049684	http://dx.doi.org/10.1371/journal.pone.0049684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185408	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000086
J	Moreno-Lopez, L; Soriano-Mas, C; Delgado-Rico, E; Rio-Valle, JS; Verdejo-Garcia, A				Moreno-Lopez, Laura; Soriano-Mas, Carles; Delgado-Rico, Elena; Rio-Valle, Jacqueline S.; Verdejo-Garcia, Antonio			Brain Structural Correlates of Reward Sensitivity and Impulsivity in Adolescents with Normal and Excess Weight	PLOS ONE			English	Article							HUMAN PARIETAL OPERCULUM; EXECUTIVE FUNCTION; OBESE ADOLESCENTS; ACTIVATION; CORTEX; ASSOCIATION; HIPPOCAMPUS; PERSONALITY; FOOD; BMI	Introduction: Neuroscience evidence suggests that adolescent obesity is linked to brain dysfunctions associated with enhanced reward and somatosensory processing and reduced impulse control during food processing. Comparatively less is known about the role of more stable brain structural measures and their link to personality traits and neuropsychological factors on the presentation of adolescent obesity. Here we aimed to investigate regional brain anatomy in adolescents with excess weight vs. lean controls. We also aimed to contrast the associations between brain structure and personality and cognitive measures in both groups. Methods: Fifty-two adolescents (16 with normal weight and 36 with excess weight) were scanned using magnetic resonance imaging and completed the Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ), the UPPS-P scale, and the Stroop task. Voxel-based morphometry (VBM) was used to assess possible between-group differences in regional gray matter (GM) and to measure the putative differences in the way reward and punishment sensitivity, impulsivity and inhibitory control relate to regional GM volumes, which were analyzed using both region of interest (ROI) and whole brain analyses. The ROIs included areas involved in reward/somatosensory processing (striatum, somatosensory cortices) and motivation/impulse control (hippocampus, prefrontal cortex). Results: Excess weight adolescents showed increased GM volume in the right hippocampus. Voxel-wise volumes of the second somatosensory cortex (SII) were correlated with reward sensitivity and positive urgency in lean controls, but this association was missed in excess weight adolescents. Moreover, Stroop performance correlated with dorsolateral prefrontal cortex volumes in controls but not in excess weight adolescents. Conclusion: Adolescents with excess weight have structural abnormalities in brain regions associated with somatosensory processing and motivation.	[Moreno-Lopez, Laura; Delgado-Rico, Elena; Verdejo-Garcia, Antonio] Univ Granada, Dept Personal Evaluat & Psychol Treatment, Granada, Spain; [Soriano-Mas, Carles] Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain; [Soriano-Mas, Carles] Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos Hlth Inst 3, Granada, Spain; [Rio-Valle, Jacqueline S.] Univ Granada, Dept Nursing, Granada, Spain; [Verdejo-Garcia, Antonio] Univ Granada, Inst Neurosci Federico Oloriz, Granada, Spain	University of Granada; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Granada; University of Granada	Verdejo-Garcia, A (corresponding author), Univ Granada, Dept Personal Evaluat & Psychol Treatment, Granada, Spain.	averdejo@ugr.es	Verdejo-Garcia, Antonio/AAV-1147-2021; Moreno-López, Laura/K-9568-2015; Soriano-Mas, Carles/E-4028-2019; Rio-Valle, Jacqueline Schmidt/I-6333-2017	Verdejo-Garcia, Antonio/0000-0001-8874-9339; Moreno-López, Laura/0000-0003-3687-7237; Soriano-Mas, Carles/0000-0003-4574-6597; Rio-Valle, Jacqueline Schmidt/0000-0003-2775-0058; Delgado Rico, Elena/0000-0001-9424-8928	BRAINOBE from the Andalusia Council of Science and Innovation; INTEROBE from the Ministry of Economy and Competitiveness [PSI2010-17290]; FPU predoctoral research grant from the Spanish Ministry of Science and Innovation [AP2007-03583]; 'Miguel Servet' contract from the Carlos III Health Institute [CP10/00604]	BRAINOBE from the Andalusia Council of Science and Innovation; INTEROBE from the Ministry of Economy and Competitiveness; FPU predoctoral research grant from the Spanish Ministry of Science and Innovation; 'Miguel Servet' contract from the Carlos III Health Institute	This study has been funded by BRAINOBE from the Andalusia Council of Science and Innovation and INTEROBE (PSI2010-17290) from the Ministry of Economy and Competitiveness (PI: Antonio Verdejo-Garcia). LML is supported by a FPU predoctoral research grant (AP2007-03583) from the Spanish Ministry of Science and Innovation. CSM is funded by a 'Miguel Servet' contract from the Carlos III Health Institute (CP10/00604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre G., 2004, INVENTARIO CLIN ADOL; Caseras X, 2003, PERS INDIV DIFFER, V34, P999, DOI 10.1016/S0191-8869(02)00084-3; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; Delgado-Rico E, 2012, OBESITY, V20, P1604, DOI 10.1038/oby.2012.47; Delis DC, 2001, D KEFS EXAMINERS MAN, DOI DOI 10.1037/T15082-000; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Ernst M, 2009, NEUROSCI BIOBEHAV R, V33, P367, DOI 10.1016/j.neubiorev.2008.10.009; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Garner D.M., 1998, INVENTARIO TRASTORNO; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Honea RA, 2012, AM J MED GENET B, V159B, P243, DOI 10.1002/ajmg.b.32022; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Moreno-Lopez L, 2012, DRUG ALCOHOL DEPEN, V125, P208, DOI 10.1016/j.drugalcdep.2012.02.012; Shishida K, 2006, NEUROPSYCHOBIOLOGY, V54, P215, DOI 10.1159/000100370; Smith GT, 2007, ASSESSMENT, V14, P155, DOI 10.1177/1073191106295527; Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; Stice E, 2011, J NEUROSCI, V31, P4360, DOI 10.1523/JNEUROSCI.6604-10.2011; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Tracy AL, 2001, BEHAV BRAIN RES, V127, P13, DOI 10.1016/S0166-4328(01)00364-3; van den Berg L, 2011, INT J OBESITY, V35, P1301, DOI 10.1038/ijo.2011.116; Veldhuizen MG, 2011, HUM BRAIN MAPP, V32, P2256, DOI 10.1002/hbm.21188; Verdejo-Garcia A, 2010, J PERS ASSESS, V92, P70, DOI 10.1080/00223890903382369; Wallner-Liebmann S, 2010, OBESITY, V18, P1552, DOI 10.1038/oby.2010.26; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Wang GJ, 2002, NEUROREPORT, V13, P1151, DOI 10.1097/00001756-200207020-00016; Weinstein AM, 2012, BRAIN BEHAV IMMUN, V26, P811, DOI 10.1016/j.bbi.2011.11.008; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; Yokum S, 2012, INT J OBESITY, V36, P656, DOI 10.1038/ijo.2011.175; Ziauddeen H, 2012, NAT REV NEUROSCI, V13, P279, DOI 10.1038/nrn3212	38	54	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49185	10.1371/journal.pone.0049185	http://dx.doi.org/10.1371/journal.pone.0049185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185306	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000033
J	Piggott, JJ; Lange, K; Townsend, CR; Matthaei, CD				Piggott, Jeremy J.; Lange, Katharina; Townsend, Colin R.; Matthaei, Christoph D.			Multiple Stressors in Agricultural Streams: A Mesocosm Study of Interactions among Raised Water Temperature, Sediment Addition and Nutrient Enrichment	PLOS ONE			English	Article							FINE SEDIMENT; NEW-ZEALAND; BENTHIC ALGAE; LEAF-LITTER; LAND-USE; ECOSYSTEMS; FRESH; RESPONSES; IMPACTS; BONFERRONI	Changes to land use affect streams through nutrient enrichment, increased inputs of sediment and, where riparian vegetation has been removed, raised water temperature. We manipulated all three stressors in experimental streamside channels for 30 days and determined the individual and pair-wise combined effects on benthic invertebrate and algal communities and on leaf decay, a measure of ecosystem functioning. We added nutrients (phosphorus+nitrogen; high, intermediate, natural) and/or sediment (grain size 0.2 mm; high, intermediate, natural) to 18 channels supplied with water from a nearby stream. Temperature was increased by 1.4 degrees C in half the channels, simulating the loss of upstream and adjacent riparian shade. Sediment affected 93% of all biological response variables (either as an individual effect or via an interaction with another stressor) generally in a negative manner, while nutrient enrichment affected 59% (mostly positive) and raised temperature 59% (mostly positive). More of the algal components of the community responded to stressors acting individually than did invertebrate components, whereas pair-wise stressor interactions were more common in the invertebrate community. Stressors interacted often and in a complex manner, with interactions between sediment and temperature most common. Thus, the negative impact of high sediment on taxon richness of both algae and invertebrates was stronger at raised temperature, further reducing biodiversity. In addition, the decay rate of leaf material (strength loss) accelerated with nutrient enrichment at ambient but not at raised temperature. A key implication of our findings for resource managers is that the removal of riparian shading from streams already subjected to high sediment inputs, or land-use changes that increase erosion or nutrient runoff in a landscape without riparian buffers, may have unexpected effects on stream health. We highlight the likely importance of intact or restored buffer strips, both in reducing sediment input and in maintaining cooler water temperatures.	[Piggott, Jeremy J.; Lange, Katharina; Townsend, Colin R.; Matthaei, Christoph D.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	Piggott, JJ (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	jeremy.piggott@otago.ac.nz	Piggott, Jeremy/K-6157-2017; Matthaei, Christoph D./H-8928-2013; Townsend, Colin/AAZ-2027-2020	Piggott, Jeremy/0000-0002-1515-1878; Lange, Katharina/0000-0002-5016-4527	New Zealand's Foundation for Research, Science and Technology [C01X0307]	New Zealand's Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	Funding was provided by New Zealand's Foundation for Research, Science and Technology (www.msi.govt.nz) contract C01X0307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Angradi TR, 1999, J N AM BENTHOL SOC, V18, P49, DOI 10.2307/1468008; Biggs B.J.F., 2000, STREAM PERIPHYTON MO; Biggs Barry J. F., 1996, P31, DOI 10.1016/B978-012668450-6/50031-X; Burkholder Joann M., 1996, P253, DOI 10.1016/B978-012668450-6/50038-2; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Davies-Colley RJ, 2005, ECOL ENG, V24, P525, DOI 10.1016/j.ecoleng.2004.01.006; Denicola Dean M., 1996, P149, DOI 10.1016/B978-012668450-6/50035-7; Dodds WK, 2007, TRENDS ECOL EVOL, V22, P669, DOI 10.1016/j.tree.2007.07.010; Ferreira V, 2011, GLOBAL CHANGE BIOL, V17, P551, DOI 10.1111/j.1365-2486.2010.02185.x; Field A., 2009, DISCOVERING STAT USI; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Friberg N, 2009, FRESHWATER BIOL, V54, P2051, DOI 10.1111/j.1365-2427.2009.02234.x; Garson DG, 2012, GLM UNIVARIATE ANOVA; GESSNER MO, 1989, ARCH HYDROBIOL, V115, P81; GESSNER MO, 1991, FRESHWATER BIOL, V26, P387, DOI 10.1111/j.1365-2427.1991.tb01406.x; Groffman P, 2006, ECOSYSTEMS, V9, P1, DOI 10.1007/s10021-003-0142-z; Herrmann PB, 2009, THESIS U OTAGO DUMED; Herrmann PB, 2012, FRESHWATER BIOL, V57, P2487, DOI 10.1111/fwb.12019; Lange K, 2011, FRESHWATER BIOL, V56, P264, DOI 10.1111/j.1365-2427.2010.02492.x; Matthaei CD, 2006, FRESHWATER BIOL, V51, P2154, DOI 10.1111/j.1365-2427.2006.01643.x; Matthaei CD, 2010, J APPL ECOL, V47, P639, DOI 10.1111/j.1365-2664.2010.01809.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Niyogi DK, 2007, ENVIRON MANAGE, V39, P213, DOI 10.1007/s00267-005-0310-3; ODUM EP, 1979, BIOSCIENCE, V29, P349, DOI 10.2307/1307690; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; PRINGLE CM, 1990, ECOLOGY, V71, P905, DOI 10.2307/1937362; Quinn GP, 2003, EXPT DESIGN DATA ANA; QUINN JM, 1994, NEW ZEAL J MAR FRESH, V28, P391, DOI 10.1080/00288330.1994.9516629; QUINN JM, 1992, NEW ZEAL J MAR FRESH, V26, P259, DOI 10.1080/00288330.1992.9516520; Quinn John M., 2000, P208; Rutherford JC, 2004, MAR FRESHWATER RES, V55, P737, DOI 10.1071/MF04120; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schneck F, 2011, J N AM BENTHOL SOC, V30, P1049, DOI 10.1899/11-044.1; Townsend CR, 2008, J APPL ECOL, V45, P1810, DOI 10.1111/j.1365-2664.2008.01548.x; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; WINTERBOURN MJ, 2006, B ENTOMOL SOC NZ, V14, P1; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019; Woodward G, 2010, PHILOS T R SOC B, V365, P2093, DOI 10.1098/rstb.2010.0055; Young RG, 2008, J N AM BENTHOL SOC, V27, P605, DOI 10.1899/07-121.1	44	133	134	7	186	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49873	10.1371/journal.pone.0049873	http://dx.doi.org/10.1371/journal.pone.0049873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185471	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000133
J	Shao, JX; Liu, XY; Wang, R; Zhang, GS; Yu, F				Shao, Jingxia; Liu, Xiayan; Wang, Rui; Zhang, Gaisheng; Yu, Fei			The Over-Expression of an Arabidopsis B3 Transcription Factor, ABS2/NGAL1, Leads to the Loss of Flower Petals	PLOS ONE			English	Article							RABBIT-EARS; GENE; PROTEIN; RAV1; ESTABLISHMENT; VIVIPAROUS-1; MECHANISMS; NETWORKS; POLARITY	Transcriptional regulations are involved in many aspects of plant development and are mainly achieved through the actions of transcription factors (TF). To investigate the mechanisms of plant development, we carried out genetic screens for mutants with abnormal shoot development. Taking an activation tagging approach, we isolated a gain-of-function mutant abs2-1D (abnormal shoot 2-1D). abs2-1D showed pleiotropic growth defects at both the vegetative and reproductive developmental stages. We cloned ABS2 and it encodes a RAV sub-family of plant B3 type of transcriptional factors. Phylogenetic analysis showed that ABS2 was closely related to NGATHA (NGA) genes that are involved in flower development and was previously named NGATHA-Like 1 (NGAL1). NGAL1 was expressed mainly in the root and the filament of the stamen in flower tissues and sub-cellular localization assay revealed that NGAL1 accumulated in the nucleus. Interestingly, over-expression of NGAL1 driven by the constitutive 35S promoter led to transgenic plants with conspicuous flower defects, particularly a loss-of-petal phenotype. A loss-of-function ngal1-1 mutant did not show obvious phenotype, suggesting the existence of redundant activities and also the utility of gain-of-function genetic screens. Our results show that the over-expression of NGAL1 is capable of altering flower petal development, as well as shoot development.	[Shao, Jingxia; Liu, Xiayan; Wang, Rui; Yu, Fei] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Shao, Jingxia; Liu, Xiayan; Wang, Rui; Zhang, Gaisheng; Yu, Fei] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Zhang, Gaisheng] NW A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Yu, F (corresponding author), NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	flyfeiyu@gmail.com		Wang, Rui/0000-0002-6196-0780	National Natural Science Foundation of China [31071073, 31100864]; Chinese Ministry of Education Program for New Century Excellent Talents in University [NCET-09-0657]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)Ministry of Education, China)	This work was supported by funding to FY from National Natural Science Foundation of China (31071073) and Chinese Ministry of Education Program for New Century Excellent Talents in University (NCET-09-0657), and by funding to XL from National Natural Science Foundation of China (31100864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JP, 2009, PLANT CELL, V21, P1373, DOI 10.1105/tpc.109.065482; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Alvarez-Buylla Elena R, 2010, Arabidopsis Book, V8, pe0127, DOI 10.1199/tab.0127; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Brewer PB, 2004, DEVELOPMENT, V131, P4035, DOI 10.1242/dev.01279; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Durfee T, 2003, P NATL ACAD SCI USA, V100, P8571, DOI 10.1073/pnas.1033043100; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Griffith ME, 1999, DEVELOPMENT, V126, P5635; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kagaya Y, 2009, GENES GENET SYST, V84, P95, DOI 10.1266/ggs.84.95; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Krizek BA, 2006, PLANT J, V45, P369, DOI 10.1111/j.1365-313X.2005.02633.x; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MCCARTY DR, 1989, PLANT CELL, V1, P523, DOI 10.1105/tpc.1.5.523; Meadows M G, 1981, Plant Cell Rep, V1, P77, DOI 10.1007/BF00269279; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Trigueros M, 2009, PLANT CELL, V21, P1394, DOI 10.1105/tpc.109.065508; Wang MJ, 2012, J EXP BOT, V63, P5787, DOI 10.1093/jxb/ers227; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Xing SP, 2005, DEVELOPMENT, V132, P1555, DOI 10.1242/dev.01725; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; Zhao L, 2008, PLANTA, V227, P1389, DOI 10.1007/s00425-008-0711-7	39	14	15	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49861	10.1371/journal.pone.0049861	http://dx.doi.org/10.1371/journal.pone.0049861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185464	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000127
J	Turnbull, C; Wilson, PD; Hoggard, S; Gillings, M; Palmer, C; Smith, S; Beattie, D; Hussey, S; Stow, A; Beattie, A				Turnbull, Christine; Wilson, Peter D.; Hoggard, Stephen; Gillings, Michael; Palmer, Chris; Smith, Shannon; Beattie, Doug; Hussey, Sam; Stow, Adam; Beattie, Andrew			Primordial Enemies: Fungal Pathogens in Thrips Societies	PLOS ONE			English	Article							ENTOMOPATHOGENIC FUNGUS; METAPLEURAL GLANDS; DIVERSIFICATION; EVOLUTION; ANTS	Microbial pathogens are ancient selective agents that have driven many aspects of multicellular evolution, including genetic, behavioural, chemical and immune defence systems. It appears that fungi specialised to attack insects were already present in the environments in which social insects first evolved and we hypothesise that if the early stages of social evolution required antifungal defences, then covariance between levels of sociality and antifungal defences might be evident in extant lineages, the defences becoming stronger with group size and increasing social organisation. Thus, we compared the activity of cuticular antifungal compounds in thrips species (Insecta:Thysanoptera) representing a gradient of increasing group size and sociality: solitary, communal, social and eusocial, against the entomopathogen Cordyceps bassiana. Solitary and communal species showed little or no activity. In contrast, the social and eusocial species killed this fungus, suggesting that the evolution of sociality has been accompanied by sharp increases in the effectiveness of antifungal compounds. The antiquity of fungal entomopathogens, demonstrated by fossil finds, coupled with the unequivocal response of thrips colonies to them shown here, suggests two new insights into the evolution of thrips sociality: First, traits that enabled nascent colonies to defend themselves against microbial pathogens should be added to those considered essential for social evolution. Second, limits to the strength of antimicrobials, through resource constraints or self-antibiosis, may have been overcome by increase in the numbers of individuals secreting them, thus driving increases in colony size. If this is the case for social thrips, then we may ask: did antimicrobial traits and microbes such as fungal entomopathogens play an integral part in the evolution of insect sociality in general?	[Turnbull, Christine; Wilson, Peter D.; Hoggard, Stephen; Gillings, Michael; Smith, Shannon; Beattie, Doug; Hussey, Sam; Stow, Adam; Beattie, Andrew] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Palmer, Chris] No Terr Govt, Dept Nat Resources, Alice Springs, NT, Australia	Macquarie University; Northern Territory Government	Beattie, A (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	andrew.beattie@mq.edu.au	Gillings, Michael/AAF-5772-2020; Gillings, Michael R/C-6553-2008	Gillings, Michael/0000-0002-4043-4351; Gillings, Michael R/0000-0002-4043-4351; Wilson, Peter/0000-0001-7375-0791; Stow, Adam/0000-0002-6796-4854	Australian Research Council	Australian Research Council(Australian Research Council)	This research was supported under Australian Research Council's Discovery Projects funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEATTIE AJ, 1986, ANN ENTOMOL SOC AM, V79, P448, DOI 10.1093/aesa/79.3.448; BEATTIE AJ, 1985, AM J BOT, V72, P606, DOI 10.2307/2443594; Boucias D.G., 1998, PRINCIPLES INSECT PA, P177; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Burnham L., 1978, Psyche (Cambridge), V85, P85, DOI 10.1155/1978/80816; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Fernandez-Marin H, 2006, P ROY SOC B-BIOL SCI, V273, P1689, DOI 10.1098/rspb.2006.3492; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hughes DP, 2011, BIOL LETTERS, V7, P67, DOI 10.1098/rsbl.2010.0521; Kuhlmann UC, 2000, J MOL BIOL, V301, P1163, DOI 10.1006/jmbi.2000.3945; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; MARTINEZDELCLOS X, 1995, J PALEONTOL, V69, P594, DOI 10.1017/S0022336000034983; McLeish MJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-3; Mound LA, 2007, ZOOTAXA, P395; Nikoh N, 2000, MOL BIOL EVOL, V17, P629, DOI 10.1093/oxfordjournals.molbev.a026341; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Ormond EL, 2011, FEMS MICROBIOL ECOL, V77, P229, DOI 10.1111/j.1574-6941.2011.01100.x; Pokorny R, 2005, RES MICROBIOL, V156, P932, DOI 10.1016/j.resmic.2005.04.010; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Rosengaus RB, 2004, INSECT SOC, V51, P259, DOI 10.1007/s00040-004-0749-x; Rosengaus RB, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P165, DOI 10.1007/978-90-481-3977-4_7; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; Schmid-Hempel P., 1998, Parasites in social insects.; Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8; Smith SM, 2008, J MICROBIOL METH, V72, P103, DOI 10.1016/j.mimet.2007.10.003; Stow A, 2007, BIOL LETTERS, V3, P422, DOI 10.1098/rsbl.2007.0178; Stow A, 2010, AUST J ENTOMOL, V49, P145, DOI 10.1111/j.1440-6055.2010.00749.x; Sung GH, 2008, MOL PHYLOGENET EVOL, V49, P495, DOI 10.1016/j.ympev.2008.08.028; Taylor TN, 2005, MYCOLOGIA, V97, P269, DOI 10.3852/mycologia.97.1.269; Turnbull C, 2011, BIOL LETTERS, V7, P249, DOI 10.1098/rsbl.2010.0719; Wilson E.O., 1971, INSECT SOC; WILSON EDWARD O., 1967, PSYCHE J ENTOMOL, V74, P1, DOI 10.1155/1967/89604; Yamoah E, 2008, AUST J ENTOMOL, V47, P370, DOI 10.1111/j.1440-6055.2008.00655.x; Zar JH., 2010, BIOSTAT ANAL; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	38	5	6	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49737	10.1371/journal.pone.0049737	http://dx.doi.org/10.1371/journal.pone.0049737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185420	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000096
J	Yang, X; Jiao, YM; Wang, R; Ji, YX; Zhang, HW; Zhang, YH; Chen, DX; Zhang, T; Wu, H				Yang, Xue; Jiao, Yan-mei; Wang, Rui; Ji, Yun-xia; Zhang, Hong-wei; Zhang, Yong-hong; Chen, De-xi; Zhang, Tong; Wu, Hao			High CCR5 Density on Central Memory CD4(+) T Cells in Acute HIV-1 Infection Is Mostly Associated with Rapid Disease Progression	PLOS ONE			English	Article							ESTROGEN-RECEPTOR STATUS; BREAST-CANCER CELLS; NEOADJUVANT CHEMOTHERAPY; HIGH-THROUGHPUT; EXPRESSION; CHEMOSENSITIVITY; SIGNATURE; GROWTH; LINES; CLASSIFICATION	CD4+ central memory T cells play a critical role in the pathogenesis of simian immunodeficiency virus disease, and the CCR5 density on the surface of CD4 T cells is an important factor in human immunodeficiency virus (HIV)-1 disease progression. We hypothesized that quantifying central memory cells and CCR5 expression in the early stages of HIV-infection could provide useful prognostic information. We enrolled two different groups of acute HIV-infected subjects. One group progressed to CD4 T cell numbers below 250 cells/mu l within 2 years (CD4 Low group), while the other group maintained CD4 cell counts above 450 cells/mu l over 2 years (CD4 High group). We compared the CCR5 levels and percentage of CD4 subsets between the two groups during the 1st year of HIV infection. We found no differences between the two groups regarding the percentage of naive, central memory and effector memory subsets of CD4 cells during the 1st year of HIV-1 infection. CCR5 levels on CD4+ CM subset was higher in the CD4 Low group compared with the CD4 High group during the 1st year of HIV-1 infection. High CCR5 levels on CD4 central memory cells in acute HIV infection are mostly associated with rapid disease progression. Our data suggest that low CCR5 expression on CD4 central memory cells protects CD4 cells from direct virus infection and favors the preservation of CD4(+) T cell homeostasis.	[Yang, Xue; Jiao, Yan-mei; Wang, Rui; Ji, Yun-xia; Zhang, Hong-wei; Zhang, Yong-hong; Chen, De-xi; Zhang, Tong; Wu, Hao] Capital Med Univ, Ctr Infect Dis, Beijing Youan Hosp, Beijing, Peoples R China	Capital Medical University	Jiao, YM (corresponding author), Capital Med Univ, Ctr Infect Dis, Beijing Youan Hosp, Beijing, Peoples R China.	jiaoyanmei@sina.com; whdoc900@gmail.com.com	Zhang, Tong/HGC-1090-2022		National 12th Five-Year Major Projects of China [2012ZX10001-003, 2012ZX10001-006]; Beijing Municipal of Science and Technology Major Project [D09050703590901]; National Natural Science Foundation of China [81101250]; Capital Health in the Development of Research and Special Projiect of China [2011-2018-02]; Beijing Key Laboratory [BZ0089]	National 12th Five-Year Major Projects of China; Beijing Municipal of Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Health in the Development of Research and Special Projiect of China; Beijing Key Laboratory	This study was supported in part by the National 12th Five-Year Major Projects of China (2012ZX10001-003, 2012ZX10001-006), the Beijing Municipal of Science and Technology Major Project (D09050703590901), the National Natural Science Foundation of China (81101250), Capital Health in the Development of Research and Special Projiect of China(2011-2018-02) and the Beijing Key Laboratory (BZ0089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse S, 2010, SEER CANC STAT REV; Andre F, 2006, NAT CLIN PRACT ONCOL, V3, P621, DOI 10.1038/ncponc0636; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Brower Stacey L., 2008, V414, P57; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Casa AJ, 2012, BREAST CANCER RES TR, V132, P61, DOI 10.1007/s10549-011-1540-0; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Coutant C, 2011, CLIN CANCER RES, V17, P2591, DOI 10.1158/1078-0432.CCR-10-1045; Gajdos C, 2002, J SURG ONCOL, V80, P4, DOI 10.1002/jso.10090; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Gruvberger S, 2001, CANCER RES, V61, P5979; Heinzman JM, 2010, JALA-J LAB AUTOM, V15, P7, DOI 10.1016/j.jala.2009.08.010; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; K Shen, 2011, CANCER RES, V70, P2; Kadra G, 2012, BREAST CANC RES TREA, P1; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Lee JK, 2010, CLIN CANCER RES, V16, P711, DOI 10.1158/1078-0432.CCR-09-2247; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Liedtke C, 2010, BREAST CANCER RES TR, V121, P301, DOI 10.1007/s10549-009-0445-7; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mieog JSD, 2009, EXPERT OPIN PHARMACO, V10, P1423, DOI 10.1517/14656560903002105; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Moreno-Aspitia A, 2011, CRITICAL REV ONCOLOG; Nagji AS, 2010, MOL CANCER THER, V9, P2834, DOI 10.1158/1535-7163.MCT-10-0327; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sachelarie I, 2006, ONCOLOGIST, V11, P574, DOI 10.1634/theoncologist.11-6-574; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Shen K, 2011, 2011 ASCO ANN M; Shiang C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2735; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528; Stevens TA, 2006, ONCOGENE, V25, P5426, DOI 10.1038/sj.onc.1209529; Tanizaki J, 2011, ONCOGENE, V30, P4097, DOI 10.1038/onc.2011.111; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009	46	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49526	10.1371/journal.pone.0049526	http://dx.doi.org/10.1371/journal.pone.0049526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185351	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000060
J	Vazquez-Fernandez, E; Alonso, J; Pastrana, MA; Ramos, A; Stitz, L; Vidal, E; Dynin, I; Petsch, B; Silva, CJ; Requena, JR				Vazquez-Fernandez, Ester; Alonso, Jana; Pastrana, Miguel A.; Ramos, Adriana; Stitz, Lothar; Vidal, Enric; Dynin, Irina; Petsch, Benjamin; Silva, Christopher J.; Requena, Jesus R.			Structural Organization of Mammalian Prions as Probed by Limited Proteolysis	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE PRION; TRUNCATED FORMS; PROTEIN; IDENTIFICATION; PRP	Elucidation of the structure of PrPSc continues to be one major challenge in prion research. The mechanism of propagation of these infectious agents will not be understood until their structure is solved. Given that high resolution techniques such as NMR or X-ray crystallography cannot be used, a number of lower resolution analytical approaches have been attempted. Thus, limited proteolysis has been successfully used to pinpoint flexible regions within prion multimers (PrPSc). However, the presence of covalently attached sugar antennae and glycosylphosphatidylinositol (GPI) moieties makes mass spectrometry-based analysis impractical. In order to surmount these difficulties we analyzed PrPSc from transgenic mice expressing prion protein (PrP) lacking the GPI membrane anchor. Such animals produce prions that are devoid of the GPI anchor and sugar antennae, and, thereby, permit the detection and location of flexible, proteinase K (PK) susceptible regions by Western blot and mass spectrometry-based analysis. GPI-less PrPSc samples were digested with PK. PK-resistant peptides were identified, and found to correspond to molecules cleaved at positions 81, 85, 89, 116, 118, 133, 134, 141, 152, 153, 162, 169 and 179. The first 10 peptides (to position 153), match very well with PK cleavage sites we previously identified in wild type PrPSc. These results reinforce the hypothesis that the structure of PrPSc consists of a series of highly PK-resistant beta-sheet strands connected by short flexible PK-sensitive loops and turns. A sizeable C-terminal stretch of PrPSc is highly resistant to PK and therefore perhaps also contains beta-sheet secondary structure.	[Vazquez-Fernandez, Ester; Pastrana, Miguel A.; Ramos, Adriana; Requena, Jesus R.] Univ Santiago de Compostela, CIMUS Biomed Res Inst, IDIS, Santiago De Compostela, Spain; [Alonso, Jana] IDIS, Prote Unit, Santiago De Compostela, Spain; [Stitz, Lothar; Petsch, Benjamin] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany; [Vidal, Enric] UAB IRTA, Priocat Lab, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Dynin, Irina; Silva, Christopher J.] USDA, Western Reg Res Ctr, Albany, CA 94710 USA; [Requena, Jesus R.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Friedrich Loeffler Institute; IRTA; United States Department of Agriculture (USDA); Universidade de Santiago de Compostela	Vazquez-Fernandez, E (corresponding author), Univ Santiago de Compostela, CIMUS Biomed Res Inst, IDIS, Santiago De Compostela, Spain.	ester.vazquez@usc.es; jesus.requena@usc.es	Petsch, Benni/AAL-7767-2020; Silva, Christopher/AAC-6593-2019; Vidal, Enric/P-2901-2019; Silva, Christopher/T-9568-2019; Lorenzo, Jana Alonso/B-2869-2012; Vidal, Enric/I-1679-2014	Petsch, Benni/0000-0001-7431-0683; Vidal, Enric/0000-0002-4965-3286; Silva, Christopher/0000-0003-4521-6377; Lorenzo, Jana Alonso/0000-0002-2304-8715; Vidal, Enric/0000-0002-4965-3286	EC [FP7 222887]	EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by EC grant FP7 222887 "Priority". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Harman JL, 2009, JAVMA-J AM VET MED A, V234, P59, DOI 10.2460/javma.234.1.59; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; Makarava N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002419; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sim VL, 2009, NEUROBIOL AGING, V30, P2031, DOI 10.1016/j.neurobiolaging.2008.02.016; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	28	36	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50111	10.1371/journal.pone.0050111	http://dx.doi.org/10.1371/journal.pone.0050111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185550	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700071
J	Lee, YW; Yang, CC; Mok, GSP; Wu, TH				Lee, Yi-Wei; Yang, Ching-Ching; Mok, Greta S. P.; Wu, Tung-Hsin			Infant Cardiac CT Angiography with 64-Slice and 256-Slice CT: Comparison of Radiation Dose and Image Quality Using a Pediatric Phantom	PLOS ONE			English	Article							DUAL-SOURCE CT; MAGNETIC-RESONANCE; CORONARY-ANGIOGRAPHY; CHILDREN; WINDOWS; CANCER; RISKS	Background: The aims of this study were to investigate the image quality and radiation exposure of pediatric protocols for cardiac CT angiography (CTA) in infants under one year of age. Methodology/Principal Findings: Cardiac CTA examinations were performed using an anthropomorphic phantom representing a 1-year-old child scanned with non-electrocardiogram-gated (NG), retrospectively electrocardiogram-gated helical (RGH) and prospectively electrocardiogram-gated axial (PGA) techniques in 64-slice and 256-slice CT scanners. The thermoluminescent dosimeters (TLD) were used for direct organ dose measurement, while dose-length product and effective mAs were also used to estimate the patient dose. For image quality, noise and signal-to-noise-ratio (SNR) were assessed based on regions-of-interest drawn on the reconstructed CT images, and were compared with the proposed cardiac image quantum index (CIQI). Estimated dose results were in accordant to the measured doses. The NG scan showed the best image quality in terms of noise and SNR. The PGA scan had better image quality than the RGH scan with 83.70% dose reduction. Noise and SNR were also corresponded to the proposed CIQI. Conclusions/Significance: The PGA scan protocol was a good choice in balancing radiation exposure and image quality for infant cardiac CTA. We also suggested that the effective mAs and the CIQI were suitable in assessing the tradeoffs between radiation dose and image quality for cardiac CTA in infants. These results are useful for future implementation of dose reduction strategies in pediatric cardiac CTA protocols.	[Lee, Yi-Wei; Wu, Tung-Hsin] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lee, Yi-Wei] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lee, Yi-Wei] Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan; [Yang, Ching-Ching] Tzu Chi Coll Technol, Dept Radiol Technol, Hualien, Taiwan; [Mok, Greta S. P.] Univ Macau, Fac Sci & Technol, Dept Elect & Elect Engn, Macau, Peoples R China	National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung Memorial Hospital; Tzu Chi University of Science & Technology; University of Macau	Wu, TH (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	tung@ym.edu.tw	Mok, Greta/AAC-5207-2021	Yang, Ching-Ching/0000-0002-9420-3102	National Science Council of Taiwan [NSC99-2314-B-010-043-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was financially supported by National Science Council of Taiwan (NSC99-2314-B-010-043-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini D, 2009, AM J CARDIOL, V103, P1349, DOI 10.1016/j.amjcard.2009.01.343; [Anonymous], 2007, ICRP PUBLICATION, V37, P1; Bacher K, 2005, CIRCULATION, V111, P83, DOI 10.1161/01.CIR.0000151098.52656.3A; Ben Saad M, 2009, PEDIATR RADIOL, V39, P668, DOI 10.1007/s00247-009-1209-6; Bertell R, 2007, INT J HEALTH SERV, V37, P419, DOI 10.2190/7841-2700-348T-041X; Boxt LM, 2004, J MAGN RESON IMAGING, V19, P827, DOI 10.1002/jmri.20077; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Desbiolles L, 2007, EUR RADIOL, V17, P2819, DOI 10.1007/s00330-007-0693-z; Goo HW, 2005, PEDIATR RADIOL, V35, P792, DOI 10.1007/s00247-005-1482-y; Goo HW, 2011, PEDIATR RADIOL, V41, P250, DOI 10.1007/s00247-010-1886-1; Hamon M, 2008, RADIOLOGY, V247, P679, DOI 10.1148/radiol.2473071132; Hlaihel C, 2011, BRIT J RADIOL, V84, P51, DOI 10.1259/bjr/13222537; Huang MP, 2011, PEDIATR RADIOL, V41, P858, DOI 10.1007/s00247-011-2079-2; Huda W, 2000, MED PHYS, V27, P838, DOI 10.1118/1.598949; Law WY, 2011, ACAD RADIOL, V18, P31, DOI 10.1016/j.acra.2010.07.013; Leschka S, 2008, EUR RADIOL, V18, P1809, DOI 10.1007/s00330-008-0966-1; Mok GSP, 2010, ACAD RADIOL, V17, P1386, DOI 10.1016/j.acra.2010.06.011; Morgan-Hughes GJ, 2005, HEART, V91, P308, DOI 10.1136/hrt.2004.034892; Nazeri I, 2009, AM J CARDIOL, V103, P667, DOI 10.1016/j.amjcard.2008.10.040; Ntsinjana HN, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-51; Pages J, 2003, BRIT J RADIOL, V76, P803, DOI 10.1259/bjr/92706933; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Rassow J, 2000, BRIT J RADIOL, V73, P172, DOI 10.1259/bjr.73.866.10884731; Samyn MM, 2004, INT J CARDIOVAS IMAG, V20, P569, DOI 10.1007/s10554-004-7021-3; Schilham A, 2010, RADIOGRAPHICS, V30, P1057, DOI 10.1148/rg.304095167; SMITH C, 1981, SURGERY, V90, P20; Taylor AJ, 2010, CIRCULATION, V122, pE525, DOI 10.1161/CIR.0b013e3181fcae66; TAYLOR LM, 1990, J VASC SURG, V11, P297, DOI 10.1067/mva.1990.17099; Tsai IC, 2008, PEDIATR RADIOL, V38, P438, DOI 10.1007/s00247-008-0761-9	29	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49609	10.1371/journal.pone.0049609	http://dx.doi.org/10.1371/journal.pone.0049609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185380	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000067
J	Osei-Poku, J; Han, C; Mbogo, CM; Jiggins, FM				Osei-Poku, Jewelna; Han, Calvin; Mbogo, Charles M.; Jiggins, Francis M.			Identification of Wolbachia Strains in Mosquito Disease Vectors	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; CYTOPLASMIC INCOMPATIBILITY; BLOCKS DENGUE; DROSOPHILA; SEQUENCE; DIPTERA; ENDOSYMBIONT; INFECTIONS; PHYLOGENY; SYMBIONT	Wolbachia bacteria are common endosymbionts of insects, and some strains are known to protect their hosts against RNA viruses and other parasites. This has led to the suggestion that releasing Wolbachia-infected mosquitoes could prevent the transmission of arboviruses and other human parasites. We have identified Wolbachia in Kenyan populations of the yellow fever vector Aedes bromeliae and its relative Aedes metallicus, and in Mansonia uniformis and Mansonia africana, which are vectors of lymphatic filariasis. These Wolbachia strains cluster together on the bacterial phylogeny, and belong to bacterial clades that have recombined with other unrelated strains. These new Wolbachia strains may be affecting disease transmission rates of infected mosquito species, and could be transferred into other mosquito vectors as part of control programs.	[Osei-Poku, Jewelna; Han, Calvin; Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Mbogo, Charles M.] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya	University of Cambridge; Kenya Medical Research Institute	Osei-Poku, J (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	j.osei-poku@gen.cam.ac.uk		Akorli, Jewelna/0000-0002-3972-0860; Jiggins, Francis Michael/0000-0001-7470-8157	Wellcome Trust [WT094664]; Royal Society Research Fellowship; Darwin Trust of Edinburgh studentship; Genetics Society Heredity Fieldwork Grant; Royal Entomological Society ORF; Clare College (Cambridge) Chibnall Travel Grant	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society Research Fellowship(Royal Society of London); Darwin Trust of Edinburgh studentship; Genetics Society Heredity Fieldwork Grant; Royal Entomological Society ORF; Clare College (Cambridge) Chibnall Travel Grant	This work was funded by Wellcome Trust project grant WT094664. FMJ is supported by a Royal Society Research Fellowship and JOP by a Darwin Trust of Edinburgh studentship. Travel grants for this work were provided by the Genetics Society Heredity Fieldwork Grant, the Royal Entomological Society ORF and Clare College (Cambridge) Chibnall Travel Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SEQ VERS 4 5 SEQ AN; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Clancy DJ, 1996, TRENDS ECOL EVOL, V11, P145, DOI 10.1016/0169-5347(96)30006-2; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hertig M, 1924, J MED RES, V44, P329; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; HUANG YM, 1986, J MED ENTOMOL, V23, P196, DOI 10.1093/jmedent/23.2.196; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Jiggins FM, 2002, MOL ECOL, V11, P1275, DOI 10.1046/j.1365-294X.2002.01532.x; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2; Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087; Mavingui P, 2012, J BACTERIOL, V194, P1840, DOI 10.1128/JB.00036-12; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Rambaut A., 2006, FIGTREE V1 3 1; Rasgon JL, 2004, J MED ENTOMOL, V41, P255, DOI 10.1603/0022-2585-41.2.255; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Schulenburg JHGV, 2001, APPL ENVIRON MICROB, V67, P270, DOI 10.1128/AEM.67.1.270-277.2001; Sinkins SP, 2005, NATURE, V436, P257, DOI 10.1038/nature03629; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; TRPIS M, 1981, J HERED, V72, P313, DOI 10.1093/oxfordjournals.jhered.a109513; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Ughasi J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-89; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	52	24	27	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49922	10.1371/journal.pone.0049922	http://dx.doi.org/10.1371/journal.pone.0049922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185484	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000143
J	Tarkkonen, KM; Nilsson, EM; Kahkonen, TE; Dey, JH; Heikkila, JE; Tuomela, JM; Liu, Q; Hynes, NE; Harkonen, PL				Tarkkonen, Kati M.; Nilsson, Emeli M.; Kahkonen, Tiina E.; Dey, Julien H.; Heikkila, Jari E.; Tuomela, Johanna M.; Liu, Qing; Hynes, Nancy E.; Harkonen, Pirkko L.			Differential Roles of Fibroblast Growth Factor Receptors (FGFR) 1, 2 and 3 in the Regulation of S115 Breast Cancer Cell Growth	PLOS ONE			English	Article							PROSTATIC INTRAEPITHELIAL NEOPLASIA; GENOME-WIDE ASSOCIATION; MAMMARY-TUMOR CELLS; THERAPEUTIC TARGET; 8P11-12 AMPLICON; IN-VIVO; EXPRESSION; ANDROGEN; PROLIFERATION; AMPLIFICATION	Fibroblast growth factors (FGFs) regulate the growth and progression of breast cancer. FGF signaling is transduced through FGF receptors 1-4, which have oncogenic or anti-oncogenic roles depending on the ligand and the cellular context. Our aim was to clarify the roles of FGFR1-3 in breast cancer cell growth in vitro and in vivo. Pools of S115 mouse breast cancer cells expressing shRNA against FGFR1, 2 and 3 were created by lentiviral gene transfer, resulting in cells with downregulated expression of FGFR1, FGFR2 or FGFR3 (shR1, shR2 and shR3 cells, respectively) and shLacZ controls. FGFR1-silenced shR1 cells formed small, poorly vascularized tumors in nude mice. Silencing of FGFR2 in shR2 cells was associated with strong upregulation of FGFR1 expression and the formation of large, highly vascularized tumors compared to the control tumors. Silencing FGFR3 did not affect cell survival or tumor growth. Overexpressing FGFR2 in control cells did not affect FGFR1 expression, suggesting that high FGFR1 expression in shR2 cells and tumors was associated with FGFR2 silencing by indirect mechanisms. The expression of FGFR1 was, however, increased by the addition of FGF-8 to starved shLacZ or MCF-7 cells and decreased by the FGFR inhibitor PD173074 in shR2 cells with an elevated FGFR1 level. In conclusion, our results demonstrate that FGFR1 is crucial for S115 breast cancer cell proliferation and tumor growth and angiogenesis, whereas FGFR2 and FGFR3 are less critical for the growth of these cells. The results also suggest that the expression of FGFR1 itself is regulated by FGF-8 and FGF signaling, which may be of importance in breast tumors expressing FGFs at a high level.	[Tarkkonen, Kati M.; Kahkonen, Tiina E.; Tuomela, Johanna M.; Harkonen, Pirkko L.] Univ Turku, Dept Cell Biol & Anat, Inst Biomed, Turku, Finland; [Nilsson, Emeli M.; Liu, Qing] Lund Univ, Dept Lab Med, Lund, Sweden; [Heikkila, Jari E.] Abo Akad Univ, Dept Biochem & Pharm, SF-20500 Turku, Finland; [Tuomela, Johanna M.] Pharmatest Serv Ltd, Turku, Finland; [Dey, Julien H.; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Tarkkonen, Kati M.] Turku Grad Sch Biomed Sci, Turku, Finland; [Kahkonen, Tiina E.] FinPharma Doctoral Program, Drug Discovery Sect, Turku, Finland	University of Turku; Lund University; Abo Akademi University; Pharmatest Services; Friedrich Miescher Institute for Biomedical Research; University of Turku	Tarkkonen, KM (corresponding author), Univ Turku, Dept Cell Biol & Anat, Inst Biomed, Turku, Finland.	ktarkko@utu.fi		Tuomela, Johanna/0000-0003-4390-4563	Swedish Cancer Foundation; Swedish Research Council; Sigrid Juselius Foundation, Finland; Finnish Cultural Foundation; Turku University Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation, Finland(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Turku University Foundation	This work was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council, the Sigrid Juselius Foundation, Finland, the Finnish Cultural Foundation and the Turku University Foundation. These funders did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADNANE J, 1991, ONCOGENE, V6, P659; Bernard-Pierrot I, 2008, CANCER RES, V68, P7165, DOI 10.1158/0008-5472.CAN-08-1360; Courjal F, 1997, CANCER RES, V57, P4360; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Darbre P D, 1988, Cancer Treat Res, V40, P307; Dey JH, 2010, THESIS, DOI [10.5451/unibas-005213494, DOI 10.5451/UNIBAS-005213494]; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Dorkin TJ, 1999, ONCOGENE, V18, P2755, DOI 10.1038/sj.onc.1202624; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Elsheikh SE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1665; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Francavilla C, 2009, SEMIN CANCER BIOL, V19, P298, DOI 10.1016/j.semcancer.2009.05.004; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Freeman KW, 2003, CANCER RES, V63, P6237; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Gnanapragasam V, 2003, BRIT J CANCER, V88, P1432, DOI 10.1038/sj.bjc.6600875; Goldfarb Mitchell, 1996, Cytokine and Growth Factor Reviews, V7, P311, DOI 10.1016/S1359-6101(96)00039-1; HARKONEN PL, 1990, EXP CELL RES, V186, P288, DOI 10.1016/0014-4827(90)90308-W; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hynes NE, 2010, CANCER RES, V70, P5199, DOI 10.1158/0008-5472.CAN-10-0918; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; Jin CL, 2003, CANCER RES, V63, P8784; Kallio A, 2008, MOL CELL ENDOCRINOL, V289, P38, DOI 10.1016/j.mce.2008.03.005; Kanai M, 2009, GENE, V438, P49, DOI 10.1016/j.gene.2009.03.004; Katoh M, 2009, J INVEST DERMATOL, V129, P1861, DOI 10.1038/jid.2009.97; Kettunen P, 1998, DEV GENET, V22, P374, DOI 10.1002/(SICI)1520-6408(1998)22:4<374::AID-DVG7>3.0.CO;2-3; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattila MA, 2007, CYTOKINE GROWTH F R, V18, P257, DOI 10.1016/j.cytogfr.2007.04.010; Mattila MMT, 2001, ONCOGENE, V20, P2791, DOI 10.1038/sj.onc.1204430; Mott NN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010143; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Musumeci M, 2011, ONCOGENE, V30, P4231, DOI 10.1038/onc.2011.140; Nilsson EM, 2012, MOL CELL ENDOCRINOL, V358, P104, DOI 10.1016/j.mce.2012.03.009; Nilsson EM, 2010, EXP CELL RES, V316, P800, DOI 10.1016/j.yexcr.2009.11.019; Ornitz DM, 2001, GENOME BIOL, V2; OSBORNE CK, 1987, BREAST CANCER RES TR, V9, P111, DOI 10.1007/BF01807363; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; Ray ME, 2004, CANCER RES, V64, P40, DOI 10.1158/0008-5472.CAN-03-1022; Ruohola JK, 2001, CANCER RES, V61, P4229; RUOHOLA JK, 1995, ENDOCRINOLOGY, V136, P2179, DOI 10.1210/en.136.5.2179; Seyed M, 2007, GENE, V400, P150, DOI 10.1016/j.gene.2007.06.010; Tanaka A, 2002, VIRCHOWS ARCH, V441, P380, DOI 10.1007/s00428-002-0687-9; Tarkkonen K, 2010, GROWTH FACTORS, V28, P256, DOI 10.3109/08977191003745480; Tashiro E, 2003, CANCER RES, V63, P424; Tuittila MT, 2000, J VIROL, V74, P4579, DOI 10.1128/JVI.74.10.4579-4589.2000; Turner N, 2010, ONCOGENE; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Valve EM, 2001, LAB INVEST, V81, P815, DOI 10.1038/labinvest.3780291; WARRI AM, 1993, JNCI-J NATL CANCER I, V85, P1412, DOI 10.1093/jnci/85.17.1412; Xian W, 2007, MOL ENDOCRINOL, V21, P987, DOI 10.1210/me.2006-0518; Yasumoto H, 2004, PROSTATE, V61, P236, DOI 10.1002/pros.20093	54	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49970	10.1371/journal.pone.0049970	http://dx.doi.org/10.1371/journal.pone.0049970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185502	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000154
J	Xu, WB; Liu, WW; Huang, GY; Zou, ZJ; Cai, ZY; Xu, WG				Xu, Wenbing; Liu, Wenwu; Huang, Guoyang; Zou, ZiJiao; Cai, Zhiyu; Xu, Weigang			Decompression Illness: Clinical Aspects of 5278 Consecutive Cases Treated in a Single Hyperbaric Unit	PLOS ONE			English	Article							DIVERS	Background: Decompression illness (DCI) is a major concern in pressure-related activities. Due to its specific prerequisite conditions, DCI is rare in comparison with other illnesses and most physicians are inexperienced in treatment. In a fishery area in northern China, during the past decade, tens of thousands of divers engaged in seafood harvesting and thousands suffered from DCI. We established a hyperbaric facility there and treated the majority of the cases. Methods and Results: A total of 5,278 DCI cases were admitted in our facility from February 2000 through December 2010 and treated using our recompression schedules. Cutaneous abnormalities, joint and muscular pain and neurological manifestations were three most common symptoms. The initial symptom occurred within 6 h after surfacing in 98.9% of cases, with an overall median latency of 62 min. The shorter the latent time, the more serious the symptoms would be (P<0.0001). Nine cases died before recompression and 5,269 were treated using four recompression schedules, with an overall effectiveness rate of 99.3%. The full recovery rate decreased with the increase of the delay from the onset of symptoms to the treatment (P<0.0001). Conclusions: DCI presents specific occurrence rules. Recompression should be administered as soon as possible and should never be abandoned irrespective of the delay. The recompression schedules used were effective and flexible for variety conditions of DCI.	[Xu, Wenbing; Liu, Wenwu; Huang, Guoyang; Zou, ZiJiao; Cai, Zhiyu; Xu, Weigang] Second Mil Med Univ, Fac Naval Med, Dept Diving Med, Shanghai, Peoples R China	Naval Medical University	Xu, WG (corresponding author), Second Mil Med Univ, Fac Naval Med, Dept Diving Med, Shanghai, Peoples R China.	wgxu@hotmail.com	xu, wei/HHD-2891-2022	Liu, Wenwu/0000-0003-1530-8860	National Natural Science Foundation of China [81171873]; Science & Technology Program of Chinese Liberation Army [08G064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Program of Chinese Liberation Army	This work was supported partly by the National Natural Science Foundation of China No. 81171873 and the Science & Technology Program of Chinese Liberation Army No. 08G064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROJ DIV EXPL PROJ O; Bennett PB, 1990, DIVING ACCIDENT MANA; Berghage TE, 1978, 7816 NAV MED RES DEV; Blatteau JE, 2011, DIVING HYPERB MED, V41, P129; FRANCIS TJR, 1988, UNDERSEA BIOMED RES, V15, P403; Gao GK, 2009, UNDERSEA HYPERBAR M, V36, P33; Gempp E, 2008, AVIAT SPACE ENVIR MD, V79, P1112, DOI 10.3357/ASEM.2376.2008; GOLDING F C, 1960, Br J Ind Med, V17, P167; Gorman DF, 1991, DESCRIBING DECOMPRES, P6; Kot Jacek, 2004, Int Marit Health, V55, P103; LEITCH DR, 1986, AVIAT SPACE ENVIR MD, V57, P931; Liu Y, 2010, CHIN J IND MED, V23, P52; Moon RE., 2003, ADJUNCTIVE THERAPY D; Pearson RR, 1984, PHYS GUIDE DIVING ME, P333; Ross JAS., 2000, CLIN AUDIT OUTCOME M; Stipp W., 2007, 550 RR, P1; Thalmann E, 1996, TREATMENT DECOMPRESS; Tourigny PD, 2012, EMERG MED CLIN N AM, V30, P501, DOI 10.1016/j.emc.2011.10.006; US Navy Department, 2008, 0910LP1060957 NAVSEA; Vann R.D., 2004, BOVE DAVIS DIVING ME, V4th ed., P127, DOI DOI 10.1016/B978-0-7216-9424-5.X5001-1; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Weisher DD, 2008, UNDERSEA HYPERBAR M, V35, P159; Xu WG, 2010, DIVING MED, P99; 李学文, 2002, [中华航海医学与高气压医学杂志, Chinese journal of nautical medicine and hyperbaric medicine], V9, P105	24	21	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50079	10.1371/journal.pone.0050079	http://dx.doi.org/10.1371/journal.pone.0050079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185538	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000178
J	Homola, GA; Jbabdi, S; Beckmann, CF; Bartsch, AJ				Homola, Gyoergy A.; Jbabdi, Saad; Beckmann, Christian F.; Bartsch, Andreas J.			A Brain Network Processing the Age of Faces	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN VISUAL-CORTEX; HUMAN NEURAL SYSTEM; CORTICAL SURFACE; FACIAL ATTRACTIVENESS; FUNCTIONAL-ANALYSIS; COORDINATE SYSTEM; RIGHT-HEMISPHERE; NATURAL VISION; FMRI EVIDENCE	Age is one of the most salient aspects in faces and of fundamental cognitive and social relevance. Although face processing has been studied extensively, brain regions responsive to age have yet to be localized. Using evocative face morphs and fMRI, we segregate two areas extending beyond the previously established face-sensitive core network, centered on the inferior temporal sulci and angular gyri bilaterally, both of which process changes of facial age. By means of probabilistic tractography, we compare their patterns of functional activation and structural connectivity. The ventral portion of Wernicke's understudied perpendicular association fasciculus is shown to interconnect the two areas, and activation within these clusters is related to the probability of fiber connectivity between them. In addition, post-hoc age-rating competence is found to be associated with high response magnitudes in the left angular gyrus. Our results provide the first evidence that facial age has a distinct representation pattern in the posterior human brain. We propose that particular face-sensitive nodes interact with additional object-unselective quantification modules to obtain individual estimates of facial age. This brain network processing the age of faces differs from the cortical areas that have previously been linked to less developmental but instantly changeable face aspects. Our probabilistic method of associating activations with connectivity patterns reveals an exemplary link that can be used to further study, assess and quantify structure-function relationships.	[Homola, Gyoergy A.] Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany; [Jbabdi, Saad; Beckmann, Christian F.; Bartsch, Andreas J.] Univ Oxford, Ctr Funct MRI Brain, Oxford, England; [Beckmann, Christian F.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Beckmann, Christian F.] Univ Twente, MIRA Inst, Nijmegen, Netherlands; [Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany	University of Wurzburg; University of Oxford; Radboud University Nijmegen; Ruprecht Karls University Heidelberg	Homola, GA (corresponding author), Univ Wurzburg, Dept Neuroradiol, Wurzburg, Germany.	homola@neuroradiologie.uni-wuerzburg.de	Beckmann, Christian F./E-6374-2012	Beckmann, Christian F./0000-0002-3373-3193; Jbabdi, Saad/0000-0003-3234-5639	UK Medical Research Council [G0800578]; German Doppelfeld Foundation; German Research Foundation (DFG); University of Wurzburg; MRC [G0800578] Funding Source: UKRI; Medical Research Council [G0800578] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Doppelfeld Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (G0800578) and the German Doppelfeld Foundation (2008-2011), with its publishing being funded by the German Research Foundation (DFG) and the University of Wurzburg (Open Access Publishing funding program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Blanz V., 1999, SIGGRAPH; Brodmann K, 1909, VERGLEICHENDE LOKALI, p[131, 230]; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BRUYER R, 1991, INT J NEUROSCI, V61, P19, DOI 10.3109/00207459108986268; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dejerine J, 1895, ANATOMIE CTR NERVEUX, p[757, 778]; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; DERENZI E, 1989, NEUROPSYCHOLOGIA, V27, P839, DOI 10.1016/0028-3932(89)90007-9; Duvernoy HM, 1999, HUMAN BRAIN SURFACE, P6; Ebner NC, 2008, BEHAV RES METHODS, V40, P130, DOI [10.3758/BRM.40.1.130, 10.3738/BRM.40.1.130]; Ebner NC, 2011, NEUROCASE, V17, P260, DOI 10.1080/13554794.2010.536953; Ellis H.D., 1983, FUNCTIONS RIGHT CERE, P33; ELLIS HD, 1981, PERCEIVING REMEMBERI, P171; Ellis HD, 1986, NEUROPSYCHOLOGY FACE, P1; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Ffytche DH, 2005, PHILOS T R SOC B, V360, P767, DOI 10.1098/rstb.2005.1621; Fine JG, 2009, BEHAV BRAIN RES, V201, P137, DOI 10.1016/j.bbr.2009.02.009; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fox CJ, 2009, HUM BRAIN MAPP, V30, P1637, DOI 10.1002/hbm.20630; Freeman JB, 2010, CEREB CORTEX, V20, P1314, DOI 10.1093/cercor/bhp195; Furl N, 2010, CEREB CORTEX, V20, P694, DOI 10.1093/cercor/bhp140; Furl N, 2007, P NATL ACAD SCI USA, V104, P13485, DOI 10.1073/pnas.0702548104; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; George PA, 1998, PERCEPTION, V27, P1123, DOI 10.1068/p271123; George PA, 1998, PERCEPTION, V27, P295, DOI 10.1068/p270295; Gobel SM, 2006, CORTEX, V42, P774, DOI 10.1016/S0010-9452(08)70416-7; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; GREENBLATT SH, 1973, BRAIN, V96, P307, DOI 10.1093/brain/96.2.307; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Haist F, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00181; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Jbabdi S., 2011, BRAIN CONNE IN PRESS; Jbabdi S, 2012, NAT NEUROSCI, V15, P171, DOI 10.1038/nn.3031; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang F, 2006, PSYCHOL SCI, V17, P493, DOI 10.1111/j.1467-9280.2006.01734.x; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Kadosh KC, 2010, J COGNITIVE NEUROSCI, V22, P903, DOI 10.1162/jocn.2009.21224; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kaul C, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00238; Kauppi Jukka-Pekka, 2010, Front Neuroinform, V4, P5, DOI 10.3389/fninf.2010.00005; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Lee LC, 2010, NEUROPSYCHOLOGIA, V48, P477, DOI 10.1016/j.neuropsychologia.2009.10.005; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Liang XY, 2010, SOC NEUROSCI-UK, V5, P320, DOI 10.1080/17470911003619916; Loffler G, 2005, NAT NEUROSCI, V8, P1386, DOI 10.1038/nn1538; MCGRAW KO, 1989, J GENET PSYCHOL, V150, P251, DOI 10.1080/00221325.1989.9914595; MCNEIL JE, 1991, Q J EXP PSYCHOL-A, V43, P267, DOI 10.1080/14640749108400970; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Ng M, 2006, P NATL ACAD SCI USA, V103, P19552, DOI 10.1073/pnas.0605358104; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Noback CR, 1975, HUMAN NERVOUS SYSTEM, P451; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; O'Toole AJ, 1999, IMAGE VISION COMPUT, V18, P9, DOI 10.1016/S0262-8856(99)00012-8; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park U, 2010, IEEE T PATTERN ANAL, V32, P947, DOI 10.1109/TPAMI.2010.14; Perrett DI, 2002, P ROY SOC B-BIOL SCI, V269, P873, DOI 10.1098/rspb.2002.1971; Pitcher D, 2011, NEUROIMAGE, V56, P2356, DOI 10.1016/j.neuroimage.2011.03.067; Quain J, 1891, QUAINS ELEMENTS AN 1, VIII, P165; Ramanathan N, 2006, IEEE T IMAGE PROCESS, V15, P3349, DOI 10.1109/TIP.2006.881993; Ramanathan N, 2009, J VISUAL LANG COMPUT, V20, P131, DOI 10.1016/j.jvlc.2009.01.011; Raz G, 2012, NEUROIMAGE, V60, P1448, DOI 10.1016/j.neuroimage.2011.12.084; Ross J, 1883, BRAIN, V6, P398; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Sachs H, 1892, HEMISPHARENMARK MENS, p[6, 8, 15, 23, 26, 29]; Saygin ZM, 2012, NAT NEUROSCI, V15, P321, DOI 10.1038/nn.3001; Scherf S, 2010, FRONTIERS HUMAN NEUR, V4; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; TENG EL, 1979, NEUROPSYCHOLOGIA, V17, P41, DOI 10.1016/0028-3932(79)90020-4; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 2008, P NATL ACAD SCI USA, V105, P3605, DOI 10.1073/pnas.0712274105; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; Tsukiura T, 2011, SOC COGN AFFECT NEUR, V6, P138, DOI 10.1093/scan/nsq025; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; von Economo C, 1927, ZELLAUFBAU GROSSHIRN, p[2, 84]; Wallis G, 2008, J VISION, V8, DOI 10.1167/8.3.20; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Wernicke C, 1877, DEUT MED WOCHENSCHR, V12, P2; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7; ZEKI S, 1991, J NEUROSCI, V11, P641	113	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49451	10.1371/journal.pone.0049451	http://dx.doi.org/10.1371/journal.pone.0049451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185334	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700033
J	Palgunow, D; Klapper, M; Doring, F				Palgunow, Daniela; Klapper, Maja; Doering, Frank			Dietary Restriction during Development Enlarges Intestinal and Hypodermal Lipid Droplets in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; CALORIC RESTRICTION; C-ELEGANS; PHOSPHOCHOLINE BIOSYNTHESIS; N-METHYLTRANSFERASE; INDUCED LONGEVITY; METABOLIC-RATE; REGULATES FAT; PPAR-ALPHA; BODY-SIZE	Dietary restriction (DR) extends lifespan in man species and modulates evolutionary conserved signalling and metabolic pathways. Most of these studies were done in adult animals. Here we investigated fat phenotypes of C. elegans larvae and adults which were exposed to DR during development. This approach was named "developmental-DR'' (dDR). Moderate as well as stringent dDR increased the triglyceride to protein ratio in L4 larvae and adult worms. This alteration was accompanied by a marked expansion of intestinal and hypodermal lipid droplets. In comparison to ad libitum condition, the relative proportion of fat stored in large lipid droplets (>50 mu m(3)) was increased by a factor of about 5 to 6 in larvae exposed to dDR. Microarray-based expression profiling identified several dDR-regulated genes of lipolysis and lipogenesis which may contribute to the observed fat phenotypes. In conclusion, dDR increases the triglyceride to protein ratio, enlarges lipid droplets and alters the expression of genes functioning in lipid metabolism in C. elegans. These changes might be an effective adaptation to conserve fat stores in animals subjected to limiting food supply during development.	[Palgunow, Daniela; Klapper, Maja; Doering, Frank] Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany	University of Kiel	Doring, F (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany.	sek@molprev.uni-kiel.de			Deutsche Forschungsgemeinschaft (DFG) in the context of the Cluster of Excellence "Inflammation at Interfaces'' at the University of Kiel; German Ministry of Education and Research [BMBF 0315681]	Deutsche Forschungsgemeinschaft (DFG) in the context of the Cluster of Excellence "Inflammation at Interfaces'' at the University of Kiel(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a structural grant from the Deutsche Forschungsgemeinschaft (DFG) in the context of the Cluster of Excellence "Inflammation at Interfaces'' at the University of Kiel and by a grant form the German Ministry of Education and Research (BMBF 0315681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnio V, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00012; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; BRENNER S, 1974, GENETICS, V77, P71; Castro C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-36; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Elle IC, 2011, BIOCHEM J, V437, P231, DOI 10.1042/BJ20102099; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HOSONO R, 1989, EXP GERONTOL, V24, P251, DOI 10.1016/0531-5565(89)90016-8; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Klapper M, 2011, J LIPID RES, V52, P1281, DOI 10.1194/jlr.D011940; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee Eun-Young, 2009, V462, P167, DOI 10.1007/978-1-60327-115-8_11; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Li XS, 2010, OBESITY, V18, P456, DOI 10.1038/oby.2009.312; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Michels KB, 2004, JAMA-J AM MED ASSOC, V291, P1226, DOI 10.1001/jama.291.10.1226; Mullaney BC, 2010, CELL METAB, V12, P398, DOI 10.1016/j.cmet.2010.08.013; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Park SK, 2010, FASEB J, V24, P383, DOI 10.1096/fj.09-142984; ROBERTSON FW, 1959, GENETICS, V44, P869; Salomon MP, 2009, GENETICS, V183, P685, DOI 10.1534/genetics.109.107383; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Schlotterer A, 2010, AGING CELL, V9, P420, DOI 10.1111/j.1474-9726.2010.00572.x; So SH, 2011, GENES CELLS, V16, P639, DOI 10.1111/j.1365-2443.2011.01514.x; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Szewczyk NJ, 2006, J EXP BIOL, V209, P4129, DOI 10.1242/jeb.02492; Tain LS, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-28; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; WEINDRUCH R, 1988, J GERONTOL, V43, pB40, DOI 10.1093/geronj/43.2.B40; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Xu M, 2011, J BIOL CHEM, V286, P28111, DOI 10.1074/jbc.M111.227165; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhang J, 2011, J MOL BIOL, V411, P537, DOI 10.1016/j.jmb.2011.06.011; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107	71	31	31	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e46198	10.1371/journal.pone.0046198	http://dx.doi.org/10.1371/journal.pone.0046198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185233	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700002
J	Hadorn, M; Boenzli, E; Hotz, PE; Hanczyc, MM				Hadorn, Maik; Boenzli, Eva; Hotz, Peter Eggenberger; Hanczyc, Martin M.			Hierarchical Unilamellar Vesicles of Controlled Compositional Heterogeneity	PLOS ONE			English	Article							GIANT VESICLES; LIPID VESICLES; LIPOSOMES; ENCAPSULATION; RELEASE; BILAYER	Eukaryotic life contains hierarchical vesicular architectures (i.e. organelles) that are crucial for material production and trafficking, information storage and access, as well as energy production. In order to perform specific tasks, these compartments differ among each other in their membrane composition and their internal cargo and also differ from the cell membrane and the cytosol. Man-made structures that reproduce this nested architecture not only offer a deeper understanding of the functionalities and evolution of organelle-bearing eukaryotic life but also allow the engineering of novel biomimetic technologies. Here, we show the newly developed vesicle-in-water-in-oil emulsion transfer preparation technique to result in giant unilamellar vesicles internally compartmentalized by unilamellar vesicles of different membrane composition and internal cargo, i.e. hierarchical unilamellar vesicles of controlled compositional heterogeneity. The compartmentalized giant unilamellar vesicles were subsequently isolated by a separation step exploiting the heterogeneity of the membrane composition and the encapsulated cargo. Due to the controlled, efficient, and technically straightforward character of the new preparation technique, this study allows the hierarchical fabrication of compartmentalized giant unilamellar vesicles of controlled compositional heterogeneity and will ease the development of eukaryotic cell mimics that resemble their natural templates as well as the fabrication of novel multi-agent drug delivery systems for combination therapies and complex artificial microreactors.	[Hadorn, Maik; Boenzli, Eva; Hanczyc, Martin M.] Univ So Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Hotz, Peter Eggenberger] Univ Zurich, Dept Informat, Zurich, Switzerland	University of Southern Denmark; University of Zurich	Hadorn, M (corresponding author), Univ So Denmark, Dept Phys Chem & Pharm, Odense, Denmark.	hadorn@sdu.dk	Hadorn, Maik/I-8909-2012	Hadorn, Maik/0000-0003-4530-9346; Hanczyc, Martin/0000-0002-5453-2139	Danish National Research Foundation through the Center for Fundamental Living technologies (FlinT); European Community's Seventh Framework Programme (FP7) [249032]	Danish National Research Foundation through the Center for Fundamental Living technologies (FlinT); European Community's Seventh Framework Programme (FP7)	The research leading to these results has received funding from the Danish National Research Foundation through the Center for Fundamental Living technologies (FlinT) and from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 249032 (MATCHIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl PL, 2003, METHOD ENZYMOL, V367, P80; Bolinger PY, 2008, ANGEW CHEM INT EDIT, V47, P5544, DOI 10.1002/anie.200801606; Bolinger PY, 2004, J AM CHEM SOC, V126, P8594, DOI 10.1021/ja049023u; Boyer C, 2007, ACS NANO, V1, P176, DOI 10.1021/nn7002025; Bui AV, 2004, J FOOD ENG, V62, P345, DOI 10.1016/S0260-8774(03)00249-8; Chiu DT, 1999, SCIENCE, V283, P1892, DOI 10.1126/science.283.5409.1892; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Dominak LM, 2007, LANGMUIR, V23, P7148, DOI 10.1021/la063687v; Fenz SF, 2012, INTEGR BIOL-UK, V4, P982, DOI 10.1039/c2ib00188h; Gomez-Hens A, 2005, TRAC-TREND ANAL CHEM, V24, P9, DOI 10.1016/j.trac.2004.07.017; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Ishii K, 2009, CHEMBIOCHEM, V10, P251, DOI 10.1002/cbic.200800482; Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747; Katayama K, 2002, INT J PHARM, V248, P93, DOI 10.1016/S0378-5173(02)00427-1; KIM S, 1983, BIOCHIM BIOPHYS ACTA, V728, P339, DOI 10.1016/0005-2736(83)90504-7; KULKARNI SB, 1995, J MICROENCAPSUL, V12, P229, DOI 10.3109/02652049509010292; LASIC DD, 1988, BIOCHEM J, V256, P1; Menger FM, 1996, LANGMUIR, V12, P4479, DOI 10.1021/la960370u; Michel M, 2004, LANGMUIR, V20, P6127, DOI 10.1021/la049862u; Nardi J, 1999, PHYS REV LETT, V82, P5168, DOI 10.1103/PhysRevLett.82.5168; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Nomura S, 2003, CHEMBIOCHEM, V4, P1172, DOI 10.1002/cbic.200300630; Okumura Y, 2011, MEMBRANES, V1, P265, DOI 10.3390/membranes1040265; Okumura Y, 2011, LANGMUIR, V27, P3279, DOI 10.1021/la2004485; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Walker SA, 1997, NATURE, V387, P61, DOI 10.1038/387061a0; Yamabe K, 2003, J CONTROL RELEASE, V90, P71, DOI 10.1016/S0168-3659(03)00159-7; Zawada ZH, 2004, CELL MOL BIOL LETT, V9, P589; Zhang HB, 2011, EXPERT OPIN DRUG DEL, V8, P171, DOI 10.1517/17425247.2011.547470	31	24	24	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50156	10.1371/journal.pone.0050156	http://dx.doi.org/10.1371/journal.pone.0050156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185563	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800071
J	Lima, VD; Le, A; Nosyk, B; Barrios, R; Yip, B; Hogg, RS; Harrigan, PR; Montaner, JSG				Lima, Viviane D.; Le, Adrian; Nosyk, Bohdan; Barrios, Rolando; Yip, Benita; Hogg, Robert S.; Harrigan, P. Richard; Montaner, Julio S. G.			Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy	PLOS ONE			English	Article							SOCIETY-USA PANEL; ACTIVE ANTIRETROVIRAL THERAPY; UPDATED RECOMMENDATIONS; INFECTION; INDIVIDUALS; ADHERENCE	Background: We developed and validated a new and simple metric, the Programmatic Compliance Score (PCS), based on the IAS-USA antiretroviral therapy management guidelines for HIV-infected adults, as a predictor of all-cause mortality, at a program-wide level. We hypothesized that non-compliance would be associated with the highest probability of mortality. Methods and Findings: 3543 antiretroviral-naive HIV-infected patients aged >= 19 years who initiated antiretroviral therapy between January 1, 2000 and August 31, 2009 in British Columbia (BC), Canada, were followed until August 31, 2010. The PCS is composed by six non-performance indicators based on the IAS-USA guidelines: (1) having<3 CD4 count tests in the first year after starting antiretroviral therapy; (2) having<3 plasma viral load tests in the first year after starting antiretroviral therapy; (3) not having drug resistance testing done prior to starting antiretroviral therapy; (4) starting on a non-recommended antiretroviral therapy regimen; (5) starting therapy with CD<200 cells/mm(3); and (6) not achieving viral suppression within 6 months since antiretroviral therapy initiation. The sum of these six indicators was used to develop the PCS score-higher score indicates poorer performance. The main outcome was all-cause mortality. Each PCS component was independently associated with mortality. In the mortality analysis, the odds ratio (OR) for PCS >= 4 versus 0 was 22.37 (95% CI 10.46-47.84). Conclusions: PCS was strongly associated with all-cause mortality. These results lend independent validation to the IAS-USA treatment guidelines for HIV-infected adults. Further efforts are warranted to enhance the PCS as a means to further improve clinical outcomes. These should be specifically evaluated and targeted at healthcare providers and patients.	[Lima, Viviane D.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Lima, Viviane D.; Harrigan, P. Richard; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Dept Med, Div AIDS, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Simon Fraser University	Lima, VD (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	vlima@cfenet.ubc.ca	Montaner, Julio/K-7621-2012; Le, Adrian/ABG-3288-2020	Hogg, Robert/0000-0003-3463-5488	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Ministry of Health Services, Province of British Columbia, through a Knowledge Translation Award from the Canadian Institutes of Health Research [1DP1DA026182-01]; National Institute on Drug Abuse, at the United States National Institutes of Health; CIHR/GSK Research Chair in Clinical Virology; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033851, DP1DA026182] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Ministry of Health Services, Province of British Columbia, through a Knowledge Translation Award from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute on Drug Abuse, at the United States National Institutes of Health; CIHR/GSK Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	During this work, VDL was supported by the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research through Fellowship Awards. BN is a Canadian Institutes of Health Research Bisby Fellow. JSGM is supported by the Ministry of Health Services, Province of British Columbia, through a Knowledge Translation Award from the Canadian Institutes of Health Research and through an Avant-Garde Award (No. 1DP1DA026182-01) from the National Institute on Drug Abuse, at the United States National Institutes of Health. PRH is supported by CIHR/GSK Research Chair in Clinical Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Cescon AM, 2011, HIV MED, V12, P352, DOI 10.1111/j.1468-1293.2010.00890.x; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; McNeil Jr DG, 2011, NEW WORK TIMES; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moore DM, 2009, JAIDS-J ACQ IMM DEF, V52, P357, DOI 10.1097/QAI.0b013e3181b62933; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Steyerberg E., 2010, CLIN PREDICTION MODE; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	21	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e47859	10.1371/journal.pone.0047859	http://dx.doi.org/10.1371/journal.pone.0047859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185244	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800005
J	Zachariah, RM; Olson, CO; Ezeonwuka, C; Rastegar, M				Zachariah, Robby M.; Olson, Carl O.; Ezeonwuka, Chinelo; Rastegar, Mojgan			Novel MeCP2 Isoform-Specific Antibody Reveals the Endogenous MeCP2E1 Expression in Murine Brain, Primary Neurons and Astrocytes	PLOS ONE			English	Article							CPG-BINDING-PROTEIN; RETT-SYNDROME; MOUSE MODEL; MENTAL-RETARDATION; DEFICIENCY; MUTATIONS; MICE; EXON-1; DNA; TRANSCRIPTION	Rett Syndrome (RTT) is a severe neurological disorder in young females, and is caused by mutations in the X-linked MECP2 gene. MECP2/Mecp2 gene encodes for two protein isoforms; MeCP2E1 and MeCP2E2 that are identical except for the N-terminus region of the protein. In brain, MECP2E1 transcripts are 10X higher, and MeCP2E1 is suggested to be the relevant isoform for RTT. However, due to the unavailability of MeCP2 isoform-specific antibodies, the endogenous expression pattern of MeCP2E1 is unknown. To gain insight into the expression of MeCP2E1 in brain, we have developed an anti-MeCP2E1 antibody and validated its specificity in cells exogenously expressing individual MeCP2 isoforms. This antibody does not show any cross-reactivity with MeCP2E2 and detects endogenous MeCP2E1 in mice brain, with no signal in Mecp2(tm1.1Bird) y/ - null mice. Additionally, we show the endogenous MeCP2E1 expression throughout different brain regions in adult mice, and demonstrate its highest expression in the brain cortex. Our results also indicate that MeCP2E1 is highly expressed in primary neurons, as compared to primary astrocytes. This is the first report of the endogenous MeCP2E1 expression at the protein levels, providing novel avenues for understanding different aspects of MeCP2 function.	[Zachariah, Robby M.; Olson, Carl O.; Ezeonwuka, Chinelo; Rastegar, Mojgan] Univ Manitoba, Fac Med, Regenerat Med Program, Dept Biochem & Med Genet, Winnipeg, MB, Canada	University of Manitoba	Rastegar, M (corresponding author), Univ Manitoba, Fac Med, Regenerat Med Program, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	rastegar@cc.umanitoba.ca	Rastegar, Mojgan/T-9394-2019	Rastegar, Mojgan/0000-0003-3619-6116	Manitoba Institute of Child Health (MICH) Small Grant and Operating Funds; Scottish Rite Charitable Foundation of Canada (SRCFC) [10110]; Manitoba Health Research Council (MHRC) Establishment and Operating Funds; Health Sciences Centre Foundation (HSCF) Grant; MHRC-MICH Studentship Award; MHRC-UMGF Studentship Award	Manitoba Institute of Child Health (MICH) Small Grant and Operating Funds; Scottish Rite Charitable Foundation of Canada (SRCFC); Manitoba Health Research Council (MHRC) Establishment and Operating Funds; Health Sciences Centre Foundation (HSCF) Grant; MHRC-MICH Studentship Award; MHRC-UMGF Studentship Award	This work is supported by funds from the Manitoba Institute of Child Health (MICH) Small Grant and Operating Funds, Scottish Rite Charitable Foundation of Canada (SRCFC, Grant 10110), Manitoba Health Research Council (MHRC) Establishment and Operating Funds, and Health Sciences Centre Foundation (HSCF) Grant. RMZ is a recipient of MHRC-MICH Studentship Award and CE is a recipient of MHRC-UMGF Studentship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2005, HUM MOL GENET, V14, P3709, DOI 10.1093/hmg/ddi402; Adachi M, 2009, J NEUROSCI, V29, P4218, DOI 10.1523/JNEUROSCI.4225-08.2009; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Geerdink N, 2002, NEUROPEDIATRICS, V33, P33, DOI 10.1055/s-2002-23598; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gianakopoulos PJ, 2012, AM J MED GENET B, V159B, P210, DOI 10.1002/ajmg.b.32015; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Itoh M, 2012, J BIOL CHEM, V287, P13859, DOI 10.1074/jbc.M111.309864; Jugloff DGM, 2008, HUM MOL GENET, V17, P1386, DOI 10.1093/hmg/ddn026; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kerr B, 2012, EUR J HUM GENET, V20, P69, DOI 10.1038/ejhg.2011.145; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Minh VCN, 2012, J NEUROSCI, V32, P10021, DOI 10.1523/JNEUROSCI.1316-12.2012; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Saunders CJ, 2009, AM J MED GENET A, V149A, P1019, DOI 10.1002/ajmg.a.32776; Saxena A, 2006, J MED GENET, V43, P470, DOI 10.1136/jmg.2005.036244; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Shao ZJ, 2009, J NEUROSCI RES, V87, P2520, DOI 10.1002/jnr.22086; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Thambirajah AA, 2012, NUCLEIC ACIDS RES, V40, P2884, DOI 10.1093/nar/gkr1066; Watson P, 2001, J MED GENET, V38, P224, DOI 10.1136/jmg.38.4.224; Zachariah RM, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/415825	44	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49763	10.1371/journal.pone.0049763	http://dx.doi.org/10.1371/journal.pone.0049763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185431	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800050
J	Gapp, IW; Congreve, CR; Lieberman, BS				Gapp, I. Wesley; Congreve, Curtis R.; Lieberman, Bruce S.			Unraveling the Phylogenetic Relationships of the Eccoptochilinae, an Enigmatic Array of Ordovician Cheirurid Trilobites	PLOS ONE			English	Article								The Cheiruridae are a diverse group of trilobites and several subfamilies within the clade have been the focus of recent phylogenetic studies. This paper focuses on the relationships of one of those subfamilies, the Ordovician Eccoptochilinae. We analyze sixteen species from six genera within the traditionally defined group, using the pilekiid Anacheirurus frederici as an outgroup. To assess the monophyly of the Eccoptochilinae seven sphaerexochine species, Kawina arnoldi, Sphaerexochus arenosus, S. atacius, S. latifrons, S. mirus, S. parvus, and S. scabridus were included in the analysis as well. The results of this analysis show that the genus Eccoptochile represents a paraphyletic grade and species traditionally assigned to Parasphaerexochus and Skelipyx plot within Pseudosphaerexochus. Also, representative species of Sphaerexochinae plot within the traditionally defined Eccoptochilinae, suggesting Eccoptochilinae itself is paraphyletic. To resolve this, we propose all species of Pseudosphaerexochus be placed within Sphaerexochinae and Eccoptochilinae be restricted to a monotypic Eccoptochile clavigera.	[Gapp, I. Wesley; Congreve, Curtis R.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; [Lieberman, Bruce S.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Gapp, I. Wesley; Congreve, Curtis R.; Lieberman, Bruce S.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas	Gapp, IW (corresponding author), Univ Kansas, Dept Geol, Lawrence, KS 66045 USA.	wes123@ku.edu		Congreve, Curtis/0000-0003-3476-1257	NSF [DEB-0716162]	NSF(National Science Foundation (NSF))	This research was supported by NSF DEB-0716162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain JM, 1998, J PALEONTOL, V72, P698, DOI 10.1017/S0022336000040403; Adrain Jonathan M., 1997, Bulletin of the Natural History Museum Geology Series, V53, P79; Angelin NP, 1854, PARS 1 CRUSTACEA FOR, V2; Beyrich E, 1845, UEBER CINIGE BOHMISC; Congreve CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021304; Congreve CR, 2010, J PALEONTOL, V84, P128, DOI 10.1666/09-026.1; Congreve Curtis R., 2008, Open Paleontology Journal, V1, P24, DOI 10.2174/1874425700801010024; Ebach MC, 1999, J PALEONTOL, V73, P431, DOI 10.1017/S0022336000027955; Ebach MC, 2001, CLADISTICS, V17; Evitt W. R., 1951, Journal of Paleontology, V25, P587; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hawle I, 1847, PRODOM MONOGRAHIE BO; Ingham JK, 1974, UPPER ORDOVICIAN T 2; Rustan JJ, 2012, REV MEX CIENC GEOL, V29, P346; Kutorga S, 1854, ZAPISKA IMPERATORSKA, V13, P105; Lane PD, 1971, BRIT CHEIRURIDAE TRI; Lieberman BS, 2010, ARTHROPOD STRUCT DEV, V39, P111, DOI 10.1016/j.asd.2009.10.004; Linnarsson JGO, 1866, K SVENSKA VETENSK AK, V8, P161; M'Coy F., 1849, ANN MAGAZINE NATUR 2, V4, P161, DOI DOI 10.1080/03745486009494810; Maddison WP, 2011, MESQUITE MODULAR SYS; Nikolaisen F, 1965, MIDDLE ORDOVICIAN OS, P18; Opik, 1937, ACTA COMMENTATIONES, V32, P1; Parnaste H, 2003, SPEC PAP PALAEONTOL, P241; Prantl F, 1948, SB NAR MUZ PRAZE GEO, V1, P1; Pribyl A., 1985, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V83, P107; PRIBYL A, 1984, Palaeontologische Zeitschrift, V58, P119; Pribyl A, 1964, MEM ACAD SCI ST PETE, V133, P161; Rambaut A., 2009, FIGTREE 1 3 1; Raymond PE, 1913, TXB PALAEONTOLOGY, P692; Rustan JJ, 2010, J PALEONTOL, V84, P1082, DOI 10.1666/09-166.1; Salter J. W., 1864, MONOGRAPH BRIT TRILO; SALTER JW, 1853, MEMOIRS GEOLOGICAL S; Schmidt F., 1881, MEMOIRES LACADEMIE I, V30, P1; Whittard W. F., 1940, Annals & Magazine of Natural History Series 11, V5, P153; WHITTINGTON H. B., 1966, J PALEONTOL, V40, P696; Whittington H. B., 1954, Memoirs Geological Society of America, VNo. 59, P1; Whittington HB, 1997, TREATISE INVERTEBRAT, P530; WILEY EO, 1979, SYST ZOOL, V28, P308; Wiley EO, 2011, PHYLOGENETICS THEORY	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49115	10.1371/journal.pone.0049115	http://dx.doi.org/10.1371/journal.pone.0049115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173046	gold, Green Submitted, Green Published			2022-12-25	WOS:000311885300016
J	Jeng, WJ; Lin, CY; Chen, JY; Huang, CW; Huang, CH; Sheen, IS				Jeng, Wen-Juei; Lin, Chun-Yen; Chen, Ji-Yih; Huang, Chang-Wen; Huang, Chien-Hao; Sheen, I-Shyan			None of the Six SNPs of IL28B Could Predict Treatment Responses in Genotype 2 Chronic HCV Infected Patients by Propensity Score Matching Analysis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ALPHA-2B PLUS RIBAVIRIN; PEGYLATED INTERFERON-ALPHA; PEGINTERFERON ALPHA-2B; VIROLOGICAL RESPONSE; GENETIC-VARIATION; TREATMENT DURATION; THERAPY; VIRUS; 40KD	Background & Aims: A combination of pegylated interferon-alpha and ribavirin (PR) is the standard therapy for patients with chronic hepatitis C. The impact of polymorphism of interleukin-28B (IL28B) on sustained virological response (SVR) to PR has been well documented in patients with CHC genotype-1 (GT1), but it is controversial in genotype-2 (GT2) CHC patients. This study investigated the predictability of six single nucleotide polymorphisms (SNP) of IL28B on the treatment responses of PR in patients with CHC GT2. Method: 197 CHC GT2 consecutive patients who received PR treatment in our prospective cohort were enrolled. Hepatitis C virus (HCV) genotyping, quantification of HCV-RNA and genotyping of the ten SNPs of IL28B were performed. Six SNPs of IL28B were chosen for analysis. The propensity score matching (PSM) analysis was applied using patients with CHC GT1 in another prospective cohort as a positive comparison to avoid covariate bias. Results: The distribution of the six SNPs was similar in GT1 and GT2 patients. Five of these SNPs had strong association with treatment responses in GT1 but not in GT2 patients. After PSM analysis, these five SNPs still showed strong association with rapid virological response (RVR), cEVR and SVR in GT1 and had no influence in GT2 patients. Furthermore, rs12979860 and baseline viral load were the predictors for both RVR and SVR in GT1 patients. However, only baseline viral load could predict RVR and SVR in GT2 patients. In addition, in patients without RVR, rs12979860 was the only predictor for SVR in GT1 but no predictor for SVR was found in GT2. Conclusions: The genetic polymorphisms of IL28B had no impact on treatment responses in GT2 patients.	[Jeng, Wen-Juei; Lin, Chun-Yen; Huang, Chang-Wen; Huang, Chien-Hao; Sheen, I-Shyan] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Div Hepatol, Tao Yuan, Taiwan; [Lin, Chun-Yen; Chen, Ji-Yih; Sheen, I-Shyan] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chen, Ji-Yih] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Rheumatol Allergy & Immunol, Tao Yuan, Taiwan; [Jeng, Wen-Juei] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University	Sheen, IS (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Gastroenterol & Hepatol, Div Hepatol, Tao Yuan, Taiwan.	issheen.jks@gmail.com		Lin, Chun-Yen/0000-0003-3007-3190	National Science Council, Taiwan [NMRP: 98-3112-B-182A-003, NMRP: 360021]; Chang Gung Memorial Hospital [CMRPG 390682, 37542, 360463]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by NMRP: 98-3112-B-182A-003 and NMRP: 360021 from the National Science Council, Taiwan, and CMRPG 390682, 37542, 360463 from Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Bruno S, 2004, J HEPATOL, V41, P474, DOI 10.1016/j.jhep.2004.05.012; Chen JY, 2011, GENES IMMUN, V12, P300, DOI 10.1038/gene.2011.1; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hung HH, 2011, CLIN GASTROENTEROL H, V9, P79, DOI 10.1016/j.cgh.2010.08.018; Kamal SM, 2004, HEPATOLOGY, V39, P1721, DOI 10.1002/hep.20266; Kawaoka T, 2011, J HEPATOL, V54, P408, DOI 10.1016/j.jhep.2010.07.032; Lin CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018322; Lindh M, 2011, J INFECT DIS, V203, P1748, DOI 10.1093/infdis/jir193; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Pearl J, 2009, UNDERSTANDING PROPEN; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rizzetto M, 2004, HEPATOLOGY, V40, p252A; Rumi MG, 2010, GASTROENTEROLOGY, V138, P108, DOI [10.1053/j.gastro.2009.08.071, 10.1053/j.gastro.2010.04.037]; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Yu ML, 2008, HEPATOLOGY, V47, P1884, DOI 10.1002/hep.22319; Yu ML, 2007, GUT, V56, P553, DOI 10.1136/gut.2006.102558; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/S0168-8278(04)00060-1, 10.1016/j.jhep.2004.02.007]	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e48217	10.1371/journal.pone.0048217	http://dx.doi.org/10.1371/journal.pone.0048217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173032	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300002
J	Okamura, T; Yanobu-Takanashi, R; Takeuchi, F; Isono, M; Akiyama, K; Shimizu, Y; Goto, M; Liang, YQ; Yamamoto, K; Katsuya, T; Fujioka, A; Ohnaka, K; Takayanagi, R; Ogihara, T; Yamori, Y; Kato, N				Okamura, Tadashi; Yanobu-Takanashi, Rieko; Takeuchi, Fumihiko; Isono, Masato; Akiyama, Koichi; Shimizu, Yukiko; Goto, Motohito; Liang, Yi-Qiang; Yamamoto, Ken; Katsuya, Tomohiro; Fujioka, Akihiro; Ohnaka, Keizo; Takayanagi, Ryoichi; Ogihara, Toshio; Yamori, Yukio; Kato, Norihiro			Deletion of CDKAL1 Affects High-Fat Diet-Induced Fat Accumulation and Glucose-Stimulated Insulin Secretion in Mice, Indicating Relevance to Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; TRANSCRIPTION FACTOR; COMMON VARIANTS; TCF7L2 POLYMORPHISMS; BETA-CELLS; RISK LOCI; TYPE-2; POPULATION; PATTERNS	Background/Objective: The CDKAL1 gene is among the best-replicated susceptibility loci for type 2 diabetes, originally identified by genome-wide association studies in humans. To clarify a physiological importance of CDKAL1, we examined effects of a global Cdkal1-null mutation in mice and also evaluated the influence of a CDKAL1 risk allele on body mass index (BMI) in Japanese subjects. Methods: In Cdkal1-deficient (Cdkal1(-/-)) mice, we performed oral glucose tolerance test, insulin tolerance test, and perfusion experiments with and without high-fat feeding. Based on the findings in mice, we tested genetic association of CDKAL1 variants with BMI, as a measure of adiposity, and type 2 diabetes in Japanese. Principal Findings: On a standard diet, Cdkal1(-/-) mice were modestly lighter in weight than wild-type littermates without major alterations in glucose metabolism. On a high fat diet, Cdkal1(-/-) mice showed significant reduction in fat accumulation (17% reduction in %intraabdominal fat, P = 0.023 vs. wild-type littermates) with less impaired insulin sensitivity at an early stage. High fat feeding did not potentiate insulin secretion in Cdkal1(-/-) mice (1.0-fold), contrary to the results in wild-type littermates (1.6-fold, P<0.01). Inversely, at a later stage, Cdkal1(-/-) mice showed more prominent impairment of insulin sensitivity and glucose tolerance. mRNA expression analysis indicated that Scd1 might function as a critical mediator of the altered metabolism in Cdkal1(-/-) mice. In accordance with the findings in mice, a nominally significant (P<0.05) association between CDKAL1 rs4712523 and BMI was replicated in 2 Japanese general populations comprising 5,695 and 12,569 samples; the risk allele for type 2 diabetes was also associated with decreased BMI. Conclusions: Cdkal1 gene deletion is accompanied by modestly impaired insulin secretion and longitudinal fluctuations in insulin sensitivity during high-fat feeding in mice. CDKAL1 may affect such compensatory mechanisms regulating glucose homeostasis through interaction with diet.	[Takeuchi, Fumihiko; Isono, Masato; Akiyama, Koichi; Liang, Yi-Qiang; Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Okamura, Tadashi; Yanobu-Takanashi, Rieko; Shimizu, Yukiko; Goto, Motohito] Natl Ctr Global Hlth & Med, Res Inst, Div Anim Model, Dept Infect Dis, Tokyo, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 812, Japan; [Katsuya, Tomohiro] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Katsuya, Tomohiro; Ogihara, Toshio] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Fujioka, Akihiro] Amagasaki Hlth Med Fdn, Amagasaki, Hyogo, Japan; [Ohnaka, Keizo] Kyushu Univ, Grad Sch Med Sci, Dept Geriatr Med, Fukuoka 812, Japan; [Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Ogihara, Toshio] Morinomiya Univ Med Sci, Osaka, Japan; [Yamori, Yukio] Mukogawa Womens Univ, Inst World Hlth Dev, Mukogawa, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Kyushu University; Osaka University; Osaka University; Kyushu University; Kyushu University; Mukogawa Women's University	Kato, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan.	nokato@ri.ncgm.go.jp		yuan ren, hou teng/0000-0001-6288-4583; Akiyama, Koichi/0000-0001-8801-4893	Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (the National Institute of Biomedical Innovation Organization); National Center for Global Health and Medicine; Ministry of Health, Labour and Welfare	Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (the National Institute of Biomedical Innovation Organization); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (the National Institute of Biomedical Innovation Organization); the grant of National Center for Global Health and Medicine; and Grant-in-Aid from the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2002, AM J PHYSIOL-ENDOC M, V283, pE738, DOI 10.1152/ajpendo.00199.2002; Araki K, 1990, CELL MOL BIOL NOISY, V45, P737; Cauchi S, 2008, OBESITY, V16, P476, DOI 10.1038/oby.2007.77; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Dehwah MAS, 2010, GENET MOL RES, V9, P1109, DOI 10.4238/vol9-2gmr802; Erber E, 2010, DIABETES CARE, V33, P532, DOI 10.2337/dc09-1621; FILIPPONI P, 1983, ENDOCRINOLOGY, V113, P1972, DOI 10.1210/endo-113-6-1972; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gambino R, 2010, DIABETES CARE, V33, P1233, DOI 10.2337/dc09-1690; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; Nagare T, 2011, J BIOL CHEM, V286, P37458, DOI 10.1074/jbc.M111.242651; Nanri A, 2008, AM J CLIN NUTR, V87, P1488, DOI 10.1093/ajcn/87.5.1488; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Oyama K, 2006, DIABETES, V55, P1930, DOI 10.2337/db05-1459; Pecioska S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008541; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quaranta M, 2009, GENES IMMUN, V10, P654, DOI 10.1038/gene.2009.51; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Stancakova A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; 't Hart LM, 2010, DIABETES, V59, P287, DOI 10.2337/db09-0736; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; Timpson NJ, 2009, DIABETES, V58, P505, DOI 10.2337/db08-0906; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Winzell MS, 2007, METABOLISM, V56, P122, DOI 10.1016/j.metabol.2006.09.008; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhao JH, 2009, DIABETES, V58, P2414, DOI 10.2337/db09-0506	43	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49055	10.1371/journal.pone.0049055	http://dx.doi.org/10.1371/journal.pone.0049055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173044	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300014
J	Choi, HH; Choi, HK; Jung, SY; Hyle, J; Kim, BJ; Yoon, K; Cho, EJ; Youn, HD; Lahti, JM; Qin, J; Kim, ST				Choi, H-H; Choi, H-K; Jung, S. Y.; Hyle, J.; Kim, B-J; Yoon, K.; Cho, E-J; Youn, H-D; Lahti, J. M.; Qin, J.; Kim, S-T			CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11p110	ONCOGENE			English	Article						CHK2; pre-mRNA splicing; CDK11; DNA damage response pathway	DNA-DAMAGE CHECKPOINT; ACTIVATION; CANCER; P53; SUSCEPTIBILITY; COMPLEXES; BRCA1; CELLS; CHEK2; ATM	Checkpoint kinase 2 (CHK2) kinase is a key mediator in many cellular responses to genotoxic stresses, including ionizing radiation (IR) and topoisomerase inhibitors. Upon IR, CHK2 is activated by ataxia telangiectasia mutated kinase and regulates the S-phase and G1-S checkpoints, apoptosis and DNA repair by phosphorylating downstream target proteins, such as p53 and Brca1. In addition, CHK2 is thought to be a multi-organ cancer susceptibility gene. In this study, we used a tandem affinity purification strategy to identify proteins that interact with CHK2 kinase. Cyclin-dependent kinase 11 (CDK11)(p110) kinase, implicated in pre-mRNA splicing and transcription, was identified as a CHK2-interacting protein. CHK2 kinase phosphorylated CDK11(p110) on serine 737 in vitro. Unexpectedly, CHK2 kinase constitutively phosphorylated CDK11(p110) in a DNA damage-independent manner. At a molecular level, CDK11(p110) phosphorylation was required for homodimerization without affecting its kinase activity. Overexpression of CHK2 promoted pre-mRNA splicing. Conversely, CHK2 depletion decreased endogenous splicing activity. Mutation of the phosphorylation site in CDK11(p110) to alanine abrogated its splicing-activating activity. These results provide the first evidence that CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).	[Choi, H-H; Choi, H-K; Kim, S-T] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, 300 Chunchung Dong, Suwon 440746, South Korea; [Jung, S. Y.; Kim, B-J; Qin, J.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Ctr Mol Discovery, Houston, TX 77030 USA; [Hyle, J.; Lahti, J. M.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Yoon, K.] Sungkyunkwan Univ, Sch Life Sci & Biotechnol, Suwon 440746, South Korea; [Cho, E-J] Sungkyunkwan Univ, Sch Pharm, Suwon 440746, South Korea; [Youn, H-D] Seoul Natl Univ, Coll Med, Canc Res Inst, Natl Res Lab Metab Checkpoint,Dept Biomed Sci, Seoul, South Korea; [Youn, H-D] Seoul Natl Univ, Coll Med, Canc Res Inst, Natl Res Lab Metab Checkpoint,Dept Biochem & Mol, Seoul, South Korea	Sungkyunkwan University (SKKU); Baylor College of Medicine; St Jude Children's Research Hospital; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Seoul National University (SNU); Seoul National University (SNU)	Kim, ST (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, 300 Chunchung Dong, Suwon 440746, South Korea.	stkim@skku.edu	Lahti, Jari/P-7987-2018; Cho, Eun-Jung/AAR-1785-2020	Lahti, Jari/0000-0002-4310-5297; Cho, Eun-Jung/0000-0002-6610-5329; Yoon, Keejung/0000-0002-2361-9039; Jung, Sung Yun/0000-0003-1521-7977	NRF [20110008174]; Ministry of Science and Technology, Republic of Korea.; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA067938] Funding Source: NIH RePORTER	NRF; Ministry of Science and Technology, Republic of Korea.(Ministry of Science & Technology (MOST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Richard R Vaillancourt for providing HA-CDK11<SUP>p110</SUP> expression vector; Dr Anglus I Lamond for pBSAL4 plasmid; Dr Gideon Dreyfuss for pCMV-Luc 2CP/ARE and pCMV-Luc 2CP/Intron/ARE plasmids; Dr Eperon for the pTN24 plasmids; Dr Jin-Hyun Ahn for pDEST-SG5-HA, pDEST-SG5-flag destination vectors and early passage human diploid fibroblast cell lines. This work was supported by NRF Grants 20110008174, funded by the Ministry of Science and Technology, Republic of Korea.	Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Blencowe BJ, 2003, CURR BIOL, V13, pR149, DOI 10.1016/S0960-9822(03)00079-4; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 2000, GENE DEV, V14, P278; Chi YY, 2011, J BIOL CHEM, V286, P1748, DOI 10.1074/jbc.M110.107367; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Darbon JM, 2000, J BIOL CHEM, V275, P15363, DOI 10.1074/jbc.275.20.15363; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Franck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014600; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lee SB, 2001, CANCER RES, V61, P8062; Loyer P, 2008, J BIOL CHEM, V283, P7721, DOI 10.1074/jbc.M708188200; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Sachs NA, 2003, BBA-GEN SUBJECTS, V1624, P98, DOI 10.1016/j.bbagen.2003.10.001; Seo GJ, 2003, BIOCHEM BIOPH RES CO, V304, P339, DOI 10.1016/S0006-291X(03)00589-8; Shieh SY, 2000, GENE DEV, V14, P289; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; Valente ST, 2009, MOL CELL, V36, P279, DOI 10.1016/j.molcel.2009.10.004; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	41	21	29	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					108	115		10.1038/onc.2012.535	http://dx.doi.org/10.1038/onc.2012.535			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23178491	Green Accepted			2022-12-25	WOS:000329212000012
J	Crotty, TM; Nakano, T; Stafforini, DM; Topham, MK				Crotty, Tracy M.; Nakano, Tomoyuki; Stafforini, Diana M.; Topham, Matthew K.			Diacylglycerol Kinase delta Modulates Akt Phosphorylation through Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase 2 (PHLPP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; PROSTATE-CANCER; C-ALPHA; PROMOTES APOPTOSIS; INSULIN-RESISTANCE; IN-VITRO; ACTIVATION; PATHWAY; PKC	Discovering proteins that modulate Akt signaling has become a critical task, given the oncogenic role of Akt in a wide variety of cancers. We have discovered a novel diacylglycerol signaling pathway that promotes dephosphorylation of Akt. This pathway is regulated by diacylglycerol kinase delta (DGK delta). In DGK delta-deficient cells, we found reduced Akt phosphorylation downstream of three receptor tyrosine kinases. Phosphorylation upstream of Akt was not affected. Our data indicate that PKC alpha, which is excessively active in DGK delta-deficient cells, promotes dephosphorylation of Akt through pleckstrin homology domain leucine-rich repeats protein phosphatase (PHLPP) 2. Depletion of either PKC alpha or PHLPP2 rescued Akt phosphorylation in DGK delta-deficient cells. In contrast, depletion of PHLPP1, another Akt phosphatase, failed to rescue Akt phosphorylation. Other PHLPP substrates were not affected by DGK delta deficiency, suggesting mechanisms allowing specific modulation of Akt dephosphorylation. We found that beta-arrestin 1 acted as a scaffold for PHLPP2 and Akt1, providing a mechanism for specificity. Because of its ability to reduce Akt phosphorylation, we tested whether depletion of DGK delta could attenuate tumorigenic properties of cultured cells and found that DGK delta deficiency reduced cell proliferation and migration and enhanced apoptosis. We have, thus, discovered a novel pathway in which diacylglycerol signaling negatively regulates Akt activity. Our collective data indicate that DGK delta is a pertinent cancer target, and our studies could lay the groundwork for development of novel cancer therapeutics.	[Crotty, Tracy M.; Nakano, Tomoyuki; Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Topham, Matthew K.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Topham, MK (corresponding author), 2000 E Circle Hope, Salt Lake City, UT 84112 USA.	matt.topham@hci.utah.edu			National Institutes of Health [R01-CA95463]; Huntsman Cancer Foundation; R. Harold Burton Foundation; Cancer Center Support Grant [P30-CA042014]; NATIONAL CANCER INSTITUTE [R01CA095463, P30CA042014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; R. Harold Burton Foundation; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA95463 (to M. K. T.). This work was also supported by the Huntsman Cancer Foundation, the R. Harold Burton Foundation, and by Cancer Center Support Grant P30-CA042014 for support of core facilities.	Al-Salihi MA, 2007, CELL SIGNAL, V19, P1956, DOI 10.1016/j.cellsig.2007.05.003; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bacchiocchi R, 2005, BLOOD, V106, P2175, DOI 10.1182/blood-2005-01-0316; BAIRD WM, 1971, CANCER RES, V31, P1074; Baldanzi G, 2004, ONCOGENE, V23, P4828, DOI 10.1038/sj.onc.1207633; BLUMBERG PM, 1983, ANN NY ACAD SCI, V407, P303, DOI 10.1111/j.1749-6632.1983.tb47836.x; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cai JJ, 2010, J BIOL CHEM, V285, P6952, DOI 10.1074/jbc.M109.055731; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hellwinkel OJC, 2008, BJU INT, V101, P1454, DOI 10.1111/j.1464-410X.2008.07540.x; Kakefuda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013447; Leitges M, 2002, MOL ENDOCRINOL, V16, P1203; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu JY, 2011, J BIOL CHEM, V286, P6510, DOI 10.1074/jbc.M110.183087; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	46	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1439	1447		10.1074/jbc.M112.407379	http://dx.doi.org/10.1074/jbc.M112.407379			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184957	hybrid, Green Published			2022-12-25	WOS:000313751400002
J	Chambers, JW; Howard, S; LoGrasso, PV				Chambers, Jeremy W.; Howard, Shannon; LoGrasso, Philip V.			Blocking c-Jun N-terminal Kinase (JNK) Translocation to the Mitochondria Prevents 6-Hydroxydopamine-induced Toxicity in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE ACTIVITY; PARKINSONS-DISEASE; PEPTIDE INHIBITOR; CRITICAL FEATURES; COMPLEX-I; ACTIVATION; NEURONS; MODEL; BIOENERGETICS; EXPRESSION	Because oxidative stress and mitochondrial dysfunction are well known contributors to Parkinson disease (PD), we set out to investigate the role mitochondrial JNK plays in the etiology of 6-hydroxydopamine-induced (6-OHDA) oxidative stress, mitochondrial dysfunction, and neurotoxicity in SHSY5Y cells and neuroprotection and motor behavioral protection in vivo. To do this, we utilized a cell-permeable peptide of the outer mitochondrial membrane protein, Sab (SH3BP5), as an inhibitor of JNK mitochondrial translocation. In vitro studies showed that 6-OHDA induced JNK translocation to the mitochondria and that inhibition of mitochondrial JNK signaling by Tat-Sab(KIM1) protected against 6-OHDA-induced oxidative stress, mitochondrial dysfunction, and neurotoxicity. Administration of Tat-Sab(KIM1) via an intracerebral injection into the mid-forebrain bundle increased the number of tyrosine hydroxylase immunoreactive neurons in the substantia nigra pars compacta by 2-fold (p < 0.05) in animals lesioned with 6-OHDA, compared with animals treated only with 6-OHDA into the nigrostriatal pathway. In addition, Tat-Sab(KIM1) decreased the D-amphetamine-induced unilateral rotations associated with the lesion by 30% (p < 0.05). Steady-state brain levels of Tat-Sab(KIM1) at day 7 were 750 nM, which was similar to 3.4-fold higher than the IC50 for this peptide versus Sab protein. Collectively, these data suggest that 6-OHDA induced JNK translocation to the mitochondria and that blocking this translocation reduced oxidative stress, mitochondrial dysfunction, and neurotoxicity both in vitro and in vivo. Moreover, the data suggest that inhibitors that block association of JNKs with the mitochondria may be useful neuroprotective agents for the treatment of Parkinson disease.	[LoGrasso, Philip V.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, PV (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	lograsso@scripps.edu		Chambers, Jeremy/0000-0002-6143-3091	National Institutes of Health [U01NS057153-04]; Saul and Theresa Esman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saul and Theresa Esman Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01NS057153-04 (to P. L.). This work was also supported by The Saul and Theresa Esman Foundation. Philip LoGrasso serves as a consultant for OPKO Health.	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Barr RK, 2004, J BIOL CHEM, V279, P36327, DOI 10.1074/jbc.M402181200; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Chambers JW, 2011, ACS CHEM BIOL, V6, P808, DOI 10.1021/cb200062a; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chambers JW, 2011, ACS CHEM NEUROSCI, V2, P198, DOI 10.1021/cn100109k; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Pan J, 2007, NEUROSCI LETT, V428, P82, DOI 10.1016/j.neulet.2007.09.032; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Vaudano E, 2001, EUR J NEUROSCI, V13, P1, DOI 10.1046/j.1460-9568.2001.01356.x; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Xia XG, 2001, P NATL ACAD SCI USA, V98, P10433, DOI 10.1073/pnas.181182298; Zhao Y, 2009, MOL CELL NEUROSCI, V41, P186, DOI 10.1016/j.mcn.2009.02.012; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x; Zhou QQ, 2009, FEBS LETT, V583, P1132, DOI 10.1016/j.febslet.2009.02.043	21	56	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1079	1087		10.1074/jbc.M112.421354	http://dx.doi.org/10.1074/jbc.M112.421354			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184940	Green Published, hybrid			2022-12-25	WOS:000313570300031
J	Elhaik, E				Elhaik, Eran			Empirical Distributions of F-ST from Large-Scale Human Polymorphism Data	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; NATURAL-SELECTION; GENETIC-STRUCTURE; ALLELE FREQUENCY; FINITE NUMBER; DRIFT; SIGNATURES; DIVERSITY; PATTERNS	Studies of the apportionment of human genetic variation have long established that most human variation is within population groups and that the additional variation between population groups is small but greatest when comparing different continental populations. These studies often used Wright's F-ST that apportions the standardized variance in allele frequencies within and between population groups. Because local adaptations increase population differentiation, high-F-ST may be found at closely linked loci under selection and used to identify genes undergoing directional or heterotic selection. We re-examined these processes using HapMap data. We analyzed 3 million SNPs on 602 samples from eight worldwide populations and a consensus subset of 1 million SNPs found in all populations. We identified four major features of the data: First, a hierarchically F-ST analysis showed that only a paucity (12%) of the total genetic variation is distributed between continental populations and even a lesser genetic variation (1%) is found between intra-continental populations. Second, the global FST distribution closely follows an exponential distribution. Third, although the overall F-ST distribution is similarly shaped (inverse J), F-ST distributions varies markedly by allele frequency when divided into non-overlapping groups by allele frequency range. Because the mean allele frequency is a crude indicator of allele age, these distributions mark the time-dependent change in genetic differentiation. Finally, the change in mean-F-ST of these groups is linear in allele frequency. These results suggest that investigating the extremes of the F-ST distribution for each allele frequency group is more efficient for detecting selection. Consequently, we demonstrate that such extreme SNPs are more clustered along the chromosomes than expected from linkage disequilibrium for each allele frequency group. These genomic regions are therefore likely candidates for natural selection.	[Elhaik, Eran] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21218 USA; [Elhaik, Eran] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Elhaik, E (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21218 USA.	eelhaik@jhsph.edu	Elhaik, Eran/H-6838-2019	Elhaik, Eran/0000-0003-4795-1084	NIH [HG005214]; NIMH [T32MH014592]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work of EE was supported by in part by NIH grant HG005214 and NIMH training grant T32MH014592. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Balloux F, 2002, MOL ECOL, V11, P771, DOI 10.1046/j.1365-294X.2002.01474.x; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Buclin T, 2009, CLIN TRIALS HDB; Chakravarti A, 2009, NATURE, V457, P380, DOI 10.1038/457380a; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; EXCOFFIER L, 1992, GENETICS, V131, P479; Fry AE, 2006, AM J HUM GENET, V78, P1053, DOI 10.1086/504160; Gardner M, 2007, HUM GENET, V121, P759, DOI 10.1007/s00439-007-0364-9; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hannelius U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-54; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; KIMURA M, 1973, GENETICS, V75, P199; Kullo IJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-48; Kurtz AK, 1967, STAT DICT TERMS SYMB; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; LEWONTIN RC, 1973, GENETICS, V74, P175; LILLIEFO.HW, 1969, J AM STAT ASSOC, V64, P387, DOI 10.2307/2283748; MacCluer JW, 1974, GENETIC DISTANCE, P77; Mackelprang R, 2006, HUM GENET, V119, P255, DOI 10.1007/s00439-005-0111-z; Mahasirimongkol S, 2006, J HUM GENET, V51, P896, DOI 10.1007/s10038-006-0041-1; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McVean GAT, 2002, GENETICS, V162, P987; MULLER HJ, 1950, AM J HUM GENET, V2, P111; NEI M, 1977, THEOR POPUL BIOL, V11, P291, DOI 10.1016/0040-5809(77)90013-2; NEI M, 1977, THEOR POPUL BIOL, V11, P307, DOI 10.1016/0040-5809(77)90014-4; Nei M., 1987, MOL EVOLUTIONARY GEN; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rottenstreich S, 2007, THEOR POPUL BIOL, V72, P485, DOI 10.1016/j.tpb.2007.08.007; Sabbagh A, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-21; Shama LNS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-278; Shriver Mark D, 2004, Hum Genomics, V1, P274; SLATKIN M, 1991, GENETICS, V127, P627; Sokal RR, 1995, BIOMETRY; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S, 1943, GENETICS, V28, P114; Wright S., 1978, EVOLUTION GENETICS P, V4; Zar JH, 1999, BIOSTATISTICAL ANAL	59	33	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49837	10.1371/journal.pone.0049837	http://dx.doi.org/10.1371/journal.pone.0049837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185452	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000118
J	Kim, SH; Jun, HJ; Jang, SI; You, JC				Kim, Seon Hee; Jun, Hyun Jeong; Jang, Soo In; You, Ji Chang			The Determination of Importance of Sequences Neighboring the Psi Sequence in Lentiviral Vector Transduction and Packaging Efficiency	PLOS ONE			English	Article							GENE DELIVERY; STEM-LOOP; RNA; DIMERIZATION; REGION; PROTEIN; AFFINITY; SIGNAL	A number of lentiviral vector systems have been developed for gene delivery and therapy by eliminating and/or modifying viral genetic elements. However, all lentiviral vector systems derived from HIV-1 must have a viral packaging signal sequence, Psi (Psi), which is placed downstream of 59 long terminal repeat in a transgene plasmid to effectively package and deliver transgene mRNA. In this study, we examined feasible regions or sequences around Psi that could be manipulated to further modify the packaging sequence. Surprisingly, we found that the sequences immediately upstream of the Psi are highly refractory to any modification and resulted in transgene vectors with very poor gene transduction efficiency. Analysis around the Psi region revealed that there are a few sites that can be used for manipulation of the Psi sequence without disturbing the virus production as well as the efficiency of transgene RNA packaging and gene transduction. By exploiting this new vector system, we investigated the requirement of each of four individual stem-loops of the Psi sequence by deletion mapping analysis and found that all stem-loops, including the SL4 region, are needed for efficient transgene RNA packaging and gene delivery. These results suggest a possible frame of the lentiviral vector that might be useful for further modifying the region/sequence around the packaging sequence as well as directly on the Psi sequence without destroying transduction efficiency.	[Kim, Seon Hee; Jang, Soo In; You, Ji Chang] Catholic Univ Korea, Sch Med, Dept Pathol, Natl Res Lab Mol Virol, Seoul, South Korea; [Jun, Hyun Jeong; You, Ji Chang] Avixgen Inc, Seoul, South Korea	Catholic University of Korea	You, JC (corresponding author), Catholic Univ Korea, Sch Med, Dept Pathol, Natl Res Lab Mol Virol, Seoul, South Korea.	jiyou@catholic.ac.kr			National Research Foundation [2008-2004183/M10863000011-08N6300-01110]; Korean Ministry of Education, Science and Technology (MEST)	National Research Foundation; Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a National Research Foundation grant (2008-2004183/M10863000011-08N6300-01110) funded by the Korean Ministry of Education, Science and Technology (MEST, http://english.mest.go.kr/enMain.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; Amarasinghe GK, 2001, J MOL BIOL, V314, P961, DOI 10.1006/jmbi.2000.5182; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Clever JL, 2000, J VIROL, V74, P541, DOI 10.1128/JVI.74.1.541-546.2000; Clever JL, 2002, J VIROL, V76, P12381, DOI 10.1128/JVI.76.23.12381-12387.2002; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; Delenda C, 2002, CURR TOP MICROBIOL, V261, P123; Dropulic B, 2011, HUM GENE THER, V22, P649, DOI 10.1089/hum.2011.058; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Kim SH, 2009, BIOCHEM BIOPH RES CO, V383, P192, DOI 10.1016/j.bbrc.2009.03.150; Kim VN, 1998, J VIROL, V72, P811, DOI 10.1128/JVI.72.1.811-816.1998; Lotze MT, 2002, CANCER GENE THER, V9, P692, DOI 10.1038/sj.cgt.7700493; McBride MS, 1997, J VIROL, V71, P2050, DOI 10.1128/JVI.71.3.2050-2058.1997; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; Naldini L, 2000, ADV VIRUS RES, V55, P599, DOI 10.1016/S0065-3527(00)55020-9; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pauwels K, 2009, CURR GENE THER, V9, P459, DOI 10.2174/156652309790031120; Roldan A, 2004, J BIOL CHEM, V279, P39886, DOI 10.1074/jbc.M405632200; Russell RS, 2003, J VIROL, V77, P84, DOI 10.1128/JVI.77.1.84-96.2003; Sakuragi J, 2003, J VIROL, V77, P4060, DOI 10.1128/JVI.77.7.4060-4069.2003; Sakuragi JI, 2007, J VIROL, V81, P7985, DOI 10.1128/JVI.00429-07; Song R, 2008, BIOCHEMISTRY-US, V47, P3283, DOI 10.1021/bi7023173; Spriggs S, 2008, BIOCHEMISTRY-US, V47, P13064, DOI 10.1021/bi8014373; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Yu E, 2003, J MOL BIOL, V330, P211, DOI 10.1016/S0022-2836(03)00589-8; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	29	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50148	10.1371/journal.pone.0050148	http://dx.doi.org/10.1371/journal.pone.0050148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185560	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000191
J	Lin, YM; Hsu, CJ; Liao, YY; Chou, MC; Tang, CH				Lin, Yu-Min; Hsu, Chin-Jung; Liao, Yuan-Ya; Chou, Ming-Chih; Tang, Chih-Hsin			The CCL2/CCR2 Axis Enhances Vascular Cell Adhesion Molecule-1 Expression in Human Synovial Fibroblasts	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; KINASE-C-DELTA; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; IL-6 PRODUCTION; FACTOR-ALPHA; KNEE-JOINTS; OSTEOARTHRITIS	Background: Chemokine ligand 2 (CCL2), also known as monocyte chemoattractant protein-1 (MCP-1), belongs to the CC chemokine family that is associated with the disease status and outcomes of osteoarthritis (OA). Here, we investigated the intracellular signaling pathways involved in CCL2-induced vascular cell adhesion molecule-1 (VCAM-1) expression in human OA synovial fibroblasts (OASFs). Methodology/Principal Findings: Stimulation of OASFs with CCL2 induced VCAM-1 expression. CCL2-mediated VCAM-1 expression was attenuated by CCR2 inhibitor (RS102895), PKCd inhibitor (rottlerin), p38MAPK inhibitor (SB203580), and AP-1 inhibitors (curcumin and tanshinone IIA). Stimulation of cells with CCL2 increased PKCd and p38MAPK activation. Treatment of OASFs with CCL2 also increased the c-Jun phosphorylation and c-Jun binding to the AP-1 element on the VCAM-1 promoter. Moreover, CCL2-mediated CCR2, PKCd, p38MAPK, and AP-1 pathway promoted the adhesion of monocytes to the OASFs monolayer. Conclusions/Significance: Our results suggest that CCL2 increases VCAM-1 expression in human OASFs via the CCR2, PKCd, p38MAPK, c-Jun, and AP-1 signaling pathway. The CCL2-induced VCAM-1 expression promoted monocytes adhesion to human OASFs.	[Lin, Yu-Min; Chou, Ming-Chih] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Yu-Min] Taichung Vet Gen Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Hsu, Chin-Jung] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Hsu, Chin-Jung] China Med Univ Hosp, Dept Orthopaed, Taichung, Taiwan; [Liao, Yuan-Ya] Chung Shan Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	Chung Shan Medical University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan	Chou, MC (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	cshe032@csh.org.tw; chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, NSC100-2320-B-039-028-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3 and NSC100-2320-B-039-028-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1998, J BIOL CHEM, V273, P4616, DOI 10.1074/jbc.273.8.4616; AKAHOSHI T, 1993, ARTHRITIS RHEUM-US, V36, P762, DOI 10.1002/art.1780360605; Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Basu A, 2008, CANCER RES, V68, P2795, DOI 10.1158/0008-5472.CAN-07-6244; Cai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019559; Chiu YC, 2008, MOL IMMUNOL, V45, P1587, DOI 10.1016/j.molimm.2007.10.004; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Eisinger K, 2012, EXP MOL PATHOL, V92, P90, DOI 10.1016/j.yexmp.2011.10.006; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Hamanishi C, 1996, J LAB CLIN MED, V127, P540, DOI 10.1016/S0022-2143(96)90144-4; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Juarranz Y, 2008, ARTHRITIS RHEUM, V58, P1086, DOI 10.1002/art.23403; Kalichman L, 2011, CLIN EXP RHEUMATOL, V29, P544; Karatay S, 2004, ANN CLIN LAB SCI, V34, P330; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Lazzerini G, 2009, NITRIC OXIDE-BIOL CH, V21, P184, DOI 10.1016/j.niox.2009.07.007; Leitges M, 2001, LAB INVEST, V81, P1087, DOI 10.1038/labinvest.3780321; Levinger I, 2011, ARTHRITIS RHEUM-US, V63, P1343, DOI 10.1002/art.30287; Lin WN, 2009, CELL SIGNAL, V21, P1385, DOI 10.1016/j.cellsig.2009.04.006; Luo SF, 2010, ARTHRITIS RHEUM-US, V62, P105, DOI 10.1002/art.25060; Madry H, 2012, KNEE SURG SPORT TR A, V20, P407, DOI 10.1007/s00167-011-1705-8; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Qureshi MH, 2003, J IMMUNOL, V171, P4700, DOI 10.4049/jimmunol.171.9.4700; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Schett G, 2009, ARTHRITIS RHEUM-US, V60, P2381, DOI 10.1002/art.24757; Shen PC, 2011, OSTEOARTHR CARTILAGE, V19, P728, DOI 10.1016/j.joca.2011.02.014; Sucosky P, 2009, ARTERIOSCL THROM VAS, V29, P254, DOI 10.1161/ATVBAHA.108.176347; Szekanecz Z, 2003, SEMIN IMMUNOL, V15, P15, DOI 10.1016/S1044-5323(02)00124-0; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tang CH, 2012, BIOCHEM PHARMACOL, V83, P335, DOI 10.1016/j.bcp.2011.11.013; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Wagner EF, 2010, ANN RHEUM DIS, V69, P86, DOI 10.1136/ard.2009.119396; Wang YC, 2003, ANAL BIOCHEM, V319, P206, DOI 10.1016/S0003-2697(03)00330-0; Zhang TQ, 2006, EUR J IMMUNOL, V36, P457, DOI 10.1002/eji.200526208; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108	39	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49999	10.1371/journal.pone.0049999	http://dx.doi.org/10.1371/journal.pone.0049999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185512	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000162
J	Oliva, CF; Jacquet, M; Gilles, J; Lemperiere, G; Maquart, PO; Quilici, S; Schooneman, F; Vreysen, MJB; Boyer, S				Oliva, Clelia F.; Jacquet, Maxime; Gilles, Jeremie; Lemperiere, Guy; Maquart, Pierre-Olivier; Quilici, Serge; Schooneman, Francois; Vreysen, Marc J. B.; Boyer, Sebastien			The Sterile Insect Technique for Controlling Populations of Aedes albopictus (Diptera: Culicidae) on Reunion Island: Mating Vigour of Sterilized Males	PLOS ONE			English	Article							COMPETITIVENESS; AEGYPTI; RADIATION; MOSQUITO; RELEASE	Reunion Island suffers from high densities of the chikungunya and dengue vector Aedes albopictus. The sterile insect technique (SIT) offers a promising strategy for mosquito-borne diseases prevention and control. For such a strategy to be effective, sterile males need to be competitive enough to fulfil their intended function by reducing wild mosquito populations in natura. We studied the effect of irradiation on sexual maturation and mating success of males, and compared the sexual competitiveness of sterile versus wild males in the presence of wild females in semi-field conditions. For all untreated or sterile males, sexual maturation was completed within 13 to 20 h post-emergence and some males were able to inseminate females when 15 h old. In the absence of competition, untreated and sterile males were able to inseminate the same number of virgin females during 48 h, in small laboratory cages: an average of 93% of females was inseminated no matter the treatment, the age of males, and the sex ratio. Daily mating success of single sterile males followed the same pattern as for untreated ones, although they inseminated significantly fewer females after the ninth day. The competitiveness index of sterile males in semi-field conditions was only 0.14 when they were released at 1-day old, but improved to 0.53 when the release occurred after a 5-day period in laboratory conditions. In SIT simulation experiments, a 5: 1 sterile to wild male ratio allowed a two-fold reduction of the wild population's fertility. This suggests that sterile males could be sufficiently competitive to mate with wild females within the framework of an SIT component as part of an AW-IPM programme for suppressing a wild population of Ae. albopictus in Reunion Island. It will be of interest to minimise the prerelease period in controlled conditions to ensure a good competitiveness without increasing mass rearing costs.	[Oliva, Clelia F.; Jacquet, Maxime; Lemperiere, Guy; Maquart, Pierre-Olivier; Boyer, Sebastien] Malad Infecti & Vecteurs Ecol Genet Evolut & Cont, Montpellier, France; [Oliva, Clelia F.; Jacquet, Maxime; Lemperiere, Guy; Maquart, Pierre-Olivier; Boyer, Sebastien] Ctr Rech & Veille Malad Emergentes Ocean Indien, St Clotilde, Reunion, France; [Oliva, Clelia F.; Gilles, Jeremie; Quilici, Serge; Vreysen, Marc J. B.] IAEA, Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food, A-1400 Vienna, Austria; [Schooneman, Francois] Etab Francais Sang, St Denis, Reunion, France; [Quilici, Serge] Univ La Reunion, Cirad, UMR PVBMT Cirad, St Pierre, Reunion, France	International Atomic Energy Agency; CIRAD; University of La Reunion	Oliva, CF (corresponding author), Malad Infecti & Vecteurs Ecol Genet Evolut & Cont, Montpellier, France.	cleliaoliva@gmail.com		Maquart, Pierre-Olivier/0000-0003-4725-9821; Jacquet, Maxime/0000-0003-0690-1232; Oliva, Clelia/0000-0001-7728-1654; Boyer, Sebastien/0000-0002-2946-586X	Reunion Region Council; European Social Funds; Insect Pest Control Laboratory (IPCL) of the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture of the International Atomic Energy Agency (IAEA); French Ministry of Health; European Regional Development Fund (ERDF) within the "SIT feasibility programme" in Reunion	Reunion Region Council; European Social Funds(European Social Fund (ESF)); Insect Pest Control Laboratory (IPCL) of the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture of the International Atomic Energy Agency (IAEA); French Ministry of Health; European Regional Development Fund (ERDF) within the "SIT feasibility programme" in Reunion	The project is supported by the Reunion Region Council, the European Social Funds, and the Insect Pest Control Laboratory (IPCL) of the Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture of the International Atomic Energy Agency (IAEA). This work was supported by the Reunion Island Region Council and the European Social Funds through a PhD grant to CFO. This study was jointly funded by the French Ministry of Health and the European Regional Development Fund (ERDF) within the "SIT feasibility programme" in Reunion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malek A. A., 1975, . The use of isotopes in pesticides and pest control. Proceedings of a symposium held in Beirut-Lebanon, March 1974., P161; Alphey L, 2002, INSECT BIOCHEM MOLEC, V32, P1243, DOI 10.1016/S0965-1748(02)00087-5; [Anonymous], 2010, R LANG ENV STAT COMP; Asman SM, 1983, FIELD RELEASE RADIO; Bagny L, 2009, J MED ENTOMOL, V46, P1541, DOI 10.1603/033.046.0644; BAKER RH, 1979, ANN ENTOMOL SOC AM, V72, P751, DOI 10.1093/aesa/72.6.751; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Bellini R, 2012, J MED ENTOM IN PRESS, V49; Benedict MQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S4; Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Chastel Claude, 2005, Bull Acad Natl Med, V189, P1827; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; DAVIS AN, 1959, J ECON ENTOMOL, V52, P868, DOI 10.1093/jee/52.5.868; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313; ECONOMOPOULOS A P, 1972, Environmental Entomology, V1, P490, DOI 10.1093/ee/1.4.490; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869; GROSCH DS, 1962, ANNU REV ENTOMOL, V7, P81, DOI 10.1146/annurev.en.07.010162.000501; GROVER KK, 1979, MOSQ NEWS, V39, P490; Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350; Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Helinski MEH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S6; HISS EA, 1972, J INSECT PHYSIOL, V18, P2217, DOI 10.1016/0022-1910(72)90250-8; HOOPER GHS, 1981, J ECON ENTOMOL, V74, P119, DOI 10.1093/jee/74.1.119; Huho BJ, 2007, J EXP BIOL, V210, P2939, DOI 10.1242/jeb.005033; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Klowden MJ, 2006, J INSECT PHYSIOL, V52, P679, DOI 10.1016/j.jinsphys.2006.03.006; Klowden MJ, 1999, J AM MOSQUITO CONTR, V15, P213; KRISHNAMURTHY BS, 1977, INDIAN J MED RES, V65, P1; LaBrecque GC, 1965, ADV INSECT POPULATIO; Lacroix R, 2009, MED VET ENTOMOL, V23, P160, DOI 10.1111/j.1365-2915.2009.00806.x; LEAHY M. G., 1965, MOSQUITO NEWS, V25, P448; Mahon RJ, 1996, FRONTIERS OF POPULATION ECOLOGY, P561; Marshall J. F., 1938, BRIT MOSQUITOES; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUID CAR US LAB AN; Oliva CF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-135; Parker A, 2007, FLA ENTOMOL, V90, P88, DOI 10.1653/0015-4040(2007)90[88:SITAMF]2.0.CO;2; PATTERSON RS, 1975, MOSQ NEWS, V35, P1; PROVERBS MD, 1969, ANNU REV ENTOMOL, V14, P81, DOI 10.1146/annurev.en.14.010169.000501; REISEN WK, 1980, ANN ENTOMOL SOC AM, V73, P479, DOI 10.1093/aesa/73.4.479; Reisen WK, 2003, WAG UR FRON, V2, P25; RIEMANN JG, 1967, ANN ENTOMOL SOC AM, V60, P308, DOI 10.1093/aesa/60.2.308; Robinson AS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S1; SPIELMAN A, 1969, J INSECT PHYSIOL, V15, P1471, DOI 10.1016/0022-1910(69)90168-1; SPIELMAN A, 1967, BIOL BULL-US, V132, P404, DOI 10.2307/1539644; TANTAWY AO, 1967, J ECON ENTOMOL, V60, P696, DOI 10.1093/jee/60.3.696; WEIDHAAS DE, 1974, AM J TROP MED HYG, V23, P298, DOI 10.4269/ajtmh.1974.23.298	50	111	114	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49414	10.1371/journal.pone.0049414	http://dx.doi.org/10.1371/journal.pone.0049414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185329	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000047
J	Teyssier, JR; Chauvet-Gelinier, JC; Ragot, S; Bonin, B				Teyssier, Jean-Raymond; Chauvet-Gelinier, Jean-Christophe; Ragot, Sylviane; Bonin, Bernard			Up-Regulation of leucocytes Genes Implicated in Telomere Dysfunction and Cellular Senescence Correlates with Depression and Anxiety Severity Scores	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; DNA-DAMAGE; OXIDATIVE STRESS; MAJOR DEPRESSION; EXPRESSION; BIOMARKER; LENGTH; P16(INK4A); CELLS; POPULATION	Background: Major depressive disorder (MDD) is frequently associated with chronic medical illness responsible of increased disability and mortality. Inflammation and oxidative stress are considered to be the major mediators of the allostatic load, and has been shown to correlate with telomere erosion in the leucocytes of MDD patients, leading to the model of accelerated aging. However, the significance of telomere length as an exclusive biomarker of aging has been questioned on both methodological and biological grounds. Furthermore, telomeres significantly shorten only in patients with long lasting MDD. Sensitive and dynamic functional biomarkers of aging would be clinically useful to evaluate the somatic impact of MDD. Methodology: To address this issue we have measured in the blood leucocytes of MDD patients (N = 17) and controls (N = 16) the expression of two genes identified as robust biomarkers of human aging and telomere dysfunction: p16(INK4a) and STMN1. We have also quantified the transcripts of genes involved in the repair of oxidative DNA damage at telomeres (OGG1), telomere regulation and elongation (TERT), and in the response to biopsychological stress (FOS and DUSP1). Results: The OGG1, p16(INK4a), and STMN1 gene were significantly up-regulated (25 to 100%) in the leucocytes of MDD patients. Expression of p16(INK4a) and STMN1 was directly correlated with anxiety scores in the depression group, and that of p16(INK4a), STMN and TERT with the depression and anxiety scores in the combined sample (MDD plus controls). Furthermore, we identified a unique correlative pattern of gene expression in the leucocytes of MDD subjects. Conclusions: Expression of p16(INK4) and STMN1 is a promising biomarker for future epidemiological assessment of the somatic impact of depressive and anxious symptoms, at both clinical and subclinical level in both depressive patients and general population.	[Teyssier, Jean-Raymond; Ragot, Sylviane] Univ Hosp, Dept Genet & Lab Mol Genet, Dijon, France; [Teyssier, Jean-Raymond; Chauvet-Gelinier, Jean-Christophe; Bonin, Bernard] Univ Hosp, Psychiat Unit, Dijon, France; [Teyssier, Jean-Raymond; Chauvet-Gelinier, Jean-Christophe; Bonin, Bernard] Univ Burgundy, Lab Psychopathol & Med Psychol, Dijon, France	CHU Dijon Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne	Teyssier, JR (corresponding author), Univ Hosp, Dept Genet & Lab Mol Genet, Dijon, France.	teyssier@u-bourgogne.fr			University Hospital of Dijon (Hospital Protocol of Clinical Research) [2009-A01146-51]	University Hospital of Dijon (Hospital Protocol of Clinical Research)	This study has been supported by the University Hospital of Dijon (Hospital Protocol of Clinical Research No2009-A01146-51).	Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Brocke B, 2010, AM J MED GENET B, V153B, P243, DOI 10.1002/ajmg.b.30989; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Capuron L, 2008, BIOL PSYCHIAT, V64, P896, DOI 10.1016/j.biopsych.2008.05.019; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cifuentes-Rojas C, 2012, MUTAT RES-FUND MOL M, V730, P20, DOI 10.1016/j.mrfmmm.2011.10.003; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Ehlis AC, 2011, AM J MED GENET B, V156B, P291, DOI 10.1002/ajmg.b.31161; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Hartmann N, 2010, DEPRESS ANXIETY, V27, P1111, DOI 10.1002/da.20749; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2006, MECH AGEING DEV, V127, P16, DOI 10.1016/j.mad.2005.09.002; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Jacobs JJL, 2005, CELL CYCLE, V4, P1364, DOI 10.4161/cc.4.10.2104; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227; Krishnadas R, 2012, J NEUROL NEUROSUR PS, V83, P495, DOI 10.1136/jnnp-2011-301779; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Le-Niculescu H, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.1; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Lu J, 2010, EMBO J, V29, P398, DOI 10.1038/emboj.2009.355; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McIntyre RS, 2007, ANN CLIN PSYCHIAT, V4, P257; Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, pE1363, DOI 10.1073/pnas.1112414108; Murphy JM, 2008, SOC PSYCH PSYCH EPID, V43, P594, DOI 10.1007/s00127-008-0323-3; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; O'Donovan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019687; Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rusyn I, 2004, CANCER RES, V64, P1050, DOI 10.1158/0008-5472.CAN-03-3027; Saliques S, 2011, ATHEROSCLEROSIS, V219, P931, DOI 10.1016/j.atherosclerosis.2011.09.026; Saliques S, 2011, ATHEROSCLEROSIS, V219, P753, DOI 10.1016/j.atherosclerosis.2011.09.011; Shiels PG, 2010, J GERONTOL A-BIOL, V65, P789, DOI 10.1093/gerona/glq095; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Song ZF, 2010, AGING CELL, V9, P607, DOI 10.1111/j.1474-9726.2010.00583.x; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Teyssier JR, 2011, PSYCHIAT RES, V186, P244, DOI 10.1016/j.psychres.2010.07.030; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wikgren M, 2012, BIOL PSYCHIAT, V71, P294, DOI 10.1016/j.biopsych.2011.09.015; Wolkowitz OM, 2012, MOL PSYCHIATR, V17, P164, DOI 10.1038/mp.2010.133; Wolkowitz Owen M, 2011, Dialogues Clin Neurosci, V13, P25; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Xu G, 2008, MECH AGEING DEV, V129, P366, DOI 10.1016/j.mad.2008.03.001; Zhang XF, 2012, INT J MOL SCI, V13, P5866, DOI 10.3390/ijms13055866; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	66	47	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49677	10.1371/journal.pone.0049677	http://dx.doi.org/10.1371/journal.pone.0049677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185405	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000084
J	Xu, F; Helfen, L; Suhonen, H; Elgrabli, D; Bayat, S; Reischig, P; Baumbach, T; Cloetens, P				Xu, Feng; Helfen, Lukas; Suhonen, Heikki; Elgrabli, Dan; Bayat, Sam; Reischig, Peter; Baumbach, Tilo; Cloetens, Peter			Correlative Nanoscale 3D Imaging of Structure and Composition in Extended Objects	PLOS ONE			English	Article							COMPUTED LAMINOGRAPHY; TOMOGRAPHY; PROTON; CELLS	Structure and composition at the nanoscale determine the behavior of biological systems and engineered materials. The drive to understand and control this behavior has placed strong demands on developing methods for high resolution imaging. In general, the improvement of three-dimensional (3D) resolution is accomplished by tightening constraints: reduced manageable specimen sizes, decreasing analyzable volumes, degrading contrasts, and increasing sample preparation efforts. Aiming to overcome these limitations, we present a non-destructive and multiple-contrast imaging technique, using principles of X-ray laminography, thus generalizing tomography towards laterally extended objects. We retain advantages that are usually restricted to 2D microscopic imaging, such as scanning of large areas and subsequent zooming-in towards a region of interest at the highest possible resolution. Our technique permits correlating the 3D structure and the elemental distribution yielding a high sensitivity to variations of the electron density via coherent imaging and to local trace element quantification through X-ray fluorescence. We demonstrate the method by imaging a lithographic nanostructure and an aluminum alloy. Analyzing a biological system, we visualize in lung tissue the subcellular response to toxic stress after exposure to nanotubes. We show that most of the nanotubes are trapped inside alveolar macrophages, while a small portion of the nanotubes has crossed the barrier to the cellular space of the alveolar wall. In general, our method is non-destructive and can be combined with different sample environmental or loading conditions. We therefore anticipate that correlative X-ray nano-laminography will enable a variety of in situ and in operando 3D studies.	[Xu, Feng; Helfen, Lukas; Reischig, Peter; Baumbach, Tilo] Karlsruhe Inst Technol, Inst Synchrotron Radiat, Eggenstein Leopoldshafen, Germany; [Xu, Feng; Helfen, Lukas; Suhonen, Heikki; Reischig, Peter; Cloetens, Peter] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Elgrabli, Dan] Inst Natl Environm Ind & Risques, Verneuil En Halatte, France; [Bayat, Sam] Univ Picardie Jules Verne, Ctr Hosp Univ Amiens, Amiens, France	Helmholtz Association; Karlsruhe Institute of Technology; European Synchrotron Radiation Facility (ESRF); Institut National de l'Environnement Industriel et des Risques (INERIS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Xu, F (corresponding author), Karlsruhe Inst Technol, Inst Synchrotron Radiat, Eggenstein Leopoldshafen, Germany.	feng.xu@kit.edu	Baumbach, Tilo Gerd/K-5355-2013; Helfen, Lukas/AFS-0908-2022; BAYAT, Sam/N-4238-2018; Suhonen, Heikki/B-7851-2012; Cloetens, Peter/AAJ-6131-2020	Helfen, Lukas/0000-0002-5243-2310; BAYAT, Sam/0000-0002-8565-0293; Suhonen, Heikki/0000-0002-0337-6308; Cloetens, Peter/0000-0002-4129-9091				Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023; Corezzi S, 2009, ANAL BIOCHEM, V388, P33, DOI 10.1016/j.ab.2009.01.044; Elgrabli D, 2007, NANOTOXICOLOGY, V1, P266, DOI 10.1080/17435390701775136; Elgrabli D, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-20; Fahimian BP, 2010, PHYS MED BIOL, V55, P5383, DOI 10.1088/0031-9155/55/18/008; Fan ZY, 2009, NAT MATER, V8, P648, DOI [10.1038/NMAT2493, 10.1038/nmat2493]; Helfen L, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1854735; Helfen L, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3596566; Helfen L, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3089237; Kak AC., 2001, PRINCIPLES COMPUTERI, P275, DOI DOI 10.1137/1.9780898719277.CH7; Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671; Kwon OH, 2010, SCIENCE, V328, P1668, DOI 10.1126/science.1190470; Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]; McRae R, 2009, CHEM REV, V109, P4780, DOI 10.1021/cr900223a; Mimura H, 2010, NAT PHYS, V6, P122, DOI 10.1038/NPHYS1457; Moghaddam S, 2010, NAT NANOTECHNOL, V5, P230, DOI [10.1038/nnano.2010.13, 10.1038/NNANO.2010.13]; Ortega R, 2009, J R SOC INTERFACE, V6, pS649, DOI 10.1098/rsif.2009.0166.focus; Requena G, 2009, SCRIPTA MATER, V61, P760, DOI 10.1016/j.scriptamat.2009.06.025; Ryan CG, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012013; Sakdinawat A, 2010, NAT PHOTONICS, V4, P840, DOI 10.1038/nphoton.2010.267; Salvo L, 2003, NUCL INSTRUM METH B, V200, P273, DOI 10.1016/S0168-583X(02)01689-0; Shekhawat GS, 2005, SCIENCE, V310, P89, DOI 10.1126/science.1117694; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Watanabe N, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012022; Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]; Xu F, 2012, OPT EXPRESS, V20, P794, DOI 10.1364/OE.20.000794	30	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50124	10.1371/journal.pone.0050124	http://dx.doi.org/10.1371/journal.pone.0050124			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185554	Green Published, gold			2022-12-25	WOS:000311333800070
J	Zheng, X; Vittar, NBR; Gai, XH; Fernandez-Barrena, MG; Moser, CD; Hu, CL; Almada, LL; McCleary-Wheeler, AL; Elsawa, SF; Vrabel, AM; Shire, AM; Comba, A; Thorgeirsson, SS; Kim, Y; Liu, QG; Fernandez-Zapico, ME; Roberts, LR				Zheng, Xin; Vittar, Natalia B. Rumie; Gai, Xiaohong; Fernandez-Barrena, Maite G.; Moser, Catherine D.; Hu, Chunling; Almada, Luciana L.; McCleary-Wheeler, Angela L.; Elsawa, Sherine F.; Vrabel, Anne M.; Shire, Abdirashid M.; Comba, Andrea; Thorgeirsson, Snorri S.; Kim, Youngsoo; Liu, Qingguang; Fernandez-Zapico, Martin E.; Roberts, Lewis R.			The Transcription Factor GLI1 Mediates TGF beta 1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; SONIC HEDGEHOG; RISK-FACTORS; CELLS; BETA; METASTASIS; RECURRENCE; CANCER; SNAIL	The role of the epithelial-to-mesenchymal transition (EMT) during hepatocellular carcinoma (HCC) progression is well established, however the regulatory mechanisms modulating this phenomenon remain unclear. Here, we demonstrate that transcription factor glioma-associated oncogene 1 (GLI1) modulates EMT through direct up-regulation of SNAI1 and serves as a downstream effector of the transforming growth factor-beta 1 (TGF beta 1) pathway, a well-known regulator of EMT in cancer cells. Overexpression of GLI1 increased proliferation, viability, migration, invasion, and colony formation by HCC cells. Conversely, GLI1 knockdown led to a decrease in all the above-mentioned cancer-associated phenotypes in HCC cells. Further analysis of GLI1 regulated cellular functions showed that this transcription factor is able to induce EMT and identified SNAI1 as a transcriptional target of GLI1 mediating this cellular effect in HCC cells. Moreover, we demonstrated that an intact GLI1-SNAI1 axis is required by TGF beta 1 to induce EMT in these cells. Together, these findings define a novel cellular mechanism regulated by GLI1, which controls the growth and EMT phenotype in HCC.	[Zheng, Xin; Vittar, Natalia B. Rumie; Gai, Xiaohong; Fernandez-Barrena, Maite G.; Moser, Catherine D.; Hu, Chunling; Almada, Luciana L.; McCleary-Wheeler, Angela L.; Vrabel, Anne M.; Shire, Abdirashid M.; Comba, Andrea; Fernandez-Zapico, Martin E.; Roberts, Lewis R.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Zheng, Xin; Gai, Xiaohong; Liu, Qingguang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China; [Zheng, Xin; Vittar, Natalia B. Rumie; Gai, Xiaohong; Fernandez-Barrena, Maite G.; Moser, Catherine D.; Hu, Chunling; Almada, Luciana L.; McCleary-Wheeler, Angela L.; Elsawa, Sherine F.; Vrabel, Anne M.; Shire, Abdirashid M.; Comba, Andrea; Fernandez-Zapico, Martin E.; Roberts, Lewis R.] Mayo Clin, Ctr Canc, Rochester, MN USA; [Vittar, Natalia B. Rumie; Fernandez-Barrena, Maite G.; Almada, Luciana L.; McCleary-Wheeler, Angela L.; Elsawa, Sherine F.; Vrabel, Anne M.; Comba, Andrea; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN USA; [Elsawa, Sherine F.] No Illinois Univ, Dept Biol Sci, De Kalb, IL USA; [Thorgeirsson, Snorri S.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kim, Youngsoo] Isis Pharmaceut Inc, Carlsbad, CA USA	Mayo Clinic; Xi'an Jiaotong University; Mayo Clinic; Mayo Clinic; Northern Illinois University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Isis Pharmaceuticals Inc	Roberts, LR (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	roberts.lewis@mayo.edu	ZHENG, XIN/H-2342-2016; Fernandez-Barrena, Maite G/J-8040-2014; Zheng, Xin/AAX-4333-2021	ZHENG, XIN/0000-0002-6328-0834; Fernandez-Barrena, Maite G/0000-0003-0375-6236; Roberts, Lewis/0000-0001-7885-8574; Hu, Chunling/0000-0002-6814-4639	National Institutes of Health [CA100882, CA128633, CA165076]; Mayo Clinic Center for Cell Signaling in Gastroenterology [NIDDK P30DK084567]; Mayo Clinic Cancer Center [CA15083]; Mayo Clinic Center for Translational Science Activities (NIH/NCRR CTSA) [KL2 RR024151]; American Gastroenterological Association Foundation for Digestive Health and Nutrition Bridgin Grant; NATIONAL CANCER INSTITUTE [P30CA015083, R01CA100882, R01CA165076, R21CA128633, R56CA100882] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Cell Signaling in Gastroenterology; Mayo Clinic Cancer Center; Mayo Clinic Center for Translational Science Activities (NIH/NCRR CTSA); American Gastroenterological Association Foundation for Digestive Health and Nutrition Bridgin Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants CA100882 and CA128633 (to LRR) and CA165076 (to LRR and MEFZ); the Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK P30DK084567) (to MEFZ); the Mayo Clinic Cancer Center (CA15083), the Mayo Clinic Center for Translational Science Activities (NIH/NCRR CTSA Grant Number KL2 RR024151), and an American Gastroenterological Association Foundation for Digestive Health and Nutrition Bridging Grant (to LRR). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chung KY, 2011, HEPATOLOGY, V54, P307, DOI 10.1002/hep.24372; Eguchi S, 2011, BRIT J SURG, V98, P552, DOI 10.1002/bjs.7393; Ferlay J, 2010, INT J CANC; Fiaschi M, 2011, AM J PATHOL, V179, P2569, DOI 10.1016/j.ajpath.2011.07.033; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Hanazaki K, 2000, J AM COLL SURGEONS, V191, P381, DOI 10.1016/S1072-7515(00)00700-6; Kim SH, 2011, J GASTROINTEST SURG, V15, P598, DOI 10.1007/s11605-011-1452-7; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; Kondili LA, 2007, EJSO-EUR J SURG ONC, V33, P868, DOI 10.1016/j.ejso.2006.10.001; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kuphal S, 2011, ONCOGENE, V30, P4523, DOI 10.1038/onc.2011.163; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Leopold PL, 2012, SEMIN CANC BIOL; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Pakala SB, 2011, ONCOGENE, V30, P2230, DOI 10.1038/onc.2010.608; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Reichl P, 2012, CURR PHARM DES; Roessler Stephanie, 2007, Future Oncol, V3, P429, DOI 10.2217/14796694.3.4.429; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schiemann WP, 2007, EXPERT REV ANTICANC, V7, P609, DOI 10.1586/14737140.7.5.609; Schlitt HJ, 1999, J CLIN ONCOL, V17, P324, DOI 10.1200/JCO.1999.17.1.324; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Sun CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018878; Sun VCY, 2008, CLIN J ONCOL NURS, V12, P759, DOI 10.1188/08.CJON.759-766; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Wanshura LEC, 2011, CANCER RES, V71, P5336, DOI 10.1158/0008-5472.CAN-10-2633; Wu J, 2011, ONCOGENE; Xu Z, 2003, CELL RES, V13, P343, DOI 10.1038/sj.cr.7290179; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P617, DOI 10.1016/j.cgh.2011.03.027; Zhang HJ, 2011, MOL CELL BIOCHEM, V355, P309, DOI 10.1007/s11010-011-0869-3; Zheng X, 2010, MOL MED REP, V3, P965, DOI 10.3892/mmr.2010.375	40	63	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49581	10.1371/journal.pone.0049581	http://dx.doi.org/10.1371/journal.pone.0049581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185371	gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800040
J	del Campillo, E; Gaddam, S; Mettle-Amuah, D; Heneks, J				del Campillo, Elena; Gaddam, Sivacharan; Mettle-Amuah, Dorinne; Heneks, Jean			A Tale of Two Tissues: AtGH9C1 Is an Endo-beta-1,4-Glucanase Involved in Root Hair and Endosperm Development in Arabidopsis	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; PLANT-CELL WALL; GENE-EXPRESSION; PHOSPHORUS AVAILABILITY; CRYSTALLINE CELLULOSE; ABSCISIC-ACID; THALIANA; GROWTH; XYLOGLUCAN; ENZYMES	Arabidopsis AtGH9C1 is an endo-beta-1,4-glucanase possessing a carbohydrate-binding domain CBM49). Analysis of AtGH9C1 expression by promoter-reporter GUS, RT-PCR, public transcriptome databases and GFP protein tagging demonstrated a high and selective expression of AtGH9C1 in root hairs and in the endosperm. Expression in root hair cells started prior to bulge formation and continued during hair elongation. AtGH9C1 expression increased with treatments that increase density ACC) or length sucrose) of root hairs. Expression in the endosperm extended sequentially to the micropylar, peripheral and chalazal compartments. A mutant with reduced AtGH9C1 expression had a delay in germination and a marked reduction in root hair presence. Complementation of the mutant partially improved both germination and root hair density. Experiments with ectopically expressed AtGH9C1-GFP with and without the CBM49, demonstrated that both forms of the protein are secreted and that CBM49 targets the protein to specific regions of the cell wall, but what makes these regions special is still unknown. The amino acid alignment of angiosperm GH9 genes with C-terminal extensions illustrate that AtGH9C1 belongs to a different clade than its tomato homolog, S1GH9C1. The latter has a CBM49 that was shown to bind crystalline cellulose. We suggest that AtGH9C1 is associated with the weakening of the cell wall during formation and growth of the root hair as well as with the sequential anterior-posterior breakdown of the endosperm cell wall that provides space for the growing embryo. Thus, is likely that the CBM49 of AtGH9C1 recognizes a form of cellulose or glucan polymer that is prevalent in the wall of these specialized tissues and that is different than the one recognized by S1GH9C1.	[del Campillo, Elena; Gaddam, Sivacharan; Mettle-Amuah, Dorinne; Heneks, Jean] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	del Campillo, E (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	edelcamp@umd.edu			National Science Foundation [IPB 9817983]; United States Department of Agriculture [2001-35304-10088]; HHMI	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); HHMI(Howard Hughes Medical Institute)	This work was originally supported by National Science Foundation, Grant IPB 9817983, and United States Department of Agriculture, Grant 2001-35304-10088 to EdC. Since 2005 the authors have not received extramural funding except for an HHMI Undergraduate Research Fellowship to SG (2008-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bates TR, 1996, PLANT CELL ENVIRON, V19, P529, DOI 10.1111/j.1365-3040.1996.tb00386.x; Baumberger N, 2001, GENE DEV, V15, P1128, DOI 10.1101/gad.200201; Berger F, 2003, CURR OPIN PLANT BIOL, V6, P42, DOI 10.1016/S1369526602000043; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1999, ANNU REV PLANT PHYS, V50, P391, DOI 10.1146/annurev.arplant.50.1.391; Day RC, 2008, PLANT PHYSIOL, V148, P1964, DOI 10.1104/pp.108.128108; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Dugas DV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-514; Ermolaeva MD, 2003, PLANT MOL BIOL, V51, P859, DOI 10.1023/A:1023001130337; FARKAS V, 1988, CARBOHYD RES, V184, P213, DOI 10.1016/0008-6215(88)80019-3; Freixes S, 2002, PLANT CELL ENVIRON, V25, P1357, DOI 10.1046/j.1365-3040.2002.00912.x; FRY SC, 1995, ANNU REV PLANT PHYS, V46, P497, DOI 10.1146/annurev.pp.46.060195.002433; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Grierson C., 2002, ARABIDOPSIS BOOK; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Kormos J, 2000, BIOCHEMISTRY-US, V39, P8844, DOI 10.1021/bi000607s; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehtio J, 2001, FUNCTIONAL STUDIES E; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Ma Z, 2001, PLANT CELL ENVIRON, V24, P459, DOI 10.1046/j.1365-3040.2001.00695.x; Maris A, 2009, J EXP BOT, V60, P3959, DOI 10.1093/jxb/erp229; Martin C, 2001, CURR OPIN PLANT BIOL, V4, P540, DOI 10.1016/S1369-5266(00)00213-2; MCDOUGALL GJ, 1990, PLANT PHYSIOL, V93, P1042, DOI 10.1104/pp.93.3.1042; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Olsen OA, 2001, ANNU REV PLANT PHYS, V52, P233, DOI 10.1146/annurev.arplant.52.1.233; Osato Y, 2006, J PLANT RES, V119, P153, DOI 10.1007/s10265-006-0262-6; OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579; Otegui Marisa S., 2007, V8, P159, DOI 10.1007/7089_2007_113; Otegui MS, 2002, PLANT CELL, V14, P1311, DOI 10.1105/tpc.010486; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Schiefelbein JW, 2000, PLANT PHYSIOL, V124, P1525, DOI 10.1104/pp.124.4.1525; Shaw SL, 2000, PLANT PHYSIOL, V124, P959, DOI 10.1104/pp.124.3.959; Shpigel E, 1998, PLANT PHYSIOL, V117, P1185, DOI 10.1104/pp.117.4.1185; Spolaore S, 2003, J EXP BOT, V54, P271, DOI [10.1093/jxb/54.381.271, 10.1093/jxb/erg025]; Sturcova A, 2004, BIOMACROMOLECULES, V5, P1333, DOI 10.1021/bm034517p; Tanimoto M, 1995, PLANT J, V8, P943, DOI 10.1046/j.1365-313X.1995.8060943.x; TOMME P, 1991, J BIOL CHEM, V266, P10313; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Trainotti L, 2006, J EXP BOT, V57, P589, DOI 10.1093/jxb/erj043; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Urbanowicz BR, 2007, J BIOL CHEM, V282, P12066, DOI 10.1074/jbc.M607925200; Urbanowicz BR, 2007, PLANT PHYSIOL, V144, P1693, DOI 10.1104/pp.107.102574; Vissenberg K, 2001, PLANT PHYSIOL, V127, P1125, DOI 10.1104/pp.010295; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529	66	10	10	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49363	10.1371/journal.pone.0049363	http://dx.doi.org/10.1371/journal.pone.0049363			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173056	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885300031
J	Culver-Cochran, AE; Chadwick, BP				Culver-Cochran, Ashley E.; Chadwick, Brian P.			The WSTF-ISWI Chromatin Remodeling Complex Transiently Associates with the Human Inactive X Chromosome during Late S-Phase Prior to BRCA1 and gamma-H2AX	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; POLYMERASE-I TRANSCRIPTION; HISTONE H3; XIST GENE; CELL-CYCLE; FACULTATIVE HETEROCHROMATIN; EPIGENETIC INHERITANCE; WILLIAMS-SYNDROME; H2AX PHOSPHORYLATION; REPLICATION FOCI	Replicating the genome prior to each somatic cell division not only requires precise duplication of the genetic information, but also accurately reestablishing the epigenetic signatures that instruct how the genetic material is to be interpreted in the daughter cells. The mammalian inactive X chromosome (Xi), which is faithfully inherited in a silent state in each daughter cell, provides an excellent model of epigenetic regulation. While much is known about the early stages of X chromosome inactivation, much less is understood with regards to retaining the Xi chromatin through somatic cell division. Here we report that the WSTF-ISWI chromatin remodeling complex (WICH) associates with the Xi during late S-phase as the Xi DNA is replicated. Elevated levels of WICH at the Xi is restricted to late S-phase and appears before BRCA1 and gamma-H2A. X. The sequential appearance of WICH and BRCA1/gamma-H2A. X implicate each as performing important but distinct roles in the maturation and maintenance of heterochromatin at the Xi.	[Culver-Cochran, Ashley E.; Chadwick, Brian P.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Culver-Cochran, AE (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	chadwick@bio.fsu.edu		Chadwick, Brian/0000-0001-5272-8384; Cochran, Ashley/0000-0002-2744-1864	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073120] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM073120, R01 GM073120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Ashe A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r182; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Barnett C, 2011, BIOCHEM CELL BIOL, V89, P12, DOI 10.1139/O10-114; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; Bozhenok L, 2002, EMBO J, V21, P2231, DOI 10.1093/emboj/21.9.2231; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chadwick BP, 2005, CHROMOSOMA, V114, P432, DOI 10.1007/s00412-005-0029-1; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chadwick BP, 2003, HUM MOL GENET, V12, P2167, DOI 10.1093/hmg/ddg229; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Chan KM, 2011, P NATL ACAD SCI USA, V108, P16699, DOI 10.1073/pnas.1107616108; Chen YM, 1996, CANCER RES, V56, P3168; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Finelli P, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-16; Ganesan S, 2002, CELL, V111, P393, DOI 10.1016/S0092-8674(02)01052-8; Garner E, 2009, DNA REPAIR, V8, P1025, DOI 10.1016/j.dnarep.2009.04.015; GILBERT CW, 1962, NATURE, V195, P869, DOI 10.1038/195869a0; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Horakova AH, 2010, CHROMOSOMA, V119, P227, DOI 10.1007/s00412-009-0252-2; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; JANSEN RP, 1991, J CELL BIOL, V113, P715, DOI 10.1083/jcb.113.4.715; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lazzaro MA, 2001, J NEUROCHEM, V77, P1145, DOI 10.1046/j.1471-4159.2001.00324.x; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lu XJ, 1998, GENOMICS, V54, P241, DOI 10.1006/geno.1998.5578; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; McLaughlin CR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r37; Mise N, 1996, EXP CELL RES, V223, P193, DOI 10.1006/excr.1996.0073; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; MORISHIMA A, 1962, P NATL ACAD SCI USA, V48, P756, DOI 10.1073/pnas.48.5.756; Pageau GJ, 2007, J CELL BIOCHEM, V100, P835, DOI 10.1002/jcb.21188; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peoples RJ, 1998, CYTOGENET CELL GENET, V82, P238, DOI 10.1159/000015110; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; PFEIFER GP, 1990, GENE DEV, V4, P1277, DOI 10.1101/gad.4.8.1277; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Poot RA, 2005, CELL CYCLE, V4, P543, DOI 10.4161/cc.4.4.1624; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; RACK KA, 1994, HUM MOL GENET, V3, P1053, DOI 10.1093/hmg/3.7.1053; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sado T, 1996, DEV DYNAM, V205, P421, DOI 10.1002/(SICI)1097-0177(199604)205:4<421::AID-AJA6>3.0.CO;2-K; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Schwab RAV, 2011, JOVE-J VIS EXP, DOI 10.3791/3255; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; TAKAGI N, 1993, GENETICA, V88, P107, DOI 10.1007/BF02424467; TAKAGI N, 1983, EXP CELL RES, V145, P397, DOI 10.1016/0014-4827(83)90018-6; TAKAGI N, 1983, CELL, V34, P1053, DOI 10.1016/0092-8674(83)90563-9; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vintermist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019184; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xiao CY, 2007, CELL, V128, P977, DOI 10.1016/j.cell.2007.01.034; Yan OY, 2005, BIOCHEM BIOPH RES CO, V337, P875, DOI 10.1016/j.bbrc.2005.09.122; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Yoshimura K, 2009, P NATL ACAD SCI USA, V106, P9280, DOI 10.1073/pnas.0901184106; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	90	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e50023	10.1371/journal.pone.0050023	http://dx.doi.org/10.1371/journal.pone.0050023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166813	gold, Green Submitted, Green Published			2022-12-25	WOS:000311151900212
J	Lee, TH; Park, JM; Leem, SH; Kang, TH				Lee, T-H; Park, J-M; Leem, S-H; Kang, T-H			Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair	ONCOGENE			English	Article						XPA; ATR; HERC2; protein stability; posttranslational modification	PIGMENTOSUM GROUP-A; INDUCED DNA-DAMAGE; XERODERMA-PIGMENTOSUM; E3 LIGASE; PROTEIN; KINASE; PHOTOPRODUCTS; RECOGNITION; ACTIVATION; CELLS	ATR (ATM and Rad3-related) is an essential regulator of the nucleotide excision repair (NER) mechanism. For NER activation, ATR phosphorylates XPA, the rate-limiting factor in the NER pathway. However, the role of XPA phosphorylation at serine 196 by ATR has been elusive. Here we show that ATR-mediated XPA phosphorylation enhances XPA stability by inhibiting HERC2-mediated ubiquitination and subsequent degradation. We analyzed stabilization of XPA with substitutions of Ser 196 either to aspartate (S196D), a phosphomimetic mutation, or to alanine (S196A), a phosphodeficient mutation. Upon ultraviolet damage, ATR facilitated HERC2 dissociation from the XPA complex to induce XPA stabilization. However, this regulation was abrogated in S196A-complemented XPA-deficient cells due to persistent association of HERC2 with this XPA complex, resulting in enhanced ubiquitination of S196A. Conversely, the S196D substitution showed delayed degradation kinetics compared with the wild-type and less binding with HERC2, resulting in reduced ubiquitination of S196D. We also found that XPA phosphorylation enhanced the chromatin retention of XPA, the interaction with its binding partners following DNA damage. Taken together, our study presents a novel control mechanism in the NER pathway by regulating the steady-state level of XPA through posttranslational modifications by which ATR-mediated phosphorylation induces XPA stabilization by antagonizing HERC2-catalyzed XPA ubiquitination.	[Lee, T-H; Park, J-M; Leem, S-H; Kang, T-H] Dong A Univ, Dept Biol Sci, Pusan 604714, South Korea	Dong A University	Kang, TH (corresponding author), Dong A Univ, Dept Biol Sci, 840 Hadan 2 Dong, Pusan 604714, South Korea.	thkang@dau.ac.kr	Kang, Tae-Hong/Y-8294-2019	Kang, Tae-Hong/0000-0002-6013-900X; Lee, Tae-Hee/0000-0002-6263-6499	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology (MEST) [2011-0013804, 2012-0003981]; Collaborative research Program of Nuclear Medical Sciences through the Dongnam Institute of Radiological & Medical Sciences; MEST and Busan Metropolitan city [2011-0593]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Collaborative research Program of Nuclear Medical Sciences through the Dongnam Institute of Radiological & Medical Sciences; MEST and Busan Metropolitan city(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (MEST) (2011-0013804 and 2012-0003981). This study was also supported by 2011 Collaborative research Program of Nuclear Medical Sciences through the Dongnam Institute of Radiological & Medical Sciences funded by the MEST and Busan Metropolitan city (2011-0593).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; D Bomgarden R, 2006, EMBO J, V25, P2605, DOI 10.1038/sj.emboj.7601123; Dzagnidze A, 2007, J NEUROSCI, V27, P9451, DOI 10.1523/JNEUROSCI.0523-07.2007; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Izawa N, 2011, CANCER RES, V71, P5621, DOI 10.1158/0008-5472.CAN-11-0385; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2008, BBA-MOL CELL RES, V1783, P49, DOI 10.1016/j.bbamcr.2007.10.011; Kang TH, 2006, NAT CELL BIOL, V8, P863, DOI 10.1038/ncb1447; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kang TH, 2009, CELL CYCLE, V8, P1665, DOI 10.4161/cc.8.11.8707; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028326; Liu LR, 2010, J CELL PHYSIOL, V224, P585, DOI 10.1002/jcp.22205; Liu QH, 2000, GENE DEV, V14, P1448; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Nguyen TA, 2010, DNA REPAIR, V9, P813, DOI 10.1016/j.dnarep.2010.04.005; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perdiz D, 2000, J BIOL CHEM, V275, P26732; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Saijo M, 2011, J BIOL CHEM, V286, P5476, DOI 10.1074/jbc.M110.172916; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; States JC, 1998, HUM MUTAT, V12, P103, DOI 10.1002/(SICI)1098-1004(1998)12:2<103::AID-HUMU5>3.0.CO;2-6; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	46	49	50	1	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					19	25		10.1038/onc.2012.539	http://dx.doi.org/10.1038/onc.2012.539			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23178497				2022-12-25	WOS:000329212000003
J	Di, K; Linskey, ME; Bota, DA				Di, K.; Linskey, M. E.; Bota, D. A.			TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth	ONCOGENE			English	Article						TRIM11; oncogene; EGFR; malignant glioma; tumor formation	GLIOBLASTOMA STEM-CELLS; MALIGNANT GLIOMAS; PROGENITOR CELLS; EXPRESSION; CANCER; IDENTIFICATION; RECEPTOR; SYSTEM; NESTIN; GENE	TRIM11 (tripartite motif-containing protein 11), an E3 ubiquitin ligase, is known to be involved in the development of the central nervous system. However, very little is known regarding the role of TRIM11 in cancer biology. Here, we examined the expression profile of TRIM11, along with two stem cell markers CD133 and nestin, in multiple glioma patient specimens, glioma primary cultures derived from tumors taken at surgery and normal neural stem/progenitor cells (NSCs). The oncogenic function of TRIM11 in glioma biology was investigated by knockdown and/or overexpression in vitro and in vivo experiments. Our results showed that TRIM11 expression levels were upregulated in malignant glioma specimens and in high-grade glioma-derived primary cultures, whereas remaining low in glioblastoma multiforme (GBM) stable cell lines, low-grade glioma-derived primary cultures and NSCs. The expression pattern of TRIM11 strongly correlated with that of CD133 and nestin and differentiation status of malignant glioma cells. Knock down of TRIM11 inhibited proliferation, migration and invasion of GBM cells, significantly decreased epidermal growth factor receptor (EGFR) levels and mitogen-activated protein kinase activity, and downregulated HB-EGF (heparin-binding EGF-like growth factor) mRNA levels. Meanwhile, TRIM11 overexpression promoted a stem-like phenotype in vitro (tumorsphere formation) and enhanced glial tumor growth in immunocompromised mice. These findings suggest that TRIM11 might be an indicator of glioma malignancy and has an oncogenic function mediated through the EGFR signaling pathway. TRIM11 overexpression potentially leads to a more aggressive glioma phenotype, along with increased malignant tumor growth and poor survival. Taken together, clarification of the biological function of TRIM11 and pathways it affects may provide novel therapeutic strategies for treating malignant glioma patients.	[Di, K.; Linskey, M. E.; Bota, D. A.] UC Irvine Sch Med, Dept Neurol Surg, Orange, CA 92868 USA; [Linskey, M. E.; Bota, D. A.] UC Irvine Chao Family Comprehens Canc Ctr, Orange, CA USA; [Bota, D. A.] UC Irvine Sch Med, Dept Neurol, Orange, CA 92868 USA		Bota, DA (corresponding author), UC Irvine Sch Med, UC Irvine Med Ctr, 101 City Dr South,Shanbrom Hall,Suite 121, Orange, CA 92868 USA.	dbota@uci.edu		Bota, Daniela/0000-0002-9680-9060	Community Foundation of Jewish Federation; University of California, Irvine; UCI Cancer Center from the National Cancer Institute [P30CA062203]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS072234] Funding Source: NIH RePORTER	Community Foundation of Jewish Federation; University of California, Irvine(University of California System); UCI Cancer Center from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Xing Gong for the preparation of glioma primary cultures, Dr Ronald C Kim for the neuropathological diagnosis of tumor samples and Dr Abhishek Chaturbedi for the organization of the tumor list used in the study. This work was supported by research funds donated by Ralph and Suzanne Stern and the Community Foundation of Jewish Federation. This study was also supported, in part, by start-up funds to DAB from the University of California, Irvine and the UCI Cancer Center Award Number P30CA062203 from the National Cancer Institute.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BIGNER SH, 1990, CANCER RES, V50, P8017; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Corn BW, 2009, J NEURO-ONCOL, V95, P247, DOI 10.1007/s11060-009-9923-3; Dey M, 2011, STEM CELL REV REP, V7, P119, DOI 10.1007/s12015-010-9132-7; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; FREDENS K, 1986, HISTOCHEMISTRY, V84, P247, DOI 10.1007/BF00495790; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Gong X, 2011, NEUROLOGY, V76, P1126, DOI 10.1212/WNL.0b013e318212a89f; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hong SJ, 2008, BIOCHEM BIOPH RES CO, V368, P650, DOI 10.1016/j.bbrc.2008.01.165; Ishikawa H, 2006, FEBS LETT, V580, P4784, DOI 10.1016/j.febslet.2006.07.066; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Kurihara H, 2000, GENE THER, V7, P686, DOI 10.1038/sj.gt.3301129; Li ZZ, 2009, J BIOL CHEM, V284, P16705, DOI 10.1074/jbc.R900013200; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Ma YH, 2008, J NEURO-ONCOL, V86, P31, DOI 10.1007/s11060-007-9439-7; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Pistollato F, 2009, STEM CELLS, V27, P7, DOI 10.1634/stemcells.2008-0402; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Rao RD, 2003, FRONT BIOSCI-LANDMRK, V8, pE270, DOI 10.2741/897; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmidinger M, 2003, J NEURO-ONCOL, V63, P55, DOI 10.1023/A:1023740303162; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Sherman JH, 2011, J NEUROSCI METH, V198, P99, DOI 10.1016/j.jneumeth.2011.03.003; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suo ZH, 2002, INT J SURG PATHOL, V10, P91, DOI 10.1177/106689690201000202; Tarbe N, 2002, ANTICANCER RES, V22, P2015; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang MY, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-85; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou XD, 2009, J INT MED RES, V37, P503, DOI 10.1177/147323000903700226; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	46	53	56	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5038	5047		10.1038/onc.2012.531	http://dx.doi.org/10.1038/onc.2012.531			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23178488	Green Accepted, Green Submitted			2022-12-25	WOS:000325937900005
J	Brown, BL; Lord, DM; Grigoriu, S; Peti, W; Page, R				Brown, Breann L.; Lord, Dana M.; Grigoriu, Simina; Peti, Wolfgang; Page, Rebecca			The Escherichia coli Toxin MqsR Destabilizes the Transcriptional Repression Complex Formed between the Antitoxin MqsA and the mqsRA Operon Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MULTIDRUG TOLERANCE; CRYSTAL-STRUCTURE; BIOFILM FORMATION; STRUCTURAL BASIS; PERSISTER CELLS; ANTIDOTE; RELE; CCDA; DNA	Bacterial biofilms are complex communities of cells containing an increased prevalence of dormant cells known as persisters, which are characterized by an up-regulation of genes known as toxin-antitoxin (TA) modules. The association of toxins with their cognate antitoxins neutralizes toxin activity, allowing for normal cell growth. Additionally, protein antitoxins bind their own promoters and repress transcription, whereas the toxins serve as co-repressors. Recently, TA pairs have been shown to regulate their own transcription through a phenomenon known as conditional cooperativity, where the TA complexes bind operator DNA and repress transcription only when present in the proper stoichiometric amounts. The most differentially up-regulated gene in persister cells is mqsR, a gene that, with the antitoxin mqsA, constitutes a TA module. Here, we reveal that, unlike other TA systems, MqsR is not a transcription co-repressor but instead functions to destabilize the MqsA-DNA complex. We further show that DNA binding is not regulated by conditional cooperativity. Finally, using biophysical studies, we show that complex formation between MqsR and MqsA results in an exceptionally stable interaction, resulting in a subnanomolar dissociation constant that is similar to that observed between MqsA and DNA. In combination with crystallographic studies, this work reveals that MqsA binding to DNA and MqsR is mutually exclusive. To our knowledge, this is the first TA system in which the toxin does not function as a transcriptional co-repressor, but instead functions to destabilize the antitoxin-operator complex under all conditions, and thus defines another unique feature of the mqsRA TA module.	[Brown, Breann L.; Lord, Dana M.; Peti, Wolfgang] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Grigoriu, Simina; Page, Rebecca] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Peti, Wolfgang] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Page, R (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Box GE 4, Providence, RI 02912 USA.	rebecca_page@brown.edu	Peti, Wolfgang/L-3492-2014		National Science Foundation-CAREER Award [MCB-0952550]; National Institutes of Health-NINDS Predoctoral Fellowship Award [F31NS062630]; National Science Foundation-Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship; National Science Foundation-EPSCoR [1004057, 0554548]; National Institutes of Health [1S10RR020923]; Rhode Island Science and Technology Advisory Council grant; Division of Biology and Medicine, Brown University; National Institutes of Health (NCRR) [P30RR031153, P20RR018728, S10RR02763]; Lifespan Rhode Island Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031153, S10RR020923, P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103410, T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS062630] Funding Source: NIH RePORTER; Direct For Biological Sciences [0952550] Funding Source: National Science Foundation; Office of Integrative Activities [1004057] Funding Source: National Science Foundation	National Science Foundation-CAREER Award(National Science Foundation (NSF)); National Institutes of Health-NINDS Predoctoral Fellowship Award; National Science Foundation-Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship; National Science Foundation-EPSCoR(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Science and Technology Advisory Council grant; Division of Biology and Medicine, Brown University; National Institutes of Health (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Lifespan Rhode Island Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Science Foundation-CAREER Award MCB-0952550 (to R. P.), National Institutes of Health-NINDS Predoctoral Fellowship Award F31NS062630 (to B. L. B.), and a National Science Foundation-Experimental Program to Stimulate Competitive Research (EPSCoR) graduate fellowship (to D. M. L.). This research is based in part upon work conducted using the Rhode Island National Science Foundation-EPSCoR Proteomics Shared Resource Facility, which is supported in part by the National Science Foundation-EPSCoR Grant 1004057, National Institutes of Health Grant 1S10RR020923, a Rhode Island Science and Technology Advisory Council grant, and the Division of Biology and Medicine, Brown University. This research is based in part upon work conducted in the Center for Genomics and Proteomics Core Facility with partial support from the National Institutes of Health (NCRR Grants P30RR031153, P20RR018728, and S10RR02763), National Science Foundation-EPSCoR Grant 0554548, Lifespan Rhode Island Hospital, and the Division of Biology and Medicine, Brown University.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Bigger JW, 1944, LANCET, V2, P497; Blower TR, 2009, J BACTERIOL, V191, P6029, DOI 10.1128/JB.00720-09; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Brown BL, 2010, ACTA CRYSTALLOGR F, V66, P1060, DOI 10.1107/S1744309110028617; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Falla TJ, 1998, ANTIMICROB AGENTS CH, V42, P3282, DOI 10.1128/AAC.42.12.3282; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kim Y, 2010, ENVIRON MICROBIOL, V12, P1105, DOI 10.1111/j.1462-2920.2009.02147.x; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson R, 1998, J BACTERIOL, V180, P6342; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; TAM JE, 1989, MOL GEN GENET, V219, P26, DOI 10.1007/BF00261153; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Wilbur JS, 2005, BIOCHEMISTRY-US, V44, P12515, DOI 10.1021/bi0511080; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	50	59	63	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1286	1294		10.1074/jbc.M112.421008	http://dx.doi.org/10.1074/jbc.M112.421008			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23172222	Green Published, hybrid			2022-12-25	WOS:000313570300050
J	Helwig, M; Hoshino, A; Berridge, C; Lee, SN; Lorenzen, N; Otzen, DE; Eriksen, JL; Lindberg, I				Helwig, Michael; Hoshino, Akina; Berridge, Casey; Lee, Sang-Nam; Lorenzen, Nikolai; Otzen, Daniel E.; Eriksen, Jason L.; Lindberg, Iris			The Neuroendocrine Protein 7B2 Suppresses the Aggregation of Neurodegenerative Disease-related Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; HEAT-SHOCK PROTEINS; ALPHA-SYNUCLEIN; CONVERTASE PC2; A-BETA; CHAPERONE; BIOMARKERS; TAU; IDENTIFICATION; MODULATION	Neurodegenerative diseases such as Alzheimer (AD) and Parkinson (PD) are characterized by abnormal aggregation of misfolded beta-sheet-rich proteins, including amyloid-beta (A beta)-derived peptides and tau in AD and alpha-synuclein in PD. Correct folding and assembly of these proteins are controlled by ubiquitously expressed molecular chaperones; however, our understanding of neuron-specific chaperones and their involvement in the pathogenesis of neurodegenerative diseases is limited. We here describe novel chaperone-like functions for the secretory protein 7B2, which is widely expressed in neuronal and endocrine tissues. In in vitro experiments, 7B2 efficiently prevented fibrillation and formation of A beta(1-42), A beta(1-40), and alpha-synuclein aggregates at a molar ratio of 1:10. In cell culture experiments, inclusion of recombinant 7B2, either in the medium of Neuro-2A cells or intracellularly via adenoviral 7B2 overexpression, blocked the neurocytotoxic effect of A beta(1-42) and significantly increased cell viability. Conversely, knockdown of 7B2 by RNAi increased A beta(1-42)-induced cytotoxicity. In the brains of APP/PSEN1 mice, a model of AD amyloidosis, immunoreactive 7B2 co-localized with aggregation-prone proteins and their respective aggregates. Furthermore, in the hippocampus and substantia nigra of human AD-and PD-affected brains, 7B2 was highly co-localized with A beta plaques and alpha-synuclein deposits, strongly suggesting physiological association. Our data provide insight into novel functions of 7B2 and establish this neural protein as an anti-aggregation chaperone associated with neurodegenerative disease.	[Helwig, Michael; Hoshino, Akina; Lindberg, Iris] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Berridge, Casey; Eriksen, Jason L.] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, Houston, TX 77204 USA; [Lee, Sang-Nam] Yonsei Univ, Res Ctr Nat Human Def Syst, Coll Med, Seoul 120752, South Korea; [Lorenzen, Nikolai; Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark	University System of Maryland; University of Maryland Baltimore; University of Houston System; University of Houston; Yonsei University; Yonsei University Health System; Aarhus University	Lindberg, I (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, HSF 2,Rm S251,20 Penn St, Baltimore, MD 21201 USA.	ilind001@umaryland.edu	Lindberg, Iris/Q-3825-2019; Eriksen, Jason/A-8054-2008	Eriksen, Jason/0000-0003-1549-4165; Otzen, Daniel/0000-0002-2918-8989	National Institutes of Health [1R01DK49703, 1R15AG039008]; Alzheimer's Association [NIRG-08-92033]; Michael J. Fox Foundation for Parkinson's Research; German Academy of Sciences Leopoldina Foundation Post-doctoral Grant [LPDS 2009-33]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R15AG039008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Michael J. Fox Foundation for Parkinson's Research; German Academy of Sciences Leopoldina Foundation Post-doctoral Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01DK49703 (to I. L.) and 1R15AG039008 (to J. L. E.). This work was also supported by Alzheimer's Association Grant NIRG-08-92033 (to J. L. E.), the Michael J. Fox Foundation for Parkinson's Research (to N. L. and D. E. O.), and German Academy of Sciences Leopoldina Foundation Post-doctoral Grant LPDS 2009-33 (to M. H.).	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Bianchi FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022370; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; CHAUDHURI B, 1995, BIOCHEM BIOPH RES CO, V211, P417, DOI 10.1006/bbrc.1995.1830; Clemente C, 1985, GRAYS ANATOMY HUMAN, V30th; Croisier E, 2006, NEUROPATH APPL NEURO, V32, P351, DOI 10.1111/j.1365-2990.2006.00722.x; Dasgupta I, 2012, BIOCHEMISTRY-US, V51, P7456, DOI 10.1021/bi300871k; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Finehout EJ, 2007, ANN NEUROL, V61, P120, DOI 10.1002/ana.21038; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Helwig M, 2011, J BIOL CHEM, V286, P42504, DOI 10.1074/jbc.M111.281980; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; IGUCHI H, 1984, NEUROENDOCRINOLOGY, V39, P453, DOI 10.1159/000124020; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; KJAER A, 1995, NEUROENDOCRINOLOGY, V61, P167, DOI 10.1159/000126837; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SN, 2008, ENDOCRINOLOGY, V149, P4116, DOI 10.1210/en.2008-0064; Lee SN, 2006, J BIOL CHEM, V281, P3312, DOI 10.1074/jbc.M506635200; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Mbikay M, 2001, BIOCHEM J, V357, P329, DOI 10.1042/0264-6021:3570329; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muller L, 1999, J BIOL CHEM, V274, P21471, DOI 10.1074/jbc.274.30.21471; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Ranganathan S, 2005, J NEUROCHEM, V95, P1461, DOI 10.1111/j.1471-4159.2005.03478.x; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P511; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sasaki K, 2009, MOL CELL PROTEOMICS, V8, P1638, DOI 10.1074/mcp.M900044-MCP200; Seidel B, 1998, DNA CELL BIOL, V17, P1017, DOI 10.1089/dna.1998.17.1017; SIGAFOOS J, 1993, CELL MOL NEUROBIOL, V13, P271, DOI 10.1007/BF00733755; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Winsky-Sommerer R, 2003, NEUROSCIENCE, V122, P437, DOI 10.1016/S0306-4522(03)00560-8; Wu ZC, 2012, ADV CLIN CHEM, V56, P155, DOI 10.1016/B978-0-12-394317-0.00011-X; Zhu XR, 1996, J BIOL CHEM, V271, P23582, DOI 10.1074/jbc.271.38.23582	54	30	35	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1114	1124		10.1074/jbc.M112.417071	http://dx.doi.org/10.1074/jbc.M112.417071			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23172224	hybrid, Green Published			2022-12-25	WOS:000313570300034
J	Braud, S; Ciufolini, MA; Harosh, I				Braud, Sandrine; Ciufolini, Marco A.; Harosh, Itzik			Enteropeptidase: A Gene Associated with a Starvation Human Phenotype and a Novel Target for Obesity Treatment	PLOS ONE			English	Article							INTESTINAL ENTEROKINASE DEFICIENCY; BODY-WEIGHT; LIGHT-CHAIN; TRYPSINOGEN; ORLISTAT; DIET	Background: Obesity research focuses essentially on gene targets associated with the obese phenotype. None of these targets have yet provided a viable drug therapy. Focusing instead on genes that are involved in energy absorption and that are associated with a "human starvation phenotype", we have identified enteropeptidase (EP), a gene associated with congenital enteropeptidase deficiency, as a novel target for obesity treatment. The advantages of this target are that the gene is expressed exclusively in the brush border of the intestine; it is peripheral and not redundant. Methodology/Principal Findings: Potent and selective EP inhibitors were designed around a boroarginine or borolysine motif. Oral administration of these compounds to mice restricted the bioavailability of dietary energy, and in a long-term treatment it significantly diminished the rate of increase in body weight, despite ad libitum food intake. No adverse reactions of the type seen with lipase inhibitors, such as diarrhea or steatorrhea, were observed. This validates EP as a novel, druggable target for obesity treatment. Conclusions: In vivo testing of novel boroarginine or borolysine-based EP inhibitors validates a novel approach to the treatment of obesity.	[Braud, Sandrine; Harosh, Itzik] ObeTherapy Biotechnol, Evry, France; [Ciufolini, Marco A.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	University of British Columbia	Harosh, I (corresponding author), ObeTherapy Biotechnol, Evry, France.	haroshitzik@gmail.com						Ahima RS, 2001, TRENDS MOL MED, V7, P205, DOI 10.1016/S1471-4914(01)01989-X; Amat L, 1976, ANN ESP PEDIAT, V11, P219; Bays HE, 2011, DRUG TODAY, V47, P903, DOI 10.1358/dot.2011.47.12.1718738; Braud S, 2010, FUTURE MED CHEM, V2, P1777, DOI [10.4155/fmc.10.263, 10.4155/FMC.10.263]; Bruce KD, 2010, J NUTR, V140, P648, DOI 10.3945/jn.109.111179; Chiesi M, 2001, TRENDS PHARMACOL SCI, V22, P247, DOI 10.1016/S0165-6147(00)01664-3; Ciangura C, 2012, REV MED INTERNE, V33, P318, DOI 10.1016/j.revmed.2011.12.008; FOLLETT GF, 1976, ACTA PAEDIATR SCAND, V65, P653, DOI 10.1111/j.1651-2227.1976.tb04948.x; Gasparian ME, 2006, BIOCHEMISTRY-MOSCOW+, V71, P113, DOI 10.1134/S0006297906020015; GHISHAN FK, 1983, GASTROENTEROLOGY, V85, P727; Hadorn B, 1969, LANCET, V293, P812; Harosh I., 2010, U.S. Patent, Patent No. [2010,0311690, 20100311690]; HAWORTH JC, 1975, ARCH DIS CHILD, V50, P277; HAWORTH JC, 1971, J PEDIATR-US, V78, P481, DOI 10.1016/S0022-3476(71)80231-7; Holzinger A, 2002, AM J HUM GENET, V70, P20, DOI 10.1086/338456; Hutton B, 2004, AM J CLIN NUTR, V80, P1461, DOI 10.1093/ajcn/80.6.1461; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Lu DS, 1999, J MOL BIOL, V292, P361, DOI 10.1006/jmbi.1999.3089; Nazarian R, 2009, CURR OPIN INVEST DR, V10, P1236; Polonovski C, 1970, CLIN STUDY ARCH FR P, V27, P677; Reed DR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-4; Rezacova P, 2009, J MED CHEM, V52, P7132, DOI 10.1021/jm9011388; Richelsen B, 2007, DIABETES CARE, V30, P27, DOI 10.2337/dc06-0210; Spano JP, 2005, B CANCER, V92, P945; TARNOPOLSKY MA, 1992, J APPL PHYSIOL, V73, P1986, DOI 10.1152/jappl.1992.73.5.1986; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; YAMASHINA I, 1956, BIOCHIM BIOPHYS ACTA, V20, P433, DOI 10.1016/0006-3002(56)90329-8; Zhang YK, 2010, BIOORG MED CHEM LETT, V20, P2270, DOI 10.1016/j.bmcl.2010.02.010	28	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49612	10.1371/journal.pone.0049612	http://dx.doi.org/10.1371/journal.pone.0049612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185382	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000069
J	Frost, S; Ho, O; Login, FH; Weise, CF; Wolf-Watz, H; Wolf-Watz, M				Frost, Stefan; Ho, Oanh; Login, Frederic H.; Weise, Christoph F.; Wolf-Watz, Hans; Wolf-Watz, Magnus			Autoproteolysis and Intramolecular Dissociation of Yersinia YscU Precedes Secretion of Its C-Terminal Polypeptide YscU(CC)	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY SWITCH; OUTER-MEMBRANE PROTEINS; TARGET-CELL CONTACT; III SECRETION; SALMONELLA-TYPHIMURIUM; NEEDLE LENGTH; EUKARYOTIC CELLS; YOP PROTEINS; EXPRESSION; ENTEROCOLITICA	Type III secretion system mediated secretion and translocation of Yop-effector proteins across the eukaryotic target cell membrane by pathogenic Yersinia is highly organized and is dependent on a switching event from secretion of early structural substrates to late effector substrates (Yops). Substrate switching can be mimicked in vitro by modulating the calcium levels in the growth medium. YscU that is essential for regulation of this switch undergoes autoproteolysis at a conserved N up arrow PTH motif, resulting in a 10 kDa C-terminal polypeptide fragment denoted YscU(CC). Here we show that depletion of calcium induces intramolecular dissociation of YscU(CC) from YscU followed by secretion of the YscU(CC) polypeptide. Thus, YscU(CC) behaved in vivo as a Yop protein with respect to secretion properties. Further, destabilized yscU mutants displayed increased rates of dissociation of YscU(CC) in vitro resulting in enhanced Yop secretion in vivo at 30 degrees C relative to the wild-type strain. These findings provide strong support to the relevance of YscU(CC) dissociation for Yop secretion. We propose that YscU(CC) orchestrates a block in the secretion channel that is eliminated by calcium depletion. Further, the striking homology between different members of the YscU/FlhB family suggests that this protein family possess regulatory functions also in other bacteria using comparable mechanisms.	[Frost, Stefan; Login, Frederic H.; Wolf-Watz, Hans] Umea Univ, Dept Mol Biol, Umea, Sweden; [Frost, Stefan; Login, Frederic H.; Wolf-Watz, Hans] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Ho, Oanh; Weise, Christoph F.; Wolf-Watz, Magnus] Umea Univ, Dept Chem, Chem Biol Ctr, Umea, Sweden	Umea University; Umea University; Umea University	Wolf-Watz, H (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	hans.wolf-watz@molbiol.umu.se; magnus.wolf-watz@chem.umu.se			Swedish Research Council; UCMR Linnaeus Postdoctoral Program; Laboratory of Molecular Infection Medicine Sweden; Umea University Young Researcher Award	Swedish Research Council(Swedish Research CouncilEuropean Commission); UCMR Linnaeus Postdoctoral Program; Laboratory of Molecular Infection Medicine Sweden; Umea University Young Researcher Award	This research was financially supported by the Swedish Research Council (HWW and MWW), the UCMR Linnaeus Postdoctoral Program (to HWW), the Laboratory of Molecular Infection Medicine Sweden (MIMS, to HWW), and an Umea University Young Researcher Award (to MWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; BOLIN I, 1985, INFECT IMMUN, V48, P234; Botteaux A, 2008, MOL MICROBIOL, V70, P1515, DOI 10.1111/j.1365-2958.2008.06499.x; Consalvi V, 2000, PROTEIN ENG, V13, P501, DOI 10.1093/protein/13.7.501; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Durant JA, 2000, J FOOD PROTECT, V63, P573, DOI 10.4315/0362-028X-63.5.573; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; HEESEMANN J, 1984, INFECT IMMUN, V46, P105, DOI 10.1128/IAI.46.1.105-110.1984; Helgstrand M, 2000, J BIOMOL NMR, V18, P329, DOI 10.1023/A:1026729404698; HIGUCHI K, 1959, J BACTERIOL, V77, P317, DOI 10.1128/JB.77.3.317-321.1959; HILLS GM, 1952, J GEN MICROBIOL, V6, P64, DOI 10.1099/00221287-6-1-2-64; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lavander M, 2003, ADV EXP MED BIOL, V529, P109; Lountos GT, 2009, PROTEIN SCI, V18, P467, DOI 10.1002/pro.56; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Morris DP, 2010, BIOCHEMISTRY-US, V49, P6386, DOI 10.1021/bi100487p; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; PORTNOY DA, 1981, J BACTERIOL, V148, P877, DOI 10.1128/JB.148.3.877-883.1981; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; van Holde KE, 1998, PHYS BIOCH; Wiesand U, 2009, J MOL BIOL, V385, P854, DOI 10.1016/j.jmb.2008.10.034; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; ZAHORCHAK RJ, 1979, J BACTERIOL, V139, P792, DOI 10.1128/JB.139.3.792-799.1979	41	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49349	10.1371/journal.pone.0049349	http://dx.doi.org/10.1371/journal.pone.0049349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185318	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000040
J	Gallegos, ME; Balakrishnan, S; Chandramouli, P; Arora, S; Azameera, A; Babushekar, A; Bargoma, E; Bokhari, A; Chava, SK; Das, P; Desai, M; Decena, D; Saramma, SDD; Dey, B; Doss, AL; Gor, N; Gudiputi, L; Guo, CY; Hande, S; Jensen, M; Jones, S; Jones, N; Jorgens, D; Karamchedu, P; Kamrani, K; Kolora, LD; Kristensen, L; Kwan, K; Lau, H; Maharaj, P; Mander, N; Mangipudi, K; Menakuru, H; Mody, V; Mohanty, S; Mukkamala, S; Mundra, SA; Nagaraju, S; Narayanaswamy, R; Ndungu-Case, C; Noorbakhsh, M; Patel, J; Patel, P; Pendem, SV; Ponakala, A; Rath, M; Robles, MC; Rokkam, D; Roth, C; Sasidharan, P; Shah, S; Tandon, S; Suprai, J; Tina, QNT; Uthayaruban, R; Varma, A; Ved, U; Wang, ZR; Yu, Z				Gallegos, Maria E.; Balakrishnan, Sanjeev; Chandramouli, Priya; Arora, Shaily; Azameera, Aruna; Babushekar, Anitha; Bargoma, Emilee; Bokhari, Abdulmalik; Chava, Siva Kumari; Das, Pranti; Desai, Meetali; Decena, Darlene; Saramma, Sonia Dev Devadas; Dey, Bodhidipra; Doss, Anna-Louise; Gor, Nilang; Gudiputi, Lakshmi; Guo, Chunyuan; Hande, Sonali; Jensen, Megan; Jones, Samantha; Jones, Norman; Jorgens, Danielle; Karamchedu, Padma; Kamrani, Kambiz; Kolora, Lakshmi Divya; Kristensen, Line; Kwan, Kelly; Lau, Henry; Maharaj, Pranesh; Mander, Navneet; Mangipudi, Kalyani; Menakuru, Himabindu; Mody, Vaishali; Mohanty, Sandeepa; Mukkamala, Sridevi; Mundra, Sheena A.; Nagaraju, Sudharani; Narayanaswamy, Rajhalutshimi; Ndungu-Case, Catherine; Noorbakhsh, Mersedeh; Patel, Jigna; Patel, Puja; Pendem, Swetha Vandana; Ponakala, Anusha; Rath, Madhusikta; Robles, Michael C.; Rokkam, Deepti; Roth, Caroline; Sasidharan, Preeti; Shah, Sapana; Tandon, Shweta; Suprai, Jagdip; Tina Quynh Nhu Truong; Uthayaruban, Rubatharshini; Varma, Ajitha; Ved, Urvi; Wang, Zeran; Yu, Zhe			The C. elegans Rab Family: Identification, Classification and Toolkit Construction	PLOS ONE			English	Article							GTPASE RECOGNITION; SCIENCE-EDUCATION; INTRON POSITIONS; STRUCTURAL BASIS; ORFEOME CLONING; PROTEIN; EVOLUTION; GENE; REVEALS; MECHANISM	Rab monomeric GTPases regulate specific aspects of vesicle transport in eukaryotes including coat recruitment, uncoating, fission, motility, target selection and fusion. Moreover, individual Rab proteins function at specific sites within the cell, for example the ER, golgi and early endosome. Importantly, the localization and function of individual Rab subfamily members are often conserved underscoring the significant contributions that model organisms such as Caenorhabditis elegans can make towards a better understanding of human disease caused by Rab and vesicle trafficking malfunction. With this in mind, a bioinformatics approach was first taken to identify and classify the complete C. elegans Rab family placing individual Rabs into specific subfamilies based on molecular phylogenetics. For genes that were difficult to classify by sequence similarity alone, we did a comparative analysis of intron position among specific subfamilies from yeast to humans. This two-pronged approach allowed the classification of 30 out of 31 C. elegans Rab proteins identified here including Rab31/Rab50, a likely member of the last eukaryotic common ancestor (LECA). Second, a molecular toolset was created to facilitate research on biological processes that involve Rab proteins. Specifically, we used Gateway-compatible C. elegans ORFeome clones as starting material to create 44 full-length, sequence-verified, dominant-negative (DN) and constitutive active (CA) rab open reading frames (ORFs). Development of this toolset provided independent research projects for students enrolled in a research-based molecular techniques course at California State University, East Bay (CSUEB).	[Gallegos, Maria E.; Balakrishnan, Sanjeev; Chandramouli, Priya; Arora, Shaily; Azameera, Aruna; Babushekar, Anitha; Bargoma, Emilee; Bokhari, Abdulmalik; Chava, Siva Kumari; Das, Pranti; Desai, Meetali; Decena, Darlene; Saramma, Sonia Dev Devadas; Dey, Bodhidipra; Doss, Anna-Louise; Gor, Nilang; Gudiputi, Lakshmi; Guo, Chunyuan; Hande, Sonali; Jensen, Megan; Jones, Samantha; Jones, Norman; Jorgens, Danielle; Karamchedu, Padma; Kamrani, Kambiz; Kolora, Lakshmi Divya; Kristensen, Line; Kwan, Kelly; Lau, Henry; Maharaj, Pranesh; Mander, Navneet; Mangipudi, Kalyani; Menakuru, Himabindu; Mody, Vaishali; Mohanty, Sandeepa; Mukkamala, Sridevi; Mundra, Sheena A.; Nagaraju, Sudharani; Narayanaswamy, Rajhalutshimi; Ndungu-Case, Catherine; Noorbakhsh, Mersedeh; Patel, Jigna; Patel, Puja; Pendem, Swetha Vandana; Ponakala, Anusha; Rath, Madhusikta; Robles, Michael C.; Rokkam, Deepti; Roth, Caroline; Sasidharan, Preeti; Shah, Sapana; Tandon, Shweta; Suprai, Jagdip; Tina Quynh Nhu Truong; Uthayaruban, Rubatharshini; Varma, Ajitha; Ved, Urvi; Wang, Zeran; Yu, Zhe] Calif State Univ E Bay, Dept Biol Sci, Hayward, CA USA	California State University System; California State University East Bay	Gallegos, ME (corresponding author), Calif State Univ E Bay, Dept Biol Sci, Hayward, CA USA.	maria.gallegos@csueastbay.edu	Kamrani, Kambiz/Q-7836-2017	Kamrani, Kambiz/0000-0001-7826-7328; Jorgens, Danielle/0000-0002-7143-0118	Department of Biological Sciences at California State University, East Bay	Department of Biological Sciences at California State University, East Bay	This work was funded by the Department of Biological Sciences at California State University, East Bay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aboobaker A, 2010, ADV EXP MED BIOL, V689, P101; Advisory Committee to the National Science Foundation Directorate for Education Resources H, 1996, SHAP FUT NEW EXP UND; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, pF495, DOI 10.1152/ajprenal.00198.2010; Baldauf SL, 2003, TRENDS GENET, V19, P345, DOI 10.1016/S0168-9525(03)00112-4; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Betts MJ, 2001, EMBO J, V20, P5354, DOI 10.1093/emboj/20.19.5354; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Brame CJ, 2008, CBE-LIFE SCI EDUC, V7, P410, DOI 10.1187/cbe.08-07-0036; Brandner CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-321; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; Brenner Kerry, 2003, Cell Biol Educ, V2, P85, DOI 10.1187/cbe.02-11-0053; Brighouse A, 2010, CELL MOL LIFE SCI, V67, P3449, DOI 10.1007/s00018-010-0436-1; Broman KW, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346175; Carmel L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-192; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Collins RN, 2005, METHOD ENZYMOL, V403, P19, DOI 10.1016/S0076-6879(05)03003-X; Copley RR, 2004, EVOL DEV, V6, P164, DOI 10.1111/j.1525-142X.2004.04021.x; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; Davis WM, PLASMID EDITOR; Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Eggenschwiler JT, 2006, DEV BIOL, V290, P1, DOI 10.1016/j.ydbio.2005.09.022; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Elias M, 2012, J CELL SCI, V125, P2500, DOI 10.1242/jcs.101378; Erdman RA, 2000, J BIOL CHEM, V275, P3848, DOI 10.1074/jbc.275.6.3848; Evans PM, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-22; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; Fischer Caleb Nathaniel, 2011, Yale Journal of Biology and Medicine, V84, P247; Fridolfsson HN, 2010, DEV BIOL, V338, P237, DOI 10.1016/j.ydbio.2009.12.004; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; Handley MTW, 2008, BIOCHEM BIOPH RES CO, V373, P275, DOI 10.1016/j.bbrc.2008.06.043; Henricson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-412; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; JOBERTY G, 1993, FEBS LETT, V330, P323, DOI 10.1016/0014-5793(93)80897-4; Jones MC, 2009, TRAFFIC, V10, P754, DOI 10.1111/j.1600-0854.2009.00898.x; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Knutson K, 2010, BIOCHEM MOL BIOL EDU, V38, P324, DOI 10.1002/bmb.20401; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kumar S, 2012, MOL BIOL EVOL, V29, P457, DOI 10.1093/molbev/msr202; Lamesch P, 2004, GENOME RES, V14, P2064, DOI 10.1101/gr.2496804; Lau JM, 2009, CBE-LIFE SCI EDUC, V8, P326, DOI 10.1187/cbe.09-05-0036; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Lee SH, 2008, FEBS LETT, V582, P4107, DOI 10.1016/j.febslet.2008.11.008; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; LI GP, 1993, J BIOL CHEM, V268, P24475; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lopatto David, 2007, CBE Life Sci Educ, V6, P297, DOI 10.1187/cbe.07-06-0039; Lopatto David, 2004, Cell Biol Educ, V3, P270, DOI 10.1187/cbe.04-07-0045; Mackiewicz P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-101; MACNICOL AM, 1993, CELL, V73, P571, DOI 10.1016/0092-8674(93)90143-E; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; Mishra A, 2010, P NATL ACAD SCI USA, V107, P10866, DOI 10.1073/pnas.1000843107; Mitra S, 2011, SEMIN CELL DEV BIOL, V22, P57, DOI 10.1016/j.semcdb.2010.12.005; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Morton JJ, 2011, METHOD CELL BIOL, V106, P187, DOI 10.1016/B978-0-12-544172-8.00007-4; Moskovitz C, 2011, SCIENCE, V332, P919, DOI 10.1126/science.1200353; Mruk DD, 2007, J ANDROL, V28, P742, DOI 10.2164/jandrol.106.002204; Narasimhan SD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001377; National Research Council US, 1996, NAT SCI ED STAND; O'Halloran DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031614; Pataki C, 2010, GENETICS, V184, P1051, DOI 10.1534/genetics.109.112060; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Prokopenko SN, 2000, GENETICS, V156, P1691; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rajagopala SV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-470; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Russell S. H, 2006, EVALUATION NSF SUPPO; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Saito-Nakano Y, 2005, EXP PARASITOL, V110, P244, DOI 10.1016/j.exppara.2005.02.021; Sann SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037930; Schroeder BK, 2005, APPL ENVIRON MICROB, V71, P5858, DOI 10.1128/AEM.71.10.5858-5864.2005; Schwartz SL, 2008, J CELL SCI, V121, P246, DOI 10.1242/jcs.03495; Shao WJ, 2013, DIABETES, V62, P789, DOI 10.2337/db12-0365; Shay B, 2009, PROTEIN EXPRES PURIF, V68, P90, DOI 10.1016/j.pep.2009.06.008; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stoltzfus A, 1997, P NATL ACAD SCI USA, V94, P10739, DOI 10.1073/pnas.94.20.10739; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka D, 2008, GENES CELLS, V13, P1141, DOI 10.1111/j.1365-2443.2008.01232.x; Tekinay T, 2006, EUKARYOT CELL, V5, P1797, DOI 10.1128/EC.00342-05; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Treacy DJ, 2011, CBE-LIFE SCI EDUC, V10, P18, DOI 10.1187/cbe.10-07-0085; Turchin A, 1999, BIOTECHNIQUES, V26, P672, DOI 10.2144/99264st02; Voutev R, 2008, GENETICS, V180, P103, DOI 10.1534/genetics.108.090274; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; Warner A, 2011, MOL BIOL CELL, V22, P2551, DOI 10.1091/mbc.E10-12-0941; Weaver GC, 2008, NAT CHEM BIOL, V4, P577, DOI 10.1038/nchembio1008-577; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilson AL, 1998, BIOCHEM J, V333, P497, DOI 10.1042/bj3330497; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Wilson RK, 1999, TRENDS GENET, V15, P51, DOI 10.1016/S0168-9525(98)01666-7; Winter JF, 2012, NAT CELL BIOL, V14, P666, DOI 10.1038/ncb2508; Woller B, 2011, BBA-MOL CELL RES, V1813, P1198, DOI 10.1016/j.bbamcr.2011.03.005; Wu YW, 2009, J BIOL CHEM, V284, P13185, DOI 10.1074/jbc.M900579200; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zeiser E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020082; Zimek A, 2008, EUR J CELL BIOL, V87, P305, DOI 10.1016/j.ejcb.2008.01.003	130	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49387	10.1371/journal.pone.0049387	http://dx.doi.org/10.1371/journal.pone.0049387			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185324	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000045
J	Klos, KS; Kim, S; Alexander, CM				Klos, Kristine S.; Kim, Soyoung; Alexander, Caroline M.			Genotoxic Exposure during Juvenile Growth of Mammary Gland Depletes Stem Cell Activity and Inhibits Wnt Signaling	PLOS ONE			English	Article							BREAST-CANCER; EPITHELIAL-CELLS; BASAL; TUMORIGENESIS; RADIATION; RENEWAL; PHOSPHORYLATION; PROGENITORS; RESISTANCE; INDUCTION	Various types of somatic stem cell have been tested for their response to genotoxic exposure, since these cells are likely to be important to regeneration, aging and cancer. In this study, we evaluated the response of mammary stem cells to genotoxic exposure during ductal growth in juveniles. Exposure to the polycyclic aromatic hydrocarbon (DMBA; 7,12 dimethylbenz[a] anthracene) had no gross effect on outgrowth and morphogenesis of the ductal tree, or upon lobuloalveolar growth during pregnancy. However, by fat pad assay, we found that mammary stem cell activity was reduced by 80% in glands from adults that were exposed to genotoxins as juveniles. The associated basal cell lineage was depleted. Both basal and luminal cells showed a robust response to genotoxic exposure (including gamma H2AX phosphorylation, pS(15)p53 and pT(68)Chk2), with durable hyperproliferation, but little cytotoxicity. Since the phenotype of these glands (low basal cell fraction, low stem cell activity) phenocopies mammary glands with loss of function for Wnt signaling, we measured Wnt signaling in genotoxin-exposed glands, and found a durable reduction in the activation of the canonical signaling Wnt receptors, Lrp5/6. Furthermore, when mammary epithelial cells were treated with Wnt3a, DMBA exposure reduced the basal cell population and Lrp activation was ablated. We conclude that during active ductal growth, Wnt-dependent mammary stem cells are sensitized to cell death by genotoxin exposure. Our conclusion may be important for other tissues, since all solid tumor stem cell activities have been shown to be Wnt-dependent to date.	[Klos, Kristine S.; Kim, Soyoung; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Alexander, CM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu			Era of Hope Scholar Award [W81XWH-06-1-0491]; University of Wisconsin Carbone Comprehensive Cancer Center [NIH/NCI P30 CA014520-UW]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Era of Hope Scholar Award; University of Wisconsin Carbone Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Era of Hope Scholar Award to CMA (W81XWH-06-1-0491), and the shared services provided by the University of Wisconsin Carbone Comprehensive Cancer Center (NIH/NCI P30 CA014520-UW Comprehensive Cancer Center Support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C. M., 2012, COLD SPRING IN PRESS; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Ariazi JL, 2005, MOL CARCINOGEN, V43, P155, DOI 10.1002/mc.20104; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; ETHIER SP, 1982, J NATL CANCER I, V69, P1199; Evans JR, 2010, BREAST CANCER RES TR, V122, P159, DOI 10.1007/s10549-009-0542-7; Huper G, 2007, CANCER RES, V67, P2990, DOI 10.1158/0008-5472.CAN-06-4065; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Kim SH, 2011, PLOS ONE, V6; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060; Mandriota SJ, 2010, J BIOL CHEM, V285, P13092, DOI 10.1074/jbc.M109.078360; Mastroianni M, 2010, CANCER LETT, V289, P23, DOI 10.1016/j.canlet.2009.07.012; MEDINA D, 1974, J NATL CANCER I, V53, P213, DOI 10.1093/jnci/53.1.213; Medina D, 1996, J MAMMARY GLAND BIOL, V1, P5, DOI 10.1007/BF02096299; Mehta RG, 2000, EUR J CANCER, V36, P1275, DOI 10.1016/S0959-8049(00)00100-3; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Olive PL, 2004, INT J RADIAT ONCOL, V58, P331, DOI 10.1016/j.ijrobp.2003.09.028; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Regan JL, 2012, ONCOGENE, V31, P869, DOI 10.1038/onc.2011.289; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Ruzankina Y, 2007, BRIT J CANCER, V97, P1189, DOI 10.1038/sj.bjc.6604029; Schoppy DW, 2010, CELL CYCLE, V9, P1313, DOI 10.4161/cc.9.7.11194; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shehata M, BREAST CANC IN PRESS; SHIMADA Y, 1994, RADIAT RES, V137, P118, DOI 10.2307/3578800; Smart DJ, 2011, MUTAT RES-FUND MOL M, V715, P25, DOI 10.1016/j.mrfmmm.2011.07.001; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Van Keymeulen A, 2011, NATURE; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278	43	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49902	10.1371/journal.pone.0049902	http://dx.doi.org/10.1371/journal.pone.0049902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185480	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000139
J	Kurvers, RHJM; Hamblin, S; Giraldeau, LA				Kurvers, Ralf H. J. M.; Hamblin, Steven; Giraldeau, Luc-Alain			The Effect of Exploration on the Use of Producer-Scrounger Tactics	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; GENETIC ALGORITHMS; FITNESS CONSEQUENCES; DECISION-MAKING; BARNACLE GEESE; PERSONALITY; INFORMATION; ECOLOGY; BOLDNESS; PREDICTS	Individuals foraging in groups can use two different tactics for obtaining food resources. Individuals can either search for food sources themselves (producing) or they can join food discoveries of others (scrounging). In this study we use a genetic algorithm in a spatially explicit producer-scrounger game to explore how individuals compromise between exploration (an important axis of animal personality) and scrounging and how characteristics of the environment affect this compromise. Agents varied in exploration and scrounging and a genetic algorithm searched for the optimal combination of exploration and scrounging. The foraging environments featured different levels of patch richness, predation and patch density. Our simulations show that under conditions of low patch densities slow exploring scroungers were favored whereas high patch density favored fast exploring individuals that either produced (at low patch richness) or scrounged (at high patch richness). In high predation environments fast exploring individuals were selected for but only at low to intermediate patch densities. Predation did not affect scrounging behavior. We did not find a divergence of exploration 'types' within a given environment, but there was a general association between exploration and scrounging across different environments: high rates of scrounging were observed over nearly the full spectrum of exploration values, whereas high rates of producing were only observed at high exploration values, suggesting that cases in which slow explorers start producing should be rare. Our results indicate that the spatial arrangement of food resources can affect the optimal social attraction rules between agents, the optimality of foraging tactic and the interaction between both.	[Kurvers, Ralf H. J. M.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Kurvers, Ralf H. J. M.] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Hamblin, Steven; Giraldeau, Luc-Alain] Univ Quebec, Dept Biol Sci, Montreal, PQ H3C 3P8, Canada; [Hamblin, Steven] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Wageningen University & Research; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Quebec; University of Quebec Montreal; University of New South Wales Sydney	Kurvers, RHJM (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.	ralf.kurvers@igb-berlin.de	Kurvers, Ralf/Q-8830-2017; Hamblin, Steven/J-7995-2012	Kurvers, Ralf/0000-0002-3460-0392; Hamblin, Steven/0000-0003-1812-1532	Faunafonds; Koniklijke Nederlandse Jagers Vereniging (KNJV) (The Netherlands); Natural Sciences and Engineering Research Council of Canada (NSERC); Natural Sciences and Engineering Research Council of Canada (NSERC) Alexander Graham Bell Canada Graduate Scholarship (CGS)	Faunafonds; Koniklijke Nederlandse Jagers Vereniging (KNJV) (The Netherlands)(Netherlands Government); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC) Alexander Graham Bell Canada Graduate Scholarship (CGS)	RHJMK was financially supported by the Faunafonds and the Koniklijke Nederlandse Jagers Vereniging (KNJV) (The Netherlands). SH was financially supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to L-AG and a Natural Sciences and Engineering Research Council of Canada (NSERC) Alexander Graham Bell Canada Graduate Scholarship (CGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; BARNARD CJ, 1981, ANIM BEHAV, V29, P543, DOI 10.1016/S0003-3472(81)80117-0; Barta Z, 1998, BEHAV ECOL SOCIOBIOL, V42, P217, DOI 10.1007/s002650050433; Barta Z, 1997, P ROY SOC B-BIOL SCI, V264, P1233, DOI 10.1098/rspb.1997.0170; Barta Z, 2001, BEHAV ECOL, V12, P121, DOI 10.1093/beheco/12.2.121; Barta Z, 2000, AM NAT, V155, P570, DOI 10.1086/303342; Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Beauchamp G, 2008, ANIM BEHAV, V76, P1935, DOI 10.1016/j.anbehav.2008.08.017; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Bremner-Harrison S, 2004, ANIM CONSERV, V7, P313, DOI 10.1017/S1367943004001490; Brodersen J, 2012, ENVIRON BIOL FISH, V93, P305, DOI 10.1007/s10641-011-9914-z; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; CARACO T, 1991, J THEOR BIOL, V153, P559, DOI 10.1016/S0022-5193(05)80156-0; Carere C, 2005, BEHAVIOUR, V142, P1149, DOI 10.1163/156853905774539436; Carter AJ, 2010, BEHAV ECOL, V21, P655, DOI 10.1093/beheco/arq036; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; CLARK CW, 1984, AM NAT, V123, P626, DOI 10.1086/284228; Coolen I, 2002, BEHAV ECOL SOCIOBIOL, V52, P232, DOI 10.1007/s00265-002-0500-4; Coolen I, 2001, ANIM BEHAV, V61, P895, DOI 10.1006/anbe.2000.1678; Cote J, 2008, P ROY SOC B-BIOL SCI, V275, P2851, DOI 10.1098/rspb.2008.0783; Cucherousset J, 2011, OECOLOGIA, V167, P75, DOI 10.1007/s00442-011-1974-4; David M, 2011, ANIM BEHAV, V82, P61, DOI 10.1016/j.anbehav.2011.03.025; Dingemanse NJ, 2009, P R SOC B, V276, P1285, DOI 10.1098/rspb.2008.1555; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; DUGATKIN LA, 1992, BEHAV ECOL, V3, P124, DOI 10.1093/beheco/3.2.124; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Flynn RE, 2001, ETHOLOGY, V107, P249, DOI 10.1046/j.1439-0310.2001.00657.x; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Hamblin S, 2007, ANIM BEHAV, V74, P1005, DOI 10.1016/j.anbehav.2007.01.013; Hamblin S, 2009, ANIM BEHAV, V78, P1343, DOI 10.1016/j.anbehav.2009.09.001; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Haupt R.L., 2004, PRACTICAL GENETIC AL, VSecond, DOI DOI 10.1002/0471671746; Koops MA, 1996, ANIM BEHAV, V51, P773, DOI 10.1006/anbe.1996.0082; Kurvers RHJM, 2012, BEHAV ECOL, V23, P51, DOI 10.1093/beheco/arr148; Kurvers RHJM, 2011, P ROY SOC B-BIOL SCI, V278, P2018, DOI 10.1098/rspb.2010.2266; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; LINDSTROM K, 1993, ANN ZOOL FENN, V30, P225; Livoreil B, 1997, ANIM BEHAV, V54, P967, DOI 10.1006/anbe.1997.0489; Mathot KJ, 2008, BEHAV ECOL, V19, P131, DOI 10.1093/beheco/arm114; Michelena P, 2009, BEHAV ECOL, V20, P145, DOI 10.1093/beheco/arn126; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; Nolet BA, 2012, BEHAV ECOL, DOI [10.1093/beheco/ars1091, DOI 10.1093/BEHECO/ARS1091]; Nomura T, 1997, INT JOINT CONF ARTIF, P936; Patrick SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026383; Ranta E, 1996, ANIM BEHAV, V51, P171, DOI 10.1006/anbe.1996.0014; Ranta E, 1998, ANIM BEHAV, V55, P737, DOI 10.1006/anbe.1997.0649; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Ruxton GD, 2008, J THEOR BIOL, V250, P435, DOI 10.1016/j.jtbi.2007.10.022; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; STAMPS JA, 1991, AM ZOOL, V31, P338; SUMIDA BH, 1990, J THEOR BIOL, V147, P59, DOI 10.1016/S0022-5193(05)80252-8; VICKERY WL, 1991, AM NAT, V137, P847, DOI 10.1086/285197; WALTZ EC, 1982, AM NAT, V119, P73, DOI 10.1086/283891; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Wright A.H., 1991, FDN GENETIC ALGORITH, P205, DOI DOI 10.1016/B978-0-08-050684-5.50016-1	64	9	9	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49400	10.1371/journal.pone.0049400	http://dx.doi.org/10.1371/journal.pone.0049400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185327	Green Published, gold			2022-12-25	WOS:000311821000046
J	Marin, I				Marin, Ignacio			Origin and Diversification of TRIM Ubiquitin Ligases	PLOS ONE			English	Article							COMPARATIVE GENOMICS; FAMILY PROTEINS; RBR FAMILY; KAPPA-B; GENE; REVEALS; VIRUS; ACTIVATION; DOMAIN; RNA	Most proteins of the TRIM family (also known as RBCC family) are ubiquitin ligases that share a peculiar protein structure, characterized by including an N-terminal RING finger domain closely followed by one or two B-boxes. Additional protein domains found at their C termini have been used to classify TRIM proteins into classes. TRIMs are involved in multiple cellular processes and many of them are essential components of the innate immunity system of animal species. In humans, it has been shown that mutations in several TRIM-encoding genes lead to diverse genetic diseases and contribute to several types of cancer. They had been hitherto detected only in animals. In this work, by comprehensively analyzing the available diversity of TRIM and TRIM-like protein sequences and evaluating their evolutionary patterns, an improved classification of the TRIM family is obtained. Members of one of the TRIM subfamilies defined, called Subfamily A, turn to be present not only in animals, but also in many other eukaryotes, such as fungi, apusozoans, alveolates, excavates and plants. The rest of subfamilies are animal-specific and several of them originated only recently. Subfamily A proteins are characterized by containing a MATH domain, suggesting a potential evolutionary connection between TRIM proteins and a different type of ubiquitin ligases, known as TRAFs, which contain quite similar MATH domains. These results indicate that the TRIM family emerged much earlier than so far thought and contribute to our understanding of its origin and diversification. The structural and evolutionary links with the TRAF family of ubiquitin ligases can be experimentally explored to determine whether functional connections also exist.	CSIC, Inst Biomed Valencia IBV CSIC, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Marin, I (corresponding author), CSIC, Inst Biomed Valencia IBV CSIC, Valencia, Spain.	imarin@ibv.csic.es	Marin, Ignacio/A-9524-2009	Marin, Ignacio/0000-0002-1315-8961	Spanish Government [BFU2011-30063]	Spanish Government(Spanish GovernmentEuropean Commission)	Research was supported by Grant BFU2011-30063 (Spanish Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 1997, CELL, V90, P797; Ammermann I, 2008, J VIROL, V82, P5127, DOI 10.1128/JVI.02647-07; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Bouazzaoui A, 2006, VIROLOGY, V356, P79, DOI 10.1016/j.virol.2006.07.025; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Chung JY, 2002, J CELL SCI, V115, P679; Corcoran MM, 2004, GENE CHROMOSOME CANC, V40, P285, DOI 10.1002/gcc.20046; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Du Pasquier Louis, 2009, Journal of Biology (London), V8, P50, DOI 10.1186/jbiol150; Duprez E, 1999, J CELL SCI, V112, P381; Dwivedi B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-211; Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hes FJ, 2009, J PATHOL, V218, P143, DOI 10.1002/path.2552; Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10; Karlberg S, 2009, MODERN PATHOL, V22, P570, DOI 10.1038/modpathol.2009.13; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Keech CL, 1996, PATHOLOGY, V28, P54, DOI 10.1080/00313029600169533; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kurata R, 2010, BIOCHEM BIOPH RES CO, V401, P533, DOI 10.1016/j.bbrc.2010.09.088; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Lott ST, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000068; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-331; Marin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011579; Marin I, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-56; Marin I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-267; Marin I, 2009, J MOL EVOL, V69, P54, DOI 10.1007/s00239-009-9252-3; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Nicholas KB., 1997, GENEDOC TOOL EDITING; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Poole E, 2009, J VIROL, V83, P3581, DOI 10.1128/JVI.02072-08; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Roma-Mateo C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-225; Saccone V, 2008, HUM MUTAT, V29, P240, DOI 10.1002/humu.20633; Salomonsson S, 2005, J EXP MED, V201, P11, DOI 10.1084/jem.20041859; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shi H, 2010, INT J MOL EPIDEMIOL, V1, P53; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tae H, 2009, EUR BIOPHYS J BIOPHY, V39, P51, DOI 10.1007/s00249-009-0455-8; TAKAHASHI M, 1988, ONCOGENE, V3, P571; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang J, 2011, J VIROL, V85, P3733, DOI 10.1128/JVI.02546-10; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yap MW, 2008, J VIROL, V82, P5429, DOI 10.1128/JVI.02462-07; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Zapata JM, 2007, ADV EXP MED BIOL, V597, P1; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zirn B, 2006, INT J CANCER, V118, P1954, DOI 10.1002/ijc.21564; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	97	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50030	10.1371/journal.pone.0050030	http://dx.doi.org/10.1371/journal.pone.0050030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185523	Green Published, gold			2022-12-25	WOS:000311821000168
J	Nissim, O; Melis, M; Diaz, G; Kleiner, DE; Tice, A; Fantola, G; Zamboni, F; Mishra, L; Farci, P				Nissim, Oriel; Melis, Marta; Diaz, Giacomo; Kleiner, David E.; Tice, Ashley; Fantola, Giovanni; Zamboni, Fausto; Mishra, Lopa; Farci, Patrizia			Liver Regeneration Signature in Hepatitis B Virus (HBV)-Associated Acute Liver Failure Identified by Gene Expression Profiling	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PROGENITOR CELLS; STEM-CELLS; STELLATE CELLS; GROWTH-FACTOR; ACTIVATION; FIBROSIS; SIMILARITIES; DISEASES; CANCERS	Introduction: The liver has inherent regenerative capacity via mitotic division of mature hepatocytes or, when the hepatic loss is massive or hepatocyte proliferation is impaired, through activation of hepatic stem/progenitor cells (HSPC). The dramatic clinical course of acute liver failure (ALF) has posed major limitations to investigating the molecular mechanisms of liver regeneration and the role of HSPC in this setting. We investigated the molecular mechanisms of liver regeneration in 4 patients who underwent liver transplantation for hepatitis B virus (HBV)-associated ALF. Methods and Findings: Gene expression profiling of 17 liver specimens from the 4 ALF cases and individual specimens from 10 liver donors documented a distinct gene signature for ALF. However, unsupervised multidimensional scaling and hierarchical clustering identified two clusters of ALF that segregated according to histopathological severity massive hepatic necrosis (MHN; 2 patients) and submassive hepatic necrosis (SHN; 2 patients). We found that ALF is characterized by a strong HSPC gene signature, along with ductular reaction, both of which are more prominent in MHN. Interestingly, no evidence of further lineage differentiation was seen in MHN, whereas in SHN we detected cells with hepatocyte-like morphology. Strikingly, ALF was associated with a strong tumorigenesis gene signature. MHN had the greatest upregulation of stem cell genes (EpCAM, CK19, CK7), whereas the most up-regulated genes in SHN were related to cellular growth and proliferation. The extent of liver necrosis correlated with an overriding fibrogenesis gene signature, reflecting the wound-healing process. Conclusion: Our data provide evidence for a distinct gene signature in HBV-associated ALF whose intensity is directly correlated with the histopathological severity. HSPC activation and fibrogenesis positively correlated with the extent of liver necrosis. Moreover, we detected a tumorigenesis gene signature in ALF, emphasizing the close relationship between liver regeneration and liver cancer.	[Nissim, Oriel; Melis, Marta; Tice, Ashley; Farci, Patrizia] NIAID, Hepat Pathogenesis Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Diaz, Giacomo] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Kleiner, David E.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; [Fantola, Giovanni; Zamboni, Fausto] Brotzu Hosp, Liver Transplantat Ctr, Cagliari, Italy; [Mishra, Lopa] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cagliari; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center	Farci, P (corresponding author), NIAID, Hepat Pathogenesis Sect, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pfarci@niaid.nih.gov	Kleiner, David E/N-2770-2013	Kleiner, David E/0000-0003-3442-4453; Mishra, Lopa/0000-0002-6850-0808	NIH, National Institute of Allergy and Infectious Diseases and National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA130821, P30CA016672, ZICBC010687, R01CA106614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000999] Funding Source: NIH RePORTER	NIH, National Institute of Allergy and Infectious Diseases and National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases and National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Chiu CC, 2009, HISTOCHEM CELL BIOL, V132, P479, DOI 10.1007/s00418-009-0634-9; Craig CEH, 2004, SEMIN LIVER DIS, V24, P49; Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754; Diehl AM, 2012, NAT MED, V18, P497, DOI 10.1038/nm.2719; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Fujishima S, 2010, ARCH PATHOL LAB MED, V134, P1136, DOI 10.1043/2009-0144-OA.1; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Heringlake S, 2010, J HEPATOL, V52, P220, DOI 10.1016/j.jhep.2009.11.005; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Huang CC, 2005, MODERN PATHOL, V18, P941, DOI 10.1038/modpathol.3800374; Hyndman D, 1999, ADV EXP MED BIOL, V463, P427; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Korn EL, 2007, STAT MED, V26, P4428, DOI 10.1002/sim.2865; Kung JWC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/984248; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; Liu ZW, 2012, BIOCHEM J, V442, P273, DOI 10.1042/BJ20111322; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Nakayama M, 2006, MECH DEVELOP, V123, P580, DOI 10.1016/j.mod.2006.05.001; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Pi LY, 2005, GASTROENTEROLOGY, V128, P2077, DOI 10.1053/j.gastro.2005.03.081; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Riss J, 2006, CANCER RES, V66, P7216, DOI 10.1158/0008-5472.CAN-06-0040; Roskams TA, 2003, SEMIN LIVER DIS, V23, P385; Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614; Schiodt FV, 2006, LIVER TRANSPLANT, V12, P1776, DOI 10.1002/lt.20886; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614; TREY C, 1972, CAN MED ASSOC J, V106, P525; Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Wray J, 2012, TRENDS CELL BIOL, V22, P159, DOI 10.1016/j.tcb.2011.11.004; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047	44	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49611	10.1371/journal.pone.0049611	http://dx.doi.org/10.1371/journal.pone.0049611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185381	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000068
J	Tamazawa, S; Takasaki, K; Tamaki, H; Kamagata, Y; Hanada, S				Tamazawa, Satoshi; Takasaki, Kazuto; Tamaki, Hideyuki; Kamagata, Yoichi; Hanada, Satoshi			Metagenomic and Biochemical Characterizations of Sulfur Oxidation Metabolism in Uncultured Large Sausage-Shaped Bacterium in Hot Spring Microbial Mats	PLOS ONE			English	Article							C-SULFIDE DEHYDROGENASE; YELLOWSTONE-NATIONAL-PARK; ORGANIZING MAP SOM; SP-NOV.; SULFURIHYDROGENIBIUM-SUBTERRANEUM; GENUS SULFURIHYDROGENIBIUM; PHOTOSYNTHETIC BACTERIUM; SPECIES COMPOSITION; COMMUNITY STRUCTURE; DIVERSITY	So-called "sulfur-turf" microbial mats in sulfide containing hot springs (55-70 degrees C, pH 7.3-8.3) in Japan were dominated by a large sausage-shaped bacterium (LSSB) that is closely related to the genus Sulfurihydrogenibium. Several previous reports proposed that the LSSB would be involved in sulfide oxidation in hot spring. However, the LSSB has not been isolated yet, thus there has been no clear evidence showing whether it possesses any genes and enzymes responsible for sulfide oxidation. To verify this, we investigated sulfide oxidation potential in the LSSB using a metagenomic approach and subsequent biochemical analysis. Genome fragments of the LSSB (a total of 3.7 Mb sequence including overlapping fragments) were obtained from the metagenomic fosmid library constructed from genomic DNA of the sulfur-turf mats. The sequence annotation clearly revealed that the LSSB possesses sulfur oxidation-related genes coding sulfide dehydrogenase (SD), sulfide-quinone reductase and sulfite dehydrogenase. The gene encoding SD, the key enzyme for sulfide oxidation, was successfully cloned and heterologously expressed in Escherichia coli. The purified recombinant enzyme clearly showed SD activity with optimum temperature and pH of 60 degrees C and 8.0, respectively, which were consistent with the environmental conditions in the hot spring where the sulfur-turf thrives. Furthermore, the affinity of SD to sulfide was relatively high, which also reflected the environment where the sulfide could be continuously supplied. This is the first report showing that the LSSB harbors sulfide oxidizing metabolism adapted to the hot spring environment and can be involved in sulfide oxidation in the sulfur-turf microbial mats.	[Tamazawa, Satoshi; Takasaki, Kazuto; Tamaki, Hideyuki; Kamagata, Yoichi; Hanada, Satoshi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Tamazawa, Satoshi; Hanada, Satoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kamagata, Yoichi] Hokkaido Univ, Div Appl Biosci, Grad Sch Agr, Sapporo, Hokkaido, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Hokkaido University	Tamaki, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	tamaki-hideyuki@aist.go.jp	Tamaki, Hideyuki/M-9863-2016; Tamazawa, Satohsi/X-1204-2019					Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Aguiar P, 2004, INT J SYST EVOL MICR, V54, P33, DOI 10.1099/ijs.0.02790-0; BARTSCH RG, 1960, J BIOL CHEM, V235, P825; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTILLO MCG, 1994, ARCH BIOCHEM BIOPHYS, V315, P262, DOI 10.1006/abbi.1994.1498; CHEN ZW, 1994, SCIENCE, V266, P430, DOI 10.1126/science.7939681; D'Imperio S, 2008, APPL ENVIRON MICROB, V74, P5802, DOI 10.1128/AEM.00852-08; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flores GE, 2008, INT J SYST EVOL MICR, V58, P1153, DOI 10.1099/ijs.0.65570-0; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Griesbeck C, 2002, BIOCHEMISTRY-US, V41, P11552, DOI 10.1021/bi026032b; Hanada S, 2002, INT J SYST EVOL MICR, V52, P187, DOI 10.1099/00207713-52-1-187; Hjorleifsdottir S, 2001, MICROBIAL ECOL, V42, P117; Hugler M, 2007, ENVIRON MICROBIOL, V9, P81, DOI 10.1111/j.1462-2920.2006.01118.x; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Kanaya S, 2001, GENE, V276, P89, DOI 10.1016/S0378-1119(01)00673-4; Kostanjevecki V, 2000, J BACTERIOL, V182, P3097, DOI 10.1128/JB.182.11.3097-3103.2000; Kubo K, 2011, SYST APPL MICROBIOL, V34, P293, DOI 10.1016/j.syapm.2010.12.002; KUSAI A, 1973, FEBS LETT, V34, P235, DOI 10.1016/0014-5793(73)80801-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau MCY, 2009, EXTREMOPHILES, V13, P139, DOI 10.1007/s00792-008-0205-3; MAKI Y, 1986, J GEN APPL MICROBIOL, V32, P203, DOI 10.2323/jgam.32.203; MAKI Y, 1987, J GEN APPL MICROBIOL, V33, P123, DOI 10.2323/jgam.33.123; Maki Y., 1991, B JPN SOC MICROB ECO, V6, P33; Mitsumori M, 2010, J APPL MICROBIOL, V109, P763, DOI 10.1111/j.1365-2672.2010.04703.x; Nakagawa S, 2005, INT J SYST EVOL MICR, V55, P2263, DOI 10.1099/ijs.0.63708-0; Nakagawa T, 2003, APPL ENVIRON MICROB, V69, P7044, DOI 10.1128/AEM.69.12.7044-7057.2003; Nakagawa T, 2002, J GEN APPL MICROBIOL, V48, P211, DOI 10.2323/jgam.48.211; O'Neill AH, 2008, INT J SYST EVOL MICR, V58, P1147, DOI 10.1099/ijs.0.65431-0; Ogawa T, 2010, BIOSCI BIOTECH BIOCH, V74, P771, DOI 10.1271/bbb.90815; Quentmeier A, 2004, BIOCHEMISTRY-US, V43, P14696, DOI 10.1021/bi048568y; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Reysenbach AL, 2009, J BACTERIOL, V191, P1992, DOI 10.1128/JB.01645-08; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Skirnisdottir S, 2000, APPL ENVIRON MICROB, V66, P2835, DOI 10.1128/AEM.66.7.2835-2841.2000; Takai K, 2003, INT J SYST EVOL MICR, V53, P823, DOI 10.1099/ijs.0.02506-0; Takai K, 2002, APPL ENVIRON MICROB, V68, P3046, DOI 10.1128/AEM.68.6.3046-3054.2002; Tamaki H, 2005, APPL ENVIRON MICROB, V71, P2162, DOI 10.1128/AEM.71.4.2162-2169.2005; Tamaki H, 2011, INT J SYST EVOL MICR, V61, P1442, DOI 10.1099/ijs.0.025643-0; Visser JM, 1997, ARCH MICROBIOL, V167, P295, DOI 10.1007/s002030050447; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Yamamoto H, 1998, APPL ENVIRON MICROB, V64, P1680; Yamanaka T, 1976, FLAVINS FLAVOPROTEIN, P292; YAMAOKA T, 1978, PLANT CELL PHYSIOL, V19, P943, DOI 10.1093/oxfordjournals.pcp.a075684; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	48	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49793	10.1371/journal.pone.0049793	http://dx.doi.org/10.1371/journal.pone.0049793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185438	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000110
J	Wieben, ED; Aleff, RA; Tosakulwong, N; Butz, ML; Highsmith, WE; Edwards, AO; Baratz, KH				Wieben, Eric D.; Aleff, Ross A.; Tosakulwong, Nirubol; Butz, Malinda L.; Highsmith, W. Edward; Edwards, Albert O.; Baratz, Keith H.			A Common Trinucleotide Repeat Expansion within the Transcription Factor 4 (TCF4, E2-2) Gene Predicts Fuchs Corneal Dystrophy	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PITT-HOPKINS-SYNDROME; ENDOTHELIAL DYSTROPHY; MENTAL-RETARDATION; MISSENSE MUTATIONS; CTG REPEAT; INHERITANCE; APOPTOSIS; HAPLOINSUFFICIENCY; PATHOGENESIS	Fuchs endothelial corneal dystrophy (FECD) is a common, familial disease of the corneal endothelium and is the leading indication for corneal transplantation. Variation in the transcription factor 4 (TCF4) gene has been identified as a major contributor to the disease. We tested for an association between an intronic TGC trinucleotide repeat in TCF4 and FECD by determining repeat length in 66 affected participants with severe FECD and 63 participants with normal corneas in a 3-stage discovery/replication/validation study. PCR primers flanking the TGC repeat were used to amplify leukocyte-derived genomic DNA. Repeat length was determined by direct sequencing, short tandem repeat (STR) assay and Southern blotting. Genomic Southern blots were used to evaluate samples for which only a single allele was identified by STR analysis. Compiling data for 3 arms of the study, a TGC repeat length >50 was present in 79% of FECD cases and in 3% of normal controls cases (p<0.001). Among cases, 52 of 66 (79%) subjects had >50 TGC repeats, 13 (20%) had <40 repeats and 1 (2%) had an intermediate repeat length. In comparison, only 2 of 63 (3%) unaffected control subjects had >50 repeats, 60 (95%) had <40 repeats and 1 (2%) had an intermediate repeat length. The repeat length was greater than 1000 in 4 FECD cases. The sensitivity and specificity of >50 TGC repeats identifying FECD in this patient cohort was 79% and 96%, respectively Expanded TGC repeat was more specific for FECD cases than the previously identified, highly associated, single nucleotide polymorphism, rs613872 (specificity = 79%). The TGC trinucleotide repeat expansion in TCF4 is strongly associated with FECD, and a repeat length >50 is highly specific for the disease This association suggests that trinucleotide expansion may play a pathogenic role in the majority of FECD cases and is a predictor of disease risk.	[Baratz, Keith H.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Wieben, Eric D.; Aleff, Ross A.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Tosakulwong, Nirubol] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Butz, Malinda L.; Highsmith, W. Edward] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Edwards, Albert O.] Univ Oregon & Oregon Retina, Inst Mol Biol, Eugene, OR USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Oregon	Baratz, KH (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	baratz.keith@mayo.edu			National Institutes of Health, Bethesda, MD [UL1 RR024150, EY014467]; Foundation Fighting Blindness; Owing Mills, MD; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY; Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014467] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Owing Mills, MD; American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health (grant #UL1 RR024150 and EY014467), Bethesda, MD; the Foundation Fighting Blindness, Owing Mills, MD; the American Health Assistance Foundation, Clarksburg, MD; Research to Prevent Blindness, New York, NY; and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Borderie VM, 2000, INVEST OPHTH VIS SCI, V41, P2501; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; Brockschmidt A, 2007, HUM MOL GENET, V16, P1488, DOI 10.1093/hmg/ddm099; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CHI HH, 1958, AM J OPHTHALMOL, V45, P518, DOI 10.1016/0002-9394(58)90521-X; Engler C, 2010, AM J OPHTHALMOL, V149, P194, DOI 10.1016/j.ajo.2009.09.009; Eye Bank Association of America, 2011, EYE BANK STAT REP; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Group T. H. D. C. R., 1993, CELL, V72, P971, DOI [10.1016/0092-8674(93)90585-E8458085, DOI 10.1016/0092-8674(93)90585-E8458085]; Jun AS, 2012, HUM MOL GENET, V21, P384, DOI 10.1093/hmg/ddr473; Jurkunas UV, 2008, INVEST OPHTH VIS SCI, V49, P2956, DOI 10.1167/iovs.07-1529; Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; KRACHMER JH, 1980, OPHTHALMOLOGICA, V181, P301, DOI 10.1159/000309068; Kuot A, 2012, EUR J HUM GENET, V20, P632, DOI 10.1038/ejhg.2011.248; Li QJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1597; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; Mackey DA, 2012, CORNEA, V31, P162, DOI 10.1097/ICO.0b013e318226155f; MAGOVERN M, 1979, OPHTHALMOLOGY, V86, P1897; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2011, INVEST OPHTH VIS SCI, V52, P2825, DOI 10.1167/iovs.10-6497; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; ROSENBLUM P, 1980, AM J OPHTHALMOL, V90, P455, DOI 10.1016/S0002-9394(14)75011-1; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Zoega GM, 2006, OPHTHALMOLOGY, V113, P565, DOI 10.1016/j.ophtha.2005.12.014; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	31	148	156	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49083	10.1371/journal.pone.0049083	http://dx.doi.org/10.1371/journal.pone.0049083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185296	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000028
J	Yoshida, A; Sakaguchi, T; Irie, T				Yoshida, Asuka; Sakaguchi, Takemasa; Irie, Takashi			Passage of a Sendai Virus Recombinant in Embryonated Chicken Eggs Leads to Markedly Rapid Accumulation of U-to-C Transitions in a Limited Region of the Viral Genome	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; BIASED HYPERMUTATION; INFECTED-CELLS; TERMINAL HALF; V PROTEIN; REPLICATION; GENE; PATHOGENESIS; ACTIVATION; EXPRESSION	The P gene of paramyxoviruses is unique in producing not only P but also "accessory'' C and/or V proteins. Successful generation of C- or V-deficient recombinant viruses using a reverse genetics technique has been revealing their importance in viral pathogenesis as well as replication. As for Sendai virus (SeV), the C proteins, a nested set of four polypeptides C', C, Y1, and Y2, have been shown to exert multiple functions in escaping from the host innate immunity, inhibiting virus-induced apoptosis, promoting virus assembly and budding, and regulating viral RNA synthesis. In this study, we subjected the 4C(-) recombinant lacking expression of all four C proteins to serial passages through eggs, and found the rapid emergence of a C- recovered revertant virus. Unlike the SeV strains or the recombinants reported previously or tested in this study, this was caused by an exceptionally quick accumulation of U-to-C transitions in a limited region of the 4C(-) genome causing recovery of the C protein expression. These results suggest that a lack of C proteins could lead unexpectedly to strong selective pressures, and that the C proteins might play more critical roles in SeV replication than ever reported.	[Yoshida, Asuka; Sakaguchi, Takemasa; Irie, Takashi] Hiroshima Univ, Dept Virol, Inst Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Irie, T (corresponding author), Hiroshima Univ, Dept Virol, Inst Biomed & Hlth Sci, Hiroshima, Japan.	tirie@hiroshima-u.ac.jp	Sakaguchi, Takemasa/H-1488-2019	Sakaguchi, Takemasa/0000-0002-3754-1252	JSPS KAKENHI [23790505]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 23790505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; CATTANEO R, 1992, CURR TOP MICROBIOL, V176, P63; CURRAN J, 1992, VIROLOGY, V189, P647, DOI 10.1016/0042-6822(92)90588-G; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Fujii Y, 2002, VIRUS GENES, V25, P189, DOI 10.1023/A:1020165919672; Fujii Y, 2001, VIRUS GENES, V22, P47, DOI 10.1023/A:1008130318633; Garcin D, 2002, VIROLOGY, V295, P256, DOI 10.1006/viro.2001.1342; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Garcin D, 2001, J VIROL, V75, P6800, DOI 10.1128/JVI.75.15.6800-6807.2001; Garcin D, 1997, VIROLOGY, V238, P424, DOI 10.1006/viro.1997.8836; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Hasan MK, 2000, J VIROL, V74, P5619, DOI 10.1128/JVI.74.12.5619-5628.2000; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Irie T, 2007, J VIROL, V81, P2263, DOI 10.1128/JVI.02218-06; Irie T, 2010, VIROLOGY, V405, P334, DOI 10.1016/j.virol.2010.06.031; Irie T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010719; Itoh M, 1997, J GEN VIROL, V78, P3207, DOI 10.1099/0022-1317-78-12-3207; Jayan GC, 2002, J VIROL, V76, P3819, DOI 10.1128/JVI.76.8.3819-3827.2002; Jordan IK, 2000, MOL BIOL EVOL, V17, P75, DOI 10.1093/oxfordjournals.molbev.a026240; Kato A, 1997, J VIROL, V71, P7266, DOI 10.1128/JVI.71.10.7266-7272.1997; Kato A, 2002, J VIROL, V76, P7114, DOI 10.1128/JVI.76.14.7114-7124.2002; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; Kiyotani K, 2001, ARCH VIROL, V146, P893, DOI 10.1007/s007050170123; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Komatsu T, 2002, FEBS LETT, V511, P139, DOI 10.1016/S0014-5793(01)03301-4; Komatsu T, 2007, MICROBES INFECT, V9, P954, DOI 10.1016/j.micinf.2007.03.014; Koyama AH, 2003, MICROBES INFECT, V5, P373, DOI 10.1016/S1286-4579(03)00043-1; Kurotani A, 1998, GENES CELLS, V3, P111, DOI 10.1046/j.1365-2443.1998.00170.x; Lamb R.A., 2006, FIELDS VIROLOGY, P1449; LAMB RA, 1977, VIROLOGY, V81, P382, DOI 10.1016/0042-6822(77)90154-4; LAMB RA, 1977, VIROLOGY, V81, P371, DOI 10.1016/0042-6822(77)90153-2; Nagai Y, 2011, BIOLOGY OF PARAMYXOVIRUSES, P115; Phuphuakrat A, 2008, J VIROL, V82, P10864, DOI 10.1128/JVI.00238-08; PORTNER A, 1986, VIRUS RES, V6, P109, DOI 10.1016/0168-1702(86)90043-2; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; SAKAGUCHI T, 1994, ARCH VIROL, V135, P159, DOI 10.1007/BF01309773; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Tapparel C, 1997, J VIROL, V71, P9588, DOI 10.1128/JVI.71.12.9588-9599.1997; YAMADA H, 1990, ARCH VIROL, V113, P245, DOI 10.1007/BF01316677	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49968	10.1371/journal.pone.0049968	http://dx.doi.org/10.1371/journal.pone.0049968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185501	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000153
J	Hanot, M; Boivin, A; Malesys, C; Beuve, M; Colliaux, A; Foray, N; Douki, T; Ardail, D; Rodriguez-Lafrasse, C				Hanot, Maite; Boivin, Anthony; Malesys, Celine; Beuve, Michael; Colliaux, Anthony; Foray, Nicolas; Douki, Thierry; Ardail, Dominique; Rodriguez-Lafrasse, Claire			Glutathione Depletion and Carbon Ion Radiation Potentiate Clustered DNA Lesions, Cell Death and Prevent Chromosomal Changes in Cancer Cells Progeny	PLOS ONE			English	Article							X-RAYS; IONIZING-RADIATION; MICRONUCLEUS ASSAY; N-ACETYLCYSTEINE; OXIDATIVE STRESS; TUMOR-CELLS; NECK-CANCER; HEAVY-IONS; DAMAGE; INDUCTION	Poor local control and tumor escape are of major concern in head-and-neck cancers treated by conventional radiotherapy or hadrontherapy. Reduced glutathione (GSH) is suspected of playing an important role in mechanisms leading to radioresistance, and its depletion should enable oxidative stress insult, thereby modifying the nature of DNA lesions and the subsequent chromosomal changes that potentially lead to tumor escape. This study aimed to highlight the impact of a GSH-depletion strategy (dimethylfumarate, and L-buthionine sulfoximine association) combined with carbon ion or X-ray irradiation on types of DNA lesions (sparse or clustered) and the subsequent transmission of chromosomal changes to the progeny in a radioresistant cell line (SQ20B) expressing a high endogenous GSH content. Results are compared with those of a radiosensitive cell line (SCC61) displaying a low endogenous GSH level. DNA damage measurements (gamma H2AX/comet assay) demonstrated that a transient GSH depletion in resistant SQ20B cells potentiated the effects of irradiation by initially increasing sparse DNA breaks and oxidative lesions after X-ray irradiation, while carbon ion irradiation enhanced the complexity of clustered oxidative damage. Moreover, residual DNA double-strand breaks were measured whatever the radiation qualities. The nature of the initial DNA lesions and amount of residual DNA damage were similar to those observed in sensitive SCC61 cells after both types of irradiation. Misrepaired or unrepaired lesions may lead to chromosomal changes, estimated in cell progeny by the cytome assay. Both types of irradiation induced aberrations in nondepleted resistant SQ20B and sensitive SCC61 cells. The GSH-depletion strategy prevented the transmission of aberrations (complex rearrangements and chromosome break or loss) in radioresistant SQ20B only when associated with carbon ion irradiation. A GSH-depleting strategy combined with hadrontherapy may thus have considerable advantage in the care of patients, by minimizing genomic instability and improving the local control.	[Hanot, Maite; Boivin, Anthony; Malesys, Celine; Ardail, Dominique; Rodriguez-Lafrasse, Claire] Fac Med Lyon Sud, EMR3738, Lab Radiobiol Cellulaire & Mol, Oullins, France; [Hanot, Maite] Fdn Synergie Lyon Canc, Lyon, France; [Beuve, Michael; Foray, Nicolas] Univ Lyon 1, CNRS, Inst Phys Nucl Lyon, UMR 5822,IN2P3, F-69622 Villeurbanne, France; [Foray, Nicolas] Fac Med Lyon Sud, Inst Natl Sante & Rech Med, Grp Radiobiol, U836, Oullins, France; [Douki, Thierry] CEA, Serv Chim Inorgan & Biol UMR E CEA UJF 3, Lab Les Acides Nucl, Grenoble, France; [Rodriguez-Lafrasse, Claire] Ctr Hosp Lyon Sud, Ctr Biol Sud, Hosp Civils Lyon, Unite Med Oncol Mol & Transfert, F-69310 Pierre Benite, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; CHU Lyon	Rodriguez-Lafrasse, C (corresponding author), Fac Med Lyon Sud, EMR3738, Lab Radiobiol Cellulaire & Mol, Oullins, France.	claire.rodriguez@univ-lyon1.fr	Rodriguez-Lafrasse, Claire/G-7741-2018; Foray, Nicolas/I-4755-2018; Beuve, Michaël/A-4310-2008; Thierry, Douki/H-2108-2018; Foray, Nicolas/Q-2363-2019	Foray, Nicolas/0000-0002-1282-1303; Beuve, Michaël/0000-0002-0516-6232; Thierry, Douki/0000-0002-5022-071X; Foray, Nicolas/0000-0002-1282-1303	ETOILE's Research Program through the Regional Programme of Research in Hadrontherapy/Lyon University, under CPER; Fondation Synergie Lyon Cancer; Ligue contre le cancer (Ain)	ETOILE's Research Program through the Regional Programme of Research in Hadrontherapy/Lyon University, under CPER; Fondation Synergie Lyon Cancer; Ligue contre le cancer (Ain)	This research was supported by ETOILE's Research Program through the Regional Programme of Research in Hadrontherapy/Lyon University, under CPER 2007-13 funding and Fondation Synergie Lyon Cancer and Ligue contre le cancer (Ain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alphonse G, 2002, INT J RADIAT BIOL, V78, P821, DOI 10.1080/09553000210153943; Anderson GR, 2001, CURRENT SCI, V81; Bergeron F, 2010, P NATL ACAD SCI USA, V107, P5528, DOI 10.1073/pnas.1000193107; Beuve M, 2008, INT J RADIAT ONCOL, V71, P635, DOI 10.1016/j.ijrobp.2007.10.050; Boivin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014558; Cadet J, 2012, CANC LETT; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Durante M, 2005, RADIAT RES, V164, P467, DOI 10.1667/RR3359.1; Dutta A, 2005, MUTAGENESIS, V20, P329, DOI 10.1093/mutage/gei046; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2006, MUTAT RES-FUND MOL M, V600, P58, DOI 10.1016/j.mrfmmm.2006.05.028; Fenech M, 2009, MUTAT RES-REV MUTAT, V681, P111, DOI 10.1016/j.mrrev.2008.11.003; Fokas E, 2009, BBA-REV CANCER, V1796, P216, DOI 10.1016/j.bbcan.2009.07.005; Fujii Y, 2010, MUTAT RES-GEN TOX EN, V699, P58, DOI 10.1016/j.mrgentox.2010.04.003; Hamada N, 2008, MUTAT RES-FUND MOL M, V637, P190, DOI 10.1016/j.mrfmmm.2007.07.002; Hamada N, 2009, J RADIAT RES, V50, P1, DOI 10.1269/jrr.08070; Hanot M, 2009, INT J RADIAT ONCOL, V75, P1247, DOI 10.1016/j.ijrobp.2009.07.014; Heddle JA, 2011, MUTAGENESIS, V26, P3, DOI 10.1093/mutage/geq085; Heine T, 2006, FREE RADICAL BIO MED, V40, P801, DOI 10.1016/j.freeradbiomed.2005.10.033; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Jereczek-Fossa BA, 2006, HEAD NECK-J SCI SPEC, V28, P750, DOI 10.1002/hed.20448; Johannes C, 2010, MUTAT RES-GEN TOX EN, V701, P80, DOI 10.1016/j.mrgentox.2010.05.005; Koyama S, 1998, MUTAT RES-FUND MOL M, V421, P45, DOI 10.1016/S0027-5107(98)00153-5; Lee R, 2010, MUTAT RES-GEN TOX EN, V701, P52, DOI 10.1016/j.mrgentox.2010.03.004; Maalouf M, 2009, INT J RADIAT ONCOL, V74, P200, DOI 10.1016/j.ijrobp.2009.01.012; Mansour HH, 2008, BIOCHEM PHARMACOL, V75, P773, DOI 10.1016/j.bcp.2007.09.018; Mateuca R, 2006, BIOCHIMIE, V88, P1515, DOI 10.1016/j.biochi.2006.07.004; MIURA M, 1991, RADIAT RES, V126, P229, DOI 10.2307/3577823; Mizoe J, 2004, INT J RADIAT ONCOL, V60, P358, DOI 10.1016/j.ijrobp.2004.02.067; Odom RY, 2009, NUTR CANCER, V61, P332, DOI 10.1080/01635580802549982; Pujari G, 2010, MUTAT RES-GEN TOX EN, V696, P154, DOI 10.1016/j.mrgentox.2010.01.006; Pujari G, 2009, MUTAT RES-GEN TOX EN, V675, P23, DOI 10.1016/j.mrgentox.2009.02.001; Ray S, 2007, INT J RADIAT BIOL, V83, P347, DOI 10.1080/09553000701317887; Ray S, 2006, CELL PROLIFERAT, V39, P37, DOI 10.1111/j.1365-2184.2006.00365.x; Ritter S, 2010, MUTAT RES-GEN TOX EN, V701, P38, DOI 10.1016/j.mrgentox.2010.04.007; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; SMEETS MFMA, 1994, RADIAT RES, V140, P153, DOI 10.2307/3578897; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Suzuki M, 1998, ADV SPACE RES, V22, P561, DOI 10.1016/S0273-1177(98)00078-7; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tulard A, 2003, FREE RADICAL BIO MED, V35, P68, DOI 10.1016/S0891-5849(03)00243-0; Virsik-Kopp P, 2004, CYTOGENET GENOME RES, V104, P221, DOI 10.1159/000077493; Vral A, 2011, MUTAGENESIS, V26, P11, DOI 10.1093/mutage/geq078; WEICHSELBAUM RR, 1986, P NATL ACAD SCI USA, V83, P2684, DOI 10.1073/pnas.83.8.2684; Wiseman Sam M, 2004, Surg Oncol Clin N Am, V13, P1, DOI 10.1016/S1055-3207(03)00118-2; Zhao Y, 2009, FREE RADICAL BIO MED, V47, P176, DOI 10.1016/j.freeradbiomed.2009.04.022	50	29	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e44367	10.1371/journal.pone.0044367	http://dx.doi.org/10.1371/journal.pone.0044367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185232	Green Published, gold			2022-12-25	WOS:000311535700001
J	Herman, D; Thomas, CM; Stekel, DJ				Herman, Dorota; Thomas, Christopher M.; Stekel, Dov J.			Adaptation for Protein Synthesis Efficiency in a Naturally Occurring Self-Regulating Operon	PLOS ONE			English	Article							RANGE PLASMID RK2; GLOBAL REGULATOR; INTRINSIC NOISE; NETWORKS; KORA; EVOLUTION; AUTOREGULATION; COOPERATIVITY; PSEUDOMONAS; EXPRESSION	The korAB operon in RK2 plasmids is a beautiful natural example of a negatively and cooperatively self-regulating operon. It has been particularly well characterized both experimentally and with mathematical models. We have carried out a detailed investigation of the role of the regulatory mechanism using a biologically grounded mechanistic multi-scale stochastic model that includes plasmid gene regulation and replication in the context of host growth and cell division. We use the model to compare four hypotheses for the action of the regulatory mechanism: increased robustness to extrinsic factors, decreased protein fluctuations, faster response-time of the operon and reduced host burden through improved efficiency of protein production. We find that the strongest impact of all elements of the regulatory architecture is on improving the efficiency of protein synthesis by reduction in the number of mRNA molecules needed to be produced, leading to a greater than ten-fold reduction in host energy required to express these plasmid proteins. A smaller but still significant role is seen for speeding response times, but this is not materially improved by the cooperativity. The self-regulating mechanisms have the least impact on protein fluctuations and robustness. While reduction of host burden is evident in a plasmid context, negative self-regulation is a widely seen motif for chromosomal genes. We propose that an important evolutionary driver for negatively self-regulated genes is to improve the efficiency of protein synthesis.	[Herman, Dorota; Stekel, Dov J.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Herman, Dorota; Thomas, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Herman, Dorota] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium	University of Nottingham; University of Birmingham; Flanders Institute for Biotechnology (VIB); Ghent University	Stekel, DJ (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	dov.stekel@nottingham.ac.uk	Thomas, Christopher M/J-8258-2017; Stekel, Dov/F-3053-2014	Thomas, Christopher M/0000-0002-2810-0455; Stekel, Dov/0000-0002-2492-8079; Herman, Dorota/0000-0001-7836-8989	Darwin Trust of Edinburgh; BBSRC REI [BB/D524624/1]; Biotechnology and Biological Sciences Research Council [BB/D524624/1] Funding Source: researchfish; BBSRC [BB/D524624/1] Funding Source: UKRI	Darwin Trust of Edinburgh; BBSRC REI(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DH was funded by the Darwin Trust of Edinburgh. Computer simulations were carried out using the Birmingham Biosciences High Performance Compute Cluster, funded by BBSRC REI grant BB/D524624/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl MI, 2007, PLASMID, V58, P31, DOI 10.1016/j.plasmid.2006.11.007; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Bingle LEH, 2008, MOL MICROBIOL, V70, P1502, DOI 10.1111/j.1365-2958.2008.06498.x; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chiu CM, 2008, PLASMID, V59, P163, DOI 10.1016/j.plasmid.2008.02.001; Chu DF, BIOSYSTEMS, V104, P99; DUNNY GM, 1985, P NATL ACAD SCI USA, V82, P8582, DOI 10.1073/pnas.82.24.8582; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Herman D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-119; HOLLOWAY BW, 1973, GENET RES, V21, P103, DOI 10.1017/S0016672300013252; Jagura-Burdzy G, 1999, MOL MICROBIOL, V32, P519, DOI 10.1046/j.1365-2958.1999.01365.x; JAGURA-BURDZY G, 1995, J MOL BIOL, V253, P39, DOI 10.1006/jmbi.1995.0534; Jenkins DJ, 2009, ARTIF LIFE, V15, P259, DOI 10.1162/artl.2009.Stekel.006; Kim KH, 2010, MATH BIOSCI, V226, P109, DOI 10.1016/j.mbs.2010.04.004; Kostelidou K, 1999, J MOL BIOL, V289, P211, DOI 10.1006/jmbi.1999.2761; Kostelidou K, 2002, BBA-GENE STRUCT EXPR, V1576, P110, DOI 10.1016/S0167-4781(02)00306-8; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Sevastsyanovich YR, 2008, MICROBIOL-SGM, V154, P2929, DOI 10.1099/mic.0.2008/017939-0; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Stekel DJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-6; Stekel DJ, 2012, ADV EXP MED BIOL, V751, P301, DOI 10.1007/978-1-4614-3567-9_14; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; THOMAS CM, 1987, ANNU REV MICROBIOL, V41, P77, DOI 10.1146/annurev.mi.41.100187.000453; Toettcher JE, 2010, P NATL ACAD SCI USA, V107, P17047, DOI 10.1073/pnas.1005615107; Zabet RN, 2011, J THEOR BIOL, V284, P82	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49678	10.1371/journal.pone.0049678	http://dx.doi.org/10.1371/journal.pone.0049678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185406	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700049
J	Lin, SP; Lee, YT; Wang, JY; Miller, SA; Chiou, SH; Hung, MC; Hung, SC				Lin, Shih-Pei; Lee, Yi-Ting; Wang, Jir-You; Miller, Stephanie A.; Chiou, Shih-Hwa; Hung, Mien-Chie; Hung, Shih-Chieh			Survival of Cancer Stem Cells under Hypoxia and Serum Depletion via Decrease in PP2A Activity and Activation of p38-MAPKAPK2-Hsp27	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; CYTOCHROME-C; HEAT-SHOCK; NEGATIVE REGULATOR; TUMOR-SUPPRESSOR; HSP27; PHOSPHORYLATION; MAINTENANCE; THERAPY; CHEMOTHERAPY	Hypoxia and serum depletion are common features of solid tumors that occur upon antiangiogenesis, irradiation and chemotherapy across a wide variety of malignancies. Here we show that tumor cells expressing CD133, a marker for colorectal cancer initiating or stem cells, are enriched and survive under hypoxia and serum depletion conditions, whereas CD133- cells undergo apoptosis. CD133+ tumor cells increase cancer stem cell and epithelial-mesenchymal transition properties. Moreover, via screening a panel of tyrosine and serine/threonine kinase pathways, we identified Hsp27 is constitutively activated in CD133+ cells rather than CD133- cell under hypoxia and serum depletion conditions. However, there was no difference in Hsp27 activation between CD133+ and CD133- cells under normal growth condition. Hsp27 activation, which was mediated by the p38MAPK-MAPKAPK2-Hsp27 pathway, is required for CD133+ cells to inhibit caspase 9 and 3 cleavage. In addition, inhibition of Hsp27 signaling sensitizes CD133+ cells to hypoxia and serum depletion -induced apoptosis. Moreover, the antiapoptotic pathway is also activated in spheroid culture-enriched CD133+ cancer stem cells from a variety of solid tumor cells including lung, brain and oral cancer, suggesting it is a common pathway activated in cancer stem cells from multiple tumor types. Thus, activation of PP2A or inactivation of the p38MAPK-MAPKAPK2-Hsp27 pathway may develop new strategies for cancer therapy by suppression of their TIC population.	[Miller, Stephanie A.; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lin, Shih-Pei; Lee, Yi-Ting; Wang, Jir-You; Chiou, Shih-Hwa; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chiou, Shih-Hwa; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Lin, Shih-Pei; Lee, Yi-Ting; Wang, Jir-You; Chiou, Shih-Hwa; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Med Res & Educ, Stem Cell Lab, Taipei, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Coll Med, Grad Inst Canc Biol, Taichung, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mhung@mdanderson.org; hungsc@vghtpe.gov.tw	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	National Science Council [97-3111-B-010-001, 99-3111-B-010-005-]; Taipei Veterans General Hospital [V98E1-002]; MD Anderson Cancer Center/China Medical University and Hospital Sister Institution Fund; National Yang-Ming University, Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); MD Anderson Cancer Center/China Medical University and Hospital Sister Institution Fund; National Yang-Ming University, Ministry of Education	This study was supported in part by the National Science Council (97-3111-B-010-001, and 99-3111-B-010-005-), Taipei Veterans General Hospital (V98E1-002), the MD Anderson Cancer Center/China Medical University and Hospital Sister Institution Fund, and the National Yang-Ming University, Ministry of Education. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Begum N, 1999, BIOCHEM J, V344, P895, DOI 10.1042/0264-6021:3440895; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; CAIRNS J, 1994, J BIOL CHEM, V269, P9176; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Denekamp J, 1998, ADV ENZYME REGUL, V38, P281, DOI 10.1016/S0065-2571(97)00015-0; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Garrido C, 1998, CANCER RES, V58, P5495; Gaur P, 2011, GASTROENTEROLOGY, V141, P1728, DOI 10.1053/j.gastro.2011.07.037; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kostenko S, 2009, CELL MOL LIFE SCI, V66, P3289, DOI 10.1007/s00018-009-0086-3; Liao Y, 2004, CANCER RES, V64, P5938, DOI 10.1158/0008-5472.CAN-04-1533; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shin KD, 2005, J BIOL CHEM, V280, P41439, DOI 10.1074/jbc.M507209200; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tsai KS, 2011, GASTROENTEROLOGY, V141, P1046, DOI 10.1053/j.gastro.2011.05.045; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591	38	71	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49605	10.1371/journal.pone.0049605	http://dx.doi.org/10.1371/journal.pone.0049605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185379	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700043
J	Dimitrov, D; Nogues-Bravo, D; Scharff, N				Dimitrov, Dimitar; Nogues-Bravo, David; Scharff, Nikolaj			Why Do Tropical Mountains Support Exceptionally High Biodiversity? The Eastern Arc Mountains and the Drivers of Saintpaulia Diversity	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; MOLECULAR EVOLUTION; NICHE CONSERVATISM; ULUGURU MOUNTAINS; DIVERGENCE TIMES; LIFE-HISTORY; FOREST; GESNERIACEAE	We combine information about the evolutionary history and distributional patterns of the genus Saintpaulia H. Wendl. (Gesneriaceae; 'African violets') to elucidate the factors and processes behind the accumulation of species in tropical montane areas of high biodiversity concentration. We find that high levels of biodiversity in the Eastern Arc Mountains are the result of pre-Quaternary speciation processes and environmental stability. Our results support the hypothesis that climatically stable mountaintops may have acted as climatic refugia for lowland lineages during the Pleistocene by preventing extinctions. In addition, we found evidence for the existence of lowland micro-refugia during the Pleistocene, which may explain the high species diversity of East African coastal forests. We discuss the conservation implications of the results in the context of future climate change.	[Dimitrov, Dimitar; Scharff, Nikolaj] Univ Copenhagen, Zool Museum, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Nogues-Bravo, David] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Dimitrov, D (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	dimitard.gwu@gmail.com	Dimitrov, Dimitar/A-9563-2009; Scharff, Nikolaj/A-4787-2013	Dimitrov, Dimitar/0000-0001-5830-5702; Scharff, Nikolaj/0000-0001-6809-2878; Nogues-Bravo, David/0000-0002-4060-0153	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	Funding for this research was provided by the Danish National Research Foundation (www.dg.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Axelrod D. I., 1978, Monographiae Biologicae, V31, P79; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Burgess N, 2002, ORYX, V36, P140, DOI 10.1017/S0030605302000212; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Burgess N. D., 2000, Coastal forests of eastern Africa; BURTT B. L., 1964, NOTES ROY BOT GARD EDINBURGH, V25, P191; BURTT B. L., 1958, NOTES ROY BOT GARDEN EDINBURGH, V22, P547; Burtt BL, 1947, GARD CHRON, V3, P22; Caro Sarah E., 2006, BIOS, V77, P72, DOI 10.1893/0005-3155(2006)77[72:UACSGT]2.0.CO;2; Citerne HL, 2000, ANN BOT-LONDON, V86, P167, DOI 10.1006/anbo.2000.1178; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Couvreur TLP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-54; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; CROWE TM, 1982, J ZOOL, V198, P417, DOI 10.1111/jzo.1982.198.4.417; Darbyshire I, 2006, FLORA TROPICAL E AFR, P1; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; DIAMOND AW, 1980, J ZOOL, V191, P379; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eastwood A., 1998, Curtis's Botanical Magazine, V15, P49, DOI 10.1111/1467-8748.00132; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Finch J, 2009, QUATERNARY RES, V72, P111, DOI 10.1016/j.yqres.2009.02.005; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Fjeldsa J, 2008, AFR J ECOL, V46, P235, DOI 10.1111/j.1365-2028.2008.00992.x; GAUT BS, 1992, J MOL EVOL, V35, P292, DOI 10.1007/BF00161167; Griffiths C., 1993, BIOGEOGRAPHY ECOLOGY, P9, DOI DOI 10.1017/CBO9780511895692.002; Hamilton A.C., 1982, ENV HIST E AFRICA ST; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Haston Elspeth M., 2009, Curtis's Botanical Magazine, V26, P270; Haywood AM, 2011, PHILOS T R SOC A, V369, P933, DOI 10.1098/rsta.2010.0317; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Jacobs BF, 2004, PHILOS T R SOC B, V359, P1573, DOI 10.1098/rstb.2004.1533; Kamino Luciana H Y, 2012, Biol Lett, V8, P324, DOI 10.1098/rsbl.2011.0942; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Katz RW, 2002, CLIM RES, V20, P167, DOI 10.3354/cr020167; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kolehmainen J, 2007, PLANT ECOL, V192, P85, DOI 10.1007/s11258-006-9228-y; Lindqvist Charlotte, 2001, Systematics and Geography of Plants, V71, P37, DOI 10.2307/3668751; Lindqvist Charlotte, 1999, Kew Bulletin, V54, P363, DOI 10.2307/4115813; Loader SP, 2007, BIOL LETTERS, V3, P505, DOI 10.1098/rsbl.2007.0266; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Measey GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026606; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Mittermeier RA., 2005, HOTSPOTS REVISITED E; Moller M, 2009, AM J BOT, V96, P989, DOI 10.3732/ajb.0800291; Moller M, 1997, AM J BOT, V84, P956, DOI 10.2307/2446286; Moller M, 1997, P ROY SOC B-BIOL SCI, V264, P1827, DOI 10.1098/rspb.1997.0252; Moreau R. E., 1966, P1; Mumbi CT, 2008, QUATERNARY RES, V69, P326, DOI 10.1016/j.yqres.2007.10.012; Murphy J, 1999, J CLIMATE, V12, P2256, DOI 10.1175/1520-0442(1999)012<2256:AEOSAD>2.0.CO;2; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiu YL, 2010, J SYST EVOL, V48, P391, DOI 10.1111/j.1759-6831.2010.00097.x; Rambaut A., 2007, TRACER V1 4; Ramirez J, 2010, 1 INT CTR TROP AGR; Roalson EH, 2008, SYST BOT, V33, P159, DOI 10.1600/036364408783887429; Ruiz-Labourdette D, 2012, J BIOGEOGR, V39, P162, DOI 10.1111/j.1365-2699.2011.02592.x; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tabor Karyn, 2010, Journal of East African Natural History, V99, P19, DOI 10.2982/028.099.0102; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	73	35	36	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48908	10.1371/journal.pone.0048908	http://dx.doi.org/10.1371/journal.pone.0048908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185283	Green Published, gold			2022-12-25	WOS:000311333800014
J	Goncalves, JP; Francisco, AP; Moreau, Y; Madeira, SC				Goncalves, Joana P.; Francisco, Alexandre P.; Moreau, Yves; Madeira, Sara C.			Interactogeneous: Disease Gene Prioritization Using Heterogeneous Networks and Full Topology Scores	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX I; OXIDASE-B MAOB; PARKINSONS-DISEASE; TYROSINE-HYDROXYLASE; PROTEIN; EXPRESSION; GENOME; IDENTIFICATION; ASSOCIATIONS; DATABASE	Disease gene prioritization aims to suggest potential implications of genes in disease susceptibility. Often accomplished in a guilt-by-association scheme, promising candidates are sorted according to their relatedness to known disease genes. Network-based methods have been successfully exploiting this concept by capturing the interaction of genes or proteins into a score. Nonetheless, most current approaches yield at least some of the following limitations: (1) networks comprise only curated physical interactions leading to poor genome coverage and density, and bias toward a particular source; (2) scores focus on adjacencies (direct links) or the most direct paths (shortest paths) within a constrained neighborhood around the disease genes, ignoring potentially informative indirect paths; (3) global clustering is widely applied to partition the network in an unsupervised manner, attributing little importance to prior knowledge; (4) confidence weights and their contribution to edge differentiation and ranking reliability are often disregarded. We hypothesize that network-based prioritization related to local clustering on graphs and considering full topology of weighted gene association networks integrating heterogeneous sources should overcome the above challenges. We term such a strategy interactogeneous. We conducted cross-validation tests to assess the impact of network sources, alternative path inclusion and confidence weights on the prioritization of putative genes for 29 diseases. Heat diffusion ranking proved the best prioritization method overall, increasing the gap to neighborhood and shortest paths scores mostly on single source networks. Heterogeneous associations consistently delivered superior performance over single source data across the majority of methods. Results on the contribution of confidence weights were inconclusive. Finally, the best Interactogeneous strategy, heat diffusion ranking and associations from the STRING database, was used to prioritize genes for Parkinson's disease. This method effectively recovered known genes and uncovered interesting candidates which could be linked to pathogenic mechanisms of the disease.	[Goncalves, Joana P.; Francisco, Alexandre P.; Madeira, Sara C.] INESC ID, Knowledge Discovery & Bioinformat Grp, Lisbon, Portugal; [Goncalves, Joana P.; Francisco, Alexandre P.; Madeira, Sara C.] Univ Tecn Lisboa, Inst Super Tecn, Comp Sci & Engn Dept, Lisbon, Portugal; [Moreau, Yves] Katholieke Univ Leuven, Dept Elect Engn, Louvain, Belgium	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; KU Leuven	Goncalves, JP (corresponding author), INESC ID, Knowledge Discovery & Bioinformat Grp, Lisbon, Portugal.	jpg@kdbio.inesc-id.pt; sara.madeira@ist.utl.pt	Francisco, Alexandre/B-9429-2009; Gonçalves, Joana/GSI-9858-2022; Madeira, Sara/C-5494-2008; Gonçalves, Joana/B-2330-2009; Madeira, Sara/AAR-3658-2020	Francisco, Alexandre/0000-0003-4852-1641; Madeira, Sara/0000-0002-1459-8096; Gonçalves, Joana/0000-0001-6072-9627; Madeira, Sara/0000-0002-1459-8096; Moreau, Yves/0000-0002-4647-6560	national funds through Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-OE/EEI/LA0021/2011, SFRH/BD/36586/2007, PTDC/EIA-EIA/111239/2009]	national funds through Fundacao para a Ciencia e a Tecnologia (FCT)	This work was supported by national funds through Fundacao para a Ciencia e a Tecnologia (FCT), under project PEst-OE/EEI/LA0021/2011; doctoral grant SFRH/BD/36586/2007 to JPG; and project contract PTDC/EIA-EIA/111239/2009 to Neuroclinomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; [Anonymous], 2005, P 5 INT WORKSH BIOIN, DOI DOI 10.1145/1134030.1134042; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bademci G, 2010, HUM MUTAT, V31, pE1767, DOI 10.1002/humu.21351; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Belin AC, 2008, FEBS J, V275, P1377, DOI 10.1111/j.1742-4658.2008.06301.x; Bialecka M, 2007, PARKINSONISM RELAT D, V13, P224, DOI 10.1016/j.parkreldis.2006.10.006; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Brighina L, 2007, NEUROSCI LETT, V420, P229, DOI 10.1016/j.neulet.2007.05.021; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chatr-aryamontri A, 2008, METHODS MOL BIOL, V484, P305, DOI 10.1007/978-1-59745-398-1_20; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chung F., 1999, ELECTRON J COMB, V6, pR12; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Cormen T., 2009, INTRO ALGORITHMS; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Goncalves JP, 2011, BIOINFORMATICS, V27, P3149, DOI 10.1093/bioinformatics/btr546; Haavik J, 1998, MOL NEUROBIOL, V16, P285, DOI 10.1007/BF02741387; Haixuan Yang, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P431, DOI 10.1145/1277741.1277815; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hattori N, 1998, GENOMICS, V49, P52, DOI 10.1006/geno.1997.5192; Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lavedan C, 1998, GENOMICS, V54, P173, DOI 10.1006/geno.1998.5556; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li YJ, 2003, HUM MOL GENET, V12, P3259, DOI 10.1093/hmg/ddg357; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Lin L, 2009, TRENDS NEUROSCI, V32, P142, DOI 10.1016/j.tins.2008.11.006; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Mellick GD, 1999, MOVEMENT DISORD, V14, P219, DOI 10.1002/1531-8257(199903)14:2<219::AID-MDS1003>3.3.CO;2-0; Milenkovic T, 2010, J R SOC INTERFACE, V7, P423, DOI 10.1098/rsif.2009.0192; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Radivojac P, 2008, PROTEINS, V72, P1030, DOI 10.1002/prot.21989; Robertson S, 2008, P 31 ANN INT ACM SIG, P689, DOI [10.1145/1390334.1390453, DOI 10.1145/1390334.1390453]; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Shen J, 2010, NEURODEGENER DIS, V7, P80, DOI 10.1159/000285511; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; SMITH CAD, 1992, LANCET, V339, P1375, DOI 10.1016/0140-6736(92)91196-F; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiffin N, 2009, GENOME MED, V1, DOI 10.1186/gm77; Vahedi S, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-66; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Voevodski K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-297; White S., 2003, P 9 ACM SIGKDD INT C, P266, DOI [DOI 10.1145/956750.956782, 10.1145/956750.956782]; Wider C, 2010, CURR OPIN NEUROL, V23, P388, DOI 10.1097/WCO.0b013e32833b1f4c; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289	67	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49634	10.1371/journal.pone.0049634	http://dx.doi.org/10.1371/journal.pone.0049634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185389	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800044
J	Stevens, EL; Baugher, JD; Shirley, MD; Frelin, LP; Pevsner, J				Stevens, Eric L.; Baugher, Joseph D.; Shirley, Matthew D.; Frelin, Laurence P.; Pevsner, Jonathan			Unexpected Relationships and Inbreeding in HapMap Phase III Populations	PLOS ONE			English	Article							HUMAN GENE-EXPRESSION; GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATION; SELECTIVE SWEEPS; HUMAN-EVOLUTION; HAPLOTYPE MAP; HOMOZYGOSITY; LONG; RARE; RECONSTRUCTION	Correct annotation of the genetic relationships between samples is essential for population genomic studies, which could be biased by errors or omissions. To this end, we used identity-by-state (IBS) and identity-by-descent (IBD) methods to assess genetic relatedness of individuals within HapMap phase III data. We analyzed data from 1,397 individuals across 11 ethnic populations. Our results support previous studies (Pemberton et al., 2010; Kyriazopoulou-Panagiotopoulou et al., 2011) assessing unknown relatedness present within this population. Additionally, we present evidence for 1,657 novel pairwise relationships across 9 populations. Surprisingly, significant Cotterman's coefficients of relatedness K1 (IBD1) values were detected between pairs of known parents. Furthermore, significant K2 (IBD2) values were detected in 32 previously annotated parent-child relationships. Consistent with a hypothesis of inbreeding, regions of homozygosity (ROH) were identified in the offspring of related parents, of which a subset overlapped those reported in previous studies (Gibson et al. 2010; Johnson et al. 2011). In total, we inferred 28 inbred individuals with ROH that overlapped areas of relatedness between the parents and/or IBD2 sharing at a different genomic locus between a child and a parent. Finally, 8 previously annotated parent-child relationships had unexpected K0 (IBD0) values (resulting from a chromosomal abnormality or genotype error), and 10 previously annotated second-degree relationships along with 38 other novel pairwise relationships had unexpected IBD2 (indicating two separate paths of recent ancestry). These newly described types of relatedness may impact the outcome of previous studies and should inform the design of future studies relying on the HapMap Phase III resource.	[Stevens, Eric L.; Pevsner, Jonathan] Johns Hopkins Sch Med, Predoctoral Program Human Genet, Baltimore, MD USA; [Baugher, Joseph D.; Shirley, Matthew D.; Pevsner, Jonathan] Johns Hopkins Sch Med, Program Biochem Cellular & Mol Biol, Baltimore, MD USA; [Frelin, Laurence P.; Pevsner, Jonathan] Kennedy Krieger, Dept Neurol, Hugo W Moser Res Inst, Baltimore, MD USA; [Pevsner, Jonathan] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Pevsner, J (corresponding author), Johns Hopkins Sch Med, Predoctoral Program Human Genet, Baltimore, MD USA.	pevsner@kennedykrieger.org		Shirley, Matthew/0000-0003-0855-9274; stevens, Eric/0000-0001-6044-7611; Baugher, Joseph/0000-0003-2466-3047	NIGMS NIH HHS [T32 GM007814] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cotterman C, 1974, THESIS DOWDEN HUTCHI; Curtis D, 2010, HUM HERED, V69, P184, DOI 10.1159/000289592; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gusev A, 2012, MOL BIOL EVOL, V29, P473, DOI 10.1093/molbev/msr133; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Hill WG, 2011, GENET RES, V93, P47, DOI 10.1017/S0016672310000480; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Huang L, 2011, GENET EPIDEMIOL, V35, P766, DOI 10.1002/gepi.20626; Johnson TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r21; Kirkpatrick B, 2011, J COMPUT BIOL, V18, P1481, DOI 10.1089/cmb.2011.0156; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Kyriazopoulou-Panagiotopoulou S, 2011, BIOINFORMATICS, V27, pI333, DOI 10.1093/bioinformatics/btr243; Lee WC, 2003, ANN HUM GENET, V67, P618, DOI 10.1046/j.1529-8817.2003.00063.x; Leutenegger AL, 2011, EUR J HUM GENET, V19, P583, DOI 10.1038/ejhg.2010.205; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roberson EDO, 2009, PLOS ONE, V4; Stevens EL, 2011, PLOS GENET, V7; Stevens EL, 2012, EUR J HUM GENET; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; 1992, SCIENCE, V258, P148	40	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49575	10.1371/journal.pone.0049575	http://dx.doi.org/10.1371/journal.pone.0049575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185369	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800038
J	Kolb, RH; Greer, PM; Cao, PT; Cowan, KH; Yan, Y				Kolb, Ryan H.; Greer, Patrick M.; Cao, Phu T.; Cowan, Kenneth H.; Yan, Ying			ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; CELL-CYCLE ARREST; MITOTIC CHROMOSOME CONDENSATION; 14-3-3 PROTEIN-BINDING; IONIZING-RADIATION; HISTONE H3; TYROSINE PHOSPHORYLATION; INDUCED APOPTOSIS; BREAST-CANCER; CHEMOTHERAPEUTIC DRUGS	Topo II poisons, which target topoisomerase II (topo II) to generate enzyme mediated DNA damage, have been commonly used for anti-cancer treatment. While clinical evidence demonstrate a capability of topo II poisons in inducing apoptosis in cancer cells, accumulating evidence also show that topo II poison treatment frequently results in cell cycle arrest in cancer cells, which was associated with subsequent resistance to these treatments. Results in this report indicate that treatment of MCF-7 and T47D breast cancer cells with topo II poisons resulted in an increased phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1/2) and an subsequent induction of G2/M cell cycle arrest. Furthermore, inhibition of ERK1/2 activation using specific inhibitors markedly attenuated the topo II poison-induced G2/M arrest and diminished the topo II poison-induced activation of ATR and Chk1 kinases. Moreover, decreased expression of ATR by specific shRNA diminished topo II poison-induced G2/M arrest but had no effect on topo II poison-induced ERK1/2 activation. In contrast, inhibition of ERK1/2 signaling had little, if any, effect on topo II poison-induced ATM activation. In addition, ATM inhibition by either incubation of cells with ATM specific inhibitor or transfection of cells with ATM specific siRNA did not block topo II poison-induced G2/M arrest. Ultimately, inhibition of ERK1/2 signaling greatly enhanced topo II poison-induced apoptosis. These results implicate a critical role for ERK1/2 signaling in the activation of G2/M checkpoint response following topo II poison treatment, which protects cells from topo II poison-induced apoptosis.	[Kolb, Ryan H.; Greer, Patrick M.; Cao, Phu T.; Cowan, Kenneth H.; Yan, Ying] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Yan, Y (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	yyan@unmc.edu		Kolb, Ryan/0000-0001-6305-2885	Nebraska DHHSLB506 grant [2010-40]; NCI [NCI T32 CA009476]; NCI Cancer Center Support Grant [P30CA036727]; NATIONAL CANCER INSTITUTE [T32CA009476, P30CA036727] Funding Source: NIH RePORTER	Nebraska DHHSLB506 grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Nebraska DHHSLB506 grant (2010-40), NCI Training Grant (NCI T32 CA009476), and NCI Cancer Center Support Grant (P30CA036727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahn JY, 2000, CANCER RES, V60, P5934; Andres JL, 1998, ONCOGENE, V16, P2229, DOI 10.1038/sj.onc.1201752; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Brantley-Finley C, 2003, BIOCHEM PHARMACOL, V66, P459, DOI 10.1016/S0006-2952(03)00255-7; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Charrier-Savournin FB, 2004, MOL BIOL CELL, V15, P3965, DOI 10.1091/mbc.E03-12-0871; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Gatei M, 2000, CANCER RES, V60, P3299; Gewirtz DA, 2000, BREAST CANCER RES TR, V62, P223, DOI 10.1023/A:1006414422919; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Ho CC, 2005, EXP CELL RES, V304, P1, DOI 10.1016/j.yexcr.2004.10.016; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jin ZH, 2005, ONCOGENE, V24, P1973, DOI 10.1038/sj.onc.1208408; KHARBANDA S, 1994, CANCER RES, V54, P1412; Kim HS, 2009, PHARMACOLOGY, V84, P300, DOI 10.1159/000245937; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Lin YC, 2008, CELL SIGNAL, V20, P258, DOI 10.1016/j.cellsig.2007.10.017; Liu QH, 2000, GENE DEV, V14, P1448; Liu SQ, 2006, DIGEST LIVER DIS, V38, P310, DOI 10.1016/j.dld.2006.01.012; Liu WH, 2011, INT J BIOCHEM CELL B, V43, P1708, DOI 10.1016/j.biocel.2011.08.004; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Mitchell C, 2011, CANCER BIOL THER, V12, P215, DOI 10.4161/cbt.12.3.16218; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Navarro R, 2006, ANN NY ACAD SCI, V1090, P419, DOI 10.1196/annals.1378.045; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; O'Connell MJ, 2005, J CELL SCI, V118, P1, DOI 10.1242/jcs.01626; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; OConnor PM, 1997, CANCER RES, V57, P4285; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Potter AJ, 2005, MUTAT RES-FUND MOL M, V572, P27, DOI 10.1016/j.mrfmmm.2004.11.018; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sauve DM, 1999, J CELL BIOL, V145, P225, DOI 10.1083/jcb.145.2.225; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Van Gijn R., 2000, J ONCOL PHARM PRACT, V6, P92, DOI 10.1177/107815520000600303; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Wei FX, 2010, CELL SIGNAL, V22, P1783, DOI 10.1016/j.cellsig.2010.07.007; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu Bo, 2004, Methods Mol Biol, V281, P283; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268; Yan Y, 1997, J BIOL CHEM, V272, P15220, DOI 10.1074/jbc.272.24.15220; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492; Yan Y, 2002, J BIOL CHEM, V277, P33422, DOI 10.1074/jbc.M201147200; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu Q, 2002, CANCER RES, V62, P5743; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	80	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50281	10.1371/journal.pone.0050281	http://dx.doi.org/10.1371/journal.pone.0050281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166842	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300098
J	Miranda, JG; Weaver, AL; Qin, Y; Park, JG; Stoddard, CI; Lin, MZ; Palmer, AE				Miranda, Jose G.; Weaver, Amanda L.; Qin, Yan; Park, J. Genevieve; Stoddard, Caitlin I.; Lin, Michael Z.; Palmer, Amy E.			New Alternately Colored FRET Sensors for Simultaneous Monitoring of Zn2+ in Multiple Cellular Locations	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; GENETICALLY ENCODED SENSORS; RESONANCE ENERGY-TRANSFER; MONOMERIC RED; ZINC STATUS; BIOSENSORS; BRIGHT; CELLS; ORANGE; METALLOTHIONEIN	Genetically encoded sensors based on fluorescence resonance energy transfer (FRET) are powerful tools for reporting on ions, molecules and biochemical reactions in living cells. Here we describe the development of new sensors for Zn2+ based on alternate FRET-pairs that do not involve the traditional CFP and YFP. Zn2+ is an essential micronutrient and plays fundamental roles in cell biology. Consequently there is a pressing need for robust sensors to monitor Zn2+ levels and dynamics in cells with high spatial and temporal resolution. Here we develop a suite of sensors using alternate FRET pairs, including tSapphire/TagRFP, tSapphire/mKO, Clover/mRuby2, mOrange2/mCherry, and mOrange2/mKATE. These sensors were targeted to both the nucleus and cytosol and characterized and validated in living cells. Sensors based on the new FRET pair Clover/mRuby2 displayed a higher dynamic range and better signal-to-noise ratio than the remaining sensors tested and were optimal for monitoring changes in cytosolic and nuclear Zn2+. Using a green-red sensor targeted to the nucleus and cyan-yellow sensor targeted to either the ER, Golgi, or mitochondria, we were able to monitor Zn2+ uptake simultaneously in two compartments, revealing that nuclear Zn2+ rises quickly, whereas the ER, Golgi, and mitochondria all sequester Zn2+ more slowly and with a delay of 600-700 sec. Lastly, these studies provide the first glimpse of nuclear Zn2+ and reveal that nuclear Zn2+ is buffered at a higher level than cytosolic Zn2+.	[Miranda, Jose G.; Weaver, Amanda L.; Qin, Yan; Park, J. Genevieve; Stoddard, Caitlin I.; Palmer, Amy E.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Miranda, Jose G.; Weaver, Amanda L.; Qin, Yan; Park, J. Genevieve; Stoddard, Caitlin I.; Palmer, Amy E.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Lin, Michael Z.] Stanford Med Sch, Dept Pediat & Engn, Stanford, CA USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Stanford University	Palmer, AE (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	amy.palmer@colorado.edu	Qin, Yan/A-1103-2014; Miranda, Jose/HCI-6099-2022	Qin, Yan/0000-0003-3640-0105; Lin, Michael/0000-0002-0492-1961	National Institutes of Health [F31 GM093443, GM084027, GM084027-S1]; Alfred P. Sloan Fellowship; Burroughs Wellcome Career Award for Medical Scientist; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, F31GM093443, R01GM084027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Burroughs Wellcome Career Award for Medical Scientist; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank the following agencies for financial support: NIH Predoctoral Fellowship (F31 GM093443) to J.G.M., NIH GM084027 and GM084027-S1 to A. E. P. Research in the Palmer Lab is also supported by an Alfred P. Sloan Fellowship (http://www.sloan.org/). This work was supported by a Burroughs Wellcome Career Award for Medical Scientist (http://www.bwfund.org/pages/188/Career-Awards-for-Medical-Scientists/) and a National Institutes of Health grant to M.Z.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Andreini C, 2009, ACCOUNTS CHEM RES, V42, P1471, DOI 10.1021/ar900015x; Carlson HJ, 2009, CURR OPIN BIOTECH, V20, P19, DOI 10.1016/j.copbio.2009.01.003; Davidson MW, 2009, NAT METHODS, V6, P713, DOI 10.1038/nmeth1009-713; Ding YD, 2011, ANAL CHEM, V83, P9687, DOI 10.1021/ac202595g; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; Du S, 2002, J NEUROSCI, V22, P7408; Gandhi MS, 2008, J CARDIOVASC PHARM, V52, P245, DOI 10.1097/FJC.0b013e3181833eb8; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Grant DM, 2008, BIOPHYS J, V95, pL69, DOI 10.1529/biophysj.108.139204; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Lam AJ, 2012, NAT METHODS; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Ni QA, 2011, NAT CHEM BIOL, V7, P34, DOI 10.1038/NCHEMBIO.478; Niino Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006036; Ouyang MX, 2010, CANCER RES, V70, P2204, DOI 10.1158/0008-5472.CAN-09-3698; Park JG, 2011, ACS CHEM BIOL; Perry DK, 1997, J BIOL CHEM, V272, P18530, DOI 10.1074/jbc.272.30.18530; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Sorensen MB, 1999, MOL HUM REPROD, V5, P338, DOI 10.1093/molehr/5.4.338; Spahl DU, 2003, P NATL ACAD SCI USA, V100, P13952, DOI 10.1073/pnas.2335190100; Stoecker BJ, 2009, EUR J CLIN NUTR, V63, P916, DOI 10.1038/ejcn.2008.77; Takeda A, 2012, J TRACE ELEM MED BIO, V26, P80, DOI 10.1016/j.jtemb.2012.03.016; TSUJIKAWA K, 1991, FEBS LETT, V283, P239, DOI 10.1016/0014-5793(91)80597-V; VanEngelenburg SB, 2008, CURR OPIN CHEM BIOL, V12, P60, DOI 10.1016/j.cbpa.2008.01.020; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; West DC, 2012, MOL PHARMACEUT, V9, P1425, DOI 10.1021/mp200673n; Yoshida K, 2008, MOL HUM REPROD, V14, P151, DOI 10.1093/molehr/gan003; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	42	71	71	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49371	10.1371/journal.pone.0049371	http://dx.doi.org/10.1371/journal.pone.0049371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173058	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300033
J	Saez, CA; Lobos, MG; Macaya, EC; Oliva, D; Quiroz, W; Brown, MT				Saez, Claudio A.; Gabriela Lobos, M.; Macaya, Erasmo C.; Oliva, Doris; Quiroz, Waldo; Brown, Murray T.			Variation in Patterns of Metal Accumulation in Thallus Parts of Lessonia trabeculata (Laminariales; Phaeophyceae): Implications for Biomonitoring	PLOS ONE			English	Article							BROWN-ALGAE; HEAVY-METALS; OXIDATIVE STRESS; REEF FISHES; KELP; CD; CADMIUM; SEAWEED; COPPER; BIOSORPTION	Seaweeds are well known to concentrate metals from seawater and have been employed as monitors of metal pollution in coastal waters and estuaries. However, research showing that various intrinsic and extrinsic factors can influence metal accumulation, raises doubts about the basis for using seaweeds in biomonitoring programmes. The thallus of brown seaweeds of the order Laminariales (kelps) is morphologically complex but there is limited information about the variation in metal accumulation between the different parts, which might result in erroneous conclusions being drawn if not accounted for in the biomonitoring protocol. To assess patterns of individual metals in the differentiated parts of the thallus (blade, stipe, holdfast), concentrations of a wide range of essential and non-essential metals (Fe, Cr, Cu, Zn, Mn, Pb, Cd, Ni and Al) were measured in the kelp Lessonia trabeculata. Seaweeds were collected from three sampling stations located at 5, 30 and 60 m from an illegal sewage outfall close to Ventanas, Chile and from a pristine location at Faro Curaumilla. For the majority of metals the highest concentrations in bottom sediment and seaweed samples were found at the site closest to the outfall, with concentrations decreasing with distance from the outfall and at control stations; the exception was Cd, concentrations of which were higher at control stations. The patterns of metal concentrations in different thallus parts were metal specific and independent of sampling station. These results and the available literature suggest that biomonitoring of metals using seaweeds must take account of differences in the accumulation of metals in thallus parts of complex seaweeds.	[Saez, Claudio A.; Brown, Murray T.] Univ Plymouth, Sch Marine Sci & Engn, Fac Sci & Technol, Plymouth PL4 8AA, Devon, England; [Saez, Claudio A.; Gabriela Lobos, M.] Univ Valparaiso, Dept Quim & Bioquim, Fac Ciencias, Valparaiso, Chile; [Saez, Claudio A.; Oliva, Doris] Univ Valparaiso, Fac Ciencias, Dept Biol & Ciencias Ambient, Valparaiso, Chile; [Macaya, Erasmo C.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Oceanog, Concepcion, Chile; [Quiroz, Waldo] Pontificia Univ Catolica Valparaiso, Inst Quim, Lab Quim Analit & Ambiental, Valparaiso, Chile	University of Plymouth; Universidad de Valparaiso; Universidad de Valparaiso; Universidad de Concepcion; Pontificia Universidad Catolica de Valparaiso	Saez, CA (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Fac Sci & Technol, Plymouth PL4 8AA, Devon, England.	claudio.saez.a@gmail.com	Macaya, Erasmo/G-5291-2012; Sáez, Claudio/AAP-6923-2021; Macaya, Erasmo C/B-8651-2011; OLIVA, DORIS/AAM-8600-2021; Saez, Claudio/F-5978-2015; Brown, Murray/K-5291-2014	Sáez, Claudio/0000-0002-5037-3484; Saez, Claudio/0000-0002-5037-3484; Brown, Murray/0000-0003-2655-8611; Oliva, Doris/0000-0002-2792-3492; Macaya, Erasmo/0000-0002-9878-483X	FONDECYT [11080235]; CONICYT Becas Chile Scholarship [72110557]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Becas Chile Scholarship	Source of funding were FONDECYT (Project 11080235) and CONICYT Becas Chile Scholarship (72110557)www.conicyt.cl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1988, MAR CHEM, V23, P145, DOI 10.1016/0304-4203(88)90028-X; Abe K, 2001, MAR CHEM, V74, P197, DOI 10.1016/S0304-4203(01)00015-9; Amiard JC, 2004, ARCH ENVIRON CON TOX, V48, P68, DOI 10.1007/s00244-003-0180-8; Barreiro R, 2002, ENVIRON MONIT ASSESS, V75, P121, DOI 10.1023/A:1014479612811; BLACK WAP, 1952, J MAR BIOL ASSOC UK, V30, P575, DOI 10.1017/S0025315400012984; Brown MT, 2012, ECOTOXICOLOGY, V21, P591, DOI 10.1007/s10646-011-0819-6; Brown Murray T., 1998, Chapman & Hall Ecotoxicology Series, V7, P185; BRULAND KW, 1994, GEOCHIM COSMOCHIM AC, V58, P3171, DOI 10.1016/0016-7037(94)90044-2; BRULAND KW, 1980, EARTH PLANET SC LETT, V47, P176, DOI 10.1016/0012-821X(80)90035-7; BRYAN GW, 1969, J MAR BIOL ASSOC UK, V49, P225, DOI 10.1017/S0025315400046531; BRYAN GW, 1973, J MAR BIOL ASSOC UK, V53, P705, DOI 10.1017/S0025315400058902; Bunluesin S, 2007, WATER AIR SOIL POLL, V180, P225, DOI 10.1007/s11270-006-9265-0; Burger J, 2007, ENVIRON MONIT ASSESS, V128, P311, DOI 10.1007/s10661-006-9314-6; Butterworth FM, 2001, BIOMONITORS BIOMARKE; Chandia NP, 2001, CARBOHYD POLYM, V46, P81, DOI 10.1016/S0144-8617(00)00286-1; Collen J, 2003, ARCH ENVIRON CON TOX, V45, P337, DOI 10.1007/s00244-003-0196-0; Connan S, 2011, AQUAT TOXICOL, V104, P1, DOI 10.1016/j.aquatox.2011.03.016; Davenport AC, 2007, ECOLOGY, V88, P1548, DOI 10.1890/06-0880; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; DEBAAR HJW, 1994, MAR CHEM, V46, P261, DOI 10.1016/0304-4203(94)90082-5; Elbaz A, 2010, ECOTOXICOLOGY, V19, P1285, DOI 10.1007/s10646-010-0514-z; ELBAZPOULICHET F, 1987, MAR CHEM, V22, P125, DOI 10.1016/0304-4203(87)90004-1; Ferrer L, 2006, ECOTOX ENVIRON SAFE, V65, P209, DOI 10.1016/j.ecoenv.2005.06.010; FUGE R, 1974, MARINE POLLUTION B, V5, P9, DOI DOI 10.1016/0025-326X(74)90026-5; Fuge R., 1973, MAR CHEM, V1, P281, DOI 10.1016/0304-4203(73)90018-2; Gledhill M, 1998, MAR ENVIRON RES, V45, P295, DOI 10.1016/S0141-1136(98)00100-7; Gledhill M, 1999, J PHYCOL, V35, P501, DOI 10.1046/j.1529-8817.1999.3530501.x; HAUG A, 1961, ACTA CHEM SCAND, V15, P1794, DOI 10.3891/acta.chem.scand.15-1794; HAUG A, 1958, ACTA CHEM SCAND, V12, P650, DOI 10.3891/acta.chem.scand.12-0650; Hedouin L, 2006, SCI TOTAL ENVIRON, V366, P154, DOI 10.1016/j.scitotenv.2005.10.022; HIGGINS HW, 1987, AUST J MAR FRESH RES, V38, P317; HOLBROOK SJ, 1990, B MAR SCI, V47, P104; Lee R., 2008, PHYCOLOGY, VFourth, DOI DOI 10.1016/j.energy.2014.06.023; Margalef R, 1983, LIMNOLOGIA; Markert B., 2003, BIOINDICATORS BIOMON; MARKHAM JW, 1980, MAR ECOL PROG SER, V3, P31, DOI 10.3354/meps003031; Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571; MUNDA IM, 1986, BOT MAR, V29, P341, DOI 10.1515/botm.1986.29.4.341; MUNDA IM, 1988, PSZNI MAR ECOL, V9, P213; Beltrame MO, 2010, SCI TOTAL ENVIRON, V408, P531, DOI 10.1016/j.scitotenv.2009.09.051; Pawlik-Skowronska B, 2007, AQUAT TOXICOL, V83, P190, DOI 10.1016/j.aquatox.2007.04.003; PEDERSEN A, 1984, HYDROBIOLOGIA, V116, P498, DOI 10.1007/BF00027732; Percival E., 1967, CHEM ENZYMOLOGY MARI, DOI DOI 10.1002/ANGE; Pereira P, 2010, ECOTOX ENVIRON SAFE, V73, P805, DOI 10.1016/j.ecoenv.2010.02.020; Phillips D.J.H., 1990, P81; PHILLIPS DJH, 1977, ENVIRON POLLUT, V13, P281, DOI 10.1016/0013-9327(77)90047-7; Piotrowska-Niczyporuk A, 2012, PLANT PHYSIOL BIOCH, V52, P52, DOI 10.1016/j.plaphy.2011.11.009; Puranik PR, 1999, HYDROMETALLURGY, V52, P189, DOI 10.1016/S0304-386X(99)00017-1; RAGAN MA, 1980, J EXP MAR BIOL ECOL, V44, P261, DOI 10.1016/0022-0981(80)90157-4; RAGAN MA, 1979, J EXP MAR BIOL ECOL, V36, P91, DOI 10.1016/0022-0981(79)90102-3; Ray S, 1980, CANADIAN TECHNICAL R, V96, P12; Saez CA, 2012, CHEM ECOL, V28, P1, DOI 10.1080/02757540.2011.619529; Salgado LT, 2005, PROTOPLASMA, V225, P123, DOI 10.1007/s00709-004-0066-2; Sanchiz C, 1999, BOT MAR, V42, P157, DOI 10.1515/BOT.1999.018; SEGEGOD, 2001, MINSEGPRES DS 2000; Shibata T, 2006, J APPL PHYCOL, V18, P787, DOI 10.1007/s10811-006-9094-y; Silva N, 2003, INVESTIGACIONES MARI, V31, P73; Stengel DB, 2005, ESTUAR COAST SHELF S, V65, P687, DOI 10.1016/j.ecss.2005.07.003; Strub P.T., 1998, SEA, P273; SUEUR S, 1982, LIMNOL OCEANOGR, V27, P536, DOI 10.4319/lo.1982.27.3.0536; Swanson AK, 2002, AQUAT BOT, V73, P241, DOI 10.1016/S0304-3770(02)00035-9; VENEGAS M, 1993, BOT MAR, V36, P47, DOI 10.1515/botm.1993.36.1.47; VILLOUTA E, 1986, PHYCOLOGIA, V25, P81, DOI 10.2216/i0031-8884-25-1-81.1; YOUNG ML, 1975, J MAR BIOL ASSOC UK, V55, P583, DOI 10.1017/S0025315400017276; Zhou JL, 1998, ENVIRON POLLUT, V101, P67, DOI 10.1016/S0269-7491(98)00034-7	66	31	31	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50170	10.1371/journal.pone.0050170	http://dx.doi.org/10.1371/journal.pone.0050170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166836	Green Published, gold			2022-12-25	WOS:000311885300092
J	Marsden, CG; Wright, MJ; Carrier, L; Moroz, K; Rowan, BG				Marsden, Carolyn G.; Wright, Mary Jo; Carrier, Latonya; Moroz, Krzysztof; Rowan, Brian G.			Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Metastatic Phenotype during Metastatic Latency in the Bone	PLOS ONE			English	Article							DISSEMINATED TUMOR-CELLS; HEMATOPOIETIC STEM-CELLS; E-CADHERIN EXPRESSION; NUCLEAR E-CADHERIN; MARROW MICROMETASTASIS; INITIATING CELLS; EPITHELIAL-CELLS; PRIMARY SURGERY; BETA-CATENIN; CARCINOMA	Background: Disseminated tumor cells (DTCs) in the bone marrow may exist in a dormant state for extended periods of time, maintaining the ability to proliferate upon activation, engraft at new sites, and form detectable metastases. However, understanding of the behavior and biology of dormant breast cancer cells in the bone marrow niche remains limited, as well as their potential involvement in tumor recurrence and metastasis. Therefore, the purpose of this study was to investigate the tumorigenicity and metastatic potential of dormant disseminated breast cancer cells (prior to activation) in the bone marrow. Methodology/Principal Findings: Total bone marrow, isolated from mice previously injected with tumorspheres into the mammary fat pad, was injected into the mammary fat pad of NUDE mice. As a negative control, bone marrow isolated from non-injected mice was injected into the mammary fat pad of NUDE mice. The resultant tumors were analyzed by immunohistochemistry for expression of epithelial and mesenchymal markers. Mouse lungs, livers, and kidneys were analyzed by H+E staining to detect metastases. The injection of bone marrow isolated from mice previously injected with tumorspheres into the mammary fat pad, resulted in large tumor formation in the mammary fat pad 2 months post-injection. However, the injection of bone marrow isolated from non-injected mice did not result in tumor formation in the mammary fat pad. The DTC-derived tumors exhibited accelerated development of metastatic lesions within the lung, liver and kidney. The resultant tumors and the majority of metastatic lesions within the lung and liver exhibited a mesenchymal-like phenotype. Conclusions/Significance: Dormant DTCs within the bone marrow are highly malignant upon injection into the mammary fat pad, with the accelerated development of metastatic lesions within the lung, liver and kidney. These results suggest the acquisition of a more aggressive phenotype of DTCs during metastatic latency within the bone marrow microenvironment.	[Marsden, Carolyn G.; Carrier, Latonya; Rowan, Brian G.] Tulane Univ, Hlth Sci Ctr, Louisiana Canc Res Consortium, Dept Struct & Cellular Biol, New Orleans, LA 70118 USA; [Wright, Mary Jo] Tulane Univ, Sch Med, Louisiana Canc Res Consortium, Dept Surg, New Orleans, LA 70118 USA; [Moroz, Krzysztof] Tulane Univ, Sch Med, Louisiana Canc Res Consortium, Sect Surg Pathol & Cytopathol, New Orleans, LA 70118 USA	Tulane University; Tulane University; Tulane University	Rowan, BG (corresponding author), Tulane Univ, Hlth Sci Ctr, Louisiana Canc Res Consortium, Dept Struct & Cellular Biol, New Orleans, LA 70118 USA.	browan@tulane.edu			DOD [BC093134]; Louisiana Cancer Research Consortium	DOD(United States Department of Defense); Louisiana Cancer Research Consortium	CGM was supported by a DOD Breast Cancer Research Program Predoctoral Traineeship Award BC093134. This project was supported, in part, by a seed grant from the Louisiana Cancer Research Consortium (BGR).] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Allgayer H, 2008, APMIS, V116, P602, DOI 10.1111/j.1600-0463.2008.00997.x; Anbalagan M, 2012, MOL CANCER THER, P1535; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Bidard FC, 2008, CLIN CANCER RES, V14, P3306, DOI 10.1158/1078-0432.CCR-07-4749; Braun S, 2001, CANCER RES, V61, P1890; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cardamone MD, 2009, P NATL ACAD SCI USA, V106, P7420, DOI 10.1073/pnas.0903033106; Chetty R, 2008, HISTOPATHOLOGY, V52, P325, DOI 10.1111/j.1365-2559.2007.02949.x; Chetty R, 2008, HUM PATHOL, V39, P1407, DOI 10.1016/j.humpath.2008.05.015; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Diel IJ, 1996, JNCI-J NATL CANCER I, V88, P1652, DOI 10.1093/jnci/88.22.1652; Ditsch N, 2003, RECENT RES CANCER, V162, P141; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Elston MS, 2009, J CLIN ENDOCR METAB, V94, P1436, DOI 10.1210/jc.2008-2075; Engel J, 2003, EUR J CANCER, V39, P1794, DOI 10.1016/S0959-8049(03)00422-2; Fehm T, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2143; Feuerer M, 2001, INT J CANCER, V92, P96, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1152>3.0.CO;2-Q; Gebauer G, 2001, J CLIN ONCOL, V19, P3669, DOI 10.1200/JCO.2001.19.16.3669; Gervais ML, 2007, LAB INVEST, V87, P1252, DOI 10.1038/labinvest.3700684; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Habeck M, 2000, MOL MED TODAY, V6, P256, DOI 10.1016/S1357-4310(00)01733-0; Hajra KM, 2002, CANCER RES, V62, P1613; Han AC, 2000, ARCH PATHOL LAB MED, V124, P1147; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klein CA, 2006, CELL CYCLE, V5, P1788, DOI 10.4161/cc.5.16.3097; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Leung CT, 2009, CELL, V139, P1226, DOI 10.1016/j.cell.2009.12.013; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Marsden CG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-10; Marsden CG, 2009, METHODS MOL BIOL, V590, P363, DOI 10.1007/978-1-60327-378-7_23; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Nicola MHA, 2003, CLIN EXP METASTAS, V20, P471, DOI 10.1023/A:1025462417256; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Ohishi Y, 2011, HISTOPATHOLOGY, V58, P423, DOI 10.1111/j.1365-2559.2011.03761.x; Pachmann K, 2005, CLIN CHEM LAB MED, V43, P617, DOI 10.1515/CCLM.2005.107; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Phadke PA, 2006, CLIN CANCER RES, V12, P1431, DOI 10.1158/1078-0432.CCR-05-1806; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prasad CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-325; Rao G, 2004, CANCER RES, V64, P2874, DOI 10.1158/0008-5472.CAN-03-3121; Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200; Salahshor S, 2001, BREAST CANCER RES, V3, P199, DOI 10.1186/bcr295; Salahshor S, 2008, MODERN PATHOL, V21, P271, DOI 10.1038/modpathol.3800990; Sauer T, 2001, DIAGN CYTOPATHOL, V25, P382, DOI 10.1002/dc.10030; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Siclari VA, 2006, CANCER METAST REV, V25, P621, DOI 10.1007/s10555-006-9023-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Welch DR, 2008, CANCER RES, V68, P9578, DOI 10.1158/0008-5472.CAN-08-3360; WHEELOCK MJ, 1987, J CELL BIOCHEM, V34, P187, DOI 10.1002/jcb.240340305; Wiedswang G, 2003, CYTOTHERAPY, V5, P40, DOI 10.1080/14653240310000065; Wiedswang G, 2004, CLIN CANCER RES, V10, P5342, DOI 10.1158/1078-0432.CCR-04-0245	73	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e47587	10.1371/journal.pone.0047587	http://dx.doi.org/10.1371/journal.pone.0047587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23173031	gold, Green Published, Green Submitted			2022-12-25	WOS:000311272300004
J	Iolyeva, M; Karaman, S; Willrodt, AH; Weingartner, S; Vigl, B; Halin, C				Iolyeva, Maria; Karaman, Sinem; Willrodt, Ann-Helen; Weingartner, Stephanie; Vigl, Benjamin; Halin, Cornelia			Novel role for ALCAM in lymphatic network formation and function	FASEB JOURNAL			English	Article						adhesion molecule; lymphangiogenesis; dendritic; cell migration	CELL-ADHESION MOLECULE; ANGIOGENESIS; TRAFFICKING; VASCULATURE; MIGRATION; JUNCTIONS; CD6; LYMPHANGIOGENESIS; ANGIOPOIETIN-2; IDENTIFICATION	Adhesion molecules play an important role in vascular biology because they mediate vascular stability, permeability, and leukocyte trafficking to and from tissues. Performing microarray analyses, we have recently identified activated leukocyte cell adhesion molecule (ALCAM) as an inflammation-induced gene in lymphatic endothelial cells (LECs). ALCAM belongs to the immunoglobulin superfamily and engages in homophilic as well as heterophilic interactions. In this study, we found ALCAM to be expressed at the protein level in human and murine lymphatic and blood vascular endothelial cells in vitro and in the vasculature of human and murine tissues in vivo. Functional in vitro experiments revealed that ALCAM mediates adhesive interactions, migration, and tube formation in LECs, suggesting a role for ALCAM in lymphatic vessel (LV) stability and in lymphangiogenesis. Furthermore, ALCAM supported dendritic cell (DC) adhesion to lymphatic endothelium. In agreement with these findings, experiments performed in ALCAM(-/-) mice detected reduced LEC numbers in various tissues and defects in the formation of an organized LV network. Moreover, DC migration from lung to draining lymph nodes was compromised in ALCAM(-/-) mice. Collectively, our data reveal a novel role for ALCAM in stabilizing LEC-LEC interactions and in the organization and function of the LV network.-Iolyeva, M., Karaman, S., Willrodt, A.-H., Weingartner, S., Vigl, B., Halin, C. Novel role for ALCAM in lymphatic network formation and function. FASEB J. 27, 978-990 (2013). www.fasebj.org	[Iolyeva, Maria; Karaman, Sinem; Willrodt, Ann-Helen; Weingartner, Stephanie; Vigl, Benjamin; Halin, Cornelia] ETH, Inst Pharmaceut Sci, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Halin, C (corresponding author), ETH, Inst Pharmaceut Sci, Wolfgang Pauli Str 10,HCI H413, CH-8093 Zurich, Switzerland.	cornelia.halin@pharma.ethz.ch	Karaman, Sinem/C-4428-2017	Karaman, Sinem/0000-0002-0719-1773; Halin, Cornelia/0000-0002-7899-2850; Weingartner, Sebastian/0000-0002-0739-6306	Swiss National Fund [310030_138330]; Prof. Dr. Max Cloetta Foundation; ETH Zurich [0-20566_09]	Swiss National Fund(Swiss National Science Foundation (SNSF)); Prof. Dr. Max Cloetta Foundation; ETH Zurich(ETH Zurich)	The authors thank Csaba Balazs (ETH Zurich) for developing the ImageJ-based script used for image quantification and Simone Haener (ETH Zurich) for excellent technical support. Furthermore, the authors thank Joshua Weiner (University of Iowa, Iowa City, IA, USA) for providing tissue samples of ALCAM<SUP>-/-</SUP> and control mice in the beginning of the project. C.H, gratefully acknowledges financial support from the Swiss National Fund (grant 310030_138330), the Prof. Dr. Max Cloetta Foundation, and ETH Zurich (project grant 0-20566_09). M.I. designed research, performed research, analyzed data, and wrote the paper; S.K., A.H.W., and S.W. performed research and analyzed and discussed data; C.H. designed research, analyzed data, and wrote the paper. The authors declare no conflicts of interest.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Buhusi M, 2009, J NEUROSCI, V29, P15630, DOI 10.1523/JNEUROSCI.2215-09.2009; Delgado VMC, 2011, FASEB J, V25, P242, DOI 10.1096/fj.09-144907; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Cueni LN, 2009, EXP CELL RES, V315, P1715, DOI 10.1016/j.yexcr.2009.02.021; Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Garmy-Susini B, 2010, CANCER RES, V70, P3042, DOI 10.1158/0008-5472.CAN-09-3761; Garrido-Urbani S, 2008, BIOCHEM SOC T, V36, P203, DOI 10.1042/BST0360203; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Ikeda K, 2004, J BIOL CHEM, V279, P55315, DOI 10.1074/jbc.M407776200; Ishida T, 2003, J BIOL CHEM, V278, P34598, DOI 10.1074/jbc.M304890200; Jakubzick C, 2010, METHODS MOL BIOL, V595, P371, DOI 10.1007/978-1-60761-421-0_24; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Maddaluno L, 2009, J EXP MED, V206, P623, DOI 10.1084/jem.20081211; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Masedunskas A, 2006, FEBS LETT, V580, P2637, DOI 10.1016/j.febslet.2006.04.013; Mirza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037523; Ofori-Acquah SF, 2008, MICROVASC RES, V75, P391, DOI 10.1016/j.mvr.2007.10.006; Ofori-Acquah SF, 2008, TRANSL RES, V151, P122, DOI 10.1016/j.trsl.2007.09.006; Ohneda O, 2001, BLOOD, V98, P2134, DOI 10.1182/blood.V98.7.2134; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; PATEL DD, 1995, J EXP MED, V181, P1563, DOI 10.1084/jem.181.4.1563; Pfeiffer F, 2008, EUR J IMMUNOL, V38, P2142, DOI 10.1002/eji.200838140; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Schliemann C, 2010, BLOOD, V115, P736, DOI 10.1182/blood-2009-08-239004; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Singer NG, 2002, INT IMMUNOL, V14, P585, DOI 10.1093/intimm/dxf025; Swart GWM, 2005, CANCER METAST REV, V24, P223, DOI 10.1007/s10555-005-1573-0; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; Vestweber D, 2012, ANN NY ACAD SCI, V1257, P184, DOI 10.1111/j.1749-6632.2012.06558.x; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Vigl B, 2009, EXP CELL RES, V315, P336, DOI 10.1016/j.yexcr.2008.10.020; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P231; Weiner JA, 2004, MOL CELL NEUROSCI, V27, P59, DOI 10.1016/j.mcn.2004.06.005; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Zimmerman AW, 2006, BLOOD, V107, P3212, DOI 10.1182/blood-2005-09-3881	43	36	38	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					978	990		10.1096/fj.12-217844	http://dx.doi.org/10.1096/fj.12-217844			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23169771				2022-12-25	WOS:000315585200013
J	Adonin, LS; Shaposhnikova, TG; Podgornaya, O				Adonin, Leonid S.; Shaposhnikova, Tatyana G.; Podgornaya, Olga			Aurelia aurita (Cnidaria) Oocytes' Contact Plate Structure and Development	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ZONA-PELLUCIDA; PENETRATION; DROSOPHILA; OVULATION; PROTEINS; SEARCH; FIBERS; CELLS; EGGS	One of the A. aurita medusa main mesoglea polypeptides, mesoglein, has been described previously. Mesoglein belongs to ZP-domain protein family and therefore we focused on A. aurita oogenesis. Antibodies against mesoglein (AB RA47) stain the plate in the place where germinal epithelium contacts oocyte on the paraffin sections. According to its position, we named the structure found the "contact plate". Our main instrument was AB against mesoglein. ZP-domain occupies about half of the whole amino acid sequence of the mesoglein. Immunoblot after SDS-PAGE and AU-PAGE reveals two charged and high M-r bands among the female gonad germinal epithelium polypeptides. One of the gonads' polypeptides M-r corresponds to that of mesogleal cells, the other ones' M-r is higher. The morphological description of contact plate formation is the subject of the current work. Two types of AB RA47 positive granules were observed during progressive oogenesis stages. Granules form the contact plate in mature oocyte. Contact plate of A. aurita oocyte marks its animal pole and resembles Zona Pellucida by the following features: (1) it attracts spermatozoids; (2) the material of the contact plate is synthesized by oocyte and stored in granules; (3) these granules and the contact plate itself contain ZP domain protein(s); (4) contact plate is an extracellular structure made up of fiber bundles similar to those of conventional Zona Pellucida.	[Adonin, Leonid S.; Podgornaya, Olga] Inst Cytol RAS, St Petersburg, Russia; [Adonin, Leonid S.; Shaposhnikova, Tatyana G.; Podgornaya, Olga] St Petersburg State Univ, Fac Biol & Soil Sci, Dept Cytol & Histol, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Saint Petersburg State University	Podgornaya, O (corresponding author), Inst Cytol RAS, St Petersburg, Russia.	opodg@yahoo.com	Podgornaya, Olga/E-4325-2013; Shaposhnikova, Tatiana/J-9443-2013	Podgornaya, Olga/0000-0001-5065-5783; Shaposhnikova, Tatiana/0000-0001-7433-0772	Russian Foundation for Basic Research [09-04-01145-a, 12-04-01497-?, 12-04-31240-young_a]; presidium RAS (MCB)	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); presidium RAS (MCB)	This work was supported by the Russian Foundation for Basic Research (grants 09-04-01145-a, 12-04-01497-?, 12-04-31240-young_a) and a grant from presidium RAS (MCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonin L.S., 2009, CELL TISSUE BIOL, V3, P283; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bouillon J, 1977, CAH BIOL MAR, V13, P339; CHAPMAN G, 1959, Q J MICROSC SCI, V100, P599; Chapman G, 1966, S ZOOL SOC LOND, V16, P147; ECKELBARGER KJ, 1988, MAR BIOL, V100, P103, DOI 10.1007/BF00392960; ELDER HY, 1973, BIOL BULL-US, V144, P43, DOI 10.2307/1540146; Fitch KR, 1998, CURR TOP DEV BIOL, V38, P1; Geyer G, 1973, ULTRAHISTOCHEMIE, P488; GILULA NB, 1978, J CELL BIOL, V78, P58, DOI 10.1083/jcb.78.1.58; Ivanova-Kazas OM, 1975, COMP EMBRYOLOGY INVE, P15; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matveev IV, 2007, GENE, V399, P20, DOI 10.1016/j.gene.2007.04.034; Matveev IV, 2012, J EXP ZOOL PART B, V318B, P1, DOI 10.1002/jez.b.21440; MCMASTER R, 1978, BIOL REPROD, V19, P212, DOI 10.1095/biolreprod19.1.212; Napara T.O., 1996, Tsitologiya, V38, P465; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; PARR EL, 1973, BIOL REPROD, V8, P531, DOI 10.1093/biolreprod/8.5.531; PELUSO JJ, 1980, BIOL REPROD, V22, P999, DOI 10.1095/biolreprod22.4.999; Pirs E, 1962, HISTOCHEMISTRY THEOR, P1078; Podgornaya OI, 1998, CELL STRUCT FUNCT, V23, P349, DOI 10.1247/csf.23.349; Qazi MCB, 2003, DEV BIOL, V256, P195, DOI 10.1016/S0012-1606(02)00125-2; Russell SF, 1970, MEDUSAE BRIT ISLES; SARRAS MP, 1991, DEV BIOL, V148, P481, DOI 10.1016/0012-1606(91)90266-6; Shaposhnikova T, 2005, CELL BIOL INT, V29, P952, DOI 10.1016/j.cellbi.2005.08.008; SZOLLOSI DG, 1961, J BIOPHYS BIOCHEM CY, V10, P275, DOI 10.1083/jcb.10.2.275; Tarin JJ, 2005, FERTILIZATION PROTOZ, P355; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Waterborg J. H, 2002, PROTEIN PROTOCOLS HD, P1146; WEBER C, 1985, TISSUE CELL, V17, P811, DOI 10.1016/0040-8166(85)90038-2; Wong JL, 2006, CURR TOP DEV BIOL, V72, P1, DOI 10.1016/S0070-2153(05)72001-9	32	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e46542	10.1371/journal.pone.0046542	http://dx.doi.org/10.1371/journal.pone.0046542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185235	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000004
J	Anand, A; Sharma, NK; Gupta, A; Prabhakar, S; Sharma, SK; Singh, R; Gupta, PK				Anand, Akshay; Sharma, Neel Kamal; Gupta, Amod; Prabhakar, Sudesh; Sharma, Suresh Kumar; Singh, Ramandeep; Gupta, Pawan Kumar			Single Nucleotide Polymorphisms in MCP-1 and Its Receptor Are Associated with the Risk of Age Related Macular Degeneration	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CCL2; INHIBITION; EXPRESSION; CHEMOKINES; TLR4; CCR2	Background: Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population. We have shown previously that mice deficient in monocyte chemoattractant protein-1 (MCP1/CCL2) or its receptor (CCR2) develop the features of AMD in senescent mice, however, the human genetic evidence so far is contradictory. We hypothesized that any dysfunction in the CCL2 and its receptor result could be the contributing factor in pathogenesis of AMD. Methods and Findings: 133 AMD patients and 80 healthy controls were enrolled for this study. Single neucleotid Polymorphism for CCL2 and CCR2 was analyzed by real time PCR. CCL2 levels were determined by enzyme-linked immunosorbent assay (ELISA) after normalization to total serum protein and percentage (%) of CCR2 expressing peripheral blood mononuclear cells (PBMCs) was evaluated using Flow Cytometry. The genotype and allele frequency for both CCL2 and CCR2 was found to be significantly different between AMD and normal controls. The CCL2 ELISA levels were significantly higher in AMD patients and flow Cytometry analysis revealed significantly reduced CCR2 expressing PBMCs in AMD patients as compared to normal controls. Conclusions: We analyzed the association between single neucleotide polymorphisms (SNPs) of CCL2 (rs4586) and CCR2 (rs1799865) with their respective protein levels. Our results revealed that individuals possessing both SNPs are at a higher risk of development of AMD.	[Anand, Akshay; Sharma, Neel Kamal; Prabhakar, Sudesh; Gupta, Pawan Kumar] PGIMER, Dept Neurol, Chandigarh, India; [Gupta, Amod; Singh, Ramandeep] PGIMER, Dept Ophthalmol, Chandigarh, India; [Sharma, Suresh Kumar] Panjab Univ, Dept Stat, Chandigarh 160014, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University	Anand, A (corresponding author), PGIMER, Dept Neurol, Chandigarh, India.	akshay1anand@rediffmail.com	Gupta, Amod/V-7633-2017	Gupta, Amod/0000-0001-8427-5738	Department of Science and Technology [SR/SO/HS-109/205]	Department of Science and Technology(Department of Science & Technology (India))	The funding of study was from Department of Science and Technology(F. No. SR/SO/HS-109/205 dated 1-05-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022818; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Despriet DDG, 2008, INVEST OPHTH VIS SCI, V49, P364, DOI 10.1167/iovs.07-0656; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; Haas P, 2011, CURR EYE RES, V36, P143, DOI 10.3109/02713683.2010.533808; Harmon BT, 2010, J APPL PHYSIOL, V109, P1779, DOI 10.1152/japplphysiol.00633.2010; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Jemaa R, 2008, CLIN CHIM ACTA, V390, P122, DOI 10.1016/j.cca.2008.01.004; Jonas JB, 2010, ARCH OPHTHALMOL-CHIC, V128, P1281, DOI 10.1001/archophthalmol.2010.227; Kaur I, 2006, INVEST OPHTH VIS SCI, V47, P3729, DOI 10.1167/iovs.05-1430; Kim MP, 2007, ATHEROSCLEROSIS, V193, P366, DOI 10.1016/j.atherosclerosis.2006.06.029; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; McDermott DH, 2005, CIRCULATION, V112, P1113, DOI 10.1161/CIRCULATIONAHA.105.543579; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Raoul W, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-87; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Sharma NK, 2009, ANN NEUROSCI, V16, P62, DOI 10.5214/ans.0972.7531.2009.160208; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085	28	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49905	10.1371/journal.pone.0049905	http://dx.doi.org/10.1371/journal.pone.0049905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185481	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000140
J	Devey, LR; Richards, JA; O'Connor, RA; Borthwick, G; Clay, S; Howie, AF; Wigmore, SJ; Anderton, SM; Howie, SEM				Devey, Luke R.; Richards, James A.; O'Connor, Richard A.; Borthwick, Gary; Clay, Spike; Howie, A. Forbes; Wigmore, Stephen J.; Anderton, Stephen M.; Howie, Sarah E. M.			Ischemic Preconditioning in the Liver Is Independent of Regulatory T Cell Activity	PLOS ONE			English	Article							REPERFUSION INJURY; TGF-BETA; LYMPHOCYTES; EXPANSION; RECEPTOR; INFLAMMATION; SUPPRESSION; CONTRIBUTE; INDUCTION; AGONIST	Ischemic preconditioning (IPC) protects organs from ischemia reperfusion injury (IRI) through unknown mechanisms. Effector T cell populations have been implicated in the pathogenesis of IRI, and T regulatory cells (Treg) have become a putative therapeutic target, with suggested involvement in IPC. We explored the role of Treg in hepatic IRI and IPC in detail. IPC significantly reduced injury following ischemia reperfusion insults. Treg were mobilized rapidly to the circulation and liver after IRI, but IPC did not further increase Treg numbers, nor was it associated with modulation of circulating pro-inflammatory chemokine or cytokine profiles. We used two techniques to deplete Treg from mice prior to IRI. Neither Treg depleted FoxP3.LuciDTR mice, nor wildtyoe mice depleted of Tregs with PC61, were more susceptible to IRI compared with controls. Despite successful enrichment of Treg in the liver, by adoptive transfer of both iTreg and nTreg or by in vivo expansion of Treg with IL-2/anti-IL-2 complexes, no protection against IRI was observed. We have explored the role of Treg in IRI and IPC using a variety of techniques to deplete and enrich them within both the liver and systemically. This work represents an important negative finding that Treg are not implicated in IPC and are unlikely to have translational potential in hepatic IRI.	[Devey, Luke R.; Richards, James A.; O'Connor, Richard A.; Borthwick, Gary; Clay, Spike; Howie, A. Forbes; Wigmore, Stephen J.; Anderton, Stephen M.; Howie, Sarah E. M.] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Edinburgh	Devey, LR (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.	luke@devey.net	Wigmore, Stephen/AAF-3562-2019	Wigmore, Stephen/0000-0002-3614-8002; Devey, Luke/0000-0002-1289-7332; Richards, James/0000-0001-9049-5745; O'Connor, Richard/0000-0001-7100-0233; Howie, Sarah/0000-0001-7291-3499	Academy of Medical Sciences; Health Foundation, United Kingdom; Medical Research Council (UK) [G1100084, G0801924]; MRC [G0901697, G1100084, G0801924] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-CSF3-Devey] Funding Source: researchfish; Medical Research Council [G0801924, G1100084, G0901697] Funding Source: researchfish	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Health Foundation, United Kingdom; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in the form of a post-doctoral Clinician Scientist Fellowship to Luke Devey, (534,862) pound made by the Academy of Medical Sciences (www.acmedsci.ac.uk) and Health Foundation (www.health.org.uk), United Kingdom. The Anderton laboratory is funded by project grants from the Medical Research Council (UK) including G1100084 (876,851) pound and G0801924 (1,912,721) pound. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo DM, 2002, AM J TRANSPLANT, V2, P843, DOI 10.1034/j.1600-6143.2002.20906.x; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080; Burne-Taney MJ, 2006, J IMMUNOL, V176, P7015, DOI 10.4049/jimmunol.176.11.7015; Caldwell CC, 2005, AM J PHYSIOL-GASTR L, V289, pG969, DOI 10.1152/ajpgi.00223.2005; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Devey L, 2008, LAB ANIM-UK, V42, P12, DOI 10.1258/la.2007.06009e; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Devey L, 2009, TRANSPLANTATION, V88, P308, DOI 10.1097/TP.0b013e3181ae3067; Devey LR, 2007, TRANSPLANTATION, V84, P70, DOI 10.1097/01.tp.0000268072.04260.69; Feng M, 2012, INT IMMUNOPHARMACOL, V12, P189, DOI 10.1016/j.intimp.2011.11.010; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Horie Y, 1999, MICROCIRCULATION, V6, P267; Kinsey GR, 2010, KIDNEY INT, V77, P771, DOI 10.1038/ki.2010.12; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Kuboki S, 2009, AM J PHYSIOL-GASTR L, V296, pG1054, DOI 10.1152/ajpgi.90464.2008; Lai LW, 2007, KIDNEY INT, V71, P1223, DOI 10.1038/sj.ki.5002203; Lai LW, 2012, KIDNEY INT, V81, P983, DOI 10.1038/ki.2011.412; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Lien YHH, 2006, KIDNEY INT, V69, P1601, DOI 10.1038/sj.ki.5000360; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Lu L, 2009, INT IMMUNOPHARMACOL, V9, P549, DOI 10.1016/j.intimp.2009.01.020; Monteiro RMM, 2009, TRANSPL IMMUNOL, V21, P50, DOI 10.1016/j.trim.2009.02.003; O'Connor RA, 2010, J IMMUNOL, V185, P7235, DOI 10.4049/jimmunol.1001551; Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d; Savransky V, 2006, KIDNEY INT, V69, P233, DOI 10.1038/sj.ki.5000038; Serafin A, 2004, HEPATOLOGY, V39, P688, DOI 10.1002/hep.20089; Stephens LA, 2009, EUR J IMMUNOL, V39, P1108, DOI 10.1002/eji.200839073; Suffner J, 2010, J IMMUNOL, V184, P1810, DOI 10.4049/jimmunol.0902420; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Zwacka RM, 1997, J CLIN INVEST, V100, P279, DOI 10.1172/JCI119533	36	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49647	10.1371/journal.pone.0049647	http://dx.doi.org/10.1371/journal.pone.0049647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185394	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000075
J	Gomes, RA; Franco, C; Da Costa, G; Planchon, S; Renaut, J; Ribeiro, RM; Pinto, F; Silva, MS; Coelho, AV; Freire, AP; Cordeiro, C				Gomes, Ricardo A.; Franco, Catarina; Da Costa, Goncalo; Planchon, Sebastien; Renaut, Jenny; Ribeiro, Raquel M.; Pinto, Francisco; Silva, Marta Sousa; Coelho, Ana Varela; Freire, Ana Ponces; Cordeiro, Carlos			The Proteome Response to Amyloid Protein Expression In Vivo	PLOS ONE			English	Article							ELONGATION-FACTOR 1A; HEAT-SHOCK RESPONSE; LARGE GENE LISTS; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; TRANSTHYRETIN DEPOSITION; INTEGRATIVE ANALYSIS; MASS-SPECTROMETRY; YEAST-CELLS; POLYNEUROPATHY	Protein misfolding disorders such as Alzheimer, Parkinson and transthyretin amyloidosis are characterized by the formation of protein amyloid deposits. Although the nature and location of the aggregated proteins varies between different diseases, they all share similar molecular pathways of protein unfolding, aggregation and amyloid deposition. Most effects of these proteins are likely to occur at the proteome level, a virtually unexplored reality. To investigate the effects of an amyloid protein expression on the cellular proteome, we created a yeast expression system using human transthyretin (TTR) as a model amyloidogenic protein. We used Saccharomyces cerevisiae, a living test tube, to express native TTR (non-amyloidogenic) and the amyloidogenic TTR variant L55P, the later forming aggregates when expressed in yeast. Differential proteome changes were quantitatively analyzed by 2D-differential in gel electrophoresis (2D-DIGE). We show that the expression of the amyloidogenic TTR-L55P causes a metabolic shift towards energy production, increased superoxide dismutase expression as well as of several molecular chaperones involved in protein refolding. Among these chaperones, members of the HSP70 family and the peptidyl-prolyl-cis-trans isomerase (PPIase) were identified. The latter is highly relevant considering that it was previously found to be a TTR interacting partner in the plasma of ATTR patients but not in healthy or asymptomatic subjects. The small ubiquitin-like modifier (SUMO) expression is also increased. Our findings suggest that refolding and degradation pathways are activated, causing an increased demand of energetic resources, thus the metabolic shift. Additionally, oxidative stress appears to be a consequence of the amyloidogenic process, posing an enhanced threat to cell survival.	[Gomes, Ricardo A.; Da Costa, Goncalo; Ribeiro, Raquel M.; Pinto, Francisco; Silva, Marta Sousa; Freire, Ana Ponces; Cordeiro, Carlos] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, Lisbon, Portugal; [Gomes, Ricardo A.; Franco, Catarina; Coelho, Ana Varela] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Planchon, Sebastien; Renaut, Jenny] Ctr Rech Publ Gabriel Lippmann, Dept Environnent & Agrobiotechnol, Belvaux, Luxembourg	Universidade de Lisboa; Universidade Nova de Lisboa; Luxembourg Institute of Science & Technology	Cordeiro, C (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim, Lisbon, Portugal.	caac@fc.ul.pt	Coelho, Ana V Varela/O-3977-2014; Renaut, Jenny/K-3216-2012; Silva, Marta Sousa/N-2084-2019; Coelho, Ana V/H-8885-2012; Planchon, Sébastien/ABG-8342-2020; FT-ICR-MS, Lisboa/T-5273-2018; Franco, Catarina F/K-6386-2013; da Costa, Gonçalo/H-9059-2012; Costa, Goncalo/G-9100-2014; Pinto, Francisco/A-7443-2008; Gomes, Ricardo/E-8379-2012	Coelho, Ana V Varela/0000-0002-6143-4203; Renaut, Jenny/0000-0002-0450-3866; Silva, Marta Sousa/0000-0002-3080-9682; Coelho, Ana V/0000-0002-6143-4203; Planchon, Sébastien/0000-0002-0455-0574; Franco, Catarina F/0000-0003-2288-1518; da Costa, Gonçalo/0000-0001-8732-4478; Costa, Goncalo/0000-0001-8732-4478; Pinto, Francisco/0000-0002-4217-0054; Cordeiro, Carlos/0000-0001-6327-8606; Gomes, Ricardo/0000-0001-7155-0059; Ponces-Freire, Ana/0000-0003-2280-8193	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/41037/2007, PEst-OE/QUI/UI0612/2011, PTDC/QUI/70610/2006, REDE/1501/REM/2005]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Work was supported by grants SFRH/BPD/41037/2007 (R.A.G.), PEst-OE/QUI/UI0612/2011, PTDC/QUI/70610/2006 and REDE/1501/REM/2005 from the Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-32; ANDO Y, 1993, INTERNAL MED, V32, P920, DOI 10.2169/internalmedicine.32.920; ARAKI S, 1995, INTERNAL MED, V34, P703, DOI 10.2169/internalmedicine.34.703; Ausubel F., 1999, CURRENT PROTOCOLS MO; Bandhakavi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001598; Bektas M, 2005, INT J BIOCHEM CELL B, V37, P91, DOI 10.1016/j.biocel.2004.05.016; Bruckmann A, 2004, BIOCHEM J, V382, P867, DOI 10.1042/BJ20031885; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Choi ID, 2008, BIOCHEM BIOPH RES CO, V377, P395, DOI 10.1016/j.bbrc.2008.09.146; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; da Costa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024850; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GHISO J, 1994, MOL NEUROBIOL, V8, P49, DOI 10.1007/BF02778007; GLERUM DM, 1995, J BIOL CHEM, V270, P15585, DOI 10.1074/jbc.270.26.15585; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gomes R, 2005, BIOCHEM J, V385, P339, DOI 10.1042/BJ20040833; Gomes RA, 2006, FEBS J, V273, P5273, DOI 10.1111/j.1742-4658.2006.05520.x; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ichimura T, 2004, BIOCHEMISTRY-US, V43, P6149, DOI 10.1021/bi035421i; IIDA H, 1985, NATURE, V315, P688, DOI 10.1038/315688a0; JACOBSON DR, 1992, HUM GENET, V89, P353; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; Kim JH, 2009, J BIOL CHEM, V284, P10400, DOI 10.1074/jbc.M900377200; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Kramer ML, 2008, BIOTECHNIQUES, V44, P403, DOI 10.2144/000112691; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Li YH, 2003, P NATL ACAD SCI USA, V100, P259, DOI 10.1073/pnas.0235361100; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nagaraj N., 2011, MOL CELL PROTEOMICS; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Olsson M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-130; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro Tiago Fleming, 2007, Semin Pediatr Neurol, V14, P15, DOI 10.1016/j.spen.2006.11.005; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Peisker K, 2010, BBA-MOL CELL RES, V1803, P662, DOI 10.1016/j.bbamcr.2010.03.005; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Santos SD, 2007, J PATHOL, V213, P200, DOI 10.1002/path.2224; Santos SD, 2010, NEUROBIOL AGING, V31, P280, DOI 10.1016/j.neurobiolaging.2008.04.001; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Teixeira PF, 2006, J BIOL CHEM, V281, P21998, DOI 10.1074/jbc.M602302200; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	61	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50123	10.1371/journal.pone.0050123	http://dx.doi.org/10.1371/journal.pone.0050123			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185553	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000186
J	Li, Y; Wang, Q; Li, XY; Xiao, X; Sun, FS; Wang, C; Hu, W; Feng, ZJ; Chang, JL; Chen, MJ; Wang, YS; Li, KX; Yang, GX; He, GY				Li, Yin; Wang, Qiong; Li, Xiaoyan; Xiao, Xin; Sun, Fusheng; Wang, Cheng; Hu, Wei; Feng, Zhijuan; Chang, Junli; Chen, Mingjie; Wang, Yuesheng; Li, Kexiu; Yang, Guangxiao; He, Guangyuan			Coexpression of the High Molecular Weight Glutenin Subunit 1Ax1 and Puroindoline Improves Dough Mixing Properties in Durum Wheat (Triticum turgidum L. ssp durum)	PLOS ONE			English	Article							GRAIN-SOFTNESS PROTEIN; TECHNOLOGICAL QUALITY; FUNCTIONAL-PROPERTIES; MIXOGRAPH PARAMETERS; TRANSGENIC LINES; BAKING QUALITY; MARKER GENES; EXPRESSION; STARCH; SEED	Wheat end-use quality mainly derives from two interrelated characteristics: the compositions of gluten proteins and grain hardness. The composition of gluten proteins determines dough rheological properties and thus confers the unique viscoelastic property on dough. One group of gluten proteins, high molecular weight glutenin subunits (HMW-GS), plays an important role in dough functional properties. On the other hand, grain hardness, which influences the milling process of flour, is controlled by Puroindoline a (Pina) and Puroindoline b (Pinb) genes. However, little is known about the combined effects of HMW-GS and PINs on dough functional properties. In this study, we crossed a Pina-expressing transgenic line with a 1Ax1-expressing line of durum wheat and screened out lines coexpressing 1Ax1 and Pina or lines expressing either 1Ax1 or Pina. Dough mixing analysis of these lines demonstrated that expression of 1Ax1 improved both dough strength and over-mixing tolerance, while expression of PINA detrimentally affected the dough resistance to extension. In lines coexpressing 1Ax1 and Pina, faster hydration of flour during mixing was observed possibly due to the lower water absorption and damaged starch caused by PINA expression. In addition, expression of 1Ax1 appeared to compensate the detrimental effect of PINA on dough resistance to extension. Consequently, coexpression of 1Ax1 and PINA in durum wheat had combined effects on dough mixing behaviors with a better dough strength and resistance to extension than those from lines expressing either 1Ax1 or Pina. The results in our study suggest that simultaneous modulation of dough strength and grain hardness in durum wheat could significantly improve its breadmaking quality and may not even impair its pastamaking potential. Therefore, coexpression of 1Ax1 and PINA in durum wheat has useful implications for breeding durum wheat with dual functionality (for pasta and bread) and may improve the economic values of durum wheat.	[Li, Yin; Wang, Qiong; Li, Xiaoyan; Xiao, Xin; Sun, Fusheng; Wang, Cheng; Hu, Wei; Feng, Zhijuan; Chang, Junli; Chen, Mingjie; Wang, Yuesheng; Li, Kexiu; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol HUST, Key Lab Mol Biophys, China UK HUST Rres Genet Engn & Genom Joint Lab, Genet Engn Int Cooperat Base Chinese Minist Sci &, Wuhan, Peoples R China	Huazhong University of Science & Technology	Yang, GX (corresponding author), Huazhong Univ Sci & Technol HUST, Key Lab Mol Biophys, China UK HUST Rres Genet Engn & Genom Joint Lab, Genet Engn Int Cooperat Base Chinese Minist Sci &, Wuhan, Peoples R China.	ygx@hust.edu.cn; hegy@hust.edu.cn		wang, qiong/0000-0002-6898-6879	National Science and Technology Major Project of China [2011ZX08002-004, 2011ZX08010-004]; International S & T Cooperation Key Projects of MoST [2009DFB30340]; National Natural Science Foundation of China [30871524, 31071403]; National Natural Science Foundation of Hubei, China [2010 CBD 02403]; Wuhan Municipal S & T research project [201120922286]	National Science and Technology Major Project of China; International S & T Cooperation Key Projects of MoST; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei, China; Wuhan Municipal S & T research project	This work was supported by the National Science and Technology Major Project of China (2011ZX08002-004; 2011ZX08010-004) (http://www.nmp.gov.cn/), International S & T Cooperation Key Projects of MoST (2009DFB30340), the National Natural Science Foundation of China (No. 30871524 and No. 31071403) (http://www.nsfc.gov.cn/Portal0/default152.htm) the National Natural Science Foundation of Hubei, China (2010 CBD 02403) and Wuhan Municipal S & T research project (201120922286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altpeter F, 1996, NAT BIOTECHNOL, V14, P1155, DOI 10.1038/nbt0996-1155; American Association of Cereal Chemists, 2000, APPR METH AACC; Barro F, 2003, MOL BREEDING, V12, P223, DOI 10.1023/A:1026367214120; Barro F, 2002, THEOR APPL GENET, V105, P980, DOI 10.1007/s00122-002-0996-z; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Beecher B, 2002, THEOR APPL GENET, V105, P870, DOI 10.1007/s00122-002-1034-x; Blechl A, 2007, J CEREAL SCI, V45, P172, DOI 10.1016/j.jcs.2006.07.009; Bordes J, 2008, J CEREAL SCI, V48, P569, DOI 10.1016/j.jcs.2008.05.005; Bushuk W, 1998, EUPHYTICA, V100, P137, DOI 10.1023/A:1018368316547; Campbell KG, 2001, CROP SCI, V41, P1275, DOI 10.2135/cropsci2001.4141275x; Chen MJ, 2005, THEOR APPL GENET, V111, P1159, DOI 10.1007/s00122-005-0047-7; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; DEXTER JE, 1994, J CEREAL SCI, V20, P139, DOI 10.1006/jcrs.1994.1054; Dubreil L, 2002, J AGR FOOD CHEM, V50, P6078, DOI 10.1021/jf020277d; DuPont FM, 2005, J AGR FOOD CHEM, V53, P1575, DOI 10.1021/jf048697l; Gazza L, 2008, P 11 INT WHEAT GEN S, P339; Gazza L, 2011, J CEREAL SCI, V54, P481, DOI 10.1016/j.jcs.2011.09.003; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; GREENWELL P, 1986, CEREAL CHEM, V63, P379; HALFORD NG, 1992, THEOR APPL GENET, V83, P373, DOI 10.1007/BF00224285; Hansen M, 2007, J EXP BOT, V58, P3987, DOI 10.1093/jxb/erm254; He GY, 1999, MOL BREEDING, V5, P377, DOI 10.1023/A:1009681321708; Hogg AC, 2005, CROP SCI, V45, P871, DOI 10.2135/cropsci2004.0113; Hogg AC, 2004, THEOR APPL GENET, V108, P1089, DOI 10.1007/s00122-003-1518-3; JOLLY CJ, 1993, THEOR APPL GENET, V86, P589, DOI 10.1007/BF00838714; JOPPA LR, 1988, GENOME, V30, P222, DOI 10.1139/g88-038; Kawakatsu T, 2010, PLANT PHYSIOL, V154, P1842, DOI 10.1104/pp.110.164343; Krishnamurthy K, 2001, NAT BIOTECHNOL, V19, P162, DOI 10.1038/84435; Law C. N., 1978, Seed protein improvement by nuclear technique. Proceedings of the two Research Co-ordination Meetings, Baden, 28 March - 1 April 1977 and Vienna, 26-30 September 1977. Aneuploids in wheat protein improvement., P483; Leon E, 2009, J CEREAL SCI, V49, P148, DOI 10.1016/j.jcs.2008.08.002; Leon E, 2010, J CEREAL SCI, V51, P13, DOI 10.1016/j.jcs.2009.09.001; Liu Y, 2007, GENET RESOUR CROP EV, V54, P865, DOI 10.1007/s10722-006-9154-9; Lopes-Da-Silva JA, 2007, J AGR FOOD CHEM, V55, P5636, DOI 10.1021/jf070379+; Luo L, 2008, MOL BIOL REP, V35, P195, DOI 10.1007/s11033-007-9070-x; Martin JM, 2006, THEOR APPL GENET, V113, P1563, DOI 10.1007/s00122-006-0404-1; Martinant JP, 1998, J CEREAL SCI, V27, P179, DOI 10.1006/jcrs.1997.0156; Mattern P. J., 1973, Proceedings of the Fourth International Wheat Genetics Symposium. Cytogenetics., P703; Miao YJ, 2012, AMINO ACIDS, V43, P1689, DOI 10.1007/s00726-012-1250-x; Miller RA, 1997, CEREAL CHEM, V74, P669, DOI 10.1094/CCHEM.1997.74.5.669; Ohm JB, 1999, CEREAL CHEM, V76, P606, DOI 10.1094/CCHEM.1999.76.5.606; Ohm JB, 1998, CEREAL CHEM, V75, P156, DOI 10.1094/CCHEM.1998.75.1.156; Piston F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024754; Pomeranz Y., 1990, Advances in Cereal Science and Technology, V10, P471; Rakszegi M, 2008, J CEREAL SCI, V47, P310, DOI 10.1016/j.jcs.2007.04.010; Rakszegi M, 2005, J CEREAL SCI, V42, P15, DOI 10.1016/j.jcs.2005.02.006; Ramessar K, 2007, TRANSGENIC RES, V16, P261, DOI 10.1007/s11248-007-9083-1; Rao BN, 2010, J CEREAL SCI, V51, P299, DOI 10.1016/j.jcs.2010.01.004; Rooke L, 1999, THEOR APPL GENET, V99, P851, DOI 10.1007/s001220051305; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry Peter R, 2003, Adv Food Nutr Res, V45, P219; Shewry PR, 2006, THEOR APPL GENET, V113, P128, DOI 10.1007/s00122-006-0279-1; SLAUGHTER DC, 1992, CEREAL CHEM, V69, P428; Swan CG, 2006, CROP SCI, V46, P1656, DOI 10.2135/cropsci2005.06-0135; Tosi P, 2005, MOL BREEDING, V16, P113, DOI 10.1007/s11032-005-5912-1; Vasil IK, 2001, J PLANT PHYSIOL, V158, P521, DOI 10.1078/0176-1617-00365; Wanjugi HW, 2007, CROP SCI, V47, P67, DOI 10.2135/cropsci2006.05.0310; Young, 2007, TECHNOLOGY BREADMAKI, P299, DOI DOI 10.1007/0-387-38565-7_11; Zhang JR, 2009, PLANT BIOTECHNOL J, V7, P733, DOI 10.1111/j.1467-7652.2009.00438.x; Ziemann M, 2008, PLANT SCI, V175, P307, DOI 10.1016/j.plantsci.2008.05.006	60	6	6	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50057	10.1371/journal.pone.0050057	http://dx.doi.org/10.1371/journal.pone.0050057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185532	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000174
J	Van Colen, C; Rossi, F; Montserrat, F; Andersson, MGI; Gribsholt, B; Herman, PMJ; Degraer, S; Vincx, M; Ysebaert, T; Middelburg, JJ				Van Colen, Carl; Rossi, Francesca; Montserrat, Francesc; Andersson, Maria G. I.; Gribsholt, Britta; Herman, Peter M. J.; Degraer, Steven; Vincx, Magda; Ysebaert, Tom; Middelburg, Jack J.			Organism-Sediment Interactions Govern Post-Hypoxia Recovery of Ecosystem Functioning	PLOS ONE			English	Article							BACTERIAL ASSEMBLAGES; MARINE; BIODIVERSITY; DIVERSITY; MODEL; BIOTURBATION; RECOLONIZATION; COMMUNITIES; IRRIGATION; INTENSITY	Hypoxia represents one of the major causes of biodiversity and ecosystem functioning loss for coastal waters. Since eutrophication-induced hypoxic events are becoming increasingly frequent and intense, understanding the response of ecosystems to hypoxia is of primary importance to understand and predict the stability of ecosystem functioning. Such ecological stability may greatly depend on the recovery patterns of communities and the return time of the system properties associated to these patterns. Here, we have examined how the reassembly of a benthic community contributed to the recovery of ecosystem functioning following experimentally-induced hypoxia in a tidal flat. We demonstrate that organism-sediment interactions that depend on organism size and relate to mobility traits and sediment reworking capacities are generally more important than recovering species richness to set the return time of the measured sediment processes and properties. Specifically, increasing macrofauna bioturbation potential during community reassembly significantly contributed to the recovery of sediment processes and properties such as denitrification, bedload sediment transport, primary production and deep pore water ammonium concentration. Such bioturbation potential was due to the replacement of the small-sized organisms that recolonised at early stages by large-sized bioturbating organisms, which had a disproportionately stronger influence on sediment. This study suggests that the complete recovery of organism-sediment interactions is a necessary condition for ecosystem functioning recovery, and that such process requires long periods after disturbance due to the slow growth of juveniles into adult stages involved in these interactions. Consequently, repeated episodes of disturbance at intervals smaller than the time needed for the system to fully recover organism-sediment interactions may greatly impair the resilience of ecosystem functioning.	[Van Colen, Carl; Degraer, Steven; Vincx, Magda] Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium; [Rossi, Francesca; Montserrat, Francesc; Andersson, Maria G. I.; Gribsholt, Britta; Herman, Peter M. J.; Ysebaert, Tom; Middelburg, Jack J.] Netherlands Inst Sea Res NIOZ Yerseke, Yerseke, Netherlands; [Rossi, Francesca] Univ Montpellier 2, IRD, Ecol Syst Marins Cotiers Ecosysm UMR CNRS 5119, F-34095 Montpellier, France; [Degraer, Steven] Royal Belgian Inst Nat Sci, Marine Ecosyst Management Sect, Management Unit N Sea Math Model, Brussels, Belgium; [Ysebaert, Tom] Wageningen Univ, Inst Marine Resources & Ecosyst Studies, Yerseke, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands	Ghent University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Royal Belgian Institute of Natural Sciences; Wageningen University & Research; Utrecht University	Van Colen, C (corresponding author), Univ Ghent, Marine Biol Sect, Dept Biol, B-9000 Ghent, Belgium.	carl.vancolen@ugent.be	Rossi, Francesca/G-2807-2013; Middelburg, Jack/B-4951-2011; Herman, Peter M.J./A-9018-2011; Montserrat, Francesc/HCI-2107-2022; Montserrat, Francesc/H-2930-2016	Rossi, Francesca/0000-0003-1928-9193; Middelburg, Jack/0000-0003-3601-9072; Herman, Peter M.J./0000-0003-2188-6341; Montserrat, Francesc/0000-0002-9882-3376	Flemish Fund for Scientific Research [FWO-1.2.380.11.N.00]; institute for the Promotion of Innovation through Science and Technology in Flanders, Belgium (IWT Vlaanderen); Special Research Fund of Ghent University; Netherlands Organisation of Scientific Research; Dutch Technology Foundation; Darwin Center for Biogeosciences; Danish Agency for Science, Technology and Innovation	Flemish Fund for Scientific Research(FWO); institute for the Promotion of Innovation through Science and Technology in Flanders, Belgium (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Special Research Fund of Ghent University(Ghent University); Netherlands Organisation of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Technology Foundation(Technologiestichting STW); Darwin Center for Biogeosciences; Danish Agency for Science, Technology and Innovation	CVC acknowledges a postdoctoral fellowship provided by the Flemish Fund for Scientific Research (FWO-1.2.380.11.N.00). Additional funding was provided by the Research fund and the institute for the Promotion of Innovation through Science and Technology in Flanders, Belgium (IWT Vlaanderen), the Special Research Fund of Ghent University, the Netherlands Organisation of Scientific Research, the Dutch Technology Foundation, the Darwin Center for Biogeosciences and by the Danish Agency for Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller RC, 1998, J MAR RES, V56, P905, DOI 10.1357/002224098321667413; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BERNER RA, 1985, AM J SCI, V285, P193, DOI 10.2475/ajs.285.3.193; Bolam SG, 2002, ECOL MONOGR, V72, P599, DOI 10.1890/0012-9615(2002)072[0599:DBAEPI]2.0.CO;2; Braeckman U, 2011, MAR ECOL PROG SER, V422, P179, DOI 10.3354/meps08910; Conley DJ, 2009, HYDROBIOLOGIA, V629, P21, DOI 10.1007/s10750-009-9764-2; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; de Leeuw, 2007, ZICHTLIJNEN, V113, P38; DEJONG DJ, 1995, HYDROBIOLOGIA, V311, P21, DOI 10.1007/BF00008568; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Emmerson MC, 2000, OIKOS, V91, P195; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Gilbert F, 1998, MAR ECOL PROG SER, V163, P99, DOI 10.3354/meps163099; Gilbertson WW, 2012, FEMS MICROBIOL ECOL, V82, P11, DOI 10.1111/j.1574-6941.2012.01400.x; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Herman PMJ, 1999, ADV ECOL RES, V29, P195; Hicks Natalie, 2011, BMC Ecology, V11, P7, DOI 10.1186/1472-6785-11-7; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Katsev S, 2007, LIMNOL OCEANOGR, V52, P2555, DOI 10.4319/lo.2007.52.6.2555; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Langenheder S, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-14; Laverock B, 2010, ISME J, V4, P1531, DOI 10.1038/ismej.2010.86; LAVERY PS, 1991, ESTUAR COAST SHELF S, V32, P281, DOI 10.1016/0272-7714(91)90021-3; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Middelburg JJ, 2009, BIOGEOSCIENCES, V6, P1273, DOI 10.5194/bg-6-1273-2009; Middelburg J.K., 2004, RESP AQUATIC ECOSYST, P206; Montserrat F, 2008, MAR ECOL PROG SER, V372, P43, DOI 10.3354/meps07769; Morse JW, 2007, MAR CHEM, V106, P239, DOI 10.1016/j.marchem.2006.02.003; Na T, 2008, J MAR RES, V66, P691, DOI 10.1357/002224008787536826; Norkko A, 2006, J EXP MAR BIOL ECOL, V330, P195, DOI 10.1016/j.jembe.2005.12.027; NOWELL ARM, 1981, MAR GEOL, V42, P133, DOI 10.1016/0025-3227(81)90161-4; Orvain F, 2004, MAR ECOL PROG SER, V278, P205, DOI 10.3354/meps278205; Parsons T.R., 1984, MANUAL CHEM BIOL MET, V15, P419, DOI 10.1016/0025-326x(84)90262-5; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Plante CJ, 2004, MICROB ECOL, V48, P154, DOI 10.1007/s00248-003-1031-x; Quinn Q. P., 2002, EXPT DESIGN DATA ANA; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; RHOADS DC, 1982, MAR ECOL PROG SER, V8, P115, DOI 10.3354/meps008115; Romanuk TN, 2009, OIKOS, V118, P819, DOI 10.1111/j.1600-0706.2008.17273.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Slocum ET, 2006, J EXP MAR BIOL ECOL, V337, P147, DOI 10.1016/j.jembe.2006.06.012; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Tevesz M.J.S., 1982, ANIMAL SEDIMENT RELA, P100, DOI DOI 10.1007/978-1-4757-1317-6_2; THAMDRUP B, 1994, GEOCHIM COSMOCHIM AC, V58, P5115, DOI 10.1016/0016-7037(94)90298-4; Thrush SF, 1996, ECOLOGY, V77, P2472, DOI 10.2307/2265747; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Van Colen C, 2010, J EXP MAR BIOL ECOL, V385, P79, DOI 10.1016/j.jembe.2010.01.009; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Van Colen C, 2009, MAR ECOL PROG SER, V381, P189, DOI 10.3354/meps07914; Van Colen C, 2008, MAR ECOL PROG SER, V372, P31, DOI 10.3354/meps07640; Van De Koppel J, 2001, ECOLOGY, V82, P3449, DOI 10.1890/0012-9658(2001)082[3449:DASSOI]2.0.CO;2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Volkenborn N, 2010, LIMNOL OCEANOGR, V55, P1231, DOI 10.4319/lo.2010.55.3.1231; Waldbusser GG, 2004, LIMNOL OCEANOGR, V49, P1482, DOI 10.4319/lo.2004.49.5.1482; Watling L, 2001, J SEA RES, V46, P309, DOI 10.1016/S1385-1101(01)00083-1; Webb AP, 2004, MAR ECOL PROG SER, V268, P205, DOI 10.3354/meps268205; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wuchter C, 2007, P NATL ACAD SCI USA, V104, P5704, DOI 10.1073/pnas.0701630104; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zajac RN, 1998, HYDROBIOLOGIA, V375-76, P227, DOI 10.1023/A:1017032200173; Zhang J, 2010, BIOGEOSCIENCES, V7, P1443, DOI 10.5194/bg-7-1443-2010; [No title captured]	79	41	41	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49795	10.1371/journal.pone.0049795	http://dx.doi.org/10.1371/journal.pone.0049795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185440	Green Published, gold			2022-12-25	WOS:000311821000111
J	Huang, L; Jiang, HF; Ren, XP; Chen, YN; Xiao, YJ; Zhao, XY; Tang, M; Huang, JQ; Upadhyaya, HD; Liao, BS				Huang, Li; Jiang, Huifang; Ren, Xiaoping; Chen, Yuning; Xiao, Yingjie; Zhao, Xinyan; Tang, Mei; Huang, Jiaquan; Upadhyaya, Hari D.; Liao, Boshou			Abundant Microsatellite Diversity and Oil Content in Wild Arachis Species	PLOS ONE			English	Article							CULTIVATED PEANUT; GENETIC DIVERSITY; HYPOGAEA L.; LINKAGE DISEQUILIBRIUM; SSR MARKERS; GERM-PLASM; IDENTIFICATION; DOMESTICATION; ASSOCIATION; ACCESSIONS	The peanut (Arachis hypogaea) is an important oil crop. Breeding for high oil content is becoming increasingly important. Wild Arachis species have been reported to harbor genes for many valuable traits that may enable the improvement of cultivated Arachis hypogaea, such as resistance to pests and disease. However, only limited information is available on variation in oil content. In the present study, a collection of 72 wild Arachis accessions representing 19 species and 3 cultivated peanut accessions were genotyped using 136 genome-wide SSR markers and phenotyped for oil content over three growing seasons. The wild Arachis accessions showed abundant diversity across the 19 species. A. duranensis exhibited the highest diversity, with a Shannon-Weaver diversity index of 0.35. A total of 129 unique alleles were detected in the species studied. A. rigonii exhibited the largest number of unique alleles (75), indicating that this species is highly differentiated. AMOVA and genetic distance analyses confirmed the genetic differentiation between the wild Arachis species. The majority of SSR alleles were detected exclusively in the wild species and not in A. hypogaea, indicating that directional selection or the hitchhiking effect has played an important role in the domestication of the cultivated peanut. The 75 accessions were grouped into three clusters based on population structure and phylogenic analysis, consistent with their taxonomic sections, species and genome types. A. villosa and A. batizocoi were grouped with A. hypogaea, suggesting the close relationship between these two diploid wild species and the cultivated peanut. Considerable phenotypic variation in oil content was observed among different sections and species. Nine alleles were identified as associated with oil content based on association analysis, of these, three alleles were associated with higher oil content but were absent in the cultivated peanut. The results demonstrated that there is great potential to increase the oil content in A. hypogaea by using the wild Arachis germplasm.	[Huang, Li; Jiang, Huifang; Ren, Xiaoping; Chen, Yuning; Zhao, Xinyan; Tang, Mei; Huang, Jiaquan; Liao, Boshou] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China; [Xiao, Yingjie] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Xiao, Yingjie] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China; [Upadhyaya, Hari D.] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Andhra Pradesh, India	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Huazhong Agricultural University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Liao, BS (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China.	lboshou@hotmail.com	Updhayaya, Hari/C-4858-2014	Updhayaya, Hari/0000-0002-5166-6844	National Basic Research Program of China [2011CB109300]; Crop Germplasm Program [NB09-2130135-4]; National Science Fund of China [31271764]	National Basic Research Program of China(National Basic Research Program of China); Crop Germplasm Program; National Science Fund of China(National Natural Science Foundation of China (NSFC))	The authors are grateful to the research grants from the National Basic Research Program of China (2011CB109300) and Crop Germplasm Program (NB09-2130135-4) and the National Science Fund of China (No. 31271764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelici CMLCD, 2008, GENET MOL BIOL, V31, P79, DOI 10.1590/S1415-47572008000100016; [Anonymous], 1994, PEANUT SCI, DOI DOI 10.3146/i0095-3679-21-2-7; Barkley NA, 2007, GENET RES, V89, P93, DOI 10.1017/S0016672307008695; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chen BenYin, 2008, Journal of Tropical and Subtropical Botany, V16, P296; [陈本银 CHEN Benyin], 2008, [华北农学报, Acta Agriculturae Boreali-Sinica], V23, P170; Chen S, 2008, GENOME, V51, P1, DOI [10.1139/G07-095, 10.1139/g07-095]; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferguson ME, 2004, THEOR APPL GENET, V108, P1064, DOI 10.1007/s00122-003-1535-2; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gimenes MA, 2002, GENET MOL BIOL, V25, P349, DOI 10.1590/S1415-47572002000300017; Gimenes MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-9; GREGORY MP, 1979, J HERED, V70, P185, DOI 10.1093/oxfordjournals.jhered.a109231; Gregory W. C., 1980, Advances in legume science, P469; HALWARD TM, 1991, GENOME, V34, P1013, DOI 10.1139/g91-156; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; He GH, 2005, EUPHYTICA, V142, P131, DOI 10.1007/s10681-005-1043-3; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Hopkins MS, 1999, CROP SCI, V39, P1243, DOI 10.2135/cropsci1999.0011183X003900040047x; Huang Li, 2011, Acta Agronomica Sinica, V37, P1967, DOI 10.3724/SP.J.1006.2011.01967; Isleib T. G., 2001, Peanut Science, V28, P96, DOI 10.3146/i0095-3679-28-2-11; Jiang HuiFang, 2006, Chinese Journal of Oil Crop Sciences, V28, P421; Johnson DR, 1977, PEANUT SCI, V4, P9, DOI [10.3146/i0095-3679-4-1-3, DOI 10.3146/I0095-3679-4-1-3]; KOCHERT G, 1991, THEOR APPL GENET, V81, P565, DOI 10.1007/BF00226719; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Koppolu R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-15; Krapovickas A., 1994, Bonplandia, V8, P1; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mallikarjuna N, 2002, EUPHYTICA, V126, P161, DOI 10.1023/A:1016379132324; Mallikarjuna N, 2011, GENET RESOUR CROP EV, V58, P889, DOI 10.1007/s10722-010-9627-8; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; Moretzsohn Marcio de Carvalho, 2004, BMC Plant Biology, V4, P11, DOI 10.1186/1471-2229-4-11; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Pritchard JK, 2000, GENETICS, V155, P945; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rohlf FJ., 2006, NTSYS PC NUMERICAL T; SAS Institute, 1999, SAS STAT US GUID VER; Seijo JG, 2004, AM J BOT, V91, P1294, DOI 10.3732/ajb.91.9.1294; Smartt J., 1982, PEANUT SCI TECHNOLOG, P21; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; STARR J L, 1990, Peanut Science, V17, P106, DOI 10.3146/i0095-3679-17-2-14; Subrahmanyam P., 1985, Proceedings of an international workshop on cytogenetics of Arachis, 31 October-2 November 1983, ICRISAT Center, Patancheru, India., P49; Tang Mei, 2012, Acta Agronomica Sinica, V38, P1221, DOI 10.3724/SP.J.1006.2012.01221; Upadhyaya Hari D., 2006, Plant Genetic Resources Characterization and Utilization, V4, P25, DOI 10.1079/PGR2006107; Upadhyaya HD, 2011, EUPHYTICA, V182, P103, DOI 10.1007/s10681-011-0518-7; Valls J. F. M., 1985, Proceedings of an international workshop on cytogenetics of Arachis, 31 October-2 November 1983, ICRISAT Center, Patancheru, India., P15; Valls JF, 2005, BONPLANDIA, V14, P35, DOI [10.30972/bon.141-21387, DOI 10.2307/41941266]; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Xu Z, 1987, CHIN OIL CROP SCI, P91; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Younas M, 2012, MOL BIOL REP, V39, P5105, DOI 10.1007/s11033-011-1306-0; Young ND, 1996, GENOME MAPPING PLANT, P211	58	17	21	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50002	10.1371/journal.pone.0050002	http://dx.doi.org/10.1371/journal.pone.0050002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185514	Green Published, gold			2022-12-25	WOS:000311535700062
J	Kumar, S; Mehta, K				Kumar, Santosh; Mehta, Kapil			Tissue Transglutaminase Constitutively Activates HIF-1 alpha Promoter and Nuclear Factor-kappa B via a Non-Canonical Pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; DRUG-RESISTANCE; EXPRESSION; INFLAMMATION; METASTASIS; SURVIVAL; INHIBITION; APOPTOSIS; CIRCUITRY	Constitutive activation of nuclear factor kappa B (NF-kappa B) has been linked with carcinogenesis and cancer progression, including metastasis, chemoresistance, and radiation resistance. However, the molecular mechanisms that result in constitutive activation of NF-kappa B are poorly understood. Here we show that chronic expression of the pro-inflammatory protein tissue transglutaminase (TG2) reprograms the transcription regulatory network in epithelial cells via constitutive activation of NF-kappa B. TG2-induced NF-kappa B binds the functional NF-kappa B binding site in hypoxia-inducible factor-1 (HIF-1 alpha) promoter and results in its increased expression at transcription and protein levels even under normoxic conditions. TG2/NF-kappa B-induced HIF-1 was deemed essential for increased expression of some transcription repressors, like Zeb1, Zeb2, Snail, and Twist. Unlike tumor necrosis factor-alpha (TNF alpha), TG2 did not require I kappa B kinase (IKK) for NF-kappa B activation. Our data suggest that TG2 binds with I kappa B alpha and results in its rapid degradation via a non-proteasomal pathway. Importantly, the catalytically inactive (C277S) mutant form of TG2 was as effective as was wild-type TG2 in activating NF-kappa B and inducing HIF-1 expression. We also found that TG2 interacted with p65/RelA protein, both in the cytosolic and the nuclear compartment. The TG2/p65(NF-kappa B) complex binds to the HIF-1 promoter and induced its transcriptional regulation. Inhibition of TG2 or p65/RelA also inhibited the HIF-1 alpha expression and attenuated Zeb1, Zeb2, and Twist expression. To our knowledge, these findings show for the first time a direct link between TG2, NF-kappa B, and HIF-1 alpha, demonstrating TG2's important role in cancer progression.	[Kumar, Santosh; Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Mehta, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kmehta@mdanderson.org			National Institutes of Health grant [CA135218]; Susan G. Komen for Cure Foundation; NATIONAL CANCER INSTITUTE [R21CA135218] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by a National Institutes of Health grant (CA135218) and the Susan G. Komen for Cure Foundation(http://ww5.komen.org/). The funders had no role in study design, data collection, and analysis, the decision to publish, or the preparation of the manuscript.	Arlt A, 2002, INT J CLIN PHARM TH, V40, P336; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Budillon A, 2011, AMINO ACIDS, DOI 10.007/s00726-011-1167-9; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Enzler T, 2011, CANCER DISCOV, V1, P496, DOI 10.1158/2159-8290.CD-11-0143; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Jung HJ, 2012, BLOOD; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kim DS, 2011, ONCOGENE, V30, P4780, DOI 10.1038/onc.2011.183; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kumar A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3085; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Kumar S, 2013, AMINO ACIDS, V44, P81, DOI 10.1007/s00726-011-1139-0; Lee JM, 2004, J BIOL CHEM, V279, P53725, DOI 10.1074/jbc.M407627200; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mehta K, 2005, PROG EXP TUMOR RES, V38, P1; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Oh K, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3034; Park KS, 2010, J CANCER RES CLIN, V136, P493, DOI 10.1007/s00432-009-0681-6; Park KS, 2009, FRONT BIOSCI-LANDMRK, V14, P1945, DOI 10.2741/3354; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Satpathy M, 2011, CANCER RES, V67, P7194; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Solinas G, 2010, CANCER METAST REV, V29, P243, DOI 10.1007/s10555-010-9227-2; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Verma A, 2007, CURR CANCER DRUG TAR, V7, P559, DOI 10.2174/156800907781662275; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Yuan LY, 2008, J NEURO-ONCOL, V90, P125, DOI 10.1007/s11060-008-9642-1; Yuan LY, 2011, J NEURO-ONCOL, V103, P207, DOI 10.1007/s11060-010-0379-2; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690	48	59	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49321	10.1371/journal.pone.0049321	http://dx.doi.org/10.1371/journal.pone.0049321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185316	Green Submitted, gold, Green Published			2022-12-25	WOS:000311333800021
J	Yan, M; Zhang, YF; Guo, WJ; Wang, XF				Yan, Min; Zhang, Yifan; Guo, Wenjuan; Wang, Xiaofeng			Soybean Endo-beta-Mannanase GmMAN1 Is Not Associated with Leaf Abscission, but Might Be Involved in the Response to Wounding	PLOS ONE			English	Article							CELL-SEPARATION PROCESSES; FLOWER ABSCISSION; GENE-EXPRESSION; MICROPYLAR ENDOSPERM; MOLECULAR-CLONING; SAMBUCUS-NIGRA; BIOCHEMICAL-CHARACTERIZATION; MESSENGER-RNA; TOMATO FRUITS; APICAL BUDS	The objective of this work is to investigate the relationship between endo-beta-mannanase and leaf abscission, and response to wounding in soybean (Glycine max). An endo-b-mannanase gene GmMAN1 was cloned from the abscission zone in petiole explants, and was heterologously expressed in E. coli. Polyclonal antibodies were raised against the fusion protein. The increases in activity, isoform numbers, and amounts of transcripts and proteins of GmMAN1 were found not only in the abscission zone but also in the non-abscission zone during petiole abscission in the explants, but not in these two tissues during leaf abscission artificially induced by ethephon treatment in the intact plants. The changes in endo-b-mannanase expression patterns in these two tissues were probably induced by the inherent mechanical wounding during the preparation of explants. When soybean plants were wounded by removing half of the leaf blade of the first pair of true leaves, the transcripts and proteins of GmMAN1 were induced in the leaves and stem, leading to the increases in enzyme activity and isoform numbers in them. It is concluded that the soybean endo-b-mannanase GmMAN1 is not associated with leaf abscission, but might be involved in the response to wounding.	[Yan, Min; Zhang, Yifan; Guo, Wenjuan; Wang, Xiaofeng] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Wang, XF (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	xfwang@scau.edu.cn			Natural Science Foundation of China [30571123]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (30571123) of the Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AP, 2002, CURR SCI INDIA, V82, P58; Agusti J, 2008, J EXP BOT, V59, P2717, DOI 10.1093/jxb/ern138; Akiyama T, 2009, J PLANT PHYSIOL, V166, P1814, DOI 10.1016/j.jplph.2009.06.002; Baron C, 1995, ANNU REV GENET, V29, P107, DOI 10.1146/annurev.ge.29.120195.000543; Belfield EJ, 2005, J EXP BOT, V56, P817, DOI 10.1093/jxb/eri076; Bergey DR, 1999, P NATL ACAD SCI USA, V96, P1756, DOI 10.1073/pnas.96.4.1756; Bewley JD, 2000, J EXP BOT, V51, P529, DOI 10.1093/jexbot/51.344.529; Bewley JD, 1997, PLANTA, V203, P454, DOI 10.1007/s004250050214; BONGHI C, 1992, PLANT MOL BIOL, V20, P839, DOI 10.1007/BF00027155; Bourgault R, 2002, PLANT PHYSIOL, V130, P1254, DOI 10.1104/pp.011890; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choudhury SR, 2010, PLANT CELL REP, V29, P813, DOI 10.1007/s00299-010-0866-0; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Ferrarese L, 1995, PLANT MOL BIOL, V29, P735, DOI 10.1007/BF00041164; Filichkin SA, 2004, PLANT PHYSIOL, V134, P1080, DOI 10.1104/pp.103.035998; Gonzalez-Carranza ZH, 2002, PLANT PHYSIOL, V128, P534, DOI 10.1104/pp.010610; Gonzalez-Carranza ZH, 1998, TRENDS PLANT SCI, V3, P10, DOI 10.1016/S1360-1385(97)01132-1; GonzalezBosch C, 1997, PLANT PHYSIOL, V114, P1541, DOI 10.1104/pp.114.4.1541; Hong SB, 2000, PLANT PHYSIOL, V123, P869, DOI 10.1104/pp.123.3.869; Iglesias-Fernandez R, 2011, PLANTA, V233, P25, DOI 10.1007/s00425-010-1257-z; Kalaitzis P, 1997, PLANT PHYSIOL, V113, P1303, DOI 10.1104/pp.113.4.1303; KEMMERER EC, 1994, PLANT PHYSIOL, V104, P557, DOI 10.1104/pp.104.2.557; Krishnaveni S, 1999, PLANT SCI, V144, P9, DOI 10.1016/S0168-9452(99)00049-7; LASHBROOK CC, 1994, PLANT CELL, V6, P1485, DOI 10.1105/tpc.6.10.1485; LEWIS L N, 1970, Plant Physiology (Rockville), V46, P194, DOI 10.1104/pp.46.2.194; Li XiaoHong, 2007, Journal of Shenyang Agricultural University, V38, P780; Lin JY, 2011, J AGR FOOD CHEM, V59, P4622, DOI 10.1021/jf104785k; Malek L., 1991, Seed Science Research, V1, P45, DOI 10.1017/S0960258500000623; Marraccini P, 2001, PLANTA, V213, P296, DOI 10.1007/s004250100541; NONOGAKI H, 1992, PHYSIOL PLANTARUM, V85, P167, DOI 10.1111/j.1399-3054.1992.tb04719.x; Nonogaki H, 2000, PLANT PHYSIOL, V123, P1235, DOI 10.1104/pp.123.4.1235; Ren YF, 2008, SEED SCI RES, V18, P139, DOI 10.1017/S0960258508037987; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Roberts JA, 2000, ANN BOT-LONDON, V86, P223, DOI 10.1006/anbo.2000.1203; Rosas-Cardenas FDF, 2007, POSTHARVEST BIOL TEC, V44, P254, DOI 10.1016/j.postharvbio.2006.12.008; Sanchez RA, 1997, SEED SCI RES, V7, P27, DOI 10.1017/S0960258500003330; Sane AP, 2007, PLANT SCI, V172, P481, DOI 10.1016/j.plantsci.2006.10.005; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SEXTON R, 1982, ANNU REV PLANT PHYS, V33, P133, DOI 10.1146/annurev.pp.33.060182.001025; Slovakova L, 2000, EUR J PLANT PATHOL, V106, P543, DOI 10.1023/A:1008722318178; TAYLOR JE, 1993, J EXP BOT, V44, P93, DOI 10.1093/jxb/44.1.93; TAYLOR JE, 1994, PLANT MOL BIOL, V24, P961, DOI 10.1007/BF00014449; TUCKER GA, 1984, PLANTA, V160, P164, DOI 10.1007/BF00392865; Tucker ML, 2007, J EXP BOT, V58, P3395, DOI 10.1093/jxb/erm188; TUCKER ML, 1991, PLANTA, V186, P52, DOI 10.1007/BF00201497; Wang AX, 2004, SEED SCI RES, V14, P267, DOI 10.1079/SSR2004176	46	6	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49197	10.1371/journal.pone.0049197	http://dx.doi.org/10.1371/journal.pone.0049197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173047	gold, Green Submitted, Green Published			2022-12-25	WOS:000311885300017
J	Bisikirska, BC; Adam, SJ; Alvarez, MJ; Rajbhandari, P; Cox, R; Lefebvre, C; Wang, K; Rieckhof, GE; Felsher, DW; Califano, A				Bisikirska, B. C.; Adam, S. J.; Alvarez, M. J.; Rajbhandari, P.; Cox, R.; Lefebvre, C.; Wang, K.; Rieckhof, G. E.; Felsher, D. W.; Califano, A.			STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma	ONCOGENE			English	Article						STK38; MYC post-translational modifications; protein turnover; transcriptional activity; protein-protein interaction	NDR PROTEIN-KINASE; C-MYC; TRANSCRIPTION FACTOR; TUMOR-REGRESSION; ACTIVATION; COMPLEX; BINDING; DNA; PHOSPHORYLATION; IDENTIFICATION	The MYC protooncogene is associated with the pathogenesis of most human neoplasia. Conversely, its experimental inactivation elicits oncogene addiction. Besides constituting a formidable therapeutic target, MYC also has an essential function in normal physiology, thus creating the need for context-specific targeting strategies. The analysis of post-translational MYC activity modulation yields novel targets for MYC inactivation. Specifically, following regulatory network analysis in human B-cells, we identify a novel role of the STK38 kinase as a regulator of MYC activity and a candidate target for abrogating tumorigenesis in MYC-addicted lymphoma. We found that STK38 regulates MYC protein stability and turnover in a kinase activity-dependent manner. STK38 kinase inactivation abrogates apoptosis following B-cell receptor activation, whereas its silencing significantly decreases MYC levels and increases apoptosis. Moreover, STK38 knockdown suppresses growth of MYC-addicted tumors in vivo, thus providing a novel viable target for treating these malignancies.	[Bisikirska, B. C.; Alvarez, M. J.; Rajbhandari, P.; Cox, R.; Lefebvre, C.; Rieckhof, G. E.; Califano, A.] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [Adam, S. J.; Felsher, D. W.] Stanford Univ, Div Oncol, Dept Med, Stanford, CA 94305 USA; [Adam, S. J.; Felsher, D. W.] Stanford Univ, Div Oncol, Dept Pathol, Stanford, CA 94305 USA; [Cox, R.] Riverdale Country Sch, Bronx, NY USA; [Wang, K.; Califano, A.] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Wang, K.] Pfizer Inc, San Diego, CA USA; [Califano, A.] Columbia Univ, Dept Pathol & Genet & Dev, New York, NY USA	Columbia University; Stanford University; Stanford University; Columbia University; Pfizer; Columbia University	Felsher, DW (corresponding author), Stanford Univ, Div Oncol, Dept Med, 1120 CCSR 269 Campus Dr, Stanford, CA 94305 USA.	dfelsher@stanford.edu; califano@c2b2.columbia.edu	Lefebvre, Celine/E-6290-2013	Wang, Kai/0000-0003-0567-3004; Califano, Andrea/0000-0003-4742-3679	NCI [R01CA109755]; NIAID [R01AI066116]; NCBC NIH Roadmap Initiative [U54CA121852]; Burroughs Welcome Fund Career Award; Damon Runyon Foundation; NIH [R01CA089305, R01CA105102]; National Cancer Institute's in-vivo Cellular and Molecular Imaging Center [P50CA114747]; Integrative Cancer Biology Program [1P20CA112973]; NIH/NCI [P01CA034233]; Leukemia and Lymphoma Society [R6223-07]; American Cancer Society [PF-10-237-01-TBG]; NATIONAL CANCER INSTITUTE [R01CA109755, R01CA105102, P50CA114747, R01CA170378, R01CA089305, P01CA034233, U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008798] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCBC NIH Roadmap Initiative; Burroughs Welcome Fund Career Award(Burroughs Wellcome Fund); Damon Runyon Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute's in-vivo Cellular and Molecular Imaging Center; Integrative Cancer Biology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Riccardo Dalla-Favera for critical review of this manuscript and Masumichi Saito for supplying MYC deletion mutant expression vectors (both from Columbia University). This work was supported by the NCI (R01CA109755), the NIAID (R01AI066116) and the NCBC NIH Roadmap Initiative (U54CA121852) (AC), Burroughs Welcome Fund Career Award, the Damon Runyon Foundation Lilly Clinical Investigator Award, NIH (R01CA089305, R01CA105102), National Cancer Institute's in-vivo Cellular and Molecular Imaging Center (P50CA114747), Integrative Cancer Biology Program (1P20CA112973), NIH/NCI (P01CA034233), the Leukemia and Lymphoma Society Translational Research grant number R6223-07 (DWF), and the American Cancer Society Fellowship PF-10-237-01-TBG (SJA).	Adeyinka A, 2002, CLIN CANCER RES, V8, P3788; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Bansal M, 2012, METHODS MOL BIOL, V786, P131, DOI 10.1007/978-1-61779-292-2_8; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bhattacharya S, 2003, BIOCHEMISTRY-US, V42, P14416, DOI 10.1021/bi035089a; BLACKWELL TK, 1990, SCIENCE, V250, P1149, DOI 10.1126/science.2251503; BONNEFOYBERARD N, 1994, BLOOD, V83, P1051; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; Cornils H, 2011, CELL CYCLE, V10, P1897, DOI 10.4161/cc.10.12.15826; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Cui DX, 2005, WORLD J GASTROENTERO, V11, P1273, DOI 10.3748/wjg.v11.i9.1273; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Engelberg D, 2004, SEMIN CANCER BIOL, V14, P271, DOI 10.1016/j.semcancer.2004.04.006; Enomoto A, 2008, ONCOGENE, V27, P1930, DOI 10.1038/sj.onc.1210828; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 2004, SEMIN CANCER BIOL, V14, P1, DOI 10.1016/j.semcancer.2003.11.001; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Herbst A, 2004, ONCOGENE, V23, P3863, DOI 10.1038/sj.onc.1207492; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Kaptein JS, 1996, J BIOL CHEM, V271, P18875, DOI 10.1074/jbc.271.31.18875; Karlsson A, 2003, BLOOD, V101, P2797, DOI 10.1182/blood-2002-10-3091; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MILLWARD T, 1995, P NATL ACAD SCI USA, V92, P5022, DOI 10.1073/pnas.92.11.5022; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Millward TA, 1998, EMBO J, V17, P5913, DOI 10.1093/emboj/17.20.5913; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Mooney LM, 2004, J BIOL CHEM, V279, P11843, DOI 10.1074/jbc.M311841200; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Sakamuro D, 1999, ONCOGENE, V18, P2942, DOI 10.1038/sj.onc.1202725; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamaskovic R, 2003, J BIOL CHEM, V278, P6710, DOI 10.1074/jbc.M210590200; Tran PT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002018; Tsvetkov P, 2009, NAT CHEM BIOL, V5, P778, DOI 10.1038/nchembio.233; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P264; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	52	30	33	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 7	2013	32	45					5283	5291		10.1038/onc.2012.543	http://dx.doi.org/10.1038/onc.2012.543			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	251IS	23178486	Green Accepted, hybrid			2022-12-25	WOS:000326922100004
J	Huang, H; Jin, T; Wang, L; Wang, FL; Zhang, R; Pan, Y; Wang, ZZ; Chen, Y				Huang, Heng; Jin, Ting; Wang, Lin; Wang, Fulong; Zhang, Rui; Pan, Yi; Wang, Zhenzhen; Chen, Yan			The RAS Guanyl Nucleotide-releasing Protein RasGRP1 Is Involved in Lymphatic Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; VASCULAR DEVELOPMENT; FACTOR-C; LYMPHANGIOGENESIS; DOWNSTREAM; ACTIVATION; MECHANISMS; SYSTEM; CELLS; CCBE1	The molecular basis of the lymphatic development remains largely unknown. Using zebrafish as a model, we discovered a novel role for the Ras guanine-releasing protein 1 (RasGRP1), a protein involved in Ras activation in lymphangiogenesis. Secondary lymphatic sprouts from the posterior cardinal vein give rise to thoracic duct which is the first lymphatic vessel in zebrafish. Knockdown of rasgrp1 by injecting morpholino in zebrafish embryos impaired formation of thoracic duct accompanied by pericardial and truck edema, whereas blood vessel development of the embryos was largely unaffected. In rasgrp1-knockdown embryos, the number of sprouts producing the string of parachordal lymphangioblast cells was reduced. Meanwhile the total number of the secondary sprouts was not changed. As a result, the number of venous intersegmental vessels was increased, whereas the number of lymphatic vessel was reduced at a later stage. The lymphatic developmental defects caused by rasgrp1 knockdown could be rescued by ectopic expression of a constitutively active HRas. Further analysis revealed that RasGRP1 knockdown could synergize with flt4/vegfr3 knockdown to induce defects in lymphangiogenesis. Taken together, this finding demonstrates a critical role for RasGRP1 in lymphatic development in zebrafish.	[Huang, Heng; Jin, Ting; Wang, Lin; Wang, Fulong; Zhang, Rui; Pan, Yi; Wang, Zhenzhen; Chen, Yan] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Chen, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	ychen3@sibs.ac.cn	Wang, Fulong/AAY-1178-2021	Wang, Fulong/0000-0002-7083-9675	Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; National Natural Science Foundation of China [30830037, 81021002, 81130077, 30971660]; Chinese Academy of Sciences [KSCX2-EW-R-08]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Ministry of Science and Technology of China Research Grant 2012CB524900 (to Y. C.) and 2010CB529506 (to Y. P. and Z. W.); by National Natural Science Foundation of China Grants 30830037, 81021002, and 81130077 (to Y. C.) and 30971660 (to Y. P.); and by Chinese Academy of Sciences Grant KSCX2-EW-R-08 (to Y. C.).	Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Ehrhardt A, 2004, MOL CELL BIOL, V24, P6311, DOI 10.1128/MCB.24.14.6311-6323.2004; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Geudens I, 2010, ARTERIOSCL THROM VAS, V30, P1695, DOI 10.1161/ATVBAHA.110.203034; Gomez GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004994; Hermans K, 2010, BLOOD, V116, P3356, DOI 10.1182/blood-2009-11-254557; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Hong CC, 2006, CURR BIOL, V16, P1366, DOI 10.1016/j.cub.2006.05.046; Huang H, 2012, ARTERIOSCL THROM VAS, V32, P2158, DOI 10.1161/ATVBAHA.112.252775; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Jin T, 2012, CELL RES, V22, P661, DOI 10.1038/cr.2011.161; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Westerfield M., 1995, ZEBRAFISH BOOK, P144; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	32	5	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2355	2364		10.1074/jbc.M112.418202	http://dx.doi.org/10.1074/jbc.M112.418202			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23184941	hybrid, Green Published			2022-12-25	WOS:000314211500024
J	Humphrey, RK; Yu, SMA; Bellary, A; Gonuguntla, S; Yebra, M; Jhala, US				Humphrey, Rohan K.; Yu, Shu Mei A.; Bellary, Aditi; Gonuguntla, Sumati; Yebra, Myra; Jhala, Ulupi S.			Lysine 63-linked Ubiquitination Modulates Mixed Lineage Kinase-3 Interaction with JIP1 Scaffold Protein in Cytokine-induced Pancreatic beta Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR; INDUCED APOPTOSIS; FACTORS TRAFS; IN-VIVO; ACTIVATION; A20; PHOSPHORYLATION; FAMILY; JNK	The mixed lineage kinase MLK3 plays a crucial role in compromising mitochondrial integrity and functions as a proapoptotic competence factor in the early stages of cytokine-induced pancreatic beta cell death. In an effort to identify mechanisms that regulate MLK3 activity in beta cells, we discovered that IL-1 beta stimulates Lys-63-linked ubiquitination of MLK3 via a conserved, TRAF6-binding peptapeptide motif in the catalytic domain of the kinase. TRAF6-mediated ubiquitination was required for dissociation of inactive monomeric MLK3 from the scaffold protein IB1/JIP1, facilitating the subsequent dimerization, autophosphorylation, and catalytic activation of MLK3. Inability to ubiquitinate MLK3, or the presence of A20, an upstream Lys-63-linked deubiquitinase, strongly curtailed the ability of MLK3 to affect the proapoptotic translocation of BAX in cytokine-stimulated pancreatic beta cells, an early step in the progression toward beta cell death. These studies suggest a novel mechanism for MLK3 activation and provide new clues for therapeutic intervention in promoting beta cell survival.	[Humphrey, Rohan K.; Yu, Shu Mei A.; Bellary, Aditi; Gonuguntla, Sumati; Yebra, Myra; Jhala, Ulupi S.] Univ Calif San Diego, Pediat Diabet Res Ctr, Sch Med, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Jhala, US (corresponding author), Pediat Diabet Res Ctr, 3525 John Hopkins Court, San Diego, CA 92121 USA.	ujhala@ucsd.edu			National Institutes of Health Grant [R01DK080147]; Juvenile Diabetes Research Foundation Research Grant [40-2009-706]; Hillblom Foundation network grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080147] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Research Grant(Juvenile Diabetes Research Foundation); Hillblom Foundation network grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080147. This work was also supported by Juvenile Diabetes Research Foundation Research Grant 40-2009-706 and by a Hillblom Foundation network grant.	Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Bollyky PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005063; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Dupraz P, 2000, J BIOL CHEM, V275, P37672, DOI 10.1074/jbc.M005150200; Fan YH, 2011, CELL SIGNAL, V23, P660, DOI 10.1016/j.cellsig.2010.11.017; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Grey ST, 2003, J IMMUNOL, V170, P6250, DOI 10.4049/jimmunol.170.12.6250; Habelhah Hasem, 2010, Genes Cancer, V1, P735; Haefliger JA, 2003, J CELL SCI, V116, P1463, DOI 10.1242/jcs.00356; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Hudkins RL, 2008, J MED CHEM, V51, P5680, DOI 10.1021/jm8005838; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Jadhav T, 2008, BIOCHEM BIOPH RES CO, V371, P521, DOI 10.1016/j.bbrc.2008.04.138; Jadhav Trafina S, 2011, BMC Proc, V5 Suppl 2, pS4, DOI 10.1186/1753-6561-5-S2-S4; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Korchnak AC, 2009, CELL SIGNAL, V21, P1620, DOI 10.1016/j.cellsig.2009.06.008; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Ling ZD, 2003, DIABETES, V52, P2497, DOI 10.2337/diabetes.52.10.2497; Martin F, 2011, NAT GENET, V43, P822, DOI 10.1038/ng.916; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nihalani D, 2000, J BIOL CHEM, V275, P7273, DOI 10.1074/jbc.275.10.7273; Nihalani D, 2001, EMBO J, V20, P3447, DOI 10.1093/emboj/20.13.3447; Nihalani D, 2003, J BIOL CHEM, V278, P28694, DOI 10.1074/jbc.M304212200; Nihalani D, 2007, MOL CELL BIOL, V27, P2431, DOI 10.1128/MCB.01479-06; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Pullen SS, 1999, BIOCHEMISTRY-US, V38, P10168, DOI 10.1021/bi9909905; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; Wang LH, 2004, ANNU REV PHARMACOL, V44, P451, DOI 10.1146/annurev.pharmtox.44.101802.121840; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zou WG, 2011, J CLIN INVEST, V121, P4383, DOI 10.1172/JCI59041	69	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2428	2440		10.1074/jbc.M112.425884	http://dx.doi.org/10.1074/jbc.M112.425884			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23172226	Green Published, hybrid			2022-12-25	WOS:000314211500030
J	Zhang, CC; Li, YL; Wu, YN; Wang, LY; Wang, XN; Du, J				Zhang, Congcong; Li, Yulin; Wu, Yina; Wang, Luya; Wang, Xiaonan; Du, Jie			Interleukin-6/Signal Transducer and Activator of Transcription 3 (STAT3) Pathway Is Essential for Macrophage Infiltration and Myoblast Proliferation during Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; SKELETAL-MUSCLE; ALTERED INFLAMMATION; IL-6; PROTEIN; CELLS; DIFFERENTIATION; CYTOKINES; RECEPTOR; SIGNAL	Inflammation and microenvironment play a crucial role in muscle regeneration. IL (interleukin)-6, as a multifunctional cytokine is involved in the processes. However, the causative effect of IL-6 in muscle regeneration remains unclear. In a mouse model of cardiotoxin-induced muscle injury/regeneration, infiltrated monocytes/macrophages produce a high level of IL-6 started on 1 day (24 h) after injury. In IL-6 knock-out (-/-) mice, the muscle regeneration procedure was impaired along with decreased myogenic determination factor (MyoD) and myogenin mRNA level and increased interstitial fibrosis. The IL-6(-/-) mice exhibited less macrophage infiltration, lower inflammatory cytokine (IL-1 beta, inducible NO synthase, Transforming growth factor (TGF)-beta 1, and IL-10) and chemokine (CCL2, CCL3, and CCL5) expression, and inhibited myoblast proliferation. In vitro, IL-6 deficiency or Signal Transducer and Activator of Transcription 3 (STAT3) knockdown in activated macrophage attenuated the expression of CCL2, CCL3, but not CCL5, which resulted in less macrophage migration. Moreover, inflammatory macrophages promoted myoblast proliferation in an IL-6-dependent manner. Finally, adoptive transfer IL-6(+/+) BM cells into IL-6(-/-) mice rescued the impaired regeneration with improved MyoD and myogenin expression. Taken together, IL-6 expression and the activated STAT3 signaling pathway in monocytes/macrophages is a critical mediator of macrophage migration and myoblast proliferation during muscle regeneration.	[Zhang, Congcong; Li, Yulin; Wu, Yina; Wang, Luya; Wang, Xiaonan; Du, Jie] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing An Zhen Hosp, Beijing 100029, Peoples R China; [Du, Jie] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing 100029, Peoples R China	Capital Medical University	Du, J (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing An Zhen Hosp, 2 Anzhen Rd, Beijing 100029, Peoples R China.	jdu@bcm.edu	Li, yulin/AGZ-5611-2022		National Science Foundation of China [31090363, 81230006]; Chinese Ministry of Science and Technology [2009CB522205, 2012CB945104]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060268] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Science Foundation of China Grants 31090363 and 81230006 and Chinese Ministry of Science and Technology Grants 2009CB522205 and 2012CB945104.	Al-Shanti N, 2008, GROWTH FACTORS, V26, P61, DOI 10.1080/08977190802025024; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Boeynaems JM, 2006, J INVEST DERMATOL, V126, P943, DOI 10.1038/sj.jid.5700233; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Hara M, 2011, J EXP MED, V208, P715, DOI 10.1084/jem.20101059; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jougasaki M, 2010, BRIT J PHARMACOL, V159, P1294, DOI 10.1111/j.1476-5381.2009.00612.x; Kami K, 1998, MUSCLE NERVE, V21, P819, DOI 10.1002/(SICI)1097-4598(199806)21:6<819::AID-MUS20>3.0.CO;2-M; Kami K, 2000, J HISTOCHEM CYTOCHEM, V48, P1203, DOI 10.1177/002215540004800904; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397; Luo Y., 2012, EUR J CANC; Panayi GS, 2004, CURR OPIN IMMUNOL, V16, P531, DOI 10.1016/j.coi.2004.05.017; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027739; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275	36	186	192	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1489	1499		10.1074/jbc.M112.419788	http://dx.doi.org/10.1074/jbc.M112.419788			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184935	Green Published, hybrid			2022-12-25	WOS:000313751400007
J	Chen, J; Chen, JY; Chen, SZ; Zhang, C; Zhang, LQ; Xiao, X; Das, A; Zhao, YH; Yuan, B; Morris, M; Zhao, B; Chen, YF				Chen, Ji; Chen, Jianying; Chen, Shuzhen; Zhang, Cheng; Zhang, Liangqing; Xiao, Xiang; Das, Avik; Zhao, Yuhui; Yuan, Bin; Morris, Mariana; Zhao, Bin; Chen, Yanfang			Transfusion of CXCR4-Primed Endothelial Progenitor Cells Reduces Cerebral Ischemic Damage and Promotes Repair in db/db Diabetic Mice	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; FUNCTIONAL RECOVERY; TRANSPLANTATION; PROLIFERATION; EXPRESSION; LEPTIN; FACTOR-1-ALPHA; MOBILIZATION; RECRUITMENT; MIGRATION	This study investigated the role of stromal cell-derived factor-1 alpha (SDF-1 alpha)/CXC chemokine receptor 4 (CXCR4) axis in brain and endothelial progenitor cells (EPCs), and explored the efficacy of CXCR4 primed EPCs in treating ischemic stroke in diabetes. The db/db diabetic and db/+ mice were used in this study. Levels of plasma SDF-1 alpha and circulating CD34+CXCR4+ cells were measured. Brain SDF-1 alpha and CXCR4 expression were quantified at basal and after middle cerebral artery occlusion (MCAO). In in vitro study, EPCs were transfected with adenovirus carrying null (Ad-null) or CXCR4 (Ad-CXCR4) followed with high glucose (HG) treatment for 4 days. For pathway block experiments, cells were pre-incubated with PI3K inhibitor or nitric oxide synthase (NOS) inhibitor for two hours. The CXCR4 expression, function and apoptosis of EPCs were determined. The p-Akt/Akt and p-eNOS/eNOS expression in EPCs were also measured. In in vivo study, EPCs transfected with Ad-null or Ad-CXCR4 were infused into mice via tail vein. On day 2 and 7, the cerebral blood flow, neurologic deficit score, infarct volume, cerebral microvascular density, angiogenesis and neurogenesis were determined. We found: 1) The levels of plasma SDF-1 alpha and circulating CD34+CXCR4+ cells were decreased in db/db mice; 2) The basal level of SDF-1 alpha and MCAO-induced up-regulation of SDF-1 alpha/CXCR4 axis were reduced in the brain of db/db mice; 3) Ad-CXCR4 transfection increased CXCR4 expression in EPCs and enhanced EPC colonic forming capacity; 4) Ad-CXCR4 transfection prevented EPCs from HG-induced dysfunction (migration and tube formation) and apoptosis via activation of PI3K/Akt/eNOS signal pathway; 4) Ad-CXCR4 transfection enhanced the efficacy of EPC infusion in attenuating infarct volume and promoting angiogenesis and neurogenesis. Our data suggest that Ad-CXCR4 primed EPCs have better therapeutic effects for ischemia stroke in diabetes than unmodified EPCs do.	[Chen, Ji; Chen, Shuzhen; Zhang, Cheng; Xiao, Xiang; Das, Avik; Zhao, Yuhui; Yuan, Bin; Morris, Mariana; Chen, Yanfang] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Chen, Ji; Chen, Jianying; Zhang, Liangqing; Yuan, Bin; Zhao, Bin; Chen, Yanfang] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Guangdong, Peoples R China; [Chen, Ji; Chen, Jianying; Zhang, Liangqing; Yuan, Bin; Zhao, Bin; Chen, Yanfang] Guangdong Med Coll, Affiliated Hosp, Dept Neurol, Zhanjiang, Guangdong, Peoples R China; [Zhao, Yuhui] Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning, Guangxi, Peoples R China	University System of Ohio; Wright State University Dayton; Guangdong Medical University; Guangdong Medical University; Guangxi Medical University	Chen, YF (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA.	yanfang.chen@wright.edu		Bihl, Ji/0000-0003-2404-1782; chen, shuzhen/0000-0001-5709-9978	American Diabetes Association (ADA) [1-10-BS-25]; National Heart, Lung, and Blood Institute [HL-098637, HL-093567]; National Natural Science Foundation of China [NSFC 81070878, 81271214, 81270195, 81270196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098637, R01HL093567] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Diabetes Association (ADA) (1-10-BS-25, Y.C.), the National Heart, Lung, and Blood Institute (HL-098637, Y.C. and HL-093567, M.M.), the National Natural Science Foundation of China (NSFC 81070878, 81271214, 81270195, 81270196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Badillo AT, 2007, J SURG RES, V143, P35, DOI 10.1016/j.jss.2007.03.051; Bermudez DM, 2011, J VASC SURG, V53, P774, DOI 10.1016/j.jvs.2010.10.056; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Chen J, 2011, AM J PHYSIOL-ENDOC M, V301, pE62, DOI 10.1152/ajpendo.00026.2011; Chen SZ, 2009, AM J PHYSIOL-REG I, V297, pR1526, DOI 10.1152/ajpregu.91040.2008; Chen TG, 2006, CELL PROLIFERAT, V39, P117, DOI 10.1111/j.1365-2184.2006.00375.x; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Cheng YX, 2012, INT J MOL MED, V30, P870, DOI 10.3892/ijmm.2012.1083; Cui X, 2009, J NEUROSCI RES, V87, P86, DOI 10.1002/jnr.21836; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Egan CG, 2008, DIABETOLOGIA, V51, P1296, DOI 10.1007/s00125-008-0939-6; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Foubert P, 2008, CIRC RES, V103, P751, DOI 10.1161/CIRCRESAHA.108.175083; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Ghorbani A, 2011, EXP CLIN ENDOCR DIAB, V119, P343, DOI 10.1055/s-0031-1275662; Girouard H, 2008, AM J PHYSIOL-HEART C, V294, pH156, DOI 10.1152/ajpheart.01137.2007; Hamed S, 2010, THROMB RES, V126, P166, DOI 10.1016/j.thromres.2010.03.002; Ingram DA, 2008, DIABETES, V57, P724, DOI 10.2337/db07-1507; Jie W, 2010, INT J EXP PATHOL, V91, P436, DOI 10.1111/j.1365-2613.2010.00720.x; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Kitahata Y, 2010, INT ARCH ALLERGY IMM, V152, P22, DOI 10.1159/000312122; Leu S, 2011, INT J CARDIOL, V150, P156, DOI 10.1016/j.ijcard.2010.03.007; Mantzoros CS, 1998, CLIN ENDOCRINOL, V49, P551, DOI 10.1046/j.1365-2265.1998.00571.x; Marrotte EJ, 2010, J CLIN INVEST, V120, P4207, DOI 10.1172/JCI36858; Mendoza-Naranjo A, 2012, CELL BIOL INT; Oh BJ, 2010, BIOCHEM BIOPH RES CO, V398, P627, DOI 10.1016/j.bbrc.2010.06.108; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676; Quirici N, 2001, BRIT J HAEMATOL, V115, P186, DOI 10.1046/j.1365-2141.2001.03077.x; Schroeter MR, 2012, CARDIOVASC RES, V93, P170, DOI 10.1093/cvr/cvr275; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Yokoi H, 2010, ARTERIOSCL THROM VAS, V30, P60, DOI 10.1161/ATVBAHA.109.192161; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f; Zheng H, 2008, ATHEROSCLEROSIS, V201, P36, DOI 10.1016/j.atherosclerosis.2008.02.011	50	28	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50105	10.1371/journal.pone.0050105	http://dx.doi.org/10.1371/journal.pone.0050105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185548	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000183
J	Singh, YT; Mazumdar-Leighton, S; Saikia, M; Pant, P; Kashung, S; Neog, K; Chakravorty, R; Nair, S; Nagaraju, J; Babu, CR				Singh, Y. Tunginba; Mazumdar-Leighton, Sudeshna; Saikia, Mahaswetta; Pant, Prashant; Kashung, Sochanngam; Neog, Kartik; Chakravorty, Rajen; Nair, Suresh; Nagaraju, Javaregowda; Babu, Cheerukeri Raghavendra			Genetic Variation within Native Populations of Endemic Silkmoth Antheraea assamensis (Helfer) from Northeast India Indicates Need for In Situ Conservation	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; TRANSPOSABLE ELEMENTS; LEPIDOPTERA-SATURNIIDAE; BOMBYX-MORI; SILKWORM; MARKERS; DNA; MICROSATELLITES; DIVERSITY; ISSR	A. assamensis is a phytophagous Lepidoptera from Northeast India reared on host trees of Lauraceae family for its characteristic cocoon silk. Source of these cocoons are domesticated farm stocks that crash frequently and/or wild insect populations that provide new cultures. The need to reduce dependence on wild populations for cocoons necessitates assessment of genetic diversity in cultivated and wild populations. Molecular markers based on PCR of Inter-simple sequence repeats (ISSR) and simple sequence repeats (SSR) were used with four populations of wild insects and eleven populations of cultivated insects. Wild populations had high genetic diversity estimates (H-I = 0.25; H-S = 0.28; H-E = 0.42) and at least one population contained private alleles. Both marker systems indicated that genetic variability within populations examined was significantly high. Among cultivated populations, insects of the Upper Assam region (H-I = 0.19; H-S = 0.18; H-E = 0) were genetically distinct (F-ST = 0.38 with both marker systems) from insects of Lower Assam (H-I = 0.24; H-S = 0.25; H-E = 0.3). Sequencing of polymorphic amplicons suggested transposition as a mechanism for maintaining genomic diversity. Implications for conservation of native populations in the wild and preserving in-farm diversity are discussed.	[Singh, Y. Tunginba; Mazumdar-Leighton, Sudeshna; Saikia, Mahaswetta; Pant, Prashant; Kashung, Sochanngam] Univ Delhi, Dept Bot, Delhi 110007, India; [Neog, Kartik; Chakravorty, Rajen] Cent Muga & Eri Res & Training Inst, Ladoigarh, Assam, India; [Singh, Y. Tunginba; Nair, Suresh] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Babu, Cheerukeri Raghavendra] Univ Delhi, Ctr Management Degraded Ecosyst, Delhi 110007, India	University of Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Delhi	Mazumdar-Leighton, S (corresponding author), Univ Delhi, Dept Bot, Delhi 110007, India.	smazumdar@botany.du.ac.in		Pant, Prashant/0000-0002-2060-2127	Department of Biotechnology, Government of India [BT/PR5233/PBD/19/116/2004-7]; Department of Biotechnology; Council of Scientific and Industrial Research, Govt. of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This research was supported by grant (BT/PR5233/PBD/19/116/2004-7) from Department of Biotechnology, Government of India to SML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A resource lab instrumentation loan from Bio-Rad Inc., India, is gratefully acknowledged. Ph.D. fellowships from Department of Biotechnology (to MS and PP) and Council of Scientific and Industrial Research, Govt. of India, (to YTS and SK) are acknowledged.	Abbot Patrick, 2001, Journal of Insect Science (Tucson), V1, pUnpaginated; Allen CE, 2011, ANNU REV ENTOMOL, V56, P445, DOI 10.1146/annurev-ento-120709-144828; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arunkumar KP, 2009, MOL ECOL RESOUR, V9, P268, DOI 10.1111/j.1755-0998.2008.02414.x; Arunkumar KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043716; Bahulikar Rahul A., 2004, BMC Ecology, V4, P12, DOI 10.1186/1472-6785-4-12; Beeson C.F.C., 1941, ECOLOGY CONTROL FORE; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; BETTS CR, 1988, J EXP BIOL, V138, P271; Biemont C, 1999, GENETICA, V105, P43, DOI 10.1023/A:1003718520490; Bindroo BB, 2006, INDIAN SILK, V44, P13; Bornet B, 2002, GENOME, V45, P890, DOI [10.1139/g02-061, 10.1139/G02-061]; Chatterjee S. N., 2004, Genetika, V40, P1618; Chowdhury SN, 2001, SERICULTURE WEAVING; Coates BS, 2010, J MOL EVOL, V70, P275, DOI 10.1007/s00239-010-9330-6; Dongen SV, 1998, HEREDITY, V80, P92; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; Good IL, 2009, ARCHAEOMETRY, V51, P457, DOI 10.1111/j.1475-4754.2008.00454.x; HENRY JM, 1990, ANAL BIOCHEM, V185, P147, DOI 10.1016/0003-2697(90)90270-J; Holsinger K. E., 2003, HICKORY PACKAGE ANAL; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Huang XH, 2008, PLANT PHYSIOL, V148, P25, DOI 10.1104/pp.108.121491; Hugon T, 1837, J ASIATIC SOC BENGAL, V6, P21; Kar PK, 2005, GENETICA, V125, P173, DOI 10.1007/s10709-005-7002-z; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Kovach WL., 2007, MVSP A MULTIVARIATE; Lepetit D, 2002, MOL ECOL, V11, P347, DOI 10.1046/j.1365-294X.2002.01470.x; Mazumdar-Leighton S, 2001, INSECT BIOCHEM MOLEC, V31, P633, DOI 10.1016/S0965-1748(00)00168-5; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; MILLER MP, 1998, AMOVA PREP 1 01 PROG; MILLER MP, 1997, TOOL POPULATION GENE; NAGARAJA GM, 1995, ELECTROPHORESIS, V16, P1633, DOI 10.1002/elps.11501601270; Nath Ramesh, 2009, International Journal of Tropical Insect Science, V29, P70, DOI 10.1017/S1742758409990075; Nei M., 1987, MOL EVOLUTIONARY GEN; Neog K, 2010, AFR J BIOTECHNOL, V9, P1746; Nevo E., 1984, Lecture Notes in Biomathematics, V53, P13; Notter DR, 1999, J ANIM SCI, V77, P61; OLIVER CG, 1972, EVOLUTION, V26, P221, DOI 10.1111/j.1558-5646.1972.tb00189.x; Osanai-Futahashi M, 2008, INSECT BIOCHEM MOLEC, V38, P1046, DOI 10.1016/j.ibmb.2008.05.012; Pradeep Appukuttan R., 2005, Journal of Applied Genetics, V46, P291; Pritchard JK, 2000, GENETICS, V155, P945; Purkait B, 2004, WTR SCI TEC LIBR, V47, P113; Reddy KD, 1999, HEREDITY, V83, P681, DOI 10.1046/j.1365-2540.1999.00607.x; Saha M, 2008, J ECON ENTOMOL, V101, P1176, DOI 10.1603/0022-0493(2008)101[1176:DORAPD]2.0.CO;2; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sarma JN, 2005, GEOMORPHOLOGY, V70, P226, DOI 10.1016/j.geomorph.2005.02.007; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; Singh KC, 2006, SERICULTURE SERIBIOD, P8; Singh YT, 2010, THESIS U DELHI INDIA; Smit A, 1996, REPEATMASKER OPEN 30; Sokal RR, 1995, BIOMETRY; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Toro MA, 2005, PHILOS T R SOC B, V360, P1367, DOI 10.1098/rstb.2005.1680; TRAUT W, 1987, GENETICS, V115, P493; Vijayan K, 2006, J INSECT SCI, V30, P1536; Weir B. S., 1996, GENETIC DATA ANAL; WHITE TCR, 1972, PAC INSECTS, V14, P669; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	66	11	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49972	10.1371/journal.pone.0049972	http://dx.doi.org/10.1371/journal.pone.0049972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185503	Green Published, gold			2022-12-25	WOS:000311821000155
J	Tsai, YL; Chiang, YR; Wu, CF; Narberhaus, F; Lai, EM				Tsai, Yun-Long; Chiang, Yin-Ru; Wu, Chih-Feng; Narberhaus, Franz; Lai, Erh-Min			One out of Four: HspL but No Other Small Heat Shock Protein of Agrobacterium tumefaciens Acts as Efficient Virulence-Promoting VirB8 Chaperone	PLOS ONE			English	Article							ALPHA-CRYSTALLIN DOMAIN; IV SECRETION; OLIGOMERIZATION; EXPRESSION; STABILITY; SUBUNIT; RANGE	Alpha-crystallin-type small heat shock proteins (sHsps) are ubiquitously distributed in most eukaryotes and prokaryotes. Four sHsp genes named hspL, hspC, hspAT1, and hspAT2 were identified in Agrobacterium tumefaciens, a plant pathogenic bacterium capable of unique interkingdom DNA transfer via type IV secretion system (T4SS). HspL is highly expressed in virulence-induced growth condition and functions as a VirB8 chaperone to promote T4SS-mediated DNA transfer. Here, we used genetic and biochemical approaches to investigate the involvement of the other three sHsps in T4SS and discovered the molecular basis underlying the dominant function of HspL in promoting T4SS function. While single deletion of hspL but no other sHsp gene reduced T4SS-mediated DNA transfer and tumorigenesis efficiency, additional deletion of other sHsp genes in the hspL deletion background caused synergistic effects in the virulence phenotypes. This is correlated with the high induction of hspL and only modest increase of hspC, hspAT1, and hspAT2 at their mRNA and protein abundance in virulence-induced growth condition. Interestingly, overexpression of any single sHsp gene alone in the quadruple mutant caused increased T4SS-mediated DNA transfer and tumorigenesis. Thermal aggregation protecting assays in vitro indicated that all four sHsps exhibit chaperone activity for the model substrate citrate synthase but only HspL functions as efficient chaperone for VirB8. The higher VirB8 chaperone activity of HspL was also demonstrated in vivo, in which lower amounts of HspL than other sHsps were sufficient in maintaining VirB8 homeostasis in A. tumefaciens. Domain swapping between HspL and HspAT2 indicated that N-terminal, central alpha-crystallin, and C-terminal domains of HspL all contribute to HspL function as an efficient VirB8 chaperone. Taken together, we suggest that the dominant role of HspL in promoting T4SS function is based on its higher expression in virulence-induced condition and its more efficient VirB8 chaperone activity as compared to other sHsps.	[Tsai, Yun-Long; Chiang, Yin-Ru; Wu, Chih-Feng; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Narberhaus, Franz] Ruhr Univ Bochum, Lehrstuhl Biol Mikroorganismen, Bochum, Germany	Academia Sinica - Taiwan; Ruhr University Bochum	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	emlai@gate.sinica.edu.tw	Lai, Erh-Min/ABG-9558-2020; Chiang, Yin-Ru/L-7727-2019	Lai, Erh-Min/0000-0003-3630-8683; Narberhaus, Franz/0000-0002-8552-5310; Chiang, Yin-Ru/0000-0001-6899-3166	Taiwan National Science Council (NSC) [NSC 95-2320-B-001-009, NSC 98-2311-B-001 -002-MY3]; NSC; German Academic Exchange Service [0970029248P]; Taiwan National Science Council [0970029248P]; Academia Sinica Summit project	Taiwan National Science Council (NSC)(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica Summit project	This work was in part supported by the Taiwan National Science Council (NSC) (http://web1.nsc.gov.tw/) grants NSC 95-2320-B-001-009 and NSC 98-2311-B-001 -002-MY3 to EML and an NSC postdoctoral fellowship to YLT and a joint grant from the German Academic Exchange Service and the Taiwan National Science Council (PPP grant no. 0970029248P) to FN and EML. YLT and YRC were supported by NSC postdoctoral fellowship and Academia Sinica Summit project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Balsiger S, 2004, J BACTERIOL, V186, P6824, DOI 10.1128/JB.186.20.6824-6829.2004; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Berengian AR, 1999, J BIOL CHEM, V274, P6305, DOI 10.1074/jbc.274.10.6305; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; EMORY SA, 1990, J BACTERIOL, V172, P4472, DOI 10.1128/jb.172.8.4472-4481.1990; Fernando P, 2000, CELL STRESS CHAPERON, V5, P148, DOI 10.1379/1466-1268(2000)005<0148:FCOXSH>2.0.CO;2; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; Haslbeck M, 2004, EMBO J, V23, P638, DOI 10.1038/sj.emboj.7600080; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; KADO CI, 1970, PHYTOPATHOLOGY, V60, P969, DOI 10.1094/Phyto-60-969; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Lai EM, 2006, PROTEOMICS, V6, P4130, DOI 10.1002/pmic.200600254; Lentze N, 2003, J MOL BIOL, V328, P927, DOI 10.1016/S0022-2836(03)00356-5; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Munchbach M, 1999, EUR J BIOCHEM, V264, P39, DOI 10.1046/j.1432-1327.1999.00567.x; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Rosen R, 2002, J BACTERIOL, V184, P1772, DOI 10.1128/JB.184.6.1772-1778.2002; Sambrook J, 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Studer S, 2002, EUR J BIOCHEM, V269, P3578, DOI 10.1046/j.1432-1033.2002.03049.x; Studer S, 2000, J BIOL CHEM, V275, P37212, DOI 10.1074/jbc.M004701200; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Tsai YL, 2010, J BIOL CHEM, V285, P19757, DOI 10.1074/jbc.M110.110296; Tsai YL, 2009, MICROBIOL-SGM, V155, P3270, DOI 10.1099/mic.0.030676-0; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938	36	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49685	10.1371/journal.pone.0049685	http://dx.doi.org/10.1371/journal.pone.0049685			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185409	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000087
J	Zheng, SA; Zheng, XQ; Chen, C				Zheng, Shun-an; Zheng, Xiangqun; Chen, Chun			Leaching Behavior of Heavy Metals and Transformation of Their Speciation in Polluted Soil Receiving Simulated Acid Rain	PLOS ONE			English	Article							CHARGE SOILS; ZINC; FRACTIONATION; COPPER; LEAD; MOBILITY; CADMIUM; IMPACTS; IONS	Heavy metals that leach from contaminated soils under acid rain are of increasing concern. In this study, simulated acid rain (SAR) was pumped through columns of artificially contaminated purple soil. Column leaching tests and sequential extraction were conducted for the heavy metals Cu, Pb, Cd, and Zn to determine the extent of their leaching as well as to examine the transformation of their speciation in the artificially contaminated soil columns. Results showed that the maximum leachate concentrations of Cu, Pb, Cd, and Zn were less than those specified in the Chinese Quality Standards for Groundwater (Grade IV), thereby suggesting that the heavy metals that leached from the polluted purple soil receiving acid rain may not pose as risks to water quality. Most of the Pb and Cd leachate concentrations were below their detection limits. By contrast, higher Cu and Zn leachate concentrations were found because they were released by the soil in larger amounts as compared with those of Pb and Cd. The differences in the Cu and Zn leachate concentrations between the controls (SAR at pH 5.6) and the treatments (SAR at pH 3.0 and 4.5) were significant. Similar trends were observed in the total leached amounts of Cu and Zn. The proportions of Cu, Pb, Cd, and Zn in the EXC and OX fractions were generally increased after the leaching experiment at three pH levels, whereas those of the RES, OM, and CAR fractions were slightly decreased. Acid rain favors the leaching of heavy metals from the contaminated purple soil and makes the heavy metal fractions become more labile. Moreover, a pH decrease from 5.6 to 3.0 significantly enhanced such effects.	[Zheng, Shun-an; Zheng, Xiangqun; Chen, Chun] Minist Agr, Agroenvironm Protect Inst, Tianjin, Peoples R China; [Zheng, Shun-an; Zheng, Xiangqun; Chen, Chun] Minist Agr, Key Lab Prod Environm & Agroprod Safety, Tianjin, Peoples R China; [Zheng, Shun-an; Zheng, Xiangqun; Chen, Chun] Tianjin Key Lab Agroenvironm & Agroprod Safety, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Zheng, SA (corresponding author), Minist Agr, Agroenvironm Protect Inst, Tianjin, Peoples R China.	zhengshunan@gmail.com			Central Public Research Institutes Basic Funds for Research and Development (Agro-Environmental Protection Institute, Ministry of Agriculture)	Central Public Research Institutes Basic Funds for Research and Development (Agro-Environmental Protection Institute, Ministry of Agriculture)	This work was financially supported by Central Public Research Institutes Basic Funds for Research and Development (Agro-Environmental Protection Institute, Ministry of Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ENV SCI MANAGEMENT; Gao YJ, 2009, NUTR CYCL AGROECOSYS, V85, P109, DOI 10.1007/s10705-009-9252-0; Grolimund D, 1996, ENVIRON SCI TECHNOL, V30, P3118, DOI 10.1021/es960246x; Guo ZH, 2005, J ENVIRON SCI, V17, P332; Kabala C, 2001, J ENVIRON QUAL, V30, P485, DOI 10.2134/jeq2001.302485x; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Lee SZ, 1998, J HAZARD MATER, V63, P37, DOI 10.1016/S0304-3894(98)00203-9; Li QL, 2010, ACTA GEOCHIM, V29, P100, DOI 10.1007/s11631-010-0100-3; Li ZB, 2009, SOIL TILL RES, V105, P285, DOI 10.1016/j.still.2009.04.002; Ling DJ, 2010, ECOTOX ENVIRON SAFE, V73, P1914, DOI 10.1016/j.ecoenv.2010.07.024; Lu R, 2000, METHODS SOIL AGROCHE; Ma LQ, 1997, J ENVIRON QUAL, V26, P259, DOI 10.2134/jeq1997.00472425002600010036x; Martinez CE, 2000, ENVIRON POLLUT, V107, P153, DOI 10.1016/S0269-7491(99)00111-6; Singh A, 2008, J ENVIRON BIOL, V29, P15; TACK FMG, 1995, INT J ENVIRON AN CH, V59, P225, DOI 10.1080/03067319508041330; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Wang M, 2009, J ZHEJIANG UNIV-SC B, V10, P563, DOI 10.1631/jzus.B0920037; Wilson MJ, 1996, APPL GEOCHEM, V11, P133, DOI 10.1016/0883-2927(95)00088-7; Wu FZ, 2010, J HAZARD MATER, V177, P268, DOI 10.1016/j.jhazmat.2009.12.028; XIANG HF, 1995, GEODERMA, V66, P121, DOI 10.1016/0016-7061(94)00067-K; Xie ZQ, 2009, J GEOGR SCI, V19, P489, DOI 10.1007/s11442-009-0489-y; ZHANG FS, 1991, SOIL SCI, V151, P436, DOI 10.1097/00010694-199106000-00005; Zhang H, 2006, ENVIRON TOXICOL CHEM, V25, P664, DOI 10.1897/04-664R.1; Zhang JE, 2007, CHEMOSPHERE, V67, P2131, DOI 10.1016/j.chemosphere.2006.12.095; Zhu MX, 2005, APPL GEOCHEM, V20, P169, DOI 10.1016/j.apgeochem.2004.06.003	25	56	58	9	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49664	10.1371/journal.pone.0049664	http://dx.doi.org/10.1371/journal.pone.0049664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185399	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000079
J	Kallsen, K; Andresen, E; Heine, H				Kallsen, Kimberley; Andresen, Ellen; Heine, Holger			Histone Deacetylase (HDAC) 1 Controls the Expression of Beta Defensin 1 in Human Lung Epithelial Cells	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN BETA-DEFENSIN-1; ANTIMICROBIAL PEPTIDES; INHIBITORS; ASSOCIATION; IMMUNITY; INNATE; TRANSCRIPTION; ACETYLATION; APOPTOSIS	Deregulation of the expression human beta defensin 1 (DEFB1), an antimicrobial peptide, has been implicated in the pathogenesis of COPD and asthma. Since the molecular mechanisms that regulate DEFB1 gene expression are widely unknown, the epigenetic processes involved in the regulation of the constitutive expression of DEFB1 in lung epithelial cells (A549) were investigated. The data demonstrate that histone deacetylases (HDACs) participate in the regulation of DEFB1 gene expression. Inhibition of the class I HDACs, HDACs 1-3, increases DEFB1 gene expression in A549 cells. Chromatin immunoprecipitation (ChIP) assays revealed that the inhibition of the class I HDACs also results in modifications of the chromatin at the DEFB1 promoter. Histone modifications, histone H3 acetylation and H3K4 trimethylation, that are associated with transcriptional activation, were found to increase after inhibition of HDACs 1-3. Finally, RNAi knockdown experiments identified HDAC1 as the sole HDAC responsible for maintaining the constitutive level of DEFB1 transcription. Taken together, our data reveal epigenetic mechanisms which are the basis of the maintenance of the constitutive gene expression of human beta defensin 1.	[Kallsen, Kimberley; Andresen, Ellen; Heine, Holger] Airway Res Ctr N, Res Ctr Borstel, Div Innate Immun, Borstel, Germany	Forschungszentrum Borstel	Heine, H (corresponding author), Airway Res Ctr N, Res Ctr Borstel, Div Innate Immun, Borstel, Germany.	hheine@fz-borstel.de	Heine, Holger/H-4552-2012	Heine, Holger/0000-0001-8128-5068	German Research Council (DFG), Bonn, Germany [SFB617]	German Research Council (DFG), Bonn, Germany(German Research Foundation (DFG))	HH and EA were supported by the German Research Council (DFG, SFB617), Bonn, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock Ian M, 2005, COPD, V2, P445; Adcock IM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-21; Adenuga D, 2009, AM J RESP CELL MOL, V40, P464, DOI 10.1165/rcmb.2008-0255OC; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Andresen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021898; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; de Oca EPM, 2007, INT ARCH ALLERGY IMM, V142, P211, DOI 10.1159/000097023; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Duits LA, 2002, IMMUNOLOGY, V106, P517, DOI 10.1046/j.1365-2567.2002.01430.x; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Halili MA, 2010, J LEUKOCYTE BIOL, V87, P1103, DOI 10.1189/jlb.0509363; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hu ED, 2003, J PHARMACOL EXP THER, V307, P720, DOI 10.1124/jpet.103.055541; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kwon HJ, 1998, P NATL ACAD SCI USA, V95, P3356, DOI 10.1073/pnas.95.7.3356; Laubel DM, 2006, CURR TOP MICROBIOL, V306, P153; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; Levy H, 2005, J ALLERGY CLIN IMMUN, V115, P252, DOI 10.1016/j.jaci.2004.11.013; Matsushita I, 2002, BIOCHEM BIOPH RES CO, V291, P17, DOI 10.1006/bbrc.2002.6395; MURPHY CJ, 1993, J CELL PHYSIOL, V155, P408, DOI 10.1002/jcp.1041550223; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rosato RR, 2003, CANCER BIOL THER, V2, P30; Schaefer AS, 2010, GENES IMMUN, V11, P45, DOI 10.1038/gene.2009.75; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; Sherman H, 2006, MOL IMMUNOL, V43, P1617, DOI 10.1016/j.molimm.2005.09.013; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; Vogelmeier C, 2007, Pneumologie, V61, pe1, DOI 10.1055/s-2007-959200; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yoshida M, 2001, CANCER CHEMOTH PHARM, V48, pS20, DOI 10.1007/s002800100300; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4; Zhu BD, 2003, ACTA PHARMACOL SIN, V24, P907	44	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50000	10.1371/journal.pone.0050000	http://dx.doi.org/10.1371/journal.pone.0050000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185513	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700061
J	Oxlade, O; Murray, M				Oxlade, Olivia; Murray, Megan			Tuberculosis and Poverty: Why Are the Poor at Greater Risk in India?	PLOS ONE			English	Article							SOCIAL DETERMINANTS; PREVALENCE; TRENDS; COSTS; EPIDEMIOLOGY; EXPENDITURE; BURDEN; STATES	Background: Although poverty is widely recognized as an important risk factor for tuberculosis (TB) disease, the specific proximal risk factors that mediate this association are less clear. The objective of our study was to investigate the mechanisms by which poverty increases the risk of TB. Methods: Using individual level data from 198,754 people from the 2006 Demographic Health Survey (DHS) for India, we assessed self-reported TB status, TB determinants and household socioeconomic status. We used these data to calculate the population attributable fractions (PAF) for each key TB risk factor based on the prevalence of determinants and estimates of the effect of these risk factors derived from published sources. We conducted a mediation analysis using principal components analysis (PCA) and regression to demonstrate how the association between poverty and TB prevalence is mediated. Results: The prevalence of self-reported TB in the 2006 DHS for India was 545 per 100,000 and ranged from 201 in the highest quintile to 1100 in the lowest quintile. Among those in the poorest population, the PAFs for low body mass index (BMI) and indoor air pollution were 34.2% and 28.5% respectively. Conclusion: TB control strategies should be targeted to the poorest populations that are most at risk, and should address the most important determinants of disease-specifically low BMI and indoor air pollution.	[Oxlade, Olivia; Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Murray, Megan] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Murray, Megan] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Murray, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	mmurray@hsph.harvard.edu			Canadian Institute of Health Research [FRN 106987]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The Canadian Institute of Health Research [FRN 106987 to OO] ( http://www.cihr-irsc.gc.ca). No additional funding to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Boccia D, 2009, AM J TROP MED HYG, V80, P1004, DOI 10.4269/ajtmh.2009.80.1004; CANTWELL MF, 1994, JAMA-J AM MED ASSOC, V272, P535, DOI 10.1001/jama.272.7.535; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Creswell J, 2011, INT J TUBERC LUNG D, V15, P431, DOI 10.5588/ijtld.10.0654; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; ENARSON DA, 1989, AM J EPIDEMIOL, V129, P1268, DOI 10.1093/oxfordjournals.aje.a115246; Falkingham J, 2002, MEASURING HLTH POVER; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; FREEDMAN LS, 1992, STAT MED, V11, P167, DOI 10.1002/sim.4780110204; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; Glynn JR, 2000, T ROY SOC TROP MED H, V94, P500, DOI 10.1016/S0035-9203(00)90065-8; Gopi PG, 2005, INDIAN J MED RES, V122, P243; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Hoa NB, 2011, INT J TUBERC LUNG D, V15, P32; Janssens JP, 2008, EUR RESPIR J, V32, P1415, DOI 10.1183/09031936.00078708; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; John KR, 2009, INT J TUBERC LUNG D, V13, P1281; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Murray M, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P64, DOI 10.5588/ijtld.10.0535; Murray M, 2010, TUBERCULOSIS; Oxlade O, 2009, INT J TUBERC LUNG D, V13, P1238; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; SCHOEMAN JH, 1991, INT J EPIDEMIOL, V20, P435, DOI 10.1093/ije/20.2.435; Shenassa ED, 2007, AM J PUBLIC HEALTH, V97, P1893, DOI 10.2105/AJPH.2006.093773; UNAIDS, 2011, COUNTR PROF JOINT UN; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, 2009, GLOB TUB CONTR 2009; WHO, 2010, GLOB TUB CONTR 2010; World Health Organization, 2007, GLOB TUB CONTR 2008; World Health Organization (WHO), 2012, GLOB DAT BOD MASS IN	44	119	125	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e47533	10.1371/journal.pone.0047533	http://dx.doi.org/10.1371/journal.pone.0047533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040PB	23185241	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800003
J	Richards, R; Dempski, RE				Richards, Ryan; Dempski, Robert E.			Re-Introduction of Transmembrane Serine Residues Reduce the Minimum Pore Diameter of Channelrhodopsin-2	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; PROTON TRANSLOCATION; THREONINE RESIDUES; CRYSTAL-STRUCTURE; MYELINATED NERVE; SODIUM-CHANNEL; ALPHA-HELICES; METAL CATIONS; LIGHT; BACTERIORHODOPSIN	Channelrhodopsin-2 (ChR2) is a microbial-type rhodopsin found in the green algae Chlamydomonas reinhardtii. Under physiological conditions, ChR2 is an inwardly rectifying cation channel that permeates a wide range of mono-and divalent cations. Although this protein shares a high sequence homology with other microbial-type rhodopsins, which are ion pumps, ChR2 is an ion channel. A sequence alignment of ChR2 with bacteriorhodopsin, a proton pump, reveals that ChR2 lacks specific motifs and residues, such as serine and threonine, known to contribute to non-covalent interactions within transmembrane domains. We hypothesized that reintroduction of the eight transmembrane serine residues present in bacteriorhodopsin, but not in ChR2, will restrict the conformational flexibility and reduce the pore diameter of ChR2. In this work, eight single serine mutations were created at homologous positions in ChR2. Additionally, an endogenous transmembrane serine was replaced with alanine. We measured kinetics, changes in reversal potential, and permeability ratios in different alkali metal solutions using two-electrode voltage clamp. Applying excluded volume theory, we calculated the minimum pore diameter of ChR2 constructs. An analysis of the results from our experiments show that reintroducing serine residues into the transmembrane domain of ChR2 can restrict the minimum pore diameter through inter-and intrahelical hydrogen bonds while the removal of a transmembrane serine results in a larger pore diameter. Therefore, multiple positions along the intracellular side of the transmembrane domains contribute to the cation permeability of ChR2.	[Richards, Ryan; Dempski, Robert E.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Dempski, RE (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA.	rdempski@wpi.edu	Richards, Ryan/B-3513-2008	Richards, Ryan/0000-0001-8792-3964	Worcester Polytechnic Institute Research Foundation	Worcester Polytechnic Institute Research Foundation	The research was funded by the Worcester Polytechnic Institute Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamian L, 2003, J MOL BIOL, V327, P251, DOI 10.1016/S0022-2836(03)00041-X; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Braun FJ, 1999, BIOPHYS J, V76, P1668, DOI 10.1016/S0006-3495(99)77326-1; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; COHEN BN, 1992, J GEN PHYSIOL, V100, P373, DOI 10.1085/jgp.100.3.373; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; Ehlenbeck S, 2002, BIOPHYS J, V82, P740, DOI 10.1016/S0006-3495(02)75436-2; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Feldbauer K, 2009, P NATL ACAD SCI USA, V106, P12317, DOI 10.1073/pnas.0905852106; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; GREGORET LM, 1991, PROTEINS, V9, P99, DOI 10.1002/prot.340090204; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HEGEMANN P, 1991, BIOPHYS J, V60, P1477, DOI 10.1016/S0006-3495(91)82183-X; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; LAWSON MA, 1991, BIOPHYS J, V60, P1490, DOI 10.1016/S0006-3495(91)82184-1; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; MARTI T, 1991, J BIOL CHEM, V266, P6919; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; Nack M, 2012, FEBS LETT, V586, P1344, DOI 10.1016/j.febslet.2012.03.047; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Nikolic Konstantin, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1626; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peralavarez-Marin A, 2004, J BIOL CHEM, V279, P16403, DOI 10.1074/jbc.M313988200; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Radzwill N, 2001, BIOPHYS J, V80, P2856, DOI 10.1016/S0006-3495(01)76252-2; Richards R, 2011, JOVE-J VIS EXP, DOI 10.3791/2627; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Smart OS, 1997, BIOPHYS J, V72, P1109, DOI 10.1016/S0006-3495(97)78760-5; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x	50	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50018	10.1371/journal.pone.0050018	http://dx.doi.org/10.1371/journal.pone.0050018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185520	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800066
J	Terry, SJ; Elbediwy, A; Zihni, C; Harris, AR; Bailly, M; Charras, GT; Balda, MS; Matter, K				Terry, Stephen J.; Elbediwy, Ahmed; Zihni, Ceniz; Harris, Andrew R.; Bailly, Maryse; Charras, Guillaume T.; Balda, Maria S.; Matter, Karl			Stimulation of Cortical Myosin Phosphorylation by p114RhoGEF Drives Cell Migration and Tumor Cell Invasion	PLOS ONE			English	Article							SMOOTH-MUSCLE; RHO GTPASES; IDENTIFICATION; ACTOMYOSIN; ACTIVATION; ADHESION; REVEALS; COMPLEX; BARRIER; PROTEIN	Actinomyosin activity is an important driver of cell locomotion and has been shown to promote collective cell migration of epithelial sheets as well as single cell migration and tumor cell invasion. However, the molecular mechanisms underlying activation of cortical myosin to stimulate single cell movement, and the relationship between the mechanisms that drive single cell locomotion and those that mediate collective cell migration of epithelial sheets are incompletely understood. Here, we demonstrate that p114RhoGEF, an activator of RhoA that associates with non-muscle myosin IIA, regulates collective cell migration of epithelial sheets and tumor cell invasion. Depletion of p114RhoGEF resulted in specific spatial inhibition of myosin activation at cell-cell contacts in migrating epithelial sheets and the cortex of migrating single cells, but only affected double and not single phosphorylation of myosin light chain. In agreement, overall elasticity and contractility of the cells, processes that rely on persistent and more constant forces, were not affected, suggesting that p114RhoGEF mediates process-specific myosin activation. Locomotion was p114RhoGEF-dependent on Matrigel, which favors more roundish cells and amoeboid-like actinomyosin-driven movement, but not on fibronectin, which stimulates flatter cells and lamellipodia-driven, mesenchymal-like migration. Accordingly, depletion of p114RhoGEF led to reduced RhoA, but increased Rac activity. Invasion of 3D matrices was p114RhoGEF-dependent under conditions that do not require metalloproteinase activity, supporting a role of p114RhoGEF in myosin-dependent, amoeboid-like locomotion. Our data demonstrate that p114RhoGEF drives cortical myosin activation by stimulating myosin light chain double phosphorylation and, thereby, collective cell migration of epithelial sheets and amoeboid-like motility of tumor cells.	[Terry, Stephen J.; Elbediwy, Ahmed; Zihni, Ceniz; Bailly, Maryse; Balda, Maria S.; Matter, Karl] UCL, Dept Cell Biol, UCL Inst Ophthalmol, London, England; [Harris, Andrew R.; Charras, Guillaume T.] UCL, London Ctr Nanotechnol, London, England; [Harris, Andrew R.] UCL, Dept Chem, Doctorate Program Engn, London, England; [Harris, Andrew R.] UCL, Dept Phys, London, England; [Charras, Guillaume T.] UCL, Dept Cell & Dev Biol, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Balda, MS (corresponding author), UCL, Dept Cell Biol, UCL Inst Ophthalmol, London, England.	m.balda@ucl.ac.uk; k.matter@ucl.ac.uk	Matter, Karl/C-4880-2008; Terry, Stephen/AAC-8511-2019; Charras, Guillaume/F-8571-2014; Bailly, Maryse/C-1663-2008	Matter, Karl/0000-0001-8026-7220; Charras, Guillaume/0000-0002-7902-0279; Bailly, Maryse/0000-0002-0593-6356; zihni, ceniz/0000-0002-7961-5336; Terry, Stephen/0000-0001-8195-898X; /0000-0002-8427-6746; Elbediwy, Ahmed/0000-0002-2102-7339	Wellcome Trust [084678/Z/08/Z]; Fight for Sight [1665]; Biotechnology and Biological Sciences Research Council [BB/H002294/1, BB/J015032/1] Funding Source: researchfish; Medical Research Council [G0400678, G0801049] Funding Source: researchfish; BBSRC [BB/J015032/1, BB/H002294/1] Funding Source: UKRI; MRC [G0801049, G0400678] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Fight for Sight; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by grants from the Wellcome Trust (084678/Z/08/Z) and Fight for Sight (1665) to Karl Matter and Maria S. Balda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Clark AG, 2009, CURR BIOL, V19, P1389, DOI 10.1016/j.cub.2009.06.044; Dahlmann-Noor AH, 2007, EXP CELL RES, V313, P4158, DOI 10.1016/j.yexcr.2007.07.040; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Harris AR, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/34/345102; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; IKEBE M, 1986, J BIOL CHEM, V261, P36; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Liao YC, 2012, ONCOGENE, V31, P3086, DOI 10.1038/onc.2011.476; Martin TA, 2010, INT J MOL MED, V26, P721, DOI 10.3892/ijmm_00000519; Martin-Martin B, 2011, EUR J CELL BIOL, V90, P26, DOI 10.1016/j.ejcb.2010.09.008; Matsubayashi Y, 2011, J CELL SCI, V124, P1017, DOI 10.1242/jcs.080853; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Nakajima H, 2011, J CELL BIOL, V195, P245, DOI 10.1083/jcb.201104118; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Ridgway LD, 2010, J CELL BIOCHEM, V111, P1299, DOI 10.1002/jcb.22854; Samarin S, 2009, FRONT BIOSCI-LANDMRK, V14, P1129, DOI 10.2741/3298; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; UMEMOTO S, 1989, J BIOL CHEM, V264, P1431; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zelenka PS, 2008, SEMIN CELL DEV BIOL, V19, P113, DOI 10.1016/j.semcdb.2007.10.001	41	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							10.1371	10.1371/journal.pone.0050188	http://dx.doi.org/10.1371/journal.pone.0050188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185572	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000311333800073
J	Yu, L; Rao, CM; Shi, XC; Li, YH; Gao, K; Li, XG; Wang, JZ				Yu, Lei; Rao, Chunming; Shi, Xinchang; Li, Yonghong; Gao, Kai; Li, Xuguang; Wang, Junzhi			A Novel Bioassay for the Activity Determination of Therapeutic Human Brain Natriuretic Peptide (BNP)	PLOS ONE			English	Article							DECOMPENSATED HEART-FAILURE; GUANYLATE-CYCLASE; RECEPTOR	Background: Recombinant human brain natriuretic peptide (rhBNP) is an important peptide-based therapeutic drug indicated for the treatment of acute heart failure. Accurate determination of the potency of therapeutic rhBNP is crucial for the safety and efficacy of the drug. The current bioassay involves use of rabbit aortic strips, with experiments being complicated and time-consuming and markedly variable in results. Animal-less methods with better precision and accuracy should be explored. We have therefore developed an alternative cell-based assay, which relies on the ability of BNP to induce cGMP production in HEK293 cells expressing BNP receptor guanylyl cyclase-A. Methodology/Principal Findings: An alternative assay based on the measurement of BNP-induced cGMP production was developed. Specifically, the bioassay employs cells engineered to express BNP receptor guanylyl cyclase-A (GCA). Upon rhBNP stimulation, the levels of the second messager cGMP in these cells drastically increased and subsequently secreted into culture supernatants. The quantity of cGMP, which corresponds to the rhBNP activity, was determined using a competitive ELISA developed by us. Compared with the traditional assay, the novel cell-based assay demonstrated better reproducibility and precision. Conclusion/Significance: The optimized cell-based assay is much simpler, more rapid and precise compared with the traditional assay using animal tissues. To our knowledge, this is the first report on a novel and viable alternative assay for rhBNP potency analysis.	[Yu, Lei; Rao, Chunming; Shi, Xinchang; Li, Yonghong; Gao, Kai; Wang, Junzhi] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China; [Li, Xuguang] Hlth Canada, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada	National Institute of Food & Drug Control - China; Health Canada	Wang, JZ (corresponding author), Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China.	wangjz@nicpbp.org.cn			Chinese governmental grants [2009ZX09307-001, 2012ZX09304-010]	Chinese governmental grants	The current study was sponsored by Chinese governmental grants (2009ZX09307-001 and 2012ZX09304-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cauliez B, 2005, ANN BIOL CLIN-PARIS, V63, P15; Chen BY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020477; Colbert Katberine, 2003, Crit Care Nurs Q, V26, P40; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; Dickey DM, 2010, MOL PHARMACOL, V78, P431, DOI 10.1124/mol.110.066084; Dries DL, 2007, HYPERTENSION, V49, P971, DOI 10.1161/HYPERTENSIONAHA.107.087254; Duda T, 2010, MOL CELL BIOCHEM, V334, P37, DOI 10.1007/s11010-009-0335-7; Gassanov N, 2012, EUR J CLIN PHARMACOL, V68, P223, DOI 10.1007/s00228-011-1117-1; Goetze JP, 2012, CLIN CHEM, V58, P83, DOI 10.1373/clinchem.2011.165696; Goy MF, 2001, BIOCHEM J, V358, P379, DOI 10.1042/0264-6021:3580379; Hunter I, 2012, ADV CLIN CHEM, V58, P45, DOI 10.1016/B978-0-12-394383-5.00009-6; Iyengar S, 2004, EXPERT OPIN PHARMACO, V5, P901, DOI 10.1517/eoph.5.4.901.30159; Keating GM, 2003, DRUGS, V63, P47, DOI 10.2165/00003495-200363010-00004; Kishimoto I, 2009, CURR CARDIOL REV, V5, P45, DOI 10.2174/157340309787048068; Larocque L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174615; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; Mills Roger M, 2002, Congest Heart Fail, V8, P270, DOI 10.1111/j.1527-5299.2002.01154.x; Mire-Sluis AR, 2001, PHARM RES-DORDR, V18, P1239, DOI 10.1023/A:1013067424248; Misono KS, 2002, MOL CELL BIOCHEM, V230, P49, DOI 10.1023/A:1014257621362; Misono KS, 2011, FEBS J, V278, P1818, DOI 10.1111/j.1742-4658.2011.08083.x; Morris TS, 2009, BIOPHARM INT, V22; Pan SC, 2009, P NATL ACAD SCI USA, V106, P11282, DOI 10.1073/pnas.0811851106; Pandey KN, 2011, CAN J PHYSIOL PHARM, V89, P557, DOI [10.1139/Y11-054, 10.1139/y11-054]; Rao C-M, 2002, CHINESE J PHARM ANAL, P346; Rautureau Y., 2010, Autonomic & Autacoid Pharmacology, V30, P185, DOI 10.1111/j.1474-8673.2009.00449.x; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; Spreca A, 2000, HISTOCHEM J, V32, P725, DOI 10.1023/A:1004149010623; Sun ZY, 2005, PROTEIN EXPRES PURIF, V43, P26, DOI 10.1016/j.pep.2005.05.005; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; Watanabe H, 2009, J BIOL CHEM, V284, P12373, DOI 10.1074/jbc.M809236200; Wu Zhi-Jun, 2012, Yichuan, V34, P127, DOI 10.3724/SP.J.1005.2012.00127	32	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49934	10.1371/journal.pone.0049934	http://dx.doi.org/10.1371/journal.pone.0049934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185490	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800062
J	Park, EH; Walker, SE; Zhou, FJ; Lee, JM; Rajagopal, V; Lorsch, JR; Hinnebusch, AG				Park, Eun-Hee; Walker, Sarah E.; Zhou, Fujun; Lee, Joseph M.; Rajagopal, Vaishnavi; Lorsch, Jon R.; Hinnebusch, Alan G.			Yeast Eukaryotic Initiation Factor 4B (eIF4B) Enhances Complex Assembly between eIF4A and eIF4G in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START CODON SELECTION; TRANSLATION INITIATION; BINDING-PROTEIN; MESSENGER-RNA; MAMMALIAN TRANSLATION; SHUTTLE VECTORS; CAP; SUBUNITS; ASSOCIATION; HOMOLOG	Translation initiation factor eIF4F (eukaryotic initiation factor 4F), composed of eIF4E, eIF4G, and eIF4A, binds to the m(7)G cap structure of mRNA and stimulates recruitment of the 43S preinitiation complex and subsequent scanning to the initiation codon. The HEAT domain of eIF4G stabilizes the active conformation of eIF4A required for its RNA helicase activity. Mammalian eIF4B also stimulates eIF4A activity, but this function appears to be lacking in yeast, making it unclear how yeast eIF4B (yeIF4B/Tif3) stimulates translation. We identified Ts- mutations in the HEAT domains of yeast eIF4G1 and eIF4G2 that are suppressed by overexpressing either yeIF4B or eIF4A, whereas others are suppressed only by eIF4A overexpression. Importantly, suppression of HEAT domain substitutions by yeIF4B overexpression was correlated with the restoration of native eIF4A.eIF4G complexes in vivo, and the rescue of specific mutant eIF4A.eIF4G complexes by yeIF4B was reconstituted in vitro. Association of eIF4A with WT eIF4G in vivo also was enhanced by yeIF4B overexpression and was impaired in cells lacking yeIF4B. Furthermore, we detected native complexes containing eIF4G and yeIF4B but lacking eIF4A. These and other findings lead us to propose that yeIF4B acts in vivo to promote eIF4F assembly by enhancing a conformation of the HEAT domain of yeast eIF4G conducive for stable binding to eIF4A.	[Park, Eun-Hee; Zhou, Fujun; Hinnebusch, Alan G.] Eunice K Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Walker, Sarah E.; Rajagopal, Vaishnavi; Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Lee, Joseph M.] NIDDK, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hinnebusch, AG (corresponding author), Eunice K Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	ahinnebusch@nih.gov	Walker, Sarah/U-1609-2019	Walker, Sarah/0000-0002-9983-2485; Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health; National Institutes of Health [GM62128]; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program and National Institutes of Health Grant GM62128 (to J. R. L.). This work was also supported by an American Heart Association award (to S. E. W.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; [Anonymous], 1991, Methods Enzymol, V194, P1; BLUM S, 1992, P NATL ACAD SCI USA, V89, P7664, DOI 10.1073/pnas.89.16.7664; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Clarkson BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009114; COPPOLECCHIA R, 1993, EMBO J, V12, P4005, DOI 10.1002/j.1460-2075.1993.tb06078.x; delaCruz J, 1997, P NATL ACAD SCI USA, V94, P5201, DOI 10.1073/pnas.94.10.5201; Dominguez D, 1999, J BIOL CHEM, V274, P26720, DOI 10.1074/jbc.274.38.26720; Dominguez D, 2001, BIOCHEM J, V355, P223, DOI 10.1042/0264-6021:3550223; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOYER C, 1989, J BIOL CHEM, V264, P7603; GOYER C, 1993, MOL CELL BIOL, V13, P4860, DOI 10.1128/MCB.13.8.4860; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; Hilbert M, 2011, NUCLEIC ACIDS RES, V39, P2260, DOI 10.1093/nar/gkq1127; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; LANKER S, 1992, J BIOL CHEM, V267, P21167; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, MOL CELL BIOL, V16, P5328; Methot N, 1996, RNA, V2, P38; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; NARANDA T, 1994, J BIOL CHEM, V269, P14465; Neff CL, 1999, MOL CELL BIOL, V19, P5557; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Pestova T. V., 2007, CSH MONOGR, P87; Phan L, 2001, EMBO J, V20, P2954, DOI 10.1093/emboj/20.11.2954; Rajagopal V, 2012, J BIOL CHEM, V287, P20301, DOI 10.1074/jbc.M112.347278; REID GA, 1982, J BIOL CHEM, V257, P3056; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; SIKORSKI RS, 1989, GENETICS, V122, P19; Spirin AS, 2009, BIOCHEMISTRY-US, V48, P10688, DOI 10.1021/bi901379a; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	49	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2340	2354		10.1074/jbc.M112.398537	http://dx.doi.org/10.1074/jbc.M112.398537			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23184954	Green Published, hybrid			2022-12-25	WOS:000314211500023
J	Barthelemy, I; Uriarte, A; Drougard, C; Unterfinger, Y; Thibaud, JL; Blot, S				Barthelemy, Ines; Uriarte, Ane; Drougard, Carole; Unterfinger, Yves; Thibaud, Jean-Laurent; Blot, Stephane			Effects of an Immunosuppressive Treatment in the GRMD Dog Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; STEM-CELLS; EXPRESSION; TRANSPLANTATION; PREDNISOLONE; CALCINEURIN; EFFICACY; GAIT	The GRMD (Golden retriever muscular dystrophy) dog has been widely used in pre-clinical trials targeting DMD (Duchenne muscular dystrophy), using in many cases a concurrent immune-suppressive treatment. The aim of this study is to assess if such a treatment could have an effect on the disease course of these animals. Seven GRMD dogs were treated with an association of cyclosporine A (immunosuppressive dosage) and prednisolone (2 mg/kg/d) during 7 months, from 2 to 9 months of age. A multi-parametric evaluation was performed during this period which allowed us to demonstrate that this treatment had several significant effects on the disease progression. The gait quality as assessed by 3D-accelerometry was dramatically improved. This was consistent with the evolution of other parameters towards a significant improvement, such as the clinical motor score, the post-tetanic relaxation and the serum CK levels. In contrast the isometric force measurement as well as the histological evaluation argued in favor of a more severe disease progression. In view of the disease modifying effects which have been observed in this study it should be concluded that immunosuppressive treatments should be used with caution when carrying out pre-clinical studies in this canine model of DMD. They also highlight the importance of using a large range of multi-parametric evaluation tools to reliably draw any conclusion from trials involving dystrophin-deficient dogs, which reproduce the complexity of the human disease.	[Barthelemy, Ines; Uriarte, Ane; Drougard, Carole; Unterfinger, Yves; Thibaud, Jean-Laurent; Blot, Stephane] Univ Paris Est, Ecole Natl Vet Alfort, UPR Neurobiol, Maisons Alfort, France	Ecole Nationale Veterinaire d'Alfort (ENVA)	Blot, S (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, UPR Neurobiol, Maisons Alfort, France.	sblot@vet-alfort.fr	Blot, Stephane/K-7573-2019; Blot, Stephane/F-7420-2011	Barthelemy, Ines/0000-0002-4747-5893; Drougard, Carole/0000-0001-6526-104X; Blot, Stephane/0000-0002-8982-0317	Association Francaise contre les Myopathies (AFM)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work has been funded by the Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Barthelemy I, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-75; Barthelemy I, 2009, NEUROMUSCULAR DISORD, V19, P788, DOI 10.1016/j.nmd.2009.07.014; Bartlett RJ, 1996, AM J VET RES, V57, P650; Berthelemy I, 2007, NEUROMUSCULAR DISORD, V17, P898, DOI 10.1016/j.nmd.2007.06.456; Bretag AH, 2007, NATURE, V450, pE23, DOI 10.1038/nature06437; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Daftary AS, 2007, PEDIATRICS, V119, pE320, DOI 10.1542/peds.2006-1400; Dell'Agnola C, 2004, BLOOD, V104, P4311, DOI 10.1182/blood-2004-06-2247; Giger JM, 2004, J APPL PHYSIOL, V97, P475, DOI 10.1152/japplphysiol.00763.2003; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Howell JM, 1998, HUM GENE THER, V9, P629, DOI 10.1089/hum.1998.9.5-629; Kirschner J, 2010, LANCET NEUROL; LENNON TP, 1987, TRANSPLANTATION, V44, P799, DOI 10.1097/00007890-198712000-00016; Liu JMK, 2004, MUSCLE NERVE, V30, P767, DOI 10.1002/mus.20154; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Markham LW, 2008, NEUROMUSCULAR DISORD, V18, P365, DOI 10.1016/j.nmd.2008.03.002; Marsh AP, 2010, NEUROMUSCULAR DISORD, V20, P16, DOI 10.1016/j.nmd.2009.10.007; Merlini L, 2003, MUSCLE NERVE, V27, P222, DOI 10.1002/mus.10319; METZINGER L, 1995, BRIT J PHARMACOL, V116, P2811, DOI 10.1111/j.1476-5381.1995.tb15930.x; Michel RN, 2004, P NUTR SOC, V63, P341, DOI 10.1079/PNS2004362; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; Nicolas-Metral V, 2001, J MUSCLE RES CELL M, V22, P69, DOI 10.1023/A:1010384625954; Pradhan S, 2006, J NEUROL, V253, P1309, DOI 10.1007/s00415-006-0212-1; Rouger K, 2011, AM J PATHOL, V179, P2501, DOI 10.1016/j.ajpath.2011.07.022; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; SHARMA KR, 1995, NEUROLOGY, V45, P306, DOI 10.1212/WNL.45.2.306; SHARMA KR, 1993, NEUROLOGY, V43, P527, DOI 10.1212/WNL.43.3_Part_1.527; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; Thibaud JL, 2007, NEUROMUSCULAR DISORD, V17, P575, DOI 10.1016/j.nmd.2007.03.013; Torrente Y, 2007, CELL TRANSPLANT, V16, P563, DOI 10.3727/000000007783465064; Townsend D, 2010, J CLIN INVEST, V120, P1140, DOI 10.1172/JCI41329; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7; Wang ZJ, 2007, MOL THER, V15, P1160, DOI 10.1038/sj.mt.6300161; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Wong BLY, 2002, J CHILD NEUROL, V17, P183, DOI 10.1177/088307380201700306; Yiu EM, 2008, NEUROL INDIA, V56, P236; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Yuasa K, 2007, GENE THER, V14, P1249, DOI 10.1038/sj.gt.3302984	43	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48478	10.1371/journal.pone.0048478	http://dx.doi.org/10.1371/journal.pone.0048478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185260	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000014
J	Chen, WL; Huang, XQ; Zhao, LY; Li, J; Chen, JW; Xiao, Y; Huang, YY; Liu, J; Wang, GL; Guan, YY				Chen, Wen-Liang; Huang, Xiong-Qing; Zhao, Li-Yan; Li, Jie; Chen, Jian-Wen; Xiao, Ying; Huang, Yun-Ying; Liu, Jie; Wang, Guan-Lei; Guan, Yong-Yuan			Involvement of Kv1.5 Protein in Oxidative Vascular Endothelial Cell Injury	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; XYLOKETAL B PROTECTS; I-KUR BLOCKER; UNCOUPLING PROTEIN-2; OXIDIZED LDL; MITOCHONDRIAL DYSFUNCTION; DIPHENYLPHOSPHINE OXIDE; PULMONARY-HYPERTENSION; POTASSIUM CHANNELS; K+ CHANNELS	Endothelial injury related to oxidative stress is a key event in cardiovascular diseases, such as hypertension and atherosclerosis. The activation of the redox-sensitive Kv1.5 potassium channel mediates mitochondrial reactive oxygen species (ROS)-induced apoptosis in vascular smooth muscle cells and some cancer cells. Kv1.5 channel is therefore taken as a new potential therapeutic target for pulmonary hypertension and cancers. Although Kv1.5 is abundantly expressed in vascular endothelium, there is little knowledge of its role in endothelial injury related to oxidative stress. We found that DPO-1, a specific inhibitor of Kv1.5, attenuated H2O2-evoked endothelial cell apoptosis in an in vivo rat carotid arterial model. In human umbilical vein endothelial cells (HUVECs) and human pulmonary arterial endothelial cells (HPAECs), angiotensin II and oxLDL time-or concentration-dependently enhanced Kv1.5 protein expression in parallel with the production of intracellular ROS and endothelial cell injury. Moreover, siRNA-mediated knockdown of Kv1.5 attenuated, whereas adenovirus-mediated Kv1.5 cDNA overexpression enhanced oxLDL-induced cellular damage, NADPH oxidase and mitochondria-derived ROS production and restored the decrease in protein expression of mitochondria uncoupling protein 2 (UCP2). Collectively, these data suggest that Kv1.5 may play an important role in oxidative vascular endothelial injury.	[Zhao, Li-Yan; Huang, Yun-Ying; Liu, Jie; Wang, Guan-Lei; Guan, Yong-Yuan] Sun Yat Sen Univ, Dept Pharmacol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Wen-Liang] Guangzhou Med Univ, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Huang, Xiong-Qing; Xiao, Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jian-Wen] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, HEMC, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wang, GL (corresponding author), Sun Yat Sen Univ, Dept Pharmacol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	wangglei@mail.sysu.edu.cn			National Basic Research Program of China (973 Project) [2009CB521903]; 863 project [2006AA09Z440]; National Key New Drug Creation Program from the Ministry of Science and Technology of the People's Republic of China [2009ZX09103-039]; National Natural Science Foundation of China [30873059, 30900578]	National Basic Research Program of China (973 Project)(National Basic Research Program of China); 863 project(National High Technology Research and Development Program of China); National Key New Drug Creation Program from the Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Project. No. 2009CB521903), the 863 project (2006AA09Z440), the National Key New Drug Creation Program (2009ZX09103-039) from the Ministry of Science and Technology of the People's Republic of China, and the National Natural Science Foundation of China (No. 30873059, 30900578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Baliga RS, 2011, BRIT J PHARMACOL, V163, P125, DOI 10.1111/j.1476-5381.2010.01164.x; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brevnova EE, 2004, AM J PHYSIOL-CELL PH, V287, pC715, DOI 10.1152/ajpcell.00050.2004; Chen JW, 2004, CIRC RES, V94, P370, DOI 10.1161/01.RES.0000113782.07824.BE; Chen WL, 2009, BIOCHEM PHARMACOL, V78, P941, DOI 10.1016/j.bcp.2009.05.029; Chowdhury SKR, 2010, AM J PHYSIOL-ENDOC M, V298, pE89, DOI 10.1152/ajpendo.00433.2009; Derdak Z, 2009, METHODS MOL BIOL, V559, P205, DOI 10.1007/978-1-60327-017-5_15; Dimmeler S, 1997, CIRC RES, V81, P970; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Ehrlich JR, 2008, J AM COLL CARDIOL, V51, P787, DOI 10.1016/j.jacc.2007.08.067; Feng JL, 1997, CIRC RES, V80, P572, DOI 10.1161/01.RES.80.4.572; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Guo W, 1998, J MOL CELL CARDIOL, V30, P157, DOI 10.1006/jmcc.1997.0584; Haim TE, 2010, J MOL CELL CARDIOL, V48, P395, DOI 10.1016/j.yjmcc.2009.10.004; Hanna IR, 2002, ANTIOXID REDOX SIGN, V4, P899, DOI 10.1089/152308602762197443; He XY, 2011, CIRC RES, V108, P164, DOI 10.1161/CIRCRESAHA.110.234369; Kume N, 2004, CIRC RES, V94, P269, DOI 10.1161/01.RES.0000119804.92239.97; Lagrutta A, 2006, J PHARMACOL EXP THER, V317, P1054, DOI 10.1124/jpet.106.101162; Lee KU, 2005, CIRC RES, V96, P1200, DOI 10.1161/01.RES.0000170075.73039.5b; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Michelakis EV, 2004, J MOL CELL CARDIOL, V37, P1119, DOI 10.1016/j.yjmcc.2004.09.007; Moreno I, 2003, J PHARMACOL EXP THER, V304, P862, DOI 10.1124/jpet.102.042325; Moukdar F, 2009, J LIPID RES, V50, P59, DOI 10.1194/jlr.M800273-JLR200; Puddu P, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-112; Regan CP, 2006, J PHARMACOL EXP THER, V316, P727, DOI 10.1124/jpet.105.094839; Sayeed A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.30; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; Song CY, 2005, KIDNEY INT, V67, P1743, DOI 10.1111/j.1523-1755.2005.00271.x; Stuelten CH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-25; Stump GL, 2005, J PHARMACOL EXP THER, V315, P1362, DOI 10.1124/jpet.105.092197; Sudoh N, 2001, CIRCULATION, V103, P724; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Tian XY, 2012, CIRC RES, V110, P1211, DOI [10.1161/CIRCRESAHA.111.262170, 10.1161/circresaha.111.262170]; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Wirth KJ, 2007, J CARDIOVASC PHARM, V49, P197, DOI 10.1097/FJC.0b013e318032002f; Wu SD, 2006, BIOORG MED CHEM LETT, V16, P6213, DOI 10.1016/j.bmcl.2006.09.021; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xi H, 2007, ATHEROSCLEROSIS, V191, P281, DOI 10.1016/j.atherosclerosis.2006.05.040; Zhang L, 2012, APOPTOSIS, V17, P25, DOI 10.1007/s10495-011-0653-6; Zhao J, 2009, BRAIN RES, V1302, P240, DOI 10.1016/j.brainres.2009.09.034; Zmijewski JW, 2005, BIOCHEM SOC T, V33, P1385, DOI 10.1042/BST0331385; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	48	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49758	10.1371/journal.pone.0049758	http://dx.doi.org/10.1371/journal.pone.0049758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185428	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000102
J	Leijten, JCH; Teixeira, LSM; Landman, EBM; van Blitterswijk, CA; Karperien, M				Leijten, Jeroen C. H.; Teixeira, Liliana S. Moreira; Landman, Ellie B. M.; van Blitterswijk, Clemens A.; Karperien, Marcel			Hypoxia Inhibits Hypertrophic Differentiation and Endochondral Ossification in Explanted Tibiae	PLOS ONE			English	Article							OXYGEN-TENSION; EPIPHYSEAL CHONDROCYTES; ARTICULAR-CARTILAGE; INDUCIBLE FACTORS; PROLIFERATION; EXPRESSION; PROTEIN; PLATE	Purpose: Hypertrophic differentiation of growth plate chondrocytes induces angiogenesis which alleviates hypoxia normally present in cartilage. In the current study, we aim to determine whether alleviation of hypoxia is merely a downstream effect of hypertrophic differentiation as previously described or whether alleviation of hypoxia and consequent changes in oxygen tension mediated signaling events also plays an active role in regulating the hypertrophic differentiation process itself. Materials and Methods: Fetal mouse tibiae (E17.5) explants were cultured up to 21 days under normoxic or hypoxic conditions (21% and 2.5% oxygen respectively). Tibiae were analyzed on growth kinetics, histology, gene expression and protein secretion. Results: The oxygen level had a strong influence on the development of explanted fetal tibiae. Compared to hypoxia, normoxia increased the length of the tibiae, length of the hypertrophic zone, calcification of the cartilage and mRNA levels of hypertrophic differentiation-related genes e.g. MMP9, MMP13, RUNX2, COL10A1 and ALPL. Compared to normoxia, hypoxia increased the size of the cartilaginous epiphysis, length of the resting zone, calcification of the bone and mRNA levels of hyaline cartilage-related genes e.g. ACAN, COL2A1 and SOX9. Additionally, hypoxia enhanced the mRNA and protein expression of the secreted articular cartilage markers GREM1, FRZB and DKK1, which are able to inhibit hypertrophic differentiation. Conclusions: Collectively our data suggests that oxygen levels play an active role in the regulation of hypertrophic differentiation of hyaline chondrocytes. Normoxia stimulates hypertrophic differentiation evidenced by the expression of hypertrophic differentiation related genes. In contrast, hypoxia suppresses hypertrophic differentiation of chondrocytes, which might be at least partially explained by the induction of GREM1, FRZB and DKK1 expression.	[Leijten, Jeroen C. H.; Teixeira, Liliana S. Moreira; Landman, Ellie B. M.; Karperien, Marcel] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, NL-7500 AE Enschede, Netherlands; [van Blitterswijk, Clemens A.] Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Engn, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente	Karperien, M (corresponding author), Univ Twente, Fac Sci & Technol, MIRA Inst Biomed Technol & Tech Med, Dept Dev BioEngn, POB 217, NL-7500 AE Enschede, Netherlands.	h.b.j.karperien@utwente.nl	Leijten, Jeroen/G-5311-2011; Teixeira, Liliana Sofia Moreira/G-6293-2011; Karperien, Marcel/R-3270-2018	Leijten, Jeroen/0000-0002-8063-207X; Teixeira, Liliana Sofia Moreira/0000-0001-5039-8369; Karperien, Marcel/0000-0003-0751-0604; van Blitterswijk, Clemens/0000-0003-2371-4615; /0000-0002-5839-4626	TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; OAcontrol of the research program of the BioMedical Materials institute [P2.02]; Dutch Ministry of Economic Affairs, Agriculture and Innovation	TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; OAcontrol of the research program of the BioMedical Materials institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation	The authors gratefully acknowledge the support of the TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. This research was supported by the Project P2.02 OAcontrol of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Cho YS, 2008, BBA-MOL CELL RES, V1783, P323, DOI 10.1016/j.bbamcr.2007.11.017; Cramer T, 2004, OSTEOARTHR CARTILAGE, V12, P433, DOI 10.1016/j.joca.2004.02.003; De Spiegelaere W, 2010, ANAT HISTOL EMBRYOL, V39, P376, DOI 10.1111/j.1439-0264.2010.01005.x; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Strobel S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2942; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Zhou SD, 2004, ARTHRITIS RHEUM-US, V50, P3915, DOI 10.1002/art.20675; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	18	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49896	10.1371/journal.pone.0049896	http://dx.doi.org/10.1371/journal.pone.0049896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185479	Green Published, gold			2022-12-25	WOS:000311821000138
J	Yang, ZG; Wang, XF; He, Y; Qi, L; Yu, LQ; Xue, BZ; Shi, H				Yang, Zhenggang; Wang, Xianfeng; He, Yin; Qi, Ling; Yu, Liqing; Xue, Bingzhong; Shi, Hang			The Full Capacity of AICAR to Reduce Obesity-Induced Inflammation and Insulin Resistance Requires Myeloid SIRT1	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; ALTERNATIVE ACTIVATION; PPAR-GAMMA; METABOLISM; MICE; SENSITIVITY	Chronic Inflammation is a key link between obesity and insulin resistance. We previously showed that two nutrient sensors AMP-activated protein kinase (AMPK) and SIRT1 interact to regulate macrophage inflammation. AMPK is also a molecular target of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), which has been shown to reduce insulin resistance in various animal models. Here we aim to determine whether the therapeutic effects of AICAR against insulin resistance involve its anti-inflammatory function, which requires macrophage SIRT1. Long-term administration of low-dose AICAR significantly suppressed adipose inflammation in established diet-induced obese mice. This was associated with improved glucose homeostasis and insulin sensitivity without changes of body weight. In contrast, SIRT1 deletion in myeloid SIRT1 knockout (MSKO) mice increased infiltration of classically activated M1 macrophages and decreased alternatively activated M2 macrophages in adipose tissue. As a result, MSKO mice on high fat (HF) diets exhibited impaired insulin signaling in skeletal muscle, fat, and liver, and developed systemic insulin resistance in glucose tolerance tests, insulin tolerance tests, and hyperinsulinemic-euglycemic clamp experiments. Interestingly, the beneficial effects of AICAR on adipose inflammation and insulin sensitivity were absent in MSKO mice fed HF diets, suggesting that the full capacity of AICAR to antagonize obesity-induced inflammation and insulin resistance requires myeloid SIRT1. In summary, AICAR negatively regulates HF diet-induced inflammation, which requires myeloid SIRT1, thereby contributing to the protection against insulin resistance. Myeloid SIRT1 is a therapeutic target of the anti-inflammatory and insulin-sensitizing effects of AICAR.	[Yang, Zhenggang; Wang, Xianfeng; Xue, Bingzhong; Shi, Hang] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA; [Yang, Zhenggang] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Infect Dis Diag & Treatment, Hangzhou 310003, Zhejiang, Peoples R China; [He, Yin; Qi, Ling] Cornell Univ, Grad Program Genet & Dev, Ithaca, NY USA; [Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Yu, Liqing] Univ Maryland, Dept Anim Sci, College Pk, MD 20742 USA; [Xue, Bingzhong; Shi, Hang] Georgia State Univ, Dept Biol, Atlanta, GA USA	Wake Forest University; Wake Forest Baptist Medical Center; Zhejiang University; Cornell University; Cornell University; University System of Maryland; University of Maryland College Park; University System of Georgia; Georgia State University	Xue, BZ (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Winston Salem, NC 27103 USA.	bxue@gsu.edu; hshi3@gsu.edu	, 许开源 18362929861 赛德阳光口腔/AFX-1820-2022; Zeng, Maomao/M-1422-2013; Zhou, Yanheng/ABG-5432-2021	Zeng, Maomao/0000-0001-9259-1992; Zhou, Yanheng/0000-0002-5610-9967; Qi, Ling/0000-0001-8229-0184	National Institute of Health (NIH) [R01DK084172]; American Heart Association (AHA) [11GRNT7370080, P30 AG21332]; NIH [R01HL107500, R01DK082582]; AHA Scientist Development Grant [10SDG3900046]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Scientist Development Grant(American Heart Association)	This work was supported by National Institute of Health (NIH) grants R01DK084172, American Heart Association (AHA) Mid-Atlantic Affiliate Grant-in-Aid 11GRNT7370080 and P30 AG21332 (to HS), NIH grant R01HL107500 and AHA Scientist Development Grant 10SDG3900046 (to BX) and NIH grant R01DK082582 (to LQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Buhl ES, 2002, DIABETES, V51, P2199, DOI 10.2337/diabetes.51.7.2199; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Inouye KE, 2007, DIABETES, V56, P2242, DOI 10.2337/db07-0425; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; LAN F, 2008, J BIOL CHEM; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang XF, 2011, ENDOCRINOLOGY, V152, P836, DOI 10.1210/en.2010-0855; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki T, 2009, AM J PHYSL ENDOCRINO; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08	42	51	54	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49935	10.1371/journal.pone.0049935	http://dx.doi.org/10.1371/journal.pone.0049935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23183898	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000146
J	Lucas, LD; French, SS				Lucas, LeiLani D.; French, Susannah S.			Stress-Induced Tradeoffs in a Free-Living Lizard across a Variable Landscape: Consequences for Individuals and Populations	PLOS ONE			English	Article							FEMALE TREE LIZARDS; REPRODUCTIVE EFFORT; OXIDATIVE STRESS; IMMUNE FUNCTION; RESTRAINT STRESS; METABOLIC COST; HOUSE SPARROWS; BASE-LINE; CORTICOSTERONE; IMMUNOCOMPETENCE	Current life history theory suggests that the allocation of energetic resources between competing physiological needs should be dictated by an individual's longevity and pace of life. One key physiological pathway likely to contribute to the partitioning of resources is the vertebrate stress response. By increasing circulating glucocorticoids the stress response can exert a suite of physiological effects, such as altering immune function. We investigated the effects of stress physiology on individual immunity, reproduction and oxidative stress, across an urban landscape. We sampled populations in and around St. George, Utah, examining corticosterone in response to restraint stress, two innate immune measures, reproductive output, and the presence of both reactive oxygen metabolites and antioxidant binding capacity, in populations of common side-blotched lizards (Uta stansburiana) experiencing variable levels of environmental stress. Additionally, using capture-mark-recapture techniques, we examined the relationships between these physiological parameters and population-level differences. Our results reveal elevated physiological stress corresponds with suppressed immunity and increased oxidative stress. Interestingly, urban populations experiencing the most physiological stress also exhibited greater reproductive output and decreased survival relative to rural populations experiencing less physiological stress, demonstrating a tradeoff between reproduction and life maintenance processes. Our results suggest that environmental stress may augment life history strategy in this fast-paced species, and that shifts in life history strategy can in turn affect the population at large. Finally, the urban environment poses definite challenges for organisms, and while it appears that side-blotched lizards are adjusting physiologically, it is unknown what fitness costs these physiological adjustments accrue.	[Lucas, LeiLani D.; French, Susannah S.] Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Lucas, LD (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	leilani.lucas@usu.edu			Dr. French's USU start-up line	Dr. French's USU start-up line	Funding was provided by Dr. French's USU start-up line. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Anderson DR, 1999, BIRD STUDY, V46, P14; Angelier F, 2007, BEHAV ECOL SOCIOBIOL, V61, P611, DOI 10.1007/s00265-006-0290-1; Angelier F, 2009, GEN COMP ENDOCR, V163, P142, DOI 10.1016/j.ygcen.2009.03.028; Angilletta MJ, 2000, FUNCT ECOL, V14, P39, DOI 10.1046/j.1365-2435.2000.00387.x; Berger S, 2005, HORM BEHAV, V47, P419, DOI 10.1016/j.yhbeh.2004.11.011; Biondi M, 2001, EFFECTS STRESS IMMUN; Bjelakovic G, 2007, J Basic Clin Physiol Pharmacol, V18, P115; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Bonier F, 2012, HORM BEHAV, V61, P763, DOI 10.1016/j.yhbeh.2012.03.016; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Bourgeon S, 2006, J EXP BIOL, V209, P4957, DOI 10.1242/jeb.02610; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Costantini D, 2006, J COMP PHYSIOL B, V176, P575, DOI 10.1007/s00360-006-0080-0; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Cote J, 2010, GEN COMP ENDOCR, V166, P142, DOI 10.1016/j.ygcen.2009.11.008; Cox RM, 2010, FUNCT ECOL, V24, P1262, DOI 10.1111/j.1365-2435.2010.01756.x; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Drazen DL, 2003, CAN J ZOOL, V81, P1406, DOI 10.1139/Z03-120; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Fokidis HB, 2009, GEN COMP ENDOCR, V160, P259, DOI 10.1016/j.ygcen.2008.12.005; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; French SS, 2006, GEN COMP ENDOCR, V145, P128, DOI 10.1016/j.ygcen.2005.08.005; French SS, 2008, J COMP PHYSIOL B, V178, P997, DOI 10.1007/s00360-008-0290-8; French SS, 2008, GEN COMP ENDOCR, V155, P148, DOI 10.1016/j.ygcen.2007.04.007; French SS, 2007, J EXP BIOL, V210, P2859, DOI 10.1242/jeb.005348; French SS, 2007, AM NAT, V170, P79, DOI 10.1086/518569; French SS, 2012, BIOL OPEN, V1, P482, DOI 10.1242/bio.2012919; French SS, 2010, HORM BEHAV, V58, P792, DOI 10.1016/j.yhbeh.2010.08.001; Friedl TWP, 2005, EVOL ECOL, V19, P221, DOI 10.1007/s10682-005-0509-z; Gilman CA, 2007, J EXP BIOL, V210, P1859, DOI 10.1242/jeb.001875; HAHN WE, 1965, J EXP ZOOL, V158, P79, DOI 10.1002/jez.1401580108; Hanssen SA, 2003, OECOLOGIA, V136, P457, DOI 10.1007/s00442-003-1282-8; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Hawlena H, 2008, COMP BIOCHEM PHYS A, V150, P66, DOI 10.1016/j.cbpa.2008.03.004; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; LACK D, 1948, IBIS, V90, P25, DOI 10.1111/j.1474-919X.1948.tb01399.x; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Liebl AL, 2009, FUNCT ECOL, V23, P1091, DOI 10.1111/j.1365-2435.2009.01592.x; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2005, GEN COMP ENDOCR, V140, P126, DOI 10.1016/j.ygcen.2004.10.010; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Metcalf CJE, 2007, TRENDS ECOL EVOL, V22, P205, DOI 10.1016/j.tree.2006.12.001; Meylan S, 2010, GEN COMP ENDOCR, V169, P158, DOI 10.1016/j.ygcen.2010.08.002; MOORE MC, 1991, GEN COMP ENDOCR, V81, P217, DOI 10.1016/0016-6480(91)90006-R; Moore MC, 1986, J COMP PHYSIOL A, V35, P1193; Moreno J, 1999, P ROY SOC B-BIOL SCI, V266, P1105, DOI 10.1098/rspb.1999.0750; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nelson RJ, 1996, Q REV BIOL, V71, P511, DOI 10.1086/419555; Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001; Nilsson JA, 2001, OECOLOGIA, V128, P187, DOI 10.1007/s004420100653; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Olsson M, 2000, P ROY SOC B-BIOL SCI, V267, P2339, DOI 10.1098/rspb.2000.1289; Owen-Ashley NT, 2006, J EXP BIOL, V209, P3062, DOI 10.1242/jeb.02371; Padgett DA, 1998, BRAIN BEHAV IMMUN, V12, P64, DOI 10.1006/brbi.1997.0512; PARKER W S, 1974, Journal of Herpetology, V8, P135, DOI 10.2307/1562809; Rojas IG, 2000, J DENT RES, V79, P393; Romero LM, 2002, BIOL CONSERV, V108, P371, DOI 10.1016/S0006-3207(02)00128-3; Rook G, 2000, ANN NY ACAD SCI, V917, P913; SAAD AH, 1989, THYMUS, V14, P223; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; Schoech SJ, 2007, GEN COMP ENDOCR, V154, P150, DOI 10.1016/j.ygcen.2007.05.027; Serra V, 2000, ANN NY ACAD SCI, V908, P327; Sheridan JF, 2004, WORLD J SURG, V28, P327, DOI 10.1007/s00268-003-7404-y; TINKLE DW, 1965, EVOLUTION, V19, P569, DOI 10.2307/2406255; TINKLE DW, 1962, ECOLOGY, V43, P223, DOI 10.2307/1931978; van de Crommenacker J, 2010, J EXP BIOL, V213, P3527, DOI 10.1242/jeb.045591; Vassalle C, 2008, CLIN BIOCHEM, V41, P1162, DOI 10.1016/j.clinbiochem.2008.07.005; Vassalle Cristina, 2008, V477, P31, DOI 10.1007/978-1-60327-517-0_3; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WILSON BS, 1992, COPEIA, P691; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Woodley SK, 2002, GEN COMP ENDOCR, V128, P143, DOI 10.1016/S0016-6480(02)00068-0; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	84	60	60	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49895	10.1371/journal.pone.0049895	http://dx.doi.org/10.1371/journal.pone.0049895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185478	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700055
J	Zwick, A; Regier, JC; Zwickl, DJ				Zwick, Andreas; Regier, Jerome C.; Zwickl, Derrick J.			Resolving Discrepancy between Nucleotides and Amino Acids in Deep-Level Arthropod Phylogenomics: Differentiating Serine Codons in 21-Amino-Acid Models	PLOS ONE			English	Article							BASE-COMPOSITIONAL HETEROGENEITY; PROTEIN-CODING SEQUENCES; PHYLOGENETIC INFERENCE; SUBSTITUTION MODELS; INFERRED TREES; EVOLUTION; DATABASE; ORIGINS; DOMAINS; PANDIT	Background: In a previous study of higher-level arthropod phylogeny, analyses of nucleotide sequences from 62 protein-coding nuclear genes for 80 panarthopod species yielded significantly higher bootstrap support for selected nodes than did amino acids. This study investigates the cause of that discrepancy. Methodology/Principal Findings: The hypothesis is tested that failure to distinguish the serine residues encoded by two disjunct clusters of codons (TCN, AGY) in amino acid analyses leads to this discrepancy. In one test, the two clusters of serine codons (Ser1, Ser2) are conceptually translated as separate amino acids. Analysis of the resulting 21-amino-acid data matrix shows striking increases in bootstrap support, in some cases matching that in nucleotide analyses. In a second approach, nucleotide and 20-amino-acid data sets are artificially altered through targeted deletions, modifications, and replacements, revealing the pivotal contributions of distinct Ser1 and Ser2 codons. We confirm that previous methods of coding nonsynonymous nucleotide change are robust and computationally efficient by introducing two new degeneracy coding methods. We demonstrate for degeneracy coding that neither compositional heterogeneity at the level of nucleotides nor codon usage bias between Ser1 and Ser2 clusters of codons (or their separately coded amino acids) is a major source of non-phylogenetic signal. Conclusions: The incongruity in support between amino-acid and nucleotide analyses of the forementioned arthropod data set is resolved by showing that "standard'' 20-amino-acid analyses yield lower node support specifically when serine provides crucial signal. Separate coding of Ser1 and Ser2 residues yields support commensurate with that found by degenerated nucleotides, without introducing phylogenetic artifacts. While exclusion of all serine data leads to reduced support for serine-sensitive nodes, these nodes are still recovered in the ML topology, indicating that the enhanced signal from Ser1 and Ser2 is not qualitatively different from that of the other amino acids.	[Zwick, Andreas] State Museum Nat Hist, Dept Entomol, Stuttgart, Germany; [Regier, Jerome C.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Regier, Jerome C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Zwickl, Derrick J.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Kansas	Zwick, A (corresponding author), State Museum Nat Hist, Dept Entomol, Stuttgart, Germany.	andreas.zwick@smns-bw.de; regier@umd.edu; zwickl@email.arizona.edu	Zwick, Andreas/A-5735-2015	Zwick, Andreas/0000-0002-7532-1752	National Science Foundation, U.S.A. [0531626, 1042845, 0120635]; Direct For Biological Sciences [1042845] Funding Source: National Science Foundation	National Science Foundation, U.S.A.(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by grants from the National Science Foundation, U.S.A. (grant numbers 0531626, 1042845 and 0120635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averof M, 2000, SCIENCE, V287, P1283, DOI 10.1126/science.287.5456.1283; Bazinet A. L, 2009, DISTRIBUTED GRID COM; Brenneis G, 2008, EVOL DEV, V10, P717, DOI 10.1111/j.1525-142X.2008.00285.x; Colgan DJ, 2000, ZOOL SCR, V29, P29, DOI 10.1046/j.1463-6409.2000.00021.x; Dunlop JA, 2005, J ZOOL SYST EVOL RES, V43, P8, DOI 10.1111/j.1439-0469.2004.00284.x; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ertas B, 2009, MOL BIOL EVOL, V26, P2711, DOI 10.1093/molbev/msp186; Gai YH, 2006, ZOOL SCI, V23, P1101, DOI 10.2108/zsj.23.1101; Gruber KF, 2007, SYST BIOL, V56, P83, DOI 10.1080/10635150601182939; Inagaki Y, 2004, SYST BIOL, V53, P582, DOI 10.1080/10635150490468756; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Koenemann S, 2010, ARTHROPOD STRUCT DEV, V39, P88, DOI 10.1016/j.asd.2009.10.003; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; LOCKHART PJ, 1992, J MOL EVOL, V34, P153; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Maddison WP, 2002, MACCLADE 4 ANAL PHYL; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Ren FR, 2005, SYST BIOL, V54, P808, DOI 10.1080/10635150500354688; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Song HJ, 2010, SYST ENTOMOL, V35, P429, DOI 10.1111/j.1365-3113.2009.00517.x; Susko E, 2007, MOL BIOL EVOL, V24, P2139, DOI 10.1093/molbev/msm144; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Whelan S, 2003, BIOINFORMATICS, V19, P1556, DOI 10.1093/bioinformatics/btg188; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087; Zwickl D., 2006, GARLI GENETIC ALGORI	31	82	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e47450	10.1371/journal.pone.0047450	http://dx.doi.org/10.1371/journal.pone.0047450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185239	gold, Green Submitted, Green Published			2022-12-25	WOS:000311535700004
J	Tumban, E; Peabody, J; Tyler, M; Peabody, DS; Chackerian, B				Tumban, Ebenezer; Peabody, Julianne; Tyler, Mitchell; Peabody, David S.; Chackerian, Bryce			VLPs Displaying a Single L2 Epitope Induce Broadly Cross-Neutralizing Antibodies against Human Papillomavirus	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; MINOR CAPSID PROTEIN; NONVACCINE HPV TYPES; IMMUNOGENIC DISPLAY; DIVERSE PEPTIDES; YOUNG-WOMEN; VACCINE; INFECTION; EFFICACY; TYPE-18	Background: Virus-like Particles (VLPs) display can be used to increase the immunogenicity of heterologous antigens. Here, we report the use of a bacteriophage MS2-based VLP display platform to develop a monovalent vaccine targeting a broadly neutralizing epitope in the minor capsid protein human papillomavirus (HPV) that provides broad protection from diverse HPV types in a mouse pseudovirus infection model. Methodology/Principal Findings: Peptides spanning a previously described cross-neutralizing epitope from HPV type 16 were genetically inserted at the N-terminus of MS2 bacteriophage coat protein. Three of the four recombinant L2-coat proteins assembled into VLPs. L2-VLPs elicited high-titer anti-L2 antibodies in mice, similar to recombinant VLPs that we had previously made in which the L2 peptide was displayed on a surface-exposed loop on VLPs of a related bacteriophage, PP7. Somewhat surprisingly, L2-MS2 VLPs elicited antibodies that were much more broadly cross-reactive with L2 peptides from diverse HPV isolates than L2-PP7 VLPs. Similarly, mice immunized with L2-MS2 VLPs were protected from genital and cutaneous infection by highly diverse HPV pseudovirus types. Conclusion/Significance: We show that peptides can be displayed in a highly immunogenic fashion at the N-terminus of MS2 coat protein VLPs. A VLP-based vaccine targeting HPV L2 elicits broadly cross-reactive and cross-protective antibodies to heterologous HPV types. L2-VLPs could serve as the basis of a broadly protective second generation HPV vaccine.	[Tumban, Ebenezer; Peabody, Julianne; Tyler, Mitchell; Peabody, David S.; Chackerian, Bryce] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico	Tumban, E (corresponding author), Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	etumban@salud.unm.edu; bchackerian@salud.unm.edu			Sexually Transmitted Infections Cooperative Research Center (STI-CRC) of the US National Institutes of Health [U19 AI084081]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084081, T32AI007538] Funding Source: NIH RePORTER	Sexually Transmitted Infections Cooperative Research Center (STI-CRC) of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Studies at the University of New Mexico were supported by a Sexually Transmitted Infections Cooperative Research Center (STI-CRC) of the US National Institutes of Health (U19 AI084081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Caldeira JC, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-22; Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Campos SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004463; Chackerian B, 2011, J MOL BIOL, V409, P225, DOI 10.1016/j.jmb.2011.03.072; CHRISTENSEN ND, 1991, VIROLOGY, V181, P572, DOI 10.1016/0042-6822(91)90890-N; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Kawana K, 2003, VACCINE, V21, P4256, DOI 10.1016/S0264-410X(03)00454-7; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Peabody DS, 2008, J MOL BIOL, V380, P252, DOI 10.1016/j.jmb.2008.04.049; Peabody DS, 1997, ARCH BIOCHEM BIOPHYS, V347, P85, DOI 10.1006/abbi.1997.0312; Peres J, 2011, J NATL CANCER I, V103, P360, DOI 10.1093/jnci/djr053; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Smith ML, 2006, VIROLOGY, V348, P475, DOI 10.1016/j.virol.2005.12.039; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Tumban E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023310; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1	36	68	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49751	10.1371/journal.pone.0049751	http://dx.doi.org/10.1371/journal.pone.0049751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185426	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800048
J	Whitin, JC; Jang, TC; Merchant, M; Yu, TTS; Lau, K; Recht, B; Cohen, HJ; Recht, L				Whitin, John C.; Jang, Taichang; Merchant, Milton; Yu, Tom T-S.; Lau, Kenneth; Recht, Benjamin; Cohen, Harvey J.; Recht, Lawrence			Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma Model	PLOS ONE			English	Article							EXPERIMENTAL BRAIN-TUMORS; PROSTAGLANDIN-D SYNTHASE; GLUTAMYL-TRANSFERASE TRANSPEPTIDASE; ELECTRON-MICROSCOPE; SUBEPENDYMAL PLATE; SEQUENTIAL LIGHT; CHOROID-PLEXUS; SERUM; EXPRESSION; ENU	Background: Understanding the early relationship between brain tumor cells and their environment could lead to more sensitive biomarkers and new therapeutic strategies. We have been using a rodent model of neurocarcinogenesis in which all animals develop brain tumors by six months of age to establish two early landmarks in glioma development: the appearance of a nestin(+) cell at thirty days of age and the appearance of cellular hyperplasia between 60 and 120 days of age. We now report an assessment of the CSF proteome to determine the changes in protein composition that occur during this period. Materials and Methods: Nestin(+) cell clusters and microtumors were assessed in 63 ethylnitrosourea-exposed rats on 30, 60, and 90 days of age. CSF was obtained from the cisterna magna from 101 exposed and control rats at 30, 60, and 90 days and then analyzed using mass spectrometry. Differentially expressed peaks were isolated and identified. Results: Nestin(+) cells were noted in all ethylnitrosourea-exposed rats assessed pathologically. Small microtumors were noted in 0%, 18%, and 67% of 30-, 60-, and 90-day old rats, respectively (p<0.05, Chi square). False Discovery Rate analysis of peak intensities showed that the number of true discoveries with p<0.05 increased markedly with increasing age. Isolation and identification of highly differentially detected proteins at 90 days of age revealed increases in albumin and a fragment of alpha 1 macroglobulin and alterations in glutathionylated transthyretin. Conclusions: The presence of increased albumin, fragments of cerebrospinal fluid proteins, and glutathione breakdown in temporal association with the development of cellular hyperplasia, suggests that, similar to many other systemic cancers, inflammation and oxidative stress is playing an important early role in the host's response to brain tumor development and may be involved in affecting the early growth of brain tumor.	[Whitin, John C.; Yu, Tom T-S.; Lau, Kenneth; Cohen, Harvey J.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Jang, Taichang; Merchant, Milton; Recht, Lawrence] Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA; [Lau, Kenneth] Stanford Univ, Dept Radiol, Canary Ctr, Sch Med, Stanford, CA 94305 USA; [Recht, Benjamin] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA	Stanford University; Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Cohen, HJ (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	punko@stanford.edu; LRecht@stanford.edu			Canary Foundation	Canary Foundation	These studies were supported by a grant from the Canary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backos DS, 2012, BIOCHEM PHARMACOL, V83, P1005, DOI 10.1016/j.bcp.2011.11.016; Beuckmann CT, 2000, J COMP NEUROL, V428, P62, DOI 10.1002/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E; Cserr H F, 1988, Ann N Y Acad Sci, V529, P9, DOI 10.1111/j.1749-6632.1988.tb51415.x; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fujii J, 2011, J CLIN BIOCHEM NUTR, V49, P70, DOI 10.3164/jcbn.10-138SR; Fung ET, 2005, INT J CANCER, V115, P783, DOI 10.1002/ijc.20928; Gollapalli K, 2012, PROTEOMICS, V12, P2378, DOI 10.1002/pmic.201200002; HERBERT J, 1986, NEUROLOGY, V36, P900, DOI 10.1212/WNL.36.7.900; IKEDA T, 1989, ACTA PATHOL JAPON, V39, P487; Jang T, 2008, J NEUROSURG, V108, P782, DOI 10.3171/JNS/2008/108/4/0782; Jang TC, 2006, AM J PATHOL, V168, P1676, DOI 10.2353/ajpath.2006.050400; Jang TC, 2004, NEUROBIOL DIS, V15, P544, DOI 10.1016/j.nbd.2003.11.016; Joshi A, 2010, FRONT BIOSCI-LANDMRK, V15, P180, DOI 10.2741/3614; Khwaja FW, 2006, CLIN CANCER RES, V12, P6331, DOI 10.1158/1078-0432.CCR-06-1296; LANTOS PL, 1979, ACTA NEUROPATHOL, V45, P167, DOI 10.1007/BF00702668; LANTOS PL, 1976, EXPERIENTIA, V32, P1467, DOI 10.1007/BF01937439; Lignelid H, 1997, ACTA NEUROPATHOL, V93, P494, DOI 10.1007/s004010050644; Lim A, 2003, PROTEIN SCI, V12, P1775, DOI 10.1110/ps.0349703; Ling XB, 2009, BIOINFORMATICS, V25, P1461, DOI 10.1093/bioinformatics/btp176; Liu AY, 2011, CANCER BIOMARK, V9, P141, DOI 10.3233/CBM-2011-0174; Melegos DN, 1997, PROSTAGLANDINS, V54, P463, DOI 10.1016/S0090-6980(97)00062-2; MENNEL HD, 1985, EXP PATHOL-JENA, V28, P207, DOI 10.1016/S0232-1513(85)80010-4; Ogawa M, 1998, TISSUE CELL, V30, P597, DOI 10.1016/S0040-8166(98)80078-5; Osborne MR, 2000, IMA J NUMER ANAL, V20, P389, DOI 10.1093/imanum/20.3.389; PAPANDRIKOPOULOU A, 1989, EUR J BIOCHEM, V183, P693, DOI 10.1111/j.1432-1033.1989.tb21100.x; Park CK, 2009, J NEURO-ONCOL, V94, P31, DOI 10.1007/s11060-009-9805-8; Payne CA, 2008, MOL CANCER THER, V7, P3420, DOI 10.1158/1535-7163.MCT-08-0629; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; PILKINGTON GJ, 1979, ACTA NEUROPATHOL, V45, P177, DOI 10.1007/BF00702669; Rajagopal MU, 2011, PROTEOMICS, V11, P935, DOI 10.1002/pmic.201000198; Roy S, 2008, J CLIN ONCOL, V26, P96, DOI 10.1200/JCO.2007.12.1053; SCHIFFER D, 1978, ACTA NEUROPATHOL, V41, P27, DOI 10.1007/BF00689553; SCHIFFER D, 1980, ACTA NEUROPATHOL, V49, P117, DOI 10.1007/BF00690751; Schuhmann MU, 2010, EJSO-EUR J SURG ONC, V36, P201, DOI 10.1016/j.ejso.2009.07.010; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; SHINE HD, 1981, BRAIN RES, V217, P339, DOI 10.1016/0006-8993(81)90009-3; Skipor J, 2008, ACTA NEUROBIOL EXP, V68, P414; Soltys SG, 2004, CLIN CANCER RES, V10, P4806, DOI 10.1158/1078-0432.CCR-03-0469; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; THOMSON CE, 1990, J AM VET MED ASSOC, V196, P1841; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tumani H, 1998, ANN NEUROL, V44, P882, DOI 10.1002/ana.410440606; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; van Kempen LCL, 2006, EUR J CANCER, V42, P728, DOI 10.1016/j.ejca.2006.01.004; Wadsworth JT, 2004, ARCH OTOLARYNGOL, V130, P98, DOI 10.1001/archotol.130.1.98; WEISNER B, 1978, J NEUROL SCI, V37, P205, DOI 10.1016/0022-510X(78)90204-6; YOSHINO T, 1985, ACTA NEUROPATHOL, V66, P167, DOI 10.1007/BF00688694; YOSHINO T, 1985, ACTA PATHOL JAPON, V35, P1397; You JS, 2005, PROTEOMICS, V5, P290, DOI 10.1002/pmic.200400889; Zhang HS, 2007, J NEURO-ONCOL, V84, P315, DOI 10.1007/s11060-007-9376-5; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	51	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49724	10.1371/journal.pone.0049724	http://dx.doi.org/10.1371/journal.pone.0049724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185417	gold, Green Published, Green Submitted			2022-12-25	WOS:000311333800047
J	Zhao, H; Chen, CS; Zhang, HC; Zhou, XL; Mei, LL; Chen, CH; Chen, L; Cao, ZY; Dong, Q				Zhao, Hui; Chen, Chuansheng; Zhang, Hongchuan; Zhou, Xinlin; Mei, Leilei; Chen, Chunhui; Chen, Lan; Cao, Zhongyu; Dong, Qi			Is Order the Defining Feature of Magnitude Representation? An ERP Study on Learning Numerical Magnitude and Spatial Order of Artificial Symbols	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; HUMAN INFANTS; MULTIPLICATION FACTS; NUMBER; N400; ACTIVATION; PARIETAL; COMMON; WORDS	Using an artificial-number learning paradigm and the ERP technique, the present study investigated neural mechanisms involved in the learning of magnitude and spatial order. 54 college students were divided into 2 groups matched in age, gender, and school major. One group was asked to learn the associations between magnitude (dot patterns) and the meaningless Gibson symbols, and the other group learned the associations between spatial order (horizontal positions on the screen) and the same set of symbols. Results revealed differentiated neural mechanisms underlying the learning processes of symbolic magnitude and spatial order. Compared to magnitude learning, spatial-order learning showed a later and reversed distance effect. Furthermore, an analysis of the order-priming effect showed that order was not inherent to the learning of magnitude. Results of this study showed a dissociation between magnitude and order, which supports the numerosity code hypothesis of mental representations of magnitude.	[Zhao, Hui; Zhou, Xinlin; Mei, Leilei; Chen, Chunhui; Chen, Lan; Cao, Zhongyu; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Zhang, Hongchuan] Cent Univ Finance & Econ, Sch Social Dev, Beijing, Peoples R China	Beijing Normal University; University of California System; University of California Irvine; Central University of Finance & Economics	Dong, Q (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	dongqi@bnu.edu.cn		Chen, Chuansheng/0000-0002-8224-1005	Program for Changjiang Scholars and Innovative Research Teams at Universities [IRT0710]; National 973 Project [2003CB716803]; Youth Fund by the State Key Laboratory of Cognitive Neuroscience and Learning	Program for Changjiang Scholars and Innovative Research Teams at Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National 973 Project(National Basic Research Program of China); Youth Fund by the State Key Laboratory of Cognitive Neuroscience and Learning	This research was supported by the Program for Changjiang Scholars and Innovative Research Teams at Universities (IRT0710), the National 973 Project (2003CB716803) and Youth Fund by the State Key Laboratory of Cognitive Neuroscience and Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; Brannon EM, 2002, COGNITION, V83, P223, DOI 10.1016/S0010-0277(02)00005-7; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Delazer M, 1997, COGN NEUROPSYCHOL, V14, P613; Fias W, 2007, J NEUROSCI, V27, P8952, DOI 10.1523/JNEUROSCI.2076-07.2007; Fogelson N, 2004, CLIN NEUROPHYSIOL, V115, P1349, DOI 10.1016/j.clinph.2004.01.010; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Galfano G, 2004, NEUROPSYCHOLOGIA, V42, P1370, DOI 10.1016/j.neuropsychologia.2004.02.010; Galfano G, 2009, CORTEX, V45, P1167, DOI 10.1016/j.cortex.2008.09.003; Ganis G, 1996, J COGNITIVE NEUROSCI, V8, P89, DOI 10.1162/jocn.1996.8.2.89; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; HOLCOMB PJ, 1994, BRAIN COGNITION, V24, P259, DOI 10.1006/brcg.1994.1014; Ischebeck A, 2008, HUM BRAIN MAPP, V29, P894, DOI 10.1002/hbm.20433; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Jou J, 2003, AM J PSYCHOL, V116, P543, DOI 10.2307/1423660; Kadosh RC, 2007, NEURON, V53, P307, DOI 10.1016/j.neuron.2006.12.025; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; Kutas M, 1998, EVOKED POTENTIAL, V108, P456, DOI 10.1016/S0168-5597(98)00023-9; Luck S.J., 2005, INTRO EVENT RELATED; Lyons IM, 2009, J COGNITIVE NEUROSCI, V21, P1720, DOI 10.1162/jocn.2009.21124; Marshuetz C, 2000, J COGNITIVE NEUROSCI, V12, P130, DOI 10.1162/08989290051137459; Niedeggen M, 1999, PSYCHOPHYSIOLOGY, V36, P307, DOI 10.1017/S0048577299980149; Niedeggen M, 1999, PSYCHOL SCI, V10, P271, DOI 10.1111/1467-9280.00149; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Prado J, 2010, CEREB CORTEX, V20, P720, DOI 10.1093/cercor/bhp137; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; STARKEY P, 1990, COGNITION, V36, P97, DOI 10.1016/0010-0277(90)90001-Z; STARKEY P, 1980, SCIENCE, V210, P1033, DOI 10.1126/science.7434014; Szucs D, 2005, COGNITIVE BRAIN RES, V22, P289, DOI 10.1016/j.cogbrainres.2004.04.010; Szucs D, 2004, NEUROSCI LETT, V360, P65, DOI 10.1016/j.neulet.2004.02.038; Szucs D, 2004, COGNITIVE BRAIN RES, V19, P10, DOI 10.1016/j.cogbrainres.2003.11.002; Szucs D, 2007, NEUROSCI LETT, V412, P18, DOI 10.1016/j.neulet.2006.08.090; Tan LH, 2000, HUM BRAIN MAPP, V10, P16; Tang YY, 2006, P NATL ACAD SCI USA, V103, P10775, DOI 10.1073/pnas.0604416103; Turconi E, 2004, COGNITIVE BRAIN RES, V21, P22, DOI 10.1016/j.cogbrainres.2004.05.003; Turconi E, 2005, DIFFERENTIAL PROCESS; Tzelgov J, 2000, J EXP PSYCHOL LEARN, V26, P103, DOI 10.1037/0278-7393.26.1.103; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x; Xu F., 2000, COGNITION, V74; [赵晖 Zhao Hui], 2008, [心理科学, Psychological Science], V31, P524; Zhou XL, 2006, NEUROREPORT, V17, P991, DOI 10.1097/01.wnr.0000221840.12632.9f; Zorzi M., 2005, HDB MATH COGNITION, V19, P67	49	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49565	10.1371/journal.pone.0049565	http://dx.doi.org/10.1371/journal.pone.0049565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040PB	23185363	gold, Green Published			2022-12-25	WOS:000311333800034
J	Henrich, TJ; Wood, BR; Kuritzkes, DR				Henrich, Timothy J.; Wood, Brian R.; Kuritzkes, Daniel R.			Increased Risk of Virologic Rebound in Patients on Antiviral Therapy with a Detectable HIV Load < 48 Copies/mL	PLOS ONE			English	Article							COBAS AMPLIPREP/COBAS TAQMAN; LOW-LEVEL VIREMIA; TREATED PATIENTS; VERSION 2.0; RNA; ASSAY; QUANTIFICATION; MANAGEMENT	We investigated the independent effects of HIV-1 ''target not detected'' measurements versus those that were detectable but below the limit of quantification by Taqman RT-PCR assay on subsequent viral rebound as there are conflicting data regarding the clinical implications of arbitrary or isolated low-level viremia. Cox proportional hazard regression modeling was used to investigate the independent effects of the first HIV-1 load measurement after introduction of the Taqman RT-PCR assay (time-point 0 [T0]), pre-T0 viral loads, CD4 T cell count, race/ethnicity, gender, age and NNRTI use on risk of a confirmed VL >50, >200, >400 and >1000 copies/mL at 22 months follow-up in analyses of all patients and propensity-matched baseline cohorts. 778 patients had a viral load that was either not detected by RT-PCR (N = 596) or detectable, but below the limit of quantification (N = 182) at T0. Detectable viremia, lower T0 CD4 count, decreased age, and having detectable or unknown VL within a year prior to T0 were each associated with viral rebound to >50, >200 and >400 copies/mL. Overall failure rates were low and <5.5% of all patients had confirmed VL >1000 copies/mL. A majority of patients with rebound >200 copies/mL subsequently re-suppressed (28 of 53). A detectable VL <48 copies/mL was independently and significantly associated with subsequent viral rebound, and is cause for clinical concern.	[Henrich, Timothy J.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Henrich, TJ (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	thenrich@partners.org			NIH/NIAID [K23AI098480]; Virology Specialty Laboratory from the AIDS Clinical Trials Group [UM1 AI068636]; Gilead; Merck; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068636, P30AI060354, K23AI098480] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Virology Specialty Laboratory from the AIDS Clinical Trials Group; Gilead(Gilead Sciences); Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the NIH/NIAID K23AI098480 to T.J.H.; UM1 AI068636 to D. R. K. through a Virology Specialty Laboratory subcontract from the AIDS Clinical Trials Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D.R.K. is a consultant to and has received honoraria from Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, InnoVirVax, Koronis, Merck, Roche, Roxane, Sangamo, ViiV, ViroStatics and VIRxSYS; he has received grant support from Gilead and Merck, and speaking honoraria from Gilead and Roche. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Babady NE, 2010, J CLIN MICROBIOL, V48, P969, DOI 10.1128/JCM.01394-09; Charpentier C, 2012, J ANTIMICROB CHEMOTH, V67, P2231, DOI 10.1093/jac/dks191; de Boer MGJ, 2010, J CLIN MICROBIOL, V48, P4301, DOI 10.1128/JCM.00598-10; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Doyle T, 2012, CURR OPIN INFECT DIS, V25, P17, DOI 10.1097/QCO.0b013e32834ef5d9; Gianotti N, 2012, J ANTIMICROB CHEMOTH, V67, P213, DOI 10.1093/jac/dkr422; Karlsson AC, 2004, AIDS, V18, P981, DOI 10.1097/00002030-200404300-00005; Lubelchek RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006008; Maggiolo F, 2012, JAIDS-J ACQ IMM DEF, V60, P473, DOI 10.1097/QAI.0b013e3182567a57; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Pas S, 2010, J CLIN MICROBIOL, V48, P1195, DOI 10.1128/JCM.01832-09; Pascual-Pareja JF, 2010, J CLIN MICROBIOL, V48, P1911, DOI 10.1128/JCM.02388-09; Pyne MT, 2012, J VIROL METHODS, V184, P106, DOI 10.1016/j.jviromet.2012.05.007; Smit E, 2009, JAIDS-J ACQ IMM DEF, V51, P364, DOI 10.1097/QAI.0b013e3181aa13b3; Taiwo B, 2011, J INFECT DIS, V204, P515, DOI 10.1093/infdis/jir353; Willig JH, 2010, JAIDS-J ACQ IMM DEF, V54, P442, DOI 10.1097/QAI.0b013e3181d01d1d	16	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e50065	10.1371/journal.pone.0050065	http://dx.doi.org/10.1371/journal.pone.0050065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166820	Green Submitted, Green Published, gold			2022-12-25	WOS:000311272300085
J	Kalincik, T; Vaneckova, M; Tyblova, M; Krasensky, J; Seidl, Z; Havrdova, E; Horakova, D				Kalincik, Tomas; Vaneckova, Manuela; Tyblova, Michaela; Krasensky, Jan; Seidl, Zdenek; Havrdova, Eva; Horakova, Dana			Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROMES; GRAY-MATTER ATROPHY; FOLLOW-UP; DISABILITY; RELAPSES; ABNORMALITIES; PROGRESSION; CONVERSION; ATTACKS; DAMAGE	Objectives: To compare clinical and MRI parameters between patients with clinically isolated syndrome and those converting to clinically definite multiple sclerosis within 2 years, to identify volumetric MRI predictors of this conversion and to assess effect of early relapses. Methods: The SET study comprised 220 patients with clinically isolated syndrome treated with interferon beta (mean age, 29 years; Expanded Disability Status Scale, 1.5). Three patients with missing data were excluded from the analysis. Physical disability, time to clinically definite multiple sclerosis and volumetric MRI data were recorded for 2 years. Results: Patients reaching clinically definite multiple sclerosis showed impaired recovery of neurological function, faster decrease in corpus callosum cross-sectional area, higher T2 lesion volume and more contrast-enhancing lesions. Six-month decrease in corpus callosum cross-sectional area (>= 1%) and baseline T2 lesion volume (>= 5 cm(3)) predicted clinically definite multiple sclerosis within 2 years (hazard ratios 2.5 and 1.8, respectively). Of 22 patients fulfilling both predictive criteria, 83% reached clinically definite multiple sclerosis (hazard ratio 6.5). More relapses were associated with poorer recovery of neurological function and accelerated brain atrophy. Conclusions: Neurological impairment is more permanent, brain atrophy is accelerated and focal inflammatory activity is greater in patients converting to clinically definite multiple sclerosis. Six-month corpus callosum atrophy and baseline T2 lesion volume jointly help predict individual risk of clinically definite multiple sclerosis. Early relapses contribute to permanent damage of the central nervous system.	[Kalincik, Tomas; Tyblova, Michaela; Havrdova, Eva; Horakova, Dana] Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic; [Kalincik, Tomas; Tyblova, Michaela; Havrdova, Eva; Horakova, Dana] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic; [Kalincik, Tomas; Vaneckova, Manuela; Tyblova, Michaela; Krasensky, Jan; Seidl, Zdenek; Havrdova, Eva; Horakova, Dana] Gen Univ Hosp, Prague, Czech Republic; [Kalincik, Tomas] Univ Melbourne, Melbourne Brain Ctr, Dept Med, Melbourne, Vic, Australia; [Vaneckova, Manuela; Krasensky, Jan; Seidl, Zdenek] Charles Univ Prague, Dept Radiol, Fac Med 1, Prague, Czech Republic	Charles University Prague; Charles University Prague; General University Hospital Prague; University of Melbourne; Charles University Prague	Kalincik, T (corresponding author), Charles Univ Prague, Dept Neurol, Fac Med 1, Prague, Czech Republic.	tomas.kalincik@unimelb.edu.au	Vaneckova, Manuela/M-1301-2017; Havrdova, Eva Kubala/P-4892-2017; Horakova, Dana/D-4649-2011; Horakova, Dana/O-3598-2017; Tyblova, Michaela/O-3170-2017	Vaneckova, Manuela/0000-0002-8784-7997; Havrdova, Eva Kubala/0000-0002-9543-4359; Horakova, Dana/0000-0003-1915-0036; Tyblova, Michaela/0000-0002-9091-8629; Kalincik, Tomas/0000-0003-3778-1376	Czech Ministries of Education and Health [NT13237-4/2012, MSM 0021620849, PRVOUK-P26/LF1/4, RVO-VFN64165/2012]; Biogen Idec; Merck Serono; Novartis; Genzyme; Teva; Bayer Shering	Czech Ministries of Education and Health; Biogen Idec(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); Genzyme(Sanofi-AventisGenzyme Corporation); Teva(Teva Pharmaceutical Industries); Bayer Shering	The study was supported by Czech Ministries of Education and Health [NT13237-4/2012, MSM 0021620849, PRVOUK-P26/LF1/4, RVO-VFN64165/2012] and Biogen Idec (http://www.biogenidec.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: TK received compensation for travel and honoraria from Biogen Idec, Sanofi Aventis, Teva and Merck Serono. MV received compensation for travel and honoraria from Biogen Idec. MT received compensation for travel and honoraria from Biogen Idec, Sanofi Aventis, Teva and Merck Serono. JK received compensation for travel and honoraria from Biogen Idec and Sanofi Aventis. ZS received compensation for travel and honoraria from Biogen Idec. EH received speaker honoraria and consultant fees from Biogen Idec, Merck Serono, Novartis, Genzyme and Teva, as well as support for research activities from Biogen Idec and Merck Serono. DH received speaker honoraria and consultant fees from Biogen Idec, Novartis, Merck Serono and Bayer Shering, as well as support for research activities from Biogen Idec. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Calabrese M, 2011, NEUROLOGY, V77, P257, DOI 10.1212/WNL.0b013e318220abd4; Chard DT, 2011, J NEUROL NEUROSUR PS, V82, P176, DOI 10.1136/jnnp.2010.208660; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; Dalton CM, 2002, J NEUROL NEUROSUR PS, V73, P141, DOI 10.1136/jnnp.73.2.141; Di Filippo M, 2010, J NEUROL NEUROSUR PS, V81, P204, DOI 10.1136/jnnp.2009.171769; Filippi M, 2004, LANCET, V364, P1489, DOI 10.1016/S0140-6736(04)17271-1; Filippi M, 2003, BRAIN, V126, P433, DOI 10.1093/brain/awg038; Goodin DS, 2012, PLOS ONE, V6; HAWKINS CP, 1991, BRAIN, V114, P801, DOI 10.1093/brain/114.2.801; Horakova D, 2012, ACTA NEUROL SCAND; Hutchinson M, 2011, MULT SCLER J, V17, P1417, DOI 10.1177/1352458511427512; Kalincik T, 2012, CLIN NEUROL NEUROSUR, V114, P940, DOI 10.1016/j.clineuro.2012.02.014; Lublin FD, 2003, NEUROLOGY, V61, P1528, DOI 10.1212/01.WNL.0000096175.39831.21; Mesaros S, 2009, HUM BRAIN MAPP, V30, P2656, DOI 10.1002/hbm.20692; MILLER DH, 1988, J NEUROL NEUROSUR PS, V51, P1569, DOI 10.1136/jnnp.51.12.1569; MORRISSEY SP, 1993, BRAIN, V116, P135, DOI 10.1093/brain/116.1.135; O'Riordan JI, 1998, BRAIN, V121, P495, DOI 10.1093/brain/121.3.495; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Rovaris M, 2003, BRAIN, V126, P2323, DOI 10.1093/brain/awg232; Sailer M, 1999, NEUROLOGY, V52, P599, DOI 10.1212/WNL.52.3.599; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Sigal T, 2012, J NEUROIMAGING, V22, P33, DOI 10.1111/j.1552-6569.2010.00556.x; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tintore M, 2006, NEUROLOGY, V67, P968, DOI 10.1212/01.wnl.0000237354.10144.ec; Tintore M, 2010, NEUROLOGY, V75, P1933, DOI 10.1212/WNL.0b013e3181feb26f; Tremlett H, 2009, NEUROLOGY, V73, P1616, DOI 10.1212/WNL.0b013e3181c1e44f; Vaneckova M, 2012, EUR NEUROL, V68, P23, DOI 10.1159/000337683	32	88	90	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e50101	10.1371/journal.pone.0050101	http://dx.doi.org/10.1371/journal.pone.0050101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166826	Green Submitted, Green Published, gold			2022-12-25	WOS:000311272300087
J	Zhang, JS; Xie, SS; Ma, WB; Teng, Y; Tian, Y; Huang, XX; Zhang, YL				Zhang, Jinsong; Xie, Shengsong; Ma, Wubin; Teng, Yu; Tian, Ye; Huang, Xingxu; Zhang, Yonglian			A Newly Identified MicroRNA, mmu-miR-7578, Functions as a Negative Regulator on Inflammatory Cytokines Tumor Necrosis Factor-alpha and Interleukin-6 via Targeting Egr1 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; POSSIBLE ROLES; EXPRESSION; CELLS; EGR-1; INDUCTION; MURINE; LIPOPOLYSACCHARIDE; STIMULATION; PROTEINS	Appropriate innate immune responses are required to protect an organism against foreign pathogens, and the immune response must be tightly controlled. Here, we report a new microRNA (miRNA) identified from a small RNA library from the epididymis, termed miR-7578, that acts as a negative regulator of inflammatory responses. It was abundantly expressed in immune-related organs and induced by lipopolysaccharide in the lung and epididymis, as well as macrophages stimulated with diverse Toll-like receptor ligands, in an NF-kappa B-dependent manner. mmu-miR-7578 inhibited the release of pro-inflammatory cytokines, including TNF alpha and IL6, by regulating its target gene Egr1, which encodes a transcription factor that activates TNF alpha and NF-kappa B expression. Transgenic mice overexpressing mmu-miR-7578 displayed higher resistance to endotoxin shock and lower plasma levels of TNF alpha and IL6, indicating that this miRNA acted as a negative molecule of immune response. In sum, we report a previously uncharacterized LPS-responsive miRNA that controls inflammatory response in a feedback loop by fine-tuning a key transcription factor in vivo.	[Zhang, Jinsong; Xie, Shengsong; Ma, Wubin; Tian, Ye; Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; [Teng, Yu] Tsinghua Univ, Peking Union Med Coll, Chinese Acad Med Sci, State Key Lab Med Mol Biol,Inst Basic Med Sci, Beijing 100005, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University	Huang, XX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Key Lab Mol Androl, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	xingxuhuang@mail.nju.edu.cn; ylzhang@sibcb.ac.cn	Ma, Wubin/P-3045-2017	Zhang, Jinsong/0000-0002-6457-0235; huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [30930053, 31040025]; Chinese Academy of Sciences Knowledge Innovation Program [KSXC2-EW-R-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Knowledge Innovation Program(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30930053 and 31040025 and Chinese Academy of Sciences Knowledge Innovation Program Grant KSXC2-EW-R-07.	Albrecht C, 2010, CARDIOVASC RES, V86, P321, DOI 10.1093/cvr/cvq032; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen XM, 2007, J BIOL CHEM, V282, P28929, DOI 10.1074/jbc.M702633200; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schmidt J, 2008, GASTROENTEROLOGY, V135, P926, DOI 10.1053/j.gastro.2008.05.079; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Silverman ES, 2001, AM J RESP CRIT CARE, V163, P778, DOI 10.1164/ajrccm.163.3.2003123; SKERKA C, 1995, J BIOL CHEM, V270, P22500, DOI 10.1074/jbc.270.38.22500; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhao YT, 2008, IMMUNOL LETT, V119, P84, DOI 10.1016/j.imlet.2008.05.002	35	22	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4310	4320		10.1074/jbc.M112.351197	http://dx.doi.org/10.1074/jbc.M112.351197			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23184950	hybrid, Green Published			2022-12-25	WOS:000314845000059
J	Westphal, CH; Chandra, SS				Westphal, Christopher H.; Chandra, Sreeganga S.			Monomeric Synucleins Generate Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; MICE LACKING; SECONDARY STRUCTURE; SYNAPTIC VESICLES; GAMMA-SYNUCLEIN; LIPID VESICLES; CSP-ALPHA; BINDING; MUTATION	Synucleins are a family of presynaptic membrane binding proteins. alpha-Synuclein, the principal member of this family, is mutated in familial Parkinson disease. To gain insight into the molecular functions of synucleins, we performed an unbiased proteomic screen and identified synaptic protein changes in alpha beta gamma-synuclein knock-out brains. We observed increases in the levels of select membrane curvature sensing/generating proteins. One of the most prominent changes was for the N-BAR protein endophilin A1. Here we demonstrate that the levels of synucleins and endophilin A1 are reciprocally regulated and that they are functionally related. We show that all synucleins can robustly generate membrane curvature similar to endophilins. However, only monomeric but not tetrameric alpha-synuclein can bend membranes. Further, A30P alpha-synuclein, a Parkinson disease mutant that disrupts protein folding, is also deficient in this activity. This suggests that synucleins generate membrane curvature through the asymmetric insertion of their N-terminal amphipathic helix. Based on our findings, we propose to include synucleins in the class of amphipathic helix-containing proteins that sense and generate membrane curvature. These results advance our understanding of the physiological function of synucleins.	[Chandra, Sreeganga S.] Yale Univ, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06536 USA; [Westphal, Christopher H.] Yale Univ, Dept Cell Biol, New Haven, CT 06536 USA; [Chandra, Sreeganga S.] Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06536 USA	Yale University; Yale University; Yale University	Chandra, SS (corresponding author), Yale Univ, Dept Neurol, Program Cellular Neurosci Neurodegenerat & Repair, 295 Congress Ave, New Haven, CT 06536 USA.	sreeganga.chandra@yale.edu			National Institutes of Health [R01 NS064963, T32GM7223]; Bumpus Foundation; Anonymous Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bumpus Foundation; Anonymous Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by grants from the National Institutes of Health (R01 NS064963), the Bumpus Foundation, and an Anonymous Foundation grant (to S. S. C.). The proteomics was done with the support of the Yale Keck NIDA Neuroproteomic Center (P30 DA018343).; Supported in part by NIH Grant T32GM7223.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Davalos A, 2010, MOL CELL PROTEOMICS, V9, P2109, DOI 10.1074/mcp.M110.001289; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drescher M, 2012, CHEMBIOCHEM, V13, P761, DOI 10.1002/cbic.201200059; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez-Busnadiego R, 2011, J ELECTRON MICROSC, V60, pS137, DOI 10.1093/jmicro/dfr018; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gaugler MN, 2012, ACTA NEUROPATHOL, V123, P653, DOI 10.1007/s00401-012-0963-y; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakajo S, 1996, BRAIN RES, V741, P180, DOI 10.1016/S0006-8993(96)00914-6; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; Pandey AP, 2011, J PHYS CHEM B, V115, P5886, DOI 10.1021/jp1121917; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sung YH, 2006, PROTEIN SCI, V15, P1162, DOI 10.1110/ps.051803606; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tannu NS, 2006, PROG BRAIN RES, V158, P41, DOI 10.1016/S0079-6123(06)58003-3; Ulmer TS, 2005, J BIOL CHEM, V280, P43179, DOI 10.1074/jbc.M507624200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Wu Terence L., 2006, V328, P71; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029	65	127	128	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1829	1840		10.1074/jbc.M112.418871	http://dx.doi.org/10.1074/jbc.M112.418871			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184946	hybrid, Green Published			2022-12-25	WOS:000313751400038
J	Yuan, ZZ; Yan, XJ; Zhang, AD; Chen, B; Shen, YQ; Jin, ML				Yuan, Zeng-zhi; Yan, Xiao-jie; Zhang, An-ding; Chen, Bo; Shen, Yue-quan; Jin, Mei-lin			Molecular Mechanism by Which Surface Antigen HP0197 Mediates Host Cell Attachment in the Pathogenic Bacteria Streptococcus suis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; CRYSTAL-STRUCTURE; HEPARIN; GLYCOSAMINOGLYCANS; IDENTIFICATION; WALL; ADHERENCE; SORTASE	Streptococcus suis, one of the most important and prevalent pathogens in swine, presents a major challenge to global public health. HP0197 is an S. suis surface antigen that was previously identified by immunoproteomics and can bind to the host cell surface. Here, we investigated the interaction between HP0197 and the host cell surface glycosaminoglycans (GAGs) using indirect immunofluorescence and cell adhesion inhibition assays. In addition, we determined that a novel 18-kDa domain in the N-terminal region of HP0197 functions as the GAG-binding domain. We then solved the three-dimensional structures of the N-terminal 18-kDa and C-terminal G5 domains using x-ray crystallography. Based on this structural information, the GAG-binding sites in HP0197 were predicted and subsequently verified using site-directed mutagenesis and indirect immunofluorescence. The results indicate that the positively charged residues on the exposed surface of the 18-kDa domain, which are primarily lysines, likely play a critical role in the HP0197-heparin interaction that mediates bacterium-host cell adhesion. Understanding this molecular mechanism may provide a basis for the development of effective drugs and therapeutic strategies for treating streptococcal infections.	[Yuan, Zeng-zhi; Zhang, An-ding; Chen, Bo; Jin, Mei-lin] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan 430070, Hubei, Peoples R China; [Yan, Xiao-jie; Shen, Yue-quan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 30071, Peoples R China; [Yan, Xiao-jie; Shen, Yue-quan] Nankai Univ, Coll Life Sci, Tianjin 30071, Peoples R China	Huazhong Agricultural University; Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 30071, Peoples R China.	yshen@nankai.edu.cn; jml8328@126.com	Shen, Yuequan/C-8950-2013; yuan, zonghui/A-1158-2017	Shen, Yuequan/0000-0002-3775-0900; 	National Natural Science Foundation of China [31121004, 30901076]; 973 Program [2012CB518805]; 863 Program [2011AA10A210]; Chinese Major Special Science and Technology Project [2012ZX10004214]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); 863 Program(National High Technology Research and Development Program of China); Chinese Major Special Science and Technology Project	This work was supported by National Natural Science Foundation of China Grants 31121004 and 30901076, 973 Program Grant 2012CB518805, 863 Program Grant 2011AA10A210, and Chinese Major Special Science and Technology Project Grant 2012ZX10004214.	Baron MJ, 2004, J BIOL CHEM, V279, P24714, DOI 10.1074/jbc.M402164200; Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Benga L, 2005, J VET MED B, V52, P392, DOI 10.1111/j.1439-0450.2005.00880.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Chang YC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002082; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Fry EE, 1999, EMBO J, V18, P543, DOI 10.1093/emboj/18.3.543; Hui ACF, 2005, CLIN NEUROL NEUROSUR, V107, P366, DOI 10.1016/j.clineuro.2004.10.006; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; KAY R, 1995, QJM-INT J MED, V88, P39; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Patrie KM, 1999, BIOCHEMISTRY-US, V38, P9264, DOI 10.1021/bi9903345; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rostand KS, 1997, INFECT IMMUN, V65, P1; Ruggiero A, 2009, J MOL BIOL, V385, P153, DOI 10.1016/j.jmb.2008.10.042; Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Siepen JA, 2003, PROTEIN SCI, V12, P2348, DOI 10.1110/ps.03234503; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang AD, 2010, VET MICROBIOL, V140, P171, DOI 10.1016/j.vetmic.2009.06.034; Zhang AD, 2009, VACCINE, V27, P5209, DOI 10.1016/j.vaccine.2009.06.074; Zhu Hong, 2006, Weishengwu Xuebao, V46, P635; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	39	13	18	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					956	963		10.1074/jbc.M112.388686	http://dx.doi.org/10.1074/jbc.M112.388686			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184929	Green Published, hybrid			2022-12-25	WOS:000313570300020
J	Fernandez-Salas, E; Wang, J; Molina, Y; Nelson, JB; Jacky, BPS; Aoki, KR				Fernandez-Salas, Ester; Wang, Joanne; Molina, Yanira; Nelson, Jeremy B.; Jacky, Birgitte P. S.; Aoki, K. Roger			Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; TOXIN-A; LIGHT-CHAIN; IDENTIFICATION; SENSITIVITY; VALIDATION; TETANUS; NEURONS	Botulinum neurotoxin serotype A (BoNT/A), a potent therapeutic used to treat various disorders, inhibits vesicular neurotransmitter exocytosis by cleaving SNAP25. Development of cell-based potency assays (CBPAs) to assess the biological function of BoNT/A have been challenging because of its potency. CBPAs can evaluate the key steps of BoNT action: receptor binding, internalization-translocation, and catalytic activity; and therefore could replace the current mouse bioassay. Primary neurons possess appropriate sensitivity to develop potential replacement assays but those potency assays are difficult to perform and validate. This report describes a CBPA utilizing differentiated human neuroblastoma SiMa cells and a sandwich ELISA that measures BoNT/A-dependent intracellular increase of cleaved SNAP25. Assay sensitivity is similar to the mouse bioassay and measures neurotoxin biological activity in bulk drug substance and BOTOX (R) product (onabotulinumtoxinA). Validation of a version of this CBPA in a Quality Control laboratory has led to FDA, Health Canada, and European Union approval for potency testing of BOTOX (R), BOTOX (R) Cosmetic, and Vistabel (R). Moreover, we also developed and optimized a BoNT/A CBPA screening assay that can be used for the discovery of novel BoNT/A inhibitors to treat human disease.	[Fernandez-Salas, Ester; Wang, Joanne; Molina, Yanira; Nelson, Jeremy B.; Jacky, Birgitte P. S.; Aoki, K. Roger] Allergan Pharmaceut Inc, Dept Biol Sci, Irvine, CA USA	AbbVie; Allergan	Fernandez-Salas, E (corresponding author), Allergan Pharmaceut Inc, Dept Biol Sci, Irvine, CA USA.	fernandez_ester@allergan.com			Allergan Inc	Allergan Inc(AbbVieAllergan)	The research reported in this manuscript was solely funded by Allergan Inc (www.allergan.com). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Allergan upper management reviewed the manuscript and approved its submission for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler S, 2010, ATLA-ALTERN LAB ANIM, V38, P315, DOI 10.1177/026119291003800401; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; Apostolidis A, 2008, J NEURAL TRANSM, V115, P593, DOI 10.1007/s00702-007-0862-x; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Barr JR, 2005, EMERG INFECT DIS, V11, P1578, DOI 10.3201/eid1110.041279; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Burstein R, 2009, TOXICON, V54, P624, DOI 10.1016/j.toxicon.2009.01.009; Capek P, 2010, TOXINS, V2, P24, DOI [10.3390/toxins2010024, 10.3390/toxins2020024]; Dolly JO, 2006, EUR J NEUROL, V13, P1, DOI 10.1111/j.1468-1331.2006.01648.x; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Ferreira JL, 2004, J FOOD PROTECT, V67, P203, DOI 10.4315/0362-028X-67.1.203; Ferreira JL, 2003, J AOAC INT, V86, P314; Gilmore MA, 2011, ANAL BIOCHEM, V413, P36, DOI 10.1016/j.ab.2011.01.043; Goschel H, 1997, EXP NEUROL, V147, P96, DOI 10.1006/exnr.1997.6580; Grate JW, 2010, TRAC-TREND ANAL CHEM, V29, P1137, DOI 10.1016/j.trac.2010.07.005; Hakami RM, 2010, TRENDS MICROBIOL, V18, P164, DOI 10.1016/j.tim.2010.02.001; Huber A, 2008, ATLA-ALTERN LAB ANIM, V36, P141, DOI 10.1177/026119290803600205; Jones RGA, 2008, J IMMUNOL METHODS, V329, P92, DOI 10.1016/j.jim.2007.09.014; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Keller JE, 2004, BIOCHEMISTRY-US, V43, P526, DOI 10.1021/bi0356698; Kiris E, 2011, STEM CELL RES, V6, P195, DOI 10.1016/j.scr.2011.01.002; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Marini P, 1999, CANCER GENET CYTOGEN, V112, P161, DOI 10.1016/S0165-4608(98)00269-6; McNutt P, 2011, BIOCHEM BIOPH RES CO, V405, P85, DOI 10.1016/j.bbrc.2010.12.132; Min D, 2004, P NATL ACAD SCI USA, V101, P14701, DOI 10.1073/pnas.0404107101; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; NICEATM-ICCVAM/ECVAM, 2008, NIH PUBL; Pellett S, 2011, BIOCHEM BIOPH RES CO, V404, P388, DOI 10.1016/j.bbrc.2010.11.128; Pellett S, 2010, J PHARMACOL TOX MET, V61, P304, DOI 10.1016/j.vascn.2010.01.003; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; Purkiss JR, 2001, NEUROTOXICOLOGY, V22, P447, DOI 10.1016/S0161-813X(01)00042-0; Rasetti-Escargueil C, 2009, TOXICON, V53, P503, DOI 10.1016/j.toxicon.2009.01.019; Ross JA, 2011, ANAL BIOCHEM, V413, P43, DOI 10.1016/j.ab.2011.01.045; Rowe B, 2010, ANAL BIOCHEM, V396, P188, DOI 10.1016/j.ab.2009.09.034; Schieman C., 2010, EXPERT REV DERMATOL, V5, P31, DOI [10.1586/edm.09.61, DOI 10.1586/EDM.09.61]; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; Schulte-Mattler WJ, 2008, CNS DRUGS, V22, P725, DOI 10.2165/00023210-200822090-00002; Sesardic D, 1996, PHARMACOL TOXICOL, V78, P283, DOI 10.1111/j.1600-0773.1996.tb01376.x; Sesardic D., 2009, NC3RS            MAR, P1; Sheridan RE, 2005, TOXICON, V45, P377, DOI 10.1016/j.toxicon.2004.11.009; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stahl AM, 2007, J BIOMOL SCREEN, V12, P370, DOI 10.1177/1087057106299163; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Verderio C, 2007, TRAFFIC, V8, P142, DOI 10.1111/j.1600-0854.2006.00520.x; Welch MJ, 2000, TOXICON, V38, P245, DOI 10.1016/S0041-0101(99)00153-1; Whitemarsh RCM, 2012, TOXICOL SCI, V126, P426, DOI 10.1093/toxsci/kfr354; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZHOU LQ, 1995, BIOCHEMISTRY-US, V34, P15175, DOI 10.1021/bi00046a025	51	69	85	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49516	10.1371/journal.pone.0049516	http://dx.doi.org/10.1371/journal.pone.0049516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185348	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000059
J	Helfrich, C; Pierau, SS; Freitag, CM; Roeper, J; Ziemann, U; Bender, S				Helfrich, Christian; Pierau, Simone S.; Freitag, Christine M.; Roeper, Jochen; Ziemann, Ulf; Bender, Stephan			Monitoring Cortical Excitability during Repetitive Transcranial Magnetic Stimulation in Children with ADHD: A Single-Blind, Sham-Controlled TMS-EEG Study	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; HUMAN MOTOR CORTEX; THETA-BURST STIMULATION; 1 HZ RTMS; INTRACORTICAL INHIBITION; AUDITORY-STIMULI; ATTENTION; RESPONSES; MOVEMENT; CIRCUITS	Background: Repetitive transcranial magnetic stimulation (rTMS) allows non-invasive stimulation of the human brain. However, no suitable marker has yet been established to monitor the immediate rTMS effects on cortical areas in children. Objective: TMS-evoked EEG potentials (TEPs) could present a well-suited marker for real-time monitoring. Monitoring is particularly important in children where only few data about rTMS effects and safety are currently available. Methods: In a single-blind sham-controlled study, twenty-five school-aged children with ADHD received subthreshold 1 Hz-rTMS to the primary motor cortex. The TMS-evoked N100 was measured by 64-channel-EEG pre, during and post rTMS, and compared to sham stimulation as an intraindividual control condition. Results: TMS-evoked N100 amplitude decreased during 1 Hz-rTMS and, at the group level, reached a stable plateau after approximately 500 pulses. N100 amplitude to supra-threshold single pulses post rTMS confirmed the amplitude reduction in comparison to the pre-rTMS level while sham stimulation had no influence. EEG source analysis indicated that the TMS-evoked N100 change reflected rTMS effects in the stimulated motor cortex. Amplitude changes in TMS-evoked N100 and MEPs (pre versus post 1 Hz-rTMS) correlated significantly, but this correlation was also found for pre versus post sham stimulation. Conclusion: The TMS-evoked N100 represents a promising candidate marker to monitor rTMS effects on cortical excitability in children with ADHD. TMS-evoked N100 can be employed to monitor real-time effects of TMS for subthreshold intensities. Though TMS-evoked N100 was a more sensitive parameter for rTMS-specific changes than MEPs in our sample, further studies are necessary to demonstrate whether clinical rTMS effects can be predicted from rTMS-induced changes in TMS-evoked N100 amplitude and to clarify the relationship between rTMS-induced changes in TMS-evoked N100 and MEP amplitudes. The TMS-evoked N100 amplitude reduction after 1 Hz-rTMS could either reflect a globally decreased cortical response to the TMS pulse or a specific decrease in inhibition.	[Helfrich, Christian; Pierau, Simone S.; Freitag, Christine M.; Bender, Stephan] Goethe Univ Frankfurt, Univ Hosp Child & Adolescent Psychiat Psychosomat, Frankfurt, Germany; [Bender, Stephan] Carl Gustav Carus Univ Technol, Child & Adolescent Psychiat Hosp, Fac Med, Sect Clin Neurophysiol & Multimodal Imaging, Dresden, Germany; [Helfrich, Christian; Roeper, Jochen] Goethe Univ Frankfurt, Inst Neurophysiol, Frankfurt, Germany; [Ziemann, Ulf] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Stroke, Tubingen, Germany	Goethe University Frankfurt; Technische Universitat Dresden; Goethe University Frankfurt; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bender, S (corresponding author), Goethe Univ Frankfurt, Univ Hosp Child & Adolescent Psychiat Psychosomat, Frankfurt, Germany.	Stephan.Bender@uniklinikum-dresden.de	Ziemann, Ulf/AAY-9125-2020; Bender, Stephan/AAT-1266-2021	Roeper, Jochen/0000-0003-2145-8742; Freitag, Christine Margarete/0000-0001-9676-4782	Medical Faculty at the Goethe University; Frankfurt/Main; Interdisciplinary Center for Neurosciences Frankfurt	Medical Faculty at the Goethe University; Frankfurt/Main; Interdisciplinary Center for Neurosciences Frankfurt	The study was supported by the Medical Faculty at the Goethe University, Frankfurt/Main via a grant (Young Scientists Program) to SB as well as by the Interdisciplinary Center for Neurosciences Frankfurt; Plasticity via magnetic brain stimulation: cellular mechanism - modeling - modulation via a grant to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender S, 2005, ANN NEUROL, V58, P58, DOI 10.1002/ana.20521; Bender S, 2006, NEUROIMAGE, V32, P333, DOI 10.1016/j.neuroimage.2006.03.009; Bender S, 2006, NEUROIMAGE, V33, P759, DOI 10.1016/j.neuroimage.2006.07.003; Bikmullina R, 2009, EXP BRAIN RES, V194, P517, DOI 10.1007/s00221-009-1723-7; Bloch Y, 2010, WORLD J BIOL PSYCHIA, V11, P755, DOI 10.3109/15622975.2010.484466; Bonnard M, 2009, EUR J NEUROSCI, V30, P913, DOI 10.1111/j.1460-9568.2009.06864.x; Bruckmann S, 2012, BRAIN, V135, P2215, DOI 10.1093/brain/aws071; Buchmann J, 2007, BIOL PSYCHIAT, V62, P963, DOI 10.1016/j.biopsych.2007.05.010; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Fierro B, 2007, EXP BRAIN RES, V176, P440, DOI 10.1007/s00221-006-0628-y; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fitzgerald PB, 2009, CLIN NEUROPHYSIOL, V120, P1706, DOI 10.1016/j.clinph.2009.06.019; Fregni F, 2006, CLIN NEUROPHYSIOL, V117, P1217, DOI 10.1016/j.clinph.2006.02.015; Garvey MA, 2001, J CHILD NEUROL, V16, P891, DOI 10.1177/088307380101601205; Gilbert DL, 2011, NEUROLOGY, V76, P615, DOI 10.1212/WNL.0b013e31820c2ebd; Gilbert DL, 2006, NEUROPSYCHOPHARMACOL, V31, P442, DOI 10.1038/sj.npp.1300806; Gilbert DL, 2004, CLIN NEUROPHYSIOL, V115, P1730, DOI 10.1016/j.clinph.2003.10.037; HAMBURGER H L, 1991, Brain Topography, V3, P391, DOI 10.1007/BF01129642; Hansenne M, 2004, BIOL PSYCHOL, V67, P331, DOI 10.1016/j.biopsycho.2004.01.004; Huang YZ, 2009, CLIN NEUROPHYSIOL, V120, P796, DOI 10.1016/j.clinph.2009.01.003; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Ilmoniemi RJ, 2010, BRAIN TOPOGR, V22, P233, DOI 10.1007/s10548-009-0123-4; Kahkonen S, 2005, NEUROIMAGE, V24, P955, DOI 10.1016/j.neuroimage.2004.09.048; Kahkonen S, 2007, J NEUROSCI METH, V166, P104, DOI 10.1016/j.jneumeth.2007.06.030; Kicic D, 2008, NEUROSCIENCE, V152, P1119, DOI 10.1016/j.neuroscience.2008.01.043; Koch G, 2008, CLIN NEUROPHYSIOL, V119, P2559, DOI 10.1016/j.clinph.2008.08.008; Komssi S, 2004, HUM BRAIN MAPP, V21, P154, DOI 10.1002/hbm.10159; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Maki H, 2011, NEUROIMAGE, V54, P2706, DOI 10.1016/j.neuroimage.2010.11.041; Merrin EL, 2006, INT J PSYCHOPHYSIOL, V60, P330, DOI 10.1016/j.ijpsycho.2005.05.012; Moll GH, 2000, NEUROSCI LETT, V284, P121, DOI 10.1016/S0304-3940(00)00980-0; Moll GH, 2001, ANN NEUROL, V49, P393, DOI 10.1002/ana.77; Moll GH, 2001, Z KINDER JUG-PSYCH, V29, P312, DOI 10.1024//1422-4917.29.4.312; Mosher JC, 1999, IEEE T SIGNAL PROCES, V47, P332, DOI 10.1109/78.740118; Niederhofer H, 2008, PSYCHIAT DANUB, V20, P91; Nikulin VV, 2003, EUR J NEUROSCI, V18, P1206, DOI 10.1046/j.1460-9568.2003.02858.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PICTON T, 1995, HDB NEUROPHYSIOLOGY; Quintana H, 2005, J ECT, V21, P88, DOI 10.1097/01.yct.0000162556.02720.58; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Rossi S, 2000, CEREB CORTEX, V10, P802, DOI 10.1093/cercor/10.8.802; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Schneider M, 2007, J NEURAL TRANSM-SUPP, P303; Schneider S., 2009, KINDER DIPS DIAGNOST, V2nd; SCHRODER J, 1993, Z KLIN PSYCHOL PSYCH, V41, P190; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; SKRANDIES W, 1989, Brain Topography, V2, P73, DOI 10.1007/BF01128845; Spieser L, 2010, NEUROIMAGE, V52, P316, DOI 10.1016/j.neuroimage.2010.04.020; Taylor PCJ, 2010, HUM BRAIN MAPP, V31, P1408, DOI 10.1002/hbm.20941; Veniero D, 2010, J NEUROPHYSIOL, V104, P1578, DOI 10.1152/jn.00172.2010; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; World Medical Association, WMA DECL HELS ETH PR; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 2008, BRAIN STIMUL, V1, P164, DOI 10.1016/j.brs.2008.06.006	54	33	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50073	10.1371/journal.pone.0050073	http://dx.doi.org/10.1371/journal.pone.0050073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185537	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000177
J	Jacobo-Albavera, L; Aguayo-de la Rosa, PI; Villarreal-Molina, T; Villamil-Ramirez, H; Leon-Mimila, P; Romero-Hidalgo, S; Lopez-Contreras, BE; Sanchez-Munoz, F; Bojalil, R; Gonzalez-Barrios, JA; Aguilar-Salinas, CA; Canizales-Quinteros, S				Jacobo-Albavera, Leonor; Aguayo-de la Rosa, Pablo I.; Villarreal-Molina, Teresa; Villamil-Ramirez, Hugo; Leon-Mimila, Paola; Romero-Hidalgo, Sandra; Lopez-Contreras, Blanca E.; Sanchez-Munoz, Fausto; Bojalil, Rafael; Antonio Gonzalez-Barrios, Juan; Aguilar-Salinas, Carlos A.; Canizales-Quinteros, Samuel			VNN1 Gene Expression Levels and the G-137T Polymorphism Are Associated with HDL-C Levels in Mexican Prepubertal Children	PLOS ONE			English	Article							PLASMA-LIPID LEVELS; CHOLESTEROL LEVELS; LOCI; ADMIXTURE; PREVALENCE; OBESITY; VARIANT; TRAITS; LIVER; RISK	Background: VNN1 gene expression levels and the G-137T polymorphism have been associated with high density lipoprotein cholesterol (HDL-C) levels in Mexican American adults. We aim to evaluate the contribution of VNN1 gene expression and the G-137T variant to HDL-C levels and other metabolic traits in Mexican prepubertal children. Methodology/Principal Findings: VNN1 mRNA expression levels were quantified in peripheral blood leukocytes from 224 unrelated Mexican-Mestizo children aged 6-8 years (107 boys and 117 girls) and were genotyped for the G-137T variant (rs4897612). To account for population stratification, a panel of 10 ancestry informative markers was analyzed. After adjustment for admixture, the TT genotype was significantly associated with lower VNN1 mRNA expression levels (P = 2.9 x 10(-5)), decreased HDL-C levels (beta = -6.19, P = 0.028) and with higher body mass index (BMI) z-score (beta = 0.48, P = 0.024) in the total sample. In addition, VNN1 expression showed a positive correlation with HDL-C levels (r = 0.220; P = 0.017) and a negative correlation with BMI z-score (r = -0.225; P = 0.015) only in girls. Conclusion/Significance: Our data suggest that VNN1 gene expression and the G-137T variant are associated with HDL-C levels in Mexican children, particularly in prepubertal girls.	[Jacobo-Albavera, Leonor; Aguayo-de la Rosa, Pablo I.; Villamil-Ramirez, Hugo; Leon-Mimila, Paola; Canizales-Quinteros, Samuel] INCMNSZ, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico; [Jacobo-Albavera, Leonor; Aguayo-de la Rosa, Pablo I.; Villamil-Ramirez, Hugo; Leon-Mimila, Paola; Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico; [Villarreal-Molina, Teresa; Romero-Hidalgo, Sandra; Lopez-Contreras, Blanca E.] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Sanchez-Munoz, Fausto; Bojalil, Rafael] Inst Nacl Cardiol Ignacio Chavez, Dept Immunol, Mexico City, DF, Mexico; [Bojalil, Rafael] UAM Xochimilco, Dept Cuidado Salud, Mexico City, DF, Mexico; [Antonio Gonzalez-Barrios, Juan] ISSSTE, Hosp Reg Primero Octubre, Lab Med Genom, Mexico City, DF, Mexico; [Aguilar-Salinas, Carlos A.] INCMNSZ, Dept Endocrinol & Metab, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; National Institute of Cardiology - Mexico; Universidad Autonoma Metropolitana - Mexico	Canizales-Quinteros, S (corresponding author), INCMNSZ, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico.	cani@servidor.unam.mx	Salinas, Carlos A Aguilar/AAL-4491-2020; Leon-Mimila, Paola/U-2375-2019	VILLARREAL MOLINA, TERESA/0000-0003-4450-7690; Jacobo-Albavera, Leonor/0000-0001-5129-8108; Gonzalez-Barrios, Juan Antonio/0000-0002-8083-9628; SANCHEZ-MUNOZ, FAUSTO/0000-0001-6556-1632; Romero-Hidalgo, Sandra/0000-0003-3077-7825; Leon, Paola/0000-0001-6334-1492	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [85010]; PAIP [4194-16]; CONACyT [195399, 244112, 234714]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAIP; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grant 85010 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT, http://www.conacyt.mx/Paginas/default.aspx) and was partially supported by PAIP 4194-16. LJA is in the PhD Program from Ciencias Biomedicas at Universidad Nacional Autonoma de Mexico (UNAM). LJA, HVR and PLM are recipients of the CONACyT scholarship number 195399, 244112 and 234714, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2001, J LIPID RES, V42, P1298; Bocos C, 1998, ENVIRON TOXICOL PHAR, V6, P59, DOI 10.1016/S1382-6689(98)00020-9; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Brown WM, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S32; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Di Leandro L, 2008, FREE RADICAL BIO MED, V44, P1088, DOI 10.1016/j.freeradbiomed.2007.12.015; Dumitrescu L, 2011, ANN HUM GENET, V75, P589, DOI 10.1111/j.1469-1809.2011.00664.x; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Feitosa MF, 2009, ATHEROSCLEROSIS, V204, P171, DOI 10.1016/j.atherosclerosis.2008.09.007; Flores-Dorantes T, 2010, CLIN CHIM ACTA, V411, P1214, DOI 10.1016/j.cca.2010.04.025; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garces C, 2003, J CLIN ENDOCR METAB, V88, P3997, DOI 10.1210/jc.2003-030459; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Idaghdour Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000052; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Kaskow BJ, 2012, BIOCHEM BIOPH RES CO, V417, P653, DOI 10.1016/j.bbrc.2011.11.099; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; LISKER R, 1990, HUM BIOL, V62, P791; Lopez-Simon L, 2009, CLIN CHIM ACTA, V403, P203, DOI 10.1016/j.cca.2009.03.002; Lusis AJ, 2004, CIRCULATION, V110, P2066, DOI 10.1161/01.CIR.0000143098.98869.F8; Ma J, 2007, ATHEROSCLEROSIS, V191, P63, DOI 10.1016/j.atherosclerosis.2006.05.032; Martinez-Marignac VL, 2007, HUM GENET, V120, P807, DOI 10.1007/s00439-006-0273-3; Mouritzen P., 2005, NAT METHODS, V2, P313; Nathan BM, 2008, CURR OPIN ENDOCRINOL, V15, P21, DOI 10.1097/MED.0b013e3282f43d19; Posadas-Sanchez R, 2007, METABOLISM, V56, P1666, DOI 10.1016/j.metabol.2007.07.009; Qasim Atif, 2006, Curr Atheroscler Rep, V8, P198, DOI 10.1007/s11883-006-0074-0; Saland JM, 2007, CURR OPIN PEDIATR, V19, P183, DOI 10.1097/MOP.0b013e3280208519; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Villarreal-Molina MT, 2007, DIABETES, V56, P1881, DOI 10.2337/db06-0905; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yamazaki K, 2002, BIOCHEM BIOPH RES CO, V290, P1114, DOI 10.1006/bbrc.2001.6319; Yang HC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-346; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	42	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49818	10.1371/journal.pone.0049818	http://dx.doi.org/10.1371/journal.pone.0049818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185446	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000115
J	Johnson, MTJ; Carpenter, EJ; Tian, ZJ; Bruskiewich, R; Burris, JN; Carrigan, CT; Chase, MW; Clarke, ND; Covshoff, S; dePamphilis, CW; Edger, PP; Goh, F; Graham, S; Greiner, S; Hibberd, JM; Jordon-Thaden, I; Kutchan, TM; Leebens-Mack, J; Melkonian, M; Miles, N; Myburg, H; Patterson, J; Pires, JC; Ralph, P; Rolf, M; Sage, RF; Soltis, D; Soltis, P; Stevenson, D; Stewart, CN; Surek, B; Thomsen, CJM; Villarreal, JC; Wu, XL; Zhang, Y; Deyholos, MK; Wong, GKS				Johnson, Marc T. J.; Carpenter, Eric J.; Tian, Zhijian; Bruskiewich, Richard; Burris, Jason N.; Carrigan, Charlotte T.; Chase, Mark W.; Clarke, Neil D.; Covshoff, Sarah; dePamphilis, Claude W.; Edger, Patrick P.; Goh, Falicia; Graham, Sean; Greiner, Stephan; Hibberd, Julian M.; Jordon-Thaden, Ingrid; Kutchan, Toni M.; Leebens-Mack, James; Melkonian, Michael; Miles, Nicholas; Myburg, Henrietta; Patterson, Jordan; Pires, J. Chris; Ralph, Paula; Rolf, Megan; Sage, Rowan F.; Soltis, Douglas; Soltis, Pamela; Stevenson, Dennis; Stewart, C. Neal, Jr.; Surek, Barbara; Thomsen, Christina J. M.; Villarreal, Juan Carlos; Wu, Xiaolei; Zhang, Yong; Deyholos, Michael K.; Wong, Gane Ka-Shu			Evaluating Methods for Isolating Total RNA and Predicting the Success of Sequencing Phylogenetically Diverse Plant Transcriptomes	PLOS ONE			English	Article							REVEALS; ECOLOGY; SEQ; MAP	Next-generation sequencing plays a central role in the characterization and quantification of transcriptomes. Although numerous metrics are purported to quantify the quality of RNA, there have been no large-scale empirical evaluations of the major determinants of sequencing success. We used a combination of existing and newly developed methods to isolate total RNA from 1115 samples from 695 plant species in 324 families, which represents >900 million years of phylogenetic diversity from green algae through flowering plants, including many plants of economic importance. We then sequenced 629 of these samples on Illumina GAIIx and HiSeq platforms and performed a large comparative analysis to identify predictors of RNA quality and the diversity of putative genes (scaffolds) expressed within samples. Tissue types (e. g., leaf vs. flower) varied in RNA quality, sequencing depth and the number of scaffolds. Tissue age also influenced RNA quality but not the number of scaffolds >= 1000 bp. Overall, 36% of the variation in the number of scaffolds was explained by metrics of RNA integrity (RIN score), RNA purity (OD 260/230), sequencing platform (GAIIx vs HiSeq) and the amount of total RNA used for sequencing. However, our results show that the most commonly used measures of RNA quality (e. g., RIN) are weak predictors of the number of scaffolds because Illumina sequencing is robust to variation in RNA quality. These results provide novel insight into the methods that are most important in isolating high quality RNA for sequencing and assembling plant transcriptomes. The methods and recommendations provided here could increase the efficiency and decrease the cost of RNA sequencing for individual labs and genome centers.	[Johnson, Marc T. J.; Thomsen, Christina J. M.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Carpenter, Eric J.; Patterson, Jordan; Deyholos, Michael K.; Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Tian, Zhijian; Wu, Xiaolei; Zhang, Yong; Wong, Gane Ka-Shu] BGI Shenzhen, Shenzhen, Peoples R China; [Bruskiewich, Richard] Int Rice Res Inst, Manila, Philippines; [Burris, Jason N.; Stewart, C. Neal, Jr.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA; [Carrigan, Charlotte T.; Leebens-Mack, James] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Clarke, Neil D.; Goh, Falicia] Genome Inst Singapore, Singapore, Singapore; [Covshoff, Sarah; Hibberd, Julian M.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [dePamphilis, Claude W.; Ralph, Paula] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [dePamphilis, Claude W.; Ralph, Paula] Penn State Univ, Huck Inst Life Sci, Intercoll Grad Program Plant Biol, University Pk, PA 16802 USA; [Edger, Patrick P.; Pires, J. Chris] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Graham, Sean] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Graham, Sean] Univ British Columbia, UBC Bot Garden, Vancouver, BC V5Z 1M9, Canada; [Greiner, Stephan] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Jordon-Thaden, Ingrid; Miles, Nicholas; Soltis, Douglas] Univ Florida, Dept Biol, Gainesville, FL USA; [Kutchan, Toni M.; Rolf, Megan] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Melkonian, Michael; Surek, Barbara] Univ Cologne, Cologne Bioctr, Dept Bot, D-50931 Cologne, Germany; [Myburg, Henrietta] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Sage, Rowan F.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Jordon-Thaden, Ingrid; Miles, Nicholas; Soltis, Pamela] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Stevenson, Dennis] New York Bot Garden, Bronx, NY 10458 USA; [Villarreal, Juan Carlos] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Toronto; University Toronto Mississauga; University of Alberta; Beijing Genomics Institute (BGI); CGIAR; International Rice Research Institute (IRRI); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia; Royal Botanic Gardens, Kew; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Missouri System; University of Missouri Columbia; University of British Columbia; University of British Columbia; Max Planck Society; State University System of Florida; University of Florida; Donald Danforth Plant Science Center; University of Cologne; University of North Carolina; North Carolina State University; University of Toronto; State University System of Florida; University of Florida; New York Botanical Garden; University of Connecticut; University of Alberta	Johnson, MTJ (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	marc.johnson@utoronto.ca; gane@ualberta.ca	WONG, Gane Ka-Shu/G-5784-2013; dePamphilis, Claude W/P-6652-2016; Edger, Patrick/AAP-3846-2021; Pires, J. Chris/O-5122-2014; Soltis, Douglas/L-5957-2015; Graham, Sean W/L-3944-2014; Kutchan, Toni/L-4625-2013; Clarke, Neil/D-9613-2014; Aguilar, Juan Carlos Villarreal/C-6277-2018; Jordon-Thaden, Ingrid/A-5619-2012; Edger, Patrick/ABE-6442-2020; Chase, Mark W/A-6642-2011; Greiner, Stephan/D-9742-2012; Leebens-Mack, James/AAF-6770-2019	WONG, Gane Ka-Shu/0000-0001-6108-5560; Pires, J. Chris/0000-0001-9682-2639; Graham, Sean W/0000-0001-8209-5231; Aguilar, Juan Carlos Villarreal/0000-0002-0770-1446; Jordon-Thaden, Ingrid/0000-0001-6225-6034; Greiner, Stephan/0000-0003-3369-0354; Leebens-Mack, James/0000-0003-4811-2231; Goh, Falicia/0000-0002-8373-7408; Augustin, Megan/0000-0002-8430-6466; Covshoff, Sarah/0000-0001-7942-0312; wu, xiaolei/0000-0002-5467-8293	Government of Alberta (Ministry of Advanced Education and Technology); Musea Ventures; BGI-Shenzhen; Alberta's Informatics Circle of Research Excellence (iCORE); iPlant (NSF(National Science Foundation)) [DBI-0735191]; NSERC Canada; NSF [DEB-0919869, DEB-0830009, DEB-0829868, DEB-1110443, DEB-1146603, PGR-0638595, IOS-0922742, DEB-0919254, DEB-082762, EF-0629817, IOS-0421604, DDIG-0910258]; National Institutes of Health (NIH) [1R01DA025197-01]; USDA National Institute of Food and Agriculture; University of Tennessee Agricultural Experiment Station; Agency for Science, Technology and Research (Singapore); Max Planck Society; University of Cologne; Royal Botanic Gardens, Kew, UK; International Rice Research Institute C4 project through the Bill & Melinda Gates Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025197] Funding Source: NIH RePORTER	Government of Alberta (Ministry of Advanced Education and Technology); Musea Ventures; BGI-Shenzhen; Alberta's Informatics Circle of Research Excellence (iCORE); iPlant (NSF(National Science Foundation))(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); University of Tennessee Agricultural Experiment Station; Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Cologne; Royal Botanic Gardens, Kew, UK; International Rice Research Institute C4 project through the Bill & Melinda Gates Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The 1KP Consortium is supported by the Government of Alberta (Ministry of Advanced Education and Technology), Musea Ventures, BGI-Shenzhen, Alberta's Informatics Circle of Research Excellence (iCORE), and iPlant (NSF(National Science Foundation) grant DBI-0735191). NSERC Canada supported M. Deyholos, S. Graham, M. Johnson and R. Sage. NSF supported M. Johnson (DEB-0919869), J. Leebens-Mack and C. dePamphilis (DEB-0830009, DEB-0829868), J. Pires and P. Edger (DEB-1110443, DEB-1146603), D. and P. Soltis (PGR-0638595, IOS-0922742, DEB-0919254), D. Stevenson (DEB-082762, EF-0629817, IOS-0421604) and J. Villarreal (DDIG-0910258). National Institutes of Health (NIH) supported T. Kutchan, C. dePamphilis and J. Leebens-Mack (1R01DA025197-01). USDA National Institute of Food and Agriculture and the University of Tennessee Agricultural Experiment Station supported J. Burris and C. Stewart. The Agency for Science, Technology and Research (Singapore) supported F. Goh and N. Clarke. The Max Planck Society supported S. Greiner and the University of Cologne supported M. Melkonian and B. Surek. The Royal Botanic Gardens, Kew, UK, supported M. Chase. S. Covshoff, J. Hibberd, R. Sage and R. Bruskiewich were funded by the International Rice Research Institute C4 project through the Bill & Melinda Gates Foundation. The funds from Musea Ventures came in the form of a charitable donation to the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Babu S., 2011, ASSESSING INTEGRITY; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Berenbaum MR, 2008, PLANT PHYSIOL, V146, P804, DOI 10.1104/pp.107.113472; Bilgin DD, 2009, NAT PROTOC, V4, P333, DOI 10.1038/nprot.2008.249; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Farrell Jr R.E., 2009, RNA METHODOLOGIES, V4th, P45; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Gayral P, 2011, MOL ECOL RESOUR, V11, P650, DOI 10.1111/j.1755-0998.2011.03010.x; Grierson CS, 2011, NEW PHYTOL, V192, P6, DOI 10.1111/j.1469-8137.2011.03859.x; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Illumina, 2011, ILL PUB; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kaufmann K, 2010, NAT PROTOC, V5, P457, DOI 10.1038/nprot.2009.244; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Macel M, 2010, MOL ECOL RESOUR, V10, P583, DOI 10.1111/j.1755-0998.2010.02854.x; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pico de Coana Y, 2010, MOL BIOTECHNOL, V44, P127, DOI 10.1007/s12033-009-9219-z; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Sambrook J, 2001, MOL CLONING LAB MANU; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Walter J, 2012, ARTHROPOD-PLANT INTE, V6, P15, DOI 10.1007/s11829-011-9157-0; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	41	121	126	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50226	10.1371/journal.pone.0050226	http://dx.doi.org/10.1371/journal.pone.0050226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185583	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000204
J	Larcombe, L; Mookherjee, N; Slater, J; Slivinski, C; Singer, M; Whaley, C; Denechezhe, L; Matyas, S; Turner-Brannen, E; Nickerson, P; Orr, P				Larcombe, Linda; Mookherjee, Neeloffer; Slater, Joyce; Slivinski, Caroline; Singer, Matthew; Whaley, Chris; Denechezhe, Lizette; Matyas, Sara; Turner-Brannen, Emily; Nickerson, Peter; Orr, Pamela			Vitamin D in a Northern Canadian First Nation Population: Dietary Intake, Serum Concentrations and Functional Gene Polymorphisms	PLOS ONE			English	Article							D-BINDING-PROTEIN; D-RECEPTOR GENE; BREAST-CANCER RISK; D DEFICIENCY; PULMONARY TUBERCULOSIS; IMMUNE FUNCTION; GC-GLOBULIN; VDR GENE; ASSOCIATION; VARIANTS	The wide spectrum of vitamin D activity has focused attention on its potential role in the elevated burden of disease in a northern Canadian First Nations (Dene) cohort. Vitamin D insufficiency, and gene polymorphisms in the vitamin D receptor (VDR) and vitamin D binding protein (VDBP) have been implicated in susceptibility to infectious and chronic diseases. The objectives of this study were to determine the contribution of vitamin D from food, and measure the serum concentrations of 25-hydroxyvitamin D-3 (25-OHD3) and VDBP in Dene participants. Single nucleotide polymorphisms (SNPs) associated with the dysregulation of the innate immune response were typed and counted. Potential correlations between the SNPs and serum concentrations of 25-OHD3 and VDBP were evaluated. Venous blood was collected in summer and winter over a one-year period and analyzed for 25-OHD3 and VDBP concentrations (N = 46). A questionnaire was administered to determine the amount of dietary vitamin D consumed. Sixty-one percent and 30% of the participants had 25-OHD3 serum concentrations,75 nmol/L in the winter and summer respectively. Mean vitamin D binding protein concentrations were within the normal range in the winter but below normal in the summer. VDBP and VDR gene polymorphisms affect the bioavailability and regulation of 25-OHD3. The Dene had a high frequency of the VDBP D432E-G allele (71%) and the Gc1 genotype (90%), associated with high concentrations of VDBP and a high binding affinity to 25-OHD3. The Dene had a high frequency of VDR Fok1-f allele (82%), which has been associated with a down-regulated Th1 immune response. VDBP and VDR polymorphisms, and low winter 25-OHD3 serum concentrations may be risk factors for infectious diseases and chronic conditions related to the dysregulation of the vitamin D pathway.	[Larcombe, Linda; Mookherjee, Neeloffer; Slivinski, Caroline; Singer, Matthew; Whaley, Chris; Matyas, Sara; Nickerson, Peter; Orr, Pamela] Univ Manitoba, Fac Med, Dept Internal Med, Winnipeg, MB R3E 0W3, Canada; [Larcombe, Linda; Orr, Pamela] Univ Manitoba, Fac Med, Dept Med Microbiol, Winnipeg, MB, Canada; [Larcombe, Linda; Orr, Pamela] Univ Manitoba, Fac Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Mookherjee, Neeloffer; Turner-Brannen, Emily; Nickerson, Peter] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada; [Slater, Joyce] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB, Canada; [Denechezhe, Lizette] Northlands Denesuline First Nation, Lac Brochet, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Larcombe, L (corresponding author), Univ Manitoba, Fac Med, Dept Internal Med, Winnipeg, MB R3E 0W3, Canada.	llarcombe@hsc.mb.ca	Slater, Joyce/R-6721-2017	Slater, Joyce/0000-0003-1881-0004; Mookherjee, Neeloffer/0000-0002-9350-4157; Larcombe, Linda/0000-0002-7828-1290; Nickerson, Peter/0000-0002-7393-7799	Canadian Institutes of Health Research; National Sanitarium Association (Canada)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sanitarium Association (Canada)	Funding for this research was provided by the Canadian Institutes of Health Research and the National Sanitarium Association (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; Andraos C, 2011, HUM IMMUNOL, V72, P262, DOI 10.1016/j.humimm.2010.12.010; Arai H, 2001, J BONE MINER RES, V16, P1256, DOI 10.1359/jbmr.2001.16.7.1256; Babb C, 2007, TUBERCULOSIS, V87, P295, DOI 10.1016/j.tube.2007.03.001; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Bikle DD, 2011, VITAM HORM, V86, P1, DOI 10.1016/B978-0-12-386960-9.00001-0; Chen WY, 2005, CANCER EPIDEM BIOMAR, V14, P2335, DOI 10.1158/1055-9965.EPI-05-0283; Chishimba L, 2010, THORAX, V65, P456, DOI 10.1136/thx.2009.128793; Chun RF, 2010, J CLIN ENDOCR METAB, V95, P3368, DOI 10.1210/jc.2010-0195; EATON SB, 1991, AM J CLIN NUTR, V54, pS281, DOI 10.1093/ajcn/54.1.281S; El Hayek J, 2010, J NUTR, V140, P1839, DOI 10.3945/jn.110.124644; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Fischer PR, 2000, J BONE MINER RES, V15, P2206, DOI 10.1359/jbmr.2000.15.11.2206; Fu L, 2009, CLIN BIOCHEM, V42, P1174, DOI 10.1016/j.clinbiochem.2009.03.008; GLOTH FM, 1995, JAMA-J AM MED ASSOC, V274, P1683, DOI 10.1001/jama.274.21.1683; Gombart AF, 2009, CLIN INFECT DIS, V48, P418, DOI 10.1086/596314; Gordon BC, 1981, MUSK OX, V28, P1; Gozdzik A, 2011, J STEROID BIOCHEM, V127, P405, DOI 10.1016/j.jsbmb.2011.05.009; Hanley DA, 2010, CAN MED ASSOC J, V182, pE610, DOI 10.1503/cmaj.080663; Health Canada, 1999, TUBERCULOSIS 1 NATIO; Health Canada, 2007, CAN NUTR FIL; Helm J., 2000, PEOPLE DENENDEH ETHN; Hewison M, 2012, P NUTR SOC, V71, P50, DOI 10.1017/S0029665111001650; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; Holick MF, 2003, RECENT RESULTS CANC, V164, P3; Jain R, 2012, METABOLISM, V61, P293, DOI 10.1016/j.metabol.2011.06.018; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Kresfelder TL, 2011, J MED VIROL, V83, P1834, DOI 10.1002/jmv.22179; Kuhnlein HV, 2004, J NUTR, V134, P1447, DOI 10.1093/jn/134.6.1447; Larcombe L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040692; Larcombe L, 2011, INT J CIRCUMPOL HEAL, V70, P141, DOI 10.3402/ijch.v70i2.17806; Larcombe LA, 2008, J INFECT DIS, V198, P1175, DOI 10.1086/592049; Lauridsen AL, 2001, CLIN CHEM, V47, P753; LEBRUN JB, 1993, CAN J PUBLIC HEALTH, V84, P394; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lodge A, 2006, TUBERCULOSIS REMOTE; Lombard Z, 2006, HUM IMMUNOL, V67, P643, DOI 10.1016/j.humimm.2006.04.008; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; MOFFATT MEK, 1995, CAN J PHYSIOL PHARM, V73, P754, DOI 10.1139/y95-100; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Motsinger-Reif AA, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-37; Realegeno S, 2011, P NATL ACAD SCI USA, V108, P18861, DOI 10.1073/pnas.1116513108; Receveur O, 1997, J NUTR, V127, P2179, DOI 10.1093/jn/127.11.2179; Rejnmark L, 2004, CALCIFIED TISSUE INT, V74, P255, DOI 10.1007/s00223-003-0110-9; Rook GAW, 2012, CLIN REV ALLERG IMMU, V42, P5, DOI 10.1007/s12016-011-8285-8; Roth DE, 2008, J INFECT DIS, V197, P676, DOI 10.1086/527488; Sainz J, 1997, NEW ENGL J MED, V337, P77, DOI 10.1056/NEJM199707103370202; Selvaraj P, 2004, J CLIN IMMUNOL, V24, P523, DOI 10.1023/B:JOCI.0000040923.07879.31; Sharma PR, 2011, INFECT GENET EVOL, V11, P1456, DOI 10.1016/j.meegid.2011.05.019; Sinotte M, 2008, ENDOCR-RELAT CANCER, V15, P975, DOI 10.1677/ERC-08-0056; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Smolders J, 2009, AUTOIMMUN REV, V8, P621, DOI 10.1016/j.autrev.2009.02.009; SPECKER BL, 1986, J PEDIATR GASTR NUTR, V5, P290, DOI 10.1097/00005176-198605020-00022; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; Statistics Canada, 2008, 2006 CENS AB PEOPL C; Statistics Canada, 2009, VIT D STAT CAN MEAS; SZATHMARY EJE, 1987, HUM GENET, V75, P368, DOI 10.1007/BF00284110; SZATHMARY EJE, 1987, SOC SCI MED, V24, P791, DOI 10.1016/0277-9536(87)90181-X; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; Weiler HA, 2007, J NUTR, V137, P461, DOI 10.1093/jn/137.2.461; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Windelinckx A, 2007, OSTEOPOROSIS INT, V18, P1235, DOI 10.1007/s00198-007-0374-4; Wu HY, 2009, NUTR RES, V29, P255, DOI 10.1016/j.nutres.2009.03.006; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779	66	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49872	10.1371/journal.pone.0049872	http://dx.doi.org/10.1371/journal.pone.0049872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185470	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000132
J	Nyquist, KB; Panagopoulos, I; Thorsen, J; Haugom, L; Gorunova, L; Bjerkehagen, B; Fossa, A; Guriby, M; Nome, T; Lothe, RA; Skotheim, RI; Heim, S; Micci, F				Nyquist, Kaja B.; Panagopoulos, Ioannis; Thorsen, Jim; Haugom, Lisbeth; Gorunova, Ludmila; Bjerkehagen, Bodil; Fossa, Alexander; Guriby, Marianne; Nome, Torfinn; Lothe, Ragnhild A.; Skotheim, Rolf I.; Heim, Sverre; Micci, Francesca			Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; INTERFERON REGULATORY FACTOR-2; ACUTE LYMPHOBLASTIC-LEUKEMIA; HOMEOBOX GENE; HUMAN CDX1; HOX GENES; EXPRESSION; PROTEIN; CANCER; HOMEODOMAIN	Mesenchymal chondrosarcomas (MCs) account for 3-10% of primary chondrosarcomas. The cytogenetic literature includes only ten such tumours with karyotypic information and no specific aberrations have been identified. Using a purely molecular genetic approach a HEY1-NCOA2 fusion gene was recently detected in 10 of 15 investigated MCs. The fusion probably arises through intrachromosomal rearrangement of chromosome arm 8 q. We report a new case of MC showing a t(1;5)(q42;q32) as the sole karyotypic aberration. Through FISH and whole transcriptome sequencing analysis we found a novel fusion between the IRF2BP2 gene and the transcription factor CDX1 gene arising from the translocation. The IRF2BP2-CDX1 has not formerly been described in human neoplasia. In our hospital's archives three more cases of MC were found, and we examined them looking for the supposedly more common HEY1-NCOA2 fusion, finding it in all three tumours but not in the case showing t(1; 5) and IRF2BP2-CDX1 gene fusion. This demonstrates that genetic heterogeneity exists in mesenchymal chondrosarcoma.	[Nyquist, Kaja B.; Panagopoulos, Ioannis; Thorsen, Jim; Haugom, Lisbeth; Gorunova, Ludmila; Heim, Sverre; Micci, Francesca] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Med Informat, Sect Canc Cytogenet, Oslo, Norway; [Nyquist, Kaja B.; Panagopoulos, Ioannis; Thorsen, Jim; Haugom, Lisbeth; Gorunova, Ludmila; Guriby, Marianne; Nome, Torfinn; Lothe, Ragnhild A.; Skotheim, Rolf I.; Heim, Sverre; Micci, Francesca] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Nyquist, Kaja B.; Heim, Sverre] Univ Oslo, Fac Med, Oslo, Norway; [Bjerkehagen, Bodil] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Fossa, Alexander] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Guriby, Marianne; Nome, Torfinn; Lothe, Ragnhild A.; Skotheim, Rolf I.] Oslo Univ Hosp, Inst Canc Res, Norwegian Radium Hosp, Dept Canc Prevent, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Nyquist, KB (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Med Informat, Sect Canc Cytogenet, Oslo, Norway.	k.b.nyquist@medisin.uio.no	Nome, Torfinn/E-5475-2015; Skotheim, Rolf I./H-6192-2017	Nome, Torfinn/0000-0003-1659-132X; Skotheim, Rolf I./0000-0002-5609-4048; Lothe, Ragnhild A./0000-0002-1693-1032; Panagopoulos, Ioannis/0000-0003-2159-5341	Norwegian Cancer Society; South-Eastern Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority	The study was supported by grants from the Norwegian Cancer Society and the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrey LE, 2000, J CLIN ONCOL, V18, P3144, DOI 10.1200/JCO.2000.18.17.3144; BONNER CA, 1995, GENOMICS, V28, P206, DOI 10.1006/geno.1995.1132; Carneiro FRG, 2011, MOL CELL BIOL, V31, P2889, DOI 10.1128/MCB.00974-10; Cesari M, 2007, TUMORI J, V93, P423; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; Chase A, 1999, BLOOD, V93, P1025, DOI 10.1182/blood.V93.3.1025.403a20_1025_1031; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Dantonello TM, 2008, CANCER, V112, P2424, DOI 10.1002/cncr.23457; Fletcher CDM, 2002, WHO CLASSIFICATION T; Frohling S, 2007, CELL CYCLE, V6, P2241, DOI 10.4161/cc.6.18.4656; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Kalendar R, 2011, GENOMICS, V98, P137, DOI 10.1016/j.ygeno.2011.04.009; Kang JM, 2011, J KOREAN MED SCI, V26, P647, DOI 10.3346/jkms.2011.26.5.647; Koeppel M, 2009, NUCLEIC ACIDS RES, V37, P322, DOI 10.1093/nar/gkn940; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Mallo GV, 1997, INT J CANCER, V74, P35, DOI 10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1; Mandahl N., 2001, METHODS SOLID TUMOR, V3rd; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Mitelman F, 2012, MITELMAN DATABASE CH; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; NAKASHIMA Y, 1986, CANCER-AM CANCER SOC, V57, P2444, DOI 10.1002/1097-0142(19860615)57:12<2444::AID-CNCR2820571233>3.0.CO;2-K; Nakashima Y, 2002, WHO CLASSIFICATION S; Nyquist KB, 2011, CANCER GENET-NY, V204, P147, DOI 10.1016/j.cancergen.2011.01.003; Riedel RF, 2009, CURR TREAT OPTION ON, V10, P94, DOI 10.1007/s11864-009-0088-2; Riedt T, 2009, BLOOD, V113, P4049, DOI 10.1182/blood-2008-12-196634; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Silberg DG, 1997, GASTROENTEROLOGY, V113, P478, DOI 10.1053/gast.1997.v113.pm9247467; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TREISMAN J, 1992, BIOESSAYS, V14, P145, DOI 10.1002/bies.950140302; Wang L, 2012, GENE CHROMOSOME CANC, V51, P127, DOI 10.1002/gcc.20937; Wong NACS, 2004, P NATL ACAD SCI USA, V101, P574, DOI 10.1073/pnas.0307190101	35	50	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49705	10.1371/journal.pone.0049705	http://dx.doi.org/10.1371/journal.pone.0049705			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185413	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000091
J	Ou, Y; Zhang, Y; Cheng, M; Rattner, JB; Dobrinski, I; van der Hoorn, FA				Ou, Young; Zhang, Ying; Cheng, Min; Rattner, Jerome B.; Dobrinski, Ina; van der Hoorn, Frans A.			Targeting of CRMP-2 to the Primary Cilium Is Modulated by GSK-3 beta	PLOS ONE			English	Article							RESPONSE MEDIATOR PROTEIN-2; GLYCOGEN-SYNTHASE KINASE-3; POLYCYSTIC KIDNEY-DISEASE; KINESIN LIGHT-CHAIN; NEURONAL CILIA; CARGO RELEASE; OUTER SEGMENT; MOTOR PROTEIN; PHOSPHORYLATION; LOCALIZATION	CRMP-2 plays a pivotal role in promoting axon formation, neurite outgrowth and elongation in neuronal cells. CRMP-2's role in other cells is unknown. Our preliminary results showed CRMP-2 expression in cilia of fibroblasts. To localize CRMP-2, define its role and study the regulation of CRMP-2's expression in cilia we carried out the following experiments. We find that in fibroblasts CRMP-2 localizes to the centrosome and is associated with the basal body and - at a low level-is present in primary cilia. Phosphorylated pCRMP-2 can only be detected at the basal body. RNAi knockdown of CRMP-2 interfered with primary cilium assembly demonstrating a critical requirement for CRMP-2. Deletion analysis of CRMP-2 identified a 51 amino acid sequence in the C-terminus that is required for targeting to the basal body and primary cilium. This domain contains GSK-3 beta phosphorylation sites as well as two repeats of the VxPx motif, previously identified as a cilium targeting signal in other primary cilium proteins. To our surprise, mutation of the CRMP-2 VxPx motifs did not eliminate primary cilium targeting. Instead, mutation of the GSK-3 beta phosphorylation sites abolished CRMP-2 targeting to the primary cilium without affecting basal body localization. Treatment of cells with lithium, a potent GSK-3 beta inhibitor, or with two specific GSK-3 beta inhibitors (the L803-mts peptide inhibitor and CHIR99021) resulted in cilium elongation and decreased basal body levels of pCRMP-2 as well as increased levels of total CRMP-2 at the primary cilium. In summary, we identified CRMP-2 as a protein critically involved in primary cilia formation. To our knowledge this is the first demonstration of modulation of primary cilium targeting by GSK-3 beta.	[Ou, Young; Zhang, Ying; Cheng, Min; van der Hoorn, Frans A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Rattner, Jerome B.] Univ Calgary, Dept Cell Biol & Anat, Fac Med, Calgary, AB, Canada; [Dobrinski, Ina] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	van der Hoorn, FA (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	fvdhoorn@ucalgary.ca			Canadian Institutes of Health Research [MOP-111008]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [2 R01 RR17359-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR017359] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the Canadian Institutes of Health Research to FAvdH (MOP-111008) and by a grant from by the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health (Grant Number 2 R01 RR17359-10) to ID. YZ was the recipient of a Canadian Institutes of Health Research doctoral studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally S, 2008, NAT CELL BIOL, V10, P3, DOI 10.1038/ncb0108-3; Arimura N, 2009, J NEUROCHEM, V111, P380, DOI 10.1111/j.1471-4159.2009.06317.x; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Bhullar B, 2003, J BIOL CHEM, V278, P16159, DOI 10.1074/jbc.M213126200; Bork K, 2010, NEUROREPORT, V21, P641, DOI 10.1097/WNR.0b013e32833a7d53; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Du J, 2010, P NATL ACAD SCI USA, V107, P11573, DOI 10.1073/pnas.0913138107; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Fitzgerald C, 2006, J BIOL CHEM, V281, P38172, DOI 10.1074/jbc.M606010200; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HO PTC, 1989, J CELL PHYSIOL, V139, P398, DOI 10.1002/jcp.1041390224; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Hurd TW, 2011, J CELL SCI, V124, P718, DOI 10.1242/jcs.070839; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Junco A, 2001, BIOL REPROD, V64, P1320, DOI 10.1095/biolreprod64.5.1320; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Mahjoub MR, 2012, CURR BIOL, V22, P1628, DOI 10.1016/j.cub.2012.06.057; Manser C, 2011, ONCOGENE, P10; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McGlashan SR, 2008, DEV DYNAM, V237, P2013, DOI 10.1002/dvdy.21501; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Ou YC, 2000, CELL MOTIL CYTOSKEL, V47, P13, DOI 10.1002/1097-0169(200009)47:1<13::AID-CM2>3.0.CO;2-C; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; Ou YY, 2002, J CELL SCI, V115, P1825; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Rahajeng J, 2010, J BIOL CHEM, V285, P31918, DOI 10.1074/jbc.C110.166066; Rao R, 2007, DIABETOLOGIA, V50, P452, DOI 10.1007/s00125-006-0552-5; Rattner JB, 2010, HISTOL HISTOPATHOL, V25, P865, DOI 10.14670/HH-25.865; Ricard D, 2000, MOL CELL NEUROSCI, V16, P324, DOI 10.1006/mcne.2000.0888; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; SUNG CH, 1994, J NEUROSCI, V14, P5818; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Tao BL, 2009, J AM SOC NEPHROL, V20, P2570, DOI 10.1681/ASN.2009020188; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Toda H, 2008, GENE DEV, V22, P3292, DOI 10.1101/gad.1734608; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Verhey KJ, 2011, BIOCHEM SOC T, V39, P1120, DOI 10.1042/BST0391120; Wang GH, 2009, J LIPID RES, V50, P2103, DOI 10.1194/jlr.M900097-JLR200; Ward HH, 2011, MOL BIOL CELL, V22, P3289, DOI 10.1091/mbc.E11-01-0082; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhang Y, 2004, DEV BIOL, V275, P23, DOI 10.1016/j.ydbio.2004.07.014; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301	72	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48773	10.1371/journal.pone.0048773	http://dx.doi.org/10.1371/journal.pone.0048773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185275	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000022
J	Valette, M; Poitou, C; Le Beyec, J; Bouillot, JL; Clement, K; Czernichow, S				Valette, Marion; Poitou, Christine; Le Beyec, Johanne; Bouillot, Jean-Luc; Clement, Karine; Czernichow, Sebastien			Melanocortin-4 Receptor Mutations and Polymorphisms Do Not Affect Weight Loss after Bariatric Surgery	PLOS ONE			English	Article							OBESITY; MC4R; GENE; MORTALITY; MASS	Bariatric surgery is the most effective long term weight-loss therapy for severe and morbidly obese patients. Melanocortin-4 Receptor (MC4R) mutations, the most frequent known cause of monogenic obesity, affect the regulation of energy homeostasis. The impact of such mutations on weight loss after bariatric surgery is still debated. The objective is to determine the impact of MC4R status on weight loss in obese subjects over one year after bariatric surgery. A total of 648 patients, who were referred to bariatric surgery in a single clinical nutrition department, were genotyped for their MC4R status. The following four groups were categorized: functional MC4R mutations, MC4R single nucleotide polymorphisms (SNPs): Val103Ile (V103L) and Ile251Leu (I251L), MC4R variant rs17782313 (downstream of MC4R) and MC4R SNP A-178C on the promoter. Each patient was matched with two randomly paired controls without mutation. Matching factors were age, sex, baseline weight and type of surgery procedure (Roux-en-Y gastric bypass and adjustable gastric banding). We compared weight loss between cases and controls at 3, 6 and 12 months after surgery. Among 648 patients, we identified 9 carriers of functional MC4R mutations, 10 carriers of MC4R V103L and I251L SNPs, 7 carriers of the rs17792313 variant and 22 carriers of the A-178C SNP. Weight loss at 3, 6 and 12 months did not differ between cases and controls, whatever the MC4R mutations. This is the first case-control study to show that MC4R mutations and polymorphisms do not affect weight loss and body composition over one year after bariatric surgery.	[Valette, Marion] Univ Paris 13, Nutr Epidemiol Res Unit UMR INSERM U557, INRA U1125, CNAM,CRNH IdF, Bobigny, France; [Poitou, Christine; Clement, Karine] Hop La Pitie Salpetriere, Heart & Metab Dept, Assistance Publ Hop Paris, Paris, France; [Poitou, Christine; Clement, Karine] Inst Natl Sante & Rech Med, Team7 U872, Cordelier Res Ctr, Paris, France; [Poitou, Christine; Le Beyec, Johanne; Clement, Karine] Univ Paris 06, Paris, France; [Le Beyec, Johanne] Hop La Pitie Salpetriere, Nutrigen Unit, Endocrinol & Oncol Biochem Dept, Assistance Publ Hop Paris, Paris, France; [Bouillot, Jean-Luc; Czernichow, Sebastien] Ambroise Pare Hosp, Dept Med Surg, AP HP, Boulogne, France; [Czernichow, Sebastien] Univ Versailles St Quentin Yvelines, Boulogne, France; [Czernichow, Sebastien] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Valette, M (corresponding author), Univ Paris 13, Nutr Epidemiol Res Unit UMR INSERM U557, INRA U1125, CNAM,CRNH IdF, Bobigny, France.	sebastien.czernichow@apr.aphp.fr	Clément, karine/R-1120-2017; Valette, Marion/AAC-3924-2019; Poitou, Christine/GVT-6117-2022	Valette, Marion/0000-0002-2113-824X; Poitou, Christine/0000-0001-7769-6331; Le Beyec - Le Bihan, johanne/0000-0002-5647-2002	foundation NRJ - Institute de France; University Paris 13	foundation NRJ - Institute de France; University Paris 13	The study was supported by a research grant from the foundation NRJ - Institute de France(http://fondation.nrj.fr/index.php. M. Valette is supported by a fellowship from the University Paris 13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan IR, 2011, INT J OBESITY, V35, P457, DOI 10.1038/ijo.2010.168; Aslan IR, 2011, OBES SURG, V21, P930, DOI 10.1007/s11695-010-0295-8; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2009, OBES SURG, V19, P1605, DOI 10.1007/s11695-009-0014-5; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Goergen M, 2011, Bull Soc Sci Med Grand Duche Luxemb, P7; Hatoum IJ, 2011, J CLIN ENDOCR METAB, V96, pE1630, DOI 10.1210/jc.2011-1130; Hatoum IJ, 2012, J CLIN ENDOCRINOL ME, V97; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Mirshahi UL, 2011, J CLIN ENDOCR METAB, V96, pE2088, DOI 10.1210/jc.2011-1549; Ranadive SA, 2008, ENDOCRIN METAB CLIN, V37, P733, DOI 10.1016/j.ecl.2008.07.003; Sarzynski MA, 2011, INT J OBESITY, V35, P676, DOI 10.1038/ijo.2010.166; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tan K, 2009, ENDOCRINOLOGY, V150, P114, DOI 10.1210/en.2008-0721; Valli-Jaakola K, 2006, HORM RES, V66, P61, DOI 10.1159/000093469; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	22	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48221	10.1371/journal.pone.0048221	http://dx.doi.org/10.1371/journal.pone.0048221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185251	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000009
J	Xie, YJ; Mao, Y; Lai, DW; Zhang, W; Shen, WB				Xie, Yanjie; Mao, Yu; Lai, Diwen; Zhang, Wei; Shen, Wenbiao			H-2 Enhances Arabidopsis Salt Tolerance by Manipulating ZAT10/12-Mediated Antioxidant Defence and Controlling Sodium Exclusion	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; OXYGEN GENE NETWORK; MOLECULAR-HYDROGEN; OXIDATIVE STRESS; ION HOMEOSTASIS; UP-REGULATION; METABOLISM; EXPRESSION; OVEREXPRESSION; PROTEIN	Background: The metabolism of hydrogen gas (H-2) in bacteria and algae has been extensively studied for the interesting of developing H-2-based fuel. Recently, H-2 is recognized as a therapeutic antioxidant and activates several signalling pathways in clinical trials. However, underlying physiological roles and mechanisms of H-2 in plants as well as its signalling cascade remain unknown. Methodology/Principal Findings: In this report, histochemical, molecular, immunological and genetic approaches were applied to characterize the participation of H-2 in enhancing Arabidopsis salt tolerance. An increase of endogenous H-2 release was observed 6 hr after exposure to 150 mM NaCl. Arabidopsis pretreated with 50% H-2-saturated liquid medium, mimicking the induction of endogenous H-2 release when subsequently exposed to NaCl, effectively decreased salinity-induced growth inhibition. Further results showed that H-2 pretreatment modulated genes/proteins of zinc-finger transcription factor ZAT10/12 and related antioxidant defence enzymes, thus significantly counteracting the NaCl-induced reactive oxygen species (ROS) overproduction and lipid peroxidation. Additionally, H-2 pretreatment maintained ion homeostasis by regulating the antiporters and H+ pump responsible for Na+ exclusion (in particular) and compartmentation. Genetic evidence suggested that SOS1 and cAPX1 might be the target genes of H-2 signalling. Conclusions: Overall, our findings indicate that H-2 acts as a novel and cytoprotective regulator in coupling ZAT10/12-mediated antioxidant defence and maintenance of ion homeostasis in the improvement of Arabidopsis salt tolerance.	[Xie, Yanjie; Mao, Yu; Lai, Diwen; Zhang, Wei; Shen, Wenbiao] Nanjing Agr Univ, Co Lab, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Xie, Yanjie; Mao, Yu; Lai, Diwen; Zhang, Wei; Shen, Wenbiao] Nanjing Agr Univ, Carl Zeiss Far E, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Shen, WB (corresponding author), Nanjing Agr Univ, Co Lab, Coll Life Sci, Nanjing, Jiangsu, Peoples R China.	wbshenh@njau.edu.cn			National Natural Science Foundation of China [31170241]; Education Department of Jiangsu [200910]; Fundamental Research Funds for the Central Universities [KYZ200905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Jiangsu; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant no. 31170241), the Education Department of Jiangsu (grant no. 200910), and the Fundamental Research Funds for the Central Universities (grant no. KYZ200905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Barton RM, 1999, J BIOL CHEM, V274, P30008, DOI 10.1074/jbc.274.42.30008; Bonifacio A, 2011, PLANT CELL ENVIRON, V34, P1705, DOI 10.1111/j.1365-3040.2011.02366.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavazza C, 2008, J INORG BIOCHEM, V102, P1359, DOI 10.1016/j.jinorgbio.2008.01.027; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Esquivel MG, 2011, TRENDS BIOTECHNOL, V29, P595, DOI 10.1016/j.tibtech.2011.06.008; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Fukuda KI, 2007, BIOCHEM BIOPH RES CO, V361, P670, DOI 10.1016/j.bbrc.2007.07.088; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Han Y, 2008, NEW PHYTOL, V177, P155, DOI 10.1111/j.1469-8137.2007.02251.x; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Huang C, 2007, BIOCHEM BIOPH RES CO, V361, P670; Itoh T, 2011, BIOCHEM BIOPH RES CO, V411, P143, DOI 10.1016/j.bbrc.2011.06.116; Itoh T, 2009, BIOCHEM BIOPH RES CO, V389, P651, DOI 10.1016/j.bbrc.2009.09.047; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Kangasjarvi S, 2008, BIOCHEM J, V412, P275, DOI 10.1042/BJ20080030; Lv WT, 2011, PLANT PHYSIOL, V156, P1921, DOI 10.1104/pp.111.175810; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morimoto K, 2005, FEMS MICROBIOL LETT, V246, P229, DOI 10.1016/j.femsle.2005.04.014; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2012, BBA-GEN SUBJECTS, V1820, P586, DOI 10.1016/j.bbagen.2011.05.006; Ohta S, 2011, CURR PHARM DESIGN, V17, P2241, DOI 10.2174/138161211797052664; RENWICK GM, 1964, PLANT PHYSIOL, V39, P303, DOI 10.1104/pp.39.3.303; ROESSLER PG, 1984, PLANT PHYSIOL, V76, P1086, DOI 10.1104/pp.76.4.1086; Shekhawat GS, 2010, J EXP BOT, V61, P2255, DOI 10.1093/jxb/erq074; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Suorsa M, 2012, PLANT CELL, V24, P2934, DOI 10.1105/tpc.112.097162; TORRES V, 1986, ARCH BIOCHEM BIOPHYS, V245, P174, DOI 10.1016/0003-9861(86)90202-X; TORRES V, 1984, ANN NY ACAD SCI, V434, P296, DOI 10.1111/j.1749-6632.1984.tb29849.x; Visnovitz T, 2012, PHYSIOL PLANTARUM, V144, P382, DOI 10.1111/j.1399-3054.2012.01578.x; Wood KC, 2007, NAT MED, V13, P673, DOI 10.1038/nm0607-673; Wu SJ, 1996, PLANT CELL, V8, P617, DOI 10.1105/tpc.8.4.617; Xie YJ, 2011, PLANT J, V66, P280, DOI 10.1111/j.1365-313X.2011.04488.x; Xie YJ, 2012, J EXP BOT, V63, P3869, DOI [10.1093/jxb/ers078, 10.1093/jxb/ers201]; Xie YJ, 2008, PLANT CELL ENVIRON, V31, P1864, DOI 10.1111/j.1365-3040.2008.01888.x; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	49	98	114	12	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49800	10.1371/journal.pone.0049800	http://dx.doi.org/10.1371/journal.pone.0049800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185443	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000113
J	Xing, JC; Tufano, RP; Murugan, AK; Liu, DX; Wand, G; Ladenson, PW; Xing, MZ; Trink, B				Xing, Jeffrey C.; Tufano, Ralph P.; Murugan, Avaniyapuram Kannan; Liu, Dingxie; Wand, Gary; Ladenson, Paul W.; Xing, Mingzhao; Trink, Barry			Single Nucleotide Polymorphism rs17849071 G/T in the PIK3CA Gene Is Inversely Associated with Follicular Thyroid Cancer and PIK3CA Amplification	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT; COMMON VARIANTS; HIGH-FREQUENCY; BRAF MUTATION; PATHWAY; RET; DISCOVERY; RISK	The proto-oncogene PIK3CA has been well studied for its activating mutations and genomic amplifications but not single nucleotide polymorphism (SNP) in thyroid cancer. We investigated SNP rs17849071 (minor allele G and major allele T) in PIK3CA in thyroid tumors in 503 subjects by PCR and sequencing of a region of intron 9 carrying this SNP. This SNP was found in both normal and thyroid tumor tissues as well as in different generations of a studied family, confirming it to be a germline genetic event in thyroid tumor patients. In comparison with normal subjects, a dramatically lower prevalence of the heterozygous genotype G/T at rs17849071 was found in patients with follicular thyroid cancer (FTC). Specifically, rs17849071G/T was found in 15% (18/117) normal subjects vs. 1.3% (1/77) FTC patients, with an odds ratio of 0.07 (95% CI 0.01-0.55; P = 0.001). This represents a 93% risk reduction for FTC with this SNP. In contrast, no difference was seen with benign thyroid neoplasms in which the prevalence of rs17849071G/T was 13.1% (17/130), with an odds ratio of 0.83 (95% CI 0.40-1.69; P = 0.72). There was a trend of lower prevalences of rs17849071G/T and odds ratio in other types of thyroid cancer without statistical significance. We also found an interesting inverse relationship of rs17849071G/T with PIK3CA amplification. With copy number >= 4 defined as copy gain, 2.9% (1/34) rs17849071G/T vs. 19.0% (67/352) rs17849071T/T cases displayed PIK3CA amplification (P = 0.01). Conversely, 1.5% (1/68) cases with PIK3CA amplification vs. 10.4% (33/318) cases without PIK3CA amplification harbored rs17849071G/T (P = 0.01). This provides an explanation for the reciprocal relationship of rs17849071G/T with FTC, since PIK3CA amplification is an important oncogenic mechanism in thyroid cancer, particularly FTC. Thus, the present study uncovers an interesting phenomenon that rs17849071G/T is protective against FTC possibly through preventing PIK3CA amplifications.	[Xing, Jeffrey C.; Tufano, Ralph P.; Trink, Barry] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Murugan, Avaniyapuram Kannan; Liu, Dingxie; Wand, Gary; Ladenson, Paul W.; Xing, Mingzhao] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Xing, JC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	mxing1@jhmi.edu	Liu, Dingxie/C-2181-2011; Murugan, Avaniyapuram Kannan/AAI-8222-2020	Murugan, Avaniyapuram Kannan/0000-0002-3096-6100; Xing, Jeffrey/0000-0003-0696-1390; Liu, Dingxie/0000-0002-8061-5704	National Institutes of Health [R01CA134225]; NATIONAL CANCER INSTITUTE [R01CA134225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grant R01CA134225. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2008, J CLIN ENDOCR METAB, V93, P611, DOI 10.1210/jc.2007-1717; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Churg A, 2005, TOXICOL APPL PHARM, V208, P37, DOI 10.1016/j.taap.2005.01.013; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hartmann C, 2005, ACTA NEUROPATHOL, V109, P639, DOI 10.1007/s00401-005-1000-1; Ho T, 2005, LARYNGOSCOPE, V115, P1035, DOI 10.1097/01.MLG.0000162653.22384.10; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Howlader N, 2012, SEER CANCER STATISTI; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Magalhaes PKR, 2004, THYROID, V14, P848, DOI 10.1089/1050725042451239; McIver Bryan, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P221, DOI 10.2174/1568008043339802; Saji M, 2010, MOL CELL ENDOCRINOL, V321, P20, DOI 10.1016/j.mce.2009.10.016; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santarpia L, 2008, J CLIN ENDOCR METAB, V93, P278, DOI 10.1210/jc.2007-1076; Santoro M, 2004, ENDOCRINOLOGY, V145, P5448, DOI 10.1210/en.2004-0922; Stephens LA, 2005, THYROID, V15, P100, DOI 10.1089/thy.2005.15.100; Sturgis EM, 2005, LARYNGOSCOPE, V115, P938, DOI 10.1097/01.MLG.0000163765.88158.86; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vasko V, 2003, J CLIN ENDOCR METAB, V88, P2745, DOI 10.1210/jc.2002-021186; Wang YG, 2007, J CLIN ENDOCR METAB, V92, P2387, DOI 10.1210/jc.2006-2019; Wu GJ, 2005, BREAST CANCER RES, V7, pR609, DOI 10.1186/bcr1262; Wu GJ, 2005, J CLIN ENDOCR METAB, V90, P4688, DOI 10.1210/jc.2004-2281; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646	29	11	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49192	10.1371/journal.pone.0049192	http://dx.doi.org/10.1371/journal.pone.0049192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185308	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000034
J	Zhang, B; Jiao, J; Liu, Y; Guo, LX; Zhou, B; Li, GQ; Yao, ZJ; Zhou, GB				Zhang, Bo; Jiao, Jiao; Liu, Ying; Guo, Liang-Xia; Zhou, Bo; Li, Gang-Qin; Yao, Zhu-Jun; Zhou, Guang-Biao			Gefitinib Analogue V1801 Induces Apoptosis of T790M EGFR-Harboring Lung Cancer Cells by Up-Regulation of the BH-3 Only Protein Noxa	PLOS ONE			English	Article							BCL-2 FAMILY; C-MYC; INHIBITORS; RESISTANCE; MUTATIONS; ERLOTINIB; ANTAGONISTS; MEDIATOR; BALANCE; GROWTH	Treatment of non-small cell lung cancer (NSCLC) with drugs targeting the epidermal growth factor receptor (EGFR), e. g., gefitinib and erlotinib, will eventually fail because of the development of secondary mutations such as T790M in EGFR. Strategies to overcome this resistance are therefore an urgent need. In this study, we synthesized a dozen of novel gefitinib analogues and evaluated their effects on L858R/T790M-EGFR harboring NSCLC cells, and reported that one of these gefitinib mimetics, N-(2-bromo-5-(trifluoromethyl) phenyl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine (hereafter, V1801), triggered apoptosis of the NSCLC cells and overcame gefitinib-resistance in mice inoculated with NCI-H1975 cells. Though V1801 only moderately inhibited EGFR kinase activity, it markedly induced the expression of the BH3-only protein Noxa, and Noxa silencing significantly reduced V1801-induced apoptosis of NCI-H1975 cells. It is showed that V1801 interfered with the expression of the transcription factor c-Myc and the extracellular signal regulated kinase (Erk) pathway. V1801 in combination with proteasome inhibitor bortezomib exerted enhanced cytotoxicity in NCI-H1975 cells possibly due to potentiated induction of Noxa expression. These data indicate that gefinitib analogues with weak EGFR inhibitory activity may overcome drug-resistance via activation of BH-3 only pro-apoptotic proteins, and V1801 may have therapeutic potentials for NSCLC.	[Jiao, Jiao; Li, Gang-Qin; Yao, Zhu-Jun] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Zhang, Bo; Guo, Liang-Xia; Zhou, Bo; Zhou, Guang-Biao] Chinese Acad Sci, Inst Zool, Div Mol Carcinogenesis & Targeted Therapy Canc, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Zhang, Bo] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Ying] Tsinghua Univ, Shenzhen Key Lab Gene & Antibody Therapy, Div Life & Hlth Sci, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Yao, ZJ (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	yaoz@sioc.ac.cn; gbzhou@ioz.ac.cn	Zhou, Guangbiao/J-6575-2017; Zhou, Guang-Biao/ABG-5795-2021; Yao, Zhu-Jun/E-7635-2015	Zhou, Guangbiao/0000-0002-6327-2316; Zhou, Guang-Biao/0000-0001-6778-7133	National Key Program for Basic Research [2012CB910800, 2010CB833200, 2010CB529201]; National Natural Science Foundation [81071930, 81171925, 20972160, 21172220]; Special Foundation of President; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX1-YW-R-26, KSCX2-YW-R-235]; National Major Scientific and Technological Program for Drug Discovery [2009ZX09103-101]	National Key Program for Basic Research(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Foundation of President; Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Major Scientific and Technological Program for Drug Discovery	This work was supported by the National Key Program for Basic Research (2012CB910800, 2010CB833200, 2010CB529201), the National Natural Science Foundation (No. 81071930, 81171925, 20972160 and 21172220), the Special Foundation of President and the Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-26 and KSCX2-YW-R-235), and the National Major Scientific and Technological Program for Drug Discovery (2009ZX09103-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dang CV, 1999, MOL CELL BIOL, V19, P1; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fang HT, 2012, P NATL ACAD SCI USA, V109, P2521, DOI 10.1073/pnas.1121341109; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hauck P, 2009, MOL CANCER THER, V8, P883, DOI 10.1158/1535-7163.MCT-08-1118; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hu Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006257; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kim Y, 2012, MOL CANCER THER, V11, P784, DOI 10.1158/1535-7163.MCT-11-0750; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Lin CL, 2011, CELL DEATH DIFFER, V18, P1651, DOI 10.1038/cdd.2011.80; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021930; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020159; Mei YD, 2007, NEOPLASIA, V9, P871, DOI 10.1593/neo.07589; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Phelps RM, 1996, J CELL BIOCHEM, P32; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Schuler M, 2003, CELL DEATH DIFFER, V10, P451, DOI 10.1038/sj.cdd.4401180; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sheridan C, 2010, ONCOGENE, V29, P6428, DOI 10.1038/onc.2010.380; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Tang Z, 2008, BRIT J CANCER, V99, P911, DOI 10.1038/sj.bjc.6604559; Tong JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016781; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wu XQ, 2011, CHEM BIOL DRUG DES, V78, P932, DOI 10.1111/j.1747-0285.2011.01234.x; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	46	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48748	10.1371/journal.pone.0048748	http://dx.doi.org/10.1371/journal.pone.0048748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185274	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000021
J	Camoes, MJ; Paulo, P; Ribeiro, FR; Barros-Silva, JD; Almeida, M; Costa, VL; Cerveira, N; Skotheim, RI; Lothe, RA; Henrique, R; Jeronimo, C; Teixeira, MR				Camoes, Maria J.; Paulo, Paula; Ribeiro, Franclim R.; Barros-Silva, Joao D.; Almeida, Mafalda; Costa, Vera L.; Cerveira, Nuno; Skotheim, Rolf I.; Lothe, Ragnhild A.; Henrique, Rui; Jeronimo, Carmen; Teixeira, Manuel R.			Potential Downstream Target Genes of Aberrant ETS Transcription Factors Are Differentially Affected in Ewing's Sarcoma and Prostate Carcinoma	PLOS ONE			English	Article							NUCLEAR RECEPTOR DAX1; RESPONSE ELEMENTS; IN-VITRO; TRANSFORMING GENE; TGF-BETA; CANCER; FAMILY; FUSION; EWS/FLI-1; TMPRSS2	FLI1 and ERG, the major ETS transcription factors involved in rearrangements in the Ewing's sarcoma family of tumors (ESFT) and in prostate carcinomas (PCa), respectively, belong to the same subfamily, having 98% sequence identity in the DNA binding domain. We therefore decided to investigate whether the aberrant transcription factors in both malignancies have some common downstream targets. We crossed a publicly available list of all putative EWSR1-FLI1 target genes in ESFT with our microarray expression data on 24 PCa and 6 non-malignant prostate tissues (NPT) and choose four genes among the top-most differentially expressed between PCa with (PCa ERG+) and without (PCa ETS-) ETS fusion genes (HIST1H4L, KCNN2, ECRG4 and LDOC1), as well as four well-validated direct targets of the EWSR1-FLI1 chimeric protein in ESFT (NR0B1, CAV1, IGFBP3 and TGFBR2). Using quantitative expression analysis in 16 ESFT and seven alveolar rhabdomyosarcomas (ARMS), we were able to validate the four genes previously described as direct targets of the EWSR1-FLI1 oncoprotein, showing overexpression of CAV1 and NR0B1 and underexpression of IGFBP3 and TGFBR2 in ESFT as compared to ARMS. Although none of these four genes showed significant expression differences between PCa ERG+ and PCa ETS-, CAV1, IGFBP3 and TGFBR2 were less expressed in PCa in an independent series of 56 PCa and 15 NPT, as also observed for ECRG4 and LDOC1, suggesting a role in prostate carcinogenesis in general. On the other hand, we demonstrate for the first time that both HIST1H4L and KCNN2 are significantly overexpressed in PCa ERG+ and that ERG binds to the promoter of these genes. Conversely, KCNN2 was found underexpressed in ESFT relative to ARMS, suggesting that the EWSR1-ETS oncoprotein may have the opposite effect of ERG rearrangements in PCa. We conclude that aberrant ETS transcription factors modulate target genes differently in ESFT and PCa.	[Camoes, Maria J.; Paulo, Paula; Ribeiro, Franclim R.; Barros-Silva, Joao D.; Almeida, Mafalda; Costa, Vera L.; Cerveira, Nuno; Jeronimo, Carmen; Teixeira, Manuel R.] Portuguese Oncol Inst Porto, Dept Genet, Oporto, Portugal; [Camoes, Maria J.; Paulo, Paula; Ribeiro, Franclim R.; Barros-Silva, Joao D.; Cerveira, Nuno; Teixeira, Manuel R.] Portuguese Oncol Inst Porto, Res Ctr, Canc Genet Grp, Oporto, Portugal; [Almeida, Mafalda; Costa, Vera L.; Henrique, Rui; Jeronimo, Carmen] Portuguese Oncol Inst, Canc Epigenet Grp, Res Ctr, Oporto, Portugal; [Skotheim, Rolf I.; Lothe, Ragnhild A.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Skotheim, Rolf I.; Lothe, Ragnhild A.; Teixeira, Manuel R.] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Henrique, Rui] Portuguese Oncol Inst Porto, Dept Pathol, Oporto, Portugal; [Henrique, Rui; Jeronimo, Carmen; Teixeira, Manuel R.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal	Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; University of Oslo; University of Oslo; Portuguese Institute of Oncology; Universidade do Porto	Teixeira, MR (corresponding author), Portuguese Oncol Inst Porto, Dept Genet, Oporto, Portugal.	manuel.teixeira@ipoporto.min-saude.pt	Teixeira, Manuel António Rodrigues/E-4885-2011; Skotheim, Rolf I./H-6192-2017; Teixeira, Manuel AC/AAZ-7251-2020; Jerónimo, Carmen/H-3284-2013; Henrique, Rui Manuel Ferreira/I-2757-2013; Paulo, Paula/F-1441-2016; Ribeiro, Franclim/D-8173-2013	Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Skotheim, Rolf I./0000-0002-5609-4048; Teixeira, Manuel AC/0000-0002-1959-0624; Jerónimo, Carmen/0000-0003-4186-5345; Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Paulo, Paula/0000-0001-8387-2127; Almeida, Mafalda/0000-0002-3894-4248; Lothe, Ragnhild A./0000-0002-1693-1032; Barros Silva, Joao Diogo/0000-0002-6648-0217; Cerveira, Nuno/0000-0001-5098-3840	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU/OBD/70543/2006, SAU-Norte-776, SFRH/BPD/26492/2006, SFRH/BD/27669/2006, SFRH/BD/23374/2005, SFRH/BD/46574/2008]; Norwegian Cancer Society [PR-2007-0166, PR-2006-0442]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	This study was supported by research grants PTDC/SAU/OBD/70543/2006 and SAU-Norte-776 awarded by Fundacao para a Ciencia e a Tecnologia (FCT). FRR (SFRH/BPD/26492/2006), PP (SFRH/BD/27669/2006), VLC (SFRH/BD/23374/2005), and JDBS (SFRH/BD/46574/2008) are research fellows funded by FCT. RIS (PR-2007-0166), and RAL (PR-2006-0442) are supported by grants from the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 1999, GENE CHROMOSOME CANC, V26, P275, DOI 10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.0.CO;2-3; Barros R, 2011, GUT, V60, P290, DOI 10.1136/gut.2010.222323; Cerveira N, 2005, CANCER GENET CYTOGEN, V163, P138, DOI 10.1016/j.cancergencyto.2005.06.020; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; Chansky HA, 2004, J ORTHOPAED RES, V22, P910, DOI 10.1016/j.orthres.2003.12.008; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Cui J, 2001, PROSTATE, V46, P249, DOI 10.1002/1097-0045(20010215)46:3<249::AID-PROS1030>3.0.CO;2-#; Danielpour D, 2005, EUR J CANCER, V41, P846, DOI 10.1016/j.ejca.2004.12.027; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Guo YP, 1997, INT J CANCER, V71, P573, DOI 10.1002/(SICI)1097-0215(19970516)71:4<573::AID-IJC11>3.3.CO;2-1; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Laudet V, 1999, ONCOGENE, V18, P1351, DOI 10.1038/sj.onc.1202444; Li LW, 2009, INT J CANCER, V125, P1505, DOI 10.1002/ijc.24513; MAO XH, 1994, J BIOL CHEM, V269, P18216; Massie CE, 2011, METHODS MOL BIOL, V776, P255, DOI 10.1007/978-1-61779-243-4_15; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Meier VS, 1998, DIAGN MOL PATHOL, V7, P29, DOI 10.1097/00019606-199802000-00006; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Nagasaki K, 2003, INT J CANCER, V105, P454, DOI 10.1002/ijc.11122; Nakamura Y, 2009, ENDOCR J, V56, P39, DOI 10.1507/endocrj.K08E-177; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Patel M, 2012, GENOME RES, V22, P259, DOI 10.1101/gr.125666.111; Paulo P, 2012, NEOPLASIA, V14, P600, DOI 10.1593/neo.12600; Paulo P, 2012, GENE CHROMOSOME CANC, V51, P240, DOI 10.1002/gcc.20948; Pearson Helen, 2003, Methods Mol Biol, V226, P33; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Pflueger D, 2009, NEOPLASIA, V11, P804, DOI 10.1593/neo.09572; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Ribeiro FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022317; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sato N, 2003, CANCER RES, V63, P3735; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Szatanik M, 2008, NEUROGENETICS, V9, P237, DOI 10.1007/s10048-008-0136-2; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Williams RH, 1996, CLIN CANCER RES, V2, P635; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x	55	13	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49819	10.1371/journal.pone.0049819	http://dx.doi.org/10.1371/journal.pone.0049819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185447	gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800053
J	Jayaratne, YSN; McGrath, CPJ; Zwahlen, RA				Jayaratne, Yasas S. N.; McGrath, Colman P. J.; Zwahlen, Roger A.			How Accurate Are the Fusion of Cone-Beam CT and 3-D Stereophotographic Images?	PLOS ONE			English	Article							REGISTRATION; PRECISION; MODEL	Background: Cone-beam Computed Tomography (CBCT) and stereophotography are two of the latest imaging modalities available for three-dimensional (3-D) visualization of craniofacial structures. However, CBCT provides only limited information on surface texture. This can be overcome by combining the bone images derived from CBCT with 3-D photographs. The objectives of this study were 1) to evaluate the feasibility of integrating 3-D Photos and CBCT images 2) to assess degree of error that may occur during the above processes and 3) to identify facial regions that would be most appropriate for 3-D image registration. Methodology: CBCT scans and stereophotographic images from 29 patients were used for this study. Two 3-D images corresponding to the skin and bone were extracted from the CBCT data. The 3-D photo was superimposed on the CBCT skin image using relatively immobile areas of the face as a reference. 3-D colour maps were used to assess the accuracy of superimposition were distance differences between the CBCT and 3-D photo were recorded as the signed average and the Root Mean Square (RMS) error. Principal Findings:: The signed average and RMS of the distance differences between the registered surfaces were -0.018 (+/- 0.129) mm and 0.739 (+/- 0.239) mm respectively. The most errors were found in areas surrounding the lips and the eyes, while minimal errors were noted in the forehead, root of the nose and zygoma. Conclusions: CBCT and 3-D photographic data can be successfully fused with minimal errors. When compared to RMS, the signed average was found to under-represent the registration error. The virtual 3-D composite craniofacial models permit concurrent assessment of bone and soft tissues during diagnosis and treatment planning.	[Jayaratne, Yasas S. N.; Zwahlen, Roger A.] Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Hong Kong, Hong Kong, Peoples R China; [McGrath, Colman P. J.] Univ Hong Kong, Fac Dent, Discipline Periodontol & Publ Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Zwahlen, RA (corresponding author), Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Hong Kong, Hong Kong, Peoples R China.	zwahlen@hku.hk		McGrath, Colman Patrick Joseph/0000-0001-9379-0889; ZWAHLEN, Roger Arthur/0000-0003-4666-7567; Jayaratne, Yasas/0000-0002-4813-648X				Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Ayoub AF, 2007, INT J ORAL MAX SURG, V36, P423, DOI 10.1016/j.ijom.2007.02.003; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Curry S., 2001, SEMIN ORTHOD, V7, P258, DOI [10.1053/sodo.2001.25422, DOI 10.1053/SODO.2001.25422]; De Groeve P, 2001, LECT NOTES COMPUTER, V2208, P991; GRAYSON B, 1988, AM J ORTHOD DENTOFAC, V94, P327, DOI 10.1016/0889-5406(88)90058-3; Ip HHS, 1996, VISUAL COMPUT, V12, P254, DOI 10.1007/s003710050063; Jayaratne YSN, 2010, J PLAST RECONSTR AES, V63, P1840, DOI 10.1016/j.bjps.2010.03.013; Jayaratne YSN, 2010, SURG INNOV, V17, P217, DOI 10.1177/1553350610371626; Jayaratne YSN, 2010, SURG INNOV, V17, P198, DOI 10.1177/1553350610370752; Khambay Balvinder, 2002, Int J Adult Orthodon Orthognath Surg, V17, P331; Lane C, 2008, AM J ORTHOD DENTOFAC, V133, P612, DOI 10.1016/j.ajodo.2007.03.023; Maal TJJ, 2008, INT J ORAL MAX SURG, V37, P641, DOI 10.1016/j.ijom.2008.04.012; Schendel SA, 2011, FACIAL PLAST SURG CL, V19, P577, DOI 10.1016/j.fsc.2011.07.002; Trotman CA, 1998, CLEFT PALATE-CRAN J, V35, P132, DOI 10.1597/1545-1569(1998)035<0132:SOAMFT>2.3.CO;2; VANNIER MW, 1988, RADIOLOGY, V169, P860, DOI 10.1148/radiology.169.3.3263667; Weinberg SM, 2006, J CRANIOFAC SURG, V17, P477, DOI 10.1097/00001665-200605000-00015; Xia J, 2000, INT J ORAL MAX SURG, V29, P2, DOI 10.1016/S0901-5027(00)80115-0	18	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49585	10.1371/journal.pone.0049585	http://dx.doi.org/10.1371/journal.pone.0049585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185372	gold, Green Published			2022-12-25	WOS:000311333800041
J	Gharaee-Kermani, M; Kasina, S; Moore, BB; Thomas, D; Mehra, R; Macoska, JA				Gharaee-Kermani, Mehrnaz; Kasina, Sathish; Moore, Bethany B.; Thomas, Dafydd; Mehra, Rohit; Macoska, Jill A.			CXC-Type Chemokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; REACTIVE STROMA; GROWTH-FACTOR; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; CELLULAR PROLIFERATION; PULMONARY-FIBROSIS; MOLECULAR TARGETS; EPITHELIAL-CELLS; HUMAN BLADDER	Recent studies from our group suggest that extracellular matrix (ECM) deposition and fibrosis characterize the peri-urethral prostate tissues of some men suffering from Lower Urinary Tract Symptoms (LUTS) and that fibrosis may be a contributing factor to the etiology of LUTS. Fibrosis can generally be regarded as an errant wound-healing process in response to chronic inflammation, and several studies have shown that the aging prostate tissue microenvironment is rich with inflammatory cells and proteins. However, it is unclear whether these same inflammatory proteins, particularly CXC-type chemokines, can mediate myofibroblast phenoconversion and the ECM deposition necessary for the development of prostatic tissue fibrosis. To examine this, immortalized and primary prostate stromal fibroblasts treated with TGF-beta 1, CXCL5, CXCL8, or CXCL12 were evaluated morphologically by microscopy, by immunofluorescence and qRT-PCR for alpha SMA, collagen 1, vimentin, calponin, and tenascin protein and transcript expression, and by gel contraction assays for functional myofibroblast phenoconversion. The results of these studies showed that that immortalized and primary prostate stromal fibroblasts are induced to express collagen 1 and 3 and alpha SMA gene transcripts and proteins and to undergo complete and functional myofibroblast phenoconversion in response to CXC-type chemokines, even in the absence of exogenous TGF-beta 1. Moreover, CXCL12-mediated myofibroblast phenoconversion can be completely abrogated by inhibition of the CXCL12 receptor, CXCR4. These findings suggest that CXC-type chemokines, which comprise inflammatory proteins known to be highly expressed in the aging prostate, can efficiently and completely mediate myofibroblast phenoconversion and may thereby promote fibrotic changes in prostate tissue architecture associated with the development and progression of male lower urinary tract dysfunction.	[Gharaee-Kermani, Mehrnaz; Kasina, Sathish; Macoska, Jill A.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Moore, Bethany B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Moore, Bethany B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Thomas, Dafydd; Mehra, Rohit] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Macoska, JA (corresponding author), Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA.	jcoska@umich.edu		Moore, Bethany/0000-0003-3051-745X	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P20DK090770]; Michigan Institute for Clinical & Health Research (MICHR) NIH [UL1RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090770, P20DK090870] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Michigan Institute for Clinical & Health Research (MICHR) NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) award P20DK090770 (JAM) and by the Michigan Institute for Clinical & Health Research (MICHR) NIH Clinical & Translational Science Award (CTSA) UL1RR024986 (MGK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas MI, 2001, INT J ANDROL, V24, P37, DOI 10.1046/j.1365-2605.2001.00267.x; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Begley L, 2006, GENE CHROMOSOME CANC, V45, P136, DOI 10.1002/gcc.20274; Begley L, 2005, AGING CELL, V4, P291, DOI 10.1111/j.1474-9726.2005.00173.x; Begley LA, 2008, CYTOKINE, V43, P194, DOI 10.1016/j.cyto.2008.05.012; Begley LA, 2007, J BIOL CHEM, V282, P26767, DOI 10.1074/jbc.M700440200; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Charlton RG, 1999, BJU INT, V84, P953; Chkhotua A, 2002, TRANSPL IMMUNOL, V9, P165, DOI 10.1016/S0966-3274(02)00003-5; Comperat E, 2006, EUR UROL, V50, P1058, DOI 10.1016/j.eururo.2006.01.025; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cunnington RH, 2011, AM J PHYSIOL-CELL PH, V300, pC176, DOI 10.1152/ajpcell.00050.2010; DEERING RE, 1994, UROLOGY, V44, P64, DOI 10.1016/S0090-4295(94)80011-1; Detlefsen S, 2005, VIRCHOWS ARCH, V447, P800, DOI 10.1007/s00428-005-0032-1; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; EASTHAM JA, 1995, LAB INVEST, V73, P628; ELBADAWI A, 1993, J UROLOGY, V150, P1657, DOI 10.1016/S0022-5347(17)35867-6; Francisco IFS, 2004, INT J CANCER, V112, P213, DOI 10.1002/ijc.20388; Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677; Morales MG, 2011, J PATHOL, V225, P490, DOI 10.1002/path.2952; Gharaee-Kermani M, 2009, CURR MED CHEM, V16, P1400, DOI 10.2174/092986709787846497; Goldacre MJ, 2009, BEST PRACT RES CL GA, V23, P793, DOI 10.1016/j.bpg.2009.10.008; Gosling JA, 1997, EUR UROL, V32, P9; Gur S, 2008, DRUGS, V68, P209, DOI 10.2165/00003495-200868020-00005; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Hjelmeland LM, 1999, INVEST OPHTH VIS SCI, V40, P1; Huang XM, 2003, FRONT BIOSCI-LANDMRK, V8, pS740, DOI 10.2741/1093; International Union of Immunological Societies/World Health Organization Subcommittee on chemokine nomenclature, 2001, J Leukoc Biol, V70, P465; Jinnin M, 2010, J DERMATOL, V37, P11, DOI 10.1111/j.1346-8138.2009.00738.x; Kajstura J, 2000, AM J PATHOL, V156, P813, DOI 10.1016/S0002-9440(10)64949-8; Kasina S, 2012, MOL CELL ENDOCRINOL, V351, P249, DOI 10.1016/j.mce.2011.12.015; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.2381; Laborde Eric E, 2009, Rev Urol, V11, pS19; LEPOR H, 1992, J UROLOGY, V148, P414, DOI 10.1016/S0022-5347(17)36619-3; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Macoska JA, 2004, CANCER GENET CYTOGEN, V154, P36, DOI 10.1016/j.cancergencyto.2004.02.013; McDowell KL, 2010, PROSTATE, V70, P377, DOI 10.1002/pros.21071; McVary KT, 2007, CLIN THER, V29, P387, DOI 10.1016/S0149-2918(07)80077-4; Meigs JB, 2001, J CLIN EPIDEMIOL, V54, P935, DOI 10.1016/S0895-4356(01)00351-1; MORI H, 1990, PROSTATE, V16, P71, DOI 10.1002/pros.2990160108; Nickel JC, 1999, BJU INT, V84, P976; Nishimura F, 1997, Oral Dis, V3, P162; Novo E, 2009, INT J BIOCHEM CELL B, V41, P2089, DOI 10.1016/j.biocel.2009.03.010; Okada H, 1998, AM J PHYSIOL-RENAL, V275, pF306, DOI 10.1152/ajprenal.1998.275.2.F306; Parsons JK, 2008, UROLOGY, V72, P318, DOI 10.1016/j.urology.2008.03.057; Penna G, 2009, J IMMUNOL, V182, P4056, DOI 10.4049/jimmunol.0801875; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Rodrigues AA, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.09.033; Royuela M, 1998, GROWTH FACTORS, V16, P101, DOI 10.3109/08977199809002121; Schauer IG, 2008, UROLOGY, V72, P205, DOI 10.1016/j.urology.2007.11.083; Schauer IG, 2009, PROSTATE, V69, P373, DOI 10.1002/pros.20886; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Somoza B, 2006, CARDIOVASC RES, V69, P764, DOI 10.1016/j.cardiores.2005.08.021; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; THEYER G, 1992, LAB INVEST, V66, P96; Tuxhorn J.A., 2002, REACTIVE STROMA HUMA; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Van Hoozen BE, 2000, TOXICOLOGY, V147, P1, DOI 10.1016/S0300-483X(00)00142-6; Verhamme KMC, 2002, EUR UROL, V42, P323, DOI 10.1016/S0302-2838(02)00354-8; Wang JX, 2011, AM J PHYSIOL-HEART C, V301, pH2073, DOI 10.1152/ajpheart.00157.2011; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xie YP, 2012, EXP BIOL MED, V237, P853, DOI 10.1258/ebm.2012.012070; Zhao H, 2002, BIOCHEM BIOPH RES CO, V292, P482, DOI 10.1006/bbrc.2002.6660	74	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49278	10.1371/journal.pone.0049278	http://dx.doi.org/10.1371/journal.pone.0049278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173053	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885300024
J	Ribeiro, AR; Barbaglio, A; Oliveira, MJ; Ribeiro, CC; Wilkie, IC; Carnevali, MDC; Barbosa, MA				Ribeiro, Ana R.; Barbaglio, Alice; Oliveira, Maria J.; Ribeiro, Cristina C.; Wilkie, Iain C.; Carnevali, Maria D. Candia; Barbosa, Mario A.			Matrix Metalloproteinases in a Sea Urchin Ligament with Adaptable Mechanical Properties	PLOS ONE			English	Article							COLLAGEN-FIBRIL; EXTRACELLULAR-MATRIX; RIPENING PROCESS; CUCUMARIA-FRONDOSA; STIFFENING FACTOR; TISSUE; CUCUMBER; INHIBITORS; DERMIS; CATCH	Mutable collagenous tissues (MCTs) of echinoderms show reversible changes in tensile properties (mutability) that are initiated and modulated by the nervous system via the activities of cells known as juxtaligamental cells. The molecular mechanism underpinning this mechanical adaptability has still to be elucidated. Adaptable connective tissues are also present in mammals, most notably in the uterine cervix, in which changes in stiffness result partly from changes in the balance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). There have been no attempts to assess the potential involvement of MMPs in the echinoderm mutability phenomenon, apart from studies dealing with a process whose relationship to the latter is uncertain. In this investigation we used the compass depressor ligaments (CDLs) of the sea-urchin Paracentrotus lividus. The effect of a synthetic MMP inhibitor - galardin - on the biomechanical properties of CDLs in different mechanical states ("standard", "compliant" and "stiff") was evaluated by dynamic mechanical analysis, and the presence of MMPs in normal and galardin-treated CDLs was determined semi-quantitatively by gelatin zymography. Galardin reversibly increased the stiffness and storage modulus of CDLs in all three states, although its effect was significantly lower in stiff than in standard or compliant CDLs. Gelatin zymography revealed a progressive increase in total gelatinolytic activity between the compliant, standard and stiff states, which was possibly due primarily to higher molecular weight components resulting from the inhibition and degradation of MMPs. Galardin caused no change in the gelatinolytic activity of stiff CDLs, a pronounced and statistically significant reduction in that of standard CDLs, and a pronounced, but not statistically significant, reduction in that of compliant CDLs. Our results provide evidence that MMPs may contribute to the variable tensility of the CDLs, in the light of which we provide an updated hypothesis for the regulatory mechanism controlling MCT mutability.	[Ribeiro, Ana R.; Oliveira, Maria J.; Ribeiro, Cristina C.; Barbosa, Mario A.] Univ Porto, NEWTherapies Grp, INEB Inst Engn Biomed, P-4100 Oporto, Portugal; [Ribeiro, Ana R.; Barbosa, Mario A.] Univ Porto, FEUP Fac Eng, Dept Engn Met & Mat, P-4100 Oporto, Portugal; [Barbaglio, Alice; Carnevali, Maria D. Candia] Univ Milan, Dept Life Sci, Milan, Italy; [Oliveira, Maria J.] Univ Porto, FMUP Fac Med, P-4100 Oporto, Portugal; [Ribeiro, Cristina C.] ISEP Inst Super Engn Porto, Dept Fis, Oporto, Portugal; [Wilkie, Iain C.] Glasgow Caledonian Univ, Dept Biol & Biomed Sci, Glasgow G4 0BA, Lanark, Scotland; [Barbosa, Mario A.] Univ Porto, ICBAS Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; University of Milan; Universidade do Porto; Polytechnic Institute of Porto; Glasgow Caledonian University; Universidade do Porto	Ribeiro, AR (corresponding author), Univ Porto, NEWTherapies Grp, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	analopes@ineb.up.pt; mbarbosa@ineb.up.pt	Ribeiro, Ana/ABE-9964-2021; Ribeiro, Ana R L P/D-3165-2012; Barbosa, Mário A/F-5964-2011; Ribeiro, Cristina C/O-1842-2017; Candia Carnevali, M. Daniela/I-8048-2015; Oliveira, Maria Jose/K-3275-2013; Barbaglio, Alice/A-4365-2012	Ribeiro, Ana/0000-0003-1349-9595; Ribeiro, Ana R L P/0000-0003-1349-9595; Barbosa, Mário A/0000-0003-3568-7482; Ribeiro, Cristina C/0000-0002-7802-7364; Candia Carnevali, M. Daniela/0000-0002-0215-8843; Oliveira, Maria Jose/0000-0002-0724-0272; Barbaglio, Alice/0000-0003-0122-0331	Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation); Portuguese Foundation for Science and Technology (FCT) (SFRH) [BD/40541/2007]; Fundo Europeu de Desenvolvimento Regional (FEDER) through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT) [PEst? C/SAU/LA0002/2011]	Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation)(Fondazione Cariplo); Portuguese Foundation for Science and Technology (FCT) (SFRH); Fundo Europeu de Desenvolvimento Regional (FEDER) through the Programa Operacional Factores de Competitividade - COMPETE; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research received financial support from the Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation)-advanced Material projects 2009 (Mimesis - Marine Invertebrates Models & Engineered Substrates for Innovative bio-Scaffolds) and from the Portuguese Foundation for Science and Technology (FCT) (SFRH grant BD/40541/2007). This work was also financed by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the Programa Operacional Factores de Competitividade - COMPETE and by Portuguese funds through Fundacao para a Ciencia e a Tecnologia (FCT) in the framework of the project PEst? C/SAU/LA0002/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Arnoczky SP, 2007, AM J SPORT MED, V35, P763, DOI 10.1177/0363546506296043; Auge F, 2003, BIOORG MED CHEM LETT, V13, P1783, DOI 10.1016/S0960-894X(03)00214-2; Barbaglio A, 2011, MAR ENVIRON RES, P1; Breschi L, 2010, DENT MATER, V26, P571, DOI 10.1016/j.dental.2010.02.007; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Hanemaaijer R, 1998, Adv Dent Res, V12, P114; Hao JL, 1999, EXP EYE RES, V69, P595, DOI 10.1006/exer.1999.0755; Hill RB, 1998, EXP BIOL ONLINE SA1, V3, P18; Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8; Ingersoll EP, 1998, DEV BIOL, V196, P95, DOI 10.1006/dbio.1998.8857; JUNQUEIRA LCU, 1980, REV CAN BIOL EXPTL, V39, P157; Kadler KE, 1996, BIOCHEM J, V316, P1; Ledingham MA, 1999, HUM REPROD, V14, P2089, DOI 10.1093/humrep/14.8.2089; Lee MH, 2004, J CELL SCI, V117, P4015, DOI 10.1242/jcs.01223; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Miriam F-F, 2010, BIOCHIM BIOPHYS ACTA, V1803, P3, DOI DOI 10.1016/J.BBAMCR.2009.07.004; Motokawa T, 2004, BIOL BULL-US, V206, P4, DOI 10.2307/1543193; Motokawa T, 2003, BIOL BULL-US, V205, P261, DOI 10.2307/1543290; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Rahkonen L, 2009, HUM REPROD, V24, P2693, DOI 10.1093/humrep/dep284; Ribeiro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024822; Santos R, 2005, J EXP BIOL, V208, P2277, DOI 10.1242/jeb.01641; Schlembach D, 2009, EUR J OBSTET GYN R B, V144, pS70, DOI 10.1016/j.ejogrb.2009.02.036; Sennstrom MB, 2003, ACTA OBSTET GYN SCAN, V82, P904, DOI 10.1034/j.1600-0412.2003.00249.x; Sharpe C, 2001, BIOCHEM CELL BIOL, V79, P461; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Stygar D, 2002, BIOL REPROD, V67, P889, DOI 10.1095/biolreprod.102.005116; Szulgit G, 2007, BIOESSAYS, V29, P645, DOI 10.1002/bies.20597; Takemae N, 2009, BIOL BULL-US, V216, P45; Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221; Timmons B, 2010, TRENDS ENDOCRIN MET, V21, P353, DOI 10.1016/j.tem.2010.01.011; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; TROTTER JA, 1995, J EXP BIOL, V198, P1951; TROTTER JA, 1994, CELL TISSUE RES, V275, P451, DOI 10.1007/BF00318814; Trotter JA, 1996, MATRIX BIOL, V15, P99, DOI 10.1016/S0945-053X(96)90151-1; TROTTER JA, 1989, CELL TISSUE RES, V258, P527; Trotter JA, 1995, COMP BIOCHEM PHYS A, V112, P463, DOI 10.1016/0300-9629(95)02015-2; Trotter JA, 2000, J MOL BIOL, V300, P531, DOI 10.1006/jmbi.2000.3879; Van Engelen E, 2008, MOL REPROD DEV, V75, P1669, DOI 10.1002/mrd.20908; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wilkie IC, 2006, J EXP BIOL, V209, P4436, DOI 10.1242/jeb.02527; Wilkie IC, 2010, J EXP BIOL, V213, P2104, DOI 10.1242/jeb.039578; Wilkie I.C., 1988, P25; WILKIE IC, 1994, B ZOOL, V61, P39, DOI 10.1080/11250009409355857; WILKIE IC, 1992, ZOOMORPHOLOGY, V112, P143, DOI 10.1007/BF01633105; WILKIE IC, 1979, CELL TISSUE RES, V197, P515; Wilkie IC, 2005, PROG MOLEC, V39, P221; Winkler M, 1999, J PERINAT MED, V27, P45, DOI 10.1515/JPM.1999.006; Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149	56	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49016	10.1371/journal.pone.0049016	http://dx.doi.org/10.1371/journal.pone.0049016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173042	gold, Green Published			2022-12-25	WOS:000311885300012
J	Jin, S; Mutvei, AP; Chivukula, IV; Andersson, ER; Ramskold, D; Sandberg, R; Lee, KL; Kronqvist, P; Mamaeva, V; Ostling, P; Mpindi, JP; Kallioniemi, O; Screpanti, I; Poellinger, L; Sahlgren, C; Lendahl, U				Jin, S.; Mutvei, A. P.; Chivukula, I. V.; Andersson, E. R.; Ramskold, D.; Sandberg, R.; Lee, K. L.; Kronqvist, P.; Mamaeva, V.; Ostling, P.; Mpindi, J-P; Kallioniemi, O.; Screpanti, I.; Poellinger, L.; Sahlgren, C.; Lendahl, U.			Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKK alpha/IKKb	ONCOGENE			English	Article						cytokine; inflammation; tumor stroma; estrogen receptor; breast cancer; BCL	ESTROGEN-RECEPTOR; CROSS-TALK; CANCER; EXPRESSION; PATHWAY; BINDING; KINASE; REPRESSION; SUPPRESSOR; INHIBITOR	Notch signaling is frequently hyperactivated in breast cancer, but how the enhanced signaling contributes to the tumor process is less well understood. In this report, we identify the proinflammatory cytokine interleukin-6 (IL-6) as a novel Notch target in breast tumor cells. Enhanced Notch signaling upregulated IL-6 expression, leading to activation of autocrine and paracrine Janus kinase/signal transducers and activators of transcription signaling. IL-6 upregulation was mediated by non-canonical Notch signaling, as it could be effectuated by a cytoplasmically localized Notch intracellular domain and was independent of the DNA-binding protein CSL. Instead, Notch-mediated IL-6 upregulation was controlled by two proteins in the nuclear factor (NF)-kappa B signaling cascade, IK kappa alpha and IKKb (inhibitor of nuclear factor kappa-B kinase subunit alpha and beta, respectively), as well as by p53. Activation of IL-6 by Notch required IKKa/IKKb function, but interestingly, did not engage canonical NF-kB signaling, in contrast to IL-6 activation by inflammatory agents such as lipopolysaccharide. With regard to p53 status, IL-6 expression was upregulated by Notch when p53 was mutated or lost, and restoring wild-type p53 into p53-mutated or -deficient cells abrogated the IL-6 upregulation. Furthermore, Notch-induced transcriptomes from p53 wild-type and -mutated breast tumor cell lines differed extensively, and for a subset of genes upregulated by Notch in a p53-mutant cell line, this upregulation was reduced by wild-type p53. In conclusion, we identify IL-6 as a novel non-canonical Notch target gene, and reveal roles for p53 and IKKa/IKKb in noncanonical Notch signaling in breast cancer and in the generation of cell context-dependent diversity in the Notch signaling output.	[Jin, S.; Mutvei, A. P.; Chivukula, I. V.; Andersson, E. R.; Ramskold, D.; Sandberg, R.; Poellinger, L.; Lendahl, U.] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Ramskold, D.; Sandberg, R.] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; [Lee, K. L.; Poellinger, L.] Natl Univ Singapore, Singapore 117548, Singapore; [Kronqvist, P.] Univ Turku, Dept Pathol, Turku, Finland; [Mamaeva, V.; Sahlgren, C.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Mamaeva, V.; Sahlgren, C.] Abo Akad Univ, Turku, Finland; [Ostling, P.; Mpindi, J-P; Kallioniemi, O.] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Screpanti, I.] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy	Karolinska Institutet; Ludwig Institute for Cancer Research; National University of Singapore; University of Turku; University of Turku; Abo Akademi University; University of Helsinki; Sapienza University Rome	Lendahl, U (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285,Eulers Vag 3, SE-17177 Stockholm, Sweden.	Urban.Lendahl@ki.se	Andersson, Emma R/J-4236-2012; Kallioniemi, Olli P/H-5111-2011; LEE, Kian Leong/E-3584-2013; Andersson, Emma/AAB-8532-2019	Andersson, Emma R/0000-0002-8608-625X; Kallioniemi, Olli P/0000-0002-3231-0332; LEE, Kian Leong/0000-0002-0443-2746; Andersson, Emma/0000-0002-8608-625X; Ramskold, Daniel/0000-0003-2892-673X; Ostling, Paivi/0000-0001-5501-466X; Sandberg, Rickard/0000-0001-6473-1740; Lendahl, Urban/0000-0001-9543-8141; Chivukula, Indira/0000-0003-4416-3808; MUTVEI, ANDERS/0000-0002-2498-5225	Swedish Cancer Society; Swedish Research Council; EC; EuroSyStem and NotchIT; Karolinska Institutet (BRECT, Theme Center in Regenerative Medicine and a Distinguished Professor Award)	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); EC(European CommissionEuropean Commission Joint Research Centre); EuroSyStem and NotchIT; Karolinska Institutet (BRECT, Theme Center in Regenerative Medicine and a Distinguished Professor Award)	This work was financially supported by the Swedish Cancer Society, the Swedish Research Council (DBRM and Project Grant), the EC projects EuroSyStem and NotchIT, Karolinska Institutet (BRECT, Theme Center in Regenerative Medicine and a Distinguished Professor Award). We are grateful to Susanne Bergstedt, Rasmus Niemi and Sinikka Kollanus for technical assistance.	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; CHUNG CN, 1994, NUCLEIC ACIDS RES, V22, P2938, DOI 10.1093/nar/22.15.2938; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heitzler P, 2010, CURR TOP DEV BIOL, V92, P457, DOI 10.1016/S0070-2153(10)92014-0; Johnston DA, 2009, GENE, V435, P36, DOI 10.1016/j.gene.2009.01.003; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Muggerud AA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-26; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Raafat A, 2009, ONCOGENE, V28, P219, DOI 10.1038/onc.2008.379; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schneider G, 2011, BBA-REV CANCER, V1815, P90, DOI 10.1016/j.bbcan.2010.10.003; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Selivanova G, 1999, MOL CELL BIOL, V19, P3395; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Speiser J, 2012, INT J SURG PATHOL, V20, P139, DOI 10.1177/1066896911427035; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sun Y, 2011, J CELL SCI, V124, P1067, DOI 10.1242/jcs.068965; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang YA, 2008, INT J CANCER, V123, P1536, DOI 10.1002/ijc.23671; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zeng B, 2008, CANCER RES, V68, P5397, DOI 10.1158/0008-5472.CAN-07-6792	53	96	99	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2013	32	41					4892	4902		10.1038/onc.2012.517	http://dx.doi.org/10.1038/onc.2012.517			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	235KQ	23178494	Green Published, hybrid			2022-12-25	WOS:000325717800005
J	Chowdhury, B; Hemming, R; Hombach-Klonisch, S; Flamion, B; Triggs-Raine, B				Chowdhury, Biswajit; Hemming, Richard; Hombach-Klonisch, Sabine; Flamion, Bruno; Triggs-Raine, Barbara			Murine Hyaluronidase 2 Deficiency Results in Extracellular Hyaluronan Accumulation and Severe Cardiopulmonary Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-VALVE; MUCOPOLYSACCHARIDOSIS-IX; MOUSE MODEL; EXPRESSION; CD44; MANIFESTATIONS; MORPHOGENESIS; PROTEOGLYCAN; ACTIVATION; CATABOLISM	Hyaluronidase (HYAL) 2 is a membrane-anchored protein that is proposed to hydrolyze hyaluronan (HA) to smaller fragments that are internalized for breakdown. Initial studies of a Hyal2 knock-out (KO) mouse revealed a mild phenotype with high serum HA, supporting a role for HYAL2 in HA breakdown. We now describe a severe cardiac phenotype, deemed acute, in 54% of Hyal2 KO mice on an outbred background; Hyal2 KO mice without the severe cardiac phenotype were designated non-acute. Histological studies of the heart revealed that the valves of all Hyal2 KO mice were expanded and the extracellular matrix was disorganized. HA was detected throughout the expanded valves, and electron microscopy confirmed that the accumulating material, presumed to be HA, was extracellular. Both acute and non-acute Hyal2 KO mice also exhibited increased HA in the interstitial extracellular matrix of atrial cardiomyocytes compared with control mice. Consistent with the changes in heart structure, upper ventricular cardiomyocytes in acute Hyal2 KO mice demonstrated significant hypertrophy compared with non-acute KO and control mice. When the lungs were examined, evidence of severe fibrosis was detected in acute Hyal2 KO mice but not in non-acute Hyal2 KO or control mice. Total serum and heart HA levels, as well as size, were increased in acute and non-acute Hyal2 KO mice compared with control mice. These findings indicate that HYAL2 is essential for the breakdown of extracellular HA. In its absence, extracellular HA accumulates and, in some cases, can lead to cardiopulmonary dysfunction. Alterations in HYAL2 function should be considered as a potential contributor to cardiac pathologies in humans.	[Chowdhury, Biswajit; Hemming, Richard; Triggs-Raine, Barbara] Univ Manitoba, Fac Med, Dept Biochem & Med Genet, Winnipeg, MB R3E 0J9, Canada; [Hombach-Klonisch, Sabine] Univ Manitoba, Fac Med, Dept Human Anat & Cell Sci, Winnipeg, MB R3E 0J9, Canada; [Hombach-Klonisch, Sabine] Univ Manitoba, Fac Med, Dept Obstet Gynecol & Reprod Med, Winnipeg, MB R3E 0J9, Canada; [Hombach-Klonisch, Sabine; Triggs-Raine, Barbara] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB R3E 0J9, Canada; [Flamion, Bruno] Univ Namur, Namur Res Inst Life Sci NARILIS, Mol Physiol Res Unit URPHYM, B-5000 Namur, Belgium	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Namur	Triggs-Raine, B (corresponding author), Univ Manitoba, Fac Med, Dept Biochem & Med Genet, 745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	traine@cc.umanitoba.ca	Triggs-Raine, Barbara/AAF-6209-2021; Chowdhury, Biswajit/AAN-9131-2020	Triggs-Raine, Barbara/0000-0003-4719-6779; Chowdhury, Biswajit/0000-0003-0203-8072; Hombach-Klonisch, Sabine/0000-0001-8071-2486	Canadian Institutes of Health Research [MP-89873]; Manitoba Health Research Council; University of Manitoba	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; University of Manitoba	This work was supported in part by Canadian Institutes of Health Research Grant MP-89873.; Supported by a joint studentship from the Manitoba Health Research Council and the University of Manitoba.	ALLEN T. C., 1994, LAB METHODS HISTOTEC, P53; Andre B, 2011, BIOCHEM BIOPH RES CO, V411, P175, DOI 10.1016/j.bbrc.2011.06.125; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Atmuri V, 2008, MATRIX BIOL, V27, P653, DOI 10.1016/j.matbio.2008.07.006; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007/s10545-011-9359-8; Camenisch T D, 2001, Exp Clin Cardiol, V6, P4; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Chow G, 2006, OSTEOARTHR CARTILAGE, V14, P849, DOI 10.1016/j.joca.2006.02.009; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka TB, 1998, GENOMICS, V48, P63, DOI 10.1006/geno.1997.5158; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; GAFFNEY E, 1994, LAB METHODS HISTOTEC, P149; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Gupta V, 2009, CARDIOVASC PATHOL, V18, P191, DOI 10.1016/j.carpath.2008.05.001; Gushulak L, 2012, J BIOL CHEM, V287, P16689, DOI 10.1074/jbc.M112.350447; HASCALL VC, 1999, BIOL SYNOVIAL JOINT, P101; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hoffmeister A, 1999, EUR J HEART FAIL, V1, P293, DOI 10.1016/S1388-9842(99)00030-6; Jadin L, 2008, FASEB J, V22, P4316, DOI 10.1096/fj.08-111997; Jordan MC, 2005, MOL GENET METAB, V86, P233, DOI 10.1016/j.ymgme.2005.05.003; Kern CB, 2010, MATRIX BIOL, V29, P304, DOI 10.1016/j.matbio.2010.01.005; Lepperdinger G, 2001, MATRIX BIOL, V20, P509, DOI 10.1016/S0945-053X(01)00170-6; Martin DC, 2008, HUM MOL GENET, V17, P1904, DOI 10.1093/hmg/ddn088; Natowicz MR, 1996, NEW ENGL J MED, V335, P1029, DOI 10.1056/NEJM199610033351405; Plaas A H, 2001, Methods Mol Biol, V171, P117; Pohl M, 2000, DEV BIOL, V224, P312, DOI 10.1006/dbio.2000.9783; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Stephens EH, 2008, ACTA BIOMATER, V4, P1148, DOI 10.1016/j.actbio.2008.03.014; Stephens EH, 2011, CARDIOVASC PATHOL, V20, P334, DOI [10.1016/j.carpath.2010.10.002, 10.1016/j.carpath.2010.07.004]; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Strauch OF, 2003, PEDIATR RES, V54, P701, DOI 10.1203/01.PDR.0000084085.65972.3F; Triggs-Raine B, 1999, P NATL ACAD SCI USA, V96, P6296, DOI 10.1073/pnas.96.11.6296; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; Vyavahare N, 1999, J BIOMED MATER RES, V46, P44	37	41	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					520	528		10.1074/jbc.M112.393629	http://dx.doi.org/10.1074/jbc.M112.393629			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23172227	Green Published, hybrid			2022-12-25	WOS:000313197200052
J	Feng, YF; Wang, L; Li, X; Ma, ZS; Zhang, Y; Zhang, ZY; Lei, W				Feng, Ya-Fei; Wang, Lin; Li, Xiang; Ma, Zhen-Sheng; Zhang, Yang; Zhang, Zhi-Yong; Lei, Wei			Influence of Architecture of beta-Tricalcium Phosphate Scaffolds on Biological Performance in Repairing Segmental Bone Defects	PLOS ONE			English	Article							IN-VIVO; GRAFT SUBSTITUTES; MANDIBULAR RECONSTRUCTION; MORPHOGENETIC PROTEIN-2; INTERNAL STRUCTURE; VASCULARIZATION; ANGIOGENESIS; BIOMATERIALS; OSTEOGENESIS; CELLS	Background: Although three-dimensional (3D) beta-tricalcium phosphate (beta-TCP) scaffolds serve as promising bone graft substitutes for the segmental bone defect treatment, no consensus has been achieved regarding their optimal 3D architecture. Methods: In this study, we has systematically compared four types of beta-TCP bone graft substitutes with different 3D architectures, including two types of porous scaffolds, one type of tubular scaffolds and one type of solid scaffolds, for their efficacy in treating segmental bone defect in a rabbit model. Results: Our study has demonstrated that when compared to the traditional porous and solid scaffolds, tubular scaffolds promoted significantly higher amount of new bone formation in the defect regions as shown by X-ray, micro CT examinations and histological analysis, restored much greater mechanical properties of the damaged bone evidenced by the biomechanical testing, and eventually achieved the complete union of segmental defect. Moreover, the implantation of tubular scaffolds enhanced the neo-vascularization at the defect region with higher bone metabolic activities than others, as indicated by the bone scintigraphy assay. Conclusions: This study has further the current knowledge regarding the profound influence of overall 3D architecture of beta-TCP scaffolds on their in vivo defect healing performance and illuminated the promising potential use of tubular scaffolds as effective bone graft substitute in treating large segmental bone defects.	[Feng, Ya-Fei; Wang, Lin; Ma, Zhen-Sheng; Zhang, Yang; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China; [Li, Xiang] Shanghai Jiao Tong Univ, Sch Mech Engn, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China; [Zhang, Zhi-Yong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tissue Engn, Shanghai Peoples Hosp 9,Dept Plast & Reconstruct, Shanghai 200030, Peoples R China; [Zhang, Zhi-Yong] Natl Tissue Engn Ctr China, Shanghai, Peoples R China	Air Force Military Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lei, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China.	mr.zhiyong@gmail.com; leiwei@fmmu.edu.cn	zhang, zhiyong/G-3227-2010; Wang, Lin/J-8805-2018	zhang, zhiyong/0000-0001-7903-1544; Wang, Lin/0000-0001-5937-6318; Lei, Wei/0000-0002-7346-6915	National Natural Science Foundation of China [31170913/C1002, 81101353]; Xijing Zhutui Project [SJZT10Z09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xijing Zhutui Project	This work was supported by the Research Fund for the National Natural Science Foundation of China (No. 31170913/C1002) to Wei Lei and National Natural Science Foundation of China (No. 81101353) and Xijing Zhutui Project (SJZT10Z09) to Zhi-Yong Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148; Botchwey E, 2011, TISSUE EN B IN PRESS; Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44; Calori GM, 2011, INJURY, V42, pS56, DOI 10.1016/j.injury.2011.06.011; Cao L, 2012, J BIOMED MATER RES B, V100B, P1229, DOI 10.1002/jbm.b.32687; DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307; De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465; Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014; Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701; Gerard C, 2010, J BIOMED MATER RES A, V93A, P615, DOI 10.1002/jbm.a.32568; Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006; Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007; Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648; Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Henslee AM, 2011, ACTA BIOMATER, V7, P3627, DOI 10.1016/j.actbio.2011.06.043; Jamell GA, 1996, OPHTHALMIC PLAST REC, V12, P127, DOI 10.1097/00002341-199606000-00007; Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035; Kneser U, 2006, TISSUE ENG, V12, P1721, DOI 10.1089/ten.2006.12.1721; Kokemueller H, 2010, INT J ORAL MAX SURG, V39, P379, DOI 10.1016/j.ijom.2010.01.010; Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105; Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006; Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020; Lohfeld S, 2012, ACTA BIOMATERIALIA; Love C, 2003, RADIOGRAPHICS, V23, P341, DOI 10.1148/rg.232025103; Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819; Ogunsalu CO, 2008, W INDIAN MED J, V57, P166; PROLO DJ, 1985, CLIN ORTHOP RELAT R, P322; Roldan JC, 2010, J CRANIO MAXILL SURG, V38, P423, DOI 10.1016/j.jcms.2010.01.003; Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033; Schimming R, 2000, ORAL SURG ORAL MED O, V90, P679, DOI 10.1067/moe.2000.111026; Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462; Simon JL, 2003, J BIOMED MATER RES A, V66A, P275, DOI 10.1002/jbm.a.10569; Son JS, 2011, J BIOMED MATER RES A, V99A, P638, DOI 10.1002/jbm.a.33223; Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4; Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035; Wang L, 2010, BIOMATERIALS, V31, P9452, DOI 10.1016/j.biomaterials.2010.08.036; Wang L, 2009, J BIOMED MATER RES A, V91A, P102, DOI 10.1002/jbm.a.32189; Wang Min, 2009, Zhongguo Gu Shang, V22, P609; Yu HD, 2010, CHEM COMMUN, V46, P6578, DOI 10.1039/c0cc01348j; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047; Zhang ZY, 2012, BIOMATERIALS, V33, P2656, DOI 10.1016/j.biomaterials.2011.12.025; Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078; Zhang ZY, 2012, CELL TRANSPLANT; Zhong WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040833; Zhou J, 2010, BIOMATERIALS, V31, P1171, DOI 10.1016/j.biomaterials.2009.10.043; Zhou M, 2010, BIOMATERIALS, V31, P4935, DOI 10.1016/j.biomaterials.2010.02.072	52	24	26	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49955	10.1371/journal.pone.0049955	http://dx.doi.org/10.1371/journal.pone.0049955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185494	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000148
J	Li, XR; Lee, J; Parsons, D; Janaurajs, K; Standaert, DG				Li, Xinru; Lee, Jenny; Parsons, Dee; Janaurajs, Karen; Standaert, David G.			Evaluation of TorsinA as a Target for Parkinson Disease Therapy in Mouse Models	PLOS ONE			English	Article							DYSTONIA GENE DYT1; ALPHA-SYNUCLEIN; MICE; PROTEIN; EXPRESSION; MUTANT; MPTP	Parkinson disease (PD) is a common and disabling disorder. No current therapy can slow or reverse disease progression. An important aspect of research in this field is target validation, a systematic approach to evaluating the likelihood that modification of a certain molecule, mechanism or biological pathway may be useful for the development of pharmacological or molecular treatments for the disease. TorsinA, a member of the AAA+ family of chaperone proteins, has been proposed as a potential target of neuroprotective therapy. TorsinA is found in Lewy bodies in human PD, and can suppress toxicity in cellular and invertebrate models of PD. Here, we evaluated the neuroprotective properties of torsinA in mouse models of PD based on intoxication with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as well as recombinant adeno associated virus (rAAV) induced overexpression of alpha-synuclein (alpha-syn). Using either transgenic mice with overexpression of human torsinA (hWT mice) or mice in which torsinA expression was induced using an rAAV vector, we found no evidence for protection against acute MPTP intoxication. Similarly, genetic deletion of the endogenous mouse gene for torsinA (Dyt1) using an rAAV delivered Cre recombinase did not enhance the vulnerability of dopaminergic neurons to MPTP. Overexpression of alpha-syn using rAAV in the mouse substantia nigra lead to a loss of TH positive neurons six months after administration, and no difference in the degree of loss was observed between transgenic animals expressing forms of torsinA and wild type controls. Collectively, we did not observe evidence for a protective effect of torsinA in the mouse models we examined. Each of these models has limitations, and there is no single model with established predictive value with respect to the human disease. Nevertheless, these data do seem to support the view that torsinA is unlikely to be successfully translated as a target of therapy for human PD.	[Li, Xinru; Lee, Jenny; Parsons, Dee; Janaurajs, Karen; Standaert, David G.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Standaert, DG (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA.	dstandaert@uab.edu		Standaert, David/0000-0003-2921-8348	Michael J. Fox Foundation for Parkinson Research; United States Public Health Service grant [NS037409]; University of Alabama Neuroscience Blueprint Core Center [NS57098]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS037409, P50NS037409, P30NS057098] Funding Source: NIH RePORTER	Michael J. Fox Foundation for Parkinson Research; United States Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); University of Alabama Neuroscience Blueprint Core Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Target Validation 2009 award from the Michael J. Fox Foundation for Parkinson Research, United States Public Health Service grant NS037409, and the University of Alabama Neuroscience Blueprint Core Center (NS57098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augood SJ, 1998, ANN NEUROL, V43, P669, DOI 10.1002/ana.410430518; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI US; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Scammell TE, 2003, J NEUROSCI, V23, P5762; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Sharma N, 2001, AM J PATHOL, V159, P339, DOI 10.1016/S0002-9440(10)61700-2; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Standaert DG, 2011, NEUROBIOL DIS, V42, P148, DOI 10.1016/j.nbd.2011.01.012; Standaert DG, 2010, DIS MODEL MECH, V3, P259, DOI 10.1242/dmm.004192; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Ulusoy Ayse, 2010, Prog Brain Res, V184, P89, DOI 10.1016/S0079-6123(10)84005-1; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; YACOUBIAN TA, 2008, BIOCH BIOPHYS ACTA; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027	26	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50063	10.1371/journal.pone.0050063	http://dx.doi.org/10.1371/journal.pone.0050063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185535	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000176
J	Camacho, E; Sepulveda, VE; Goldman, WE; San-Blas, G; Nino-Vega, GA				Camacho, Emma; Sepulveda, Victoria E.; Goldman, William E.; San-Blas, Gioconda; Nino-Vega, Gustavo A.			Expression of Paracoccidioides brasiliensis AMY1 in a Histoplasma capsulatum amy1 Mutant, Relates an alpha-(1,4)-Amylase to Cell Wall alpha-(1,3)-Glucan Synthesis	PLOS ONE			English	Article							ALPHA-AMYLASE FAMILY; ANALYSIS REVEALS; MYCELIAL FORMS; GLUCAN; MORPHOGENESIS; GENE; YEAST; ENZYMES; ALPHA-1,3-GLUCAN; SPECTROSCOPY	In the cell walls of the pathogenic yeast phases of Paracoccidioides brasiliensis, Blastomyces dermatitidis and Histoplasma capsulatum, the outer alpha-(1,3)-glucan layer behaves as a virulence factor. In H. capsulatum, an alpha-(1,4)-amylase gene (AMY1) is essential for the synthesis of this polysaccharide, hence related to virulence. An orthologous gene to H. capsulatum AMY1 was identified in P. brasiliensis and also labeled AMY1. P. brasiliensis AMY1 transcriptional levels were increased during the yeast phase, which correlates with the presence of alpha-(1,3)-glucan as the major yeast cell wall polysaccharide. Complementation of a H. capsulatum amy1 mutant strain with P. brasiliensis AMY1, suggests that P. brasiliensis Amy1p may play a role in the synthesis of cell wall alpha-(1,3)-glucan. To study some biochemical properties of P. brasiliensis Amy1p, the enzyme was overexpressed, purified and studied its activity profile with starch and amylopeptin. It showed a relatively higher hydrolyzing activity on amylopeptin than starch, producing oligosaccharides from 4 to 5 glucose residues. Our findings show that P. brasiliensis Amy1p produces maltooligosaccharides which may act as a primer molecule for the fungal cell wall alpha-(1,3)-glucan biosynthesis by Ags1p.	[Camacho, Emma; San-Blas, Gioconda; Nino-Vega, Gustavo A.] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Caracas, Venezuela; [Sepulveda, Victoria E.; Goldman, William E.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Sepulveda, Victoria E.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA	Venezuelan Institute Science Research; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL)	Nino-Vega, GA (corresponding author), Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Caracas, Venezuela.	gnino@ivic.gob.ve	Niño-Vega, Gustavo A/M-5333-2018; Niño-Vega, Gustavo/AAI-2621-2019; Sepúlveda, Victoria/P-8609-2018; Camacho, Emma/AAE-5285-2019	Niño-Vega, Gustavo A/0000-0003-3760-5620; Niño-Vega, Gustavo/0000-0003-3760-5620; Sepúlveda, Victoria/0000-0003-2085-9667; Camacho, Emma/0000-0001-8591-8176; Goldman, William/0000-0002-1551-6718	International Centre for Genetic Engineering and Biotechnology, Trieste, Italy [ICGEB-VEN05]; Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela [112]; FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela	International Centre for Genetic Engineering and Biotechnology, Trieste, Italy; Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela; FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela	This work was partially supported by Project ICGEB-VEN05 of the International Centre for Genetic Engineering and Biotechnology, Trieste, Italy, and project 112 from Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela. EC was recipient of a Ph.D scholarship awarded by FONACIT (Fondo Nacional de Ciencia, Tecnologia e Innovacion) Caracas, Venezuela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adt I, 2006, ARCH MICROBIOL, V185, P277, DOI 10.1007/s00203-006-0094-8; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benoliel B, 2005, GENET MOL RES, V4, P450; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; CARBONELL LM, 1970, J BACTERIOL, V101, P636, DOI 10.1128/JB.101.2.636-642.1970; da Silva MDC, 2008, CARBOHYD RES, V343, P793, DOI 10.1016/j.carres.2007.12.021; Da Lage JL, 2004, CELL MOL LIFE SCI, V61, P97, DOI 10.1007/s00018-003-3334-y; Davies GJ, 1999, NAT STRUCT BIOL, V6, P406, DOI 10.1038/8200; EISSENBERG LG, 1988, J LEUKOCYTE BIOL, V43, P483, DOI 10.1002/jlb.43.6.483; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Francoise S, 2010, MED MYCOL, V48, P35, DOI 10.3109/13693780802713356; Garcia I, 2006, MOL MICROBIOL, V59, P836, DOI 10.1111/j.1365-2958.2005.04995.x; Grun CH, 2005, GLYCOBIOLOGY, V15, P245, DOI 10.1093/glycob/cwi002; Hochstenbach F, 1998, P NATL ACAD SCI USA, V95, P9161, DOI 10.1073/pnas.95.16.9161; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; Holbrook ED, 2011, J PROTEOME RES, V10, P1929, DOI 10.1021/pr1011697; Janecek S, 1997, PROG BIOPHYS MOL BIO, V67, P67, DOI 10.1016/S0079-6107(97)00015-1; KANETSUNA F, 1972, J BACTERIOL, V110, P208, DOI 10.1128/JB.110.1.208-218.1972; KANETSUNA F, 1974, MYCOPATH MYCOL APPL, V54, P1, DOI 10.1007/BF02055967; KANETSUNA F, 1969, J BACTERIOL, V97, P1036, DOI 10.1128/JB.97.3.1036-1041.1969; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kuriki T, 1999, J BIOSCI BIOENG, V87, P557, DOI 10.1016/S1389-1723(99)80114-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YL, 2004, APPL SPECTROSC, V58, P745, DOI 10.1366/000370204873006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Marion CL, 2006, MOL MICROBIOL, V62, P970, DOI 10.1111/j.1365-2958.2006.05436.x; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; Morita T, 2006, BIOSCI BIOTECH BIOCH, V70, P1454, DOI 10.1271/bbb.50693; Nino-Vega GA, 2000, MED MYCOL, V38, P31, DOI 10.1080/mmy.38.1.31.39; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; RANDEZGIL F, 1993, FEMS MICROBIOL LETT, V112, P119, DOI 10.1016/0378-1097(93)90547-F; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rappleye CA, 2007, P NATL ACAD SCI USA, V104, P1366, DOI 10.1073/pnas.0609848104; Reese AJ, 2003, MOL MICROBIOL, V50, P1401, DOI 10.1046/j.1365-2958.2003.03780.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; SANBLAS G, 1977, INFECT IMMUN, V15, P343, DOI 10.1128/IAI.15.2.343-346.1977; Sebghati TS, 2000, SCIENCE, V290, P1368, DOI 10.1126/science.290.5495.1368; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; Theodoro RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037694; Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s; van der Kaaij RA, 2007, EUKARYOT CELL, V6, P1178, DOI 10.1128/EC.00354-06; van der Kaaij RM, 2007, MICROBIOL-SGM, V153, P4003, DOI 10.1099/mic.0.2007/008607-0; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; Woods JP, 1998, INFECT IMMUN, V66, P1697, DOI 10.1128/IAI.66.4.1697-1707.1998; WORSHAM PL, 1988, J MED VET MYCOL, V26, P137; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7; Zekovic DB, 2005, CRIT REV BIOTECHNOL, V25, P205, DOI 10.1080/07388550500376166	55	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50201	10.1371/journal.pone.0050201	http://dx.doi.org/10.1371/journal.pone.0050201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185578	Green Submitted, Green Published, gold			2022-12-25	WOS:000311535700078
J	Chander, BS; Chakravarthy, VS				Chander, Bankim Subhash; Chakravarthy, V. Srinivasa			A Computational Model of Neuro-Glio-Vascular Loop Interactions	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SYNAPTIC ACTIVITY; BLOOD-VOLUME; ASTROCYTES; BRAIN; CALCIUM; STIMULATION; ACTIVATION; DEPRESSION; VASOMOTION	We present a computational, biophysical model of neuron-astrocyte-vessel interaction. Unlike other cells, neurons convey "hunger'' signals to the vascular network via an intervening layer of glial cells (astrocytes); vessels dilate and release glucose which fuels neuronal firing. Existing computational models focus on only parts of this loop (neuron -> astrocyte -> vessel -> neuron), whereas the proposed model describes the entire loop. Neuronal firing causes release of a neurotransmitter like glutamate which triggers release of vasodilator by astrocytes via a cascade of biochemical events. Vasodilators released from astrocytic endfeet cause blood vessels to dilate and release glucose into the interstitium, part of which is taken up by the astrocyticendfeet. Glucose is converted into lactate in the astrocyte and transported into the neuron. Glucose from the interstitium and lactate (produced from glucose) influx from astrocyte are converted into ATP in the neuron. Neuronal ATP is used to drive the Na+/K+ ATPase pumps, which maintain ionic gradients necessary for neuronal firing. When placed in the metabolic loop, the neuron exhibits sustained firing only when the stimulation current is more than a minimum threshold. For various combinations of initial neuronal [ATP] and external current, the neuron exhibits a variety of firing patterns including sustained firing, firing after an initial pause, burst firing etc. Neurovascular interactions under conditions of constricted vessels are also studied. Most models of cerebral circulation describe neurovascular interactions exclusively in the "forward'' neuron -> vessel direction. The proposed model indicates possibility of "reverse'' influence also, with vasomotion rhythms influencing neural firing patterns. Another idea that emerges out of the proposed work is that brain's computations may be more comprehensively understood in terms of neuro-glial-vascular dynamics and not in terms of neural firing alone.	[Chander, Bankim Subhash; Chakravarthy, V. Srinivasa] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Chakravarthy, VS (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	schakra@iitm.ac.in	Chander, Bankim/AGW-9807-2022	Chakravarthy, Srinivasa/0000-0002-2453-1637; Subhash Chander, Bankim/0000-0002-3206-8822	Department of Science and Technology, India	Department of Science and Technology, India(Department of Science & Technology (India))	Funding was in part by the Department of Science and Technology, India. http://www.dst.gov.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bennett MR, 2008, J THEOR BIOL, V250, P172, DOI 10.1016/j.jtbi.2007.08.024; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; Boumezbeur F, 2005, J CEREBR BLOOD F MET, V25, P1418, DOI 10.1038/sj.jcbfm.9600145; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CONNOR JA, 1977, BIOPHYS J, V18, P81, DOI 10.1016/S0006-3495(77)85598-7; Di Garbo A, 2007, BIOSYSTEMS, V89, P74, DOI 10.1016/j.biosystems.2006.05.013; Dick GM, 2010, EXP BIOL MED, V235, P10, DOI 10.1258/ebm.2009.009201; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Fink CC, 1999, BIOPHYS J, V77, P617, DOI 10.1016/S0006-3495(99)76918-3; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; Gandrakota R, 2010, NEURAL COMPUT, V22, P949, DOI 10.1162/neco.2009.01-09-945; Gibson WG, 2007, NEUROCOMPUTING, V70, P1674, DOI 10.1016/j.neucom.2006.10.071; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Izhikevich EM, 2001, NEURAL NETWORKS, V14, P883, DOI 10.1016/S0893-6080(01)00078-8; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Lavrentovich M, 2008, J THEOR BIOL, V251, P553, DOI 10.1016/j.jtbi.2007.12.011; Lee CCJ, 2009, J COMPUT NEUROSCI, V26, P459, DOI 10.1007/s10827-008-0122-6; Lemon G, 2003, J THEOR BIOL, V223, P93, DOI 10.1016/S0022-5193(03)00079-1; Li PL, 1997, CIRC RES, V80, P877; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Nadkarni S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.268101; Nadkarni S, 2004, PHYS BIOL, V1, P35, DOI 10.1088/1478-3967/1/1/004; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Postnov DE, 2007, BIOSYSTEMS, V89, P84, DOI 10.1016/j.biosystems.2006.04.012; Pradhan RK, 2007, MICROVASC RES, V74, P51, DOI 10.1016/j.mvr.2007.02.004; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Secomb TW, 2002, MICROCIRCULATION, V9, P377, DOI 10.1038/sj.mn.7800146; TERPOGOSSIAN MM, 1975, RADIOLOGY, V114, P89, DOI 10.1148/114.1.89	33	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48802	10.1371/journal.pone.0048802	http://dx.doi.org/10.1371/journal.pone.0048802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185276	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700016
J	Fajs, L; Durmisi, E; Knap, N; Strle, F; Avsic-Zupanc, T				Fajs, Luka; Durmisi, Emina; Knap, Natasa; Strle, Franc; Avsic-Zupanc, Tatjana			Phylogeographic Characterization of Tick-Borne Encephalitis Virus from Patients, Rodents and Ticks in Slovenia	PLOS ONE			English	Article							MOSAIC STRUCTURE; RECOMBINATION; SEQUENCES; TBE	Tick-borne encephalitis virus (TBEV) is the most important arboviral agent causing infections of the central nervous system in central Europe. Previous studies have shown that TBEV exhibits pronounced genetic variability, which is often correlated to the geographical origin of TBEV. Genetic variability of TBEV has previously been studied predominantly in rodents and ticks, while information about the variability in patients is scarce. In order to understand the molecular relationships of TBEV between natural hosts, vectors and humans, as well as correlation between phylogenetic and geographical clustering, sequences of TBEV E and NS5 protein genes, were obtained by direct sequencing of RT-PCR products from TBE-confirmed patients as well as from rodents and ticks collected from TBE-endemic regions in Slovenia. A total of 27 partial E protein gene sequences representing 15 human, 4 rodent and 8 tick samples and 30 partial NS5 protein gene sequences representing 17 human, 5 rodent and 8 tick samples were obtained. The complete genome sequence of TBEV strain Ljubljana I was simultaneously obtained. Phylogenetic analysis of the E and NS5 protein gene sequences revealed a high degree of TBEV variability in patients, ticks and rodents. Furthermore, an evident correlation between geographical and phylogenetic clustering was shown that was independent of the TBEV host. Moreover, we show the presence of a possible recombination event in the TBEV genome obtained from a patient sample, which was supported with multiple recombination event detection methods. This is the first study that simultaneously analyzed the genetic relationships of directly sequenced TBEV samples from patients, ticks and rodents and provides the largest set of patient-derived TBEV sequences up to date. In addition, we have confirmed the geographical clustering of TBEV sequences in Slovenia and have provided evidence of a possible recombination event in the TBEV genome, obtained from a patient.	[Fajs, Luka; Durmisi, Emina; Knap, Natasa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia	University of Ljubljana; University Medical Centre Ljubljana	Avsic-Zupanc, T (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	tatjana.avsic@mf.uni-lj.si		Knap, Natasa/0000-0002-8068-7302; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688	European Commission (European Virus Archive, FP7 CAPACITIES project) [228292]; EU grant [GOCE-2003-010284 EDEN]	European Commission (European Virus Archive, FP7 CAPACITIES project); EU grant(European Commission)	This study was partially funded by European Commission (European Virus Archive, FP7 CAPACITIES project, GA no. 228292 and EU grant GOCE-2003-010284 EDEN). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVSICZUPANC T, 1995, CLIN DIAGN VIROL, V4, P51, DOI 10.1016/0928-0197(94)00062-Y; Bakhvalova VN, 2000, VIRUS RES, V70, P1, DOI 10.1016/S0168-1702(00)00174-X; BLASKOVIC D, 1972, PROG MED VIROL, V14, P275; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durmisi E, 2011, VECTOR-BORNE ZOONOT, V11, P659, DOI 10.1089/vbz.2010.0054; Gaumann R, 2011, J MED VIROL, V83, P853, DOI 10.1002/jmv.21993; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Golovljova I, 2004, J MED VIROL, V74, P580, DOI 10.1002/jmv.20224; Haglund M, 2003, J MED VIROL, V71, P610, DOI 10.1002/jmv.10497; Han XQ, 2005, J MED VIROL, V77, P249, DOI 10.1002/jmv.20444; Hudson PJ, 2001, MED VET ENTOMOL, V15, P304, DOI 10.1046/j.0269-283x.2001.00317.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Knap N, 2012, VECTOR-BORNE ZOONOT, V12, P236, DOI 10.1089/vbz.2011.0728; Kollaritsch H, 2011, VACCINE, V29, P4556, DOI 10.1016/j.vaccine.2011.04.061; Kupca AM, 2010, TICKS TICK-BORNE DIS, V1, P44, DOI 10.1016/j.ttbdis.2009.11.002; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; SMITH JM, 1992, J MOL EVOL, V34, P126; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Suss J, 2002, INT J MED MICROBIOL, V291, P34; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uzcategui NY, 2012, J GEN VIROL, V93, P786, DOI 10.1099/vir.0.035766-0; Weidmann M, 2011, J GEN VIROL, V92, P1906, DOI 10.1099/vir.0.032417-0; Weidmann M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-81; Yun SM, 2011, VIRUS GENES, V42, P307, DOI 10.1007/s11262-011-0575-y	32	25	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48420	10.1371/journal.pone.0048420	http://dx.doi.org/10.1371/journal.pone.0048420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185257	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700011
J	Niederlechner, S; Klawitter, J; Baird, C; Kallweit, AR; Christians, U; Wischmeyer, PE				Niederlechner, Stefanie; Klawitter, Jelena; Baird, Christine; Kallweit, Alyssa R.; Christians, Uwe; Wischmeyer, Paul E.			Fibronectin-Integrin Signaling Is Required for L-Glutamine's Protection against Gut Injury	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN-70 EXPRESSION; BACTERIAL TRANSLOCATION; EPITHELIAL-CELLS; APOPTOSIS; ACTIVATION; STRESS; INVOLVEMENT; INCREASES; KINASE; MATRIX	Background: Extracellular matrix (ECM) stabilization and fibronectin (FN)-Integrin signaling can mediate cellular protection. L-glutamine (GLN) is known to prevent apoptosis after injury. However, it is currently unknown if ECM stabilization and FN-Integrin osmosensing pathways are related to GLN's cell protective mechanism in the intestine. Methods: IEC-6 cells were treated with GLN with or without FN siRNA, integrin inhibitor GRGDSP, control peptide GRGESP or ERK1/2 inhibitors PD98059 and UO126 under basal and stressed conditions. Cell survival measured via MTS assay. Phosphorylated and/or total levels of cleaved caspase-3, cleaved PARP, Bax, Bcl-2, heat shock proteins (HSPs), ERK1/2 and transcription factor HSF-1 assessed via Western blotting. Cell size and F-actin morphology quantified by confocal fluorescence microscopy and intracellular GLN concentration by LC-MS/MS. Results: GLN's prevention of FN degradation after hyperthermia attenuated apoptosis. Additionally, inhibition of FN-Integrin interaction by GRGDSP and ERK1/2 kinase inhibition by PD98059 inhibited GLN's protective effect. GRGDSP attenuated GLN-mediated increases in ERK1/2 phosphorylation and HSF-1 levels. PD98059 and GRGDSP also decreased HSP levels after GLN treatment. Finally, GRGDSP attenuated GLN-mediated increases in cell area size and disrupted F-actin assembly, but had no effect on intracellular GLN concentrations. Conclusion: Taken together, this data suggests that prevention of FN degradation and the FN-Integrin signaling play a key role in GLN-mediated cellular protection. GLN's signaling via the FN-Integrin pathway is associated with HSP induction via ERK1/2 and HSF-1 activation leading to reduced apoptosis after gut injury.	[Niederlechner, Stefanie; Klawitter, Jelena; Baird, Christine; Kallweit, Alyssa R.; Christians, Uwe; Wischmeyer, Paul E.] Univ Colorado, Dept Anesthesiol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Niederlechner, S (corresponding author), Univ Colorado, Dept Anesthesiol, Aurora, CO USA.	Stefanie.Niederlechner@ucdenver.edu	Klawitter, Jost/F-3976-2015	Klawitter, Jost/0000-0002-6413-4820	National Institutes of Health, National Institute of General Medical Science [R01-GM-078312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078312] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, National Institute of General Medical Science grant R01-GM-078312 (to P.E. Wischmeyer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; GIANOTTI L, 1995, JPEN-PARENTER ENTER, V19, P69, DOI 10.1177/014860719501900169; Goke M, 1996, AM J PHYSIOL-GASTR L, V271, pG729, DOI 10.1152/ajpgi.1996.271.5.G729; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Hamiel CR, 2009, AM J PHYSIOL-CELL PH, V297, pC1509, DOI 10.1152/ajpcell.00240.2009; Han SW, 2006, ONCOGENE, V25, P4341, DOI 10.1038/sj.onc.1209460; HAUSSINGER D, 1992, TRENDS PHARMACOL SCI, V13, P371, DOI 10.1016/0165-6147(92)90114-L; Haussinger D, 2001, J NUTR, V131, p2509S, DOI 10.1093/jn/131.9.2509S; Haussinger Dieter, 2004, Molecular Aspects of Medicine, V25, P221, DOI 10.1016/j.mam.2004.02.001; HUANG LE, 1995, BIOCHEM J, V307, P347, DOI 10.1042/bj3070347; Hung JJ, 1998, J BIOL CHEM, V273, P31924, DOI 10.1074/jbc.273.48.31924; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Keller JM, 2008, COMP BIOCHEM PHYS A, V150, P307, DOI 10.1016/j.cbpa.2008.03.021; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; KLIMBERG VS, 1990, ARCH SURG-CHICAGO, V125, P1040, DOI 10.1001/archsurg.1990.01410200104017; Kolachala VL, 2007, J BIOL CHEM, V282, P32965, DOI 10.1074/jbc.M704388200; Lambert GP, 2002, J APPL PHYSIOL, V92, P1750, DOI 10.1152/japplphysiol.00787.2001; Larson SD, 2007, AM J PHYSIOL-GASTR L, V293, pG1262, DOI 10.1152/ajpgi.00254.2007; Lavoinne A, 1998, BIOCHIMIE, V80, P807, DOI 10.1016/S0300-9084(00)88875-6; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Morrison AL, 2006, AM J PHYSIOL-CELL PH, V290, pC1625, DOI 10.1152/ajpcell.00635.2005; Oehler R, 2004, METABOLIC THERAPEUTI, P169; Oudemans-van Straaten HM, 2001, INTENS CARE MED, V27, P84, DOI 10.1007/s001340000703; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Prosser C, 2004, J APPL PHYSIOL, V96, P650, DOI 10.1152/japplphysiol.00295.2003; QUARONI A, 1978, P NATL ACAD SCI USA, V75, P5548, DOI 10.1073/pnas.75.11.5548; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Saleem S, 2009, J PATHOL, V219, P182, DOI 10.1002/path.2577; Schliess F, 1999, FASEB J, V13, P1557, DOI 10.1096/fasebj.13.12.1557; Schliess F, 2007, FEBS J, V274, P5799, DOI 10.1111/j.1742-4658.2007.06100.x; Sen S, 2011, ANN BIOMED ENG, V39, P1163, DOI 10.1007/s10439-010-0195-z; SOUBA WW, 1991, ANNU REV NUTR, V11, P285, DOI 10.1146/annurev.nu.11.070191.001441; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Uehara K, 2005, CRIT CARE MED, V33, P381, DOI 10.1097/01.CCM.0000153407.14237.7F; Valenick LV, 2005, EXP CELL RES, V309, P48, DOI 10.1016/j.yexcr.2005.05.024; vom Dahl S, 2003, J BIOL CHEM, V278, P27088, DOI 10.1074/jbc.M210699200; WISCHMEYER P, 1993, MAYO CLIN PROC, V68, P978, DOI 10.1016/S0025-6196(12)62270-8; Wischmeyer PE, 1997, AM J PHYSIOL-GASTR L, V272, pG879, DOI 10.1152/ajpgi.1997.272.4.G879; Wischmeyer PE, 2002, NUTRITION, V18, P225, DOI 10.1016/S0899-9007(01)00796-1; Wischmeyer PE, 2001, CRIT CARE MED, V29, P2075, DOI 10.1097/00003246-200111000-00006; Yee KL, 2008, IET SYST BIOL, V2, P8, DOI 10.1049/iet-syb:20060058; Yu J, 2010, INT J HYPERTHER, V26, P538, DOI 10.3109/02656736.2010.481276; ZAPATASIRVENT RL, 1994, CRIT CARE MED, V22, P690, DOI 10.1097/00003246-199404000-00027; Ziegler T R, 2000, Curr Opin Clin Nutr Metab Care, V3, P355, DOI 10.1097/00075197-200009000-00005	50	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50185	10.1371/journal.pone.0050185	http://dx.doi.org/10.1371/journal.pone.0050185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185570	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700077
J	Zampell, JC; Yan, A; Elhadad, S; Avraham, T; Weitman, E; Mehrara, BJ				Zampell, Jamie C.; Yan, Alan; Elhadad, Sonia; Avraham, Tomer; Weitman, Evan; Mehrara, Babak J.			CD4+Cells Regulate Fibrosis and Lymphangiogenesis in Response to Lymphatic Fluid Stasis	PLOS ONE			English	Article							FILARIAL LYMPHEDEMA; PERIPHERAL LYMPH; IMMUNE PROTEINS; BREAST-CANCER; WOUND REPAIR; REGENERATION; INSUFFICIENCY; EXPRESSION; SKIN	Introduction: Lymphedema is a chronic disorder that occurs commonly after lymph node removal for cancer treatment and is characterized by swelling, fibrosis, inflammation, and adipose deposition. Although previous histological studies have investigated inflammatory changes that occur in lymphedema, the precise cellular make up of the inflammatory infiltrate remains unknown. It is also unclear if this inflammatory response plays a causal role in the pathology of lymphedema. The purpose of this study was therefore to characterize the inflammatory response to lymphatic stasis and determine if these responses are necessary for the pathological changes that occur in lymphedema. Methods: We used mouse-tail lymphedema and axillary lymph node dissection (ANLD) models in order to study tissue inflammatory changes. Single cell suspensions were created and analyzed using multi-color flow cytometry to identify individual cell types. We utilized antibody depletion techniques to analyze the causal role of CD4+, CD8+, and CD25+ cells in the regulation of inflammation, fibrosis, adipose deposition, and lymphangiogenesis. Results: Lymphedema in the mouse-tail resulted in a mixed inflammatory cell response with significant increases in T-helper, T-regulatory, neutrophils, macrophages, and dendritic cell populations. Interestingly, we found that ALND resulted in significant increases in T-helper cells suggesting that these adaptive immune responses precede changes in macrophage and dendritic cell infiltration. In support of this we found that depletion of CD4+, but not CD8 or CD25+ cells, significantly decreased tail lymphedema, inflammation, fibrosis, and adipose deposition. In addition, depletion of CD4+ cells significantly increased lymphangiogenesis both in our tail model and also in an inflammatory lymphangiogenesis model. Conclusions: Lymphedema and lymphatic stasis result in CD4+ cell inflammation and infiltration of mature T-helper cells. Loss of CD4+ but not CD8+ or CD25+ cell inflammation markedly decreases the pathological changes associated with lymphedema. In addition, CD4+ cells regulate lymphangiogenesis during wound repair and inflammatory lymphangiogenesis.	[Zampell, Jamie C.; Yan, Alan; Elhadad, Sonia; Avraham, Tomer; Weitman, Evan; Mehrara, Babak J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Mehrara, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA.	mehrarab@mskcc.org	Elhadad, Sonia/GRF-6466-2022	Elhadad, Sonia/0000-0002-0139-6487	Plastic Surgery Education Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111130] Funding Source: NIH RePORTER	Plastic Surgery Education Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a Plastic Surgery Education Foundation Research Fellowship: "Mechanisms regulating fibrosis in chronic lymphedema" (Award: $50,000; PI: Jamie Zampell; 100% Effort; Mentor: Babak J. Mehrara, M. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Avraham T, 2010, AM J PHYSIOL-CELL PH, V299, pC589, DOI 10.1152/ajpcell.00535.2009; Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Cormier JN, 2010, CANCER-AM CANCER SOC, V116, P5138, DOI 10.1002/cncr.25458; GALKOWSKA H, 1986, LYMPHOLOGY, V19, P139; Hayes SC, 2008, J CLIN ONCOL, V26, P3536, DOI 10.1200/JCO.2007.14.4899; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kim KE, 2009, AM J PATHOL, V175, P1733, DOI 10.2353/ajpath.2009.090133; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Mehrara BJ, 2010, FASEB J, V24, P4877, DOI 10.1096/fj.10-155762; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008380; Olszewski Waldemar L, 2003, Lymphat Res Biol, V1, P235, DOI 10.1089/153968503768330265; OLSZEWSKI WL, 1993, TROP MED PARASITOL, V44, P40; OLSZEWSKI WL, 1978, LYMPHOLOGY, V11, P174; OLSZEWSKI WL, 1990, LYMPHOLOGY, V23, P23; OLSZEWSKI WL, 1992, LYMPHOLOGY, V25, P166; Petrek JA, 1998, CANCER-AM CANCER SOC, V83, P2776, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2776::AID-CNCR25>3.0.CO;2-V; Rockson SG, 2008, ANN NY ACAD SCI, V1131, P147, DOI 10.1196/annals.1413.014; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; STARK RB, 1965, AM J SURG, V110, P394, DOI 10.1016/0002-9610(65)90078-4; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Winer S, 2012, IMMUNOL CELL BIOL; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010; Zampell JC, 2011, FASEB J	30	118	126	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49940	10.1371/journal.pone.0049940	http://dx.doi.org/10.1371/journal.pone.0049940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185491	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700057
J	Doroudchi, M; Yegorov, O; Baumgartner, T; Kernaleguen, AE; Breton, G; Ndongala, ML; Boulassel, MR; Routy, JP; Bernard, NF; Sekaly, RP; Yassine-Diab, B				Doroudchi, Mehrnoosh; Yegorov, Oleg; Baumgartner, Tom; Kernaleguen, Anne-Elen; Breton, Gaelle; Ndongala, Michel L.; Boulassel, Mohamed-Rachid; Routy, Jean-Pierre; Bernard, Nicole F.; Sekaly, Rafick-Pierre; Yassine-Diab, Bader			Autologous HIV-1 Clade-B Nef Peptides Elicit Increased Frequency, Breadth and Function of CD8(+) T-Cells Compared to Consensus Peptides	PLOS ONE			English	Article							HLA-B; CROSS-REACTIVITY; IMMUNE SELECTION; VACCINE DESIGN; RESPONSES; INFECTION; EPITOPE; IMMUNODOMINANCE; LYMPHOCYTES; DIVERSITY	Objective: To determine the function and phenotype of CD8(+) T-cells targeting consensus and autologous sequences of entire HIV-1 Nef protein. Methods: Multiparameter flow cytometry-based analysis was used to evaluate the responses of two treatment naive HIV-infected individuals, during primary and the chronic phases of infection. Results: A greater breadth and magnitude of CD8 IFN-gamma responses to autologous compared to clade-B consensus peptides was observed in both subjects. Cross recognition between autologous and consensus peptides decreased in both subjects during progression from primary to chronic infection. The frequencies of TEMRA and TEM CD8(+) T-cells targeting autologous peptides were higher than those targeting consensus peptides and were more polyfunctional (IFN-gamma(+) Gr-B+ CD107a(+)). Conclusions: Our data indicate superior sensitivity and specificity of autologous peptides. The functional and maturational aspects of "real'' versus "cross-recognized'' responses were also found to differ, highlighting the importance of a sequence-specific approach towards understanding HIV immune response.	[Doroudchi, Mehrnoosh; Yegorov, Oleg; Baumgartner, Tom; Kernaleguen, Anne-Elen; Breton, Gaelle; Sekaly, Rafick-Pierre; Yassine-Diab, Bader] Ctr Rech Ctr Hosp Univ Montreal CR CHUM St Luc, Immunol Lab, Montreal, PQ, Canada; [Doroudchi, Mehrnoosh; Yegorov, Oleg; Baumgartner, Tom; Kernaleguen, Anne-Elen; Breton, Gaelle; Sekaly, Rafick-Pierre; Yassine-Diab, Bader] Univ Montreal, Dept Microbiol & Immunol, Immunol Lab, Montreal, PQ H3C 3J7, Canada; [Doroudchi, Mehrnoosh; Yegorov, Oleg; Baumgartner, Tom; Kernaleguen, Anne-Elen; Breton, Gaelle; Sekaly, Rafick-Pierre; Yassine-Diab, Bader] Univ Montreal, INSERM, U743, CR CHUM, Montreal, PQ, Canada; [Doroudchi, Mehrnoosh] Shiraz Univ Med Sci, Sch Med, Dept Immunol, Shiraz, Iran; [Yegorov, Oleg; Sekaly, Rafick-Pierre] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Ndongala, Michel L.; Bernard, Nicole F.] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Boulassel, Mohamed-Rachid; Routy, Jean-Pierre] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Immunodeficiency Serv, Montreal, PQ H3A 1A1, Canada; [Boulassel, Mohamed-Rachid; Routy, Jean-Pierre] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Div Hematol, Montreal, PQ H3A 1A1, Canada; [Yassine-Diab, Bader] Caprion ImmuneCarta Serv, Montreal, PQ, Canada	Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Shiraz University of Medical Science; Vaccine & Gene Therapy Institute of Florida; McGill University; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital	Yassine-Diab, B (corresponding author), Ctr Rech Ctr Hosp Univ Montreal CR CHUM St Luc, Immunol Lab, Montreal, PQ, Canada.	bader.yassine-diab@umontreal.ca	Doroudchi, Mehrnoosh/C-2123-2011	Doroudchi, Mehrnoosh/0000-0003-4067-5400	National Institutes of Health (NIH) [2 R01 AI043261]; Canadian Institutes of Health Research (CIHR) [HGC-14975]; Reseau Fonds de la Recherche en Sante-Syndrome Immuno-Deficitaire Acquis (FRSQ-SIDA) Reseau Sida/Quebec Aids Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043261] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau Fonds de la Recherche en Sante-Syndrome Immuno-Deficitaire Acquis (FRSQ-SIDA) Reseau Sida/Quebec Aids Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by National Institutes of Health (NIH) # 2 R01 AI043261 - Effect of viral escape on memory T-cell maturation (http://grants.nih.gov/grants/guide/index.html), Canadian Institutes of Health Research (CIHR) # HGC-14975 - Transmission of HIV and pathogenesis of primary HIV infection (http://www.cihr-irsc.gc.ca/e/193.html), and the Reseau Fonds de la Recherche en Sante-Syndrome Immuno-Deficitaire Acquis (FRSQ-SIDA) Reseau Sida/Quebec Aids Network (http://www.frsq.gouv.qc.ca/en/financement/regles_generales/regles_gen.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2001, P NATL ACAD SCI USA, V98, P1781, DOI 10.1073/pnas.98.4.1781; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Almeida CAM, 2011, J IMMUNOL, V187, P2502, DOI 10.4049/jimmunol.1100691; Almeida CAM, 2010, VACCINE, V28, P6052, DOI 10.1016/j.vaccine.2010.06.091; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Auphan-Anezin N, 2006, EUR J IMMUNOL, V36, P1856, DOI 10.1002/eji.200635895; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Bernardin F, 2003, AIDS RES HUM RETROV, V19, P1009, DOI 10.1089/088922203322588369; Bihl F, 2006, J IMMUNOL, V176, P4094, DOI 10.4049/jimmunol.176.7.4094; Boris Schmid V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003525; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Campbell TD, 2008, ETHNIC DIS, V18; Cellerai C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018164; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Culshaw A, 2011, JAIDS-J ACQ IMM DEF, DOI [10.1097/QAI.1090b1013e318248780c, DOI 10.1097/QAI.1090B1013E318248780C]; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; DOMINGO E, 1993, J GEN VIROL, V74, P2039, DOI 10.1099/0022-1317-74-10-2039; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Ganusov VV, 2011, J VIROL, V85, P10518, DOI 10.1128/JVI.00655-11; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Guimezanes A, 2003, EUR J IMMUNOL, V33, P3060, DOI 10.1002/eji.200324249; Haas G, 1996, J IMMUNOL, V157, P4212; Janbazian L, 2012, J IMMUNOL, V188, P1156, DOI 10.4049/jimmunol.1102610; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kloverpris HN, 2012, J VIROL, V86, P919, DOI 10.1128/JVI.06150-11; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Lazaro E, 2011, J CLIN INVEST, V121, P2480, DOI 10.1172/JCI44932; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lee SK, 2002, J CLIN INVEST, V110, P1339, DOI 10.1172/JCI0216028; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lichterfeld M, 2005, TRENDS IMMUNOL, V26, P166, DOI 10.1016/j.it.2005.01.003; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Ndongala ML, 2009, CLIN IMMUNOL, V131, P277, DOI 10.1016/j.clim.2008.11.006; Novitsky V, 2002, J VIROL, V76, P5435, DOI 10.1128/JVI.76.11.5435-5451.2002; Rolland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017969; Schaubert KL, 2007, J IMMUNOL, V178, P7756, DOI 10.4049/jimmunol.178.12.7756; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Tilton JC, 2007, J VIROL, V81, P2713, DOI 10.1128/JVI.01830-06; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; van Bockel DJ, 2011, J IMMUNOL, V186, P359, DOI 10.4049/jimmunol.1001807; Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Yusim K, 2009, 0905941 LAUR	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49562	10.1371/journal.pone.0049562	http://dx.doi.org/10.1371/journal.pone.0049562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185362	gold, Green Published, Green Submitted			2022-12-25	WOS:000311333800033
J	Klaff, LS; Gill, SE; Wisse, BE; Mittelsteadt, K; Matute-Bello, G; Chen, P; Altemeier, WA				Klaff, Lindy S.; Gill, Sean E.; Wisse, Brent E.; Mittelsteadt, Kristen; Matute-Bello, Gustavo; Chen, Peter; Altemeier, William A.			Lipopolysaccharide-Induced Lung Injury Is Independent of Serum Vitamin D Concentration	PLOS ONE			English	Article							D DEFICIENCY; 1,25-DIHYDROXYVITAMIN D-3; RESPIRATORY-INFECTION; NUTRITIONAL RICKETS; D-RECEPTOR; CELLS; RISK; TUBERCULOSIS; ASSOCIATION; PREVALENCE	Vitamin D deficiency is increasing in incidence around the world. Vitamin D, a fat-soluble vitamin, has documented effects on the innate and adaptive immune system, including macrophage and T regulatory (Treg) cell function. Since Treg cells are important in acute lung injury resolution, we hypothesized that vitamin D deficiency increases the severity of injury and delays injury resolution in lipopolysaccharide (LPS) induced acute lung injury. Vitamin D deficient mice were generated, using C57BL/6 mice, through diet modification and limited exposure to ultraviolet light. At 8 weeks of age, vitamin D deficient and sufficient mice received 2.5 g/kg of LPS or saline intratracheal. At 1 day, 3 days and 10 days, mice were anesthetized and lung elastance measured. Mice were euthanized and bronchoalveolar lavage fluid, lungs and serum were collected. Ex vivo neutrophil chemotaxis was evaluated, using neutrophils from vitamin D sufficient and deficient mice exposed to the chemoattractants, KC/CXCL1 and C5a, and to bronchoalveolar lavage fluid from LPS-exposed mice. We found no difference in the degree of lung injury. Leukocytes were mildly decreased in the bronchoalveolar fluid of vitamin D deficient mice at 1 day. Ex-vivo, neutrophils from vitamin D deficient mice showed impaired chemotaxis to KC but not to C5a. Vitamin D deficiency modestly impairs neutrophil chemotaxis; however, it does not affect lung injury or its resolution in an LPS model of acute lung injury.	[Klaff, Lindy S.; Gill, Sean E.; Mittelsteadt, Kristen; Matute-Bello, Gustavo; Chen, Peter; Altemeier, William A.] Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA 98195 USA; [Wisse, Brent E.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Altemeier, WA (corresponding author), Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA 98195 USA.	billa@u.washington.edu	Gill, Sean E/G-4057-2012	Chen, Peter/0000-0002-5330-1718; Altemeier, William/0000-0001-8860-405X	National Heart, Lung and Blood Institute [HL104996, HL086883, HL103868]; Parker B. Francis Fellowship; Glen Hyatt Estate Fund for IPF Research; National Institute of Diabetes and Digestive and Kidney Diseases [DK089507]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086883, K08HL084396, F32HL104996, R01HL103868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507, R01DK074758] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Parker B. Francis Fellowship; Glen Hyatt Estate Fund for IPF Research; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the following funding sources: 1) National Heart, Lung and Blood Institute, grant numbers HL104996, HL086883, and HL103868 (http://www.nhlbi.nih.gov/); 2) A Parker B. Francis Fellowship (http://www.francisfellowships.org/); 3) Glen Hyatt Estate Fund for IPF Research (no url available); 4) National Institute of Diabetes and Digestive and Kidney Diseases, grant number DK089507 (http:??www.niddk.nih.gov/). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Baeke F, 2011, J IMMUNOL, V186, P132, DOI 10.4049/jimmunol.1000695; Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Carpenter KJ, 1999, J NUTR, V129, P923, DOI 10.1093/jn/129.5.923; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hess AF, 1922, AM J PUBLIC HEALTH, V12, P104, DOI 10.2105/AJPH.12.2.104; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Kemmis CM, 2006, J NUTR, V136, P887, DOI 10.1093/jn/136.4.887; Kuo YT, 2010, J FOOD SCI, V75, pH200, DOI 10.1111/j.1750-3841.2010.01704.x; Leow L, 2011, RESPIROLOGY, V16, P611, DOI 10.1111/j.1440-1843.2011.01924.x; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; LORENTE F, 1976, ACTA PAEDIATR SCAND, V65, P695, DOI 10.1111/j.1651-2227.1976.tb04956.x; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; McNally JD, 2009, PEDIATR PULM, V44, P981, DOI 10.1002/ppul.21089; Muhe L, 1997, LANCET, V349, P1801, DOI 10.1016/S0140-6736(96)12098-5; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Najada AS, 2004, J TROP PEDIATRICS, V50, P364, DOI 10.1093/tropej/50.6.364; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Safran JB, 1998, J BIOL CHEM, V273, P29935, DOI 10.1074/jbc.273.45.29935; SCHUESSLER TF, 1995, IEEE T BIO-MED ENG, V42, P860, DOI 10.1109/10.412653; Seah AS, 2011, ANN BIOMED ENG, V39, P1505, DOI 10.1007/s10439-010-0237-6; Shih PK, 2011, J SURG RES, V171, P323, DOI 10.1016/j.jss.2010.03.008; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P335, DOI 10.1081/IPH-120014721; Takano Y, 2011, STEROIDS, V76, P1305, DOI 10.1016/j.steroids.2011.06.009; Tangpricha V, 2001, LANCET, V357, P1673, DOI 10.1016/S0140-6736(00)04831-5; Tseng M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-191; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Xue ML, 2002, IMMUNOL CELL BIOL, V80, P340, DOI 10.1046/j.1440-1711.80.4august.1.x; Yazici G, 2011, J RADIAT RES, V52, P616, DOI 10.1269/jrr.11033; Zosky GR, 2011, AM J RESP CRIT CARE, V183	45	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49076	10.1371/journal.pone.0049076	http://dx.doi.org/10.1371/journal.pone.0049076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185294	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800016
J	Waters, A; Blanchette, F; Kim, AD				Waters, Aaron; Blanchette, Francois; Kim, Arnold D.			Modeling Huddling Penguins	PLOS ONE			English	Article							EMPEROR PENGUINS; BEHAVIOR	We present a systematic and quantitative model of huddling penguins. In this mathematical model, each individual penguin in the huddle seeks only to reduce its own heat loss. Consequently, penguins on the boundary of the huddle that are most exposed to the wind move downwind to more sheltered locations along the boundary. In contrast, penguins in the interior of the huddle neither have the space to move nor experience a significant heat loss, and they therefore remain stationary. Through these individual movements, the entire huddle experiences a robust cumulative effect that we identify, describe, and quantify. This mathematical model requires a calculation of the wind flowing around the huddle and of the resulting temperature distribution. Both of these must be recomputed each time an individual penguin moves since the huddle shape changes. Using our simulation results, we find that the key parameters affecting the huddle dynamics are the number of penguins in the huddle, the wind strength, and the amount of uncertainty in the movement of the penguins. Moreover, we find that the lone assumption of individual penguins minimizing their own heat loss results in all penguins having approximately equal access to the warmth of the huddle.	[Waters, Aaron; Blanchette, Francois; Kim, Arnold D.] Univ Calif Merced, Merced, CA 95344 USA	University of California System; University of California Merced	Blanchette, F (corresponding author), Univ Calif Merced, Merced, CA 95344 USA.	fblanchette@ucmerced.edu	Kim, Arnold/HCH-3268-2022	Kim, Arnold/0000-0002-8945-4038	University of California Merced	University of California Merced(University of California System)	This research was solely supported by start-up funds provided by the University of California Merced. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson D J, 1990, ELEMENTARY FLUID DYN; Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Ancel A, 2009, P ROY SOC B-BIOL SCI, V276, P2163, DOI 10.1098/rspb.2009.0140; Brown J, 2011, COMPLEX VARIABLES AP; Canals M, 2011, COMPLEXITY, V17, P35, DOI 10.1002/cplx.20370; Driscoll T, 2012, SCHWARZ CHRISTTOFEL; Faghri A., 2006, TRANSPORT PHENOMENA; Gilbert C, 2008, J EXP BIOL, V211, P1, DOI 10.1242/jeb.005785; Gilbert C, 2008, POLAR BIOL, V31, P163, DOI 10.1007/s00300-007-0343-6; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Jacquet L., 2005, MARCHE EMPEREUR; Jarman M., 1973, Bulletin Br Antarct Surv, VNo. 33-34, P57; Kirkwood R, 1999, EMU, V99, P40, DOI 10.1071/MU99006; Kreith F, 2000, PRINCIPLES HEAT TRAN; LEMAHO Y, 1977, AM SCI, V65, P680; McCafferty DJ, 2011, COMP BIOCHEM PHYS A, V158, P337, DOI 10.1016/j.cbpa.2010.09.012; Prevost J, 1961, ECOLOGIE MANCHOT EMP; Schlichting H., 1961, BOUNDARY LAYER THEOR, V121; Stead G, 2003, THESIS U SHEFFIELD U; Zitterbart DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020260	21	28	28	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50277	10.1371/journal.pone.0050277	http://dx.doi.org/10.1371/journal.pone.0050277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166841	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885300097
J	Yu, HY; Xu, JC; Okuto, E; Luedeling, E				Yu, Haiying; Xu, Jianchu; Okuto, Erick; Luedeling, Eike			Seasonal Response of Grasslands to Climate Change on the Tibetan Plateau	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; PRIMARY PRODUCTIVITY; VEGETATION; PHENOLOGY; REGRESSION; REDUCTION; DROUGHT; TRENDS; GROWTH; FOREST	Background: Monitoring vegetation dynamics and their responses to climate change has been the subject of considerable research. This paper aims to detect change trends in grassland activity on the Tibetan Plateau between 1982 and 2006 and relate these to changes in climate. Methodology/Principal Findings: Grassland activity was analyzed by evaluating remotely sensed Normalized Difference Vegetation Index (NDVI) data collected at 15-day intervals between 1982 and 2006. The timings of vegetation stages (start of green-up, beginning of the growing season, plant maturity, start of senescence and end of the growing season) were assessed using the NDVI ratio method. Mean NDVI values were determined for major vegetation stages (green-up, fast growth, maturity and senescence). All vegetation variables were linked with datasets of monthly temperature and precipitation, and correlations between variables were established using Partial Least Squares regression. Most parts of the Tibetan Plateau showed significantly increasing temperatures, as well as clear advances in late season phenological stages by several weeks. Rainfall trends and significant long-term changes in early season phenology occurred on small parts of the plateau. Vegetation activity increased significantly for all vegetation stages. Most of these changes were related to increasing temperatures during the growing season and in some cases during the previous winter. Precipitation effects appeared less pronounced. Warming thus appears to have shortened the growing season, while increasing vegetation activity. Conclusions/Significance: Shortening of the growing season despite a longer thermally favorable period implies that vegetation on the Tibetan Plateau is unable to exploit additional thermal resources availed by climate change. Ecosystem composition may no longer be well attuned to the local temperature regime, which has changed rapidly over the past three decades. This apparent lag of the vegetation assemblage behind changes in climate should be taken into account when projecting the impacts of climate change on ecosystem processes.	[Okuto, Erick; Luedeling, Eike] World Agroforestry Ctr, Nairobi, Kenya; [Yu, Haiying; Xu, Jianchu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Yu, Haiying; Xu, Jianchu] E Asia Program, World Agroforestry Ctr, Kunming, Peoples R China	CGIAR; World Agroforestry (ICRAF); Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Luedeling, E (corresponding author), World Agroforestry Ctr, Nairobi, Kenya.	E.Luedeling@cgiar.org	Xu, Jianchu/Y-2890-2019; Luedeling, Eike/I-3269-2019; Luedeling, Eike/A-5662-2012	Luedeling, Eike/0000-0002-7316-3631; Luedeling, Eike/0000-0002-7316-3631	National Natural Science Foundation of China [31101753]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is funded by National Natural Science Foundation of China (31101753). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonan GB, 2003, GLOBAL CHANGE BIOL, V9, P1543, DOI 10.1046/j.1365-2486.2003.00681.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; de Beurs KM, 2005, INT J REMOTE SENS, V26, P1551, DOI 10.1080/01431160512331326657; Frich P, 2002, CLIMATE RES, V19, P193, DOI 10.3354/cr019193; Hijmans RJ, 2015, RASTER GEOGRAPHIC DA; Hu J, 2010, GLOBAL CHANGE BIOL, V16, P771, DOI 10.1111/j.1365-2486.2009.01967.x; Jeong SJ, 2011, CLIM DYNAM, V37, P821, DOI 10.1007/s00382-010-0827-x; Jia GSJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018268; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Luedeling E, 2012, AGR FOREST METEOROL, V158, P43, DOI 10.1016/j.agrformet.2011.10.020; Luedeling E, 2009, INT J APPL EARTH OBS, V11, P244, DOI 10.1016/j.jag.2009.03.002; Matsuura K, 2009, TERRESTRIAL AIR TEMP; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mevik B.H., 2011, PLS PARTIAL LEAST SQ; Min M, 2005, T ASAE, V48, P455, DOI 10.13031/2013.18308; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Olsen JE, 2006, ACTA HORTIC, P157, DOI 10.17660/ActaHortic.2006.727.18; Peylin P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002214; Piao SL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028205; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; R Core Team, 2021, R LANG ENV STAT COMP; Ranjitkar S, 2013, INT J BIOMETEOROL, V57, P225, DOI 10.1007/s00484-012-0548-4; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Schwalm CR, 2010, GLOBAL CHANGE BIOL, V16, P657, DOI 10.1111/j.1365-2486.2009.01991.x; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Slayback DA, 2003, GLOBAL CHANGE BIOL, V9, P1, DOI 10.1046/j.1365-2486.2003.00507.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Verburg PH, 2011, GLOBAL CHANGE BIOL, V17, P974, DOI 10.1111/j.1365-2486.2010.02307.x; Viner D, 2007, PLANT GROWTH CLIMATE, P1; Wang XH, 2011, P NATL ACAD SCI USA, V108, P1240, DOI 10.1073/pnas.1014425108; Watson R, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, pIX; WEBB W, 1978, ECOLOGY, V59, P1239, DOI 10.2307/1938237; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wold S., 1995, QSAR CHEMOMETRIC MET, V2, P195; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Xu WX, 2007, CHINESE GEOGR SCI, V17, P151, DOI 10.1007/s11769-007-0151-5; Yang XF, 2012, FUNGAL DIVERS, V56, P189, DOI 10.1007/s13225-012-0163-z; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zeng B, 2008, VEGETATION RESPONSES; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	51	51	56	3	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49230	10.1371/journal.pone.0049230	http://dx.doi.org/10.1371/journal.pone.0049230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173048	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300018
J	Saberi, P; Gamarel, KE; Neilands, TB; Comfort, M; Sheon, N; Darbes, LA; Johnson, MO				Saberi, Parya; Gamarel, Kristi E.; Neilands, Torsten B.; Comfort, Megan; Sheon, Nicolas; Darbes, Lynae A.; Johnson, Mallory O.			Ambiguity, Ambivalence, and Apprehensions of Taking HIV-1 Pre-Exposure Prophylaxis among Male Couples in San Francisco: A Mixed Methods Study	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; LIMITED KNOWLEDGE; RISK BEHAVIOR; UNITED-STATES; PREVENTION; INFECTION; IMPACT; MEN; GAY; CHEMOPROPHYLAXIS	Objective: We conducted a mixed-methods study to examine serodiscordant and seroconcordant (HIV-positive/HIV-positive) male couples' PrEP awareness, concerns regarding health care providers offering PrEP to the community, and correlates of PrEP uptake by the HIV-negative member of the couple. Design: Qualitative sub-study included one-on-one interviews to gain a deeper understanding of participants' awareness of and experiences with PrEP and concerns regarding health care providers offering PrEP to men who have sex with men (MSM). Quantitative analyses consisted of a cross-sectional study in which participants were asked about the likelihood of PrEP uptake by the HIV-negative member of the couple and level of agreement with health care providers offering PrEP to anyone requesting it. Methods: We used multivariable regression to examine associations between PrEP questions and covariates of interest and employed an inductive approach to identify key qualitative themes. Results: Among 328 men (164 couples), 62% had heard about PrEP, but approximately one-quarter were mistaking it with post-exposure prophylaxis. The majority of participants had low endorsement of PrEP uptake and 40% were uncertain if health care providers should offer PrEP to anyone requesting it. Qualitative interviews with 32 men suggest that this uncertainty likely stems from concerns regarding increased risk compensation. Likelihood of future PrEP uptake by the HIV-negative member of the couple was positively associated with unprotected insertive anal intercourse but negatively correlated with unprotected receptive anal intercourse. Conclusions: Findings suggest that those at greatest risk may not be receptive of PrEP. Those who engage in moderate risk express more interest in PrEP; however, many voice concerns of increased risk behavior in tandem with PrEP use. Results indicate a need for further education of MSM communities and the need to determine appropriate populations in which PrEP can have the highest impact.	[Saberi, Parya; Neilands, Torsten B.; Sheon, Nicolas; Darbes, Lynae A.; Johnson, Mallory O.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Saberi, P (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	parya.saberi@ucsf.edu	Gamarel, Kristi/ABE-1108-2021	Darbes, Lynae/0000-0003-4738-6812; Gamarel, Kristi/0000-0001-9405-7515	NIAID NIH HHS [P30 AI027763] Funding Source: Medline; NIMH NIH HHS [K24 MH087220, K24MH087220, F32 MH086323, F32MH086323, K23 MH097649] Funding Source: Medline; NINR NIH HHS [R01NR010187, R01 NR010187] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097649, K24MH087220, F32MH086323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010187] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; [Anonymous], MICR TRIALS NETW STA; Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Brooks RA, 2012, AIDS PATIENT CARE ST, V26, P87, DOI 10.1089/apc.2011.0283; Buchbinder S, 2012, C RETR OPP INF SEATT; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guest G, 2008, SEX TRANSM DIS, V35, P1002, DOI 10.1097/OLQ.0b013e3181812939; Harrell FE, 2001, REGRESSION MODELING; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Johnson MO, 2011, AIDS BEHAV; Johnson MO, 2006, RELATIONSHIP FACTORS; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kellerman SE, 2006, JAIDS-J ACQ IMM DEF, V43, P376, DOI 10.1097/01.qai.0000234085.18914.d5; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Liu AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023688; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077	30	73	75	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e50061	10.1371/journal.pone.0050061	http://dx.doi.org/10.1371/journal.pone.0050061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166819	Green Published, gold			2022-12-25	WOS:000311151900214
J	Fang, L; Du, WW; Yang, XL; Chen, K; Ghanekar, A; Levy, G; Yang, WN; Yee, AJ; Lu, WY; Xuan, JW; Gao, ZL; Xie, F; He, CY; Deng, ZQ; Yang, BB				Fang, Ling; Du, William W.; Yang, Xiangling; Chen, Kui; Ghanekar, Anand; Levy, Gary; Yang, Weining; Yee, Albert J.; Lu, Wei-Yang; Xuan, Jim W.; Gao, Zhongli; Xie, Feng; He, Chengyan; Deng, Zhaoqun; Yang, Burton B.			Versican 3 '-untranslated region (3 '-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity	FASEB JOURNAL			English	Article						microRNA; transgenic mice; noncoding RNA	PROMOTES TUMOR-GROWTH; OSTEOBLAST DIFFERENTIATION; CELL-PROLIFERATION; ISOFORM EXPRESSION; MICRORNA FUNCTIONS; BREAST-CANCER; G3 DOMAIN; PG-M; PROTEOGLYCAN; ANGIOGENESIS	This study was designed to explore the role of versican in the development of hepatocellular carcinoma (HCC). Ectopic expression of the versican 3'-untranslated region (3'-UTR) was studied as a competitive endogenous RNA for regulating miRNA functions. We used this approach to modulate the expression of versican and its related proteins in 3'-UTR transgenic mice and in the liver cancer cell line HepG2, stably transfected with the 3'-UTR or a control vector. We demonstrated that transgenic mice expressing the versican 3'-UTR developed HCC and increased expression of versican isoforms V0 and V1. HepG2 cells transfected with versican 3'-UTR displayed increased proliferation, survival, migration, invasion, colony formation, and enhanced endothelial cell growth, but decreased apoptosis. We found that versican 3'-UTR could bind to miRNAs miR-133a, miR-199a*, miR-144, and miR-431 and also interacted with CD34 and fibronectin. As a consequence, expression of versican, CD34, and fibronectin was up-regulated by ectopic transfection of the versican 3'-UTR, which was confirmed in HepG2 cells and in transgenic mice as compared with wild-type controls. Transfection with siRNAs targeting the versican 3'-UTR abolished the effects of the 3'-UTR. Taken together, these results demonstrate that versican V0 and V1 isoforms play important roles in HCC development and that versican mRNAs compete with endogenous RNAs in regulating miRNA functions.-Fang, L., Du, W. W., Yang, X., Chen, K., Ghanekar, A., Levy, G., Yang, W., Yee, A. J., Lu, W.-Y., Xuan, J. W., Gao, Z., Xie, F., He, C., Deng, Z., Yang, B. B. Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. 27, 907-919 (2013). www.fasebj.org	[Fang, Ling; Du, William W.; Yang, Xiangling; Yang, Weining; Yee, Albert J.; Deng, Zhaoqun; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Fang, Ling; Du, William W.; Yang, Xiangling; Deng, Zhaoqun; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Ghanekar, Anand] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Levy, Gary] Univ Toronto, Inst Transplantat, Toronto, ON, Canada; [Chen, Kui; Ghanekar, Anand] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Lu, Wei-Yang] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Xuan, Jim W.] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada; [Gao, Zhongli; Xie, Feng; He, Chengyan] Jilin Univ, China Japan Union Hosp, Changchun, Jilin, Peoples R China	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Western University (University of Western Ontario); Western University (University of Western Ontario); Jilin University	Yang, BB (corresponding author), Sunnybrook Hlth Sci Ctr, Res Bldg,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca	Lu, Wei-Yang/K-4404-2013	Yang, Xiangling/0000-0002-5881-4299	Natural Sciences and Engineering Research Council of Canada (NSERC) [227937-2012]; Heart and Stroke Foundation of Ontario [CI 7418]; NSERC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC; 227937-2012) to B.B.Y., who is the recipient of a Career Investigator award (CI 7418) from the Heart and Stroke Foundation of Ontario. W.Y. was a recipient of an NSERC Undergraduate Summer Research award.	Arslan F, 2007, BRIT J CANCER, V96, P1560, DOI 10.1038/sj.bjc.6603766; Brown LF, 1999, CLIN CANCER RES, V5, P1041; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; ITO K, 1995, J BIOL CHEM, V270, P958, DOI 10.1074/jbc.270.2.958; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee D. Y., PLOS ONE, V5; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lee SC, 2011, FEBS LETT, V585, P2610, DOI 10.1016/j.febslet.2011.07.016; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lin HM, 2007, ONCOL REP, V17, P1541; MARGOLIS RU, 1994, METHOD ENZYMOL, V245, P105; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; MORITA H, 1990, BIOCHEM J, V265, P61, DOI 10.1042/bj2650061; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Rutnam ZJ, 2012, J CELL SCI, V125, P2075, DOI 10.1242/jcs100818; Schmalfeldt M, 1998, J BIOL CHEM, V273, P15758, DOI 10.1074/jbc.273.25.15758; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Setoguchi T., CANC SCI, V102, P883; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; SHINOMURA T, 1993, J BIOL CHEM, V268, P14461; Swami M, 2010, NAT REV CANCER, V10, P535, DOI 10.1038/nrc2898; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; YAMAGATA M, 1993, J CELL SCI, V106, P55; Yang XL, 2012, CELL CYCLE, V11, P3097, DOI 10.4161/cc.21503; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zheng PS, 2004, J CELL SCI, V117, P5887, DOI 10.1242/jcs.01516; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	42	102	110	0	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					907	919		10.1096/fj.12-220905	http://dx.doi.org/10.1096/fj.12-220905			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23180826				2022-12-25	WOS:000315585200007
J	Chen, K; Piszczek, G; Carter, C; Tjandra, N				Chen, Kang; Piszczek, Grzegorz; Carter, Carol; Tjandra, Nico			The Maturational Refolding of the beta-Hairpin Motif of Equine Infectious Anemia Virus Capsid Protein Extends Its Helix alpha 1 at Capsid Assembly Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ROUS-SARCOMA-VIRUS; N-TERMINAL DOMAIN; MOLECULAR-STRUCTURE DETERMINATION; PFIZER MONKEY VIRUS; NMR CHEMICAL-SHIFTS; HUMAN CYCLOPHILIN-A; IN-VITRO; CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION	A retroviral capsid (CA) protein consists of two helical domains, CA(N) and CA(C), which drive hexamer and dimer formations, respectively, to form a capsid lattice. The N-terminal 13 residues of CA refold to a beta-hairpin motif upon processing from its precursor polyprotein Gag. The beta-hairpin is essential for correct CA assembly but unexpectedly it is not within any CA oligomeric interfaces. To understand the beta-hairpin function we studied the full-length CA protein from equine infectious anemia virus (EIAV), a lentivirus sharing the same cone-shaped capsid core as HIV-1. Solution NMR spectroscopy is perfectly suited to study EIAV-CA that dimerizes weaker than HIV-1-CA. Comparison between the wild-type (wt) EIAV-CA and a variant lacking the beta-hairpin structure demonstrated that folding of the beta-hairpin specifically extended the N terminus of helix alpha 1 from Tyr(20) to Pro(17). This coil to helix transition involves the conserved sequence of Thr(16)-Pro(17)-Arg(18) (Ser(16)-Pro(17)-Arg(18) in HIV-1-CA). The extended region of helix alpha 1 constituted an expanded EIAV-CA(N) oligomeric interface and overlapped with the HIV-1-CA hexamer-core residue Arg(18), helical in structure and pivotal in assembly. Therefore we propose the function of the maturational refolding of the beta-hairpin in CA assembly is to extend helix alpha 1 at the N terminus to enhance the CA(N) oligomerization along the capsid assembly core interface. In addition, NMR resonance line broadening indicated the presence of micro-millisecond exchange kinetics due to the EIAV-CA(N) domain oligomerization, independent to the faster EIAV-CA(C) domain dimerization.	[Chen, Kang; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz] NHLBI, Biophys Facil, NIH, Bethesda, MD 20892 USA; [Carter, Carol] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carter, C (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	ccarter@ms.cc.sunysb.edu; tjandran@nhlbi.nih.gov	Piszczek, Grzegorz/GYU-2029-2022	Chen, Kang/0000-0003-0276-2474	National Institutes of Health Intramural Research Program of NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338, ZIAHL001048] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NHLBI.	Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bouamr F, 2005, J BIOL CHEM, V280, P6792, DOI 10.1074/jbc.M408119200; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Cairns TM, 2001, J VIROL, V75, P242, DOI 10.1128/JVI.75.1.242-250.2001; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Ehrlich LS, 2001, BIOPHYS J, V81, P586, DOI 10.1016/S0006-3495(01)75725-6; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; GRONENBORN AM, 1994, J BIOMOL NMR, V4, P455; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; HARPER ET, 1993, BIOCHEMISTRY-US, V32, P7605, DOI 10.1021/bi00081a001; HAUSDORF G, 1994, J VIROL METHODS, V50, P1, DOI 10.1016/0166-0934(94)90158-9; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; LAURENT AG, 1989, J VIROL, V63, P4074, DOI 10.1128/JVI.63.9.4074-4078.1989; Lopez CS, 2011, VIROLOGY, V417, P137, DOI 10.1016/j.virol.2011.05.011; Macek P, 2009, J MOL BIOL, V392, P100, DOI 10.1016/j.jmb.2009.06.029; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Nandhagopal N, 2004, J MOL BIOL, V335, P275, DOI 10.1016/j.jmb.2003.10.034; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626; Rayne F, 2001, J VIROL, V75, P5277, DOI 10.1128/JVI.75.11.5277-5287.2001; Roa A, 2012, J VIROL, V86, P1717, DOI 10.1128/JVI.05811-11; ROBERTS MM, 1989, BIOCHEM BIOPH RES CO, V160, P486, DOI 10.1016/0006-291X(89)92459-5; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; STEPHENS RM, 1986, SCIENCE, V231, P589, DOI 10.1126/science.3003905; Strauss J.H., 2008, VIRUSES HUMAN DIS, pvii+468; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wildova M, 2008, VIROLOGY, V380, P157, DOI 10.1016/j.virol.2008.07.021; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561; Yang DW, 1999, J AM CHEM SOC, V121, P2571, DOI 10.1021/ja984056t; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	80	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1511	1520		10.1074/jbc.M112.425140	http://dx.doi.org/10.1074/jbc.M112.425140			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184932	hybrid, Green Published			2022-12-25	WOS:000313751400009
J	Minges, JT; Su, SF; Grossman, G; Blackwelder, AJ; Pop, EA; Mohler, JL; Wilson, EM				Minges, John T.; Su, Shifeng; Grossman, Gail; Blackwelder, Amanda J.; Pop, Elena A.; Mohler, James L.; Wilson, Elizabeth M.			Melanoma Antigen-A11 (MAGE-A11) Enhances Transcriptional Activity by Linking Androgen Receptor Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; COOH-TERMINAL INTERACTION; PROSTATE-CANCER CELLS; ACTIVATION FUNCTION 2; TUMOR VIRUS PROMOTER; PROTEIN-KINASE; GENE-EXPRESSION; COACTIVATOR INTERACTIONS; PROGESTERONE-RECEPTOR; COREGULATOR MAGE-11	Prostate cancer growth and progression depend on androgen receptor (AR) signaling through transcriptional mechanisms that require interactions with coregulatory proteins, one of which is the primate-specific steroid receptor coregulator melanoma antigen-A11 (MAGE-A11). In this report, we provide evidence how increased expression of MAGE-A11 during prostate cancer progression enhances AR signaling and prostate cancer growth. MAGE-A11 protein levels were highest in castration-recurrent prostate cancer. The cyclic AMP-induced increase in androgen-dependent and androgen-independent AR transcriptional activity correlated with an increase in MAGE-A11 and was inhibited by silencing MAGE-A11 expression. MAGE-A11 mediated synergistic AR transcriptional activity in LAPC-4 prostate cancer cells. The ability of MAGE-A11 to rescue transcriptional activity of complementary inactive AR mutants and promote coimmunoprecipitation between unlike forms of AR suggests that MAGE-A11 links transcriptionally active AR dimers. A model for the AR.MAGE-A11 multidimeric complex is proposed in which one AR FXXLF motif of the AR dimer engages in the androgen-dependent AR NH2- and carboxyl-terminal interaction, whereas the second FXXLF motif region of the AR dimer interacts with dimeric MAGE-A11. The AR.MAGE-A11 multidimeric complex accounts for the dual functions of the AR FXXLF motif in the androgen-dependent AR NH2- and carboxyl-terminal interaction and binding MAGE-A11 and for synergy between reported AR splice variants and full-length AR. We conclude that the increased expression of MAGE-A11 in castration-recurrent prostate cancer, which is enhanced by cyclic AMP signaling, increases AR-dependent growth of prostate cancer by MAGE-A11 forming a molecular bridge between transcriptionally active AR dimers.	[Minges, John T.; Su, Shifeng; Blackwelder, Amanda J.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Dept Pediat, Chapel Hill, NC 27599 USA; [Grossman, Gail; Wilson, Elizabeth M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Pop, Elena A.; Mohler, James L.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Mohler, James L.] SUNY Buffalo, Dept Urol, Buffalo, NY 14263 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, Dept Pediat, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			National Institutes of Health, United States Public Health Service grant from NICHD [HD16910]; Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [HD067721, U54-HD35041]; NCI [P01-CA77739]; NCI Cancer Center [CA016056, CA034026]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, U54HD035041, R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016056, P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health, United States Public Health Service grant from NICHD; Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants HD16910, a United States Public Health Service grant from NICHD; HD067721 of Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; P01-CA77739 from the NCI; and CA016056 and CA034026, NCI Cancer Center support grants (to Roswell Park Cancer Institute and the University of North Carolina at Chapel Hill, respectively).	ARCHER TK, 1994, MOL ENDOCRINOL, V8, P568, DOI 10.1210/me.8.5.568; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2012, MOL CELL ENDOCRINOL, V348, P403, DOI 10.1016/j.mce.2011.03.026; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Beato M, 1996, J MOL MED, V74, P711, DOI 10.1007/s001090050076; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; DEBELLIS A, 1992, MOL ENDOCRINOL, V6, P1909, DOI 10.1210/me.6.11.1909; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Godoy A, 2011, PROSTATE, V71, P1033, DOI 10.1002/pros.21318; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 1998, CANCER RES, V58, P5718; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Jain A, 2002, MOL ENDOCRINOL, V16, P2323, DOI 10.1210/me.2002-0004; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Lagarde WH, 2012, J BIOL CHEM, V287, P10905, DOI 10.1074/jbc.M111.336081; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUISI B, 1995, NATURE, V375, P359, DOI 10.1038/375359a0; MAJORS J, 1983, P NATL ACAD SCI-BIOL, V80, P5866, DOI 10.1073/pnas.80.19.5866; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Prefontaine GG, 1999, J BIOL CHEM, V274, P26713, DOI 10.1074/jbc.274.38.26713; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; QUIGLEY A, 1992, MOL ENDOCRINOL, V6, P1103; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Singh SS, 2004, ANAL QUANT CYTOL, V26, P194; Steketee K, 2002, EUR J BIOCHEM, V269, P5780, DOI 10.1046/j.1432-1033.2002.03276.x; Su SF, 2012, J BIOL CHEM, V287, P34809, DOI 10.1074/jbc.M112.372797; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tamrazi A, 2002, MOL ENDOCRINOL, V16, P2706, DOI 10.1210/me.2002-0250; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; WONG CI, 1993, J BIOL CHEM, V268, P19004; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491; ZHOU ZX, 1994, RECENT PROG HORM RES, V49, P249; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	67	32	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1939	1952		10.1074/jbc.M112.428409	http://dx.doi.org/10.1074/jbc.M112.428409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23172223	hybrid, Green Published			2022-12-25	WOS:000313751400047
J	Johnson, JS; Lacki, MJ; Thomas, SC; Grider, JF				Johnson, Joseph S.; Lacki, Michael J.; Thomas, Steven C.; Grider, John F.			Frequent Arousals from Winter Torpor in Rafinesque's Big-Eared Bat (Corynorhinus rafinesquii)	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; WHITE-NOSE SYNDROME; BODY-TEMPERATURE; HORSESHOE BATS; MAMMALIAN HIBERNATION; ENERGY AVAILABILITY; VESPERTILIONID BATS; PLECOTUS-AURITUS; RADIOTRANSMITTERS; PATTERNS	Extensive use of torpor is a common winter survival strategy among bats; however, data comparing various torpor behaviors among species are scarce. Winter torpor behaviors are likely to vary among species with different physiologies and species inhabiting different regional climates. Understanding these differences may be important in identifying differing susceptibilities of species to white-nose syndrome (WNS) in North America. We fitted 24 Rafinesque's big-eared bats (Corynorhinus rafinesquii) with temperature-sensitive radio-transmitters, and monitored 128 PIT-tagged big-eared bats, during the winter months of 2010 to 2012. We tested the hypothesis that Rafinesque's big-eared bats use torpor less often than values reported for other North American cave-hibernators. Additionally, we tested the hypothesis that Rafinesque's big-eared bats arouse on winter nights more suitable for nocturnal foraging. Radio-tagged bats used short (2.4 d +/- 0.3 (SE)), shallow (13.9 degrees C +/- 0.6) torpor bouts and switched roosts every 4.1 d +/- 0.6. Probability of arousal from torpor increased linearly with ambient temperature at sunset (P<0.0001), and 83% (n = 86) of arousals occurred within 1 hr of sunset. Activity of PIT-tagged bats at an artificial maternity/hibernaculum roost between November and March was positively correlated with ambient temperature at sunset (P<0.0001), with males more active at the roost than females. These data show Rafinesque's big-eared bat is a shallow hibernator and is relatively active during winter. We hypothesize that winter activity patterns provide Corynorhinus species with an ecological and physiological defense against the fungus causing WNS, and that these bats may be better suited to withstand fungal infection than other cave-hibernating bat species in eastern North America.	[Johnson, Joseph S.; Lacki, Michael J.] Univ Kentucky, Dept Forestry, Lexington, KY 40546 USA; [Thomas, Steven C.] Natl Pk Serv, Mammoth Cave, KY USA; [Grider, John F.] Univ N Carolina, Dept Biol, Greensboro, NC 27412 USA	University of Kentucky; United States Department of the Interior; University of North Carolina; University of North Carolina Greensboro	Johnson, JS (corresponding author), Univ Kentucky, Dept Forestry, Lexington, KY 40546 USA.	joseph.johnson@uky.edu			University of Kentucky, College of Agriculture; Kentucky Agricultural Experiment Station (KAES) [12-09-067]	University of Kentucky, College of Agriculture; Kentucky Agricultural Experiment Station (KAES)	Funding for this research was provided by the University of Kentucky, College of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank T. Carter for his invaluable help with PIT-tagging bats for this study. We also thank R. Toomey and L. Scoggins of the NPS, and L. Dodd and B. Augustine of the University of Kentucky for their assistance and suggestions. This investigation is connected with a project of the Kentucky Agricultural Experiment Station (KAES No. 12-09-067) and is published with the approval of the director.	Barclay RMR, 1996, J MAMMAL, V77, P1102, DOI 10.2307/1382791; Bayless Mylea L., 2011, U S Forest Service General Technical Report SRS, V145, P13; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bouma HR, 2011, P NATL ACAD SCI USA, V108, P2052, DOI 10.1073/pnas.1008823108; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; BRACK V, 1985, CAN J ZOOL, V63, P2952, DOI 10.1139/z85-442; Braun E.L, 1950, SOIL SCI, V71, P155, DOI [10.1097/00010694-195102000-00012, DOI 10.1097/00010694-195102000-00012]; Carter Timothy C., 2009, Bat Research News, V50, P81; CLARK MK, 1990, THESIS N CAROLINA ST; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; FRENCH AR, 1985, J COMP PHYSIOL B, V156, P13, DOI 10.1007/BF00692921; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Halsall AL, 2012, J MAMMAL, V93, P497, DOI 10.1644/11-MAMM-A-262.1; HAYS GC, 1992, PHYSIOL ZOOL, V65, P554, DOI 10.1086/physzool.65.3.30157969; Heller HC, 2004, ANNU REV PHYSIOL, V66, P275, DOI 10.1146/annurev.physiol.66.032102.115313; Hoffmeister DF, 1963, ILLINOIS STATE ACAD, V55, P87; Hope PR, 2012, J COMP PHYSIOL B, V182, P569, DOI 10.1007/s00360-011-0631-x; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Jonasson KA, 2012, J EXP BIOL, V215, P2141, DOI 10.1242/jeb.066514; Jonasson KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021061; JONES C, 1977, Mammalian Species, V69, P1; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; Kisser B, 2012, AM MIDL NAT, V167, P396, DOI 10.1674/0003-0031-167.2.396; Kurta A, 2002, J MAMMAL, V83, P585, DOI 10.1644/1545-1542(2002)083<0585:PAMOBI>2.0.CO;2; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Luis AD, 2006, FUNCT ECOL, V20, P471, DOI 10.1111/j.1365-2435.2006.01119.x; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Park KJ, 2000, FUNCT ECOL, V14, P580, DOI 10.1046/j.1365-2435.2000.00460.x; Prendergast BJ, 2002, AM J PHYSIOL-REG I, V282, pR1054, DOI 10.1152/ajpregu.00562.2001; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; RICE C.L., 2009, M S THESIS; ROER H, 1969, Bonner Zoologische Beitraege, V20, P378; Sasse D. Blake, 2011, U S Forest Service General Technical Report SRS, V145, P123; Siemers BM, 2004, BEHAV ECOL SOCIOBIOL, V56, P464, DOI 10.1007/s00265-004-0807-4; SPEAKMAN JR, 1986, J ZOOL, V210, P515; Stihler CW, 2011, CONSERVATION MANAGEM, P75; Storm JJ, 2011, ACTA THERIOL, V56, P123, DOI 10.1007/s13364-010-0018-5; Thomas DW, 1997, FUNCT ECOL, V11, P585, DOI 10.1046/j.1365-2435.1997.00129.x; Trousdale AW, 2008, J MAMMAL, V89, P477, DOI 10.1644/07-MAMM-A-117R.1; TWENTE JW, 1985, CAN J ZOOL, V63, P2955, DOI 10.1139/z85-443; WANG LCH, 1979, CAN J ZOOL, V57, P149, DOI 10.1139/z79-012; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Willis CKR, 2003, J COMP PHYSIOL B, V173, P379, DOI 10.1007/s00360-003-0343-y; Willis CKR, 2007, PHYSIOL BIOCHEM ZOOL, V80, P643, DOI 10.1086/521085; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076; YOUNG PJ, 1990, OECOLOGIA, V83, P504, DOI 10.1007/BF00317201; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	52	31	33	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49754	10.1371/journal.pone.0049754	http://dx.doi.org/10.1371/journal.pone.0049754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185427	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000101
J	Leese, F; Brand, P; Rozenberg, A; Mayer, C; Agrawal, S; Dambach, J; Dietz, L; Doemel, JS; Goodall-Copstake, WP; Held, C; Jackson, JA; Lampert, KP; Linse, K; Macher, JN; Nolzen, J; Raupach, MJ; Rivera, NT; Schubart, CD; Striewski, S; Tollrian, R; Sands, CJ				Leese, Florian; Brand, Philipp; Rozenberg, Andrey; Mayer, Christoph; Agrawal, Shobhit; Dambach, Johannes; Dietz, Lars; Doemel, Jana S.; Goodall-Copstake, William P.; Held, Christoph; Jackson, Jennifer A.; Lampert, Kathrin P.; Linse, Katrin; Macher, Jan N.; Nolzen, Jennifer; Raupach, Michael J.; Rivera, Nicole T.; Schubart, Christoph D.; Striewski, Sebastian; Tollrian, Ralph; Sands, Chester J.			Exploring Pandora's Box: Potential and Pitfalls of Low Coverage Genome Surveys for Evolutionary Biology	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; MITOCHONDRIAL GENOME; MICROSATELLITE DEVELOPMENT; READ ALIGNMENT; GENERATION; DNA; MARKERS; BLAST; MULTILOCUS; DISCOVERY	High throughput sequencing technologies are revolutionizing genetic research. With this "rise of the machines'', genomic sequences can be obtained even for unknown genomes within a short time and for reasonable costs. This has enabled evolutionary biologists studying genetically unexplored species to identify molecular markers or genomic regions of interest (e. g. micro- and minisatellites, mitochondrial and nuclear genes) by sequencing only a fraction of the genome. However, when using such datasets from non-model species, it is possible that DNA from non-target contaminant species such as bacteria, viruses, fungi, or other eukaryotic organisms may complicate the interpretation of the results. In this study we analysed 14 genomic pyrosequencing libraries of aquatic non-model taxa from four major evolutionary lineages. We quantified the amount of suitable micro-and minisatellites, mitochondrial genomes, known nuclear genes and transposable elements and searched for contamination from various sources using bioinformatic approaches. Our results show that in all sequence libraries with estimated coverage of about 0.02-25%, many appropriate micro-and minisatellites, mitochondrial gene sequences and nuclear genes from different KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways could be identified and characterized. These can serve as markers for phylogenetic and population genetic analyses. A central finding of our study is that several genomic libraries suffered from different biases owing to non-target DNA or mobile elements. In particular, viruses, bacteria or eukaryote endosymbionts contributed significantly (up to 10%) to some of the libraries analysed. If not identified as such, genetic markers developed from high-throughput sequencing data for non-model organisms may bias evolutionary studies or fail completely in experimental tests. In conclusion, our study demonstrates the enormous potential of low-coverage genome survey sequences and suggests bioinformatic analysis workflows. The results also advise a more sophisticated filtering for problematic sequences and non-target genome sequences prior to developing markers.	[Leese, Florian; Brand, Philipp; Rozenberg, Andrey; Dietz, Lars; Doemel, Jana S.; Lampert, Kathrin P.; Macher, Jan N.; Nolzen, Jennifer; Striewski, Sebastian; Tollrian, Ralph] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Bochum, Germany; [Leese, Florian; Goodall-Copstake, William P.; Jackson, Jennifer A.; Linse, Katrin; Sands, Chester J.] British Antarctic Survey, Cambridge CB3 0ET, England; [Agrawal, Shobhit; Held, Christoph] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Mayer, Christoph; Dambach, Johannes] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Raupach, Michael J.] German Ctr Marine Biodivers Res, Mol Taxon Grp, Wilhelmshaven, Germany; [Rivera, Nicole T.; Schubart, Christoph D.] Univ Regensburg, Dept Evolut Behav & Genet, Regensburg, Germany	Ruhr University Bochum; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Regensburg	Leese, F (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Univ Str 150, Bochum, Germany.	florian.leese@rub.de	Mayer, Christoph/AAD-6696-2019; Jackson, Jennifer/E-7997-2013; Brand, Philipp/H-4473-2019; Leese, Florian/D-4277-2012; Raupach, Michael J./AAF-7566-2020; Goodall-Copestake, William/CAF-6866-2022; Raupach, Michael/G-7072-2012	Mayer, Christoph/0000-0001-5104-6621; Brand, Philipp/0000-0003-4287-4753; Leese, Florian/0000-0002-5465-913X; Raupach, Michael J./0000-0001-8299-6697; Sands, Chester/0000-0003-1028-0328; Rozenberg, Andrey/0000-0001-9534-2297; Linse, Katrin/0000-0003-3477-3047	German Research Foundation (DFG) [LE 2323/2, MA 3684/3, (SPP) 1158]; European Science Foundation; Antarctic Science Bursary grant; DFG [1460/3, 1460/8, RA 1688/2]; Crustacean Society; Consortium Grant [NE/DO1249X/1]; British Antarctic Survey Polar Science for Planet Earth Programme; Natural Environment Research Council; NERC [bas0100026, bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025, bas0100026] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); European Science Foundation(European Science Foundation (ESF)European Commission); Antarctic Science Bursary grant; DFG(German Research Foundation (DFG)); Crustacean Society; Consortium Grant; British Antarctic Survey Polar Science for Planet Earth Programme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	FL and CM were supported by German Research Foundation (DFG) grants LE 2323/2 and MA 3684/3 within the DFG priority programme (SPP) 1158. FL was furthermore supported by a European Science Foundation "Frontiers of Speciation Research" exchange grant to Cambridge, UK. CJS was supported by an Antarctic Science Bursary grant. CDS and NTR were supported by DFG grants 1460/3, 1460/8, by Jurgen Heinze, and by a student scholarship of The Crustacean Society to NTR. KL and JJ were supported by Consortium Grant (NE/DO1249X/1) and the British Antarctic Survey Polar Science for Planet Earth Programme both funded by The Natural Environment Research Council. JD was supported by DFG grant RA 1688/2. SS was supported by a scheme to support specific activities of doctoral students of the rectorate of the Ruhr University Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Alba MM, 2002, BIOINFORMATICS, V18, P672, DOI 10.1093/bioinformatics/18.5.672; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Blanca J, 2011, SFF EXTRACT; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949; Chen LL, 2000, DIS AQUAT ORGAN, V40, P157, DOI 10.3354/dao040157; Chevreux B, 2005, THESIS RUPRECHT KARL; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Dietz L, 2011, MOL PHYLOGENET EVOL, V58, P553, DOI 10.1016/j.ympev.2010.12.016; Drummond A., 2011, GENEIOUS V5 4 6; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Feldmeyer B, 2010, MOL PHYLOGENET EVOL, V57, P1329, DOI 10.1016/j.ympev.2010.09.012; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Goldstein D, 1999, MICROSATELLITES EVOL; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Groenenberg DSJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-114; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; HANCOCK JM, 1994, COMPUT APPL BIOSCI, V10, P67; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hossain MS, 2001, AQUACULTURE, V198, P1, DOI 10.1016/S0044-8486(00)00571-8; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Jeffery NW, 2012, POLAR BIOL, V35, P959, DOI 10.1007/s00300-011-1137-4; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kilpert F, 2012, MOL PHYLOGENET EVOL, V64, P106, DOI 10.1016/j.ympev.2012.03.013; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Laurin-Lemay S, 2012, CURR BIOL, V22, pR593, DOI 10.1016/j.cub.2012.06.013; Leese F, 2008, LIMNOL OCEANOGR-METH, V6, P412, DOI 10.4319/lom.2008.6.412; Lepais O, 2011, MOL ECOL RESOUR, V11, P711, DOI 10.1111/j.1755-0998.2011.03002.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Martin JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-560; Mayer C., 2010, PHOBOS VERSION 3 3 1; Mayer C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-277; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Murray AE, 2007, PHILOS T R SOC B, V362, P2259, DOI 10.1098/rstb.2006.1944; Nederbragt AJ, 2010, SEQUENCING, DOI DOI 10.1155/2010/782465; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Perry JC, 2011, J HERED, V102, P125, DOI 10.1093/jhered/esq099; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Polato NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028634; Rasmussen DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-382; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Rooks DJ, 2010, GENES-BASEL, V1, P210, DOI 10.3390/genes1020210; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Rozen S, 2000, Methods Mol Biol, V132, P365; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Twing KI, 2011, WATER RES, V45, P1897, DOI 10.1016/j.watres.2010.12.013; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; Widenius M., 2002, MYSQL REFERENCE MANU; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	82	29	29	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49202	10.1371/journal.pone.0049202	http://dx.doi.org/10.1371/journal.pone.0049202			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185309	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000311821000035
J	Snoeren, N; van Hooff, SR; Adam, R; van Hillegersberg, R; Voest, EE; Guettier, C; van Diest, PJ; Nijkamp, MW; Brok, MO; van Leenen, D; Koerkamp, MJAG; Holstege, FCP; Rinkes, IHMB				Snoeren, Nikol; van Hooff, Sander R.; Adam, Rene; van Hillegersberg, Richard; Voest, Emile E.; Guettier, Catherine; van Diest, Paul J.; Nijkamp, Maarten W.; Brok, Mariel O.; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.; Rinkes, Inne H. M. Borel			Exploring Gene Expression Signatures for Predicting Disease Free Survival after Resection of Colorectal Cancer Liver Metastases	PLOS ONE			English	Article							HEPATIC RESECTION; PROGNOSTIC-FACTORS; DUKES-B; RECURRENCE; PROFILES; MARKERS; SINGLE	Background and Objectives: This study was designed to identify and validate gene signatures that can predict disease free survival (DFS) in patients undergoing a radical resection for their colorectal liver metastases (CRLM). Methods: Tumor gene expression profiles were collected from 119 patients undergoing surgery for their CRLM in the Paul Brousse Hospital (France) and the University Medical Center Utrecht (The Netherlands). Patients were divided into high and low risk groups. A randomly selected training set was used to find predictive gene signatures. The ability of these gene signatures to predict DFS was tested in an independent validation set comprising the remaining patients. Furthermore, 5 known clinical risk scores were tested in our complete patient cohort. Result: No gene signature was found that significantly predicted DFS in the validation set. In contrast, three out of five clinical risk scores were able to predict DFS in our patient cohort. Conclusions: No gene signature was found that could predict DFS in patients undergoing CRLM resection. Three out of five clinical risk scores were able to predict DFS in our patient cohort. These results emphasize the need for validating risk scores in independent patient groups and suggest improved designs for future studies.	[Snoeren, Nikol; van Hillegersberg, Richard; Nijkamp, Maarten W.; Rinkes, Inne H. M. Borel] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [van Hooff, Sander R.; Brok, Mariel O.; van Leenen, Dik; Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; [Adam, Rene] Hop Paul Brousse, AP HP, Dept Surg, Ctr Hepatobiliaire, Villejuif, France; [Voest, Emile E.] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands; [Guettier, Catherine] Hop Paul Brousse, AP HP, Ctr Hepatobiliaire, Dept Pathol, Villejuif, France; [van Diest, Paul J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Utrecht University; Utrecht University Medical Center	Rinkes, IHMB (corresponding author), Univ Med Ctr Utrecht, Dept Surg, Heidelberglaan 100, Utrecht, Netherlands.	i.h.m.borelrinkes@umcutrecht.nl	Holstege, Frank/AAM-9944-2021	Groot Koerkamp, Marian JA/0000-0002-0867-0821	Dutch Cancer Society [2007-3923]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society grant 2007-3923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; Crowe PJ, 2001, WORLD J SURG, V25, P996, DOI 10.1007/s00268-001-0069-5; D'Angelica M, 2011, ANN SURG ONCOL, V18, P1096, DOI 10.1245/s10434-010-1409-1; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Frederiksen CM, 2003, J CANCER RES CLIN, V129, P263, DOI 10.1007/s00432-003-0434-x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Iwatsuki S, 1999, J AM COLL SURGEONS, V189, P291, DOI 10.1016/S1072-7515(99)00089-7; Lauss M, 2010, CLIN CANCER RES, V16, P4421, DOI 10.1158/1078-0432.CCR-10-0606; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mutsaerts ELAR, 2005, J GASTROINTEST SURG, V9, P178, DOI 10.1016/j.gassur.2004.06.005; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Reissfelder C, 2009, ANN SURG ONCOL, V16, P3279, DOI 10.1245/s10434-009-0654-7; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Takahashi S, 2003, SURGERY, V133, P627, DOI 10.1067/msy.2003.151; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zakaria S, 2007, ANN SURG, V246, P183, DOI 10.1097/SLA.0b013e3180603039	29	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49442	10.1371/journal.pone.0049442	http://dx.doi.org/10.1371/journal.pone.0049442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185333	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000049
J	Dokla, EM; Mahmoud, AH; Elsayed, MSA; El-Khatib, AH; Linscheid, MW; Abouzid, KA				Dokla, Eman M.; Mahmoud, Amr H.; Elsayed, Mohamed S. A.; El-Khatib, Ahmed H.; Linscheid, Michael W.; Abouzid, Khaled A.			Applying Ligands Profiling Using Multiple Extended Electron Distribution Based Field Templates and Feature Trees Similarity Searching in the Discovery of New Generation of Urea-Based Antineoplastic Kinase Inhibitors	PLOS ONE			English	Article							SPLEEN TYROSINE KINASE; ANTICANCER DRUG DISCOVERY; T-CELL-RECEPTOR; PHARMACOLOGICAL EVALUATION; BIOLOGICAL-ACTIVITY; POTENT INHIBITORS; GENE-EXPRESSION; INTERACTION MAP; FAMILY KINASE; SYK KINASE	This study provides a comprehensive computational procedure for the discovery of novel urea-based antineoplastic kinase inhibitors while focusing on diversification of both chemotype and selectivity pattern. It presents a systematic structural analysis of the different binding motifs of urea-based kinase inhibitors and the corresponding configurations of the kinase enzymes. The computational model depends on simultaneous application of two protocols. The first protocol applies multiple consecutive validated virtual screening filters including SMARTS, support vector-machine model (ROC = 0.98), Bayesian model (ROC = 0.86) and structure-based pharmacophore filters based on urea-based kinase inhibitors complexes retrieved from literature. This is followed by hits profiling against different extended electron distribution (XED) based field templates representing different kinase targets. The second protocol enables cancericidal activity verification by using the algorithm of feature trees (Ftrees) similarity searching against NCI database. Being a proof-of-concept study, this combined procedure was experimentally validated by its utilization in developing a novel series of urea-based derivatives of strong anticancer activity. This new series is based on 3-benzylbenzo[d]thiazol-2(3H)-one scaffold which has interesting chemical feasibility and wide diversification capability. Antineoplastic activity of this series was assayed in vitro against NCI 60 tumor-cell lines showing very strong inhibition of GI(50) as low as 0.9 uM. Additionally, its mechanism was unleashed using KINEX (TM) protein kinase microarray-based small molecule inhibitor profiling platform and cell cycle analysis showing a peculiar selectivity pattern against Zap70, c-src, Mink1, csk and MeKK2 kinases. Interestingly, it showed activity on syk kinase confirming the recent studies finding of the high activity of diphenyl urea containing compounds against this kinase. Allover, the new series, which is based on a new kinase scaffold with interesting chemical diversification capabilities, showed that it exhibits its "emergent'' properties by perturbing multiple unexplored kinase pathways.	[Dokla, Eman M.; Mahmoud, Amr H.; Elsayed, Mohamed S. A.; Abouzid, Khaled A.] Ain Shams Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt; [El-Khatib, Ahmed H.; Linscheid, Michael W.] Humboldt Univ, Dept Chem, D-10099 Berlin, Germany	Egyptian Knowledge Bank (EKB); Ain Shams University; Humboldt University of Berlin	Dokla, EM (corresponding author), Ain Shams Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt.	emanelawady@pharma.asu.edu.eg	Dokla, Eman/GLU-7635-2022; Linscheid, Michael/ABB-7808-2020; Abouzid, Khaled/S-8284-2019; Linscheid, Michael W/D-2125-2009; El-Khatib, Ahmed H./F-3370-2015	Dokla, Eman/0000-0002-2770-6439; Abouzid, Khaled/0000-0001-9851-5624; Linscheid, Michael W/0000-0002-8902-1734; Elsayed, Mohamed/0000-0002-1353-7259				ABDELAAL SM, 1992, J HETEROCYCLIC CHEM, V29, P1069, DOI 10.1002/jhet.5570290506; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Bamborough P, 2011, J MED CHEM, V54, P5131, DOI 10.1021/jm200349b; Bigelow CC, 1992, BIOCH MOL BIOL, V3, P61; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; BROWN E, 1994, TETRAHEDRON, V50, P10309, DOI 10.1016/S0040-4020(01)81763-4; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chayama K, 2001, P NATL ACAD SCI USA, V98, P4599, DOI 10.1073/pnas.081021898; Cheeseright T, 2006, J CHEM INF MODEL, V46, P665, DOI 10.1021/ci050357s; Cheeseright T, 2007, EXPERT OPIN DRUG DIS, V2, P131, DOI 10.1517/17460441.2.1.131; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Cywin CL, 2003, BIOORG MED CHEM LETT, V13, P1415, DOI 10.1016/S0960-894X(03)00163-X; DAMICO JJ, 1989, J HETEROCYCLIC CHEM, V26, P1245, DOI 10.1002/jhet.5570260508; Dumas J, 2004, CURR OPIN DRUG DISC, V7, P600; Dumas J, 2002, CURR OPIN DRUG DISC, V5, P718; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fang XL, 2004, J CHEM INF COMP SCI, V44, P249, DOI 10.1021/ci034209i; Farmer LJ, 2008, BIOORG MED CHEM LETT, V18, P6231, DOI 10.1016/j.bmcl.2008.09.106; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Franek W, 1996, MONATSH CHEM, V127, P895, DOI 10.1007/BF00807029; Froeyen P, 1993, PHOSPHORUS SULFUR, V78, P161; Gururajan M, 2007, J IMMUNOL, V178, P111, DOI 10.4049/jimmunol.178.1.111; Harrington E., 2002, PCT Int. Appl., Patent No. [WO 2002/096905, 2002096905]; Herdieckerhoff E., 1938, US Patent, Patent No. [US2108712, 2108712]; Hirabayashi A, 2008, BIOORGAN MED CHEM, V16, P9247, DOI 10.1016/j.bmc.2008.09.015; Hirabayashi A, 2008, BIOORGAN MED CHEM, V16, P7347, DOI 10.1016/j.bmc.2008.06.017; Hisamichi H, 2005, BIOORGAN MED CHEM, V13, P4936, DOI 10.1016/j.bmc.2005.05.033; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Kaneko S, 2011, P NATL ACAD SCI USA, V108, P11127, DOI 10.1073/pnas.1104128108; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lackey KE, 2006, CURR TOP MED CHEM, V6, P435, DOI 10.2174/156802606776743156; Lai JYQ, 2003, BIOORG MED CHEM LETT, V13, P3111, DOI 10.1016/S0960-894X(03)00658-9; Leach AR, 2010, J MED CHEM, V53, P539, DOI 10.1021/jm900817u; Li HQ, 2009, ANTI-CANCER AGENT ME, V9, P471, DOI 10.2174/1871520610909040471; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Ling S, 2008, HETEROATOM CHEM, V19, P2, DOI 10.1002/hc.20375; MACKIE A, 1954, J CHEM SOC, P4430, DOI 10.1039/jr9540004430; Mazuc E, 2008, J ALLERGY CLIN IMMUN, V122, P188, DOI 10.1016/j.jaci.2008.04.026; Miduturu Chandrasekhar V, 2011, CHEM BIOL, V18, P868; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Okano M, 2009, Diffraction optical element, Patent No. [JP4238296B2, 4238296]; PAOLO P, 2000, Patent No. 2000026203; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Rana A, 2008, EUR J MED CHEM, V43, P1114, DOI 10.1016/j.ejmech.2007.07.008; RAREY M, 2006, METHODS PRINC MED CH, V32, P81; Rinaldi A, 2006, BRIT J HAEMATOL, V132, P303, DOI 10.1111/j.1365-2141.2005.05883.x; Rossi AB, 2006, J ALLERGY CLIN IMMUN, V118, P749, DOI 10.1016/j.jaci.2006.05.023; Schaefer BC, 1999, IMMUNITY, V11, P411, DOI 10.1016/S1074-7613(00)80116-8; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Song EY, 2008, EUR J MED CHEM, V43, P1519, DOI 10.1016/j.ejmech.2007.10.008; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Vapnik V., 1995, NATURE STAT LEARNING, V38, P409; Vieth M, 2009, J MED CHEM, V52, P6456, DOI 10.1021/jm901147e; Wang WY, 2007, BIOCHEM PHARMACOL, V74, P601, DOI 10.1016/j.bcp.2007.06.001; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Yamamoto N, 2003, ANAL BIOCHEM, V315, P256, DOI 10.1016/S0003-2697(03)00026-5; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	60	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49284	10.1371/journal.pone.0049284	http://dx.doi.org/10.1371/journal.pone.0049284			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185312	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700027
J	Goktug, AN; Ong, SS; Chen, TS				Goktug, Asli N.; Ong, Su Sien; Chen, Taosheng			GUItars: A GUI Tool for Analysis of High-Throughput RNA Interference Screening Data	PLOS ONE			English	Article							FALSE NONDISCOVERY RATES; ASSAY QUALITY ASSESSMENT; HIT SELECTION; STATISTICAL-METHODS; DISCOVERY; PARAMETER; GENE; SSMD	Background: High-throughput RNA interference (RNAi) screening has become a widely used approach to elucidating gene functions. However, analysis and annotation of large data sets generated from these screens has been a challenge for researchers without a programming background. Over the years, numerous data analysis methods were produced for plate quality control and hit selection and implemented by a few open-access software packages. Recently, strictly standardized mean difference (SSMD) has become a widely used method for RNAi screening analysis mainly due to its better control of false negative and false positive rates and its ability to quantify RNAi effects with a statistical basis. We have developed GUItars to enable researchers without a programming background to use SSMD as both a plate quality and a hit selection metric to analyze large data sets. Results: The software is accompanied by an intuitive graphical user interface for easy and rapid analysis workflow. SSMD analysis methods have been provided to the users along with traditionally-used z-score, normalized percent activity, and t-test methods for hit selection. GUItars is capable of analyzing large-scale data sets from screens with or without replicates. The software is designed to automatically generate and save numerous graphical outputs known to be among the most informative high-throughput data visualization tools capturing plate-wise and screen-wise performances. Graphical outputs are also written in HTML format for easy access, and a comprehensive summary of screening results is written into tab-delimited output files. Conclusion: With GUItars, we demonstrated robust SSMD-based analysis workflow on a 3840-gene small interfering RNA (siRNA) library and identified 200 siRNAs that increased and 150 siRNAs that decreased the assay activities with moderate to stronger effects. GUItars enables rapid analysis and illustration of data from large- or small-scale RNAi screens using SSMD and other traditional analysis methods. The software is freely available at http://sourceforge.net/projects/guitars/.	[Goktug, Asli N.; Ong, Su Sien; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Chen, TS (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	taosheng.chen@stjude.org	Chen, Taosheng/I-6351-2013	Chen, Taosheng/0000-0001-6420-3809	American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital; National Cancer Institute [P30CA027165]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital, and National Cancer Institute grant P30CA027165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Carralot JP, 2012, BIOINFORMATICS, V28, P261, DOI 10.1093/bioinformatics/btr648; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Gribbon P, 2005, J BIOMOL SCREEN, V10, P99, DOI 10.1177/1087057104271957; Gunter B, 2003, J BIOMOL SCREEN, V8, P624, DOI 10.1177/1087057103258284; Huber PJ, 1981, ROBUST STAT; Kevorkov D, 2005, J BIOMOL SCREEN, V10, P557, DOI 10.1177/1087057105276989; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kummel A, 2010, J BIOMOL SCREEN, V15, P95, DOI 10.1177/1087057109351311; Mahanthappa N, 2005, PHARMACOGENOMICS, V6, P879, DOI 10.2217/14622416.6.8.879; Makarenkov V, 2007, BIOINFORMATICS, V23, P1648, DOI 10.1093/bioinformatics/btm145; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Pelz O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-185; Prummer M, 2012, J BIOMOL SCREEN, V17, P519, DOI 10.1177/1087057111431278; Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014; ROUSSEEUW PJ, 1991, J CHEMOMETR, V5, P1, DOI 10.1002/cem.1180050103; Sui YX, 2007, J BIOMOL SCREEN, V12, P229, DOI 10.1177/1087057106296498; Tukey JW, 1977, EXPLORATORY DATA ANA; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XD, 2011, OPTIMAL HIGH THROUGH; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhang XD, 2007, J BIOMOL SCREEN, V12, P497, DOI 10.1177/1087057107300646; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851; Zhang XHD, 2010, J BIOMOL SCREEN, V15, P1116, DOI 10.1177/1087057110381783; Zhang XHD, 2010, J BIOMOL SCREEN, V15, P1123, DOI 10.1177/1087057110381919; Zhang XD, 2010, PHARMACOGENOMICS, V11, P199, DOI [10.2217/pgs.09.136, 10.2217/PGS.09.136]; Zhang XD, 2009, PHARMACOGENOMICS, V10, P345, DOI 10.2217/14622416.10.3.345	32	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49386	10.1371/journal.pone.0049386	http://dx.doi.org/10.1371/journal.pone.0049386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185323	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700029
J	Hobbelen, PHF; Samuel, MD; LaPointe, DA; Atkinson, CT				Hobbelen, Peter H. F.; Samuel, Michael D.; LaPointe, Dennis A.; Atkinson, Carter T.			Modeling Future Conservation of Hawaiian Honeycreepers by Mosquito Management and Translocation of Disease-Tolerant Amakihi	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS DIPTERA; MALARIA PLASMODIUM-RELICTUM; AVIAN MALARIA; CLIMATE-CHANGE; BIRDS; DYNAMICS; EPIZOOTIOLOGY; TRANSMISSION; CULICIDAE; EVOLUTION	Avian malaria is an important cause of the decline of endemic Hawaiian honeycreepers. Because of the complexity of this disease system we used a computer model of avian malaria in forest birds to evaluate how two proposed conservation strategies: 1) reduction of habitat for mosquito larvae and 2) establishment of a low-elevation, malaria-tolerant honeycreeper (Hawaii Amakihi) to mid-elevation forests would affect native Hawaiian honeycreeper populations. We evaluated these approaches in mid-elevation forests, where malaria transmission is seasonal and control strategies are more likely to work. Our model suggests the potential benefit of larval habitat reduction depends on the level of malaria transmission, abundance of larval cavities, and the ability to substantially reduce these cavities. Permanent reduction in larval habitat of >80% may be needed to control abundance of infectious mosquitoes and benefit bird populations. Establishment of malaria-tolerant Amakihi in mid-elevation forests increases Amakihi abundance, creates a larger disease reservoir, and increases the abundance of infectious mosquitoes which may negatively impact other honeycreepers. For mid-elevation sites where bird populations are severely affected by avian malaria, malaria-tolerant Amakihi had little impact on other honeycreepers. Both management strategies may benefit native Hawaiian honeycreepers, but benefits depend on specific forest characteristics, the amount of reduction in larval habitat that can be achieved, and how malaria transmission is affected by temperature.	[Samuel, Michael D.] Univ Wisconsin, Wisconsin Cooperat Wildlife Res Unit, US Geol Survey, Madison, WI 53706 USA; [Hobbelen, Peter H. F.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Samuel, MD (corresponding author), Univ Wisconsin, Wisconsin Cooperat Wildlife Res Unit, US Geol Survey, Madison, WI 53706 USA.	mdsamuel@wisc.edu		LaPointe, Dennis/0000-0002-6323-263X	National Science Foundation [DEB 0083944]; U.S. Geological Survey Wildlife and Invasive Species Programs	National Science Foundation(National Science Foundation (NSF)); U.S. Geological Survey Wildlife and Invasive Species Programs	This work was supported with funding from the National Science Foundation (DEB 0083944) and the U.S. Geological Survey Wildlife and Invasive Species Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada JA, 2004, J MED ENTOMOL, V41, P1157, DOI 10.1603/0022-2585-41.6.1157; Ahumada Jorge A., 2009, P331; [Anonymous], 2003, MOSQUITOES THEIR CON; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Atkinson CT, 2010, J AVIAN BIOL, V41, P357, DOI 10.1111/j.1600-048X.2009.04915.x; Atkinson Carter T., 2009, P234; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Atkinson CT, 2001, J WILDLIFE DIS, V37, P20, DOI 10.7589/0090-3558-37.1.20; Banko Paul C., 2009, P159; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Cann RL, 1999, GENETICS AND THE EXTINCTION OF SPECIES, P121; Foster JT, 2007, MOL ECOL, V16, P4738, DOI 10.1111/j.1365-294X.2007.03550.x; FREED LA, 1989, BIOSCIENCE, V39, P475, DOI 10.2307/1311141; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Giambelluca TW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034377; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Hobbelen PHF, 2013, THEOR ECOL-NETH, V6, P31, DOI 10.1007/s12080-011-0154-9; Jacobi James D., 1995, P376; Kilpatrick AM, 2006, BIOL CONSERV, V128, P475, DOI 10.1016/j.biocon.2005.10.014; Lapointe DA, 2008, J MED ENTOMOL, V45, P600, DOI 10.1603/0022-2585(2008)45[600:DOCQDC]2.0.CO;2; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Lapointe Dennis A., 2009, P405; Leonard DL, 2008, BIOL CONSERV, V141, P2054, DOI 10.1016/j.biocon.2008.06.001; Mackinnon MJ, 2004, PLOS BIOL, V2, P1286, DOI 10.1371/journal.pbio.0020230; MOUNTAINSPRING S, 1985, ECOL MONOGR, V55, P219, DOI 10.2307/1942558; Rock KS, 2012, ECOL MODEL, V235, P26, DOI 10.1016/j.ecolmodel.2012.04.004; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Schmolke A, 2010, TRENDS ECOL EVOL, V25, P479, DOI 10.1016/j.tree.2010.05.001; Scott JM, 2009, NATURE, V457, P956, DOI 10.1038/457956b; SCOTT JM, 2002, EVOLUTION ECOLOGY CO; Stankey G.H., 2005, ADAPTIVE MANAGEMENT, P73; The Mathworks, 2008, MATL VERS R2008A; Timm O, 2009, J CLIMATE, V22, P4261, DOI 10.1175/2009JCLI2833.1; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Wolf CM, 1998, BIOL CONSERV, V86, P243; Woodworth BL, 2005, P NATL ACAD SCI USA, V102, P1531, DOI 10.1073/pnas.0409454102; Yorinks N, 2000, AUK, V117, P731, DOI 10.1642/0004-8038(2000)117[0731:EOMOAB]2.0.CO;2	39	11	11	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49594	10.1371/journal.pone.0049594	http://dx.doi.org/10.1371/journal.pone.0049594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185375	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700041
J	Jaime, GRL; Kashani, AH; Saati, S; Martin, G; Chader, G; Humayun, MS				Jaime, Gilberto Raul Lopez; Kashani, Amir H.; Saati, Saloomeh; Martin, Gabriel; Chader, Gerald; Humayun, Mark S.			Acute Variations in Retinal Vascular Oxygen Content in a Rabbit Model of Retinal Venous Occlusion	PLOS ONE			English	Article							VEIN OCCLUSION; SATURATION; FUNDUS; BLOOD; OXIMETRY; INTRAVITREAL; CALIBRATION; WAVELENGTH; VESSELS	Purpose: To study the variation in intravascular oxygen saturation (oximetry) during an acute retinal vein occlusion (RVO) using hyperspectral computed tomographic spectroscopy based oximetry measurements. Methods: Thirty rabbits were dilated and anesthetized for experiments. Baseline oximetry measurements were made using a custom-made hyperspectral computed tomographic imaging spectrometer coupled to a fundus camera. RVO were induced using argon green laser following an intravenous injection of Rose Bengal. RVO induction was confirmed by fluorescein angiography. Retinal oximetry measurements were repeated in arterial and venous branches one hour after RVO induction and up to 4 weeks afterwards. Comparison of retinal oximetry before and after vein occlusion was made using the Student T-test. Results: One hour after RVO induction, we observed statistically significant reductions in the intravascular oxygen saturation in temporal retinal arteries (85.1 +/- 6.1% vs. 80.6 +/- 6.6%; p<0.0001) and veins (71.4 +/- 5.5% vs. 64.0 +/- 4.7%; p<0.0001). This decrease was reversible in animals that spontaneously recannulated the vein occlusion. There were no statistically significant differences in oxygen saturation in the nasal control arteries and veins before and after temporal vein RVO induction. Conclusions: We demonstrate, for the first time, acute changes in the intravascular oxygen content of retinal vessels 1 hour after RVO. These changes are reversible upon spontaneous recannulation of retinal vessels. This study demonstrates that hyperspectral computer tomographic spectroscopy based oximetry can detect physiological variations in intravascular retinal oxygen saturation. The study also provides the first qualitative and quantitative evidence of the variation in retinal vascular oxygen content directly attributable to an acute retinal vein occlusion.	[Kashani, Amir H.] William Beaumont Hosp, Dept Ophthalmol, Royal Oak, MI 48072 USA; [Kashani, Amir H.] Associated Retinal Consultants PC, Royal Oak, MI USA; [Jaime, Gilberto Raul Lopez; Saati, Saloomeh; Chader, Gerald; Humayun, Mark S.] Univ So Calif, Doheny Eye Inst, Los Angeles, CA USA; [Humayun, Mark S.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Humayun, Mark S.] Univ So Calif, Dept Neurosci, Los Angeles, CA USA; [Humayun, Mark S.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Martin, Gabriel] Reichert Technol, Buffalo, NY USA	Beaumont Health; Doheny Eye Institute; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Kashani, AH (corresponding author), William Beaumont Hosp, Dept Ophthalmol, Royal Oak, MI 48072 USA.	kashani.ah@gmail.com			National Science Foundation (NSF) Engineering Research Center for Biomimetic and Microelectronic Systems at the University of Southern California [NSF EEC-0310723]; United States National Institutes of Health (NIH) Core Biostatistics Module at the Doheny Eye Institute (NIH) [5P30EY003040-30]; Jean Perkins Foundation; Reichert Technologies; Reichert Technologies Inc	National Science Foundation (NSF) Engineering Research Center for Biomimetic and Microelectronic Systems at the University of Southern California(National Science Foundation (NSF)); United States National Institutes of Health (NIH) Core Biostatistics Module at the Doheny Eye Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jean Perkins Foundation; Reichert Technologies; Reichert Technologies Inc	The authors would like to acknowledge funding support from the National Science Foundation (NSF) Engineering Research Center for Biomimetic and Microelectronic Systems at the University of Southern California (NSF EEC-0310723), United States National Institutes of Health (NIH) Core Biostatistics Module at the Doheny Eye Institute (NIH Core Grant 5P30EY003040-30), the Jean Perkins Foundation and Reichert Technologies. The funders had no role in study design, data collection and decision to publish, or preparation of the manuscript. GM and Reichert Technologies are responsible for the software algorithms used in the data analysis but were not responsible for or part of the actual data collection or analysis.; The authors have read the journal's policy and have the following conflicts. The University of Southern California has received research funding from Reichert Technologies Inc in support of this project. AHK and MSH have filed for intellectual property claims relating to the methods in the manuscript. GM is an employee of Reichert Technologies which has a commercial interest in the technology discussed in the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ameri H, 2008, GRAEF ARCH CLIN EXP, V246, P1429, DOI 10.1007/s00417-008-0878-4; Ameri H, 2008, RETINA-J RET VIT DIS, V28, P350, DOI 10.1097/IAE.0b013e318140580c; Ashman Ross A., 2001, International Ophthalmology, V23, P343, DOI 10.1023/A:1014406831412; Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; COHEN AJ, 1976, IEEE T BIO-MED ENG, V23, P391, DOI 10.1109/TBME.1976.324650; DELORI FC, 1988, APPL OPTICS, V27, P1113, DOI 10.1364/AO.27.001113; Denninghoff KR, 2003, J APPL PHYSIOL, V94, P891, DOI 10.1152/japplphysiol.01197.2001; DESCOUR M, 1995, APPL OPTICS, V34, P4817, DOI 10.1364/AO.34.004817; DESCOUR MR, 1995, P SOC PHOTO-OPT INS, V2480, P48, DOI 10.1117/12.210908; GLOSTER J, 1967, EXP EYE RES, V6, P187, DOI 10.1016/S0014-4835(67)80032-0; Gorman A, 2010, OPT EXPRESS, V18, P5602, DOI 10.1364/OE.18.005602; Hammer H., 2001, International Ophthalmology, V23, P291, DOI 10.1023/A:1014430009122; Hammer M, 2001, IEEE T BIO-MED ENG, V48, P592, DOI 10.1109/10.918598; HAMMER M, 2010, INVEST OPHTH VIS SCI, V52, P274; Hammer M, 2009, GRAEF ARCH CLIN EXP, V247, P1025, DOI 10.1007/s00417-009-1078-6; Hammer M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976032; Hardarson SH, 2012, ACTA OPHTHALMOL; Hardarson SH, 2006, INVEST OPHTH VIS SCI, V47, P5011, DOI 10.1167/iovs.06-0039; Hardarson SH, 2012, ACTA OPHTHALMOL, V90, P466, DOI 10.1111/j.1755-3768.2011.02109.x; Hardarson SH, 2012, BRIT J OPHTHALMOL, V96, P560, DOI 10.1136/bjophthalmol-2011-300640; Hardarson SH, 2010, AM J OPHTHALMOL, V150, P871, DOI 10.1016/j.ajo.2010.06.020; Hardarson SH, 2009, INVEST OPHTH VIS SCI, V50, P2308, DOI 10.1167/iovs.08-2576; Harris A, 2003, OPHTHAL SURG LAS IM, V34, P152, DOI 10.3928/1542-8877-20030301-16; Hayreh SS, 2003, OPHTHALMOLOGICA, V217, P167, DOI 10.1159/000068980; HICKAM JB, 1963, CIRCULATION, V27, P375, DOI 10.1161/01.CIR.27.3.375; Hirohara Y, 2007, OPT REV, V14, P151, DOI 10.1007/BF02919416; HYVARINEN L, 1967, ACTA OPHTHALMOL, V45, P862; HYVARINEN L, 1967, ACTA OPHTHALMOL, V45, P852; Johnson WR, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2434950; Kashani AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024482; Khoobehi B, 2004, INVEST OPHTH VIS SCI, V45, P1464, DOI 10.1167/iovs.03-1069; LAING RA, 1975, INVEST OPHTH VISUAL, V14, P606; Larsson J, 1998, BRIT J OPHTHALMOL, V82, P1438, DOI 10.1136/bjo.82.12.1438; Mordant DJ, 2011, INVEST OPHTH VIS SCI, V52, P2851, DOI 10.1167/iovs.10-6217; Nelson DA, 2005, OPHTHAL SURG LAS IM, V36, P57; Ninomiya H, 2008, J VET MED SCI, V70, P887, DOI 10.1292/jvms.70.887; Nourrit V, 2010, J FR OPHTALMOL, V33, P686, DOI 10.1016/j.jfo.2010.10.010; ROYSTER AJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P1608, DOI 10.1001/archopht.1988.01060140776054; Salyer DA, 2006, CURR EYE RES, V31, P617, DOI 10.1080/02713680600760493; Shahidi M, 2010, INVEST OPHTH VIS SCI, V51, P4766, DOI 10.1167/iovs.09-4710; SUGIYAMA K, 1992, INVEST OPHTH VIS SCI, V33, P2251; Traustason S, 2009, BRIT J OPHTHALMOL, V93, P1064, DOI 10.1136/bjo.2008.148460; Wankhede M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316299	43	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50179	10.1371/journal.pone.0050179	http://dx.doi.org/10.1371/journal.pone.0050179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185567	Green Submitted, Green Published, gold			2022-12-25	WOS:000311535700075
J	Tan, XC; Wang, S; Yang, B; Zhu, LY; Yin, B; Chao, TF; Zhao, JZ; Yuan, JG; Qiang, BQ; Peng, XZ				Tan, Xiaochao; Wang, Shan; Yang, Bin; Zhu, Liyuan; Yin, Bin; Chao, Tengfei; Zhao, Jizong; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong			The CREB-miR-9 Negative Feedback Minicircuitry Coordinates the Migration and Proliferation of Glioma Cells	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CANCER METASTASIS; LUNG-CANCER; EXPRESSION; GLIOBLASTOMA; GROWTH; GENE; CREB; MICRORNA; TARGETS	Migration-proliferation dichotomy is a common mechanism in gliomagenesis; however, an understanding of the exact molecular mechanism of this "go or grow" phenomenon remains largely incomplete. In the present study, we first found that microRNA-9 (miR-9) is highly expressed in glioma cells. MiR-9 inhibited the proliferation and promoted the migration of glioma cells by directly targeting cyclic AMP response element-binding protein (CREB) and neurofibromin 1 (NF1), respectively. Our data also suggested a migration-inhibitory role for CREB through directly regulating the transcription of NF1. Furthermore, we found that the transcription of miR-9-1 is under CREB's control, forming a negative feedback minicircuitry. Taken together, miR-9 inhibits proliferation but promotes migration, whereas CREB plays a pro-proliferative and anti-migratory role, suggesting that the CREB-miR-9 negative feedback minicircuitry plays a critical role in the determination of "go or grow" in glioma cells.	[Tan, Xiaochao; Wang, Shan; Yang, Bin; Zhu, Liyuan; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China; [Tan, Xiaochao; Wang, Shan; Yang, Bin; Zhu, Liyuan; Yin, Bin; Yuan, Jiangang; Qiang, Boqin; Peng, Xiaozhong] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chao, Tengfei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan 430074, Peoples R China; [Zhao, Jizong] Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology; Capital Medical University	Qiang, BQ (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China.	Qiang.boqin@imicams.ac.cn; pengxiaozhong@pumc.edu.cn	tan, xiaochao/AAG-6239-2021		'973' project [2011CBA01104, 2007CB946902, 2009CB825403]; National Sciences Foundation of China [30825023, 31071203]; Program for New Century Excellent Talents [NCET-07-0505]; '111' project	'973' project(National Basic Research Program of China); National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); '111' project(Ministry of Education, China - 111 Project)	This work was supported by the grants received from '973' project (2011CBA01104, 2007CB946902 and 2009CB825403), National Sciences Foundation of China (30825023, 31071203), Program for New Century Excellent Talents (NCET-07-0505) and '111' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Chao Teng-Fei, 2008, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V30, P268; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Guo LM, 2009, FEBS J, V276, P5537, DOI 10.1111/j.1742-4658.2009.07237.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heller G, 2012, CLIN CANCER RES, V18, P1619, DOI 10.1158/1078-0432.CCR-11-2450; Horing E, ACTA NEUROPATHOL; Horing E, 2012, ACTA NEUROPATHOL; Hsu PY, 2009, CANCER RES, V69, P5936, DOI 10.1158/0008-5472.CAN-08-4914; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kong WQ, 2012, FEBS J, V279, P1252, DOI 10.1111/j.1742-4658.2012.08519.x; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Ozawa T, 2005, J BIOL CHEM, V280, P39524, DOI 10.1074/jbc.M503707200; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Son J, 2010, BIOCHEM BIOPH RES CO, V398, P309, DOI 10.1016/j.bbrc.2010.06.087; Starinsky-Elbaz S, 2009, MOL CELL NEUROSCI, V42, P278, DOI 10.1016/j.mcn.2009.07.014; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tan XC, 2012, P NATL ACAD SCI USA, V109, P15805, DOI 10.1073/pnas.1207787109; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Wu S. M., 2011, ONCOGENE; Zhang H, 2012, MOL CANC THER; Zhu L, 2012, MED ONCOL, V29, P1037, DOI 10.1007/s12032-011-9975-z; Zou MX, 2004, ONCOGENE, V23, P330, DOI 10.1038/sj.onc.1207053	37	68	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49570	10.1371/journal.pone.0049570	http://dx.doi.org/10.1371/journal.pone.0049570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185366	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700038
J	Thakur, GA; Sengupta, SM; Grizenko, N; Choudhry, Z; Joober, R				Thakur, Geeta A.; Sengupta, Sarojini M.; Grizenko, Natalie; Choudhry, Zia; Joober, Ridha			Comprehensive Phenotype/Genotype Analyses of the Norepinephrine Transporter Gene (SLC6A2) in ADHD: Relation to Maternal Smoking during Pregnancy	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NO EVIDENCE; NORADRENALINE TRANSPORTER; CANDIDATE GENES; METHYLPHENIDATE RESPONSE; HYPERKINETIC DISORDER; DOPAMINE TRANSPORTER; CRITERION VALIDITY; ASSOCIATION	Objective: Despite strong pharmacological evidence implicating the norepinephrine transporter in ADHD, genetic studies have yielded largely insignificant results. We tested the association between 30 tag SNPs within the SLC6A2 gene and ADHD, with stratification based on maternal smoking during pregnancy, an environmental factor strongly associated with ADHD. Methods: Children (6-12 years old) diagnosed with ADHD according to DSM-IV criteria were comprehensively evaluated with regard to several behavioral and cognitive dimensions of ADHD as well as response to a fixed dose of methylphenidate (MPH) using a double-blind placebo controlled crossover trial. Family-based association tests (FBAT), including categorical and quantitative trait analyses, were conducted in 377 nuclear families. Results: A highly significant association was observed with rs36021 (and linked SNPs) in the group where mothers smoked during pregnancy. Association was noted with categorical DSM-IV ADHD diagnosis (Z = 3.74, P = 0.0002), behavioral assessments by parents (CBCL, P = 0.00008), as well as restless-impulsive subscale scores on Conners'-teachers (P = 0.006) and parents (P = 0.006). In this subgroup, significant association was also observed with cognitive deficits, more specifically sustained attention, spatial working memory, planning, and response inhibition. The risk allele was associated with significant improvement of behavior as measured by research staff (Z = 3.28, P = 0.001), parents (Z = 2.62, P = 0.009), as well as evaluation in the simulated academic environment (Z = 3.58, P = 0.0003). Conclusions: By using maternal smoking during pregnancy to index a putatively more homogeneous group of ADHD, highly significant associations were observed between tag SNPs within SLC6A2 and ADHD diagnosis, behavioral and cognitive measures relevant to ADHD and response to MPH. This comprehensive phenotype/genotype analysis may help to further understand this complex disorder and improve its treatment. Clinical trial registration information - Clinical and Pharmacogenetic Study of Attention Deficit with Hyperactivity Disorder (ADHD); www.clinicaltrials.gov; NCT00483106.	[Thakur, Geeta A.; Sengupta, Sarojini M.; Grizenko, Natalie; Choudhry, Zia; Joober, Ridha] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Thakur, Geeta A.; Joober, Ridha] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada; [Grizenko, Natalie; Joober, Ridha] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Choudhry, Zia; Joober, Ridha] McGill Univ, Dept Human Genet, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Sengupta, SM (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	sarojini.sengupta@douglas.mcgill.ca			Fonds de la recherche en sante du Quebec; Canadian Institutes of Health Research; CIHR; NARSAD Young Investigator Award; Dr. Mortimer D. Sackler Developmental Psychology Investigator Award	Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); NARSAD Young Investigator Award(NARSAD); Dr. Mortimer D. Sackler Developmental Psychology Investigator Award	This work was supported in part by grants from the Fonds de la recherche en sante du Quebec and the Canadian Institutes of Health Research to RJ. GAT holds a Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award from CIHR. SS is a recipient of the 2008 NARSAD Young Investigator and 2009 Dr. Mortimer D. Sackler Developmental Psychology Investigator Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; Arnsten AFT, 2011, PHARMACOL BIOCHEM BE, V99, P211, DOI 10.1016/j.pbb.2011.01.020; Barkley R. A, 2014, ATTENTION DEFICIT HY; Barr CL, 2002, AM J MED GENET, V114, P255, DOI 10.1002/ajmg.10193; Biederman J, 2002, J Atten Disord, V6 Suppl 1, pS101; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Biederman J, 2008, AM J MED GENET B, V147B, P1511, DOI 10.1002/ajmg.b.30874; Bobb AJ, 2005, AM J MED GENET B, V134B, P67, DOI 10.1002/ajmg.b.30142; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; BRUSS M, 1993, HUM GENET, V91, P278; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cho SC, 2011, J PSYCHOPHARMACOLOGY; Cho SC, 2008, NEUROPSYCHOBIOLOGY, V57, P131, DOI 10.1159/000138916; Choudhry Z., 2012, J CHILD PSYCHOL PSYC; Conners C. K, 2000, CONNERS CPT 2 TECHNI CONNERS CPT 2 TECHNI; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Conners CK, 1995, CONNERS CONTINUOUS P; De Luca V, 2004, AM J MED GENET B, V124B, P38, DOI 10.1002/ajmg.b.20075; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Ehrich M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni038; Ernst M, 2001, J AM ACAD CHILD PSY, V40, P630, DOI 10.1097/00004583-200106000-00007; Faraone SV, 2004, J CLIN PSYCHOPHARM, V24, P24, DOI 10.1097/01.jcp.0000108984.11879.95; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fischer M, 1998, J LEARN DISABIL, V31, P608, DOI 10.1177/002221949803100611; Forero DA, 2009, J PSYCHIATR NEUROSCI, V34, P361; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grizenko N, 2006, J AM ACAD CHILD PSY, V45, P47, DOI 10.1097/01.chi.0000184932.64294.d9; Gruber R, 2007, SLEEP, V30, P1003, DOI 10.1093/sleep/30.8.1003; Hanna GL, 1996, J CHILD ADOL PSYCHOP, V6, P63, DOI 10.1089/cap.1996.6.63; Heaton R.K., 1993, WISCONSIN CARD SORTI; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hudziak JJ, 2005, AM J PSYCHIAT, V162, P1614, DOI 10.1176/appi.ajp.162.9.1614; Joung Y, 2010, AM J MED GENET B, V153B, P691, DOI 10.1002/ajmg.b.31012; Karama S, 2009, J ATTEN DISORD, V12, P442, DOI 10.1177/1087054708314605; Kebir O, 2009, J PSYCHIATR NEUROSCI, V34, P88; Kim BN, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-57; Kim CH, 2008, ANN NY ACAD SCI, V1129, P256, DOI 10.1196/annals.1417.023; Kim CH, 2006, P NATL ACAD SCI USA, V103, P19164, DOI 10.1073/pnas.0510836103; Kim JW, 2008, MOL PSYCHIATR, V13, P624, DOI 10.1038/sj.mp.4002090; Kollins SH, 2008, AM J MED GENET B, V147B, P1580, DOI 10.1002/ajmg.b.30876; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Langley K, 2005, Minerva Pediatr, V57, P359; Lee SH, 2011, PSYCHIAT RES, V186, P338, DOI 10.1016/j.psychres.2010.08.033; Lindblad F, 2010, NICOTINE TOB RES, V12, P408, DOI 10.1093/ntr/ntq017; Linnet KM, 2005, PEDIATRICS, V116, P462, DOI 10.1542/peds.2004-2054; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Madras BK, 2005, BIOL PSYCHIAT, V57, P1397, DOI 10.1016/j.biopsych.2004.10.011; McClernon FJ, 2008, ANN NY ACAD SCI, V1141, P131, DOI 10.1196/annals.1441.016; McEvoy B, 2002, AM J MED GENET, V114, P665, DOI 10.1002/ajmg.10416; Mick E, 2008, AM J MED GENET B, V147B, P1412, DOI 10.1002/ajmg.b.30865; Mitsis EM, 2000, J AM ACAD CHILD PSY, V39, P308, DOI 10.1097/00004583-200003000-00012; Muller UC, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-55; Obel C, 2011, INT J EPIDEMIOL, V40, P338, DOI 10.1093/ije/dyq185; Obel C, 2009, INT J EPIDEMIOL, V38, P698, DOI 10.1093/ije/dym290; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Pomerleau O F, 1995, J Subst Abuse, V7, P373, DOI 10.1016/0899-3289(95)90030-6; PORZGEN P, 1995, BIOCHEM BIOPH RES CO, V215, P1145, DOI 10.1006/bbrc.1995.2582; Renner TJ, 2011, ADHD-ATTEND DEFICIT, V3, P285, DOI 10.1007/s12402-011-0060-4; Retz W, 2008, J NEURAL TRANSM, V115, P323, DOI 10.1007/s00702-007-0822-5; Rieppi R, 2002, J AM ACAD CHILD PSY, V41, P269, DOI 10.1097/00004583-200203000-00006; Sengupta S, 2008, NEUROPSYCHOPHARMACOL, V33, P3069, DOI 10.1038/npp.2008.85; Sengupta SM, 2012, J PSYCHIATR NEUROSCI, V37, P129, DOI 10.1503/jpn.110073; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHEKIM WO, 1983, BIOL PSYCHIAT, V18, P707; Sheslow D., 1990, WIDE RANGE ASSESSMEN; Song DH, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-12; Song J, 2011, INT CLIN PSYCHOPHARM, V26, P107, DOI 10.1097/YIC.0b013e32834152d1; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taerk Evan, 2004, BMC Med Genet, V5, P30, DOI 10.1186/1471-2350-5-30; Thakur G. A., 2012, NICOTINE TOBACCO RES; Thapar A, 2006, MOL PSYCHIATR, V11, P714, DOI 10.1038/sj.mp.4001831; TOULIATOS J, 1981, J ABNORM CHILD PSYCH, V9, P347, DOI 10.1007/BF00916839; UHL GR, 1994, J EXP BIOL, V196, P229; Volkow N D, 2001, J Neurosci, V21, pRC121; Wallis D, 2010, DRUG NEWS PERSPECT, V23, P438, DOI 10.1358/dnp.2010.23.7.1472296; Weschler D, 1991, WESCHLER INTELLINGEN; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Xu X, 2008, AM J MED GENET B, V147B, P1564, DOI 10.1002/ajmg.b.30872; Xu XH, 2005, AM J MED GENET B, V134B, P115, DOI 10.1002/ajmg.b.30160; Yang L, 2004, J AM ACAD CHILD PSY, V43, P1154, DOI 10.1097/01.chi.0000131134.63368.46	84	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49616	10.1371/journal.pone.0049616	http://dx.doi.org/10.1371/journal.pone.0049616			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185385	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700045
J	Glenn, WK; Heng, B; Delprado, W; Iacopetta, B; Whitaker, NJ; Lawson, JS				Glenn, Wendy K.; Heng, Benjamin; Delprado, Warick; Iacopetta, Barry; Whitaker, Noel J.; Lawson, James S.			Epstein-Barr Virus, Human Papillomavirus and Mouse Mammary Tumour Virus as Multiple Viruses in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-CELLS; INFECTION; DNA; CARCINOMA; SEQUENCES; WOMEN; PROGRESSION; PREVALENCE; SAMPLES; BLOOD	Background: The purpose of this investigation is to determine if Epstein Barr virus (EBV), high risk human papillomavirus (HPV), and mouse mammary tumour viruses (MMTV) co-exist in some breast cancers. Materials and Methods: All the specimens were from women residing in Australia. For investigations based on standard PCR, we used fresh frozen DNA extracts from 50 unselected invasive breast cancers. For normal breast specimens, we used DNA extracts from epithelial cells from milk donated by 40 lactating women. For investigations based on in situ PCR we used 27 unselected archival formalin fixed breast cancer specimens and 18 unselected archival formalin fixed normal breast specimens from women who had breast reduction surgery. Thirteen of these fixed breast cancer specimens were ductal carcinoma in situ (dcis) and 14 were predominantly invasive ductal carcinomas (idc). Results: EBV sequences were identified in 68%, high risk HPV sequences in 50%, and MMTV sequences in 78% of DNA extracted from 50 invasive breast cancer specimens. These same viruses were identified in selected normal and breast cancer specimens by in situ PCR. Sequences from more than one viral type were identified in 72% of the same breast cancer specimens. Normal controls showed these viruses were also present in epithelial cells in human milk - EBV (35%), HPV, 20%) and MMTV (32%) of 40 milk samples from normal lactating women, with multiple viruses being identified in 13% of the same milk samples. Conclusions: We conclude that (i) EBV, HPV and MMTV gene sequences are present and co-exist in many human breast cancers, (ii) the presence of these viruses in breast cancer is associated with young age of diagnosis and possibly an increased grade of breast cancer.	[Glenn, Wendy K.; Heng, Benjamin; Whitaker, Noel J.; Lawson, James S.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Delprado, Warick] Moir Pathol, Hanly, Douglass, Sydney, NSW, Australia; [Iacopetta, Barry] Univ Western Australia, Univ Dept Surg, Perth, WA 6009, Australia	University of New South Wales Sydney; University of Western Australia	Lawson, JS (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	james.lawson@unsw.edu.au	Heng, Ruiwen benjamin/U-7383-2019	Heng, Ruiwen benjamin/0000-0002-0247-2920				Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; Antonsson A, 2011, J MED VIROL, V83, P2157, DOI 10.1002/jmv.22223; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Buehring G. C., 2007, P AM ASSOC CANC RES, V48, P1747; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Chen ACH, 2009, J MED VIROL, V81, P1792, DOI 10.1002/jmv.21592; CINQUE P, 1993, LANCET, V342, P398, DOI 10.1016/0140-6736(93)92814-A; DAWKINS HJS, 1993, PATHOLOGY, V25, P124, DOI 10.3109/00313029309084784; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fina F, 2001, BRIT J CANCER, V84, P783, DOI 10.1054/bjoc.2000.1672; Ford CE, 2004, CANCER RES, V64, P4755, DOI 10.1158/0008-5472.CAN-03-3804; Hagensee ME, 2011, INT CTR GEN ENG BIOT; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Huang J, 2003, J VIROL, V77, P13267, DOI 10.1128/JVI.77.24.13267-13274.2003; Johal H, 2011, BREAST CANCER RES TR, V129, P149, DOI 10.1007/s10549-011-1421-6; Johal H, 2010, J MED VIROL, V82, P1044, DOI 10.1002/jmv.21754; Joshi D, 2012, BREAST CANCER RES TR, V135, P1, DOI 10.1007/s10549-011-1921-4; Joshi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008180; JUNKER AK, 1991, AM J MED SCI, V302, P220, DOI 10.1097/00000441-199110000-00005; Kalkan A, 2005, MED PRIN PRACT, V14, P268, DOI 10.1159/000085748; Khan NA, 2008, BRIT J CANCER, V99, P408, DOI 10.1038/sj.bjc.6604502; Krawczyk E, 2008, AM J PATHOL, V173, P682, DOI 10.2353/ajpath.2008.080280; Lawson JS, 2008, BRIT J CANCER, V98, P510, DOI 10.1038/sj.bjc.6604104; Lawson JS, 2009, BRIT J CANCER, V101, P1351, DOI 10.1038/sj.bjc.6605328; Lawson James S, 2010, Cancers (Basel), V2, P752, DOI 10.3390/cancers2020752; Lawson JS, 2010, CANCER RES, V70, P3576, DOI 10.1158/0008-5472.CAN-09-4160; Lin JH, 2007, J VIROL, V81, P5705, DOI 10.1128/JVI.00076-07; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Mammas IN, 2011, PATHOL ONCOL RES, V17, P103, DOI 10.1007/s12253-010-9288-0; Mazouni C, 2011, BRIT J CANCER, V104, P332, DOI 10.1038/sj.bjc.6606048; Mazzanti CM, 2011, AM J PATHOL, V179, P2083, DOI 10.1016/j.ajpath.2011.06.046; Murray PG, 2006, J PATHOL, V209, P427, DOI 10.1002/path.2032; Nuovo GJ, 2007, HUM PATHOL, V38, P1123, DOI 10.1016/j.humpath.2007.04.005; Park DJ, 2011, BREAST CANCER RES TR, V125, P229, DOI 10.1007/s10549-010-0946-4; Peran I, 2010, BRIT J CANCER, V102, P1549, DOI 10.1038/sj.bjc.6605671; Perkins RS, 2006, BREAST CANCER RES, V8, DOI 10.1186/BCR1627; Schneider F, 2008, PLOS BIOL, V6, P86, DOI 10.1371/journal.pbio.0060008; Speck P, 2000, J NATL CANCER I, V92, P1849, DOI 10.1093/jnci/92.22.1849; WANG Y, 1995, CANCER RES, V55, P5173; Xue SA, 2003, BRIT J CANCER, V89, P113, DOI 10.1038/sj.bjc.6601027; Yasui Y, 2001, CANCER EPIDEM BIOMAR, V10, P9	41	102	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48788	10.1371/journal.pone.0048788	http://dx.doi.org/10.1371/journal.pone.0048788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23183846	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800010
J	Singh, NN; Seo, J; Rahn, SJ; Singh, RN				Singh, Natalia N.; Seo, Joonbae; Rahn, Sarah J.; Singh, Ravindra N.			A Multi-Exon-Skipping Detection Assay Reveals Surprising Diversity of Splice Isoforms of Spinal Muscular Atrophy Genes	PLOS ONE			English	Article							SURVIVAL MOTOR-NEURON; MESSENGER-RNA; MOUSE MODEL; SMN EXPRESSION; COMPLEX; IDENTIFICATION; SPECIFICITY; ASSOCIATION; PROMOTERS; INCLUSION	Humans have two near identical copies of Survival Motor Neuron gene: SMN1 and SMN2. Loss of SMN1 coupled with the predominant skipping of SMN2 exon 7 causes spinal muscular atrophy (SMA), a neurodegenerative disease. SMA patient cells devoid of SMN1 provide a powerful system to examine splicing pattern of various SMN2 exons. Until now, similar system to examine splicing of SMN1 exons was unavailable. We have recently screened several patient cell lines derived from various diseases, including SMA, Alzheimer's disease, Parkinson's disease and Batten disease. Here we report a Batten disease cell line that lacks functional SMN2, as an ideal system to examine pre-mRNA splicing of SMN1. We employ a multiple-exon-skipping detection assay (MESDA) to capture simultaneously skipping of multiple exons. Our results show surprising diversity of splice isoforms and reveal novel splicing events that include skipping of exon 4 and co-skipping of three adjacent exons of SMN. Contrary to the general belief, MESDA captured oxidative-stress induced skipping of SMN1 exon 5 in several cell types, including non-neuronal cells. We further demonstrate that the predominant SMN2 exon 7 skipping induced by oxidative stress is modulated by a combinatorial control that includes promoter sequence, endogenous context, and the weak splice sites. We also show that an 8-mer antisense oligonucleotide blocking a recently described GC-rich sequence prevents SMN2 exon 7 skipping under the conditions of oxidative stress. Our findings bring new insight into splicing regulation of an essential housekeeping gene linked to neurodegeneration and infant mortality.	[Singh, Natalia N.; Seo, Joonbae; Rahn, Sarah J.; Singh, Ravindra N.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA	Iowa State University	Singh, RN (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	singhr@iastate.edu		Singh, Ravindra/0000-0001-5399-2662	United States National Institutes of Health [R01 NS055925, R21 NS072259, R21 NS080294]; Salsbury Endowment (Iowa State University, Ames, IA, USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055925, R21NS080294, R21NS072259] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Salsbury Endowment (Iowa State University, Ames, IA, USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from United States National Institutes of Health (R01 NS055925, R21 NS072259 and R21 NS080294) and Salsbury Endowment (Iowa State University, Ames, IA, USA) to RNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila AM, 2007, J CLIN INVEST, V117, P659, DOI 10.1172/JCI29562; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Bowerman M, 2007, J MOL NEUROSCI, V32, P120, DOI 10.1007/s12031-007-0024-5; Cauchi RJ, 2010, BIOESSAYS, V32, P1077, DOI 10.1002/bies.201000088; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; David CJ, 2008, GENE DEV, V22, P279, DOI 10.1101/gad.1643108; Deng N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr042; Disher K, 2007, GENOME, V50, P946, DOI 10.1139/G07-074; Dutertre M, 2011, RNA BIOL, V8, P740, DOI 10.4161/rna.8.5.16016; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Echaniz-Laguna A, 1999, AM J HUM GENET, V64, P1365, DOI 10.1086/302372; Echaniz-Laguna A, 2002, J NEUROL, V249, P290, DOI 10.1007/s004150200007; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Fuentes JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015769; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Garbes L, 2009, HUM MOL GENET, V18, P3645, DOI 10.1093/hmg/ddp313; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Jalanko A, 2006, BBA-MOL BASIS DIS, V1762, P934, DOI 10.1016/j.bbadis.2006.09.001; Kashima T, 2007, P NATL ACAD SCI USA, V104, P3426, DOI 10.1073/pnas.0700343104; Kim J, 2010, ANN CLIN LAB SCI, V40, P368; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lenzken SC, 2011, HUM MUTAT, V32, P168, DOI 10.1002/humu.21394; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Maracchioni A, 2007, J NEUROCHEM, V100, P142, DOI 10.1111/j.1471-4159.2006.04204.x; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matlin AJ, 2007, ADV EXP MED BIOL, V623, P14, DOI 10.1007/978-0-387-77374-2_2; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; Monani UR, 1999, BBA-GENE STRUCT EXPR, V1445, P330, DOI 10.1016/S0167-4781(99)00060-3; Montes M, 2012, MOL CELL BIOL, V32, P751, DOI 10.1128/MCB.06255-11; Munoz MJ, 2010, TRENDS BIOCHEM SCI, V35, P497, DOI 10.1016/j.tibs.2010.03.010; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Peter CJ, 2011, HUM MOL GENET, V20, P1701, DOI 10.1093/hmg/ddr046; Porensky P.N., 2011, HUM MOL GENET; Renvoise B, 2006, J CELL SCI, V119, P680, DOI 10.1242/jcs.02782; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Shababi M, 2010, DRUG NEWS PERSPECT, V23, P475, DOI 10.1358/dnp.2010.23.8.1507295; Singh NN, 2011, RNA BIOL, V8, P600, DOI 10.4161/rna.8.4.16224; Singh NN, 2011, MOL CELL BIOL, V31, P935, DOI 10.1128/MCB.00945-10; Singh NN, 2010, RNA, V16, P1167, DOI 10.1261/rna.2154310; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Singh NN, 2004, BIOCHEM BIOPH RES CO, V315, P381, DOI 10.1016/j.bbrc.2004.01.067; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Strasswimmer J, 1999, HUM MOL GENET, V8, P1219, DOI 10.1093/hmg/8.7.1219; Takaku M, 2011, BIOCHEMISTRY-US, V50, P6797, DOI 10.1021/bi200828g; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Todd AG, 2010, BIOCHEM BIOPH RES CO, V394, P211, DOI 10.1016/j.bbrc.2010.02.158; Vitte J, 2007, AM J PATHOL, V171, P1269, DOI 10.2353/ajpath.2007.070399; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Williams JH, 2009, J NEUROSCI, V29, P7633, DOI 10.1523/JNEUROSCI.0950-09.2009; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wirth B, 2006, PROG MOLEC, V44, P109; Xing Y, 2007, ADV EXP MED BIOL, V623, P36, DOI 10.1007/978-0-387-77374-2_3; Yu Y, 2008, CELL, V135, P1224, DOI 10.1016/j.cell.2008.10.046; Zhang ZY, 2011, J BIOL CHEM, V286, P10126, DOI 10.1074/jbc.M110.183970; Zou T, 2011, CELL MOL NEUROBIOL, V31, P541, DOI 10.1007/s10571-011-9647-8	78	44	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49595	10.1371/journal.pone.0049595	http://dx.doi.org/10.1371/journal.pone.0049595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185376	Green Submitted, gold, Green Published			2022-12-25	WOS:000311333800042
J	Slep, KC				Slep, Kevin C.			Structure of the Human Discs Large 1 PDZ2-Adenomatous Polyposis Coli Cytoskeletal Polarity Complex: Insight into Peptide Engagement and PDZ Clustering	PLOS ONE			English	Article							APC TUMOR-SUPPRESSOR; HUMAN HOMOLOG; BETA-CATENIN; GENE-PRODUCT; PROTEIN; BINDING; TANDEM; KINASE; MICROTUBULES; ASSOCIATION	The membrane associated guanylate kinase (MAGUK) family member, human Discs Large 1 (hDlg1) uses a PDZ domain array to interact with the polarity determinant, the Adenomatous Polyposis Coli (APC) microtubule plus end binding protein. The hDLG1-APC complex mediates a dynamic attachment between microtubule plus ends and polarized cortical determinants in epithelial cells, stem cells, and neuronal synapses. Using its multi-domain architecture, hDlg1 both scaffolds and regulates the polarity factors it engages. Molecular details underlying the hDlg1-APC interaction and insight into how the hDlg1 PDZ array may cluster and regulate its binding factors remain to be determined. Here, I present the crystal structure of the hDlg1 PDZ2-APC complex and the molecular determinants that mediate APC binding. The hDlg1 PDZ2-APC complex also provides insight into potential modes of ligand-dependent PDZ domain clustering that may parallel Dlg scaffold regulatory mechanisms. The hDlg1 PDZ2-APC complex presented here represents a core biological complex that bridges polarized cortical determinants with the dynamic microtubule cytoskeleton.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu			National Institutes of Health [1R01GM094415]; March of Dimes grant [1-FY11-434]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes grant(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM094415 to KCS and March of Dimes grant 1-FY11-434 to K. C. S. (http://www.nih.gov/; http://www.marchofdimes.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bezprozvanny I, 2001, FEBS LETT, V509, P457, DOI 10.1016/S0014-5793(01)03214-8; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; Cierpicki T, 2005, STRUCTURE, V13, P319, DOI 10.1016/j.str.2004.12.014; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2009, ADV EXP MED BIOL, V656, P30, DOI 10.1007/978-1-4419-1145-2_3; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Haq SR, 2010, J BIOL CHEM, V285, P18051, DOI 10.1074/jbc.M110.110833; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Iizuka-Kogo A, 2005, HISTOCHEM CELL BIOL, V123, P67, DOI 10.1007/s00418-004-0729-2; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kang BS, 2003, STRUCTURE, V11, P459, DOI 10.1016/S0969-2126(03)00052-2; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Laprise P, 2004, J BIOL CHEM, V279, P10157, DOI 10.1074/jbc.M309843200; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Long JF, 2008, J MOL BIOL, V375, P1457, DOI 10.1016/j.jmb.2007.11.088; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; McCann JJ, 2011, STRUCTURE, V19, P810, DOI 10.1016/j.str.2011.02.017; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; MUNEMITSU S, 1994, CANCER RES, V54, P3676; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Niethammer M, 1996, J NEUROSCI, V16, P2157; Oliva C, 2012, DEV NEUROBIOL, V72, P57, DOI 10.1002/dneu.20949; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; Reilein A, 2005, NAT CELL BIOL, V7, P463, DOI 10.1038/ncb1248; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu HJ, 1998, J CELL SCI, V111, P2365; Zhang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023507; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	52	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50097	10.1371/journal.pone.0050097	http://dx.doi.org/10.1371/journal.pone.0050097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185543	Green Submitted, gold, Green Published			2022-12-25	WOS:000311333800068
J	Karakas, M; Woetzel, N; Staritzbichler, R; Alexander, N; Weiner, BE; Meiler, J				Karakas, Mert; Woetzel, Nils; Staritzbichler, Rene; Alexander, Nathan; Weiner, Brian E.; Meiler, Jens			BCL::Fold - De Novo Prediction of Complex and Large Protein Topologies by Assembly of Secondary Structure Elements	PLOS ONE			English	Article							FOLD DETERMINATION; DATA-BANK; NMR; GENERATION; SEQUENCE; DETERMINANTS; CONSTRAINTS; DISTANCE; ROSETTA; REGIONS	Computational de novo protein structure prediction is limited to small proteins of simple topology. The present work explores an approach to extend beyond the current limitations through assembling protein topologies from idealized alpha-helices and beta-strands. The algorithm performs a Monte Carlo Metropolis simulated annealing folding simulation. It optimizes a knowledge-based potential that analyzes radius of gyration, beta-strand pairing, secondary structure element (SSE) packing, amino acid pair distance, amino acid environment, contact order, secondary structure prediction agreement and loop closure. Discontinuation of the protein chain favors sampling of non-local contacts and thereby creation of complex protein topologies. The folding simulation is accelerated through exclusion of flexible loop regions further reducing the size of the conformational search space. The algorithm is benchmarked on 66 proteins with lengths between 83 and 293 amino acids. For 61 out of these proteins, the best SSE-only models obtained have an RMSD100 below 8.0 angstrom and recover more than 20% of the native contacts. The algorithm assembles protein topologies with up to 215 residues and a relative contact order of 0.46. The method is tailored to be used in conjunction with low-resolution or sparse experimental data sets which often provide restraints for regions of defined secondary structure.	[Karakas, Mert; Woetzel, Nils; Staritzbichler, Rene; Alexander, Nathan; Weiner, Brian E.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Struct Biol Ctr, Nashville, TN 37212 USA	Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Struct Biol Ctr, Nashville, TN 37212 USA.	jens.meiler@vanderbilt.edu		Meiler, Jens/0000-0001-8945-193X; Staritzbichler, Rene/0000-0002-6719-2997	National Institute of Health [GM080403]; National Science Foundation [0742762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, T32GM008320] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grant GM080403 from the National Institute of Health and grant 0742762 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Alexander N, 2008, STRUCTURE, V16, P181, DOI 10.1016/j.str.2007.11.015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Bonneau R, 2002, J MOL BIOL, V322, P65, DOI 10.1016/S0022-2836(02)00698-8; Bonneau R, 2002, PROTEIN SCI, V11, P1937, DOI 10.1110/ps.3790102; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Bradley P, 2005, PROTEINS, V61, P128, DOI 10.1002/prot.20729; Bradley P, 2003, PROTEINS, V53, P457, DOI 10.1002/prot.10552; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Chandonia JM, 1999, PROTEINS, V35, P293; Chen HL, 2011, STRUCTURE, V19, P484, DOI 10.1016/j.str.2011.02.002; Chivian D, 2005, PROTEINS, V61, P157, DOI 10.1002/prot.20733; Daga PR, 2010, CURR TOP MED CHEM, V10, P84, DOI 10.2174/156802610790232314; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Galzitskaya OV, 2003, PROTEIN SCI, V12, P696, DOI 10.1110/ps.0233103; Ganguly S, 2011, STRUCTURE, V19, P441, DOI 10.1016/j.str.2011.03.008; Grana O, 2005, PROTEINS, V61, P214, DOI 10.1002/prot.20739; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; Hirst SJ, 2011, J STRUCT BIOL, V173, P506, DOI 10.1016/j.jsb.2010.10.013; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Karplus K, 1997, PROTEINS, P134; Kazmier K, 2011, J STRUCT BIOL, V173, P549, DOI 10.1016/j.jsb.2010.11.003; Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190; Kolinski A, 1998, PROTEINS, V32, P475, DOI 10.1002/(SICI)1097-0134(19980901)32:4<475::AID-PROT6>3.3.CO;2-B; Kryshtafovych A, 2009, PROTEINS, V77, P5, DOI 10.1002/prot.22517; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhn M, 2004, PROTEINS, V54, P282, DOI 10.1002/prot.10589; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; Latek D, 2011, J COMPUT CHEM, V32, P536, DOI 10.1002/jcc.21640; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Lindert S, 2009, J VIROL, V83, P11491, DOI 10.1128/JVI.01214-09; Lindert S, 2009, STRUCTURE, V17, P990, DOI 10.1016/j.str.2009.06.001; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu JF, 2001, PROTEIN SCI, V10, P1970, DOI 10.1110/ps.10101; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Meiler J, 2003, P NATL ACAD SCI USA, V100, P15404, DOI 10.1073/pnas.2434121100; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Moult J, 1997, PROTEINS, P2; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; ROST B, 1994, J MOL BIOL, V235, P13, DOI 10.1016/S0022-2836(05)80007-5; Rost B, 1996, METHOD ENZYMOL, V266, P525; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Rost Burkhard, 2003, Methods Biochem Anal, V44, P559; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Simoncini D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038799; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Singh P, 2010, ANAL CHEM, V82, P2636, DOI 10.1021/ac1000724; Skrisovska L, 2010, J BIOMOL NMR, V46, P51, DOI 10.1007/s10858-009-9362-7; Smith JA, 2007, BIOCHEMISTRY-US, V46, P14141, DOI 10.1021/bi701597s; Stevens RC, 2001, SCIENCE, V294, P89, DOI 10.1126/science.1066011; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang X, 2011, STRUCTURE, V19, P1138, DOI 10.1016/j.str.2011.06.001; Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Zhou HY, 2007, BIOPHYS J, V93, P1510, DOI 10.1529/biophysj.107.109959; Zhou HY, 2009, PROTEINS, V77, P123, DOI 10.1002/prot.22501; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	86	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49240	10.1371/journal.pone.0049240	http://dx.doi.org/10.1371/journal.pone.0049240			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173050	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300020
J	Wang, XD; Kou, XX; He, DQ; Zeng, MM; Meng, Z; Bi, RY; Liu, Y; Zhang, JN; Gan, YH; Zhou, YH				Wang, Xue-Dong; Kou, Xiao-Xing; He, Dan-Qing; Zeng, Min-Min; Meng, Zhen; Bi, Rui-Yun; Liu, Yan; Zhang, Jie-Ni; Gan, Ye-Hua; Zhou, Yan-Heng			Progression of Cartilage Degradation, Bone Resorption and Pain in Rat Temporomandibular Joint Osteoarthritis Induced by Injection of Iodoacetate	PLOS ONE			English	Article							GENE-EXPRESSION; FIBROBLAST DIFFERENTIATION; CONDYLAR CARTILAGE; DOWN-REGULATION; MODEL; CHONDROCYTES; INDUCTION; APOPTOSIS; DISORDERS; INFLAMMATION	Background: Osteoarthritis (OA) is an important subtype of temporomandibular disorders. A simple and reproducible animal model that mimics the histopathologic changes, both in the cartilage and subchondral bone, and clinical symptoms of temporomandibular joint osteoarthritis (TMJOA) would help in our understanding of its process and underlying mechanism. Objective: To explore whether injection of monosodium iodoacetate (MIA) into the upper compartment of rat TMJ could induce OA-like lesions. Methods: Female rats were injected with varied doses of MIA into the upper compartment and observed for up to 12 weeks. Histologic, radiographic, behavioral, and molecular changes in the TMJ were evaluated by light and electron microscopy, MicroCT scanning, head withdrawal threshold test, real-time PCR, immunohistochemistry, and TUNEL assay. Results: The intermediate zone of the disc loosened by 1 day post-MIA injection and thinned thereafter. Injection of an MIA dose of 0.5 mg or higher induced typical OA-like lesions in the TMJ within 4 weeks. Condylar destruction presented in a time-dependent manner, including chondrocyte apoptosis in the early stages, subsequent cartilage matrix disorganization and subchondral bone erosion, fibrosis, subchondral bone sclerosis, and osteophyte formation in the late stages. Nociceptive responses increased in the early stages, corresponding to severe synovitis. Furthermore, chondrocyte apoptosis and an imbalance between anabolism and catabolism of cartilage and subchondral bone might account for the condylar destruction. Conclusions: Multi-level data demonstrated a reliable and convenient rat model of TMJOA could be induced by MIA injection into the upper compartment. The model might facilitate TMJOA related researches.	[Wang, Xue-Dong; Kou, Xiao-Xing; He, Dan-Qing; Zeng, Min-Min; Liu, Yan; Zhang, Jie-Ni; Zhou, Yan-Heng] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China; [Meng, Zhen; Bi, Rui-Yun; Gan, Ye-Hua] Peking Univ, Sch & Hosp Stomatol, Ctr Temporomandibular Disorders & Orofacial Pain, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, XD (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China.	kqyehuagan@bjmu.edu.cn; yanhengzhou@gmail.com	, 许开源 18362929861 赛德阳光口腔/AFX-1820-2022; Zeng, Maomao/M-1422-2013; Zhou, Yanheng/ABG-5432-2021	Zeng, Maomao/0000-0001-9259-1992; Zhou, Yanheng/0000-0002-5610-9967; Qi, Ling/0000-0001-8229-0184	National Natural Science Foundation of China [81070849]; China International Science and Technology Cooperation [2010DFB32980]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Science and Technology Cooperation	This project is supported by the National Natural Science Foundation of China (Grant No. 81070849) and China International Science and Technology Cooperation (Grant No. 2010DFB32980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2002, ARTHRITIS RHEUM-US, V46, P1986, DOI 10.1002/art.10554; Bao JP, 2010, MOL BIOL REP, V37, P3265, DOI 10.1007/s11033-009-9911-x; Bar-Yehuda S, 2009, ARTHRITIS RHEUM-US, V60, P3061, DOI 10.1002/art.24817; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Beek M, 2001, J DENT RES, V80, P1913, DOI 10.1177/00220345010800101001; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P363; Brandt KD, 2002, BIORHEOLOGY, V39, P221; Campos MIG, 2008, INT J ORAL MAX SURG, V37, P529, DOI 10.1016/j.ijom.2008.02.011; Chagin AS, 2007, BONE, V40, P1415, DOI 10.1016/j.bone.2006.12.066; Cledes G, 2006, INT J ORAL MAX SURG, V35, P1026, DOI 10.1016/j.ijom.2006.05.003; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Deschner J, 2006, OSTEOARTHR CARTILAGE, V14, P264, DOI 10.1016/j.joca.2005.09.005; DIJKGRAAF LC, 1995, J ORAL MAXIL SURG, V53, P1182, DOI 10.1016/0278-2391(95)90632-0; Duygu G, 2011, INT J ORAL MAXILLOFA; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Fujisawa T, 2003, J DENT RES, V82, P731, DOI 10.1177/154405910308200914; Gao Y, 2011, J ETHNOPHARMACOL, V138, P472, DOI 10.1016/j.jep.2011.09.029; Grossin L, 2006, FASEB J, V20, P65, DOI 10.1096/fj.04-2889com; Gruber HE, 2003, CELLS TISSUES ORGANS, V174, P17, DOI 10.1159/000070571; Guingamp C, 1997, ARTHRITIS RHEUM, V40, P1670, DOI 10.1002/art.1780400917; Guler N, 2011, INT J ORAL MAXILLOFA; Hashimoto S, 1997, ARTHRITIS RHEUM-US, V40, P1749, DOI 10.1002/art.1780401004; Im HJ, 2010, ARTHRITIS RHEUM-US, V62, P2995, DOI 10.1002/art.27608; Imirzalioglu P, 2009, ORAL SURG ORAL MED O, V108, P693, DOI 10.1016/j.tripleo.2009.05.030; Israel HA, 1998, J ORAL MAXIL SURG, V56, P1023, DOI 10.1016/S0278-2391(98)90246-4; KALBHEN DA, 1987, J RHEUMATOL, V14, P130; Karsdal MA, 2008, OSTEOARTHR CARTILAGE, V16, P638, DOI 10.1016/j.joca.2008.01.014; Kijima K, 2004, TOXICOL APPL PHARM, V200, P103, DOI 10.1016/j.taap.2004.03.015; Kinkel MD, 2003, J CELL BIOCHEM, V88, P941, DOI 10.1002/jcb.10442; Kou XX, 2011, ARTHRITIS RHEUM-US, V63, P1888, DOI 10.1002/art.30334; Kouri-Floras JB, 2002, ULTRASTRUCT PATHOL, V26, P33, DOI 10.1080/01913120252934314; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Li CJ, 2012, J ORAL MAXIL SURG, V70, P37, DOI 10.1016/j.joms.2011.04.009; Liu Y, 2011, ACTA BIOMATER, V7, P1742, DOI 10.1016/j.actbio.2010.11.028; Meng JH, 2005, OSTEOARTHR CARTILAGE, V13, P1115, DOI 10.1016/j.joca.2005.03.010; Mohan G, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3543; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nam J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024320; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Schmitter M, 2010, INT J PROSTHODONT, V23, P544; Schuelert N, 2010, OSTEOARTHR CARTILAGE, V18, P1536, DOI 10.1016/j.joca.2010.09.005; Shen G, 2005, J DENT RES, V84, P691, DOI 10.1177/154405910508400802; Stegenga B, 2001, J OROFAC PAIN, V15, P193; STEGENGA B, 1989, J ORAL MAXIL SURG, V47, P249, DOI 10.1016/0278-2391(89)90227-9; Takahashi T, 1999, J ORAL MAXIL SURG, V57, P1187, DOI 10.1016/S0278-2391(99)90483-4; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; Tian YF, 2007, ACTA ANAESTH SCAND, V51, P158, DOI 10.1111/j.1399-6576.2006.01161.x; Wadhwa S, 2005, OSTEOARTHR CARTILAGE, V13, P817, DOI 10.1016/j.joca.2005.04.016; Wang XD, 2012, J DENT RES, V91, P499, DOI 10.1177/0022034512441946; Wang XD, 2012, J DENT RES; Wu YW, 2010, J NEUROSCI, V30, P8710, DOI 10.1523/JNEUROSCI.6323-09.2010; Xinmin Yin, 2005, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V100, pe35, DOI 10.1016/j.tripleo.2004.12.025; Zarb GA, 1999, J OROFAC PAIN, V13, P295	54	51	54	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45036	10.1371/journal.pone.0045036	http://dx.doi.org/10.1371/journal.pone.0045036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	23183898	Green Submitted, gold, Green Published			2022-12-25	WOS:000308638700105
J	Bojovic, B; Ho, HY; Wu, J; Crowe, DL				Bojovic, B.; Ho, H-Y; Wu, J.; Crowe, D. L.			Stem cell expansion during carcinogenesis in stem cell-depleted conditional telomeric repeat factor 2 null mutant mice	ONCOGENE			English	Article						telomere; DNA damage; apoptosis; genomic instability	HAIR FOLLICLE BULGE; TRF2; CANCER; SKIN; EXPRESSION; PROTEIN; ATM; DEGRADATION; MAINTENANCE; EPIDERMIS	To examine the role of telomeric repeat-binding factor 2 (TRF2) in epithelial tumorigenesis, we characterized conditional loss of TRF2 expression in the basal layer of mouse epidermis. These mice exhibit some characteristics of dyskeratosis congenita, a human stem cell depletion syndrome caused by telomere dysfunction. The epidermis in conditional TRF2 null mice exhibited DNA damage response and apoptosis, which correlated with stem cell depletion. The stem cell population in conditional TRF2 null epidermis exhibited shorter telomeres than those in control mice. Squamous cell carcinomas induced in conditional TRF2 null mice developed with increased latency and slower growth due to reduced numbers of proliferating cells as the result of increased apoptosis. TRF2 null epidermal stem cells were found in both primary and metastatic tumors. Despite the low-grade phenotype of the conditional TRF2 null primary tumors, the number of metastatic lesions was similar to control cancers. Basal cells from TRF2 null tumors demonstrated extreme telomere shortening and dramatically increased numbers of telomeric signals by fluorescence in situ hybridization due to increased genomic instability and aneuploidy in these cancers. DNA damage response signals were detected at telomeres in TRF2 null tumor cells from these mice. The increased genomic instability in these tumors correlated with eightfold expansion of the transformed stem cell population compared with that in control cancers. We concluded that genomic instability resulting from loss of TRF2 expression provides biological advantages to the cancer stem cell population.	[Bojovic, B.; Ho, H-Y; Wu, J.; Crowe, D. L.] Univ Illinois, Ctr Canc, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Crowe, DL (corresponding author), Univ Illinois, Ctr Canc, 801S Paulina St,Room 530C, Chicago, IL 60612 USA.	dlcrowe@uic.edu	Wu, Jianchun/AAX-3533-2020	Wu, Jianchun/0000-0002-8473-9368	National Institutes of Health [DE14283]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE014283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by National Institutes of Health Grant No. DE14283.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Attwooll CL, 2009, MOL CELL BIOL, V29, P5540, DOI 10.1128/MCB.00479-09; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606; Deng YB, 2009, NATURE, V460, P914, DOI 10.1038/nature08196; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; He H, 2009, MOL CELL BIOL, V29, P229, DOI 10.1128/MCB.01400-08; Heath J, 2009, J INVEST DERMATOL, V129, P2358, DOI 10.1038/jid.2009.102; Hockemeyer D, 2008, GENE DEV, V22, P1773, DOI 10.1101/gad.1679208; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Ku TKS, 2007, MOL CANCER RES, V5, P351, DOI 10.1158/1541-7786.MCR-06-0238; Kusumbe AP, 2009, CANCER RES, V69, P9245, DOI 10.1158/0008-5472.CAN-09-2802; Lantuejoul S, 2010, CLIN CANCER RES, V16, P2979, DOI 10.1158/1078-0432.CCR-10-0142; Liang Y, 2010, J BIOL CHEM, V285, P4931, DOI 10.1074/jbc.M109.048397; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Matsutani N, 2001, INT J ONCOL, V19, P507; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Munoz P, 2006, CELL CYCLE, V5, P718, DOI 10.4161/cc.5.7.2636; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003; Siegl-Cachedenier I, 2007, J CELL BIOL, V179, P277, DOI 10.1083/jcb.200704141; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stout GJ, 2009, DIS MODEL MECH, V2, P139, DOI 10.1242/dmm.002121; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011	50	9	9	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2013	32	43					5156	5166		10.1038/onc.2012.555	http://dx.doi.org/10.1038/onc.2012.555			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	240JY	23178498	Green Accepted			2022-12-25	WOS:000326093200003
J	Bartoletti, M; Rubin, T; Chalvet, F; Netter, S; Dos Santos, N; Poisot, E; Paces-Fessy, M; Cumenal, D; Peronnet, F; Pret, AM; Theodore, L				Bartoletti, Mathieu; Rubin, Thomas; Chalvet, Fabienne; Netter, Sophie; Dos Santos, Nicolas; Poisot, Emilie; Paces-Fessy, Melanie; Cumenal, Delphine; Peronnet, Frederique; Pret, Anne-Marie; Theodore, Laurent			Genetic Basis for Developmental Homeostasis of Germline Stem Cell Niche Number: A Network of Tramtrack-Group Nuclear BTB Factors	PLOS ONE			English	Article							DROSOPHILA OVARY MORPHOGENESIS; PROTEIN INTERACTION MOTIF; BRIC-A-BRAC; GAGA FACTOR; PHENOTYPIC PLASTICITY; OVARIOLE NUMBER; BTB/POZ DOMAIN; POLYCOMB-GROUP; DNA-BINDING; ECDYSONE RECEPTOR	The potential to produce new cells during adult life depends on the number of stem cell niches and the capacity of stem cells to divide, and is therefore under the control of programs ensuring developmental homeostasis. However, it remains generally unknown how the number of stem cell niches is controlled. In the insect ovary, each germline stem cell (GSC) niche is embedded in a functional unit called an ovariole. The number of ovarioles, and thus the number of GSC niches, varies widely among species. In Drosophila, morphogenesis of ovarioles starts in larvae with the formation of terminal filaments (TFs), each made of 8-10 cells that pile up and sort in stacks. TFs constitute organizers of individual germline stem cell niches during larval and early pupal development. In the Drosophila melanogaster subgroup, the number of ovarioles varies interspecifically from 8 to 20. Here we show that pipsqueak, Trithorax-like, batman and the bric-a-brac (bab) locus, all encoding nuclear BTB/POZ factors of the Tramtrack Group, are involved in limiting the number of ovarioles in D. melanogaster. At least two different processes are differentially perturbed by reducing the function of these genes. We found that when the bab dose is reduced, sorting of TF cells into TFs was affected such that each TF contains fewer cells and more TFs are formed. In contrast, psq mutants exhibited a greater number of TF cells per ovary, with a normal number of cells per TF, thereby leading to formation of more TFs per ovary than in the wild type. Our results indicate that two parallel genetic pathways under the control of a network of nuclear BTB factors are combined in order to negatively control the number of germline stem cell niches.	[Bartoletti, Mathieu; Chalvet, Fabienne; Netter, Sophie; Pret, Anne-Marie; Theodore, Laurent] CNRS, Ctr Genet Mol, Unite Propre Rech 3404, Gif Sur Yvette, France; [Bartoletti, Mathieu; Rubin, Thomas; Netter, Sophie; Dos Santos, Nicolas; Poisot, Emilie; Paces-Fessy, Melanie; Pret, Anne-Marie] Univ Versailles St Quentin, Dept Biol, Versailles, France; [Bartoletti, Mathieu; Rubin, Thomas; Chalvet, Fabienne; Netter, Sophie; Dos Santos, Nicolas; Poisot, Emilie; Paces-Fessy, Melanie; Theodore, Laurent] Univ Versailles St Quentin, Lab Genet & Biol Cellulaire, Equipe Associee 4589, Versailles, France; [Chalvet, Fabienne; Theodore, Laurent] Univ Paris 11, Dept Biol, Orsay, France; [Paces-Fessy, Melanie; Cumenal, Delphine; Peronnet, Frederique] Univ Paris 06, Paris, France; [Paces-Fessy, Melanie; Cumenal, Delphine; Peronnet, Frederique] CNRS, Biol Dev Unite Mixte Rech 7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Theodore, L (corresponding author), CNRS, Ctr Genet Mol, Unite Propre Rech 3404, Gif Sur Yvette, France.	laurent.theodore@u-psud.fr	Peronnet, Frederique/J-7101-2015; Rubin, Thomas/L-4788-2017	Peronnet, Frederique/0000-0003-1354-240X; rubin, thomas/0000-0002-6774-1917; Bartoletti, Mathieu/0000-0003-3648-5524	National Centre for Scientific Research; Universite de Versailles Saint-Quentin; Region Ilede-France [SESAME1655]; Association pour la Recherche sur le Cancer [ARC 4710]	National Centre for Scientific Research; Universite de Versailles Saint-Quentin; Region Ilede-France(Region Ile-de-France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by National Centre for Scientific Research and Universite de Versailles Saint-Quentin, and grants from Region Ilede-France (convention SESAME1655) and Association pour la Recherche sur le Cancer (ARC 4710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bergland AO, 2008, GENETICS, V180, P567, DOI 10.1534/genetics.108.088906; Bickel RD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001275; Bolivar J, 2006, DEV DYNAM, V235, P2969, DOI 10.1002/dvdy.20967; Bonchuk A, 2011, J MOL BIOL, V412, P423, DOI 10.1016/j.jmb.2011.07.052; Camara N, 2008, CURR TOP DEV BIOL, V83, P65, DOI 10.1016/S0070-2153(08)00403-1; Capella ICS, 1998, J INSECT PHYSIOL, V44, P385, DOI 10.1016/S0022-1910(98)00027-4; Chalvet F, 2011, DROSOPHILA INFO SERV, V94, P158; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; Couderc JL, 2002, DEVELOPMENT, V129, P2419; COYNE JA, 1991, GENET RES, V57, P113, DOI 10.1017/S0016672300029177; Dansereau David A., 2008, V450, P3, DOI 10.1007/978-1-60327-214-8_1; DAVID JR, 1975, NATURE, V257, P588, DOI 10.1038/257588a0; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; DELPUECH JM, 1995, EVOLUTION, V49, P670, DOI [10.2307/2410320, 10.1111/j.1558-5646.1995.tb02303.x]; Dos-Santos N, 2008, INT J DEV BIOL, V52, P21, DOI 10.1387/ijdb.072406nd; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Faucheux M, 2001, MOL GENET GENOMICS, V265, P14, DOI 10.1007/s004380000391; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Gancz D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001202; Gibert JM, 2007, PLOS GENET, V3, P266, DOI 10.1371/journal.pgen.0030030; Gibert JM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001280; Gibert P, 2004, GENETICA, V120, P165, DOI 10.1023/B:GENE.0000017639.62427.8b; GODT D, 1995, DEVELOPMENT, V121, P173; Green DA, 2011, CELL TISSUE RES, V344, P207, DOI 10.1007/s00441-011-1150-5; Greenberg AJ, 2001, MOL CELL BIOL, V21, P8565, DOI 10.1128/MCB.21.24.8565-8574.2001; Hodin J, 1998, DEV GENES EVOL, V208, P304, DOI 10.1007/s004270050186; Hodin J, 2000, EVOLUTION, V54, P1638, DOI 10.1111/j.0014-3820.2000.tb00708.x; Hodin J, 2000, DEV GENES EVOL, V210, P358, DOI 10.1007/s004270000079; HOROWITZ H, 1995, GENETICS, V139, P327; Horowitz H, 1996, DEVELOPMENT, V122, P1859; Hsu HJ, 2011, DEV BIOL, V350, P290, DOI 10.1016/j.ydbio.2010.11.032; Huang DH, 2002, MOL CELL BIOL, V22, P6261, DOI 10.1128/MCB.22.17.6261-6271.2002; King RC, 1970, DROSOPHILA MELANOGAS; Kirilly D, 2011, DEVELOPMENT, V138, P5087, DOI 10.1242/dev.067850; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Kumar S, 2011, BIOINFORMATION, V7, P29; Lehmann M, 2004, TRENDS GENET, V20, P15, DOI 10.1016/j.tig.2003.11.005; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; LOUIS J, 1986, ACTA OECOL-OEC GEN, V7, P215; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Matharu NK, 2010, J MOL BIOL, V400, P434, DOI 10.1016/j.jmb.2010.05.010; Mishra K, 2003, MECH DEVELOP, V120, P681, DOI 10.1016/S0925-4773(03)00046-7; Morris LX, 2011, DEVELOPMENT, V138, P2207, DOI 10.1242/dev.065508; Orgogozo V, 2006, GENETICS, V173, P197, DOI 10.1534/genetics.105.054098; Pointud JC, 2001, DEV BIOL, V237, P368, DOI 10.1006/dbio.2001.0358; Rojas-Rios P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001298; SAHUTBARNOLA I, 1995, DEV BIOL, V170, P127, DOI 10.1006/dbio.1995.1201; SahutBarnola I, 1996, ROUX ARCH DEV BIOL, V205, P356, DOI 10.1007/BF00377215; Sarikaya DP, 2012, DEV BIOL, V363, P279, DOI 10.1016/j.ydbio.2011.12.017; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; THOMASORILLARD M, 1984, GENETICS, V107, P635; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Wayne ML, 2001, GENET RES, V77, P107, DOI 10.1017/S0016672300004894; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhu CH, 2003, DEVELOPMENT, V130, P2579, DOI 10.1242/dev.00499; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	72	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49958	10.1371/journal.pone.0049958	http://dx.doi.org/10.1371/journal.pone.0049958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185495	Green Published, gold			2022-12-25	WOS:000311821000149
J	Hu, YB; Feng, LP; Li, YL; Zhang, Y; Lu, P; Rayner, S; Chen, SY				Hu, Yangbo; Feng, Lipeng; Li, Yunlong; Zhang, Yong; Lu, Pei; Rayner, Simon; Chen, Shiyun			Ribosomal Binding Site Switching: An Effective Strategy for High-Throughput Cloning Constructions	PLOS ONE			English	Article							POSITIVE-SELECTION VECTORS; BACILLUS-SUBTILIS; PCR PRODUCTS; GENE; SEQUENCE	Direct cloning of PCR fragments by TA cloning or blunt end ligation are two simple methods which would greatly benefit high-throughput (HTP) cloning constructions if the efficiency can be improved. In this study, we have developed a ribosomal binding site (RBS) switching strategy for direct cloning of PCR fragments. RBS is an A/G rich region upstream of the translational start codon and is essential for gene expression. Change from A/G to T/C in the RBS blocks its activity and thereby abolishes gene expression. Based on this property, we introduced an inactive RBS upstream of a selectable marker gene, and designed a fragment insertion site within this inactive RBS. Forward and reverse insertions of specifically tailed fragments will respectively form an active and inactive RBS, thus all background from vector self-ligation and fragment reverse insertions will be eliminated due to the non-expression of the marker gene. The effectiveness of our strategy for TA cloning and blunt end ligation are confirmed. Application of this strategy to gene over-expression, a bacterial two-hybrid system, a bacterial one-hybrid system, and promoter bank construction are also verified. The advantages of this simple procedure, together with its low cost and high efficiency, makes our strategy extremely useful in HTP cloning constructions.	[Hu, Yangbo; Feng, Lipeng; Li, Yunlong; Zhang, Yong; Lu, Pei; Rayner, Simon; Chen, Shiyun] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China; [Feng, Lipeng; Li, Yunlong] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, SY (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan, Peoples R China.	sychen@wh.iov.cn	rayner, simon/N-7715-2013	rayner, simon/0000-0001-8703-9140; Feng, Lipeng/0000-0003-1696-6435; Zhang, Yong/0000-0003-0510-1655; chen, shi yun/0000-0002-6224-2975	National Natural Science Foundation of China [31170133]; National Transgenic Program of China [2011ZX08009-003-001-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Program of China	Funding was provided by the National Natural Science Foundation of China [31170133] and the National Transgenic Program of China [2011ZX08009-003-001-003]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; BERNARD P, 1994, GENE, V148, P71, DOI 10.1016/0378-1119(94)90235-6; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1447, DOI 10.1111/j.1365-2958.1991.tb00791.x; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; D'Arpa P, 2009, COLD SPRING HARB PRO; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Gabant P, 1997, BIOTECHNIQUES, V23, P938, DOI 10.2144/97235pf01; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Horn D, 2005, BIOTECHNIQUES, V39, P40, DOI 10.2144/05391BM03; HSIAO KC, 1993, NUCLEIC ACIDS RES, V21, P5528, DOI 10.1093/nar/21.23.5528; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Keese P, 1996, NUCLEIC ACIDS RES, V24, P3474, DOI 10.1093/nar/24.17.3474; Kim HG, 2004, BIOTECHNOL LETT, V26, P1659, DOI 10.1007/s10529-004-3518-z; Liu XD, 2010, ANAL BIOCHEM, V405, P272, DOI 10.1016/j.ab.2010.06.031; Malo MS, 2003, BIOTECHNIQUES, V34, P1250; Miura H, 2011, ANAL BIOCHEM, V416, P237, DOI 10.1016/j.ab.2011.04.040; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Sambrook J, 2006, BLUNT END CLONING PC; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; Seeliger JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029266; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Zeng JM, 2012, J PROTEOME RES, V11, P4682, DOI 10.1021/pr3006233	30	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50142	10.1371/journal.pone.0050142	http://dx.doi.org/10.1371/journal.pone.0050142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185557	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000189
J	Komada, Y; Yamane, T; Kadota, D; Isono, K; Takakura, N; Hayashi, SI; Yamazaki, H				Komada, Yukiya; Yamane, Toshiyuki; Kadota, Daiji; Isono, Kana; Takakura, Nobuyuki; Hayashi, Shin-Ichi; Yamazaki, Hidetoshi			Origins and Properties of Dental, Thymic, and Bone Marrow Mesenchymal Cells and Their Stem Cells	PLOS ONE			English	Article							CREST-DERIVED CELLS; NEURAL CREST; IN-VITRO; SELF-RENEWAL; DISTINCT ORIGINS; B-LYMPHOPOIESIS; MOUSE; DIFFERENTIATION; MICE; EXPRESSION	Mesenchymal cells arise from the neural crest (NC) or mesoderm. However, it is difficult to distinguish NC-derived cells from mesoderm-derived cells. Using double-transgenic mouse systems encoding P0-Cre, Wnt1-Cre, Mesp1-Cre, and Rosa26EYFP, which enabled us to trace NC-derived or mesoderm-derived cells as YFP-expressing cells, we demonstrated for the first time that both NC-derived (P0- or Wnt1-labeled) and mesoderm-derived (Mesp1-labeled) cells contribute to the development of dental, thymic, and bone marrow (BM) mesenchyme from the fetal stage to the adult stage. Irrespective of the tissues involved, NC-derived and mesoderm-derived cells contributed mainly to perivascular cells and endothelial cells, respectively. Dental and thymic mesenchyme were composed of either NC-derived or mesoderm-derived cells, whereas half of the BM mesenchyme was composed of cells that were not derived from the NC or mesoderm. However, a colony-forming unit-fibroblast (CFU-F) assay indicated that CFU-Fs in the dental pulp, thymus, and BM were composed of NC-derived and mesoderm-derived cells. Secondary CFU-F assays were used to estimate the self-renewal potential, which showed that CFU-Fs in the teeth, thymus, and BM were entirely NC-derived cells, entirely mesoderm-derived cells, and mostly NC-derived cells, respectively. Colony formation was inhibited drastically by the addition of anti-platelet-derived growth factor receptor-beta antibody, regardless of the tissue and its origin. Furthermore, dental mesenchyme expressed genes encoding critical hematopoietic factors, such as interleukin-7, stem cell factor, and cysteine-X-cysteine (CXC) chemokine ligand 12, which supports the differentiation of B lymphocytes and osteoclasts. Therefore, the mesenchymal stem cells found in these tissues had different origins, but similar properties in each organ.	[Komada, Yukiya; Yamane, Toshiyuki; Kadota, Daiji; Isono, Kana; Yamazaki, Hidetoshi] Mie Univ, Grad Sch Med, Dept Stem Cell & Dev Biol, Tsu, Mie 514, Japan; [Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 565, Japan; [Hayashi, Shin-Ichi] Tottori Univ, Fac Med, Div Immunol, Sch Life Sci, Yonago, Tottori 683, Japan	Mie University; Osaka University; Tottori University	Yamazaki, H (corresponding author), Mie Univ, Grad Sch Med, Dept Stem Cell & Dev Biol, Tsu, Mie 514, Japan.	yamazaki@doc.medic.mie-u.ac.jp	Yamane, Toshiyuki/V-8160-2019	Yamane, Toshiyuki/0000-0001-9906-4714	Japan Society for the Promotion of Science [21390489, 21659422]; Molecular Medical Science Institute, Takeda Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [23590460] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Molecular Medical Science Institute, Takeda Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (B) (no. 21390489: HY) and Challenging Exploratory Research (no. 21659422: HY) from the Japan Society for the Promotion of Science and by funding from the Molecular Medical Science Institute, Takeda Pharmaceutical Co., Ltd. (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 1997, TRENDS GENET, V13, P276, DOI 10.1016/S0168-9525(97)01187-6; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bensidhoum M, 2004, BLOOD, V103, P3313, DOI 10.1182/blood-2003-04-1121; BOCKMAN DE, 1984, SCIENCE, V223, P498, DOI 10.1126/science.6606851; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chung UI, 2004, J ORTHOP SCI, V9, P410, DOI 10.1007/s00776-004-0786-3; COULY GF, 1993, DEVELOPMENT, V117, P409; Dani C, 1997, J CELL SCI, V110, P1279; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gilbert SF, 2010, DEV BIOL, P413; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kramer J, 2003, METHOD ENZYMOL, V365, P251; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kubota Y, 2011, J EXP MED, V208, P949, DOI 10.1084/jem.20102187; LEDOUARIN NM, 1975, J EXP MED, V142, P17, DOI 10.1084/jem.142.1.17; LEDOUARIN NM, 1999, NEURAL CREST, P304; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; MESSING A, 1992, NEURON, V8, P507, DOI 10.1016/0896-6273(92)90279-M; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Saga Y, 1999, DEVELOPMENT, V126, P3437; Sano H, 2001, CIRCULATION, V103, P2955, DOI 10.1161/01.CIR.103.24.2955; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tagaya H, 2000, BLOOD, V95, P3363, DOI 10.1182/blood.V95.11.3363.011k29_3363_3370; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yamazaki H, 2005, INT IMMUNOL, V17, P549, DOI 10.1093/intimm/dxh237; Yamazaki H, 2001, EXP HEMATOL, V29, P68, DOI 10.1016/S0301-472X(00)00626-3; Yamazaki H, 2007, STEM CELLS, V25, P78, DOI 10.1634/stemcells.2006-0360; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	52	56	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e46436	10.1371/journal.pone.0046436	http://dx.doi.org/10.1371/journal.pone.0046436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185234	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000003
J	Martin, J; French, K; Major, R				Martin, John; French, Kris; Major, Richard			Behavioural Adaptation of a Bird from Transient Wetland Specialist to an Urban Resident	PLOS ONE			English	Article							IBIS THRESKIORNIS-MOLUCCA; SITE FIDELITY; AUSTRALIAN WATERBIRDS; BREEDING DISPERSAL; SACRED IBIS; POPULATION; MANAGEMENT; SURVIVAL; SUCCESS; ESTABLISHMENT	Dramatic population increases of the native white ibis in urban areas have resulted in their classification as a nuisance species. In response to community and industry complaints, land managers have attempted to deter the growing population by destroying ibis nests and eggs over the last twenty years. However, our understanding of ibis ecology is poor and a question of particular importance for management is whether ibis show sufficient site fidelity to justify site-level management of nuisance populations. Ibis in non-urban areas have been observed to be highly transient and capable of moving hundreds of kilometres. In urban areas the population has been observed to vary seasonally, but at some sites ibis are always observed and are thought to be behaving as residents. To measure the level of site fidelity, we colour banded 93 adult ibis at an urban park and conducted 3-day surveys each fortnight over one year, then each quarter over four years. From the quarterly data, the first year resighting rate was 89% for females (n = 59) and 76% for males (n = 34); this decreased to 41% of females and 21% of males in the fourth year. Ibis are known to be highly mobile, and 70% of females and 77% of males were observed at additional sites within the surrounding region (up to 50 km distant). Our results indicate that a large proportion of ibis have chosen residency over transience both within the study site and across the broader urban region. Consequently the establishment of refuge breeding habitat should be a priority localised management may be effective at particular sites, but it is likely to have an impact across the broader population.	[Martin, John; French, Kris] Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia; [Martin, John; Major, Richard] Australian Museum, Sydney, NSW 2000, Australia	University of Wollongong; Australian Museum	Martin, J (corresponding author), Univ Wollongong, Sch Biol Sci, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia.	john.martin@rbgsyd.nsw.gov.au	French, Kris/I-8202-2012	French, Kris/0000-0001-6938-2017; Major, Richard/0000-0002-1334-9864; Martin, John/0000-0003-2731-9292	W.V. Scott Charitable Trust; Waste Services New South Wales (NSW) Environmental Solutions; Centennial Parklands Foundation; NSW Office of Environment and Heritage; Australian Museum	W.V. Scott Charitable Trust; Waste Services New South Wales (NSW) Environmental Solutions; Centennial Parklands Foundation; NSW Office of Environment and Heritage; Australian Museum	We thank the W.V. Scott Charitable Trust, Waste Services New South Wales (NSW) Environmental Solutions, the Centennial Parklands Foundation, the NSW Office of Environment and Heritage and the Australian Museum for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belant JL, 1997, LANDSCAPE URBAN PLAN, V38, P245, DOI 10.1016/S0169-2046(97)00037-6; Bowman Reed, 2001, P569; Brandis KJ, 2011, ENVIRON MANAGE, V48, P489, DOI 10.1007/s00267-011-9705-5; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carrick R., 1962, Wild Res, V7, P71; Clergeau P, 2006, BIOL INVASIONS, V8, P1381, DOI 10.1007/s10530-006-0002-9; Cohen JB, 2011, J FIELD ORNITHOL, V82, P379, DOI 10.1111/j.1557-9263.2011.00341.x; Corben D, 2003, THESIS U TECHNOLOGY; COULSON JC, 1987, J APPL ECOL, V24, P789, DOI 10.2307/2403981; COWLING SJ, 1981, EMU, V81, P33, DOI 10.1071/MU9810033; Dingle Hugh, 2001, P247; Epstein JH, 2006, ECOHEALTH, V3, P290, DOI 10.1007/s10393-006-0064-2; Evans KL, 2012, OIKOS, V121, P634, DOI 10.1111/j.1600-0706.2011.19722.x; Fox AD, 2002, BIRD STUDY, V49, P42, DOI 10.1080/00063650209461243; Fuxjager MJ, 2010, ANIM BEHAV, V80, P921, DOI 10.1016/j.anbehav.2010.08.018; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Grund MD, 2002, J WILDLIFE MANAGE, V66, P123, DOI 10.2307/3802878; Haas CA, 1998, AUK, V115, P929, DOI 10.2307/4089511; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; Herring G, 2008, BIOL INVASIONS, V10, P969, DOI 10.1007/s10530-007-9174-1; HESTBECK JB, 1991, ECOLOGY, V72, P523, DOI 10.2307/2937193; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Howell R.G., 1982, Proceedings of the Vertebrate Pest Conference, V10, P21; Ji WH, 2004, WILDLIFE RES, V31, P543, DOI 10.1071/WR02048; Johnston Richard F., 2001, P49; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kingsford RT, 2010, MAR FRESHWATER RES, V61, P875, DOI 10.1071/MF09088; Kingsford RT, 2000, AUSTRAL ECOL, V25, P109, DOI 10.1111/j.1442-9993.2000.tb00012.x; Kingsford RT, 2002, EMU, V102, P47, DOI 10.1071/MU01030; Kingsford RT, 1999, WILDLIFE RES, V26, P351, DOI 10.1071/WR96062; Lank D.B., 1979, WADER STUDY GROUP B, V27, P41; Lemly AD, 2000, ENVIRON MANAGE, V25, P485, DOI 10.1007/s002679910039; LOWE KW, 1984, THESIS U MELBOURNE A; Marchant S, 1990, HDB AUSTR NZ ANTAR B, V1; Martin J, 2010, WILDLIFE RES, V37, P230, DOI 10.1071/WR10047; Martin JM, 2007, WILDLIFE RES, V34, P319, DOI 10.1071/WR07005; Martin JM, 2011, LANDSCAPE URBAN PLAN, V102, P65, DOI 10.1016/j.landurbplan.2011.03.010; Martin JM, 2010, WATERBIRDS, V33, P264, DOI 10.1675/063.033.0218; Marzluff John M., 2001, P331; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Murray Nicholas J., 2006, Corella, V30, P41; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Porter JL, 2006, 37 NSW NAT PARKS WIL; Prange S, 2003, J WILDLIFE MANAGE, V67, P324, DOI 10.2307/3802774; PYKE GH, 1989, EMU, V89, P30, DOI 10.1071/MU9890030; Ridoutt C, 2011, THESIS U NEW S WALES; Saggese K, 2011, BEHAV ECOLOGY, V22, P39; Smith ACM, 2009, THESIS U TECHNOLOGY; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Stracey CM, 2012, J AVIAN BIOL, V43, P50, DOI 10.1111/j.1600-048X.2011.05520.x; SWITZER PV, 1993, EVOL ECOL, V7, P533, DOI 10.1007/BF01237820; Tortosa FS, 2002, WATERBIRDS, V25, P39, DOI 10.1675/1524-4695(2002)025[0039:EORDOB]2.0.CO;2; Tuyttens FAM, 2000, J ANIM ECOL, V69, P815, DOI 10.1046/j.1365-2656.2000.00437.x; van der Ree R, 2006, J ZOOL, V268, P177, DOI 10.1111/j.1469-7998.2005.00005.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Withey JC, 2009, LANDSCAPE ECOL, V24, P281, DOI 10.1007/s10980-008-9305-9	57	8	9	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50006	10.1371/journal.pone.0050006	http://dx.doi.org/10.1371/journal.pone.0050006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185518	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000165
J	Maul, B; Becker, M; Gembardt, F; Becker, A; Schultheiss, HP; Siems, WE; Walther, T				Maul, Bjoern; Becker, Matthias; Gembardt, Florian; Becker, Axel; Schultheiss, Heinz-Peter; Siems, Wolf-Eberhard; Walther, Thomas			Genetic Deficiency in Neprilysin or Its Pharmacological Inhibition Initiate Excessive Stress-Induced Alcohol Consumption in Mice	PLOS ONE			English	Article							NEUTRAL ENDOPEPTIDASE; MODULATION; RECEPTOR	Both acquired and inherited genetic factors contribute to excessive alcohol consumption and the corresponding development of addiction. Here we show that the genetic deficiency in neprilysin [NEP] did not change the kinetics of alcohol degradation but led to an increase in alcohol intake in mice in a 2-bottle-free-choice paradigm after one single stress stimulus (intruder). A repetition of such stress led to an irreversible elevated alcohol consumption. This phenomenon could be also observed in wild-type mice receiving an orally active NEP inhibitor. We therefore elucidated the stress behavior in NEP-deficient mice. In an Elevated Plus Maze, NEP knockouts crossed more often the area between the arms, implicating a significant stronger stress response. Furthermore, such animals showed a decreased locomotor activity under intense light in a locomotor activity test, identifying such mice to be more responsive in aversive situations than their wild-type controls. Since the reduction in NEP activity itself does not lead to significant signs of an altered alcohol preference in mice but requires an environmental stimulus, our findings build a bridge between stress components and genetic factors in the development of alcoholism. Therefore, targeting NEP activity might be a very attractive approach for the treatment of alcohol abuse in a society with increasing social and financial stress.	[Walther, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Expt & Clin Pharmacol & Toxicol, D-6800 Mannheim, Germany; [Walther, Thomas] Univ Leipzig, Dept Pediat Surg, Ctr Fetal Med, Leipzig, Germany; [Walther, Thomas] Univ Leipzig, Dept Obstet, Div Women & Child Hlth, Leipzig, Germany; [Maul, Bjoern; Becker, Matthias; Siems, Wolf-Eberhard] Leibnizinst Mol Pharmakol, Dept Biochem Neurobiol, Berlin, Germany; [Gembardt, Florian] Excellence Cluster Cardiopulm Syst, Dept Cardiac Pathobiol, Giessen, Germany; [Gembardt, Florian] Univ Hosp Dresden, Dept Nephrol MK3, Dresden, Germany; [Becker, Axel] Univ Magdeburg, Inst Pharmacol & Toxicol, D-39106 Magdeburg, Germany; [Schultheiss, Heinz-Peter] Charite Campus Benjamin Franklin, Dept Cardiol, Berlin, Germany	Ruprecht Karls University Heidelberg; Leipzig University; Leipzig University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Walther, T (corresponding author), Heidelberg Univ, Med Fac Mannheim, Inst Expt & Clin Pharmacol & Toxicol, D-6800 Mannheim, Germany.	thomas.walther2011@gmail.com	Gembardt, Florian/H-2360-2011; Becker, Axel/G-1808-2013	Gembardt, Florian/0000-0003-2739-345X; Becker, Axel/0000-0002-3406-3558; Becker, Matthias/0000-0001-9965-6648	Deutsche Forschungsgemeinschaft (DFG) [SI 483/3-2, SI 483/3-3, WA1441/18/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant (SI 483/3-2 and -3, as well as WA1441/18/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AC, 2006, PLOS MED, V3, P956, DOI 10.1371/journal.pmed.0030209; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Becker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012793; Blanchard DC, 1998, NEUROSCI BIOBEHAV R, V22, P597, DOI 10.1016/S0149-7634(97)00054-7; Brady KT, 1999, ALCOHOL RES HEALTH, V23, P263; Cuculi F, 2011, EXPERT OPIN INV DRUG, V20, P457, DOI 10.1517/13543784.2011.556617; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Faber F, 2006, REGUL PEPTIDES, V136, P130, DOI 10.1016/j.regpep.2006.06.001; FILE SE, 1995, ADV BIOCHEM PSYCHOPH, V48, P93; GOODRICK CL, 1973, J COMP PHYSIOL PSYCH, V84, P73, DOI 10.1037/h0035054; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Johnson GD, 2000, ANAL BIOCHEM, V286, P112, DOI 10.1006/abio.2000.4772; Kaye B, 1997, XENOBIOTICA, V27, P1091, DOI 10.1080/004982597240046; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Maul B, 2005, FASEB J, V19, P1474, DOI 10.1096/fj.05-3742com; Maul J, 2001, FASEB J, V15, P1640, DOI 10.1096/fj.00-097fje; McDowell G, 2000, CARDIOVASC DRUG REV, V18, P259; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; National Institute of Alcohol Abuse and Alcoholism, 2000, US C ALC HLTH; Oroszi G, 2004, PHARMACOGENOMICS, V5, P1037, DOI 10.1517/14622416.5.8.1037; Siems WE, 2000, EUR J PHARMACOL, V397, P327, DOI 10.1016/S0014-2999(00)00222-3; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Spanagel R, 2003, BEST PRACT RES CL GA, V17, P507, DOI 10.1016/S1521-6918(03)00031-3; Valentinuzzi VS, 2000, PHYSIOL BEHAV, V69, P269, DOI 10.1016/S0031-9384(00)00219-5; Van Oudenhove L, 2011, J CLIN INVEST, V121, P3094, DOI 10.1172/JCI46380; Walther T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004590; Winkler A, 1998, BBA-MOL BASIS DIS, V1406, P219, DOI 10.1016/S0925-4439(97)00041-0	28	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50187	10.1371/journal.pone.0050187	http://dx.doi.org/10.1371/journal.pone.0050187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185571	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000196
J	Santoro, D; Winter, L; Muller, A; Vogt, J; Renz, W; Ozerdem, C; Grassl, A; Tkachenko, V; Schulz-Menger, J; Niendorf, T				Santoro, Davide; Winter, Lukas; Mueller, Alexander; Vogt, Julia; Renz, Wolfgang; Oezerdem, Celal; Graessl, Andreas; Tkachenko, Valeriy; Schulz-Menger, Jeanette; Niendorf, Thoralf			Detailing Radio Frequency Heating Induced by Coronary Stents: A 7.0 Tesla Magnetic Resonance Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PROTON CHEMICAL-SHIFT; MR THERMOMETRY; SAFETY; TISSUE; TRENDS	The sensitivity gain of ultrahigh field Magnetic Resonance (UHF-MR) holds the promise to enhance spatial and temporal resolution. Such improvements could be beneficial for cardiovascular MR. However, intracoronary stents used for treatment of coronary artery disease are currently considered to be contra-indications for UHF-MR. The antenna effect induced by a stent together with RF wavelength shortening could increase local radiofrequency (RF) power deposition at 7.0 T and bears the potential to induce local heating, which might cause tissue damage. Realizing these constraints, this work examines RF heating effects of stents using electro-magnetic field (EMF) simulations and phantoms with properties that mimic myocardium. For this purpose, RF power deposition that exceeds the clinical limits was induced by a dedicated birdcage coil. Fiber optic probes and MR thermometry were applied for temperature monitoring using agarose phantoms containing copper tubes or coronary stents. The results demonstrate an agreement between RF heating induced temperature changes derived from EMF simulations versus MR thermometry. The birdcage coil tailored for RF heating was capable of irradiating power exceeding the specific-absorption rate (SAR) limits defined by the IEC guidelines by a factor of three. This setup afforded RF induced temperature changes up to +27 K in a reference phantom. The maximum extra temperature increase, induced by a copper tube or a coronary stent was less than 3 K. The coronary stents examined showed an RF heating behavior similar to a copper tube. Our results suggest that, if IEC guidelines for local/global SAR are followed, the extra RF heating induced in myocardial tissue by stents may not be significant versus the baseline heating induced by the energy deposited by a tailored cardiac transmit RF coil at 7.0 T, and may be smaller if not insignificant than the extra RF heating observed under the circumstances used in this study.	[Santoro, Davide; Winter, Lukas; Mueller, Alexander; Vogt, Julia; Renz, Wolfgang; Oezerdem, Celal; Graessl, Andreas; Schulz-Menger, Jeanette; Niendorf, Thoralf] Max Delbruck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany; [Mueller, Alexander; Vogt, Julia] Humboldt Univ, Dept Phys, Berlin, Germany; [Renz, Wolfgang] Siemens Healthcare, Erlangen, Germany; [Tkachenko, Valeriy; Schulz-Menger, Jeanette; Niendorf, Thoralf] Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany; [Tkachenko, Valeriy; Schulz-Menger, Jeanette] HELIOS Klinikum Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Siemens AG; Siemens Germany; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken	Niendorf, T (corresponding author), Max Delbruck Ctr Mol Med, Berlin Ultrahigh Field Facil, Berlin, Germany.	Thoralf.Niendorf@mdc-berlin.de	Köszegi, Julia-Marie/O-4605-2019; Niendorf, Thoralf/H-7738-2013	Niendorf, Thoralf/0000-0001-7584-6527; Schulz-Menger, Jeanette/0000-0003-3100-1092; Winter, Lukas/0000-0002-4381-275X	Max Delbruck Centrum for Molecular Medicine	Max Delbruck Centrum for Molecular Medicine	This study was founded through institutional funding by the Max Delbruck Centrum for Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, HEALTH PHYS, V87, P20; Carpenter JP, 2011, CIRCULATION, V123, P1519, DOI 10.1161/CIRCULATIONAHA.110.007641; CHOU CK, 1984, BIOELECTROMAGNETICS, V5, P435, DOI 10.1002/bem.2250050408; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Commission IE, 2013, 60601233 IEC; Dall'Armellina E, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-15; Dempsey MF, 2001, CLIN RADIOL, V56, P457, DOI 10.1053/crad.2000.0688; Dieringer MA, 2011, J MAGN RESON IMAGING, V33, P736, DOI 10.1002/jmri.22451; Duru F, 2001, EUR HEART J, V22, P113, DOI 10.1053/euhj.2000.2149; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Friedrich Matthias G, 1999, Int J Cardiovasc Intervent, V2, P217; Funieru M, 2007, SIMULATION ELECTROME; Gabriel C, 1996, AIR FORCE MATERIEL C; Goergen CJ, 2011, J CARDIOVASC TRANSL, V4, P493, DOI 10.1007/s12265-011-9284-0; Horstkotte D, 2011, CLIN RES CARDIOL, V100, P187, DOI 10.1007/s00392-010-0244-5; Huang SN, 2010, CURR CARDIOVASC IMAG, V3, P26, DOI 10.1007/s12410-010-9007-y; ISHIHARA Y, 1995, MAGNET RESON MED, V34, P814, DOI 10.1002/mrm.1910340606; Kuroda K, 2005, INT J HYPERTHER, V21, P547, DOI 10.1080/02656730500204495; Muranaka Hiroyuki, 2007, Magn Reson Med Sci, V6, P199, DOI 10.2463/mrms.6.199; Niendorf T, 2010, EUR RADIOL, V20, P2806, DOI 10.1007/s00330-010-1902-8; Nordbeck P, 2008, MAGN RESON MED, V60, P312, DOI 10.1002/mrm.21475; Nordbeck P, 2012, MAGN RESON MED, V68, P1963, DOI 10.1002/mrm.24197; Nordbeck P, 2009, MAGN RESON MED, V61, P570, DOI 10.1002/mrm.21881; Oh S, 2010, MAGN RESON MED, V63, P218, DOI 10.1002/mrm.22174; Peters RD, 2000, MAGN RESON MED, V43, P62, DOI 10.1002/(SICI)1522-2594(200001)43:1<62::AID-MRM8>3.0.CO;2-1; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Rawson NSB, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-25; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Roguin A, 2008, EUROPACE, V10, P334, DOI 10.1093/europace/eun021; Santoro D, 2010, FA CUP PHASE BASED F, P4943; Santoro D, 2011, MAGN RESON MED, V65, P1166, DOI 10.1002/mrm.22683; Schroeder AP, 2000, J CARDIOV MAGN RESON, V2, P43, DOI 10.3109/10976640009148672; Shah RV, 2012, RADIOLOGY, V262, P742, DOI 10.1148/radiol.11120013; Shellock FG, 1999, AM J ROENTGENOL, V173, P543, DOI 10.2214/ajr.173.3.10470877; Shellock FG, 2005, J CARDIOVASC MAGN R, V7, P415, DOI 10.1081/JCMR-200053588; Strohm O, 1999, J CARDIOV MAGN RESON, V1, P239, DOI 10.3109/10976649909088336; Thavendiranathan P, 2012, CIRC-CARDIOVASC IMAG, V5, P102, DOI 10.1161/CIRCIMAGING.111.967836; Ulrich MR, 2003, AM J CARDIOL, V92, P836, DOI 10.1016/S0002-9149(03)00895-6; von Knobelsdorff-Brenkenhoff F, 2012, J MAGN RESON IMAGING, V36, P20, DOI 10.1002/jmri.23580; Weerasinghe DP, 2009, INT J ENV RES PUB HE, V6, P232, DOI 10.3390/ijerph6010245; Weiland T, 2003, 33RD EUROPEAN MICROWAVE CONFERENCE, VOLS 1-3, CONFERENCE PROCEEDINGS, P591; Winter L, 2012, EUR RADIOL; Wonneberger U, 2010, J MAGN RESON IMAGING, V31, P1499, DOI 10.1002/jmri.22197	43	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49963	10.1371/journal.pone.0049963	http://dx.doi.org/10.1371/journal.pone.0049963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185498	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000311821000151
J	Selvaratnam, R; Mazhab-Jafari, MT; Das, R; Melacini, G				Selvaratnam, Rajeevan; Mazhab-Jafari, Mohammad T.; Das, Rahul; Melacini, Giuseppe			The Auto-Inhibitory Role of the EPAC Hinge Helix as Mapped by NMR	PLOS ONE			English	Article							CAMP-BINDING DOMAIN; PROTEIN-KINASE-A; CYCLIC-AMP; DEPENDENT ALLOSTERY; REGULATORY SUBUNIT; MAPPING ALLOSTERY; CHEMICAL-SHIFTS; ACTIVATION; DYNAMICS; AUTOINHIBITION	The cyclic-AMP binding domain (CBD) is the central regulatory unit of exchange proteins activated by cAMP (EPAC). The CBD maintains EPAC in a state of auto-inhibition in the absence of the allosteric effector, cAMP. When cAMP binds to the CBD such auto-inhibition is released, leading to EPAC activation. It has been shown that a key feature of such cAMP-dependent activation process is the partial destabilization of a structurally conserved hinge helix at the C-terminus of the CBD. However, the role of this helix in auto-inhibition is currently not fully understood. Here we utilize a series of progressive deletion mutants that mimic the hinge helix destabilization caused by cAMP to show that such helix is also a pivotal auto-inhibitory element of apo-EPAC. The effect of the deletion mutations on the auto-inhibitory apo/inactive vs. apo/active equilibrium was evaluated using recently developed NMR chemical shift projection and covariance analysis methods. Our results show that, even in the absence of cAMP, the C-terminal region of the hinge helix is tightly coupled to other conserved allosteric structural elements of the CBD and perturbations that destabilize the hinge helix shift the auto-inhibitory equilibrium toward the apo/active conformations. These findings explain the apparently counterintuitive observation that cAMP binds more tightly to shorter than longer EPAC constructs. These results are relevant for CBDs in general and rationalize why substrates sensitize CBD-containing systems to cAMP. Furthermore, the NMR analyses presented here are expected to be generally useful to quantitatively evaluate how mutations affect conformational equilibria.	[Selvaratnam, Rajeevan; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Mazhab-Jafari, Mohammad T.; Das, Rahul; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University; McMaster University	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada.	melacin@mcmaster.ca	Das, Rahul/AAU-5123-2020	Das, Rahul/0000-0001-7841-8229; Selvaratnam, Rajeevan/0000-0003-4457-616X; Mazhab-Jafari, Mohammad T./0000-0003-0207-5877	Canadian Institute of Health Research (CIHR); National Sciences and Engineering Research Council (NSERC); Ontario Graduate Scholarship; McMaster University	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); McMaster University	Funding sources include: Canadian Institute of Health Research (CIHR) (http://www.cihr-irsc.gc.ca), National Sciences and Engineering Research Council (NSERC) (http://www.nserc-crsng.gc.ca), Ontario Graduate Scholarship, and McMaster University (http://www.mcmaster.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aden J, 2007, J AM CHEM SOC, V129, P14003, DOI 10.1021/ja075055g; Anand GS, 2010, MOL CELL PROTEOMICS, V9, P2225, DOI 10.1074/mcp.M900388-MCP200; Badireddy S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.110.004390; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Esposito V, 2006, J BIOMOL NMR, V36, P64, DOI 10.1007/s10858-006-9050-9; GODDARD TD, 2004, SPARKY VERSION 3; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Hayashi I, 2007, NAT STRUCT MOL BIOL, V14, P980, DOI 10.1038/nsmb1299; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; McNicholl ET, 2010, J BIOL CHEM, V285, P15523, DOI 10.1074/jbc.M110.105783; Popovych N, 2009, P NATL ACAD SCI US; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2012, BIOCHEM SOC T, V40, P219, DOI 10.1042/BST20110628; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Stockman BJ, 2002, PROG NUCL MAG RES SP, V41, P187, DOI 10.1016/S0079-6565(02)00049-3; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng L, 2011, P NATL ACAD SCI USA, V108, P1337, DOI 10.1073/pnas.1015125108	40	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48707	10.1371/journal.pone.0048707	http://dx.doi.org/10.1371/journal.pone.0048707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185272	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000019
J	Silva, NM; Pereira, L; Poloni, ES; Currat, M				Silva, Nuno M.; Pereira, Luisa; Poloni, Estella S.; Currat, Mathias			Human Neutral Genetic Variation and Forensic STR Data	PLOS ONE			English	Article							RECENT HUMAN PHYLOGENIES; TANDEM REPEAT LOCI; POPULATION-GENETICS; DIVERSITY; INFERENCE; DNA; HAPLOTYPES; GEOGRAPHY; MUTATION; MARKERS	The forensic genetics field is generating extensive population data on polymorphism of short tandem repeats (STR) markers in globally distributed samples. In this study we explored and quantified the informative power of these datasets to address issues related to human evolution and diversity, by using two online resources: an allele frequency dataset representing 141 populations summing up to almost 26 thousand individuals; a genotype dataset consisting of 42 populations and more than 11 thousand individuals. We show that the genetic relationships between populations based on forensic STRs are best explained by geography, as observed when analysing other worldwide datasets generated specifically to study human diversity. However, the global level of genetic differentiation between populations (as measured by a fixation index) is about half the value estimated with those other datasets, which contain a much higher number of markers but much less individuals. We suggest that the main factor explaining this difference is an ascertainment bias in forensics data resulting from the choice of markers for individual identification. We show that this choice results in average low variance of heterozygosity across world regions, and hence in low differentiation among populations. Thus, the forensic genetic markers currently produced for the purpose of individual assignment and identification allow the detection of the patterns of neutral genetic structure that characterize the human population but they do underestimate the levels of this genetic structure compared to the datasets of STRs (or other kinds of markers) generated specifically to study the diversity of human populations.	[Silva, Nuno M.; Pereira, Luisa] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, P-4100 Oporto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Poloni, Estella S.; Currat, Mathias] Univ Geneva, Lab Anthropol Genet & Peopling Hist, Dept Genet & Evolut, Anthropol Unit, Geneva, Switzerland	Universidade do Porto; Universidade do Porto; University of Geneva	Currat, M (corresponding author), Univ Geneva, Lab Anthropol Genet & Peopling Hist, Dept Genet & Evolut, Anthropol Unit, Geneva, Switzerland.	mathias.currat@unige.ch	Pereira, Luisa/H-3050-2011	Pereira, Luisa/0000-0002-4271-1527; Poloni, Estella S./0000-0002-8465-003X	FCT, the Portuguese Foundation for Science and Technology [SFRH/BD/69119/2010]; FCT; Swiss National Science Foundation [31003A-127465]; AGP laboratory	FCT, the Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); AGP laboratory	FCT, the Portuguese Foundation for Science and Technology, supported this work through the personal grant NMS (SFRH/BD/69119/2010). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. MC was supported by Swiss National Science Foundation grant 31003A-127465, and EP and MC were supported by intramural funds of the AGP laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-47; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; Budowle B, 2001, Leg Med (Tokyo), V3, P29, DOI 10.1016/S1344-6223(01)00008-6; Budowle B, 1998, CODIS PCR BASED SHOR; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Butler John M, 2007, Biotechniques, V43, pii; Cann HM, 2002, SCIENCE, V296, P261; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Crossetti SG, 2008, AM J HUM BIOL, V20, P704, DOI 10.1002/ajhb.20798; Currat M, 2010, BMC EVOLUTIONARY BIO, V10; Di Cristofaro J, 2012, FORENSIC SCI INT-GEN, V6, pE44, DOI 10.1016/j.fsigen.2011.03.004; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2003, SCIENCE, V300; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Gaibar M, 2010, ANN HUM BIOL, V37, P254, DOI 10.3109/03014460903341851; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kidd KK, 2006, FORENSIC SCI INT, V164, P20, DOI 10.1016/j.forsciint.2005.11.017; LEWONTIN RC, 1991, SCIENCE, V254, P1745, DOI 10.1126/science.1845040; Listman JB, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-21; Mack S.J., 2006, IMMUNOBIOLOGY HUMAN, P560; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Martins JA, 2011, MOL BIOL REP, V38, P5397, DOI 10.1007/s11033-011-0693-6; Michalakis Y, 1996, GENETICS, V142, P1061; Montinaro F, 2012, FORENSIC SCI INT GEN; Nachman MW, 2000, GENETICS, V156, P297; Nei M., 1987, MOL EVOLUTIONARY GEN; Pamplona JP, 2008, FORENS SCI INT-GEN S, V1, P656, DOI 10.1016/j.fsigss.2007.10.136; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pemberton TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-612; Pereira L, 2010, INT J LEGAL MED; Phillips C, 2011, FORENSIC SCI INT-GEN, V5, P155, DOI 10.1016/j.fsigen.2010.02.003; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Quintana-Murci L, 2003, AM J PHYS ANTHROPOL, V121, P157, DOI 10.1002/ajpa.10187; R Development Core Team, 2007, R LANG ENV STAT COMP; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ray N, 2002, LAB GENETICS BIOMETR; REYNOLDS J, 1983, GENETICS, V105, P767; Rohlf F. J., 1994, STAT TABLES; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2003, SCIENCE, V300; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rowold DJ, 2003, FORENSIC SCI INT, V133, P260, DOI 10.1016/S0379-0738(03)00073-2; Sanchez-Mazas A, 2011, IMMUNOLOGY, V133, P143, DOI 10.1111/j.1365-2567.2011.03438.x; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Sun GY, 2003, EUR J HUM GENET, V11, P39, DOI 10.1038/sj.ejhg.5200902; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	60	43	45	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49666	10.1371/journal.pone.0049666	http://dx.doi.org/10.1371/journal.pone.0049666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185401	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000081
J	Villegas, R; Delahanty, R; Gao, YT; Long, JR; Williams, SM; Xiang, YB; Cai, H; Li, HL; Hu, F; Cai, QY; Zheng, W; Shu, XO				Villegas, Raquel; Delahanty, Ryan; Gao, Yu-Tang; Long, Jirong; Williams, Scott M.; Xiang, Yong-Bing; Cai, Hui; Li, Hong-Lan; Hu, Frank; Cai, Qiuyin; Zheng, Wei; Shu, Xiao-Ou			Joint Effect of Genetic and Lifestyle Risk Factors on Type 2 Diabetes Risk among Chinese Men and Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PHYSICAL-ACTIVITY QUESTIONNAIRE; VARIANTS; HEALTH; SUSCEPTIBILITY; LOCI; REPRODUCIBILITY; REPLICATION; VALIDITY; PROGRAM	More than 40 genetic susceptibility loci have been reported for type 2 diabetes (T2D). Recently, the combined effect of genetic variants has been investigated by calculating a genetic risk score. We evaluated 36 genome-wide association study (GWAS) identified SNPs in 2,679 T2D cases and 3322 controls in middle-age Han Chinese. Fourteen SNPs were significantly associated with T2D in analysis adjusted for age, sex and BMI. We calculated two genetic risk scores (GRS) (GRS1 with all the 36 SNPs and GRS2 with the 14 SNPs significantly associated with T2D). The odds ratio for T2D with each GRS point (per risk allele) was 1.08 (95% CI: 1.06-1.09) for GRS1 and 1.15 (95% CI: 1.13-1.18) for GRS2. The OR for quintiles were 1.00, 1.26, 1.69, 1.95 and 2.18 (P<0.0001) for GRS1 and 1.00, 1.33, 1.60, 2.03 and 2.80 (P<0.001) for GRS2. Participants in the higher tertile of GRS1 and the higher BMI category had a higher risk of T2D compared to those on the lower tertiles of the GRS1 and of BMI (OR = 11.08; 95% CI: 7.39-16.62). We found similar results when we investigated joint effects between GRS1 and WHR terciles and exercise participation. We finally investigated the joint effect between tertiles of GRSs and a composite high risk score (no exercise participation and high BMI and WHR) on T2D risk. We found that compared to participants with low GRS1 and no high risk factors for T2D, those with high GRS1 and three high risk factors had a higher risk of T2D (OR = 13.06; 95% CI: 8.65-19.72) but the interaction factor was of marginal significance. The association was accentuated when we repeated analysis with the GRS2. In conclusion we found an association between GRS and lifestyle factors, alone and in combination, contributed to the risk of and T2D among middle age Chinese.	[Villegas, Raquel; Delahanty, Ryan; Long, Jirong; Cai, Hui; Cai, Qiuyin; Zheng, Wei; Shu, Xiao-Ou] Vanderbilt Univ, Med Ctr, Dept Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37203 USA; [Gao, Yu-Tang; Xiang, Yong-Bing; Li, Hong-Lan] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Williams, Scott M.] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Hu, Frank] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Vanderbilt University; Shanghai Jiao Tong University; Dartmouth College; Harvard University; Harvard T.H. Chan School of Public Health	Villegas, R (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37203 USA.	raquel.villegas@vanderbilt.edu	Gao, Yu/HGE-1937-2022; Williams, Scott/B-9491-2012; Williams, Scott/Q-4812-2019; Zheng, Wei/O-3351-2013; Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; zhang, weihua/GXV-1334-2022	Williams, Scott/0000-0002-4835-9544; Zheng, Wei/0000-0003-1226-070X; Long, Jirong/0000-0002-7433-9766	United States National Institutes of Health (NIH) [KO1 DK082639, R01CA124558, R01CA64277, R37CA70867, R01CA90899, R01CA100374]; NIH [R01 CA118229, R01CA92585]; Allen Foundation; Vanderbilt CTSA from the National Center for Research Resources (NCRR)/NIH [1 UL1 RR024975]; Department of Defense [BC050791]; Vanderbilt-Ingram Cancer Center [P30 CA68485];  [R01CA122756];  [DK58845];  [HG004399]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA070867, R01CA090899, R01CA124558, R01CA118229, R01CA100374, R01CA064277, R01CA092585, R01CA122756, R37CA070867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, K01DK082639] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Foundation; Vanderbilt CTSA from the National Center for Research Resources (NCRR)/NIH; Department of Defense(United States Department of Defense); Vanderbilt-Ingram Cancer Center; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the United States National Institutes of Health (NIH) grants KO1 DK082639, R01CA124558, R01CA64277, R37CA70867, R01CA90899 and R01CA100374, as well as Ingram professorship funds and research award funds to WZ, R01 CA118229, R01CA92585 from the NIH and a research grant from Allen Foundation Fund to XOS, the Vanderbilt CTSA grant 1 UL1 RR024975 from the National Center for Research Resources (NCRR)/NIH to JL, R01CA122756 and Department of Defense Idea Award BC050791 to QC, and DK58845 and HG004399 to FBH. Sample preparation, SBCS/SWHS GWAS scanning, and SWHS/SMHS targeted genotyping were conducted at the Survey and Biospecimen Shared Resources and Vanderbilt Microarray Shared Resources that are supported in part by the Vanderbilt-Ingram Cancer Center (P30 CA68485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cooke JN, 2012, DIABETES CARE, V35, P287, DOI 10.2337/dc11-0957; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Hindorff LA, CATALOG PUBLISHED GE; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Jurj AL, 2007, AM J EPIDEMIOL, V165, P1124, DOI 10.1093/aje/kwk119; Lin X, 2009, DIABETOLOGIA, V52, P600, DOI 10.1007/s00125-008-1254-y; Matthews CE, 2003, AM J EPIDEMIOL, V158, P1114, DOI 10.1093/aje/kwg255; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi Q, 2010, DIABETOLOGIA, V53, P2163, DOI 10.1007/s00125-010-1826-5; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tabara Y, 2011, METABOLISM, V60, P1634, DOI 10.1016/j.metabol.2011.03.014; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; WHO SG, 1985, WHO SG TECHN REP SER; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang X, 2004, INT J OBESITY, V28, P734, DOI 10.1038/sj.ijo.0802634; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	27	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49464	10.1371/journal.pone.0049464	http://dx.doi.org/10.1371/journal.pone.0049464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185337	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000050
J	Xue, M; Shi, XM; Zhang, J; Zhao, Y; Cui, HY; Hu, SL; Gao, HB; Cui, XL; Wang, YF				Xue, Mei; Shi, Xingming; Zhang, Jing; Zhao, Yan; Cui, Hongyu; Hu, Shunlei; Gao, Hongbo; Cui, Xianlan; Wang, Yun-Feng			Identification of a Conserved B-cell Epitope on Reticuloendotheliosis Virus Envelope Protein by Screening a Phage-displayed Random Peptide Library	PLOS ONE			English	Article							HYPERVARIABLE REGION-1; MONOCLONAL-ANTIBODIES; CHICKENS; DISEASE; STRAIN; TRANSFORMATION; GLYCOPROTEIN; TERMINUS; SEQUENCE	Background: The gp90 protein of avian reticuloendotheliosis-associated virus (REV-A) is an important envelope glycoprotein, which is responsible for inducing protective antibody immune responses in animals. B-cell epitopes on the gp90 protein of REV have not been well studied and reported. Methods and Results: This study describes the identification of a linear B-cell epitope on the gp90 protein by screening a phage-displayed 12-mer random peptide library with the neutralizing monoclonal antibody (mAb) A9E8 directed against the gp90. The mAb A9E8 recognized phages displaying peptides with the consensus motif SVQYHPL. Amino acid sequence of the motif exactly matched (213)SVQYHPL(219) of the gp90. Further identification of the displayed B cell epitope was conducted using a set of truncated peptides expressed as GST fusion proteins and the Western blot results indicated that (213)SVQYHPL(219) was the minimal determinant of the linear B cell epitope recognized by the mAb A9E8. Moreover, an eight amino acid peptide SVQYHPLA was proven to be the minimal unit of the epitope with the maximal binding activity to mAb A9E8. The REV-A-positive chicken serum reacted with the minimal linear epitopes in Western blot, revealing the importance of the eight amino acids of the epitope in antibody-epitope binding activity. Furthermore, we found that the epitope is a common motif shared among REV-A and other members of REV group. Conclusions and Significance: We identified (213)SVQYHPL(219) as a gp90-specific linear B-cell epitope recognized by the neutralizing mAb A9E8. The results in this study may have potential applications in development of diagnostic techniques and epitope-based marker vaccines against REV-A and other viruses of the REV group.	[Xue, Mei; Shi, Xingming; Zhang, Jing; Zhao, Yan; Cui, Hongyu; Hu, Shunlei; Gao, Hongbo; Wang, Yun-Feng] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China; [Cui, Xianlan] Dept Primary Ind Pk Water & Environm, Hlth Anim Lab, Hobart, Tas, Australia	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, YF (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China.	yfwang@hvri.ac.cn	Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286	National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China [SKLVBP201212]	National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China	This work was supported by the National Key Laboratory of Veterinary Biotechnology as Basic Research Programs of China (SKLVBP201212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa T, 2007, VIRUS RES, V124, P68, DOI 10.1016/j.virusres.2006.10.002; Bohls RL, 2006, VIRUS RES, V119, P187, DOI 10.1016/j.virusres.2006.01.011; CAVANAGH D, 1988, VIRUS RES, V11, P141, DOI 10.1016/0168-1702(88)90039-1; CHEN PY, 1987, ARCH VIROL, V93, P233, DOI 10.1007/BF01310977; Coffin JM, 1996, NATURE, V382, P762, DOI 10.1038/382762a0; COOK MK, 1969, J NATL CANCER I, V43, P203; CUI ZZ, 1986, J IMMUNOL, V136, P4237; Davidson I, 1996, VET MICROBIOL, V49, P273, DOI 10.1016/0378-1135(95)00183-2; Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059; Esumi M, 2002, VACCINE, V20, P3095, DOI 10.1016/S0264-410X(02)00271-2; HEINE HG, 1991, J GEN VIROL, V72, P1835, DOI 10.1099/0022-1317-72-8-1835; HOELZER JD, 1979, VIROLOGY, V93, P20, DOI 10.1016/0042-6822(79)90272-1; HOELZER JD, 1980, VIROLOGY, V100, P462, DOI 10.1016/0042-6822(80)90536-X; JAVAHERIAN K, 1990, SCIENCE, V250, P1590, DOI 10.1126/science.1703322; Kouzmitcheva GA, 2001, CLIN DIAGN LAB IMMUN, V8, P150, DOI 10.1128/CDLI.8.1.150-160.2001; LANGEVELD JPM, 1994, J VIROL, V68, P4506, DOI 10.1128/JVI.68.7.4506-4513.1994; Li K, 2012, VACCINE, V30, P2273, DOI 10.1016/j.vaccine.2012.01.075; Lim XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029751; Lin XA, 2010, CLIN VACCINE IMMUNOL, V17, P778, DOI 10.1128/CVI.00405-09; LUDFORD CG, 1972, EXP PARASITOL, V31, P29, DOI 10.1016/0014-4894(72)90044-6; Peng WP, 2008, VIRUS RES, V135, P267, DOI 10.1016/j.virusres.2008.04.003; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; TRAGER W, 1959, P SOC EXP BIOL MED, V101, P578, DOI 10.3181/00379727-101-25023; TSAI WP, 1986, VIROLOGY, V155, P567, DOI 10.1016/0042-6822(86)90217-5; TSAI WP, 1988, VIROLOGY, V166, P608, DOI 10.1016/0042-6822(88)90535-1; WICKUS GG, 1973, NATURE-NEW BIOL, V245, P65, DOI 10.1038/newbio245065a0; WITTER RL, 1981, AVIAN DIS, V25, P374, DOI 10.2307/1589930	30	52	54	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49842	10.1371/journal.pone.0049842	http://dx.doi.org/10.1371/journal.pone.0049842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185456	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000121
J	Zielinski, BA; Anderson, JS; Froehlich, AL; Prigge, MBD; Nielsen, JA; Cooperrider, JR; Cariello, AN; Fletcher, PT; Alexander, AL; Lange, N; Bigler, ED; Lainhart, JE				Zielinski, Brandon A.; Anderson, Jeffrey S.; Froehlich, Alyson L.; Prigge, Molly B. D.; Nielsen, Jared A.; Cooperrider, Jason R.; Cariello, Annahir N.; Fletcher, P. Thomas; Alexander, Andrew L.; Lange, Nicholas; Bigler, Erin D.; Lainhart, Janet E.			scMRI Reveals Large-Scale Brain Network Abnormalities in Autism	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; FUNCTIONAL CONNECTIVITY; SPECTRUM DISORDERS; DEFAULT-MODE; CORPUS-CALLOSUM; FRONTAL-CORTEX; COMMUNICATION DEFICITS; CORTICAL CONNECTIVITY; STRUCTURAL COVARIANCE; MRI	Autism is a complex neurological condition characterized by childhood onset of dysfunction in multiple cognitive domains including socio-emotional function, speech and language, and processing of internally versus externally directed stimuli. Although gross brain anatomic differences in autism are well established, recent studies investigating regional differences in brain structure and function have yielded divergent and seemingly contradictory results. How regional abnormalities relate to the autistic phenotype remains unclear. We hypothesized that autism exhibits distinct perturbations in network-level brain architecture, and that cognitive dysfunction may be reflected by abnormal network structure. Network-level anatomic abnormalities in autism have not been previously described. We used structural covariance MRI to investigate network-level differences in gray matter structure within two large-scale networks strongly implicated in autism, the salience network and the default mode network, in autistic subjects and age-, gender-, and IQ-matched controls. We report specific perturbations in brain network architecture in the salience and default-mode networks consistent with clinical manifestations of autism. Extent and distribution of the salience network, involved in social-emotional regulation of environmental stimuli, is restricted in autism. In contrast, posterior elements of the default mode network have increased spatial distribution, suggesting a 'posteriorization' of this network. These findings are consistent with a network-based model of autism, and suggest a unifying interpretation of previous work. Moreover, we provide evidence of specific abnormalities in brain network architecture underlying autism that are quantifiable using standard clinical MRI.	[Zielinski, Brandon A.] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; [Zielinski, Brandon A.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Anderson, Jeffrey S.] Univ Utah, Dept Neuroradiol, Salt Lake City, UT USA; [Anderson, Jeffrey S.; Nielsen, Jared A.; Cooperrider, Jason R.; Lainhart, Janet E.] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT USA; [Anderson, Jeffrey S.; Bigler, Erin D.; Lainhart, Janet E.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Froehlich, Alyson L.; Prigge, Molly B. D.; Nielsen, Jared A.; Cooperrider, Jason R.; Cariello, Annahir N.; Lainhart, Janet E.] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Fletcher, P. Thomas] Univ Utah, Sch Comp, Salt Lake City, UT USA; [Fletcher, P. Thomas] Univ Utah, Sci Comp & Imaging Inst, Salt Lake City, UT USA; [Alexander, Andrew L.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Lange, Nicholas] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Lange, Nicholas] Harvard Univ, Sch Med, Dept Biostat, Boston, MA USA; [Lange, Nicholas] McLean Hosp, Neurostat Lab, Belmont, MA 02178 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; Brigham Young University; Brigham Young University	Zielinski, BA (corresponding author), Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA.	brandon.zielinski@utah.edu		Anderson, Jeffrey/0000-0002-9669-3846; Nielsen, Jared/0000-0002-2717-193X	NIH CHRCDA [5K12HD001410-10]; NIMH [RO1MH080826, P50MH60450]; NINDS [R01NS34783]; NIDCD [1F31 DC10143-01, T32DC008553]; Primary Children's Medical Center Foundation; Autism Speaks Mentor-based Predoctoral Fellowship [1677]; Ben B. and Iris M. Margolis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001410, P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060450, R01MH080826, K08MH092697, K08MH100609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC010143, T32DC008553] Funding Source: NIH RePORTER	NIH CHRCDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Primary Children's Medical Center Foundation; Autism Speaks Mentor-based Predoctoral Fellowship; Ben B. and Iris M. Margolis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by NIH CHRCDA 5K12HD001410-10; NIMH RO1MH080826, P50MH60450; NINDS R01NS34783; NIDCD 1F31 DC10143-01, T32DC008553; Primary Children's Medical Center Foundation; Autism Speaks Mentor-based Predoctoral Fellowship (1677); Ben B. and Iris M. Margolis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Anderson JS, 2010, AM J NEURORADIOL, V31, P131, DOI 10.3174/ajnr.A1789; Anderson JS, 2011, BRAIN CONNECT, V1, P147, DOI 10.1089/brain.2011.0007; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonilha L, 2008, BRAIN DEV-JPN, V30, P396, DOI 10.1016/j.braindev.2007.11.006; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Casanova MF, 2006, NEUROSCIENTIST, V12, P435, DOI 10.1177/1073858406290375; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2005, INT J DEV NEUROSCI, V23, P153, DOI 10.1016/j.ijdevneu.2005.01.003; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hardan AY, 2006, J CHILD NEUROL, V21, P866, DOI 10.1177/08830738060210100701; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hazlett HC, 2006, BIOL PSYCHIAT, V59, P1, DOI 10.1016/j.biopsych.2005.06.015; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Jones TB, 2010, NEUROIMAGE, V49, P401, DOI 10.1016/j.neuroimage.2009.07.051; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Kana RK, 2011, PHYS LIFE REV, V8, P410, DOI 10.1016/j.plrev.2011.10.001; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Kanner L, 1943, NERV CHILD, V2, P217; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Mengotti P, 2011, BRAIN RES BULL, V84, P189, DOI 10.1016/j.brainresbull.2010.12.002; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Mitchell SR, 2009, AM J PSYCHIAT, V166, P917, DOI 10.1176/appi.ajp.2009.08101538; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Schmitz N, 2007, NEUROSCI LETT, V412, P12, DOI 10.1016/j.neulet.2006.07.077; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Seeley WW, 2006, ANN NEUROL, V60, P660, DOI 10.1002/ana.21055; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stigler KA, 2011, BRAIN RES, V1380, P146, DOI 10.1016/j.brainres.2010.11.076; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; Uddin LQ, 2009, NEUROSCI BIOBEHAV R, V33, P1198, DOI 10.1016/j.neubiorev.2009.06.002; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107	79	58	60	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49172	10.1371/journal.pone.0049172	http://dx.doi.org/10.1371/journal.pone.0049172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185305	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000032
J	Gilad, A; Meirovithz, E; Leshem, A; Arieli, A; Slovin, H				Gilad, Ariel; Meirovithz, Elhanan; Leshem, Amir; Arieli, Amos; Slovin, Hamutal			Collinear Stimuli Induce Local and Cross-Areal Coherence in the Visual Cortex of Behaving Monkeys	PLOS ONE			English	Article							CONTOUR INTEGRATION; NEURONAL SYNCHRONY; DEPENDENT SYNCHRONIZATION; SPATIOTEMPORAL PATTERNS; INTRINSIC CONNECTIONS; FEEDBACK CONNECTIONS; LATERAL INTERACTIONS; SPATIAL INTERACTIONS; CORTICAL DYNAMICS; CELL RESPONSES	Background: Collinear patterns of local visual stimuli are used to study contextual effects in the visual system. Previous studies have shown that proximal collinear flankers, unlike orthogonal, can enhance the detection of a low contrast central element. However, the direct neural interactions between cortical populations processing the individual flanker elements and the central element are largely unknown. Methodology/Principal Findings: Using voltage-sensitive dye imaging (VSDI) we imaged neural population responses in V1 and V2 areas in fixating monkeys while they were presented with collinear or orthogonal arrays of Gabor patches. We then studied the spatio-temporal interactions between neuronal populations processing individual Gabor patches in the two conditions. Time-frequency analysis of the stimulus-evoked VSDI signal showed power increase mainly in low frequencies, i.e., the alpha band (alpha; 7-14 Hz). Power in the alpha-band was more discriminative at a single trial level than other neuronal population measures. Importantly, the collinear condition showed an increased intra-areal (V1-V1 and V2-V2) and inter-areal (V1-V2) alpha-coherence with shorter latencies than the orthogonal condition, both before and after the removal of the stimulus contribution. alpha-coherence appeared between discrete neural populations processing the individual Gabor patches: the central element and the flankers. Conclusions/Significance: Our findings suggest that collinear effects are mediated by synchronization in a distributed network of proximal and distant neuronal populations within and across V1 and V2.	[Gilad, Ariel; Meirovithz, Elhanan; Slovin, Hamutal] Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Ramat Gan, Israel; [Leshem, Amir] Bar Ilan Univ, Sch Engn, Ramat Gan, Israel; [Arieli, Amos] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Bar Ilan University; Bar Ilan University; Weizmann Institute of Science	Gilad, A (corresponding author), Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Ramat Gan, Israel.	ariel.gilad@mail.huji.ac.il		Slovin, Hamutal/0000-0001-6350-8141; Leshem, Amir/0000-0002-2265-7463	German Israeli Foundation; Israel Science Foundation	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the German Israeli Foundation, and the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arieli A, 2002, J NEUROSCI METH, V114, P119, DOI 10.1016/S0165-0270(01)00507-6; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Ayzenshtat I, 2010, J NEUROSCI, V30, P11232, DOI 10.1523/JNEUROSCI.5177-09.2010; BALLARD DH, 1983, NATURE, V306, P21, DOI 10.1038/306021a0; Bauer R, 2002, EXP BRAIN RES, V147, P145, DOI 10.1007/s00221-002-1178-6; Bonneh Y, 1998, VISION RES, V38, P3541, DOI 10.1016/S0042-6989(98)00045-5; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Bullier J, 2001, PROG BRAIN RES, V134, P193; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; Gilbert C, 2000, VISION RES, V40, P1217, DOI 10.1016/S0042-6989(99)00234-5; Grinvald A, 2005, P NATL ACAD SCI USA, V102, P14125, DOI 10.1073/pnas.0506755102; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Hess RF, 2003, J PHYSIOL-PARIS, V97, P105, DOI 10.1016/j.jphysparis.2003.09.013; HUBEL DH, 1969, NATURE, V221, P747, DOI 10.1038/221747a0; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kasamatsu T, 2001, EXP BRAIN RES, V138, P163, DOI 10.1007/s002210100675; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Kubota T, 2004, NEURAL NETWORKS, V17, P411, DOI 10.1016/j.neunet.2003.12.001; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Meirovithz E, 2010, CEREB CORTEX, V20, P1293, DOI 10.1093/cercor/bhp191; Mizobe K, 2001, VISUAL NEUROSCI, V18, P377, DOI 10.1017/S0952523801183045; Palanca BJA, 2005, NEURON, V46, P333, DOI 10.1016/j.neuron.2005.03.002; Petrov Y, 2006, J VISION, V6, P170, DOI 10.1167/6.2.8; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Polat U, 2007, VISION RES, V47, P2473, DOI 10.1016/j.visres.2007.06.007; Pooresmaeili A, 2010, J NEUROSCI, V30, P12745, DOI 10.1523/JNEUROSCI.6071-09.2010; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Roskies AL, 1999, NEURON, V24, P7, DOI 10.1016/S0896-6273(00)80817-X; Samonds JM, 2006, J NEUROPHYSIOL, V95, P2602, DOI 10.1152/jn.01070.2005; Schira MM, 2007, J NEUROPHYSIOL, V97, P4284, DOI 10.1152/jn.00972.2006; Schira MM, 2009, J NEUROSCI, V29, P9050, DOI 10.1523/JNEUROSCI.1760-09.2009; Shani R, 2005, VISION RES, V45, P2009, DOI 10.1016/j.visres.2005.01.024; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Siegel M, 2003, J NEUROSCI, V23, P4251; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; Solomon JA, 2000, VISION RES, V40, P279, DOI 10.1016/S0275-5408(99)00059-9; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TSO DY, 1988, J NEUROSCI, V8, P1712; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; von der Malsburg C, 1981, CORRELATION THEORY B; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640	65	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49391	10.1371/journal.pone.0049391	http://dx.doi.org/10.1371/journal.pone.0049391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185325	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800023
J	Thomas, RL; Fellowes, MDE; Baker, PJ				Thomas, Rebecca L.; Fellowes, Mark D. E.; Baker, Philip J.			Spatio-Temporal Variation in Predation by Urban Domestic Cats (Felis catus) and the Acceptability of Possible Management Actions in the UK	PLOS ONE			English	Article							HOUSE CATS; PET CATS; WILDLIFE; PREY; IMPACT; DENSITIES; EFFICACY; LANDSCAPES; OWNERSHIP; AUSTRALIA	Urban domestic cat (Felis catus) populations can attain exceedingly high densities and are not limited by natural prey availability. This has generated concerns that they may negatively affect prey populations, leading to calls for management. We enlisted cat-owners to record prey returned home to estimate patterns of predation by free-roaming pets in different localities within the town of Reading, UK and questionnaire surveys were used to quantify attitudes to different possible management strategies. Prey return rates were highly variable: only 20% of cats returned >= 4 dead prey annually. Consequently, approximately 65% of owners received no prey in a given season, but this declined to 22% after eight seasons. The estimated mean predation rate was 18.3 prey cat(-1) year(-1) but this varied markedly both spatially and temporally: per capita predation rates declined with increasing cat density. Comparisons with estimates of the density of six common bird prey species indicated that cats killed numbers equivalent to adult density on c. 39% of occasions. Population modeling studies suggest that such predation rates could significantly reduce the size of local bird populations for common urban species. Conversely, most urban residents did not consider cat predation to be a significant problem. Collar-mounted anti-predation devices were the only management action acceptable to the majority of urban residents (65%), but were less acceptable to cat-owners because of perceived risks to their pets; only 24% of cats were fitted with such devices. Overall, cat predation did appear to be of sufficient magnitude to affect some prey populations, although further investigation of some key aspects of cat predation is warranted. Management of the predation behavior of urban cat populations in the UK is likely to be challenging and achieving this would require considerable engagement with cat owners.	[Thomas, Rebecca L.; Fellowes, Mark D. E.; Baker, Philip J.] Univ Reading, Sch Biol Sci, Reading, Berks, England	University of Reading	Thomas, RL (corresponding author), Univ Reading, Sch Biol Sci, Harborne Bldg, Reading, Berks, England.	rebecca.thomas@reading.ac.uk	Thomas, Rebecca/E-6896-2016; Fellowes, Mark/O-8053-2019	Thomas, Rebecca/0000-0001-8784-1707; Fellowes, Mark/0000-0001-5431-8637	NERC	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by NERC (www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash SJ, 2003, WILDLIFE SOC B, V31, P334; Baker P.J., 2010, URBAN CARNIVORES ECO, P157; Baker PJ, 2008, IBIS, V150, P86, DOI 10.1111/j.1474-919X.2008.00836.x; Baker PJ, 2005, MAMMAL REV, V35, P302, DOI 10.1111/j.1365-2907.2005.00071.x; Barratt DG, 1998, WILDLIFE RES, V25, P475, DOI 10.1071/WR97026; Barratt DG, 1997, WILDLIFE RES, V24, P263, DOI 10.1071/WR96020; Buckland S.T., 2001, pi; Calver M, 2007, BIOL CONSERV, V137, P341, DOI 10.1016/j.biocon.2007.02.015; Calver MC, 2011, BIOL CONSERV, V144, P1895, DOI 10.1016/j.biocon.2011.04.015; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Clark N.A., 1998, PILOT FIELD TRIAL EF; Clark N.A., 1999, PROGR REPORT EFFECTI; Coleman J, 1996, PROBE, V172, P1; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; de Tores PJ, 2012, FENCING FOR CONSERVATION: RESTRICTION OF EVOLUTIONARY POTENTIAL OR A RIPOSTE TO THREATENING PROCESSES?, P21, DOI 10.1007/978-1-4614-0902-1_3; Dickman C., 1996, OVERVIEW IMPACTS FER; Dickman Christopher R., 2009, Human-Wildlife Conflicts, V3, P41; Driscoll CA, 2009, SCI AM, V300, P68, DOI 10.1038/scientificamerican0609-68; FITZGERALD BM, 1990, ENVIRON CONSERV, V17, P168, DOI 10.1017/S0376892900031970; Fitzgerald BM, 2000, DOMESTIC CAT; GEORGE WG, 1974, WILSON BULL, V86, P384; Gillies C, 2003, J ZOOL, V259, P309, DOI 10.1017/S095283690200328X; Gordon JK, 2010, WILDLIFE RES, V37, P372, DOI 10.1071/WR09127; Grayson J, 2002, AUST VET J, V80, P536, DOI 10.1111/j.1751-0813.2002.tb11030.x; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Holt AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002400; JARVIS PJ, 1990, ENVIRON CONSERV, V17, P169, DOI 10.1017/S0376892900031982; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Kays RW, 2004, ANIM CONSERV, V7, P273, DOI 10.1017/S1367943004001489; Krauze-Gryz D, 2012, J ZOOLOGY N A N A; Lepczyk CA, 2004, BIOL CONSERV, V115, P191, DOI 10.1016/S0006-3207(03)00107-1; Liberg Olof, 2000, P119; Lilith M, 2006, AUSTRAL ECOL, V31, P176, DOI 10.1111/j.1442-9993.2006.01582.x; Lilith Maggie, 2010, Pacific Conservation Biology, V16, P162; Lilith M, 2008, TOO CLOSE FOR COMFORT : CONTENTIOUS ISSUES IN HUMAN-WILDLIFE ENCOUNTERS, P65; Long JL, 2003, INTRO MAMMALS WORLD; Maclean M, 2007, THESIS U EXETER; Maclean MM, 2008, IBIS, V150, P100, DOI 10.1111/j.1474-919X.2008.00864.x; MAY RM, 1988, NATURE, V332, P392, DOI 10.1038/332392a0; McNicholas J, 2005, BMJ-BRIT MED J, V331, P1252, DOI 10.1136/bmj.331.7527.1252; Metsers EM, 2010, WILDLIFE RES, V37, P47, DOI 10.1071/WR09070; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Morgan SA, 2009, WILDLIFE RES, V36, P574, DOI 10.1071/WR09023; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Nelson SH, 2006, APPL ANIM BEHAV SCI, V96, P83, DOI 10.1016/j.applanim.2005.05.005; Nelson SH, 2005, APPL ANIM BEHAV SCI, V94, P273, DOI 10.1016/j.applanim.2005.04.003; Newson SE, 2008, J APPL ECOL, V45, P1330, DOI 10.1111/j.1365-2664.2008.01480.x; Nicoll M, 2010, METHODS ECOLOGY EVOL, V9999; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; Patronek GJ, 1998, J AM VET MED ASSOC, V212, P218; PROULX G, 1988, ENVIRON CONSERV, V15, P358, DOI 10.1017/S0376892900029878; Reynolds JC, 1996, MAMMAL REV, V26, P127, DOI 10.1111/j.1365-2907.1996.tb00150.x; Ruxton GD, 2002, J ZOOL, V256, P81, DOI 10.1017/S0952836902000109; Shirley C, 1999, AUST VET J, V77, P134; Sims V, 2008, DIVERS DISTRIB, V14, P387, DOI 10.1111/j.1472-4642.2007.00444.x; Siriwardena GM, 1998, BIRD STUDY, V45, P276, DOI 10.1080/00063659809461099; SMIT T, 1980, TIJDSCHR DIERGENEESK, V105, P327; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; Tschanz B, 2011, EUR J WILDLIFE RES, V57, P597, DOI 10.1007/s10344-010-0470-1; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Winter L, 2006, IMPACTS FERAL FREE R; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x	63	66	70	3	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49369	10.1371/journal.pone.0049369	http://dx.doi.org/10.1371/journal.pone.0049369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173057	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000311885300032
J	Xie, Y; Avello, M; Schirle, M; McWhinnie, E; Feng, Y; Bric-Furlong, E; Wilson, C; Nathans, R; Zhang, J; Kirschner, MW; Huang, SMA; Cong, F				Xie, Yang; Avello, Monika; Schirle, Markus; McWhinnie, Elizabeth; Feng, Yan; Bric-Furlong, Eva; Wilson, Christopher; Nathans, Robin; Zhang, Jing; Kirschner, Marc W.; Huang, Shih-Min A.; Cong, Feng			Deubiquitinase FAM/USP9X Interacts with the E3 Ubiquitin Ligase SMURF1 Protein and Protects It from Ligase Activity-dependent Self-degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; FUNCTIONAL DIVERSITY; NEDD4 FAMILY; HECT FAMILY; WW DOMAINS; C2 DOMAIN; ENZYME; RHOA; PHOSPHORYLATION; INHIBITION	Ubiquitination is an essential post-translational modification that mediates diverse cellular functions. SMAD-specific E3 ubiquitin protein ligase 1 (SMURF1) belongs to the Nedd4 family of HECT ubiquitin ligases that directly catalyzes ubiquitin conjugation onto diverse substrates. As a result, SMURF1 regulates a great variety of cellular physiologies including bone morphogenetic protein (BMP) signaling, cell migration, and planar cell polarity. Structurally, SMURF1 consists of a C2 domain, two WW domain repeats, and a catalytic HECT domain essential for its E3 ubiquitin ligase activity. This modular architecture allows for interactions with other proteins, which are either substrates or adaptors of SMURF1. Despite the increasing number of SMURF1 substrates identified, current knowledge regarding regulatory proteins and their modes of action on controlling SMURF1 activity is still limited. In this study, we employed quantitative mass spectrometry to analyze SMURF1-associated cellular complexes, and identified the deubiquitinase FAM/USP9X as a novel interacting protein for SMURF1. Through domain mapping study, we found the second WW domain of SMURF1 and the carboxyl terminus of USP9X critical for this interaction. SMURF1 is autoubiquitinated through its intrinsic HECT E3 ligase activity, and is degraded by the proteasome. USP9X association antagonizes this activity, resulting in deubiquitination and stabilization of SMURF1. In MDA-MB-231 breast cancer cells, SMURF1 expression is elevated and is required for cellular motility. USP9X stabilizes endogenous SMURF1 in MDA-MB-231 cells. Depletion of USP9X led to down-regulation of SMURF1 and significantly impaired cellular migration. Taken together, our data reveal USP9X as an important regulatory protein of SMURF1 and suggest that the association between deubiquitinase and E3 ligase may serve as a common strategy to control the cellular protein dynamics through modulating E3 ligase stability.	[Xie, Yang; Avello, Monika; Schirle, Markus; McWhinnie, Elizabeth; Feng, Yan; Bric-Furlong, Eva; Wilson, Christopher; Nathans, Robin; Zhang, Jing; Huang, Shih-Min A.; Cong, Feng] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; Harvard University; Harvard Medical School	Cong, F (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	alex.huang@sanofi.com; feng.cong@novartis.com		Wilson, Christopher/0000-0002-9146-522X				Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; Crose LES, 2009, J BIOL CHEM, V284, P13301, DOI 10.1074/jbc.C900009200; Cui Y, 2011, EMBO J, V30, P2675, DOI 10.1038/emboj.2011.155; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kwei KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023924; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rotin D, 1998, CURR TOP MICROBIOL, V228, P115; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sangadala S, 2007, PROTEINS, V68, P690, DOI 10.1002/prot.21429; Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; THOMPSON EW, 1988, CANCER RES, V48, P6764; Wan LX, 2011, MOL CELL, V44, P721, DOI 10.1016/j.molcel.2011.09.024; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wilkinson S C, 1997, Adv Dent Res, V11, P515; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yuan C, 2012, J BIOL CHEM, V287, P17006, DOI 10.1074/jbc.M112.341198; Zhao L, 2010, J BONE MINER RES, V25, P1246, DOI 10.1002/jbmr.28; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	59	82	84	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2976	2985		10.1074/jbc.M112.430066	http://dx.doi.org/10.1074/jbc.M112.430066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23184937	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000314397900008
J	Feller, A; Georis, I; Tate, JJ; Cooper, TG; Dubois, E				Feller, Andre; Georis, Isabelle; Tate, Jennifer J.; Cooper, Terrance G.; Dubois, Evelyne			Alterations in the Ure2 alpha Cap Domain Elicit Different GATA Factor Responses to Rapamycin Treatment and Nitrogen Limitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 GLUTAMATE-DEHYDROGENASES; UREIDOSUCCINIC ACID UPTAKE; TOR SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; CATABOLITE REPRESSION; NUCLEAR-LOCALIZATION; INTRACELLULAR-LOCALIZATION; METHIONINE SULFOXIMINE; GLN3 PHOSPHORYLATION; CARBON STARVATION	Ure2 is a phosphoprotein and central negative regulator of nitrogen-responsive Gln3/Gat1 localization and their ability to activate transcription. This negative regulation is achieved by the formation of Ure2-Gln3 and -Gat1 complexes that are thought to sequester these GATA factors in the cytoplasm of cells cultured in excess nitrogen. Ure2 itself is a dimer the monomer of which consists of two core domains and a flexible protruding alpha cap. Here, we show that alterations in this alpha cap abolish rapamycin-elicited nuclear Gln3 and, to a more limited extent, Gat1 localization. In contrast, these alterations have little demonstrable effect on the Gln3 and Gat1 responses to nitrogen limitation. Using two-dimensional PAGE we resolved eight rather than the two previously reported Ure2 isoforms and demonstrated Ure2 dephosphorylation to be stimulus-specific, occurring after rapamycin treatment but only minimally if at all in nitrogen-limited cells. Alteration of the alpha cap significantly diminished the response of Ure2 dephosphorylation to the TorC1 inhibitor, rapamycin. Furthermore, in contrast to Gln3, rapamycin-elicited Ure2 dephosphorylation occurred independently of Sit4 and Pph21/22 (PP2A) as well as Siw14, Ptc1, and Ppz1. Together, our data suggest that distinct regions of Ure2 are associated with the receipt and/or implementation of signals calling for cessation of GATA factor sequestration in the cytoplasm. This in turn is more consistent with the existence of distinct pathways for TorC1- and nitrogen limitation-dependent control than it is with these stimuli representing sequential steps in a single regulatory pathway.	[Feller, Andre; Georis, Isabelle; Dubois, Evelyne] Univ Libre Bruxelles, Microbiol Lab, Inst Rech Microbiol JM Wiame, B-1070 Brussels, Belgium; [Tate, Jennifer J.; Cooper, Terrance G.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Universite Libre de Bruxelles; University of Tennessee System; University of Tennessee Health Science Center	Cooper, TG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	tcooper@uthsc.edu		Cooper, Terrance G./0000-0002-7651-9963	National Institutes of Health [GM-35642-23A1]; Commission Communautaire Francaise (COCOF); Fonds de la Recherche Fondamentale Collective [FRFC 2.4547.11]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commission Communautaire Francaise (COCOF); Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35642-23A1 and (to J.J.T., R. Rai, and T. G. C.). This work was also supported by Commission Communautaire Francaise (COCOF) and the Fonds de la Recherche Fondamentale Collective (FRFC 2.4547.11) (to I. G. and E. D.).	AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carvalho J, 2003, J BIOL CHEM, V278, P16878, DOI 10.1074/jbc.M300429200; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Cooper TG, 2004, TOP CURR GENET, V7, P225; Cox KH, 2004, J BIOL CHEM, V279, P19294, DOI 10.1074/jbc.M309240200; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; DRILLIEN R, 1972, J BACTERIOL, V109, P203, DOI 10.1128/JB.109.1.203-208.1972; DRILLIEN R, 1973, BIOCHEM BIOPH RES CO, V53, P367, DOI 10.1016/0006-291X(73)90671-2; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; Georis I, 2008, J BIOL CHEM, V283, P8919, DOI 10.1074/jbc.M708811200; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Georis I, 2011, MOL CELL BIOL, V31, P92, DOI 10.1128/MCB.00482-10; Georis I, 2009, GENETICS, V181, P861, DOI 10.1534/genetics.108.099051; Gonzalez A, 2009, MOL CELL BIOL, V29, P2876, DOI 10.1128/MCB.01740-08; GRENSON M, 1974, MOL GEN GENET, V128, P73, DOI 10.1007/BF00267295; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hirasaki M, 2008, GENE, V409, P34, DOI 10.1016/j.gene.2007.11.005; Hirasaki M, 2011, J BIOSCI BIOENG, V111, P249, DOI 10.1016/j.jbiosc.2010.11.013; Hirasaki M, 2010, J BIOSCI BIOENG, V109, P433, DOI 10.1016/j.jbiosc.2009.10.023; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; Kulkarni AA, 2001, J BIOL CHEM, V276, P32136, DOI 10.1074/jbc.M104580200; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Tate JJ, 2007, J BIOL CHEM, V282, P18467, DOI 10.1074/jbc.M609550200; Tate JJ, 2006, J BIOL CHEM, V281, P37980, DOI 10.1074/jbc.M606973200; Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200; Tate JJ, 2010, J BIOL CHEM, V285, P17880, DOI 10.1074/jbc.M109.085712; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Tate JJ, 2005, J BIOL CHEM, V280, P27195, DOI 10.1074/jbc.M504052200; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Wickner RB, 1999, J BIOL CHEM, V274, P555, DOI 10.1074/jbc.274.2.555; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239	59	22	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1841	1855		10.1074/jbc.M112.385054	http://dx.doi.org/10.1074/jbc.M112.385054			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184930	Green Published, hybrid			2022-12-25	WOS:000313751400039
J	Freimanis, GL; Owusu-Ofori, S; Allain, JP				Freimanis, Graham Lee; Owusu-Ofori, Shirley; Allain, Jean-Pierre			Hepatitis B Virus Infection Does Not Significantly Influence Plasmodium Parasite Density in Asymptomatic Infections in Ghanaian Transfusion Recipients	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SUB-SAHARAN AFRICA; GENOTYPE-E; FALCIPARUM INFECTIONS; HIGH PREVALENCE; BLOOD-DONORS; WEST-AFRICA; MALARIA; BRAZIL; EPIDEMIOLOGY	Background: Areas endemic for malaria and Hepatitis B virus (HBV) infection largely overlap geographically. A recent study has suggested the existence of an interaction between the two pathogens in symptomatic co-infected individuals on the South-American continent. We examined this issue in a hyperendemic area for both pathogens in sub-Saharan Africa. Methodology and Findings: Pre-transfusion samples from a retrospective cohort of 154 blood transfusion recipients were screened for both serological and molecular markers of HBV and Plasmodium genomes using species-specific nested PCR and quantitative real-time PCR. Thirty-seven individuals met exclusion criteria and were subsequently eliminated from further analysis. Of 117 participants, 90% of recipients exhibited evidence of exposure to HBV, 42% with HBsAg and/or HBV DNA and 48% anti-HBc reactive without detectable HBV DNA. Plasmodium genome prevalence by NAT was 50%. Parasitemic individuals were significantly younger than non-parasitemic individuals (P = 0.04). Parasitemia level was not significantly lower in individuals with HBV DNA positive infections compared to those with HBV DNA negative exposures. HBV DNA load was not significantly different in parasitemic and non-parasitemic individuals. Conclusion: The data presented suggests that, in sub-Saharan Africa, asymptomatic co-infections with these two ubiquitous pathogens do not appear to significantly affect each other and evolve independently.	[Freimanis, Graham Lee; Allain, Jean-Pierre] Univ Cambridge, Dept Haematol, Div Transfus Med, Cambridge, England; [Owusu-Ofori, Shirley] Komfo Anokye Teaching Hosp, Transfus Med Unit, Kumasi, Ghana	University of Cambridge; Kwame Nkrumah University Science & Technology	Allain, JP (corresponding author), Univ Cambridge, Dept Haematol, Div Transfus Med, Cambridge, England.	jpa1000@cam.ac.uk			FP6 EC [SP23-CT-2006-006487]	FP6 EC	This study was supported in part by a grant from the FP6 EC (SP23-CT-2006-006487) for the BOTIA repository. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abonuusum A, 2011, PARASITOL RES, V108, P1465, DOI 10.1007/s00436-010-2195-1; Aernan PT, 2011, ASIAN PAC J TROP MED, V4, P224, DOI 10.1016/S1995-7645(11)60074-6; Allain JP, 2003, BLOOD, V101, P2419, DOI 10.1182/blood-2002-04-1084; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Andrade BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019841; Awoonor-Williams JK, 2011, GHANA HLTH REPORT 20, P1; Barcus MJ, 2002, AM J TROP MED HYG, V66, P140, DOI 10.4269/ajtmh.2002.66.140; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Bertolini DA, 2010, REV INST MED TROP SP, V52, P25, DOI 10.1590/S0036-46652010000100004; Braga WSM, 2006, REV SOC BRAS MED TRO, V39, P27, DOI 10.1590/S0037-86822006000100005; BROWN AE, 1992, J INFECT DIS, V166, P1465, DOI 10.1093/infdis/166.6.1465; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Candotti D, 2006, J VIRAL HEPATITIS, V13, P715, DOI 10.1111/j.1365-2893.2006.00741.x; Candotti D, 2007, J GEN VIROL, V88, P2686, DOI 10.1099/vir.0.83102-0; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Freimanis GL, 2012, TRANSFUSION IN PRESS; Gobbini F, 2012, TRANSFUSION; Hartgers FC, 2008, PARASITOLOGY, V135, P855, DOI 10.1017/S0031182008000401; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Huy TTT, 2006, J MED VIROL, V78, P178, DOI 10.1002/jmv.20525; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Lefrere JJ, 2005, TRANSFUS CLIN BIOL, V12, P93, DOI 10.1016/j.tracli.2005.04.002; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Ouwe-Missi-Oukem-Boyer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016034; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Pasquetto V, 2000, J EXP MED, V192, P529, DOI 10.1084/jem.192.4.529; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sanchez JL, 2002, J CLIN MICROBIOL, V40, P2381, DOI 10.1128/JCM.40.7.2381-2386.2002; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374; Tonial GC, 2011, REV SOC BRAS MED TRO, V44, P416, DOI 10.1590/S0037-86822011000400003; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013	40	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49967	10.1371/journal.pone.0049967	http://dx.doi.org/10.1371/journal.pone.0049967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185500	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000152
J	Kolb, P; Phan, K; Gao, ZG; Marko, AC; Sali, A; Jacobson, KA				Kolb, Peter; Phan, Khai; Gao, Zhan-Guo; Marko, Adam C.; Sali, Andrej; Jacobson, Kenneth A.			Limits of Ligand Selectivity from Docking to Models: In Silico Screening for A(1) Adenosine Receptor Antagonists	PLOS ONE			English	Article							DISCOVERY; IDENTIFICATION; PHARMACOLOGY; RADIOLIGAND; DERIVATIVES; CHEMISTRY; LOOPS	G protein-coupled receptors (GPCRs) are attractive targets for pharmaceutical research. With the recent determination of several GPCR X-ray structures, the applicability of structure-based computational methods for ligand identification, such as docking, has increased. Yet, as only about 1% of GPCRs have a known structure, receptor homology modeling remains necessary. In order to investigate the usability of homology models and the inherent selectivity of a particular model in relation to close homologs, we constructed multiple homology models for the A(1) adenosine receptor (A(1)AR) and docked similar to 2.2 M lead-like compounds. High-ranking molecules were tested on the A(1)AR as well as the close homologs A(2A)AR and A(3)AR. While the screen yielded numerous potent and novel ligands (hit rate 21% and highest affinity of 400 nM), it delivered few selective compounds. Moreover, most compounds appeared in the top ranks of only one model. These findings have implications for future screens.	[Kolb, Peter; Marko, Adam C.; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Phan, Khai; Gao, Zhan-Guo; Jacobson, Kenneth A.] NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Marko, Adam C.; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California San Francisco	Kolb, P (corresponding author), Univ Marburg, Dept Pharmaceut Chem, Marburg, Germany.	peter.kolb@uni-marburg.de; kajacobs@helix.nih.gov	Kolb, Peter/A-3782-2008; Jacobson, Kenneth Alan/A-1530-2009	Kolb, Peter/0000-0003-4089-614X; Jacobson, Kenneth Alan/0000-0001-8104-1493	DFG Emmy-Noether Fellowship [KO 4095/1-1]; National Institutes of Health/National Institute of General Medical Sciences [R01 GM083960]; National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program [1ZIADK031117-24]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083960] Funding Source: NIH RePORTER	DFG Emmy-Noether Fellowship(German Research Foundation (DFG)); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from a DFG Emmy-Noether Fellowship KO 4095/1-1 to PK (www.dfg.de), a National Institutes of Health/National Institute of General Medical Sciences R01 GM083960 grant to AS (www.nigms.nih.gov), and a National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Program (1ZIADK031117-24) to KAJ (http://www2.niddk.nih.gov/NIDDKLabs/NIDDKLabsAbout.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baraldi PG, 2002, J MED CHEM, V45, P770, DOI 10.1021/jm0109614; Baraldi PG, 2012, J MED CHEM, V55, P5676, DOI 10.1021/jm300087j; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jacobson KA, 2012, MOL PHARMACOL, V82, P361, DOI 10.1124/mol.112.079335; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; JARVIS MF, 1989, J PHARMACOL EXP THER, V251, P888; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; KLOTZ KN, 1989, N-S ARCH PHARMACOL, V340, P679, DOI 10.1007/BF00717744; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Kolb P, 2011, ANGEW CHEM INT EDIT, V50, P11573, DOI 10.1002/anie.201105869; Kolb P, 2009, CURR OPIN BIOTECH, V20, P429, DOI 10.1016/j.copbio.2009.08.003; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Massarelli I, 2008, EUR J MED CHEM, V43, P114, DOI 10.1016/j.ejmech.2007.02.009; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mitrovic V, 2009, CIRC-HEART FAIL, V2, P523, DOI 10.1161/CIRCHEARTFAILURE.108.798389; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Mysinger MM, 2012, P NATL ACAD SCI USA, V109, P5517, DOI 10.1073/pnas.1120431109; Olah M., 2004, CHEMOINFORMATICS DRU, P223; OLAH ME, 1994, MOL PHARMACOL, V45, P978; Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Phatak SS, 2010, J CHEM INF MODEL, V50, P2119, DOI 10.1021/ci100285f; Rivkees SA, 1999, J BIOL CHEM, V274, P3617, DOI 10.1074/jbc.274.6.3617; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sabio M, 2008, BIOORG MED CHEM LETT, V18, P5391, DOI 10.1016/j.bmcl.2008.09.046; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SHOICHET BK, 1993, PROTEIN ENG, V6, P723, DOI 10.1093/protein/6.7.723; Shoichet BK, 1999, PROTEINS, V34, P4, DOI 10.1002/(SICI)1097-0134(19990101)34:1<4::AID-PROT2>3.0.CO;2-6; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Slawsky MT, 2009, EXPERT OPIN PHARMACO, V10, P311, DOI [10.1517/14656560802682213, 10.1517/14656560802682213 ]; Steffen A, 2009, J CHEM INF MODEL, V49, P338, DOI 10.1021/ci800326z; Terai T, 1996, DRUG DEVELOP RES, V39, P47, DOI 10.1002/(SICI)1098-2299(19960901)39:1<47::AID-DDR6>3.0.CO;2-K; Wawer M, 2010, J CHEM INF MODEL, V50, P1395, DOI 10.1021/ci100197b; Wu B, 2012, SCIENCE, V330, P1066	50	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49910	10.1371/journal.pone.0049910	http://dx.doi.org/10.1371/journal.pone.0049910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185482	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000141
J	Pinheiro, FL; Schultz, CL				Pinheiro, Felipe L.; Schultz, Cesar L.			An Unusual Pterosaur Specimen (Pterodactyloidea, ? Azhdarchoidea) from the Early Cretaceous Romualdo Formation of Brazil, and the Evolution of the Pterodactyloid Palate	PLOS ONE			English	Article							SANTANA FORMATION; CRANIAL CREST; CHINA; TAPEJARIDAE; PHYLOGENY; DIVERSITY; SKULL	A new and unusual specimen of a probable azhdarchoid pterosaur is described for the Early Cretaceous (Albian) Romualdo Formation of Brazil. The specimen consists of a palate that, although fragmentary, has a unique morphology differing from all other known pterosaurs with preservation of palatal elements. The new specimen probably indicates the presence of a yet undescribed pterodactyloid taxon for Romualdo Formation and brings new information on pterosaur diversity of this sedimentary unity. Mainly due to the rarity of pterodactyloid specimens with palate preservation, this structure has been overlooked in this clade. Here, we reassess the palatal anatomy of Pterodactyloidea, revealing an intriguing variety of morphotypes and evolutionary trends, some of them described here for the first time. The morphological disparity displayed by different pterodactyloid taxa may be further evidence of the presence of diverse feeding strategies within the clade.	[Pinheiro, Felipe L.; Schultz, Cesar L.] Univ Fed Rio Grande do Sul, IGeo, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil; [Pinheiro, Felipe L.] Bayer Staatssammlung Palaontol & Geol, Munich, Germany	Universidade Federal do Rio Grande do Sul	Pinheiro, FL (corresponding author), Univ Fed Rio Grande do Sul, IGeo, Dept Paleontol & Estratig, Ave Bento Goncalves, Porto Alegre, RS, Brazil.	fl_pinheiro@yahoo.com.br	Schultz, Cesar/I-4127-2013	Schultz, Cesar/0000-0001-7121-0409	Richard Gilder Graduate School; Deutscher Akademischer Austauschdienst; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Richard Gilder Graduate School; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding visit to AMNH was funded by a Collection Study Grant (Richard Gilder Graduate School - http://rggs.amnh.org/), whereas research at the Bayerische Staatssammlung fur Palaontologie und Geologie was possible thanks to a Deutscher Akademischer Austauschdienst (http://www.daad.de/) scholarship. This work was also partially funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) through scholarships granted to FLP and CLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Assine M.L, 2007, B GEOCIENCIAS PETROB, V15, P371; Assine M. L., 1992, REV BRASILEIRA GEOCI, V22, P289; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P264; Bennett S. C., 2001, PALAEONTOGR ABT A, V260, P1; Bennett SC, 2007, NEUES JAHRB GEOL P-A, V245, P23, DOI 10.1127/0077-7749/2007/0245-0023; Buffetaut E, 1996, B SOC GEOL FR, V167, P753; Buffetaut E., 1995, 2 INT S LITH LIM, P49; Butler RJ, 2009, PALEOBIOLOGY, V35, P432, DOI 10.1666/0094-8373-35.3.432; Cai Z., 1994, VERTEBRATA PALASIATI, V32, P181; CAMPOS DD, 1985, AN ACAD BRAS CIENC, V57, P453; Campos Diogenes De A., 1997, Anais da Academia Brasileira de Ciencias, V69, P83; Cuvier G, 1809, ANN MUS HIST NATUR, V13, P1; Eaton G. F., 1910, Memoirs of the Connecticut Academy of Arts and Sciences New Haven, V2; Eck Kristina, 2011, Swiss Journal of Palaeontology, V130, P277, DOI 10.1007/s13358-011-0024-5; Elgin RA, 2012, HIST BIOL, V24, P586, DOI 10.1080/08912963.2011.613467; Frey Eberhard, 2003, Geological Society Special Publication, V217, P65, DOI 10.1144/GSL.SP.2003.217.01.06; Howse Stafford C.B., 2001, Palaeontological Association Field Guides to Fossils, V10, P324; Kaup J, 1834, ISIS, V3, P311; Kellner A.W.A., 1989, Anais da Academia Brasileira de Ciencias, V61, P439; KELLNER A W A, 1988, Anais da Academia Brasileira de Ciencias, V60, P459; Kellner A.W.A., 1996, THESIS; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner Alexander W.A., 2007, Boletim do Museu Nacional Nova Serie Geologia, V75, P1; Kellner Alexander Wilhelm Armin, 1994, Anais da Academia Brasileira de Ciencias, V66, P467; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Kellner AWA, 2001, DESCRIPTION NEW SPEC; LAWSON DA, 1975, SCIENCE, V188, P676, DOI 10.1126/science.188.4189.676-a; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P453; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lu JC, 2012, ACTA GEOL SIN-ENGL, V86, P287, DOI 10.1111/j.1755-6724.2012.00658.x; Lu JC, 2008, NATURWISSENSCHAFTEN, V95, P891, DOI 10.1007/s00114-008-0397-5; MABESOONE JM, 1973, PALAEOGEOGR PALAEOCL, V14, P97, DOI 10.1016/0031-0182(73)90006-0; MARSH OC, 1876, AM J SCI, V12, P479; Martill DM, 2007, CRETACEOUS RES, V28, P895, DOI 10.1016/j.cretres.2007.01.002; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Martill DM, 2011, CRETACEOUS RES, V32, P236, DOI 10.1016/j.cretres.2010.12.008; MEYER H, 1852, PALAEONTOGRAPHICA, V2, P82; Meyer HV, 1834, MUSEUM SENCKENBERGIA, V1, P3; Meyer HV, 1847, HOMOEOSAURUS MAXIMIL; Meyer HV, 1856, NEUES JB MINERALOGIE, P826; NESOV LA, 1984, PALEONTOL ZH, P47; Osi A, 2011, LETHAIA, V44, P136, DOI 10.1111/j.1502-3931.2010.00230.x; Osi A, 2010, ANAT REC, V293, P243, DOI 10.1002/ar.21053; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; Plieninger F, 1901, PALAEONTOGRAPHICA, V48, P65; Price L. I., 1954, Notas Serv geol Brasil, V71, P1; Quenstedt FA, 1853, PTERODACTYLUS SUEVIC; Theodori C, 1830, FRORIEPS NOTIZEN NAT, V632, P1; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 1997, Historical Biology, V12, P199; Veldmeijer A.J., 2006, THESIS; Veldmeijer Andre J., 2003, Scripta Geologica, V125, P35; Veldmeijer Andre J., 2005, Deinsea (Rotterdam), P67; Vullo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038900; Wang XL, 2008, P NATL ACAD SCI USA, V105, P1983, DOI 10.1073/pnas.0707728105; Wang XL, 2012, NATURWISSENSCHAFTEN, V99, P249, DOI 10.1007/s00114-012-0889-1; Wang XL, 2009, AN ACAD BRAS CIENC, V81, P793, DOI 10.1590/S0001-37652009000400016; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Wellenhofer P., 1987, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V27, P175; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; WELLNHOFER P, 1985, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V187, P105; Wellnhofer P., 1970, ABH BAYER AKAD WISS, V141, P1; Wellnhofer P., 1978, PTEROSAURIA; Wellnhofer P., 1991, ILLUSTRATED ENCY PTE, P192; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Williston SW, 1902, J GEOL, V10, P520, DOI 10.1086/621025; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witton MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033170; Witton MP, 2009, CRETACEOUS RES, V30, P1293, DOI 10.1016/j.cretres.2009.07.006; Witton MP, 2008, PALAEONTOLOGY, V51, P1289, DOI 10.1111/j.1475-4983.2008.00811.x; Young C.C, 1964, VERTEBRATA PALA SIAT, V8, P221; Young CC, 1973, SPECIAL PUBLICATION, V11, P18	77	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50088	10.1371/journal.pone.0050088	http://dx.doi.org/10.1371/journal.pone.0050088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185539	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000179
J	Ward, JK; Roy, DS; Chatterjee, I; Bone, CR; Springer, CJ; Kelly, JK				Ward, Joy K.; Roy, Debosree Samanta; Chatterjee, Iera; Bone, Courtney R.; Springer, Clint J.; Kelly, John K.			Identification of a Major QTL That Alters Flowering Time at Elevated [CO2] in Arabidopsis thaliana	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PLANT-POLLINATOR INTERACTIONS; ATMOSPHERIC CARBON-DIOXIDE; INBRED LINE POPULATIONS; EVOLUTIONARY RESPONSES; LANDSBERG ERECTA; PHENOLOGY; ENVIRONMENTS; BRASSICA; GROWTH	Background: The transition from vegetative to reproductive stages marks a major milestone in plant development. It is clear that global change factors (e. g., increasing [CO2] and temperature) have already had and will continue to have a large impact on plant flowering times in the future. Increasing atmospheric [CO2] has recently been shown to affect flowering time, and may produce even greater responses than increasing temperature. Much is known about the genes influencing flowering time, although their relevance to changing [CO2] is not well understood. Thus, we present the first study to identify QTL (Quantitative Trait Loci) that affect flowering time at elevated [CO2] in Arabidopsis thaliana. Methodology/Principal Findings: We developed our mapping population by crossing a genotype previously selected for high fitness at elevated [CO2] (SG, Selection Genotype) to a Cape Verde genotype (Cvi-0). SG exhibits delayed flowering at elevated [CO2], whereas Cvi-0 is non-responsive to elevated [CO2] for flowering time. We mapped one major QTL to the upper portion of chromosome 1 that explains 1/3 of the difference in flowering time between current and elevated [CO2] between the SG and Cvi-0 parents. This QTL also alters the stage at which flowering occurs, as determined from higher rosette leaf number at flowering in RILs (Recombinant Inbred Lines) harboring the SG allele. A follow-up study using Arabidopsis mutants for flowering time genes within the significant QTL suggests MOTHER OF FT AND TFL1 (MFT) as a potential candidate gene for altered flowering time at elevated [CO2]. Conclusion/Significance: This work sheds light on the underlying genetic architecture that controls flowering time at elevated [CO2]. Prior to this work, very little to nothing was known about these mechanisms at the genomic level. Such a broader understanding will be key for better predicting shifts in plant phenology and for developing successful crops for future environments.	[Ward, Joy K.; Roy, Debosree Samanta; Chatterjee, Iera; Bone, Courtney R.; Springer, Clint J.; Kelly, John K.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University of Kansas	Ward, JK (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	joyward@ku.edu		Springer, Clint/0000-0002-3566-1680	National Science Foundation (NSF) [IOS 0517668, IOS 0746822, IOS 0951254]; Wohlgemuth Faculty Scholar award	National Science Foundation (NSF)(National Science Foundation (NSF)); Wohlgemuth Faculty Scholar award	This project was supported by funding from National Science Foundation (NSF) to JKW through IOS 0517668 and IOS 0746822. The Wohlgemuth Faculty Scholar award (endowed by Ms. Dorothy Lynch) and the Department of Ecology & Evolutionary Biology at the University of Kansas also provided generous support to JKW. JKK was supported by NSF through IOS 0951254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 1998, GENETICS, V149, P749; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Anderson JT, 2011, EVOLUTION, V65, P771, DOI 10.1111/j.1558-5646.2010.01175.x; Bae HH, 2004, FIELD CROP RES, V90, P61, DOI 10.1016/j.fcr.2004.07.005; Bandaranayake CK, 2004, EUPHYTICA, V137, P361, DOI 10.1023/B:EUPH.0000040493.61991.01; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Bodbyl-Roels SA, 2011, EVOLUTION, V65, P2541; Botto JF, 2007, PLANT CELL ENVIRON, V30, P1465, DOI 10.1111/j.1365-3040.2007.01722.x; Castro JC, 2009, J EXP BOT, V60, P2945, DOI 10.1093/jxb/erp170; CHURCHILL GA, 1994, GENETICS, V138, P963; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; El-Lithy ME, 2010, PLANT CELL ENVIRON, V33, P1369, DOI 10.1111/j.1365-3040.2010.02155.x; Hanson J, 2009, CURR OPIN PLANT BIOL, V12, P562, DOI 10.1016/j.pbi.2009.07.014; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Iwata H, 2006, BREEDING SCI, V56, P371, DOI 10.1270/jsbbs.56.371; Johnston A, 2008, INT J PLANT SCI, V169, P1210, DOI 10.1086/591978; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kuittinen H, 1997, THEOR APPL GENET, V95, P573, DOI 10.1007/s001220050598; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liu W, 2011, THEOR APPL GENET, V123, P545, DOI 10.1007/s00122-011-1606-8; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lou P, 2011, THEOR APPL GENET, V123, P397, DOI 10.1007/s00122-011-1592-x; Marriage TN, 2009, HEREDITY, V103, P310, DOI 10.1038/hdy.2009.67; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Ohto M, 2001, PLANT PHYSIOL, V127, P252, DOI 10.1104/pp.127.1.252; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Rafferty NE, 2011, ECOL LETT, V14, P69, DOI 10.1111/j.1461-0248.2010.01557.x; REEKIE EG, 1991, CAN J BOT, V69, P2475, DOI 10.1139/b91-307; REEKIE JYC, 1994, CAN J BOT, V72, P533, DOI 10.1139/b94-071; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Song X, 2009, NEW PHYTOL, V181, P339, DOI 10.1111/j.1469-8137.2008.02669.x; Springer CJ, 2008, NEW PHYTOL, V178, P63, DOI 10.1111/j.1469-8137.2008.02387.x; Springer CJ, 2007, NEW PHYTOL, V176, P243, DOI 10.1111/j.1469-8137.2007.02196.x; Strange A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019949; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Uptmoor R, 2008, MOL BREEDING, V21, P205, DOI 10.1007/s11032-007-9121-y; Wang S., 2007, WINDOWS QTL CARTOGRA; Ward JK, 2000, OECOLOGIA, V123, P330, DOI 10.1007/s004420051019; Ward JK, 2004, ECOL LETT, V7, P427, DOI 10.1111/j.1461-0248.2004.00589.x; Ward JK, 1997, PLANT CELL ENVIRON, V20, P254, DOI 10.1046/j.1365-3040.1997.d01-59.x; Weinig C, 2002, GENETICS, V162, P1875; Wolkovich EM, 2012, NATURE ADV ON LINE; Yan ZQ, 2010, RUSS J PLANT PHYSL+, V57, P166, DOI 10.1134/S1021443710020020; Yoo SY, 2004, MOL CELLS, V17, P95	51	17	18	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49028	10.1371/journal.pone.0049028	http://dx.doi.org/10.1371/journal.pone.0049028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185291	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000025
J	Chen, ZH; Xu, P; Salyards, GW; Harvey, SB; Rada, B; Fu, ZF; He, B				Chen, Zhenhai; Xu, Pei; Salyards, Gregory W.; Harvey, Stephen B.; Rada, Balazs; Fu, Zhen F.; He, Biao			Evaluating a Parainfluenza Virus 5-Based Vaccine in a Host with Pre-Existing Immunity against Parainfluenza Virus 5	PLOS ONE			English	Article							BORDETELLA-BRONCHISEPTICA VACCINE; EQUINE INFLUENZA-VIRUS; MONOCLONAL-ANTIBODIES; IMMUNOLOGICAL RELATIONSHIPS; RESPIRATORY-DISEASE; MULTIPLE-SCLEROSIS; PARAMYXOVIRUS SV5; SIMIAN VIRUS-5; KENNEL COUGH; CANINE	Parainfluenza virus 5 (PIV5), formerly known as simian virus 5 (SV5), is a paramyxovirus often referred to as canine parainfluenza virus (CPI) in the veterinary field. PIV5 is thought to be a contributing factor to kennel cough. Kennel cough vaccines containing live PIV5 have been used in dogs for many decades. PIV5 is not known to cause any diseases in humans or other animals. PIV5 has been used as a vector for vaccine development for humans and animals. One critical question concerning the use of PIV5 as a vector is whether prior exposure to PIV5 would prevent the use of PIV5-based vaccines. In this work, we have examined immunogenicity of a recombinant PIV5 expressing hemagglutinin (HA) of influenza A virus subtype 3 (rPIV5-H3) in dogs that were immunized against PIV5. We found that vaccination of the dogs containing neutralizing antibodies against PIV5 with rPIV5-H3 generated immunity against influenza A virus, indicting that PIV5-based vaccine is immunogenic in dogs with prior exposure. Furthermore, we have examined exposure of PIV5 in human populations. We have detected neutralizing antibody (nAb) against PIV5 in 13 out of 45 human serum samples (about 29 percent). The nAb titers in humans were lower than that in vaccinated dogs, suggesting that nAb in humans is unlikely to prevent PIV5 from being an efficacious vector in humans.	[Chen, Zhenhai; Xu, Pei; Rada, Balazs; He, Biao] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Xu, Pei] Penn State Univ, Intercoll Grad Program Cell & Dev Biol, University Pk, PA 16802 USA; [Salyards, Gregory W.; Harvey, Stephen B.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA USA; [Salyards, Gregory W.; Harvey, Stephen B.] Univ Georgia, Univ Res Anim Resources, Athens, GA USA; [Fu, Zhen F.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	He, B (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	bhe@uga.edu	chen, zhenhai/L-4023-2013		National Institute of Allergy and Infectious Disease [R01AI070847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070847] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Disease (R01AI070847) to B.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimilli S, 2006, J VIROL, V80, P3416, DOI 10.1128/JVI.80.7.3416-3427.2006; ATOYNATAN T, 1969, AM J EPIDEMIOL, V89, P472, DOI 10.1093/oxfordjournals.aje.a120959; AZETAKA M, 1988, JPN J VET SCI, V50, P851; BINN LN, 1967, P SOC EXP BIOL MED, V126, P140, DOI 10.3181/00379727-126-32386; Chatziandreou N, 2004, J GEN VIROL, V85, P3007, DOI 10.1099/vir.0.80200-0; CHLADEK DW, 1981, AM J VET RES, V42, P266; CHOPPIN PW, 1964, VIROLOGY, V23, P224, DOI 10.1016/0042-6822(64)90286-7; CORNWELL HJC, 1976, VET REC, V98, P301, DOI 10.1136/vr.98.15.301; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Daly JM, 2008, EMERG INFECT DIS, V14, P461, DOI 10.3201/eid1403.070643; GOSWAMI KKA, 1987, NATURE, V327, P244, DOI 10.1038/327244a0; GOSWAMI KKA, 1984, J GEN VIROL, V65, P1295, DOI 10.1099/0022-1317-65-8-1295; He B, 1997, VIROLOGY, V237, P249, DOI 10.1006/viro.1997.8801; HSIUNG GD, 1972, PROG MED VIROL, V14, P241; HULL RN, 1956, AM J HYG, V63, P204, DOI 10.1093/oxfordjournals.aje.a119804; KOMADA H, 1991, ARCH VIROL, V116, P277, DOI 10.1007/BF01319249; KONTOR EJ, 1981, AM J VET RES, V42, P1694; Lamb R.A., 2001, FIELDS VIROLOGY; Li SJ, 2010, INFECT GENET EVOL, V10, P1286, DOI 10.1016/j.meegid.2010.08.010; Li Z, 2012, J VIROL; MCCANDLISH IAP, 1978, VET REC, V102, P298, DOI 10.1136/vr.102.14.293; Mueller S, 1998, J VIROL, V72, P20, DOI 10.1128/JVI.72.1.20-31.1998; Paterson RG, 1993, MOL VIROLOGY PRACTIC, P35; RANDALL RE, 1988, J GEN VIROL, V69, P2051, DOI 10.1099/0022-1317-69-8-2051; ROSENBERG FJ, 1971, AM J EPIDEMIOL, V94, P147, DOI 10.1093/oxfordjournals.aje.a121307; Sun DY, 2011, J VIROL, V85, P8376, DOI 10.1128/JVI.00618-11; Team RDC, 2003, R PROJ STAT COMP; Tompkins SM, 2007, VIROLOGY, V362, P139, DOI 10.1016/j.virol.2006.12.005; TRIBE GW, 1966, BRIT J EXP PATHOL, V47, P472; TSURUDOME M, 1989, VIROLOGY, V171, P38, DOI 10.1016/0042-6822(89)90508-4; VANDVIK B, 1989, NATURE, V338, P769, DOI 10.1038/338769a0; WHO, 2002, MANUAL ON ANIMAL DIA; Xu P, 2011, VIROLOGY, V417, P126, DOI 10.1016/j.virol.2011.05.003; YOUNG DF, 1990, J VIROL, V64, P5403, DOI 10.1128/JVI.64.11.5403-5411.1990; ZAKSTELSKAYA LY, 1976, ACTA VIROL, V20, P506; Zhang LQ, 2011, VIROLOGY, V421, P67, DOI 10.1016/j.virol.2011.08.020	36	28	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50144	10.1371/journal.pone.0050144	http://dx.doi.org/10.1371/journal.pone.0050144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185558	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700073
J	Hsu, PY; Harmer, SL				Hsu, Polly Yingshan; Harmer, Stacey L.			Circadian Phase Has Profound Effects on Differential Expression Analysis	PLOS ONE			English	Article							KEY PATHWAYS; MICROARRAY ANALYSIS; ARABIDOPSIS; TRANSCRIPTION; RHYTHMS; CLOCK; TOC1; GROWTH; MOUSE; LIGHT	Circadian rhythms are physiological and behavioral cycles with a period of approximately 24 hours that are generated by an endogenous clock, or oscillator. Found in diverse organisms, they are precisely controlled and provide growth and fitness benefits. Numerous microarray studies examining circadian control of gene expression have reported that a substantial fraction of the genomes of many organisms is clock-controlled. Here we show that a long-period mutant in Arabidopsis, rve8-1, has a global alteration in phase of all clock-controlled genes. After several days in constant environmental conditions, at which point the mutant and control plants have very different circadian phases, we found 1557 genes to be differentially expressed in rve8-1, almost all of which are clock-regulated. However, after adjusting for this phase difference, only a handful show overall expression level differences between rve8-1 and wild type. Thus the apparent differential expression is mainly due to the phase difference between these two genotypes. These findings prompted us to examine the effect of phase on gene expression within a single genotype. Using samples of wild-type plants harvested at thirty-minute intervals, we demonstrated that even this small difference in circadian phase significantly influences the results of differential expression analysis. Our study demonstrates the robust influence of the circadian clock on the transcriptome and provides a cautionary note for all biologists performing genome-level expression analysis.	[Hsu, Polly Yingshan; Harmer, Stacey L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Harmer, SL (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	slharmer@ucdavis.edu		Hsu, Polly/0000-0001-7071-5798; Harmer, Stacey/0000-0001-6813-6682	National Institutes of Health, National Institute of General Medical Sciences (NIGMS) [GM069418]; Taiwan Merit Scholarship [NSC-095-SAF-I-564-014-TMS]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069418] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Taiwan Merit Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Institute of General Medical Sciences (NIGMS) (http://www.nigms.nih.gov/) [grant number GM069418] and the Taiwan Merit Scholarship (http://web1.nsc.gov.tw/) [grant number: NSC-095-SAF-I-564-014-TMS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bengtsson H., 2008, 745 U CAL DEP STAT; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Farinas B, 2011, PLANT J, V66, P318, DOI 10.1111/j.1365-313X.2011.04484.x; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Huang W, 2012, SCIENCE; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Martin-Tryon EL, 2007, PLANT PHYSIOL, V143, P473, DOI 10.1104/pp.106.088757; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Ptacek LJ, 2007, COLD SPRING HARB SYM, V72, P273; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rawat R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001350; Rehrauer H, 2010, PLANT PHYSIOL, V152, P487, DOI 10.1104/pp.109.150185; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Straume M, 2004, METHOD ENZYMOL, V383, P149; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Swinton J., 2011, VENNERABLE VENN EULE; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	41	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49853	10.1371/journal.pone.0049853	http://dx.doi.org/10.1371/journal.pone.0049853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185460	gold, Green Submitted, Green Published			2022-12-25	WOS:000311535700054
J	Njomo, DW; Amuyunzu-Nyamongo, M; Magambo, JK; Njenga, SM				Njomo, Doris W.; Amuyunzu-Nyamongo, Mary; Magambo, Japheth K.; Njenga, Sammy M.			The Role of Personal Opinions and Experiences in Compliance with Mass Drug Administration for Lymphatic Filariasis Elimination in Kenya	PLOS ONE			English	Article							BANCROFTIAN FILARIASIS; KWALE DISTRICT; PROGRAM; LEOGANE; DIETHYLCARBAMAZINE; PARTICIPATION; ALBENDAZOLE; COVERAGE; INDIA	Background: The main strategy adopted for Lymphatic Filariasis (LF) elimination globally is annual mass drug administration (MDA) for 4 to 6 rounds. At least 65% of the population at risk should be treated in each round for LF elimination to occur. In Kenya, MDA using diethylcarbamazine citrate (DEC) and albendazole data shows declining compliance (proportion of eligible populations who receive and swallow the drugs) levels (85%-62.8%). The present study's aim was to determine the role of personal opinions and experiences in compliance with MDA. Methods/Findings: This was a retrospective cross-sectional study conducted between January and September 2009 in two districts based on December 2008 MDA round. In each district, one location with high and one with low compliance was selected. Through systematic sampling, nine villages were selected and interviewer-based questionnaires administered to 965 household heads or adult representatives also systematically sampled. The qualitative data were generated from opinion leaders, LF patients with clinical signs and community drug distributors (CDDs) all purposively selected and interviewed. Sixteen focus group discussions (FGDs) were also conducted with single-sex adult and youth male and female groups. Chi square test was used to assess the statistical significance of differences in compliance with treatment based on the records reviewed. The house-to-house method of drug distribution influenced compliance. Over one-quarter (27%) in low compared to 15% in high compliance villages disliked this method. Problems related to size, number and taste of the drugs were more common in low (16.4%) than in high (14.4%) compliance villages. Reasons for failure to take the drugs were associated with compliance (p<0.001). The reasons given included: feeling that the drugs were not necessary, CDD not visiting to issue the drugs, being absent and thinking that the drugs were meant for only the patients with LF clinical signs. A dislike for modern medicine prevailed more in low (6.7%) than in high (1.2%) compliance villages. Experience of side effects influenced compliance (P<0.001). The common side effects experienced included giddiness, fever, headache and vomiting. Social support, alcohol and substance use were not associated with compliance in both types of villages (p>0.05). Conclusions/Significance:: Community sensitization on treatment, drugs used, their regimen and distribution method involving all leaders should be strengthened by the Programme Implementers. The communities need to be made aware of the potential side effects of the drugs and that health personnel are on standby for the management of side effects in order to build confidence and increase the compliance levels.	[Njomo, Doris W.; Njenga, Sammy M.] Kenya Med Res Inst KEMRI, Eastern & So Africa Ctr Int Parasite Control ESAC, Nairobi, Kenya; [Amuyunzu-Nyamongo, Mary] African Inst Hlth & Dev, Nairobi, Kenya; [Njomo, Doris W.; Magambo, Japheth K.] Jomo Kenyatta Univ Agr & Technol, Inst Trop Med & Infect Dis, Nairobi, Kenya	Kenya Medical Research Institute; Jomo Kenyatta University of Agriculture & Technology	Njomo, DW (corresponding author), Kenya Med Res Inst KEMRI, Eastern & So Africa Ctr Int Parasite Control ESAC, Nairobi, Kenya.	dnjomo@kemri.org		Njenga, Sammy/0000-0001-6309-476X	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) [A61106]; African Doctoral Dissertation Research Fellowship (ADDRF) through the African Population and Health Research Centre (APHRC); International Development Research Centre (IDRC); Ford Foundation	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR)(World Health Organization); African Doctoral Dissertation Research Fellowship (ADDRF) through the African Population and Health Research Centre (APHRC); International Development Research Centre (IDRC); Ford Foundation	This study received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) ID Number A61106 and The African Doctoral Dissertation Research Fellowship (ADDRF) through the African Population and Health Research Centre (APHRC) in partnership with International Development Research Centre (IDRC) and Ford Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo MLE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-14; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2004, Wkly Epidemiol Rec, V79, P417; [Anonymous], 2009, KEN POP HOUS CENS HI, P1; Babu B, 2004, TROP MED INT HEALTH, V9, P702, DOI 10.1111/j.1365-3156.2004.01247.x; Babu BV, 2003, TROP DOCT, V33, P79, DOI 10.1177/004947550303300208; Bockarie MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1686; Brown Celia A, 2008, BMC Pregnancy Childbirth, V8, P2, DOI 10.1186/1471-2393-8-2; Carter A., 2010, FACTORS CONTRIBUTE L; Christensen SM, 1993, FOLK PSYCHOL PHILOS; Damer TE, 2008, ATTACKING FAULTY REA, P14; EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S; Katabarwa N, 1998, ANN TROP MED PARASIT, V94, P343; KHAN M E, 1991, World Health Statistics Quarterly, V44, P145; Kyelem D, 2007, THESIS U LIVERPOOL, P252; Lakwo T L, 2006, East Afr Med J, V83, P326; Mathieu E, 2004, ANN TROP MED PARASIT, V98, P703, DOI 10.1179/000349804X3135; Mathieu E, 2006, TROP MED INT HEALTH, V11, P862, DOI 10.1111/j.1365-3156.2006.01626.x; McLaughlin SI, 2003, AM J TROP MED HYG, V68, P568, DOI 10.4269/ajtmh.2003.68.568; Mohammed KA, 2006, TRENDS PARASITOL, V22, P340, DOI 10.1016/j.pt.2006.05.010; Mukoko DAN, 2004, ANN TROP MED PARASIT, V98, P801, DOI 10.1179/000349804X3225; Njenga SM, 2008, T ROY SOC TROP MED H, V102, P1017, DOI 10.1016/j.trstmh.2008.04.039; Njenga SM, 2000, E AFR MED J, V77, P245; Njomo D. W., 2012, Southern African Journal of Epidemiology & Infection, V27, P66; Njomo DW, 2012, AFRICAN J HLTH SCI, V20, P42; Plaisier AP, 2000, PARASITOL TODAY, V16, P298, DOI 10.1016/S0169-4758(00)01691-4; Ramaiah KD, 2000, TROP MED INT HEALTH, V5, P842, DOI 10.1046/j.1365-3156.2000.00659.x; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; Stroebe W, 2000, MODERATORS STRESS HL, P236; Wanji S, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-39; WEERASOORIYA MV, 2007, FILARIA J, V6, P6; *WHO, 1995, WORLD HLTH REP 1995, P118; Yirga D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-48	33	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48395	10.1371/journal.pone.0048395	http://dx.doi.org/10.1371/journal.pone.0048395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185256	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800006
J	Rasmussen, TL; Shi, XZ; Wallis, A; Kweon, J; Zirbes, KM; Koyano-Nakagawa, N; Garry, DJ				Rasmussen, Tara L.; Shi, Xiaozhong; Wallis, Alicia; Kweon, Junghun; Zirbes, Katie M.; Koyano-Nakagawa, Naoko; Garry, Daniel J.			VEGF/Flk1 Signaling Cascade Transactivates Etv2 Gene Expression	PLOS ONE			English	Article							FATE; LETHALITY; EMBRYOS; BLOOD; FLK1	Previous reports regarding the genetic hierarchy between Ets related protein 71 (Er71/Etv2) and Flk1 is unclear. In the present study, we pursued a genetic approach to define the molecular cascade between Etv2 and Flk1. Using a transgenic Etv2-EYFP reporter mouse, we examined the expression pattern of Etv2 relative to Flk1 in the early conceptus. Etv2-EYFP was expressed in subset of Flk1 positive cells during primitive streak stages, suggesting that Flk1 is upstream of Etv2 during gastrulation. Analysis of reporter gene expression in Flk1 and Etv2 mutant mice further supports the hypothesis that Flk1 is necessary for Etv2 expression. The frequency of cells expressing Flk1 in Etv2 mutants is only modestly altered (21% decrease), whereas expression of the Etv2-EYFP transgenic reporter was severely reduced in the Flk1 null background. We further demonstrate using transcriptional assays that, in the presence of Flk1, the Etv2 promoter is activated by VEGF, the Flk1 ligand. Pharmacological inhibition studies demonstrate that VEGF mediated activation is dependent on p38 MAPK, which activates Creb. We identify the VEGF response element in the Etv2 promoter and demonstrate that Creb binds to this motif by EMSA and ChIP assays. In summary, we provide new evidence that VEGF activates Etv2 by signaling through Flk1, which activates Creb through the p38 MAPK signaling cascade.				garry@umn.edu		Wallis, Alicia/0000-0001-5510-6273	National Institutes of Health [U01 HL100407, R01 HL085729]; American Heart Association (Jon Holden DeHaan Foundation) [0970499]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, R01HL085729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Jon Holden DeHaan Foundation)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding support was obtained from the National Institutes of Health (U01 HL100407 and R01 HL085729, www.nih.gov) and the American Heart Association (Jon Holden DeHaan Foundation 0970499, www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caprioli A, 2011, CIRCULATION, V123, P1633, DOI 10.1161/CIRCULATIONAHA.110.008185; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Issbrucker K, 2002, FASEB J, V16, P262, DOI 10.1096/fj.02-0329fje; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kaufman M.H., 1992, ATLAS MOUSE DEV; Koyano-Nakagawa N, 2012, STEM CELLS; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Sase H, 2009, J CELL SCI, V122, P3303, DOI 10.1242/jcs.049908; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; Shi XZ, 2010, BIOCHEM J, V428, P213, DOI 10.1042/BJ20091906; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Wareing S, 2012, STEM CELLS, V30, P1521, DOI 10.1002/stem.1115; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041	22	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50103	10.1371/journal.pone.0050103	http://dx.doi.org/10.1371/journal.pone.0050103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185546	gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800069
J	Zhang, ZY; Yang, ZH; Zhu, B; Hu, J; Liew, CW; Zhang, YY; Leopold, JA; Handy, DE; Loscalzo, J; Stanton, RC				Zhang, Zhaoyun; Yang, Zhihong; Zhu, Bo; Hu, Ji; Liew, Chong Wee; Zhang, Yingyi; Leopold, Jane A.; Handy, Diane E.; Loscalzo, Joseph; Stanton, Robert C.			Increasing Glucose 6-Phosphate Dehydrogenase Activity Restores Redox Balance in Vascular Endothelial Cells Exposed to High Glucose	PLOS ONE			English	Article							INHIBITS SUPEROXIDE FORMATION; OXIDATIVE STRESS; DIABETIC COMPLICATIONS; CELLULAR REDOX; OXIDANT STRESS; NITRIC-OXIDE; BLOOD-CELLS; NADPH; EXPRESSION; GLUTATHIONE	Previous studies have shown that high glucose increases reactive oxygen species (ROS) in endothelial cells that contributes to vascular dysfunction and atherosclerosis. Accumulation of ROS is due to dysregulated redox balance between ROS-producing systems and antioxidant systems. Previous research from our laboratory has shown that high glucose decreases the principal cellular reductant, NADPH by impairing the activity of glucose 6-phosphate dehydrogenase (G6PD). We and others also have shown that the high glucose-induced decrease in G6PD activity is mediated, at least in part, by cAMP-dependent protein kinase A (PKA). As both the major antioxidant enzymes and NADPH oxidase, a major source of ROS, use NADPH as substrate, we explored whether G6PD activity was a critical mediator of redox balance. We found that overexpression of G6PD by pAD-G6PD infection restored redox balance. Moreover inhibition of PKA decreased ROS accumulation and increased redox enzymes, while not altering the protein expression level of redox enzymes. Interestingly, high glucose stimulated an increase in NADPH oxidase (NOX) and colocalization of G6PD with NOX, which was inhibited by the PKA inhibitor. Lastly, inhibition of PKA ameliorated high glucose mediated increase in cell death and inhibition of cell growth. These studies illustrate that increasing G6PD activity restores redox balance in endothelial cells exposed to high glucose, which is a potentially important therapeutic target to protect ECs from the deleterious effects of high glucose.	[Zhang, Zhaoyun; Yang, Zhihong; Liew, Chong Wee; Stanton, Robert C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Zhang, Zhaoyun] Huashan Hosp, Div Endocrinol & Metab, Shanghai, Peoples R China; [Zhang, Yingyi; Leopold, Jane A.; Handy, Diane E.; Loscalzo, Joseph] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Zhu, Bo] Nanfang Hosp, Div Endocrinol & Metab, Guangzhou, Guangdong, Peoples R China; [Hu, Ji] Soochow Univ, Affiliated Hosp 2, Div Endocrinol & Metab, Suzhou, Peoples R China	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Fudan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Southern Medical University - China; Soochow University - China	Stanton, RC (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA.	robert.stanton@joslin.harvard.edu	Loscalzo, Joseph/ABD-8980-2021	Handy, Diane/0000-0002-4310-8527; Liew, Chong Wee/0000-0001-9904-0958	National Institutes of Health (NIH)/The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK54380]; NIH/National Heart, Lung, and Blood Institute (NHLBI) [R37-HL61795, R01-HL58796, P01-HL81587, K02 HL081110, U54-HL70819]; National Natural Science Foundation of China (NSFC) [30900502]; SCSTM [11PJ1402000]; SMHB [XYQ2011002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105301, K02HL081110, R01HL058976, P01HL081587, U54HL070819, R37HL061795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); SCSTM; SMHB; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH)/The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant #R01-DK54380 to RCS; NIH/National Heart, Lung, and Blood Institute (NHLBI) grants # R37-HL61795, R01-HL58796 and P01-HL81587 to JL; and K02 HL081110 and U54-HL70819 to JAL, The National Natural Science Foundation of China (NSFC) grant # 30900502, SCSTM grant # 11PJ1402000 and SMHB grant XYQ2011002 to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktutan U, 2000, ARTERIOSCL THROM VAS, V20, P1903, DOI 10.1161/01.ATV.20.8.1903; Beisswenger PJ, 2005, DIABETES, V54, P3274, DOI 10.2337/diabetes.54.11.3274; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; CALVO JC, 1979, HORM METAB RES, V11, P161, DOI 10.1055/s-0028-1092701; Chiu DTY, 1997, J BIOMED SCI, V4, P256, DOI 10.1007/BF02253426; COSTAGLIOLA C, 1990, CLIN PHYSIOL BIOCH, V8, P204; Diaz-Flores M, 2006, LIFE SCI, V78, P2601, DOI 10.1016/j.lfs.2005.10.022; Ding H, 2007, J CELL PHYSIOL, V212, P682, DOI 10.1002/jcp.21063; Fatokun AA, 2008, FRONT BIOSCI-LANDMRK, V13, P3288, DOI 10.2741/2926; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; FREY RS, 2008, ANTIOXID REDOX SIGNA; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Greindling K, 1994, CIRC RES, V74, P1141; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Kalinina EV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1493, DOI 10.1134/S0006297908130099; Kamal K, 1998, J CELL BIOCHEM, V71, P491, DOI 10.1002/(SICI)1097-4644(19981215)71:4<491::AID-JCB4>3.0.CO;2-P; Kim JS, 2007, J BIOL CHEM, V282, P34787, DOI 10.1074/jbc.M704754200; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; KURODA A, 1990, ARCH HISTOL CYTOL, V53, P193, DOI 10.1679/aohc.53.193; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leopold JA, 2001, FASEB J, V15, P1771, DOI 10.1096/fj.00-0893fje; Lubos E, 2008, FRONT BIOSCI-LANDMRK, V13, P5323, DOI 10.2741/3084; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Martini G, 1996, BIOESSAYS, V18, P631, DOI 10.1002/bies.950180806; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MUGGEO M, 1993, HORM METAB RES, V25, P160, DOI 10.1055/s-2007-1002068; Muzaffar S, 2008, BRIT J PHARMACOL, V155, P984, DOI 10.1038/bjp.2008.326; Muzaffar S, 2008, J VASC RES, V45, P521, DOI 10.1159/000129686; Nakagami H, 2005, CURR DIABETES REV, V1, P59, DOI 10.2174/1573399052952550; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Nogueira-Machado JA, 2006, DIABETES METAB, V32, P331, DOI 10.1016/S1262-3636(07)70287-2; Okouchi M, 2005, CURR NEUROVASC RES, V2, P375, DOI 10.2174/156720205774962665; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; ROSA LFBPC, 1995, BIOCHEM J, V310, P709, DOI 10.1042/bj3100709; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Sheu ML, 2008, FREE RADICAL BIO MED, V44, P2043, DOI 10.1016/j.freeradbiomed.2008.03.014; STANTON RC, 1988, AM J PHYSIOL, V254, pC267, DOI 10.1152/ajpcell.1988.254.2.C267; STANTON RC, 1991, J BIOL CHEM, V266, P12442; TARACH JS, 1978, ACTA HISTOCHEM, V61, P257, DOI 10.1016/S0065-1281(78)80072-5; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; Ulusu NN, 2003, NEUROCHEM RES, V28, P815, DOI 10.1023/A:1023202805255; VanderJagt DJ, 2001, CLIN BIOCHEM, V34, P265, DOI 10.1016/S0009-9120(01)00204-1; Xu YZ, 2005, AM J PHYSIOL-RENAL, V289, pF1040, DOI 10.1152/ajprenal.00076.2005; Zhang ZQ, 2000, J BIOL CHEM, V275, P40042, DOI 10.1074/jbc.M007505200	50	37	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49128	10.1371/journal.pone.0049128	http://dx.doi.org/10.1371/journal.pone.0049128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185302	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800019
J	Wang, J; Gildea, JJ; Yue, W				Wang, J.; Gildea, J. J.; Yue, W.			Aromatase overexpression induces malignant changes in estrogen receptor a negative MCF-10A cells	ONCOGENE			English	Article						aromatase; MCF-10A; estrogen; breast cancer; stem cell	BREAST-CANCER CELLS; MOLECULAR ETIOLOGY; ADIPOSE-TISSUE; BRCA1; RISK; BIOMARKERS; TUMOR; EXPRESSION; LINK; 17-BETA-ESTRADIOL	Estrogen is a risk factor of breast cancer. Elevated expression of aromatase (estrogen synthase) in breast tissues increases local estradiol concentrations and is associated with breast cancer development, but the causal relationship between aromatase and breast cancer has not been identified. Accumulating data suggest that both estrogen receptor (ER)-dependent and -independent effects are involved in estrogen carcinogenesis. We established a model by expressing aromatase in ER alpha - MCF-10A human breast epithelial cells to investigate ER alpha-independent effects of estrogen in the process of malignant transformation. Overexpression of aromatase significantly increased anchorage-independent growth. Parental- or vector-expressing MCF-10A cells did not form colonies under the same conditions. The anchorage-independent growth of MCF-10A(arom) cells can be completely abolished by pretreatment with the aromatase inhibitor, letrozole. Neither MCF-10A(arom) nor MCF-10A(vector) cells grown in monolayer were affected by short-term exposure to estradiol. Enhanced motility is another characteristic of cellular transformation. Motility of MCF-10A(arom) cells was increased, which could be inhibited by letrozole. Increases in stem cell population in breast cancer tissues are associated with tumor recurrence and metastasis. CD44(high)/CD24(low) is a stem cell marker. We found that CD24 mRNA levels were reduced in MCF-10A(arom) cells compared with those in parental- and vector-transfected cells. By examining individual clones of MCF-10A(arom) with various aromatase activities, we found that the CD24 mRNA levels were inversely correlated with aromatase activity. The ability of MCF-10A(arom) cells to form mammospheres in the absence of serum was increased. Our results suggest that overexpression of aromatase in MCF-10A cells causes malignant transformation. Estrogen metabolite-mediated genotoxicity and induction of a stem cell/progenitor cell population are possible mechanisms. These studies provide additional evidence for ER alpha-independent mechanism(s) in estrogen carcinogenesis and implicate superiority of aromatase inhibitors to antiestrogens for breast cancer prevention.	[Wang, J.; Yue, W.] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA 22908 USA; Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Yue, W (corresponding author), Univ Virginia Hlth Syst, Dept Med, Fountaine Res Pk,POB 801416, Charlottesville, VA 22908 USA.	wy9c@virginia.edu			DOD [DOD DAMD17-01-1-0444, DAMD17-01-1-0445]	DOD(United States Department of Defense)	This study is supported by DOD Grants: DOD DAMD17-01-1-0444 and DAMD17-01-1-0445. Human aromatase cDNA plasmid was kindly provided by Dr Shiuan Chen (Beckman Institute at City of Hope, Duarte, CA, USA). Measurement of estrogen metabolites was performed by Dr Cavalieri at the Laboratory of Eppley Institute for Research in Cancer and Allied Diseases (University of Nebraska Medical Center Omaha, NE, USA).	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; BERKOVITZ GD, 1985, J CLIN INVEST, V75, P1763, DOI 10.1172/JCI111888; BULARD J, 1987, J CLIN ENDOCR METAB, V64, P618, DOI 10.1210/jcem-64-3-618; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Chand AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-148; Chen WY, 2006, ARCH INTERN MED, V166, P1027, DOI 10.1001/archinte.166.9.1027; DEOME KB, 1959, CANCER RES, V19, P515; Diaz-Cruz ES, 2011, CANCER RES, V71, P5477, DOI 10.1158/0008-5472.CAN-10-4652; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; FEINLEIB M, 1968, JNCI-J NATL CANCER I, V41, P315; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Gaikwad NW, 2008, INT J CANCER, V122, P1949, DOI 10.1002/ijc.23329; Gaikwad NW, 2009, BREAST CANCER-BASIC, V3, P1; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Hu YF, 2005, ONCOGENE, V24, P8343, DOI 10.1038/sj.onc.1208985; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kaaks R, 2005, ENDOCR-RELAT CANCER, V12, P1071, DOI 10.1677/erc.1.01038; Kotsopoulos J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2790; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lu F, 2007, J STEROID BIOCHEM, V105, P150, DOI 10.1016/j.jsbmb.2006.12.102; Lu ML, 2006, J CLIN ENDOCR METAB, V91, P4514, DOI 10.1210/jc.2006-1364; Maurice KT, 2005, CAN VET J, V46, P644; ONEILL JS, 1988, BRIT MED J, V296, P741, DOI 10.1136/bmj.296.6624.741; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Rogan EG, 2003, CARCINOGENESIS, V24, P697, DOI 10.1093/carcin/bgg004; Russo J, 2002, J STEROID BIOCHEM, V80, P149, DOI 10.1016/S0960-0760(01)00183-2; Russo J, 2000, J Natl Cancer Inst Monogr, P17; Russo J, 2006, FASEB J, V20, P1622, DOI 10.1096/fj.05-5399com; Shen YM, 2006, CHEM RES TOXICOL, V19, P1441, DOI 10.1021/tx0601206; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Tekmal RR, 1996, CANCER RES, V56, P3180; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; TRICHOPOULOS D, 1972, JNCI-J NATL CANCER I, V48, P605; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yager JD, 2012, TRANSL ENDOCRINOL ME, V3, P1; Yue W, 2003, J STEROID BIOCHEM, V86, P265, DOI 10.1016/S0960-0760(03)00366-2; Yue W, 2002, ENDOCRINOLOGY, V143, P3221, DOI 10.1210/en.2002-220186; Yue W, 1998, CANCER RES, V58, P927; Yue W, 2010, INT J CANCER, V127, P1748, DOI 10.1002/ijc.25207; ZHOU D, 1990, CANCER RES, V50, P6949	46	12	15	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 31	2013	32	44					5233	5240		10.1038/onc.2012.558	http://dx.doi.org/10.1038/onc.2012.558			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	245XH	23178495				2022-12-25	WOS:000326497100006
J	Gupta, A; Jha, S; Engel, DA; Ornelles, DA; Dutta, A				Gupta, A.; Jha, S.; Engel, D. A.; Ornelles, D. A.; Dutta, A.			Tip60 degradation by adenovirus relieves transcriptional repression of viral transcriptional activator EIA	ONCOGENE			English	Article						HAT; Tip60; EIA; adenovirus	DNA-DAMAGE RESPONSE; CELL-CYCLE ARREST; HISTONE ACETYLTRANSFERASE; PROTEIN-VII; ACETYLATION; COMPLEX; E1A; CHROMATIN; P53; TRANSFORMATION	Adenoviruses are linear double-stranded DNA viruses that infect human and rodent cell lines, occasionally transform them and cause tumors in animal models. The host cell challenges the virus in multifaceted ways to restrain viral gene expression and DNA replication, and sometimes even eliminates the infected cells by programmed cell death. To combat these challenges, adenoviruses abrogate the cellular DNA damage response pathway. Tip60 is a lysine acetyltransferase that acetylates histones and other proteins to regulate gene expression, DNA damage response, apoptosis and cell cycle regulation. Tip60 is a bona fide tumor suppressor as mice that are haploid for Tip60 are predisposed to tumors. We have discovered that Tip60 is degraded by adenovirus oncoproteins EIB55K and E4orf6 by a proteasome-mediated pathway. Tip60 binds to the immediate early adenovirus promoter and suppresses adenovirus EIA gene expression, which is a master regulator of adenovirus transcription, at least partly through retention of the virally encoded repressor pVII on this promoter. Thus, degradation of Tip60 by the adenoviral early proteins is important for efficient viral early gene transcription and for changes in expression of cellular genes.	[Gupta, A.; Jha, S.; Dutta, A.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Engel, D. A.] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Ornelles, D. A.] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC USA	University of Virginia; University of Virginia; Wake Forest University	Dutta, A (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, 1300 Jefferson Pk Ave,Box 800733, Charlottesville, VA 22908 USA.	ad8q@virginia.edu	Jha, Sudhakar/B-2308-2009; Dutta, Anindya/P-3203-2016; Jha, Sudhakar/S-3550-2019	Jha, Sudhakar/0000-0002-5093-4843; Dutta, Anindya/0000-0002-4319-0073	US army Postdoctoral fellowship for breast cancer research [DOD-W81XWH1110687];  [RO1 GM084465]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084465] Funding Source: NIH RePORTER	US army Postdoctoral fellowship for breast cancer research; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of Dutta laboratory for lively discussions and helpful comments. This work was supported by RO1 GM084465 to AD. AG was supported by US army Postdoctoral fellowship for breast cancer research DOD-W81XWH1110687.	Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; Bhoumik A, 2008, J BIOL CHEM, V283, P17605, DOI 10.1074/jbc.M802030200; Blackford AN, 2010, P NATL ACAD SCI USA, V107, P12251, DOI 10.1073/pnas.0914605107; Chen JN, 2007, VIROLOGY, V369, P411, DOI 10.1016/j.virol.2007.08.012; Col E, 2005, EMBO J, V24, P2634, DOI 10.1038/sj.emboj.7600734; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ferrari R, 2009, NAT REV GENET, V10, P290, DOI 10.1038/nrg2539; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Johnson JS, 2004, J VIROL, V78, P6459, DOI 10.1128/JVI.78.12.6459-6468.2004; Karen KA, 2011, J VIROL, V85, P4135, DOI 10.1128/JVI.02540-10; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; MARTON MJ, 1990, J VIROL, V64, P2345, DOI 10.1128/JVI.64.5.2345-2359.1990; MORAN E, 1993, FASEB J, V7, P880, DOI 10.1096/fasebj.7.10.8344487; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nevels M, 2001, J VIROL, V75, P3089, DOI 10.1128/JVI.75.7.3089-3094.2001; Niller HH, 2011, CANCER LETT, V305, P200, DOI 10.1016/j.canlet.2010.08.007; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Reitsma JM, 2011, CELL HOST MICROBE, V9, P103, DOI 10.1016/j.chom.2011.01.006; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Sha JF, 2010, J VIROL, V84, P4050, DOI 10.1128/JVI.02131-09; Shamay M, 2012, J VIROL, V86, P5179, DOI 10.1128/JVI.00169-12; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; ZANTEMA A, 1985, VIROLOGY, V142, P44, DOI 10.1016/0042-6822(85)90421-0	44	47	49	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5017	5025		10.1038/onc.2012.534	http://dx.doi.org/10.1038/onc.2012.534			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23178490	Green Accepted, Green Submitted			2022-12-25	WOS:000325937900003
J	Makkonen, M; Bertling, E; Chebotareva, NA; Baum, J; Lappalainen, P				Makkonen, Maarit; Bertling, Enni; Chebotareva, Natalia A.; Baum, Jake; Lappalainen, Pekka			Mammalian and Malaria Parasite Cyclase-associated Proteins Catalyze Nucleotide Exchange on G-actin through a Conserved Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPOLYMERIZING FACTOR; FILAMENT TURNOVER; SRV2/CAP COMPLEX; REGULATES ACTIN; CELL POLARITY; ATP-ACTIN; ADP-ACTIN; COFILIN; PROFILIN; CAP	Cyclase-associated proteins (CAPs) are among the most highly conserved regulators of actin dynamics, being present in organisms from mammals to apicomplexan parasites. Yeast, plant, and mammalian CAPs are large multidomain proteins, which catalyze nucleotide exchange on actin monomers from ADP to ATP and recycle actin monomers from actin-depolymerizing factor (ADF)/cofilin for new rounds of filament assembly. However, the mechanism by which CAPs promote nucleotide exchange is not known. Furthermore, how apicomplexan CAPs, which lack many domains present in yeast and mammalian CAPs, contribute to actin dynamics is not understood. We show that, like yeast Srv2/CAP, mouse CAP1 interacts with ADF/cofilin and ADP-G-actin through its N-terminal alpha-helical and C-terminal beta-strand domains, respectively. However, in the variation to yeast Srv2/CAP, mouse CAP1 has two adjacent profilin-binding sites, and it interacts with ATP-actin monomers with high affinity through its WH2 domain. Importantly, we revealed that the C-terminal beta-sheet domain of mouse CAP1 is essential and sufficient for catalyzing nucleotide exchange on actin monomers, although the adjacent WH2 domain is not required for this function. Supporting these data, we show that the malaria parasite Plasmodium falciparum CAP, which is entirely composed of the beta-sheet domain, efficiently promotes nucleotide exchange on actin monomers. Collectively, this study provides evidence that catalyzing nucleotide exchange on actin monomers via the beta-sheet domain is the most highly conserved function of CAPs from mammals to apicomplexan parasites. Other functions, including interactions with profilin and ADF/cofilin, evolved in more complex organisms to adjust the specific role of CAPs in actin dynamics.	[Makkonen, Maarit; Bertling, Enni; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Chebotareva, Natalia A.] Russian Acad Sci, Bach Inst Biochem, Moscow 11907, Russia; [Baum, Jake] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	University of Helsinki; Research Center of Biotechnology RAS; Russian Academy of Sciences; Walter & Eliza Hall Institute; University of Melbourne	Lappalainen, P (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland.	pekka.lappalainen@helsinki.fi	; Chebotareva, Natalia/X-6019-2018	Baum, Jake/0000-0002-0275-352X; Lappalainen, Pekka/0000-0001-6227-0354; Chebotareva, Natalia/0000-0002-3505-8777	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Helsinki Graduate Program in Biotechnology and Molecular Biology; program "Molecular and Cell Biology" from the Russian Academy of Sciences; Australian Research Council Future Fellowship [FT100100112]; Human Frontier Science Organization Grant [RGY0071/2011]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Helsinki Graduate Program in Biotechnology and Molecular Biology; program "Molecular and Cell Biology" from the Russian Academy of Sciences; Australian Research Council Future Fellowship(Australian Research Council); Human Frontier Science Organization Grant(Human Frontier Science Program)	This work was supported in part by grants from the Academy of Finland, the Sigrid Juselius Foundation, and Biocentrum Helsinki (to P. L.).; Funded by a fellowship from the Helsinki Graduate Program in Biotechnology and Molecular Biology.; Supported by the program "Molecular and Cell Biology" from the Russian Academy of Sciences.; Supported by Australian Research Council Future Fellowship FT100100112 and by Human Frontier Science Organization Grant RGY0071/2011.	Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Barrero RA, 2002, PLANT CELL, V14, P149, DOI 10.1105/tpc.010301; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chaudhry F., 2012, MOL BIOL CE IN PRESS; Chaudhry F, 2007, MOL BIOL CELL, V18, P3002, DOI 10.1091/mbc.E06-11-1041; Chaudhry F, 2010, CYTOSKELETON, V67, P120, DOI 10.1002/cm.20429; DiNubile MJ, 1999, CELL MOTIL CYTOSKEL, V43, P10, DOI 10.1002/(SICI)1097-0169(1999)43:1<10::AID-CM2>3.3.CO;2-M; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Effendi K, 2013, EXP CELL RES, V319, P35, DOI 10.1016/j.yexcr.2012.09.013; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Frenal K, 2009, CELL HOST MICROBE, V5, P602, DOI 10.1016/j.chom.2009.05.013; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Hliscs M, 2010, J BIOL CHEM, V285, P11572, DOI 10.1074/jbc.M109.054916; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Kardos R, 2009, BIOPHYS J, V96, P2335, DOI 10.1016/j.bpj.2008.12.3906; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Michelot A, 2011, CURR BIOL, V21, pR560, DOI 10.1016/j.cub.2011.06.019; Moriyama K, 2002, J CELL SCI, V115, P1591; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Nomura K, 2012, J CELL SCI, V125, P4077, DOI 10.1242/jcs.104950; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Ojala PJ, 2002, MOL BIOL CELL, V13, P3811, DOI 10.1091/mbc.E02-03-0157; Olshina MA, 2012, IUBMB LIFE, V64, P370, DOI 10.1002/iub.1014; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Peche V. S., 2012, CELL MOL LI IN PRESS; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; Singh BK, 2011, J BIOL CHEM, V286, P28256, DOI 10.1074/jbc.M111.211730; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Turunen SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034910; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Wong W, 2011, P NATL ACAD SCI USA, V108, P9869, DOI 10.1073/pnas.1018927108; Yusof AM, 2005, PROTEINS, V58, P255, DOI 10.1002/prot.20314	54	47	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					984	994		10.1074/jbc.M112.435719	http://dx.doi.org/10.1074/jbc.M112.435719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184938	hybrid, Green Published			2022-12-25	WOS:000313570300023
J	Nagao, K; Iwai, Y; Miyashita, T				Nagao, Kazuaki; Iwai, Yujiro; Miyashita, Toshiyuki			RCAN1 Is an Important Mediator of Glucocorticoid-Induced Apoptosis in Human Leukemic Cells	PLOS ONE			English	Article							BINDING PROTEIN CREB; ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPRESSION PATTERNS; GENE-EXPRESSION; KINASE-A; RECEPTOR; ACTIVATION; MECHANISMS; PATHWAY; PHOSPHORYLATION	Glucocorticoid (GC) is a major therapeutic agent for the treatment of leukemia because of its ability to induce apoptosis in lymphoid cells. The mechanism causing apoptosis, however, is still controversial. Since the glucocorticoid receptor is a transcription factor, some of its target genes are expected to be implicated in apoptosis. In this study, using a GC-sensitive human pre-B leukemia cell line, Nalm-6, the FK506 binding protein 51 (FKBP5) and regulator of calcineurin 1 (RCAN1) genes were disrupted by homologous recombination, since the expression of both is up-regulated by GC in GC-sensitive but not in GC-resistant leukemic cell lines. While the disruption of FKBP5 had a marginal effect on GC-induced apoptosis, that of RCAN1 resulted in marked resistance to GC. In addition, overexpression of RCAN1 rendered cells more sensitive to DEX. In RCAN1-disrupted cells, levels of some pro-apoptotic and anti-apoptotic Bcl-2 family proteins were decreased and increased, respectively. Finally, phosphorylation of cAMP-response element binding protein (CREB) and up-regulation of CREB target genes by GC were inhibited by RCAN1 disruption, and treatment with a cAMP-inducing agent, forskolin, restored the sensitivity to GC in RCAN1-disrupted Nalm-6 cells. These findings suggest that up-regulation of RCAN1 expression followed by activation of the CREB pathway is required in GC-induced apoptosis.	[Nagao, Kazuaki; Iwai, Yujiro; Miyashita, Toshiyuki] Kitasato Univ, Grad Sch Med Sci, Dept Mol Genet, Sagamihara, Kanagawa 228, Japan	Kitasato University	Miyashita, T (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Mol Genet, Sagamihara, Kanagawa 228, Japan.	tmiyashi@med.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Kitasato University Research Grant for Young Researchers; Grants-in-Aid for Scientific Research [23501269] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kitasato University Research Grant for Young Researchers; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and by a Kitasato University Research Grant for Young Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; BAUGHMAN G, 1995, MOL CELL BIOL, V15, P4395; BOUTILLIER AL, 1992, J BIOL CHEM, V267, P23520; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Hirakawa Yasuko, 2009, J Mol Signal, V4, P6, DOI 10.1186/1750-2187-4-6; Huseby S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.124; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kim SS, 2011, J BIOL CHEM, V286, P37841, DOI 10.1074/jbc.M111.232165; Kim YS, 2006, J BIOL CHEM, V281, P39051, DOI 10.1074/jbc.M604659200; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; Krajewska M, 1996, CANCER RES, V56, P2422; Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; LUO Y, 1989, CANCER RES, V49, P706; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; Miyashita T, 1998, CELL DEATH DIFFER, V5, P1034, DOI 10.1038/sj.cdd.4400442; MIYASHITA T, 1993, BLOOD, V81, P151; Myklebust JH, 1999, J CELL PHYSIOL, V180, P71; Nagao K, 2005, GENOMICS, V85, P462, DOI 10.1016/j.ygeno.2004.11.014; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Poppek D, 2006, BIOCHEM J, V400, P511, DOI 10.1042/BJ20060463; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Riccardi C, 1999, CELL DEATH DIFFER, V6, P1182, DOI 10.1038/sj.cdd.4400609; Saeki K, 1999, BIOCHEM J, V343, P249, DOI 10.1042/0264-6021:3430249; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Seo SR, 2009, FEBS LETT, V583, P3140, DOI 10.1016/j.febslet.2009.09.019; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SIMONS SS, 1989, J BIOL CHEM, V264, P14493; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; Tissing WJE, 2003, LEUKEMIA, V17, P17, DOI 10.1038/sj.leu.2402733; U M, 2004, LEUKEMIA, V18, P1850, DOI 10.1038/sj.leu.2403516; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; XIE HJ, 1995, J IMMUNOL, V154, P1717; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yoshida NL, 2002, BIOCHEM BIOPH RES CO, V293, P1254; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; ZHAO Y, 1995, J IMMUNOL, V154, P6346; Zhao YN, 2011, MED ONCOL, V28, P1609, DOI 10.1007/s12032-010-9641-x	48	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49926	10.1371/journal.pone.0049926	http://dx.doi.org/10.1371/journal.pone.0049926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185487	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000144
J	Sun, LF; Pei, KQ; Wang, F; Ding, Q; Bing, YH; Gao, B; Zheng, Y; Liang, Y; Ma, KP				Sun, Lifu; Pei, Kequan; Wang, Fang; Ding, Qiong; Bing, Yanhong; Gao, Bo; Zheng, Yu; Liang, Yu; Ma, Keping			Different Distribution Patterns between Putative Ercoid Mycorrhizal and Other Fungal Assemblages in Roots of Rhododendron decorum in the Southwest of China	PLOS ONE			English	Article							SOIL DISTURBANCE; COMMUNITY COMPOSITION; HAIR ROOTS; DIVERSITY; ERICACEAE; PLANTS; INFECTIVITY; ENDOPHYTES; PHYLOGENY; DYNAMICS	Fungal diversity within plant roots is affected by several factors such as dispersal limitation, habitat filtering, and plant host preference. Given the differences in life style between symbiotic and non-symbiotic fungi, the main factors affecting these two groups of fungi may be different. We assessed the diversity of root associated fungi of Rhododendron decorum using internal transcribed spacer (ITS) sequencing and terminal restriction fragment length polymorphism (T-RFLP) analysis, and our aim was to evaluate the role of different factors in structuring ericoid mycorrhizal (ERM) and non-ericoid mycorrhizal (NEM) fungal communities. Thirty-five fungal operational taxonomic units (OTUs) were found in roots of R. decorum, of which 25 were putative ERM fungal species. Of the two main groups of known ERM, helotialean fungi were more abundant and common than sebacinalean species. Geographic and host patterning of the fungal assemblages were different for ERM and NEM. The distribution of putative ERM fungal terminal restriction fragments (TRFs) showed that there were more common species within ERM than in the NEM fungal assemblages. Results of Mantel tests indicated that the composition of NEM fungal assemblages correlated with geographic parameters while ERM fungal assemblages lacked a significant geographic pattern and instead were correlated with host genotype. Redundancy analysis (RDA) showed that the NEM fungal assemblages were significantly correlated with latitude, longitude, elevation, mean annual precipitation (MAP), and axis 2 of a host-genetic principle component analysis (PCA), while ERM fungal assemblages correlated only with latitude and axis 1 of the host-genetic PCA. We conclude that ERM and NEM assemblages are affected by different factors, with the host genetic composition more important for ERM and geographic factors more important for NEM assemblages. Our results contribute to understanding the roles of dispersal limitation, abiotic factors and biotic interactions in structuring fungal communities in plant roots.	[Sun, Lifu; Pei, Kequan; Wang, Fang; Ding, Qiong; Bing, Yanhong; Gao, Bo; Zheng, Yu; Liang, Yu; Ma, Keping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Sun, Lifu] Shaoxing Univ, Coll Life Sci, Shaoxing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Shaoxing University	Liang, Y (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	coolrain@ibcas.ac.cn	Pei, Kequan/HDO-8289-2022; wang, fang/GYD-4295-2022; Liang, Yu/D-3184-2011	Liang, Yu/0000-0003-4259-6028; Sun, Lifu/0000-0002-2615-0547	National Natural Science Foundation of China [30930005, 31170469, 31170495]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (30930005), (31170469) and (31170495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TR, 2003, NEW PHYTOL, V160, P255, DOI 10.1046/j.1469-8137.2003.00885.x; Artz RRE, 2007, MICROB ECOL, V54, P508, DOI 10.1007/s00248-007-9220-7; Bennett LT, 2003, PLANT ECOL, V164, P185, DOI 10.1023/A:1021253600712; Berch SM, 2002, PLANT SOIL, V244, P55, DOI 10.1023/A:1020291516884; Bever JD, 1996, J ECOL, V84, P71, DOI 10.2307/2261701; Bougoure DS, 2007, MOL ECOL, V16, P4624, DOI 10.1111/j.1365-294X.2007.03540.x; Bougoure DS, 2005, ENVIRON MICROBIOL, V7, P1743, DOI 10.1111/j.1462-2920.2005.00919.x; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cairney JWG, 2002, NEW PHYTOL, V154, P305, DOI 10.1046/j.1469-8137.2002.00398.x; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; Cui QA, 2010, PLANT SOIL, V334, P209, DOI 10.1007/s11104-010-0375-5; De Deyn GB, BIOL LETT, V7, P75; EVANS DG, 1990, NEW PHYTOL, V114, P65, DOI 10.1111/j.1469-8137.1990.tb00374.x; Fang MY, 2005, FLORA CHINA, V14, P332; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GOTELLI NJ, 1987, AM NAT, V130, P18, DOI 10.1086/284695; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Grelet GA, 2009, NEW PHYTOL, V182, P359, DOI 10.1111/j.1469-8137.2009.02813.x; Guo LD, 2000, NEW PHYTOL, V147, P617, DOI 10.1046/j.1469-8137.2000.00716.x; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; He ZL, 2004, RED SOILS OF CHINA: THEIR NATURE, MANAGEMENT AND UTILIZATION, P29; HOLM S, 1979, SCAND J STAT, V6, P65; Horton TR, 1998, NEW PHYTOL, V139, P331, DOI 10.1046/j.1469-8137.1998.00185.x; Hundsdoerfer AK, 2005, ORG DIVERS EVOL, V5, P173, DOI 10.1016/j.ode.2004.11.012; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; JASPER DA, 1989, NEW PHYTOL, V112, P93, DOI 10.1111/j.1469-8137.1989.tb00313.x; JASPER DA, 1991, NEW PHYTOL, V118, P471, DOI 10.1111/j.1469-8137.1991.tb00029.x; JASPER DA, 1989, NEW PHYTOL, V112, P101, DOI 10.1111/j.1469-8137.1989.tb00314.x; Johnson D, 2005, J EXP BOT, V56, P1751, DOI 10.1093/jxb/eri192; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Kron KA, 2002, BOT REV, V68, P335, DOI 10.1663/0006-8101(2002)068[0335:PCOEMA]2.0.CO;2; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Liew Edward C. Y., 1998, Fungal Diversity, V1, P1; Liu Y, 2005, MYCORRHIZA, V15, P187, DOI 10.1007/s00572-004-0320-7; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; McCune B., 2006, PC ORD MULTIVARIATE; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McLean CB, 1999, NEW PHYTOL, V144, P351, DOI 10.1046/j.1469-8137.1999.00510.x; Midgley DJ, 2004, PLANT SOIL, V259, P137, DOI 10.1023/B:PLSO.0000020947.13655.9f; Oksanen J., 2011, R PACKAGE VERSION, P117; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Read DJ, 1996, ANN BOT-LONDON, V77, P365, DOI 10.1006/anbo.1996.0044; REINHARD S, 1994, EXPERIENTIA, V50, P890, DOI 10.1007/BF01923475; Marquez SS, 2008, FUNGAL DIVERS, V33, P87; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith MD, 1999, OECOLOGIA, V121, P574, DOI 10.1007/s004420050964; Smith SE, 1997, MYCORRHIZAL SYMBIOSE; Su YY, 2010, FUNGAL DIVERS, V43, P93, DOI 10.1007/s13225-010-0040-6; Tian W, 2011, MYCOLOGIA, V103, P703, DOI 10.3852/10-296; van de Voorde TFJ, 2010, NEW PHYTOL, V186, P746, DOI 10.1111/j.1469-8137.2010.03216.x; Wilkinson DM, 2001, J BIOGEOGR, V28, P285, DOI 10.1046/j.1365-2699.2001.00518.x; Zhou LS, 2009, SOIL BIOL BIOCHEM, V41, P796, DOI 10.1016/j.soilbio.2009.01.019	54	19	22	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49867	10.1371/journal.pone.0049867	http://dx.doi.org/10.1371/journal.pone.0049867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185466	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000128
J	Guo, XY; Xiang, J; Wang, YY; O'Brien, H; Kabbouche, M; Horn, P; Powers, SW; Hershey, AD				Guo, Xinyao; Xiang, Jing; Wang, Yingying; O'Brien, Hope; Kabbouche, Marielle; Horn, Paul; Powers, Scott W.; Hershey, Andrew D.			Aberrant Neuromagnetic Activation in the Motor Cortex in Children with Acute Migraine: A Magnetoencephalography Study	PLOS ONE			English	Article							PEDIATRIC HEADACHE; GAMMA-OSCILLATIONS; HYPEREXCITABILITY; FREQUENCY	Migraine attacks have been shown to interfere with normal function in the brain such as motor or sensory function. However, to date, there has been no clinical neurophysiology study focusing on the motor function in children with migraine during headache attacks. To investigate the motor function in children with migraine, twenty-six children with acute migraine, meeting International Classification of Headache Disorders criteria and age-and gender-matched healthy children were studied using a 275-channel magnetoencephalography system. A finger-tapping paradigm was designed to elicit neuromagnetic activation in the motor cortex. Children with migraine showed significantly prolonged latency of movement-evoked magnetic fields (MEF) during finger movement compared with the controls. The correlation coefficient of MEF latency and age in children with migraine was significantly different from that in healthy controls. The spectral power of high gamma (65-150 Hz) oscillations during finger movement in the primary motor cortex is also significantly higher in children with migraine than in controls. The alteration of responding latency and aberrant high gamma oscillations suggest that the developmental trajectory of motor function in children with migraine is impaired during migraine attacks and/or developmentally delayed. This finding indicates that childhood migraine may affect the development of brain function and result in long-term problems.	[Guo, Xinyao; Xiang, Jing; Wang, Yingying; O'Brien, Hope; Kabbouche, Marielle; Horn, Paul; Hershey, Andrew D.] Cincinnati Childrens Hosp, Dept Neurol, Med Ctr, Cincinnati, OH USA; [Guo, Xinyao] Xi An Jiao Tong Univ, Dept Human Anat & Histol Embryol, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Xiang, Jing; O'Brien, Hope; Kabbouche, Marielle; Hershey, Andrew D.] Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; [Horn, Paul] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA; [Powers, Scott W.] Cincinnati Childrens Hosp, Med Ctr, Dept Behav Med & Clin Psychol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Xi'an Jiaotong University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Xiang, J (corresponding author), Cincinnati Childrens Hosp, Dept Neurol, Med Ctr, Cincinnati, OH USA.	jing.xiang@cchmc.org	O'Brien, Hope/AAZ-9717-2020; O'Brien, Hope Lorraine/AHB-9810-2022; Hershey, Andrew D./K-1245-2019; Wang, Yingying/I-2705-2018	Hershey, Andrew D./0000-0002-1598-7536; Wang, Yingying/0000-0001-6502-1388; Xiang, Jing/0000-0003-0242-5590; Powers, Scott/0000-0002-5348-9650	National Institute of Neurological Disorders and Stroke (NINDS) [R21NS072817]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072817] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project described was supported by Grant Number R21NS072817 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Aurora SK, 2005, HEADACHE, V45, P546, DOI 10.1111/j.1526-4610.2005.05108.x; Bender S, 2006, NEUROIMAGE, V33, P759, DOI 10.1016/j.neuroimage.2006.07.003; Bigal ME, 2011, CURR NEUROL NEUROSCI, V11, P139, DOI 10.1007/s11910-010-0175-6; Bowyer SM, 2005, J CLIN NEUROPHYSIOL, V22, P65, DOI 10.1097/01.WNP.0000150928.23523.A9; Braunitzer G, 2011, CEPHALALGIA, V31, P1048, DOI 10.1177/0333102411410611; Brighina F, 2010, CEPHALALGIA, V30, P46, DOI 10.1111/j.1468-2982.2009.01870.x; Brighina F, 2009, CEREBELLUM, V8, P260, DOI 10.1007/s12311-008-0090-4; Chen WT, 2011, BRAIN, V134, P2387, DOI 10.1093/brain/awr157; Cheyne D, 2008, NEUROIMAGE, V42, P332, DOI 10.1016/j.neuroimage.2008.04.178; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Dockstader C, 2012, HUM BRAIN MAPP, V33, P179, DOI 10.1002/hbm.21203; Erdler M, 2000, NEUROIMAGE, V11, P697, DOI 10.1006/nimg.2000.0579; Hamalainen Matti S., 1992, Brain Topography, V5, P95, DOI 10.1007/BF01129036; Hershey AD, 2012, HEADACHE, V52, P327, DOI 10.1111/j.1526-4610.2011.02085.x; Hershey AD, 2010, PEDIATR ANN, V39, P416, DOI 10.3928/00904481-20100623-06; Huo XL, 2011, BRAIN TOPOGR, V23, P375, DOI 10.1007/s10548-010-0151-0; Huo XL, 2010, BRAIN DEV-JPN, V32, P619, DOI 10.1016/j.braindev.2009.09.021; Jacobs H, 2012, HEADACHE, V52, P333, DOI 10.1111/j.1526-4610.2011.02086.x; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Korostenskaja M, 2011, INT J NEUROSCI, V121, P355, DOI 10.3109/00207454.2011.560312; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; Nagasawa T, 2010, HUM BRAIN MAPP, V31, P1627, DOI 10.1002/hbm.20963; Rocca MA, 2003, STROKE, V34, P665, DOI 10.1161/01.STR.0000057977.06681.11; Schmitz N, 2008, HEADACHE, V48, P1044, DOI 10.1111/j.1526-4610.2008.01133.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Siniatchkin M, 2010, J HEADACHE PAIN, V11, P105, DOI 10.1007/s10194-009-0180-9; Slater S, 2009, CEPHALALGIA, V29, P969, DOI 10.1111/j.1468-2982.2008.01827.x; Split W, 1999, HEADACHE, V39, P494, DOI 10.1046/j.1526-4610.1999.3907494.x; Stufflebeam SM, 2008, NEUROIMAGE, V42, P710, DOI 10.1016/j.neuroimage.2008.04.264; Szurhaj W, 2005, EUR J NEUROSCI, V21, P1223, DOI 10.1111/j.1460-9568.2005.03966.x; Wang XS, 2010, HEADACHE, V50, P1005, DOI 10.1111/j.1526-4610.2010.01674.x; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Xiang J, 2001, NEUROREPORT, V12, P3923, DOI 10.1097/00001756-200112210-00014	36	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50095	10.1371/journal.pone.0050095	http://dx.doi.org/10.1371/journal.pone.0050095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185541	Green Published, gold			2022-12-25	WOS:000311535700069
J	Jayasinghe, SS; Pathirana, KD; Buckley, NA				Jayasinghe, Sudheera S.; Pathirana, Kithsiri D.; Buckley, Nick A.			Effects of Acute Organophosphorus Poisoning on Function of Peripheral Nerves: A Cohort Study	PLOS ONE			English	Article							INTERMEDIATE SYNDROME; PESTICIDE EXPOSURE; WORKERS	Background: Following acute organophosphorus (OP) poisoning patients complain of numbness without objective sensory abnormalities or other features of OP induced delayed polyneuropathy. The aim of this study was to measure peripheral nerve function after acute exposure to OP. Methods: A cohort study was conducted with age, gender and occupation matched controls. Motor nerve conduction velocity (MNCV), amplitude and area of compound muscle action potential (CMAP), sensory nerve conduction velocity (SNCV), F-waves and electromyography (EMG) on the deltoid and the first dorsal interosseous muscles on the dominant side were performed, following acute OP poisoning. All neurophysiological assessments except EMG were performed on the controls. Assessments were performed on the day of discharge from the hospital (the first assessment) and six weeks (the second assessment) after the exposure. The controls were assessed only once. Results: There were 70 patients (50 males) and 70 controls. Fifty-three patients attended for the second assessment. In the first assessment MNCV of all the motor nerves examined, CMAP amplitude and SNCV of ulnar nerve, median and ulnar F-wave occurrence in the patients were significantly reduced compared to the controls. In the second assessment significant reduction was found in SNCV of both sensory nerves examined, MNCV of ulnar nerve, CMAP amplitude of common peroneal nerve, F-wave occurrence of median and ulnar nerves. No abnormalities were detected in the patients when compared to the standard cut-off values of nerve conduction studies except F-wave occurrence. EMG studies did not show any abnormality. Conclusion: There was no strong evidence of irreversible peripheral nerve damage following acute OP poisoning, however further studies are required.	[Jayasinghe, Sudheera S.] Univ Ruhuna, Fac Med, Dept Pharmacol, Galle, Sri Lanka; [Jayasinghe, Sudheera S.; Buckley, Nick A.] Univ Peradeniya, Fac Med, S Asian Clin Toxicol Res Collaborat, Peradeniya, Sri Lanka; [Pathirana, Kithsiri D.] Univ Ruhuna, Fac Med, Dept Med, Galle, Sri Lanka; [Buckley, Nick A.] Univ NSW, Prince Wales Hosp, Sch Clin, Sydney, NSW, Australia	University Ruhuna; University of Peradeniya; University Ruhuna; University of New South Wales Sydney	Jayasinghe, SS (corresponding author), Univ Ruhuna, Fac Med, Dept Pharmacol, Galle, Sri Lanka.	sudheerasj@yahoo.com	Buckley, Nicholas A/D-4030-2012	Buckley, Nicholas A/0000-0002-6326-4711	Wellcome Trust; National Health and Medical Research Council International Collaborative research grant [GR071669MA]	Wellcome Trust(Wellcome TrustEuropean Commission); National Health and Medical Research Council International Collaborative research grant	This study was supported by Wellcome Trust and National Health and Medical Research Council International Collaborative research grant (GR071669MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminoff MJ, 2005, ELECTRODIAGNOSIS CLI, P231; Annual Health Bulletin, 2003, ANN HLTH B HLTH MIN, P21; BOULDIN TW, 1979, AM J PATHOL, V94, P253; DESILVA HJ, 1992, LANCET, V339, P1136, DOI 10.1016/0140-6736(92)90733-J; Eddleston M, 2008, QJM-INT J MED, V101, P467, DOI 10.1093/qjmed/hcn026; Engel LS, 1998, ARCH ENVIRON HEALTH, V53, P7, DOI 10.1080/00039899809605684; Jayarathnam J, 1982, B WORLD HEALTH ORGAN, V60, P615; Jayaratnam J, 1990, WORLD HLTH STAT Q, V1, P139; Jayawardane P, 2008, PLOS MED, V5, P1143, DOI 10.1371/journal.pmed.0050147; Johnson S, 1996, J Assoc Physicians India, V44, P529; Kamel F, 2004, ENVIRON HEALTH PERSP, V112, P950, DOI 10.1289/ehp.7135; MISRA UK, 1988, ARCH TOXICOL, V61, P496, DOI 10.1007/BF00293697; Pawar KS, 2006, LANCET, V368, P2136, DOI 10.1016/S0140-6736(06)69862-0; ROSENSTOCK L, 1991, LANCET, V338, P223, DOI 10.1016/0140-6736(91)90356-T; RUIJTEN MWMM, 1994, ARCH ENVIRON HEALTH, V49, P188, DOI 10.1080/00039896.1994.9940381; SENANAYAKE N, 1987, NEW ENGL J MED, V316, P761, DOI 10.1056/NEJM198703263161301; SENANAYAKE N, 1982, NEW ENGL J MED, V306, P155, DOI 10.1056/NEJM198201213060306; Singh S, 2000, NEUROL INDIA, V48, P308; STEENLAND K, 1994, AM J PUBLIC HEALTH, V84, P731, DOI 10.2105/AJPH.84.5.731; Steenland K, 2000, ENVIRON HEALTH PERSP, V108, P293, DOI 10.2307/3454346; STEPHENS R, 1995, LANCET, V345, P1135, DOI 10.1016/S0140-6736(95)90976-1; Worek F, 1999, CLIN CHIM ACTA, V288, P73, DOI 10.1016/S0009-8981(99)00144-8	22	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49405	10.1371/journal.pone.0049405	http://dx.doi.org/10.1371/journal.pone.0049405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185328	Green Published, gold			2022-12-25	WOS:000311535700030
J	Bustos, S; Gomez, C; Hausmann, R; Hidalgo, CA				Bustos, Sebastian; Gomez, Charles; Hausmann, Ricardo; Hidalgo, Cesar A.			The Dynamics of Nestedness Predicts the Evolution of Industrial Ecosystems	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; BIODIVERSITY; POLLINATION; MATRIX; MODEL	In economic systems, the mix of products that countries make or export has been shown to be a strong leading indicator of economic growth. Hence, methods to characterize and predict the structure of the network connecting countries to the products that they export are relevant for understanding the dynamics of economic development. Here we study the presence and absence of industries in international and domestic economies and show that these networks are significantly nested. This means that the less filled rows and columns of these networks' adjacency matrices tend to be subsets of the fuller rows and columns. Moreover, we show that their nestedness remains constant over time and that it is sustained by both, a bias for industries that deviate from the networks' nestedness to disappear, and a bias for the industries that are missing according to nestedness to appear. This makes the appearance and disappearance of individual industries in each location predictable. We interpret the high level of nestedness observed in these networks in the context of the neutral model of development introduced by Hidalgo and Hausmann (2009). We show that the model can reproduce the high level of nestedness observed in these networks only when we assume a high level of heterogeneity in the distribution of capabilities available in countries and required by products. In the context of the neutral model, this implies that the high level of nestedness observed in these economic networks emerges as a combination of both, the complementarity of inputs and heterogeneity in the number of capabilities available in countries and required by products. The stability of nestedness in industrial ecosystems, and the predictability implied by it, demonstrates the importance of the study of network properties in the evolution of economic networks.	[Bustos, Sebastian; Hausmann, Ricardo; Hidalgo, Cesar A.] Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA; [Bustos, Sebastian; Hausmann, Ricardo] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Gomez, Charles] Stanford Univ, Grad Sch Educ, Stanford, CA 94305 USA; [Hausmann, Ricardo] Santa Fe Inst, Santa Fe, NM 87501 USA; [Hidalgo, Cesar A.] MIT, Media Lab, Cambridge, MA 02139 USA; [Hidalgo, Cesar A.] Inst Sistemas Complejos Valparaiso, Valparaiso, Chile	Harvard University; Harvard University; Stanford University; The Santa Fe Institute; Massachusetts Institute of Technology (MIT)	Hidalgo, CA (corresponding author), Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA.	hidalgo@mit.edu	Gomez, Charles J./J-1255-2019; Hidalgo, Cesar A./B-5155-2009	Gomez, Charles J./0000-0002-2982-7728; Hidalgo, Cesar A./0000-0002-6977-9492; /0000-0002-6031-5982	Asahi Broadcast Corporation Career Development Chair; Santo Domingo Foundation; Standard Bank	Asahi Broadcast Corporation Career Development Chair; Santo Domingo Foundation; Standard Bank	The authors received commercial funding through the Asahi Broadcast Corporation Career Development Chair, Standard Bank and Santo Domingo Foundation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; BALASSA B, 1986, REV ECON STAT, V68, P315, DOI 10.2307/1925512; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Bryce DJ, 2009, MANAGE SCI, V55, P1570, DOI 10.1287/mnsc.1090.1040; Darlington P.J., 1957, ZOOGEOGRAPHY GEOGRAP; Daubenmire R, 1975, J BIOGEOGRAPHY, V2; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Gilarranz LJ, 2012, OIKOS, V121, P1154, DOI 10.1111/j.1600-0706.2011.19592.x; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Hausmann R., 2011, ATLAS EC COMPLEXITY; Hausmann R, 2007, J ECON GROWTH, V12, P1, DOI 10.1007/s10887-006-9009-4; Hausmann R, 2011, J ECON GROWTH, V16, P309, DOI 10.1007/s10887-011-9071-4; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; HULTEN E, 1937, OUTLINE HIST ARTIC B; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; LEONTIEF WW, 1965, SCI AM, V212, P25, DOI 10.1038/scientificamerican0465-25; Maron M, 2004, OIKOS, V106, P433, DOI 10.1111/j.0030-1299.2004.13199.x; Neffke F, 2008, WORKING PAPER SERIES; Neffke F, 2011, ECON GEOGR, V87, P237, DOI 10.1111/j.1944-8287.2011.01121.x; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; TEECE DJ, 1994, J ECON BEHAV ORGAN, V23, P1, DOI 10.1016/0167-2681(94)90094-9; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; ZWEIG MH, 1993, CLIN CHEM, V39, P561	35	69	74	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49393	10.1371/journal.pone.0049393	http://dx.doi.org/10.1371/journal.pone.0049393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185326	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800024
J	Huang, C; Wu, JJ; Liao, RJ; Zhang, W				Huang, Chao; Wu, Jingjing; Liao, Rujia; Zhang, Wei			SKF83959, an Agonist of Phosphatidylinositol-Linked D-1-Like Receptors, Promotes ERK1/2 Activation and Cell Migration in Cultured Rat Astrocytes	PLOS ONE			English	Article							D-1 DOPAMINE-RECEPTORS; PROTEIN-KINASE-II; RELEASE; PKC; MATRIX-METALLOPROTEINASE-9; PROLIFERATION; PHARMACOLOGY; EXPRESSION; CURRENTS; DISEASE	Extracellular signal-regulated kinase 1/2 (ERK1/2) is a member of the mitogen-activated protein kinase family. It can mediate cell migration. Classical dopamine receptor-mediated ERK1/2 phosphorylation is widely studied in neurons. Here, we report that ERK1/2 phosphorylation is also modulated by putative phosphatidylinositol-linked D-1-like receptors in cultured rat astrocytes. 6-chloro-7,8-dihydroxy-3-methyl-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine (SKF83959), an agonist of the putative phosphatidylinositol-linked D-1-like receptors, was found to enhance ERK1/2 phosphorylation, which then promoted the migration of cultured astrocytes. The SKF83959-induced ERK1/2 phosphorylation was found to be Ca2+-independent based on the following observations: i. chelating intracellular Ca2+ did not inhibit ERK1/2 phosphorylation and astrocyte migration; ii. blockage of the release of intracellular Ca2+ from the endoplasmic reticulum by an inhibitor of inositol 1,4,5-trisphosphate (IP3) receptor did not attenuate ERK1/2 phosphorylation. However, inhibition of phospholipase C (PLC), the upstream molecule of internal Ca2+ release, disabled SKF83959's ability to elevate the level of ERK1/2 phosphorylation. Both non-selective protein kinase C (PKC) inhibitor and PKC delta selective inhibitor prevented ERK1/2 phosphorylation increase and astrocyte migration, but PKC alpha inhibitor did not. This suggests that Ca2+-independent and diacylglycerol-dependent PKC delta acts downstream of putative phosphatidylinositol-linked D-1-like receptor activation and mediates SKF83959-induced elevation of ERK1/2 phosphorylation in order to modulate astrocyte migration. In conclusion, our results demonstrate that SKF83959-induced increases in ERK1/2 phosphorylation and astrocyte migration are dependent on PLC-PKC delta signals. This might help us to further understand the functions of the putative phosphatidylinositol-linked D-1-like receptors in the nervous system.	[Huang, Chao; Liao, Rujia; Zhang, Wei] Nantong Univ, Sch Med, Dept Pharmacol, Nantong, Jiangsu, Peoples R China; [Wu, Jingjing] Suzhou Kowloon Hosp, Dept Internal Med, Suzhou, Jiangsu, Peoples R China	Nantong University	Zhang, W (corresponding author), Nantong Univ, Sch Med, Dept Pharmacol, Nantong, Jiangsu, Peoples R China.	asicampa@yahoo.com.cn		liao, ru-jia/0000-0001-6928-4003	National Natural Science Foundation of China [20110490115, 81102428]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China for Postdoctors (No. 20110490115) and the National Natural Science Foundation of China to Dr. Chao Huang (No. 81102428).	Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hiramatsu Y, 2002, DIABETES, V51, P2804, DOI 10.2337/diabetes.51.9.2804; Hsieh HL, 2008, GLIA, V56, P619, DOI 10.1002/glia.20637; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Huang C, 2010, GLIA, V58, P1415, DOI 10.1002/glia.21017; Ikeda Y, 2006, BASIC RES CARDIOL, V101, P418, DOI 10.1007/s00395-006-0595-2; Jacobsen KX, 2008, NEUROBIOL DIS, V29, P117, DOI 10.1016/j.nbd.2007.08.003; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Krebs C, 2003, J NEUROSCI, V23, P3364; LIN CW, 1995, MOL PHARMACOL, V47, P131; Liu J, 2009, CELL MOL NEUROBIOL, V29, P317, DOI 10.1007/s10571-008-9323-9; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Ma LQ, 2009, J NEUROPHYSIOL, V101, P2230, DOI 10.1152/jn.90345.2008; Magnaghi V, 2007, CURR NEUROPHARMACOL, V5, P47, DOI 10.2174/157015907780077132; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mu H, 2009, AM J PHYSIOL-HEART C, V297, pH400, DOI 10.1152/ajpheart.01254.2008; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Pivonello R, 2007, EUR J ENDOCRINOL, V156, pS13, DOI 10.1530/eje.1.02353; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; VERMEULEN RJ, 1994, EUR J PHARM-MOLEC PH, V269, P121, DOI 10.1016/0922-4106(94)90034-5; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; YARBRO JW, 1992, SEMIN ONCOL, V19, P1; Zhang H, 2007, NEUROPHARMACOLOGY, V53, P125, DOI 10.1016/j.neuropharm.2007.04.004; Zhang XH, 2009, J NEUROSCI, V29, P7766, DOI 10.1523/JNEUROSCI.0389-09.2009; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016; Zhen XC, 2004, MOL PHARMACOL, V66, P1500, DOI 10.1124/mol.104.002279	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49954	10.1371/journal.pone.0049954	http://dx.doi.org/10.1371/journal.pone.0049954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185493	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800063
J	Komazawa, O; Kaneko, S; K'Opiyo, J; Kiche, I; Wanyua, S; Shimada, M; Karama, M				Komazawa, Osuke; Kaneko, Satoshi; K'Opiyo, James; Kiche, Ibrahim; Wanyua, Sheru; Shimada, Masaaki; Karama, Mohamed			Are Long-Lasting Insecticidal Nets Effective for Preventing Childhood Deaths among Non-Net Users? A Community-Based Cohort Study in Western Kenya	PLOS ONE			English	Article							TREATED NETS; PLASMODIUM-FALCIPARUM; MALARIA TRANSMISSION; MORTALITY; COVERAGE; ZOOPROPHYLAXIS; POPULATIONS; INFECTION; MOSQUITOS; CHILDREN	Background: Increasing the distribution and use of insecticide-treated nets (ITNs) in Sub-Saharan Africa has made controlling malaria with ITNs more practical. We evaluated community effects induced by ITNs, specifically long-lasting insecticidal nets (LLINs), under ordinary conditions in an endemic malaria area of Western Kenya. Methods: Using the database from Mbita Health and Demographic Surveillance System (HDSS), children younger than 5 years old were assessed over four survey periods. We analyzed the effect of bed net usage, LLIN density and population density of young people around a child on all-cause child mortality (ACCM) rates using Cox PH models. Results: During the study, 14,554 children were followed and 250 deaths were recorded. The adjusted hazard ratios (HRs) for LLIN usage compared with no net usage were not significant among the models: 1.08 (95% CI 0.76-1.52), 1.19 (95% CI 0.69-2.08) and 0.92 (95% CI 0.42-2.02) for LLIN users, untreated net users, and any net users, respectively. A significant increasing linear trend in risk across LLIN density quartiles (HR = 1.25; 95% CI 1.03-1.51) and a decreasing linear trend in risk across young population density quartiles among non-net user children (HR = 0.77; 95% CI 0.63-0.94) were observed. Conclusions: Although our data showed that current LLIN coverage level (about 35%) could induce a community effect to protect children sleeping without bed nets even in a malaria-endemic area, it appears that a better system is needed to monitor the current malaria situation globally in order to optimize malaria control programs with limited resources.	[Komazawa, Osuke; Kaneko, Satoshi; Shimada, Masaaki] Nagasaki Univ NUITM, Inst Trop Med, Dept Ecoepidemiol, Nagasaki, Japan; [Kaneko, Satoshi; Karama, Mohamed] Nagasaki Univ, Grad Sch Int Hlth Dev, Nagasaki 852, Japan; [Karama, Mohamed] Kenya Med Res Inst KEMRI, Ctr Publ Hlth Res, Nairobi, Kenya; [Kaneko, Satoshi; K'Opiyo, James; Kiche, Ibrahim; Wanyua, Sheru; Shimada, Masaaki; Karama, Mohamed] NUITM KEMRI Project, Nairobi, Kenya; [Kiche, Ibrahim] Int Ctr Insect Physiol & Ecol ICIPE, Mbita, Kenya	Nagasaki University; Nagasaki University; Kenya Medical Research Institute; International Centre of Insect Physiology & Ecology (ICIPE)	Kaneko, S (corresponding author), Nagasaki Univ NUITM, Inst Trop Med, Dept Ecoepidemiol, Nagasaki, Japan.	skaneko@nagasaki-u.ac.jp		Kaneko, Satoshi/0000-0001-9464-0911; Wanyua Muuo, Sheru/0000-0002-0246-6600	Special Funds for Education and Research; (KAKENHI) from the MEXT [22406023]; Sumitomo Chemical Co., Ltd.; Global Center of Excellence (gCOE) Program at Nagasaki University; Grants-in-Aid for Scientific Research [22406023] Funding Source: KAKEN	Special Funds for Education and Research; (KAKENHI) from the MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Chemical Co., Ltd.(Sumitomo Chem Co Ltd); Global Center of Excellence (gCOE) Program at Nagasaki University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was, in part, supported by Special Funds for Education and Research granted to Nagasaki University by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); by a Grant-in-Aid for Scientific Research (B) (KAKENHI) 22406023 from the MEXT; by Sumitomo Chemical Co., Ltd.; and by the Global Center of Excellence (gCOE) Program at Nagasaki University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2004, COCHRANE DB SYST REV; Barnett AG, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-26; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Eng JLV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-133; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328; Gibson J, 2007, WORLD BANK RES OBSER, V22, P217, DOI 10.1093/wbro/lkm009; Gosoniu L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-356; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Grabowsky M, 2008, NATURE, V451, P1051, DOI 10.1038/4511051a; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hothorn Ludwig A, 2009, Epidemiol Perspect Innov, V6, P1, DOI 10.1186/1742-5573-6-1; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Kaburi JC, 2009, J VECTOR DIS, V46, P184; Kaneko S., 2007, Tropical Medicine and Health, V35, P37, DOI 10.2149/tmh.35.37; Kaneko S, 2012, J EPIDEMIOL, V22, P276, DOI 10.2188/jea.JE20110078; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Klinkenberg E, 2010, T ROY SOC TROP MED H, V104, P496, DOI 10.1016/j.trstmh.2010.03.004; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Miller JM, 2007, JAMA-J AM MED ASSOC, V297, P2241, DOI 10.1001/jama.297.20.2241; Minakawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032725; Njenga SM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-90; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Noor AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-369; Pettifor A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-331; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Rowe AK, 2007, AM J TROP MED HYG, V77, P48, DOI 10.4269/ajtmh.2007.77.48; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Shigidi MMT, 2004, AM J TROP MED HYG, V71, P754, DOI 10.4269/ajtmh.2004.71.754; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; SOTA T, 1989, MED VET ENTOMOL, V3, P337, DOI 10.1111/j.1365-2915.1989.tb00240.x; Steketee RW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008409; Turner Elizabeth L, 2010, Epidemiol Perspect Innov, V7, P9, DOI 10.1186/1742-5573-7-9; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2005, MAL CONTR COMPL EM I; Williams FLR, 2002, OCCUP ENVIRON MED, V59, P2, DOI 10.1136/oem.59.1.2; Yamamoto SS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-283	44	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49604	10.1371/journal.pone.0049604	http://dx.doi.org/10.1371/journal.pone.0049604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185378	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800043
J	Thakur, A; Lum, LG; Schalk, D; Azmi, A; Banerjee, S; Sarkar, FH; Mohommad, R				Thakur, Archana; Lum, Lawrence G.; Schalk, Dana; Azmi, Asfar; Banerjee, Sanjeev; Sarkar, Fazlul H.; Mohommad, Ramzi			Pan-Bcl-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells	PLOS ONE			English	Article							ANTI-HER2/NEU BISPECIFIC ANTIBODY; SMALL-MOLECULE INHIBITOR; FACTOR RECEPTOR EGFR; COLON-CANCER CELLS; BCL-X-L; PANCREATIC-CANCER; ANTITUMOR IMMUNITY; IN-VITRO; COMBINATION; APOPTOSIS	Pancreatic cancer is a deadly disease and has the worst prognosis among almost all cancers and is in dire need of new and improved therapeutic strategies. Conditioning of tumor cells with chemotherapeutic drug has been shown to enhance the anti-tumor effects of cancer vaccines and adoptive cell therapy. In this study, we investigated the immunomodulatory effects of pan-Bcl-2 inhibitor AT-101 on pancreatic cancer (PC) cell cytotoxicity by activated T cells (ATC). The effects of AT-101 on cytotoxicity, early apoptosis, and Granzyme B (GrzB) and IFN-gamma signaling pathways were evaluated during EGFR bispecific antibody armed ATC (aATC)-mediated killing of L3.6pl and MiaPaCa-2 PC cells pre-sensitized with AT-101. We found that pretreatment of tumor cells with AT-101 enhanced susceptibility of L3.6pl and MiaPaCa-2 tumor cells to ATC and aATC-mediated cytotoxicity, which was in part mediated via enhanced release of cytolytic granule GrzB from ATC and aATC. AT-101-sensitized L3.6pl cells showed up-regulation of IFN-gamma-mediated induction in the phosphorylation of Ser(727)-Stat1(pS(727)-Stat1), and IFN-gamma induced dephosphorylation of phospho-Tyr(705)-Stat3 (pY (705)-Stat3). Priming (conditioning) of PC cells with AT-101 can significantly enhance the anti-tumor activity of EGFRBi armed ATC through increased IFN-gamma induced activation of pS(727)-Stat1 and inhibition of pY(705)-Stat3 phosphorylation, and resulting in increased ratio of pro-apoptotic to anti-apoptotic proteins. Our results verify enhanced cytotoxicity after a novel chemotherapy conditioning strategy against PC that warrants further in vivo and clinical investigations.	[Thakur, Archana; Lum, Lawrence G.; Schalk, Dana] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA; Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA; Wayne State Univ, Dept Med, Karmanos Canc Inst, Detroit, MI 48202 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Thakur, A (corresponding author), Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA.	thakur@karmanos.org		AZMI, ASFAR/0000-0003-1178-9505	National Institutes of Health (NIH) [R01 CA 109389, R01 CA 092344, R01 CA 140412]; National Cancer Institute [5P39 CA 022453]; Leukemia and Lymphoma Society [6066-06, 6092-09]; Susan G. Komen Foundation translational grant [BCTR0707125]; Michigan Cell Therapy Center for Excellence grant from the State of Michigan [1819]; Barbara Ann Karmanos Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA109389, R01CA092344, P30CA022453] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Susan G. Komen Foundation translational grant(Susan G. Komen Breast Cancer Foundation); Michigan Cell Therapy Center for Excellence grant from the State of Michigan; Barbara Ann Karmanos Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were funded in part by National Institutes of Health (NIH), R01 CA 109389 (RMM), R01 CA 092344 (LGL), and R01 CA 140412 (LGL); 5P39 CA 022453 from the National Cancer Institute; translational grants #6066-06 and #6092-09 from the Leukemia and Lymphoma Society (LGL); Susan G. Komen Foundation translational grant #BCTR0707125 (LGL); a Michigan Cell Therapy Center for Excellence grant from the State of Michigan #1819; and startup funds from the Barbara Ann Karmanos Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, CANCER RES, V60, P6101; Antonia SJ, 2006, CLIN CANCER RES, V12, P878, DOI 10.1158/1078-0432.CCR-05-2013; Appay V, 2007, J IMMUNOTHER, V30, P240, DOI 10.1097/01.cji.0000211332.68643.98; Arlen PM, 2006, J CLIN ONCOL, V24, p107S; Bolitho P, 2005, TISSUE ANTIGENS, V66, P365; Bolitho P, 2009, P NATL ACAD SCI USA, V106, P2723, DOI 10.1073/pnas.0809008106; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Chia DJ, 2006, J BIOL CHEM, V281, P6552, DOI 10.1074/jbc.M510903200; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Del Poeta G, 2003, BLOOD, V101, P2125, DOI 10.1182/blood-2002-06-1714; Emens LA, 2005, CANCER RES, V65, P8059, DOI 10.1158/0008-5472.CAN-05-1797; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Eralp Y, 2004, BREAST CANCER RES, V6, pR275, DOI 10.1186/bcr787; Fang P, 2006, EXP CELL RES, V312, P1229, DOI 10.1016/j.yexcr.2005.12.011; Friess H, 1999, DIGEST SURG, V16, P281, DOI 10.1159/000018737; Garnett CT, 2008, CLIN CANCER RES, V14, P3536, DOI 10.1158/1078-0432.CCR-07-4025; Grabert RC, 2006, CLIN CANCER RES, V12, P569, DOI 10.1158/1078-0432.CCR-05-2005; Grabert RC, 2002, BLOOD, V100, p55B; James DF, 2006, J CLIN ONCOL, V24, p362S; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kingsley E, 2009, J CLIN ONCOL, V27; Ko HJ, 2007, CANCER RES, V67, P7477, DOI 10.1158/0008-5472.CAN-06-4639; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Liu G, 2009, CLIN CANCER RES, V15, P3172, DOI 10.1158/1078-0432.CCR-08-2985; Loberg RD, 2007, NEOPLASIA, V9, P1030, DOI 10.1593/neo.07778; MacVicar GR, 2009, J CLIN ONCOL, V27; Menard C, 2008, CANCER IMMUNOL IMMUN, V57, P1579, DOI 10.1007/s00262-008-0505-6; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Mohammad RM, 2005, PANCREAS, V31, P317, DOI 10.1097/01.mpa.0000179731.46210.01; Mohammad RM, 2005, MOL CANCER THER, V4, P13; Nistico P, 2009, INT J CANCER, V124, P130, DOI 10.1002/ijc.23886; Nowak AK, 2003, CANCER RES, V63, P4490; Oliver CL, 2004, CLIN CANCER RES, V10, P7757, DOI 10.1158/1078-0432.CCR-04-0551; Osorio LM, 1997, BLOOD, V89, P2833, DOI 10.1182/blood.V89.8.2833; Radfar S, 2009, J IMMUNOL, V183, P6800, DOI 10.4049/jimmunol.0901747; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Reusch U, 2006, CLIN CANCER RES, V12, P183, DOI 10.1158/1078-0432.CCR-05-1855; Saleh MN, 2009, J CLIN ONCOL, V27; Sen M, 2001, J HEMATOTH STEM CELL, V10, P247, DOI 10.1089/15258160151134944; Sinicrope FA, 2005, MOL CANCER THER, V4, P1475, DOI 10.1158/1535-7163.MCT-05-0137; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Sung BK, 2010, J BIOL CHEM, V285, P35418, DOI 10.1074/jbc.M110.172767; Sutton VR, 2000, J EXP MED, V192, P1403, DOI 10.1084/jem.192.10.1403; Thakur A, 2011, CANCER IMMUNOL IMMUN, V60, P1707, DOI 10.1007/s00262-011-1056-9; Thakur A, 2011, J IMMUNOTHER, V34, P457, DOI 10.1097/CJI.0b013e31821dcba5; Tzeng CWD, 2007, J SURG RES, V143, P20, DOI 10.1016/j.jss.2007.01.051; Tzeng CWD, 2007, SURGERY, V141, P464, DOI 10.1016/j.surg.2006.09.009; Yoshino T, 2006, CLIN CANCER RES, V12, P6116, DOI 10.1158/1078-0432.CCR-06-0147	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e47520	10.1371/journal.pone.0047520	http://dx.doi.org/10.1371/journal.pone.0047520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185240	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800002
J	Tian, P; Sun, Y; Li, YX; Liu, X; Wan, L; Li, J; Ma, Y; Xu, AL; Fu, YG; Zou, H				Tian, Peng; Sun, Yu; Li, Yuxin; Liu, Xiang; Wan, Liang; Li, Jie; Ma, Yun; Xu, Anlong; Fu, Yonggui; Zou, Hua			A Global Analysis of Tandem 3 ' UTRs in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MESSENGER-RNA POLYADENYLATION; 3' UNTRANSLATED REGIONS; CANCER; CELLS; IDENTIFICATION; PATHOGENESIS; MICROARRAY; PROTEIN	Background: Alternative polyadenylation (APA) is emerging as a widespread mechanism of gene regulation. The usage of APA sites allows a single gene to encode multiple mRNA transcripts with different 3'-untranslated region (3'UTR) lengths. Many disease processes reflect the importance of the regulation of APA site switching. The objective of this study was to explore the profiling of tandem APA sites in nasal polyps compared with nasal uncinate process mucosa. Methods: Sequencing of APA sites (SAPAS) based on second-generation sequencing technology was undertaken to investigate the use of tandem APA sites and identify gene expression patterns in samples from the nasal polyps and nasal uncinate process mucosa of two patients with chronic rhinosinusitis with nasal polyps. The findings of the SAPAS analysis were validated via quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Results: First, the results showed a switching of 3'UTR lengths in nasal polyps compared with nasal uncinate process mucosa. From the two patients, 105 genes that were detected in both patients in the nasal polyps were switched to distal poly(A) sites, and 90 such genes were switched to proximal poly(A) sites. Several Gene Ontology terms were enriched in the list of genes with switched APA sites, including transcription regulation, cell cycle, apoptosis, and metabolism. Second, we detected genes that showed differential expression with at least a 3-fold difference between nasal polyp tissue and nasal uncinate process mucosa. Between the two sample types, 627 genes exhibited differential expression. The qRT-PCR results confirmed our SAPAS results. Conclusion: APA site-switching events of 3'UTRs are prevalent in nasal polyp tissue, and the regulation of gene expression mediated by APA may play an important role in the formation and persistence of nasal polyps. Our results may provide new insights into the possible pathophysiologic processes involved in nasal polyps.	[Sun, Yu; Li, Yuxin; Wan, Liang; Li, Jie; Xu, Anlong; Fu, Yonggui] Sun Yat Sen Univ, Higher Educ Mega Ctr, Coll Life Sci,Dept Biochem, State Key Lab Biocontrol,Guangdong Prov Key Lab P, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Peng; Liu, Xiang; Ma, Yun; Zou, Hua] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Fu, YG (corresponding author), Sun Yat Sen Univ, Higher Educ Mega Ctr, Coll Life Sci,Dept Biochem, State Key Lab Biocontrol,Guangdong Prov Key Lab P, Guangzhou 510275, Guangdong, Peoples R China.	fuyg@mail.sysu.edu.cn; zouhua28@163.com	Li, Yuxin/K-9197-2016; Sun, Yu/D-4237-2016; Li, Jie/N-5859-2015	Li, Yuxin/0000-0001-9739-9860; Li, Jie/0000-0002-8328-3274; Fu, Yonggui/0000-0001-6469-3430	National Natural Science Foundation of China [30801012]; Fundamental Research Funds for the Central Universities; Natural Science Fund of Guangdong Province [9151008901000134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province)	Funding for the study was provided by: 1. National Natural Science Foundation of China (No. 30801012 to Y.F.); 2. Fundamental Research Funds for the Central Universities to Y.F.; and 3. Natural Science Fund of Guangdong Province (No. 9151008901000134 to H.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Alcivar A, 2003, ONCOGENE, V22, P291, DOI 10.1038/sj.onc.1206099; Ardehali MM, 2011, ANN DIAGN PATHOL, V15, P233, DOI 10.1016/j.anndiagpath.2010.10.009; Arnold M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036694; Bhaskaran N, 2009, PROTEOM CLIN APPL, V3, P68, DOI 10.1002/prca.200800045; Bloethner S, 2008, GENE CHROMOSOME CANC, V47, P1076, DOI 10.1002/gcc.20598; Fokkens W, 2007, RHINOLOGY, V45, P97; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2006, FEBS LETT, V580, P940, DOI 10.1016/j.febslet.2005.09.105; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Jian W, 2009, AM J OTOLARYNG, V30, P24, DOI 10.1016/j.amjoto.2008.01.003; Katanaev VL, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1428, DOI 10.1134/S0006297910120023; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lindfors K, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-53; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Olaguibel JM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-50; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Milani P, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/458427; Otto BA, 2008, CURR OPIN OTOLARYNGO, V16, P270, DOI 10.1097/MOO.0b013e3282fb2885; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Qiu ZF, 2008, AM J RHINOL, V22, P106, DOI 10.2500/ajr.2008.22.3139; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rostkowska-Nadolska B, 2011, AURIS NASUS LARYNX, V38, P58, DOI 10.1016/j.anl.2010.05.002; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; Sekigawa T, 2009, CLIN EXP ALLERGY, V39, P972, DOI 10.1111/j.1365-2222.2009.03229.x; Simon HU, 1997, J IMMUNOL, V158, P3902; Soong R, 2009, BRIT J CANCER, V100, P676, DOI 10.1038/sj.bjc.6604899; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; van Drunen CM, 2012, CURR ALLERGY ASTHM R, V12, P120, DOI 10.1007/s11882-012-0249-4; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Watelet JB, 2004, ALLERGY, V59, P54, DOI 10.1046/j.1398-9995.2003.00364.x; Yoshifuku K, 2007, RHINOLOGY, V45, P235; Zander KA, 2009, AM J RHINOL ALLERGY, V23, P268, DOI 10.2500/ajra.2009.23.3314	39	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48997	10.1371/journal.pone.0048997	http://dx.doi.org/10.1371/journal.pone.0048997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185289	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800015
J	Howards, PP; Hertz-Picciotto, I; Bech, BH; Nohr, EA; Andersen, AMN; Poole, C; Olsen, J				Howards, Penelope P.; Hertz-Picciotto, Irva; Bech, Bodil H.; Nohr, Ellen A.; Andersen, Anne-Marie Nybo; Poole, Charles; Olsen, Jorn			Spontaneous Abortion and a Diet Drug Containing Caffeine and Ephedrine: A Study within the Danish National Birth Cohort	PLOS ONE			English	Article							RISK-FACTORS; COFFEE CONSUMPTION; MISCARRIAGE; PREGNANCY; ALCOHOL; POPULATION; CIGARETTE; NAUSEA	Background: Medications may be consumed periconceptionally before a woman knows she is pregnant. In this study, the authors evaluate the association of a prescription diet drug (Letigen) containing ephedrine (20 mg) and caffeine (200 mg) with spontaneous abortion (SAB) in the Danish National Birth Cohort. Methods: Women were recruited during their first prenatal visit from 1996-2002. Pre-conception and early pregnancy medication use was reported on the enrollment form, and pregnancy outcome was determined by linking the mother's Civil Registration Number to the Medical Birth Registry and the National Hospital Discharge Register. Of 97,903 eligible pregnancies, 4,443 ended in SAB between 5 and 20 completed gestational weeks, inclusive. Letigen use was reported for 565 pregnancies. Cox regression models accounting for left truncation were fit to estimate the effect of pre-conception and early pregnancy Letigen use on SAB. Principal Findings: The estimated maternal age-adjusted hazard ratio for SAB was 1.1 (95% confidence interval 0.8-1.6) for any periconceptional Letigen use compared to no periconceptional use. Conclusions: Although Letigen has high levels of caffeine (the recommended 3 pills/day are approximately equivalent to caffeine from 6 cups of coffee), periconceptional use does not appear to be associated with an appreciably increased hazard of clinically recognized SAB.	[Howards, Penelope P.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Hertz-Picciotto, Irva] Univ Calif Davis, Dept Publ Hlth Sci, Div Environm & Occupat Hlth, Davis, CA 95616 USA; [Bech, Bodil H.; Nohr, Ellen A.; Olsen, Jorn] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Andersen, Anne-Marie Nybo] Univ Copenhagen, Dept Publ Hlth, Epidemiol Sect, Copenhagen, Denmark; [Poole, Charles] Univ N Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Publ Hlth, Chapel Hill, NC USA	Emory University; Rollins School Public Health; University of California System; University of California Davis; Aarhus University; University of Copenhagen; University of North Carolina; University of North Carolina Chapel Hill	Howards, PP (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	penelope.howards@emory.edu	Andersen, Anne-Marie Nybo/E-4993-2013; Nybo Andersen, Anne-Marie/AAA-1997-2022; Bech, Bodil Hammer/B-9646-2016	Andersen, Anne-Marie Nybo/0000-0002-4296-8488; Nybo Andersen, Anne-Marie/0000-0002-4296-8488; Bech, Bodil Hammer/0000-0002-0287-3687; Howards, Penelope/0000-0001-7539-8701; Hertz-Picciotto, Irva/0000-0001-6952-2390	Danish National Research Foundation; Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Danish Epidemiology Science Centre; Graduate School at the University of North Carolina, Chapel Hill	Danish National Research Foundation(Danmarks Grundforskningsfond); Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Danish Epidemiology Science Centre; Graduate School at the University of North Carolina, Chapel Hill	The Danish National Research Foundation has established the Danish Epidemiology Science Centre that initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this foundation. Additional support for the Danish National Birth Cohort was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, and the Augustinus Foundation. This particular study was supported by a grant from the Danish Epidemiology Science Centre and a dissertation completion fellowship from the Graduate School at the University of North Carolina, Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency DM, 2003, COMPANY ACCOUNT 2002; [Anonymous], 2010, OBSTET GYNECOLOGY, V116, P467; [Anonymous], 2002, LGEMIDDELKATALOGET 2; ARMSTRONG BG, 1992, AM J PUBLIC HEALTH, V82, P85, DOI 10.2105/AJPH.82.1.85; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; Bech BH, 2005, AM J EPIDEMIOL, V162, P983, DOI 10.1093/aje/kwi317; Bitsko RH, 2008, BIRTH DEFECTS RES A, V82, P553, DOI 10.1002/bdra.20472; Bracken MB, 2002, EPIDEMIOLOGY, V13, P165, DOI 10.1097/00001648-200203000-00011; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Dlugosz L, 1996, EPIDEMIOLOGY, V7, P250, DOI 10.1097/00001648-199605000-00006; DLUGOSZ L, 1992, EPIDEMIOL REV, V14, P83, DOI 10.1093/oxfordjournals.epirev.a036093; DOMINGUEZROJAS V, 1994, EUR J EPIDEMIOL, V10, P665, DOI 10.1007/BF01719278; Due P, 2007, OBES REV, V8, P187, DOI 10.1111/j.1467-789X.2006.00291.x; Fenster L, 1991, Epidemiology, V2, P168, DOI 10.1097/00001648-199105000-00002; Fenster L, 1991, Epidemiology, V2, P313, DOI 10.1097/00001648-199107000-00017; Fenster L, 1997, EPIDEMIOLOGY, V8, P515, DOI 10.1097/00001648-199709000-00008; Food Standards Agency, 2008, FOOD STANDARDS AGENC; Giannelli M, 2003, PAEDIATR PERINAT EP, V17, P316, DOI 10.1046/j.1365-3016.2003.00523.x; Greenwood DC, 2010, EUR J EPIDEMIOL, V25, P275, DOI 10.1007/s10654-010-9443-7; Howards PP, 2007, AM J EPIDEMIOL, V165, P444, DOI 10.1093/aje/kwk027; Howards PP, 2006, AM J EPIDEMIOL, V164, P1126, DOI 10.1093/aje/kwj327; INFANTERIVARD C, 1993, JAMA-J AM MED ASSOC, V270, P2940, DOI 10.1001/jama.270.24.2940; Klebanoff MA, 1999, NEW ENGL J MED, V341, P1639, DOI 10.1056/NEJM199911253412202; KLINE J, 1994, JAMA-J AM MED ASSOC, V272, P27, DOI 10.1001/jama.1994.03520010037016; KLINE J, 1991, EPIDEMIOLOGY, V2, P409, DOI 10.1097/00001648-199111000-00004; Maconochie N, 2007, BJOG-INT J OBSTET GY, V114, P170, DOI 10.1111/j.1471-0528.2006.01193.x; MILLS JL, 1993, JAMA-J AM MED ASSOC, V269, P593, DOI 10.1001/jama.269.5.593; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Parazzini F, 1998, HUM REPROD, V13, P2286, DOI 10.1093/humrep/13.8.2286; PARAZZINI F, 1991, INT J EPIDEMIOL, V20, P157, DOI 10.1093/ije/20.1.157; PARAZZINI F, 1994, JAMA-J AM MED ASSOC, V272, P28; Pollack AZ, 2010, FERTIL STERIL, V93, P304, DOI 10.1016/j.fertnstert.2009.07.992; Rasch V, 2003, ACTA OBSTET GYN SCAN, V82, P182, DOI 10.1034/j.1600-0412.2003.00078.x; Savitz DA, 2008, EPIDEMIOLOGY, V19, P55, DOI 10.1097/EDE.0b013e31815c09b9; Signorello LB, 2004, EPIDEMIOLOGY, V15, P229, DOI 10.1097/01.ede.0000112221.24237.0c; Stein Z, 1991, Epidemiology, V2, P163; Tolstrup JS, 2003, HUM REPROD, V18, P2704, DOI 10.1093/humrep/deg480; U.S. Food and Drug Administration, 2004, FDA ANNOUNCES RULE P; U.S. Food and Drug Administration, 2012, SUMMARY MINUTES OF T; WEATHERSBEE PS, 1977, POSTGRAD MED, V62, P64, DOI 10.1080/00325481.1977.11714605; Wen WQ, 2001, EPIDEMIOLOGY, V12, P38, DOI 10.1097/00001648-200101000-00008; Weng X, 2008, AM J OBSTET GYNECOL, V198	42	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50372	10.1371/journal.pone.0050372	http://dx.doi.org/10.1371/journal.pone.0050372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166844	Green Submitted, gold, Green Published			2022-12-25	WOS:000311885300100
J	Saha, S; Hunter, WB; Reese, J; Morgan, JK; Marutani-Hert, M; Huang, H; Lindeberg, M				Saha, Surya; Hunter, Wayne B.; Reese, Justin; Morgan, J. Kent; Marutani-Hert, Mizuri; Huang, Hong; Lindeberg, Magdalen			Survey of Endosymbionts in the Diaphorina citri Metagenome and Assembly of a Wolbachia wDi Draft Genome	PLOS ONE			English	Article							IV SECRETION SYSTEM; TAMARIXIA-RADIATA; SEQUENCE; POPULATIONS; DNA; IDENTIFICATION; PSYLLIDAE; SYMBIONTS; PHYLOGENY; EVOLUTION	Diaphorina citri (Hemiptera: Psyllidae), the Asian citrus psyllid, is the insect vector of Ca. Liberibacter asiaticus, the causal agent of citrus greening disease. Sequencing of the D. citri metagenome has been initiated to gain better understanding of the biology of this organism and the potential roles of its bacterial endosymbionts. To corroborate candidate endosymbionts previously identified by rDNA amplification, raw reads from the D. citri metagenome sequence were mapped to reference genome sequences. Results of the read mapping provided the most support for Wolbachia and an enteric bacterium most similar to Salmonella. Wolbachia-derived reads were extracted using the complete genome sequences for four Wolbachia strains. Reads were assembled into a draft genome sequence, and the annotation assessed for the presence of features potentially involved in host interaction. Genome alignment with the complete sequences reveals membership of Wolbachia wDi in supergroup B, further supported by phylogenetic analysis of FtsZ. FtsZ and Wsp phylogenies additionally indicate that the Wolbachia strain in the Florida D. citri isolate falls into a sub-clade of supergroup B, distinct from Wolbachia present in Chinese D. citri isolates, supporting the hypothesis that the D. citri introduced into Florida did not originate from China.	[Saha, Surya; Lindeberg, Magdalen] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA; [Hunter, Wayne B.; Morgan, J. Kent; Marutani-Hert, Mizuri] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA; [Reese, Justin] Genformatic LLC, Alpharetta, GA USA; [Huang, Hong] Univ S Florida, Sch Informat, Tampa, FL USA	Cornell University; United States Department of Agriculture (USDA); State University System of Florida; University of South Florida	Lindeberg, M (corresponding author), Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14850 USA.	ml16@cornell.edu	Huang, Hong/G-5957-2016; Saha, Surya/S-9548-2018; hunter, wayne/AAB-9096-2020	Huang, Hong/0000-0002-8957-4881; Saha, Surya/0000-0002-1160-1413; hunter, wayne/0000-0001-8603-3337; Lindeberg, Magdalen/0000-0001-6386-4066	USDA, ARS, Subtropical Research Unit, U.S. Horticultural Research Laboratory, Fort Pierce, FL, USA; Citrus Research Board, Visalia, CA, USA; Citrus Research and Development Foundation [123]	USDA, ARS, Subtropical Research Unit, U.S. Horticultural Research Laboratory, Fort Pierce, FL, USA; Citrus Research Board, Visalia, CA, USA; Citrus Research and Development Foundation	Funding for this project came from the USDA, ARS, Subtropical Research Unit, U.S. Horticultural Research Laboratory, Fort Pierce, FL, USA; and the Citrus Research Board, Visalia, CA, USA (FY2011-2012) and from the Citrus Research and Development Foundation grant FCATP08 #123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arthofer W, 2009, ENVIRON MICROBIOL, V11, P1923, DOI 10.1111/j.1462-2920.2009.01914.x; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Atyame CM, 2011, MOL ECOL, V20, P286, DOI 10.1111/j.1365-294X.2010.04937.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Barr NB, 2009, J ECON ENTOMOL, V102, P2325, DOI 10.1603/029.102.0639; Bian G, PLOS PATHOG, V6; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Boykin LM, 2012, J EC ENTOMO IN PRESS; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chou JH, 2007, INT J SYST EVOL MICR, V57, P887, DOI 10.1099/ijs.0.64551-0; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Duron O, 2007, J BACTERIOL, V189, P4442, DOI 10.1128/JB.00142-07; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gupta AK, 2012, FEMS MICROBIOL ECOL, V79, P581, DOI 10.1111/j.1574-6941.2011.01248.x; Hail D, 2012, ENVIRON ENTOMOL, V41, P98, DOI 10.1603/EN11198; Halbert SE, 2004, FLA ENTOMOL, V87, P401, DOI 10.1653/0015-4040(2004)087[0401:DOTACP]2.0.CO;2; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hoy M.A., 2004, CLASSICAL BIOL CONTR; HOY MA, 2000, CITRUS IND, V81, P48; Kikuchi Y, P NATL ACAD SCI; Klasson L, 2008, MOL BIOL EVOL, V25, P1877, DOI 10.1093/molbev/msn133; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Liu R, 2011, PLANT DIS, V95, P431, DOI 10.1094/PDIS-04-10-0300; Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087; Marutani-Hert M, 2011, SOUTHWEST ENTOMOL, V36, P323; Marutani-Hert M, 2009, IN VITRO CELL DEV-AN, V45, P317, DOI 10.1007/s11626-009-9188-3; Mavingui P, 2012, J BACTERIOL, V194, P1840, DOI 10.1128/JB.00036-12; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; Michaund J.P., 2004, BIOL CONTROL, V296, P260; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park J, 2004, CELL MICROBIOL, V6, P743, DOI 10.1111/j.1462-5822.2004.00400.x; Pichon S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-55; Pichon S, 2009, BIOCHEM BIOPH RES CO, V385, P557, DOI 10.1016/j.bbrc.2009.05.118; Pinel N, 2008, INT J SYST EVOL MICR, V58, P2147, DOI 10.1099/ijs.0.65174-0; Pluke RWH, 2008, FLA ENTOMOL, V91, P36, DOI 10.1653/0015-4040(2008)091[0036:CFPDCH]2.0.CO;2; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rinke R, 2011, GENET MOL RES, V10, P2679, DOI 10.4238/2011.November.1.1; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salzberg SL, 2009, J BACTERIOL, V191, P1725, DOI 10.1128/JB.01731-08; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Schneider DI, 2012, J INVERTEBR PATHOL; Sedgwick SG, 1998, J MOL BIOL, V281, P763, DOI 10.1006/jmbi.1998.1996; Sloan DB, 2012, MOL BIOL EVOL; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Subandiyah S, 2000, ZOOL SCI, V17, P983, DOI 10.2108/zsj.17.983; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, pCh4, DOI DOI 10.1002/0471250953.BI0410S25; Thaochan N, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13101; Vandekerckhove TTM, 1999, FEMS MICROBIOL LETT, V180, P279, DOI 10.1111/j.1574-6968.1999.tb08807.x; Walker T, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-39; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zerbino D, 2008, GENOME RES; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09	81	48	53	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50067	10.1371/journal.pone.0050067	http://dx.doi.org/10.1371/journal.pone.0050067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166822	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300083
J	Zhuang, JL; Zhang, JH; Lwin, ST; Edwards, JR; Edwards, CM; Mundy, GR; Yang, XL				Zhuang, Junling; Zhang, Jianghong; Lwin, Seint T.; Edwards, James R.; Edwards, Claire M.; Mundy, Gregory R.; Yang, Xiangli			Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; TUMOR BURDEN; BONE-DISEASE; GROWTH; PRENYLATION; ACTIVATION; THALIDOMIDE; EXPANSION; PROTEINS; POTENT	Osteoclasts play a key role in the development of cancer-associated osteolytic lesions. The number and activity of osteoclasts are often enhanced by tumors. However, the origin of osteoclasts is unknown. Myeloid-derived suppressor cells (MDSCs) are one of the pre-metastatic niche components that are induced to expand by tumor cells. Here we show that the MDSCs can differentiate into mature and functional osteoclasts in vitro and in vivo. Inoculation of 5TGM1-GFP myeloma cells into C57BL6/KaLwRij mice led to a significant expansion of MDSCs in blood, spleen, and bone marrow over time. When grown in osteoclastogenic media in vitro, MDSCs from tumor-challenged mice displayed 14 times greater potential to differentiate into mature and functional osteoclasts than those from non-tumor controls. Importantly, MDSCs from tumor-challenged LacZ transgenic mice differentiated into LacZ+osteoclasts in vivo. Furthermore, a significant increase in tumor burden and bone loss accompanied by increased number of osteoclasts was observed in mice co-inoculated with tumor-challenged MDSCs and 5TGM1 cells compared to the control animals received 5TGM1 cells alone. Finally, treatment of MDSCs from myeloma-challenged mice with Zoledronic acid (ZA), a potent inhibitor of bone resorption, inhibited the number of osteoclasts formed in MDSC cultures and the expansion of MDSCs and bone lesions in mice. Collectively, these data provide in vitro and in vivo evidence that tumor-induced MDSCs exacerbate cancer-associated bone destruction by directly serving as osteoclast precursors.	[Zhuang, Junling; Zhang, Jianghong; Edwards, James R.; Mundy, Gregory R.; Yang, Xiangli] Vanderbilt Univ, Med Ctr, Dept Med & Pharmacol, Nashville, TN 37212 USA; [Lwin, Seint T.; Edwards, Claire M.; Mundy, Gregory R.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Zhuang, Junling] Peking Union Med Coll Hosp, Dept Hematol, Beijing, Peoples R China	Vanderbilt University; Vanderbilt University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhuang, JL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med & Pharmacol, Nashville, TN 37212 USA.	zhuangjunling@hotmail.com; xiangli.yang@vanderbilt.edu	Zhuang, Junling/AAZ-4944-2021; Edwards, Claire/D-7114-2011	Zhuang, Junling/0000-0002-1228-0551; Edwards, Claire/0000-0002-1257-5659	NIH NCI [P01 CA40035-22]; NATIONAL CANCER INSTITUTE [R01CA137116, P01CA040035] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by NIH NCI P01 CA40035-22. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; Avcu F, 2005, EUR J HAEMATOL, V74, P496, DOI 10.1111/j.1600-0609.2005.00427.x; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Benford HL, 1999, MOL PHARMACOL, V56, P131, DOI 10.1124/mol.56.1.131; Chambers TJ, 2010, ANN NY ACAD SCI, V1192, P19, DOI 10.1111/j.1749-6632.2009.05224.x; Dallas SL, 1999, BLOOD, V93, P1697, DOI 10.1182/blood.V93.5.1697.405a17_1697_1706; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Derenne S, 1999, J BONE MINER RES, V14, P2048, DOI 10.1359/jbmr.1999.14.12.2048; Dunn LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006896; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Fowler JA, 2009, DIS MODEL MECH, V2, P604, DOI 10.1242/dmm.003160; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Granholm S, 2008, J CELL BIOCHEM, V104, P920, DOI 10.1002/jcb.21674; GREEN JR, 1994, J BONE MINER RES, V9, P745; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Hofmann G, 2001, J BIOL CHEM, V276, P4923, DOI 10.1074/jbc.M005682200; Kaplan RN, 2006, CANCER METAST REV, V25, P521, DOI 10.1007/s10555-006-9036-9; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kim YS, 2012, J IMMUNOL, V188, P4226, DOI 10.4049/jimmunol.1103040; Liu QF, 2011, INT J CANCER, V129, P2662, DOI 10.1002/ijc.25921; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; Psaila Bethan, 2006, Breast Dis, V26, P65; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Radl J, 1999, PATHOL BIOL, V47, P109; Roelofs AJ, 2006, INT J CANCER, V119, P1254, DOI 10.1002/ijc.21977; Rogers MJ, 1999, BONE, V24, p73S, DOI 10.1016/S8756-3282(99)00070-8; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; van Rhee F, 2008, BLOOD, V112, P1035, DOI 10.1182/blood-2008-02-140954; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	38	86	87	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e48871	10.1371/journal.pone.0048871	http://dx.doi.org/10.1371/journal.pone.0048871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173040	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300010
J	Kenche, H; Baty, CJ; Vedagiri, K; Shapiro, SD; Blumental-Perry, A				Kenche, Harshavardhan; Baty, Catherine J.; Vedagiri, Kokilavani; Shapiro, Steven D.; Blumental-Perry, Anna			Cigarette smoking affects oxidative protein folding in endoplasmic reticulum by modifying protein disulfide isomerase	FASEB JOURNAL			English	Article						COPD; ER stress response	OBSTRUCTIVE PULMONARY-DISEASE; ER STRESS; MOLECULAR CHAPERONE; BOND FORMATION; HUMAN LUNG; AUTOPHAGY; CELLS; TRANSCRIPTION; GLUTATHIONE; EXPRESSION	The endoplasmic reticulum (ER) stress response (ERSR) and associated protein aggregation, is under investigation for its role in human diseases, including chronic obstructive pulmonary disease (COPD) where cigarette smoking (CS) is a risk factor for disease development. Our hypothesis states that CS-associated oxidative stress interferes with oxidative protein folding in the ER and elicits ERSR. We investigated ERSR induction following acute CS exposure and delineated mechanisms of CS-induced ERSR. Lung lysates from mice exposed or not to one cigarette were tested for activation of the ERSR. Up to 4-fold increase in phosphorylation of eIF2 alpha and nuclear form of ATF6 was detected in CS-exposed animals. CS affected the formation of disulfide bonds through excessive posttranslational oxidation of protein disulfide isomerase (PDI). Increased amounts of complexes between PDI and its client proteins persisted in CS-exposed samples. BiP was not a constituent of these complexes, demonstrating the specificity of the early effects of CS exposure on ER. Disturbances in protein folding were accompanied by changes in the organization of ER network and ER exit sites. Our results provide evidence that ERSR is induced early in response to CS exposure and identifies the first known ER-resident target of CS PDI, demonstrating that CS affects oxidative protein folding.-Kenche, H., Baty, C. J., Vedagiri, K., Shapiro, S. D., Blumental-Perry, A. Cigarette smoking affects oxidative protein folding in endoplasmic reticulum by modifying protein disulfide isomerase. FASEB J. 27, 965-977 (2013). www.fasebj.org	[Kenche, Harshavardhan; Vedagiri, Kokilavani; Blumental-Perry, Anna] Mem Hlth Univ Med Ctr, Anderson Canc Inst, Savannah, GA 31405 USA; [Blumental-Perry, Anna] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA USA; [Baty, Catherine J.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Shapiro, Steven D.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Mercer University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Blumental-Perry, A (corresponding author), Mem Hlth Univ Med Ctr, Anderson Canc Inst, Hoskins Res Bldg,4700 Waters Ave, Savannah, GA 31405 USA.	perry_a@mercer.edu			ATS/Alpha-1 Foundation; Flight Attendant Medical Research Institute [092207]; Curtis and Elizabeth Anderson Cancer Institute	ATS/Alpha-1 Foundation; Flight Attendant Medical Research Institute; Curtis and Elizabeth Anderson Cancer Institute	The authors thank Celia Reynolds for editorial and technical help, Jenny Karlsson for help with live imaging, and Jeremy Brown for help with the ImageJ macro for analysis of intensity of IHC staining. This research was funded by an ATS/Alpha-1 Foundation partnership grant in alpha 1-antitrypsin deficiency (A.B.-P.), a Flight Attendant Medical Research Institute Young Clinical Scientist Award (grant 092207; A.B.-P.), and by the Welcome Fund from the Curtis and Elizabeth Anderson Cancer Institute.	Aksoy R. J., 2011, AM J RESP CRIT CARE, V183, pA4094; An CH, 2012, AM J PHYSIOL-LUNG C, V303, pL748, DOI 10.1152/ajplung.00102.2012; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Aoshiba K, 2003, INHAL TOXICOL, V15, P1029, DOI 10.1080/08958370390226431; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Bezemer GFG, 2012, PHARMACOL REV, V64, P337, DOI 10.1124/pr.111.004622; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Blumental-Perry A, 2012, CURR MOL MED, V12, P883, DOI 10.2174/156652412801318764; Blumental-Perry A., 2012, ENDO RETICU STRESS C, V1, P1; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Cantin Andre M, 2010, Proc Am Thorac Soc, V7, P368, DOI 10.1513/pats.201001-014AW; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Dombroski BA, 2010, AM J HUM GENET, V86, P719, DOI 10.1016/j.ajhg.2010.03.017; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Geraghty P, 2011, INT J CHRONIC OBSTR, V6, P309, DOI 10.2147/COPD.S19599; Haspel JA, 2011, AM J RESP CRIT CARE, V184, P1237, DOI 10.1164/rccm.201106-0966CI; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hengstermann A, 2008, FREE RADICAL BIO MED, V44, P1097, DOI 10.1016/j.freeradbiomed.2007.12.009; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P713, DOI 10.1513/pats.200605-104SF; Hetz C, 2011, CURR OPIN CELL BIOL, V23, P123, DOI 10.1016/j.ceb.2011.01.004; Jacob C, 2012, CHEM RES TOXICOL, V25, P588, DOI 10.1021/tx200342b; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Kelsen SG, 2012, PULM PHARMACOL THER, V25, P447, DOI 10.1016/j.pupt.2012.07.005; Kim KM, 2012, INT J CANCER, V131, pE362, DOI 10.1002/ijc.26463; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Lawless MW, 2012, CYTOKINE, V59, P195, DOI 10.1016/j.cyto.2012.04.003; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Mao CH, 2006, J BIOL CHEM, V281, P8877, DOI 10.1074/jbc.M505784200; Marcinak Stefan J, 2010, Proc Am Thorac Soc, V7, P356, DOI 10.1513/pats.201001-015AW; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Nawa D, 2007, GLYCOBIOLOGY, V17, P913, DOI 10.1093/glycob/cwm067; Oda K, 1996, BIOCHEM J, V316, P623, DOI 10.1042/bj3160623; Ribeiro CMP, 2012, CURR MOL MED, V12, P872; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Ryter Stefan W, 2010, Proc Am Thorac Soc, V7, P40, DOI 10.1513/pats.200909-100JS; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shapiro SD, 2005, AM J RESP CELL MOL, V32, P367, DOI 10.1165/rcmb.F296; Stephens DJ, 2000, J CELL SCI, V113, P2177; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vidal RL, 2012, HUM MOL GENET, V21, P2245, DOI 10.1093/hmg/dds040; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046144; Wang Y, 2000, J BIOL CHEM, V275, P27013; Weston RT, 2010, ADV EXP MED BIOL, V687, P65; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wilhelm JE, 2005, DEV CELL, V9, P675, DOI 10.1016/j.devcel.2005.09.015; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	63	57	58	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					965	977		10.1096/fj.12-216234	http://dx.doi.org/10.1096/fj.12-216234			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23169770				2022-12-25	WOS:000315585200012
J	Mogami, H; Kishore, AH; Shi, H; Keller, PW; Akgul, Y; Word, RA				Mogami, Haruta; Kishore, Annavarapu Hari; Shi, Haolin; Keller, Patrick W.; Akgul, Yucel; Word, R. Ann			Fetal Fibronectin Signaling Induces Matrix Metalloproteases and Cyclooxygenase-2 (COX-2) in Amnion Cells and Preterm Birth in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTOR-4; PREMATURE RUPTURE; HUMAN-PLASMA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; BINDING DOMAIN; HUMAN PLACENTA; MOUSE VAGINA; EXTRA DOMAIN	Fetal fibronectin (fFN) in cervical and vaginal secretions has been used as a predictor of preterm delivery. Here, we clarified the pathological function of fFN on cell type-specific matrix metalloproteinases (MMPs) and prostaglandin synthesis in fetal membranes. Treatment of amnion mesenchymal cells with fFN resulted in dramatic increases in MMP-1 and MMP-9 mRNA and enzymatic activity as well as COX-2 mRNA and prostaglandin E-2 synthesis, activating both NF kappa B and ERK1/2 signaling. Fetal FN-induced increases in MMPs and COX-2 were mediated through its extra domain A and Toll-like receptor 4 expressed in mesenchymal cells. Lipopolysaccharide and TNF-alpha increased the release of free FN in medium of amnion epithelial cells in culture. Finally, injection of fFN in pregnant mice resulted in preterm birth. Collectively, these results indicate that fFN is not only a marker of preterm delivery but also plays a significant role in the pathogenesis of preterm labor and premature rupture of fetal membranes.	[Word, R. Ann] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, Div Reprod Endocrinol & Urogynecol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Word, RA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Cecil H & Ida Green Ctr Reprod Biol Sci, Div Reprod Endocrinol & Urogynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ruth.word@utsouthwestern.edu	Akgul, Yucel/M-1745-2013	akgul, yucel/0000-0001-8880-9821	National Institutes of Health [HD11149]; SUMITOMO Life Social Welfare Service Foundation; Human Tissue and Biologic Fluid Core Laboratory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD011149] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD011149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUMITOMO Life Social Welfare Service Foundation; Human Tissue and Biologic Fluid Core Laboratory; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD11149. This work was also supported by a fellowship from the SUMITOMO Life Social Welfare Service Foundation and the Human Tissue and Biologic Fluid Core Laboratory.	Athayde N, 1998, AM J OBSTET GYNECOL, V179, P1248, DOI 10.1016/S0002-9378(98)70141-3; Becher N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-45; Casey ML, 1996, BIOL REPROD, V55, P1253, DOI 10.1095/biolreprod55.6.1253; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Challis JRG, 2002, REPRODUCTION, V124, P1; DRAPER D, 1995, AM J OBSTET GYNECOL, V173, P1506, DOI 10.1016/0002-9378(95)90640-1; Drewes PG, 2007, AM J PATHOL, V170, P578, DOI 10.2353/ajpath.2007.060662; DUCHESNE MJ, 1978, PROSTAG OTH LIPID M, V15, P19, DOI 10.1016/S0090-6980(78)80003-3; Dudley DJ, 1996, BIOL REPROD, V55, P992, DOI 10.1095/biolreprod55.5.992; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Filipovich Y, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.038; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; HARGER JH, 1990, AM J OBSTET GYNECOL, V163, P130, DOI 10.1016/S0002-9378(11)90686-3; Hirsch E, 1999, AM J OBSTET GYNECOL, V180, P429, DOI 10.1016/S0002-9378(99)70227-9; Jackson GM, 1996, J SOC GYNECOL INVEST, V3, P85, DOI 10.1016/1071-5576(95)00050-X; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; KORNBLIHTT AR, 1984, EMBO J, V3, P221, DOI 10.1002/j.1460-2075.1984.tb01787.x; Leon CG, 2008, PHARM RES-DORDR, V25, P1751, DOI 10.1007/s11095-008-9571-x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li W, 2007, BIOL REPROD, V76, P654, DOI 10.1095/biolreprod.106.057034; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P914, DOI 10.1067/mob.2000.108879; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; OYAMA F, 1989, BIOCHEMISTRY-US, V28, P1428, DOI 10.1021/bi00429a072; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Pressman EK, 2002, AM J OBSTET GYNECOL, V187, P672, DOI 10.1067/mob.2002.125742; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; Rahn DD, 2009, AM J PATHOL, V174, P206, DOI 10.2353/ajpath.2009.080212; Retta SF, 1999, METH MOL B, V96, P119; Romer LH, 1995, BIOCHEM CELL BIOL, V73, P515, DOI 10.1139/o95-057; ROMERO R, 1987, AM J OBSTET GYNECOL, V157, P1461, DOI 10.1016/S0002-9378(87)80245-4; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1065, DOI 10.1016/0002-9378(95)91327-0; Sanchez-Ramos L, 2009, OBSTET GYNECOL, V114, P631, DOI 10.1097/AOG.0b013e3181b47217; Sil H, 2011, ONCOL RES, V19, P335, DOI 10.3727/096504011X13079697132925; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Strakova Z, 1998, AM J PHYSIOL-ENDOC M, V274, pE634, DOI 10.1152/ajpendo.1998.274.4.E634; THERRIEN M, 1993, MOL CELL BIOL, V13, P2342, DOI 10.1128/MCB.13.4.2342; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Wieslander CK, 2008, BIOL REPROD, V78, P521, DOI 10.1095/biolreprod.107.063024; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yoshimura K, 2005, J SOC GYNECOL INVEST, V12, P533, DOI 10.1016/j.jsgi.2005.06.006; Zakar T, 1998, BBA-LIPID LIPID MET, V1391, P37, DOI 10.1016/S0005-2760(97)00195-1; ZHU BCR, 1984, J BIOL CHEM, V259, P3962	56	37	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1953	1966		10.1074/jbc.M112.424366	http://dx.doi.org/10.1074/jbc.M112.424366			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184961	Green Published, hybrid			2022-12-25	WOS:000313751400048
J	Ahmad, M; Ansari, A; Tarique, M; Satsangi, AT; Tuteja, R				Ahmad, Moaz; Ansari, Abulaish; Tarique, Mohammed; Satsangi, Akash Tripathi; Tuteja, Renu			Plasmodium falciparum UvrD Helicase Translocates in 3 ' to 5 ' Direction, Colocalizes with MLH and Modulates Its Activity through Physical Interaction	PLOS ONE			English	Article							MISMATCH-REPAIR; DNA HELICASE; ESCHERICHIA-COLI; MALARIA; PROTEIN; PURIFICATION; MUTATIONS; SEQUENCE; HOMOLOG; BIPOLAR	Malaria is a global disease and a major health problem. The control of malaria is a daunting task due to the increasing drug resistance. Therefore, there is an urgent need to identify and characterize novel parasite specific drug targets. In the present study we report the biochemical characterization of parasite specific UvrD helicase from Plasmodium falciparum. The N-terminal fragment (PfUDN) containing UvrD helicase domain, which consists of helicase motifs Q, Ia-Id, II, III and most of motif IV, and the C-terminal fragment (PfUDC1) containing UvrD helicase C terminal domain, consisting of remaining part of motif IV and motifs IVa-IVc and 161 amino acids of intervening sequence between motif IV and V, possess ssDNA-dependent ATPase and DNA helicase activities in vitro. Using immunodepletion assays we show that the ATPase and helicase activities are attributable to PfUDN and PfUDC1 proteins. The helicase activity can utilize the hydrolysis of all the nucleotide and deoxynucleotide triphosphates and the direction of unwinding is 3' to 5'. The endogenous P. falciparum UvrD contains the characteristic DNA helicase activity. PfUDN interacts with PfMLH (P. falciparum MutL homologue) and modulates the endonuclease activity of PfMLH and PfMLH positively regulates the unwinding activity of PfUDN. We show that PfUvrD is expressed in the nucleus distinctly in the schizont stages of the intraerythrocytic development of the parasite and it colocalizes with PfMLH. These studies will make an important contribution in understanding the nucleic acid transaction in the malaria parasite.	[Ahmad, Moaz; Ansari, Abulaish; Tarique, Mohammed; Satsangi, Akash Tripathi; Tuteja, Renu] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Tuteja, R (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, Aruna Asaf Ali Marg, New Delhi, India.	renu@icgeb.res.in	Ansari, Abulaish/GLQ-8370-2022		Department of Biotechnology, Government of India; Defence Research and Development Organization, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Defence Research and Development Organization, Government of India(Defence Research & Development Organisation (DRDO))	This work is partially supported by funds from Department of Biotechnology, Government of India, and Defence Research and Development Organization, Government of India grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmad M, 2012, MOL BIOCHEM PARASIT, V181, P153; An LX, 2005, J BIOL CHEM, V280, P28952, DOI 10.1074/jbc.M503096200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; Castellini MA, 2011, MOL BIOCHEM PARASIT, V177, P143, DOI 10.1016/j.molbiopara.2011.02.004; Chene P, 2008, BIOCHEM SYST ECOL, V36, P101, DOI 10.1016/j.bse.2007.08.001; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Collins R, 2003, EXTREMOPHILES, V7, P35, DOI 10.1007/s00792-002-0293-4; Curti E, 2007, J BACTERIOL, V189, P1542, DOI 10.1128/JB.01421-06; Eshleman James R., 1995, Current Opinion in Oncology, V7, P83; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jiricny J, 1996, CANCER SURV, V28, P47; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; Mauris J, 2010, J BIOL CHEM, V285, P11087, DOI 10.1074/jbc.M109.050955; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Naqvi A, 2003, J BACTERIOL, V185, P6633, DOI 10.1128/JB.185.22.6633-6639.2003; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan A, 2005, MOL BIOCHEM PARASIT, V144, P133, DOI 10.1016/j.molbiopara.2005.08.006; Pradhan A, 2007, J MOL BIOL, V373, P268, DOI 10.1016/j.jmb.2007.07.056; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; RONG L, 1993, J BIOL CHEM, V268, P1252; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shankar J, 2008, GENE, V410, P223, DOI 10.1016/j.gene.2007.12.015; Sharma R, 2012, FEBS J, V279, P2134, DOI 10.1111/j.1742-4658.2012.08599.x; Sinha KM, 2008, BIOCHEMISTRY-US, V47, P9355, DOI 10.1021/bi800725q; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Tarique M, 2012, MOL BIOCHEM PARASIT, V181, P153, DOI 10.1016/j.molbiopara.2011.10.012; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TUTEJA N, 1993, NUCLEIC ACIDS RES, V21, P2323, DOI 10.1093/nar/21.10.2323; Tuteja N, 2001, CRIT REV BIOCHEM MOL, V36, P261, DOI 10.1080/20014091074192; Tuteja R, 2007, FEBS J, V274, P4670, DOI 10.1111/j.1742-4658.2007.05997.x; Tuteja R, 2007, FEBS J, V274, P4699, DOI 10.1111/j.1742-4658.2007.06000.x; Tuteja R, 2007, FEBS J, V274, P4669, DOI 10.1111/j.1742-4658.2007.05996.x; Umar A, 1996, EUR J BIOCHEM, V238, P297, DOI 10.1111/j.1432-1033.1996.0297z.x; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197	50	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49385	10.1371/journal.pone.0049385	http://dx.doi.org/10.1371/journal.pone.0049385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185322	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000044
J	Black, KH; Camens, AB; Archer, M; Hand, SJ				Black, Karen H.; Camens, Aaron B.; Archer, Michael; Hand, Suzanne J.			Herds Overhead: Nimbadon lavarackorum (Diprotodontidae), Heavyweight Marsupial Herbivores in the Miocene Forests of Australia	PLOS ONE			English	Article							FUNCTIONAL-ADAPTIVE ANATOMY; MAYULESTES-FEROX; LOCOMOTOR BEHAVIOR; EXTANT MARSUPIALS; PALEOBIOLOGY; FORELIMB; RIVERSLEIGH; MORPHOLOGY; KANGAROOS; EVOLUTION	The marsupial family Diprotodontidae (Diprotodontia, Vombatiformes) is a group of extinct large-bodied (60-2500 kg) wombat-like herbivores that were common and geographically widespread in Cenozoic fossil deposits of Australia and New Guinea. Typically they are regarded to be gregarious, terrestrial quadrupeds and have been likened in body form among placental groups to sheep, rhinoceros and hippopotami. Arguably, one of the best represented species is the zygomaturine diprotodontid Nimbadon lavarackorum which is known from exceptionally well-preserved cranial and postcranial material from the middle Miocene cave deposit AL90, in the Riversleigh World Heritage Area, northwestern Queensland. Here we describe and functionally analyse the appendicular skeleton of Nimbadon lavarackorum and reveal a far more unique lifestyle for this plesiomorphic and smallest of diprotodontids. Striking similarities are evident between the skeleton of Nimbadon and that of the extant arboreal koala Phascolarctos cinereus, including the powerfully built forelimbs, highly mobile shoulder and elbow joints, proportionately large manus and pes (both with a semi-opposable digit I) and exceedingly large, recurved and laterally compressed claws. Combined with the unique (among australidelphians) proportionately shortened hindlimbs of Nimbadon, these features suggest adept climbing ability, probable suspensory behaviour, and an arboreal lifestyle. At approximately 70 kg, Nimbadon is the largest herbivorous mammal to have occupied the forest canopies of Australia - an ecological niche that is no longer occupied in any Australian ecosystem and one that further expands the already significant niche diversity displayed by marsupials during the Cenozoic.	[Black, Karen H.; Archer, Michael; Hand, Suzanne J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Camens, Aaron B.] Univ Adelaide, Dept Earth & Environm Sci, Adelaide, SA, Australia	University of New South Wales Sydney; University of Adelaide	Black, KH (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	k.black@unsw.edu.au; aaron.b.camens@gmail.com	Hand, Suzanne J/C-3853-2008	Hand, Suzanne/0000-0002-4940-3391; Black, Karen/0000-0003-0645-5172; Archer, Michael/0000-0002-0304-4039	Australian Research Council [LP0989969, LP100200486, DP1094569]; Xstrata Copper Community Partnership Program North Queensland, Outback at Isa; Mount Isa City Council; Queensland Museum; University of New South Wales; Environment Australia; Queensland Department of Environment and Heritage; Phil Creaser; CREATE fund at UNSW	Australian Research Council(Australian Research Council); Xstrata Copper Community Partnership Program North Queensland, Outback at Isa; Mount Isa City Council; Queensland Museum; University of New South Wales; Environment Australia; Queensland Department of Environment and Heritage; Phil Creaser; CREATE fund at UNSW	The Riversleigh Fossil Project is supported by the Australian Research Council (LP0989969, LP100200486, DP1094569), Xstrata Copper Community Partnership Program North Queensland, Outback at Isa, Mount Isa City Council, Queensland Museum, University of New South Wales, Environment Australia, Queensland Department of Environment and Heritage, and Phil Creaser and the CREATE fund at UNSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer M., 2006, ALCHERINGA AUSTRALAS, V30, P1, DOI DOI 10.1080/03115510609506851; Argot C, 2003, J MORPHOL, V255, P279, DOI 10.1002/jmor.10062; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Black K, 1999, AUST MAMMAL, V21, P16; Black K, 1999, AUST MAMMAL, V21, P34; Black K. H., ACTA PALAEO IN PRESS; Black K, 2007, ALCHERINGA, V31, P17, DOI 10.1080/03115510601123601; Black Karen, 1997, Memoirs of the Queensland Museum, V41, P181; Black Karen, 1997, Memoirs of the Queensland Museum, V41, P187; Black KH, 2012, J VERTEBR PALEONTOL, V32, P125, DOI 10.1080/02724634.2012.626825; Black KH, 2010, J VERTEBR PALEONTOL, V30, P993, DOI 10.1080/02724634.2010.483567; Black KH, 2010, AM MUS NOVIT, P1, DOI 10.1206/666.1; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; Camens AB, 2010, J MAMM EVOL, V17, P3, DOI 10.1007/s10914-009-9121-2; Candela AM, 2008, J MORPHOL, V269, P552, DOI 10.1002/jmor.10606; CARTMILL M, 1979, AM J PHYS ANTHROPOL, V50, P497, DOI 10.1002/ajpa.1330500402; Elftman HO, 1929, B AM MUS NAT HIST, V58, P189; Hand S. J., 1993, Memoirs of the Queensland Museum, V33, P193; Hildebrand M, 1974, ANAL VERTEBRATE STRU, VFirst; HUNT KD, 1991, AM J PHYS ANTHROPOL, V86, P521, DOI 10.1002/ajpa.1330860408; Jungers WL, 1997, P NATL ACAD SCI USA, V94, P11998, DOI 10.1073/pnas.94.22.11998; JUNGERS WL, 1978, AM J PHYS ANTHROPOL, V49, P303, DOI 10.1002/ajpa.1330490303; LANDRY STUART O., 1958, AMER MIDLAND NAT, V60, P100, DOI 10.2307/2422468; Lee A.K., 1989, P740; Lee AK, 1988, KOALA NATURAL HIST; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; MCEVOY J S, 1982, Bulletin of the American Museum of Natural History, V173, P337; Munson CJ, 1992, POSTCRANIAL DESCRIPT, pi; Murray P., 2000, MEMOIRS QUEEN VICTOR, V105, P1; Murray Peter, 2000, MAGNT Research Report, V6, P1; Napier J. R., 1961, Symposia of the Zoological Society of London, P115; Price GJ, 2008, ZOOL J LINN SOC-LOND, V153, P369, DOI 10.1111/j.1096-3642.2008.00387.x; Price GJ, 2009, J QUATERNARY SCI, V24, P1029, DOI 10.1002/jqs.1285; PROCTERGRAY E, 1986, J MAMMAL, V67, P343, DOI 10.2307/1380888; Salton Justine A., 2008, P51, DOI 10.1007/978-1-4020-6997-0_4; Stirling I., 1993, BEARS MAJESTIC CREAT; Stirton R. A., 1967, Bulletin Bureau of Mineral Resources Geology and Geophysics Australia, V85, P149; Szalay Frederick S., 1994, pi; TAYLOR ME, 1976, J MORPHOL, V148, P227, DOI 10.1002/jmor.1051480208; TAYLOR ME, 1974, J MORPHOL, V143, P307, DOI 10.1002/jmor.1051430305; Travouillon KJ, 2011, PALEOBIOLOGY, V37, P696, DOI 10.1666/09050.1; Warburton NM, 2011, J MORPHOL, V272, P1230, DOI 10.1002/jmor.10979; Weisbecker V, 2006, ZOOL J LINN SOC-LOND, V146, P369, DOI 10.1111/j.1096-3642.2006.00208.x; Weisbecker V, 2008, PALAEONTOLOGY, V51, P321, DOI 10.1111/j.1475-4983.2007.00750.x	45	18	20	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48213	10.1371/journal.pone.0048213	http://dx.doi.org/10.1371/journal.pone.0048213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185250	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000008
J	Gertz, M; Giang, TTN; Fischer, F; Suenkel, B; Schlicker, C; Franzel, B; Tomaschewski, J; Aladini, F; Becker, C; Wolters, D; Steegborn, C				Gertz, Melanie; Giang Thi Tuyet Nguyen; Fischer, Frank; Suenkel, Benjamin; Schlicker, Christine; Fraenzel, Benjamin; Tomaschewski, Jana; Aladini, Firouzeh; Becker, Christian; Wolters, Dirk; Steegborn, Clemens			A Molecular Mechanism for Direct Sirtuin Activation by Resveratrol	PLOS ONE			English	Article							STRUCTURAL BASIS; HISTONE DEACETYLASES; CALORIE RESTRICTION; DIFFRACTION DATA; INHIBITORS; SOFTWARE; INSIGHTS; SURVIVAL; TARGETS; NAD(+)	Sirtuins are protein deacetylases regulating metabolism, stress responses, and aging processes, and they were suggested to mediate the lifespan extending effect of a low calorie diet. Sirtuin activation by the polyphenol resveratrol can mimic such lifespan extending effects and alleviate metabolic diseases. The mechanism of Sirtuin stimulation is unknown, hindering the development of improved activators. Here we show that resveratrol inhibits human Sirt3 and stimulates Sirt5, in addition to Sirt1, against fluorophore-labeled peptide substrates but also against peptides and proteins lacking the non-physiological fluorophore modification. We further present crystal structures of Sirt3 and Sirt5 in complex with fluorogenic substrate peptide and modulator. The compound acts as a top cover, closing the Sirtuin's polypeptide binding pocket and influencing details of peptide binding by directly interacting with this substrate. Our results provide a mechanism for the direct activation of Sirtuins by small molecules and suggest that activators have to be tailored to a specific Sirtuin/substrate pair.	[Gertz, Melanie; Giang Thi Tuyet Nguyen; Fischer, Frank; Suenkel, Benjamin; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, Bayreuth, Germany; [Schlicker, Christine; Tomaschewski, Jana] Ruhr Univ Bochum, Dept Physiol Chem, Bochum, Germany; [Fraenzel, Benjamin; Wolters, Dirk] Ruhr Univ Bochum, Dept Analyt Chem, Bochum, Germany; [Aladini, Firouzeh; Becker, Christian] Univ Vienna, Inst Biol Chem, Vienna, Austria	University of Bayreuth; Ruhr University Bochum; Ruhr University Bochum; University of Vienna	Steegborn, C (corresponding author), Univ Bayreuth, Dept Biochem, Bayreuth, Germany.	Clemens.Steegborn@uni-bayreuth.de		Nguyen, Giang Thi Tuyet/0000-0002-3536-9903; Suenkel, Benjamin/0000-0001-9774-4492	FoRUM [F539-2007]; Deutsche Forschungsgemeinschaft [STE1701/5, WO1214/3]; German Research Foundation; University of Bayreuth	FoRUM; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); University of Bayreuth	This work was supported by FoRUM (grant F539-2007 to C.St.) and Deutsche Forschungsgemeinschaft (STE1701/5 to C. Steegborn, WO1214/3 to D. W.). This publication was funded by the German Research Foundation and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Cen Y, 2010, BBA-PROTEINS PROTEOM, V1804, P1635, DOI 10.1016/j.bbapap.2009.11.010; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Dudley JI, 2008, J AGR FOOD CHEM, V56, P9362, DOI 10.1021/jf801791d; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finnin MS, 2001, NAT STRUCT BIOL, V8, P621, DOI 10.1038/89668; Fischer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045098; Gertz M, 2009, BIOCHIM BIOPHYS ACTA, V1804, P1658; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Heitweg B, 2003, ANAL BIOCHEM, V319, P42, DOI 10.1016/S0003-2697(03)00276-8; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Mahlknecht U, 2006, CYTOGENET GENOME RES, V112, P208, DOI 10.1159/000089872; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moniot S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00016; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Neugebauer RC, 2008, CURR PHARM DESIGN, V14, P562; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Sanders BD, 2007, MOL CELL, V25, P463, DOI 10.1016/j.molcel.2006.12.022; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schlicker C, 2011, AGING-US, V3, P852, DOI 10.18632/aging.100388; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Trapp J, 2006, J MED CHEM, V49, P7307, DOI 10.1021/jm060118b; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang HY, 2007, AGING CELL, V6, P35, DOI 10.1111/j.1474-9726.2006.00259.x; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Zhao KH, 2004, P NATL ACAD SCI USA, V101, P8563, DOI 10.1073/pnas.0401057101	62	174	179	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49761	10.1371/journal.pone.0049761	http://dx.doi.org/10.1371/journal.pone.0049761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185430	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000103
J	Monras, JP; Diaz, V; Bravo, D; Montes, RA; Chasteen, TG; Osorio-Roman, IO; Vasquez, CC; Perez-Donoso, JM				Monras, Juan P.; Diaz, Victor; Bravo, Denisse; Montes, Rebecca A.; Chasteen, Thomas G.; Osorio-Roman, Igor O.; Vasquez, Claudio C.; Perez-Donoso, Jose M.			Enhanced Glutathione Content Allows the In Vivo Synthesis of Fluorescent CdTe Nanoparticles by Escherichia coli	PLOS ONE			English	Article							ONE-POT SYNTHESIS; QUANTUM DOTS; MAGNETOTACTIC BACTERIA; METAL NANOPARTICLES; MICROBIAL SYNTHESIS; CDS NANOCRYSTALS; BIOSYNTHESIS; TELLURITE; CELL; LUMINESCENT	The vast application of fluorescent semiconductor nanoparticles (NPs) or quantum dots (QDs) has prompted the development of new, cheap and safer methods that allow generating QDs with improved biocompatibility. In this context, green or biological QDs production represents a still unexplored area. This work reports the intracellular CdTe QDs biosynthesis in bacteria. Escherichia coli overexpressing the gshA gene, involved in glutathione (GSH) biosynthesis, was used to produce CdTe QDs. Cells exhibited higher reduced thiols, GSH and Cd/Te contents that allow generating fluorescent intracellular NP-like structures when exposed to CdCl2 and K2TeO3. Fluorescence microscopy revealed that QDs-producing cells accumulate defined structures of various colors, suggesting the production of differently-sized NPs. Purified fluorescent NPs exhibited structural and spectroscopic properties characteristic of CdTe QDs, as size and absorption/emission spectra. Elemental analysis confirmed that biosynthesized QDs were formed by Cd and Te with Cd/Te ratios expected for CdTe QDs. Finally, fluorescent properties of QDs-producing cells, such as color and intensity, were improved by temperature control and the use of reducing buffers.	[Monras, Juan P.; Diaz, Victor; Perez-Donoso, Jose M.] Univ Chile, Microbiol & Bionanotechnol Res Grp, Lab Bioquim, Dept Bioquim & Biol Mol,Fac Ciencias Quim & Farma, Santiago, Chile; [Monras, Juan P.; Diaz, Victor; Vasquez, Claudio C.; Perez-Donoso, Jose M.] Univ Santiago Chile, Lab Microbiol Mol, Dept Biol, Santiago, Chile; [Bravo, Denisse] Univ Chile, Microbiol Lab, Fac Odontol, Santiago, Chile; [Montes, Rebecca A.; Chasteen, Thomas G.] Sam Houston State Univ, Dept Chem, Huntsville, TX 77340 USA; [Osorio-Roman, Igor O.] Pontificia Univ Catolica Chile, Dept Quim Inorgan, Santiago, Chile; [Monras, Juan P.] Univ Andres Bello, Dept Ciencias Biol, Santiago, Chile	Universidad de Chile; Universidad de Santiago de Chile; Universidad de Chile; Texas State University System; Sam Houston State University; Pontificia Universidad Catolica de Chile; Universidad Andres Bello	Perez-Donoso, JM (corresponding author), Univ Chile, Microbiol & Bionanotechnol Res Grp, Lab Bioquim, Dept Bioquim & Biol Mol,Fac Ciencias Quim & Farma, Santiago, Chile.	jose.perez@ciq.uchile.cl	Chasteen, Thomas G/B-6601-2009; Osorio, Igor/AEX-9230-2022; Pérez-Donoso, José M./G-3668-2013; Osorio, Igor/E-1083-2016	Pérez-Donoso, José M./0000-0002-9506-1716; Osorio, Igor/0000-0001-7502-8698	FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica) [1090097, 11110076, 11100067, 11110077]; Dicyt-USACH (Direccion de Investigacion-Universidad de Santiago de Chile) [021043PD]; IFS (International Foundation for Science, Sweden) [F/4733]; Welch Foundation [X-011]; CONICYT (Comision Nacional de Ciencia y Tecnologia)	FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Dicyt-USACH (Direccion de Investigacion-Universidad de Santiago de Chile); IFS (International Foundation for Science, Sweden)(International Foundation for Science); Welch Foundation(The Welch Foundation); CONICYT (Comision Nacional de Ciencia y Tecnologia)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT (Fondo Nacional de Investigacion Cientifica y Tecnologica) grants # 1090097 (CCV), # 11110076 (D. B.), # 11100067 (IOO) and # 11110077 (JMP). Dicyt-USACH (Direccion de Investigacion-Universidad de Santiago de Chile) # 021043PD and IFS (International Foundation for Science, Sweden) # F/4733 grants to JMP, grant # X-011 from the Welch Foundation to TGC and RAM, and a doctoral fellowship from CONICYT (Comision Nacional de Ciencia y Tecnologia) to JPM are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2003, NANOTECHNOLOGY, V14, P824, DOI 10.1088/0957-4484/14/7/323; Allen S, 2001, METHODS CELL SCI, V22, P305; Araya MA, 2004, J BIOL INORG CHEM, V9, P609, DOI 10.1007/s00775-004-0554-z; Avazeri C, 1997, MICROBIOL-SGM, V143, P1181, DOI 10.1099/00221287-143-4-1181; Azzazy HME, 2007, CLIN BIOCHEM, V40, P917, DOI 10.1016/j.clinbiochem.2007.05.018; Bang JH, 2009, ACS NANO, V3, P1467, DOI 10.1021/nn900324q; Bao HF, 2010, ACTA BIOMATER, V6, P3534, DOI 10.1016/j.actbio.2010.03.030; Bao HF, 2010, NANO RES, V3, P481, DOI 10.1007/s12274-010-0008-6; Bao HF, 2006, SMALL, V2, P476, DOI 10.1002/smll.200500346; Bharde AA, 2008, LANGMUIR, V24, P5787, DOI 10.1021/la704019p; Calderon IL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000070; Castro ME, 2009, BIOCHEM BIOPH RES CO, V380, P148, DOI 10.1016/j.bbrc.2009.01.078; Chasteen TG, 2009, FEMS MICROBIOL REV, V33, P820, DOI 10.1111/j.1574-6976.2009.00177.x; Cui R, 2009, ADV FUNCT MATER, V19, P2359, DOI 10.1002/adfm.200801492; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k; GUSHIMA H, 1984, NUCLEIC ACIDS RES, V12, P9299, DOI 10.1093/nar/12.24.9299; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Hoshino A, 2007, J ARTIF ORGANS, V10, P149, DOI 10.1007/s10047-007-0379-y; Kang SH, 2008, ANGEW CHEM INT EDIT, V47, P5186, DOI 10.1002/anie.200705806; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Kowshik M, 2002, BIOTECHNOL BIOENG, V78, P583, DOI 10.1002/bit.10233; Kumar SA, 2007, J BIOMED NANOTECHNOL, V3, P190, DOI 10.1166/jbn.2007.027; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; Liu YF, 2006, J PHYS CHEM B, V110, P16992, DOI 10.1021/jp063085k; Mandal A, 2008, J PHYS CHEM C, V112, P8244, DOI 10.1021/jp801043e; Mandal D, 2006, APPL MICROBIOL BIOT, V69, P485, DOI 10.1007/s00253-005-0179-3; Matsunaga T, 2007, TRENDS BIOTECHNOL, V25, P182, DOI 10.1016/j.tibtech.2007.02.002; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Mi CC, 2011, J BIOTECHNOL, V153, P125, DOI 10.1016/j.jbiotec.2011.03.014; MURATA K, 1982, APPL ENVIRON MICROB, V44, P1444, DOI 10.1128/AEM.44.6.1444-1448.1982; Park TJ, 2010, ANGEW CHEM INT EDIT, V49, P7019, DOI 10.1002/anie.201001524; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Perez JM, 2006, BIOL RES, V39, P661, DOI 10.4067/S0716-97602006000500009; Perez-Donoso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030741; Qian HF, 2006, SMALL, V2, P747, DOI 10.1002/smll.200500530; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schneider R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225101; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152; Sweeney RY, 2004, CHEM BIOL, V11, P1553, DOI 10.1016/j.chembiol.2004.08.022; Tian JN, 2009, J COLLOID INTERF SCI, V336, P504, DOI 10.1016/j.jcis.2009.04.064; Turner RJ, 1999, MICROBIOL-UK, V145, P2549, DOI 10.1099/00221287-145-9-2549; Ying E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002222; Zheng YG, 2007, ADV MATER, V19, P376, DOI 10.1002/adma.200600342	49	53	55	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48657	10.1371/journal.pone.0048657	http://dx.doi.org/10.1371/journal.pone.0048657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185270	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000018
J	Pareja-Tobes, P; Manrique, M; Pareja-Tobes, E; Pareja, E; Tobes, R				Pareja-Tobes, Pablo; Manrique, Marina; Pareja-Tobes, Eduardo; Pareja, Eduardo; Tobes, Raquel			BG7: A New Approach for Bacterial Genome Annotation Designed for Next Generation Sequencing Data	PLOS ONE			English	Article							STANDARD OPERATING PROCEDURE; WEB SERVER	BG7 is a new system for de novo bacterial, archaeal and viral genome annotation based on a new approach specifically designed for annotating genomes sequenced with next generation sequencing technologies. The system is versatile and able to annotate genes even in the step of preliminary assembly of the genome. It is especially efficient detecting unexpected genes horizontally acquired from bacterial or archaeal distant genomes, phages, plasmids, and mobile elements. From the initial phases of the gene annotation process, BG7 exploits the massive availability of annotated protein sequences in databases. BG7 predicts ORFs and infers their function based on protein similarity with a wide set of reference proteins, integrating ORF prediction and functional annotation phases in just one step. BG7 is especially tolerant to sequencing errors in start and stop codons, to frameshifts, and to assembly or scaffolding errors. The system is also tolerant to the high level of gene fragmentation which is frequently found in not fully assembled genomes. BG7 current version which is developed in Java, takes advantage of Amazon Web Services (AWS) cloud computing features, but it can also be run locally in any operating system. BG7 is a fast, automated and scalable system that can cope with the challenge of analyzing the huge amount of genomes that are being sequenced with NGS technologies. Its capabilities and efficiency were demonstrated in the 2011 EHEC Germany outbreak in which BG7 was used to get the first annotations right the next day after the first entero-hemorrhagic E. coli genome sequences were made publicly available. The suitability of BG7 for genome annotation has been proved for Illumina, 454, Ion Torrent, and PacBio sequencing technologies. Besides, thanks to its plasticity, our system could be very easily adapted to work with new technologies in the future.	[Pareja-Tobes, Pablo; Manrique, Marina; Pareja-Tobes, Eduardo; Pareja, Eduardo; Tobes, Raquel] Oh Sequences Res Grp, Bioinformat Era7, Granada, Spain		Tobes, R (corresponding author), Oh Sequences Res Grp, Bioinformat Era7, Granada, Spain.	rtobes@era7.com	Manrique, Marina/GYQ-5538-2022	Tobes, Raquel/0000-0001-7032-8720	Agencia de Innovacion y Desarrollo de Andalucia [PID 1465]; Spanish Ministerio de Ciencia e Innovacion [IPT-2011-0735-010000]	Agencia de Innovacion y Desarrollo de Andalucia; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work has been partially funded by the PID 1465 project of the Agencia de Innovacion y Desarrollo de Andalucia and by Grant "brachVac" IPT-2011-0735-010000 from Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Fusaro VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002147; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Hemmerich C, 2010, BIOINFORMATICS, V26, P1122, DOI 10.1093/bioinformatics/btq090; Kumar K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017469; Lee D, 2009, BIOSCI BIOTECH BIOCH, V73, P213, DOI 10.1271/bbb.80567; Manrique M, 2011, NATURE PRECEDINGS; Mavromatis K, 2009, STAND GENOMIC SCI, V1, P63, DOI 10.4056/sigs.632; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593	20	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49239	10.1371/journal.pone.0049239	http://dx.doi.org/10.1371/journal.pone.0049239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185310	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000036
J	Telford, RD; Cunningham, RB; Telford, RM; Riley, M; Abhayaratna, WP				Telford, Richard D.; Cunningham, Ross B.; Telford, Rohan M.; Riley, Malcolm; Abhayaratna, Walter P.			Determinants of Childhood Adiposity: Evidence from the Australian LOOK Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; FAT INTAKE; ENERGY-EXPENDITURE; BODY FATNESS; CHILDREN; OVERWEIGHT; OBESITY; HEALTH; BOYS	Background: To contribute to the current debate as to the relative influences of dietary intake and physical activity on the development of adiposity in community-based children. Methods: Participants were 734 boys and girls measured at age 8, 10 and 12 years for percent body fat (dual emission x-ray absorptiometry), physical activity (pedometers, accelerometers); and dietary intake (1 and 2-day records), with assessments of pubertal development and socioeconomic status. Results: Cross-sectional relationships revealed that boys and girls with higher percent body fat were less physically active, both in terms of steps per day and moderate and vigorous physical activity (both sexes p<0.001 for both measures). However, fatter children did not consume more energy, fat, carbohydrate or sugar; boys with higher percent body fat actually consumed less carbohydrate (p = 0.01) and energy (p = 0.05). Longitudinal analysis (combined data from both sexes) was weaker, but supported the cross-sectional findings, showing that children who reduced their PA over the four years increased their percent body fat (p = 0.04). Relationships in the 8 year-olds and also in the leanest quartile of all children, where adiposity-related underreporting was unlikely, were consistent with those of the whole group, indicating that underreporting did not influence our findings. Conclusions: These data provide support for the premise that physical activity is the main source of variation in the percent body fat of healthy community-based Australian children. General community strategies involving dietary intake and physical activity to combat childhood obesity may benefit by making physical activity the foremost focus of attention.	[Telford, Richard D.; Abhayaratna, Walter P.] Australian Natl Univ, Coll Med Biol & Environm, Canberra, ACT, Australia; [Telford, Richard D.; Abhayaratna, Walter P.] Canberra Hosp, Acad Unit Internal Med, Canberra, ACT, Australia; [Cunningham, Ross B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Telford, Rohan M.] Univ Canberra, Ctr Res & Act Publ Hlth, Canberra, ACT 2601, Australia; [Riley, Malcolm] Commonwealth Sci & Ind Res Org, Div Food & Nutr Sci, Melbourne, Vic, Australia	Australian National University; Australian National University; Canberra Hospital; Australian National University; University of Canberra; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Telford, RD (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Canberra, ACT, Australia.	rtelford@cominst.org.au	Riley, Malcolm/B-5296-2011	Riley, Malcolm/0000-0003-3040-8616; Abhayaratna, Walter/0000-0002-4908-0641; Telford, Richard/0000-0003-4485-9362; Telford, Rohan/0000-0002-1723-2559	Commonwealth Education Trust (London, UK); Canberra Hospital Salaried Staff Specialists Private Practice Fund	Commonwealth Education Trust (London, UK); Canberra Hospital Salaried Staff Specialists Private Practice Fund	The financial support provided by the Commonwealth Education Trust (London, UK) was vital to the completion of this work, and the authors thank the Board of Trustees for supporting them over several years. The authors also thank members of The Canberra Hospital Salaried Staff Specialists Private Practice Fund for their financial contribution to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics website, AUSTR BUR STAT INF P; Bleich SN, 2010, INT J OBES LOND, V35, P1; Brixval CS, 2009, OBESITY FACTS, V2, P166, DOI 10.1159/000219134; Butte NF, 2007, OBESITY, V15, P3056, DOI 10.1038/oby.2007.364; Chaput JP, 2011, J OBES, V2011, DOI 10.1155/2011/360257; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Commonwealth Scientific Industrial Research Organisation (CSIRO) Preventative Health National Research Flagship and the University of South Australia, 2008, 2007 AUSTR NAT CHILD; DeLany JP, 2004, AM J CLIN NUTR, V79, P268; DUKE PM, 1980, PEDIATRICS, V66, P918; Ekelund U, 2004, AM J CLIN NUTR, V80, P584; Fulton JE, 2009, AM J PREV MED, V37, pS40, DOI 10.1016/j.amepre.2009.04.010; Galway NW, 2006, INTRO MIXED MODELLIN, P1; GAZZANIGA JM, 1993, AM J CLIN NUTR, V58, P21, DOI 10.1093/ajcn/58.1.21; Gutin B, 2010, INT J OBES LOND, V35, P29; Hands B, 2003, READ H RESULTS CHILD; Katz DL, 2011, INT J OBESITY, V35, P33, DOI 10.1038/ijo.2010.218; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Maffeis C, 1996, INT J OBESITY, V20, P170; Ness AR, 2007, PLOS MED, V4, P476, DOI 10.1371/journal.pmed.0040097; Nicklas TA, 2011, NUTR RES, V31, P338, DOI 10.1016/j.nutres.2011.03.014; Parikh T, 2011, SPORTS MED, V41, P477, DOI 10.2165/11588750-000000000-00000; Plachta-Danielzik S, 2010, PUBLIC HEALTH NUTR, V13, P1870, DOI 10.1017/S1368980010000583; Popkin BM, 2011, P NUTR SOC, V70, P82, DOI 10.1017/S0029665110003903; Rangan AM, 2011, NUTRIENTS, V3, P186, DOI 10.3390/nu3020186; Ricketts CD, 1997, EUR J CLIN NUTR, V51, P778, DOI 10.1038/sj.ejcn.1600487; Rolland-Cachera MF, 2001, OBESE OVERWEIGHT CHI, P69; Ruxton CHS, 2010, CRIT REV FOOD SCI, V50, P1, DOI 10.1080/10408390802248569; Sanigorski AM, 2007, PUBLIC HEALTH NUTR, V10, P152, DOI 10.1017/S1368980007246634; Tanner JM, 1962, GROWTH ADOLESCENCE, P1; Telford RD, 2008, ANN HUM BIOL, V35, P334, DOI 10.1080/03014460802014625; Telford RD, 2012, AM J PUBLIC HEALTH, V102, P368, DOI 10.2105/AJPH.2011.300220; Telford RD, 2009, ANN HUM BIOL, V36, P669, DOI 10.3109/03014460902960271; Telford RD, 2009, PEDIATR DIABETES, V10, P500, DOI 10.1111/j.1399-5448.2009.00513.x; Telford RD, 2009, J SCI MED SPORT, V12, P156, DOI 10.1016/j.jsams.2007.03.009; Trost SG, 2003, INT J OBESITY, V27, P834, DOI 10.1038/sj.ijo.0802311; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Woodward-Lopez G, 2011, PUBLIC HEALTH NUTR, V14, P499, DOI 10.1017/S1368980010002375	38	20	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50014	10.1371/journal.pone.0050014	http://dx.doi.org/10.1371/journal.pone.0050014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185519	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000166
J	Yuan, YY; Guo, WW; Tang, J; Zhang, GZ; Wang, GJ; Han, MY; Zhang, X; Yang, SM; He, DZZ; Dai, P				Yuan, Yongyi; Guo, Weiwei; Tang, Jie; Zhang, Guozheng; Wang, Guojian; Han, Mingyu; Zhang, Xun; Yang, Shiming; He, David Z. Z.; Dai, Pu			Molecular Epidemiology and Functional Assessment of Novel Allelic Variants of SLC26A4 in Non-Syndromic Hearing Loss Patients with Enlarged Vestibular Aqueduct in China	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; GENOTYPE-PHENOTYPE CORRELATION; PENDRED-SYNDROME; MUTATION SPECTRUM; ANION TRANSPORTER; UNIQUE SPECTRUM; INNER-EAR; WILD-TYPE; PDS GENE; IMPAIRMENT	Background: Mutations in SLC26A4, which encodes pendrin, are a common cause of deafness. SLC26A4 mutations are responsible for Pendred syndrome and non-syndromic enlarged vestibular aqueduct (EVA). The mutation spectrum of SLC26A4 varies widely among ethnic groups. To investigate the incidence of EVA in Chinese population and to provide appropriate genetic testing and counseling to patients with SLC26A4 variants, we conducted a large-scale molecular epidemiological survey of SLC26A4. Methods: A total of 2352 unrelated non-syndromic hearing loss patients from 27 different regions of China were included. Hot spot regions of SLC26A4, exons 8, 10 and 19 were sequenced. For patients with one allelic variant in the hot spot regions, the other exons were sequenced one by one until two mutant alleles had been identified. Patients with SLC26A4 variants were then examined by temporal bone computed tomography scan for radiological diagnosis of EVA. Ten SLC26A4 variants were cloned for functional study. Confocal microscopy and radioisotope techniques were used to examine the membrane expression of pendrin and transporter function. Results: Of the 86 types of variants found, 47 have never been reported. The ratio of EVA in the Chinese deaf population was at least 11%, and that in patients of Han ethnicity reached at least 13%. The mutational spectrum and mutation detection rate of SLC26A4 are distinct among both ethnicities and regions of Mainland China. Most of the variants caused retention of pendrin in the intracellular region. All the mutant pendrins showed significantly reduced transport capability. Conclusion: An overall description of the molecular epidemiological findings of SLC26A4 in China is provided. The functional assessment procedure can be applied to identification of pathogenicity of variants. These findings are valuable for genetic diagnosis, genetic counseling, prenatal testing and pre-implantation diagnosis in EVA families.	[Yuan, Yongyi; Guo, Weiwei; Wang, Guojian; Han, Mingyu; Yang, Shiming; Dai, Pu] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Tang, Jie; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Zhang, Guozheng; Zhang, Xun] Hebei Med Univ, Hosp 3, Dept Otolaryngol, Shijiazhuang, Hebei Province, Peoples R China; [Yuan, Yongyi; Wang, Guojian; Han, Mingyu; Dai, Pu] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otolaryngol, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital; Creighton University; Hebei Medical University; Chinese People's Liberation Army General Hospital	Yang, SM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China.	yangsm301@263.net; davidhe@creighton.edu; daipu301@vip.sina.com	Tang, Jie/GNW-2318-2022	Tang, Jie/0000-0001-7882-4462; Yuan, Yongyi/0000-0002-7936-4776; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	Chinese National Nature Science Foundation [30728030, 31071109, 81230020]; State 863 High Technology Research & Development Key Project of China [SQ2010AA0221634001]; Minister of Science and Technology [2012BAI09B02]; National Basic Research Program of China (973 Program) [2012CB967900, 2012CB967901, 2011CBA01000]; Chinese National Nature Science Foundation Research Grant [30801285, 81000415]; Beijing Nova programme [2009B34, 2010B081]; National Institutes of Health, National Institute on Deafness and Other Communication Disorders [R01 DC 004696]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); State 863 High Technology Research & Development Key Project of China; Minister of Science and Technology; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Nature Science Foundation Research Grant; Beijing Nova programme(Beijing Municipal Science & Technology Commission); National Institutes of Health, National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Chinese National Nature Science Foundation Research Grant (30728030,31071109,81230020), State 863 High Technology Research & Development Key Project of China(SQ2010AA0221634001) and grant from the Minister of Science and Technology (2012BAI09B02) to PD, the National Basic Research Program of China (973 Program) (#2012CB967900, #2012CB967901, 2011CBA01000) to SY. Chinese National Nature Science Foundation Research Grant (30801285) and Beijing Nova programme (2009B34) to YY, Chinese National Nature Science Foundation Research Grant (81000415) and Beijing Nova programme (2010B081) to GW, National Institutes of Health grant R01 DC 004696 from the National Institute on Deafness and Other Communication Disorders to JT and DZZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Blons H, 2004, CLIN GENET, V66, P333, DOI 10.1111/j.1399-0004.2004.00296.x; Campbell C, 2001, HUM MUTAT, V17, P403, DOI 10.1002/humu.1116; Chang E, MUTATION LOCATION SL; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Dai P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-74; Dai P, 2009, PHYSIOL GENOMICS, V38, P281, DOI 10.1152/physiolgenomics.00047.2009; Davis N, 2006, HORM RES, V65, P267, DOI 10.1159/000092513; Dossena S, 2006, CELL PHYSIOL BIOCHEM, V17, P245, DOI 10.1159/000094137; Dossena S, 2011, CELL PHYSIOL BIOCHEM, V28, P477, DOI 10.1159/000335109; Dossena S, 2009, J MOL ENDOCRINOL, V43, P93, DOI 10.1677/JME-08-0175; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Fugazzola L, 2002, PEDIATR RES, V51, P479, DOI 10.1203/00006450-200204000-00013; Fugazzola L, 2000, J CLIN ENDOCR METAB, V85, P2469, DOI 10.1210/jc.85.7.2469; Kara Cengiz, 2010, J Clin Res Pediatr Endocrinol, V2, P81, DOI 10.4274/jcrpe.v2i2.81; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Lai CC, 2007, METABOLISM, V56, P1279, DOI 10.1016/j.metabol.2007.05.013; Lopez-Bigas N, 2001, Hum Mutat, V18, P548, DOI 10.1002/humu.1238; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; Pfarr N, 2006, J CLIN ENDOCR METAB, V91, P2678, DOI 10.1210/jc.2006-0142; Phelps PD, 1998, CLIN RADIOL, V53, P268, DOI 10.1016/S0009-9260(98)80125-6; Prasad S, 2004, AM J MED GENET A, V124A, P1, DOI 10.1002/ajmg.a.20272; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Rotman-Pikielny P, 2002, HUM MOL GENET, V11, P2625, DOI 10.1093/hmg/11.21.2625; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Tang J, 2011, J BIOL CHEM, V286, P31014, DOI 10.1074/jbc.M111.259564; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; VALVASSORI GE, 1978, LARYNGOSCOPE, V88, P723; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wu CC, 2005, LARYNGOSCOPE, V115, P1060, DOI 10.1097/01.MLG.0000163339.61909.D0; Xu DR, 2011, J TRANSL MED, V9, DOI [10.1186/1479-5876-9-167, 10.1186/1479-5876-9-74]; Yoon JS, 2008, J MED GENET, V45, P411, DOI 10.1136/jmg.2007.054635; Yoshida A, 2004, ENDOCRINOLOGY, V145, P4301, DOI 10.1210/en.2004-0048; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030720; [袁永一 Yuan Yongyi], 2010, [中华耳科学杂志, Chinese Journal of Otology], V8, P292; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Zhao Juan, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P21, DOI 10.3760/cma.j.issn.1003-9406.2009.01.005	45	44	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49984	10.1371/journal.pone.0049984	http://dx.doi.org/10.1371/journal.pone.0049984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185506	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000157
J	Barro-Soria, R; Stindl, J; Muller, C; Foeckler, R; Todorov, V; Castrop, H; Strauss, O				Barro-Soria, Rene; Stindl, Julia; Mueller, Claudia; Foeckler, Renate; Todorov, Vladimir; Castrop, Hayo; Strauss, Olaf			Angiotensin-2-Mediated Ca2+ Signaling in the Retinal Pigment Epithelium: Role of Angiotensin-Receptor-Associated-Protein and TRPV2 Channel	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; II TYPE-1 RECEPTOR; CONVERTING ENZYME; PHYSICAL STIMULI; RENIN SECRETION; CALCIUM-ENTRY; RAT RETINA; ACTIVATION; EXPRESSION; NEOVASCULARIZATION	Angiotensin II (AngII) receptor (ATR) is involved in pathologic local events such as neovascularisation and inflammation including in the brain and retina. The retinal pigment epithelium (RPE) expresses ATR in its AT1R form, angiotensin-receptor-associated protein (Atrap), and transient-receptor-potential channel-V2 (TRPV2). AT1R and Atrap co-localize to the basolateral membrane of the RPE, as shown by immunostaining. Stimulation of porcine RPE (pRPE) cells by AngII results in biphasic increases in intracellular free Ca2+ inhibited by losartan. Xestospongin C (xest C) and U-73122, blockers of IP3R and PLC respectively, reduced AngII-evoked Ca2+ response. RPE cells from Atrap(-/-) mice showed smaller AngII-evoked Ca2+ peak (by 22%) and loss of sustained Ca2+ elevation compared to wild-type. The TRPV channel activator cannabidiol (CBD) at 15 mu M stimulates intracellular Ca2+-rise suggesting that porcine RPE cells express TRPV2 channels. Further evidence supporting the functional expression of TRPV2 channels comes from experiments in which 100 mu M SKF96365 (a TRPV channel inhibitor) reduced the cannabidiol-induced Ca2+-rise. Application of SKF96365 or reduction of TRPV2 expression by siRNA reduced the sustained phase of AngII-mediated Ca2+ transients by 53%. Thus systemic AngII, an effector of the local renin-angiotensin system stimulates biphasic Ca2+ transients in the RPE by releasing Ca2+ from cytosolic IP3-dependent stores and activating ATR/Atrap and TRPV2 channels to generate a sustained Ca2+ elevation.	[Barro-Soria, Rene; Stindl, Julia; Mueller, Claudia; Foeckler, Renate; Strauss, Olaf] Univ Med Ctr Regensburg, Hosp Eye, Regensburg, Germany; [Todorov, Vladimir] Tech Univ Dresden, Lab Expt Nephrol, Dresden, Germany; [Todorov, Vladimir; Castrop, Hayo] Univ Regensburg, Inst Physiol, Regensburg, Germany	University of Regensburg; Technische Universitat Dresden; University of Regensburg	Strauss, O (corresponding author), Univ Med Ctr Regensburg, Hosp Eye, Regensburg, Germany.	Olaf.Strauss@klinik.uni-regensburg.de	Strauss, Olaf/AAA-6485-2019	Strauss, Olaf/0000-0002-6272-8596; Todorov, Vladimir/0000-0002-7011-8130	Deutsche Forschungsgemeinschaft [SFB 699, DFG SFB699]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft SFB 699, TPB8 ProRetina PhD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.''; The authors want to acknowledge the technical assistance of Elfriede Eckert and Andrea Dannullis. We also acknowledge the expert technical assistance of Uwe DeVries for his help with the confocal microscope. We thank Prof. Dr. Kenneth J. Muller for comments and suggestions on the manuscript. The work was supported by the Deutsche Forschungsgemeinschaft grant (DFG SFB699 project B8). There are no commercial interests or conflicts of interest.	BERKA JL, 1995, INVEST OPHTH VIS SCI, V36, P1450; Boels K, 2001, J CELL SCI, V114, P3599; Campos AC, 2009, PROG NEURO-PSYCHOPH, V33, P1517, DOI 10.1016/j.pnpbp.2009.08.017; Chen LM, 2007, AM J PHYSIOL-RENAL, V292, pF27, DOI 10.1152/ajprenal.00193.2006; Cordeiro S, 2010, INVEST OPHTH VIS SCI, V51, P6001, DOI 10.1167/iovs.09-4720; DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; De Petrocellis L, 2012, ACTA PHYSIOL, V204, P255, DOI 10.1111/j.1748-1716.2011.02338.x; Deliyanti D, 2012, HYPERTENSION, V59, P607, DOI 10.1161/HYPERTENSIONAHA.111.188136; Downie LE, 2009, NEUROSCIENCE, V161, P195, DOI 10.1016/j.neuroscience.2009.02.084; Downie LE, 2008, GLIA, V56, P1076, DOI 10.1002/glia.20680; Fellner SK, 2005, AM J PHYSIOL-RENAL, V288, pF785, DOI 10.1152/ajprenal.00372.2004; Fletcher EL, 2010, PROG RETIN EYE RES, V29, P284, DOI 10.1016/j.preteyeres.2010.03.003; Fuller AJ, 2005, AM J PHYSIOL-RENAL, V289, pF760, DOI 10.1152/ajprenal.00422.2004; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guenther E, 1996, BRAIN RES, V718, P112, DOI 10.1016/0006-8993(96)00077-7; Hegde VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018281; JACOBI PC, 1994, INVEST OPHTH VIS SCI, V35, P973; Jurklies B, 1995, Ger J Ophthalmol, V4, P144; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kennedy BG, 2010, MOL VIS, V16, P665; Kress M, 2008, HISTOCHEM CELL BIOL, V130, P655, DOI 10.1007/s00418-008-0477-9; LASSEGUE B, 1993, BIOCHEM J, V292, P509, DOI 10.1042/bj2920509; Lopez-Ilasaca M, 2003, MOL BIOL CELL, V14, P5038, DOI 10.1091/mbc.E03-06-0383; LUCKHOFF A, 1994, BIOPHYS J, V67, P177, DOI 10.1016/S0006-3495(94)80467-9; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Milenkovic VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019364; Milenkovic VM, 2010, AM J PHYSIOL-RENAL, V299, pF396, DOI 10.1152/ajprenal.00576.2009; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Moravski CJ, 2000, HYPERTENSION, V36, P1099, DOI 10.1161/01.HYP.36.6.1099; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P1078, DOI 10.1167/iovs.04-1101; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P2321, DOI 10.1167/iovs.06-1296; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Neussert R, 2010, PFLUG ARCH EUR J PHY, V460, P163, DOI 10.1007/s00424-010-0840-2; Oppermann M, 2010, J AM SOC NEPHROL, V21, P468, DOI 10.1681/ASN.2009060658; Praddaude F, 2009, EXP EYE RES, V89, P109, DOI 10.1016/j.exer.2009.02.020; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Qin N, 2008, J NEUROSCI, V28, P6231, DOI 10.1523/JNEUROSCI.0504-08.2008; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rong P, 2001, MOL CELL ENDOCRINOL, V173, P203, DOI 10.1016/S0303-7207(00)00406-8; Ruan XP, 1996, AM J PHYSIOL-RENAL, V270, pF398, DOI 10.1152/ajprenal.1996.270.3.F398; Sarlos S, 2003, AM J PATHOL, V163, P879, DOI 10.1016/S0002-9440(10)63448-7; Schweda F, 2000, AM J PHYSIOL-RENAL, V279, pF170, DOI 10.1152/ajprenal.2000.279.1.F170; Schweda F, 2007, PHYSIOLOGY, V22, P310, DOI 10.1152/physiol.00024.2007; Senanayake PD, 2007, INVEST OPHTH VIS SCI, V48, P3301, DOI 10.1167/iovs.06-1024; Stokes AJ, 2004, J EXP MED, V200, P137, DOI 10.1084/jem.20032082; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Striker GE, 2008, AM J PHYSIOL-CELL PH, V295, pC1633, DOI 10.1152/ajpcell.00092.2008; Tanaka Y, 2005, FEBS LETT, V579, P1579, DOI 10.1016/j.febslet.2005.01.068; van Leeuwen R, 2003, EUR J EPIDEMIOL, V18, P845, DOI 10.1023/A:1025643303914; Verma A, 2012, MOL THER, V20, P28, DOI 10.1038/mt.2011.155; Wagner J, 1996, BRIT J OPHTHALMOL, V80, P159, DOI 10.1136/bjo.80.2.159; Wilkinson-Berka JL, 2010, HYPERTENSION, V55, P1454, DOI 10.1161/HYPERTENSIONAHA.109.148221; Wilkinson-Berka JL, 2007, AM J HYPERTENS, V20, P423, DOI 10.1016/j.amjhyper.2006.09.018; Wilkinson-Berka JL, 2002, MOL CELL ENDOCRINOL, V194, P201, DOI 10.1016/S0303-7207(02)00217-4; Wimmers S, 2007, INVEST OPHTH VIS SCI, V48, P5767, DOI 10.1167/iovs.07-0412; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; Zanou N, 2009, FEBS LETT, V583, P3600, DOI 10.1016/j.febslet.2009.10.033; Zhang D, 2012, PHYSIOL RES, V61, P113, DOI 10.33549/physiolres.932053; Zhang ZZ, 2011, HIPPOCAMPUS, V21, P386, DOI 10.1002/hipo.20755; Zhao HA, 2010, ENDOCRINOLOGY, V151, P5237, DOI 10.1210/en.2010-0504	61	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49624	10.1371/journal.pone.0049624	http://dx.doi.org/10.1371/journal.pone.0049624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185387	gold, Green Submitted, Green Published			2022-12-25	WOS:000311535700046
J	Dahlke, C; Maul, K; Christalla, T; Walz, N; Schult, P; Stocking, C; Grundhoff, A				Dahlke, Christine; Maul, Katrin; Christalla, Thomas; Walz, Nicole; Schult, Philipp; Stocking, Carol; Grundhoff, Adam			A microRNA Encoded by Kaposi Sarcoma-Associated Herpesvirus Promotes B-Cell Expansion In Vivo	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; DNA-SEQUENCES; C-MYB; DIFFERENTIAL EXPRESSION; HEMATOPOIETIC STEM; NUCLEAR ANTIGEN; V-FLIP; MIR-155; GENE; IDENTIFICATION	The human gammaherpesvirus Kaposi sarcoma-associated herpesvirus is strongly linked to neoplasms of endothelial and B-cell origin. The majority of tumor cells in these malignancies are latently infected, and latency genes are consequently thought to play a critical role in virus-induced tumorigenesis. One such factor is kshv-miR-K12-11, a viral microRNA that is constitutively expressed in cell lines derived from KSHV-associated tumors, and that shares perfect homology of its seed sequence with the cellular miR-155. Since miR-155 is overexpressed in a number of human tumors, it is conceivable that mimicry of miR-155 by miR-K12-11 may contribute to cellular transformation in KSHV-associated disease. Here, we have performed a side-by-side study of phenotypic alterations associated with constitutive expression of either human miR-155 or viral miR-K12-11 in bone marrow-derived hematopoietic stem cells. We demonstrate that retroviral-mediated gene transfer and hematopoietic progenitor cell transplantation into C57BL/6 mice leads to increased B-cell fractions in lymphoid organs, as well as to enhanced germinal center formation in both microRNA-expressing mouse cohorts. We furthermore identify Jarid2, a component of Polycomb repressive complex 2, as a novel validated target of miR-K12-11, and confirm its downregulation in miR-K12-11 as well as miR-155 expressing bone marrow cells. Our findings confirm and extend previous observations made in other mouse models, and underscore the notion that miR-K12-11 may have arisen to mimic miR-155 functions in KSHV-infected B-cells. The expression of miR-K12-11 may represent one mechanism by which KSHV presumably aims to reprogram naive B-cells towards supporting long-term latency, which at the same time is likely to pre-dispose infected lymphocytes to malignant transformation.	[Dahlke, Christine; Maul, Katrin; Christalla, Thomas; Walz, Nicole; Schult, Philipp; Stocking, Carol; Grundhoff, Adam] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany	Heinrich Pette Institute	Grundhoff, A (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	adam.grundhoff@hpi.uni-hamburg.de		Grundhoff, Adam/0000-0003-0940-7045; Dahlke, Christine/0000-0002-2056-9195; Schult, Philipp/0000-0002-0533-7046	Deutsche Forschungsgemeinschaft [GR 3316/1-1]; Free and Hanseatic City of Hamburg; Federal Ministry of Health	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Free and Hanseatic City of Hamburg; Federal Ministry of Health	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (GR 3316/1-1) to AG. The Heinrich-Pette-Institute is a member of the Leibniz Gemeinschaft (WGL, http://www.leibniz-gemeinschaft.de/) and is supported by the Free and Hanseatic City of Hamburg and the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; Beyer TD, 2002, SCAND J IMMUNOL, V56, P303, DOI 10.1046/j.1365-3083.2002.01139.x; Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09; Boss IW, 2011, J VIROL, V85, P9877, DOI 10.1128/JVI.05558-11; Burnside J, 2011, BMC P, V5; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Calame K, 2007, IMMUNITY, V27, P825, DOI 10.1016/j.immuni.2007.11.010; Cameron JE, 2008, VIROLOGY, V382, P257, DOI 10.1016/j.virol.2008.09.018; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; Dittmer D, 1998, J VIROL, V72, P8309, DOI 10.1128/JVI.72.10.8309-8315.1998; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Greig KT, 2010, BLOOD, V115, P2796, DOI 10.1182/blood-2009-08-239210; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Grundhoff A, 2003, J VIROL, V77, P2779, DOI 10.1128/JVI.77.4.2779-2783.2003; Grundhoff A, 2001, J VIROL, V75, P1857, DOI 10.1128/JVI.75.4.1857-1863.2001; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HARDY RR, 2007, CELL PRESS, V26, P703, DOI DOI 10.1016/J.IMMUNI.2007.05.013; Herz HM, 2012, MOL CELL BIOL, V32, P1683, DOI 10.1128/MCB.06503-11; Herz HM, 2010, GENE DEV, V24, P857, DOI 10.1101/gad.1921610; Hu JH, 2002, J VIROL, V76, P11677, DOI 10.1128/JVI.76.22.11677-11687.2002; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; Kalla M, 2012, EUR J CELL BIOL, V91, P65, DOI 10.1016/j.ejcb.2011.01.014; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; LIEBERMANN DA, 1994, STEM CELLS, V12, P352, DOI 10.1002/stem.5530120402; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Liu J, 2011, J CELL MOL MED, V15, P1474, DOI 10.1111/j.1582-4934.2010.01104.x; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martin-Perez D, 2010, BLOOD, V116, P5465, DOI 10.1182/blood-2010-05-267096; Morgan R, 2008, J VIROL, V82, P12213, DOI 10.1128/JVI.01722-08; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Panning B, 2010, CELL STEM CELL, V6, P3, DOI 10.1016/j.stem.2009.12.013; Pearce M, 2005, J VIROL, V79, P14457, DOI 10.1128/JVI.79.22.14457-14464.2005; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Puda A, 2012, AM J HEMATOL, V87, P245, DOI 10.1002/ajh.22257; Rahadiani N, 2008, BIOCHEM BIOPH RES CO, V377, P579, DOI 10.1016/j.bbrc.2008.10.007; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Richie ER, 2002, ONCOGENE, V21, P299, DOI 10.1038/sj.onc.1205051; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Roughan JE, 2009, J VIROL, V83, P3968, DOI 10.1128/JVI.02609-08; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Score J, 2012, BLOOD, V119, P1208, DOI 10.1182/blood-2011-07-367243; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Thorley-Lawson DA, 2001, NAT REV IMMUNOL, V1, P75, DOI 10.1038/35095584; Toyoda M, 2000, BIOCHEM BIOPH RES CO, V274, P332, DOI 10.1006/bbrc.2000.3138; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vrazo AC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002662; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Xu GR, 2010, RNA, V16, P1610, DOI 10.1261/rna.2194910; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578; Zhao YG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001305	84	55	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49435	10.1371/journal.pone.0049435	http://dx.doi.org/10.1371/journal.pone.0049435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185331	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700031
J	Grahn, JA; Manly, T				Grahn, Jessica A.; Manly, Tom			Common Neural Recruitment across Diverse Sustained Attention Tasks	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; MONKEY PREFRONTAL CORTEX; SPATIAL ATTENTION; UNILATERAL NEGLECT; FRONTAL LESIONS; WORKING-MEMORY; BRAIN; PERFORMANCE; ADHD	At one level "sustained attention" is simply a description of a task demand. It is often used, however, in reference to a putatively unitary capacity to remain engaged in tasks that are lengthy, dull, repetitive and/or characterised by long intervals between relevant events. Deficits in sustained attention have been reported in a range of clinical conditions. Despite this, there is paucity of well-controlled human functional imaging evidence about regions commonly recruited during diverse sustained attention tasks. Here, for the first time, we used functional magnetic resonance imaging (fMRI) to monitor brain activity patterns as healthy volunteers performed two sustained attention tasks. The first, widely used in clinical assessment, required participants to count tones separated by long unpredictable intervals. This was contrasted with a control counting condition in which tones were presented at a brisk, regular rate. The second task was the Sustained Attention to Response Test (SART) in which participants responded to sequentially presented digits with the exception of a nominated infrequent no-go target. In the control condition, no-go trials were explicitly absent, removing the requirement to maintain a readiness to withhold responses. Although there were distinct patterns of activation associated with each task relative to its control, activity common to both tasks was found in the bilateral inferior frontal operculum, anterior cingulate, and bilateral premotor cortex. Although some researchers argue for a specific role of the inferior frontal operculum in inhibition, our results are consistent with recent findings of a more general attentional role for this area. The maintenance of a goal directed stance in the absence of strong environmental facilitation is challenging and this may underpin the sensitivity of sustained attention tasks to functional difficulties in a range of clinical groups.	[Grahn, Jessica A.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Manly, Tom] Med Res Council Cognit & Brain Sci Unit, Cambridge, England; [Grahn, Jessica A.] Univ Western Ontario, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Western University (University of Western Ontario)	Grahn, JA (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	jgrahn@uwo.ca; tom.manly@mrc-cbu.cam.ac.uk	Grahn, Jessica/A-1371-2010	Grahn, Jessica/0000-0001-7270-2114	UK Medical Research Council [MC-A060-5PQ]; Medical Research Council [MC_U105559837] Funding Source: researchfish; MRC [MC_U105559837] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by UK Medical Research Council MC-A060-5PQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Dobler VB, 2005, J CHILD PSYCHOL PSYC, V46, P1230, DOI 10.1111/j.1469-7610.2005.00421.x; Dobler VB, 2003, DEV MED CHILD NEUROL, V45, P282, DOI 10.1017/S0012162203000537; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fleck DE, 2012, MOL PSYCHIATR, V17, P325, DOI 10.1038/mp.2010.108; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; George M, 2005, BRAIN COGNITION, V57, P264, DOI 10.1016/j.bandc.2004.09.003; Hampshire A, 2008, COGN AFFECT BEHAV NE, V9, P130; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Head J, 2012, EXP BRAIN RES, V216, P103, DOI 10.1007/s00221-011-2914-6; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Ikkai A, 2008, CEREB CORTEX, V18, P1384, DOI 10.1093/cercor/bhm171; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lewin JS, 1996, J COMPUT ASSIST TOMO, V20, P695, DOI 10.1097/00004728-199609000-00002; MACKWORTH JF, 1964, CAN J PSYCHOLOGY, V18, P209, DOI 10.1037/h0083302; Mackworth NH, 1948, Q J EXP PSYCHOL, V1, P6, DOI 10.1080/17470214808416738; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P1, DOI 10.1016/S0028-3932(01)00086-0; Miller EK, 1996, J NEUROSCI, V16, P5154; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; O'Connor C, 2004, BRAIN COGNITION, V54, P133, DOI 10.1016/S0278-2626(03)00268-9; O'Connor C, 2011, NEUROPSYCHOLOGY, V25, P535, DOI 10.1037/a0022767; Ogg RJ, 2008, MAGN RESON IMAGING, V26, P504, DOI 10.1016/j.mri.2007.09.004; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Paus T, 1997, J NEUROSCI, V17, P3178; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Penny W, 2003, HUMAN BRAIN FUNCTION; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P1527, DOI 10.1016/S0028-3932(97)00084-5; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Sigala N, 2008, P NATL ACAD SCI USA, V105, P11969, DOI 10.1073/pnas.0802569105; Smallwood J, 2004, CONSCIOUS COGN, V13, P657, DOI 10.1016/j.concog.2004.06.003; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Stevenson H, 2011, BRAIN COGNITION, V77, P215, DOI 10.1016/j.bandc.2011.08.007; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; Thakral PP, 2009, BRAIN RES, V1302, P157, DOI 10.1016/j.brainres.2009.09.031; Voisin J, 2006, J NEUROSCI, V26, P273, DOI 10.1523/JNEUROSCI.2967-05.2006; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8	57	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49556	10.1371/journal.pone.0049556	http://dx.doi.org/10.1371/journal.pone.0049556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185360	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700037
J	Prisby, RD; Dominguez, JM; Muller-Delp, J; Allen, MR; Delp, MD				Prisby, Rhonda D.; Dominguez, James M., II; Muller-Delp, Judy; Allen, Matthew R.; Delp, Michael D.			Aging and Estrogen Status: A Possible Endothelium-Dependent Vascular Coupling Mechanism in Bone Remodeling	PLOS ONE			English	Article							SKELETAL-MUSCLE ARTERIOLES; NITRIC-OXIDE; BLOOD-FLOW; POSTMENOPAUSAL WOMEN; OVARIECTOMIZED RATS; MINERAL DENSITY; TRABECULAR BONE; SEX STEROIDS; SHEAR-STRESS; AGED RATS	Bone loss with aging and menopause may be linked to vascular endothelial dysfunction. The purpose of the study was to determine whether putative modifications in endothelium-dependent vasodilation of the principal nutrient artery (PNA) of the femur are associated with changes in trabecular bone volume (BV/TV) with altered estrogen status in young (6 mon) and old (24 mon) female Fischer-344 rats. Animals were divided into 6 groups: 1) young intact, 2) old intact, 3) young ovariectomized (OVX), 4) old OVX, 5) young OVX plus estrogen replacement (OVX+E2), and 6) old OVX+E2. PNA endothelium-dependent vasodilation was assessed in vitro using acetylcholine. Trabecular bone volume of the distal femoral metaphysis was determined by microCT. In young rats, vasodilation was diminished by OVX and restored with estrogen replacement (intact, 82 +/- 7; OVX, 61 +/- 9; OVX+E2, 90 +/- 4%), which corresponded with similar modifications in BV/TV (intact, 28.7 +/- 1.6; OVX, 16.3 +/- 0.9; OVX+E2, 25.7 +/- 1.4%). In old animals, vasodilation was unaffected by OVX but enhanced with estrogen replacement (intact, 55 +/- 8; OVX, 59 +/- 7; OVX+E2, 92 +/- 4%). Likewise, modifications in BV/TV followed the same pattern (intact, 33.1 +/- 1.6; OVX, 34.4 +/- 3.7; OVX+E2, 42.4 +/- 2.1%). Furthermore, in old animals with low endogenous estrogen (i.e., intact and old OVX), vasodilation was correlated with BV/TV (R-2 = 0.630; P < 0.001). These data demonstrate parallel effects of estrogen on vascular endothelial function and BV/TV, and provide for a possible coupling mechanism linking endothelium-dependent vasodilation to bone remodeling.	[Dominguez, James M., II; Delp, Michael D.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA; [Dominguez, James M., II; Delp, Michael D.] Univ Florida, Ctr Exercise Sci, Gainesville, FL 32611 USA; [Prisby, Rhonda D.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Muller-Delp, Judy] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA; [Allen, Matthew R.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Delaware; State University System of Florida; University of Florida; Indiana University System; Indiana University Bloomington	Delp, MD (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32610 USA.	mdelp@ufl.edu	Allen, Matthew/A-8799-2015	Allen, Matthew/0000-0002-1174-9004; Delp, Michael/0000-0002-2916-0783; Muller-Delp, Judy/0000-0001-5322-0611	National Institutes of Health [R01 HL077224, S10-RR023710, R36 AG036816]; National Aeronautics and Space Administration [NNX08AQ62G, NNX09AP06G]; Jane Adams Edmonds Endowed Ph.D. Fellowship from the Department of Applied Physiology and Kinesiology at the University of Florida; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023710] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R36AG036816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Jane Adams Edmonds Endowed Ph.D. Fellowship from the Department of Applied Physiology and Kinesiology at the University of Florida; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institutes of Health R01 HL077224, S10-RR023710 (MicroCT equipment grant), Postdoctoral Supplement R36 AG036816, the National Aeronautics and Space Administration NNX08AQ62G and NNX09AP06G and the Jane Adams Edmonds Endowed Ph.D. Fellowship from the Department of Applied Physiology and Kinesiology at the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM ASMT, 1992, ENDOCRINOLOGY, V130, P3617, DOI 10.1210/en.130.6.3617; Bauss F, 2002, J RHEUMATOL, V29, P2200; Bergula AP, 1999, BONE, V24, P171, DOI 10.1016/S8756-3282(98)00165-3; Bergula AP, 2004, BONE, V34, P562, DOI 10.1016/j.bone.2003.11.025; Bloomfield SA, 2002, CLIN ORTHOP RELAT R, P248, DOI 10.1097/00003086-200203000-00036; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; BROOKES M, 1966, SURG GYNECOL OBSTETR, V123, P1255; BURKHARDT R, 1987, BONE, V8, P157, DOI 10.1016/8756-3282(87)90015-9; Case J, 1999, J PHARMACOL EXP THER, V291, P524; Castillo C, 2005, BIOGERONTOLOGY, V6, P49, DOI 10.1007/s10522-004-7383-x; Cheng ZQ, 2009, J BONE MINER RES, V24, P209, DOI [10.1359/JBMR.81005, 10.1359/jbmr.81005]; Colleran PN, 2000, J APPL PHYSIOL, V89, P1046, DOI 10.1152/jappl.2000.89.3.1046; COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306; DAVIS TRC, 1992, J ORTHOPAED RES, V10, P344, DOI 10.1002/jor.1100100306; Dominguez JM, 2010, BONE, V46, P813, DOI 10.1016/j.bone.2009.10.029; ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; ETTINGER B, 1985, ANN INTERN MED, V102, P319, DOI 10.7326/0003-4819-102-3-319; FIORELLI G, 1994, J BONE MINER RES, V9, P329; GHIRARDI O, 1995, EXP GERONTOL, V30, P485, DOI 10.1016/0531-5565(95)00002-X; Gonzales RJ, 2001, AM J PHYSIOL-LUNG C, V280, pL555, DOI 10.1152/ajplung.2001.280.3.L555; Griffith JF, 2008, J BONE MINER RES, V23, P1068, DOI 10.1359/JBMR.080233; Hansen VB, 2001, J ORTHOPAED RES, V19, P391, DOI 10.1016/S0736-0266(00)90026-3; HUGHES S, 1978, CLIN ORTHOP RELAT R, P332; Imai Y, 2009, ANN NY ACAD SCI, V1173, pE31, DOI 10.1111/j.1749-6632.2009.04954.x; Jaffe HL, 1930, ARCH SURG-CHICAGO, V20, P355, DOI 10.1001/archsurg.1930.01150090002001; Johnson DL, 1996, AM J PHYSIOL-ENDOC M, V271, pE205, DOI 10.1152/ajpendo.1996.271.1.E205; JOHNSTON CC, 1985, J CLIN ENDOCR METAB, V61, P905, DOI 10.1210/jcem-61-5-905; KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569; KITA K, 1987, J ORTHOPAED RES, V5, P569, DOI 10.1002/jor.1100050412; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; LAHTINEN T, 1981, J NUCL MED, V22, P966; LeBlanc AJ, 2009, AM J PHYSIOL-REG I, V297, pR1713, DOI 10.1152/ajpregu.00178.2009; Lindsay R, 1995, ESTROGEN DEFICIENCY; MACINTYRE I, 1991, P NATL ACAD SCI USA, V88, P2936, DOI 10.1073/pnas.88.7.2936; Marcus R, 1998, J CLIN ENDOCR METAB, V83, P2236, DOI 10.1210/jc.83.7.2236; McAllister TN, 2000, BIOCHEM BIOPH RES CO, V270, P643, DOI 10.1006/bbrc.2000.2467; McCarthy I, 2006, J BONE JOINT SURG AM, V88A, P4, DOI 10.2106/JBJS.F.00890; MEININGER GA, 1984, HYPERTENSION, V6, P27, DOI 10.1161/01.HYP.6.1.27; Muller-Delp JM, 2002, AM J PHYSIOL-HEART C, V283, pH1662, DOI 10.1152/ajpheart.00004.2002; NILAS L, 1987, J CLIN ENDOCR METAB, V65, P697, DOI 10.1210/jcem-65-4-697; Noguchi K, 2003, COMPARATIVE MED, V53, P404; OHTA H, 1992, J BONE MINER RES, V7, P659; Prisby RD, 2008, J TOXICOL ENV HEAL A, V71, P464, DOI 10.1080/15287390701839349; Prisby RD, 2007, J BONE MINER RES, V22, P1280, DOI 10.1359/JBMR.070415; Sanada M, 2004, ATHEROSCLEROSIS, V176, P387, DOI 10.1016/j.atherosclerosis.2004.05.021; Shahnazari M, 2010, BONE, V46, P1267, DOI 10.1016/j.bone.2009.11.019; Smalt R, 1997, AM J PHYSIOL-ENDOC M, V273, pE751, DOI 10.1152/ajpendo.1997.273.4.E751; Soukhova-O'Hare G, 2005, LIFE SCI, V77, P1799, DOI 10.1016/j.lfs.2004.10.083; Spier SA, 2004, J PHYSIOL-LONDON, V556, P947, DOI 10.1113/jphysiol.2003.060301; Sumino H, 2007, CIRC J, V71, P1555, DOI 10.1253/circj.71.1555; TURNER RT, 1994, ENDOCR REV, V15, P275, DOI 10.1210/er.15.3.275; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007	53	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48564	10.1371/journal.pone.0048564	http://dx.doi.org/10.1371/journal.pone.0048564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185266	gold, Green Submitted, Green Published			2022-12-25	WOS:000311535700015
J	Torvinen, S; Silvennoinen, M; Piitulainen, H; Narvainen, J; Tuunanen, P; Grohn, O; Koch, LG; Britton, SL; Kainulainen, H				Torvinen, Sira; Silvennoinen, Mika; Piitulainen, Harri; Narvainen, Johanna; Tuunanen, Pasi; Grohn, Olli; Koch, Lauren G.; Britton, Steven L.; Kainulainen, Heikki			Rats Bred for Low Aerobic Capacity Become Promptly Fatigued and Have Slow Metabolic Recovery after Stimulated, Maximal Muscle Contractions	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; HEAVY-CHAIN ISOFORMS; SINGLE MOTOR UNITS; EXERCISE CAPACITY; SUCCINATE-DEHYDROGENASE; MITOCHONDRIAL CONTENT; GASTROCNEMIUS-MUSCLE; RUNNING CAPACITY; FORCE PRODUCTION; ENZYME-ACTIVITY	AIM: Muscular fatigue is a complex phenomenon affected by muscle fiber type and several metabolic and ionic changes within myocytes. Mitochondria are the main determinants of muscle oxidative capacity which is also one determinant of muscle fatigability. By measuring the concentrations of intracellular stores of high-energy phosphates it is possible to estimate the energy production efficiency and metabolic recovery of the muscle. Low intrinsic aerobic capacity is known to be associated with reduced mitochondrial function. Whether low intrinsic aerobic capacity also results in slower metabolic recovery of skeletal muscle is not known. Here we studied the influence of intrinsic aerobic capacity on in vivo muscle metabolism during maximal, fatiguing electrical stimulation. METHODS: Animal subjects were genetically heterogeneous rats selectively bred to differ for non-trained treadmill running endurance, low capacity runners (LCRs) and high capacity runners (HCRs) (n = 15-19). We measured the concentrations of major phosphorus compounds and force parameters in a contracting triceps surae muscle complex using P-31-Magnetic resonance spectroscopy (P-31-MRS) combined with muscle force measurement from repeated isometric twitches. RESULTS: Our results demonstrated that phosphocreatine re-synthesis after maximal muscle stimulation was significantly slower in LCRs (p<0.05). LCR rats also became promptly fatigued and maintained the intramuscular pH poorly compared to HCRs. Half relaxation time (HRT) of the triceps surae was significantly longer in LCRs throughout the stimulation protocol (p <= 0.05) and maximal rate of torque development (MRTD) was significantly lower in LCRs compared to HCRs from 2 min 30 s onwards (p <= 0.05). CONCLUSION: We observed that LCRs are more sensitive to fatigue and have slower metabolic recovery compared to HCRs after maximal muscle contractions. These new findings are associated with reduced running capacity and with previously found lower mitochondrial content, increased body mass and higher complex disease risk of LCRs.	[Torvinen, Sira; Silvennoinen, Mika; Piitulainen, Harri; Kainulainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, Jyvaskyla, Finland; [Narvainen, Johanna; Tuunanen, Pasi; Grohn, Olli] Univ Eastern Finland, Al Virtanen Inst Mol Sci, Dept Neurobiol, Joensuu, Finland; [Piitulainen, Harri] Aalto Univ, Sch Sci, Low Temp Lab, Brain Res Unit, Espoo, Finland; [Koch, Lauren G.; Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA	University of Jyvaskyla; University of Eastern Finland; Aalto University; University of Michigan System; University of Michigan	Kainulainen, H (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, Neuromuscular Res Ctr, Jyvaskyla, Finland.	heikki.kainulainen@sport.jyu.fi	Piitulainen, Harri/K-6483-2012	Piitulainen, Harri/0000-0001-6866-6587; Silvennoinen, Mika/0000-0002-5389-8251; Karvinen, Sira/0000-0001-7731-1390; Kainulainen, Heikki/0000-0001-5102-4350	Ministry of Education and Culture (Finland); TBDP (National Doctoral Programme of Musculoskeletal Disorders and Biomaterials) Graduate School; National Center for Research Resources [R24 RR017718]; Office of Research Infrastructure Programs/OD grant from the National Institutes of Health [ROD012098A]; National Institutes of Health [RO1 DK077200]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077200] Funding Source: NIH RePORTER	Ministry of Education and Culture (Finland); TBDP (National Doctoral Programme of Musculoskeletal Disorders and Biomaterials) Graduate School; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was financially supported by the Ministry of Education and Culture (Finland) and TBDP (National Doctoral Programme of Musculoskeletal Disorders and Biomaterials) Graduate School. The LCR-HCR rat model system was funded by the National Center for Research Resources grant R24 RR017718 and is currently supported by the Office of Research Infrastructure Programs/OD grant ROD012098A (to LGK and SLB) from the National Institutes of Health. SLB was also supported by National Institutes of Health grant RO1 DK077200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DG, 1992, SPORTS MED, V13, P116, DOI 10.2165/00007256-199213020-00007; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; Bakkman L, 2010, OBESITY FACTS, V3, P371, DOI 10.1159/000320167; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Bendahan D, 2004, CELL MOL LIFE SCI, V61, P1001, DOI 10.1007/s00018-004-3345-3; Bogdanis GC, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00142; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; Carroll TJ, 2002, J PHYSIOL-LONDON, V544, P641, DOI 10.1113/jphysiol.2002.024463; Celichowski J, 2006, J PHYSIOL PHARMACOL, V57, P83; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; EDSTROM L, 1968, J NEUROL NEUROSUR PS, V31, P424, DOI 10.1136/jnnp.31.5.424; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; FUCHTBAUER EM, 1991, J HISTOCHEM CYTOCHEM, V39, P355, DOI 10.1177/39.3.1825216; GALLER S, 1994, J PHYSIOL-LONDON, V478, P513, DOI 10.1113/jphysiol.1994.sp020270; Giannesini B, 2005, MAGN RESON MED, V54, P1058, DOI 10.1002/mrm.20637; Giannesini B, 2001, FEBS LETT, V507, P25, DOI 10.1016/S0014-5793(01)02942-8; Giannesini B, 2001, J PHYSIOL-LONDON, V536, P905, DOI 10.1111/j.1469-7793.2001.00905.x; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Howlett RA, 2003, J APPL PHYSIOL, V94, P1682, DOI 10.1152/japplphysiol.00556.2002; Izquierdo M, 1999, EUR J APPL PHYSIOL, V79, P260, DOI 10.1007/s004210050504; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KEMP GJ, 1993, NMR BIOMED, V6, P66, DOI 10.1002/nbm.1940060111; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kivela R, 2010, FASEB J, V24, P4565, DOI 10.1096/fj.10-157313; Klass M, 2008, J APPL PHYSIOL, V104, P739, DOI 10.1152/japplphysiol.00550.2007; Koch LG, 2005, INTEGR COMP BIOL, V45, P405, DOI 10.1093/icb/45.3.405; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Koch LG, 2011, CIRCULATION RES; LARSSON L, 1991, J PHYSIOL-LONDON, V443, P257, DOI 10.1113/jphysiol.1991.sp018833; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Rivas DA, 2011, AM J PHYSIOL-REG I, V300, pR835, DOI 10.1152/ajpregu.00659.2010; TERMIN A, 1989, HISTOCHEMISTRY, V92, P453, DOI 10.1007/BF00524756; Ukropcova B, 2007, DIABETES, V56, P720, DOI 10.2337/db06-0521; VANDERLAARSE WJ, 1991, EXP PHYSIOL, V76, P589, DOI 10.1113/expphysiol.1991.sp003526; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Walsh B, 2006, J APPL PHYSIOL, V100, P1765, DOI 10.1152/japplphysiol.01533.2005; WEINER MW, 1990, NEUROLOGY, V40, P1888, DOI 10.1212/WNL.40.12.1888; Westerblad H, 1998, ACTA PHYSIOL SCAND, V162, P253, DOI 10.1046/j.1365-201X.1998.0301f.x; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pC195, DOI 10.1152/ajpcell.1991.261.2.C195	45	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48345	10.1371/journal.pone.0048345	http://dx.doi.org/10.1371/journal.pone.0048345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185253	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700010
J	Al Maqbali, T; Tedla, M; Weickert, MO; Mehanna, H				Al Maqbali, Talib; Tedla, Miroslav; Weickert, Martin O.; Mehanna, Hisham			Malignancy Risk Analysis in Patients with Inadequate Fine Needle Aspiration Cytology (FNAC) of the Thyroid	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; BIOPSY; MANAGEMENT; NODULES; LESIONS; ACCURACY	Background: Thyroid fine needle aspiration cytology (FNAC) is the standard diagnostic modality for thyroid nodules. However, it has limitations among which is the incidence of non-diagnostic results (Thy1). Management of cases with repeatedly non-diagnostic FNAC ranges from simple observation to surgical intervention. We aim to evaluate the incidence of malignancy in non-diagnostic FNAC, and the success rate of repeated FNAC. We also aim to evaluate risk factors for malignancy in patients with non-diagnostic FNAC. Materials and Methods: Retrospective analyses of consecutive cases with thyroid non diagnostic FNAC results were included. Results: Out of total 1657 thyroid FNAC done during the study period, there were 264 (15.9%) non-diagnostic FNAC on the first attempt. On repeating those, the rate of a non-diagnostic result on second FNAC was 61.8% and on third FNAC was 47.2%. The overall malignancy rate in Thy1 FNAC was 4.5% (42% papillary, 42% follicular and 8% anaplastic), and the yield of malignancy decreased considerably with successive non-diagnostic FNAC. Ultrasound guidance by an experienced head neck radiologist produced the lowest non-diagnostic rate (38%) on repetition compared to US guidance by a generalist radiologist (65%) and by non US guidance (90%). Conclusions: There is a low risk of malignancy in patients with a non-diagnostic FNAC result, commensurate to the risk of any nodule. The yield of malignancy decreased considerably with successive non-diagnostic FNAC.	[Al Maqbali, Talib; Tedla, Miroslav] Univ Hosp Coventry & Warwickshire, Inst Head & Neck & Educ Studies, Coventry, W Midlands, England; [Weickert, Martin O.] Univ Hosp, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry, W Midlands, England; [Weickert, Martin O.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Mehanna, Hisham] Univ Hosp, Div Off, Inst Head & Neck Studies & Educ InHANSE, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick	Al Maqbali, T (corresponding author), Univ Hosp Coventry & Warwickshire, Inst Head & Neck & Educ Studies, Coventry, W Midlands, England.	taleb4u@yahoo.com		Mehanna, Hisham/0000-0002-5544-6224; Weickert, Martin O/0000-0002-4070-8164				Al-Hureibi KA, 2003, SAUDI MED J, V24, P499; Amrikachi M, 2001, ARCH PATHOL LAB MED, V125, P484; Baier ND, 2009, AM J ROENTGENOL, V193, P1175, DOI 10.2214/AJR.08.1840; Bakshi NA, 2003, ENDOCR PATHOL, V14, P167, DOI 10.1385/EP:14:2:167; Baloch Z, 2003, DIAGN CYTOPATHOL, V29, P203, DOI 10.1002/dc.10361; Baloch ZW, 1998, THYROID, V8, P565, DOI 10.1089/thy.1998.8.565; Bellantone R, 2004, THYROID, V14, P43, DOI 10.1089/105072504322783830; Borget I, 2008, AM J CLIN PATHOL, V129, P763, DOI 10.1309/H86KM785Q9KBWPW5; British Thyroid Association, 2007, ROYAL COLLEGE OF PHY; Cai XJ, 2006, CYTOPATHOLOGY, V17, P251, DOI 10.1111/j.1365-2303.2006.00397.x; Cap J, 1999, CLIN ENDOCRINOL, V51, P509; Carmeci C, 1998, THYROID, V8, P283, DOI 10.1089/thy.1998.8.283; Caruso D, 1991, ENDOCRINOLOGIST, V1, P194, DOI 10.1097/00019616-199106000-00009; Castro M Regina, 2003, Endocr Pract, V9, P128; Ceresini G, 2004, THYROID, V14, P385, DOI 10.1089/105072504774193230; Chow LS, 2001, THYROID, V11, P1147, DOI 10.1089/10507250152740993; Corrias A, 2001, J CLIN ENDOCR METAB, V86, P4644, DOI 10.1210/jc.86.10.4644; Danese D, 1998, THYROID, V8, P15, DOI 10.1089/thy.1998.8.15; Deandrea M, 2010, THYROID, V20, P1077, DOI 10.1089/thy.2010.0015; Gharib H, 1995, Endocr Pract, V1, P410; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; Gharib Hossein, 2006, Endocr Pract, V12, P63; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Jo VY, 2011, ACTA CYTOL, V55, P539, DOI 10.1159/000333230; Kelman AS, 2001, THYROID, V11, P271, DOI 10.1089/105072501750159714; Ko HM, 2003, ACTA CYTOL, V47, P727, DOI 10.1159/000326596; Layfield LJ, 2008, DIAGN CYTOPATHOL, V36, P442, DOI 10.1002/dc.20832; MacDonald L, 1996, ACTA CYTOL, V40, P423; Mamoon Nadira, 1997, JPMA (Journal of the Pakistan Medical Association), V47, P255; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; MCHENRY CR, 1993, AM SURGEON, V59, P415; Mendelson AA, 2009, J OTOLARYNGOL-HEAD N, V38, P395, DOI 10.2310/7070.2009.080140; Oertel YC, 2006, DIAGN CYTOPATHOL, V34, P87, DOI 10.1002/dc.20460; Oertel YC, 2007, THYROID, V17, P1061, DOI 10.1089/thy.2007.0159; Orija Israel B, 2004, Endocr Pract, V10, P317; Piana S, 2011, CYTOPATHOLOGY, V22, P164, DOI 10.1111/j.1365-2303.2010.00777.x; Pu RT, 2006, DIAGN CYTOPATHOL, V34, P330, DOI 10.1002/dc.20440; Redman R, 2006, THYROID, V16, P55, DOI 10.1089/thy.2006.16.55; Renshaw AA, 2011, AM J CLIN PATHOL, V135, P750, DOI 10.1309/AJCP8FX5CLPISSSK; Richards ML, 2008, AM J SURG, V196, P398, DOI 10.1016/j.amjsurg.2007.10.017; Rossi ED, 2009, ACTA CYTOL, V53, P659, DOI 10.1159/000325407; Saleh H, 2009, ACTA CYTOL, V53, P130, DOI 10.1159/000325113; Schlinkert RT, 1997, MAYO CLIN PROC, V72, P913, DOI 10.1016/S0025-6196(11)63360-0; Schmidt T, 1997, SOUTHERN MED J, V90, P1183, DOI 10.1097/00007611-199712000-00004; Singh N, 2003, CYTOPATHOLOGY, V14, P327, DOI 10.1046/j.0956-5507.2003.00084.x; Slowinska-Klencka D, 2004, ENDOCR PATHOL, V15, P65, DOI 10.1385/EP:15:1:65; Tabaqchali MA, 2000, ANN ROY COLL SURG, V82, P149; Yoon JH, 2010, ANN SURG ONCOL, V17, P2147, DOI 10.1245/s10434-010-0992-5	48	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49078	10.1371/journal.pone.0049078	http://dx.doi.org/10.1371/journal.pone.0049078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185295	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800017
J	Alitheen, NB; McClure, SJ; Yeap, SK; Kristeen-Teo, YW; Tan, SW; McCullagh, P				Alitheen, Noorjahan Banu; McClure, Susan Jane; Yeap, Swee Keong; Kristeen-Teo, Ye Wen; Tan, Sheau Wei; McCullagh, Peter			Establishment of an In Vitro System Representing the Chicken Gut-Associated Lymphoid Tissue	PLOS ONE			English	Article							DISEASE VIRUS-INFECTION; LYMPHOCYTES; CELLS; SUBPOPULATIONS; EXPRESSION; ANTIBODIES; EPITHELIUM; FABRICIUS; CULTURES; BURSA	The bursa of Fabricius is critical for B cell development and differentiation in chick embryos. This study describes the production in vitro, from dissociated cell suspensions, of cellular agglomerates with functional similarities to the chicken bursa. Co-cultivation of epithelial and lymphoid cells obtained from embryos at the appropriate developmental stage regularly led to agglomerate formation within 48 hours. These agglomerates resembled bursal tissue in having lymphoid clusters overlaid by well organized epithelium. Whereas lymphocytes within agglomerates were predominantly Bu-1a(+), a majority of those emigrating onto the supporting membrane were Bu-1a(-) and IgM(+). Both agglomerates and emigrant cells expressed activation-induced deaminase with levels increasing after 24 hours. Emigrating cells were actively proliferating at a rate in excess of both the starting cell population and the population of cells remaining in agglomerates. The potential usefulness of this system for investigating the response of bursal tissue to avian Newcastle disease virus (strain AF2240) was examined.	[McCullagh, Peter] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Alitheen, Noorjahan Banu; Kristeen-Teo, Ye Wen] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia; [McClure, Susan Jane] CSIRO Livestock Ind, FD McMaster Lab, Armidale, NSW, Australia; [Yeap, Swee Keong; Tan, Sheau Wei] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia	Australian National University; John Curtin School of Medical Research; Universiti Putra Malaysia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universiti Putra Malaysia	McCullagh, P (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	pjdmccullagh@bigpond.com	Yeap, Swee Keong/H-9285-2013; Alitheen, Noorjahan/AAL-3713-2020	Yeap, Swee Keong/0000-0002-4736-0674; 	Fundamental grant from Ministry of Higher Education, Malaysia [05-13-03-040J]	Fundamental grant from Ministry of Higher Education, Malaysia	This study was supported by a Fundamental grant (project no. 05-13-03-040J) from the Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1988, VET REC, V123, P442, DOI 10.1136/vr.123.17.442; Alitheen N, 2001, EUR J IMMUNOL, V31, P2558, DOI 10.1002/1521-4141(200109)31:9<2558::AID-IMMU2558>3.0.CO;2-B; Balcavage WX, 1972, BIOCHEM BIOPH RES CO, V605, P11; Casteleyn C, 2010, AVIAN PATHOL, V39, P143, DOI 10.1080/03079451003786105; De Regge N, 2006, VET MICROBIOL, V113, P251, DOI 10.1016/j.vetmic.2005.11.004; EEROLA E, 1984, SCAND J IMMUNOL, V19, P493, DOI 10.1111/j.1365-3083.1984.tb00960.x; Funk PE, 1996, CURR TOP MICROBIOL, V212, P17; Henderson A J, 1990, Semin Immunol, V2, P181; HOUSSAINT E, 1987, IMMUNOLOGY, V62, P463; Kaiser P, 2000, MICROBIOL-UK, V146, P3217, DOI 10.1099/00221287-146-12-3217; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; MOORE MAS, 1966, DEV BIOL, V14, P40, DOI 10.1016/0012-1606(66)90004-2; Nagy N, 2010, DEVELOPMENT, V137, P3019, DOI 10.1242/dev.055194; Petkov DI, 2009, AVIAN DIS, V53, P347, DOI 10.1637/8456-082208-Reg.1; PINK JRL, 1987, CURR TOP MICROBIOL, V135, P57; Rogers KM, 2007, ARCH VIROL, V152, P543, DOI 10.1007/s00705-006-0865-1; Saberi A, 2008, MOL CELL BIOL, V28, P6113, DOI 10.1128/MCB.00156-08; SETO F, 1988, DEV COMP IMMUNOL, V12, P843, DOI 10.1016/0145-305X(88)90058-4; Sharma JM, 2000, DEV COMP IMMUNOL, V24, P223, DOI 10.1016/S0145-305X(99)00074-9; Siatskas C, 2000, DEV COMP IMMUNOL, V24, P37, DOI 10.1016/S0145-305X(99)00051-8; SIJTSMA SR, 1991, DEV COMP IMMUNOL, V15, P349, DOI 10.1016/0145-305X(91)90027-V; Smith PJ, 2005, SCI LAB DIAGNOSIS; St Hill CA, 1999, AM J VET RES, V60, P937; VEROMAA T, 1988, HYBRIDOMA, V7, P41, DOI 10.1089/hyb.1988.7.41; Withers DR, 2005, DEV COMP IMMUNOL, V29, P651, DOI 10.1016/j.dci.2004.11.002; Yusoff K, 1996, AVIAN PATHOL, V25, P837, DOI 10.1080/03079459608419185; Zaffuto KM, 2008, AVIAN PATHOL, V37, P25, DOI 10.1080/03079450701774850	27	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49188	10.1371/journal.pone.0049188	http://dx.doi.org/10.1371/journal.pone.0049188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185307	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800020
J	Sprater, F; Hovden, AO; Appel, S				Sprater, Florian; Hovden, Arnt-Ove; Appel, Silke			Expression of ESE-3 Isoforms in Immunogenic and Tolerogenic Human Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							ETS TRANSCRIPTION FACTOR; NF-KAPPA-B; AIRWAY INFLAMMATION; EPITHELIUM; CANCER; FAMILY; DIFFERENTIATION; ACTIVATION; ARTHRITIS; BINDING	Dendritic cells (DC) are the only hematopoietic cells expressing the epithelial specific Ets transcription factor ESE-3. Here we analyzed presence and quantity of isoforms ESE-3a, ESE-3b and ESE-3j in various immunogenic and tolerogenic human monocyte-derived DC (moDC) and blood DC populations using quantitative real time PCR and immunoblot analyses. ESE-3a and ESE-3b were detectable in all moDC populations with ESE-3b being the main transcript. ESE-3b expression was upregulated in immunogenic moDC and downregulated in tolerogenic moDC compared to immature moDC. ESE-3a had similar transcript levels in immature and immunogenic moDC and had very low levels in tolerogenic moDC. In blood DC populations only splice variant ESE-3b was detectable. ESE-3j was not detectable in any of the DC populations. These findings suggest that ESE-3b is the functionally most important ESE-3 isoform in DC.	[Sprater, Florian; Hovden, Arnt-Ove; Appel, Silke] Univ Bergen, Gade Inst, Broegelmann Res Lab, Bergen, Norway	University of Bergen	Appel, S (corresponding author), Univ Bergen, Gade Inst, Broegelmann Res Lab, Bergen, Norway.	silke.appel@gades.uib.no		Appel, Silke/0000-0002-2199-2315	Bergen Research Foundation; Norwegian Cancer Society [PR-2006-0345]	Bergen Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society)	This study was supported by the Bergen Research Foundation (to SA) and the Norwegian Cancer Society (PR-2006-0345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino D, 2012, CANC RES; Anderson AE, 2009, J LEUKOCYTE BIOL, V85, P243, DOI 10.1189/jlb.0608374; Appel S, 2006, BLOOD, V107, P3265, DOI 10.1182/blood-2005-06-2480; Appel S, 2005, BLOOD, V106, P3888, DOI 10.1182/blood-2004-12-4709; Banchereau J, 2004, IMMUNITY, V20, P539, DOI 10.1016/S1074-7613(04)00108-6; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Brenne K, 2011, HUM PATHOL; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; Charlot C, 2010, METHODS MOL BIOL, V647, P3, DOI 10.1007/978-1-60761-738-9_1; Davidson B, 2006, CLIN CANCER RES, V12, P5944, DOI 10.1158/1078-0432.CCR-06-1059; Engell-Noerregaard L, 2009, CANCER IMMUNOL IMMUN, V58, P1, DOI 10.1007/s00262-008-0568-4; Friedman AD, 1996, CURR TOP MICROBIOL, V211, P149; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Harry RA, 2010, ANN RHEUM DIS, V69, P2042, DOI 10.1136/ard.2009.126383; Healy Louise J, 2008, Open Rheumatol J, V2, P71, DOI 10.2174/1874312900802010071; Hovden AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031217; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Juang YT, 2002, J IMMUNOL, V168, P2865, DOI 10.4049/jimmunol.168.6.2865; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kushwah R, 2011, J IMMUNOL, V187, P4639, DOI 10.4049/jimmunol.1101967; Martin E, 2007, ARTHRITIS RHEUM-US, V56, P2255, DOI 10.1002/art.22655; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Palucka K, 2011, J INTERN MED, V269, P64, DOI 10.1111/j.1365-2796.2010.02317.x; Pedersen AE, 2004, IMMUNOL LETT, V91, P63, DOI 10.1016/j.imlet.2003.11.004; Schadendorf D, 2006, ANN ONCOL, V17, P563, DOI 10.1093/annonc/mdj138; Schotte R, 2004, J EXP MED, V200, P1503, DOI 10.1084/jem.20041231; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Stoop JN, 2010, ARTHRITIS RHEUM-US, V62, P3656, DOI 10.1002/art.27756; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Taniue K, 2011, EMBO REP, V12, P682, DOI 10.1038/embor.2011.81; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Wu J, 2008, CELL RES, V18, P649, DOI 10.1038/cr.2008.57; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200	47	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49577	10.1371/journal.pone.0049577	http://dx.doi.org/10.1371/journal.pone.0049577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185370	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800039
J	Suo, SB; Qiu, JD; Shi, SP; Sun, XY; Huang, SY; Chen, X; Liang, RP				Suo, Sheng-Bao; Qiu, Jian-Ding; Shi, Shao-Ping; Sun, Xing-Yu; Huang, Shu-Yun; Chen, Xiang; Liang, Ru-Ping			Position-Specific Analysis and Prediction for Protein Lysine Acetylation Based on Multiple Features	PLOS ONE			English	Article							AMINO-ACID INDEXES; POSTTRANSLATIONAL MODIFICATIONS; HISTONE ACETYLATION; CRYSTAL-STRUCTURE; WIDE PREDICTION; BINDING; MECHANISM; GCN5; ACCESSIBILITY; REFINEMENT	Protein lysine acetylation is a type of reversible post-translational modification that plays a vital role in many cellular processes, such as transcriptional regulation, apoptosis and cytokine signaling. To fully decipher the molecular mechanisms of acetylation-related biological processes, an initial but crucial step is the recognition of acetylated substrates and the corresponding acetylation sites. In this study, we developed a position-specific method named PSKAcePred for lysine acetylation prediction based on support vector machines. The residues around the acetylation sites were selected or excluded based on their entropy values. We incorporated features of amino acid composition information, evolutionary similarity and physicochemical properties to predict lysine acetylation sites. The prediction model achieved an accuracy of 79.84% and a Matthews correlation coefficient of 59.72% using the 10-fold cross-validation on balanced positive and negative samples. A feature analysis showed that all features applied in this method contributed to the acetylation process. A position-specific analysis showed that the features derived from the critical neighboring residues contributed profoundly to the acetylation site determination. The detailed analysis in this paper can help us to understand more of the acetylation mechanism and can provide guidance for the related experimental validation.	[Suo, Sheng-Bao; Qiu, Jian-Ding; Shi, Shao-Ping; Sun, Xing-Yu; Huang, Shu-Yun; Chen, Xiang; Liang, Ru-Ping] Nanchang Univ, Dept Chem, Nanchang, Peoples R China; [Qiu, Jian-Ding] Pingxiang Coll, Dept Mat & Chem Engn, Pingxiang, Peoples R China	Nanchang University; Pingxiang University	Qiu, JD (corresponding author), Nanchang Univ, Dept Chem, Nanchang, Peoples R China.	jdqiu@ncu.edu.cn	Qiu, Jianding/A-2259-2012	Qiu, Jianding/0000-0002-6793-9499; Shi, Shaoping/0000-0003-0045-868X	National Natural Science Foundation of China [20605010, 21175064]; Program for New Century Excellent Talents in University [NCET-11-1002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (20605010 and 21175064) and the Program for New Century Excellent Talents in University (NCET-11-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cai YD, 2008, BIOCHEM BIOPH RES CO, V372, P862, DOI 10.1016/j.bbrc.2008.05.143; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chung C, 2011, BIOINFORMATICS, V27, P797, DOI 10.1093/bioinformatics/btr017; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Georges E, 2007, BIOCHEMISTRY-US, V46, P7337, DOI 10.1021/bi7006228; Gnad F, 2010, BIOINFORMATICS, V26, P1666, DOI 10.1093/bioinformatics/btq260; Grant PA, 2001, GENOME BIOL, V2; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; Jiang F, 2010, EXPERT SYST APPL, V37, P6338, DOI 10.1016/j.eswa.2010.02.087; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lee TY, 2010, J COMPUT CHEM, V31, P2759, DOI 10.1002/jcc.21569; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Li H, 2009, MOL CELL PROTEOMICS, V8, P1839, DOI 10.1074/mcp.M900030-MCP200; Li SL, 2009, PROTEIN PEPTIDE LETT, V16, P977, DOI 10.2174/092986609788923338; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZX, 2011, NUCLEIC ACIDS RES, V39, pD1029, DOI 10.1093/nar/gkq939; Lu ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028228; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Marmorstein R, 2001, J MOL BIOL, V311, P433, DOI 10.1006/jmbi.2001.4859; Medzihradszky KF, 2005, METHOD ENZYMOL, V402, P209, DOI 10.1016/S0076-6879(05)02007-0; NAKAI K, 1988, PROTEIN ENG, V2, P93, DOI 10.1093/protein/2.2.93; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Neuwirth M, 2007, BIOCHEMISTRY-US, V46, P5131, DOI 10.1021/bi602602x; Nomura T, 2006, BIOPHYS J, V91, P2874, DOI 10.1529/biophysj.106.084541; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Shannon CE, 1997, M D COMPUT, V14, P306; Shen HB, 2006, J THEOR BIOL, V240, P9, DOI 10.1016/j.jtbi.2005.08.016; Sohn J, 2007, BIOPHYS CHEM, V125, P549, DOI 10.1016/j.bpc.2006.11.005; Sternglanz R, 1999, P NATL ACAD SCI USA, V96, P8807, DOI 10.1073/pnas.96.16.8807; Tan SB, 2006, EXPERT SYST APPL, V30, P290, DOI 10.1016/j.eswa.2005.07.019; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Tung CW, 2008, BMC BIOINFORMATICS, V9; Umlauf David, 2004, Methods Mol Biol, V287, P99; Urry DW, 2004, CHEM PHYS LETT, V399, P177, DOI 10.1016/j.cplett.2004.09.137; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; VIDALL G, 1968, J BIOL CHEM, V243, P6361; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; WELSCH DJ, 1988, BIOCHEMISTRY-US, V27, P4939, DOI 10.1021/bi00413a052; Xu Y, 2010, J THEOR BIOL, V264, P130, DOI 10.1016/j.jtbi.2010.01.013; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	62	68	68	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49108	10.1371/journal.pone.0049108	http://dx.doi.org/10.1371/journal.pone.0049108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173045	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300015
J	Woetzel, N; Karakas, M; Staritzbichler, R; Muller, R; Weiner, BE; Meiler, J				Woetzel, Nils; Karakas, Mert; Staritzbichler, Rene; Mueller, Ralf; Weiner, Brian E.; Meiler, Jens			BCL::Score-Knowledge Based Energy Potentials for Ranking Protein Models Represented by Idealized Secondary Structure Elements	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; X-RAY; PREDICTION; RECONSTRUCTION; CONFORMATIONS; RECOGNITION; DISTANCE; DATABASE; FORCE	The topology of most experimentally determined protein domains is defined by the relative arrangement of secondary structure elements, i.e. alpha-helices and beta-strands, which make up 50-70% of the sequence. Pairing of beta-strands defines the topology of beta-sheets. The packing of side chains between alpha-helices and beta-sheets defines the majority of the protein core. Often, limited experimental datasets restrain the position of secondary structure elements while lacking detail with respect to loop or side chain conformation. At the same time the regular structure and reduced flexibility of secondary structure elements make these interactions more predictable when compared to flexible loops and side chains. To determine the topology of the protein in such settings, we introduce a tailored knowledge-based energy function that evaluates arrangement of secondary structure elements only. Based on the amino acid C-beta atom coordinates within secondary structure elements, potentials for amino acid pair distance, amino acid environment, secondary structure element packing, beta-strand pairing, loop length, radius of gyration, contact order and secondary structure prediction agreement are defined. Separate penalty functions exclude conformations with clashes between amino acids or secondary structure elements and loops that cannot be closed. Each individual term discriminates for native-like protein structures. The composite potential significantly enriches for native-like models in three different databases of 10,000-12,000 protein models in 80-94% of the cases. The corresponding application, "BCL:: ScoreProtein," is available at www.meilerlab.org.	[Woetzel, Nils; Karakas, Mert; Staritzbichler, Rene; Mueller, Ralf; Weiner, Brian E.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37212 USA	Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37212 USA.	jens.meiler@vanderbilt.edu		Meiler, Jens/0000-0001-8945-193X; Staritzbichler, Rene/0000-0002-6719-2997	National Institute of Health [R01-GM080403]; National Science Foundation [0742762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grant R01-GM080403 from the National Institute of Health and CAREER award 0742762 by the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Alexander N, 2008, STRUCTURE, V16, P181, DOI 10.1016/j.str.2007.11.015; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; ANFINSEN CB, 1972, BIOCHEM J, V128, P737, DOI 10.1042/bj1280737; Berman HM, 2008, ACTA CRYSTALLOGR A, V64, P88, DOI 10.1107/S0108767307035623; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; Durham E, 2009, J MOL MODEL, V15, P1093, DOI 10.1007/s00894-009-0454-9; Flory P. J, 1953, PRINCIPLES POLYM CHE; Frank J, 2009, Q REV BIOPHYS, V42, P139, DOI 10.1017/S0033583509990059; Hamelryck T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013714; Hsin Jen, 2008, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0507s24; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LEPAULT J, 1983, J MICROSC-OXFORD, V129, P89, DOI 10.1111/j.1365-2818.1983.tb04163.x; Lindert S, 2009, STRUCTURE, V17, P990, DOI 10.1016/j.str.2009.06.001; Lindert S, 2009, CURR OPIN STRUC BIOL, V19, P218, DOI 10.1016/j.sbi.2009.02.010; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; NOVOTNY J, 1984, J MOL BIOL, V177, P787, DOI 10.1016/0022-2836(84)90049-4; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; Samudrala R, 2000, PROTEIN SCI, V9, P1399, DOI 10.1110/ps.9.7.1399; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Svergun DI, 2010, BIOL CHEM, V391, P737, DOI 10.1515/BC.2010.093; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059; Zemla A, 1999, PROTEINS, P22	48	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49242	10.1371/journal.pone.0049242	http://dx.doi.org/10.1371/journal.pone.0049242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173051	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300021
J	Ogami, K; Hosoda, N; Funakoshi, Y; Hoshino, S				Ogami, K.; Hosoda, N.; Funakoshi, Y.; Hoshino, S.			Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB	ONCOGENE			English	Article						Tob; Caf1; CPEB; mRNA decay; deadenylation	MESSENGER-RNA TRANSLATION; CELL-CYCLE PROGRESSION; POLY(A)-BINDING PROTEIN; GROWTH-FACTORS; DEADENYLASE; IDENTIFICATION; COMPLEX; CAF1; PROLIFERATION; HIPPOCAMPUS	The regulation of mRNA deadenylation constitutes a pivotal mechanism of the post-transcriptional control of gene expression. Here we show that the antiproliferative protein Tob, a component of the Caf1-Ccr4 deadenylase complex, is involved in regulating the expression of the proto-oncogene c-myc. The c-myc mRNA contains cis elements (CPEs) in its 3'-untranslated region (3'-UTR), which are recognized by the cytoplasmic polyadenylation element-binding protein (CPEB). CPEB recruits Caf1 deadenylase through interaction with Tob to form a ternary complex, CPEB-Tob-Caf1, and negatively regulates the expression of c-myc by accelerating the deadenylation and decay of its mRNA. In quiescent cells, c-myc mRNA is destabilized by the trans-acting complex (CPEB-Tob-Caf1), while in cells stimulated by the serum, both Tob and Caf1 are released from CPEB, and c-Myc expression is induced early after stimulation by the stabilization of its mRNA as an 'immediate-early gene'. Collectively, these results indicate that Tob is a key factor in the regulation of c-myc gene expression, which is essential for cell growth. Thus, Tob appears to function in the control of cell growth at least, in part, by regulating the expression of c-myc.	[Ogami, K.; Hosoda, N.; Funakoshi, Y.; Hoshino, S.] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Nagoya, Aichi 4678603, Japan	Nagoya City University	Hoshino, S (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	hoshino@phar.nagoya-cu.ac.jp	Ogami, Koichi/K-1160-2019	Ogami, Koichi/0000-0001-9380-9666; Hoshino, Shinichi/0000-0001-6135-7896	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112006]; Grants-in-Aid for Scientific Research [24770116] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A-B Shyu for anti-Caf1 antibody. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'RNA regulation' (No. 20112006) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; DEAN M, 1986, J BIOL CHEM, V261, P9161; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Eckmann CR, 2011, WIRES RNA, V2, P348, DOI 10.1002/wrna.56; ELLIS RE, 1995, GENETICS, V139, P561; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hosoda N, 2011, EMBO J, V30, P1311, DOI 10.1038/emboj.2011.37; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Jin M, 2005, NEUROSCIENCE, V131, P647, DOI 10.1016/j.neuroscience.2004.10.044; Kerkhoff E, 1998, ONCOGENE, V16, P211, DOI 10.1038/sj.onc.1201520; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim KC, 2011, J NEUROSCI, V31, P12118, DOI 10.1523/JNEUROSCI.1621-11.2011; KINDY MS, 1986, J BIOL CHEM, V261, P2865; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; Macnicol MC, 2010, MOL REPROD DEV, V77, P662, DOI 10.1002/mrd.21191; Maekawa M, 2002, J BIOL CHEM, V277, P37783, DOI 10.1074/jbc.M204506200; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; Pique M, 2008, CELL, V132, P434, DOI 10.1016/j.cell.2007.12.038; Ren YG, 2002, J BIOL CHEM, V277, P5982, DOI 10.1074/jbc.M111515200; Ruan L, 2010, J BIOL CHEM, V285, P27624, DOI 10.1074/jbc.M110.138867; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Uchida N, 2004, J BIOL CHEM, V279, P1383, DOI 10.1074/jbc.M309125200; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; Wang XM, 2006, BIOCHEM BIOPH RES CO, V340, P1023, DOI 10.1016/j.bbrc.2005.12.125; Wang YY, 2008, DEV BIOL, V317, P454, DOI 10.1016/j.ydbio.2008.02.033; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	45	32	35	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					55	64		10.1038/onc.2012.548	http://dx.doi.org/10.1038/onc.2012.548			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23178487				2022-12-25	WOS:000329212000007
J	Ragnarsson, L; Wang, CIA; Andersson, A; Fajarningsih, D; Monks, T; Brust, A; Rosengren, KJ; Lewis, RJ				Ragnarsson, Lotten; Wang, Ching-I Anderson; Andersson, Asa; Fajarningsih, Dewi; Monks, Thea; Brust, Andreas; Rosengren, K. Johan; Lewis, Richard J.			Conopeptide rho-TIA Defines a New Allosteric Site on the Extracellular Surface of the alpha(1B)-Adrenoceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MUSCARINIC ACETYLCHOLINE-RECEPTORS; PHASE PEPTIDE-SYNTHESIS; CRYSTAL-STRUCTURE; DISULFIDE BOND; CYSTEINE RESIDUE-110; ANTAGONIST BINDING; HORMONE RECEPTOR; LIGAND-BINDING; RHODOPSIN; PROTEINS	The G protein-coupled receptor (GPCR) superfamily is an important drug target that includes over 1000 membrane receptors that functionally couple extracellular stimuli to intracellular effectors. Despite the potential of extracellular surface (ECS) residues in GPCRs to interact with subtype-specific allosteric modulators, few ECS pharmacophores for class A receptors have been identified. Using the turkey beta(1)-adrenergic receptor crystal structure, we modeled the alpha(1B)-adrenoceptor (alpha(1B)-AR) to help identify the allosteric site for rho-conopeptide TIA, an inverse agonist at this receptor. Combining mutational radioligand binding and inositol 1-phosphate signaling studies, together with molecular docking simulations using a refined NMR structure of rho-TIA, we identified 14 residues on the ECS of the alpha(1B)-AR that influenced rho-TIA binding. Double mutant cycle analysis and docking confirmed that rho-TIA binding was dominated by a salt bridge and cation-pi between Arg-4-rho-TIA and Asp-327 and Phe-330, respectively, and a T-stacking-pi interaction between Trp-3-rho-TIA and Phe-330. Water-bridging hydrogen bonds between Asn-2-rho-TIA and Val-197, Trp-3-rho-TIA and Ser-318, and the positively charged N terminus and Glu-186, were also identified. These interactions reveal that peptide binding to the ECS on transmembrane helix 6 (TMH6) and TMH7 at the base of extracellular loop 3 (ECL3) is sufficient to allosterically inhibit agonist signaling at a GPCR. The ligand-accessible ECS residues identified provide the first view of an allosteric inhibitor pharmacophore for alpha(1)-adrenoceptors and mechanistic insight and a new set of structural constraints for the design of allosteric antagonists at related GPCRs.	[Ragnarsson, Lotten; Wang, Ching-I Anderson; Andersson, Asa; Fajarningsih, Dewi; Monks, Thea; Brust, Andreas; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	r.lewis@imb.uq.edu.au	Lewis, Richard/T-8763-2019; Ragnarsson, Lotten/A-8632-2012; Lewis, Richard J/E-8674-2013; Rosengren, K. Johan/P-4450-2016	Lewis, Richard/0000-0003-3470-923X; Ragnarsson, Lotten/0000-0002-7137-1656; Lewis, Richard J/0000-0003-3470-923X; Rosengren, K. Johan/0000-0002-5007-8434; Brust, Andreas/0000-0003-4238-5706; Fajarningsih, Nurrahmi Dewi/0000-0002-9111-9036	National Health and Medical Research Council [011246, 351446]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Project Grants 011246 and 351446 and a National Health and Medical Research Council Principal Research Fellowship (to R. J. L.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson HS, 2012, AMINO ACIDS, V43, P1471, DOI 10.1007/s00726-012-1220-3; Asher WB, 2007, J CHEM INF MODEL, V47, P1906, DOI 10.1021/ci700026v; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brust A, 2009, J MED CHEM, V52, P6991, DOI 10.1021/jm9003413; BUCK MA, 1989, ANAL BIOCHEM, V182, P295, DOI 10.1016/0003-2697(89)90597-6; Chen SH, 1999, J BIOL CHEM, V274, P16320, DOI 10.1074/jbc.274.23.16320; Chen ZJ, 2004, J BIOL CHEM, V279, P35326, DOI 10.1074/jbc.M403703200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; Correa SAA, 2006, REGUL PEPTIDES, V134, P132, DOI 10.1016/j.regpep.2006.02.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DOHLMAN HG, 1990, BIOCHEMISTRY-US, V29, P2335, DOI 10.1021/bi00461a018; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FRASER CM, 1989, J BIOL CHEM, V264, P9266; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Ilyin VA, 2004, PROTEIN SCI, V13, P1865, DOI 10.1110/ps.04672604; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; KURTENBACH E, 1990, J BIOL CHEM, V265, P13702; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; McCune DF, 2000, MOL PHARMACOL, V57, P659, DOI 10.1124/mol.57.4.659; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PERLMAN JH, 1995, J BIOL CHEM, V270, P24682, DOI 10.1074/jbc.270.42.24682; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Sharpe IA, 2003, J BIOL CHEM, V278, P34451, DOI 10.1074/jbc.M305410200; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Wang C. I., 2012, BIOCH PHARM IN PRESS; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Waugh DJJ, 2001, J BIOL CHEM, V276, P25366, DOI 10.1074/jbc.M103152200; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhong HY, 1999, EUR J PHARMACOL, V375, P261, DOI 10.1016/S0014-2999(99)00222-8; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555	56	22	23	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1814	1827		10.1074/jbc.M112.430785	http://dx.doi.org/10.1074/jbc.M112.430785			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184947	hybrid, Green Published			2022-12-25	WOS:000313751400037
J	Meshi, D; Biele, G; Korn, CW; Heekeren, HR				Meshi, Dar; Biele, Guido; Korn, Christoph W.; Heekeren, Hauke R.			How Expert Advice Influences Decision Making	PLOS ONE			English	Article							IMPROVING JUDGMENT; CINGULATE CORTEX; FRONTAL-CORTEX; BRAIN; ANTICIPATION; COMPUTATION; MECHANISMS; ROBUST	People often use expert advice when making decisions in our society, but how we are influenced by this advice has yet to be understood. To address this, using functional magnetic resonance imaging, we provided expert and novice advice to participants during an estimation task. Participants reported that they valued expert advice more than novice advice, and activity in the ventral striatum correlated with this valuation, even before decisions with the advice were made. When using advice, participants compared their initial opinion to their advisor's opinion. This comparison, termed the "opinion difference", influenced advice utilization and was represented in reward-sensitive brain regions. Finally, the left lateral orbitofrontal cortex integrated both the size of the opinion difference and the advisor's level of expertise, and average activity in this area correlated with mean advice utilization across participants. Taken together, these findings provide neural evidence for how advice engenders behavioral change during the decision-making process.	[Meshi, Dar; Korn, Christoph W.; Heekeren, Hauke R.] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany; [Meshi, Dar; Korn, Christoph W.; Heekeren, Hauke R.] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Meshi, Dar; Korn, Christoph W.; Heekeren, Hauke R.] Free Univ Berlin, Dahlem Inst Neuroimaging Emot, Berlin, Germany; [Biele, Guido] Univ Oslo, Dept Psychol, Ctr Study Human Cognit, N-0316 Oslo, Norway	Humboldt University of Berlin; Free University of Berlin; Free University of Berlin; University of Oslo	Meshi, D (corresponding author), Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany.	darmeshi@yahoo.com; hauke.heekeren@fu-berlin.de	Biele, Guido/D-2265-2011; Heekeren, Hauke/B-7739-2008	Biele, Guido/0000-0002-4225-9024; Heekeren, Hauke/0000-0001-7912-6826; Korn, Christoph/0000-0002-8228-2624; Meshi, Dar/0000-0003-0772-037X	Excellence Initiative of the German Federal Ministry of Education and Research; Humboldt University in Berlin	Excellence Initiative of the German Federal Ministry of Education and Research; Humboldt University in Berlin	This work was supported by the Excellence Initiative of the German Federal Ministry of Education and Research, and Humboldt University in Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2010, NAT REV NEUROSCI, V11, P284, DOI 10.1038/nrn2795; Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Berns GS, 2005, BIOL PSYCHIAT, V58, P245, DOI 10.1016/j.biopsych.2005.04.012; Biele G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001089; Bonaccio S, 2006, ORGAN BEHAV HUM DEC, V101, P127, DOI 10.1016/j.obhdp.2006.07.001; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Campbell-Meiklejohn DK, 2012, CURR BIOL, V22, pR123, DOI 10.1016/j.cub.2012.01.012; Campbell-Meiklejohn DK, 2010, CURR BIOL, V20, P1165, DOI 10.1016/j.cub.2010.04.055; Engelmann JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004957; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Harvey N, 1997, ORGAN BEHAV HUM DEC, V70, P117, DOI 10.1006/obhd.1997.2697; Herzog SM, 2009, PSYCHOL SCI, V20, P231, DOI 10.1111/j.1467-9280.2009.02271.x; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Jungermann H, 2005, USING EXPERTISE EXPE; Klucharev V, 2008, SOC COGN AFFECT NEUR, V3, P353, DOI 10.1093/scan/nsn022; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2007, ANN NY ACAD SCI, V1104, P54, DOI 10.1196/annals.1390.020; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Philiastides MG, 2010, P NATL ACAD SCI USA, V107, P9430, DOI 10.1073/pnas.1001732107; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Rushworth MF, 2012, CURRENT OPINION NEUR; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sniezek JA, 2001, ORGAN BEHAV HUM DEC, V84, P288, DOI 10.1006/obhd.2000.2926; Sniezek JA, 2004, J BEHAV DECIS MAKING, V17, P173, DOI 10.1002/bdm.468; Soll JB, 2009, J EXP PSYCHOL LEARN, V35, P780, DOI 10.1037/a0015145; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Yaniv I, 2004, ORGAN BEHAV HUM DEC, V93, P1, DOI 10.1016/j.obhdp.2003.08.002; Zaki J, 2011, PSYCHOL SCI, V22, P894, DOI 10.1177/0956797611411057	39	43	45	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49748	10.1371/journal.pone.0049748	http://dx.doi.org/10.1371/journal.pone.0049748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185425	Green Published, gold			2022-12-25	WOS:000311821000100
J	Chou, CH; Lin, CC; Yang, MC; Wei, CC; Liao, HD; Lin, RC; Tu, WY; Kao, TC; Hsu, CM; Cheng, JT; Chou, AK; Lee, CI; Loh, JK; Howng, SL; Hong, YR				Chou, Chia-Hua; Lin, Ching-Chih; Yang, Ming-Chang; Wei, Chih-Chang; Liao, Huei-De; Lin, Run-Chin; Tu, Wen-Yu; Kao, Tsung-Chieh; Hsu, Ching-Mei; Cheng, Jiin-Tsuey; Chou, An-Kuo; Lee, Chu-I; Loh, Joon-Khim; Howng, Shen-Long; Hong, Yi-Ren			GSK3beta-Mediated Drp1 Phosphorylation Induced Elongated Mitochondrial Morphology against Oxidative Stress	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DEPENDENT PROTEIN-KINASE; ALZHEIMERS-DISEASE; GTPASE DRP1; FISSION; NEURODEGENERATION; DEGRADATION; APOPTOSIS; AUTOPHAGY; VARIANTS	Multiple phosphorylation sites of Drp1 have been characterized for their functional importance. However, the functional consequence of GSK3beta-mediated phosphorylation of Drp1 remains unclear. In this report, we pinpointed 11 Serine/Threonine sites spanning from residue 634 similar to 736 of the GED domain and robustly confirmed Drp1 Ser693 as a novel GSK3beta phosphorylation site. Our results suggest that GSK3beta-mediated phosphorylation at Ser693 does cause a dramatic decrease of GTPase activity; in contrast, GSK3beta-mediated phosphorylation at Ser693 appears not to affect Drp1 inter-/intra-molecular interactions. After identifying Ser693 as a GSK3beta phosphorylation site, we also determined that K679 is crucial for GSK3beta-binding, which strongly suggests that Drp1 is a novel substrate for GSK3beta. Thereafter, we found that overexpressed S693D, but not S693A mutant, caused an elongated mitochondrial morphology which is similar to that of K38A, S637D and K679A mutants. Interestedly, using H89 and LiCl to inhibit PKA and GSK3beta signaling, respectively, it appears that a portion of the elongated mitochondria switched to a fragmented phenotype. In investigating the biofunctionality of phosphorylation sites within the GED domain, cells overexpressing Drp1 S693D and S637D, but not S693A, showed an acquired resistance to H2O2-induced mitochondrial fragmentation and ensuing apoptosis, which affected cytochrome c, capase-3, -7, and PARP, but not LC3B, Atg-5, Beclin-1 and Bcl2 expressions. These results also showed that the S693D group is more effective in protecting both non-neuronal and neuronal cells from apoptotic death than the S637D group. Altogether, our data suggest that GSK3beta-mediated phosphorylation at Ser693 of Drp1 may be associated with mitochondrial elongation via down-regulating apoptosis, but not autophagy upon H2O2 insult.	[Chou, Chia-Hua; Lin, Ching-Chih; Yang, Ming-Chang; Wei, Chih-Chang; Liao, Huei-De; Lin, Run-Chin; Tu, Wen-Yu; Kao, Tsung-Chieh; Hong, Yi-Ren] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, Kaohsiung, Taiwan; [Chou, Chia-Hua; Yang, Ming-Chang; Hsu, Ching-Mei; Cheng, Jiin-Tsuey; Hong, Yi-Ren] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Yang, Ming-Chang] Kaohsiung Armed Forces Gen Hosp, Lab Genet Res, Kaohsiung, Taiwan; [Chou, An-Kuo; Loh, Joon-Khim; Howng, Shen-Long; Hong, Yi-Ren] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chou, An-Kuo] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Chou, An-Kuo] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lee, Chu-I] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Loh, Joon-Khim; Howng, Shen-Long] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Fooyin University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Hong, YR (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Biochem, Kaohsiung, Taiwan.	m835016@cc.kmu.edu.tw		Hong, Yi-Ren/0000-0001-5470-6090; Yang, Ming-Chang/0000-0001-8657-8708	National Science Council [98-2320-B-037-024-MY3, 98-2321-B-037-061, 99-2321-B-037-001, 100-2314-B-037-010]; National Health Research Intitute (Taiwan) [EX100-9809SI]; National Sun Yet-San University-Kaohsiung Medical University Joint Research Project [101-020]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Intitute (Taiwan); National Sun Yet-San University-Kaohsiung Medical University Joint Research Project	This study was sponsored by National Science Council-98-2320-B-037-024-MY3; National Science Council -98-2321-B-037-061; National Science Council-99-2321-B-037-001; National Health Research Intitute-EX100-9809SI (Taiwan); National Sun Yet-San University-Kaohsiung Medical University Joint Research Project-101-020 to Yi-Ren Hong and National Science Council-100-2314-B-037-010 (Taiwan) to Shen-Long Howng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen CH, 2000, DNA CELL BIOL, V19, P189, DOI 10.1089/104454900314573; Chen CH, 2000, BIOCHEM BIOPH RES CO, V268, P893, DOI 10.1006/bbrc.2000.2197; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Cho J, 2009, J BIOL CHEM, V284, P36647, DOI 10.1074/jbc.M109.019109; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Gadjev Ilya, INT REV CELL MOL BIO, P87, DOI [DOI 10.1016/S1937-6448(10)8305-9, 10.1016/S1937-6448(08)01403-2, DOI 10.1016/S1937-6448(08)01403-2]; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hong YR, 1998, BIOCHEM BIOPH RES CO, V249, P697, DOI 10.1006/bbrc.1998.9253; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Howng SL, 2010, MOL CELL BIOCHEM, V339, P23, DOI 10.1007/s11010-009-0366-0; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lin CC, 2009, J CELL BIOCHEM, V108, P1325, DOI 10.1002/jcb.22362; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Rambold Angelika S, 2011, Commun Integr Biol, V4, P752; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Wang S, 2012, EUR J NEUROL, V19, P1015, DOI 10.1111/j.1468-1331.2012.03670.x; Wasilewski M, 2009, TRENDS ENDOCRIN MET, V20, P287, DOI 10.1016/j.tem.2009.03.007; Wilson TJ, 2012, NEUROBIOL DIS; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	41	79	82	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49112	10.1371/journal.pone.0049112	http://dx.doi.org/10.1371/journal.pone.0049112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185298	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700025
J	Levis, C; de Souza, PF; Schietti, J; Emilio, T; Pinto, JLPD; Clement, CR; Costa, FRC				Levis, Carolina; de Souza, Priscila Figueira; Schietti, Juliana; Emilio, Thaise; Purri da Veiga Pinto, Jose Luiz; Clement, Charles R.; Costa, Flavia R. C.			Historical Human Footprint on Modern Tree Species Composition in the Purus-Madeira Interfluve, Central Amazonia	PLOS ONE			English	Article							PRISTINE MYTH; FOREST; OCCUPATION; SETTLEMENT; DIVERSITY; PATTERNS; ECOLOGY; RECORDS; BRAZIL; BASIN	Background: Native Amazonian populations managed forest resources in numerous ways, often creating oligarchic forests dominated by useful trees. The scale and spatial distribution of forest modification beyond pre-Columbian settlements is still unknown, although recent studies propose that human impact away from rivers was minimal. We tested the hypothesis that past human management of the useful tree community decreases with distance from rivers. Methodology/Principal Findings: In six sites, we inventoried trees and palms with DBH >= 10 cm and collected soil for charcoal analysis; we also mapped archaeological evidence around the sites. To quantify forest manipulation, we measured the relative abundance, richness and basal area of useful trees and palms. We found a strong negative exponential relationship between forest manipulation and distance to large rivers. Plots located from 10 to 20 km from a main river had 20-40% useful arboreal species, plots between 20 and 40 km had 12-23%, plots more than 40 km had less than 15%. Soil charcoal abundance was high in the two sites closest to secondary rivers, suggesting past agricultural practices. The shortest distance between archaeological evidence and plots was found in sites near rivers. Conclusions/Significance: These results strongly suggest that past forest manipulation was not limited to the pre-Columbian settlements along major rivers, but extended over interfluvial areas considered to be primary forest today. The sustainable use of Amazonian forests will be most effective if it considers the degree of past landscape domestication, as human-modified landscapes concentrate useful plants for human sustainable use and management today.	[Levis, Carolina; Schietti, Juliana; Emilio, Thaise] INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [de Souza, Priscila Figueira] INPA, Programa Posgrad Bot, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Levis, C (corresponding author), INPA, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	carollevis@gmail.com	Clement, Charles Roland/G-6081-2010; Costa, Flavia/K-4386-2014; Schietti, Juliana/B-8226-2015; Schietti, Juliana/AAV-7451-2020; Emilio, Thaise/A-6221-2013	Clement, Charles Roland/0000-0002-8421-1029; Costa, Flavia/0000-0002-9600-4625; Schietti, Juliana/0000-0002-1687-4373; Schietti, Juliana/0000-0002-1687-4373; Emilio, Thaise/0000-0001-5415-1822	FAPEAM/FAPESP [09/53369-6]; CNPq/FAPEAM/PRONEX [673/2010]; CENBAM/MCTI/CNPq/INPA	FAPEAM/FAPESP; CNPq/FAPEAM/PRONEX; CENBAM/MCTI/CNPq/INPA	This work was supported by FAPEAM/FAPESP (project no. 09/53369-6, led by FRCC), CNPq/FAPEAM/PRONEX (project no. 673/2010 led by William E. Magnusson, INPA) and CENBAM/MCTI/CNPq/INPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALEE W, 1990, BIOTROPICA, V22, P36, DOI 10.2307/2388717; Balee W., 2010, Diversity, V2, P163; Balee W., 1989, Advances in Economic Botany, V7, P1; Barlow J, 2012, BIOL CONSERV, V151, P45, DOI 10.1016/j.biocon.2011.10.013; Brasil, 2000, SIST NAC UN CONS NAT; Brazil, 1978, PROJ RADAMBRASIL FOL; Bush MB, 2007, FRONT ECOL ENVIRON, V5, P457, DOI 10.1890/070018; Bush MB, 2007, PHILOS T R SOC B, V362, P209, DOI 10.1098/rstb.2006.1980; Cavalcante PB, 2010, FRUTAS COMESTIVEIS A; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Clark DB, 1996, J TROP ECOL, V12, P735, DOI 10.1017/S0266467400009937; Clement CR, 2010, BIOTROPICA, V42, P534, DOI 10.1111/j.1744-7429.2010.00674.x; Clement CR, 1999, ECON BOT, V53, P188, DOI 10.1007/BF02866498; Clement CR, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P159, DOI 10.1007/1-4020-2597-1_9; Cunha R.D., 2009, DOMESTICACAO MELHORA, P275; Dambrine E, 2007, ECOLOGY, V88, P1430, DOI 10.1890/05-1314; Denevan WM, 2011, GEOGR REV, V101, P576, DOI 10.1111/j.1931-0846.2011.00118.x; Denevan WM, 1996, ANN ASSOC AM GEOGR, V86, P654, DOI 10.1111/j.1467-8306.1996.tb01771.x; Erickson CL, 2006, HIST ECOL SER, P187; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Guix Juan Carlos, 2005, Grupo de Estudos Ecologicos Serie Documentos, V8, P1; Heckenberger MJ, 2007, PHILOS T R SOC B, V362, P197, DOI 10.1098/rstb.2006.1979; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; Irion G., 2010, AMAZONIAN FLOODPLAIN, P27, DOI [10.1007/978-90-481-8725-6_2, DOI 10.1007/978-90-481-8725-6_2]; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Junqueira AB, 2011, ECON BOT, V65, P85, DOI 10.1007/s12231-010-9138-8; Junqueira AB, 2010, BIODIVERS CONSERV, V19, P1933, DOI 10.1007/s10531-010-9813-1; KAHN F, 1985, BIOTROPICA, V17, P210, DOI 10.2307/2388221; KAHN F, 1990, FOREST ECOL MANAG, V33-4, P169, DOI 10.1016/0378-1127(90)90191-D; Lopez-Zent E, 2004, ETHNOBOTANY CONSERVA, P79; Magnusson WE, 2008, BIOTROPICA, V40, P409, DOI 10.1111/j.1744-7429.2008.00427.x; McMichael CH, 2012, SCIENCE, V336, P1429, DOI 10.1126/science.1219982; McMichael CH, 2012, HOLOCENE, V22, P131, DOI 10.1177/0959683611414932; Morcote-Rios G, 2001, BOT REV, V67, P309, DOI 10.1007/BF02858098; Moretzsohn MC, 2002, EUPHYTICA, V124, P35, DOI 10.1023/A:1015606304653; Parssinen M, 2009, ANTIQUITY, V83, P1084, DOI 10.1017/S0003598X00099373; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Peres CA, 2010, BIOL CONSERV, V143, P2314, DOI 10.1016/j.biocon.2010.01.021; PETERS CM, 2000, IMPERFECT BALANCE LA, P203; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno DR, 1996, QUATERNARY RES, V45, P202, DOI 10.1006/qres.1996.0020; Pitman NCA, 2011, TROP CONSERV SCI, V4, P64, DOI 10.1177/194008291100400107; Politis GG, 1996, WORLD ARCHAEOL, V27, P492, DOI 10.1080/00438243.1996.9980322; Posey D. A., 1985, Agroforestry Systems, V3, P139, DOI 10.1007/BF00122640; PRANCE G T, 1987, Conservation Biology, V1, P296, DOI 10.1111/j.1523-1739.1987.tb00050.x; Ross NJ, 2011, ECOL APPL, V21, P75, DOI 10.1890/09-0662.1; Salm R., 2005, BIOTA NEOTROP, V5, P35, DOI [10.1590/S1676-06032005000100004, DOI 10.1590/S1676-06032005000100004]; Sanford RL, 2000, US FOR SERV RMRS-P, V3, P168; Scoles R, 2012, FOREST ECOL MANAG, V265, P71, DOI 10.1016/j.foreco.2011.10.027; Scoles R, 2011, HUM ECOL, V39, P455, DOI 10.1007/s10745-011-9412-0; Shepard Glenn H., 2002, Cambridge Studies in Biological and Evolutionary Anthropology, V29, P101; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; SMITH NJH, 1980, ANN ASSOC AM GEOGR, V70, P553, DOI 10.1111/j.1467-8306.1980.tb01332.x; Souza A.D., 2011, FRUIT TREES USEFUL P, P121; Stahl PW, 2008, QUATERN INT, V180, P5, DOI 10.1016/j.quaint.2007.08.028; Svenning JC, 1999, J TROP ECOL, V15, P355, DOI 10.1017/S0266467499000875; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991; Wills KJ, 2007, PHIL T R SOC B, V362, P115; WinklerPrins AMGA, 2010, J LAT AM GEOGR, V9, P33, DOI 10.1353/lag.2010.0029; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060	61	68	71	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48559	10.1371/journal.pone.0048559	http://dx.doi.org/10.1371/journal.pone.0048559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	043II	23185264	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700013
J	Martin, KR; Narang, P; Xu, Y; Kauffman, AL; Petit, J; Xu, HE; Meurice, N; MacKeigan, JP				Martin, Katie R.; Narang, Pooja; Xu, Yong; Kauffman, Audra L.; Petit, Joachim; Xu, H. Eric; Meurice, Nathalie; MacKeigan, Jeffrey P.			Identification of Small Molecule Inhibitors of PTPs through an Integrative Virtual and Biochemical Approach	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; STRUCTURE-BASED DISCOVERY; 1B INHIBITORS; DRUG DISCOVERY; HUMAN-DISEASE; DOCKING; SIGMA; RECEPTOR; REGENERATION; MECHANISM	PTP sigma is a dual-domain receptor type protein tyrosine phosphatase (PTP) with physiologically important functions which render this enzyme an attractive biological target. Specifically, loss of PTP sigma has been shown to elicit a number of cellular phenotypes including enhanced nerve regeneration following spinal cord injury (SCI), chemoresistance in cultured cancer cells, and hyperactive autophagy, a process critical to cell survival and the clearance of pathological aggregates in neurodegenerative diseases. Owing to these functions, modulation of PTP sigma may provide therapeutic value in a variety of contexts. Furthermore, a small molecule inhibitor would provide utility in discerning the cellular functions and substrates of PTP sigma. To develop such molecules, we combined in silico modeling with in vitro phosphatase assays to identify compounds which effectively inhibit the enzymatic activity of PTP sigma. Importantly, we observed that PTP sigma inhibition was frequently mediated by oxidative species generated by compounds in solution, and we further optimized screening conditions to eliminate this effect. We identified a compound that inhibits PTP sigma with an IC50 of 10 mu M in a manner that is primarily oxidation-independent. This compound favorably binds the D1 active site of PTP sigma in silico, suggesting it functions as a competitive inhibitor. This compound will serve as a scaffold structure for future studies designed to build selectivity for PTP sigma over related PTPs.	[Martin, Katie R.; Kauffman, Audra L.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI USA; [Narang, Pooja; Petit, Joachim; Meurice, Nathalie] Mayo Clin, Scottsdale, AZ USA; [Xu, Yong; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA	Van Andel Institute; Mayo Clinic; Mayo Clinic Phoenix; Van Andel Institute	MacKeigan, JP (corresponding author), Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI USA.	jeff.mackeigan@vai.org	Xu, H. Eric/ABD-7487-2021	MacKeigan, Jeffrey/0000-0002-0198-5679; Xu, H. Eric/0000-0002-6829-8144; Martin, Katie/0000-0002-3689-4814	Department of Defense Prostate Cancer Research Program of the Office of Congressionally Directed Medical Research Programs [PC081089]; National Cancer Institute [R01CA138651]; National Institute of Mental Health [RC2MH090878]; NATIONAL CANCER INSTITUTE [R01CA138651] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research Program of the Office of Congressionally Directed Medical Research Programs(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Prostate Cancer Research Program of the Office of Congressionally Directed Medical Research Programs PC081089 to JPM. JPM is also supported by Award Number R01CA138651 from the National Cancer Institute. Award Number RC2MH090878 from the National Institute of Mental Health awarded to NM provided partial support for the work described in this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Blaskovich MAT, 2009, CURR MED CHEM, V16, P2095, DOI 10.2174/092986709788612693; Bova MP, 2004, ARCH BIOCHEM BIOPHYS, V429, P30, DOI 10.1016/j.abb.2004.05.010; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Faux C, 2007, BBA-MOL CELL RES, V1773, P1689, DOI 10.1016/j.bbamcr.2007.06.008; Floriano WB, 2004, J MED CHEM, V47, P56, DOI 10.1021/jm030271v; Fry EJ, GLIA, V58, P423; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; He R, 2012, FEBS J; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Hu X, 2004, J MOL GRAPH MODEL, V23, P175, DOI 10.1016/j.jmgm.2004.05.004; Hu X, 2006, BIOORG MED CHEM LETT, V16, P6321, DOI 10.1016/j.bmcl.2006.09.010; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lavecchia A, 2006, CHEMMEDCHEM, V1, P540, DOI 10.1007/CMDC.200500092; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Martin KR, 2011, J CELL SCI, V124, P812, DOI 10.1242/jcs.080341; Mattila E, 2011, ANTI-CANCER AGENT ME, V11, P141, DOI 10.2174/187152011794941235; McLean J, 2002, J NEUROSCI, V22, P5481; Murthy VS, 2002, BIOORGAN MED CHEM, V10, P2267, DOI 10.1016/S0968-0896(02)00056-1; N Suresh NV, 2010, J PROTEOM BIOINFORM, V3, P020; Park H, 2009, EUR J MED CHEM, V44, P3280, DOI 10.1016/j.ejmech.2009.02.011; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Sarmiento M, 2000, J MED CHEM, V43, P146, DOI 10.1021/jm990329z; Shen K, 2001, J BIOL CHEM, V276, P47311, DOI 10.1074/jbc.M106568200; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shim YS, 2005, BIOORGAN MED CHEM, V13, P1325, DOI 10.1016/j.bmc.2004.11.006; Siu R, 2007, MOL CELL BIOL, V27, P208, DOI 10.1128/MCB.00707-06; Sobhia ME, 2005, BIOORGAN MED CHEM, V13, P2331, DOI 10.1016/j.bmc.2004.12.039; Stanford SM, 2011, J MED CHEM, V54, P1640, DOI 10.1021/jm101202j; Sun JP, 2003, J BIOL CHEM, V278, P12406, DOI 10.1074/jbc.M212491200; Taha MO, 2005, J MED CHEM, V48, P8016, DOI 10.1021/jm058047o; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Tautz L, 2007, METHODS, V42, P250, DOI 10.1016/j.ymeth.2007.02.014; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Tierno MB, 2007, NAT PROTOC, V2, P1134, DOI 10.1038/nprot.2007.155; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Urbanek RA, 2001, J MED CHEM, V44, P1777, DOI 10.1021/jm000447i; Vidal D, 2007, EUR J MED CHEM, V42, P1102, DOI 10.1016/j.ejmech.2007.01.017; Wang J, 2003, J COMPUT AID MOL DES, V17, P495, DOI 10.1023/B:JCAM.0000004602.70594.5f; Wu SD, 2009, CHEMMEDCHEM, V4, P440, DOI 10.1002/cmdc.200800375; Yang CH, 2004, J MED CHEM, V47, P5984, DOI 10.1021/jm0497242; Yu X, 2007, P NATL ACAD SCI USA, V104, P19767, DOI 10.1073/pnas.0706233104; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	49	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50217	10.1371/journal.pone.0050217	http://dx.doi.org/10.1371/journal.pone.0050217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185579	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700079
J	Stavenga, DG; Leertouwer, HL; Hariyama, T; De Raedt, HA; Wilts, BD				Stavenga, Doekele G.; Leertouwer, Hein L.; Hariyama, Takahiko; De Raedt, Hans A.; Wilts, Bodo D.			Sexual Dichromatism of the Damselfly Calopteryx japonica Caused by a Melanin-Chitin Multilayer in the Male Wing Veins	PLOS ONE			English	Article							STRUCTURAL COLORS; REFRACTIVE-INDEX; INTERFERENCE; EUMELANIN; IRIDESCENCE; COLORATION; FEATHERS; SYSTEMS; BEETLE	Mature male Calopteryx japonica damselflies have dark-blue wings, due to darkly coloured wing membranes and blue reflecting veins. The membranes contain a high melanin concentration and the veins have a multilayer of melanin and chitin. Female and immature C. japonica damselflies have brown wings. We have determined the refractive index of melanin by comparing the differently pigmented wing membranes and applying Jamin-Lebedeff interference microscopy. Together with the previously measured refractive index of chitin the blue, structural colour of the male wing veins could be quantitatively explained by an optical multilayer model. The obtained melanin refractive index data will be useful in optical studies on melanized tissues, especially where melanin is concentrated in layers, thus causing iridescence.	[Stavenga, Doekele G.; Leertouwer, Hein L.; De Raedt, Hans A.; Wilts, Bodo D.] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands; [Hariyama, Takahiko] Hamamatsu Univ Sch Med, Dept Biol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan	University of Groningen; Hamamatsu University School of Medicine	Stavenga, DG (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands.	D.G.Stavenga@rug.nl	Wilts, Bodo/H-1867-2011; Institute, Zernike/W-7033-2019	Wilts, Bodo/0000-0002-2727-7128; De Raedt, Hans/0000-0001-8461-4015	Air Force Office of Scientific Research/European Office of Aerospace Research and Development AFOSR/EOARD [FA8655-08-1-3012]	Air Force Office of Scientific Research/European Office of Aerospace Research and Development AFOSR/EOARD(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This study was financially supported by the Air Force Office of Scientific Research/European Office of Aerospace Research and Development AFOSR/EOARD (grant FA8655-08-1-3012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brink DJ, 2004, J PHYS D APPL PHYS, V37, P813, DOI 10.1088/0022-3727/37/5/025; Durrer H., 1977, Denkschriften der Schweizerischen Naturforschenden Gesellschaft, V91, P1; Hariyama T, 2005, STRUCTURAL COLORS BI, P153; KURTZ SK, 1986, J INVEST DERMATOL, V87, P401; LAND MF, 1972, PROGR BIOPHYSICS MOL, V24, P77, DOI DOI 10.1016/0079-6107(72)90004-1; Leertouwer HL, 2011, OPT EXPRESS, V19, P24061, DOI 10.1364/OE.19.024061; Mason CW, 1927, J PHYS CHEM-US, V31, P321, DOI 10.1021/j150273a001; Meredith P, 2006, SOFT MATTER, V2, P37, DOI 10.1039/b511922g; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Momose M, 2011, PATHOL INT, V61, P345, DOI 10.1111/j.1440-1827.2011.02667.x; Noyes JA, 2007, OPT EXPRESS, V15, P4351, DOI 10.1364/OE.15.004351; SARNA T, 1984, PHOTOCHEM PHOTOBIOL, V39, P69, DOI 10.1111/j.1751-1097.1984.tb03406.x; SCHULTZ TD, 1985, J EXP BIOL, V117, P87; Shawkey MD, 2009, J R SOC INTERFACE, V6, pS221, DOI 10.1098/rsif.2008.0459.focus; Shawkey MD, 2006, J R SOC INTERFACE, V3, P777, DOI 10.1098/rsif.2006.0131; Stavenga DG, 2011, PHILOS T R SOC B, V366, P709, DOI 10.1098/rstb.2010.0197; Vukusic P, 2004, P ROY SOC B-BIOL SCI, V271, P595, DOI 10.1098/rspb.2003.2595; Vukusic P, 2009, J R SOC INTERFACE, V6, pS133, DOI 10.1098/rsif.2008.0386.focus; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794; Yoshioka S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051917; Zi J, 2003, P NATL ACAD SCI USA, V100, P12576, DOI 10.1073/pnas.2133313100; Zonios G, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2844710	22	68	69	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49743	10.1371/journal.pone.0049743	http://dx.doi.org/10.1371/journal.pone.0049743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185423	Green Submitted, gold, Green Published			2022-12-25	WOS:000311535700051
J	Zanoni, BC; Sunpath, H; Feeney, ME				Zanoni, Brian C.; Sunpath, Henry; Feeney, Margaret E.			Pediatric Response to Second-Line Antiretroviral Therapy in South Africa	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; PROTEASE INHIBITOR; HIV-1-INFECTED CHILDREN; VERTICAL TRANSMISSION; VIRAL SUPPRESSION; NEVIRAPINE; LOPINAVIR; PHARMACOKINETICS; RESISTANCE; RITONAVIR	Background: With improved access to pediatric antiretroviral therapy (ART) in resource-limited settings, more children could experience first-line ART treatment failure. Methods: We performed a retrospective cohort analysis using electronic medical records from HIV-infected children who initiated ART at McCord Hospital's Sinikithemba Clinic in KwaZulu-Natal, South Africa, from August 2003 to December 2010. We analyzed all records from children who began second-line ART due to first-line treatment failure. We used logistic regression to compare viral outcomes in Protease Inhibitor (PI)-based versus Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-based second-line ART, controlling for time on first-line ART, sex, and whether HIV genotyping guided the regimen change. Results: Of the 880 children who initiated ART during this time period, 80 (9.1%) switched to second-line ART due to therapeutic failure of first-line ART after a median of 95 weeks (IQR 65-147 weeks). Eight (10%) of the failures received NNRTI-based second-line ART, all of whom failed a PI-based first-line regimen. Seventy (87.5%) received PI-based second-line ART, all of whom failed a NNRTI-based first-line regimen. Two children (2.5%) received non-standard dual therapy as second-line ART. Six months after switching ART regimens, the viral suppression rate was significantly higher in the PI group (82%) than in the NNRTI group (29%; p = 0.003). Forty-one children (51%) were tested for genotypic resistance prior to switching to second-line ART. There was no significant difference in six month viral suppression (p = 0.38) between children with and without genotype testing. Conclusion: NNRTI-based second-line ART carries a high risk of virologic failure compared to PI-based second-line ART.	[Zanoni, Brian C.; Feeney, Margaret E.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Charlestown, MA USA; [Zanoni, Brian C.] Harvard Univ, Sch Med, Boston, MA USA; [Zanoni, Brian C.; Sunpath, Henry; Feeney, Margaret E.] McCord Hosp, Sinikithemba Clin, Durban, South Africa; [Zanoni, Brian C.; Sunpath, Henry; Feeney, Margaret E.] McCord Hosp, Philani Program, Durban, South Africa; [Sunpath, Henry] Nelson Mandela Sch Med, Infect Dis Unit, Durban, South Africa; [Feeney, Margaret E.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; University of Kwazulu Natal; University of California System; University of California San Francisco	Feeney, ME (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Charlestown, MA USA.	margaret.feeney@ucsf.edu	Zanoni, Brian/AAI-4916-2021		NIAID NIH HHS [P30 AI060354] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Barth RE, 2011, PEDIATR INFECT DIS J, V30, P52, DOI 10.1097/INF.0b013e3181ed2af3; Blanche S, 2009, AIDS, V23, P2005, DOI 10.1097/QAD.0b013e328330abaa; Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; Cvetkovic RS, 2003, DRUGS, V63, P769, DOI 10.2165/00003495-200363080-00004; Davies MA, 2011, JAIDS-J ACQ IMM DEF, V56, P270, DOI 10.1097/QAI.0b013e3182060610; Eley BS, 2011, PEDIATR DRUGS, V13, P303, DOI 10.2165/11593330-000000000-00000; Emmett SD, 2010, JAIDS-J ACQ IMM DEF, V54, P368, DOI 10.1097/QAI.0b013e3181cf4882; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Foca M, 2006, PEDIATRICS, V118, P146, DOI 10.1542/peds.2005-0294; Giaquinto C, 2002, AIDS, V16, P97, DOI 10.1097/00002030-200201040-00012; Hurst M, 2000, DRUGS, V60, P1371, DOI 10.2165/00003495-200060060-00009; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; McIlleron H, 2011, ANTIVIR THER, V16, P417, DOI 10.3851/IMP1757; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Moyle G, 2007, JAIDS-J ACQ IMM DEF, V45, pS19, DOI 10.1097/QAI.0b013e31806007ed; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Roge B T, 2003, HIV Med, V4, P38, DOI 10.1046/j.1468-1293.2003.00133.x; Ruel TD, 2011, CLIN INFECT DIS, V53, P592, DOI 10.1093/cid/cir484; Salazar JC, 2008, AIDS, V22, P1789, DOI 10.1097/QAD.0b013e32830c481b; South African National Department of Health, 2010, GUID MAN HIV CHILDR; South African National Department of Health, 2004, NAT ANT TREATM GUID; Sunpath H, 2008, PREVALENCE RESISTANC; Sunpath H, 2009, LONGITUDINAL ANAL PA; UNAIDS, 2011, WORLD AIDS DAY REP 2; van Zyl GU, 2010, PEDIATR INFECT DIS J, V29, P370, DOI 10.1097/INF.0b013e3181c4dada; van Zyl GU, 2009, PEDIATR INFECT DIS J, V28, P1125, DOI 10.1097/INF.0b013e3181af829d; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; *WHO, 2009, AIDS EP UPD; World Health Organization, 2010, ANT THER HIV INF INF; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706; Zanoni BC, 2011, AIDS, V25, P49, DOI 10.1097/QAD.0b013e32833f9e04	34	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49591	10.1371/journal.pone.0049591	http://dx.doi.org/10.1371/journal.pone.0049591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185373	Green Submitted, Green Published, gold			2022-12-25	WOS:000311535700039
J	Badsha, F; Kain, P; Prabhakar, S; Sundaram, S; Padinjat, R; Rodrigues, V; Hasan, G				Badsha, Farhath; Kain, Pinky; Prabhakar, Sunil; Sundaram, Susinder; Padinjat, Raghu; Rodrigues, Veronica; Hasan, Gaiti			Mutants in Drosophila TRPC Channels Reduce Olfactory Sensitivity to Carbon Dioxide	PLOS ONE			English	Article							PHOSPHOLIPASE-C GENE; AVOIDANCE-BEHAVIOR; RECEPTOR FUNCTION; CA2+ CHANNEL; IN-VIVO; CO2; RESPONSES; NEURONS; PAINLESS	Background: Members of the canonical Transient Receptor Potential (TRPC) class of cationic channels function downstream of Gaq and PLC beta in Drosophila photoreceptors for transducing visual stimuli. Gaq has recently been implicated in olfactory sensing of carbon dioxide (CO2) and other odorants. Here we investigated the role of PLC beta and TRPC channels for sensing CO2 in Drosophila. Methodology/Principal Findings: Through behavioral assays it was demonstrated that Drosophila mutants for plc21c, trp and trpl have a reduced sensitivity for CO2. Immuno-histochemical staining for TRP, TRPL and TRP gamma indicates that all three channels are expressed in Drosophila antennae including the sensory neurons that express CO2 receptors. Electrophysiological recordings obtained from the antennae of protein null alleles of TRP (trp(343)) and TRPL (trpl(302)), showed that the sensory response to multiple concentrations of CO2 was reduced. However, trpl(302); trp(343) double mutants still have a residual response to CO2. Down-regulation of TRPC channels specifically in CO2 sensing olfactory neurons reduced the response to CO2 and this reduction was obtained even upon down-regulation of the TRPCs in adult olfactory sensory neurons. Thus the reduced response to CO2 obtained from the antennae of TRPC RNAi strains is not due to a developmental defect. Conclusion: These observations show that reduction in TRPC channel function significantly reduces the sensitivity of the olfactory response to CO2 concentrations of 5% or less in adult Drosophila. It is possible that the CO2 receptors Gr63a and Gr21a activate the TRPC channels through Gaq and PLC21C.	[Badsha, Farhath; Kain, Pinky; Prabhakar, Sunil; Padinjat, Raghu; Rodrigues, Veronica; Hasan, Gaiti] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Sundaram, Susinder] Babraham Inst, Inositide Lab, Cambridge, England; [Rodrigues, Veronica] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Tata Institute of Fundamental Research (TIFR)	Hasan, G (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	gaiti@ncbs.res.in	Hasan, Gaiti/I-5851-2015; Hasan, Gaiti/P-4107-2019; kain, pinky/A-9893-2014	Hasan, Gaiti/0000-0001-7194-383X; Hasan, Gaiti/0000-0001-7194-383X; Kain, Pinky/0000-0002-3579-6032; Prabhakar, Sunil/0000-0002-3810-7976; Sundaram Gomadam, Susinder/0000-0001-7294-7648	Department of Biotechnology, Govt. of India; National Centre for Biological Sciences, Tata Institute of Fundamental Research; NCBS Central Image-Flow Facility and Department of Science and Technology, Govt. of India [SR/S5/NM-36/2005]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); National Centre for Biological Sciences, Tata Institute of Fundamental Research; NCBS Central Image-Flow Facility and Department of Science and Technology, Govt. of India	This work was supported by the Department of Biotechnology, Govt. of India and National Centre for Biological Sciences, Tata Institute of Fundamental Research. The National Centre for Biological Sciences (NCBS) imaging facilities used for this work were supported by the NCBS Central Image-Flow Facility and Department of Science and Technology, Govt. of India (No. SR/S5/NM-36/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrell L, 2005, GLOBAL CHANGE BIOL, V11, P1272, DOI 10.1111/j.1365-2486.2005.00989.x; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Banerjee S, 2006, J NEUROSCI, V26, P8278, DOI 10.1523/JNEUROSCI.1231-06.2006; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Guerenstein PG, 2004, NATURWISSENSCHAFTEN, V91, P329, DOI 10.1007/s00114-004-0532-x; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; KELLOGG FE, 1970, J INSECT PHYSIOL, V16, P99, DOI 10.1016/0022-1910(70)90117-4; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024105; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leung HT, 2000, J NEUROSCI, V20, P6797, DOI 10.1523/JNEUROSCI.20-18-06797.2000; MacPherson MR, 2005, GENETICS, V169, P1541, DOI 10.1534/genetics.104.035139; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Padinjat R, 2004, J CELL SCI, V117, P5707, DOI 10.1242/jcs.01343; Raghu P, 2009, CELL CALCIUM, V45, P566, DOI 10.1016/j.ceca.2009.03.005; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rosenzweig M, 2008, P NATL ACAD SCI USA, V105, P14668, DOI 10.1073/pnas.0805041105; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SHORTRIDGE RD, 1991, J BIOL CHEM, V266, P12474; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025890; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Yagodin S, 1998, CELL CALCIUM, V23, P219, DOI 10.1016/S0143-4160(98)90120-8; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010	52	16	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49848	10.1371/journal.pone.0049848	http://dx.doi.org/10.1371/journal.pone.0049848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185459	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800056
J	Kalyoussef, S; Nieves, E; Dinerman, E; Carpenter, C; Shankar, V; Oh, J; Burd, B; Angeletti, RH; Buckheit, KW; Fredricks, DN; Madan, RP; Keller, MJ; Herold, BC				Kalyoussef, Sabah; Nieves, Edward; Dinerman, Ellen; Carpenter, Colleen; Shankar, Viswanathan; Oh, Jamie; Burd, Berta; Angeletti, Ruth H.; Buckheit, Karen W.; Fredricks, David N.; Madan, Rebecca P.; Keller, Marla J.; Herold, Betsy C.			Lactobacillus Proteins Are Associated with the Bactericidal Activity against E. coli of Female Genital Tract Secretions	PLOS ONE			English	Article							ESCHERICHIA-COLI; COLONIZATION; VAGINOSIS; PCR	Background: Female genital tract secretions are bactericidal for Escherichia (E.) coli ex vivo. However, the intersubject variability and molecules that contribute to this activity have not been defined. Methods: The bactericidal activity and concentration of immune mediators in cervicovaginal lavage (CVL) collected from 99 healthy women were determined. Results: CVL reduced the number of E. coli colonies by 68% [-26, 100] (median [range]). CVL were active against laboratory and clinical isolates of E. coli, but were inactive against Lactobacillus species. Bactericidal activity correlated with the concentration of protein recovered (p<0.001), but not with cytokines, chemokines or antimicrobial peptides. Four CVL with >90% inhibitory activity (active) and two with <30% activity were subjected to MS/MS proteomic analysis. 215 proteins were identified and six were found exclusively in active samples. Four of these corresponded to Lactobacillus crispatus or jensenii proteins. Moreover, culture supernatants from Lactobacillus jensenii were bactericidal for E. coli. Conclusion: Both host and commensal microbiota proteins contribute to mucosal defense. Identification of these proteins will facilitate the development of strategies to maintain a healthy vaginal microbiome and prevent colonization with pathogenic bacteria such as E. coli that increase the risk for urinary tract infections, preterm labor and perinatal infection.	[Kalyoussef, Sabah; Dinerman, Ellen; Carpenter, Colleen; Oh, Jamie; Madan, Rebecca P.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Nieves, Edward; Burd, Berta; Angeletti, Ruth H.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Nieves, Edward; Angeletti, Ruth H.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Shankar, Viswanathan] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Keller, Marla J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Herold, Betsy C.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA; [Buckheit, Karen W.] ImQuest Biosci, Frederick, MD USA; [Fredricks, David N.] Univ Washington, Dept Med, Seattle, WA USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle	Herold, BC (corresponding author), Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA.	betsy.herold@einstein.yu.edu	Viswanathan, Shankar/AAX-5281-2020	Viswanathan, Shankar/0000-0003-3349-9090; Herold, Betsy/0000-0001-9974-0786	Public Health Service [U19AI067980, R01AI065309, AI079763, K23AI089271, 1S10RR019352, UL1RR02570]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065309, K23AI089271, R21AI079763, R33AI079763, R21AI067980] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grants U19AI067980, R01AI065309, AI079763, K23AI089271, 1S10RR019352, and UL1RR02570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio MAD, 2003, J CLIN MICROBIOL, V41, P1881, DOI 10.1128/JCM.41.5.1881-1887.2003; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Atassi F, 2010, FEMS MICROBIOL LETT, V304, P29, DOI 10.1111/j.1574-6968.2009.01887.x; Burgener A, 2011, J PROTEOME RES, V10, P5139, DOI 10.1021/pr200596r; Cadieux PA, 2009, J PHYSIOL PHARMACOL, V60, P13; Carey JC, 2005, AM J OBSTET GYNECOL, V192, P1341, DOI 10.1016/j.ajog.2004.12.069; Carson H J, 1997, Infect Dis Obstet Gynecol, V5, P303, DOI 10.1002/(SICI)1098-0997(1997)5:4<303::AID-IDOG8>3.0.CO;2-X; Che FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000745; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Ghartey JP, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.025; Golowczyc MA, 2007, INT J FOOD MICROBIOL, V118, P264, DOI 10.1016/j.ijfoodmicro.2007.07.042; Gupta K, 1998, J INFECT DIS, V178, P446, DOI 10.1086/515635; HERTHELIUS M, 1989, INFECT IMMUN, V57, P2447, DOI 10.1128/IAI.57.8.2447-2451.1989; Kaewsrichan J, 2006, FEMS IMMUNOL MED MIC, V48, P75, DOI 10.1111/j.1574-695X.2006.00124.x; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016475; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Matu MN, 2010, ANAEROBE, V16, P210, DOI 10.1016/j.anaerobe.2009.11.002; Mildner M, 2010, MUCOSAL IMMUNOL, V3, P602, DOI 10.1038/mi.2010.37; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; REID G, 1990, CLIN MICROBIOL REV, V3, P335, DOI 10.1128/CMR.3.4.335-344.1990; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x	26	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49506	10.1371/journal.pone.0049506	http://dx.doi.org/10.1371/journal.pone.0049506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185346	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800026
J	Thomson, MJ; Pritchard, DM; Boxall, SA; Abuderman, AA; Williams, JM; Varro, A; Crabtree, JE				Thomson, Melanie J.; Pritchard, D. Mark; Boxall, Sally A.; Abuderman, Abdul A.; Williams, Jonathan M.; Varro, Andrea; Crabtree, Jean E.			Gastric Helicobacter Infection Induces Iron Deficiency in the INS-GAS Mouse	PLOS ONE			English	Article							PYLORI-INFECTION; GENE-EXPRESSION; SERUM FERRITIN; ANEMIA; ERADICATION; CHILDREN; HEPCIDIN; ACQUISITION; MUTATION; FELIS	There is increasing evidence from clinical and population studies for a role of H. pylori infection in the aetiology of iron deficiency. Rodent models of Helicobacter infection are helpful for investigating any causal links and mechanisms of iron deficiency in the host. The aim of this study was to investigate the effects of gastric Helicobacter infection on iron deficiency and host iron metabolism/transport gene expression in hypergastrinemic INS-GAS mice. INS-GAS mice were infected with Helicobacter felis for 3, 6 and 9 months. At post mortem, blood was taken for assessment of iron status and gastric mucosa for pathology, immunohistology and analysis of gene expression. Chronic Helicobacter infection of INS-GAS mice resulted in decreased serum iron, transferrin saturation and hypoferritinemia and increased Total iron binding capacity ( TIBC). Decreased serum iron concentrations were associated with a concomitant reduction in the number of parietal cells, strengthening the association between hypochlorhydria and gastric Helicobacter-induced iron deficiency. Infection with H. felis for nine months was associated with decreased gastric expression of iron metabolism regulators hepcidin, Bmp4 and Bmp6 but increased expression of Ferroportin 1, the iron efflux protein, iron absorption genes such as Divalent metal transporter 1, Transferrin receptor 1 and also Lcn2 a siderophore-binding protein. The INS-GAS mouse is therefore a useful model for studying Helicobacter-induced iron deficiency. Furthermore, the marked changes in expression of gastric iron transporters following Helicobacter infection may be relevant to the more rapid development of carcinogenesis in the Helicobacter infected INS-GAS model.	[Thomson, Melanie J.; Boxall, Sally A.; Crabtree, Jean E.] St James Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Pritchard, D. Mark; Abuderman, Abdul A.; Williams, Jonathan M.; Varro, Andrea] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	Saint James's University Hospital; University of Leeds; University of Liverpool	Crabtree, JE (corresponding author), St James Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England.	j.crabtree@leeds.ac.uk	Varro, Andras/M-2647-2016	Williams, Jonathan/0000-0002-6617-0323; Pritchard, David Mark/0000-0001-7971-3561	Sixth Framework Programme of the European Union, Project CONTENT [INCO-DEV-3-032136]; King Fahd Medical City, Saudi Arabia	Sixth Framework Programme of the European Union, Project CONTENT; King Fahd Medical City, Saudi Arabia	This study was funded under the Sixth Framework Programme of the European Union, Project CONTENT (INCO-DEV-3-032136) and a PhD studentship to AA from King Fahd Medical City, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpizar-Alpizar W, 2009, VIRCHOWS ARCH, V455, P225, DOI 10.1007/s00428-009-0825-8; Annibale B, 2003, GUT, V52, P496, DOI 10.1136/gut.52.4.496; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Barabino A, 2002, HELICOBACTER, V7, P71, DOI 10.1046/j.1083-4389.2002.00073.x; Barabino A, 1999, J PEDIATR GASTR NUTR, V28, P116, DOI 10.1097/00005176-199901000-00027; Barros R, 2008, J PATHOL, V215, P411, DOI 10.1002/path.2369; Bleuming S, 2006, J PATHOL, V209, P190, DOI 10.1002/path.1976; CHARLTON RW, 1983, ANNU REV MED, V34, P55, DOI 10.1146/annurev.me.34.020183.000415; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; Choe YH, 2000, ACTA PAEDIATR, V89, P154, DOI 10.1080/080352500750028753; Choe YH, 1999, HELICOBACTER, V4, P135, DOI 10.1046/j.1523-5378.1999.98066.x; Ciacci C, 2004, DIGEST LIVER DIS, V36, P455, DOI 10.1016/j.dld.2004.02.008; Court M, 2002, J INFECT DIS, V186, P1348, DOI 10.1086/344321; Cui GL, 2004, CANCER RES, V64, P8160, DOI 10.1158/0008-5472.CAN-04-0876; DuBois S, 2005, AM J GASTROENTEROL, V100, P453, DOI 10.1111/j.1572-0241.2005.30252.x; Dupic F, 2002, GUT, V51, P648, DOI 10.1136/gut.51.5.648; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029007; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fukui T, 2011, J GASTROENTEROL, V46, P456, DOI 10.1007/s00535-010-0364-8; Gobel R, 2006, HELICOBACTER, V11, P529, DOI 10.1111/j.1523-5378.2006.00455.x; Hacihanefioglu A, 2004, HEPATO-GASTROENTEROL, V51, P313; Hershko C, 2005, HAEMATOLOGICA, V90, P585; Hershko C, 2009, ACTA HAEMATOL-BASEL, V122, P97, DOI 10.1159/000243793; Hornsby MJ, 2008, GASTROENTEROLOGY, V134, P1049, DOI 10.1053/j.gastro.2008.01.018; Jeon BH, 2004, HELICOBACTER, V9, P330, DOI 10.1111/j.1083-4389.2004.00239.x; Katoh M, 2007, CANCER BIOL THER, V6, P832, DOI 10.4161/cbt.6.6.4196; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Keenan JI, 2004, HELICOBACTER, V9, P643, DOI 10.1111/j.1083-4389.2004.00278.x; Konno M, 2000, J PEDIATR GASTR NUTR, V31, P52, DOI 10.1097/00005176-200007000-00012; Kovac S, 2008, AM J PHYSIOL-GASTR L, V295, pG855, DOI 10.1152/ajpgi.90359.2008; Kovac S, 2011, ENDOCRINOLOGY, V152, P3062, DOI 10.1210/en.2010-1474; Krieg L, 2011, BLOOD, V118, P6418, DOI 10.1182/blood-2011-04-350082; Kurekci AE, 2005, J TROP PEDIATRICS, V51, P166, DOI 10.1093/tropej/fmi015; Langhans N, 1997, GASTROENTEROLOGY, V112, P280, DOI 10.1016/S0016-5085(97)90000-7; Lee JH, 2009, HELICOBACTER, V14, P36, DOI 10.1111/j.1523-5378.2009.00658.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marignani M, 1997, SCAND J GASTROENTERO, V32, P617, DOI 10.3109/00365529709025109; Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003; Milman N, 1998, GASTROENTEROLOGY, V115, P268, DOI 10.1016/S0016-5085(98)70192-1; Papini E, 1998, J CLIN INVEST, V102, P813, DOI 10.1172/JCI2764; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Rogers AB, 2005, CANCER RES, V65, P10709, DOI 10.1158/0008-5472.CAN-05-1846; Schwarz P, 2012, GUT, V61, P193, DOI 10.1136/gut.2011.241208; Senkovich O, 2010, INFECT IMMUN, V78, P1841, DOI 10.1128/IAI.01258-09; Seo JK, 2002, J GASTROEN HEPATOL, V17, P754, DOI 10.1046/j.1440-1746.2002.02797.x; Steele IA, 2007, AM J PHYSIOL-GASTR L, V293, pG347, DOI 10.1152/ajpgi.00076.2007; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S; Stoltzfus RJ, 2001, J NUTR, V131, p697S; Tan SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002050; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Waidner B, 2002, INFECT IMMUN, V70, P3923, DOI 10.1128/IAI.70.7.3923-3929.2002; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Warwood M, 2006, DACIE LEWIS PRACTICA; Windle HJ, 2007, PEDIATRICS, V119, pE754, DOI 10.1542/peds.2006-2196; Worst DJ, 1999, MICROBIOL-UK, V145, P681, DOI 10.1099/13500872-145-3-681; Yang YJ, 2005, HELICOBACTER, V10, P249, DOI 10.1111/j.1523-5378.2005.00317.x; Yoshimura M, 2003, INTERNAL MED, V42, P971, DOI 10.2169/internalmedicine.42.971	57	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50194	10.1371/journal.pone.0050194	http://dx.doi.org/10.1371/journal.pone.0050194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185574	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800074
J	Ahn, M; De Genst, E; Schierle, GSK; Erdelyi, M; Kaminski, CF; Dobson, CM; Kumita, JR				Ahn, Minkoo; De Genst, Erwin; Schierle, Gabriele S. Kaminski; Erdelyi, Miklos; Kaminski, Clemens F.; Dobson, Christopher M.; Kumita, Janet R.			Analysis of the Native Structure, Stability and Aggregation of Biotinylated Human Lysozyme	PLOS ONE			English	Article							CAMELID ANTIBODY FRAGMENT; EGG-WHITE LYSOZYME; AMYLOID FIBRILS; CONFORMATIONAL STABILITY; LOCAL COOPERATIVITY; SURFACE-TOPOLOGY; VARIANT LYSOZYME; PROTEINS; SITE; SECRETION	Fibril formation by mutational variants of human lysozyme is associated with a fatal form of hereditary non-neuropathic systemic amyloidosis. Defining the mechanistic details of lysozyme aggregation is of crucial importance for understanding the origin and progression of this disease and related misfolding conditions. In this study, we show that a biotin moiety can be introduced site-specifically at Lys33 of human lysozyme. We demonstrate, using biophysical techniques, that the structure and stability of the native-state of the protein are not detectably altered by this modification, and that the ability to form amyloid fibrils is unchanged. By taking advantage of biotin-avidin interactions, we show that super-resolution fluorescence microscopy can generate detailed images of the mature fibrils. This methodology can readily enable the introduction of additional probes into the protein, thereby providing the means through which to understand, in detail, the nature of the aggregation process of lysozyme and its variants under a variety of conditions.	[Ahn, Minkoo; De Genst, Erwin; Dobson, Christopher M.; Kumita, Janet R.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Schierle, Gabriele S. Kaminski; Erdelyi, Miklos; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 1EW, England; [Erdelyi, Miklos] Natl Phys Lab, Teddington TW11 0LW, Middx, England	University of Cambridge; University of Cambridge; National Physical Laboratory - UK	Kumita, JR (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	jrk38@cam.ac.uk	Kaminski, Clemens/G-7488-2016; Kumita, Janet/AAO-5254-2021	Kaminski, Clemens/0000-0002-5194-0962; 	Korean Government; Wellcome Trust/MRC Initiative for Neurodegenerative Disorders; EPSRC [EP/H018901/1]; Alzheimer's Research UK Trust [EG2012A-1, ESG2012-1]; Biotechnology and Biological Sciences Research Council [BB/E019927/1]; Medical Research Council; Wellcome Trust; Leverhulme Trust; Alzheimers Research UK [ARUK-EG2012A-1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H018301/1] Funding Source: researchfish; Medical Research Council [G0902243, MC_G1000734] Funding Source: researchfish; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MC_G1000734, G0902243] Funding Source: UKRI	Korean Government(Korean Government); Wellcome Trust/MRC Initiative for Neurodegenerative Disorders(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimer's Research UK Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Leverhulme Trust(Leverhulme Trust); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	M.A. is supported by a Korean Government Scholarship for Overseas Studies. C. F. K. acknowledges funding from Wellcome Trust/MRC Initiative for Neurodegenerative Disorders, EPSRC (EP/H018901/1), and the Alzheimer's Research UK Trust (EG2012A-1 and ESG2012-1). This research was supported in part by a grant from the Biotechnology and Biological Sciences Research Council (BB/E019927/1 to C. M. D. and J.R.K.), the Medical Research Council (E. D. G. and C. M. D.) and Programme grants from the Wellcome Trust and the Leverhulme Trust (to C. M. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Anderson LK, 2002, CHEM-EUR J, V8, P3687, DOI 10.1002/1521-3765(20020816)8:16<3687::AID-CHEM3687>3.0.CO;2-8; Arima H, 1997, FEBS LETT, V415, P114, DOI 10.1016/S0014-5793(97)01071-5; ARTYMIUK PJ, 1981, J MOL BIOL, V152, P737, DOI 10.1016/0022-2836(81)90125-X; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Booth D R, 2000, Hum Mutat, V16, P180, DOI 10.1002/1098-1004(200008)16:2<180::AID-HUMU20>3.0.CO;2-#; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BROWN EM, 1988, BIOCHEMISTRY-US, V27, P5601, DOI 10.1021/bi00415a031; Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; Chan FTS, 2011, CHEMPHYSCHEM, V12, P500, DOI 10.1002/cphc.201000833; Chan PH, 2008, BIOCHEMISTRY-US, V47, P11041, DOI 10.1021/bi8005797; Chen X, 2012, BIOCONJUGATE CHEM, V23, P500, DOI 10.1021/bc200556n; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhulesia A, 2010, J AM CHEM SOC, V132, P15580, DOI 10.1021/ja103524m; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; Dumoulin M, 2006, ACCOUNTS CHEM RES, V39, P603, DOI 10.1021/ar050070g; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fernandez-Suarez M, 2007, NAT BIOTECHNOL, V25, P1483, DOI 10.1038/nbt1355; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; Funahashi J, 1996, J BIOCHEM, V120, P1216; Gerasov A, 2012, ANAL BIOCHEM, V420, P115, DOI 10.1016/j.ab.2011.09.018; Gillmore JD, 1999, NEPHROL DIAL TRANSPL, V14, P2639, DOI 10.1093/ndt/14.11.2639; GLOCKER MO, 1994, BIOCONJUGATE CHEM, V5, P583, DOI 10.1021/bc00030a014; Hagan CL, 2010, PROTEIN ENG DES SEL, V23, P499, DOI 10.1093/protein/gzq023; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Johnson RJK, 2005, J MOL BIOL, V352, P823, DOI 10.1016/j.jmb.2005.07.040; Johnson RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023970; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kumita JR, 2012, FASEB J, V26, P192, DOI 10.1096/fj.11-185983; Kumita JR, 2006, FEBS J, V273, P711, DOI 10.1111/j.1742-4658.2005.05099.x; Lee YC, 2002, ANAL BIOCHEM, V310, P223, DOI 10.1016/S0003-2697(02)00320-2; Mombelli E, 1997, BIOCHEMISTRY-US, V36, P8733, DOI 10.1021/bi970467v; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Mossuto ME, 2011, ANGEW CHEM INT EDIT, V50, P7048, DOI 10.1002/anie.201100986; Mossuto MF, 2010, J MOL BIOL, V402, P783, DOI 10.1016/j.jmb.2010.07.005; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Pace C N, 1986, Methods Enzymol, V131, P266; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; Rocken Christoph, 2006, Hum Mutat, V27, P119, DOI 10.1002/humu.9393; Schierle GSK, 2011, J AM CHEM SOC, V133, P12902, DOI 10.1021/ja201651w; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; SCHWERT GW, 1948, J BIOL CHEM, V172, P221; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SPASSOV VZ, 1989, BIOCHIM BIOPHYS ACTA, V999, P1, DOI 10.1016/0167-4838(89)90020-4; STOTT DI, 1989, J IMMUNOL METHODS, V119, P153, DOI 10.1016/0022-1759(89)90394-3; SUCKAU D, 1992, P NATL ACAD SCI USA, V89, P5630, DOI 10.1073/pnas.89.12.5630; Takano K, 1999, EUR J BIOCHEM, V266, P675, DOI 10.1046/j.1432-1327.1999.00918.x; TANIYAMA Y, 1992, J BIOL CHEM, V267, P4619; Teske CA, 2007, BIOTECHNOL BIOENG, V98, P193, DOI 10.1002/bit.21374; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Valleix S, 2002, KIDNEY INT, V61, P907, DOI 10.1046/j.1523-1755.2002.00205.x; van de Linde S, 2009, PHOTOCH PHOTOBIO SCI, V8, P465, DOI 10.1039/b822533h; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; van Ham TJ, 2010, J MOL BIOL, V395, P627, DOI 10.1016/j.jmb.2009.10.066; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; WALEY SG, 1953, BIOCHEM J, V55, P328, DOI 10.1042/bj0550328; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; Whyteside G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022692; Yazaki M, 2003, KIDNEY INT, V63, P1652, DOI 10.1046/j.1523-1755.2003.00904.x	68	21	21	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50192	10.1371/journal.pone.0050192	http://dx.doi.org/10.1371/journal.pone.0050192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166837	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000311885300093
J	Kesanakurti, D; Chetty, C; Maddirela, DR; Gujrati, M; Rao, JS				Kesanakurti, D.; Chetty, C.; Maddirela, D. Rajasekhar; Gujrati, M.; Rao, J. S.			Essential role of cooperative NF-kappa B and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma	ONCOGENE			English	Article						chromatin immunoprecipitation (ChIP); glioma; GST pull-down; NF-kappa B; stat3; transactivation domain (TAD)	INTERCELLULAR-ADHESION MOLECULE-1; GENE-EXPRESSION; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; MALIGNANT GLIOMAS; MYELOID-LEUKEMIA; P65/RELA SUBUNIT; TUMOR PROMOTION; TRANSCRIPTION; INFLAMMATION	Although radiotherapy improves survival in patients, glioblastoma multiformes (GBMs) tend to relapse with augmented tumor migration and invasion even after ionizing radiation (IR). Aberrant nuclear factor-kappa B (NF-kappa B) and signal transducer and activator of transcription factor 3 (Stat3) activation and interaction have been suggested in several human tumors. However, possible NF-kappa B/Stat3 interaction and the role of Stat3 in maintenance of NF-kappa B nuclear retention in GBM still remain unknown. Stat3 and NF-kappa B (p65) physically interact with one another in the nucleus in glioma tumors. Most importantly, glutathione S-transferase pull-down assays identified that Stat3 binds to the p65 transactivation domain and is present in the NF-kappa B DNA-binding complex. Irradiation significantly elevated nuclear phospho-p65/phospho-Stat3 interaction in correlation with increased intercellular adhesion molecule-1 (ICAM-1) and soluble-ICAM-1 levels, migration and invasion in human glioma xenograft cell lines 4910 and 5310. Chromatin immunopreicipitation and promoter luciferase activity assays confirmed the critical role of adjacent NF-kappa B (+399) and Stat3 (+479) binding motifs in the proximal intron-1 in elevating IR-induced ICAM-1 expression. Specific inhibition of Stat3 or NF-kappa B with Stat3. siRNA or JSH-23 severely inhibited IR-induced p65 recruitment onto ICAM-1 intron-1 and suppressed migratory properties in both the cell lines. On the other hand, Stat3C- or IR-induced Stat3 promoter recruitment was significantly decreased in p65-knockdown cells, thereby suggesting the reciprocal regulation between p65 and Stat3. We also observed a significant increase in NF-kappa B enrichment on ICAM-1 intron-1 and ICAM-1 transactivation in Stat3C overexpressing cells. In in vivo orthotopic experiments, suppression of tumor growth in Stat3.si + IR-treated mice was associated with the inhibition of IR-induced p-p65/p-Stat3 nuclear colocalization and ICAM-1 levels. To our knowledge, this is the first study showing the crucial role of NF-kappa B/Stat3 nuclear association in IR-induced ICAM-1 regulation and implies that targeting NF-kappa B/Stat3 interaction may have future therapeutic significance in glioma treatment.	[Kesanakurti, D.; Chetty, C.; Maddirela, D. Rajasekhar; Rao, J. S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA; [Gujrati, M.] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA; [Rao, J. S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Rao, JS (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61605 USA.	jsrao@uic.edu			National Institute of Neurological Disorders and Stroke [NS64535-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064535] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Noorjehan Ali for technical assistance, Shelle Abraham for manuscript preparation, Diana Meister and Sushma Jasti for manuscript review. This research was supported by award NS64535-01A2 (to JSR) from the National Institute of Neurological Disorders and Stroke. Contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH.	Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Atkinson GP, 2010, EXPERT REV NEUROTHER, V10, P575, DOI [10.1586/ern.10.21, 10.1586/ERN.10.21]; Badiga AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020614; Benezra M, 2003, J BIOL CHEM, V278, P26333, DOI 10.1074/jbc.M303076200; Berens Michael E., 1999, Neoplasia (New York), V1, P208, DOI 10.1038/sj.neo.7900034; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burim RV, 2009, CLIN EXP MED, V9, P157, DOI 10.1007/s10238-009-0040-6; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Dutta J, 2008, J VIROL, V82, P10792, DOI 10.1128/JVI.00903-08; FINE HA, 1993, CANCER, V71, P2585, DOI 10.1002/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Jang HD, 2004, J BIOL CHEM, V279, P24873, DOI 10.1074/jbc.M313018200; Kargiotis O, 2010, J NEURO-ONCOL, V100, P323, DOI 10.1007/s11060-010-0199-4; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kesanakurti D, 2012, ONCOGENE, DOI [10.1038/onc.2012.52, DOI 10.1038/0NC.2012.52)]; Kesanakurti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019341; Kesanakurti D, 2009, BIOCHEM BIOPH RES CO, V390, P427, DOI 10.1016/j.bbrc.2009.09.046; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lee H, 2011, CANCER RES, V71, P3772, DOI 10.1158/0008-5472.CAN-10-3304; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Li T, 2011, CANCER GENE THER, V18, P617, DOI 10.1038/cgt.2011.29; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lowe JM, 2010, J BIOL CHEM, V285, P5249, DOI 10.1074/jbc.M109.034579; Maenpaa A, 1997, ACTA NEUROPATHOL, V94, P216, DOI 10.1007/s004010050696; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; McDonald MW, 2011, INT J RADIAT ONCOL, V79, P130, DOI 10.1016/j.ijrobp.2009.10.048; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Roebuck KA, 1999, INT J MOL MED, V4, P223; Roland CL, 2007, SURGERY, V141, P705, DOI 10.1016/j.surg.2007.01.016; Roy J, 2001, J BIOL CHEM, V276, P14553, DOI 10.1074/jbc.M005067200; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Surh YJ, 2010, CANCER PREV RES, V3, P1379, DOI 10.1158/1940-6207.CAPR-10-0251; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Wild-Bode C, 2001, CANCER RES, V61, P2744; Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009	51	97	104	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2013	32	43					5144	5155		10.1038/onc.2012.546	http://dx.doi.org/10.1038/onc.2012.546			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	240JY	23178493	Green Accepted			2022-12-25	WOS:000326093200002
J	Luo, SL; Zhangsun, DT; Wu, Y; Zhu, XP; Hu, YY; McIntyre, M; Christensen, S; Akcan, M; Craik, DJ; McIntosh, JM				Luo, Sulan; Zhangsun, Dongting; Wu, Yong; Zhu, Xiaopeng; Hu, Yuanyan; McIntyre, Melissa; Christensen, Sean; Akcan, Muharrem; Craik, David J.; McIntosh, J. Michael			Characterization of a Novel alpha-Conotoxin from Conus textile That Selectively Targets alpha 6/alpha 3 beta 2 beta 3 Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL TEGMENTAL AREA; SUBUNIT COMPOSITION; PEPTIDE; BLOCKS; MII; STIMULATION; INHIBITION; EXPRESSION; SUBTYPES	alpha 6 beta 2 Nicotinic acetylcholine receptors (nAChRs) expressed by dopaminergic neurons in the CNS are potential therapeutic targets for the treatment of several neuropsychiatric diseases, including nicotine addiction and Parkinson disease. However, recent studies indicate that the alpha 6 subunit can also associate with the beta 4 subunit to form alpha 6 beta 4 nAChRs that are difficult to pharmacologically distinguish from alpha 6 beta 2, alpha 3 beta 4, and alpha 3 beta 2 subtypes. The current study characterized a novel 16-amino acid alpha-conotoxin (alpha-CTx) TxIB from Conus textile whose sequence is GCCSDPPCRNKHPDLC-amide as deduced from gene cloning. The peptide and an analog with an additional C-terminal glycine were chemically synthesized and tested on rat nAChRs heterologously expressed in Xenopus laevis oocytes. alpha-CTx TxIB blocked alpha 6/alpha 3 beta 2 beta 3 nAChR with an IC50 of 28 nM. In contrast, the peptide showed little or no block of other tested subtypes at concentrations up to 10 mu M. The three-dimensional solution structure of alpha-CTx TxIB was determined using NMR spectroscopy. alpha-CTx TxIB represents a uniquely selective ligand for probing the structure and function of alpha 6 beta 2 nAChRs.	[Luo, Sulan; Zhangsun, Dongting; Wu, Yong; Zhu, Xiaopeng; Hu, Yuanyan] Hainan Univ, Minist Educ, Key Lab Trop Biol Resources, Key Lab Marine Drug Haikou, Haikou Hainan 570228, Peoples R China; [McIntyre, Melissa; Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntyre, Melissa; Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Akcan, Muharrem; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Hainan University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Queensland	Luo, SL (corresponding author), Hainan Univ, Minist Educ, Key Lab Trop Biol Resources, Key Lab Marine Drug Haikou, Haikou Hainan 570228, Peoples R China.	luosulan2003@163.com	Craik, David/B-1695-2010; Akcan, Muharrem/GRX-8850-2022; Akcan, Muharrem/F-8799-2013	Craik, David/0000-0003-0007-6796; Akcan, Muharrem/0000-0002-5208-9575; 	Program for International Science & Technology Cooperation Program of China [2011DFR31210]; National Natural Science Foundation of China [81160503]; State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China [2012AA021706]; Changjiang Scholars and Innovative Research Team in University Grant PCSIRT [IRT1123]; National Institutes of Health [GM103801, GM48677]; Australian Research Council [1093115]; National Health & Medical Research Council Professorial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677, R01GM103801] Funding Source: NIH RePORTER	Program for International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China; Changjiang Scholars and Innovative Research Team in University Grant PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health & Medical Research Council Professorial Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Program for International Science & Technology Cooperation Program of China Grant 2011DFR31210, National Natural Science Foundation of China Grant 81160503, State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China Grant 2012AA021706, Changjiang Scholars and Innovative Research Team in University Grant PCSIRT, IRT1123. This work was also supported by National Institutes of Health Grants GM103801 and GM48677, and Australian Research Council Grant 1093115. D.J.C. acknowledges the support of a National Health & Medical Research Council Professorial Fellowship. Apreliminary account of some of this work was presented in the patent literature (51).	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Grady SR, 2007, BIOCHEM PHARMACOL, V74, P1235, DOI 10.1016/j.bcp.2007.07.032; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Hone AJ, 2012, FASEB J, V26, P917, DOI 10.1096/fj.11-195883; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kaiser SA, 1998, J NEUROCHEM, V70, P1069; Klimis H, 2011, PAIN, V152, P259, DOI 10.1016/j.pain.2010.09.007; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Korn D., 1995, MANUAL LIVING CONIDA, P308; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Liu J, 2009, INVEST OPHTH VIS SCI, V50, P1408, DOI 10.1167/iovs.08-2398; Lof E, 2007, PSYCHOPHARMACOLOGY, V195, P333, DOI 10.1007/s00213-007-0899-4; Lopez-Vera E, 2007, FEBS J, V274, P3972, DOI 10.1111/j.1742-4658.2007.05931.x; Luo S., 2012, Chinese patent literature, Patent No. [CN(201210277619.8)-A, 2012102776198]; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2010, J BIOL CHEM, V285, P12355, DOI 10.1074/jbc.M109.079012; Mackey EDW, 2012, J NEUROSCI, V32, P10226, DOI 10.1523/JNEUROSCI.0007-12.2012; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; MCINTOSH M, 1982, ARCH BIOCHEM BIOPHYS, V218, P329, DOI 10.1016/0003-9861(82)90351-4; Muttenthaler M, 2011, CURR PHARM DESIGN, V17, P4226, DOI 10.2174/138161211798999384; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Papke RL, 2008, NEUROPHARMACOLOGY, V54, P1189, DOI 10.1016/j.neuropharm.2008.03.010; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2011, BIOCHEM PHARMACOL, V82, P873, DOI 10.1016/j.bcp.2011.06.001; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Vailati S, 1999, MOL PHARMACOL, V56, P11, DOI 10.1124/mol.56.1.11; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang KC, 2009, ACTA PHARMACOL SIN, V30, P740, DOI 10.1038/aps.2009.63; [郑晓冬 ZHENG Xiaodong], 2011, [生物技术, Biotechnology], V21, P40	49	46	56	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					894	902		10.1074/jbc.M112.427898	http://dx.doi.org/10.1074/jbc.M112.427898			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23184959	Green Published, hybrid			2022-12-25	WOS:000313570300014
J	Blennow, K; Persson, J; Tome, M; Hanewinkel, M				Blennow, Kristina; Persson, Johannes; Tome, Margarida; Hanewinkel, Marc			Climate Change: Believing and Seeing Implies Adapting	PLOS ONE			English	Article							PERCEPTIONS; ADAPTATION; EXPERIENCE; CAPACITY; VULNERABILITY; FRAMEWORK; RISK	Knowledge of factors that trigger human response to climate change is crucial for effective climate change policy communication. Climate change has been claimed to have low salience as a risk issue because it cannot be directly experienced. Still, personal factors such as strength of belief in local effects of climate change have been shown to correlate strongly with responses to climate change and there is a growing literature on the hypothesis that personal experience of climate change (and/or its effects) explains responses to climate change. Here we provide, using survey data from 845 private forest owners operating in a wide range of bio-climatic as well as economic-social-political structures in a latitudinal gradient across Europe, the first evidence that the personal strength of belief and perception of local effects of climate change, highly significantly explain human responses to climate change. A logistic regression model was fitted to the two variables, estimating expected probabilities ranging from 0.07 (SD +/-0.01) to 0.81 (SD +/-0.03) for self-reported adaptive measures taken. Adding socio-demographic variables improved the fit, estimating expected probabilities ranging from 0.022 (SD +/-0.008) to 0.91 (SD +/-0.02). We conclude that to explain and predict adaptation to climate change, the combination of personal experience and belief must be considered.	[Blennow, Kristina] Swedish Univ Agr Sci, Fac Landscape Planning Hort & Agr Sci, Alnarp, Sweden; [Persson, Johannes] Lund Univ, Dept Philosophy, Lund, Sweden; [Tome, Margarida] Univ Tecn Lisboa, Ctr Estudos Florestais, P-1100 Lisbon, Portugal; [Hanewinkel, Marc] Swiss Fed Inst Forest Snow & Landscape Res, Res Unit Forest Resources & Management, CH-8903 Birmensdorf, Switzerland; [Hanewinkel, Marc] Univ Freiburg, Inst Forestry Econ, D-79106 Freiburg, Germany	Swedish University of Agricultural Sciences; Lund University; Universidade de Lisboa; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Freiburg	Blennow, K (corresponding author), Swedish Univ Agr Sci, Fac Landscape Planning Hort & Agr Sci, Alnarp, Sweden.	kristina.blennow@slu.se	Tomé, Margarida/F-5776-2010; hanewinkel, marc/E-5639-2011; Blennow, Kristina/D-7388-2016	Tomé, Margarida/0000-0002-6242-8593; hanewinkel, marc/0000-0003-4081-6621; Blennow, Kristina/0000-0002-7602-5322; Persson, Johannes/0000-0003-4568-1850	EU project MOTIVE [226544]; foundation for strategic environmental research programme Mistra-SWECIA; Linnaeus programme LUCID ("Lund University Centre of Excellence for Integration of Social and Natural Dimensions of Sustainability", FORMAS) [20082018]	EU project MOTIVE; foundation for strategic environmental research programme Mistra-SWECIA; Linnaeus programme LUCID ("Lund University Centre of Excellence for Integration of Social and Natural Dimensions of Sustainability", FORMAS)	The study was supported by the EU project MOTIVE ("Models for adaptive forest management", grant 226544, http://motive-project.net/) and the foundation for strategic environmental research programme Mistra-SWECIA (www.mistra-swecia.se/). Persson's research was supported by the Linnaeus programme LUCID ("Lund University Centre of Excellence for Integration of Social and Natural Dimensions of Sustainability" (www.lucid.lu.se/), FORMAS, 20082018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon F., 1620, NOVUM ORGANUM; Blennow K, 2009, GLOBAL ENVIRON CHANG, V19, P100, DOI 10.1016/j.gloenvcha.2008.10.003; BOGEN J, 1988, PHILOS REV, V97, P303, DOI 10.2307/2185445; Boykoff M. T., 2010, ROUTLEDGE HDB CLIMAT, P210; Forest Europe UNECE and FAO, 2011, STAT EUR FOR 2011 ST; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Honaker J, 2011, J STAT SOFTW, V45, P1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Hume D, 1777, ENQUIRIES CONCERNING; Imai K, 2011, ZELIG EVERYONES STAT; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; King G, 2001, WORLD POLIT, V53, P623, DOI 10.1353/wp.2001.0018; Leiserowitz A., 2012, EXTREME WEATHER CLIM; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Michotte A. E, 1963, PERCEPTION CAUSALITY; Moser SC, 2010, P NATL ACAD SCI USA, V107, P22026, DOI 10.1073/pnas.1007887107; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Persson E, 2011, REPORT STAKEHOLDER A; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebetez M, 1996, CLIMATIC CHANGE, V32, P495, DOI 10.1007/BF00140358; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Weber E.U., 1997, PERCEPTION EXPECTATI, P314; Weber EU, 2006, CLIMATIC CHANGE, V77, P103, DOI 10.1007/s10584-006-9060-3; Weber EU, 2010, WIRES CLIM CHANGE, V1, P332, DOI 10.1002/wcc.41; Whitmarsh L, 2008, J RISK RES, V11, P351, DOI 10.1080/13669870701552235	26	113	116	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50182	10.1371/journal.pone.0050182	http://dx.doi.org/10.1371/journal.pone.0050182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185568	gold, Green Published, Green Accepted			2022-12-25	WOS:000311821000195
J	Hultqvist, G; Punekar, AS; Morrone, A; Chi, CN; Engstrom, A; Selmer, M; Gianni, S; Jemth, P				Hultqvist, Greta; Punekar, Avinash S.; Morrone, Angela; Chi, Celestine N.; Engstrom, Ake; Selmer, Maria; Gianni, Stefano; Jemth, Per			Tolerance of Protein Folding to a Circular Permutation in a PDZ Domain	PLOS ONE			English	Article							PROLINE PEPTIDE ISOMERIZATION; TRANSITION-STATES; MECHANISM; PATHWAY; LANDSCAPE; DYNAMICS; KINETICS; NUCLEI; BONDS	Circular permutation is a common molecular mechanism for evolution of proteins. However, such re-arrangement of secondary structure connectivity may interfere with the folding mechanism causing accumulation of folding intermediates, which in turn can lead to misfolding. We solved the crystal structure and investigated the folding pathway of a circularly permuted variant of a PDZ domain, SAP97 PDZ2. Our data illustrate how well circular permutation may work as a mechanism for molecular evolution. The circular permutant retains the overall structure and function of the native protein domain. Further, unlike most examples in the literature, this circular permutant displays a folding mechanism that is virtually identical to that of the wild type. This observation contrasts with previous data on the circularly permuted PDZ2 domain from PTP-BL, for which the folding pathway was remarkably affected by the same mutation in sequence connectivity. The different effects of this circular permutation in two homologous proteins show the strong influence of sequence as compared to topology. Circular permutation, when peripheral to the major folding nucleus, may have little effect on folding pathways and could explain why, despite the dramatic change in primary structure, it is frequently tolerated by different protein folds.	[Punekar, Avinash S.; Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Hultqvist, Greta; Chi, Celestine N.; Engstrom, Ake; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Morrone, Angela; Gianni, Stefano] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Morrone, Angela; Gianni, Stefano] Univ Roma La Sapienza, Dipartimento Sci Biochim A Rossi Fanelli, Ist Biol & Patol Mol CNR, Rome, Italy	Uppsala University; Uppsala University; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Selmer, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	Maria.Selmer@icm.uu.se; Stefano.Gianni@uniroma1.it; Per.Jemth@imbim.uu.se	Punekar, Avinash S/J-3709-2013	Punekar, Avinash S/0000-0002-6541-9529; Hultqvist, Greta/0000-0002-4136-6792; Selmer, Maria/0000-0001-9079-2774; Gianni, Stefano/0000-0003-1653-1925	Swedish Research Council; Italian Ministero dell'Istruzione dell'Universita e della Ricerca (PNR-CNR Aging Program)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Italian Ministero dell'Istruzione dell'Universita e della Ricerca (PNR-CNR Aging Program)	This work was supported by the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) (to P.J. and M. S.) and by the Italian Ministero dell'Istruzione dell'Universita e della Ricerca (PNR-CNR Aging Program 2012-2014) (to S.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arai M, 2003, J MOL BIOL, V328, P273, DOI 10.1016/S0022-2836(03)00212-2; Bulaj G, 2004, PROTEIN SCI, V13, P1182, DOI 10.1110/ps.03563704; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; Capraro DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038512; Cellitti J, 2007, PROTEIN SCI, V16, P842, DOI 10.1110/ps.062628607; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; Chi CN, 2012, BIOFACTORS; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clementi C, 2001, J MOL BIOL, V311, P879, DOI 10.1006/jmbi.2001.4871; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Haq SR, 2010, J BIOL CHEM, V285, P18051, DOI 10.1074/jbc.M110.110833; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hultqvist G, 2012, BIOCHEM BIOPH RES CO, V421, P550, DOI 10.1016/j.bbrc.2012.04.042; Ivarsson Y, 2008, J BIOL CHEM, V283, P8954, DOI 10.1074/jbc.M707424200; Ivarsson Y, 2008, PROTEIN ENG DES SEL, V21, P155, DOI 10.1093/protein/gzm077; Ivarsson Y, 2009, J AM CHEM SOC, V131, P11727, DOI 10.1021/ja900438b; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10436, DOI 10.1021/bi00107a011; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Jung J, 2001, PROTEIN SCI, V10, P1881, DOI 10.1110/ps.05801; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIEFHABER T, 1992, J MOL BIOL, V224, P231, DOI 10.1016/0022-2836(92)90586-9; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3053, DOI 10.1021/bi00464a023; LARIVE CK, 1993, J AM CHEM SOC, V115, P2833, DOI 10.1021/ja00060a033; Li L, 2001, J MOL BIOL, V306, P121, DOI 10.1006/jmbi.2000.4375; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Lindberg M, 2002, NAT STRUCT BIOL, V9, P818, DOI 10.1038/nsb847; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Otzen DE, 1998, BIOCHEMISTRY-US, V37, P8139, DOI 10.1021/bi980250g; Pappenberger G, 2001, NAT STRUCT BIOL, V8, P452, DOI 10.1038/87624; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; SALAHUDDIN A, 1984, J BIOSCIENCE, V6, P349, DOI 10.1007/BF02703893; Saras J, 1997, J BIOL CHEM, V272, P20979, DOI 10.1074/jbc.272.34.20979; STELLWAGEN E, 1979, J MOL BIOL, V135, P217, DOI 10.1016/0022-2836(79)90348-6; Viguera AR, 1996, NAT STRUCT BIOL, V3, P874, DOI 10.1038/nsb1096-874; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030	51	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50055	10.1371/journal.pone.0050055	http://dx.doi.org/10.1371/journal.pone.0050055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185531	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000173
J	Murphy, DN; McLysaght, A				Murphy, Daniel N.; McLysaght, Aoife			De Novo Origin of Protein-Coding Genes in Murine Rodents	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENOME; EVOLUTION; RESOURCE; MICE	Background: New genes in eukaryotes are created through a variety of different mechanisms. De novo origin from non-coding DNA is a mechanism that has recently gained attention. So far, de novo genes have been described in a handful of organisms, with Drosophila being the most extensively studied. We searched for genes that have appeared de novo in the mouse and rat lineages. Methodology: Using a rigorous and conservative approach we identify 75 murine genes (69 mouse genes and 6 rat genes) for which there is good evidence of de novo origin since the divergence of mouse and rat. Each of these genes is only found in either the mouse or rat lineages, with no candidate orthologs nor evidence for potentially-unannotated orthologs in the other lineage. The veracity of each of these genes is supported by expression evidence. Additionally, their presence in one lineage and absence in the other cannot be explained by sequencing gaps. For 11 of the 75 candidate novel genes we could identify a mouse-specific mutation that led to the creation of the open reading frame (ORF) specifically in mouse. None of the six rat-specific genes had an unequivocal rat-specific mutation creating the ORF, which may at least be partly due to lower data quality for that genome. Conclusions: All 75 candidate genes presented in this study are relatively small and encode short peptides. A large number of them (51 out of 69 mouse genes and 3 out of 6 rat genes) also overlap with other genes, either within introns, or on the opposite strand. These characteristics have previously been documented for de novo genes. The description of these genes opens up the opportunity to integrate this evolutionary analysis with the rich experimental data available for these two model organisms.	[Murphy, Daniel N.; McLysaght, Aoife] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland	Trinity College Dublin	McLysaght, A (corresponding author), Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland.	aoife.mclysaght@tcd.ie		Murphy, Daniel N/0000-0002-8004-6505; McLysaght, Aoife/0000-0003-2552-6220	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by Science Foundation Ireland (www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Begun DJ, 2007, GENETICS, V176, P1131, DOI 10.1534/genetics.106.069245; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Chen ST, 2007, PLOS GENET, V3, P1131, DOI 10.1371/journal.pgen.0030107; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilson PR, 1996, P NATL ACAD SCI USA, V93, P7737, DOI 10.1073/pnas.93.15.7737; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Heinen TJAJ, 2009, CURR BIOL, V19, P1527, DOI 10.1016/j.cub.2009.07.049; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; JACOBS LL, 1980, J HUM EVOL, V9, P551, DOI 10.1016/0047-2484(80)90062-7; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Levine MT, 2006, P NATL ACAD SCI USA, V103, P9935, DOI 10.1073/pnas.0509809103; Li CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000734; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Makalowska I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-193; Marshall CR, 2008, AM J HUM GENET, V83, P106, DOI 10.1016/j.ajhg.2008.06.001; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; Siepel A, 2009, GENOME RES, V19, P1693, DOI 10.1101/gr.098376.109; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Xiao WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004603; Yang ZF, 2011, FEBS LETT, V585, P641, DOI 10.1016/j.febslet.2011.01.017; Zhang YE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000494; Zhang YE, 2010, GENOME RES, V20, P1526, DOI 10.1101/gr.107334.110; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	41	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48650	10.1371/journal.pone.0048650	http://dx.doi.org/10.1371/journal.pone.0048650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185269	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000017
J	Wesolowski, J; Caldwell, V; Paumet, F				Wesolowski, Jordan; Caldwell, Vernon; Paumet, Fabienne			A Novel Function for SNAP29 (Synaptosomal-Associated Protein of 29 kDa) in Mast Cell Phagocytosis	PLOS ONE			English	Article							LATE ENDOSOME-LYSOSOME; SYNTAXIN 7; T-SNARE; MEMBRANE TRAFFICKING; HOMOTYPIC FUSION; EXOCYTOSIS; SNAP-29; SPECIFICITY; MACROPHAGES; MECHANISMS	Mast cells play a critical role in the innate immune response to bacterial infection. They internalize and kill a variety of bacteria and process antigen for presentation to T cells via MHC molecules. Although mast cell phagocytosis appears to play a significant role during bacterial infection, little is known about the proteins involved in its regulation. In this study, we demonstrate that the SNARE protein SNAP29 is involved in mast cell phagocytosis. SNAP29 is localized in the endocytic pathway and is transiently recruited to Escherichia coli (E. coli)-containing phagosomes. Interestingly, overexpression of SNAP29 significantly increases the internalization and killing of E. coli, while it does not affect mast cell exocytosis of inflammatory mediators. To our knowledge, these data are the first to demonstrate a novel function of SNAP29 in mast cell phagocytosis and have implications in protection against bacterial infection.	[Wesolowski, Jordan; Caldwell, Vernon; Paumet, Fabienne] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Paumet, F (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	fabienne.paumet@jefferson.edu		Wesolowski, Jordan/0000-0002-4439-385X; Paumet, Fabienne/0000-0003-4466-6966	NIH [AI073486]; NCI Cancer Center Support Grant [P30 CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073486] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by a grant from the NIH (AI073486) to F.P. Research in this publication includes work carried out by both the Kimmel Cancer Center Genomic Facility and the Bioimaging Facility, which are supported in part by NCI Cancer Center Support Grant P30 CA56036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2011, J INNATE IMMUN, V3, P495, DOI 10.1159/000327714; Abraham SN, 2001, J INFECT DIS, V183, pS51, DOI 10.1086/318853; Abraham SN, 1997, INFECT IMMUN, V65, P3501, DOI 10.1128/IAI.65.9.3501-3508.1997; Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Allen LAH, 2002, J LEUKOCYTE BIOL, V72, P217; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BERON W, 1995, TRENDS CELL BIOL, V5, P100, DOI 10.1016/S0962-8924(00)88958-8; Bittner MA, 1996, J BIOL CHEM, V271, P11214, DOI 10.1074/jbc.271.19.11214; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; COHN ZA, 1960, J EXP MED, V112, P1015, DOI 10.1084/jem.112.6.1015; Collins RF, 2002, J IMMUNOL, V169, P3250, DOI 10.4049/jimmunol.169.6.3250; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Di A, 2002, NAT CELL BIOL, V4, P279, DOI 10.1038/ncb771; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Gekara NO, 2008, CELL MICROBIOL, V10, P225, DOI 10.1111/j.1462-5822.2007.01033.x; Gotte M, 1997, FEBS LETT, V411, P48, DOI 10.1016/S0014-5793(97)00575-9; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Ho YHS, 2008, J IMMUNOL, V180, P3148, DOI 10.4049/jimmunol.180.5.3148; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3; Huynh KK, 2007, PHYSIOLOGY, V22, P366, DOI 10.1152/physiol.00028.2007; Kang J, 2011, DEV BIOL, V355, P77, DOI 10.1016/j.ydbio.2011.04.013; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kreykenbohm V, 2002, EUR J CELL BIOL, V81, P273, DOI 10.1078/0171-9335-00247; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; MALAVIYA R, 1994, J IMMUNOL, V152, P1907; Malaviya R, 1996, J IMMUNOL, V156, P1490; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; Munoz S, 2009, SCAND J IMMUNOL, V70, P256, DOI 10.1111/j.1365-3083.2009.02295.x; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Pan PY, 2005, J BIOL CHEM, V280, P25769, DOI 10.1074/jbc.M502356200; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Pietrzak A, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/427473; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Ronzone E, 2012, MANIPULATION HOST VE; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Sato M, 2011, MOL BIOL CELL, V22, P2579, DOI 10.1091/mbc.E11-04-0279; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Seron K, 1998, MOL BIOL CELL, V9, P2873, DOI 10.1091/mbc.9.10.2873; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Su QN, 2001, P NATL ACAD SCI USA, V98, P14038, DOI 10.1073/pnas.251532398; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; Ward DM, 2000, MOL BIOL CELL, V11, P2327, DOI 10.1091/mbc.11.7.2327; WASSERMAN SI, 1989, ANN ALLERGY, V63, P546; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Wong SH, 1999, MOL BIOL CELL, V10, P119, DOI 10.1091/mbc.10.1.119; Xu Y, 2004, MOL MEMBR BIOL, V21, P269, DOI 10.1080/09687680410001716871	61	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49886	10.1371/journal.pone.0049886	http://dx.doi.org/10.1371/journal.pone.0049886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185475	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000136
J	Gyorgy, B; Szabo, TG; Turiak, L; Wright, M; Herczeg, P; Ledeczi, Z; Kittel, A; Polgar, A; Toth, K; Derfalvi, B; Zelenak, G; Borocz, I; Carr, B; Nagy, G; Vekey, K; Gay, S; Falus, A; Buzas, EI				Gyoergy, Bence; Szabo, Tamas G.; Turiak, Lilla; Wright, Matthew; Herczeg, Petra; Ledeczi, Zsigmond; Kittel, Agnes; Polgar, Anna; Toth, Kalman; Derfalvi, Beata; Zelenak, Gergo; Boeroecz, Istvan; Carr, Bob; Nagy, Gyoergy; Vekey, Karoly; Gay, Steffen; Falus, Andras; Buzas, Edit I.			Improved Flow Cytometric Assessment Reveals Distinct Microvesicle (Cell-Derived Microparticle) Signatures in Joint Diseases	PLOS ONE			English	Article							ARTHRITIS CLASSIFICATION CRITERIA; RHEUMATOID-ARTHRITIS; RHEUMATOLOGY/EUROPEAN LEAGUE; MEMBRANE-VESICLES; STATISTICAL-MODEL; AMERICAN-COLLEGE; SYNOVIAL-FLUID; T-CELLS; PLATELETS; BLOOD	Introduction: Microvesicles (MVs), earlier referred to as microparticles, represent a major type of extracellular vesicles currently considered as novel biomarkers in various clinical settings such as autoimmune disorders. However, the analysis of MVs in body fluids has not been fully standardized yet, and there are numerous pitfalls that hinder the correct assessment of these structures. Methods: In this study, we analyzed synovial fluid (SF) samples of patients with osteoarthritis (OA), rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). To assess factors that may confound MV detection in joint diseases, we used electron microscopy (EM), Nanoparticle Tracking Analysis (NTA) and mass spectrometry (MS). For flow cytometry, a method commonly used for phenotyping and enumeration of MVs, we combined recent advances in the field, and used a novel approach of differential detergent lysis for the exclusion of MV-mimicking non-vesicular signals. Results: EM and NTA showed that substantial amounts of particles other than MVs were present in SF samples. Beyond known MV-associated proteins, MS analysis also revealed abundant plasma-and immune complex-related proteins in MV preparations. Applying improved flow cytometric analysis, we demonstrate for the first time that CD3(+) and CD8(+) T-cell derived SF MVs are highly elevated in patients with RA compared to OA patients (p = 0.027 and p = 0.009, respectively, after Bonferroni corrections). In JIA, we identified reduced numbers of B cell-derived MVs (p = 0.009, after Bonferroni correction). Conclusions: Our results suggest that improved flow cytometric assessment of MVs facilitates the detection of previously unrecognized disease-associated vesicular signatures.	[Gyoergy, Bence; Szabo, Tamas G.; Herczeg, Petra; Ledeczi, Zsigmond; Nagy, Gyoergy; Falus, Andras; Buzas, Edit I.] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Turiak, Lilla; Vekey, Karoly] Hungarian Acad Sci, Chem Res Ctr, Budapest, Hungary; [Wright, Matthew; Carr, Bob] NanoSight Ltd, Amesbury, MA USA; [Kittel, Agnes] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Polgar, Anna] Natl Inst Rheumatism & Physiotherapy, Budapest, Hungary; [Toth, Kalman] Univ Szeged, Dept Orthopaed, Szeged, Hungary; [Derfalvi, Beata] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Zelenak, Gergo; Boeroecz, Istvan] Mil Hosp, Natl Inst Hlth, Dept Orthopaed, Budapest, Hungary; [Nagy, Gyoergy] Semmelweis Univ, Dept Rheumatol, H-1085 Budapest, Hungary; [Gay, Steffen] USZ, Zurich Ctr Integrat Human Physiol, Ctr Expt Rheumatol, Zurich, Switzerland	Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; National Institute Rheumatology & Physiotherapy; Szeged University; Semmelweis University; Semmelweis University; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Buzas, EI (corresponding author), Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary.	edit.buzas@gmail.com	Nagy, György/W-6254-2019; Szabo, Tamas Geza/E-9722-2011	Nagy, György/0000-0003-1198-3228; Szabo, Tamas Geza/0000-0001-9745-6255; Falus, Andras/0000-0002-6843-6789; Buzas, Edit/0000-0002-3744-206X; Derfalvi, Beata/0000-0001-7272-7119	Semmelweis Foundation [OTKA K 73247, NK 84043, K 77537]; Kerpel-Fronius Odon Fellowship;  [REG-KM-09-1-2009-0010];  [FP7-PEOPLE-2011-ITN - PITN-GA-2011-289033 "DYNANO'']	Semmelweis Foundation; Kerpel-Fronius Odon Fellowship; ; 	This work was supported by the Semmelweis Foundation, grants OTKA K 73247, NK 84043 and K 77537, Kerpel-Fronius Odon Fellowship, Baross Gabor (REG-KM-09-1-2009-0010) and FP7-PEOPLE-2011-ITN - PITN-GA-2011-289033 "DYNANO''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Artoni A, 2012, THROMB RES, V130, P561, DOI 10.1016/j.thromres.2012.04.012; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; BURNS CM, 1992, ARTHRITIS RHEUM, V35, P865, DOI 10.1002/art.1780350804; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; Dignat-George F, 2009, PLATELETS, V20, P225, DOI 10.1080/09537100902795500; Distler JHW, 2005, P NATL ACAD SCI USA, V102, P2892, DOI 10.1073/pnas.0409781102; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Fazou C, 2001, ARTHRITIS RHEUM, V44, P2038, DOI 10.1002/1529-0131(200109)44:9<2038::AID-ART353>3.0.CO;2-1; Finnegan S, 2011, ANN RHEUM DIS, V70, P1842, DOI 10.1136/ard.2010.148635; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Gyorgy B, 2011, BLOOD, V117, pE39, DOI 10.1182/blood-2010-09-307595; Hussein MR, 2008, PATHOL ONCOL RES, V14, P321, DOI 10.1007/s12253-008-9016-1; Kang YM, 2002, J EXP MED, V195, P1325, DOI 10.1084/jem.20011565; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lacroix R, 2010, J THROMB HAEMOST; Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032; MasukoHongo K, 1997, ANN RHEUM DIS, V56, P613, DOI 10.1136/ard.56.10.613; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Robert S, 2009, J THROMB HAEMOST, V7, P190, DOI 10.1111/j.1538-7836.2008.03200.x; Sellam J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2833; Sustar V, 2011, INT J NANOMED, V6, P2737, DOI 10.2147/IJN.S24537; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Turiak L, 2011, J PROTEOMICS, V74, P942, DOI 10.1016/j.jprot.2011.01.007; van der Zee PM, 2010, CLIN IMMUNOL, V135, P490, DOI 10.1016/j.clim.2010.01.002; Yuana Y, 2010, J THROMB HAEMOST, V8, P315, DOI 10.1111/j.1538-7836.2009.03654.x; Yuana Y, 2010, THROMB HAEMOST, V105	31	105	108	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49726	10.1371/journal.pone.0049726	http://dx.doi.org/10.1371/journal.pone.0049726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185418	Green Published, Green Accepted, gold			2022-12-25	WOS:000311535700050
J	Huang, XJ; Zhao, YY				Huang, Xiaojia; Zhao, You-Yang			Transgenic Expression of FoxM1 Promotes Endothelial Repair following Lung Injury Induced by Polymicrobial Sepsis in Mice	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; M1B TRANSCRIPTION FACTOR; BETA-CATENIN; CELLS; LIVER; PROLIFERATION; PERMEABILITY; REGENERATION; MECHANISMS; JUNCTIONS	Enhancing endothelial barrier integrity for the treatment of acute lung injury (ALI) is an emerging novel therapeutic strategy. Our previous studies have demonstrated the essential role of FoxM1 in mediating endothelial regeneration and barrier repair following lipopolysaccharide-induced lung injury. However, it remains unclear whether FoxM1 expression is sufficient to promote endothelial repair in experimental models of sepsis. Here, employing the FoxM1 transgenic (FoxM1 Tg) mice, we showed that transgenic expression of FoxM1 promoted rapid recovery of endothelial barrier function and survival in a clinically relevant model of sepsis induced by cecal ligation and puncture (CLP). We observed lung vascular permeability was rapidly recovered and returned to levels similar to baseline at 48 h post-CLP challenge in FoxM1 Tg mice whereas it remained markedly elevated in WT mice. Lung edema and inflammation were resolved only in FoxM1 Tg mice at 24 h post-CLP. 5-bromo-2-deoxyuridine incorporation assay revealed a drastic induction of endothelial proliferation in FoxM1 Tg lungs at 24h post-CLP, correlating with early induction of expression of FoxM1 target genes essential for cell cycle progression. Additionally, deletion of FoxM1 in endothelial cells, employing the mouse model with endothelial cell-restricted disruption of FoxM1 (FoxM1 CKO) resulted in impaired endothelial repair following CLP challenge. Together, these data suggest FoxM1 expression in endothelial cells is necessary and sufficient to mediate endothelial repair and thereby promote survival following sepsis challenge.	[Huang, Xiaojia; Zhao, You-Yang] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA; [Huang, Xiaojia; Zhao, You-Yang] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhao, YY (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.	yyzhao@uic.edu		ZHAO, YOU-YANG/0000-0002-0041-0339	National Institutes of Health [R01HL085462, P01HL077806]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, R01HL085462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grants R01HL085462 and P01HL077806 to YYZ. The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Cines DB, 1998, BLOOD, V91, P3527; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Kaestner KH, 2000, GENE DEV, V14, P142; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kolosova IA, 2008, AM J PHYSIOL-LUNG C, V294, pL319, DOI 10.1152/ajplung.00283.2007; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Liu YR, 2011, J EXP MED, V208, P1473, DOI 10.1084/jem.20102041; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minamino T, 2006, J CLIN INVEST, V116, P2316, DOI 10.1172/JCI29637; Mirza MK, 2010, J EXP MED, V207, P1675, DOI 10.1084/jem.20091857; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	31	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50094	10.1371/journal.pone.0050094	http://dx.doi.org/10.1371/journal.pone.0050094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185540	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700068
J	Pasquier, J; Lafont, AG; Jeng, SR; Morini, M; Dirks, R; van den Thillart, G; Tomkiewicz, J; Tostivint, H; Chang, CF; Rousseau, K; Dufour, S				Pasquier, Jeremy; Lafont, Anne-Gaelle; Jeng, Shan-Ru; Morini, Marina; Dirks, Ron; van den Thillart, Guido; Tomkiewicz, Jonna; Tostivint, Herve; Chang, Ching-Fong; Rousseau, Karine; Dufour, Sylvie			Multiple Kisspeptin Receptors in Early Osteichthyans Provide New Insights into the Evolution of This Receptor Family	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PROTEIN-COUPLED RECEPTOR-54; DIFFERENTIAL REGULATION; EUROPEAN EEL; MOLECULAR COEVOLUTION; LUTEINIZING-HORMONE; GENE-EXPRESSION; JAPANESE EEL; 2 FORMS; KISS-1	Deorphanization of GPR54 receptor a decade ago led to the characterization of the kisspeptin receptor (Kissr) in mammals and the discovery of its major role in the brain control of reproduction. While a single gene encodes for Kissr in eutherian mammals including human, other vertebrates present a variable number of Kissr genes, from none in birds, one or two in teleosts, to three in an amphibian, xenopus. In order to get more insight into the evolution of Kissr gene family, we investigated the presence of Kissr in osteichthyans of key-phylogenetical positions: the coelacanth, a representative of early sarcopterygians, the spotted gar, a non-teleost actinopterygian, and the European eel, a member of an early group of teleosts (elopomorphs). We report the occurrence of three Kissr for the first time in a teleost, the eel. As measured by quantitative RT-PCR, the three eel Kissr were differentially expressed in the brain-pituitary-gonadal axis, and differentially regulated in experimentally matured eels, as compared to prepubertal controls. Subfunctionalisation, as shown by these differences in tissue distribution and regulation, may have represented significant evolutionary constraints for the conservation of multiple Kissr paralogs in this species. Furthermore, we identified four Kissr in both coelacanth and spotted gar genomes, providing the first evidence for the presence of four Kissr in vertebrates. Phylogenetic and syntenic analyses supported the existence of four Kissr paralogs in osteichthyans and allowed to propose a clarified nomenclature of Kissr (Kissr-1 to -4) based on these paralogs. Syntenic analysis suggested that the four Kissr paralogs arose through the two rounds of whole genome duplication (1R and 2R) in early vertebrates, followed by multiple gene loss events in the actinopterygian and sarcopterygian lineages. Due to gene loss there was no impact of the teleost-specific whole genome duplication (3R) on the number of Kissr paralogs in current teleosts.	[Pasquier, Jeremy; Lafont, Anne-Gaelle; Morini, Marina; Rousseau, Karine; Dufour, Sylvie] UPMC, Museum Natl Hist Nat, Res Unit BOREA, CNRS 7208,IRD207, Paris, France; [Jeng, Shan-Ru] Natl Kaohsiung Marine Univ, Dept Aquaculture, Kaohsiung, Taiwan; [Dirks, Ron; van den Thillart, Guido] Leiden Univ, ZF Screens BV, Leiden, Netherlands; [Dirks, Ron; van den Thillart, Guido] Leiden Univ, Inst Biol, Leiden, Netherlands; [Tomkiewicz, Jonna] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Tostivint, Herve] Museum Natl Hist Nat, CNRS, MNHN Evolut Regulat Endocriniennes, UMR 7221, Paris, France; [Chang, Ching-Fong] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan; [Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Marine Bioenvironm & Biotechnol, Keelung, Taiwan	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); National Kaohsiung University of Science & Technology; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Technical University of Denmark; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); National Taiwan Ocean University; National Taiwan Ocean University	Dufour, S (corresponding author), UPMC, Museum Natl Hist Nat, Res Unit BOREA, CNRS 7208,IRD207, Paris, France.	sylvie.dufour@mnhn.fr	Morini, Marina/L-4088-2017; Tomkiewicz, Jonna/AAH-7526-2021; Tostivint, Hervé/P-8524-2019	Morini, Marina/0000-0003-3313-3419; Tomkiewicz, Jonna/0000-0002-9695-2019; Tostivint, Hervé/0000-0002-0719-0922	Ministry of Research and Education; National Research Agency, PUBERTEEL [ANR-08-BLAN-0173]; European Community, 7th Framework Programme, PRO-EEL [245257]	Ministry of Research and Education; National Research Agency, PUBERTEEL; European Community, 7th Framework Programme, PRO-EEL	JP is a recipient of a PhD fellowship from the Ministry of Research and Education. This work was supported by grants from the National Research Agency, PUBERTEEL number ANR-08-BLAN-0173 to SRJ, CFC, KR and SD, and from the European Community, 7th Framework Programme, PRO-EEL number 245257 to AGL, RD, GT, JT and SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akazome Y, 2010, J FISH BIOL, V76, P161, DOI 10.1111/j.1095-8649.2009.02496.x; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Aroua S, 2007, GEN COMP ENDOCR, V153, P333, DOI 10.1016/j.ygcen.2007.02.027; Biran J, 2008, BIOL REPROD, V79, P776, DOI 10.1095/biolreprod.107.066266; Castellano JM, 2006, ENDOCRINOLOGY, V147, P4852, DOI 10.1210/en.2006-0117; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; DUFOUR S, 1989, FISH PHYSIOL BIOCHEM, V7, P157, DOI 10.1007/BF00004702; Dufour S, 2003, EEL BIOLOGY, P373; Dufour S, 2010, J FISH BIOL, V76, P129, DOI 10.1111/j.1095-8649.2009.02499.x; DUFOUR S, 1993, FISH PHYSIOL BIOCHEM, V11, P99, DOI 10.1007/BF00004555; Filby AL, 2008, BIOL REPROD, V78, P278, DOI 10.1095/biolreprod.107.063420; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Garcia-Galiano D, 2012, ENDOCRINOLOGY, V153, P316, DOI 10.1210/en.2011-1260; Gaytan F, 2009, AM J PHYSIOL-ENDOC M, V296, pE520, DOI 10.1152/ajpendo.90895.2008; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Jeng SR, 2012, GEN COMP ENDOCR, V175, P163, DOI 10.1016/j.ygcen.2011.11.005; Kanda S, 2012, J NEUROENDOCRINOL; Kanda S, 2008, ENDOCRINOLOGY, V149, P2467, DOI 10.1210/en.2007-1503; Kim DK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00003; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; Li SS, 2009, J ENDOCRINOL, V201, P407, DOI 10.1677/JOE-09-0016; Martinez-Chavez CC, 2008, GEN COMP ENDOCR, V156, P224, DOI 10.1016/j.ygcen.2008.01.019; Mechaly AS, 2009, BIOL REPROD, V80, P60, DOI 10.1095/biolreprod.108.072173; Mohamed JS, 2007, J MOL ENDOCRINOL, V38, P235, DOI 10.1677/jme.1.02182; MONTERO M, 1995, NEUROENDOCRINOLOGY, V61, P525, DOI 10.1159/000126876; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413; Nocillado JN, 2007, GEN COMP ENDOCR, V150, P278, DOI 10.1016/j.ygcen.2006.09.008; Ohta H, 1996, AQUACULTURE, V139, P291, DOI 10.1016/0044-8486(95)01167-6; Onuma TA, 2012, FASEB J, V26, P2941, DOI 10.1096/fj.11-201095; Parhar IS, 2005, FISH PHYSIOL BIOCHEM, V31, P153, DOI 10.1007/s10695-006-0018-1; Pasqualini C, 2009, ENDOCRINOLOGY, V150, P1377, DOI 10.1210/en.2008-0578; Pasquier J, 2011, GEN COMP ENDOCR, V173, P216, DOI 10.1016/j.ygcen.2011.05.019; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Roa J, 2011, BIOL REPROD, V85, P650, DOI 10.1095/biolreprod.111.091538; Schmitz M, 2005, NEUROENDOCRINOLOGY, V81, P107, DOI 10.1159/000086404; Sebert ME, 2008, J NEUROENDOCRINOL, V20, P917, DOI 10.1111/j.1365-2826.2008.01744.x; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Shahjahan M, 2010, GEN COMP ENDOCR, V169, P48, DOI 10.1016/j.ygcen.2010.07.008; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Um HN, 2010, ANN NY ACAD SCI, V1200, P67, DOI 10.1111/j.1749-6632.2010.05508.x; Weltzien FA, 2005, ANN NY ACAD SCI, V1040, P518, DOI 10.1196/annals.1327.108; Zmora N, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097667	55	39	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48931	10.1371/journal.pone.0048931	http://dx.doi.org/10.1371/journal.pone.0048931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185286	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700020
J	Schmid, N; Pessi, G; Deng, YY; Aguilar, C; Carlier, AL; Grunau, A; Omasits, U; Zhang, LH; Ahrens, CH; Eberl, L				Schmid, Nadine; Pessi, Gabriella; Deng, Yinyue; Aguilar, Claudio; Carlier, Aurelien L.; Grunau, Alexander; Omasits, Ulrich; Zhang, Lian-Hui; Ahrens, Christian H.; Eberl, Leo			The AHL- and BDSF-Dependent Quorum Sensing Systems Control Specific and Overlapping Sets of Genes in Burkholderia cenocepacia H111	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; SOYBEAN ROOT-NODULES; LUXR-LUXI FAMILY; CEPACIA COMPLEX; TRANSCRIPTIONAL REGULATORS; QUANTITATIVE PROTEOMICS; PSEUDOMONAS-AERUGINOSA; IDENTIFICATION; VIRULENCE; SIGNAL	Quorum sensing in Burkholderia cenocepacia H111 involves two signalling systems that depend on different signal molecules, namely N-acyl homoserine lactones (AHLs) and the diffusible signal factor cis-2-dodecenoic acid (BDSF). Previous studies have shown that AHLs and BDSF control similar phenotypic traits, including biofilm formation, proteolytic activity and pathogenicity. In this study we mapped the BDSF stimulon by RNA-Seq and shotgun proteomics analysis. We demonstrate that a set of the identified BDSF-regulated genes or proteins are also controlled by AHLs, suggesting that the two regulons partially overlap. The detailed analysis of two mutually regulated operons, one encoding three lectins and the other one encoding the large surface protein BapA and its type I secretion machinery, revealed that both AHLs and BDSF are required for full expression, suggesting that the two signalling systems operate in parallel. In accordance with this, we show that both AHLs and BDSF are required for biofilm formation and protease production.	[Schmid, Nadine; Pessi, Gabriella; Aguilar, Claudio; Carlier, Aurelien L.; Grunau, Alexander; Eberl, Leo] Univ Zurich, Dept Microbiol, Zurich, Switzerland; [Deng, Yinyue; Zhang, Lian-Hui] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Omasits, Ulrich; Ahrens, Christian H.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Zurich	Eberl, L (corresponding author), Univ Zurich, Dept Microbiol, Zurich, Switzerland.	leberl@botinst.uzh.ch	Pessi, Gabriella/AGW-2342-2022; Eberl, Leo/A-8380-2012; Ahrens, Christian H./F-4656-2011; Eberl, Leo/AAE-8165-2019; Carlier, Aurelien/M-9671-2016	Eberl, Leo/0000-0002-7241-0864; Ahrens, Christian H./0000-0002-8148-7257; Carlier, Aurelien/0000-0001-7565-1586; Goldmann, Ulrich/0000-0003-1120-6912; Aguilar, Claudio/0000-0001-8551-3347; Pessi, Gabriella/0000-0002-8138-5541	Swiss National Science Foundation [31003A_122013]; Swiss SystemsX.ch initiative [IPP 2011/121]; Biomedical Research Council; Agency of Science, Technology and Research (A*Star)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss SystemsX.ch initiative; Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency of Science, Technology and Research (A*Star)(Agency for Science Technology & Research (A*STAR))	This work was financially supported by the Swiss National Science Foundation (Project 31003A_122013) to LE, the Swiss SystemsX.ch initiative (grant IPP 2011/121) to CHA and LE and the Biomedical Research Council, the Agency of Science, Technology and Research (A*Star) to LHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bi HK, 2012, MOL MICROBIOL, V83, P840, DOI 10.1111/j.1365-2958.2012.07968.x; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Carlier A, 2009, MOL MICROBIOL, V74, P903, DOI 10.1111/j.1365-2958.2009.06906.x; Carranza P, 2010, PROTEOMICS, V10, P3248, DOI 10.1002/pmic.200900460; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; Delmotte N, 2010, PROTEOMICS, V10, P1391, DOI 10.1002/pmic.200900710; Deng YY, 2012, P NATL ACAD SCI USA, V109, P15479, DOI 10.1073/pnas.1205037109; Deng YY, 2011, CHEM REV, V111, P160, DOI 10.1021/cr100354f; Deng YY, 2010, APPL ENVIRON MICROB, V76, P4675, DOI 10.1128/AEM.00480-10; Deng YY, 2009, J BACTERIOL, V191, P7270, DOI 10.1128/JB.00681-09; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gotschlich A, 2001, SYST APPL MICROBIOL, V24, P1, DOI 10.1078/0723-2020-00013; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Inhulsen S, 2012, MICROBIOLOGYOPEN, V1, P225, DOI 10.1002/mbo3.24; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Lewenza S, 1999, J BACTERIOL, V181, P748, DOI 10.1128/JB.181.3.748-756.1999; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Malott RJ, 2009, J BACTERIOL, V191, P2447, DOI 10.1128/JB.01746-08; McCarthy Y, 2010, MOL MICROBIOL, V77, P1220, DOI 10.1111/j.1365-2958.2010.07285.x; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647; Riedel K, 2006, PROTEOMICS, V6, P207, DOI 10.1002/pmic.200500097; Riedel K, 2003, ELECTROPHORESIS, V24, P740, DOI 10.1002/elps.200390089; Riedel K, 2001, MICROBIOL-SGM, V147, P3249, DOI 10.1099/00221287-147-12-3249; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; SAFARIK I, 1987, BIOTECHNOL APPL BIOC, V9, P323; STACHEL SE, 1985, EMBO J, V4, P891, DOI 10.1002/j.1460-2075.1985.tb03715.x; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Vandamme P, 1997, INT J SYST BACTERIOL, V47, P1188, DOI 10.1099/00207713-47-4-1188; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Wei YP, 2011, MOL MICROBIOL, V79, P616, DOI 10.1111/j.1365-2958.2010.07469.x; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699	46	51	53	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49966	10.1371/journal.pone.0049966	http://dx.doi.org/10.1371/journal.pone.0049966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185499	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000311535700059
J	Fonceka, D; Tossim, HA; Rivallan, R; Vignes, H; Lacut, E; de Bellis, F; Faye, I; Ndoye, O; Leal-Bertioli, SCM; Valls, JFM; Bertioli, DJ; Glaszmann, JC; Courtois, B; Rami, JF				Fonceka, Daniel; Tossim, Hodo-Abalo; Rivallan, Ronan; Vignes, Helene; Lacut, Elodie; de Bellis, Fabien; Faye, Issa; Ndoye, Ousmane; Leal-Bertioli, Soraya C. M.; Valls, Jose F. M.; Bertioli, David J.; Glaszmann, Jean-Christophe; Courtois, Brigitte; Rami, Jean-Francois			Construction of Chromosome Segment Substitution Lines in Peanut (Arachis hypogaea L.) Using a Wild Synthetic and QTL Mapping for Plant Morphology	PLOS ONE			English	Article							INTROGRESSION LINES; CULTIVATED PEANUT; INBRED LINES; POPULATION; REGISTRATION; RESISTANCE; EVOLUTION; RFLP; RICE; SET	Chromosome segment substitution lines (CSSLs) are powerful QTL mapping populations that have been used to elucidate the molecular basis of interesting traits of wild species. Cultivated peanut is an allotetraploid with limited genetic diversity. Capturing the genetic diversity from peanut wild relatives is an important objective in many peanut breeding programs. In this study, we used a marker-assisted backcrossing strategy to produce a population of 122 CSSLs from the cross between the wild synthetic allotetraploid (A. ipaensisxA. duranensis)(4x) and the cultivated Fleur11 variety. The 122 CSSLs offered a broad coverage of the peanut genome, with target wild chromosome segments averaging 39.2 cM in length. As a demonstration of the utility of these lines, four traits were evaluated in a subset of 80 CSSLs. A total of 28 lines showed significant differences from Fleur11. The linextrait significant associations were assigned to 42 QTLs: 14 for plant growth habit, 15 for height of the main stem, 12 for plant spread and one for flower color. Among the 42 QTLs, 37 were assigned to genomic regions and three QTL positions were considered putative. One important finding arising from this QTL analysis is that peanut growth habit is a complex trait that is governed by several QTLs with different effects. The CSSL population developed in this study has proved efficient for deciphering the molecular basis of trait variations and will be useful to the peanut scientific community for future QTL mapping studies.	[Fonceka, Daniel; Rivallan, Ronan; Vignes, Helene; Lacut, Elodie; de Bellis, Fabien; Glaszmann, Jean-Christophe; Courtois, Brigitte; Rami, Jean-Francois] CIRAD, UMR AGAP, Montpellier, France; [Tossim, Hodo-Abalo; Ndoye, Ousmane] ISRA Ceraas, Thies, Senegal; [Faye, Issa] Ctr Natl Rech Agron, ISRA, Bambey, Senegal; [Leal-Bertioli, Soraya C. M.; Valls, Jose F. M.] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Bertioli, David J.] Univ Brasilia, Brasilia, DF, Brazil	CIRAD; Universite de Montpellier; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia	Rami, JF (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	jean-francois.rami@cirad.fr	Valls, José Francisco Montenegro/ABD-8596-2021; COURTOIS, Brigitte/A-4004-2009	Valls, José Francisco Montenegro/0000-0002-4586-5142; COURTOIS, Brigitte/0000-0003-2118-7102	Cirad; Generation Challenge Programme [G3005.05, G4008.49, G4007.13.03]	Cirad; Generation Challenge Programme	This study was funded by the Cirad and the Generation Challenge Programme grants number G3005.05, G4008.49, and G4007.13.03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; ASHRI A, 1968, GENETICS, V60, P807; Chetelat RT, 2000, THEOR APPL GENET, V100, P232, DOI 10.1007/s001220050031; Dunnett CW, 1985, LINEAR STAT INFERENC, V35, P39; ESHED Y, 1995, GENETICS, V141, P1147; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Fonceka D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-26; Fonceka D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-103; Frary A, 2003, GENOME, V46, P235, DOI 10.1139/G02-122; Garcia GM, 2006, THEOR APPL GENET, V112, P1342, DOI 10.1007/s00122-006-0236-z; GARCIA GM, 1995, GENOME, V38, P166, DOI 10.1139/g95-021; Grandillo S, 2007, GENOMICS ASSISTED CR, V1, DOI DOI 10.1007/978-1-4020-6295-7_; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Holbrook CC, 2010, PLANT BREEDING REV, P297, DOI [10.1002/9780470650202.ch6, DOI 10.1002/9780470650202.CH6]; Jeuken MJW, 2004, THEOR APPL GENET, V109, P394, DOI 10.1007/s00122-004-1643-7; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Liu SB, 2006, THEOR APPL GENET, V112, P1360, DOI 10.1007/s00122-006-0238-x; Lorieux M, 2007, CSSL FINDER; Monforte AJ, 2000, GENOME, V43, P803, DOI 10.1139/gen-43-5-803; Nagy ED, 2010, MOL BREEDING, V26, P357, DOI 10.1007/s11032-010-9430-4; Pandey MK, 2012, PLANT BREEDING, V131, P139, DOI 10.1111/j.1439-0523.2011.01911.x; Pandey MK, 2011, BIOTECHNOL ADV; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; Schmalenbach I, 2008, THEOR APPL GENET, V117, P1093, DOI 10.1007/s00122-008-0847-7; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Simpson C. E., 2001, Peanut Science, V28, P114, DOI 10.3146/i0095-3679-28-2-12; Simpson CE, 2003, CROP SCI, V43, P1561, DOI 10.2135/cropsci2003.1561; Simpson CE, 2001, CROP SCI, V41, P918, DOI 10.2135/cropsci2001.413918x; Singh F, 1991, GENETICS BREEDING GR; STALKER HT, 1984, EUPHYTICA, V33, P529, DOI 10.1007/BF00021154; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; von Korff M, 2004, THEOR APPL GENET, V109, P1736, DOI 10.1007/s00122-004-1818-2; Wan XY, 2004, THEOR APPL GENET, V110, P71, DOI 10.1007/s00122-004-1744-3; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	37	48	53	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48642	10.1371/journal.pone.0048642	http://dx.doi.org/10.1371/journal.pone.0048642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185268	gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800008
J	Zhong, HJ; Yang, H; Chan, DSH; Leung, CH; Wang, HM; Ma, DL				Zhong, Hai-Jing; Yang, Hui; Chan, Daniel Shiu-Hin; Leung, Chung-Hang; Wang, Hui-Min; Ma, Dik-Lung			A Metal-Based Inhibitor of NEDD8-Activating Enzyme	PLOS ONE			English	Article							NF-KAPPA-B; STRUCTURE-BASED DESIGN; CULLIN-RING LIGASES; IN-VITRO; RHODIUM(II) CARBOXYLATES; TRANSCRIPTION FACTOR; CONJUGATING ENZYMES; NEDD8; COMPLEXES; DNA	A cyclometallated rhodium(III) complex [Rh(ppy)(2)(dppz)](+) (1) (where ppy = 2-phenylpyridine and dppz = dipyrido[3,2-alpha:2',3'c] phenazine dipyridophenazine) has been prepared and identified as an inhibitor of NEDD8-activating enzyme (NAE). The complex inhibited NAE activity in cell-free and cell-based assays, and suppressed the CRL-regulated substrate degradation and NF-kappa B activation in human cancer cells with potency comparable to known NAE inhibitor MLN4924. Molecular modeling analysis suggested that the overall binding mode of 1 within the binding pocket of the APPBP1/UBA3 heterodimer resembled that for MLN4924. Complex 1 is the first metal complex reported to suppress the NEDDylation pathway via inhibition of the NEDD8-activating enzyme.	[Yang, Hui; Chan, Daniel Shiu-Hin; Ma, Dik-Lung] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Zhong, Hai-Jing; Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Wang, Hui-Min] Kaohsiung Med Univ, Ctr Excellence Environm Med, Dept Fragrance & Cosmet Sci, Kaohsiung, Taiwan	Hong Kong Baptist University; University of Macau; Kaohsiung Medical University	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk		Zhong, Hai-Jing/0000-0002-1247-3150; Wang, Hui-Min/0000-0002-4692-4917; Ma, Dik-Lung/0000-0002-9515-340X	Hong Kong Baptist University [FRG2/11-12/009]; Environment and Conservation Fund (ECF) [3/2010]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM,HKBU); Health and Medical Research Fund [HMRF/11101212]; Research Grants Council [HKBU/201811]; University of Macau [SRG013-ICMS12-LCH,MYRG091(Y1-L2)-ICMS12-LCH, MYRG121 (Y1-L2)-ICMS12-LCH]	Hong Kong Baptist University; Environment and Conservation Fund (ECF); Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM,HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); University of Macau	This work is supported by Hong Kong Baptist University (FRG2/11-12/009), Environment and Conservation Fund (ECF Project 3/2010), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM,HKBU), the Health and Medical Research Fund (HMRF/11101212), the Research Grants Council (HKBU/201811) and the University of Macau (SRG013-ICMS12-LCH,MYRG091(Y1-L2)-ICMS12-LCH and MYRG121 (Y1-L2)-ICMS12-LCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2009, DALTON T, P10806, DOI 10.1039/b915357h; Angeles-Boza AM, 2006, J MED CHEM, V49, P6841, DOI 10.1021/jm060592h; Bieda R, 2010, CHEMMEDCHEM, V5, P1123, DOI 10.1002/cmdc.201000129; Bregman H, 2006, J AM CHEM SOC, V128, P877, DOI 10.1021/ja055523r; Bregman H, 2004, J AM CHEM SOC, V126, P13594, DOI 10.1021/ja046049c; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2012, METHODS MOL BIOL, V832, P577, DOI 10.1007/978-1-61779-474-2_40; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Che CM, 2010, CURR OPIN CHEM BIOL, V14, P255, DOI 10.1016/j.cbpa.2009.11.015; Chifotides HT, 2005, ACCOUNTS CHEM RES, V38, P146, DOI 10.1021/ar0302078; Chifotides HT, 2004, INORG CHEM, V43, P6177, DOI 10.1021/ic040040u; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Clarke MJ, 1999, CHEM REV, V99, P2511, DOI 10.1021/cr9804238; Debreczeni JE, 2006, ANGEW CHEM INT EDIT, V45, P1580, DOI 10.1002/anie.200503468; Dieckmann S, 2012, EUR J INORG CHEM, P813, DOI 10.1002/ejic.201101175; Dorcier A, 2006, ORGANOMETALLICS, V25, P4090, DOI 10.1021/om060394o; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Dunham SU, 2005, BIOCHEMISTRY-US, V44, P996, DOI 10.1021/bi0486637; ERCK A, 1976, CANCER RES, V36, P2204; ERCK A, 1974, P SOC EXP BIOL MED, V145, P1278; Ernst RJ, 2011, BIOCHEMISTRY-US, V50, P10919, DOI 10.1021/bi2015822; Esposito BP, 1999, J INORG BIOCHEM, V75, P55; Feng L, 2011, J AM CHEM SOC, V133, P5976, DOI 10.1021/ja1112996; Geldmacher Y, 2011, J ORGANOMET CHEM, V696, P1023, DOI 10.1016/j.jorganchem.2010.10.034; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Hartinger CG, 2009, CHEM SOC REV, V38, P391, DOI 10.1039/b707077m; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; HOWARD RA, 1976, CANCER RES, V36, P4402; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kastl A, 2012, CHEM COMMUN, V48, P1863, DOI 10.1039/c1cc15378a; Klein AV, 2009, CHEM REV, V109, P4911, DOI 10.1021/cr9001066; Leung CH, 2011, CHEM COMMUN, V47, P2511, DOI 10.1039/c0cc04927a; Liu HK, 2011, ACCOUNTS CHEM RES, V44, P349, DOI 10.1021/ar100140e; Lowry MS, 2004, J AM CHEM SOC, V126, P14129, DOI 10.1021/ja047156+; Luo Z, 2012, CANCER RES, DOI [10.1158/0008-5472.can-1112-0388, DOI 10.1158/0008-5472.CAN-1112-0388]; Ma DL, 2009, J AM CHEM SOC, V131, P1835, DOI 10.1021/ja806045x; Maksimoska J, 2008, J AM CHEM SOC, V130, P15764, DOI 10.1021/ja805555a; McDaniel ND, 2008, J AM CHEM SOC, V130, P210, DOI 10.1021/ja074478f; McMillin DW, 2012, MOL CANCER THER, V11, P942, DOI 10.1158/1535-7163.MCT-11-0563; Meggers E, 2009, CHEM COMMUN, P1001, DOI 10.1039/b813568a; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Nobili S, 2010, MED RES REV, V30, P550, DOI 10.1002/med.20168; Noffke AL, 2012, CHEM COMMUN, V48, P5219, DOI 10.1039/c2cc30678f; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pisani MJ, 2011, CHEMMEDCHEM, V6, P848, DOI 10.1002/cmdc.201100053; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Siu FM, 2012, CHEM SCI, V3, P1785, DOI 10.1039/c2sc00620k; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862; Totrov M, 1997, PROTEINS, P215; Tripathi P, 2006, CURR SCI INDIA, V90, P519; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang M, 2011, EXPERT OPIN THER TAR, V15, P253, DOI 10.1517/14728222.2011.550877; Wang P, 2010, CHEM-EUR J, V16, P6900, DOI 10.1002/chem.201000167; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Wilbuer A, 2010, ANGEW CHEM INT EDIT, V49, P3839, DOI 10.1002/anie.201000682; Xie P, 2008, ACS CHEM BIOL, V3, P305, DOI 10.1021/cb800039y; YAMADA M, 1992, B CHEM SOC JPN, V65, P1006, DOI 10.1246/bcsj.65.1006; Yang D, 2012, PLOS ONE, V7	70	32	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49574	10.1371/journal.pone.0049574	http://dx.doi.org/10.1371/journal.pone.0049574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185368	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800037
J	Gan, XB; Liu, TY; Xiong, XQ; Chen, WW; Zhou, YB; Zhu, GQ				Gan, Xian-Bing; Liu, Tong-Yan; Xiong, Xiao-Qing; Chen, Wei-Wei; Zhou, Ye-Bo; Zhu, Guo-Qing			Hydrogen Sulfide in Paraventricular Nucleus Enhances Sympathetic Activity and Cardiac Sympathetic Afferent Reflex in Chronic Heart Failure Rats	PLOS ONE			English	Article							RENOVASCULAR HYPERTENSIVE-RATS; NITRIC-OXIDE; ANG-II; NERVE DISCHARGE; AT(1) RECEPTOR; IN-VIVO; MECHANISMS; ANTISENSE; BIOLOGY; MEDIATE	Background: Intracerebroventricular infusion of NaHS, a hydrogen sulfide (H2S) donor, increased mean arterial pressure (MAP). This study was designed to determine the roles of H2S in the paraventricular nucleus (PVN) in modulating sympathetic activity and cardiac sympathetic afferent reflex (CSAR) in chronic heart failure (CHF). Methodology/Principal Findings: CHF was induced by left descending coronary artery ligation in rats. Renal sympathetic nerve activity (RSNA) and MAP were recorded under anesthesia. CSAR was evaluated by the RSNA and MAP responses to epicardial application of capsaicin. PVN microinjection of low doses of a H2S donor, GYY4137 (0.01 and 0.1 nmol), had no significant effects on RSNA, MAP and CSAR. High doses of GYY4137 (1, 2 and 4 nmol) increased baseline RSNA, MAP and heart rate (HR), and enhanced CSAR. The effects were greater in CHF rats than sham-operated rats. A cystathionine-beta-synthase (CBS) inhibitor, hydroxylamine (HA) in PVN had no significant effect on the RSNA, MAP and CSAR. CBS activity and H2S level in the PVN were decreased in CHF rats. No significant difference in CBS level in PVN was found between sham-operated rats and CHF rats. Stimulation of cardiac sympathetic afferents with capsaicin decreased CBS activity and H2S level in the PVN in both sham-operated rats and CHF rats. Conclusions: Exogenous H2S in PVN increases RSNA, MAP and HR, and enhances CSAR. The effects are greater in CHF rats than those in sham-operated rats. Endogenous H2S in PVN is not responsible for the sympathetic activation and enhanced CSAR in CHF rats.	[Gan, Xian-Bing; Liu, Tong-Yan; Xiong, Xiao-Qing; Chen, Wei-Wei; Zhou, Ye-Bo; Zhu, Guo-Qing] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Dept Physiol, Nanjing, Jiangsu, Peoples R China; [Gan, Xian-Bing] Anhui Univ Tradit Chinese Med, Dept Physiol, Hefei, Peoples R China	Nanjing Medical University; Anhui University of Chinese Medicine	Zhu, GQ (corresponding author), Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Dept Physiol, Nanjing, Jiangsu, Peoples R China.	gqzhucn@njmu.edu.cn		Zhu, Guo-Qing/0000-0002-3132-9592	Chinese National Natural Science Fund [31171095, 81000106]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by Chinese National Natural Science Fund (31171095, 81000106), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; Beltowski J., 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P173; Caliendo G, 2010, J MED CHEM, V53, P6275, DOI 10.1021/jm901638j; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Chen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040748; Chen AD, 2011, EXP PHYSIOL, V96, P94, DOI 10.1113/expphysiol.2010.054353; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Du YH, 2007, J APPL PHYSIOL, V102, P9, DOI 10.1152/japplphysiol.01032.2006; Fox B, 2012, J CELL MOL MED, V16, P896, DOI 10.1111/j.1582-4934.2011.01357.x; FRANCIS GS, 1985, AM J CARDIOL, V55, pA15, DOI 10.1016/0002-9149(85)90791-X; Francis J, 2001, AM J PHYSIOL-REG I, V281, pR1734, DOI 10.1152/ajpregu.2001.281.5.R1734; Gan XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025784; Gao J, 2012, PFLUG ARCH EUR J PHY, V463, P297, DOI 10.1007/s00424-011-1036-0; Gu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014633; Guo Q, 2011, J PHARMACOL EXP THER, V338, P458, DOI 10.1124/jpet.111.180711; Han Y, 2007, EUR J HEART FAIL, V9, P967, DOI 10.1016/j.ejheart.2007.07.004; Han Y, 2011, J APPL PHYSIOL, V110, P646, DOI 10.1152/japplphysiol.00908.2010; Hu LF, 2011, ANTIOXID REDOX SIGN, V15, P405, DOI 10.1089/ars.2010.3517; Kang YM, 2011, BASIC RES CARDIOL, V106, P1087, DOI 10.1007/s00395-011-0215-7; KRAUS JP, 1987, METHOD ENZYMOL, V143, P388; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Li YF, 2006, AM J PHYSIOL-REG I, V290, pR1035, DOI 10.1152/ajpregu.00338.2004; Li YF, 2002, AM J PHYSIOL-HEART C, V282, pH594, DOI 10.1152/ajpheart.00503.2001; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Ma R, 2005, AUTON NEUROSCI-BASIC, V118, P51, DOI 10.1016/j.autneu.2004.12.007; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Merighi S, 2012, PHARM RES; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Renga Barbara, 2011, Inflammation & Allergy Drug Targets, V10, P85; Shi Z, 2011, ACTA PHYSIOL, V203, P289, DOI 10.1111/j.1748-1716.2011.02313.x; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Streeter E, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00055; Ufnal M, 2008, ACTA NEUROBIOL EXP, V68, P382; Wang HJ, 2005, AUTON NEUROSCI-BASIC, V121, P56, DOI 10.1016/j.autneu.2005.07.003; Wang W, 2000, Heart Fail Rev, V5, P57; Wang Y, 2005, AM J PHYSIOL-HEART C, V288, pH205, DOI 10.1152/ajpheart.00497.2004; Yong QC, 2011, ANTIOXID REDOX SIGN, V14, P2081, DOI 10.1089/ars.2010.3572; Zhao Y, 2011, J AM CHEM SOC, V133, P15, DOI 10.1021/ja1085723; Zheng H, 2005, AM J PHYSIOL-HEART C, V288, pH2332, DOI 10.1152/ajpheart.00473.2004; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhu GQ, 2004, J APPL PHYSIOL, V97, P1746, DOI 10.1152/japplphysiol.00573.2004; Zhu GQ, 2004, AM J PHYSIOL-HEART C, V287, pH1828, DOI 10.1152/ajpheart.01245.2003; Zhu GQ, 2002, AM J PHYSIOL-HEART C, V282, pH2039, DOI 10.1152/ajpheart.00854.2001	48	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e50102	10.1371/journal.pone.0050102	http://dx.doi.org/10.1371/journal.pone.0050102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166827	gold, Green Submitted, Green Published			2022-12-25	WOS:000311272300088
J	El-Shazly, AE; Begon, DY; Kustermans, G; Arafa, M; Dortu, E; Henket, M; Lefebvre, PP; Louis, R; Delvenne, P				El-Shazly, Amr E.; Begon, Dominique Y.; Kustermans, Gaelle; Arafa, Mohammad; Dortu, Estelle; Henket, Monique; Lefebvre, Philippe P.; Louis, Renaud; Delvenne, Philippe			Novel Association between Vasoactive Intestinal Peptide and CRTH2 Receptor in Recruiting Eosinophils A POSSIBLE BIOCHEMICAL MECHANISM FOR ALLERGIC EOSINOPHILIC INFLAMMATION OF THE AIRWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTANCE-P; 2B4 CD244; CHEMOTAXIS; CELLS; EXPRESSION; MIGRATION; MOLECULE; KINASE	We explored the relation between vasoactive intestinal peptide (VIP), CRTH2, and eosinophil recruitment. It is shown that CRTH2 expression by eosinophils from allergic rhinitis (AR) patients and eosinophil cell line (Eol-1 cells) was up-regulated by VIP treatment. This was functional and resulted in exaggerated migratory response of cells against PGD2. Nasal challenge of AR patients resulted in a significant increase of VIP contents in nasal secretion (ELISA), and the immunohistochemical studies of allergic nasal tissues showed significant expression of VIP in association with intense eosinophil recruitment. Biochemical assays showed that VIP-induced eosinophil chemotaxis from AR patients and Eol-1 cells was mediated through the CRTH2 receptor. Cell migration against VIP was sensitive to protein kinaseC(PKC) and protein kinaseA(PKA) inhibition but not to tyrosine kinase or p38 MAPK inhibition or calcium chelation. Western blot demonstrated a novel CRTH2-mediated cytosol-to-membrane translocation of PKC-epsilon, PKC-delta, and PKA-alpha, -gamma, and -II alpha reg in Eol-1 cells upon stimulation with VIP. Confocal images and FACS demonstrated a strong association and co-localization between VIP peptide and CRTH2 molecules. Further, VIP induced PGD2 secretion from eosinophils. Our results demonstrate the first evidence of association between VIP and CRTH2 in recruiting eosinophils.	[El-Shazly, Amr E.] Liege Univ Hosp, Rhinol Unit, Dept Otorhinolaryngol & Head & Neck Surg, CHU, B-4000 Liege, Belgium; [Henket, Monique; Louis, Renaud] Liege Univ Hosp, CHU, Dept Pulmonol, GIGA Res, B-4000 Liege, Belgium; [Begon, Dominique Y.; Kustermans, Gaelle; Arafa, Mohammad; Dortu, Estelle; Delvenne, Philippe] Univ Liege, Lab Expt Pathol, Dept Pathol, GIGA Canc, B-4000 Liege, Belgium	University of Liege; University of Liege; University of Liege	El-Shazly, AE (corresponding author), Liege Univ Hosp, Rhinol Unit, Dept Otorhinolaryngol & Head & Neck Surg, CHU, B-4000 Liege, Belgium.	amrel_shazly@hotmail.com			Centre Hospitalier Universitaire de Liege [4717]	Centre Hospitalier Universitaire de Liege	This work is supported by Centre Hospitalier Universitaire de Liege Grant 4717.	Bacon KB, 1996, J EXP MED, V184, P873, DOI 10.1084/jem.184.3.873; BARANIUK JN, 1990, J CLIN INVEST, V86, P825, DOI 10.1172/JCI114780; BOKOCH GM, 1995, BLOOD, V86, P1649, DOI 10.1182/blood.V86.5.1649.bloodjournal8651649; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Dunzendorfer S, 1998, J LEUKOCYTE BIOL, V64, P828, DOI 10.1002/jlb.64.6.828; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; El-Shazly A, 1998, INT ARCH ALLERGY IMM, V117, P10, DOI 10.1159/000053563; El-Shazly AE, 2011, INT J IMMUNOPATH PH, V24, P949, DOI 10.1177/039463201102400413; El-Shazly AE, 2011, INT IMMUNOPHARMACOL, V11, P1864, DOI 10.1016/j.intimp.2011.07.017; El-Shazly Amr, 2000, Allergology International, V49, P19, DOI 10.1046/j.1440-1592.2000.00154.x; ElShazly AE, 1996, IMMUNOL INVEST, V25, P191, DOI 10.3109/08820139609059302; Fischer A, 2005, J OCCUP ENVIRON MED, V47, P20, DOI 10.1097/01.jom.0000150238.77663.49; GHATEI MA, 1982, ENDOCRINOLOGY, V111, P1248, DOI 10.1210/endo-111-4-1248; Harmar AJ, 1998, PHARMACOL REV, V50, P265; Heppt W, 2004, CLIN EXP ALLERGY, V34, P1105, DOI 10.1111/j.1365-2222.2004.01990.x; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Ishihara K, 2007, LIFE SCI, V80, P1213, DOI 10.1016/j.lfs.2006.12.016; Knall C, 1997, P NATL ACAD SCI USA, V94, P3052, DOI 10.1073/pnas.94.7.3052; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; METWALI A, 1994, J NEUROIMMUNOL, V52, P69, DOI 10.1016/0165-5728(94)90164-3; Munitz A, 2005, J IMMUNOL, V174, P110, DOI 10.4049/jimmunol.174.1.110; Munitz A, 2007, AM J RESP CRIT CARE, V175, P911, DOI 10.1164/rccm.200605-695OC; Munitz A, 2006, J IMMUNOL, V177, P77, DOI 10.4049/jimmunol.177.1.77; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; Nagata K, 1999, J IMMUNOL, V162, P1278; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nomiya R, 2008, J IMMUNOL, V180, P5680, DOI 10.4049/jimmunol.180.8.5680; NUMAO T, 1992, J IMMUNOL, V149, P3309; Okano M, 2006, AM J RHINOL, V20, P342, DOI 10.2500/ajr.2006.20.2865; Royer JF, 2007, ALLERGY, V62, P1401, DOI 10.1111/j.1398-9995.2007.01452.x; Shiraishi Y, 2005, J PHARMACOL EXP THER, V312, P954, DOI 10.1124/jpet.104.078212; SNYDERMAN R, 1984, ANNU REV IMMUNOL, V2, P257, DOI 10.1146/annurev.immunol.2.1.257; Uller L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-16	34	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1374	1384		10.1074/jbc.M112.422675	http://dx.doi.org/10.1074/jbc.M112.422675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23168411	Green Published, hybrid			2022-12-25	WOS:000313570300058
J	Haglund, L; Tillgren, V; Onnerfjord, P; Heinegard, D				Haglund, Lisbet; Tillgren, Viveka; Onnerfjord, Patrik; Heinegard, Dick			The C-terminal Peptide of Chondroadherin Modulates Cellular Activity by Selectively Binding to Heparan Sulfate Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; CARTILAGE; COLLAGEN; ADHESION; DOMAIN; RECEPTOR; DECORIN; PROTEOGLYCANS; FIBRONECTIN; INTEGRINS	Chondroadherin, a leucine-rich repeat family member, contains a very C-terminal sequence CKFPTKRSKKAGRH(359), now shown to bind to heparin with a K-D of 13 mu M. This observation led us to investigate whether chondroadherin interacts via this C-terminal heparin-binding domain with glycosaminoglycan chains of proteoglycans at the cell surface. Cells were shown to bind this heparin-binding peptide in FACS analysis, and the interaction was shown to be with glycosaminoglycans because it was abolished when sulfation was inhibited by chlorate treatment of the cells. In separate experiments, heparin and heparan sulfate inhibited the peptide interaction in a dose-dependent manner. Using a human chondrosarcoma and a murine osteoblast cell line, heparan sulfate proteoglycans were identified as the cell surface receptors involved in the binding. Different binding syndecans were identified in the two different cell lines, indicating that the same protein core of a proteoglycan may have structural and functional differences in the attached heparan sulfate chains. Upon binding to coated peptide, cells spread, demonstrating engagement of the cytoskeleton, but no focal adhesion complex was formed. The number of cells adhering via their beta(1) integrin receptor to collagen type II or chondroadherin was profoundly and rapidly enhanced by the addition of the heparin-binding peptide. The peptide added to the cells caused ERK phosphorylation, showing that it triggered intracellular signaling. The results show that heparan sulfate chains differ between various members of the proteoglycan families on a given cell, but also differ between the same proteoglycan on different cells with a potential for differential regulation of cellular activities.	[Haglund, Lisbet; Tillgren, Viveka; Onnerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Clin Sci, Rheumatol Sect, Biomed Ctr C12, SE-22184 Lund, Sweden	Lund University	Heinegard, D (corresponding author), Lund Univ, Dept Clin Sci, Rheumatol Sect, Biomed Ctr C12, BMC Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Haglund, Lisbet/N-3095-2013; Onnerfjord, Patrik/R-3131-2019	Haglund, Lisbet/0000-0002-1288-2149; Onnerfjord, Patrik/0000-0002-2345-2937	Swedish Research Council; King Gustaf V:s 80-year Fund; Osterlund Foundation; Kock Foundation; European Commission 7th Framework Program for Research; NanoDiaRa; Anamar Medical	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V:s 80-year Fund; Osterlund Foundation; Kock Foundation; European Commission 7th Framework Program for Research; NanoDiaRa; Anamar Medical	This work was supported by funding from The Swedish Research Council, the King Gustaf V:s 80-year Fund, the Osterlund Foundation, the Kock Foundation, the European Commission 7th Framework Program for Research, NanoDiaRa, and Anamar Medical.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Couchman JR, 2001, INT REV CYTOL, V207, P113; DANILOV YN, 1989, J CELL BIOL, V108, P1925, DOI 10.1083/jcb.108.5.1925; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Haglund L, 2011, J BIOL CHEM, V286, P3925, DOI 10.1074/jbc.M110.161141; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEINEGARD DK, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P95; Humphries Martin J, 2005, Novartis Found Symp, V269, P178; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; LARSSON T, 1991, J BIOL CHEM, V266, P20428; Latvanlehto A, 2003, J BIOL CHEM, V278, P37590, DOI 10.1074/jbc.M305974200; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P4903, DOI 10.1021/bi00776a005; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995; RECKLIES AD, 1992, ARTHRITIS RHEUM, V35, P1510, DOI 10.1002/art.1780351215; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; Sandell L. J., 2007, OSTEOARTHRITIS DIAGN, P73; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; SOMMARIN Y, 1989, EXP CELL RES, V184, P181, DOI 10.1016/0014-4827(89)90376-5; SOMMARIN Y, 1983, BIOCHEM J, V214, P777, DOI 10.1042/bj2140777; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Woods A, 1998, MATRIX BIOL, V17, P477, DOI 10.1016/S0945-053X(98)90095-6; YONEDA J, 1995, EXP CELL RES, V217, P169, DOI 10.1006/excr.1995.1076; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200	42	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					995	1008		10.1074/jbc.M112.430512	http://dx.doi.org/10.1074/jbc.M112.430512			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23172228	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000313570300024
J	Banerjee, A; Wu, ZS; Qian, PX; Kang, J; Liu, DX; Zhu, T; Lobie, PE				Banerjee, Arindam; Wu, Zheng-Sheng; Qian, Peng-Xu; Kang, Jian; Liu, Dong-Xu; Zhu, Tao; Lobie, Peter E.			ARTEMIN Promotes De Novo Angiogenesis in ER Negative Mammary Carcinoma through Activation of TWIST1-VEGF-A Signalling	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; MEDIATES ANTIESTROGEN RESISTANCE; BREAST-CANCER PATIENTS; TUMOR ANGIOGENESIS; VEGF-A; METASTASIS; CELLS; INVASION; EXPRESSION; RECEPTOR	The neurotrophic factor ARTEMIN (ARTN) has been reported to possess a role in mammary carcinoma progression and metastasis. Herein, we report that ARTN modulates endothelial cell behaviour and promotes angiogenesis in ER-mammary carcinoma (ER-MC). Human microvascular endothelial cells (HMEC-1) do not express ARTN but respond to exogenously added, and paracrine ARTN secreted by ER-MC cells. ARTN promoted endothelial cell proliferation, migration, invasion and 3D matrigel tube formation. Angiogenic behaviour promoted by ARTN secreted by ER-MC cells was mediated by AKT with resultant increased TWIST1 and subsequently VEGF-A expression. In a patient cohort of ER-MC, ARTN positively correlated with VEGF-A expression as measured by Spearman's rank correlation analysis. In xenograft experiments, ER-MC cells with forced expression of ARTN produced tumors with increased VEGF-A expression and increased microvessel density (CD31 and CD34) compared to tumors formed by control cells. Functional inhibition of ARTN by siRNA decreased the angiogenic effects of ER-MC cells. Bevacizumab (a humanized monoclonal anti-VEGF-A antibody) partially inhibited the ARTN mediated angiogenic effects of ER-MC cells and combined inhibition of ARTN and VEGF-A by the same resulted in further significant decrease in the angiogenic effects of ER-MC cells. Thus, ARTN stimulates de novo tumor angiogenesis mediated in part by VEGF-A. ARTN therefore co-ordinately regulates multiple aspects of tumor growth and metastasis.	[Wu, Zheng-Sheng; Qian, Peng-Xu; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Wu, Zheng-Sheng; Qian, Peng-Xu; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Banerjee, Arindam; Kang, Jian; Liu, Dong-Xu] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Wu, Zheng-Sheng] Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China; [Wu, Zheng-Sheng] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Auckland; Anhui Medical University; Fudan University; National University of Singapore; National University of Singapore	Zhu, T (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zhut@ustc.edu.cn; csipel@nus.edu.sg	Qian, Pengxu/B-9376-2016	Qian, Pengxu/0000-0001-5636-6704; Kang, Jian/0000-0001-9998-4975	Breast Cancer Research Trust, New Zealand; Dick Roberts Trust, New Zealand; Cancer Science Institute, Singapore; National Key Scientific Programme of China [2012CB934002, 2010CB912804]; Chinese Academy of Sciences [XDA01040410, 2010T2S03]; National Natural Science Foundation of China [30971492, 81101597]	Breast Cancer Research Trust, New Zealand; Dick Roberts Trust, New Zealand; Cancer Science Institute, Singapore; National Key Scientific Programme of China; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Breast Cancer Research Trust, New Zealand, The Dick Roberts Trust, New Zealand, Cancer Science Institute, Singapore, The National Key Scientific Programme of China (2012CB934002 and 2010CB912804), Chinese Academy of Sciences (XDA01040410), National Natural Science Foundation of China (30971492, and 81101597), and the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (2010T2S03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ARH, 2012, AM J PATHOL, V180, P904, DOI 10.1016/j.ajpath.2011.11.022; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Bajou K, 2002, INT J CANCER, V100, P501, DOI 10.1002/ijc.10487; Banerjee A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3054; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Brunet-Dunand SE, 2009, ENDOCRINOLOGY, V150, P1341, DOI 10.1210/en.2008-0608; Cao YH, 2007, ADV CANCER RES, V97, P203, DOI 10.1016/S0065-230X(06)97009-2; Ceyhan GO, 2006, ANN SURG, V244, P274, DOI 10.1097/01.sla.0000217642.68697.55; Eck SM, 2009, BREAST CANCER RES TR, V116, P79, DOI 10.1007/s10549-008-0085-3; El Agouza IM, 2011, ANGIOGENESIS, V14, P321, DOI 10.1007/s10456-011-9215-3; Giovannini M, 2010, CRIT REV ONCOL HEMAT, V76, P13, DOI 10.1016/j.critrevonc.2009.12.004; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kang J, 2010, ONCOGENE, V29, P3228, DOI 10.1038/onc.2010.71; Kang J, 2009, ONCOGENE, V28, P2034, DOI 10.1038/onc.2009.66; Kannan N, 2010, NEOPLASIA, V12, P1041, DOI 10.1593/neo.10916; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; Loges Sonja, 2010, Genes Cancer, V1, P12, DOI 10.1177/1947601909356574; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Manders P, 2002, BRIT J CANCER, V87, P772, DOI 10.1038/sj.bjc.6600555; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Pandey V, 2010, ENDOCRINOLOGY, V151, P909, DOI 10.1210/en.2009-0979; Relf M, 1997, CANCER RES, V57, P963; Romon R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-157; Schneider BP, 2005, J CLIN ONCOL, V23, P1782, DOI 10.1200/JCO.2005.12.017; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Skinner HD, 2004, J BIOL CHEM, V279, P45643, DOI 10.1074/jbc.M404097200; Tang JZ, 2010, MOL CANCER THER, V9, P1697, DOI 10.1158/1535-7163.MCT-09-1077; Toi M, 2001, LANCET ONCOL, V2, P667, DOI 10.1016/S1470-2045(01)00556-3; Tsutsui S, 2010, ONCOL REP, V23, P621, DOI 10.3892/or_00000677; Zhao Y, 2011, INT J DEV BIOL, V55, P477, DOI 10.1387/ijdb.103225yz; Zheng X, 2009, CANCER BIOL THER, V8, P1045, DOI 10.4161/cbt.8.11.8539	38	19	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50098	10.1371/journal.pone.0050098	http://dx.doi.org/10.1371/journal.pone.0050098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185544	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000181
J	Cruse, D; Chennu, S; Fernandez-Espejo, D; Payne, WL; Young, GB; Owen, AM				Cruse, Damian; Chennu, Srivas; Fernandez-Espejo, Davinia; Payne, William L.; Young, G. Bryan; Owen, Adrian M.			Detecting Awareness in the Vegetative State: Electroencephalographic Evidence for Attempted Movements to Command	PLOS ONE			English	Article							MINIMALLY CONSCIOUS STATE; MOTOR IMAGERY; EEG; SYNCHRONIZATION; DISORDERS; ACCURACY; RHYTHM; AREAS; COMA	Patients in the Vegetative State (VS) do not produce overt motor behavior to command and are therefore considered to be unaware of themselves and of their environments. However, we recently showed that high-density electroencephalography (EEG) can be used to detect covert command-following in some VS patients. Due to its portability and inexpensiveness, EEG assessments of awareness have the potential to contribute to a standard clinical protocol, thus improving diagnostic accuracy. However, this technique requires refinement and optimization if it is to be used widely as a clinical tool. We asked a patient who had been repeatedly diagnosed as VS for 12-years to try to move his left and right hands, between periods of rest, while EEG was recorded from four scalp electrodes. We identified appropriate and statistically reliable modulations of sensorimotor beta rhythms following commands to try to move, which could be significantly classified at a single-trial level. These reliable effects indicate that the patient attempted to follow the commands, and was therefore aware, but was unable to execute an overtly discernable action. The cognitive demands of this novel task are lower than those used previously and, crucially, allow for awareness to be determined on the basis of a 20-minute EEG recording made with only four electrodes. This approach makes EEG assessments of awareness clinically viable, and therefore has potential for inclusion in a standard assessment of awareness in the VS.	[Cruse, Damian; Fernandez-Espejo, Davinia; Owen, Adrian M.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Chennu, Srivas] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Payne, William L.] London Hlth Sci Ctr, Parkwood Hosp, London, ON, Canada; [Young, G. Bryan] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada	Western University (University of Western Ontario); University of Cambridge; London Health Sciences Centre; Western University (University of Western Ontario)	Cruse, D (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON, Canada.	dcruse@uwo.ca	Cruse, Damian/ABA-6346-2021; Williams, Jackie/B-3495-2015; Fernandez-Espejo, Davinia/AAT-5481-2021	Cruse, Damian/0000-0003-4363-5981; Fernandez-Espejo, Davinia/0000-0001-5941-7546; Chennu, Srivas/0000-0002-6840-2941	Canada Excellence Research Chair Programme; Canadian Institutes of Health Research	Canada Excellence Research Chair Programme; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was funded by the Canada Excellence Research Chair Programme, and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein TA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00005; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; [Anonymous], 2003, Clin Med (Lond), V3, P249; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Bishop C.M., 2006, PATTERN RECOGNITION; Candelieri A, 2011, J NEUROTRAUM, V28, P2013, DOI 10.1089/neu.2011.1885; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; JENNETT B, 1972, LANCET, V1, P734; Leuthold H, 2001, COGNITIVE BRAIN RES, V12, P207, DOI 10.1016/S0926-6410(01)00052-0; Maris E, 2004, PSYCHOPHYSIOLOGY, V41, P142, DOI 10.1111/j.1469-8986.2003.00139.x; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Owen AM, 2007, SCIENCE, V315, DOI 10.1126/science.1135583; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pfurtscheller G, 2008, EUR J NEUROSCI, V28, P1419, DOI 10.1111/j.1460-9568.2008.06441.x; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; Pfurtscheller G, 2009, Comput Intell Neurosci, P104180, DOI 10.1155/2009/104180; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V51, P253, DOI 10.1016/0013-4694(81)90139-5; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Pfurtscheller G., 2006, BRAIN RES; Pfurtscheller Gert, 1994, Brain Topography, V6, P269, DOI 10.1007/BF01211172; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Scott RB, 2011, CONSCIOUS COGN, V20, P936, DOI 10.1016/j.concog.2010.11.009; Society ACN, 2006, J CLIN NEUROPHYSIOLO, P23; TEASDALE G, 1974, LANCET, V2, P81	43	73	77	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49933	10.1371/journal.pone.0049933	http://dx.doi.org/10.1371/journal.pone.0049933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185489	Green Published, Green Accepted, gold			2022-12-25	WOS:000311821000145
J	de Araujo, FCF; de Rezende, AM; Fontes, CJF; Carvalho, LH; de Brito, CFA				de Araujo, Flavia Carolina F.; de Rezende, Antonio Mauro; Fontes, Cor Jesus F.; Carvalho, Luzia Helena; Alves de Brito, Cristiana F.			Multiple-Clone Activation of Hypnozoites Is the Leading Cause of Relapse in Plasmodium vivax Infection	PLOS ONE			English	Article							MICROSATELLITE ANALYSIS; POPULATION-STRUCTURE; MOLECULAR ANALYSIS; MALARIA; TRANSMISSION; FALCIPARUM; DYNAMICS; MARKERS; RISK; PRIMAQUINE	Background: Plasmodium vivax infection is characterized by a dormant hepatic stage, the hypnozoite that is activated at varying periods of time after clearance of the primary acute blood-stage, resulting in relapse. Differentiation between treatment failure and new infections requires characterization of initial infections, relapses, and clone multiplicity in vivax malaria infections. Methodology/Principal Findings: Parasite DNA obtained from primary/relapse paired blood samples of 30 patients with P. vivax infection in Brazil was analyzed using 10 molecular markers (8 microsatellites and MSP-1 blocks 2 and 10). Cloning of PCR products and genotyping was used to identify low-frequency clones of parasites. We demonstrated a high frequency of multiple-clone infections in both primary and relapse infections. Few alleles were identified per locus, but the combination of these alleles produced many haplotypes. Consequently, the majority of parasites involved in relapse showed haplotypes that were distinct from those of primary infections. Plasmodium vivax relapse was characterized by temporal variations in the predominant parasite clones. Conclusions/Significance: The high rate of low frequency alleles observed in both primary and relapse infections, along with temporal variation in the predominant alleles, might be the source of reported heterologous hypnozoite activation. Our findings complicate the concept of heterologous activation, suggesting the involvement of undetermined mechanisms based on host or environmental factors in the simultaneous activation of multiple clones of hypnozoites.	[de Araujo, Flavia Carolina F.; Carvalho, Luzia Helena; Alves de Brito, Cristiana F.] Fiocruz Minas, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil; [de Rezende, Antonio Mauro] Fiocruz Minas, Ctr Pesquisas Rene Rachou, Lab Cellular & Mol Parasitol, Belo Horizonte, MG, Brazil; [Fontes, Cor Jesus F.] Univ Fed Mato Grosso, Hosp Univ Julio Muller, Cuiaba, Mato Grasso, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso	de Brito, CFA (corresponding author), Fiocruz Minas, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.	cristiana@cpqrr.fiocruz.br	Rezende, Antonio M/S-2126-2018; Fontes, Cor JF/G-7331-2018; Carvalho, Luzia H/AAW-3461-2021; carvalho, luzia H/C-4087-2013	Rezende, Antonio M/0000-0003-4775-1779; Fontes, Cor JF/0000-0003-2756-0588; 	Pronex malaria network: CNPq/Ministry of Health-DECIT; FAPEMAT; FAPEMIG; CNPq	Pronex malaria network: CNPq/Ministry of Health-DECIT; FAPEMAT(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Pronex malaria network: CNPq/Ministry of Health-DECIT; FAPEMAT; and FAPEMIG. CAB, LHC and CJF were supported by CNPq fellowships. FFA and AMR are supported by scholarships from CNPq and Fapemig, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak T, 1998, AM J TROP MED HYG, V59, P175, DOI 10.4269/ajtmh.1998.59.175; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], COCHRANE DATABASE SY; Boyd M. F., 1947, Malaria Soc (USA), V6, P12; BOYD MARK F., 1936, AMER JOUR TROP MED, V16, P311; Chen NH, 2007, J INFECT DIS, V195, P934, DOI 10.1086/512242; CONTACOS PG, 1972, AM J TROP MED HYG, V21, P707, DOI 10.4269/ajtmh.1972.21.707; Craig AA, 1996, J INFECT DIS, V174, P373, DOI 10.1093/infdis/174.2.373; CRAIGE B, 1947, J INFECT DIS, V80, P228, DOI 10.1093/infdis/80.3.228; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; GILL CA, 1938, SEASONAL PERIODICITY; Gogtay NJ, 1999, ANN TROP MED PARASIT, V93, P809, DOI 10.1080/00034989957790; Goller JL, 2007, AM J TROP MED HYG, V76, P203, DOI 10.4269/ajtmh.2007.76.203; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Havryliuk T, 2008, EXP PARASITOL, V120, P330, DOI 10.1016/j.exppara.2008.08.012; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; HOWE CD, 1946, SCIENCE, V103, P223, DOI 10.1126/science.103.2669.223; Hulden L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-90; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806; James SP, 1926, LEAGUE NATIONS HLTH, V57, P30; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Katsuragawa TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009245; Khusmith Srisin, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P519; Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389; Koepfli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019010; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Ministerio da Saude, 2009, GUIA PRAT TRAT MAL B; Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de Vigilancia Epidemiologic, 2010, ASP EP MAL; NISHIMURA A, 1990, NUCLEIC ACIDS RES, V18, P6169, DOI 10.1093/nar/18.20.6169; Orjuela-Sanchez P, 2009, AM J TROP MED HYG, V81, P961, DOI 10.4269/ajtmh.2009.09-0337; Restrepo E, 2011, ACTA TROP, V119, P23, DOI 10.1016/j.actatropica.2011.03.012; Rezende AM, 2010, TROP MED INT HEALTH, V15, P718, DOI 10.1111/j.1365-3156.2010.02535.x; Sinton J. A., 1928, Indian Journal of Medical Research Calcutta, V16, P159; Van den Eede P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016257; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; WARREN M, 1970, EXP PARASITOL, V28, P551, DOI 10.1016/0014-4894(70)90123-2; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2010, WORLD MALARIA REPORT 2010, P1	47	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49871	10.1371/journal.pone.0049871	http://dx.doi.org/10.1371/journal.pone.0049871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185469	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000131
J	Kominami, K; Nagai, T; Sawasaki, T; Tsujimura, Y; Yashima, K; Sunaga, Y; Tsuchimochi, M; Nishimura, J; Chiba, K; Nakabayashi, J; Koyamada, K; Endo, Y; Yokota, H; Miyawaki, A; Manabe, N; Sakamaki, K				Kominami, Katsuya; Nagai, Takeharu; Sawasaki, Tatsuya; Tsujimura, Yuki; Yashima, Kenta; Sunaga, Yasuhiro; Tsuchimochi, Masateru; Nishimura, Jun; Chiba, Kumiko; Nakabayashi, Jun; Koyamada, Koji; Endo, Yaeta; Yokota, Hideo; Miyawaki, Atsushi; Manabe, Noboru; Sakamaki, Kazuhiro			In Vivo Imaging of Hierarchical Spatiotemporal Activation of Caspase-8 during Apoptosis	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; CELL-DEATH; INTERCHAIN PROTEOLYSIS; DOWN-REGULATION; MONOMERIC RED; LIVING CELLS; MODEL; SPECIFICITIES; DIMERIZATION; RIPOPTOSOME	Background: Activation of caspases is crucial for the execution of apoptosis. Although the caspase cascade associated with activation of the initiator caspase-8 (CASP8) has been investigated in molecular and biochemical detail, the dynamics of CASP8 activation are not fully understood. Methodology/Principal Findings: We have established a biosensor based on fluorescence resonance energy transfer (FRET) for visualizing apoptotic signals associated with CASP8 activation at the single-cell level. Our dual FRET (dual-FRET) system, comprising a triple fusion fluorescent protein, enabled us to simultaneously monitor the activation of CASP8 and its downstream effector, caspase-3 (CASP3) in single live cells. With the dual-FRET-based biosensor, we detected distinct activation patterns of CASP8 and CASP3 in response to various apoptotic stimuli in mammalian cells, resulting in the positive feedback amplification of CASP8 activation. We reproduced these observations by in vitro reconstitution of the cascade, with a recombinant protein mixture that included procaspases. Furthermore, using a plasma membrane-bound FRET-based biosensor, we captured the spatiotemporal dynamics of CASP8 activation by the diffusion process, suggesting the focal activation of CASP8 is sufficient to propagate apoptotic signals through death receptors. Conclusions: Our new FRET-based system visualized the activation process of both initiator and effector caspases in a single apoptotic cell and also elucidated the necessity of an amplification loop for full activation of CASP8.	[Kominami, Katsuya; Chiba, Kumiko; Sakamaki, Kazuhiro] Kyoto Univ, Dept Anim Dev & Physiol, Kyoto, Japan; [Nagai, Takeharu; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Lab Cell Funct Dynam, Wako, Saitama, Japan; [Nagai, Takeharu] Hokkaido Univ, Res Inst Elect Sci, Lab Nanosyst Physiol, Sapporo, Hokkaido, Japan; [Sawasaki, Tatsuya; Tsuchimochi, Masateru; Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Tsujimura, Yuki; Yokota, Hideo] RIKEN, Adv Sci Inst, Biores Infrastruct Construct Team, Wako, Saitama, Japan; [Yashima, Kenta] Meiji Univ, Meiji Inst Adv Study Math Sci, Kawasaki, Kanagawa, Japan; [Sunaga, Yasuhiro; Yokota, Hideo] RIKEN, Computat Sci Res Program, Cell Scale Team, Wako, Saitama, Japan; [Nishimura, Jun] Kyoto Univ, Dept Elect Engn, Kyoto 606, Japan; [Nakabayashi, Jun] Yokohama City Univ, Dept Immunol, Yokohama, Kanagawa 232, Japan; [Koyamada, Koji] Kyoto Univ, Inst Promot Excellence High Educ, Kyoto, Japan; [Manabe, Noboru] Univ Tokyo, Anim Resource Sci Ctr, Res Unit Anim Life Sci, Kasama, Ibaraki, Japan	Kyoto University; RIKEN; Hokkaido University; Ehime University; RIKEN; Meiji University; RIKEN; Kyoto University; Yokohama City University; Kyoto University; University of Tokyo	Sakamaki, K (corresponding author), Kyoto Univ, Dept Anim Dev & Physiol, Kyoto, Japan.	sakamaki.kazuhiro.7u@kyoto-u.ac.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sakamaki, Kazuhiro/0000-0002-7072-9628; Sawasaki, Tatsuya/0000-0002-7952-0556; Nagai, Takeharu/0000-0003-2650-9895	Japan Society for the Promotion of Science [13GS0008]; Grants-in-Aid for Scientific Research [22310127] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Creative Scientific Research to NM and KS from the Japan Society for the Promotion of Science (13GS0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen M, 2002, J BIOL CHEM, V277, P50761, DOI 10.1074/jbc.M210356200; Chereau D, 2003, BIOCHEMISTRY-US, V42, P4151, DOI 10.1021/bi020593l; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Conus S, 2012, J BIOL CHEM, V287, P21142, DOI 10.1074/jbc.M111.306399; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Desai BN, 2012, DEV CELL, V22, P1149, DOI 10.1016/j.devcel.2012.04.006; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Hellwig CT, 2008, J BIOL CHEM, V283, P21676, DOI 10.1074/jbc.M802889200; Huber HJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-9; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Kawai H, 2005, J PHARMACOL SCI, V97, P361, DOI 10.1254/jphs.FP0040592; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Kominami K, 2012, BBA-MOL CELL RES, V1823, P1825, DOI 10.1016/j.bbamcr.2012.07.003; Luo KQ, 2003, BIOCHEM BIOPH RES CO, V304, P217, DOI 10.1016/S0006-291X(03)00559-X; Matsuda T, 2008, NAT METHODS, V5, P339, DOI [10.1038/nmeth.1193, 10.1038/NMETH.1193]; Murphy BM, 2004, J BIOL CHEM, V279, P36916, DOI 10.1074/jbc.M402039200; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, BIOCHEM BIOPH RES CO, V319, P72, DOI 10.1016/j.bbrc.2004.04.147; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimozono S, 2008, METHOD CELL BIOL, V85, P381, DOI 10.1016/S0091-679X(08)85016-9; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Stennicke HR, 1998, BBA-PROTEIN STRUCT M, V1387, P17, DOI 10.1016/S0167-4838(98)00133-2; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thornberry NA, 2000, METHOD ENZYMOL, V322, P100; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Van de Craen M, 1999, CELL DEATH DIFFER, V6, P1117, DOI 10.1038/sj.cdd.4400589; Wu XL, 2006, CYTOM PART A, V69A, P477, DOI 10.1002/cyto.a.20300	45	20	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50218	10.1371/journal.pone.0050218	http://dx.doi.org/10.1371/journal.pone.0050218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185580	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000201
J	Lachish, S; Lawson, B; Cunningham, AA; Sheldon, BC				Lachish, Shelly; Lawson, Becki; Cunningham, Andrew A.; Sheldon, Ben C.			Epidemiology of the Emergent Disease Paridae pox in an Intensively Studied Wild Bird Population	PLOS ONE			English	Article							HAWAIIAN FOREST BIRDS; IN-HOUSE FINCHES; TIT PARUS-MAJOR; AVIAN POX; INFECTIOUS-DISEASES; CLIMATE-CHANGE; PREVALENCE; MALARIA; SEASONALITY; DYNAMICS	Paridae pox, a novel avipoxvirus infection, has recently been identified as an emerging infectious disease affecting wild tit species in Great Britain. The incursion of Paridae pox to a long-term study site where populations of wild tits have been monitored in detail for several decades provided a unique opportunity to obtain information on the local-scale epidemiological characteristics of this novel infection during a disease outbreak. Using captures of.8000 individual birds, we show that, within two years of initial emergence, Paridae pox had become established within the population of great tits (Parus major) reaching relatively high peak prevalence (10%), but was far less prevalent (<1%) in sympatric populations of several other closely related, abundant Paridae species. Nonlinear smoothing models revealed that the temporal pattern of prevalence among great tits was characterised by within-year fluctuations indicative of seasonal forcing of infection rates, which was likely driven by multiple environmental and demographic factors. There was individual heterogeneity in the course of infection and, although recovery was possible, diseased individuals were far less likely to be recaptured than healthy individuals, suggesting a survival cost of infection. This study demonstrates the value of long-term monitoring for obtaining key epidemiological data necessary to understand disease dynamics, spread and persistence in natural populations.	[Lachish, Shelly; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Lawson, Becki; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England	University of Oxford; Zoological Society of London	Lachish, S (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	shelly.lachish@zoo.ox.ac.uk	Cunningham, Andrew A/E-7536-2010; Sheldon, Ben C/A-8056-2010	Sheldon, Ben C/0000-0002-5240-7828; lawson, becki/0000-0003-1706-7140	Natural Environment Research Council [NE/I028718/1]; European Research Council [AdG250164]; NERC [NE/I028718/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by an Urgency grant from the Natural Environment Research Council (NE/I028718/1) http://www.nerc.ac.uk/, and by a European Research Council Advanced Investigator grant (AdG250164): http://erc.europa.eu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 2010, NEW ZEAL VET J, V58, P218, DOI 10.1080/00480169.2010.68868; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Altizer S, 2004, J ANIM ECOL, V73, P309, DOI 10.1111/j.0021-8790.2004.00807.x; Aruch S, 2007, J WILDLIFE DIS, V43, P567, DOI 10.7589/0090-3558-43.4.567; Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Atkinson CT, 2005, CONDOR, V107, P537, DOI 10.1650/0010-5422(2005)107[0537:POPLAM]2.0.CO;2; Buenestado F, 2004, EPIDEMIOL INFECT, V132, P369, DOI 10.1017/S095026880300178X; Carroll B, 2009, EPIDEMIOL INFECT, V137, P257, DOI 10.1017/S0950268808000836; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Dhondt AA, 2007, AVIAN PATHOL, V36, P205, DOI 10.1080/03079450701286277; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; GERLACH H, 1994, AVIAN MED PRINCIPLES, P865; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hosseini PR, 2004, P ROY SOC B-BIOL SCI, V271, P2569, DOI 10.1098/rspb.2004.2938; Illera JC, 2008, PARASITOL RES, V103, P1435, DOI 10.1007/s00436-008-1153-7; Jarvi SI, 2008, CONSERV GENET, V9, P339, DOI 10.1007/s10592-007-9346-7; Jennelle CS, 2007, ECOL APPL, V17, P154, DOI 10.1890/1051-0761(2007)017[0154:SDPADP]2.0.CO;2; Kleindorfer S, 2006, J AVIAN BIOL, V37, P69, DOI 10.1111/j.0908-8857.2006.03503.x; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lawson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040176; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Morand-Ferron J, 2011, P NATL ACAD SCI USA, V108, P15898, DOI 10.1073/pnas.1111560108; Pascual M, 2005, PLOS MED, V2, P18, DOI 10.1371/journal.pmed.0020005; Perrins C.M., 1979, BRIT TITS; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Ritchie B.W., 1995, AVIAN VIRUSES FUNCTI, P285; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Senar J. C., 2004, Animal Biodiversity and Conservation, V27, P133; SIMPSON C F, 1975, Journal of Wildlife Diseases, V11, P112; Smith GC, 2006, NEW ZEAL J ECOL, V30, P35; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Stauss MJ, 2005, J AVIAN BIOL, V36, P47, DOI 10.1111/j.0908-8857.2005.02855.x; Sterner RT, 2006, BIOL CONSERV, V131, P163, DOI 10.1016/j.biocon.2006.05.004; Svensson L., 1992, IDENTIFICATION GUIDE; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; van Riper Charles III, 2007, P131, DOI 10.1002/9780470344668.ch6; Wikelski M, 2004, ECOL SOC, V9; Wilkin TA, 2007, IBIS, V149, P110, DOI 10.1111/j.1474-919X.2007.00757.x; Young LC, 2008, J FIELD ORNITHOL, V79, P93, DOI 10.1111/j.1557-9263.2008.00149.x	42	23	23	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e38316	10.1371/journal.pone.0038316	http://dx.doi.org/10.1371/journal.pone.0038316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185230	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000001
J	Lawson, B; Lachish, S; Colvile, KM; Durrant, C; Peck, KM; Toms, MP; Sheldon, BC; Cunningham, AA				Lawson, Becki; Lachish, Shelly; Colvile, Katie M.; Durrant, Chris; Peck, Kirsi M.; Toms, Mike P.; Sheldon, Ben C.; Cunningham, Andrew A.			Emergence of a Novel Avian Pox Disease in British Tit Species	PLOS ONE			English	Article							WILD BIRDS; POXVIRUS INFECTION; AVIPOXVIRUSES; GENE; PHYLOGENIES; DISTANCE; TRENDS; VIRUS	Avian pox is a viral disease with a wide host range. In Great Britain, avian pox in birds of the Paridae family was first diagnosed in a great tit (Parus major) from south-east England in 2006. An increasing number of avian pox incidents in Paridae have been reported each year since, indicative of an emergent infection. Here, we utilise a database of opportunistic reports of garden bird mortality and morbidity to analyse spatial and temporal patterns of suspected avian pox throughout Great Britain, 2006-2010. Reports of affected Paridae (211 incidents) outnumbered reports in non-Paridae (91 incidents). The majority (90%) of Paridae incidents involved great tits. Paridae pox incidents were more likely to involve multiple individuals (77.3%) than were incidents in non-Paridae hosts (31.9%). Unlike the small wart-like lesions usually seen in non-Paridae with avian pox in Great Britain, lesions in Paridae were frequently large, often with an ulcerated surface and caseous core. Spatial analyses revealed strong clustering of suspected avian pox incidents involving Paridae hosts, but only weak, inconsistent clustering of incidents involving non-Paridae hosts. There was no spatial association between Paridae and non-Paridae incidents. We documented significant spatial spread of Paridae pox from an origin in south-east England; no spatial spread was evident for non-Paridae pox. For both host clades, there was an annual peak of reports in August/September. Sequencing of the avian poxvirus 4b core protein produced an identical viral sequence from each of 20 great tits tested from Great Britain. This sequence was identical to that from great tits from central Europe and Scandinavia. In contrast, sequence variation was evident amongst virus tested from 17 non-Paridae hosts of 5 species. Our findings show Paridae pox to be an emerging infectious disease in wild birds in Great Britain, apparently originating from viral incursion from central Europe or Scandinavia.	[Lawson, Becki; Colvile, Katie M.; Durrant, Chris; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Lachish, Shelly; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Peck, Kirsi M.] British Trust Ornithol, The Nunnery, Thetford, Norfolk, England; [Toms, Mike P.] Royal Soc Protect Birds, Sandy, Beds, England	Zoological Society of London; University of Oxford; British Trust for Ornithology; Royal Society for Protection of Birds	Lawson, B (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	becki.lawson@ioz.ac.uk	Cunningham, Andrew A/E-7536-2010; Sheldon, Ben C/A-8056-2010	Sheldon, Ben C/0000-0002-5240-7828; lawson, becki/0000-0003-1706-7140; Toms, Mike/0000-0002-0823-5336; Durrant, Christopher/0000-0002-6233-9128	Natural Environment Research Council; Natural Environment Research Council [390, NE/I028718/1]; British Veterinary Association Animal Welfare Foundation; CJ Wildbird Foods Ltd; Cranswick Pet Products; Defra; Gardman Ltd; Birdcare Standards Association; Universities Federation for Animal Welfare; RSPB; Royal Society Wolfson Research Merit Award; NERC [NE/I028718/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Veterinary Association Animal Welfare Foundation; CJ Wildbird Foods Ltd; Cranswick Pet Products; Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Gardman Ltd; Birdcare Standards Association; Universities Federation for Animal Welfare; RSPB; Royal Society Wolfson Research Merit Award(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a Natural Environment Research Council (http://www.nerc.ac.uk/) Urgency Grant from the Natural Environment Research Council 390 (NE/I028718/1) to BCS and the Garden Bird Health initiative received financial support from the following organisations: British Veterinary Association Animal Welfare Foundation (http://www.bva-awf.org.uk), CJ Wildbird Foods Ltd (http://www.birdfood.co.uk), Cranswick Pet Products (http://www.cranswickpetproducts.co.uk), Defra (http://www.defra.gov.uk/), Gardman Ltd (http://www.gardman.co.uk), RSPB (http://www.rspb.org.uk), The Birdcare Standards Association (http://www.birdcare.org.uk), and Universities Federation for Animal Welfare (http://www.ufaw.org.uk). AAC is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CJ, 2005, AVIAN DIS, V49, P601, DOI 10.1637/7369-041805R.1; Baillie S. R., 2012, 609 BTO; BINNS MM, 1989, VIROLOGY, V170, P288, DOI 10.1016/0042-6822(89)90380-2; BLACKMORE D. K., 1969, British Birds, V62, P316; Cannon AR, 2005, J APPL ECOL, V42, P659, DOI 10.1111/j.1365-2664.2005.01050.x; Census 2001, 2002, 2001 CENSUS ENGLAND; Chamberlain DE, 2005, IBIS, V147, P563, DOI 10.1111/j.1474-919x.2005.00430.x; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Edwards G. R., 1955, British Birds, V48, P186; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOODPASTURE EW, 1962, AM J PATHOL, V40, P437; Gosler AG, 2002, IBIS, V144, P1, DOI 10.1046/j.0019-1019.2001.00033.x; Gruber A, 2007, AVIAN DIS, V51, P623, DOI 10.1637/0005-2086(2007)51[623:PIIAGT]2.0.CO;2; Hansen W., 1999, FIELD MANUAL WILDLIF, P163; HOLT G, 1973, ACTA VET SCAND, V14, P201; Illera JC, 2008, PARASITOL RES, V103, P1435, DOI 10.1007/s00436-008-1153-7; Jarmin S, 2006, J GEN VIROL, V87, P2191, DOI 10.1099/vir.0.81738-0; Jarvi SI, 2008, CONSERV GENET, V9, P339, DOI 10.1007/s10592-007-9346-7; JENNINGS AR, 1954, J COMP PATHOL THERAP, V64, P356, DOI 10.1016/S0368-1742(54)80036-1; Kirmse P, 1966, B WILDLIFE DIS ASSOC, V2, P303; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Lawson B, 2010, ECOHEALTH, V7, P294, DOI 10.1007/s10393-010-0349-3; Lawson B, 2012, PHILOS T R SOC B, V367, P2852, DOI 10.1098/rstb.2012.0130; Lee LH, 1997, J VIROL METHODS, V63, P113, DOI 10.1016/S0166-0934(96)02119-2; Lierz M, 2007, J AVIAN MED SURG, V21, P50, DOI 10.1647/1082-6742(2007)21[50:AIIACO]2.0.CO;2; Literak I, 2004, FAGLAR JAMTLAND HAJE, V1, P4; Literak I, 2010, EUR J WILDLIFE RES, V56, P529, DOI 10.1007/s10344-009-0345-5; Luschow D, 2004, AVIAN DIS, V48, P453, DOI 10.1637/7111; MCCLURE HE, 1989, J FIELD ORNITHOL, V60, P421; McFerran J., 1993, VIRUS INFECT BIRDS, P1; Newson SE, 2008, J APPL ECOL, V45, P1330, DOI 10.1111/j.1365-2664.2008.01480.x; Palade EA, 2008, ACTA VET HUNG, V56, P539, DOI 10.1556/AVet.56.2008.4.11; Pennycott TW, 2003, VET REC, V152, P444; Perrins C.M., 1979, P1; Poulding R. H., 1960, British Birds, V53, P174; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Ritchie B.W., 1995, AVIAN VIRUSES FUNCTI, P285; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robinson RA, 2011, ONLINE RINGING REPOR; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Senar J. C., 2004, Animal Biodiversity and Conservation, V27, P133; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; SIMPSON C F, 1975, Journal of Wildlife Diseases, V11, P112; Snow K.R., 1990, Naturalists' Handbooks, P1; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Riper Charles III, 2007, P131, DOI 10.1002/9780470344668.ch6; VANBALEN JH, 1989, ORNIS SCAND, V20, P99, DOI 10.2307/3676875; Weli SC, 2004, ARCH VIROL, V149, P2035, DOI 10.1007/s00705-004-0357-0; Weli SC, 2004, CAN J VET RES, V68, P140; Wernham C., 2002, MIGRATION ATLAS MOVE; Woodruff CE, 1930, AM J PATHOL, V6, P713	56	41	41	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e40176	10.1371/journal.pone.0040176	http://dx.doi.org/10.1371/journal.pone.0040176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185231	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000002
J	Nellaepalli, S; Kodru, S; Tirupathi, M; Subramanyam, R				Nellaepalli, Sreedhar; Kodru, Sireesha; Tirupathi, Malavath; Subramanyam, Rajagopal			Anaerobiosis Induced State Transition: A Non Photochemical Reduction of PQ Pool Mediated by NDH in Arabidopsis thaliana	PLOS ONE			English	Article							CYCLIC ELECTRON FLOW; CHLOROPHYLL FLUORESCENCE INDUCTION; PHOTOSYSTEM-I; CHLAMYDOMONAS-REINHARDTII; PROTEIN-PHOSPHORYLATION; LIGHT ADAPTATION; REDOX STATE; C-3 PLANTS; COMPLEX-II; CHLOROPLASTS	Background: Non photochemical reduction of PQ pool and mobilization of LHCII between PSII and PSI are found to be linked under abiotic stress conditions. The interaction of non photochemical reduction of PQ pool and state transitions associated physiological changes are critically important under anaerobic condition in higher plants. Methodology/Findings: The present study focused on the effect of anaerobiosis on non-photochemical reduction of PQ pool which trigger state II transition in Arabidopsis thaliana. Upon exposure to dark-anaerobic condition the shape of the OJIP transient rise is completely altered where as in aerobic treated leaves the rise is unaltered. Rise in F-o and F-J was due to the loss of oxidized PQ pool as the PQ pool becomes more reduced. The increase in F-o' was due to the non photochemical reduction of PQ pool which activated STN7 kinase and induced LHCII phosphorylation under anaerobic condition. Further, it was observed that the phosphorylated LHCII is migrated and associated with PSI supercomplex increasing its absorption cross-section. Furthermore, evidences from crr2-2 (NDH mutant) and pgr5 mutants (deficient in non NDH pathway of cyclic electron transport) have indicated that NDH is responsible for non photochemical reduction of the PQ pool. We propose that dark anaerobic condition accelerates production of reducing equivalents (such as NADPH by various metabolic pathways) which reduce PQ pool and is mediated by NDH leading to state II transition. Conclusions/Significance: Anaerobic condition triggers non photochemical reduction of PQ pool mediated by NDH complex. The reduced PQ pool activates STN7 kinase leading to state II transition in A. thaliana.	[Nellaepalli, Sreedhar; Subramanyam, Rajagopal] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Kodru, Sireesha; Tirupathi, Malavath; Subramanyam, Rajagopal] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Subramanyam, R (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	srgsl@uohyd.ernet.in		NELLAEPALLI, SREEDHAR/0000-0002-9402-6951	Department of Biotechnology [BT/PR15132/BRB/10/909/2011]; Department of Science and Technology, India [SR/SO/BB-34/2006]	Department of Biotechnology; Department of Science and Technology, India(Department of Science & Technology (India))	RS thanks the Department of Biotechnology (No: BT/PR15132/BRB/10/909/2011;) and the Department of Science and Technology (SR/SO/BB-34/2006, FIST), India, for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BENNETT J, 1988, EUR J BIOCHEM, V171, P95, DOI 10.1111/j.1432-1033.1988.tb13763.x; BENNETT J, 1980, EUR J BIOCHEM, V104, P85, DOI 10.1111/j.1432-1033.1980.tb04403.x; BENNOUN P, 1994, BBA-BIOENERGETICS, V1186, P59, DOI 10.1016/0005-2728(94)90135-X; Bukhov N, 2004, PHOTOSYNTH RES, V82, P17, DOI 10.1023/B:PRES.0000040442.59311.72; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Ceppi MG, 2012, PHYSIOL PLANTARUM, V144, P277, DOI 10.1111/j.1399-3054.2011.01549.x; Cournac L, 2000, J BIOL CHEM, V275, P17256, DOI 10.1074/jbc.M908732199; Delosme R, 1996, BBA-BIOENERGETICS, V1273, P150, DOI 10.1016/0005-2728(95)00143-3; Ducruet JM, 1999, PHOTOSYNTHETICA, V37, P335, DOI 10.1023/A:1007124509748; Endo T, 1998, PLANT CELL PHYSIOL, V39, P1226, DOI 10.1093/oxfordjournals.pcp.a029324; Farineau J, 1999, PLANT PHYSIOL BIOCH, V37, P911, DOI 10.1016/S0981-9428(99)00105-9; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Gal A, 1997, PHYSIOL PLANTARUM, V100, P869, DOI 10.1034/j.1399-3054.1997.1000413.x; GARAB G, 1989, PLANTA, V179, P349, DOI 10.1007/BF00391080; Govindjee, 2004, ADV PHOTOSYNTH RESP, V19, P1; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Havaux M, 1996, PHOTOSYNTH RES, V47, P85, DOI 10.1007/BF00017756; Hoefnagel MHN, 1998, BBA-BIOENERGETICS, V1366, P235, DOI 10.1016/S0005-2728(98)00126-1; Ilik P, 2006, BBA-BIOENERGETICS, V1757, P12, DOI 10.1016/j.bbabio.2005.11.008; Joet T, 2002, J BIOL CHEM, V277, P31623, DOI 10.1074/jbc.M203538200; Joet T, 2002, PLANT PHYSIOL, V128, P760, DOI 10.1104/pp.010775; Johnson GN, 2005, J EXP BOT, V56, P407, DOI 10.1093/jxb/eri106; Johnson X, 2012, J BIOL CHEM, V287, P26445, DOI 10.1074/jbc.M112.370205; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Joly D, 2009, PHOTOCH PHOTOBIO SCI, V8, P167, DOI 10.1039/b815070b; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Mano J, 1995, PLANT CELL PHYSIOL, V36, P1589; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Mozzo M, 2010, BBA-BIOENERGETICS, V1797, P212, DOI 10.1016/j.bbabio.2009.10.005; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; MUNEKAGE Y, 2005, PLANT BIOTECHNOL, V22, P361; Munekage YN, 2008, PLANT CELL PHYSIOL, V49, P1688, DOI 10.1093/pcp/pcn140; Mus F, 2005, BBA-BIOENERGETICS, V1708, P322, DOI 10.1016/j.bbabio.2005.05.003; Nellaepalli S, 2011, BBA-BIOENERGETICS, V1807, P1177, DOI 10.1016/j.bbabio.2011.05.016; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; PELTIER G, 1991, P NATL ACAD SCI USA, V88, P4791, DOI 10.1073/pnas.88.11.4791; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Piven I, 2005, J BIOL CHEM, V280, P21667, DOI 10.1074/jbc.m412967200; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; REBEILLE F, 1988, PLANT PHYSIOL, V88, P973, DOI 10.1104/pp.88.4.973; Reto Strasser J, 1991, FO O J I P FLUORESCE, P423; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Schansker G, 2006, BBA-BIOENERGETICS, V1757, P787, DOI 10.1016/j.bbabio.2006.04.019; SCHREIBER U, 1974, BIOCHIM BIOPHYS ACTA, V368, P97, DOI 10.1016/0005-2728(74)90100-5; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Subramanyam R, 2006, FEBS LETT, V580, P233, DOI 10.1016/j.febslet.2005.12.003; Tikkanen M, 2011, TRENDS PLANT SCI, V16, P126, DOI 10.1016/j.tplants.2010.11.006; Toth SZ, 2007, PHOTOSYNTH RES, V93, P193, DOI 10.1007/s11120-007-9179-8; Umate P, 2008, PLANT PHYSIOL, V148, P1342, DOI 10.1104/pp.108.126060; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	66	18	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49839	10.1371/journal.pone.0049839	http://dx.doi.org/10.1371/journal.pone.0049839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185453	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000119
J	Wang, L; Yuan, Q; Chen, SH; Cai, H; Lu, MG; Liu, Y; Xu, C				Wang, Li; Yuan, Qing; Chen, Sunhong; Cai, Heng; Lu, Meige; Liu, Yue; Xu, Chen			Antimicrobial Activity and Molecular Mechanism of the CRES Protein	PLOS ONE			English	Article							MALE REPRODUCTIVE-TRACT; EPIDIDYMAL SPERMATOGENIC PROTEIN; SITE-DIRECTED MUTAGENESIS; POLYMERASE CHAIN-REACTION; UREAPLASMA-UREALYTICUM; SPERM MATURATION; BETA-DEFENSIN; PEPTIDES; FAMILY; EXPRESSION	Cystatin-related epididymal spermatogenic (CRES) protein, a member of the cystatin superfamily of cysteine protease inhibitors (also known as CST8), exhibits highly specific, age-dependent expression in mouse testis and epididymis. The CRES protein possesses four highly conserved cysteine residues which govern the overall conformation of the cystatins through the formation of two disulfide bonds. Previous studies have revealed that other cystatin family members, such as cystatin 3 and cystatin 11, show antibacterial activity in vitro. This prompted us to investigate the potential antimicrobial activity of the CRES protein. Colony forming assays and spectrophotometry were used to investigate the effects of recombinant CRES protein on Escherichia coli (E. coli) and Ureaplasma urealyticum (Uu), respectively, in vitro. After incubation of E. coli with CRES recombinant protein fused with glutathione-S-transferase (GST), a substantial decrease in colony forming units was observed, and the effect was dose and time dependent. Furthermore, it took longer for Uu to grow to plateau stage when incubated with GST-CRES recombinant protein compared with the control GST. The antibacterial and Anti-Uu activities were not impaired when the cysteine residues of CRES protein were mutated, indicating that the antimicrobial effect was not dependent on its disulfide bonds. Functional analysis of three CRES polypeptides showed that the N-terminal 30 residues (N30) had no antimicrobial activity while N60 showed similar activity as full-length CRES protein. These results suggest that the active center of CRES protein resides between amino acid residues 31 and 60 of its N-terminus. Mechanistically, E. coli membrane permeabilization was increased in a dose-dependent manner, and macromolecular synthesis was inhibited on treatment with GST-CRES. Together, our data on the antimicrobial activities of CRES protein suggest that it is a novel and innate antimicrobial protein which protecting the male reproductive tract against invading pathogens.	[Wang, Li; Yuan, Qing; Chen, Sunhong; Cai, Heng; Lu, Meige; Liu, Yue; Xu, Chen] Shanghai Jiao Tong Univ, Sch Med, Dept Histol & Embryol, Shanghai 200030, Peoples R China; [Wang, Li; Yuan, Qing; Chen, Sunhong; Cai, Heng; Lu, Meige; Liu, Yue; Xu, Chen] Shanghai Key Lab Reprod Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Histol & Embryol, Shanghai 200030, Peoples R China.	chenx@shsmu.edu.cn	Liu, Yue/GQP-1774-2022		National Natural Sciences Foundation of China [30800592]; Science and Technology Commission of Shanghai Municipality [10DZ2270600]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the National Natural Sciences Foundation of China (No. 30800592), URL: http://isisn.nsfc.gov.cn/egrantweb/, Science and Technology Commission of Shanghai Municipality (No. 10DZ2270600), URL: http://www.stcsm.gov.cn/structure, and Shanghai Leading Academic Discipline Project (No. S30201), URL: http://www.shmec.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele-Horn M, 2000, ACTA OBSTET GYN SCAN, V79, P973, DOI 10.1034/j.1600-0412.2000.079011973.x; BARIK S, 1995, MOL BIOTECHNOL, V3, P1, DOI 10.1007/BF02821329; Bhushan S, 2009, MOL CELL ENDOCRINOL, V306, P37, DOI 10.1016/j.mce.2008.10.017; BJORCK L, 1990, J VIROL, V64, P941; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Chan HC, 2005, ANDROLOGIA, V37, P200, DOI 10.1111/j.1439-0272.2005.00687.x; Chiu WWC, 2004, FERTIL STERIL, V82, P529, DOI 10.1016/j.fertnstert.2003.09.084; Collin M, 2008, J REPROD IMMUNOL, V79, P37, DOI 10.1016/j.jri.2008.08.003; CORNWALL GA, 1995, MOL REPROD DEV, V41, P37, DOI 10.1002/mrd.1080410107; Cornwall GA, 2003, MOL CELL ENDOCRINOL, V200, P1, DOI 10.1016/S0303-7207(02)00408-2; CORNWALL GA, 1992, MOL ENDOCRINOL, V6, P1653, DOI 10.1210/me.6.10.1653; Cornwall GA, 2011, J ANDROL, V32, P679, DOI 10.2164/jandrol.111.012963; Cyr DG, 2011, METHODS MOL BIOL, V762, P259, DOI 10.1007/978-1-61779-185-7_18; Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]; Guo CY, 2009, J BIOTECHNOL, V139, P33, DOI 10.1016/j.jbiotec.2008.10.003; Hall SH, 2002, J ANDROL, V23, P585; Hamil KG, 2002, ENDOCRINOLOGY, V143, P2787, DOI 10.1210/en.143.7.2787; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hsia N, 2003, ENDOCRINOLOGY, V144, P909, DOI 10.1210/en.2002-220890; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Jalkanen J, 2005, BBA-GENE STRUCT EXPR, V1730, P22, DOI 10.1016/j.bbaexp.2005.05.010; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Linge HM, 2008, J INTERF CYTOK RES, V28, P190, DOI 10.1089/jir.2007.0100; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Pellati D, 2008, EUR J OBSTET GYN R B, V140, P3, DOI 10.1016/j.ejogrb.2008.03.009; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; Raj PA, 2000, BIOPOLYMERS, V53, P281, DOI 10.1002/(SICI)1097-0282(20000405)53:4<281::AID-BIP1>3.0.CO;2-2; SHEPARD M C, 1954, Am J Syph Gonorrhea Vener Dis, V38, P113; Skerk V, 2006, CHEMOTHERAPY, V52, P9, DOI 10.1159/000090234; Sutton HG, 1999, ENDOCRINOLOGY, V140, P2721, DOI 10.1210/en.140.6.2721; Syntin P, 1999, BIOL REPROD, V60, P1542, DOI 10.1095/biolreprod60.6.1542; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Wang M, 2009, MOL REPROD DEV, V76, P794, DOI 10.1002/mrd.21027; Whelly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036394; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Xu C, 1997, ANDROLOGIA, V29, P219; Yenugu S, 2004, ENDOCRINOLOGY, V145, P3165, DOI 10.1210/en.2003-1698; Yenugu S, 2003, BIOCHEM J, V372, P473, DOI 10.1042/BJ20020225; Yenugu Suresh, 2004, Reprod Biol Endocrinol, V2, P61, DOI 10.1186/1477-7827-2-61; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yuan Q, 2007, ASIAN J ANDROL, V9, P305, DOI 10.1111/j.1745-7262.2007.00260.x; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127	42	17	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48368	10.1371/journal.pone.0048368	http://dx.doi.org/10.1371/journal.pone.0048368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185254	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000010
J	Wang, L; Shi, Y; Ju, PJ; Liu, R; Yeo, SP; Xia, YY; Owlanj, H; Feng, ZW				Wang, Lei; Shi, Yu; Ju, Peijun; Liu, Rui; Yeo, Siok Ping; Xia, Yinyan; Owlanj, Hamed; Feng, Zhiwei			Silencing of Diphthamide Synthesis 3 (Dph3) Reduces Metastasis of Murine Melanoma	PLOS ONE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; CANDIDATE TUMOR-SUPPRESSOR; UP-REGULATION; EXOCYST COMPLEX; CELL INVASION; KINASE-B; CANCER; PROTEIN; GENES; IDENTIFICATION	Melanoma is the most dangerous skin cancer due to its highly metastatic potential and resistance to chemotherapy. Currently, there is no effective treatment for melanoma once it is progressed to metastatic stage. Therefore, further study to elucidate the molecular mechanism underlying the metastasis of melanoma cells is urgently required for the improvement of melanoma treatment. In the present study, we found that diphthamide synthesis 3 (Dph3) is involved in the metastasis of B16F10 murine melanoma cells by insertional mutagenesis. We demonstrated that Dph3 disruption impairs the migration of B16F10 murine melanoma cells. The requirement of Dph3 in the migration of melanoma cells was further confirmed by gene silencing with siRNA in vitro. In corresponding to this result, overexpression of Dph3 significantly promoted the migratory ability of B16F10 and B16F0 melanoma cells. Moreover, down regulation of Dph3 expression in B16F10 melanoma cells strikingly inhibits their cellular invasion and metastasis in vivo. Finally, we found that Dph3 promotes melanoma migration and invasion through the AKT signaling pathway. To conclude, our findings suggest a novel mechanism underlying the metastasis of melanoma cells which might serve as a new intervention target for the treatment of melanoma.	[Wang, Lei; Shi, Yu; Ju, Peijun; Yeo, Siok Ping; Xia, Yinyan; Owlanj, Hamed; Feng, Zhiwei] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Liu, Rui] Xi An Jiao Tong Univ, Sch Med, Xian 710049, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Xi'an Jiaotong University	Feng, ZW (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	ZWFeng@ntu.edu.sg			School of Biological Sciences, Nanyang Technological University [M5898993 NTU]	School of Biological Sciences, Nanyang Technological University(Nanyang Technological University)	This research is supported by School of Biological Sciences, Nanyang Technological University. The grant number is M5898993 NTU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda MJ, 2003, CANCER RES, V63, P196; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; Bruening W, 1999, CANCER RES, V59, P4973; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Chen CM, 2005, CURR OPIN GENET DEV, V15, P49, DOI 10.1016/j.gde.2004.12.006; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dhawan P, 2002, CANCER RES, V62, P7335; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Giblin AV, 2001, JPRAS, V60, P32; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jemal A, 2001, JNCI-J NATL CANCER I, V93, P678, DOI 10.1093/jnci/93.9.678; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kim SO, 2007, BIOTECHNIQUES, V42, P493, DOI 10.2144/000112390; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Liang M, 2008, GENE CHROMOSOME CANC, V47, P315, DOI 10.1002/gcc.20535; LIOTTA LA, 1991, CANCER RES, V51, pS5054; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; POSTE G, 1982, CANCER RES, V42, P2770; POSTE G, 1980, CANCER RES, V40, P1636; Rofstad EK, 2005, CANCER RES, V65, P2387, DOI 10.1158/0008-5472.CAN-04-3039; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schultz DC, 1996, CANCER RES, V56, P1997; Seong I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031477; Shi Y, 2011, INT J BIOCHEM CELL B, V43, P682, DOI 10.1016/j.biocel.2011.01.016; Sjolinder M, 2004, EXP CELL RES, V294, P68, DOI 10.1016/j.yexcr.2003.09.033; Sjolinder M, 2002, FEBS LETT, V532, P211, DOI 10.1016/S0014-5793(02)03677-3; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Ugurel S, 2009, CANCER CONTROL, V16, P219, DOI 10.1177/107327480901600303; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Wang XF, 2001, EMBO REP, V2, P628, DOI 10.1093/embo-reports/kve135; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Wu FM, 2008, PROTEINS, V71, P514, DOI 10.1002/prot.21915; Zarubin T, 2005, CELL RES, V15, P439, DOI 10.1038/sj.cr.7290312; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	47	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49988	10.1371/journal.pone.0049988	http://dx.doi.org/10.1371/journal.pone.0049988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185508	Green Published, gold			2022-12-25	WOS:000311535700060
J	Wang, XX; Zhang, CY; Li, LJ; Fritsche, S; Endrigkeit, J; Zhang, WY; Long, Y; Jung, C; Meng, JL				Wang, Xingxing; Zhang, Chunyu; Li, Lingjuan; Fritsche, Steffi; Endrigkeit, Jessica; Zhang, Wenying; Long, Yan; Jung, Christian; Meng, Jinling			Unraveling the Genetic Basis of Seed Tocopherol Content and Composition in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; VITAMIN-E CONTENT; GENOME-WIDE ASSOCIATION; OILSEED RAPE; LINKAGE DISEQUILIBRIUM; ARABIDOPSIS MUTANT; 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE; POPULATION-STRUCTURE; E BIOSYNTHESIS; PLANTS	Background: Tocopherols are important antioxidants in vegetable oils; when present as vitamin E, tocopherols are an essential nutrient for humans and livestock. Rapeseed (Brassica napus L, AACC, 2 n = 38) is one of the most important oil crops and a major source of tocopherols. Although the tocopherol biosynthetic pathway has been well elucidated in the model photosynthetic organisms Arabidopsis thaliana and Synechocystis sp. PCC6803, knowledge about the genetic basis of tocopherol biosynthesis in seeds of rapeseed is scant. This project was carried out to dissect the genetic basis of seed tocopherol content and composition in rapeseed through quantitative trait loci (QTL) detection, genome-wide association analysis, and homologous gene mapping. Methodology/Principal Findings: We used a segregating Tapidor x Ningyou7 doubled haploid (TNDH) population, its reconstructed F-2 (RC-F-2) population, and a panel of 142 rapeseed accessions (association panel). Genetic effects mainly contributed to phenotypic variations in tocopherol content and composition; environmental effects were also identified. Thirty-three unique QTL were detected for tocopherol content and composition in TNDH and RC-F-2 populations. Of these, seven QTL co-localized with candidate sequences associated with tocopherol biosynthesis through in silico and linkage mapping. Several near-isogenic lines carrying introgressions from the parent with higher tocopherol content showed highly increased tocopherol content compared with the recurrent parent. Genome-wide association analysis was performed with 142 B. napus accessions. Sixty-one loci were significantly associated with tocopherol content and composition, 11 of which were localized within the confidence intervals of tocopherol QTL. Conclusions/Significance: This joint QTL, candidate gene, and association mapping study sheds light on the genetic basis of seed tocopherol biosynthesis in rapeseed. The sequences presented here may be used for marker-assisted selection of oilseed rape lines with superior tocopherol content and composition.	[Wang, Xingxing; Zhang, Chunyu; Li, Lingjuan; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Fritsche, Steffi; Endrigkeit, Jessica; Jung, Christian] Univ Kiel, Plant Breeding Inst, Kiel, Germany; [Zhang, Wenying] Yangtze Univ, Sch Agr, Inst Plant Genet & Breeding, Jinzhou, Peoples R China	Huazhong Agricultural University; University of Kiel; Yangtze University	Meng, JL (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	jmeng@mail.hzau.edu.cn	Zhang, Chun-yu/HDP-5776-2022; Zhang, Wenying/P-2509-2018	Zhang, Wenying/0000-0002-9926-4115; Fritsche, Steffi/0000-0001-5524-0392	National Basic Research and Development Program of China [2006CB101600]; China Scholarship Council; German Academic Exchange Service	National Basic Research and Development Program of China(National Basic Research Program of China); China Scholarship Council(China Scholarship Council); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the National Basic Research and Development Program of China (2006CB101600) and the Project Based Personnel Exchange Program with China Scholarship Council and German Academic Exchange Service (2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Allison DB, 1997, AM J HUM GENET, V60, P676; Almeida J, 2011, J EXP BOT, V62, P3781, DOI 10.1093/jxb/err055; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bergmuller E, 2003, PLANT MOL BIOL, V52, P1181, DOI 10.1023/B:PLAN.0000004307.62398.91; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Bus A, 2011, THEOR APPL GENET, V123, P1413, DOI 10.1007/s00122-011-1676-7; Cahoon EB, 2003, NAT BIOTECHNOL, V21, P1082, DOI 10.1038/nbt853; Chen S, 2008, GENOME, V51, P1, DOI [10.1139/G07-095, 10.1139/g07-095]; CHURCHILL GA, 1994, GENETICS, V138, P963; DellaPenna D, 2005, TRENDS PLANT SCI, V10, P574, DOI 10.1016/j.tplants.2005.10.007; DellaPenna D, 2005, J PLANT PHYSIOL, V162, P729, DOI 10.1016/j.jplph.2005.04.004; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dormann P, 2007, PLANTA, V225, P269, DOI 10.1007/s00425-006-0438-2; Ecke W, 2010, THEOR APPL GENET, V120, P921, DOI 10.1007/s00122-009-1221-0; Endrigkeit J, 2009, THEOR APPL GENET, V119, P567, DOI 10.1007/s00122-009-1066-6; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falk J, 2003, FEBS LETT, V540, P35, DOI 10.1016/S0014-5793(03)00166-2; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fritsche S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00129; Gilliland LU, 2006, P NATL ACAD SCI USA, V103, P18834, DOI 10.1073/pnas.0606221103; Goffinet B, 2000, GENETICS, V155, P463; Goffman FD, 2000, J AGR FOOD CHEM, V48, P1605, DOI 10.1021/jf9912755; Goffman FD, 2002, EUPHYTICA, V125, P189, DOI 10.1023/A:1015858618480; Goffman FD, 1999, FETT-LIPID, V101, P400; Goffman FD, 2001, CROP SCI, V41, P1072, DOI 10.2135/cropsci2001.4141072x; Goffman FD, 2001, PLANT BREEDING, V120, P182, DOI 10.1046/j.1439-0523.2001.00566.x; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunter SC, 2007, LIPIDS, V42, P97, DOI 10.1007/s11745-007-3028-6; Ischebeck T, 2006, J BIOL CHEM, V281, P2470, DOI 10.1074/jbc.M509222200; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KamalEldin A, 1997, J AM OIL CHEM SOC, V74, P375, DOI 10.1007/s11746-997-0093-1; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Koch M, 2003, EUR J BIOCHEM, V270, P84, DOI 10.1046/j.1432-1033.2003.03364.x; Kumar R, 2005, FEBS LETT, V579, P1357, DOI 10.1016/j.febslet.2005.01.030; LINDSTEDT S, 1982, J BIOL CHEM, V257, P1922; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lu YL, 2010, P NATL ACAD SCI USA, V107, P19585, DOI 10.1073/pnas.1006105107; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Marwede V, 2005, PLANT BREEDING, V124, P20, DOI 10.1111/j.1439-0523.2004.01050.x; Marwede V, 2004, CROP SCI, V44, P728, DOI 10.2135/cropsci2004.0728; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; Norris SR, 1998, PLANT PHYSIOL, V117, P1317, DOI 10.1104/pp.117.4.1317; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Porfirova S, 2002, P NATL ACAD SCI USA, V99, P12495, DOI 10.1073/pnas.182330899; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Raclaru M, 2006, MOL BREEDING, V18, P93, DOI 10.1007/s11032-006-9014-5; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Sadre R, 2006, FEBS LETT, V580, P5357, DOI 10.1016/j.febslet.2006.09.002; SAS INSTITUTE, 1999, SAS ONL DOC VERS 8 0; Sattler SE, 2004, TRENDS PLANT SCI, V9, P365, DOI 10.1016/j.tplants.2004.06.002; Sattler SE, 2003, PLANT PHYSIOL, V132, P2184, DOI 10.1104/pp.103.024257; Savidge B, 2002, PLANT PHYSIOL, V129, P321, DOI 10.1104/pp.010747; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Seppanen CM, 2010, J AM OIL CHEM SOC, V87, P469, DOI 10.1007/s11746-009-1526-9; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shintani D, 1998, SCIENCE, V282, P2098, DOI 10.1126/science.282.5396.2098; Shintani DK, 2002, FEBS LETT, V511, P1, DOI 10.1016/S0014-5793(01)03223-9; Sneath PHA, 2005, NUMERICAL TAXONOMY B, P4; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Stich B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-94; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Valentin HE, 2005, APPL MICROBIOL BIOT, V68, P436, DOI 10.1007/s00253-005-0017-7; Valentin HE, 2006, PLANT CELL, V18, P212, DOI 10.1105/tpc.105.037077; Van Eenennaam AL, 2003, PLANT CELL, V15, P3007, DOI 10.1105/tpc.015875; Wang NA, 2011, J EXP BOT, V62, P5641, DOI 10.1093/jxb/err249; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; ZENG ZB, 1994, GENETICS, V136, P1457; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; ZHU J, 1995, GENETICS, V141, P1633; Zou J, 2010, GENOME, V53, P908, DOI 10.1139/G10-075	94	11	13	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50038	10.1371/journal.pone.0050038	http://dx.doi.org/10.1371/journal.pone.0050038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185526	Green Submitted, Green Published, gold			2022-12-25	WOS:000311535700064
J	Nagy, LG; Kocsube, S; Csanadi, Z; Kovacs, GM; Petkovits, T; Vagvolgyi, C; Papp, T				Nagy, Laszlo G.; Kocsube, Sandor; Csanadi, Zoltan; Kovacs, Gabor M.; Petkovits, Tamas; Vagvoelgyi, Csaba; Papp, Tamas			Re-Mind the Gap! Insertion - Deletion Data Reveal Neglected Phylogenetic Potential of the Nuclear Ribosomal Internal Transcribed Spacer (ITS) of Fungi	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; MULTIPLE ALIGNMENTS; MOLECULAR EVOLUTION; SOFTWARE PACKAGE; DNA-SEQUENCES; MONTE-CARLO; UTILITY; REGIONS; INDELS; SIGNAL	Rapidly evolving, indel-rich phylogenetic markers play a pivotal role in our understanding of the relationships at multiple levels of the tree of life. There is extensive evidence that indels provide conserved phylogenetic signal, however, the range of phylogenetic depths for which gaps retain tree signal has not been investigated in detail. Here we address this question using the fungal internal transcribed spacer (ITS), which is central in many phylogenetic studies, molecular ecology, detection and identification of pathogenic and non-pathogenic species. ITS is repeatedly criticized for indel-induced alignment problems and the lack of phylogenetic resolution above species level, although these have not been critically investigated. In this study, we examined whether the inclusion of gap characters in the analyses shifts the phylogenetic utility of ITS alignments towards earlier divergences. By re-analyzing 115 published fungal ITS alignments, we found that indels are slightly more conserved than nucleotide substitutions, and when included in phylogenetic analyses, improved the resolution and branch support of phylogenies across an array of taxonomic ranges and extended the resolving power of ITS towards earlier nodes of phylogenetic trees. Our results reconcile previous contradicting evidence for the effects of data exclusion: in the case of more sophisticated indel placement, the exclusion of indel-rich regions from the analyses results in a loss of tree resolution, whereas in the case of simpler alignment methods, the exclusion of gapped sites improves it. Although the empirical datasets do not provide to measure alignment accuracy objectively, our results for the ITS region are consistent with previous simulations studies alignment algorithms. We suggest that sophisticated alignment algorithms and the inclusion of indels make the ITS region and potentially other rapidly evolving indel-rich loci valuable sources of phylogenetic information, which can be exploited at multiple taxonomic levels.	[Nagy, Laszlo G.; Kocsube, Sandor; Csanadi, Zoltan; Petkovits, Tamas; Vagvoelgyi, Csaba; Papp, Tamas] Univ Szeged, Dept Microbiol, Fac Sci & Informat, Szeged, Hungary; [Nagy, Laszlo G.] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Kovacs, Gabor M.] Eotvos Lorand Univ, Dept Plant Anat, Inst Biol, H-1088 Budapest, Hungary; [Kovacs, Gabor M.] Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Budapest, Hungary	Szeged University; Clark University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Nagy, LG (corresponding author), Univ Szeged, Dept Microbiol, Fac Sci & Informat, Szeged, Hungary.	cortinarius2000@yahoo.co.uk	Tamás, Papp/L-8272-2018; Kovacs, Gabor/AAF-3542-2020; Vagvolgyi, Csaba/L-8497-2018	Vagvolgyi, Csaba/0000-0003-0009-7773; Kocsube, Sandor/0000-0001-7839-0510; Papp, Tamas/0000-0001-8211-5431; Kovacs, Gabor M./0000-0001-9509-4270	Fungal Research Trust; Hungarian Research Fund [OTKA NN75255, K72776, 80188]; European Union; European Social Fund [TAMOP-4.2.2/B-10/1-2010-0012]; "Bolyai Janos'' Research Fellowship of the Hungarian Academy of Sciences	Fungal Research Trust; Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF)); "Bolyai Janos'' Research Fellowship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Fungal Research Trust (to LGN, www.fungalresearchtrust.org), the Hungarian Research Fund (OTKA NN75255, K72776, KTIA-OTKA Grant 80188) and by the European Union co-funded by the European Social Fund (Project number: TAMOP-4.2.2/B-10/1-2010-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express their gratitude for A. Loytynoja and F. Borchsenius for providing unofficial versions of PRANK<INF>+F</INF> and FastGap. S. Garnica, L. Mejia, M. Tomsovsky, K. Seifert, M. van Wyk, A. Schussler, E. Larsson, M. Groenewald, M. Gube, D. M. Walker, T. Burgess, B. Overton, D. Stubbe, A. Verkeben and P. B. Matheny are thanked for providing copies of published datasets. E. Homolya and G. Rakhely are thanked for their help with the HPC facility at the University of Szeged. G. M. Kovacs was supported by a "Bolyai Janos'' Research Fellowship of the Hungarian Academy of Sciences. Mark P Simmons and an ananymous reviewer are thanked for providing valuable comments on earlier drafts of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Belinky F, 2010, MOL BIOL EVOL, V27, P441, DOI 10.1093/molbev/msp263; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Benavides E, 2007, SYST BIOL, V56, P776, DOI 10.1080/10635150701618527; Bengtsson J, 2011, A VANLEEUWENHOEK; Bengtsson J, 2012, RES MICROBIOL, V163, P407, DOI 10.1016/j.resmic.2012.07.001; Borchsenius F, 2007, FASTGAP 1 0 8 SOFTWA; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Dwivedi B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-211; Eberhardt U, 2010, NEW PHYTOL, V187, P266, DOI 10.1111/j.1469-8137.2010.03329.x; Egan AN, 2008, MOL PHYLOGENET EVOL, V46, P532, DOI 10.1016/j.ympev.2007.10.006; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; FRITZ GN, 1994, MOL BIOL EVOL, V11, P406; Froslev TG, 2005, MOL PHYLOGENET EVOL, V37, P602, DOI 10.1016/j.ympev.2005.06.016; Gardes M., 1993, MOL ECOL, V23, P357; Gaya E, 2011, MYCOLOGIA, V103, P361, DOI 10.3852/10-120; Gonzalez D, 2006, MOL PHYLOGENET EVOL, V40, P459, DOI 10.1016/j.ympev.2006.03.022; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Iwen PC, 2002, MED MYCOL, V40, P87, DOI 10.1080/mmy.40.1.87.109; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kawakita A, 2003, MOL BIOL EVOL, V20, P87, DOI 10.1093/molbev/msg007; Kelly LJ, 2011, NEW PHYTOL, V191, P288, DOI 10.1111/j.1469-8137.2011.03677.x; Kim J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-54; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Lohne C, 2005, MOL BIOL EVOL, V22, P317, DOI 10.1093/molbev/msi019; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lutzoni F, 2000, SYST BIOL, V49, P628, DOI 10.1080/106351500750049743; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Matthee CA, 2007, MOL PHYLOGENET EVOL, V42, P827, DOI 10.1016/j.ympev.2006.10.002; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; Meusnier I, 2004, EUR J PHYCOL, V39, P83, DOI 10.1080/09670260310001646531; Miadlikowska J, 2003, MYCOLOGIA, V95, P1181, DOI 10.2307/3761919; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Nagy LG, 2009, PERSOONIA, V22, P28, DOI 10.3767/003158509X422434; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Nilsson RH, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-1; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Novak A, 2008, BIOINFORMATICS, V24, P2403, DOI 10.1093/bioinformatics/btn457; Ogden TH, 2007, SYST BIOL, V56, P182, DOI 10.1080/10635150701281102; Petkovits T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027507; Pons J, 2006, CLADISTICS, V22, P144, DOI 10.1111/j.1096-0031.2006.00088.x; Queiroz CD, 2011, MOL PHYLOGENET EVOL, V59, P293, DOI 10.1016/j.ympev.2011.01.013; Redelings BD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-40; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Ryberg M, 2009, NEW PHYTOL, V181, P471, DOI 10.1111/j.1469-8137.2008.02667.x; Ryberg M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-50; Simmons MP, 2007, MOL PHYLOGENET EVOL, V44, P724, DOI 10.1016/j.ympev.2007.04.001; Simmons MP, 2010, MOL PHYLOGENET EVOL, V57, P1004, DOI 10.1016/j.ympev.2010.09.004; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Simmons MP, 2003, MOL PHYLOGENET EVOL, V26, P444, DOI 10.1016/S1055-7903(02)00366-4; Simmons MP, 2001, SYST BIOL, V50, P454, DOI 10.1080/106351501300318049; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; Tabei Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-33; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019039; Wanke S, 2007, MOL PHYLOGENET EVOL, V42, P477, DOI 10.1016/j.ympev.2006.07.007; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532	74	91	91	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49794	10.1371/journal.pone.0049794	http://dx.doi.org/10.1371/journal.pone.0049794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185439	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800051
J	van Lettow, M; Akesson, A; Martiniuk, ALC; Ramsay, A; Chan, AK; Anderson, ST; Harries, AD; Corbett, E; Heyderman, RS; Zachariah, R; Bedell, RA				van Lettow, Monique; Akesson, Ann; Martiniuk, Alexandra L. C.; Ramsay, Andrew; Chan, Adrienne K.; Anderson, Suzanne T.; Harries, Anthony D.; Corbett, Elizabeth; Heyderman, Robert S.; Zachariah, Rony; Bedell, Richard A.			Six-Month Mortality among HIV-Infected Adults Presenting for Antiretroviral Therapy with Unexplained Weight Loss, Chronic Fever or Chronic Diarrhea in Malawi	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; SOUTH-AFRICA; CRYPTOCOCCAL ANTIGENEMIA; PULMONARY TUBERCULOSIS; PROGRAM; BACTEREMIA; OUTCOMES; START; ETIOLOGY; SERVICE	Background: In sub-Saharan Africa, early mortality is high following initiation of antiretroviral therapy (ART). We investigated 6-month outcomes and factors associated with mortality in HIV-infected adults being assessed for ART initiation and presenting with weight loss, chronic fever or diarrhea, and with negative TB sputum microscopy. Methods: A prospective cohort study was conducted in Malawi, investigating mortality in relation to ART uptake, microbiological findings and treatment of opportunistic infection (OIs), 6 months after meeting ART eligibility criteria. Results: Of 469 consecutive adults eligible for ART, 74(16%) died within 6 months of enrolment, at a median of 41 days (IQR 20-81). 370(79%) started ART at a median time of 18 days (IQR 7-40) after enrolment. Six-month case-fatality rates were higher in patients with OIs; 25/121(21%) in confirmed/clinical TB and 10/50(20%) with blood stream infection (BSI) compared to 41/308(13%) in patients with no infection identified. Median TB treatment start was 27 days (IQR 17-65) after enrolment and mortality [8 deaths (44%)] was significantly higher among 18 culture-positive patients with delayed TB diagnosis compared to patients diagnosed clinically and treated promptly with subsequent culture confirmation [6/34 (18%); p = 0.04]. Adjusted multivariable analysis, excluding deaths in the first 21 days, showed weight loss >10%, low CD4 count, severe anemia, laboratory-only TB diagnosis, and not initiating ART to be independently associated with increased risk of death. Conclusions: Mortality remains high among chronically ill patients eligible for ART. Prompt initiation of ART is vital: more than half of deaths were among patients who never started ART. Diagnostic and treatment delay for TB was strongly associated with risk of death. More than half of deaths occurred without identification of a specific infection. ART programmes need access to rapid point-of-care-diagnostic tools for OIs. The role of early empiric OI treatment in this population requires further evaluation in clinical trials.	[van Lettow, Monique; Martiniuk, Alexandra L. C.; Chan, Adrienne K.; Bedell, Richard A.] Dignitas Int, Zomba, Malawi; [van Lettow, Monique; Martiniuk, Alexandra L. C.; Chan, Adrienne K.] Univ Toronto, Toronto, ON, Canada; [Akesson, Ann] Medecins Sans Frontieres, Thyolo, Malawi; [Martiniuk, Alexandra L. C.] George Inst Global Hlth, Sydney, NSW, Australia; [Martiniuk, Alexandra L. C.] Univ Sydney, Sydney, NSW 2006, Australia; [Ramsay, Andrew] WHO, Trop Dis Res Programme, CH-1211 Geneva, Switzerland; [Ramsay, Andrew] Univ St Andrews, Sch Med, St Andrews KY16 9AJ, Fife, Scotland; [Anderson, Suzanne T.; Corbett, Elizabeth; Heyderman, Robert S.] Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Coll Med, Blantyre, Malawi; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.; Corbett, Elizabeth] London Sch Hyg & Trop Med, London WC1, England; [Zachariah, Rony] Brussels Operat Ctr, Operat Res Unit, Medecins Sans Frontieres, Luxembourg, Luxembourg; [Bedell, Richard A.] Univ British Columbia, Div Global Hlth, Vancouver, BC V5Z 1M9, Canada	University of Toronto; George Institute for Global Health; University of Sydney; University of Sydney; World Health Organization; University of St Andrews; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; Doctors Without Borders; University of British Columbia	van Lettow, M (corresponding author), Dignitas Int, Zomba, Malawi.	m.vanlettow@dignitasinternational.org	Martiniuk, Alexandra/K-2600-2019; Bedell, Richard/AAC-2595-2020	Martiniuk, Alexandra/0000-0003-1368-8206; Bedell, Richard/0000-0002-5687-8053; Corbett, Elizabeth/0000-0002-3552-3181; zachariah, rony/0000-0002-2915-9328; Heyderman, Robert/0000-0003-4573-449X	TREAT TB; USAID Cooperative Agreement; University of Sydney Fellowship	TREAT TB; USAID Cooperative Agreement(United States Agency for International Development (USAID)); University of Sydney Fellowship	This study was funded through TREAT TB - An initiative led by the International Union Against Tuberculosis and Lung Disease (the Union) and supported by a USAID Cooperative Agreement. Medecins Sans Frontieres self-funded their involvement in this study and did not receive funds from USAID. AM is funded by a University of Sydney Fellowship (2012-2014 inclusive). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald LK, 2000, J INFECT DIS, V181, P1414, DOI 10.1086/315367; Archibald LK, 1998, CLIN INFECT DIS, V26, P290, DOI 10.1086/516297; Arthur G, 2001, CLIN INFECT DIS, V33, P248, DOI 10.1086/321820; Bedell RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039347; Bell M, 2001, Int J Infect Dis, V5, P63, DOI 10.1016/S1201-9712(01)90027-X; Bizuwork T., 2007, Journal of Infection in Developing Countries, V1, P118; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cox JA, 2010, AIDS REV, V12, P183; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Government of Malawi Ministry of Health with technical support from SACEMA and WHO, 2012, IMP ASS ART TB TREAT; Hill PC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-2; Holtz TH, 2011, LANCET INFECT DIS, V11, P533, DOI 10.1016/S1473-3099(11)70057-3; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kerkhoff AD, 2011, AIDS, V25, P1003, DOI 10.1097/QAD.0b013e328345ee32; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Komati S, 2010, AIDS, V24, P1849, DOI 10.1097/QAD.0b013e32833a2507; Kumwenda M, 2011, INT J TUBERC LUNG D, V15, P1663, DOI 10.5588/ijtld.10.0741; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2011, JAIDS-J ACQ IMM DEF, V57, P136, DOI 10.1097/QAI.0b013e3182199ee9; Lawn SD, 2011, CURR OPIN INFECT DIS, V24, P34, DOI 10.1097/QCO.0b013e3283420f76; Lessells RJ, 2011, SAMJ S AFR MED J, V101, P251, DOI 10.7196/SAMJ.4378; Levesque LE, 2010, BMJ-BRIT MED J, V340, P907; Lewis DK, 2002, INT J TUBERC LUNG D, V6, P1067; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Malawi Ministry of Health, 2007, HIV SYPH SER NAT HIV; Mayanja BN, 2010, TROP MED INT HEALTH, V15, P697, DOI 10.1111/j.1365-3156.2010.02528.x; McDonald LC, 1999, LANCET, V354, P1159, DOI 10.1016/S0140-6736(98)12325-5; Muyanja SZ, 2011, TROP MED INT HEALTH, V16, P756, DOI 10.1111/j.1365-3156.2011.02754.x; Ngoma D, 2008, TROP DOCT, V38, P159, DOI 10.1258/td.2007.070244; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Ssali FN, 1998, J ACQ IMMUN DEF SYND, V19, P484, DOI 10.1097/00042560-199812150-00007; Stall N, 2011, INT J TUBERC LUNG D, V15, P641, DOI 10.5588/ijtld.10.0195; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	43	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48856	10.1371/journal.pone.0048856	http://dx.doi.org/10.1371/journal.pone.0048856			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185278	gold, Green Published, Green Accepted			2022-12-25	WOS:000311333800011
J	Nakagawa, R; Matsunaga, E; Okanoya, K				Nakagawa, Ryoko; Matsunaga, Eiji; Okanoya, Kazuo			Defects in Ultrasonic Vocalization of Cadherin-6 Knockout Mice	PLOS ONE			English	Article							HUMAN SPEECH; NEURAL PATHWAYS; BRAIN; BIRDSONG; LANGUAGE; EXPRESSION; GENE; NEUROBIOLOGY; MECHANISMS; GENERATION	Background: Although some molecules have been identified as responsible for human language disorders, there is still little information about what molecular mechanisms establish the faculty of human language. Since mice, like songbirds, produce complex ultrasonic vocalizations for intraspecific communication in several social contexts, they can be good mammalian models for studying the molecular basis of human language. Having found that cadherins are involved in the vocal development of the Bengalese finch, a songbird, we expected cadherins to also be involved in mouse vocalizations. Methodology/Principal Findings: To examine whether similar molecular mechanisms underlie the vocalizations of songbirds and mammals, we categorized behavioral deficits including vocalization in cadherin-6 knockout mice. Comparing the ultrasonic vocalizations of cadherin-6 knockout mice with those of wild-type controls, we found that the peak frequency and variations of syllables were differed between the mutant and wild-type mice in both pup-isolation and adult-courtship contexts. Vocalizations during male-male aggression behavior, in contrast, did not differ between mutant and wild-type mice. Open-field tests revealed differences in locomotors activity in both heterozygote and homozygote animals and no difference in anxiety behavior. Conclusions/Significance: Our results suggest that cadherin-6 plays essential roles in locomotor activity and ultrasonic vocalization. These findings also support the idea that different species share some of the molecular mechanisms underlying vocal behavior.	[Nakagawa, Ryoko; Matsunaga, Eiji; Okanoya, Kazuo] RIKEN Brain Sci Inst, Lab Biolinguist, Wako, Saitama, Japan; [Nakagawa, Ryoko] Hiroshima Univ, Grad Sch Biomed Sci, Lab Integrat Biosci, Hiroshima, Japan; [Matsunaga, Eiji] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan; [Okanoya, Kazuo] JST ERATO, ERATO Okanoya Emot Informat Project, Wako, Saitama, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Nakagawa, Ryoko; Okanoya, Kazuo] RIKEN Brain Sci Inst, Emot Informat Joint Res Lab, Wako, Saitama, Japan	RIKEN; Hiroshima University; RIKEN; University of Tokyo; RIKEN	Okanoya, K (corresponding author), RIKEN Brain Sci Inst, Lab Biolinguist, Wako, Saitama, Japan.	kazuookanoya@gmail.com	Satoh, Nori/C-4123-2009	Satoh, Nori/0000-0002-4480-3572	Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists [DC1]; Nakayama Foundation for Human Science grant; RIKEN Brain Science Institute general research budget	Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nakayama Foundation for Human Science grant; RIKEN Brain Science Institute general research budget	This work was supported by Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists (DC1) to RN, a Nakayama Foundation for Human Science grant to EM, and a RIKEN Brain Science Institute general research budget to KO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; Beckers GJL, 2011, HUM BIOL, V83, P191, DOI 10.3378/027.083.0204; Ben-Shachar M, 2007, CURR OPIN NEUROBIOL, V17, P258, DOI 10.1016/j.conb.2007.03.006; Berwick RC, 2011, TRENDS COGN SCI, V15, P113, DOI 10.1016/j.tics.2011.01.002; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Caylak E, 2007, AM J MED GENET B, V144B, P923, DOI 10.1002/ajmg.b.30537; Deacon TW, 2000, J COMMUN DISORD, V33, P273, DOI 10.1016/S0021-9924(00)00025-3; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Fee MS, 2010, ILAR J, V51, P362, DOI 10.1093/ilar.51.4.362; Fischer J, 2011, GENES BRAIN BEHAV, V10, P17, DOI 10.1111/j.1601-183X.2010.00610.x; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gabel LA, 2010, NEUROBIOL DIS, V38, P173, DOI 10.1016/j.nbd.2009.06.019; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Hage SR, 2006, J NEUROSCI, V26, P7105, DOI 10.1523/JNEUROSCI.1024-06.2006; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Inoue T, 2001, DEVELOPMENT, V128, P561; Inoue YU, 2008, MOL CELL NEUROSCI, V39, P95, DOI 10.1016/j.mcn.2008.05.020; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Kelley DB, 2010, CURR OPIN NEUROBIOL, V20, P748, DOI 10.1016/j.conb.2010.08.007; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Kurz A, 2010, NEUROSCIENCE, V166, P785, DOI 10.1016/j.neuroscience.2009.12.054; Ludlow CL, 2005, RESP PHYSIOL NEUROBI, V147, P205, DOI 10.1016/j.resp.2005.04.015; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; Marthiens W, 2002, BIOL CELL, V94, P315, DOI 10.1016/S0248-4900(02)00005-9; Matsunaga E, 2008, J COMP NEUROL, V508, P329, DOI 10.1002/cne.21676; Matsunaga E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025272; Matsunaga E, 2011, NEUROREPORT, V22, P629, DOI 10.1097/WNR.0b013e3283491665; Moorman S, 2011, BIOESSAYS, V33, P377, DOI 10.1002/bies.201000150; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Okanoya K, 2004, ANN NY ACAD SCI, V1016, P724, DOI 10.1196/annals.1298.026; Osterhout JA, 2011, NEURON, V71, P632, DOI 10.1016/j.neuron.2011.07.006; Petkov Christopher I, 2012, Front Evol Neurosci, V4, P12, DOI 10.3389/fnevo.2012.00012; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Simonyan K, 2003, BRAIN RES, V974, P43, DOI 10.1016/S0006-8993(03)02548-4; Suzuki SC, 2007, J NEUROSCI, V27, P3466, DOI 10.1523/JNEUROSCI.0243-07.2007; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; White SA, 2006, J NEUROSCI, V26, P10376, DOI 10.1523/JNEUROSCI.3379-06.2006; Whitney G, 1983, AUDITORY PSYCHOBIOLO, P98; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019	51	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49233	10.1371/journal.pone.0049233	http://dx.doi.org/10.1371/journal.pone.0049233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173049	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300019
J	Osei-Amo, S; Hussain, M; O'Neill, SL; Asgari, S				Osei-Amo, Solomon; Hussain, Mazhar; O'Neill, Scott L.; Asgari, Sassan			Wolbachia-Induced aae-miR-12 miRNA Negatively Regulates the Expression of MCT1 and MCM6 Genes in Wolbachia-Infected Mosquito Cell Line	PLOS ONE			English	Article							AEDES-AEGYPTI; C-ELEGANS; REPLICATION; MICRORNAS; LIN-14; DENGUE	Background: Best recognized for its role in manipulating host reproduction, the parasitic gram-negative Wolbachia pipientis is known to colonize a wide range of invertebrates. The endosymbiotic bacterium has recently been shown to cause a life-shortening effect as well as inhibiting replication of arboviruses in Aades aegypti; although the molecular mechanisms behind these effects are largely unknown. MicroRNAs (miRNAs) have been determined to have a wide range of roles in regulating gene expression in eukaryotes. A recent study showed that several A. aegypti mosquito miRNAs are differentially expressed when infected with Wolbachia. Methodology/Principal Findings: Based on the prior knowledge that one of these miRNAs, aae-miR-12, is differentially expressed in mosquitoes infected with Wolbachia, we aimed to determine any significance of this mediation. We also set out to characterize the target genes of this miRNA in the A. aegpyti genome. Bioinformatic approaches predicted a list of potential target genes and subsequent functional analyses confirmed that two of these, DNA replication licensing (MCM6) and monocarboxylate transporter (MCT1), are under the regulative control of aae-miR-12. We also demonstrated that aae-miR-12 is critical in the persistence of Wolbachia in the host cell. Conclusions/Significance: Our study has identified two target genes of aae-miR-12, a differentially expressed mosquito miRNA in Wolbachia-infected cells, and determined that the miRNA affects Wolbachia density in the host cells.	[Osei-Amo, Solomon; Hussain, Mazhar; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [O'Neill, Scott L.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	University of Queensland; Monash University	Asgari, S (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	s.asgari@uq.edu.au	Asgari, Sassan/G-2678-2011; O'Neill, Scott/R-9560-2019; O'Neill, Scott L/B-3568-2009	Asgari, Sassan/0000-0001-7885-6544; O'Neill, Scott/0000-0002-4131-3615; O'Neill, Scott L/0000-0002-4131-3615	Australian Research Council [DP110102112]; ARC DECRA fellowship [DE120101512]	Australian Research Council(Australian Research Council); ARC DECRA fellowship(Australian Research Council)	This project was supported by an Australian Research Council grant to SA (DP110102112) and an ARC DECRA fellowship to MH (DE120101512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MI, 2011, MUTAT RES-FUND MOL M, V717, P1, DOI 10.1016/j.mrfmmm.2011.03.009; Asgari S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00048; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Dedeine F, 2005, HEREDITY, V95, P394, DOI 10.1038/sj.hdy.6800739; Fehri LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009500; Filippi BM, 2008, J CELL BIOL, V183, P7, DOI 10.1083/jcb.200809056; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Harvey CB, 1996, FEBS LETT, V398, P135, DOI 10.1016/S0014-5793(96)01189-1; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Schnitger AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027435; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	20	45	48	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50049	10.1371/journal.pone.0050049	http://dx.doi.org/10.1371/journal.pone.0050049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166816	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300080
J	Risley, CL; Drake, LJ; Bundy, DAP				Risley, Claire L.; Drake, Lesley J.; Bundy, Donald A. P.			Economic Impact of HIV and Antiretroviral Therapy on Education Supply in High Prevalence Regions	PLOS ONE			English	Article								Background: We set out to estimate, for the three geographical regions with the highest HIV prevalence, (sub-Saharan Africa [SSA], the Caribbean and the Greater Mekong sub-region of East Asia), the human resource and economic impact of HIV on the supply of education from 2008 to 2015, the target date for the achievement of Education For All (EFA), contrasting the continuation of access to care, support and Antiretroviral therapy (ART) to the scenario of universal access. Methodology/Principal Findings: A costed mathematical model of the impact of HIV and ART on teacher recruitment, mortality and absenteeism (Ed-SIDA) was run using best available data for 58 countries, and results aggregated by region. It was estimated that (1) The impact of HIV on teacher supply is sufficient to derail efforts to achieve EFA in several countries and universal access can mitigate this. (2) In SSA, the 2008 costs to education of HIV were about half of those estimated in 2002. Providing universal access for teachers in SSA is cost-effective on education returns alone and provides a return of $3.99 on the dollar. (3) The impacts on education in the hyperendemic countries in Southern Africa will continue to increase to 2015 from its 2008 level, already the highest in the world. (4) If treatment roll-out is successful, numbers of HIV positive teachers are set to increase in all the regions studied. Conclusions/Significance: The return on investing in care and support is also greater in those areas with highest impact. SSA requires increased investment in teacher support, testing and particularly ART if it is to achieve EFA. The situation for teachers in the Caribbean and East Asia is similar but on a smaller scale proportionate to the lower levels of infection and greater existing access to care and support.	[Bundy, Donald A. P.] World Bank, Human Dev Network, Washington, DC 20433 USA; [Risley, Claire L.; Drake, Lesley J.] Univ London Imperial Coll Sci Technol & Med, London, England; [Risley, Claire L.] Univ Liverpool, Climate & Infect Dis Anim LUCINDA Grp, Inst Infect & Global Hlth, Neston, Cheshire, England	The World Bank; Imperial College London; University of Liverpool	Bundy, DAP (corresponding author), World Bank, Human Dev Network, 1818 H St NW, Washington, DC 20433 USA.	dbundy@worldbank.org			World Bank [DGF 304310]	World Bank(The World Bank India)	This research was funded by a Development Grant Facility Window 1 grant from the World Bank (DGF 304310; http://go.worldbank.org/OGQO8U0XN0) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, ED HIV AIDS WIND HOP; [Anonymous], HIST AFRICAN AIDS EP; Badcock-Walters P, 2003, ED MORTALITY SERVICE; Bennell P, 2006, ANTIRETROVIRAL DRUGS; Bennell P, 2005, COUNTERING IMPACT AI; Bennell P.S., 2002, CTR INT ED, P1; Boler T, 2003, POLICY RES SERIES SA; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brown T, 2006, SEX TRANSM INFECT, V82, pIII34, DOI 10.1136/sti.2006.020230; Bruns Barbara, 2003, ACHIEVING UNIVERSAL; Bundy DAP, 2009, COURAGE HOPE STORIES; Burnett N, 2005, LITERACY LIFE; Caillods F, 2008, HIV AIDS CHALLENGES; CAREC, 2004, STAT TRENDS AN CAR H; Carr-Hill R, 2004, HIV AIDS POVERTY ED; Castro V, 2007, TEACHER ABSENCES HIV; Chaudhury N, 2004, TEACHER HLTH CARE PR; Clarke DJ., 2008, HEROES VILLAINS TEAC; Cooper ES, 2007, J INT COOPERATION ED, V10, P101; Ghys PD, 2008, SEX TRANSM INFECT, V84, pI1, DOI 10.1136/sti.2008.032573; Grant KB, 2004, MITIGATING IMPACT HI; Grassly NC, 2003, AIDS, V17, P1039, DOI 10.1097/00002030-200305020-00013; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; Jukes MCH, 2005, ED HIV AIDS PREVENTI; Kelly M, 2000, PLANNING ED CONTEXT; Kinghorn A, 2005, J DEV STUD, V41, P489, DOI 10.1080/0022038042000313345; Makombe SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000620; Mills EJ, 2010, AIDS, V24, P341, DOI 10.1097/QAD.0b013e3283357e0f; Nattrass N, 2007, AJAR-AFR J AIDS RES, V6, P129, DOI 10.2989/16085900709490407; Navrozidis P, 2011, REPORT SITUATION ANA; Rosenberg S, 2000, ACT SOC S AFR ANN CO; Schleicher A, 1995, CONDITIONS PRIMARY S; Shisana O, 2005, HLTH OUR ED FOCUS HI; UNAIDS, 2009, EPP SPECTR MOD; UNAIDS, 2010, METH EST HIV INC UNA; UNAIDS, 2008, REP GLOB AIDS EP; UNAIDS, 2006, REP GLOB AIDS EP; UNESCO, 2002, ED ALL IS WORLD TRAC; UNESCO, 2008, EFA GLOBAL MONITORIN; UNESCO, 2002, AFR RESP UNESCOS STR; UNESCO, 2009, EFA GLOB MON REP 201; UNESCO, 2004, ED ALL QUAL IMP; UNESCO UIS, 2006, TEACH ED QUAL MON GL; UNICEF, 2005, STAT WORLDS CHILDR; World Bank, 2009, AV HUM CRIS GLOB DOW; World Bank and Partnership for Child Development, 2009, MOD IMP HIV AIDS ED; World Bank and Partnership for Child Development, 2001, MOD IMP HIV AIDS ED; World Bank and Partnership for Child Development, 2006, MOD IMP HIV AIDS ED	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e42909	10.1371/journal.pone.0042909	http://dx.doi.org/10.1371/journal.pone.0042909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173030	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300001
J	Inagaki-Ohara, K; Mayuzumi, H; Kato, S; Minokoshi, Y; Otsubo, T; Kawamura, YI; Dohi, T; Matsuzaki, G; Yoshimura, A				Inagaki-Ohara, K.; Mayuzumi, H.; Kato, S.; Minokoshi, Y.; Otsubo, T.; Kawamura, Y. I.; Dohi, T.; Matsuzaki, G.; Yoshimura, A.			Enhancement of leptin receptor signaling by SOCS3 deficiency induces development of gastric tumors in mice	ONCOGENE			English	Article						leptin; SOCS3; gastric tumor	MOUSE OBESE GENE; HUMAN STOMACH; OB-R; INTESTINAL INFLAMMATION; GASTROINTESTINAL-TRACT; COLORECTAL-CANCER; BINDING PROTEIN; PROTECTIVE ROLE; STEM-CELLS; EXPRESSION	Leptin acts on its receptor (ObR) in the hypothalamus to inhibit food intake and energy expenditure. Leptin and ObR are also expressed in the gastrointestinal tract; however, the physiological significance of leptin signaling in the gut remains uncertain. Suppressor of cytokine signaling 3 (SOCS3) is a key negative feedback regulator of ObR-mediated signaling in the hypothalamus. We now show that gastrointestinal epithelial cell-specific SOCS3 conditional knockout (T3b-SOCS3 cKO) mice developed gastric tumors by enhancing leptin production and the ObRb/signal transducer and activator of transcription 3 (STAT3) signaling pathway. All T3b-SOCS3 cKO mice developed tumors in the stomach but not in the bowels by 2 months of age, even though the SOCS3 deletion occurred in both the epithelium of stomach and bowels. The tumors developed in the absence of the inflammatory response and all cKO mice died within 6 months. These tumors displayed pathology and molecular alterations, such as an increase in MUC2 (Mucin 2, oligomeric mucus/gel-forming) and TFF3 (trefoil factor 3), resembling human intestinal-type gastric tumors. Administration of antileptin antibody to T3b-SOCS3 cKO mice reduced hyperplasia of gastric mucosa, which is the step of the initiation of gastric tumor. These data suggest that SOCS3 is an antigastric tumor gene that suppresses leptin overexpression and ObRb/STAT3 hyperactivation, supporting the hypothesis that the leptin/ObRb/STAT3 axis accelerates tumorigenesis and that it may represent a new therapeutic target for the treatment of gastric cancer.	[Inagaki-Ohara, K.; Mayuzumi, H.; Matsuzaki, G.] Univ Ryukyus, Trop Biosphere Res Ctr, Ctr Mol Biosci COMB, Mol Microbiol Grp, Nishihara, Okinawa 90301, Japan; [Inagaki-Ohara, K.; Minokoshi, Y.] Natl Inst Physiol Sci, Dept Dev Physiol, Div Endocrinol & Metab, Okazaki, Aichi 444, Japan; [Inagaki-Ohara, K.; Otsubo, T.; Kawamura, Y. I.; Dohi, T.] Natl Ctr Global Hlth & Med NCGM, Res Inst, Res Ctr Hepatitis & Immunol, Dept Gastroenterol, Ichikawa, Chiba 2728516, Japan; [Kato, S.] Univ Ryukyus, Grad Sch, Dept Pathol & Cell Biol, Nishihara, Okinawa 90301, Japan; [Kato, S.] Univ Ryukyus, Fac Med, Nishihara, Okinawa 90301, Japan; [Yoshimura, A.] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjyuku Ku, Tokyo, Japan	University of the Ryukyus; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of the Ryukyus; University of the Ryukyus; Keio University	Inagaki-Ohara, K (corresponding author), Natl Ctr Global Hlth & Med NCGM, Res Inst, Res Ctr Hepatitis & Immunol, Dept Gastroenterol, Konodai 1-7-1, Ichikawa, Chiba 2728516, Japan.	kyoinagaki@ri.ncgm.go.jp	Otsubo, Takeshi/G-6123-2014; Yoshimura, Akihiko/K-5515-2013; Matsuzaki, Goro/AAX-3110-2020	Minokoshi, Yasuhiko/0000-0002-7119-4805	Ministry of Education, Culture, Sports, Science and Technology of Japan [17590373, 19590432, 20599015, 23590272]; Takeda Science Foundation; Public Trust Haraguchi Memorial Cancer Research Fund; Ministry of Education, Science, Technology, Sports, and Culture of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Public Trust Haraguchi Memorial Cancer Research Fund; Ministry of Education, Science, Technology, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (17590373, 19590432, 20599015 and 23590272), the Takeda Science Foundation and the Public Trust Haraguchi Memorial Cancer Research Fund (to KI-O) and Grants-in-aid for Scientific Research (S) from the Ministry of Education, Science, Technology, Sports, and Culture of Japan (to AY). We greatly thank Dr Jun-ichi Miyazaki (Osaka University) for the gift of the T3b-IL-12 vector, Ms Kozue Takahashi and Mr Takashi Kanna (University of the Ryukyus) for animal care, Dr Atsuo T Sasaki (Harvard University) for help in creating the T3b-cre construction, Dr Richard Blumberg (Harvard Medical School) and Dr Mayu Inaba (University of Michigan) for their constructive discussion and Dr Adrian L Smith (Oxford University) for reading carefully. We also thank Dr Takeshi Arakawa (University of the Ryukyus), Dr Shiki Okamoto, Ms Kumiko Saito (NIPS), Dr Miwa Tamura-Nakano and Dr Takeshi Nitta (NCGM) for steadfast supporting and encouraging us.	Aihara T, 1999, FEBS LETT, V463, P185, DOI 10.1016/S0014-5793(99)01608-7; Attoub S, 2000, FASEB J, V14, P2329, DOI 10.1096/fj.00-0162; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Cascio S, 2009, J CELL PHYSIOL, V221, P189, DOI 10.1002/jcp.21843; Cinti S, 2000, INT J OBESITY, V24, P789, DOI 10.1038/sj.ijo.0801228; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Feldman DE, 2012, P NATL ACAD SCI USA, V109, P829, DOI 10.1073/pnas.1114438109; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Guilmeau S, 2004, CURR OPIN PHARMACOL, V4, P561, DOI 10.1016/j.coph.2004.06.008; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; Howard JM, 2010, OBES REV, V11, P863, DOI 10.1111/j.1467-789X.2010.00718.x; Inagaki-Ohara K, 2006, GUT, V55, P212, DOI 10.1136/gut.2004.062653; Inagaki-Ohara K, 2004, J IMMUNOL, V173, P1390, DOI 10.4049/jimmunol.173.2.1390; Inagaki-Ohara K, 2011, IMMUNOLOGY, V134, P448, DOI 10.1111/j.1365-2567.2011.03503.x; Ishikawa M, 2006, WORLD J GASTROENTERO, V12, P5517, DOI 10.3748/wjg.v12.i34.5517; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Koda M, 2007, J CLIN PATHOL, V60, P902, DOI 10.1136/jcp.2006.041004; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Mix H, 2000, GUT, V47, P481, DOI 10.1136/gut.47.4.481; MONTERO C, 1980, HISTOPATHOLOGY, V4, P281, DOI 10.1111/j.1365-2559.1980.tb02922.x; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Morton NM, 1998, J BIOL CHEM, V273, P26194, DOI 10.1074/jbc.273.40.26194; Nduati V, 2007, J BIOL CHEM, V282, P1359, DOI 10.1074/jbc.M604267200; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Rigby RJ, 2007, ONCOGENE, V26, P4833, DOI 10.1038/sj.onc.1210286; Rosivatz E, 2006, VIRCHOWS ARCH, V448, P277, DOI 10.1007/s00428-005-0118-9; Sitaraman S, 2004, FASEB J, V18, P696, DOI 10.1096/fj.03-0422fje; Sobhani I, 2000, GUT, V47, P178, DOI 10.1136/gut.47.2.178; Stringer EJ, 2008, FEBS LETT, V582, P2555, DOI 10.1016/j.febslet.2008.06.024; Suh E, 1996, MOL CELL BIOL, V16, P619; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wu LY, 2011, AM J PATHOL, V179, P2131, DOI 10.1016/j.ajpath.2011.06.028; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Zhang YJ, 2007, J CELL BIOCHEM, V102, P1256, DOI 10.1002/jcb.21356; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao L, 2005, WORLD J GASTROENTERO, V11, P7666, DOI 10.3748/wjg.v11.i48.7666; Zhao XL, 2007, J GASTROEN HEPATOL, V22, P1317, DOI 10.1111/j.1440-1746.2007.04941.x	53	46	47	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					74	84		10.1038/onc.2012.540	http://dx.doi.org/10.1038/onc.2012.540			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23178499				2022-12-25	WOS:000329212000009
J	Zhu, GY; Ye, RS; Jung, DY; Barron, E; Friedline, RH; Benoit, VM; Hinton, DR; Kim, JK; Lee, AS				Zhu, Genyuan; Ye, Risheng; Jung, Dae Young; Barron, Ernesto; Friedline, Randall H.; Benoit, Vivian M.; Hinton, David R.; Kim, Jason K.; Lee, Amy S.			GRP78 plays an essential role in adipogenesis and postnatal growth in mice	FASEB JOURNAL			English	Article						conditional-knockout mouse model; aP2-Cre-recombinase; adipokine secretion	UNFOLDED PROTEIN RESPONSE; EMBRYONIC-DEVELOPMENT; REGULATOR GRP78/BIP; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ER; STRESS; EXPRESSION; PATHWAY; MOUSE	To investigate the role of GRP78 in adipogenesis and metabolic homeostasis, we knocked down GRP78 in mouse embryonic fibroblasts and 3T3-L1 preadipocytes induced to undergo differentiation into adipocytes. We also created an adipose Grp78-knockout mouse utilizing the aP2 (fatty acid binding protein 4) promoter-driven Cre-recombinase. Adipogenesis was monitored by molecular markers and histology. Tissues were analyzed by micro-CT and electron microscopy. Glucose homeostasis and cytokine analysis were performed. Our results indicate that GRP78 is essential for adipocyte differentiation in vitro. aP2-cremediated GRP78 deletion leads to lipoatrophy with similar to 90% reduction in gonadal and subcutaneous white adipose tissue and brown adipose tissue, severe growth retardation, and bone defects. Despite severe abnormality in adipose mass and function, adipose Grp78-knockout mice showed normal plasma triglyceride levels, and plasma glucose and insulin levels were reduced by 40-60% compared to wild-type mice, suggesting enhanced insulin sensitivity. The endoplasmic reticulum is grossly expanded in the residual mutant white adipose tissue. Thus, these studies establish that GRP78 is required for adipocyte differentiation, glucose homeostasis, and balanced secretion of adipokines. Unexpectedly, the phenotypes and metabolic parameters of the mutant mice, which showed early postnatal mortality, are uniquely distinct from previously characterized lipodystrophic mouse models.-Zhu, G., Ye, R., Jung, D. Y., Barron, E., Friedline, R. H., Benoit, V. M., Hinton, D. R., Kim, J. K., Lee, A. S. GRP78 plays an essential role in adipogenesis and postnatal growth in mice. FASEB J. 27, 955-964 (2013). www.fasebj.org	[Zhu, Genyuan; Lee, Amy S.] Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Barron, Ernesto; Hinton, David R.] Univ So Calif, Dept Pathol, Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90089 USA; [Ye, Risheng] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dept Internal Med, Dallas, TX 75390 USA; [Jung, Dae Young; Friedline, Randall H.; Benoit, Vivian M.; Kim, Jason K.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol, Worcester, MA USA	University of Southern California; University of Southern California; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lee, AS (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, 1441 Eastlake Ave,Rm 5308, Los Angeles, CA 90089 USA.	amylee@ccnt.usc.edu	Zhu, Genyuan/R-8142-2016	Kim, Jason/0000-0002-7185-042X; Lee, Amy/0000-0002-0378-5443	U.S. National Institutes of Health (NIH) [R01 DK 079999, R01 DK 080756]; NIH from the National Cancer Institute [P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079999, U24DK093000, R01DK080756] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. My Chouinard (University of Massachusetts Medical School, Worcester, MA, USA) and Drs. Mike Gray, Yvonne Lin, and Parkash Gill [Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA] for the gifts of cell lines and reagents. The authors thank Ms. Archana Tank (USC Comprehensive Cancer Center Small Animal Imaging Core and Translational Pathology Core) and Dr. Dongyun Yang (USC Biostatistics Core) for assistance. The authors also thank the USC Comprehensive Cancer Center Cell and Tissue Imaging Core for assistance in electron microscopy. This work is supported in part by U.S. National Institutes of Health (NIH) grants R01 DK 079999 to A.S.L and R01 DK 080756 to J.K.K. The USC cores described were supported by NIH grant P30 CA014089 from the National Cancer Institute.	Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Burkart A, 2011, J BIOL CHEM, V286, P4081, DOI 10.1074/jbc.M110.134106; Federovitch CM, 2005, CURR OPIN CELL BIOL, V17, P409, DOI 10.1016/j.ceb.2005.06.010; Flint OP, 2009, TOXICOL PATHOL, V37, P65, DOI 10.1177/0192623308327119; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Lowe CE, 2012, INT J OBESITY, V36, P1248, DOI 10.1038/ijo.2011.233; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Martens K, 2010, FEBS LETT, V584, P1054, DOI 10.1016/j.febslet.2010.01.061; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; ROSS SR, 1993, GENE DEV, V7, P1318, DOI 10.1101/gad.7.7b.1318; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Verdelis K, 2011, BONE, V49, P580, DOI 10.1016/j.bone.2011.05.013; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Ye RS, 2010, AM J PATHOL, V177, P2827, DOI 10.2353/ajpath.2010.100368; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755	34	34	34	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					955	964		10.1096/fj.12-213330	http://dx.doi.org/10.1096/fj.12-213330			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23180827	Green Published			2022-12-25	WOS:000315585200011
J	Naura, AS; Kim, H; Ju, JH; Rodriguez, PC; Jordan, J; Catling, AD; Rezk, BM; Abd Elmageed, ZY; Pyakurel, K; Tarhuni, AF; Abughazleh, MQ; Errami, Y; Zerfaoui, M; Ochoa, AC; Boulares, AH				Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Rodriguez, Paulo C.; Jordan, Joaquin; Catling, Andrew D.; Rezk, Bashir M.; Abd Elmageed, Zakaria Y.; Pyakurel, Kusma; Tarhuni, Abdelmetalab F.; Abughazleh, Mohammad Q.; Errami, Youssef; Zerfaoui, Mourad; Ochoa, Augusto C.; Boulares, A. Hamid			Minocycline Blocks Asthma-associated Inflammation in Part by Interfering with the T Cell Receptor-Nuclear Factor kappa B-GATA-3-IL-4 Axis without a Prominent Effect on Poly(ADP-ribose) Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLERGIC AIRWAY INFLAMMATION; FACTOR-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; MURINE MODEL; PROTEIN-KINASE; TH2 CYTOKINES; IGE RESPONSES; ACTIVATION; INHIBITION; PREVENTS	Minocycline protects against asthma independently of its antibiotic function and was recently reported as a potent poly(ADP-ribose) polymerase (PARP) inhibitor. In an animal model of asthma, a single administration of minocycline conferred excellent protection against ovalbumin-induced airway eosinophilia, mucus hypersecretion, and Th2 cytokine production (IL-4/IL-5/IL-12(p70)/IL-13/GM-CSF) and a partial protection against airway hyperresponsiveness. These effects correlated with pronounced reduction in lung and sera allergen-specific IgE. A reduction in poly(ADP-ribose) immunoreactivity in the lungs of minocycline-treated/ovalbumin-challenged mice correlated with decreased oxidative DNA damage. The effect of minocycline on PARP may be indirect, as the drug failed to efficiently block direct PARP activation in lungs of N-methyl-N'-nitro-N-nitroso-guanidine-treated mice or H2O2-treated cells. Minocycline blocked allergen-specific IgE production in B cells potentially by modulating T cell receptor (TCR)-linked IL-4 production at the mRNA level but not through a modulation of the IL-4-JAK-STAT-6 axis, IL-2 production, or NFAT1 activation. Restoration of IL-4, ex vivo, rescued IgE production by minocycline-treated/ovalbumin-stimulated B cells. IL-4 blockade correlated with a preferential inhibition of the NF-kappa B activation arm of TCR but not GSK3, Src, p38 MAPK, or ERK1/2. Interestingly, the drug promoted a slightly higher Src and ERK1/2 phosphorylation. Inhibition of NF-kappa B was linked to a complete blockade of TCR-stimulated GATA-3 expression, a pivotal transcription factor for IL-4 expression. Minocycline also reduced TNF-alpha-mediated NF-kappa B activation and expression of dependent genes. These results show a potentially broad effect of minocycline but that it may block IgE production in part by modulating TCR function, particularly by inhibiting the signaling pathway, leading to NF-kappa B activation, GATA-3 expression, and subsequent IL-4 production.	[Naura, Amarjit S.; Kim, Hogyoung; Ju, Jihang; Rodriguez, Paulo C.; Catling, Andrew D.; Abd Elmageed, Zakaria Y.; Pyakurel, Kusma; Tarhuni, Abdelmetalab F.; Abughazleh, Mohammad Q.; Errami, Youssef; Zerfaoui, Mourad; Ochoa, Augusto C.; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Kim, Hogyoung; Ju, Jihang; Catling, Andrew D.; Pyakurel, Kusma; Tarhuni, Abdelmetalab F.; Errami, Youssef; Zerfaoui, Mourad; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Naura, Amarjit S.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; [Jordan, Joaquin] Univ Castilla La Mancha, Dpto Ciencias Med, Fac Med, Albacete 02006, Spain; [Rezk, Bashir M.] So Univ New Orleans, Dept Nat Sci, New Orleans, LA 70126 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Universidad de Castilla-La Mancha; Southern University System; Southern University New Orleans	Naura, AS (corresponding author), 533 Bolivar St 701 509, New Orleans, LA 70112 USA.	anaura@lsuhsc.edu; hboulr@lsuhsc.edu	Elmageed, Zakaria Y Abd/O-3456-2018; Rodríguez, Paulo/HDM-9539-2022	Elmageed, Zakaria Y Abd/0000-0003-4031-0348; Rodriguez, Paulo/0000-0001-7480-6566; jordan, joaquin/0000-0002-6809-3384; Errami, Youssef/0000-0002-0432-4331	National Institutes of Health [HL072889]; American Cancer Society [RSG-116608]; National Institutes of Health/COBRE [P20GM103501]; NATIONAL CANCER INSTITUTE [R21CA162133, R01CA107974] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Institutes of Health/COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant HL072889 from National Institutes of Health and grant RSG-116608 from the American Cancer Society (to A. H. B.). This work was also supported by grant National Institutes of Health/COBRE P20GM103501 (to A. S. N., with A. C. O. as overall Program Director).	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; ALVAREZGONZALEZ R, 1989, MUTAT RES, V218, P67, DOI 10.1016/0921-8777(89)90012-8; Avila PC, 2007, ANNU REV MED, V58, P185, DOI 10.1146/annurev.med.58.061705.145252; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2006, TRENDS MOL MED, V12, P515, DOI 10.1016/j.molmed.2006.09.006; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Busse PJ, 2007, CLIN EXP ALLERGY, V37, P1392, DOI 10.1111/j.1365-2222.2007.02775.x; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Daoud A, 2008, ALLERGY ASTHMA PROC, V29, P286, DOI 10.2500/aap.2008.29.3121; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Fernandes A, 2009, CURR PHARM DESIGN, V15, P2915, DOI 10.2174/138161209789058165; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; Gagliardo R, 2011, J ALLERGY CLIN IMMUN, V128, P635, DOI 10.1016/j.jaci.2011.03.045; Hamelmann Eckard, 2008, Clin Allergy Immunol, V21, P415; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Huang TY, 2009, BIOCHEM BIOPH RES CO, V389, P634, DOI 10.1016/j.bbrc.2009.09.041; Huang TY, 2009, TOXICOL APPL PHARM, V237, P69, DOI 10.1016/j.taap.2009.02.026; Hutchison S, 2008, CLIN EXP IMMUNOL, V151, P114, DOI 10.1111/j.1365-2249.2007.03509.x; Joks R, 2011, PHARMACOL RES, V64, P602, DOI 10.1016/j.phrs.2011.04.001; Joks R, 2010, INT IMMUNOL, V22, P281, DOI 10.1093/intimm/dxq004; Jordan J., 2007, Current Drug Delivery, V4, P225; Ju JH, 2010, J BIOL CHEM, V285, P41152, DOI 10.1074/jbc.M110.158352; Kuang XH, 2009, BRAIN RES, V1286, P174, DOI 10.1016/j.brainres.2009.06.007; Kuzin II, 2001, INT IMMUNOL, V13, P921, DOI 10.1093/intimm/13.7.921; Le Saux CJ, 2008, J BIOL CHEM, V283, P5760, DOI 10.1074/jbc.M701572200; Lee KS, 2004, J ALLERGY CLIN IMMUN, V113, P902, DOI 10.1016/j.jaci.2004.03.008; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Garcia-Martinez EM, 2010, BIOCHEM PHARMACOL, V79, P239, DOI 10.1016/j.bcp.2009.07.028; Matera MG, 2010, PULM PHARMACOL THER, V23, P121, DOI 10.1016/j.pupt.2009.10.007; Mustapha O, 2006, J IMMUNOL, V177, P6489, DOI 10.4049/jimmunol.177.9.6489; Naura AS, 2008, CLIN EXP ALLERGY, V38, P839, DOI 10.1111/j.1365-2222.2008.02943.x; Naura AS, 2009, EUR RESPIR J, V33, P252, DOI 10.1183/09031936.00089008; Naura AS, 2010, J IMMUNOL, V185, P3076, DOI 10.4049/jimmunol.0904214; Nikodemova M, 2006, J NEUROCHEM, V96, P314, DOI 10.1111/j.1471-4159.2005.03520.x; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Padi SSV, 2008, EUR J PHARMACOL, V601, P79, DOI 10.1016/j.ejphar.2008.10.018; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Sandler C, 2005, INFLAMM RES, V54, P304, DOI 10.1007/s00011-005-1358-5; Smith-Norowitz TA, 2002, ANN ALLERG ASTHMA IM, V89, P172, DOI 10.1016/S1081-1206(10)61934-5; Steinke JW, 2001, RESP RES, V2, P66, DOI 10.1186/rr40; Suzuki Y, 2004, J PHARMACOL EXP THER, V311, P1241, DOI 10.1124/jpet.104.072546; Szeto GL, 2011, J BIOL CHEM, V286, P11275, DOI 10.1074/jbc.M110.210518; Tao R, 2010, J CARDIOVASC PHARM, V56, P659, DOI 10.1097/FJC.0b013e3181faeaf0; Yamashita N, 2006, AM J PHYSIOL-LUNG C, V290, pL1045, DOI 10.1152/ajplung.00195.2005; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P4766, DOI 10.1167/iovs.06-0871	50	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1458	1468		10.1074/jbc.M112.419580	http://dx.doi.org/10.1074/jbc.M112.419580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184953	hybrid, Green Published			2022-12-25	WOS:000313751400004
J	Arun, PVPS; Bakku, RK; Subhashini, M; Singh, P; Prabhu, NP; Suzuki, I; Prakash, JSS				Arun, P. V. Parvati Sai; Bakku, Ranjith Kumar; Subhashini, Mranu; Singh, Pankaj; Prabhu, N. Prakash; Suzuki, Iwane; Prakash, Jogadhenu S. S.			CyanoPhyChe: A Database for Physico-Chemical Properties, Structure and Biochemical Pathway Information of Cyanobacterial Proteins	PLOS ONE			English	Article							INCLUSION-BODIES	CyanoPhyChe is a user friendly database that one can browse through for physico-chemical properties, structure and biochemical pathway information of cyanobacterial proteins. We downloaded all the protein sequences from the cyanobacterial genome database for calculating the physico-chemical properties, such as molecular weight, net charge of protein, isoelectric point, molar extinction coefficient, canonical variable for solubility, grand average hydropathy, aliphatic index, and number of charged residues. Based on the physico-chemical properties, we provide the polarity, structural stability and probability of a protein entering in to an inclusion body (PEPIB). We used the data generated on physicochemical properties, structure and biochemical pathway information of all cyanobacterial proteins to construct CyanoPhyChe. The data can be used for optimizing methods of expression and characterization of cyanobacterial proteins. Moreover, the 'Search' and data export options provided will be useful for proteome analysis. Secondary structure was predicted for all the cyanobacterial proteins using PSIPRED tool and the data generated is made accessible to researchers working on cyanobacteria. In addition, external links are provided to biological databases such as PDB and KEGG for molecular structure and biochemical pathway information, respectively. External links are also provided to different cyanobacterial databases. CyanoPhyChe can be accessed from the following URL: http://bif.uohyd.ac.in/cpc.	[Arun, P. V. Parvati Sai; Subhashini, Mranu] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India; [Bakku, Ranjith Kumar; Singh, Pankaj; Prabhu, N. Prakash; Prakash, Jogadhenu S. S.] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Suzuki, Iwane] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Hyderabad; University of Hyderabad; University of Tsukuba	Prakash, JSS (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	syamsunderp@yahoo.com	Arun, PV Parvati Sai/ABI-6028-2020; Prabhu, N. Prakash/AAV-4491-2020	Prabhu, N. Prakash/0000-0002-3024-1142; Bakku, Ranjith Kumar/0000-0001-5237-0554; Dholaniya, Pankaj Singh/0000-0001-8615-9861; Arun, PV Parvati Sai/0000-0002-9175-7900	Department of Biotechnology (DBT) [BT/PR13616/BRB/10/774/2010]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	This work was supported by a grant from the Department of Biotechnology (DBT), Project No: BT/PR13616/BRB/10/774/2010 to JSSP. This study utilized the DBT - sponsored Bioinformatics Infrastructure Facility (BIF), to School of Life Sciences, University of Hyderabad. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	ARGOS P, 1979, BIOCHEMISTRY-US, V18, P5698, DOI 10.1021/bi00592a028; CHOU PY, 1977, TRENDS BIOCHEM SCI, V2, P128, DOI 10.1016/0968-0004(77)90440-6; Creighton TE, 1993, PROTEINS STRUCTURE M, P105; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Harrison RG, 2000, INNOVATIONS, V11, P4; Idicula-Thomas S, 2005, PROTEIN SCI, V14, P582, DOI 10.1110/ps.041009005; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Koschorreck M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-49; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levene PA., 1923, J BIOL CHEM, V55, P801; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Mathura VS, 2005, BIOINFORMATION, V1, P2, DOI 10.6026/97320630001002; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; WILKINSON DL, 1991, BIO-TECHNOL, V9, P443, DOI 10.1038/nbt0591-443; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD222, DOI 10.1093/nar/gkm800	20	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49425	10.1371/journal.pone.0049425	http://dx.doi.org/10.1371/journal.pone.0049425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185330	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000048
J	Bo, M; Canese, S; Spaggiari, C; Pusceddu, A; Bertolino, M; Angiolillo, M; Giusti, M; Loreto, MF; Salvati, E; Greco, S; Bavestrello, G				Bo, Marzia; Canese, Simonepietro; Spaggiari, Costanza; Pusceddu, Antonio; Bertolino, Marco; Angiolillo, Michela; Giusti, Michela; Loreto, Maria Filomena; Salvati, Eva; Greco, Silvestro; Bavestrello, Giorgio			Deep Coral Oases in the South Tyrrhenian Sea	PLOS ONE			English	Article							MEDITERRANEAN SEA; SECONDARY PRODUCTION; PARAMURICEA-CLAVATA; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; POPULATIONS; DISTURBANCE; GORGONIANS; RUBRUM	A Mediterranean "roche du large" ecosystem, represented by four rocky shoals, located a few miles apart on a muddy bottom at 70-130 m depth in the gulf of St. Eufemia (Calabria, South Tyrrhenian Sea), was studied by means of Remotely Operated Vehicle (ROV) photo imaging. The shoals host highly diversified coral communities, mainly composed of arborescent colonies of gorgonians (Callogorgia verticillata, Paramuricea clavata, Paramuricea macrospina, Bebryce mollis, Villogorgia bebrycoides, Corallium rubrum, and Leptogorgia sarmentosa), and antipatharians (Antipathella subpinnata, Antipathes dichotoma and Parantipathes larix). The coral colonies reach high densities (up to ca. 17 colonies m(-2)) and large sizes, such as the over 1.5 m wide antipatharian colonies. We hypothesized that the abundance and composition of the coral assemblages differed significantly among the rocky shoals and with respect to the surrounding soft bottoms. Various environmental variables were tested as possible explanatory factors of the observed differences. Moreover, due to their off-coast localization, we report here that these unique ecosystems are potentially subjected to a strong pressure from the local fishing activities, which were tentatively characterized. The recorded coral beta-diversity among the shoals supports the hypothesis that these habitats behave like small oases of hard substrata interspersed in a muddy bottom. Because of their intrinsic beauty and rarity and their biological and ecological value, we stress the need of specific actions aimed at the urgent protection of these oases of biodiversity.	[Bo, Marzia; Bertolino, Marco; Bavestrello, Giorgio] Univ Genoa, Dipartimento Studio Terr & Sue Risorse, Genoa, Italy; [Canese, Simonepietro; Angiolillo, Michela; Giusti, Michela; Salvati, Eva; Greco, Silvestro] Ist Super Protez & Ric Ambientale, Rome, Italy; [Spaggiari, Costanza; Pusceddu, Antonio] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Loreto, Maria Filomena] Ist Nazl Oceanog & Geofis Sperimentale Trieste, Trieste, Italy; [Loreto, Maria Filomena] CNR UOS Bologna, Ist Sci Marine, Bologna, Italy	University of Genoa; Italian Institute for Environmental Protection & Research (ISPRA); Marche Polytechnic University; Istituto Nazionale di Oceanografia e di Geofisica Sperimentale; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Bo, M (corresponding author), Univ Genoa, Dipartimento Studio Terr & Sue Risorse, Genoa, Italy.	Marzia.Bo@unige.it	Giusti, Michela/AAV-4856-2020; Canese, Simonepietro/AAA-5499-2019; Angiolillo, Michela/L-2274-2015; Loreto, Maria Filomena/AAY-4782-2020; salvati, eva/AAC-5878-2020; CNR, Ismar/P-1247-2014	Canese, Simonepietro/0000-0001-6049-4506; Angiolillo, Michela/0000-0001-5420-8868; Loreto, Maria Filomena/0000-0003-1960-8684; salvati, eva/0000-0003-2710-1007; Giusti, Michela/0000-0002-4558-9491; CNR, Ismar/0000-0001-5351-1486; BERTOLINO, Marco/0000-0003-3233-303X; Bo, Marzia/0000-0001-8400-6722	Calabrian Regional Council for Environment [327]	Calabrian Regional Council for Environment	This study has been conducted by ISPRA (ex ICRAM), within the project no327 MoBioMarCal, financed by the Calabrian Regional Council for Environment and represents a contribution to the European Census Of Marine Life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R., 2009, P 1 MED S CONS COR O, P147; Aguiliar R., 2004, CORALS MEDITERRANEAN; Aguiliar R, 2008, PROPUESTA AREAS MARI; Aguiliar R, 2006, HABITATS DANGER; Angiolillo Michela, 2012, Marine Biodiversity Records, V5, pe4, DOI 10.1017/S1755267211000972; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; Beaulieu SE, 2001, MAR BIOL, V138, P803, DOI 10.1007/s002270000500; Beaulieu SE, 2001, DEEP-SEA RES PT I, V48, P1121, DOI 10.1016/S0967-0637(00)00055-8; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bo M, 2008, ITAL J ZOOL, V75, P185, DOI 10.1080/11250000701882908; Bo M, 2011, ITAL J ZOOL, V78, P487, DOI 10.1080/11250003.2011.568015; Bo M, 2011, ITAL J ZOOL, V78, P231, DOI 10.1080/11250001003652619; Bo M, 2009, MAR ECOL PROG SER, V397, P53, DOI 10.3354/meps08185; Bo M, 2012, P WORLD C MAR BIOD D, P27; Bo M, 2012, HYDROBIOLOGIA, V687, P163, DOI 10.1007/s10750-011-0964-1; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Bombace G, 1972, REV TRAVAUX I PECHES, V37, P159; Bongiorni L, 2010, BIOL CONSERV, V143, P1687, DOI 10.1016/j.biocon.2010.04.009; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; CICOGNA F, 1999, RED CORAL OTHER MEDI; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Coma R, 1997, J EXP MAR BIOL ECOL, V214, P107, DOI 10.1016/S0022-0981(97)00017-8; COMA R, 1995, MAR ECOL PROG SER, V119, P211, DOI 10.3354/meps119211; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; Costantini F, 2010, MAR ECOL-EVOL PERSP, V31, P261, DOI 10.1111/j.1439-0485.2009.00333.x; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Emig C.C., 1997, PUBL ESPEC I ESP OCE, V23, P23; Faranda FM, 1998, BIOL MAR MED, V5, P1793; Giacobbe Salvatore, 2007, Rapport du Congress de la CIESM, V38, P485; GILI JM, 1985, PSZNI MAR ECOL, V6, P219, DOI 10.1111/j.1439-0485.1985.tb00323.x; Giusti M., 2012, Marine Biodiversity Records, V5, pe34, DOI 10.1017/S1755267211000510; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; Gori A, 2011, MAR BIOL, V158, P143, DOI 10.1007/s00227-010-1548-8; Harmelin Jean-Georges, 1995, Marine Life, V4, P5; Jones DOB, 2007, MAR BIOL, V151, P1731, DOI 10.1007/s00227-007-0606-3; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; LePera E, 1997, SEDIMENT GEOL, V110, P81, DOI 10.1016/S0037-0738(96)00078-4; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; MAC ARTHUR ROBERT H., 1967; Matsuoka T, 2005, FISHERIES SCI, V71, P691, DOI 10.1111/j.1444-2906.2005.01019.x; Maynou F, 2011, JMBA, P1; Miller KJ, 2004, AQUAT CONSERV, V14, P75, DOI 10.1002/aqc.597; Miller KJ, 1997, MAR ECOL PROG SER, V161, P123, DOI 10.3354/meps161123; Miller KJ, 1998, MAR ECOL PROG SER, V163, P225, DOI 10.3354/meps163225; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Mistri M, 1995, MAR ECOL-P S Z N I, V16, P181, DOI 10.1111/j.1439-0485.1995.tb00404.x; MISTRI M, 1994, MAR ECOL PROG SER, V103, P291, DOI 10.3354/meps103291; Mortensen P, 2005, MAR BIOL, V147, P775, DOI 10.1007/s00227-005-1604-y; Opresko D. M., 2004, MAR MEDITERRANEO FAU, P506; Peres J.M, 1964, RECUEIL TRAVAUX STAT, V31, P1; Regione Calabria, 2008, REL GEN PIAN TUT ACQ, P541; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rossi S, 2009, INVERTEBR REPROD DEV, V53, P175, DOI 10.1080/07924259.2009.9652304; Salvati E, 2010, J MAR BIOL ASSOC UK, V90, P1331, DOI 10.1017/S0025315410000950; Schoener A., 1988, P483; Taviani M, 2005, FACIES, V50, P409, DOI 10.1007/s10347-004-0039-0; Tursi A, 2004, CHEM ECOL, V20, pS107, DOI 10.1080/02757540310001629170; Watanabe S, 2009, DEEP-SEA RES PT I, V56, P2235, DOI 10.1016/j.dsr.2009.09.003; WEINBERG S, 1978, MAR BIOL, V49, P41, DOI 10.1007/BF00390729	61	75	76	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49870	10.1371/journal.pone.0049870	http://dx.doi.org/10.1371/journal.pone.0049870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185468	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000130
J	Misra, RM; Bajaj, MS; Kale, VP				Misra, Roli M.; Bajaj, Manmohan S.; Kale, Vaijayanti P.			Vasculogenic Mimicry of HT1080 Tumour Cells In Vivo: Critical Role of HIF-1 alpha-Neuropilin-1 Axis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTORS; GENE-EXPRESSION; C-MYC; ANTIANGIOGENIC THERAPY; CLINICAL-APPLICATIONS; MOLECULAR-MECHANISMS; RNA INTERFERENCE; MELANOMA-CELLS; UP-REGULATION	HT1080 - a human fibrosarcoma-derived cell line -forms aggressive angiogenic tumours in immuno-compromised mice. In spite of its extensive use as a model of tumour angiogenesis, the molecular event(s) initiating the angiogenic program in these cells are not known. Since hypoxia stimulates tumour angiogenesis, we examined the hypoxia-induced events evoked in these cells. In contrast to cells grown under normoxic conditions, hypoxia-primed (1% O-2) HT1080 cells formed robust tubules on growth factor-reduced matrigel and formed significantly larger tumours in xenograft models in a chetomin-sensitive manner, indicating the role of HIF-1 alpha-mediated transcription in these processes. Immuno-histochemical analyses of tumours formed by GFP-expressing HT1080 cells clearly showed that the tumour cells themselves expressed various angiogenic markers including Neuropilin-1 (NRP-1) and formed functional vessels containing red blood cells, thereby unambiguously demonstrating the vasculogenic mimicry of HT1080 cells in vivo. Experiments performed with the HT1080 cells stably transfected with plasmid constructs expressing shNRP-1 or full-length NRP-1 clearly established that the HIF1 alpha-mediated up-regulation of NRP-1 played a deterministic role in the process. Hypoxia-exposure resulted in an up-regulation of c-Myc and OCT3/4 and a down-regulation of KLF4 mRNAs, suggesting their involvement in the tumour formation and angiogenesis. However, silencing of NRP-1 alone, though not affecting proliferation in culture, was sufficient to abrogate the tumour formation completely; clearly establishing that the hypoxia-mediated HIF-1 alpha-dependent up-regulation of NRP-1 is a critical molecular event involved in the vasculogenic mimicry and tumor formation by HT1080 cells in vivo.	[Misra, Roli M.; Bajaj, Manmohan S.; Kale, Vaijayanti P.] Natl Ctr Cell Sci, Stem Cell Lab, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Kale, VP (corresponding author), Natl Ctr Cell Sci, Stem Cell Lab, Natl Ctr Cell Sci Complex,Univ Pune Campus, Pune, Maharashtra, India.	vpkale@nccs.res.in	Kale, Vaijayanti/R-9342-2019	Kale, Vaijayanti/0000-0001-7498-7563	National Centre for Cell Science core grants; Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Government of India	National Centre for Cell Science core grants; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	Funding provided by National Centre for Cell Science core grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. R. L. Marathe, Hematologist, Jehangir Hospital, Pune for his expert opinion on the HE-stained slides of tumour sections; Dr. P. Deshpande and Mr. Deval for the use of hypoxia chamber; Mrs. Ashwini Atre for her help in the acquisition of images on the confocal microscope; Swapnil and Hemangini for the acquisition of cells for analyses and sorting of cells on the flow cytometer; Snehit Mhatre for helping in carrying out the sequencing reaction. We also thank Council of Scientific and Industrial Research (CSIR) and the Department of Biotechnology (DBT), Government of India, for providing the fellowships to R.M. and M.B. respectively.	Akagi M, 2003, BRIT J CANCER, V88, P796, DOI 10.1038/sj.bjc.6600811; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Arsham AM, 2004, CANCER RES, V64, P3500, DOI 10.1158/0008-5472.CAN-03-2239; Bartsch G, 2008, J UROLOGY, V179, P326, DOI 10.1016/j.juro.2007.08.086; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Coma S, 2011, CELL ADHES MIGR, V5, P266, DOI 10.4161/cam.5.3.16294; Detwiller KY, 2005, CANCER RES, V65, P5881, DOI 10.1158/0008-5472.CAN-04-4078; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Fujii H, 2009, INT J ONCOL, V34, P1381, DOI 10.3892/ijo_00000265; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Glinka Y, 2012, BIOCHEM BIOPH RES CO, V425, P775, DOI 10.1016/j.bbrc.2012.07.151; Graells J, 2004, J INVEST DERMATOL, V123, P1151, DOI 10.1111/j.0022-202X.2004.23460.x; Gray MJ, 2005, CANCER RES, V65, P3664, DOI 10.1158/0008-5472.CAN-04-2229; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Kale VP, 2004, STEM CELLS DEV, V13, P536, DOI 10.1089/1547328042417390; Kawanami D, 2009, J BIOL CHEM, V284, P20522, DOI 10.1074/jbc.M109.025346; Kaya M, 2001, Sarcoma, V5, P197, DOI 10.1080/13577140120099182; Ke J, 2007, J ORAL PATHOL MED, V36, P290, DOI 10.1111/j.1600-0714.2007.00532.x; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Knies-Bamforth UE, 2004, CANCER RES, V64, P6563, DOI 10.1158/0008-5472.CAN-03-3176; Lee HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012358; Li WL, 2000, J CELL SCI, V113, P1525; Li XY, 2011, MOL MED REP, V4, P1261, DOI 10.3892/mmr.2011.550; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; McDonald DM, 2000, AM J PATHOL, V156, P383, DOI 10.1016/S0002-9440(10)64740-2; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Nordsmark M, 2001, BRIT J CANCER, V84, P1070, DOI 10.1054/bjoc.2001.1728; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Ottino P, 2004, MOL VIS, V10, P341; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Papatriantafyllou M, 2012, NAT REV IMMUNOL, V12, DOI 10.1038/nri3323; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Patel-Hett S, 2011, INT J DEV BIOL, V55, P353, DOI 10.1387/ijdb.103213sp; Paulis YWJ, 2010, BBA-REV CANCER, V1806, P18, DOI 10.1016/j.bbcan.2010.01.001; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Rizzolio S, 2012, CANCER RES, DOI [10.1158/0008-5472, DOI 10.1158/0008-5472]; Rushing EC, 2012, HUM PATHOL, V43, P381, DOI 10.1016/j.humpath.2011.05.008; Samuel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023208; Sanz L, 2003, CANCER IMMUNOL IMMUN, V52, P643, DOI 10.1007/s00262-003-0400-0; Seftor REB, 2012, AM J PATHOL, V181, P1115, DOI 10.1016/j.ajpath.2012.07.013; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Staab A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-213; Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013; Uniewicz KA, 2011, J BIOL CHEM, V286, P12, DOI 10.1074/jbc.M110.190801; Vales A, 2007, LEUKEMIA LYMPHOMA, V48, P1997, DOI 10.1080/10428190701534424; van der Schaft DWJ, 2005, CANCER RES, V65, P11520, DOI 10.1158/0008-5472.CAN-05-2468; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Weng CH, 2012, CANCER LETT, V323, P171, DOI 10.1016/j.canlet.2012.04.010; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Zhu PF, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-124	79	44	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50153	10.1371/journal.pone.0050153	http://dx.doi.org/10.1371/journal.pone.0050153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185562	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000192
J	Salwiczek, LH; Pretot, L; Demarta, L; Proctor, D; Essler, J; Pinto, AI; Wismer, S; Stoinski, T; Brosnan, SF; Bshary, R				Salwiczek, Lucie H.; Pretot, Laurent; Demarta, Lanila; Proctor, Darby; Essler, Jennifer; Pinto, Ana I.; Wismer, Sharon; Stoinski, Tara; Brosnan, Sarah F.; Bshary, Redouan			Adult Cleaner Wrasse Outperform Capuchin Monkeys, Chimpanzees and Orang-utans in a Complex Foraging Task Derived from Cleaner - Client Reef Fish Cooperation	PLOS ONE			English	Article							SEQUENTIALLY PRESENTED SETS; QUANTITY JUDGMENTS; LABROIDES-DIMIDIATUS; PAN-TROGLODYTES; SERVICE QUALITY; CEBUS; FOOD; DISCRIMINATION; EVOLUTION; SUMMATION	The insight that animals' cognitive abilities are linked to their evolutionary history, and hence their ecology, provides the framework for the comparative approach. Despite primates renowned dietary complexity and social cognition, including cooperative abilities, we here demonstrate that cleaner wrasse outperform three primate species, capuchin monkeys, chimpanzees and orang-utans, in a foraging task involving a choice between two actions, both of which yield identical immediate rewards, but only one of which yields an additional delayed reward. The foraging task decisions involve partner choice in cleaners: they must service visiting client reef fish before resident clients to access both; otherwise the former switch to a different cleaner. Wild caught adult, but not juvenile, cleaners learned to solve the task quickly and relearned the task when it was reversed. The majority of primates failed to perform above chance after 100 trials, which is in sharp contrast to previous studies showing that primates easily learn to choose an action that yields immediate double rewards compared to an alternative action. In conclusion, the adult cleaners' ability to choose a superior action with initially neutral consequences is likely due to repeated exposure in nature, which leads to specific learned optimal foraging decision rules.	[Pretot, Laurent; Proctor, Darby; Essler, Jennifer; Brosnan, Sarah F.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Pretot, Laurent; Proctor, Darby; Essler, Jennifer; Brosnan, Sarah F.] Georgia State Univ, Language Res Ctr, Atlanta, GA 30303 USA; [Stoinski, Tara] Zoo Atlanta, Atlanta, GA USA; [Wismer, Sharon] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Salwiczek, Lucie H.] Max Planck Inst Ornithol, Dept Neurobiol, Seewiesen, Germany; [Pretot, Laurent; Demarta, Lanila; Pinto, Ana I.; Wismer, Sharon; Bshary, Redouan] Univ Neuchatel, Dept Biol, CH-2000 Neuchatel, Switzerland	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University of Zurich; Max Planck Society; University of Neuchatel	Brosnan, SF (corresponding author), Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA.	sbrosnan@gsu.edu	Proctor, Darby/AAB-2749-2019	Proctor, Darby/0000-0002-5465-6705; Wismer, Sharon/0000-0002-4253-476X; Bshary, Redouan/0000-0001-7198-8472; Pretot, Laurent/0000-0002-9936-5506	Swiss Science Foundation; National Science Foundation (United States of America) HSD grant [SES 0729244]; National Science Foundation (United States of America) CAREER award [SES 0847351]; Fondation Wutrich; Commission for Travel Grants, Swiss Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); National Science Foundation (United States of America) HSD grant; National Science Foundation (United States of America) CAREER award; Fondation Wutrich; Commission for Travel Grants, Swiss Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Swiss Science Foundation (RB; LHS), National Science Foundation (United States of America) HSD grant SES 0729244 and a National Science Foundation (United States of America) CAREER award SES 0847351 to SFB, the Fondation Wutrich (LD and LP) and by the Commission for Travel Grants, Swiss Academy of Sciences (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addessi E, 2008, ANIM COGN, V11, P275, DOI 10.1007/s10071-007-0111-6; Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2007, ANIM COGN, V10, P63, DOI 10.1007/s10071-006-0036-5; Agrillo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031923; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; BALDA RP, 1989, ANIM BEHAV, V38, P486, DOI 10.1016/S0003-3472(89)80041-7; Barbu L, 2011, ANIM BEHAV, V82, P1067, DOI 10.1016/j.anbehav.2011.07.043; Beran MJ, 2008, J COMP PSYCHOL, V122, P52, DOI 10.1037/0735-7036.122.1.52; Beran MJ, 2008, AM J PRIMATOL, V70, P191, DOI 10.1002/ajp.20474; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; Bisazza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015516; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Brosnan SF, 2011, JEPSON STUD LEADERSH, P11; Brown C., 2011, FISH COGNITION BEHAV, V2nd; Brown C, 2011, LEARNING COGNITION F; Bshary R, 2002, ECOL LETT, V5, P130, DOI 10.1046/j.1461-0248.2002.00295.x; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Bshary R, 2001, P ROY SOC B-BIOL SCI, V268, P1495, DOI 10.1098/rspb.2001.1495; Bshary R, 2011, FISH COGNITION BEHAV, P223, DOI DOI 10.1002/9781444342536.CH13; Bshary R., 2007, OXFORD HDB EVOLUTION, P83; Bshary R, 2008, NATURE, V455, P964, DOI 10.1038/nature07184; Bshary R, 2006, PLOS BIOL, V4, P2393, DOI 10.1371/journal.pbio.0040431; Bshary R, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P213, DOI 10.1007/978-3-642-02624-9_8; Bshary Redouan, 2001, P146, DOI 10.1017/CBO9780511752421.010; Byrne R.W., 1990, Primate Report, P1; Chalmeau R, 1997, INT J PRIMATOL, V18, P23, DOI 10.1023/A:1026337006136; Chittka L, 2011, CURR BIOL, V21, pR116, DOI 10.1016/j.cub.2010.12.045; Cruze WW, 1935, J COMP PSYCHOL, V19, P371, DOI 10.1037/h0063532; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; DOHL J, 1968, Zeitschrift fuer Tierpsychologie, V25, P89; Dufour V, 2007, J COMP PSYCHOL, V121, P145, DOI 10.1037/0735-7036.121.2.145; Dufour V, 2009, BIOL LETTERS, V5, P172, DOI 10.1098/rsbl.2008.0644; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Evans TA, 2010, J COMP PSYCHOL, V124, P369, DOI 10.1037/a0019855; Evans TA, 2009, ANIM COGN, V12, P97, DOI 10.1007/s10071-008-0174-z; Ferrari MCO, 2007, P ROY SOC B-BIOL SCI, V274, P1853, DOI 10.1098/rspb.2007.0297; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; HELFMAN GS, 1984, ANIM BEHAV, V32, P379, DOI 10.1016/S0003-3472(84)80272-9; Kamil Alan C., 1998, P1, DOI 10.1016/B978-012077030-4/50053-2; Kendal JR, 2009, BEHAV ECOL, V20, P238, DOI 10.1093/beheco/arp016; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Mendres KA, 2000, ANIM BEHAV, V60, P523, DOI 10.1006/anbe.2000.1512; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Oates J, 2010, CURR BIOL, V20, pR472, DOI 10.1016/j.cub.2010.04.022; Oates J, 2010, ETHOLOGY, V116, P309, DOI 10.1111/j.1439-0310.2010.01742.x; Osvath M, 2010, ANIM COGN, V13, P777, DOI 10.1007/s10071-010-0336-7; Osvath M, 2009, CURR BIOL, V19, pR190, DOI 10.1016/j.cub.2009.01.010; Pele M, 2010, ANIM COGN, V13, P263, DOI 10.1007/s10071-009-0264-6; Perry S, 2003, FOLIA PRIMATOL, V74, P109, DOI 10.1159/000070008; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Pinto A, 2011, CURR BIOL, V21, P1140, DOI 10.1016/j.cub.2011.05.021; Randall J. E., 1958, Pacific Science, V12, P327; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; Rose LM, 1997, INT J PRIMATOL, V18, P727, DOI 10.1023/A:1026343812980; Rumbaugh D.M., 1984, P569; RUMBAUGH DM, 1971, J COMP PHYSIOL PSYCH, V76, P250, DOI 10.1037/h0031401; Salwiczek LH, 2011, ETHOLOGY, V117, P939, DOI 10.1111/j.1439-0310.2011.01959.x; Shettleworth SJ, 2010, COGNITION EVOLUTION, P720; Shultz S, 2010, J COMP PSYCHOL, V124, P252, DOI 10.1037/a0018894; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Soares MC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1547; Tarsitano MS, 1999, ANIM BEHAV, V58, P255, DOI 10.1006/anbe.1999.1138; WARNER RR, 1988, NATURE, V335, P719, DOI 10.1038/335719a0	72	78	79	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49068	10.1371/journal.pone.0049068	http://dx.doi.org/10.1371/journal.pone.0049068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185293	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000027
J	Strona, G; Galli, P; Montano, S; Seveso, D; Fattorini, S				Strona, Giovanni; Galli, Paolo; Montano, Simone; Seveso, Davide; Fattorini, Simone			Global-Scale Relationships between Colonization Ability and Range Size in Marine and Freshwater Fish	PLOS ONE			English	Article							BODY-SIZE; DISPERSAL DISTANCE; LOCAL ABUNDANCE; BIOLOGY	Although fish range sizes are expected to be associated with species dispersal ability, several studies failed to find a clear relationship between range size and duration of larval stage as a measure of dispersal potential. We investigated how six characteristics of the adult phase of fishes (maximum body length, growth rate, age at first maturity, life span, trophic level and frequency of occurrence) possibly associated with colonization ability correlate with range size in both freshwater and marine species at global scale. We used more than 12 million point records to estimate range size of 1829 freshwater species and 10068 marine species. As measures of range size we used both area of occupancy and extent of occurrence. Relationships between range size and species traits were assessed using Canonical Correlation Analysis. We found that frequency of occurrence and maximum body length had a strong influence on range size measures, which is consistent with patterns previously found (at smaller scales) in several other taxa. Freshwater and marine fishes showed striking similarities, suggesting the existence of common mechanisms regulating fish biogeography in the marine and freshwater realms.	[Strona, Giovanni; Galli, Paolo; Montano, Simone; Seveso, Davide; Fattorini, Simone] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Fattorini, Simone] Univ Acores, Azorean Biodivers Grp, Angra Do Heroismo, Portugal; [Fattorini, Simone] Univ Acores, Dept Ciencias Agr, Angra Do Heroismo, Portugal	University of Milano-Bicocca; Universidade dos Acores; Universidade dos Acores	Strona, G (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	giovanni.strona@unimib.it	Fattorini, Simone/E-7075-2012; seveso, davide/C-9507-2011; Fattorini, Simone/AAR-8028-2020	Fattorini, Simone/0000-0002-4517-2135; Fattorini, Simone/0000-0002-4517-2135; Strona, Giovanni/0000-0003-2294-4013; Galli, Paolo/0000-0002-6065-8192	Department of Biotechnology and Biosciences of University of Milano-Bicocca [2-18-599000-6, U.A. 001, CUP: H47E11000010002]	Department of Biotechnology and Biosciences of University of Milano-Bicocca	This work has been supported by the Department of Biotechnology and Biosciences of University of Milano-Bicocca (grant number: 2-18-599000-6; U.A. 001; CUP: H47E11000010002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCIKOWSKI RS, 1975, MULTIVAR BEHAV RES, V10, P353, DOI 10.1207/s15327906mbr1003_8; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Bowman J, 2002, ECOLOGY, V83, P2049, DOI 10.1890/0012-9658(2002)083[2049:DDOMIP]2.0.CO;2; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FROESE R, 2000, FISHBASE 2000 CONCEP; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Gaston KJ, 1996, CONSERV BIOL, V10, P638, DOI 10.1046/j.1523-1739.1996.10020638.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hair J.F., 2006, MULTIVARIANT DATA AN, V6th; Holt RD, 1997, OIKOS, V78, P183, DOI 10.2307/3545815; Jones Geoffrey P., 2002, P81, DOI 10.1016/B978-012615185-5/50006-2; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Lasram FBR, 2008, HYDROBIOLOGIA, V607, P51, DOI 10.1007/s10750-008-9366-4; Lester SE, 2005, P ROY SOC B-BIOL SCI, V272, P585, DOI 10.1098/rspb.2004.2985; Luiz OJ, 2012, P ROY SOC B-BIOL SCI, V279, P1033, DOI 10.1098/rspb.2011.1525; McNab B. K., 1963, AM NAT, V97, P33; MINNS CK, 1995, CAN J FISH AQUAT SCI, V52, P1499, DOI 10.1139/f95-144; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Mora C, 2012, ECOGRAPHY, V35, P89, DOI 10.1111/j.1600-0587.2011.06874.x; O'Dor R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011871; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Palumbi SR, 1999, NATURE, V402, P733, DOI 10.1038/45403; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PENAS E, 1983, J EXP MAR BIOL ECOL, V68, P245, DOI 10.1016/0022-0981(83)90056-4; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pyron M, 1999, J BIOGEOGR, V26, P549, DOI 10.1046/j.1365-2699.1999.00303.x; Revell LJ, 2008, BIOINFORMATICS, V24, P1018, DOI 10.1093/bioinformatics/btn065; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Riginos C, 2001, P ROY SOC B-BIOL SCI, V268, P1931, DOI 10.1098/rspb.2001.1748; Rizzo ML, 2011, ENERGY E STAT ENERGY; Robertson DR, 2008, DIVERS DISTRIB, V14, P891, DOI 10.1111/j.1472-4642.2008.00519.x; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; STEVENS J, 1986, APPL MULTIVARIATE ST; Szekely GJ, 2005, J MULTIVARIATE ANAL, V93, P58, DOI 10.1016/j.jmva.2003.12.002; TAYLOR CM, 1994, AM NAT, V144, P549, DOI 10.1086/285694; THOMPSON B, 1991, MEAS EVAL COUNS DEV, V24, P80; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tyler EHM, 2012, GLOBAL ECOL BIOGEOGR, V21, P922, DOI 10.1111/j.1466-8238.2011.00726.x; Vanden Berghe E, 2011, OCEAN BIOGEOGRAPHIC; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; WILK MB, 1968, BIOMETRIKA, V55, P1; Woolnough DA, 2009, ECOL FRESHW FISH, V18, P83, DOI 10.1111/j.1600-0633.2008.00326.x	45	20	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49465	10.1371/journal.pone.0049465	http://dx.doi.org/10.1371/journal.pone.0049465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185338	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000051
J	Ulrich, D; Edwards, SL; White, JF; Supit, T; Ramshaw, JAM; Lo, C; Rosamilia, A; Werkmeister, JA; Gargett, CE				Ulrich, Daniela; Edwards, Sharon L.; White, Jacinta F.; Supit, Tommy; Ramshaw, John A. M.; Lo, Camden; Rosamilia, Anna; Werkmeister, Jerome A.; Gargett, Caroline E.			A Preclinical Evaluation of Alternative Synthetic Biomaterials for Fascial Defect Repair Using a Rat Abdominal Hernia Model	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; HOST RESPONSE; POLYPROPYLENE MESH; INCISIONAL HERNIA; TENSILE-STRENGTH; COLLAGEN; IMPLANTS; AUGMENTATION; TISSUE	Introduction: Fascial defects are a common problem in the abdominal wall and in the vagina leading to hernia or pelvic organ prolapse that requires mesh enhancement to reduce operation failure. However, the long-term outcome of synthetic mesh surgery may be unsatisfactory due to post-surgical complications. We hypothesized that mesh fabricated from alternative synthetic polymers may evoke a different tissue response, and provide more appropriate mechanical properties for hernia repair. Our aim was to compare the in vivo biocompatibility of new synthetic meshes with a commercial mesh. Methods: We have fabricated 3 new warp-knitted synthetic meshes from different polymers with different tensile properties polyetheretherketone (PEEK), polyamide (PA) and a composite, gelatin coated PA (PA+G). The rat abdominal hernia model was used to implant the meshes (25x35 mm, n = 24/group). After 7, 30, 60, 90 days tissues were explanted for immunohistochemical assessment of foreign body reaction and tissue integration, using CD31, CD45, CD68, alpha-SMA antibodies. The images were analysed using an image analysis software program. Biomechanical properties were uniaxially evaluated using an Instron Tensile (R) Tester. Results: This study showed that the new meshes induced complex differences in the type of foreign body reaction over the time course of implantation. The PA, and particularly the composite PA+G meshes, evoked a milder early inflammatory response, and macrophages were apparent throughout the time course. Our meshes led to better tissue integration and new collagen deposition, particularly with the PA+G meshes, as well as greater and sustained neovascularisation compared with the PP meshes. Conclusion: PA, PA+G and PEEK appear to be well tolerated and are biocompatible, evoking an overlapping and different host tissue response with time that might convey mechanical variations in the healing tissue. These new meshes comprising different polymers may provide an alternative option for future treatment of fascial defects.	[Ulrich, Daniela; Supit, Tommy; Lo, Camden; Gargett, Caroline E.] Monash Inst Med Res, Clayton, Vic, Australia; [Ulrich, Daniela] Med Univ Graz, Graz, Austria; [Edwards, Sharon L.; White, Jacinta F.; Ramshaw, John A. M.; Werkmeister, Jerome A.] CSIRO Mat Sci & Engn, Clayton, Vic, Australia; [Ulrich, Daniela; Rosamilia, Anna; Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; [Ulrich, Daniela; Rosamilia, Anna; Gargett, Caroline E.] Monash Univ, Monash Med Ctr, Monash Micro Imaging, Clayton, Vic, Australia	Monash University; Medical University of Graz; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Monash University	Gargett, CE (corresponding author), Monash Inst Med Res, Clayton, Vic, Australia.	Caroline.Gargett@med.monash.edu.au	White, Jacinta F/D-6961-2013; Gargett, Caroline E/Q-7911-2019; Gargett, Caroline Eve/I-4895-2019; Gold, Daniela/ABE-4818-2020	White, Jacinta F/0000-0002-4855-0170; Gargett, Caroline E/0000-0002-3590-2077; Gold, Daniela/0000-0002-7196-454X; Lo, Camden/0000-0002-6215-2363; Ramshaw, John A.M./0000-0002-2131-3685; Supit, Tommy/0000-0001-6276-3183	Australian National Health and Medical Research Council [1021126]; R.D Wright Career Development Award [465121]; Australian Stem Cell Centre [SDF5]; South East Melbourne Alliance for Regenerative Therapies (SMART); Victorian Government's Operational Infrastructure Support Program; Monash Postgraduate Award	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); R.D Wright Career Development Award; Australian Stem Cell Centre; South East Melbourne Alliance for Regenerative Therapies (SMART); Victorian Government's Operational Infrastructure Support Program; Monash Postgraduate Award	Supported by Australian National Health and Medical Research Council grants (1021126) (CEG, JW, AR) and R.D Wright Career Development Award 465121 (CEG), the Australian Stem Cell Centre (SDF5) and South East Melbourne Alliance for Regenerative Therapies (SMART) grants (CEG, JW, AR, SE) the Victorian Government's Operational Infrastructure Support Program and a Monash Postgraduate Award (DU). In kind support as a gift of Polypropylene meshes were kindly provided by Boston Scientific, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitch SD, 2009, EUR J OBSTET GYN R B, V144, pS146, DOI 10.1016/j.ejogrb.2009.02.022; Afonso JS, 2008, INT UROGYNECOL J, V19, P375, DOI 10.1007/s00192-007-0446-1; Garcia-Urena MA, 2007, AM J SURG, V193, P538, DOI 10.1016/j.amjsurg.2006.06.045; Bellows CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021228; Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543; Boennelycke M, 2011, INT UROGYNECOL J, V22, P191, DOI 10.1007/s00192-010-1257-3; Butters M, 2007, BRIT J SURG, V94, P562, DOI 10.1002/bjs.5733; Cassar K, 2002, BRIT J SURG, V89, P534, DOI 10.1046/j.1365-2168.2002.02083.x; de Tayrac R, 2007, INT UROGYNECOL J, V18, P513, DOI 10.1007/s00192-006-0176-9; Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2; Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004; Hunskaar S, 2005, EPIDEMIOLOGY URINARY; Konstantinovic ML, 2007, INT UROGYNECOL J, V18, P619, DOI 10.1007/s00192-006-0202-y; Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x; Lim YN, 2007, INT UROGYNECOL J, V18, P1053, DOI 10.1007/s00192-006-0290-8; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127; Oh HH, 2012, J BIOACT COMPAT POL, V27, P97, DOI 10.1177/0883911511435590; Ozog Y, 2009, INT UROGYNECOL J, V20, P435, DOI 10.1007/s00192-008-0793-6; Pereira-Lucena CG, 2010, HERNIA, V14, P299, DOI 10.1007/s10029-009-0621-z; Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y; Sailes FC, 2011, J AM COLL SURGEONS, V212, P119, DOI 10.1016/j.jamcollsurg.2010.08.021; Spelzini F, 2007, GYNECOL OBSTET INVES, V63, P155, DOI 10.1159/000096893; Stanford EJ, 2012, INT UROGYNECOL J, V23, P19, DOI 10.1007/s00192-011-1584-z; Tadokoro M, 2012, J TISSUE ENG REGEN M, V6, P253, DOI 10.1002/term.427; Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091; ZUHLKE HV, 1990, LANGENBECK ARCH CHIR, P1009	27	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50044	10.1371/journal.pone.0050044	http://dx.doi.org/10.1371/journal.pone.0050044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185528	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700065
J	Wennemers, M; Bussink, J; van den Beucken, T; Sweep, FCGJ; Span, PN				Wennemers, Marloes; Bussink, Johan; van den Beucken, Twan; Sweep, Fred C. G. J.; Span, Paul N.			Regulation of TRIB3 mRNA and Protein in Breast Cancer	PLOS ONE			English	Article							NF-KAPPA-B; TRIBBLES HOMOLOG; ER STRESS; TRB3; ACTIVATION; HYPOXIA; INHIBITION; EXPRESSION; MICRORNAS; PROGNOSIS	Tribbles homolog 3 (TRIB3) is a scaffold protein activated under hypoxic conditions and involved in several cell survival and proliferation pathways. Recently, we reported opposite associations of TRIB3 mRNA and protein with breast cancer prognosis. In this study, we investigated this discrepancy between TRIB3 mRNA and protein in human breast cancer. We provide several lines of evidence demonstrating that TRIB3 is a stabile protein which levels are not controlled by rapid protein breakdown. Interestingly, we were able to show that during anoxia TRIB3 mRNA translation was profoundly inhibited. Hypoxia induced micro RNA 24 was not responsible for the translational repression of TRIB3. Furthermore miRNA-24 expression levels in breast cancer patient specimens showed no correlation with TRIB3 mRNA or TRIB3 protein levels, or with prognosis. Thus, the expression of miRNA-24 does not explain the difference between mRNA and protein expression of TRIB3 in this cohort of breast cancer patients. In conclusion, TRIB3 protein is a stable protein which levels are predominantly regulated by translational control of TRIB3 mRNA transcript.	[Wennemers, Marloes; Sweep, Fred C. G. J.; Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Wennemers, Marloes; Bussink, Johan; Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands; [van den Beucken, Twan] Maastricht Univ, Dept Radiat Oncol, Maastro Lab, Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University	Span, PN (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands.	p.span@rther.umcn.nl	Span, Paul/G-4710-2012; Sweep, C.G.J./H-8096-2014; Bussink, Jan/N-3584-2014	Span, Paul/0000-0002-1930-6638; Sweep, C.G.J./0000-0003-1103-3070; Bussink, Johan/0000-0002-5751-4796; van den Beucken, Twan/0000-0002-2233-7558				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Ding JX, 2008, EXP CELL RES, V314, P1566, DOI 10.1016/j.yexcr.2008.01.026; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kaanders JHAM, 2002, CANCER RES, V62, P7066; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Luna C, 2011, J CELL PHYSIOL, V226, P1407, DOI 10.1002/jcp.22476; Marasa BS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000442; Martin EC, 2012, MOL CARCINOG; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Mishra PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008445; Miyoshi N, 2009, BRIT J CANCER, V101, P1664, DOI 10.1038/sj.bjc.6605361; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohoka N, BIOCH BIOPHYS RES CO, V392, P289; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Rademakers SE, 2008, MOL ONCOL, V2, P41, DOI 10.1016/j.molonc.2008.03.006; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rzymski T, 2008, ONCOGENE, V27, P4532, DOI 10.1038/onc.2008.100; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Walker JC, 2009, GENE DEV, V23, P1046, DOI 10.1101/gad.1777709; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Wennemers M, 2011, RADIOTHER ONCOL, V101, P198, DOI 10.1016/j.radonc.2011.05.057; Wu M, 2003, J BIOL CHEM, V278, P27072, DOI 10.1074/jbc.M209814200; Zhang J, 2011, ORAL ONCOL, V47, P934, DOI 10.1016/j.oraloncology.2011.06.512; Zhou Y, 2008, CELL SIGNAL, V20, P942, DOI 10.1016/j.cellsig.2008.01.010	42	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49439	10.1371/journal.pone.0049439	http://dx.doi.org/10.1371/journal.pone.0049439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185332	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700032
J	Asplund-Samuelsson, J; Bergman, B; Larsson, J				Asplund-Samuelsson, Johannes; Bergman, Birgitta; Larsson, John			Prokaryotic Caspase Homologs: Phylogenetic Patterns and Functional Characteristics Reveal Considerable Diversity	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; BACTERIUM ALCANIVORAX-BORKUMENSIS; COMPLETE GENOME SEQUENCE; LARGE PROTEIN DATABASES; SP-NOV.; DIAZOTROPHIC CYANOBACTERIUM; UNCULTURED MICROORGANISMS; SP-N; METACASPASES; APOPTOSIS	Caspases accomplish initiation and execution of apoptosis, a programmed cell death process specific to metazoans. The existence of prokaryotic caspase homologs, termed metacaspases, has been known for slightly more than a decade. Despite their potential connection to the evolution of programmed cell death in eukaryotes, the phylogenetic distribution and functions of these prokaryotic metacaspase sequences are largely uncharted, while a few experiments imply involvement in programmed cell death. Aiming at providing a more detailed picture of prokaryotic caspase homologs, we applied a computational approach based on Hidden Markov Model search profiles to identify and functionally characterize putative metacaspases in bacterial and archaeal genomes. Out of the total of 1463 analyzed genomes, merely 267 (18%) were identified to contain putative metacaspases, but their taxonomic distribution included most prokaryotic phyla and a few archaea (Euryarchaeota). Metacaspases were particularly abundant in Alphaproteobacteria, Deltaproteobacteria and Cyanobacteria, which harbor many morphologically and developmentally complex organisms, and a distinct correlation was found between abundance and phenotypic complexity in Cyanobacteria. Notably, Bacillus subtilis and Escherichia coli, known to undergo genetically regulated autolysis, lacked metacaspases. Pfam domain architecture analysis combined with operon identification revealed rich and varied configurations among the metacaspase sequences. These imply roles in programmed cell death, but also e.g. in signaling, various enzymatic activities and protein modification. Together our data show a wide and scattered distribution of caspase homologs in prokaryotes with structurally and functionally diverse subgroups, and with a potentially intriguing evolutionary role. These features will help delineate future characterizations of death pathways in prokaryotes.	[Asplund-Samuelsson, Johannes; Bergman, Birgitta; Larsson, John] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden	Stockholm University	Asplund-Samuelsson, J (corresponding author), Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden.	johannes.aspsam@gmail.com		Asplund-Samuelsson, Johannes/0000-0001-8077-5305	Baltic Sea Foundation	Baltic Sea Foundation	Financial support was obtained from The Baltic Sea 2020 Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2002, PROTEINS, V46, P355, DOI 10.1002/prot.10060; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Ardley J, 2009, ARCH MICROBIOL, V191, P311, DOI 10.1007/s00203-009-0456-0; Bae SS, 2006, J MICROBIOL BIOTECHN, V16, P1826; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Bergman Birgitta, 2008, P447; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Bozhkov PV, 2011, CELL DEATH DIFFER, V18, P1239, DOI 10.1038/cdd.2011.86; Busti E, 2006, INT J SYST EVOL MICR, V56, P1741, DOI 10.1099/ijs.0.63858-0; BUTLER YX, 1993, J BACTERIOL, V175, P3139, DOI 10.1128/JB.175.10.3139-3145.1993; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198; Chaloupka J, 1996, FOLIA MICROBIOL, V41, P451, DOI 10.1007/BF02814658; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Daligault H, 2011, STAND GENOMIC SCI, V4, P352, DOI 10.4056/sigs.1964579; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Enoksson M, 2010, CELL DEATH DIFFER, V17, P1221, DOI 10.1038/cdd.2010.45; Franche C., 2009, Plant and Soil, V321, P35, DOI 10.1007/s11104-008-9833-8; Gautam S, 2002, MOL MICROBIOL, V44, P393, DOI 10.1046/j.1365-2958.2002.02837.x; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; HOLT JG, 1968, J BACTERIOL, V95, P2407, DOI 10.1128/JB.95.6.2407-2408.1968; Jiang Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-198; Jourand P, 2004, INT J SYST EVOL MICR, V54, P2269, DOI 10.1099/ijs.0.02902-0; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; LANG NJ, 1987, J BACTERIOL, V169, P920, DOI 10.1128/jb.169.2.920-923.1987; Larsson J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-187; Lee N, 2002, CELL DEATH DIFFER, V9, P53, DOI 10.1038/sj.cdd.4400952; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Li WZ, 2002, BIOINFORMATICS, V18, P77, DOI 10.1093/bioinformatics/18.1.77; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Pagani I, 2011, STAND GENOMIC SCI, V4, P154, DOI 10.4056/sigs.1623941; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; Price MN, 2005, NUCLEIC ACIDS RES, V33, P3224, DOI 10.1093/nar/gki638; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prozorov AA, 2011, MICROBIOLOGY+, V80, P1, DOI 10.1134/S0026261711010139; Raju KK, 2007, FEMS MICROBIOL LETT, V272, P259, DOI 10.1111/j.1574-6968.2007.00763.x; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Ross C, 2006, AQUAT TOXICOL, V78, P66, DOI 10.1016/j.aquatox.2006.02.007; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabirova JS, 2008, FEMS MICROBIOL LETT, V285, P89, DOI 10.1111/j.1574-6968.2008.01222.x; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Sherman LA, 1998, PHOTOSYNTH RES, V58, P25, DOI 10.1023/A:1006137605802; Sogaard-Andersen L, 2008, CURR BIOL, V18, pR337, DOI 10.1016/j.cub.2008.02.060; Suarez MF, 2004, CURR BIOL, V14, pR339, DOI 10.1016/j.cub.2004.04.019; Swingley WD, 2008, P NATL ACAD SCI USA, V105, P2005, DOI 10.1073/pnas.0709772105; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; VANVEEN WL, 1973, A VAN LEEUW J MICROB, V39, P207, DOI 10.1007/BF02578853; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wadhawan S, 2010, FEMS MICROBIOL LETT, V312, P176, DOI 10.1111/j.1574-6968.2010.02114.x; Wang D, 2012, CELL MICROBIOL, V14, P334, DOI 10.1111/j.1462-5822.2011.01736.x; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu HM, 2000, PLANT MOL BIOL, V44, P267, DOI 10.1023/A:1026536324081	74	48	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49888	10.1371/journal.pone.0049888	http://dx.doi.org/10.1371/journal.pone.0049888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185476	gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800059
J	Petraglia, MD; Alsharekh, A; Breeze, P; Clarkson, C; Crassard, R; Drake, NA; Groucutt, HS; Jennings, R; Parker, AG; Parton, A; Roberts, RG; Shipton, C; Matheson, C; al-Omari, A; Veall, MA				Petraglia, Michael D.; Alsharekh, Abdullah; Breeze, Paul; Clarkson, Chris; Crassard, Remy; Drake, Nick A.; Groucutt, Huw S.; Jennings, Richard; Parker, Adrian G.; Parton, Ash; Roberts, Richard G.; Shipton, Ceri; Matheson, Carney; al-Omari, Abdulaziz; Veall, Margaret-Ashley			Hominin Dispersal into the Nefud Desert and Middle Palaeolithic Settlement along the Jubbah Palaeolake, Northern Arabia	PLOS ONE			English	Article							HOMO-SAPIENS; MODERN HUMANS; UPPER PLEISTOCENE; HUMAN-POPULATIONS; SOUTHERN ROUTE; AFRICA; SINGLE; EAST; ASIA; SPELEOTHEMS	The Arabian Peninsula is a key region for understanding hominin dispersals and the effect of climate change on prehistoric demography, although little information on these topics is presently available owing to the poor preservation of archaeological sites in this desert environment. Here, we describe the discovery of three stratified and buried archaeological sites in the Nefud Desert, which includes the oldest dated occupation for the region. The stone tool assemblages are identified as a Middle Palaeolithic industry that includes Levallois manufacturing methods and the production of tools on flakes. Hominin occupations correspond with humid periods, particularly Marine Isotope Stages 7 and 5 of the Late Pleistocene. The Middle Palaeolithic occupations were situated along the Jubbah palaeolake-shores, in a grassland setting with some trees. Populations procured different raw materials across the lake region to manufacture stone tools, using the implements to process plants and animals. To reach the Jubbah palaeolake, Middle Palaeolithic populations travelled into the ameliorated Nefud Desert interior, possibly gaining access from multiple directions, either using routes from the north and west (the Levant and the Sinai), the north (the Mesopotamian plains and the Euphrates basin), or the east (the Persian Gulf). The Jubbah stone tool assemblages have their own suite of technological characters, but have types reminiscent of both African Middle Stone Age and Levantine Middle Palaeolithic industries. Comparative inter-regional analysis of core technology indicates morphological similarities with the Levantine Tabun C assemblage, associated with human fossils controversially identified as either Neanderthals or Homo sapiens.	[Petraglia, Michael D.; Groucutt, Huw S.] Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Oxford, England; [Petraglia, Michael D.] Smithsonian Inst, Human Origins Program, Washington, DC 20560 USA; [Alsharekh, Abdullah] King Saud Univ, Dept Archaeol, Coll Tourism & Archaeol, Riyadh, Saudi Arabia; [Alsharekh, Abdullah] Minist Higher Educ, Riyadh, Saudi Arabia; [Breeze, Paul; Drake, Nick A.] Kings Coll London, Dept Geog, London WC2R 2LS, England; [Clarkson, Chris; Shipton, Ceri] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Crassard, Remy] CNRS, Lyon, France; [Jennings, Richard] Natl Univ Ireland Univ Coll Cork, Dept Archaeol, Cork, Ireland; [Parker, Adrian G.; Parton, Ash] Oxford Brookes Univ, Dept Geog & Anthropol, Oxford OX3 0BP, England; [Roberts, Richard G.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW, Australia; [Matheson, Carney; Veall, Margaret-Ashley] Lakehead Univ, Dept Anthropol, Paleo DNA Lab, Thunder Bay, ON P7B 5E1, Canada; [al-Omari, Abdulaziz] Taif Antiqu Off, Saudi Gen Commiss Tourism & Antiqu, At Taif, Saudi Arabia	University of Oxford; Smithsonian Institution; Smithsonian National Museum of Natural History; King Saud University; University of London; King's College London; University of Queensland; Centre National de la Recherche Scientifique (CNRS); University College Cork; Oxford Brookes University; University of Wollongong; Lakehead University	Petraglia, MD (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Oxford, England.	michael.petraglia@rlaha.ox.ac.uk	Parker, Adrian/X-2596-2019; Groucutt, Huw/GNM-5500-2022; Petraglia, Michael/ABA-9748-2021; Alsharekh, Abdullah M/AAH-3718-2019; Parker, Adrian/T-3421-2019; Matheson, Carney/ABE-5699-2020; Roberts, Richard Graham/B-8245-2013	Parker, Adrian/0000-0003-2989-7344; Matheson, Carney/0000-0002-3890-1838; Roberts, Richard Graham/0000-0002-0128-4119; Petraglia, Michael/0000-0003-2522-5727; Clarkson, Chris/0000-0002-8938-8974; Jennings, Richard/0000-0001-9996-7518; Crassard, Remy/0000-0002-2403-1894	National Geographic Society; Leakey Foundation; European Research Council [295719]; Australian Research Council; Arts and Humanities Research Council	National Geographic Society(National Geographic Society); Leakey Foundation; European Research Council(European Research Council (ERC)European Commission); Australian Research Council(Australian Research Council); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This research was funded by the National Geographic Society, the Leakey Foundation, the European Research Council (no. 295719) and the Australian Research Council. The authors acknowledge the Australian Research Council for laboratory analysis and the Arts and Humanities Research Council for a doctoral studentship to HG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bailey G, 2009, VERTEBR PALEOBIOL PA, P15, DOI 10.1007/978-90-481-2719-1_2; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Bar-Yosef O, 1999, J HUM EVOL, V37, P879, DOI 10.1006/jhev.1999.0368; Blechschmidt I, 2009, GEOMORPHOLOGY, V110, P128, DOI 10.1016/j.geomorph.2009.04.002; Burns SJ, 2001, GEOLOGY, V29, P623, DOI 10.1130/0091-7613(2001)029<0623:SEFOFC>2.0.CO;2; Cabrera VM, 2009, VERTEBR PALEOBIOL PA, P79, DOI 10.1007/978-90-481-2719-1_6; Clarkson C, 2012, QUATERN INT, V258, P165, DOI 10.1016/j.quaint.2011.11.007; Cordova CE, 2013, QUATERN INT, V300, P94, DOI 10.1016/j.quaint.2012.09.019; Dearing J., 1999, QUATERNARY RES ASS, V6, P35, DOI DOI 10.1086/427092; Delagnes A, 2012, J HUM EVOL, V63, P452, DOI 10.1016/j.jhevol.2012.03.008; Dennell R, 2012, QUATERNARY SCI REV, V47, P15, DOI 10.1016/j.quascirev.2012.05.002; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P16089, DOI 10.1073/pnas.1209494109; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Fleitmann D, 2011, QUATERNARY SCI REV, V30, P783, DOI 10.1016/j.quascirev.2011.01.004; Fleitmann D, 2009, CR GEOSCI, V341, P633, DOI 10.1016/j.crte.2009.01.006; Freidline SE, 2012, J HUM EVOL, V62, P225, DOI 10.1016/j.jhevol.2011.11.005; Frumkin A, 2011, J HUM EVOL, V60, P437, DOI 10.1016/j.jhevol.2010.03.010; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Garrard A.N., 1981, ATLAL, V5, P137; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Klein R.G., 2000, HUMAN CAREER HUMAN B, V2nd; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Oppenheimer S, 2012, QUATERN INT, V258, P88, DOI 10.1016/j.quaint.2011.07.049; Parker AG, 2009, VERTEBR PALEOBIOL PA, P39, DOI 10.1007/978-90-481-2719-1_3; Petit-Maire N, 2010, GLOBAL PLANET CHANGE, V72, P368, DOI 10.1016/j.gloplacha.2010.01.012; Petraglia MD, 2003, ANTIQUITY, V77, P671, DOI 10.1017/S0003598X00061639; PETRAGLIA MD, 2007, RETHINKING HUMAN REV, P383; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Petraglia M, 2009, P NATL ACAD SCI USA, V106, P12261, DOI 10.1073/pnas.0810842106; Petraglia MD, 2011, QUATERNARY SCI REV, V30, P1555, DOI 10.1016/j.quascirev.2011.04.006; Petraglia MD, 2011, NATURE, V470, P50, DOI 10.1038/470050a; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Preusser F, 2009, CR GEOSCI, V341, P621, DOI 10.1016/j.crte.2009.02.003; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rightmire GP, 2009, P NATL ACAD SCI USA, V106, P16046, DOI 10.1073/pnas.0903930106; Roberts RG, 2000, RADIAT MEAS, V32, P459, DOI 10.1016/S1350-4487(00)00104-9; Rose JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028239; Rose JI, 2010, CURR ANTHROPOL, V51, P849, DOI 10.1086/657397; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Rose JI, 2004, CURR ANTHROPOL, V45, P551, DOI 10.1086/423500; Rosenberg TM, 2011, GEOLOGY, V39, P1115, DOI 10.1130/G32281.1; Rosenberg TM, 2012, J QUATERNARY SCI, V27, P13, DOI 10.1002/jqs.1560; Rosenberg TM, 2011, THESIS U BERN BERN; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; SCHULZ E, 1986, HYDROBIOLOGIA, V143, P175, DOI 10.1007/BF00026660; Shea JJ, 2008, QUATERNARY SCI REV, V27, P2253, DOI 10.1016/j.quascirev.2008.08.015; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Stefan VH, 1998, J HUM EVOL, V34, P443, DOI 10.1006/jhev.1997.0210; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Stokes S, 2005, GEOL SOC AM BULL, V117, P1466, DOI 10.1130/B25554.1; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Thomas H, 1998, CR ACAD SCI II A, V326, P145, DOI 10.1016/S1251-8050(97)87459-9; Vaks A, 2007, GEOLOGY, V35, P831, DOI 10.1130/G23794A.1; Waldmann N, 2010, GEOLOGY, V38, P567, DOI 10.1130/G30654.1; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669	67	92	90	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49840	10.1371/journal.pone.0049840	http://dx.doi.org/10.1371/journal.pone.0049840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040PB	23185454	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800055
J	Silva, E; Marques, S; Osorio, H; Carvalheira, J; Thompson, G				Silva, Eliane; Marques, Sara; Osorio, Hugo; Carvalheira, Julio; Thompson, Gertrude			Endogenous Hepatitis C Virus Homolog Fragments in European Rabbit and Hare Genomes Replicate in Cell Culture	PLOS ONE			English	Article							HEMORRHAGIC-DISEASE; CORE PROTEIN; GENOTYPE; SEQUENCE; INFECTION; DISCOVERY; BOVINE; FLAVIVIRUSES; POLYMERASE; EXPRESSION	Endogenous retroviruses, non-retroviral RNA viruses and DNA viruses have been found in the mammalian genomes. The origin of Hepatitis C virus (HCV), the major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma in humans, remains unclear since its discovery. Here we show that fragments homologous to HCV structural and non-structural (NS) proteins present in the European rabbit (Oryctolagus cuniculus) and hare (Lepus europaeus) genomes replicate in bovine cell cultures. The HCV genomic homolog fragments were demonstrated by RT-PCR, PCR, mass spectrometry, and replication in bovine cell cultures by immunofluorescence assay (IFA) and immunogold electron microscopy (IEM) using specific MAbs for HCV NS3, NS4A, and NS5 proteins. These findings may lead to novel research approaches on the HCV origin, genesis, evolution and diversity.	[Silva, Eliane; Marques, Sara; Carvalheira, Julio; Thompson, Gertrude] Univ Porto, Inst Ciencias Biomed Abel Salazar ICBAS, Dept Vet Clin, P-4100 Oporto, Portugal; [Silva, Eliane; Marques, Sara; Carvalheira, Julio; Thompson, Gertrude] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet CIBIO, Vairao, Portugal; [Osorio, Hugo] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Thompson, G (corresponding author), Univ Porto, Inst Ciencias Biomed Abel Salazar ICBAS, Dept Vet Clin, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	gat1@mail.icav.up.pt	Silva, Eliane/D-5804-2016; Thompson, Gertrude/C-3133-2014; Carvalheira, Julio/L-7776-2013; Osorio, Hugo/A-7847-2012; Marques, Sara/C-3383-2013	Silva, Eliane/0000-0002-9771-8769; Thompson, Gertrude/0000-0002-3939-5762; Carvalheira, Julio/0000-0002-6882-0334; Osorio, Hugo/0000-0002-6362-8255; Marques, Sara/0000-0001-9868-0152				[Anonymous], 2003, AFCSPROCEDUREPROTOCO; ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; Bascunana CR, 1997, J CLIN MICROBIOL, V35, P2492; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; Cerutti F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-99; Chevaliez Stephane, 2006, Int J Med Sci, V3, P35; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Elvander M, 1998, ACTA VET SCAND, V39, P251; ENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8; Falcon V, 2005, BIOCHEM BIOPH RES CO, V329, P1320, DOI 10.1016/j.bbrc.2005.02.107; Germi R, 2001, J MED VIROL, V64, P6, DOI 10.1002/jmv.1010; Griffiths DJ, 2002, J VIROL, V76, P7094, DOI 10.1128/JVI.76.14.7094-7102.2002; Guo J, 2009, MOL BIOL REP, V36, P111, DOI 10.1007/s11033-007-9158-3; Hultgren C, 2004, J HEPATOL, V40, P971, DOI [10.1016/j.jhep.2004.02.002, 10.1016/S0168-8278(04)00052-2]; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kaplan DE, 2005, HEPATOLOGY, V41, P1365, DOI 10.1002/hep.20706; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Kapoor A, 2010, J VIROL, V84, P12628, DOI 10.1128/JVI.01732-10; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; McEntyre J, 2002, NCBI HDB; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Muller A, 2010, VET MICROBIOL, V140, P161, DOI 10.1016/j.vetmic.2009.07.028; Muller A, 2009, VET MICROBIOL, V135, P368, DOI 10.1016/j.vetmic.2008.09.057; NAKAO T, 1991, J GEN VIROL, V72, P2105, DOI 10.1099/0022-1317-72-9-2105; OKAMOTO H, 1992, J GEN VIROL, V73, P673, DOI 10.1099/0022-1317-73-3-673; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Ramadori G, 2001, EUR J GASTROEN HEPAT, V13, P465, DOI 10.1097/00042737-200105000-00001; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roingeard P, 2008, J VIRAL HEPATITIS, V15, P157, DOI 10.1111/j.1365-2893.2007.00953.x; Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93; Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025; Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3; SMITH BC, 1981, IN VITRO CELL DEV B, V17, P612, DOI 10.1007/BF02618460; Thomson BJ, 2009, BRIT MED BULL, V89, P153, DOI 10.1093/bmb/ldp003; Verbeeck J, 2006, J VIROL, V80, P4220, DOI 10.1128/JVI.80.9.4220-4226.2006; Vieira DS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-165; Wessner D.R., 2010, NATURE ED, V3, P37; Zhang T, 2005, HEPATOLOGY, V42, P819, DOI 10.1002/hep.20854	49	5	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49820	10.1371/journal.pone.0049820	http://dx.doi.org/10.1371/journal.pone.0049820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185448	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800054
J	Sankar, S; Bell, R; Stephens, B; Zhuo, R; Sharma, S; Bearss, DJ; Lessnick, SL				Sankar, S.; Bell, R.; Stephens, B.; Zhuo, R.; Sharma, S.; Bearss, D. J.; Lessnick, S. L.			Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma	ONCOGENE			English	Article						Ewing sarcoma; EWS/FLI; NuRD; transcription; repression	PEDIATRIC SOLID TUMORS; DNA-BINDING; RESPONSE ELEMENTS; PROTEIN-PROTEIN; FUSION GENE; EXPRESSION; REVEALS; TARGET; CELLS; TRANSFORMATION	Ewing sarcoma provides an important model for transcription-factor-mediated oncogenic transformation because of its reliance on the ETS-type fusion oncoprotein EWS/FLI. EWS/FLI functions as a transcriptional activator and transcriptional activation is required for its oncogenic activity. Here, we demonstrate that a previously less-well characterized transcriptional repressive function of the EWS/FLI fusion is also required for the transformed phenotype of Ewing sarcoma. Through comparison of EWS/FLI transcriptional profiling and genome-wide localization data, we define the complement of EWS/FLI direct downregulated target genes. We demonstrate that LOX is a previously undescribed EWS/FLI-repressed target that inhibits the transformed phenotype of Ewing sarcoma cells. Mechanistic studies demonstrate that the NuRD co-repressor complex interacts with EWS/FLI, and that its associated histone deacetylase and LSD1 activities contribute to the repressive function. Taken together, these data reveal a previously unknown molecular function for EWS/FLI, demonstrate a more highly coordinated oncogenic transcriptional hierarchy mediated by EWS/FLI than previously suspected, and implicate a new paradigm for therapeutic intervention aimed at controlling NuRD activity in Ewing sarcoma tumors.	[Sankar, S.; Stephens, B.; Sharma, S.; Bearss, D. J.; Lessnick, S. L.] Huntsman Canc Inst, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Bell, R.; Zhuo, R.; Lessnick, S. L.] Huntsman Canc Inst, Ctr Childrens Canc Res, Salt Lake City, UT 84112 USA; [Stephens, B.; Bearss, D. J.] Huntsman Canc Inst, Ctr Invest Therapeut, Salt Lake City, UT 84112 USA; [Sharma, S.] Univ Utah, Sch Med, Div Med Oncol, Salt Lake City, UT USA; [Lessnick, S. L.] Univ Utah, Sch Med, Div Pediat Hematol Oncol, Salt Lake City, UT USA	Huntsman Cancer Institute; Huntsman Cancer Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lessnick, SL (corresponding author), Huntsman Canc Inst, Ctr Childrens Canc Res, 2000 Circle Hope,Room 4242, Salt Lake City, UT 84112 USA.	stephen.lessnick@hci.utah.edu	Bearss, David/Q-9141-2019; SANKAR, SAVITA/R-6821-2017	Bearss, David/0000-0002-4280-5670; Bearss, David/0000-0002-4458-826X	HHMI Med into Grad program at the University of Utah (U2M2G); NIH/NCI [R01 CA140394, P30 CA042014]; Huntsman Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA042014, R01CA140394] Funding Source: NIH RePORTER	HHMI Med into Grad program at the University of Utah (U2M2G); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Huntsman Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Cairns, Engel and Bhaskara for discussions and critical reading of this manuscript and members of the Lessnick laboratory, and Drs Denny and Ayer, for discussions and reagents. SS acknowledges support from the HHMI Med into Grad program at the University of Utah (U2M2G). This work was supported by NIH/NCI Grants R01 CA140394 (to SLL) and P30 CA042014 (to Huntsman Cancer Institute) and funding from Imaging Diagnostics and Therapeutics Program at Huntsman Cancer Institute (to Sunil Sharma).	Arvand A, 2001, CANCER RES, V61, P5311; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Bennani-Baiti IM, 2012, HUM PATHOL, V43, P1300, DOI 10.1016/j.humpath.2011.10.010; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hollenhorst PC, 2011, GENE DEV, V25, P2147, DOI 10.1101/gad.17546311; Jaboin J, 2002, CANCER RES, V62, P6108; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Keshelava N, 2009, PEDIATR BLOOD CANCER, V53, P505, DOI 10.1002/pbc.21988; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; LESSNICK SL, 1995, ONCOGENE, V10, P423; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Owen LA, 2006, CELL CYCLE, V5, P2049, DOI 10.4161/cc.5.18.3213; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Petermann R, 1998, ONCOGENE, V17, P603, DOI 10.1038/sj.onc.1201964; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Ramakrishnan R, 2004, ONCOGENE, V23, P7087, DOI 10.1038/sj.onc.1207927; Schaefer KL, 2008, EUR J CANCER, V44, P699, DOI 10.1016/j.ejca.2008.01.020; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050	34	94	96	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5089	5100		10.1038/onc.2012.525	http://dx.doi.org/10.1038/onc.2012.525			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23178492	Green Accepted			2022-12-25	WOS:000325937900010
J	Li, L; Guan, KL				Li, Li; Guan, Kun-Liang			Microtubule-associated Protein/Microtubule Affinity-regulating Kinase 4 (MARK4) Is a Negative Regulator of the Mammalian Target of Rapamycin Complex 1 (mTORC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACIDS; RAG GTPASES; DROSOPHILA; AMPK; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; AUTOPHAGY; GROWTH; PRAS40	The mammalian target of rapamycin (mTOR) is a central cell growth regulator. It resides in two protein complexes, which in mammals are referred to as mTORC1 and mTORC2. mTORC1, which is directly inhibited by rapamycin, promotes cell growth by stimulating protein synthesis and inhibiting autophagy. A wide range of extra and intracellular signals, including growth factors, nutrients, energy levels, and various stress conditions, regulates mTORC1. Dysregulation of mTORC1 contributes to many human diseases, including cancer, cardiovascular disease, autoimmunity, and metabolic disorder. In this study, we identified MARK4, an AMP-activated kinase-related kinase, as a negative regulator of mTORC1. In Drosophila S2 cells and mammalian cells, knockdown of MARK family member increased mTORC1 activity, whereas overexpression of MARK4 in mammalian cells significantly inhibited mTORC1 activity. Interestingly, MARK4 selectively inhibits mTORC1 activation by Rag GTPases, which are involved in amino acid signaling, but does not inhibit the effect of Rheb, which directly binds to and activates mTORC1. In addition, we found that MARK4 phosphorylates Raptor, a key component of mTORC1, and this phosphorylation may interfere with Raptor-Rag interaction. Our data demonstrate MARK4 as a new negative regulator of mTORC1.	[Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022		National Institutes of Health [R01GM51586, R01CA108941]; NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM51586 and R01CA108941 (to K. L. G.).	Bright NJ, 2009, ACTA PHYSIOL, V196, P15, DOI 10.1111/j.1748-1716.2009.01971.x; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Li L, 2010, J BIOL CHEM, V285, P19705, DOI 10.1074/jbc.C110.102483; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64	24	50	52	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					703	708		10.1074/jbc.C112.396903	http://dx.doi.org/10.1074/jbc.C112.396903			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184942	hybrid, Green Published			2022-12-25	WOS:000313197200070
J	Genuis, SJ; Schwalfenberg, G; Siy, AKJ; Rodushkin, I				Genuis, Stephen J.; Schwalfenberg, Gerry; Siy, Anna-Kristen J.; Rodushkin, Ilya			Toxic Element Contamination of Natural Health Products and Pharmaceutical Preparations	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; LENGTH-OF-STAY; HEAVY-METALS; HOSPITALIZED-PATIENTS; HERBAL MEDICINE; REGULATORY CONTROL; UNITED-STATES; LEAD; MERCURY; EVENTS	Background: Concern has recently emerged regarding the safety of natural health products (NHPs)-therapies that are increasingly recommended by various health providers, including conventional physicians. Recognizing that most individuals in the Western world now consume vitamins and many take herbal agents, this study endeavored to determine levels of toxic element contamination within a range of NHPs. Methods: Toxic element testing was performed on 121 NHPs (including Ayurvedic, traditional Chinese, and various marine-source products) as well as 49 routinely prescribed pharmaceutical preparations. Testing was also performed on several batches of one prenatal supplement, with multiple samples tested within each batch. Results were compared to existing toxicant regulatory limits. Results: Toxic element contamination was found in many supplements and pharmaceuticals; levels exceeding established limits were only found in a small percentage of the NHPs tested and none of the drugs tested. Some NHPs demonstrated contamination levels above preferred daily endpoints for mercury, cadmium, lead, arsenic or aluminum. NHPs manufactured in China generally had higher levels of mercury and aluminum. Conclusions: Exposure to toxic elements is occurring regularly as a result of some contaminated NHPs. Best practices for quality control-developed and implemented by the NHP industry with government oversight-is recommended to guard the safety of unsuspecting consumers.	[Genuis, Stephen J.; Schwalfenberg, Gerry; Siy, Anna-Kristen J.] Univ Alberta, Fac Med, Edmonton, AB, Canada; [Rodushkin, Ilya] Lulea Univ Technol, Dept Geosci & Environm Engn, S-95187 Lulea, Sweden; [Rodushkin, Ilya] ALS Scandinavia AB, Lulea, Sweden	University of Alberta; Lulea University of Technology	Genuis, SJ (corresponding author), Univ Alberta, Fac Med, Edmonton, AB, Canada.	sgenuis@ualberta.ca		Rodushkin, Ilia/0000-0003-4505-4590; Schwalfenberg, Gerry/0000-0001-7874-2336				Agency for Toxic Substances Disease Registry, 2008, TOX PROF CADM; [Anonymous], 2010, NAT HLTH PROD REG CA; Barbaresi WJ, 2003, ARCH PEDIAT ADOL MED, V157, P121, DOI 10.1001/archpedi.157.2.121; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Becaria A, 2002, TOXICOL IND HEALTH, V18, P309, DOI 10.1191/0748233702th157oa; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Bent S, 2008, J GEN INTERN MED, V23, P854, DOI 10.1007/s11606-008-0632-y; Bernhoft RA, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/460508; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Buettner C, 2009, J GEN INTERN MED, V24, P1175, DOI 10.1007/s11606-009-1050-5; CAMPBELL M, 1980, J AM ACAD CHILD PSY, V19, P193, DOI 10.1016/S0002-7138(09)60697-X; Cao HB, 2010, J ENVIRON SCI-CHINA, V22, P1792, DOI 10.1016/S1001-0742(09)60321-1; (CDC). CfDCaP, 1997, MMWR-MORBID MORTAL W, V48, P27; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P582; Centers for Disease Control Department of Health and Human Services, 2009, 4 CDCP, P1; Centers for Disease Control USDfHaHS Public Health Service Agency for Toxic Substances and Disease Registry Dvision of Toxicology, 2012, AG TOX SUBST DIS REG; Chan K, 2003, CHEMOSPHERE, V52, P1361, DOI 10.1016/S0045-6535(03)00471-5; Chaudhuri A, 2005, MED HYPOTHESES, V64, P608, DOI 10.1016/j.mehy.2004.06.022; Cheng SP, 2003, ENVIRON SCI POLLUT R, V10, P192, DOI 10.1065/espr2002.11.141.1; Cheng SP, 2003, ENVIRON SCI POLLUT R, V10, P335, DOI 10.1065/espr2002.11.141.3; Chiu J, 2009, SUPPORT CARE CANCER, V17, P231, DOI 10.1007/s00520-008-0526-x; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; Cohen PA, 2012, NEW ENGL J MED, V366, P389, DOI 10.1056/NEJMp1113325; Darbre PD, 2005, J INORG BIOCHEM, V99, P1912, DOI 10.1016/j.jinorgbio.2005.06.001; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Environmental Working Group, 2009, POLL PEOPL CORD BLOO; Ernst E, 2000, B WORLD HEALTH ORGAN, V78, P252; Ernst E, 2010, INT J CLIN PRACT, V64, P1162, DOI 10.1111/j.1742-1241.2010.02352.x; Ernst E, 2002, EUR J CLIN PHARMACOL, V57, P891, DOI 10.1007/s00228-001-0400-y; Ernst E, 2002, TRENDS PHARMACOL SCI, V23, P136, DOI 10.1016/S0165-6147(00)01972-6; Ernst E, 2000, BRIT J DERMATOL, V143, P923, DOI 10.1046/j.1365-2133.2000.03822.x; Esmail N, COMPLEMENTARY ALTERN; European Food Safety Authority, 2010, EFSA J, V8, P1570, DOI [10.2903/j.efsa.2010.1570, DOI 10.2903/J.EFSA.2010.1570]; European Food Safety Authority, 2008, SAF AL DIET INT SCI; European Food Safety Authority, 2004, OP SCI PAN CONT FOOD, DOI [10.2903/j.efsa.2004.34, DOI 10.2903/J.EFSA.2004.34]; European Food Safety Authority (EFSA), 2004, EFSA J, V24, P1; Food and Drug Administration, 2011, GUID IND DI IN PRESS; Food Standards Australia New Zealand, 2011, 23 AUSTR TOT DIET ST; Fu JJ, 2008, CHEMOSPHERE, V71, P1269, DOI 10.1016/j.chemosphere.2007.11.065; Gair R, 2008, BC MED J, V50, P105; Garvey GJ, 2001, INT J ENVIRON HEAL R, V11, P63, DOI 10.1080/09603120020019656; Genuis SJ, 2006, J PERINAT MED, V34, P185, DOI 10.1515/JPM.2006.033; Genuis SJ, 2011, ARCH ENVIRON CON TOX, V61, P344, DOI 10.1007/s00244-010-9611-5; Genuis SJ, 2009, REPROD TOXICOL, V28, P115, DOI 10.1016/j.reprotox.2009.03.009; Gershwin ME, 2010, ANN NY ACAD SCI, V1190, P104, DOI 10.1111/j.1749-6632.2009.05270.x; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Green CF, 2000, J CLIN PHARM THER, V25, P355, DOI 10.1046/j.1365-2710.2000.00298.x; Harris ESJ, 2011, SCI TOTAL ENVIRON, V409, P4297, DOI 10.1016/j.scitotenv.2011.07.032; Herron RE, 2002, ALTERN THER HEALTH M, V8, P40; *HLTH CAN, 2005, BAS NAT HLTH PROD SU; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; Jayasundar R, 2008, CURRENT SCI, P908; Juntti-Patinen L, 2002, EUR J CLIN PHARMACOL, V58, P479, DOI 10.1007/s00228-002-0501-2; Kales SN, 2007, MED SCI MONITOR, V13, pCR295; Kam PCA, 2002, ANAESTHESIA, V57, P1083, DOI 10.1046/j.1365-2044.2002.02823.x; Karri SK, 2008, CURR DRUG SAF, V3, P54, DOI 10.2174/157488608783333907; Kauffman JF, 2007, REGUL TOXICOL PHARM, V48, P128, DOI 10.1016/j.yrtph.2007.03.001; KEEN RW, 1994, POSTGRAD MED J, V70, P113, DOI 10.1136/pgmj.70.820.113; KEW J, 1993, BRIT MED J, V306, P506, DOI 10.1136/bmj.306.6876.506; Khandpur S, 2008, INT J DERMATOL, V47, P618, DOI 10.1111/j.1365-4632.2008.03475.x; Ko RJ, 1998, NEW ENGL J MED, V339, P847, DOI 10.1056/NEJM199809173391214; Koh HL, 2000, DRUG SAFETY, V23, P351, DOI 10.2165/00002018-200023050-00001; Lad V, 2003, AYURVEDA BRIEF INTRO; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lo C, 2000, AM J CLIN NUTR, V72, p882S, DOI 10.1093/ajcn/72.3.882s; Lynch Emma, 2005, Expert Opin Drug Saf, V4, P769, DOI 10.1517/14740338.4.4.769; MacDonald NE, 2011, CAN MED ASSOC J, V183, P2079, DOI 10.1503/cmaj.111739; Martena MJ, 2010, FOOD ADDIT CONTAM A, V27, P190, DOI 10.1080/02652030903207235; Mazzanti G, 2008, FOOD CHEM TOXICOL, V46, P3043, DOI 10.1016/j.fct.2008.06.003; McGavock H, 2004, J EVAL CLIN PRACT, V10, P491, DOI 10.1111/j.1365-2753.2003.00471.x; Moore TJ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e53; Nahin RL, 2007, COSTS COMPLEMENTARY; National Institutes of Health, 2011, INFOFACTS DRUG REL H; Onder G, 2002, J AM GERIATR SOC, V50, P1962, DOI 10.1046/j.1532-5415.2002.50607.x; Pakade YB, 2011, B ENVIRON CONTAM TOX, V86, P133, DOI 10.1007/s00128-010-0161-3; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Phillips DP, 1998, LANCET, V351, P643, DOI 10.1016/S0140-6736(98)24009-8; Ren AG, 2011, P NATL ACAD SCI USA, V108, P12770, DOI 10.1073/pnas.1105209108; Sallon S, 2006, HUM EXP TOXICOL, V25, P405, DOI 10.1191/0960327106ht639oa; Saper RB, 2004, JAMA-J AM MED ASSOC, V292, P2868, DOI 10.1001/jama.292.23.2868; Saper RB, 2008, JAMA-J AM MED ASSOC, V300, P915, DOI 10.1001/jama.300.8.915; SHEERIN NS, 1994, BRIT J CLIN PRACT, V48, P332; Singh R, 2008, 32 NAT SYST C NSC 20, P664; Singh SK, 2010, INDIAN J PHARM SCI, V72, P24, DOI 10.4103/0250-474X.62232; Stamova B, 2011, NEUROTOX RES, V19, P31, DOI 10.1007/s12640-009-9137-7; Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483; Steele Lynn, 2000, American Journal of Infection Control, V28, P207, DOI 10.1067/mic.2000.107275; The Canadian Medical Protective Association, 2012, P12011E CMPA, P1; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Thomas KJ, 2001, COMPLEMENT THER MED, V9, P2, DOI 10.1054/ctim.2000.0407; Tian YF, 2011, NEUROTOX RES, V19, P1, DOI 10.1007/s12640-009-9126-x; Tomlinson B, 2000, J CLIN PHARMACOL, V40, P451, DOI 10.1177/00912700022009206; U.S. Department of Health and Human Services: Food and Drug Administration, 2010, GUID IND CURR GOOD M; United States Environmental Protection Agency, EPA635R05001; van Vonderen MGA, 2000, AM J GASTROENTEROL, V95, P1591, DOI 10.1016/S0002-9270(00)00897-2; Wadekar MP, 2005, J PHARMACEUT BIOMED, V39, P951, DOI 10.1016/j.jpba.2005.06.015; Webb AN, 2005, J PAEDIATR CHILD H, V41, P530, DOI 10.1111/j.1440-1754.2005.00698.x; Weidenhamer JD, 2009, SCI TOTAL ENVIRON, V407, P2447, DOI 10.1016/j.scitotenv.2008.11.031; Weingart SN, 2003, JAMA-J AM MED ASSOC, V290, P1917, DOI 10.1001/jama.290.14.1917; WONG MK, 1993, BIOL TRACE ELEM RES, V36, P135, DOI 10.1007/BF02783172; Wong SS, 1998, J AM ACAD DERMATOL, V38, P179, DOI 10.1016/S0190-9622(98)70596-1; Woolf AD, 2008, CLIN TOXICOL, V46, P841, DOI 10.1080/15563650801898536; World Health Organization ? Europe, 2009, EXP CHILDR CHEM HAZ; Yee SK, 2005, HEALTH POLICY, V71, P133, DOI 10.1016/j.healthpol.2003.09.013; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	109	61	64	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49676	10.1371/journal.pone.0049676	http://dx.doi.org/10.1371/journal.pone.0049676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185404	gold, Green Published			2022-12-25	WOS:000311821000083
J	Grohe, C; Morlo, M; Chaimanee, Y; Blondel, C; Coster, P; Valentin, X; Salem, M; Bilal, AA; Jaeger, JJ; Brunet, M				Grohe, Camille; Morlo, Michael; Chaimanee, Yaowalak; Blondel, Cecile; Coster, Pauline; Valentin, Xavier; Salem, Mustapha; Bilal, Awad A.; Jaeger, Jean-Jacques; Brunet, Michel			New Apterodontinae (Hyaenodontida) from the Eocene Locality of Dur At-Talah (Libya): Systematic, Paleoecological and Phylogenetical Implications	PLOS ONE			English	Article							AFRICAN VIVERRIDAE CARNIVORA; FUNCTIONAL-ANATOMY; MIDDLE EOCENE; LOCOMOTOR BEHAVIOR; PALEOGENE MAMMALS; CREODONTA; OLIGOCENE; EVOLUTION; SKELETON; ORIGIN	The African Hyaenodontida, mainly known from the Late Eocene and Early Oligocene Fayum depression in Egypt, show a very poor diversity in oldest Paleogene localities. Here we report new hyaenodontidans found in the late Middle Eocene deposits of Dur At-Talah (Central Libya), known to have recorded the earliest radiation of African anthropoids. The new hyaenodontidan remains are represented by dental and postcranial specimens comprising the historical material discovered by R.J.G. Savage in the last century and that of the recent Franco-Libyan campaigns. This material includes two apterodontines, in particular a subcomplete skeleton of Apterodon langebadreae nov. sp., bringing new postcranial elements to the fossil record of the genus Apterodon. Anatomical analysis of the postcranial remains of Dur At-Talah suggests a semi-aquatic lifestyle for Apterodon, a completely unusual locomotion pattern among hyaenodontidans. We also perform the first cladistic analysis of hyaenodontidans including apterodontines: Apterodon and Quasiapterodon appear close relatives to "hyainailourines'', in particular to the African Oligo-Miocene Metasinopa species. Apterodon langebadreae nov. sp. could be the most primitive species of the genus, confirming an African origin of the Apterodontinae and a further dispersion event to Europe before the early Oligocene. These data enhance our knowledge of early hyaenodontidan diversification into Africa and underline how crucial is the understanding of their evolutionary history for the improvement of Paleogene paleobiogeographic scenarii.	[Grohe, Camille; Chaimanee, Yaowalak; Blondel, Cecile; Coster, Pauline; Valentin, Xavier; Jaeger, Jean-Jacques; Brunet, Michel] Univ Poitiers, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, CNRS, UMR 7262, Poitiers, France; [Morlo, Michael] Forschunginst Senckenberg, Abt Messelforsch, Frankfurt, Germany; [Coster, Pauline] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA USA; [Salem, Mustapha] Univ Al Fatah, Dept Geol, Tripoli, Libya; [Bilal, Awad A.] Univ Garyoumis, Dept Geol, Bengahzi, Libya	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Senckenberg Gesellschaft fur Naturforschung (SGN); Al Fateh University	Grohe, C (corresponding author), Univ Montpellier 2, Inst Sci Evolut, CNRS, UMR 5554, Montpellier, France.	camille.grohe@univ-poitiers.fr	Bilal, Awad/AAP-9486-2020; Morlo, Michael/AAA-5943-2021; Blondel, cecile/AEY-9166-2022; Blondel, cecile/AAH-2618-2022	Bilal, Awad/0000-0002-4903-2682; Morlo, Michael/0000-0003-3956-7912; Blondel, cecile/0000-0002-7022-6959; chaimanee, yaowalak/0000-0002-8432-3880; Grohe, Camille/0000-0002-6697-7151	University of Poitiers; University of Al-Fateh; National Centre for Scientific Research "Eclipse II" program; Fondation des Treilles;  [ANR-05-BLAN-0235]	University of Poitiers; University of Al-Fateh; National Centre for Scientific Research "Eclipse II" program; Fondation des Treilles; 	This work was supported by the Universities of Poitiers and Al-Fateh, the National Centre for Scientific Research "Eclipse II" program, the ANR-05-BLAN-0235 and a young researcher award from the Fondation des Treilles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouessa A., 2012, J AFR EARTH SCI, V65, P72; Aiello L, 1990, INTRO HUMAN EVOLUTIO; Andreae A, 1887, BERICHT SENCKENBERGI, P125; Andrews CW, 1904, GEOLOGICAL MAGAZINE, V1, P211, DOI DOI 10.1017/S0016756800119624; ANDREWS CW, 2006, DESCRIPTIVE CATALOGU; ARAMBOURG C, 1961, CR HEBD ACAD SCI, V252, P1181; ARAMBOURG C, 1963, AFRICAN ECOLOGY HUMA, P55; Argot C, 2010, GEODIVERSITAS, V32, P65, DOI 10.5252/g2010n1a2; Barry J.C., 1988, Journal of Vertebrate Paleontology, V8, P25; BELLAIR P, 1954, CR HEBD ACAD SCI, V239, P1822; BOWN TM, 1982, J HUM EVOL, V11, P603, DOI 10.1016/S0047-2484(82)80008-0; CLEMENS WA, 1965, U ALBERTA GEOLOGY B, V2, P32; Court N, 1995, J VERTEBR PALEONTOL, V15, P650, DOI 10.1080/02724634.1995.10011254; Crochet J-Y, 2001, P 8 INT S AFR SMALL, P377; CROCHET JY, 1988, CR ACAD SCI II, V307, P1795; CROCHET JY, 1990, CR ACAD SCI II, V311, P1455; Davis D. D., 1964, Fieldiana Zoology Memoir, V3, P1; Delmer C, 2005, PREMIERES PHASES DIF; Delmer C, 2009, ACTA PALAEONTOL POL, V54, P561, DOI 10.4202/app.2007.0036; Ducrocq S, 2010, J VERTEBR PALEONTOL, V30, P293, DOI 10.1080/02724630903413065; Duringer P, 2008, SED BAS LIB 4 S GEOL; Egi N, 2005, J SYST PALAEONTOL, V3, P337, DOI 10.1017/S1477201905001707; Fischer P., 1880, B SOC GEOLOGIQUE FRA, V8, P288; Frey E., 2011, KAUPIA, V17, P107; Gebo Daniel L., 1993, Journal of Vertebrate Paleontology, V13, P125; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gheerbrant E, 2006, GEOL MAG, V143, P475, DOI 10.1017/S0016756806002032; Gheerbrant Emmanuel, 1998, Palaeovertebrata (Montpellier), V27, P155; Gheerbrant Emmanuel, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V237, P39; GINGERICH P D, 1989, Contributions from the Museum of Paleontology University of Michigan, V27, P327; Gray C., 1971, S GEOLOGY LIBYA, P215; Heinrich RE, 1997, PALAEONTOLOGY, V40, P279; Hildebrand M., 1985, P89; Holroyd AP, 1994, EXAMINATION DISPERSA; Holroyd Patricia A., 1999, Paleobios, V19, P1; Jaeger JJ, 2010, NATURE, V467, P1096, DOI 10.1038/nature09425; Jaeger JJ, 2010, ZOOL J LINN SOC-LOND, V160, P195, DOI 10.1111/j.1096-3642.2009.00600.x; JENKINS FA, 1977, J ZOOL, V181, P351; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Lange B., 1967, Annales de Paleontologie Vertebres, V53, P79; Lange-Badre Brigitte, 2005, Annales de Paleontologie, V91, P311, DOI 10.1016/j.annpal.2005.08.001; Lavrov AV, 2004, PALEONTOL J+, V38, P448; LAVROV AV, 1999, PALEONTOL J, V33, P321; LEIDY J, 1869, J ACAD NATURAL SCI P, V2, P1; Lewis M, 2010, CENOZOIC MAMMALS AFR, P549; Lillegraven J. A., 1969, U KANSAS PALEONTOLOG, V50, P1; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; Matthew W.D., 1909, MEM AM MUS NAT HIST, V9, P291; Matthew WD, 1901, B AM MUS NAT HIST, V14, P1; Matthew WD, 1906, P US NATL MUS, V30, P203, DOI DOI 10.5479/SI.00963801.30-1449.203; Mellett J.S., 1977, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V1, P1; Morlo M, 2005, J VERTEBR PALEONTOL, V25, P251, DOI 10.1671/0272-4634(2005)025[0251:NSOLMC]2.0.CO;2; Morlo M, 1999, GEOBIOS-LYON, V32, P297, DOI 10.1016/S0016-6995(99)80043-6; Morlo Michael, 2003, Contributions from the Museum of Paleontology University of Michigan, V31, P43; Morlo Michael, 2010, P269; Morlo M, 2009, J VERTEBR PALEONTOL, V29, p152A; Morlo Michael, 1999, Courier Forschungsinstitut Senckenberg, V216, P31; Osborn HF, 1909, B AM MUS NAT HIST, V26, P415; Peigne S, 2007, GEODIVERSITAS, V29, P441; Pickford M., 2008, MEM GEOL SURV NAMIBI, V20, P465; Pilgrim G. E., 1932, Palaeontologia Indica, V18, P1; Pilgrim Guy E., 1910, Records of the Geological Survey of India Calcutta, V40; Polly P. D., 1994, Journal of Vertebrate Paleontology, V14, p42A; Polly P. David, 2007, P245; Polly PD, 1996, J VERTEBR PALEONTOL, V16, P303, DOI 10.1080/02724634.1996.10011318; Polly PD, 1998, BIOL J LINN SOC, V64, P83; Ranga Rao A, 1973, DIRECTORATE GEOLOGY, V2, P1; Rasmussen DT, 2008, DEV PRIMATOL-PROG PR, P181, DOI 10.1007/978-0-387-73896-3_13; Rose KD, 2005, PALAEONTOGR ABT A, V273, P55; Rose KD, 2006, BEGINNING AGE MAMMAL, P119; Rutimeyer L., 1862, NEUE DENKSCHRIFTEN A, V19, P1; Salesa MJ, 2008, ZOOL J LINN SOC-LOND, V152, P593, DOI 10.1111/j.1096-3642.2007.00370.x; Sanders WJ, 2004, ACTA PALAEONTOL POL, V49, P365; SAVAGE R J G, 1969, Proceedings of the Geological Society of London, V1657, P167; Savage R. J. G., 1965, Proceedings of the Geological Society London, V1623, P89; SAVAGE R. J. G., 1957, PROC ZOOL SOC LONDON, V129, P151; SAVAGE ROBERT J. G., 1965, BULL BRIT MUS [NATUR HIST] GEOL, V10, P241; Schlosser M., 1911, Beitreage zur Palaeontologie u Geologie Oesterreich-Ungarns u des Orients Wien u Leipzig, V24; Schlosser Max, 1910, Zoologischer Anzeiger Jena, V35; Seiffert ER, 2008, DEV PRIMATOL-PROG PR, P71, DOI 10.1007/978-0-387-73896-3_8; Simons E.L, 1976, Postilla, VNo. 168, P1; Simons E. L., 1968, Bulletin of the Peabody Museum of Natural History, V28, P1; Smith T, 2001, BELG J ZOOL, V131, P117; Sole F, J SYSTEMATI IN PRESS; Sole F, 2011, PALAEONTOL ELECTRON, V14, P1; Sole F., 2010, PREMIERS PLACENTAIRE; Sole F, J SYSTEMATIC P UNPUB; Sole F, 2009, ZOOL J LINN SOC-LOND, V156, P827, DOI 10.1111/j.1096-3642.2008.00501.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; SZALAY F. S, 1969, B AM MUS NAT HIST, V140, P193; SZALAY FREDERICK S., 1967, AMER MUS NOVITATES, V2293, P1; Tabuce, 2002, MAMMIFERES PALEOGENE; Tabuce R, 2001, COLLOQ SEMI, P215; Taylor M.E., 1989, P382; TAYLOR ME, 1976, J MORPHOL, V148, P227, DOI 10.1002/jmor.1051480208; TAYLOR ME, 1974, J MORPHOL, V143, P307, DOI 10.1002/jmor.1051430305; Tilden CD, 1990, J VERTEBRATE PALE S3, V9, p46A; Van Valen L., 1967, Bulletin of the American Museum of Natural History, V135, P217; VAN VALEN LEIGH, 1966, BULL AMER MUS NATUR HIST, V132, P1; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; VANVALEN L, 1971, EVOLUTION, V25, P523, DOI 10.1111/j.1558-5646.1971.tb01912.x; WAGNER H, 1976, J PALEONTOL, V50, P107; Wang Xiaoming, 1993, American Museum Novitates, V3069, P1; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; WIGHT A.W.R., 1980, GEOLOGY LIBYA, P309; Willemsen GF, 1992, SCRIPTA GEOL, V101, P1; Zack SP, 2011, J PALEONTOL, V85, P315, DOI 10.1666/10-093.1	108	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49054	10.1371/journal.pone.0049054	http://dx.doi.org/10.1371/journal.pone.0049054			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185292	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000026
J	Iwamoto, T; Grandjean, L; Arikawa, K; Nakanishi, N; Caviedes, L; Coronel, J; Sheen, P; Wada, T; Taype, CA; Shaw, MA; Moore, DAJ; Gilman, RH				Iwamoto, Tomotada; Grandjean, Louis; Arikawa, Kentaro; Nakanishi, Noriko; Caviedes, Luz; Coronel, Jorge; Sheen, Patricia; Wada, Takayuki; Taype, Carmen A.; Shaw, Marie-Anne; Moore, David A. J.; Gilman, Robert H.			Genetic Diversity and Transmission Characteristics of Beijing Family Strains of Mycobacterium tuberculosis in Peru	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; SINGLE-NUCLEOTIDE-POLYMORPHISM; POPULATION-STRUCTURE ANALYSIS; VARIABLE-NUMBER; MICROSCOPIC OBSERVATION; DISCRIMINATORY ABILITY; GENOTYPE STRAINS; DRUG-RESISTANCE; 1ST INSIGHT; MIRU-VNTRS	Beijing family strains of Mycobacterium tuberculosis have attracted worldwide attention because of their wide geographical distribution and global emergence. Peru, which has a historical relationship with East Asia, is considered to be a hotspot for Beijing family strains in South America. We aimed to unveil the genetic diversity and transmission characteristics of the Beijing strains in Peru. A total of 200 Beijing family strains were identified from 2140 M. tuberculosis isolates obtained in Lima, Peru, between December 2008 and January 2010. Of them, 198 strains were classified into sublineages, on the basis of 10 sets of single nucleotide polymorphisms (SNPs). They were also subjected to variable number tandem-repeat (VNTR) typing using an international standard set of 15 loci (15-MIRU-VNTR) plus 9 additional loci optimized for Beijing strains. An additional 70 Beijing family strains, isolated between 1999 and 2006 in Lima, were also analyzed in order to make a longitudinal comparison. The Beijing family was the third largest spoligotyping clade in Peru. Its population structure, by SNP typing, was characterized by a high frequency of Sequence Type 10 (ST10), which belongs to a modern subfamily of Beijing strains (178/198, 89.9%). Twelve strains belonged to the ancient subfamily (ST3 [n = 3], ST25 [n = 1], ST19 [n = 8]). Overall, the polymorphic information content for each of the 24 loci values was low. The 24 loci VNTR showed a high clustering rate (80.3%) and a high recent transmission index (RTIn-1 = 0.707). These strongly suggest the active and ongoing transmission of Beijing family strains in the survey area. Notably, 1 VNTR genotype was found to account for 43.9% of the strains. Comparisons with data from East Asia suggested the genotype emerged as a uniquely endemic clone in Peru. A longitudinal comparison revealed the genotype was present in Lima by 1999.	[Iwamoto, Tomotada; Arikawa, Kentaro; Nakanishi, Noriko] Kobe Inst Hlth, Dept Microbiol, Kobe, Hyogo, Japan; [Grandjean, Louis] Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, London, England; [Grandjean, Louis; Moore, David A. J.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Grandjean, Louis; Moore, David A. J.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Grandjean, Louis; Caviedes, Luz; Coronel, Jorge; Sheen, Patricia; Moore, David A. J.; Gilman, Robert H.] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru; [Wada, Takayuki] Osaka City Inst Publ Hlth & Environm Sci, Dept Microbiol, Osaka 543, Japan; [Taype, Carmen A.; Shaw, Marie-Anne] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Gilman, Robert H.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia; University of Leeds; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Iwamoto, T (corresponding author), Kobe Inst Hlth, Dept Microbiol, Kobe, Hyogo, Japan.	kx2t-iwmt@asahi-net.or.jp	Iwamoto, Tomotada/I-8944-2019	Iwamoto, Tomotada/0000-0002-2650-0308; Coronel, Jorge/0000-0002-4580-6716; Grandjean, Louis/0000-0002-1457-8327	Ministry of Health, Labour and Welfare of Japan [H24-SHINKO-IPPAN-011]; MEXT/JSPS KAKENHI [24590845, R24 TW007988 NIH FIC, D43 TW006581 NIH FIC, RO1 HD059005 NIH NICHD, WT088559MA]; Wellcome Trust [078067/Z/05]; Institute for Fermentation, Osaka, Japan; US-Japan Cooperative Medical Science Program (TB and Leprosy panel); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059005] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R24TW007988, D43TW006581] Funding Source: NIH RePORTER; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Wellcome Trust(Wellcome TrustEuropean Commission); Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO)); US-Japan Cooperative Medical Science Program (TB and Leprosy panel); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Health Science Research grants(H24-SHINKO-IPPAN-011) from Ministry of Health, Labour and Welfare of Japan, MEXT/JSPS KAKENHI Grant Number 24590845, R24 TW007988 NIH FIC, D43 TW006581 NIH FIC, RO1 HD059005 NIH NICHD, WT088559MA with the Wellcome Trust, Wellcome Trust grant 078067/Z/05, a research grant of the Institute for Fermentation, Osaka, Japan, and the US-Japan Cooperative Medical Science Program (TB and Leprosy panel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Affolabi D, 2009, EMERG INFECT DIS, V15, P1123, DOI 10.3201/eid1507.080697; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Chen YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039792; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; Dou HY, 2008, INFECT GENET EVOL, V8, P323, DOI 10.1016/j.meegid.2008.02.003; Durmaz R, 2007, J CLIN MICROBIOL, V45, P4027, DOI 10.1128/JCM.01308-07; Faksri K, 2011, INFECT GENET EVOL, V11, P1142, DOI 10.1016/j.meegid.2011.04.007; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garcia de Viedma D, 2006, EMERG INFECT DIS, V12, P169; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hernandez-Pando R, 2012, INFECT GENET EVOL, V12, P725, DOI 10.1016/j.meegid.2012.02.013; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Jiao WW, 2008, J CLIN MICROBIOL, V46, P1045, DOI 10.1128/JCM.01869-07; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Lari N, 2007, J CLIN MICROBIOL, V45, P1851, DOI 10.1128/JCM.00170-07; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Luo T, 2012, J CLIN MICROBIOL, V50, P633, DOI 10.1128/JCM.05539-11; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; Millet J, 2012, INFECT GENET EVOL, V12, P637, DOI 10.1016/j.meegid.2011.06.013; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2002, RES MICROBIOL, V153, P629, DOI 10.1016/S0923-2508(02)01374-8; Mokrousov I, 2008, INFECT GENET EVOL, V8, P777, DOI 10.1016/j.meegid.2008.07.003; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Mokrousov I, 2006, ANTIMICROB AGENTS CH, V50, P2820, DOI 10.1128/AAC.00324-06; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Parwati I, 2010, J INFECT DIS, V201, P553, DOI 10.1086/650311; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Smittipat N, 2005, J CLIN MICROBIOL, V43, P5034, DOI 10.1128/JCM.43.10.5034-5043.2005; Stucki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041253; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Velji P, 2009, EMERG INFECT DIS, V15, P1609, DOI 10.3201/eid1510.090463; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Wada T, 2012, INFECT GENET EVOL, V12, P1392, DOI 10.1016/j.meegid.2012.04.029; Wada T, 2009, INFECT GENET EVOL, V9, P921, DOI 10.1016/j.meegid.2009.06.012; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Yokoyama E, 2012, INFECT GENET EVOL, V12, P630, DOI 10.1016/j.meegid.2011.10.016; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x	63	66	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49651	10.1371/journal.pone.0049651	http://dx.doi.org/10.1371/journal.pone.0049651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185395	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000311821000076
J	Kutchukian, PS; Vasilyeva, NY; Xu, J; Lindvall, MK; Dillon, MP; Glick, M; Coley, JD; Brooijmans, N				Kutchukian, Peter S.; Vasilyeva, Nadya Y.; Xu, Jordan; Lindvall, Mika K.; Dillon, Michael P.; Glick, Meir; Coley, John D.; Brooijmans, Natasja			Inside the Mind of a Medicinal Chemist: The Role of Human Bias in Compound Prioritization during Drug Discovery	PLOS ONE			English	Article							UNCONSCIOUS THOUGHT; LEAD DISCOVERY; INFORMATION; HEURISTICS; ABSORPTION; PREDICTION; FREQUENCY; SELECTION; JUDGMENT; EXPERTS	Medicinal chemists' "intuition" is critical for success in modern drug discovery. Early in the discovery process, chemists select a subset of compounds for further research, often from many viable candidates. These decisions determine the success of a discovery campaign, and ultimately what kind of drugs are developed and marketed to the public. Surprisingly little is known about the cognitive aspects of chemists' decision-making when they prioritize compounds. We investigate 1) how and to what extent chemists simplify the problem of identifying promising compounds, 2) whether chemists agree with each other about the criteria used for such decisions, and 3) how accurately chemists report the criteria they use for these decisions. Chemists were surveyed and asked to select chemical fragments that they would be willing to develop into a lead compound from a set of similar to 4,000 available fragments. Based on each chemist's selections, computational classifiers were built to model each chemist's selection strategy. Results suggest that chemists greatly simplified the problem, typically using only 1-2 of many possible parameters when making their selections. Although chemists tended to use the same parameters to select compounds, differing value preferences for these parameters led to an overall lack of consensus in compound selections. Moreover, what little agreement there was among the chemists was largely in what fragments were undesirable. Furthermore, chemists were often unaware of the parameters (such as compound size) which were statistically significant in their selections, and overestimated the number of parameters they employed. A critical evaluation of the problem space faced by medicinal chemists and cognitive models of categorization were especially useful in understanding the low consensus between chemists.	[Vasilyeva, Nadya Y.; Coley, John D.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Kutchukian, Peter S.; Glick, Meir] Novartis Inst BioMed Res, Ctr Prote Chem, Cambridge, MA USA; [Xu, Jordan; Lindvall, Mika K.; Dillon, Michael P.] Novartis Inst BioMed Res, Emeryville, CA USA; [Brooijmans, Natasja] Blueprint Med, Cambridge, MA USA	Northeastern University; Novartis; Novartis	Coley, JD (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	j.coley@neu.edu; NBrooijmans@blueprintmedicines.com	Kutchukian, Peter/A-9826-2016	Kutchukian, Peter/0000-0002-5684-1971; Coley, John/0000-0002-8641-9499	Novartis Institutes for Biomedical Research; NIBR Education Office	Novartis Institutes for Biomedical Research; NIBR Education Office	This work was supported by the Novartis Institutes for Biomedical Research, and P. S. K. is funded as a Presidential Postdoctoral Fellow by the NIBR Education Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, 2010, PIP PIL; BARSALOU LW, 1991, PSYCHOL LEARN MOTIV, V27, P1, DOI 10.1016/S0079-7421(08)60120-6; BARSALOU LW, 1985, J EXP PSYCHOL LEARN, V11, P629, DOI 10.1037/0278-7393.11.1-4.629; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323, 10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323]; Beilock SL, 2004, PSYCHON B REV, V11, P373, DOI 10.3758/BF03196585; Borgatti SP, 1996, ANTHROPAC; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Busse WD, 1996, EUR J MED CHEM, V31, P747, DOI 10.1016/0223-5234(96)83968-7; Carey JS, 2006, ORG BIOMOL CHEM, V4, P2337, DOI 10.1039/b602413k; CHAPMAN LJ, 1969, J ABNORM PSYCHOL, V74, P271, DOI 10.1037/h0027592; Chen HM, 2004, 666 U CAL; Chessari G, 2009, DRUG DISCOV TODAY, V14, P668, DOI 10.1016/j.drudis.2009.04.007; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Cooper TWJ, 2010, ANGEW CHEM INT EDIT, V49, P8082, DOI 10.1002/anie.201002238; Czerlinski Jean, 1999, SIMPLE HEURISTICS MA, P97, DOI DOI 10.1002/(SICI)1099-0771(200004/06)13:2<161::AID-BDM348>3.0.CO;2-P; Davies JW, 2006, CURR OPIN CHEM BIOL, V10, P343, DOI 10.1016/j.cbpa.2006.06.022; DeSimone RW, 2004, COMB CHEM HIGH T SCR, V7, P473, DOI 10.2174/1386207043328544; Dijksterhuis A, 2004, J PERS SOC PSYCHOL, V87, P586, DOI 10.1037/0022-3514.87.5.586; Dijksterhuis D, 2006, J EXP SOC PSYCHOL, V42, P627, DOI 10.1016/j.jesp.2005.10.008; EBBESEN EB, 1975, J PERS SOC PSYCHOL, V32, P805, DOI 10.1037/0022-3514.32.5.805; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; EINHORN HJ, 1974, J APPL PSYCHOL, V59, P562, DOI 10.1037/h0037164; Engkist O, 2003, J CHEM INF COMP SCI, V43, P155, DOI 10.1021/ci0102721; Fligner MA, 2002, TECHNOMETRICS, V44, P110, DOI 10.1198/004017002317375064; Ganellin CR, 1995, ANNU REP MED CHEM; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3, DOI DOI 10.1177/1354067X0171006; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Gigerenzer G, 2009, TOP COGN SCI, V1, P107, DOI 10.1111/j.1756-8765.2008.01006.x; GOLDBERG LR, 1968, AM PSYCHOL, V23, P483, DOI 10.1037/h0026206; Hertwig R, 2009, SOC COGNITION, V27, P661, DOI 10.1521/soco.2009.27.5.661; HOFFMAN PJ, 1968, PSYCHOL BULL, V69, P338, DOI 10.1037/h0025665; Huang Q, 2011, J CHEM INF MODEL, V51, P2768, DOI 10.1021/ci100216g; Hughes HD, 1917, IOWA AGR, V17, P424; Johnson JG, 2003, ORGAN BEHAV HUM DEC, V91, P215, DOI 10.1016/S0749-5978(03)00027-X; KONONENKO I, 1991, LECT NOTES ARTIF INT, V482, P206, DOI 10.1007/BFb0017015; Krogsgaard-Larsen P, 2005, DRUG DEVELOP RES, V66, P1, DOI 10.1002/ddr.20038; Lajiness MS, 2004, J MED CHEM, V47, P4891, DOI 10.1021/jm049740z; Langley  P., 1994, P 10 C UNC ART INT, P399, DOI DOI 10.1016/B978-1-55860-332-5.50055-9; Leeson Paul D, 2004, Drug Discov Today Technol, V1, P189, DOI 10.1016/j.ddtec.2004.11.005; LEWICKI P, 1987, J EXP PSYCHOL LEARN, V13, P523, DOI 10.1037/0278-7393.13.4.523; Lombardino JG, 2004, NAT REV DRUG DISCOV, V3, P853, DOI 10.1038/nrd1523; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Lowe D, 2005, ASPIRIN NOT APPROVAB; Luke BT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-545; Medin DL, 2006, COGNITION, V99, P237, DOI 10.1016/j.cognition.2003.12.005; MEDIN DL, 1987, COGNITIVE PSYCHOL, V19, P242, DOI 10.1016/0010-0285(87)90012-0; Medin DL, 1997, COGNITIVE PSYCHOL, V32, P49, DOI 10.1006/cogp.1997.0645; MolSoft, 2011, ICM CHEM; MURPHY GL, 1985, PSYCHOL REV, V92, P289, DOI 10.1037/0033-295X.92.3.289; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Oprea TI, 2002, J COMPUT AID MOL DES, V16, P325, DOI 10.1023/A:1020877402759; Palm K, 1997, PHARMACEUT RES, V14, P568, DOI 10.1023/A:1012188625088; PHELPS RH, 1978, ORGAN BEHAV HUM PERF, V21, P209, DOI 10.1016/0030-5073(78)90050-8; Ritchie TJ, 2009, DRUG DISCOV TODAY, V14, P1011, DOI 10.1016/j.drudis.2009.07.014; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; ROMNEY AK, 1986, AM ANTHROPOL, V88, P313, DOI 10.1525/aa.1986.88.2.02a00020; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Schuffenhauer A, 2005, CURR TOP MED CHEM, V5, P751, DOI 10.2174/1568026054637700; Schulz MN, 2009, CURR OPIN PHARMACOL, V9, P615, DOI 10.1016/j.coph.2009.04.009; SHANTEAU J, 1988, ACTA PSYCHOL, V68, P203, DOI 10.1016/0001-6918(88)90056-X; SHANTEAU J, 1992, ORGAN BEHAV HUM DEC, V53, P252, DOI 10.1016/0749-5978(92)90064-E; SHANTEAU J, 1992, ACTA PSYCHOL, V81, P75, DOI 10.1016/0001-6918(92)90012-3; Shanteau J, 2001, EXP RES APPL, P229; SLOVIC P, 1969, J APPL PSYCHOL, V53, P255, DOI 10.1037/h0027773; Stewart TR, 1997, ORGAN BEHAV HUM DEC, V69, P205, DOI 10.1006/obhd.1997.2682; Takaoka Y, 2003, J CHEM INF COMP SCI, V43, P1269, DOI 10.1021/ci034043l; Timmerman H, 2009, CHEMMEDCHEM, V4, P1055, DOI 10.1002/cmdc.200900128; TRUMBO DON A., 1962, CEREAL SCI TODAY, V7, P62; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Wallace HA, 1923, J AM SOC AGRON, V15, P300; Walters WP, 2011, J MED CHEM, V54, P6405, DOI 10.1021/jm200504p; Weller SC, 2007, FIELD METHOD, V19, P339, DOI 10.1177/1525822X07303502; WILSON TD, 1991, J PERS SOC PSYCHOL, V60, P181, DOI 10.1037/0022-3514.60.2.181; WILSON TD, 1993, PERS SOC PSYCHOL B, V19, P331, DOI 10.1177/0146167293193010	78	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48476	10.1371/journal.pone.0048476	http://dx.doi.org/10.1371/journal.pone.0048476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185259	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000013
J	Strutzenberger, P; Brehm, G; Fiedler, K				Strutzenberger, Patrick; Brehm, Gunnar; Fiedler, Konrad			DNA Barcode Sequencing from Old Type Specimens as a Tool in Taxonomy: A Case Study in the Diverse Genus Eois (Lepidoptera: Geometridae)	PLOS ONE			English	Article							EXTRACTION	In this study we report on the sequencing of the COI barcode region from 96 historical specimens (92 type specimens +4 non-types) of Eois. Eois is a diverse clade of tropical geometrid moths and is the target of a number of ongoing studies on life-histories, phylogeny, co-evolution with host plants or parasitoids, and diversity patterns across temporal and spatial dimensions. The unequivocal application of valid names is crucial for all aspects of biodiversity research as well as monitoring and conservation efforts. The availability of barcodes from historical type specimens has the potential to facilitate the much-needed acceleration of species description. We performed non-destructive DNA extraction on the abdomens of Eois specimens between 79 and 157 years of age. We used six primer combinations (recovering between 109 and 130 bp each) to target the full-length barcode sequence of each specimen. We were able to obtain sequences for 91 of 96 specimens (success rate 94.8%). Sequence length ranged from 121 bp to full barcode sequences (658 bp), the average sequence length was similar to 500 bp. We detected a moderately strong and statistically significant negative correlation between specimen age and total sequence length, which is in agreement with expectations. The abdomen proved to be an exceedingly valuable source of DNA in old specimens of Lepidoptera. Barcode sequences obtained in this study are currently being used in an effort towards a step-wise taxonomic revision of Eois. We encourage that DNA barcodes obtained from types specimens should be included in all species descriptions and revisions whenever feasible.	[Strutzenberger, Patrick; Fiedler, Konrad] Univ Vienna, Dept Trop Ecol & Anim Biodivers, Vienna, Austria; [Brehm, Gunnar] Univ Jena, Inst Spezielle Zool & Evolutionsbiol Phyletischem, Jena, Germany	University of Vienna; Friedrich Schiller University of Jena	Strutzenberger, P (corresponding author), Univ Vienna, Dept Trop Ecol & Anim Biodivers, Vienna, Austria.	patrick.strutzenberger@univie.ac.at	Fiedler, Konrad/H-8788-2019; Brehm, Gunnar/D-5831-2013	Fiedler, Konrad/0000-0002-4789-3753; Brehm, Gunnar/0000-0002-7599-2847; Strutzenberger, Patrick/0000-0003-3278-5693	Deutsche Forschungsgemeinschaft [Fi 547/10-2, RU 816]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financially supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) (grant # Fi 547/10-2 within the framework of RU 816 "Biodiversity and sustainable management of a megadiverse mountain ecosystem in south Ecuador"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Bodner F, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6701; Brehm G, 2005, J BIOGEOGR, V32, P1621, DOI 10.1111/j.1365-2699.2005.01304.x; Brehm G, 2011, ANN ENTOMOL SOC AM, V104, P1091, DOI 10.1603/AN10050; Connahs H, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.2801; Dyer L. A., 2012, CATERPILLARS PARASIT; Espeland M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-2; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hausmann A, 2009, ZOOTAXA, P1; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilt N, 2006, J TROP ECOL, V22, P155, DOI 10.1017/S0266467405003056; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Janzen DH, 2012, DYNAMIC DATABASE INV; Knolke S, 2005, INSECT SYST EVOL, V35, P401, DOI 10.1163/187631204788912463; Kolokotronis SO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-67; Lees DC, 2011, FRONT ECOL ENVIRON, V9, P322, DOI 10.1890/100098; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Overballe-Petersen S, 2012, TRENDS BIOTECHNOL, V30, P364, DOI 10.1016/j.tibtech.2012.03.007; PRINCE AM, 1992, BIOTECHNIQUES, V12, P358; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Shokralla S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021252; Stireman JO, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.3901; Strutzenberger P, 2011, J EVOLUTION BIOL, V24, P919, DOI 10.1111/j.1420-9101.2010.02216.x; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Strutzenberger P, 2010, ZOOL SCR, V39, P603, DOI 10.1111/j.1463-6409.2010.00440.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	37	38	41	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49710	10.1371/journal.pone.0049710	http://dx.doi.org/10.1371/journal.pone.0049710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185414	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000092
J	Valdivieso, AG; Clauzure, M; Marin, MC; Taminelli, GL; Copiz, MMM; Sanchez, F; Schulman, G; Teiber, ML; Santa-Coloma, TA				Valdivieso, Angel G.; Clauzure, Mariangeles; Marin, Maria C.; Taminelli, Guillermo L.; Massip Copiz, Maria M.; Sanchez, Francisco; Schulman, Gustavo; Teiber, Maria L.; Santa-Coloma, Tomas A.			The Mitochondrial Complex I Activity Is Reduced in Cells with Impaired Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function	PLOS ONE			English	Article							BLUE NATIVE ELECTROPHORESIS; MEMBRANE PROTEIN MITONEET; OXIDATIVE-PHOSPHORYLATION; NADH DEHYDROGENASE; EPITHELIAL-CELLS; ELECTRON-TRANSPORT; ENCODED SUBUNITS; CHLORIDE CHANNEL; SKELETAL-MUSCLE; EXPRESSION	Cystic fibrosis (CF) is a frequent and lethal autosomal recessive disease. It results from different possible mutations in the CFTR gene, which encodes the CFTR chloride channel. We have previously studied the differential expression of genes in CF and CF corrected cell lines, and found a reduced expression of MTND4 in CF cells. MTND4 is a mitochondrial gene encoding the MTND4 subunit of the mitochondrial Complex I (mCx-I). Since this subunit is essential for the assembly and activity of mCx-I, we have now studied whether the activity of this complex was also affected in CF cells. By using Blue Native-PAGE, the in-gel activity (IGA) of the mCx-I was found reduced in CFDE and IB3-1 cells (CF cell lines) compared with CFDE/6RepCFTR and S9 cells, respectively (CFDE and IB3-1 cells ectopically expressing wild-type CFTR). Moreover, colon carcinoma T84 and Caco-2 cells, which express wt-CFTR, either treated with CFTR inhibitors (glibenclamide, CFTR(inh)-172 or GlyH101) or transfected with a CFTR-specific shRNAi, showed a significant reduction on the IGA of mCx-I. The reduction of the mCx-I activity caused by CFTR inhibition under physiological or pathological conditions may have a profound impact on mitochondrial functions of CF and non-CF cells.	[Santa-Coloma, Tomas A.] Pontif Catholic Univ Argentina UCA, Sch Med Sci, Cellular & Mol Biol Lab, Inst Biomed Res, Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, Natl Res Council Argentina, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Santa-Coloma, TA (corresponding author), Pontif Catholic Univ Argentina UCA, Sch Med Sci, Cellular & Mol Biol Lab, Inst Biomed Res, Buenos Aires, DF, Argentina.	tsantacoloma@gmail.com	Valdivieso, Ángel/AAP-3888-2020; Santa-Coloma, Tomas/I-1254-2019	Santa-Coloma, Tomas/0000-0002-3266-1095; Clauzure, Mariangeles/0000-0002-8490-6197; Sanchez, Francisco/0000-0002-8795-168X	National Agency for the Promotion of Science and Technology (ANPCYT) [BID OC-AR 1728, PICT 2004-13970, PICT 2007-00628]; National Research Council of Argentina (CONICET) [PIP 11220080 102551]; Pontifical Catholic University of Argentina	National Agency for the Promotion of Science and Technology (ANPCYT)(ANPCyT); National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Pontifical Catholic University of Argentina	This work was supported by the National Agency for the Promotion of Science and Technology (ANPCYT), grants BID OC-AR 1728, PICT 2004-13970 and PICT 2007-00628 to TASC; The National Research Council of Argentina (CONICET), grant PIP 11220080 102551, 2009-2011 to TASC and research fellowships to AGV, MCM, MMMC and GS; and The Pontifical Catholic University of Argentina, grant to TASC and fellowships to GLT, FS, and MLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antigny F, 2009, MITOCHONDRION, V9, P232, DOI 10.1016/j.mito.2009.02.003; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Averna M, 2011, BBA-MOL CELL RES, V1813, P50, DOI 10.1016/j.bbamcr.2010.11.008; Averna M, 2010, BIOCHEM J, V430, P255, DOI 10.1042/BJ20100344; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Baxter EL, 2011, P NATL ACAD SCI USA, V108, P5266, DOI 10.1073/pnas.1017604108; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Cafferata EG, 2000, BBA-MOL BASIS DIS, V1500, P241, DOI 10.1016/S0925-4439(99)00105-2; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chomova M, 2010, GEN PHYSIOL BIOPHYS, V29, P3, DOI 10.4149/gpb_2010_01_3; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2009, ACTA CRYSTALLOGR F, V65, P654, DOI 10.1107/S1744309109019605; DEMEER K, 1995, THORAX, V50, P980, DOI 10.1136/thx.50.9.980; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6; Estell K, 2003, MOL CELL BIOL, V23, P594, DOI 10.1128/MCB.23.2.594-606.2003; FEIGAL RJ, 1982, LIFE SCI, V30, P93, DOI 10.1016/0024-3205(82)90640-3; FEIGAL RJ, 1986, ANN NY ACAD SCI, V488, P82; FEIGAL RJ, 1979, NATURE, V278, P276, DOI 10.1038/278276a0; Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25; Gonzalez-Guerrico AM, 2002, J BIOL CHEM, V277, P17239, DOI 10.1074/jbc.M112456200; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Grove DE, 2011, METHODS MOL BIOL, V741, P219, DOI 10.1007/978-1-61779-117-8_15; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Hayes E, 2011, ARCH IMMUNOL THER EX, V59, P97, DOI 10.1007/s00005-011-0113-6; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; Joshi AKR, 2011, ANAL BIOCHEM, V415, P209, DOI 10.1016/j.ab.2011.04.014; Kaundal RK, 2010, DRUG NEWS PERSPECT, V23, P241, DOI 10.1358/dnp.2010.23.4.1437710; KAZAZIAN HH, 1994, HUM MUTAT, V4, P167; Kelly M, 2010, J PHARMACOL EXP THER, V333, P60, DOI 10.1124/jpet.109.162032; Kelly-Aubert M, 2011, HUM MOL GENET, V20, P2745, DOI 10.1093/hmg/ddr173; l'Hoste S, 2010, AM J PHYSIOL-RENAL, V298, pF435, DOI 10.1152/ajprenal.00286.2009; Lei DC, 1996, GENE THER, V3, P427; Lodi R, 2000, BRAIN, V123, P1896, DOI 10.1093/brain/123.9.1896; Lojda Z, 1979, ENZYME HISTOCHEMISTR, P256; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MacVinish LJ, 2007, BRIT J PHARMACOL, V150, P1055, DOI 10.1038/sj.bjp.0707175; MAJANDER A, 1991, FEBS LETT, V292, P289, DOI 10.1016/0014-5793(91)80886-8; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Navarro A, 2010, J BIOENERG BIOMEMBR, V42, P405, DOI 10.1007/s10863-010-9309-4; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHAPIRO BL, 1982, AM J HUM GENET, V34, P846; SHAPIRO BL, 1989, LIFE SCI, V44, P1327, DOI 10.1016/0024-3205(89)90389-5; SHAPIRO BL, 1988, LANCET, V2, P290; SHAPIRO BL, 1979, P NATL ACAD SCI USA, V76, P2979, DOI 10.1073/pnas.76.6.2979; Smeitink JAM, 2004, CURR NEUROVASC RES, V1, P29, DOI 10.2174/1567202043480224; SOOD R, 1992, EMBO J, V11, P2487, DOI 10.1002/j.1460-2075.1992.tb05313.x; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; Taminelli GL, 2008, BIOCHEM BIOPH RES CO, V365, P856, DOI 10.1016/j.bbrc.2007.11.076; Tondelier D, 1999, MEDIAT INFLAMM, V8, P219, DOI 10.1080/09629359990388; Troosters T, 2009, EUR RESPIR J, V33, P99, DOI 10.1183/09031936.00091607; Valdivieso AG, 2007, BIOCHEM BIOPH RES CO, V356, P805, DOI 10.1016/j.bbrc.2007.03.057; Valdivieso AG, 2011, ANAL BIOCHEM, V418, P231, DOI 10.1016/j.ab.2011.07.029; Velsor LW, 2006, AM J RESP CELL MOL, V35, P579, DOI 10.1165/rcmb.2005-0473OC; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; WAGNER JA, 1992, P NATL ACAD SCI USA, V89, P6785, DOI 10.1073/pnas.89.15.6785; WELSH MJ, 1992, NEURON, V8, P821, DOI 10.1016/0896-6273(92)90196-K; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; WIJBURG FA, 1990, BIOCHEM INT, V22, P303; Wiley SE, 2009, METHOD ENZYMOL, V456, P233, DOI 10.1016/S0076-6879(08)04413-3; Yi JS, 2006, J IMMUNOL, V177, P852, DOI 10.4049/jimmunol.177.2.852; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhou T, 2010, BIOCHEMISTRY-US, V49, P9604, DOI 10.1021/bi101168c; Zuris JA, 2011, P NATL ACAD SCI US	74	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48059	10.1371/journal.pone.0048059	http://dx.doi.org/10.1371/journal.pone.0048059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185247	Green Published, gold			2022-12-25	WOS:000311821000007
J	Cheng, XS; Jin, XA				Cheng, Xiao-Sheng; Jin, Xian'an			The Braid Index of Complicated DNA Polyhedral Links	PLOS ONE			English	Article							JONES POLYNOMIALS; KNOT; OCTAHEDRON; GRAPHS	The goal of this paper is to determine the braid index of two types of complicated DNA polyhedral links introduced by chemists and biologists in recent years. We shall study it in a more broad context and actually consider so-called Jaeger's links (more general Traldi's links) which contain, as special cases, both four types of simple polyhedral links whose braid indexes have been determined and the above two types of complicated DNA polyhedral links. Denote by b(L) and c(L) the braid index and crossing number of an oriented link L, respectively. Roughly speaking, in this paper, we prove that b(L) = c(L)/2 + 1 for any link L in a family including Jaeger's links and contained in Traldi's links, which is obtained by combining the MFW inequality and an Ohyama's result on upper bound of the braid index. Our result may be used to to characterize and analyze the structure and complexity of DNA polyhedra and entanglement in biopolymers.	[Cheng, Xiao-Sheng; Jin, Xian'an] Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China; [Cheng, Xiao-Sheng] Huizhou Univ, Dept Math, Huizhou, Guangdong, Peoples R China	Xiamen University; Huizhou University	Jin, XA (corresponding author), Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China.	xajin@xmu.edu.cn	Jin, Xian'an/G-3486-2010		National Natural Science Foundation of China [11101174, 10831001, 11271307]; Natural Science Foundation of Guangdong Province of China [S2011040003984]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [LYM11120]; Natural Science Foundation of Fujian Province of China [2012J01019]; Fundamental Research Funds for the Central Universities [2010121007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Talents in Higher Education of Guangdong, China; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	XSC was supported by grants from the National Natural Science Foundation of China (number 11101174), Natural Science Foundation of Guangdong Province of China (number S2011040003984) and Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (number LYM11120). XJ was supported by grants from the National Natural Science Foundation of China (numbers 10831001 and 11271307), Natural Science Foundation of Fujian Province of China (number 2012J01019) and the Fundamental Research Funds for the Central Universities (number 2010121007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JW, 1923, P NATL ACAD SCI USA, V9, P93, DOI 10.1073/pnas.9.3.93; [Anonymous], KOBE J MATH; Bondy J. A, 2008, GRAPH THEORY APPL; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Cheng XS, 2012, J MATH CHEM, V50, P1386, DOI 10.1007/s10910-012-9976-y; Cheng XS, 2010, MATCH-COMMUN MATH CO, V63, P637; Cox MA, 2008, J MATH CHEM, V43, P874, DOI 10.1007/s10910-007-9323-x; Cromwell P., 2004, KNOTS LINKS; Erben CM, 2007, J AM CHEM SOC, V129, P6992, DOI 10.1021/ja071493b; FRANKS J, 1987, T AM MATH SOC, V303, P97, DOI 10.2307/2000780; FREYD P, 1985, B AM MATH SOC, V12, P239, DOI 10.1090/S0273-0979-1985-15361-3; Goodman RP, 2004, CHEM COMMUN, P1372, DOI 10.1039/b402293a; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; He Y, 2010, ANGEW CHEM INT EDIT, V49, P748, DOI 10.1002/anie.200904513; JAEGER F, 1988, P AM MATH SOC, V103, P647, DOI 10.2307/2047194; KAUFFMAN LH, 1989, DISCRETE APPL MATH, V25, P105, DOI 10.1016/0166-218X(89)90049-8; KAUFFMAN LH, 1987, TOPOLOGY, V26, P395; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; MENASCO W, 1984, TOPOLOGY, V23, P37, DOI 10.1016/0040-9383(84)90023-5; MORTON HR, 1986, MATH PROC CAMBRIDGE, V99, P107, DOI 10.1017/S0305004100063982; MURASUGI K, 1991, T AM MATH SOC, V326, P237, DOI 10.2307/2001863; MURASUGI K, 1987, TOPOLOGY, V26, P187, DOI 10.1016/0040-9383(87)90058-9; Murasugi K., 1996, KNOT THEORY ITS APPL; Nakamura T, 2004, TOPOL APPL, V135, P13, DOI 10.1016/S0166-8641(03)00109-3; OHYAMA Y, 1993, CAN J MATH, V45, P117, DOI 10.4153/CJM-1993-007-x; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; THISTLETHWAITE MB, 1987, TOPOLOGY, V26, P297, DOI 10.1016/0040-9383(87)90003-6; TRALDI L, 1989, P AM MATH SOC, V106, P279, DOI 10.2307/2047403; TUTTE WT, 1954, CAN J MATH, V6, P80, DOI 10.4153/CJM-1954-010-9; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Zhang C, 2009, J AM CHEM SOC, V131, P1413, DOI 10.1021/ja809666h; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006; Zimmermann J, 2008, ANGEW CHEM INT EDIT, V47, P3626, DOI 10.1002/anie.200702682	33	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48968	10.1371/journal.pone.0048968	http://dx.doi.org/10.1371/journal.pone.0048968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185287	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700021
J	Turner, C; Turner, P; Cararra, V; Lwe, NE; Watthanaworawit, W; Day, NP; White, NJ; Goldblatt, D; Nosten, F				Turner, Claudia; Turner, Paul; Cararra, Verena; Lwe, Naw Eh; Watthanaworawit, Wanitda; Day, Nicholas P.; White, Nicholas J.; Goldblatt, David; Nosten, Francois			A High Burden of Respiratory Syncytial Virus Associated Pneumonia in Children Less than Two Years of Age in a South East Asian Refugee Population	PLOS ONE			English	Article							CHILDHOOD PNEUMONIA; VIRAL ETIOLOGY; INFANTS; INFECTION; MORTALITY	Background: Pneumonia is a major cause of childhood mortality and morbidity approximately 1.6 million deaths and 150 million episodes occur annually in children,5 years. Respiratory syncytial virus (RSV) may be responsible for up to 25% of cases and 12% of deaths making it an important potential vaccine target, although data from South East Asia is scarce. Methods: We followed a birth cohort of Burmese refugee children, born over a one year period, for two years. Pneumonia episodes were diagnosed using WHO criteria. A chest radiograph, nasopharyngeal aspirate and non-specific markers of infection were taken during each episode. Results: The incidence of RSV-associated pneumonia was 0.24 (95% CI 0.22-0.26) episodes per child year. All children with pneumonia received antibiotic treatment, following WHO guidelines. The highest incidence was in the 2-12 month age group. The commonest diagnosis in a child with RSV-associated pneumonia was non-severe pneumonia (239/362:66.0%), however the incidence of RSV-associated severe or very severe pneumonia was 0.08 (95% CI 0.01-0.10) episodes per child year. Birth in the wet season increased the risk of severe disease in children who had their first episode of RSV-associated pneumonia aged 2-11 months (OR 28.7, 95% CI 6.6-125.0, p<0.001). RSV episodes were highly seasonal being responsible for 80.0% of all the pneumonia episodes occurring each October and November over the study period. Conclusions: There was a high incidence of RSV associated pneumonia in this refugee population. Interventions to prevent RSV infection have the potential to reduce the incidence of clinically diagnosed pneumonia and hence unnecessary antibiotic usage in this population.	[Turner, Claudia; Turner, Paul; Cararra, Verena; Lwe, Naw Eh; Watthanaworawit, Wanitda; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Turner, Claudia; Turner, Paul; Watthanaworawit, Wanitda; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Turner, Claudia; Turner, Paul; Day, Nicholas P.; White, Nicholas J.; Nosten, Francois] Univ Oxford, Ctr Trop Med, Oxford, England; [Goldblatt, David] UCL, Inst Child Hlth, Immunobiol Unit, London, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of London; University College London	Turner, C (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Thailand.	claudia@tropmedres.ac	Goldblatt, David/C-5972-2008; Carrara, Verena/R-6492-2019; White, Nick/AAC-6527-2019; Nosten, Francois/AAC-5509-2019	Goldblatt, David/0000-0002-0769-5242; Carrara, Verena/0000-0002-2758-0872; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Turner, Paul/0000-0002-1013-7815	Wellcome Trust of Great Britain [077166/Z/05]; Wellcome Trust [083735]; National Institute for Health Research [NF-SI-0611-10066] Funding Source: researchfish	Wellcome Trust of Great Britain(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	CT and FN are supported by the Wellcome Trust of Great Britain (Grant No. 077166/Z/05). PT is also supported by the Wellcome Trust (Grant 083735). SMRU is part of the Mahidol-Oxford University Tropical Medicine Research Program and is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, LANCET, V338, P1453; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Enwere G, 2007, TROP MED INT HEALTH, V12, P1377, DOI 10.1111/j.1365-3156.2007.01922.x; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Hasan K, 2006, SCAND J INFECT DIS, V38, P690, DOI 10.1080/00365540600606473; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Juven T, 2003, SCAND J PRIM HEALTH, V21, P52, DOI 10.1080/02813430310000573; Khan AJ, 2009, B WORLD HEALTH ORGAN, V87, P193, DOI 10.2471/BLT.07.048264; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Madhi SA, 2006, PEDIATR INFECT DIS J, V25, P30, DOI 10.1097/01.inf.0000195787.99199.4a; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Mandell M, 2010, PRINCIPLES PACTICE I; Mc Intosh H, 2003, FORFAR ARNEILS TXB P; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes JD, 2008, CURR OPIN INFECT DIS, V21, P639, DOI 10.1097/QCO.0b013e3283184245; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Turner P, 2010, EMERG INFECT DIS, V16, P1366, DOI 10.3201/eid1609.100220; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; WHO, 2005, INT MAN CHILDH ILLN; WHO, 2007, INT MAN CHILDH ILLN; WHO, 1999, IMPR CHILD HLTH IMCI; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50100	10.1371/journal.pone.0050100	http://dx.doi.org/10.1371/journal.pone.0050100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185545	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700070
J	Grunewalder, S; Broekhuis, F; Macdonald, DW; Wilson, AM; McNutt, JW; Shawe-Taylor, J; Hailes, S				Gruenewaelder, Steffen; Broekhuis, Femke; Macdonald, David Whyte; Wilson, Alan Martin; McNutt, John Weldon; Shawe-Taylor, John; Hailes, Stephen			Movement Activity Based Classification of Animal Behaviour with an Application to Data from Cheetah (Acinonyx jubatus)	PLOS ONE			English	Article								We propose a new method, based on machine learning techniques, for the analysis of a combination of continuous data from dataloggers and a sampling of contemporaneous behaviour observations. This data combination provides an opportunity for biologists to study behaviour at a previously unknown level of detail and accuracy; however, continuously recorded data are of little use unless the resulting large volumes of raw data can be reliably translated into actual behaviour. We address this problem by applying a Support Vector Machine and a Hidden-Markov Model that allows us to classify an animal's behaviour using a small set of field observations to calibrate continuously recorded activity data. Such classified data can be applied quantitatively to the behaviour of animals over extended periods and at times during which observation is difficult or impossible. We demonstrate the usefulness of the method by applying it to data from six cheetah (Acinonyx jubatus) in the Okavango Delta, Botswana. Cumulative activity data scores were recorded every five minutes by accelerometers embedded in GPS radio-collars for around one year on average. Direct behaviour sampling of each of the six cheetah were collected in the field for comparatively short periods. Using this approach we are able to classify each five minute activity score into a set of three key behaviour (feeding, mobile and stationary), creating a continuous behavioural sequence for the entire period for which the collars were deployed. Evaluation of our classifier with cross-validation shows the accuracy to be 83%-94%, but that the accuracy for individual classes is reduced with decreasing sample size of direct observations. We demonstrate how these processed data can be used to study behaviour identifying seasonal and gender differences in daily activity and feeding times. Results given here are unlike any that could be obtained using traditional approaches in both accuracy and detail.	[Gruenewaelder, Steffen; Shawe-Taylor, John] UCL, London, England; [Gruenewaelder, Steffen; Shawe-Taylor, John; Hailes, Stephen] UCL, Dept Comp Sci, London, England; [Broekhuis, Femke; McNutt, John Weldon] Botswana Predator Conservat Trust, Maun, Botswana; [Broekhuis, Femke; Macdonald, David Whyte] Univ Oxford, Dept Zool, Recanati Kaplan Ctr, Wildlife Conservat Res Unit WildCRU, Oxford OX1 3PS, England; [Wilson, Alan Martin; Hailes, Stephen] Univ London, Royal Vet Coll, Struct & Mot Lab, London, England	University of London; University College London; University of London; University College London; University of Oxford; University of London; University of London Royal Veterinary College	Grunewalder, S (corresponding author), UCL, London, England.	steffen@cs.ucl.ac.uk		Grunewalder, Steffen/0000-0002-4017-2048; Broekhuis, Femke/0000-0002-4216-8819; Shawe-Taylor, John/0000-0002-2030-0073; Wilson, Alan/0000-0001-9914-3455	Tom Kaplan Prize Scholarship; PG Allen Family Foundation; Lee and Juliet Folger Foundation; Nathan and Rosemarie Myhrvold; Stuart and Teresa Graham; Doug and Janet True; Woodland Park Zoo; Wild Entrust International; EPSRC CARDyAL: Cooperative Aerodynamics; Radio-based DYnamic Animal Localisation project [EP/H017402/1]; EPSRC [EP/H017402/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H017402/1] Funding Source: researchfish	Tom Kaplan Prize Scholarship; PG Allen Family Foundation; Lee and Juliet Folger Foundation; Nathan and Rosemarie Myhrvold; Stuart and Teresa Graham; Doug and Janet True; Woodland Park Zoo; Wild Entrust International; EPSRC CARDyAL: Cooperative Aerodynamics; Radio-based DYnamic Animal Localisation project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors had financial support from numerous donors including the Tom Kaplan Prize Scholarship, the PG Allen Family Foundation, the Lee and Juliet Folger Foundation, Nathan and Rosemarie Myhrvold, Stuart and Teresa Graham, Doug and Janet True, Woodland Park Zoo, Wild Entrust International. This work was funded by the EPSRC CARDyAL: Cooperative Aerodynamics and Radio-based DYnamic Animal Localisation project, EP/H017402/1. The authors confirm that there are no additional funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTUN Y, 2003, 20 INT C MACH LEARN; Caro T, 1994, CHEETAH SERENGETI GR; Caro T, 1987, J ZOOLOGY, V211; Chapelle O, 2007, NEURAL COMPUT, V19, P1155, DOI 10.1162/neco.2007.19.5.1155; Fowler M, 2007, CHEM PHYS RESTRAINT; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gottardi E, 2010, MAMMALIA, V74, P355, DOI 10.1515/MAMM.2010.058; Hart T, 2010, ANIM BEHAV, V79, P845, DOI 10.1016/j.anbehav.2009.12.033; Hart T, 2010, MARINE BIOL; McNutt J, 2007, BEHAV ECOLOGY SOCIOB; McNutt JW, 1996, ANIM BEHAV, V52, P1067, DOI 10.1006/anbe.1996.0254; Meltzer D., 2006, CHEM PHYS RESTRAINT; Moreau M, 2009, APPL ANIMAL BEHAV SC, V170, P119; Philips, 2012, ACT; Platt J., 1999, ADV LARGE MARGIN CLA; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Shepard E, 2008, ENDANGERED SPECIES R; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Wilson RP, 2008, ENDANGER SPECIES RES, V10, P29, DOI [10.3354/esr00091, DOI 10.3354/ESR00091]; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019; Yoda K, 1999, J EXP BIOL, V202, P3121	22	57	57	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49120	10.1371/journal.pone.0049120	http://dx.doi.org/10.1371/journal.pone.0049120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185301	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000311333800018
J	Su, DS; Zhao, YX; Xu, H; Wang, BL; Chen, XM; Chen, J; Wang, XR				Su, Diansan; Zhao, Yanxing; Xu, Huan; Wang, Beilei; Chen, Xuemei; Chen, Jie; Wang, Xiangrui			Isoflurane Exposure during Mid-Adulthood Attenuates Age-Related Spatial Memory Impairment in APP/PS1 Transgenic Mice	PLOS ONE			English	Article							AMYLOID-BETA; GENERAL-ANESTHESIA; NEUROPROTECTION; APOPTOSIS; YOUNG; SEVOFLURANE; PERFORMANCE; OLIGOMERS; ISCHEMIA; BRAIN	Many in vitro findings suggest that isoflurane exposure might accelerate the process of Alzheimer Disease (AD); however, no behavioral evidence exists to support this theory. In the present study, we hypothesized that exposure of APP/PS1 transgenic mice to isoflurane during mid-adulthood, which is the pre-symptomatic phase of amyloid beta (Abeta) deposition, would alter the progression of AD. Seven-month-old Tg(APPswe,PSEN1dE9)85Dbo/J transgenic mice and their wild-type littermates were exposed to 1.1% isoflurane for 2 hours per day for 5 days. Learning and memory ability was tested 48 hours and 5 months following isoflurane exposure using the Morris Water Maze and Y maze, respectively. Abeta deposition and oligomers in the hippocampus were measured by immunohistochemistry or Elisa 5 months following isoflurane exposure. We found that the performance of both the transgenic and wild-type mice in the Morris Water Maze significantly improved 48 hours following isoflurane exposure. The transgenic mice made significantly fewer discrimination errors in the Y maze following isoflurane exposure, and no differences were found between wild-type littermates 5 months following isoflurane exposure. For the transgenic mice, the Abeta plaque and oligomers in the hippocampus was significantly decreased in the 5 months following isoflurane exposure. In summary, repeated isoflurane exposure during the pre-symptomatic phase not only improved spatial memory in both the APP/PS1 transgenic and wild-type mice shortly after the exposure but also prevented age-related decline in learning and memory and attenuated the Abeta plaque and oligomers in the hippocampus of transgenic mice.	[Su, Diansan; Zhao, Yanxing; Xu, Huan; Wang, Beilei; Chen, Xuemei; Chen, Jie; Wang, Xiangrui] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, XR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Anesthesiol, Shanghai 200030, Peoples R China.	Wangxr2010@yahoo.com	su, diansan/AAA-5057-2022		Shanghai Science and Technology Development Funds [09QA1403800]; National Natural Science Foundation of China [30801069]; Shanghai Jiaotong University [YG2011MS60]	Shanghai Science and Technology Development Funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiaotong University	This study was supported by grants from Shanghai Science and Technology Development Funds (no. 09QA1403800), the National Natural Science Foundation of China (no. 30801069) and grant from Shanghai Jiaotong University (YG2011MS60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedirli N, 2012, J NEUROSURG ANESTH, V24, P336, DOI 10.1097/ANA.0b013e318266791e; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Butterfield NN, 2004, ANESTH ANALG, V98, P1305, DOI 10.1213/01.ANE.0000108484.91089.13; Carnini A, 2007, CURR ALZHEIMER RES, V4, P233; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Crosby C, 2005, ANESTH ANALG, V101, P1389, DOI 10.1213/01.ANE.0000180835.72669.AD; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jabs A, 2010, CLIN HEMORHEOL MICRO, V45, P185, DOI 10.3233/CH-2010-1297; Johnsen D, 2011, NEUROSCIENCE, V199, P368, DOI 10.1016/j.neuroscience.2011.09.053; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Luca MC, 2011, CLIN HEMORHEOL MICRO, V49, P287, DOI 10.3233/CH-2011-1479; McAuliffe JJ, 2009, ANESTHESIOLOGY, V111, P533, DOI 10.1097/ALN.0b013e3181b060d3; Pan C, 2011, ANESTHESIA ANALGESIA, P1526; Perucho J, 2010, J ALZHEIMERS DIS, V19, P1245, DOI 10.3233/JAD-2010-1318; Rammes G, 2009, NEUROPHARMACOLOGY, V56, P626, DOI 10.1016/j.neuropharm.2008.11.002; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Su D, 2011, ACTA ANAESTH SCAND, V55, P468, DOI 10.1111/j.1399-6576.2010.02385.x; Tang Junxia X, 2011, Alzheimers Dement, V7, P521, DOI 10.1016/j.jalz.2010.10.003; Volianskis A, 2010, NEUROBIOL AGING, V31, P1173, DOI 10.1016/j.neurobiolaging.2008.08.005; Wei HF, 2007, NEUROSCI LETT, V425, P59, DOI 10.1016/j.neulet.2007.08.011; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Zhang HP, 2010, ANESTH ANALG, V111, P506, DOI 10.1213/ANE.0b013e3181e45519	28	18	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50172	10.1371/journal.pone.0050172	http://dx.doi.org/10.1371/journal.pone.0050172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185565	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800072
J	Appelqvist, H; Sandin, L; Bjornstrom, K; Saftig, P; Garner, B; Ollinger, K; Kagedal, K				Appelqvist, Hanna; Sandin, Linnea; Bjornstrom, Karin; Saftig, Paul; Garner, Brett; Ollinger, Karin; Kagedal, Katarina			Sensitivity to Lysosome-Dependent Cell Death Is Directly Regulated by Lysosomal Cholesterol Content	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; CYCLODEXTRIN OVERCOMES; C1 FUNCTIONS; APOPTOSIS; TRANSPORT; ACCUMULATION; TRAFFICKING; RELEASE; PATHWAY; DEFECT	Alterations in lipid homeostasis are implicated in several neurodegenerative diseases, although the mechanisms responsible are poorly understood. We evaluated the impact of cholesterol accumulation, induced by U18666A, quinacrine or mutations in the cholesterol transporting Niemann-Pick disease type C1 (NPC1) protein, on lysosomal stability and sensitivity to lysosome-mediated cell death. We found that neurons with lysosomal cholesterol accumulation were protected from oxidative stress-induced apoptosis. In addition, human fibroblasts with cholesterol-loaded lysosomes showed higher lysosomal membrane stability than controls. Previous studies have shown that cholesterol accumulation is accompanied by the storage of lipids such as sphingomyelin, glycosphingolipids and sphingosine and an up regulation of lysosomal associated membrane protein-2 (LAMP-2), which may also influence lysosomal stability. However, in this study the use of myriocin and LAMP deficient fibroblasts excluded these factors as responsible for the rescuing effect and instead suggested that primarily lysosomal cholesterol content determineD the cellular sensitivity to toxic insults. Further strengthening this concept, depletion of cholesterol using methyl-b-cyclodextrin or 25-hydroxycholesterol decreased the stability of lysosomes and cells became more prone to undergo apoptosis. In conclusion, cholesterol content regulated lysosomal membrane permeabilization and thereby influenced cell death sensitivity. Our data suggests that lysosomal cholesterol modulation might be used as a therapeutic strategy for conditions associated with accelerated or repressed apoptosis.	[Appelqvist, Hanna; Sandin, Linnea; Ollinger, Karin; Kagedal, Katarina] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Bjornstrom, Karin] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Linkoping, Sweden; [Bjornstrom, Karin] Cty Council Ostergotland, Dept Anaesthesiol UHL, Linkoping, Sweden; [Saftig, Paul] Univ Kiel, Inst Biochem, Kiel, Germany; [Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Ollinger, Karin] Cty Council Ostergotland, Dept Clin Pathol & Clin Genet, Linkoping, Sweden	Linkoping University; Linkoping University; City Council Ostergotland; University of Kiel; University of Wollongong; University of Wollongong; City Council Ostergotland	Appelqvist, H (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden.	hanna.appelqvist@liu.se	Appelqvist, Hanna/AAX-4475-2020; Saftig, Paul/A-7966-2010		Swedish Research Council [2010-3463]; Deutsche Forschungsgemeinschaft; foundation of Olle Engqvist; foundation of Ake Wiberg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); foundation of Olle Engqvist; foundation of Ake Wiberg	This work was supported by the Swedish Research Council (2010-3463), the Deutsche Forschungsgemeinschaft, and the foundations of Olle Engqvist and Ake Wiberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; Appelqvist H, 2011, AM J PATHOL, V178, P629, DOI 10.1016/j.ajpath.2010.10.030; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Caruso JA, 2005, BIOCHEM J, V392, P325, DOI 10.1042/BJ20050313; Cheung NS, 2004, BIOCHEM BIOPH RES CO, V315, P408, DOI 10.1016/j.bbrc.2004.01.066; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432; Clement AB, 2009, J NEUROCHEM, V111, P669, DOI 10.1111/j.1471-4159.2009.06360.x; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Double KL, 2010, PROG NEUROBIOL, V92, P316, DOI 10.1016/j.pneurobio.2010.06.001; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Glaros EN, 2010, CLIN SCI, V118, P727, DOI 10.1042/CS20090452; Goldman SDB, 2010, J BIOL CHEM, V285, P4983, DOI 10.1074/jbc.M109.037622; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Hansson E., 1989, DISSECTION TISSUE CU, P92; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Kaufmann AM, 2008, J BIOL CHEM, V283, P24584, DOI 10.1074/jbc.M803715200; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Lachmann RH, 2004, NEUROBIOL DIS, V16, P654, DOI 10.1016/j.nbd.2004.05.002; Lange Y, 1999, J LIPID RES, V40, P2264; Li W, 2000, FEBS LETT, V470, P35, DOI 10.1016/S0014-5793(00)01286-2; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Reiners JJ, 2011, FREE RADICAL BIO MED, V50, P281, DOI 10.1016/j.freeradbiomed.2010.11.006; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Saftig P, 2010, BIOCHEM SOC T, V38, P1420, DOI 10.1042/BST0381420; Schneede A, 2011, J CELL MOL MED, V15, P280, DOI 10.1111/j.1582-4934.2009.00973.x; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; SOKOL J, 1988, J BIOL CHEM, V263, P3411; ZDOLSEK JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P67, DOI 10.1111/j.1751-1097.1990.tb01685.x; Zhao M, 2003, EUR J BIOCHEM, V270, P3778, DOI 10.1046/j.1432-1033.2003.03765.x	44	54	55	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50262	10.1371/journal.pone.0050262	http://dx.doi.org/10.1371/journal.pone.0050262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166840	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885300096
J	Read, TRH; Hocking, JS; Vodstrcil, LA; Tabrizi, SN; McCullough, MJ; Grulich, AE; Garland, SM; Bradshaw, CS; Chen, MY; Fairley, CK				Read, Tim R. H.; Hocking, Jane S.; Vodstrcil, Lenka A.; Tabrizi, Sepehr N.; McCullough, Michael J.; Grulich, Andrew E.; Garland, Suzanne M.; Bradshaw, Catriona S.; Chen, Marcus Y.; Fairley, Christopher K.			Oral Human Papillomavirus in Men Having Sex with Men: Risk-Factors and Sampling	PLOS ONE			English	Article							HPV INFECTION; OROPHARYNGEAL-CANCER; NATURAL-HISTORY; YOUNG-WOMEN; NECK-CANCER; PREVALENCE; HEAD; COHORT; ADULTS	Background: Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma is becoming more common. We examined prevalence and risk factors for oral HPV among men who have sex with men (MSM) and compared sampling and transport methods. Methods: In 2010, 500 MSM (249 HIV-positive) attending Melbourne Sexual Health Centre answered a questionnaire, swabbed their mouth and throat and collected a gargled oral rinse sample. Half the oral rinse was transported absorbed in a tampon (to enable postage). HPV was detected by polymerase chain reaction, and genotyped by Roche Linear Array (R). Men with HPV 16 or 18 were retested after six months. Results: Any HPV genotype was detected in 19% (95% confidence intervals (CI) 15-25%) of HIV-infected men and 7% (95% CI 4-11%) of HIV-negative men (p<0.001), and HPV 16 was detected in 4.4% (95% CI 2-8%) of HIV-infected men and 0.8% (0.1-2.8%) of HIV-negative men. Oral HPV was associated with: current smoking (adjusted odds ratio (aOR) 2.2 (95% CI: 1.2-3.9)), time since tooth-brushing (aOR per hour 0.87, 95% CI: 0.8-0.96) and number of lifetime tongue-kissing partners aOR 3.2 95% CI: (1.2-8.4) for 26-100 partners and 4.9 95% CI: (1.9-12.5) for >100 partners. Lifetime oral-penile sex partner numbers were significantly associated in a separate model: aOR 2.8(1.2-6.3) for 26-100 partners and 3.2(1.4-7.2) for >100 partners. HPV 16 and 18 persisted in 10 of 12 men after a median six months. Sensitivities of sampling methods compared to all methods combined were: oral rinse 97%, tampon-absorbed oral rinse 69%, swab 32%. Conclusions: Oral HPV was associated with HIV infection, smoking, recent tooth-brushing, and more lifetime tongue-kissing and oral sex partners. The liquid oral rinse sample was more sensitive than a tampon-absorbed oral rinse or a self-collected swab.	[Read, Tim R. H.; Vodstrcil, Lenka A.; Bradshaw, Catriona S.; Chen, Marcus Y.; Fairley, Christopher K.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Read, Tim R. H.; Vodstrcil, Lenka A.; Chen, Marcus Y.; Fairley, Christopher K.] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Hocking, Jane S.] Univ Melbourne, Ctr Womens Hlth Gender & Soc, Melbourne, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.] Univ Melbourne, Dept Microbiol & Infect Dis, Royal Womens Hosp, Dept Obstet & Gynaecol,Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [McCullough, Michael J.] Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic, Australia; [Grulich, Andrew E.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of New South Wales Sydney; Kirby Institute; Monash University	Read, TRH (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.	tread@mshc.org.au	McCullough, Michael/C-3295-2014; Vodstrcil, Lenka/AAF-8722-2020; Vodstrcil, Lenka/AAC-1896-2019; Hocking, Jane/AAD-5203-2021	Vodstrcil, Lenka/0000-0003-3679-9195; Hocking, Jane/0000-0001-9329-8501; McCullough, Michael/0000-0001-7829-4684; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678	National Health and Medical Research Council of Australia [568971]; CSL Biotherapies; Commonwealth Serum Laboratories; GlaxoSmithKline; Merck; Sanofi Pasteur MSD	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CSL Biotherapies; Commonwealth Serum Laboratories; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Sanofi Pasteur MSD	This study was funded by Program Grant number 568971 of the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CKF, JSH and AEG have received honoraria from CSL Biotherapies. CKF and AEG have received research funding from CSL Biotherapies. CKF owns shares in CSL Biotherapies, the manufacturer of Gardasil, and has received honoraria from Merck. SMG has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline, and lecture fees from Merck and Sanofi Pasteur MSD. In addition, she has received funding through her institutions to conduct HPV vaccine studies for GlaxoSmithKline and for Merck. AEG has received honoraria and travel funding from Merck, and sits on the Australian advisory board for the Gardasil vaccine. TRHR is a site investigator on a Merck-sponsored study. MYC, SNT, MJM and CSB, have no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	AustraliaPost, 2009, AUSTRALIAPOST; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Brown B, 2011, INT J STD AIDS, V22, P655, DOI 10.1258/ijsa.2011.010541; D'Souza G, 2007, INT J CANCER, V121, P143, DOI 10.1002/ijc.22667; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Garland S M, 2001, Infect Dis Obstet Gynecol, V9, P143, DOI 10.1155/S1064744901000254; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hocking JS, 2011, BRIT J CANCER, V104, P886, DOI 10.1038/sj.bjc.6606091; Hong A, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2518; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; Kreimer AR, 2004, J INFECT DIS, V189, P686, DOI 10.1086/381504; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Marais DJ, 2008, J MED VIROL, V80, P953, DOI 10.1002/jmv.21166; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Steinau M, 2012, J ORAL PATHOL MED; Stevens MP, 2008, J CLIN MICROBIOL, V46, P3813, DOI 10.1128/JCM.01169-08; Stevens MP, 2007, J CLIN MICROBIOL, V45, P2130, DOI 10.1128/JCM.02438-06; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Taybos G, 2003, AM J MED SCI, V326, P179, DOI 10.1097/00000441-200310000-00005; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; Weaver BA, 2004, J INFECT DIS, V189, P677, DOI 10.1086/381395; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180	28	60	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49324	10.1371/journal.pone.0049324	http://dx.doi.org/10.1371/journal.pone.0049324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173054	Green Published, gold			2022-12-25	WOS:000311885300028
J	Taylor, SM; Meshnick, SR; Worodria, W; Andama, A; Cattamanchi, A; Davis, JL; Yoo, SD; Byanyima, P; Kaswabuli, S; Goodman, CD; Huang, L				Taylor, Steve M.; Meshnick, Steven R.; Worodria, William; Andama, Alfred; Cattamanchi, Adithya; Davis, J. Lucian; Yoo, Samuel D.; Byanyima, Patrick; Kaswabuli, Sylvia; Goodman, Carol D.; Huang, Laurence		Int HIV-Associated Opportunistic	Low Prevalence of Pneumocystis pneumonia (PCP) but High Prevalence of Pneumocystis dihydropteroate synthase (dhps) Gene Mutations in HIV-Infected Persons in Uganda	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE GENE; HUMAN-IMMUNODEFICIENCY-VIRUS; SULFONE PROPHYLAXIS; JIROVECI PNEUMONIA; CARINII-PNEUMONIA; TRANSMISSION; RESISTANCE; CORRELATE; ETIOLOGY; ADULTS	Pneumocystis jirovecii pneumonia (PCP) is an important opportunistic infection in patients infected with HIV, but its burden is incompletely characterized in those areas of sub-Saharan Africa where HIV is prevalent. We explored the prevalence of both PCP in HIV-infected adults admitted with pneumonia to a tertiary-care hospital in Uganda and of putative P. jirovecii drug resistance by mutations in fungal dihydropteroate synthase (dhps) and dihydrofolate reductase (dhfr). In 129 consecutive patients with sputum smears negative for mycobacteria, 5 (3.9%) were diagnosed with PCP by microscopic examination of Giemsa-stained bronchoalveolar lavage fluid. Concordance was 100% between Giemsa stain and PCR (dhps and dhfr). PCP was more prevalent in patients newly-diagnosed with HIV (11.4%) than in patients with known HIV (1.1%; p = 0.007). Mortality at 2 months after discharge was 29% overall: 28% among PCP-negative patients, and 60% (3 of 5) among PCP-positive patients. In these 5 fungal isolates and an additional 8 from consecutive cases of PCP, all strains harbored mutant dhps haplotypes; all 13 isolates harbored the P57S mutation in dhps, and 3 (23%) also harbored the T55A mutation. No non-synonymous dhfr mutations were detected. PCP is an important cause of pneumonia in patients newly-diagnosed with HIV in Uganda, is associated with high mortality, and putative molecular evidence of drug resistance is prevalent. Given the reliability of field diagnosis in our cohort, future studies in sub-Saharan Africa can investigate the clinical impact of these genotypes.	[Taylor, Steve M.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Taylor, Steve M.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC USA; [Worodria, William; Andama, Alfred; Cattamanchi, Adithya; Davis, J. Lucian; Yoo, Samuel D.; Byanyima, Patrick; Kaswabuli, Sylvia; Huang, Laurence] Makerere Univ Univ Calif, San Francisco Res Collaborat, Kampala, Uganda; [Worodria, William; Andama, Alfred] Mulago Hosp, Makerere Coll Hlth Sci, Dept Med, Kampala, Uganda; [Cattamanchi, Adithya; Davis, J. Lucian; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA; [Yoo, Samuel D.] Hlth Tutors Coll Mulago, Kampala, Uganda; [Goodman, Carol D.] San Francisco Gen Hosp, Dept Lab Med, San Francisco, CA 94110 USA; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Makerere University; Mulago National Referral Hospital; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Taylor, SM (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	taylo115@email.unc.edu	Huang, Laurence/AAZ-7120-2021; Huang, Laurence/AAE-1590-2019; Davis, J. Lucian/AAC-8376-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992	National Heart, Lung, and Blood Institute [K24 HL087713, R01 HL090355]; National Institute of Allergy and Infectious Diseases [K23 AI080147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094141, K24HL087713, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI080147, P30AI027763] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Heart, Lung, and Blood Institute [K24 HL087713 and R01 HL090355 to L. H.] and by the National Institute of Allergy and Infectious Diseases [K23 AI080147 to JLD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderaye G, 2007, SCAND J INFECT DIS, V39, P1045, DOI 10.1080/00365540701474508; Alvarez-Martinez MJ, 2006, DIAGN MICR INFEC DIS, V56, P153, DOI 10.1016/j.diagmicrobio.2006.03.010; BATUNGWANAYO J, 1994, AM J RESP CRIT CARE, V149, P1591, DOI 10.1164/ajrccm.149.6.8004318; Costa MC, 2006, J ANTIMICROB CHEMOTH, V58, P1246, DOI 10.1093/jac/dkl411; CREGAN P, 1990, J CLIN MICROBIOL, V28, P2432, DOI 10.1128/JCM.28.11.2432-2436.1990; Crothers K, 2005, AIDS, V19, P801, DOI 10.1097/01.aids.0000168974.67090.70; Dini L, 2010, J CLIN MICROBIOL, V48, P2016, DOI 10.1128/JCM.02004-09; Hartung TK, 2011, AM J TROP MED HYG, V85, P105, DOI 10.4269/ajtmh.2011.10-0640; Hauser PM, 2010, CLIN INFECT DIS, V51, pE28, DOI 10.1086/655145; Helweg-Larsen J, 1999, LANCET, V354, P1347, DOI 10.1016/S0140-6736(99)03320-6; Huang L, 2000, J INFECT DIS, V182, P1192, DOI 10.1086/315824; Iliades P, 2005, ANTIMICROB AGENTS CH, V49, P741, DOI 10.1128/AAC.49.2.741-748.2005; Ioannidis JPA, 1996, ARCH INTERN MED, V156, P177, DOI 10.1001/archinte.156.2.177; KAMANFU G, 1993, AM REV RESPIR DIS, V147, P658, DOI 10.1164/ajrccm/147.3.658; Kazanjian P, 2000, J INFECT DIS, V182, P551, DOI 10.1086/315719; Kibiki G S, 2007, East Afr Med J, V84, P420; Ma L, 1999, J INFECT DIS, V180, P1969, DOI 10.1086/315148; Ma LA, 2002, J INFECT DIS, V185, P1530, DOI 10.1086/340220; MALIN AS, 1995, LANCET, V346, P1258, DOI 10.1016/S0140-6736(95)91862-0; Matos O, 2010, PARASITE, V17, P219, DOI 10.1051/parasite/2010173219; Meneau I, 2004, ANTIMICROB AGENTS CH, V48, P2610, DOI 10.1128/AAC.48.7.2610-2616.2004; Nahimana A, 2004, ANTIMICROB AGENTS CH, V48, P4301, DOI 10.1128/AAC.48.11.4301-4305.2004; Navin TR, 2001, LANCET, V358, P545, DOI 10.1016/S0140-6736(01)05705-1; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; NG VL, 1990, J CLIN MICROBIOL, V28, P975, DOI 10.1128/JCM.28.5.975-979.1990; Siripattanapipong S, 2008, MED MYCOL, V46, P389, DOI 10.1080/13693780701883722; Stein CR, 2004, EMERG INFECT DIS, V10, P1760, DOI 10.3201/eid1010.040362; Taylor SM, 2011, DIAGNOSTIC MICROBIOL; Valerio A, 2007, JAIDS-J ACQ IMM DEF, V45, P521, DOI 10.1097/QAI.0b013e3180decbe2; van Hal SJ, 2009, J CLIN MICROBIOL, V47, P1818, DOI 10.1128/JCM.02102-08; Vray M, 2008, AIDS, V22, P1323, DOI 10.1097/QAD.0b013e3282fdf8bf; Worodria W, 2003, INT J TUBERC LUNG D, V7, P117; Worodria W, 2010, EUR RESPIR J, V36, P446, DOI 10.1183/09031936.00010210; Yoo SDJ, 2010, JAIDS-J ACQ IMM DEF, V54, P269, DOI 10.1097/QAI.0b013e3181ce6b19; Zar HJ, 2004, CLIN INFECT DIS, V39, P1047, DOI 10.1086/424010	35	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49991	10.1371/journal.pone.0049991	http://dx.doi.org/10.1371/journal.pone.0049991			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166805	Green Published, gold			2022-12-25	WOS:000311885300077
J	Garaguso, I; Borlak, J				Garaguso, Ignazio; Borlak, Juergen			A Rapid Screening Assay to Search for Phosphorylated Proteins in Tissue Extracts	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; SITE-SPECIFIC PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; CANCER-CELLS; EXPRESSION; SEQUENCE; IDENTIFICATION; ENRICHMENT; PREDICTION; ANTIBODIES	Reversible protein phosphorylation is an essential mechanism in the regulation of diverse biological processes, nonetheless is frequently altered in disease. As most phosphoproteome studies are based on optimized in-vitro cell culture studies new methods are in need to improve de novo identification and characterization of phosphoproteins in extracts from tissues. Here, we describe a rapid and reliable method for the detection of phosphoproteins in tissue extract based on an experimental strategy that employs 1D and 2D SDS PAGE, Western immunoblotting of phosphoproteins, in-gel protease digestion and enrichment of phosphorpeptides using metal oxide affinity chromatography (MOAC). Subsequently, phosphoproteins are identified by MALDI-TOF-MS/MS with the CHCA-TL or DHB ML sample matrix preparation method and further characterized by various bioinformatic software tools to search for candidate kinases and phosphorylation-dependent binding motifs. The method was applied to mouse lung tissue extracts and resulted in an identification of 160 unique phosphoproteins. Notably, TiO2 enrichment of pulmonary protein extracts resulted in an identification of additional 17 phosphoproteins and 20 phosphorylation sites. By use of MOAC, new phosphorylation sites were identified as evidenced for the advanced glycosylation end product-specific receptor. So far this protein was unknown to be phosphorylated in lung tissue of mice. Overall the developed methodology allowed efficient and rapid screening of phosphorylated proteins and can be employed as a general experimental strategy for an identification of phosphoproteins in tissue extracts.	[Garaguso, Ignazio; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany	Hannover Medical School	Borlak, J (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany.	Borlak.Juergen@mh-hannover.de		Garaguso, Ignazio/0000-0003-2797-3542	Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF) [031 6154]; Lower Saxony Ministry of Culture and Sciences; Volkswagen foundation, Germany [25A.5-7251-99-3/00]; German Research Foundation (DFG)	Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Lower Saxony Ministry of Culture and Sciences; Volkswagen foundation, Germany(Volkswagen); German Research Foundation (DFG)(German Research Foundation (DFG))	The authors gratefully acknowledge support from The Virtual Liver Network (grant 031 6154) of the German Federal Ministry of Education and Research (BMBF). Part of this work was also funded by the Lower Saxony Ministry of Culture and Sciences and the Volkswagen foundation, Germany to JB. Grant number: 25A.5-7251-99-3/00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The charge for this publication was covered by the German Research Foundation (DFG) sponsorship "open access publication.''	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; COHEN B, 1990, P NATL ACAD SCI USA, V87, P4458, DOI 10.1073/pnas.87.12.4458; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Garaguso I, 2008, PROTEOMICS, V8, P2583, DOI 10.1002/pmic.200701147; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Ghafouri B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; GUY GR, 1994, ELECTROPHORESIS, V15, P417, DOI 10.1002/elps.1150150160; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jensen ON, 1999, METH MOL B, V112, P513; Kristensen DB, 2000, HEPATOLOGY, V32, P268; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Leung KY, 2001, PROTEOMICS, V1, P787; Lim YP, 2005, CLIN CANCER RES, V11, P3163, DOI 10.1158/1078-0432.CCR-04-2243; Linthicum DS, 2001, TISSUE CELL, V33, P514, DOI 10.1054/tice.2001.0205; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Noel-Georis I, 2001, DIS MARKERS, V17, P271, DOI 10.1155/2001/607263; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Predic J, 2002, BIOCHEMISTRY-US, V41, P1070, DOI 10.1021/bi0117854; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shimamura T, 2008, J THORAC ONCOL, V3, pS152, DOI 10.1097/JTO.0b013e318174ea3a; Stripp BR, 2002, AM J RESP CELL MOL, V27, P170, DOI 10.1165/ajrcmb.27.2.200200270c; Wu CH, 2002, NUCLEIC ACIDS RES, V30, P35, DOI 10.1093/nar/30.1.35; Yamagata A, 2002, PROTEOMICS, V2, P1267, DOI 10.1002/1615-9861(200209)2:9<1267::AID-PROT1267>3.0.CO;2-R; Zhang XL, 2002, RAPID COMMUN MASS SP, V16, P2325, DOI 10.1002/rcm.864; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	36	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e50025	10.1371/journal.pone.0050025	http://dx.doi.org/10.1371/journal.pone.0050025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166814	Green Published, gold			2022-12-25	WOS:000311272300084
J	Kang, YM; Sun, YH; Zhang, JY; Gao, WJ; Kang, JJ; Wang, YQ; Wang, B; Xia, GL				Kang, Youmin; Sun, Yuhan; Zhang, Jingyao; Gao, Wenjuan; Kang, Jingjing; Wang, Yongqiang; Wang, Bin; Xia, Guoliang			Treg Cell Resistance to Apoptosis in DNA Vaccination for Experimental Autoimmune Encephalomyelitis Treatment	PLOS ONE			English	Article							REGULATORY T-CELLS; RESTRICTED ANTIGEN PRESENTATION; MULTIPLE-SCLEROSIS; FK506; DEATH; ACTIVATION; DISEASES; SUPPRESSION; TACROLIMUS; PREVENTION	Background: Regulatory T (Treg) cells can be induced with DNA vaccinations and protect mice from the development of experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). Tacrolimus (FK506) has been shown to have functions on inducing immunosuppression and augmenting apoptosis of pathologic T cells in autoimmune disease. Here we examined the therapeutic effect of DNA vaccine in conjunction with FK506 on EAE. Methodology/Principal Findings: After EAE induction, C57BL/6 mice were treated with DNA vaccine in conjunction with FK506. Functional Treg cells were induced in treated EAE mice and suppressed Th1 and Th17 cell responses. Infiltrated CD4 T cells were reduced while Treg cells were induced in spinal cords of treated EAE mice. Remarkably, the activated CD4 T cells augmented apoptosis, but the induced Treg cells resisted apoptosis in treated EAE mice, resulting in alleviation of clinical EAE severity. Conclusions/Significance: DNA vaccine in conjunction with FK506 treatment ameliorates EAE by enhancing apoptosis of CD4 T cells and resisting apoptosis of induced Treg cells. Our findings implicate the potential of tolerogenic DNA vaccines for treating MS.	[Kang, Youmin; Sun, Yuhan; Zhang, Jingyao; Gao, Wenjuan; Xia, Guoliang] China Agr Univ, Coll Biol Sci, State Key Lab Agro Biotechnol, Beijing 100094, Peoples R China	China Agricultural University	Kang, YM (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agro Biotechnol, Beijing 100094, Peoples R China.	kym@cau.edu.cn		Kang, Youmin/0000-0003-2597-6117				Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Almolda B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027473; Andersson A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003682; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; DADAMIO L, 1993, EUR J IMMUNOL, V23, P747, DOI 10.1002/eji.1830230327; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Ferrera F, 2007, ANN NY ACAD SCI, V1110, P99, DOI 10.1196/annals.1423.012; Fissolo N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-139; Fissolo N, 2012, CLIN IMMUNOL, V142, P76, DOI 10.1016/j.clim.2010.11.011; Garren H, 2001, IMMUNITY, V15, P15, DOI 10.1016/S1074-7613(01)00171-6; Hashimoto Y, 2001, CLIN EXP IMMUNOL, V125, P19, DOI 10.1046/j.1365-2249.2001.01586.x; Hayashi T, 2003, RECENT PROG HORM RES, V58, P131, DOI 10.1210/rp.58.1.131; Imai A, 2007, EUR J IMMUNOL, V37, P1730, DOI 10.1002/eji.200636392; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kang YM, 2007, BIOCHEM BIOPH RES CO, V353, P1034, DOI 10.1016/j.bbrc.2006.12.124; Kang YM, 2012, IMMUNOL INVEST, V41, P249, DOI 10.3109/08820139.2011.622828; Kang YM, 2009, J GENE MED, V11, P1064, DOI 10.1002/jgm.1387; Kuerten S, 2011, APMIS, V119, P336, DOI 10.1111/j.1600-0463.2011.02744.x; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Lee YR, 2005, BLOOD, V105, P3951, DOI 10.1182/blood-2004-10-3927; Lin Xiao-jun, 2011, Zhonghua Yi Xue Za Zhi, V91, P586; Lobell A, 1998, J EXP MED, V187, P1543, DOI 10.1084/jem.187.9.1543; Lobell A, 2003, J IMMUNOL, V170, P1806, DOI 10.4049/jimmunol.170.4.1806; MACDONALD HR, 1990, NATURE, V343, P642, DOI 10.1038/343642a0; MIGITA K, 1995, J CLIN INVEST, V96, P727, DOI 10.1172/JCI118116; Migita K, 1999, TRANSPLANTATION, V68, P1018, DOI 10.1097/00007890-199910150-00020; Migita K, 1997, TRANSPLANTATION, V64, P1365, DOI 10.1097/00007890-199711150-00022; Mott KR, 2011, INVEST OPHTH VIS SCI, V52, P2321, DOI 10.1167/iovs.10-6536; Nakano A, 2007, THYROID, V17, P25, DOI 10.1089/thy.2006.0231; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Schif-Zuck S, 2006, J IMMUNOL, V177, P8241, DOI 10.4049/jimmunol.177.11.8241; Shachar I, 2012, J LEUKOCYTE BIOL; Taylor SRJ, 2007, J IMMUNOL, V178, P3474, DOI 10.4049/jimmunol.178.6.3474; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62	37	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49994	10.1371/journal.pone.0049994	http://dx.doi.org/10.1371/journal.pone.0049994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166807	Green Submitted, Green Published, gold			2022-12-25	WOS:000311151900210
J	Padilla-Benavides, T; McCann, CJ; Arguello, JM				Padilla-Benavides, Teresita; McCann, Courtney J.; Argueello, Jose M.			The Mechanism of Cu+ Transport ATPases INTERACTION WITH CU+ CHAPERONES AND THE ROLE OF TRANSIENT METAL-BINDING SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATX1 METALLOCHAPERONE; CRYSTAL-STRUCTURE; COPPER PUMP; PROTEIN; IDENTIFICATION; P-1B-ATPASES; DELIVERY; DOMAINS	Cu+-ATPases are membrane proteins that couple the hydrolysis of ATP to the efflux of cytoplasmic Cu+. In cells, soluble chaperone proteins bind and distribute cytoplasmic Cu+, delivering the ion to the transmembrane metal-binding sites in the ATPase. The structure of Legionella pneumophila Cu+-ATPase (Gourdon, P., Liu, X. Y., Skjorringe, T., Morth, J. P., Moller, L. B., Pedersen, B. P., and Nissen, P. (2011) Nature 475, 59-64) shows that a kinked transmembrane segment forms a "platform" exposed to the cytoplasm. In addition, neighboring invariant Met, Asp, and Glu are located at the "entrance" of the ion path. Mutations of amino acids in these regions of the Archaeoglobus fulgidus Cu+-ATPase CopA do not affect ATPase activity in the presence of Cu+ free in solution. However, Cu+ bound to the corresponding chaperone (CopZ) could not activate the mutated ATPases, and in parallel experiments, CopZ was unable to transfer Cu+ to CopA. Furthermore, mutation of a specific electronegative patch on the CopZ surface abolishes the ATPase activation and Cu+ transference, indicating that the region is required for the CopZ-CopA interaction. Moreover, the data suggest that the interaction is driven by the complementation of the electropositive platform in the ATPase and the electronegative Cu+ chaperone. This docking likely places the Cu+ proximal to the conserved carboxyl and thiol groups in the entrance site that induce metal release from the chaperone via ligand exchange. The initial interaction of Cu+ with the pump is transient because Cu+ is transferred from the entrance site to transmembrane metal-binding sites involved in transmembrane translocation.	[Padilla-Benavides, Teresita; McCann, Courtney J.; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Johnson, Michael D. L./B-4352-2012; Padilla-Benavides, Teresita/K-1968-2012; Arguello, Jose/D-1997-2012	Padilla-Benavides, Teresita/0000-0002-4624-0822; Arguello, Jose/0000-0003-3940-6297	National Science Foundation [MCB-0743901]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0743901 (to J. M. A.).	Arguello JM, 2012, J BIOL CHEM, V287, P13510, DOI 10.1074/jbc.R111.319343; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Banci L, 2010, NAT PROD REP, V27, P695, DOI 10.1039/b906678k; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Frausto da Silva J, 2001, BIOL CHEM ELEMENTS, P418; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Portnoy ME, 1999, J BIOL CHEM, V274, P15041, DOI 10.1074/jbc.274.21.15041; Raimunda D, 2011, BIOMETALS, V24, P467, DOI 10.1007/s10534-010-9404-3; Rice WJ, 2006, BIOCHEM BIOPH RES CO, V348, P124, DOI 10.1016/j.bbrc.2006.07.012; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Rosenzweig AC, 1999, STRUCTURE, V7, P605, DOI 10.1016/S0969-2126(99)80082-3; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Sazinsky MH, 2007, J BIOL CHEM, V282, P25950, DOI 10.1074/jbc.M703311200; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsivkovskii R, 2001, J BIOL CHEM, V276, P2234, DOI 10.1074/jbc.M003238200; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025	44	56	56	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					69	78		10.1074/jbc.M112.420810	http://dx.doi.org/10.1074/jbc.M112.420810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184962	hybrid, Green Published			2022-12-25	WOS:000313197200007
J	Yang, SY; Huang, FK; Huang, JY; Chen, S; Jakoncic, J; Leo-Macias, A; Diaz-Avalos, R; Chen, L; Zhang, JJ; Huang, XY				Yang, Shengyu; Huang, Fang-Ke; Huang, Jianyun; Chen, Shuai; Jakoncic, Jean; Leo-Macias, Alejandra; Diaz-Avalos, Ruben; Chen, Lin; Zhang, J. Jillian; Huang, Xin-Yun			Molecular Mechanism of Fascin Function in Filopodial Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE BREAST-CANCER; CROSS-LINKING PROTEIN; ACTIN-BINDING; IN-VIVO; EXPRESSION; MOTILITY; TOMOGRAPHY; CARCINOMA; ROLES; METASTASIS	Filopodia are cell surface protrusions that are essential for cell migration. This finger-like structure is supported by rigid tightly bundled actin filaments. The protein responsible for actin bundling in filopodia is fascin. However, the mechanism by which fascin functions in filopodial formation is not clear. Here we provide biochemical, cryo-electron tomographic, and x-ray crystal structural data demonstrating the unique structural characteristics of fascin. Systematic mutagenesis studies on 100 mutants of fascin indicate that there are two major actin-binding sites on fascin. Crystal structures of four fascin mutants reveal concerted conformational changes in fascin from inactive to active states in the process of actin bundling. Mutations in any one of the actin-binding sites impair the cellular function of fascin in filopodial formation. Altogether, our data reveal the molecular mechanism of fascin function in filopodial formation.	[Yang, Shengyu; Huang, Fang-Ke; Huang, Jianyun; Chen, Shuai; Chen, Lin; Zhang, J. Jillian; Huang, Xin-Yun] Cornell Univ, Dept Physiol, Weill Med Coll, New York, NY 10065 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Upton, NY 11973 USA; [Leo-Macias, Alejandra] NYU, Skirball Inst Biomol Med, Sch Med, New York, NY 10016 USA; [Diaz-Avalos, Ruben] New York Struct Biol Ctr, New York, NY 10027 USA	Cornell University; United States Department of Energy (DOE); Brookhaven National Laboratory; New York University	Huang, XY (corresponding author), Cornell Univ, Dept Physiol, Weill Med Coll, New York, NY 10065 USA.	xyhuang@med.cornell.edu	Yang, Shengyu/I-9531-2012; Leo-Macias, Alejandra/B-3159-2017	Yang, Shengyu/0000-0002-7933-6118; Leo-Macias, Alejandra/0000-0002-7579-9764	National Institutes of Health [CA136837]; NATIONAL CANCER INSTITUTE [R01CA136837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136837.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Aratyn YS, 2007, MOL BIOL CELL, V18, P3928, DOI 10.1091/mbc.E07-04-0346; BRYAN J, 1978, J MOL BIOL, V125, P207, DOI 10.1016/0022-2836(78)90345-5; Cant K, 1996, GENETICS, V143, P249; Cao DF, 2005, INT J GYNECOL PATHOL, V24, P67, DOI 10.1097/01.pgp.0000139648.17750.35; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DEROSIER D, 1977, J MOL BIOL, V113, P679, DOI 10.1016/0022-2836(77)90230-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Grothey A, 2000, BRIT J CANCER, V83, P870, DOI 10.1054/bjoc.2000.1395; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Hashimoto Y, 2004, ONCOLOGY-BASEL, V67, P262, DOI 10.1159/000081327; Jansen S, 2011, J BIOL CHEM, V286, P30087, DOI 10.1074/jbc.M111.251439; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lee K, 2010, SCIENCE, V329, P1341, DOI 10.1126/science.1191710; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Maitra A, 2002, AM J CLIN PATHOL, V118, P52; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Ono S, 1997, J BIOL CHEM, V272, P2527; OTTO JJ, 1979, CELL, V17, P285, DOI 10.1016/0092-8674(79)90154-5; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pelosi G, 2003, LUNG CANCER-J IASLC, V42, P203, DOI 10.1016/S0169-5002(03)00294-0; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; SPUDICH JA, 1979, J MOL BIOL, V129, P319, DOI 10.1016/0022-2836(79)90285-7; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tilney LG, 1998, J CELL BIOL, V143, P121, DOI 10.1083/jcb.143.1.121; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; YAMASHIROMATSUMURA S, 1985, J BIOL CHEM, V260, P5087; Yoder BJ, 2005, CLIN CANCER RES, V11, P186; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921; Zigeuner R, 2006, UROLOGY, V68, P518, DOI 10.1016/j.urology.2006.03.032	45	81	81	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					274	284		10.1074/jbc.M112.427971	http://dx.doi.org/10.1074/jbc.M112.427971			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184945	hybrid, Green Published			2022-12-25	WOS:000313197200027
J	Chen, XQ; Yang, YP; Yang, J; Zhang, ZF; Zhu, XP				Chen, Xiaoqin; Yang, Yaping; Yang, Jing; Zhang, Zhifei; Zhu, Xinping			RNAi-Mediated Silencing of Paramyosin Expression in Trichinella spiralis Results in Impaired Viability of the Parasite	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENE-FUNCTION; HAEMONCHUS-CONTORTUS; ADULT WORMS; INTERFERENCE; NEMATODE; TRICHINOSIS; SUPPRESSION; IDENTIFICATION	Background: Trichinella spiralis expresses paramyosin (Ts-PMY) not only as a structural protein but also as an immunomodulatory protein to protect the worm from being attacked by host complement components. In this study, the functions of PMY in the viability and the growth development of T. spiralis were confirmed at the first time by silencing the gene function with RNA interference technique. Methods and Findings: To understand its functions in the viability of the worm, we used RNA interference to silence the expression of Ts-pmy mRNA and protein in the parasite. Significant silencing of Ts-pmy mRNA expression in larval and adult T. spiralis was achieved by siRNA and dsRNA through soaking and electroporation. Electroporation of T. spiralis larvae with 8 mM siRNA1743 or 100 ng/ml dsRNA-PF3 resulted in 66.3% and 60.4% decrease in Ts-pmy transcript and 52.0% and 64.7% decrease in Ts-PMY protein expression, respectively, compared with larvae treated with irrelevant control siRNA or dsRNA. Larvae treated with siRNA1743 displayed significant reduction in molting (40.8%) and serious surface damage as detected with SYTOX fluorescent staining. Infection of mice with larvae electroporated with Ts-pmy siRNA1743 resulted in 37.6% decrease in adult worm burden and 23.2% decrease in muscle larvae burden compared with mice infected with control siRNA-treated larvae. In addition, adult worms recovered from mice infected with siRNA-treated larvae released 24.8% less newborn larvae. Conclusion: It is the first time RNAi was used on T. spiralis to demonstrate that silencing PMY expression in T. spiralis significantly reduces the parasite's viability and infectivity, further confirming that Ts-PMY plays an important role in the survival of T. spiralis and therefore is a promising target for vaccine development.	[Chen, Xiaoqin; Yang, Yaping; Yang, Jing; Zhang, Zhifei; Zhu, Xinping] Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China	Capital Medical University	Zhu, XP (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Parasitol, Beijing, Peoples R China.	zhuxping@ccmu.edu.cn			National Natural Science Foundation of China [81171598]; National Science and Technology Major Project [2012ZX10004220-012]; PhD Programs Foundation of the Municipal Education Commission of Beijing [20111002503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; PhD Programs Foundation of the Municipal Education Commission of Beijing	This work was supported by grants from the National Natural Science Foundation of China (81171598), the National Science and Technology Major Project (2012ZX10004220-012), and the PhD Programs Foundation of the Municipal Education Commission of Beijing (20111002503). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aboobaker AA, 2003, MOL BIOCHEM PARASIT, V129, P41, DOI 10.1016/S0166-6851(03)00092-6; Alkharouf NW, 2007, EXP PARASITOL, V115, P247, DOI 10.1016/j.exppara.2006.09.009; Britton C, 2011, EXP PARASITOL, DOI [10.1016/j.exppara.2011.08.002, DOI 10.1016/J.EX-PPARA.2011.08.002]; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Cui J, 2011, ACTA TROP, V118, P1, DOI 10.1016/j.actatropica.2011.02.005; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; Deng JS, 2007, INT J PARASITOL, V37, P67, DOI 10.1016/j.ijpara.2006.09.011; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; Dupouy-Camet J, 2009, VET PARASITOL, V159, P194, DOI 10.1016/j.vetpar.2008.10.064; EPSTEIN HF, 1985, J CELL BIOL, V100, P904, DOI 10.1083/jcb.100.3.904; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gajadhar AA, 2010, VET PARASITOL, V168, P78, DOI 10.1016/j.vetpar.2009.10.012; Geldhof P, 2006, INT J PARASITOL, V36, P801, DOI 10.1016/j.ijpara.2005.12.004; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Gobert GN, 2005, PARASITOL INT, V54, P101, DOI 10.1016/j.parint.2005.02.004; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Grishok A, 2005, FEBS LETT, V579, P5932, DOI 10.1016/j.febslet.2005.08.001; Habig JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004052; Hill DE, 2009, J FOOD PROTECT, V72, P2565, DOI 10.4315/0362-028X-72.12.2565; Hussein AS, 2002, MOL BIOCHEM PARASIT, V122, P91, DOI 10.1016/S0166-6851(02)00068-3; Islam MK, 2005, INFECT IMMUN, V73, P1995, DOI 10.1128/IAI.73.4.1995-2004.2005; Issa Z, 2005, INT J PARASITOL, V35, P935, DOI 10.1016/j.ijpara.2005.06.001; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kotze AC, 2006, MOL BIOCHEM PARASIT, V145, P101, DOI 10.1016/j.molbiopara.2005.09.012; KOZEK WJ, 1971, J PARASITOL, V57, P1015, DOI 10.2307/3277858; Krautz-Peterson G, 2007, MOL BIOCHEM PARASIT, V153, P194, DOI 10.1016/j.molbiopara.2007.03.006; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Lendner M, 2008, MOL BIOCHEM PARASIT, V161, P21, DOI 10.1016/j.molbiopara.2008.06.003; Lustigmana S, 2004, MOL BIOCHEM PARASIT, V138, P165, DOI 10.1016/j.molbiopara.2004.08.003; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Martinez-Gomez F, 2009, VET PARASITOL, V162, P171, DOI 10.1016/j.vetpar.2009.02.010; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Pfarr K, 2006, INT J PARASITOL, V36, P661, DOI 10.1016/j.ijpara.2006.01.010; Pierson L, 2010, INT J PARASITOL, V40, P605, DOI 10.1016/j.ijpara.2009.10.012; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Pozio Edoardo, 2003, Expert Rev Anti Infect Ther, V1, P471, DOI 10.1586/14787210.1.3.471; Rees-Roberts D, 2010, INT J PARASITOL, V40, P527, DOI 10.1016/j.ijpara.2009.10.006; Ribicich A, 2007, VET PARASITOL, V147, P265, DOI 10.1016/j.vetpar.2007.04.017; Roeder T, 2010, DEV COMP IMMUNOL, V34, P203, DOI 10.1016/j.dci.2009.09.010; Samarasinghe B, 2011, INT J PARASITOL, V41, P51, DOI 10.1016/j.ijpara.2010.07.005; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Struwe WB, 2010, METHOD ENZYMOL, V480, P477, DOI 10.1016/S0076-6879(10)80021-7; Wang SH, 2009, ACTA TROP, V110, P46, DOI 10.1016/j.actatropica.2009.01.003; Wei JF, 2011, VACCINE, V29, P3162, DOI 10.1016/j.vaccine.2011.02.072; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Yang J, 2008, BIOCHEM BIOPH RES CO, V365, P528, DOI 10.1016/j.bbrc.2007.11.012; Yang Jing, 2003, Chinese Journal of Zoology, V38, P52; Yang J, 2010, EXP PARASITOL, V124, P403, DOI 10.1016/j.exppara.2009.12.010; Yang YP, 2010, VACCINE, V28, P2735, DOI 10.1016/j.vaccine.2010.01.026; Zawadzki JL, 2012, PARASITOLOGY, P1; Zhang ZF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001225; Zhao QP, 2007, EXP PARASITOL, V115, P9, DOI 10.1016/j.exppara.2006.05.004	55	25	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49913	10.1371/journal.pone.0049913	http://dx.doi.org/10.1371/journal.pone.0049913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185483	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000142
J	Misra, A; Pandey, C; Sze, SK; Thanabalu, T				Misra, Ashish; Pandey, Chhiti; Sze, Siu Kwan; Thanabalu, Thirumaran			Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL-CELL-ADHESION; FACTOR RECEPTOR; CARCINOMA-CELLS; TUMOR HYPOXIA; N-WASP; GENE-EXPRESSION; CANCER-THERAPY; MIGRATION; IDENTIFICATION	Metastasis is a multi-step process which requires the conversion of polarized epithelial cells to mesenchymal cells, Epithelial-Mesenchymal Transition (EMT). EMT is essential during embryonic morphogenesis and has been implicated in the progression of primary tumors towards metastasis. Hypoxia is known to induce EMT; however the molecular mechanism is still poorly understood. Using the A431 epithelial cancer cell line, we show that cells grown under hypoxic conditions migrated faster than cells grown under normal oxygen environment. Cells grown under hypoxia showed reduced adhesion to the extracellular matrix (ECM) probably due to reduced number of Vinculin patches. Growth under hypoxic conditions also led to down regulation of E-cadherin and up regulation of vimentin expression. The increased motility of cells grown under hypoxia could be due to redistribution of Rac1 to the plasma membrane as opposed to increased expression of Rac1. EGF (Epidermal Growth Factor) is a known inducer of EMT and growth of A431 cells in the absence of oxygen led to increased expression of EGFR (EGF Receptor). Treatment of A431 cells with EGF led to reduced cell adhesion to ECM, increased cell motility and other EMT characteristics. Furthermore, this transition was blocked by the monoclonal antibody Cetuximab. Cetuximab also blocked the hypoxia-induced EMT suggesting that cell growth under hypoxic conditions led to activation of EGFR signaling and induction of EMT phenotype.	[Misra, Ashish; Pandey, Chhiti; Sze, Siu Kwan; Thanabalu, Thirumaran] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Sze, SK (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	sksze@ntu.edu.sg; thirumaran@ntu.edu.sg	Sze, Siu_kwan Newman/A-2199-2011; Thanabalu, Thirumaran/A-2216-2011; Sze, Siu Kwan/AAO-3342-2020	Sze, Siu_kwan Newman/0000-0002-5652-1687; Thanabalu, Thirumaran/0000-0001-5871-3829; Sze, Siu Kwan/0000-0002-5652-1687	ARC tier 1 [RG28/05, RG52/10]; Ministry of Education [ARC: T206B3211]; Agency for Science, Technology and Research [BMRC: 08/1/22/19/575]	ARC tier 1; Ministry of Education; Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR))	This work was partially supported by grants from the ARC tier 1 grant (RG28/05 & RG52/10 to TT), the Ministry of Education (ARC: T206B3211 to SKS), and the Agency for Science, Technology and Research (BMRC: 08/1/22/19/575 to SKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CE, 2002, J BIOL CHEM, V277, P24728, DOI 10.1074/jbc.M202512200; Azuma K, 2005, ONCOGENE, V24, P4754, DOI 10.1038/sj.onc.1208654; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Brown JM, 1999, CANCER RES, V59, P5863; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chan DA, 2007, METHOD ENZYMOL, V435, P323, DOI 10.1016/S0076-6879(07)35016-7; Cho WK, 2004, MOL THER, V10, P938, DOI 10.1016/j.ymthe.2004.07.023; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Das S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-94; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KNUDSEN KA, 1995, J CELL BIOL, V130, P67, DOI 10.1083/jcb.130.1.67; KONGER RL, 1993, J CELL PHYSIOL, V156, P515, DOI 10.1002/jcp.1041560310; Ksiazek K, 2009, AM J PATHOL, V174, P1230, DOI 10.2353/ajpath.2009.080613; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; Misra A, 2007, BIOCHEM BIOPH RES CO, V364, P908, DOI 10.1016/j.bbrc.2007.10.086; Murillo MM, 2005, ONCOGENE, V24, P4580, DOI 10.1038/sj.onc.1208664; OBRINK B, 1986, EXP CELL RES, V163, P1, DOI 10.1016/0014-4827(86)90554-9; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Park JE, 2010, MOL CELL PROTEOMICS; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Sturge J, 2002, J CELL SCI, V115, P699; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Wells A, 1998, MICROSC RES TECHNIQ, V43, P395, DOI 10.1002/(SICI)1097-0029(19981201)43:5<395::AID-JEMT6>3.0.CO;2-T; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xie H, 1998, J CELL SCI, V111, P615; Yan W, 2009, BIOCHEM BIOPH RES CO, V382, P631, DOI 10.1016/j.bbrc.2009.03.088; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	48	51	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49766	10.1371/journal.pone.0049766	http://dx.doi.org/10.1371/journal.pone.0049766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185433	Green Published, gold			2022-12-25	WOS:000311821000105
J	Wu, CH; Wang, YH; Huang, YP; Pan, SL				Wu, Chueh-Hung; Wang, Yen-Ho; Huang, Ya-Ping; Pan, Shin-Liang			Does Adhesive Capsulitis of the Shoulder Increase the Risk of Stroke? A Population-Based Propensity Score-Matched Follow-Up Study	PLOS ONE			English	Article							DIABETES-MELLITUS; FROZEN SHOULDER; ISCHEMIC-STROKE; PREVALENCE; MANIFESTATIONS; COMPLICATIONS; ASSOCIATION; DISEASE; TAIWAN	Objectives: A previous population-based study reported an increased risk of stroke after the occurrence of adhesive capsulitis of the shoulder (ACS), but there were substantial imbalances in the distribution of age and pre-existing vascular risk factors between subjects with ACS and without ACS, which might lead to a confounded association between ACS and stroke. The purpose of the present large-scale propensity score-matched population-based follow-up study was to clarify whether there is an increased stroke risk after ACS. Methods: We used a logistic regression model that includes age, sex, pre-existing comorbidities and socioeconomic status as covariates to compute the propensity score. A total of 22025 subjects with at least two ambulatory visits with the principal diagnosis of ACS in 2001 was enrolled in the ACS group. The non-ACS group consisted of 22025, propensity score-matched subjects without ACS. The stroke-free survival curves for these 2 groups were compared using the Kaplan-Meier method. Stratified Cox proportional hazard regression with patients matched on propensity score was used to estimate the effect of ACS on the occurrence of stroke. Results: During the two-year follow-up period, 657 subjects in the ACS group (2.98%) and 687 in the non-ACS group (3.12%) developed stroke. The hazard ratio (HR) of stroke for the ACS group was 0.93 compared to the non-ACS group (95% confidence interval [CI], 0.83-1.04, P = 0.1778). There was no statistically significant difference in stroke subtype distribution between the two groups (P = 0.2114). Conclusions: These findings indicate that ACS itself is not associated with an increased risk of subsequent stroke.	[Wang, Yen-Ho; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wang, Yen-Ho; Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wu, Chueh-Hung; Huang, Ya-Ping] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Phys Med & Rehabil, Yunlin, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		WU, CHUEH-HUNG/0000-0002-3979-3541; PAN, SHIN-LIANG/0000-0001-6451-4666	Department of Health (DOH), Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]	Department of Health (DOH), Executive Yuan, Republic of China	This study was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health (DOH), Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RD, 1987, JAMA-J AM MED ASSOC, V257, P949, DOI 10.1001/jama.257.7.949; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Arkkila PET, 1996, ANN RHEUM DIS, V55, P907, DOI 10.1136/ard.55.12.907; Balci N, 1999, J DIABETES COMPLICAT, V13, P135, DOI 10.1016/S1056-8727(99)00037-9; BUNKER TD, 1995, J BONE JOINT SURG BR, V77, P684, DOI 10.1302/0301-620X.77B5.7559689; Cakir M, 2003, CLIN ENDOCRINOL, V59, P162, DOI 10.1046/j.1365-2265.2003.01786.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAVIS PH, 1987, ANN NEUROL, V22, P319, DOI 10.1002/ana.410220307; De Silva DA, 2009, J NEUROL SCI, V285, P118, DOI 10.1016/j.jns.2009.06.013; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Hand C, 2008, J SHOULDER ELB SURG, V17, P231, DOI 10.1016/j.jse.2007.05.009; Hsu JE, 2011, J SHOULDER ELB SURG, V20, P502, DOI 10.1016/j.jse.2010.08.023; Kang JH, 2010, STROKE, V41, P1044, DOI 10.1161/STROKEAHA.109.575589; Lebiedz-Odrobina D, 2010, RHEUM DIS CLIN N AM, V36, P681, DOI 10.1016/j.rdc.2010.09.008; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Makela M, 1999, RHEUMATOLOGY, V38, P656, DOI 10.1093/rheumatology/38.7.656; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; MUSTACCHI P, 1985, WESTERN J MED, V143, P186; Neviaser AS, 2010, AM J SPORT MED, V38, P2346, DOI 10.1177/0363546509348048; Parsons LS., 2004, SAS SUGI, V29, P165; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Ryu JD, 2006, J SHOULDER ELB SURG, V15, P679, DOI 10.1016/j.jse.2006.01.002; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Schneeweiss S, 2000, INT J EPIDEMIOL, V29, P891, DOI 10.1093/ije/29.5.891; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; WOLF PA, 1985, STROKE, V16, P359, DOI 10.1161/01.STR.16.3.359	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49343	10.1371/journal.pone.0049343	http://dx.doi.org/10.1371/journal.pone.0049343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185317	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800022
J	Posadas, I; Santos, P; Cena, V				Posadas, Inmaculada; Santos, Pablo; Cena, Valentin			Acetaminophen Induces Human Neuroblastoma Cell Death through NFKB Activation	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; MITOCHONDRIAL PERMEABILITY TRANSITION; AMYOTROPHIC-LATERAL-SCLEROSIS; KAPPA-B; OXIDATIVE STRESS; INDUCED CYTOTOXICITY; NITRIC-OXIDE; STAGE-4 NEUROBLASTOMA; INDUCED APOPTOSIS; BETULINIC ACID	Neuroblastoma resistance to apoptosis may contribute to the aggressive behavior of this tumor. Therefore, it would be relevant to activate endogenous cellular death mechanisms as a way to improve neuroblastoma therapy. We used the neuroblastoma SH-SY5Y cell line as a model to study the mechanisms involved in acetaminophen (AAP)-mediated toxicity by measuring CYP2E1 enzymatic activity, NFkB p65 subunit activation and translocation to the nucleus, Bax accumulation into the mitochondria, cytochrome c release and caspase activation. AAP activates the intrinsic death pathway in the SH-SY5Y human neuroblastoma cell line. AAP metabolism is partially responsible for this activation, because blockade of the cytochrome CYP2E1 significantly reduced but did not totally prevent, AAP-induced SH-SY5Y cell death. AAP also induced NFkB p65 activation by phosphorylation and its translocation to the nucleus, where NFkB p65 increased IL-1 beta production. This increase contributed to neuroblastoma cell death through a mechanism involving Bax accumulation into the mitochondria, cytochrome c release and caspase3 activation. Blockade of NFkB translocation to the nucleus by the peptide SN50 prevented AAP-mediated cell death and IL-1 beta production. Moreover, overexpression of the antiapoptotic protein Bcl-x(L) did not decrease AAP-mediated IL-1 beta production, but prevented both AAP and IL-1 beta-mediated cell death. We also confirmed the AAP toxic actions on SK-N-MC neuroepithelioma and U87MG glioblastoma cell lines. The results presented here suggest that AAP activates the intrinsic death pathway in neuroblastoma cells through a mechanism involving NFkB and IL-1 beta.	[Posadas, Inmaculada; Santos, Pablo; Cena, Valentin] Univ Castilla La Mancha, UCLM CSIC, Unidad Asociada Neurodeath, Albacete, Spain; [Posadas, Inmaculada; Cena, Valentin] Inst Salud Carlos III, CIBER Enfermedades Neurodegenerativas, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Instituto de Salud Carlos III	Cena, V (corresponding author), Univ Castilla La Mancha, UCLM CSIC, Unidad Asociada Neurodeath, Albacete, Spain.	valentin.cena@gmail.com	Cena, Valentin/L-1751-2017; Posadas, Inmaculada/M-1124-2014	Cena, Valentin/0000-0001-8928-3681; Posadas, Inmaculada/0000-0003-1854-3372	Programa Ramon y Cajal from Ministerio de Educacion y Ciencia (Spain); Universidad de Castilla-La Mancha-Caja Castilla-La Mancha; Junta de Comunidades de Castilla-la Mancha [PAI07-0063, PI-2007/47]; Fondo de Investigaciones Sanitarias [PI081434]; Ministerio de Ciencia e Innovacion [BFU2011-30161-C02-01]; Consejeria de Educacion, Junta de Comunidades de Castilla-La Mancha [PII1I09-0163-002, POII10-0274-182]	Programa Ramon y Cajal from Ministerio de Educacion y Ciencia (Spain)(German Research Foundation (DFG)); Universidad de Castilla-La Mancha-Caja Castilla-La Mancha; Junta de Comunidades de Castilla-la Mancha(Junta de Comunidades de Castilla-La Mancha); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Educacion, Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha)	This work has been supported, in part, by the Programa Ramon y Cajal from Ministerio de Educacion y Ciencia (Spain) and Universidad de Castilla-La Mancha-Caja Castilla-La Mancha to IP, grants PAI07-0063 and PI-2007/47 from Junta de Comunidades de Castilla-la Mancha to IP and grants PI081434 from Fondo de Investigaciones Sanitarias, BFU2011-30161-C02-01 from Ministerio de Ciencia e Innovacion and PII1I09-0163-002 and POII10-0274-182 from Consejeria de Educacion, Junta de Comunidades de Castilla-La Mancha to VC. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal R, 2012, J PHARMACOL EXP THER, V340, P134, DOI 10.1124/jpet.111.184192; Aitken RJ, 2006, J CLIN ENDOCR METAB, V91, P4154, DOI 10.1210/jc.2006-1309; Ambros PF, 2009, BRIT J CANCER, V100, P1471, DOI 10.1038/sj.bjc.6605014; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Boulares AH, 2002, PHARMACOL TOXICOL, V90, P38, DOI 10.1034/j.1600-0773.2002.900108.x; Boulares AH, 2004, BASIC CLIN PHARMACOL, V94, P19; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Chang WY, 2012, J BIOCHEM MOL TOXIC, V26, P71, DOI 10.1002/jbt.20402; Cigremis Y, 2009, MOL CELL BIOCHEM, V323, P31, DOI 10.1007/s11010-008-9961-8; Debatin KM, 2002, ONCOGENE, V21, P8786, DOI 10.1038/sj.onc.1206039; Emery MG, 1999, J PHARMACOL EXP THER, V291, P213; Ferri A, 2004, FASEB J, V18, P1261, DOI 10.1096/fj.03-1199fje; Ferrin G, 2011, CURR PHARM DESIGN, V17, P2002, DOI 10.2174/138161211796904803; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Frye RF, 2002, BRIT J CLIN PHARMACO, V53, P155, DOI 10.1046/j.1365-2125.2002.01522.x; Fulda S, 1997, CANCER RES, V57, P4956; Ganeshan VR, 2011, PEDIATR DRUGS, V13, P245, DOI 10.2165/11591630-000000000-00000; George RE, 2010, EXPERT OPIN PHARMACO, V11, P1467, DOI 10.1517/14656566.2010.482100; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Haase GM, 1999, SEMIN SURG ONCOL, V16, P91, DOI 10.1002/(SICI)1098-2388(199903)16:2<91::AID-SSU3>3.0.CO;2-1; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heck JE, 2009, PAEDIATR PERINAT EP, V23, P125, DOI 10.1111/j.1365-3016.2008.00983.x; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jamshidzadeh A, 2008, FOOD CHEM TOXICOL, V46, P3612, DOI 10.1016/j.fct.2008.09.006; Jordan J, 2002, BRIT J PHARMACOL, V137, P993, DOI 10.1038/sj.bjp.0704953; Jung TW, 2007, J NEUROL SCI, V253, P53, DOI 10.1016/j.jns.2006.11.020; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Liang QN, 2010, TOXICOL MECH METHOD, V20, P273, DOI 10.3109/15376516.2010.482963; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Manyike PT, 2000, CLIN PHARMACOL THER, V67, P275, DOI 10.1067/mcp.2000.104736; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; McPake CR, 1998, ONCOL RES, V10, P235; Moyer AM, 2011, TOXICOL SCI, V120, P33, DOI 10.1093/toxsci/kfq375; Nassini R, 2010, FASEB J, V24, P4904, DOI 10.1096/fj.10-162438; Natoli G, 2006, CELL DEATH DIFFER, V13, P693, DOI 10.1038/sj.cdd.4401880; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Onyango IG, 2005, MOL CELL NEUROSCI, V28, P452, DOI 10.1016/j.mcn.2004.10.006; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Pearson ADJ, 2008, LANCET ONCOL, V9, P247, DOI 10.1016/S1470-2045(08)70069-X; Perez-Carrion MD, 2012, J NEUROCHEM, V120, P259, DOI 10.1111/j.1471-4159.2011.07556.x; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Posadas I, 2007, BRIT J PHARMACOL, V150, P577, DOI 10.1038/sj.bjp.0706993; Posadas I, 2012, J NEUROCHEM, V120, P515, DOI 10.1111/j.1471-4159.2011.07599.x; Posadas I, 2009, PHARM RES-DORDR, V26, P1181, DOI 10.1007/s11095-009-9839-9; REINKE LA, 1985, DRUG METAB DISPOS, V13, P548; RUMACK BH, 1975, PEDIATRICS, V55, P871; Ruppova K, 1999, GEN PHYSIOL BIOPHYS, V18, P140; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sarada S, 2008, EXP BIOL MED, V233, P1088, DOI 10.3181/0712-RM-337; Shalini S, 2007, BIOL RES, V40, P307, DOI /S0716-97602007000400005; Szabo C, 1996, SHOCK, V6, P25, DOI 10.1097/00024382-199607000-00006; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tornero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020423; Tweddle DA, 2001, MED PEDIATR ONCOL, V36, P239, DOI 10.1002/1096-911X(20010101)36:1<239::AID-MPO1058>3.0.CO;2-G; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Watabe M, 2007, J PHARMACOL EXP THER, V323, P499, DOI 10.1124/jpet.107.127597; Weinstein JL, 2003, ONCOLOGIST, V8, P278, DOI 10.1634/theoncologist.8-3-278; Windelborn JA, 2008, J NEUROCHEM, V106, P56, DOI 10.1111/j.1471-4159.2008.05349.x; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yang GD, 2007, MOL CELL BIOCHEM, V302, P187, DOI 10.1007/s11010-007-9440-7; Yang HJ, 2010, NEUROCHEM INT, V56, P128, DOI 10.1016/j.neuint.2009.09.010; Zhang Jiyan, 2003, Hematol J, V4, P277, DOI 10.1038/sj.thj.6200252	71	32	31	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50160	10.1371/journal.pone.0050160	http://dx.doi.org/10.1371/journal.pone.0050160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166834	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885300090
J	Zheng, M; Sun, Y; Liu, GX; Zhou, Y; Zhou, CG				Zheng, Ming; Sun, Ying; Liu, Gui-xia; Zhou, You; Zhou, Chun-guang			Improved Gravitation Field Algorithm and Its Application in Hierarchical Clustering	PLOS ONE			English	Article								Background: Gravitation field algorithm (GFA) is a new optimization algorithm which is based on an imitation of natural phenomena. GFA can do well both for searching global minimum and multi-minima in computational biology. But GFA needs to be improved for increasing efficiency, and modified for applying to some discrete data problems in system biology. Method: An improved GFA called IGFA was proposed in this paper. Two parts were improved in IGFA. The first one is the rule of random division, which is a reasonable strategy and makes running time shorter. The other one is rotation factor, which can improve the accuracy of IGFA. And to apply IGFA to the hierarchical clustering, the initial part and the movement operator were modified. Results: Two kinds of experiments were used to test IGFA. And IGFA was applied to hierarchical clustering. The global minimum experiment was used with IGFA, GFA, GA (genetic algorithm) and SA (simulated annealing). Multi-minima experiment was used with IGFA and GFA. The two experiments results were compared with each other and proved the efficiency of IGFA. IGFA is better than GFA both in accuracy and running time. For the hierarchical clustering, IGFA is used to optimize the smallest distance of genes pairs, and the results were compared with GA and SA, singular-linkage clustering, UPGMA. The efficiency of IGFA is proved.	[Zheng, Ming; Sun, Ying; Liu, Gui-xia; Zhou, You; Zhou, Chun-guang] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Jilin University	Zhou, Y (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	zyou@jlu.edu.cn			National Natural Science Foundation of China [60873146, 60973092, 60903097, 61172183, 61202309]; Hi-Tech Research and Development Program of China [2009AA02Z307]; Project of Science and Technology Innovation Platform of Computing and Software Science [985 En-gineering]; Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Jilin University [20111062, 20121109]; Science-Technology Development Research Project from Jilin Province of China [20101589, 201201139]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Project of Science and Technology Innovation Platform of Computing and Software Science; Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Jilin University(Jilin University); Science-Technology Development Research Project from Jilin Province of China	This work was supported by grants from The National Natural Science Foundation of China (60873146, 60973092, 60903097, 61172183, 61202309), Hi-Tech Research and Development Program of China (2009AA02Z307), Project of Science and Technology Innovation Platform of Computing and Software Science (985 En-gineering), The Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China, Graduate Innovation Fund of Jilin University (20111062, 20121109), and the Science-Technology Development Research Project from Jilin Province of China (20101589,201201139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank M, 2012, ADV ENG SOFTW, V47, P1, DOI 10.1016/j.advengsoft.2011.12.001; Chuang LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021036; Gronau I, 2007, INFORM PROCESS LETT, V104, P205, DOI 10.1016/j.ipl.2007.07.002; Gurbuzbalaban M, 2012, NONLINEAR ANAL-THEOR, V75, P1282, DOI 10.1016/j.na.2011.07.062; Kurata H, 2012, LINEAR ALGEBRA APPL, V436, P1473, DOI 10.1016/j.laa.2011.08.022; Marchetti S, 2012, COMPUT STAT DATA AN, V56, P2889, DOI 10.1016/j.csda.2012.01.023; Motiian S, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE FOR MEASUREMENT SYSTEMS AND APPLICATIONS (CIMSA), P146; Nebel ME, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-24; Peksen O, 2012, TURK J MATH, V36, P147, DOI 10.3906/mat-0911-145; Saez Y, 2005, ADV SOFT COMP, P682; Safronov V., 1972, EVOLUTION PROTOPLANE; Sakata S, 2011, STRUCT MULTIDISCIP O, V44, P393, DOI 10.1007/s00158-011-0643-x; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Schoonhoven M, 2012, TECHNOMETRICS, V54, P73, DOI 10.1080/00401706.2012.648869; Simoes R. D., 2012, PLOS ONE, V7; Sokolov A, 2005, GECCO 2005: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOLS 1 AND 2, P1589; Soler JM, 2009, COMPUT PHYS COMMUN, V180, P1134, DOI 10.1016/j.cpc.2009.01.017; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Wan X, 2006, J COMPUT PHYS, V219, P7, DOI 10.1016/j.jcp.2006.04.016; Wang HK, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-14; Wu J, 2012, REV SCI INSTRUMENTS, V83; Zaki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021821; Zhang XW, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-1; Zheng M, 2012, PROG BIOCHEM BIOPHYS, V39, P581, DOI 10.3724/SP.J.1206.2011.00311; Zheng M, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-32	27	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49039	10.1371/journal.pone.0049039	http://dx.doi.org/10.1371/journal.pone.0049039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173043	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300013
J	Yakubenko, VP; Hsi, LC; Cathcart, MK; Bhattacharjee, A				Yakubenko, Valentin P.; Hsi, Linda C.; Cathcart, Martha K.; Bhattacharjee, Ashish			From Macrophage Interleukin-13 Receptor to Foam Cell Formation MECHANISMS FOR alpha(M)beta(2) INTEGRIN INTERFERENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; HUMAN MONOCYTES; 15-LIPOXYGENASE; CD36; INDUCTION; PHOSPHORYLATION; ATHEROSCLEROSIS; LIPOXYGENASES	IL-13 is a potent stimulator of alternative monocyte/macrophage activation. During alternative activation, the expression of several proteins is induced including 15-lipoxygenase (15-LO), a lipid-peroxidating enzyme and the scavenger receptor CD36. We previously reported that alpha(M)beta(2) integrin activation or clustering suppresses the expression of both 15-LO and CD36. In this study we focused on exploring the molecular mechanisms that down-regulate CD36 expression and CD36-mediated foam cell formation in IL-13-stimulated monocytes/macrophages after alpha(M)beta(2) activation. Our studies reveal that alpha(M)beta(2) integrin activation inhibits the IL-13 activation of several critical pathways that are required for macrophage alternative activation; namely, blocking Jak2 and Tyk2 phosphorylation, which bind to the cytoplasmic tails of the IL-4R alpha/IL-13R alpha 1 complex. This leads to the inhibition of tyrosine phosphorylation of Stats (Stat1, Stat3, and Stat6) and prevents the formation of a signaling complex (containing p38MAPK, PKC delta, and Stat3) that are critical for the expression of both 15-LO and CD36. Jak2-mediated Hck activation is also inhibited, thereby preventing Stats serine phosphorylation, which is essential for downstream Stat-dependent gene transcription. Moreover, inhibition of Jak2, Tyk2, or their downstream target 15-LO with antisense oligonucleotides profoundly inhibits IL-13-induced CD36 expression and CD36-dependent foam cell formation, whereas13(S) Hydroperoxyoctadecadienoic acid (HPODE), a 15-LO product and peroxisome proliferator-activated receptor-gamma ligand, completely restores CD36 expression in monocytes treated with 15-LO antisense. alpha(M)beta(2) integrin activation controls CD36 expression and foam cell formation in alternatively activated monocyte/macrophages by blocking Tyk2/Jak2 phosphorylation via a 15-LO-dependent pathway. The discovery of this mechanism helps our understanding of the potential role of alternatively activated macrophages in atherogenesis and highlights the impact of integrin alpha(M)beta(2) on this process.	[Bhattacharjee, Ashish] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Bhattacharjee, A (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bhattaa@ccf.org			National Institutes of Health [HL051068, HL087018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018, R01HL051068] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL051068 and HL087018 (to M. K. C.).	Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Bhattacharjee A, 2006, J IMMUNOL, V177, P3771, DOI 10.4049/jimmunol.177.6.3771; Bhattacharjee A, 2011, J BIOL CHEM, V286, P36709, DOI 10.1074/jbc.M111.291492; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Cathcart MK, 2000, FREE RADICAL BIO MED, V28, P1726, DOI 10.1016/S0891-5849(00)00230-6; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng JW, 2000, J LIPID RES, V41, P688; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Huang JS, 1999, BIOCHEM J, V342, P231, DOI 10.1042/0264-6021:3420231; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; PATARROYO M, 1994, IMMUNOBIOLOGY, V191, P474, DOI 10.1016/S0171-2985(11)80453-5; Pluskota E., 2010, ATVB POSTER; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Roy B, 1998, J BIOL CHEM, V273, P32023, DOI 10.1074/jbc.273.48.32023; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wang LH, 2000, BLOOD, V95, P1249, DOI 10.1182/blood.V95.4.1249.004k39_1249_1257; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Xu B, 2003, MOL CELL BIOL, V23, P3918, DOI 10.1128/MCB.23.11.3918-3928.2003; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9	32	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2778	2788		10.1074/jbc.M112.381343	http://dx.doi.org/10.1074/jbc.M112.381343			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23184931	Green Published, hybrid			2022-12-25	WOS:000314211500061
J	Wu, GS; Zhang, LY; Li, TT; Zuniga, A; Lopaschuk, GD; Li, L; Jacobs, RL; Vance, DE				Wu, Gengshu; Zhang, Liyan; Li, Tete; Zuniga, Azeret; Lopaschuk, Gary D.; Li, Liang; Jacobs, Rene L.; Vance, Dennis E.			Choline Supplementation Promotes Hepatic Insulin Resistance in Phosphatidylethanolamine N-Methyltransferase-deficient Mice via Increased Glucagon Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-METABOLISM; CDP-CHOLINE; RECEPTOR; GLUCOSE; LIVER; RAT; PHOSPHATIDYLCHOLINE; PHOSPHOCHOLINE; METHYLATION; INVOLVEMENT	Biosynthesis of hepatic choline via phosphatidylethanolamine N-methyltransferase (PEMT) plays an important role in the development of type 2 diabetes and obesity. We investigated the mechanism(s) by which choline modulates insulin sensitivity. PEMT wild-type (Pemt(+/+)) and knock-out (Pemt(-/-)) mice received either a high fat diet (HF; 60% kcal of fat) or a high fat, high choline diet(HFHC; 4 g of choline/kg of HF diet) for 1 week. Hepatic insulin signaling and glucose and lipid homeostasis were investigated. Glucose and insulin intolerance occurred in Pemt(-/-) mice fed the HFHC diet, but not in their Pemt(-/-) littermates fed the HF diet. Plasma glucagon was elevated in Pemt(-/-) mice fed the HFHC diet compared with Pemt(-/-) mice fed the HF diet, concomitant with increased hepatic expression of glucagon receptor, phosphorylated AMP-activated protein kinase (AMPK), and phosphorylated insulin receptor substrate 1 at serine 307 (IRS1-s307). Gluconeogenesis and mitochondrial oxidative stress were markedly enhanced, whereas glucose oxidation and triacylglycerol biosynthesis were diminished in Pemt(-/-) mice fed the HFHC diet. A glucagon receptor antagonist (2-aminobenzimidazole) attenuated choline-induced hyperglycemia and insulin intolerance and blunted up-regulation of phosphorylated AMPK and IRS1-s307. Choline induces glucose and insulin intolerance in Pemt(-/-) mice through modulating plasma glucagon and its action in liver.	[Wu, Gengshu; Li, Tete; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Wu, Gengshu; Li, Tete; Jacobs, Rene L.; Vance, Dennis E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Zhang, Liyan; Lopaschuk, Gary D.] Univ Alberta, Cardiovasc Res Ctr, Mazankowski Alberta Heart Inst, Edmonton, AB T6G 2S2, Canada; [Jacobs, Rene L.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2S2, Canada; [Zuniga, Azeret; Li, Liang] Univ Alberta, Dept Chem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca	Li, Liang/D-1822-2011; Zhang, Li/GWM-7501-2022	Jacobs, Rene/0000-0002-5525-1355	Canadian Institutes of Health Research [MOP 89793]; Genome Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada)	This research was supported Canadian Institutes of Health Research Grant MOP 89793 and Genome Canada.	Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Best CH, 1932, J PHYSIOL-LONDON, V75, P405, DOI 10.1113/jphysiol.1932.sp002899; Cansev M., 2008, Autonomic & Autacoid Pharmacology, V28, P41, DOI 10.1111/j.1474-8673.2007.00416.x; Cansev M, 2008, EUR J PHARMACOL, V589, P315, DOI 10.1016/j.ejphar.2008.05.017; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DOBBS R, 1975, SCIENCE, V187, P544, DOI 10.1126/science.1089999; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; GLASER M, 1974, P NATL ACAD SCI USA, V71, P4072, DOI 10.1073/pnas.71.10.4072; Gronbaek Henning, 2008, Expert Rev Gastroenterol Hepatol, V2, P705, DOI 10.1586/17474124.2.5.705; Gu W, 2010, AM J PHYSIOL-ENDOC M, V299, pE624, DOI 10.1152/ajpendo.00102.2010; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Ilcol YO, 2008, NEUROSCI LETT, V431, P71, DOI 10.1016/j.neulet.2007.11.024; Ilcol YO, 2002, HORM METAB RES, V34, P341, DOI 10.1055/s-2002-33264; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Koek GH, 2011, CLIN CHIM ACTA, V412, P1297, DOI 10.1016/j.cca.2011.04.013; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Ling J, 2012, HEPATOLOGY, V55, P1094, DOI 10.1002/hep.24782; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mang Y, 2004, DIABETES, V53, P410; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; PRIPBUUS C, 1990, BIOCHEM J, V269, P409, DOI 10.1042/bj2690409; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; Saito S, 2001, J HUM GENET, V46, P529, DOI 10.1007/s100380170035; SILVIUS JR, 1986, BIOCHEMISTRY-US, V25, P4249, DOI 10.1021/bi00363a012; SUNDLER R, 1975, BIOCHEM J, V146, P309, DOI 10.1042/bj1460309; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Waite KA, 2004, BBA-MOL CELL BIOL L, V1636, P175, DOI 10.1016/j.bbalip.2003.10.014; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266; Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523	45	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					837	847		10.1074/jbc.M112.415117	http://dx.doi.org/10.1074/jbc.M112.415117			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23179947	hybrid, Green Published			2022-12-25	WOS:000313570300009
J	Cao, X; Yue, L; Song, JY; Wu, QY; Li, N; Luo, L; Lan, L; Yin, ZM				Cao, Xiang; Yue, Ling; Song, JiYun; Wu, Qiuyue; Li, Na; Luo, Lan; Lan, Lei; Yin, Zhimin			Inducible HSP70 Antagonizes IL-1 beta Cytocidal Effects through Inhibiting NF-kB Activation via Destabilizing TAK1 in HeLa Cells	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; I-KAPPA-B; GROWTH-FACTOR; INTERLEUKIN-1; KINASE; HEAT-SHOCK-PROTEIN-70; STABILITY; APOPTOSIS; CHAPERONE; PATHWAYS	Background: Despite several reports describing the HSP70-mediated cytoprotection against IL-1, the precise mechanism for this phenomenon remains to be determined. Methods/Principal Findings: Here we used HeLa cells, a human epithelial carcinoma cell line, to evaluate the role of inducible HSP70 in response of IL-1 beta stimulation. We found that inducible HSP70 antagonized the cytotoxicity of IL-1 beta and improved the survival of HeLa cells. Further investigation demonstrated that increased expression level of inducible HSP70 reduced the complex of TAK1 and HSP90, and promoted the degradation of TAK1 protein via proteasome pathway. By overexpression and RNAi knockdown, we showed that inducible HSP70 modulated the NF-kB but not MAPKs signalings through influencing the stability of TAK1 protein in HeLa cells. Moreover, overexpression of HSP70 attenuated the production of iNOS upon IL-1 beta stimulation, validating that inducible HSP70 serves as a cytopretective factor to antagonize the cytocidal effects of IL-1 beta in HeLa cells. Conclusions/Significance: Our observations provide evidence for a novel signaling mechanism involving HSP70, TAK1, and NF-kB in the response of IL-1 beta cytocidal effects. This research also provides insight into mechanisms by which HSP70 exerts its cytoprotective action upon toxic stimuli in tumor cells.	[Luo, Lan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Cao, Xiang; Yue, Ling; Song, JiYun; Wu, Qiuyue; Li, Na; Lan, Lei; Yin, Zhimin] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Normal University	Luo, L (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	lanluo@nju.edu.cn; lanlei1978@gmail.com; yinzhimin@njnu.edu.cn		Multhoff, Gabriele/0000-0002-2616-3137; Cao, Xiang/0000-0002-4573-8741	Natural Science Foundation of China [81072433, 81172798, 31071000]; Jiangsu Major Nature Science Foundation of High Education [12KJA180006]; Priority Academic Program Development of Jiangsu Higher Education Institutions [164320H106]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Major Nature Science Foundation of High Education; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported by grants from the Natural Science Foundation of China (Nos. 81072433, 81172798 and 31071000) and Jiangsu Major Nature Science Foundation of High Education (No. 12KJA180006) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. 164320H106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Chen Y, 2004, AM J PHYSIOL-HEART C, V287, pH1104, DOI 10.1152/ajpheart.00102.2004; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Doszczak M, 2008, CYTOKINE, V42, P243, DOI 10.1016/j.cyto.2008.02.009; ELLMAN C, 1993, J CLIN INVEST, V92, P3053, DOI 10.1172/JCI116930; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Gao YH, 2010, APOPTOSIS, V15, P822, DOI 10.1007/s10495-010-0495-7; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Guzhova I, 2006, INT REV CYTOL, V254, P101, DOI 10.1016/S0074-7696(06)54003-3; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; HURWITZ A, 1992, ENDOCRINOLOGY, V131, P1643, DOI 10.1210/en.131.4.1643; Jindal S, 1996, TRENDS BIOTECHNOL, V14, P17, DOI 10.1016/0167-7799(96)80909-7; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Liu XY, 2008, FEBS LETT, V582, P4023, DOI 10.1016/j.febslet.2008.10.053; Mahr S, 2000, GASTROENTEROLOGY, V118, P515, DOI 10.1016/S0016-5085(00)70257-5; MARGULIS BA, 1991, DIABETES, V40, P1418, DOI 10.2337/diabetes.40.11.1418; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; ONOZAKI K, 1985, J IMMUNOL, V135, P3962; Papadopoulos G, 1999, MEDIAT INFLAMM, V8, P85; Pelham HRB, 1990, FUNCTIONS HSP7O PROT; RABINOVITCH A, 1990, J CLIN ENDOCR METAB, V71, P152, DOI 10.1210/jcem-71-1-152; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Shi LJ, 2009, MOL IMMUNOL, V46, P541, DOI 10.1016/j.molimm.2008.07.019; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singleton KD, 2006, AM J PHYSIOL-LUNG C, V290, pL956, DOI 10.1152/ajplung.00466.2005; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Yang XH, 2004, J BIOL CHEM, V279, P38099, DOI 10.1074/jbc.C400318200; Yokoo T, 1997, J IMMUNOL, V159, P2886; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697	42	19	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50059	10.1371/journal.pone.0050059	http://dx.doi.org/10.1371/journal.pone.0050059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185533	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000175
J	Gemperle, C; Schmid, M; Herova, M; Marti-Jaun, J; Wuest, SJA; Loretz, C; Hersberger, M				Gemperle, Claudio; Schmid, Mattia; Herova, Magdalena; Marti-Jaun, Jacqueline; Wuest, Sophia J. A.; Loretz, Christa; Hersberger, Martin			Regulation of the Formyl Peptide Receptor 1 (FPR1) Gene in Primary Human Macrophages	PLOS ONE			English	Article							FORMYL-PEPTIDE RECEPTORS; C5A CHEMOATTRACTANT RECEPTORS; NEUTROPHIL; ACTIVATION; EXPRESSION; PHOSPHORYLATION; FORMYLPEPTIDE; INFLAMMATION; RECOGNITION; RESPONSES	The formyl peptide receptor 1 (FPR1) is mainly expressed by mammalian phagocytic leukocytes and plays a role in chemotaxis, killing of microorganisms through phagocytosis, and the generation of reactive oxygen species. A large number of ligands have been identified triggering FPR1 including formylated and non-formylated peptides of microbial and endogenous origin. While the expression of FPR1 in neutrophils has been investigated intensively, knowledge on the regulation of FPR1 expression in polarized macrophages is lacking. In this study we show that primary human neutrophils, monocytes and resting macrophages do express the receptor on their cell surface. Polarization of macrophages with IFN gamma, LPS and with the TLR8 ligand 3M-002 further increases FPR1 mRNA levels but does not consistently increase protein expression or chemotaxis towards the FPR1 ligand fMLF. In contrast, polarization of primary human macrophages with IL-4 and IL-13 leading to the alternative activated macrophages, reduces FPR1 cell surface expression and abolishes chemotaxis towards fMLF. These results show that M2 macrophages will not react to triggering of FPR1, limiting the role for FPR1 to chemotaxis and superoxide production of resting and pro-inflammatory M1 macrophages.	[Gemperle, Claudio; Schmid, Mattia; Herova, Magdalena; Marti-Jaun, Jacqueline; Wuest, Sophia J. A.; Loretz, Christa; Hersberger, Martin] Univ Childrens Hosp Zurich, Div Clin Chem & Biochem, Zurich, Switzerland; [Gemperle, Claudio; Schmid, Mattia; Herova, Magdalena; Marti-Jaun, Jacqueline; Wuest, Sophia J. A.; Loretz, Christa; Hersberger, Martin] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Gemperle, Claudio; Schmid, Mattia; Herova, Magdalena; Marti-Jaun, Jacqueline; Wuest, Sophia J. A.; Loretz, Christa; Hersberger, Martin] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Hersberger, M (corresponding author), Univ Childrens Hosp Zurich, Div Clin Chem & Biochem, Zurich, Switzerland.	martin.hersberger@kispi.uzh.ch		Hersberger, Martin/0000-0002-4472-329X	Swiss National Science Foundation; Hermann Klaus-Stiftung; Vontobel-Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Hermann Klaus-Stiftung; Vontobel-Stiftung	This work was supported by the Swiss National Science Foundation, the Hermann Klaus-Stiftung and the Vontobel-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI H, 1993, J BIOL CHEM, V268, P24247; ANTON PA, 1989, GASTROENTEROLOGY, V97, P20, DOI 10.1016/0016-5085(89)91410-8; Bellner L, 2005, J IMMUNOL, V174, P2235, DOI 10.4049/jimmunol.174.4.2235; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Dai YL, 2005, J INTERF CYTOK RES, V25, P11, DOI 10.1089/jir.2005.25.11; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Gattoni A, 2006, Clin Ter, V157, P377; Hachicha M, 1999, J EXP MED, V189, P1923, DOI 10.1084/jem.189.12.1923; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Luzina IG, 2012, J LEUKOC BIOL; Mandal P, 2005, J IMMUNOL, V175, P6085, DOI 10.4049/jimmunol.175.9.6085; Mandal P, 2007, J IMMUNOL, V178, P2542, DOI 10.4049/jimmunol.178.4.2542; Miettinen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028712; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; STOCKLEY RA, 1994, AM J RESP CRIT CARE, V149, P464, DOI 10.1164/ajrccm.149.2.8306047; Su SB, 1999, BLOOD, V93, P3885, DOI 10.1182/blood.V93.11.3885.411k19_3885_3892; TARDIF M, 1993, J IMMUNOL, V150, P3534; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wuest SJA, 2012, ATHEROSCLEROSIS, V225, P121, DOI 10.1016/j.atherosclerosis.2012.07.022; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	29	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50195	10.1371/journal.pone.0050195	http://dx.doi.org/10.1371/journal.pone.0050195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185575	gold, Green Published, Green Accepted			2022-12-25	WOS:000311821000198
J	Hayakawa, N; Koide, T; Okada, T; Murase, S; Aleksic, B; Furumura, K; Shiino, T; Nakamura, Y; Tamaji, A; Ishikawa, N; Ohoka, H; Usui, H; Banno, N; Morita, T; Goto, S; Kanai, A; Masuda, T; Ozaki, N				Hayakawa, Norika; Koide, Takayoshi; Okada, Takashi; Murase, Satomi; Aleksic, Branko; Furumura, Kaori; Shiino, Tomoko; Nakamura, Yukako; Tamaji, Ai; Ishikawa, Naoko; Ohoka, Harue; Usui, Hinako; Banno, Naomi; Morita, Tokiko; Goto, Setsuko; Kanai, Atsuko; Masuda, Tomoko; Ozaki, Norio			The Postpartum Depressive State in Relation to Perceived Rearing: A Prospective Cohort Study	PLOS ONE			English	Article							PARENTAL BONDING INSTRUMENT; POSTNATAL DEPRESSION; JAPANESE WOMEN; MOOD; REPRESENTATIONS; DISORDERS; SAMPLE; RISK; METAANALYSIS; OUTPATIENTS	Background: The relationship between perceived rearing and the postpartum depressive state remains unclear. We aimed to examine whether perceived rearing is a risk factor for postpartum depression as measured by the Edinburgh Postnatal Depression Scale (EPDS), and whether the score of perceived rearing is affected by depressive mood (the state dependency of perceived rearing). Methods: Pregnant women (n = 448, mean age 31.8+/-4.2 years) completed the EPDS as a measure of depressive state in early pregnancy (T1), late pregnancy (around 36 weeks), and at 1 month postpartum (T2), and the Parental Bonding Instrument (PBI) at T1 as a measure of perceived rearing. Changes in the EPDS and the PBI scores from T1 to T2 were compared between the non depressive (ND) group and the postpartum depressive (PD) group. Results: There were no significant differences in any PBI category for perceived rearing between the ND and PD groups at T1. EPDS scores did not change significantly from T1 to T2 in the ND group but increased significantly in the PD group. The PBI maternal care score increased significantly in the ND group (p<0.01), while decreasing in the PD group (p<0.05). Additionally, in both the ND and PD groups, significant negative correlation was observed regarding change in the EPDS and PBI maternal care scores from T1 to T2 (r = 20.28, p = 0.013). Conclusions: The present study suggests that perceived rearing is not a strong risk factor for postpartum depression as measured by the EPDS. Furthermore, the results indicated the state dependency of the PBI maternal care score.	[Hayakawa, Norika; Koide, Takayoshi; Okada, Takashi; Aleksic, Branko; Furumura, Kaori; Shiino, Tomoko; Nakamura, Yukako; Tamaji, Ai; Ishikawa, Naoko; Ohoka, Harue; Usui, Hinako; Banno, Naomi; Morita, Tokiko; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Hayakawa, Norika] Nanzan Univ, Fac Policy Studies, Seto, Japan; [Murase, Satomi] Liaison Med Marunouchi, Nagoya, Aichi, Japan; [Goto, Setsuko] Sugiyama Jogakuen Univ, Nagoya, Aichi, Japan; [Kanai, Atsuko] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi 4648601, Japan; [Masuda, Tomoko] Nagoya Univ, Grad Sch Law, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University	Okada, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan.	okada@med.nagoya-u.ac.jp	Shiino, Tomoko/M-8903-2014; Ozaki, Norio/M-8908-2014; Shiino, Tomoko/ABA-7481-2020; nakamura, yukako/M-8889-2014; Aleksic, Branko/G-1540-2011; Aleksic, Branko/L-7851-2019; OKADA, Takashi/M-8902-2014	Shiino, Tomoko/0000-0002-8750-0854; Ozaki, Norio/0000-0002-7360-4898; Shiino, Tomoko/0000-0002-8750-0854; nakamura, yukako/0000-0002-3306-7127; Aleksic, Branko/0000-0001-8982-4580; Aleksic, Branko/0000-0001-8982-4580; OKADA, Takashi/0000-0001-5580-9913	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center for Neurology and Psychiatry [21B-2]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center for Neurology and Psychiatry	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/); the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/english/); The Academic Frontier Project for Private Universities, Comparative Cognitive Science Institutes, Meijo University (http://www.meijo-u.ac.jp/english/); and Intramural Research Grant (21B-2) for Neurological and Psychiatric Disorders of National Center for Neurology and Psychiatry (http://www.ncnp.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso P, 2004, PSYCHIAT RES, V127, P267, DOI 10.1016/j.psychres.2001.12.002; Beck A, 1979, COGNITIVE THERAPY DE; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; BOYCE P, 1991, J AFFECT DISORDERS, V21, P245, DOI 10.1016/0165-0327(91)90004-C; Brockington I, 2004, LANCET, V363, P303, DOI 10.1016/S0140-6736(03)15390-1; Canetti L, 2008, J CLIN PSYCHOL, V64, P703, DOI 10.1002/jclp.20482; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Da Costa D, 1999, J PSYCHOSOM RES, V47, P609, DOI 10.1016/S0022-3999(99)00064-1; Furumura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034725; GERLSMA C, 1994, BRIT J CLIN PSYCHOL, V33, P159, DOI 10.1111/j.2044-8260.1994.tb01107.x; Gillham JE, 2007, J PSYCHOPATHOL BEHAV, V29, P125, DOI 10.1007/s10862-006-9031-z; GOTLIB IH, 1988, BRIT J PSYCHIAT, V152, P24, DOI 10.1192/bjp.152.1.24; Hornstra G, 2000, AM J CLIN NUTR, V71, p1262S, DOI 10.1093/ajcn/71.5.1262s; Ishikawa N, 2011, J PSYCHOSOM RES, V71, P264, DOI 10.1016/j.jpsychores.2011.02.001; KITAMURA T, 1993, JPN J PSYCHIAT NEUR, V47, P29; Kitamura T, 1996, BRIT J PSYCHIAT, V168, P732, DOI 10.1192/bjp.168.6.732; KUMAR R, 1994, SOC PSYCH PSYCH EPID, V29, P250, DOI 10.1007/BF00802048; KUMAR R, 1984, BRIT J PSYCHIAT, V144, P35, DOI 10.1192/bjp.144.1.35; Lewis G, 2011, J AM ACAD CHILD PSY, V50, P451, DOI 10.1016/j.jaac.2011.01.015; Lizardi H, 2005, J NERV MENT DIS, V193, P183, DOI 10.1097/01.nmd.0000154838.16100.36; MACKINNON AJ, 1989, PSYCHOL MED, V19, P1023, DOI 10.1017/S0033291700005754; Matthey S, 2000, J AFFECT DISORDERS, V60, P75, DOI 10.1016/S0165-0327(99)00159-7; McLaren L, 2007, J AFFECT DISORDERS, V100, P211, DOI 10.1016/j.jad.2006.10.021; McMahon C, 2005, J AFFECT DISORDERS, V84, P15, DOI 10.1016/j.jad.2004.05.005; Murphy E, 2010, J AFFECT DISORDERS, V125, P307, DOI 10.1016/j.jad.2010.01.003; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; MURRAY L, 1992, J CHILD PSYCHOL PSYC, V33, P543, DOI 10.1111/j.1469-7610.1992.tb00890.x; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Okano T, 1996, ARCH PSYCHIATR DIAGN, V7, P525; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; PARKER G, 1981, J AFFECT DISORDERS, V3, P131, DOI 10.1016/0165-0327(81)90038-0; PARKER G, 1992, PSYCHOL MED, V22, P657, DOI 10.1017/S0033291700038101; PARKER G, 1983, ARCH GEN PSYCHIAT, V40, P956; PARKER G, 1979, BRIT J PSYCHIAT, V134, P138, DOI 10.1192/bjp.134.2.138; Paulson JF, 2010, JAMA-J AM MED ASSOC, V303, P1961, DOI 10.1001/jama.2010.605; Pawlby S, 2008, J AFFECT DISORDERS, V107, P241, DOI 10.1016/j.jad.2007.08.002; PLANTES MM, 1988, J AFFECT DISORDERS, V15, P149, DOI 10.1016/0165-0327(88)90083-3; Sato T, 1997, ACTA PSYCHIAT SCAND, V96, P306, DOI 10.1111/j.1600-0447.1997.tb10168.x; Sharma V, 2010, J AFFECT DISORDERS, V125, P18, DOI 10.1016/j.jad.2009.09.014; Su KP, 2007, GEN HOSP PSYCHIAT, V29, P436, DOI 10.1016/j.genhosppsych.2007.05.005; Wilhelm K, 2005, PSYCHOL MED, V35, P387, DOI 10.1017/S0033291704003538; Yamashita H, 2000, J AFFECT DISORDERS, V58, P145, DOI 10.1016/S0165-0327(99)00108-1	43	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50220	10.1371/journal.pone.0050220	http://dx.doi.org/10.1371/journal.pone.0050220			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185582	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000203
J	Li, M; Cao, WQ; Liu, HF; Zhang, W; Liu, X; Cai, ZJ; Guo, J; Wang, XL; Hui, ZY; Zhang, H; Wang, JL; Wang, L				Li, Min; Cao, Wenqiang; Liu, Haifeng; Zhang, Wei; Liu, Xia; Cai, Zhijian; Guo, Jing; Wang, Xuelian; Hui, Zhaoyuan; Zhang, Hang; Wang, Jianli; Wang, Lie			MCPIP1 Down-Regulates IL-2 Expression through an ARE-Independent Pathway	PLOS ONE			English	Article							MESSENGER-RNA DECAY; AU-RICH ELEMENTS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TRISTETRAPROLIN; DESTABILIZATION; PROMOTES; DEADENYLATION; DEGRADATION; ACTIVATION	IL-2 plays a key role in the survival and proliferation of immune cells, especially T lymphocytes. Its expression is precisely regulated at transcriptional and posttranscriptional level. IL-2 is known to be regulated by RNA binding proteins, such as tristetraprolin (TTP), via an AU-rich element (ARE) in the 3'-untranslated region (3'UTR) to influence the stability of mRNA. MCPIP1, identified as a novel RNase, can degrade IL-6, IL-12 and TNF-alpha mRNA by an ARE-independent pathway in the activation of macrophages. Here, we reported that MCPIP1 was induced in the activation of T lymphocytes and negatively regulated IL-2 gene expression in both mouse and human primary T lymphocytes through destabilizing its mRNA. A set of Luciferase reporter assay demonstrated that a non-ARE conserved element in IL-2 3'UTR, which formed a stem-loop structure, responded to MCPIP1 activity. RNA immunoprecipitation and Biotin pulldown experiments further suggested that MCPIP1 could modestly bind to IL-2 mRNA. Taken together, these data demonstrate that MCPIP1 down-regulates IL-2 via an ARE-independent pathway.	[Li, Min; Cao, Wenqiang; Zhang, Wei; Liu, Xia; Cai, Zhijian; Guo, Jing; Wang, Xuelian; Hui, Zhaoyuan; Zhang, Hang; Wang, Jianli; Wang, Lie] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Haifeng] Chinese Acad Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, JL (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	jlwang@zju.edu.cn; wanglie@zju.edu.cn	Li, Min/HGA-9902-2022	cao, wenqiang/0000-0002-5024-0817	National Natural Science Foundation of China [J20111945]; National Basic Research Program of China (973 Program) [2012CB966603]; Natural Science Foundation of Zhejiang Province, China [R20110298]; Ministry of Education of China [20110101120102]; Fundamental Research Funds for the Central Universities [2011QNA7001]; National Technology Key Projects of China [008ZX1002-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Technology Key Projects of China	This work was supported by grants from the National Natural Science Foundation of China (J20111945), National Basic Research Program of China (973 Program) (2012CB966603), Natural Science Foundation of Zhejiang Province, China (R20110298), Doctoral Fund of Ministry of Education of China (20110101120102), the Fundamental Research Funds for the Central Universities (2011QNA7001) and the National Technology Key Projects of China (008ZX1002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arne B, 1984, METHOD ENZYMOL, P88; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lee HH, 2012, FEBS LETT, V586, P41, DOI 10.1016/j.febslet.2011.11.021; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; SMITH KA, 1980, NATURE, V287, P853, DOI 10.1038/287853a0; Stellato C, 2011, J IMMUNOL, V187, P441, DOI 10.4049/jimmunol.1001881; Suzuki Hiroshi I, 2011, MOL CELL, V44, P424; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	28	65	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49841	10.1371/journal.pone.0049841	http://dx.doi.org/10.1371/journal.pone.0049841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185455	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000120
J	Liu, RX; Jia, HT; Cao, XL; Huang, J; Li, F; Tao, YS; Qiu, FZ; Zheng, YL; Zhang, ZX				Liu, Ruixiang; Jia, Haitao; Cao, Xiaoliang; Huang, Jun; Li, Feng; Tao, Yongsheng; Qiu, Fazhan; Zheng, Yonglian; Zhang, Zuxin			Fine Mapping and Candidate Gene Prediction of a Pleiotropic Quantitative Trait Locus for Yield-Related Trait in Zea mays	PLOS ONE			English	Article							SET DOMAIN PROTEINS; GRAIN-YIELD; QTL ANALYSIS; MAIZE; INFLORESCENCE; COMPONENTS; ENCODES; PLANT; ARCHITECTURE; ARABIDOPSIS	The yield of maize grain is a highly complex quantitative trait that is controlled by multiple quantitative trait loci (QTLs) with small effects, and is frequently influenced by multiple genetic and environmental factors. Thus, it is challenging to clone a QTL for grain yield in the maize genome. Previously, we identified a major QTL, qKNPR6, for kernel number per row (KNPR) across multiple environments, and developed two nearly isogenic lines, SL57-6 and Ye478, which differ only in the allelic constitution at the short segment harboring the QTL. Recently, qKNPR6 was re-evaluated in segregating populations derived from SL57-6xYe478, and was narrowed down to a 2.8 cM interval, which explained 56.3% of the phenotypic variance of KNPR in 201 F-2:3 families. The QTL simultaneously affected ear length, kernel weight and grain yield. Furthermore, a large F-2 population with more than 12,800 plants, 191 recombinant chromosomes and 10 overlapping recombinant lines placed qKNPR6 into a 0.91 cM interval corresponding to 198Kb of the B73 reference genome. In this region, six genes with expressed sequence tag (EST) evidence were annotated. The expression pattern and DNA diversity of the six genes were assayed in Ye478 and SL57-6. The possible candidate gene and the pathway involved in inflorescence development were discussed.	[Liu, Ruixiang; Jia, Haitao; Cao, Xiaoliang; Huang, Jun; Li, Feng; Qiu, Fazhan; Zheng, Yonglian; Zhang, Zuxin] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Liu, Ruixiang; Cao, Xiaoliang; Tao, Yongsheng] Hebei Agr Univ, Coll Agron, Baoding, Peoples R China	Huazhong Agricultural University; Hebei Agricultural University	Zhang, ZX (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	zuxinzhang@mail.hzau.edu.cn			National Basic Research Program of China [2009CB118400, 2011CB100100]; Hi-tech Research and Development Program of China [2012AA10307]	National Basic Research Program of China(National Basic Research Program of China); Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China)	This study was financially supported by the National Basic Research Program of China (2009CB118400; 2011CB100100) and the Hi-tech Research and Development Program of China (2012AA10307). (http://www.973.gov.cn/) (http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJMONEMARSAN P, 1995, THEOR APPL GENET, V90, P415, DOI 10.1007/BF00221984; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Austin DF, 1998, CROP SCI, V38, P1296, DOI 10.2135/cropsci1998.0011183X003800050029x; Austin DF, 1996, THEOR APPL GENET, V92, P817, DOI 10.1007/BF00221893; Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Frascaroli E, 2009, THEOR APPL GENET, V118, P993, DOI 10.1007/s00122-008-0956-3; Fridman E, 2002, MOL GENET GENOMICS, V266, P821, DOI 10.1007/s00438-001-0599-4; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Graham GI, 1997, CROP SCI, V37, P1601, DOI 10.2135/cropsci1997.0011183X003700050033x; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Kim SY, 2005, PLANT CELL, V17, P3301, DOI 10.1105/tpc.105.034645; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Liu RX, 2012, PLANT MOL BIOL REP, V30, P297, DOI 10.1007/s11105-011-0346-x; Liu XH, 2011, GENET MOL RES, V10, P3267, DOI 10.4238/2011.December.22.5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XQ, 2007, MOL BREEDING, V20, P41, DOI 10.1007/s11032-006-9071-9; McSteen P, 2001, DEVELOPMENT, V128, P2881; McSteen P, 2007, PLANT PHYSIOL, V144, P1000, DOI 10.1104/pp.107.098558; Melchinger AE, 1998, GENETICS, V149, P383; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Monforte AJ, 2000, THEOR APPL GENET, V100, P471, DOI 10.1007/s001220050061; PATERSON AH, 1990, GENETICS, V124, P735; Peng B, 2011, THEOR APPL GENET, V122, P1305, DOI 10.1007/s00122-011-1532-9; Ritter MK, 2002, AM J BOT, V89, P203, DOI 10.3732/ajb.89.2.203; ROBINSON HF, 1951, AGRON J, V43, P282, DOI 10.2134/agronj1951.00021962004300060007x; Ross AJ, 2006, MAYDICA, V51, P301; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Skirpan A, 2009, PLANT CELL PHYSIOL, V50, P652, DOI 10.1093/pcp/pcp006; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Tan WeiWei, 2011, Scientia Agricultura Sinica, V44, P233; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Thorstensen T, 2011, BBA-GENE REGUL MECH, V1809, P407, DOI 10.1016/j.bbagrm.2011.05.008; Tuberosa Roberto, 2009, P501, DOI 10.1007/978-0-387-79418-1_26; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; VELDBOOM LR, 1994, THEOR APPL GENET, V89, P451, DOI 10.1007/BF00225380; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Vollbrecht Erik, 2009, P13, DOI 10.1007/978-0-387-79418-1_2; Wang P, 2012, MOL BREEDING, V29, P99, DOI 10.1007/s11032-010-9529-7; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Zhao Z, 2005, NAT CELL BIOL, V7, P1256, DOI 10.1038/ncb1329	51	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49836	10.1371/journal.pone.0049836	http://dx.doi.org/10.1371/journal.pone.0049836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185451	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000117
J	Valencia, BM; Veland, N; Alba, M; Adaui, V; Arevalo, J; Low, DE; Llanos-Cuentas, A; Boggild, AK				Mark Valencia, Braulio; Veland, Nicolas; Alba, Milena; Adaui, Vanessa; Arevalo, Jorge; Low, Donald E.; Llanos-Cuentas, Alejandro; Boggild, Andrea K.			Non-Invasive Cytology Brush PCR for the Diagnosis and Causative Species Identification of American Cutaneous Leishmaniasis in Peru	PLOS ONE			English	Article							MOLECULAR DIAGNOSIS; MICROCULTURE METHOD; PARASITES; ASSAY	Background: Traditional methods of detecting Leishmania from cutaneous lesions involve invasive diagnostic procedures, such as scrapings, which cause discomfort, require technical expertise, and carry risks of invasive procedures. We compared the performance of 2 novel, molecular-based non-invasive methods for the diagnosis of cutaneous leishmaniasis (CL). Methods: Consecutive patients presenting to the Leishmania Clinic at the Hospital Nacional Cayetano Heredia were enrolled. PCR was performed on filter paper lesion impressions (FPLIs), cytology brushes, and lancets for detection of Leishmania DNA. Smears from lesion scrapings and leishmanin skin test were also performed. Outcome measures were sensitivity and specificity. Composite reference standard was any 2 of 5 tests positive. Species identification was performed by PCR assays of positive specimens. Results: Ninety patients with 129 lesions were enrolled, 117 of which fulfilled reference criteria for a diagnosis of CL. Of these 117 lesions, 113 were positive by PCR of lancets used for lesion scrapings versus 116 by PCR of FPLIs (p = 0.930) or 116 by PCR of cytology brushes (p = 0.930). Sensitivity and specificity of PCR on lancets were 96.6% [95% CI 93.3-99.9%] and 100%, respectively. Sensitivity and specificity of FPLI PCR were 99.1% [95% CI 97.4-100%] and 100%, respectively. Sensitivity and specificity of cytology brush PCR were 99.1% [95% CI 97.4-100%] and 100%, respectively. Giemsa-stained lesion smear and leishmanin skin test had inferior sensitivities at 47.9% [95% CI 38.9-57.0%] and 82.3% [95% CI 73.9-90.7%], respectively, compared to PCR of invasive or non-invasive specimens (p<0.001). Conclusions: Cytology brush PCR constitutes a sensitive and specific alternative to traditional diagnostic assays performed on invasive specimens such as lesion scrapings. It performs comparatively to non-invasive FPLI PCR. This novel, rapid, and well-tolerated method has the potential for widespread use in the field and in pediatric populations where traditional specimen collection is difficult.	[Boggild, Andrea K.] Toronto Gen Hosp, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada; [Boggild, Andrea K.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Mark Valencia, Braulio; Veland, Nicolas; Alba, Milena; Adaui, Vanessa; Arevalo, Jorge; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia UPCH, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Arevalo, Jorge] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru; [Low, Donald E.] Publ Hlth Ontario, Publ Hlth Labs, Etobicoke, ON, Canada; [Low, Donald E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Llanos-Cuentas, Alejandro] Hosp Nacl Cayetano Heredia, Lima, Peru	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Toronto	Boggild, AK (corresponding author), Toronto Gen Hosp, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada.	andrea.boggild@utoronto.ca	Adaui, Vanessa/AAU-7219-2020; Arroyo, Braulio Mark Valencia/AAF-6136-2019	Arroyo, Braulio Mark Valencia/0000-0001-6741-3908; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; Arevalo, Jorge/0000-0003-3837-2849; Veland, Nicolas/0000-0002-3096-7867	Royal College of Physicians and Surgeons of Canada	Royal College of Physicians and Surgeons of Canada	AKB was supported by a Detweiler Traveling Fellowship through the Royal College of Physicians and Surgeons of Canada during the study period. Personnel and facility support for the Arevalo molecular laboratory (NV, MA, VA, JA) were provided by the Institutional Collaboration Framework Agreement 3 from the Belgian Directorate-General for Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdiyev AM, 2004, AM J TROP MED HYG, V70, P294, DOI 10.4269/ajtmh.2004.70.294; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; Aviles H, 1999, J PARASITOL, V85, P181, DOI 10.2307/3285616; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Boggild AK, 2007, J CLIN MICROBIOL, V45, P3680, DOI 10.1128/JCM.01286-07; Boggild AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026395; Boggild AK, 2011, J CLIN MICROBIOL, V49, P1097, DOI 10.1128/JCM.02457-10; Boggild AK, 2010, CLIN INFECT DIS, V50, pE1, DOI 10.1086/648730; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Perez JE, 2007, MEM I OSWALDO CRUZ, V102, P655, DOI 10.1590/S0074-02762007005000077; Garcia A. L., 2005, Infection Genetics and Evolution, V5, P109, DOI 10.1016/j.meegid.2004.07.003; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; LOPEZ M, 1993, AM J TROP MED HYG, V49, P348, DOI 10.4269/ajtmh.1993.49.348; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Singh S, 2006, INDIAN J MED RES, V123, P311; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; Tavares CAP, 2003, EXPERT REV MOL DIAGN, V3, P657, DOI 10.1586/14737159.3.5.657; Veland N, 2012, J CLIN MICROBIOL, V50, P495, DOI 10.1128/JCM.05061-11; Zhang WW, 2006, CLIN INFECT DIS, V42, P801, DOI 10.1086/500326	22	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49738	10.1371/journal.pone.0049738	http://dx.doi.org/10.1371/journal.pone.0049738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185421	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000097
J	Rebe, C; Filomenko, R; Raveneau, M; Chevriaux, A; Ishibashi, M; Lagrost, L; Junien, JL; Gambert, P; Masson, D				Rebe, Cedric; Filomenko, Rodolphe; Raveneau, Magalie; Chevriaux, Angelique; Ishibashi, Minako; Lagrost, Laurent; Junien, Jean Louis; Gambert, Philippe; Masson, David			Identification of Biological Markers of Liver X Receptor (LXR) Activation at the Cell Surface of Human Monocytes	PLOS ONE			English	Article							REVERSE CHOLESTEROL TRANSPORT; PHOSPHOLIPID TRANSFER PROTEIN; IN-VIVO; ATHEROSCLEROSIS; AGONISTS; ALPHA; MICE; MACROPHAGES; EXPRESSION; INCREASES	Background: Liver X receptor (LXR) alpha and LXR beta (NR1H3 and NR1H2) are oxysterol-activated nuclear receptors involved in the control of major metabolic pathways such as cholesterol homeostasis, lipogenesis, inflammation and innate immunity. Synthetic LXR agonists are currently under development and could find applications in various fields such as cardiovascular diseases, cancer, diabetes and neurodegenerative diseases. The clinical development of LXR agonists requires the identification of biological markers for pharmacodynamic studies. In this context, monocytes represent an attractive target to monitor LXR activation. They are easily accessible cells present in peripheral blood; they express LXR alpha and beta and respond to LXR agonist stimulation in vitro. The aim of our study was to identify cell surface markers of LXR agonists on monocytes. For this, we focused on clusters of differentiation (CD) markers because they are well characterized and accessible cell surface molecules allowing easy immuno-phenotyping. Methodology/Principal Findings: By using microarray analysis of monocytes treated or not with an LXR agonist in vitro, we selected three CD, i.e. CD82, CD226, CD244 for further analysis by real time PCR and flow cytometry. The three CD were up-regulated by LXR agonist treatment in vitro in a time-and dose-dependent manner and this induction was LXR specific as assessed by a SiRNA or LXR antagonist strategy. By using flow cytometry, we could demonstrate that the expression of these molecules at the cell surface of monocytes was significantly increased after LXR agonist treatment. Conclusions/Significance: We have identified three new cell surface markers that could be useful to monitor LXR activation. Future studies will be required to confirm the biological and diagnostic significance of the markers.	[Rebe, Cedric; Chevriaux, Angelique; Ishibashi, Minako; Lagrost, Laurent; Gambert, Philippe; Masson, David] Univ Bourgogne, Ctr Rech, Inst Natl Sante & Rech Med, Unite Mixte Rech 866, Dijon, France; [Rebe, Cedric; Chevriaux, Angelique] Ctr Georges Francois Leclerc, Dijon, France; [Lagrost, Laurent; Gambert, Philippe; Masson, David] Ctr Hosp Univ Dijon, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; CHU Dijon Bourgogne	Masson, D (corresponding author), Univ Bourgogne, Ctr Rech, Inst Natl Sante & Rech Med, Unite Mixte Rech 866, Dijon, France.	david.masson@chu-dijon.fr	MASSON, David/AAC-8896-2022; Masson, David/R-6633-2019; REBE, Cédric/AAD-4316-2019; MASSON, David/R-4557-2017	MASSON, David/0000-0003-1692-0699; REBE, Cédric/0000-0001-8831-145X; MASSON, David/0000-0003-1692-0699	University of Burgundy; University Hospital of Dijon; Regional Council of Burgundy; French National Institute for Medical Research (INSERM)	University of Burgundy; University Hospital of Dijon; Regional Council of Burgundy(Region Bourgogne-Franche-Comte); French National Institute for Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by the University of Burgundy, The University Hospital of Dijon, The Regional Council of Burgundy and by the French National Institute for Medical Research (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calkin AC, 2012, NAT REV MOL CELL BIO; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Costet P, 2000, J BIOL CHEM, V275, P28240; DiBlasio-Smith EA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-59; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Honzumi S, BIOCH BIOPHYS ACTA, V1811, P1136; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kase ET, 2007, DIABETOLOGIA, V50, P2171, DOI 10.1007/s00125-007-0760-7; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; Masson D, 2004, J LIPID RES, V45, P543, DOI 10.1194/jlr.M300432-JLR200; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y; Quinet EM, 2009, J LIPID RES, V50, P2358, DOI 10.1194/jlr.M900037-JLR200; Rebe C, 2009, CIRC RES, V105, P393, DOI 10.1161/CIRCRESAHA.109.201855; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Spencer TA, 2001, J MED CHEM, V44, P886, DOI 10.1021/jm0004749; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Tsai YC, 2011, FEBS LETT, V585, P3166, DOI 10.1016/j.febslet.2011.08.031; Verschuren L, 2009, J LIPID RES, V50, P301, DOI 10.1194/jlr.M800374-JLR200; Viennois E, 2012, MOL CELL ENDOCRINOL, V351, P129, DOI 10.1016/j.mce.2011.08.036; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang Y, 2012, J CLIN INVEST, V122, P1688, DOI 10.1172/JCI59817	33	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e48738	10.1371/journal.pone.0048738	http://dx.doi.org/10.1371/journal.pone.0048738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185273	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000020
J	Ropars, J; Dupont, J; Fontanillas, E; de la Vega, RCR; Malagnac, F; Coton, M; Giraud, T; Lopez-Villavicencio, M				Ropars, Jeanne; Dupont, Joelle; Fontanillas, Eric; de la Vega, Ricardo C. Rodriguez; Malagnac, Fabienne; Coton, Monika; Giraud, Tatiana; Lopez-Villavicencio, Manuela			Sex in Cheese: Evidence for Sexuality in the Fungus Penicillium roqueforti	PLOS ONE			English	Article							INDUCED POINT MUTATION; TRANSPOSABLE ELEMENTS; MATING TYPES; ASPERGILLUS-NIDULANS; POPULATION-STRUCTURE; ASEXUAL FUNGI; MEIOTIC GENES; GENOME; EVOLUTION; SEQUENCE	Although most eukaryotes reproduce sexually at some moment of their life cycle, as much as a fifth of fungal species were thought to reproduce exclusively asexually. Nevertheless, recent studies have revealed the occurrence of sex in some of these supposedly asexual species. For industrially relevant fungi, for which inoculums are produced by clonal-subcultures since decades, the potentiality for sex is of great interest for strain improvement strategies. Here, we investigated the sexual capability of the fungus Penicillium roqueforti, used as starter for blue cheese production. We present indirect evidence suggesting that recombination could be occurring in this species. The screening of a large sample of strains isolated from diverse substrates throughout the world revealed the existence of individuals of both mating types, even in the very same cheese. The MAT genes, involved in fungal sexual compatibility, appeared to evolve under purifying selection, suggesting that they are still functional. The examination of the recently sequenced genome of the FM 164 cheese strain enabled the identification of the most important genes known to be involved in meiosis, which were found to be highly conserved. Linkage disequilibria were not significant among three of the six marker pairs and 11 out of the 16 possible allelic combinations were found in the dataset. Finally, the detection of signatures of repeat induced point mutations (RIP) in repeated sequences and transposable elements reinforces the conclusion that P. roqueforti underwent more or less recent sex events. In this species of high industrial importance, the induction of a sexual cycle would open the possibility of generating new genotypes that would be extremely useful to diversify cheese products.	[Ropars, Jeanne; Dupont, Joelle; Lopez-Villavicencio, Manuela] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR CNRS MNHN 7205, F-75231 Paris, France; [Malagnac, Fabienne] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Coton, Monika] Univ Brest, UEB, Lab Univ Biodiversite & Ecol Microbienne EA 3882, SFR ScInBioS IFR148,ESMISAB, Plouzane, France; [Malagnac, Fabienne] Univ Paris Diderot, UFR Sci Vivant, Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Universite de Bretagne Occidentale; UDICE-French Research Universities; Universite Paris Cite	Ropars, J (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, UMR CNRS MNHN 7205, F-75231 Paris, France.	jropars@mnhn.fr	Rodríguez de la Vega, Ricardo/A-4542-2008; Ropars, Jeanne/O-4113-2018	Rodríguez de la Vega, Ricardo/0000-0002-9852-6654; Coton, Monika/0000-0002-0148-6802; Malagnac, Fabienne/0000-0003-1139-7691; Ropars, Jeanne/0000-0002-3740-9673; Giraud, Tatiana/0000-0002-2685-6478	ANR project "Food Microbiomes" [ANR-08-ALIA-007-02]; SPPAIL (Syndicat Professionnel des Producteurs d'Auxiliaires pour l'Industrie Laitiere); FungiSex [ANR-09-0064-01]; European Union Seventh Framework Programme [246556]	ANR project "Food Microbiomes"(French National Research Agency (ANR)); SPPAIL (Syndicat Professionnel des Producteurs d'Auxiliaires pour l'Industrie Laitiere); FungiSex; European Union Seventh Framework Programme(European Commission)	This work was partly supported by the ANR project "Food Microbiomes" (ANR-08-ALIA-007-02) coordinated by Pierre Renault and by the SPPAIL (Syndicat Professionnel des Producteurs d'Auxiliaires pour l'Industrie Laitiere). TG acknowledges the grant FungiSex ANR-09-0064-01. RCRdlV research receives funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No. 246556. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agreste, 2009, ENQ ANN LAIT PROD NA; Aguileta G, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P164; Bakkeren Guus, 2007, P389; Barraclough TG, 2003, EVOLUTION, V57, P2166; Barve MP, 2003, FUNGAL GENET BIOL, V39, P151, DOI 10.1016/S1087-1845(03)00015-X; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; Billiard S, 2011, BIOL REV, V86, P421, DOI 10.1111/j.1469-185X.2010.00153.x; Birky CW, 1999, J EVOLUTION BIOL, V12, P1013; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Braumann I, 2008, CURR GENET, V53, P287, DOI 10.1007/s00294-008-0185-y; Bruggeman J, 2003, GENETICS, V164, P479; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; CAMBARERI EB, 1991, GENETICS, V127, P699; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Clutterbuck AJ, 2004, FUNGAL GENET BIOL, V41, P308, DOI 10.1016/j.fgb.2003.11.004; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Crouch JA, 2008, FUNGAL GENET BIOL, V45, P190, DOI 10.1016/j.fgb.2007.08.004; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; Dyer PS, 2011, CURR OPIN MICROBIOL, V14, P649, DOI 10.1016/j.mib.2011.10.001; Fisher Matthew C., 2007, P201; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Giraud F, 2010, INT J FOOD MICROBIOL, V137, P204, DOI 10.1016/j.ijfoodmicro.2009.11.014; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graia F, 2001, MOL MICROBIOL, V40, P586, DOI 10.1046/j.1365-2958.2001.02367.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Halary Sebastien, 2011, Genome Biol Evol, V3, P950, DOI 10.1093/gbe/evr089; Hane JK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-478; Henk DA, PLOS PATHOGENS; Hoff B, 2008, EUKARYOT CELL, V7, P465, DOI 10.1128/EC.00430-07; Hood ME, 2005, GENETICS, V170, P1081, DOI 10.1534/genetics.105.042564; Horns F, 2012, GENOME BIOL EVOL, V4, P240, DOI 10.1093/gbe/evs005; Houbraken J, 2010, IMA FUNGUS, V1, P171, DOI 10.5598/imafungus.2010.01.02.10; Houbraken J, 2011, IMA FUNGUS, V2, P87, DOI 10.5598/imafungus.2011.02.01.12; Idnurm A, 2003, FUNGAL GENET BIOL, V39, P31, DOI 10.1016/S1087-1845(02)00588-1; Ikeda K, 2002, MOL MICROBIOL, V45, P1355, DOI 10.1046/j.1365-2958.2002.03101.x; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koufopanou V, 1997, P NATL ACAD SCI USA, V94, P5478, DOI 10.1073/pnas.94.10.5478; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Lehtonen J, 2012, TRENDS ECOL EVOL, V27, P172, DOI 10.1016/j.tree.2011.09.016; Lengeler KB, 2000, P NATL ACAD SCI USA, V97, P14455, DOI 10.1073/pnas.97.26.14455; Linde CC, 2003, FUNGAL GENET BIOL, V40, P115, DOI 10.1016/S1087-1845(03)00110-5; LOBUGLIO KF, 1993, MYCOLOGIA, V85, P592, DOI 10.2307/3760506; Lopez-Villavicencio M, 2010, FUNGAL GENET BIOL, V47, P693, DOI 10.1016/j.fgb.2010.05.002; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Milgroom MG, 1996, ANNU REV PHYTOPATHOL, V34, P457, DOI 10.1146/annurev.phyto.34.1.457; Montiel MD, 2006, FUNGAL GENET BIOL, V43, P439, DOI 10.1016/j.fgb.2006.01.011; Neafsey DE, 2010, GENOME RES, V20, P938, DOI 10.1101/gr.103911.109; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P3, DOI 10.1007/978-0-387-92207-2_2; Poggeler S, 2011, FUNGAL BIOL-UK, V115, P615, DOI 10.1016/j.funbio.2011.03.003; Poggeler S, 2001, APPL MICROBIOL BIOT, V56, P589, DOI 10.1007/s002530100721; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ropars J, 2012, INT J FOOD MICROBIOL, V155, P199, DOI 10.1016/j.ijfoodmicro.2012.02.005; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Samson RA, 2004, STUD MYCOL, P175; Samson RA, 2000, INTRO FOOD AIRBORNE; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; SELKER EU, 1987, CELL, V51, P741, DOI 10.1016/0092-8674(87)90097-3; SELKER EU, 1988, P NATL ACAD SCI USA, V85, P6870, DOI 10.1073/pnas.85.18.6870; SMITH JM, 1978, EVOLUTION SEX; Sommerhalder RJ, 2006, PHYTOPATHOLOGY, V96, P234, DOI 10.1094/PHYTO-96-0234; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Wik L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-109; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303	84	33	34	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49665	10.1371/journal.pone.0049665	http://dx.doi.org/10.1371/journal.pone.0049665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185400	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000080
J	Zakikhani, M; Bazile, M; Hashemi, S; Javeshghani, S; Avizonis, D; St Pierre, J; Pollak, MN				Zakikhani, Mahvash; Bazile, Miguel; Hashemi, Sina; Javeshghani, Shiva; Avizonis, Daina; St Pierre, Julie; Pollak, Michael N.			Alterations in Cellular Energy Metabolism Associated with the Antiproliferative Effects of the ATM Inhibitor KU-55933 and with Metformin	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA GENE; OXIDATIVE STRESS; PROTEIN-KINASE; DNA-DAMAGE; COMPLEX-II; PHOSPHORYLATION; ACTIVATION; APOPTOSIS; IDENTIFICATION; MECHANISM	KU-55933 is a specific inhibitor of the kinase activity of the protein encoded by Ataxia telangiectasia mutated (ATM), an important tumor suppressor gene with key roles in DNA repair. Unexpectedly for an inhibitor of a tumor suppressor gene, KU-55933 reduces proliferation. In view of prior preliminary evidence suggesting defective mitochondrial function in cells of patients with Ataxia Telangiectasia (AT), we examined energy metabolism of cells treated with KU-55933. The compound increased AMPK activation, glucose uptake and lactate production while reducing mitochondrial membrane potential and coupled respiration. The stimulation of glycolysis by KU-55933 did not fully compensate for the reduction in mitochondrial functions, leading to decreased cellular ATP levels and energy stress. These actions are similar to those previously described for the biguanide metformin, a partial inhibitor of respiratory complex I. Both compounds decreased mitochondrial coupled respiration and reduced cellular concentrations of fumarate, malate, citrate, and alpha-ketogluterate. Succinate levels were increased by KU-55933 levels and decreased by metformin, indicating that the effects of ATM inhibition and metformin are not identical. These observations suggest a role for ATM in mitochondrial function and show that both KU-55933 and metformin perturb the TCA cycle as well as oxidative phosphorylation.	[Zakikhani, Mahvash; Pollak, Michael N.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Zakikhani, Mahvash; Bazile, Miguel; Hashemi, Sina; Pollak, Michael N.] McGill Univ, Canc Prevent Div, Montreal, PQ, Canada; [Avizonis, Daina; St Pierre, Julie; Pollak, Michael N.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Javeshghani, Shiva; Pollak, Michael N.] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [St Pierre, Julie] McGill Univ, Dept Biochem, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Pollak, MN (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.	michael.pollak@mcgill.ca	St-Pierre, Julie/AGB-3651-2022	St-Pierre, Julie/0000-0002-2815-7099; Pollak, Michael/0000-0003-3047-0604; Avizonis, Daina/0000-0002-3843-255X	Terry Fox Foundation; Canadian Institutes of Health Research [MOP-106603, 00921-000]	Terry Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant (00921-000) to M.P., J. St-P., and others from Canadian Institutes of Health Research in partnership with The Terry Fox Foundation, and by a grant (MOP-106603) to J. St-P. from the Canadian Institutes of Health Research. J. St-P. is a FRSQ research scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Ambrose M, 2007, HUM MOL GENET, V16, P2154, DOI 10.1093/hmg/ddm166; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chiu YJ, 2011, J ORTHOP RES, V29, P1448, DOI 10.1002/jor.21398; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kruger A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001959; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Ma E-L, 2012, J ASIAN NAT IN PRESS; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Milazzo S., 2011, COCHRANE DB SYST REV, V11; Minematsu T, 2011, MOL CANCER THER, V10, P531, DOI 10.1158/1535-7163.MCT-10-0731; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Olofsson BA, 2007, MOL CANCER RES, V5, P1319, DOI 10.1158/1541-7786.MCR-07-0374; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Patel AY, 2011, BIOCHEM BIOPH RES CO, V405, P599, DOI 10.1016/j.bbrc.2011.01.075; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Reily MD, 2006, J AM CHEM SOC, V128, P12360, DOI 10.1021/ja063773h; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SCHAFER G, 1969, BIOCHIM BIOPHYS ACTA, V172, P334, DOI 10.1016/0005-2728(69)90077-2; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tomitsuka E, 2009, P JPN ACAD B-PHYS, V85, P258, DOI 10.2183/pjab.85.258; Troiano L, 2007, NAT PROTOC, V2, P2719, DOI 10.1038/nprot.2007.405; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; WAY JL, 1984, ANNU REV PHARMACOL, V24, P451, DOI 10.1146/annurev.pa.24.040184.002315; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Woods A, 2012, NAT GENET, V44, P360, DOI 10.1038/ng.2235; Xu QW, 2011, J BIOMOL NMR, V49, P207, DOI 10.1007/s10858-011-9482-8; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Yee SW, 2012, NAT GENET, V44, P359, DOI 10.1038/ng.2236; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	57	24	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49513	10.1371/journal.pone.0049513	http://dx.doi.org/10.1371/journal.pone.0049513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185347	Green Published, gold			2022-12-25	WOS:000311821000058
J	Hu, K; Meijer, JH; Shea, SA; vanderLeest, HT; Pittman-Polletta, B; Houben, T; van Oosterhout, F; Deboer, T; Scheer, FAJL				Hu, Kun; Meijer, Johanna H.; Shea, Steven A.; vanderLeest, Henk Tjebbe; Pittman-Polletta, Benjamin; Houben, Thijs; van Oosterhout, Floor; Deboer, Tom; Scheer, Frank A. J. L.			Fractal Patterns of Neural Activity Exist within the Suprachiasmatic Nucleus and Require Extrinsic Network Interactions	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; HEART-RATE DYNAMICS; CIRCADIAN PACEMAKER; IN-VIVO; MORPHOMETRIC-ANALYSIS; HUMAN-BRAIN; 1/F NOISE; NEURONS; DISEASE; FLUCTUATIONS	The mammalian central circadian pacemaker (the suprachiasmatic nucleus, SCN) contains thousands of neurons that are coupled through a complex network of interactions. In addition to the established role of the SCN in generating rhythms of,24 hours in many physiological functions, the SCN was recently shown to be necessary for normal self-similar/fractal organization of motor activity and heart rate over a wide range of time scales-from minutes to 24 hours. To test whether the neural network within the SCN is sufficient to generate such fractal patterns, we studied multi-unit neural activity of in vivo and in vitro SCNs in rodents. In vivo SCN-neural activity exhibited fractal patterns that are virtually identical in mice and rats and are similar to those in motor activity at time scales from minutes up to 10 hours. In addition, these patterns remained unchanged when the main afferent signal to the SCN, namely light, was removed. However, the fractal patterns of SCN-neural activity are not autonomous within the SCN as these patterns completely broke down in the isolated in vitro SCN despite persistence of circadian rhythmicity. Thus, SCN-neural activity is fractal in the intact organism and these fractal patterns require network interactions between the SCN and extra-SCN nodes. Such a fractal control network could underlie the fractal regulation observed in many physiological functions that involve the SCN, including motor control and heart rate regulation.	[Hu, Kun; Pittman-Polletta, Benjamin] Brigham & Womens Hosp, Div Sleep Med, Med Biodynam Program, Boston, MA 02115 USA; [Hu, Kun; Shea, Steven A.; Pittman-Polletta, Benjamin; Scheer, Frank A. J. L.] Brigham & Womens Hosp, Div Sleep Med, Med Chronobiol Program, Boston, MA 02115 USA; [Hu, Kun; Shea, Steven A.; Pittman-Polletta, Benjamin; Scheer, Frank A. J. L.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Meijer, Johanna H.; vanderLeest, Henk Tjebbe; Houben, Thijs; van Oosterhout, Floor; Deboer, Tom] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands; [Shea, Steven A.] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Oregon Health & Science University	Hu, K (corresponding author), Brigham & Womens Hosp, Div Sleep Med, Med Biodynam Program, 75 Francis St, Boston, MA 02115 USA.	khu@bics.bwh.harvard.edu; fscheer@rics.bwh.harvard.edu	Hu, Kun/AAJ-1897-2020; Scheer, Frank A.J.L./C-2795-2012; Hu, Kun/GVS-8580-2022	Scheer, Frank A.J.L./0000-0002-2014-7582; Shea, Steven/0000-0003-1949-0954; Hu, Kun/0000-0003-0350-3132	National Institutes of Health [K99HL102241, R00HL102241, K24-HL76446, P30-HL101299, R01-HL094806, T32 HL07901]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL102241, T32HL007901, P30HL101299, K24HL076446, R01HL094806, R00HL102241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health K99HL102241 and R00HL102241 to KH, K24-HL76446 to SAS, P30-HL101299 and R01-HL094806 to FAJLS, and T32 HL07901 in support of BP. The funders had no role in study design, data collection and analysis.	Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Amaral LAN, 2004, P NATL ACAD SCI USA, V101, P15551, DOI 10.1073/pnas.0404843101; Amaral LAN, 2001, PHYS REV LETT, V86, P6026, DOI 10.1103/PhysRevLett.86.6026; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Brown TM, 2008, NEUROSCI LETT, V448, P273, DOI 10.1016/j.neulet.2008.10.058; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Brown TM, 2006, J NEUROSCI METH, V156, P173, DOI 10.1016/j.jneumeth.2006.02.024; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hausdorff JM, 1996, PHYS REV E, V54, P2154, DOI 10.1103/PhysRevE.54.2154; Hofman MA, 1996, ANAT RECORD, V244, P552, DOI 10.1002/(SICI)1097-0185(199604)244:4<552::AID-AR13>3.0.CO;2-O; HOFMAN MA, 1988, J ANAT, V160, P127; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Hu K, 2008, J BIOL RHYTHM, V23, P265, DOI 10.1177/0748730408316166; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kim SI, 2005, J COMPUT NEUROSCI, V19, P39, DOI 10.1007/s10827-005-0149-x; Lin LY, 2010, RESUSCITATION, V81, P297, DOI 10.1016/j.resuscitation.2009.12.003; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Makikallio AM, 2004, NEUROLOGY, V62, P1822, DOI 10.1212/01.WNL.0000125190.10967.D5; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meijer JH, 1998, J NEUROSCI, V18, P9078; Nakamura W, 2008, CURR BIOL, V18, P381, DOI 10.1016/j.cub.2008.02.024; Peng CK, 1995, J ELECTROCARDIOL, V28, P59, DOI 10.1016/S0022-0736(95)80017-4; Reghunandanan Vallath, 2006, J Circadian Rhythms, V4, P2; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Scheer FAJL, 2001, AM J PHYSIOL-HEART C, V280, pH1391, DOI 10.1152/ajpheart.2001.280.3.H1391; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; STANLEY HE, 1992, PHYSICA A, V191, P1, DOI 10.1016/0378-4371(92)90497-E; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; van Oosterhout F, 2008, ANN NEUROL, V64, P315, DOI 10.1002/ana.21418; VANDENPOL AN, 1980, J COMP NEUROL, V191, P661, DOI 10.1002/cne.901910410; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 1998, J NEUROSCI, V18, P10709	43	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48927	10.1371/journal.pone.0048927	http://dx.doi.org/10.1371/journal.pone.0048927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185285	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700019
J	Cavalca, V; Veglia, F; Squellerio, I; De Metrio, M; Rubino, M; Porro, B; Moltrasio, M; Tremoli, E; Marenzi, G				Cavalca, Viviana; Veglia, Fabrizio; Squellerio, Isabella; De Metrio, Monica; Rubino, Mara; Porro, Benedetta; Moltrasio, Marco; Tremoli, Elena; Marenzi, Giancarlo			Circulating Levels of Dimethylarginines, Chronic Kidney Disease and Long-Term Clinical Outcome in Non-ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							ADVERSE CARDIOVASCULAR EVENTS; GLOMERULAR-FILTRATION-RATE; ACUTE CORONARY SYNDROMES; ASYMMETRIC DIMETHYLARGININE; RENAL-FUNCTION; NITRIC-OXIDE; RISK-FACTOR; SYMMETRIC DIMETHYLARGININE; PLASMA-CONCENTRATIONS; ADMA	Background: Mechanisms linking chronic kidney disease (CKD) and adverse outcomes in acute coronary syndromes (ACS) are not fully understood. Among potential key players, reduced nitric oxide (NO) synthesis due to its endogenous inhibitors, asymmetric (ADMA) and symmetric (SDMA) dimethylarginine could be involved. We measured plasma concentration of arginine, ADMA and SDMA and investigated their relationship with CKD and long-term outcome in non-ST-elevation myocardial infarction (NSTEMI). Methodology/Principal Findings: We prospectively measured arginine, ADMA, and SDMA at hospital admission in 104 NSTEMI patients. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m(2). We considered a primary end point of combined cardiac death and re-infarction at a median follow-up of 21 months. In CKD (n = 33) and no-CKD (n = 71) patients, arginine and ADMA were similar, whereas SDMA was significantly higher in CKD patients (0.656 +/- 0.23 vs. 0.42 +/- 0.12 mu mol/L; P<0.0001). Twenty-four (23%) patients had an adverse cardiac event during follow-up: 12 (36%) were CKD and 12 (17%) no-CKD patients (P = 0.02). When study population was stratified according to arginine, ADMA and SDMA median values, only SDMA (median 0.46 mu mol/L) was associated with the primary end-point (P = 0.0016). In models adjusted for age, hemoglobin and left ventricular ejection fraction, the hazard ratio (HR) for CKD and SDMA were high (HR 2.93, interquartile range [IQR] 1.15-7.53; P = 0.02 and HR 6.80, IQR 2.09-22.2; P = 0.001, respectively) but, after mutual adjustment, only SDMA remained significantly associated with the primary end point (HR 5.73, IQR 1.55-21.2; P = 0.009). Conclusions/Significance: In NSTEMI patients, elevated SDMA plasma levels are associated with CKD and worse long-term prognosis.	[Cavalca, Viviana; Veglia, Fabrizio; Squellerio, Isabella; De Metrio, Monica; Rubino, Mara; Porro, Benedetta; Moltrasio, Marco; Tremoli, Elena; Marenzi, Giancarlo] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Cavalca, Viviana] Univ Milan, Dipartimento Sci Clin & Comunita, Milan, Italy; [Tremoli, Elena] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy	IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan	Cavalca, V (corresponding author), IRCCS, Ctr Cardiol Monzino, Milan, Italy.	viviana.cavalca@unimi.it	De Metrio, Monica/ABH-6561-2020; Rubino, Mara/K-1537-2016; Porro, Benedetta/K-1390-2016; Veglia, Fabrizio/K-1958-2016; TREMOLI, ELENA/I-8126-2018	Rubino, Mara/0000-0001-7820-9814; Porro, Benedetta/0000-0002-4019-4618; Veglia, Fabrizio/0000-0002-9378-8874; De Metrio, Monica/0000-0002-1955-747X; Marenzi, Giancarlo/0000-0003-4410-4461; Cavalca, Viviana/0000-0003-1349-8365; TREMOLI, ELENA/0000-0002-0929-6106				Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Al Banchaabouchi M, 2000, PFLUG ARCH EUR J PHY, V439, P524, DOI 10.1007/s004240050973; Bae SW, 2005, AM J CARDIOL, V95, P729, DOI 10.1016/j.amjcard.2004.11.023; Bode-Boger SM, 2006, J AM SOC NEPHROL, V17, P1128, DOI 10.1681/ASN.2005101119; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Cavusoglu E, 2009, CORONARY ARTERY DIS, V20, P112, DOI 10.1097/MCA.0b013e328323982f; Cighetti G, 2009, FREE RADICAL BIO MED, V47, P307, DOI 10.1016/j.freeradbiomed.2009.05.007; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; de Jong S, 2006, ANAL BIOCHEM, V353, P287, DOI 10.1016/j.ab.2006.03.010; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fleck C, 2003, CLIN CHIM ACTA, V336, P1, DOI 10.1016/S0009-8981(03)00338-3; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Gibson CM, 2004, EUR HEART J, V25, P1998, DOI 10.1016/j.ehj.2004.08.016; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203; Jiang DJ, 2009, ATHEROSCLEROSIS, V205, P554, DOI 10.1016/j.atherosclerosis.2008.12.024; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Krzyzanowska K, 2007, DIABETIC MED, V24, P81, DOI 10.1111/j.1464-5491.2007.02018.x; Lajer M, 2008, DIABETES CARE, V31, P747, DOI 10.2337/dc07-1762; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lu TM, 2003, EUR HEART J, V24, P1912, DOI 10.1016/j.ehj.2003.08.013; Lu TM, 2011, INT J CARDIOL, V153, P135, DOI 10.1016/j.ijcard.2011.06.120; Lu TM, 2011, CLIN J AM SOC NEPHRO, V6, P1566, DOI 10.2215/CJN.08490910; Maas R, 2007, CRIT CARE MED, V35, P1876, DOI 10.1097/01.CCM.0000277038.11630.71; Marenzi G, 2006, CURR CARDIOL REV, V2, P11, DOI 10.2174/157340306775515371; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Santopinto JJ, 2003, HEART, V89, P1003, DOI 10.1136/heart.89.9.1003; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schepers E, 2011, CLIN J AM SOC NEPHRO, V6, P2374, DOI 10.2215/CJN.01720211; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Szummer K, 2009, CIRCULATION, V120, P851, DOI 10.1161/CIRCULATIONAHA.108.838169; Tang WHW, 2008, EUR HEART J, V29, P2506, DOI 10.1093/eurheartj/ehn360; Tojo A, 1997, KIDNEY INT, V52, P1593, DOI 10.1038/ki.1997.490; VALLANCE P, 1992, LANCET, V339, P572; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	42	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48499	10.1371/journal.pone.0048499	http://dx.doi.org/10.1371/journal.pone.0048499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185262	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800007
J	von Schwarzenberg, K; Wiedmann, RM; Oak, P; Schulz, S; Zischka, H; Wanner, G; Efferth, T; Trauner, D; Vollmar, AM				von Schwarzenberg, Karin; Wiedmann, Romina M.; Oak, Prajakta; Schulz, Sabine; Zischka, Hans; Wanner, Gerhard; Efferth, Thomas; Trauner, Dirk; Vollmar, Angelika M.			Mode of Cell Death Induction by Pharmacological Vacuolar H+-ATPase (V-ATPase) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON PUMP; PH HOMEOSTASIS; BAFILOMYCIN A1; IN-VITRO; HYPOXIA; APOPTOSIS; AUTOPHAGY; BNIP3; EXPRESSION; SUBUNIT	The vacuolar H+-ATPase (V-ATPase), a multisubunit proton pump, has come into focus as an attractive target in cancer invasion. However, little is known about the role of V-ATPase in cell death, and especially the underlying mechanisms remain mostly unknown. We used the myxobacterial macrolide archazolid B, a potent inhibitor of the V-ATPase, as an experimental drug as well as a chemical tool to decipher V-ATPase-related cell death signaling. We found that archazolid induced apoptosis in highly invasive tumor cells at nanomolar concentrations which was executed by the mitochondrial pathway. Prior to apoptosis induction archazolid led to the activation of a cellular stress response including activation of the hypoxia-inducible factor-1 alpha (HIF1 alpha) and autophagy. Autophagy, which was demonstrated by degradation of p62 or fusion of autophagosomes with lysosomes, was induced at low concentrations of archazolid that not yet increase pH in lysosomes. HIF1 alpha was induced due to energy stress shown by a decline of the ATP level and followed by a shutdown of energy-consuming processes. As silencing HIF1 alpha increases apoptosis, the cellular stress response was suggested to be a survival mechanism. We conclude that archazolid leads to energy stress which activates adaptive mechanisms like autophagy mediated by HIF1 alpha and finally leads to apoptosis. We propose V-ATPase as a promising drugable target in cancer therapy caught up at the interplay of apoptosis, autophagy, and cellular/metabolic stress.	[von Schwarzenberg, Karin; Wiedmann, Romina M.; Oak, Prajakta; Vollmar, Angelika M.] Univ Munich, Dept Pharm, D-81377 Munich, Germany; [Schulz, Sabine; Zischka, Hans] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Toxicol, D-80539 Neuherberg, Germany; [Wanner, Gerhard] Univ Munich, Dept Biol 1, D-81377 Munich, Germany; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Dept Pharmaceut Biol, D-55099 Mainz, Germany; [Trauner, Dirk] Univ Munich, Dept Chem, D-81377 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Johannes Gutenberg University of Mainz; University of Munich	von Schwarzenberg, K (corresponding author), Ludwig Maximilians Univ Munchen, Dept Pharm, Butenandtstr 5-13, D-81377 Munich, Germany.	karin.von.schwarzenberg@cup.uni-muenchen.de	Zischka, Hans/M-1490-2017	Zischka, Hans/0000-0002-4047-1566; Efferth, Thomas/0000-0002-3096-3292	Deutsche Forschungsgemeinschaft [FOR 1406 Vo 376/15-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant FOR 1406 Vo 376/15-1.	Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bockelmann S, 2010, J BIOL CHEM, V285, P38304, DOI 10.1074/jbc.M110.137539; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Cosse JP, 2010, BIOCHEM PHARMACOL, V80, P1160, DOI 10.1016/j.bcp.2010.07.009; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Dirsch VM, 2001, CANCER RES, V61, P5817; Drose S, 1997, J EXP BIOL, V200, P1; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Huss M, 2011, EUR J CELL BIOL, V90, P688, DOI 10.1016/j.ejcb.2011.04.009; Huss Markus, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-13; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lim JH, 2007, MOL PHARMACOL, V71, P942, DOI 10.1124/mol.106.030296; Lopez-Anton N, 2007, APOPTOSIS, V12, P141, DOI 10.1007/s10495-006-0331-2; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mellor HR, 2007, CANCER METAST REV, V26, P553, DOI 10.1007/s10555-007-9080-0; Menche D, 2007, J AM CHEM SOC, V129, P6100, DOI 10.1021/ja071461o; Morimura T, 2008, PEDIATR SURG INT, V24, P1087, DOI 10.1007/s00383-008-2229-2; Mousavi SA, 2001, BBA-BIOMEMBRANES, V1510, P243, DOI 10.1016/S0005-2736(00)00354-0; Nakashima S, 2003, J BIOCHEM, V134, P359, DOI 10.1093/jb/mvg153; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ohta T, 1996, BRIT J CANCER, V73, P1511, DOI 10.1038/bjc.1996.285; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Roethle PA, 2007, J AM CHEM SOC, V129, P8960, DOI 10.1021/ja0733033; Schneiders UM, 2009, MOL CANCER THER, V8, P2914, DOI 10.1158/1535-7163.MCT-08-1179; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Supino R, 2008, J PHARMACOL EXP THER, V324, P15, DOI 10.1124/jpet.107.128587; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Tschan MP, 2010, J INTERN MED, V268, P410, DOI 10.1111/j.1365-2796.2010.02266.x; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wu YC, 2009, BIOCHEM BIOPH RES CO, V382, P451, DOI 10.1016/j.bbrc.2009.03.051; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zamzami N, 2000, METHOD ENZYMOL, V322, P208; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	48	74	75	2	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1385	1396		10.1074/jbc.M112.412007	http://dx.doi.org/10.1074/jbc.M112.412007			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23168408	Green Published, hybrid			2022-12-25	WOS:000313570300059
J	Castro-Nunez, L; Bloem, E; Boon-Spijker, MG; van der Zwaan, C; van den Biggelaar, M; Mertens, K; Meijer, AB				Castro-Nunez, Lydia; Bloem, Esther; Boon-Spijker, Mariette G.; van der Zwaan, Carmen; van den Biggelaar, Maartje; Mertens, Koen; Meijer, Alexander B.			Distinct Roles of Ser-764 and Lys-773 at the N Terminus of von Willebrand Factor in Complex Assembly with Coagulation Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONWILLEBRAND-FACTOR; LIGHT-CHAIN; BINDING-SITE; FACTOR IXA; FACTOR-X; DOMAIN; RESIDUES; ACTIVATION; DISEASE; ANTIBODIES	Complex formation between coagulation factor VIII (FVIII) and von Willebrand factor (VWF) is of critical importance to protect FVIII from rapid in vivo clearance and degradation. We have now employed a chemical footprinting approach to identify regions on VWF involved in FVIII binding. To this end, lysine amino acid residues of VWF were chemically modified in the presence of FVIII or activated FVIII, which does not bind VWF. Nano-LC-MS analysis showed that the lysine residues of almost all identified VWF peptides were not differentially modified upon incubation of VWF with FVIII or activated FVIII. However, Lys-773 of peptide Ser-766-Leu-774 was protected from chemical modification in the presence of FVIII. In addition, peptide Ser-764-Arg-782, which comprises the first 19 amino acid residues of matureVWF, showed a differential modification of both Lys-773 and the alpha-amino group of Ser-764. To verify the role of Lys-773 and the N-terminal Ser-764 in FVIII binding, we employed VWF variants in which either Lys-773 or Ser-764 was replaced with Ala. Surface plasmon resonance analysis and competition studies revealed that VWF(K773A) exhibited reduced binding to FVIII and the FVIII light chain, which harbors the VWF-binding site. In contrast, VWF(S764A) revealed more effective binding to FVIII and the FVIII light chain compared with WTVWF. The results of our study show that the N terminus of VWF is critical for the interaction with FVIII and that Ser-764 and Lys-773 have opposite roles in the binding mechanism.	[Castro-Nunez, Lydia; Bloem, Esther; Boon-Spijker, Mariette G.; van der Zwaan, Carmen; van den Biggelaar, Maartje; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut Sci, NL-3584 CG Utrecht, Netherlands	Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl			Landsteiner Stichting voor Bloedtransfusieresearch [LSBR-0730]	Landsteiner Stichting voor Bloedtransfusieresearch	This work was supported by Landsteiner Stichting voor Bloedtransfusieresearch Grant LSBR-0730 (to A.B.M.).	Bendetowicz AV, 1998, BLOOD, V92, P529, DOI 10.1182/blood.V92.2.529.414k31_529_538; Bloem E, 2012, J BIOL CHEM, V287, P5775, DOI 10.1074/jbc.M111.308627; BRINKHOUS KM, 1985, P NATL ACAD SCI USA, V82, P8752, DOI 10.1073/pnas.82.24.8752; BRINKMAN HJM, 1994, BRIT J HAEMATOL, V87, P332, DOI 10.1111/j.1365-2141.1994.tb04918.x; Cierpicki T, 2000, PROTEIN SCI, V9, P976, DOI 10.1110/ps.9.5.976; Dayon L, 2010, J PROTEOMICS, V73, P769, DOI 10.1016/j.jprot.2009.10.015; DONG ZG, 1994, J BIOL CHEM, V269, P6753; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; FOSTER PA, 1988, J BIOL CHEM, V263, P5230; HILLEUBANKS DC, 1990, J BIOL CHEM, V265, P17854; Jacquemin M, 2009, ACTA HAEMATOL-BASEL, V121, P102, DOI 10.1159/000214849; KOEDAM JA, 1990, EUR J BIOCHEM, V189, P229, DOI 10.1111/j.1432-1033.1990.tb15481.x; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LEYTE A, 1991, J BIOL CHEM, V266, P740; LEYTE A, 1991, BIOCHEM J, V274, P257, DOI 10.1042/bj2740257; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; MERTENS K, 1985, THROMB HAEMOSTASIS, V54, P654; MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 2009, J THROMB HAEMOST, V7, P24, DOI 10.1111/j.1538-7836.2009.03375.x; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schneppenheim R, 2011, J THROMB HAEMOST, V9, P209, DOI 10.1111/j.1538-7836.2011.04324.x; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; STEL HV, 1984, BLOOD, V63, P1408; TAKAHASHI Y, 1987, BLOOD, V70, P1679; van den Biggelaar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024163; van den Biggelaar M, 2009, BLOOD, V113, P3102, DOI 10.1182/blood-2008-05-159699; van Haren SD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002246; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	36	12	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					393	400		10.1074/jbc.M112.400572	http://dx.doi.org/10.1074/jbc.M112.400572			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23168412	Green Published, hybrid			2022-12-25	WOS:000313197200040
J	Hong, TJ; Kim, S; Wi, AR; Lee, P; Kang, M; Jeong, JH; Hahn, JS				Hong, Tae-Joon; Kim, Sangkyu; Wi, Ah Ram; Lee, Peter; Kang, Miae; Jeong, Jae-Hoon; Hahn, Ji-Sook			Dynamic Nucleotide-dependent Interactions of Cysteine- and Histidine-rich Domain (CHORD)-containing Hsp90 Cochaperones Chp-1 and Melusin with Cochaperones PP5 and Sgt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE-5; DISEASE RESISTANCE; INNATE IMMUNITY; CHAPERONE MACHINERY; ATP CONCENTRATION; CO-CHAPERONE; COMPLEXES; PROTEIN-PHOSPHATASE-5; DEPHOSPHORYLATION; ACTIVATION	Mammals have two cysteine-and histidine-rich domain (CHORD)-containing Hsp90 cochaperones, Chp-1 and melusin, which are homologs of plant Rar1. It has been shown previously that Rar1 CHORD directly interacts with ADP bound to the nucleotide pocket of Hsp90. Here, we report that ADP and ATP can bind to Hsp90 cochaperones Chp-1 and PP5, inducing their conformational changes. Furthermore, we demonstrate that Chp-1 and melusin can interact with cochaperones PP5 and Sgt1 and with each other in an ATP-dependent manner. Based on the known structure of the Rar1-Hsp90 complex, His-186 has been identified as an important residue of Chp-1 for ADP/ATP binding. His-186 is necessary for the nucleotide-dependent interaction of Chp-1 not only with Hsp90 but also with Sgt1. In addition, Ca2+, which is known to bind to melusin, enhances the interactions of melusin with Hsp90 and Sgt1. Furthermore, melusin acquires the ADP preference for Hsp90 binding in the presence of Ca2+. Our newly discovered nucleotide-dependent interactions between cochaperones might provide additional complexity to the dynamics of the Hsp90 chaperone system, also suggesting potential Hsp90-independent roles for these cochaperones.	[Hong, Tae-Joon; Kim, Sangkyu; Wi, Ah Ram; Lee, Peter; Hahn, Ji-Sook] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151744, South Korea; [Kang, Miae; Jeong, Jae-Hoon] Korea Inst Radiol & Med Sci, Res Ctr Radiotherapy, Seoul 139706, South Korea	Seoul National University (SNU); Korea Institute of Radiological & Medical Sciences	Hahn, JS (corresponding author), Seoul Natl Univ, Sch Chem & Biol Engn, 1 Gwanak Ro, Seoul 151744, South Korea.	hahnjs@snu.ac.kr	Rho, Hyunji/R-6242-2016	Rho, Hyunji/0000-0001-7650-8933; Hong, Tae-Joon/0000-0003-4636-6131	Priority Research Centers Program Grant from the National Research Foundation of Korea (NRF) [2011-0031388]; Ministry of Education, Science and Technology	Priority Research Centers Program Grant from the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Priority Research Centers Program Grant 2011-0031388 from the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology.	Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Brancaccio M, 2003, FEBS LETT, V551, P47, DOI 10.1016/S0014-5793(03)00892-5; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chua CS, 2010, CELL MOL LIFE SCI, V67, P1675, DOI 10.1007/s00018-010-0275-0; Conde R, 2005, J BIOL CHEM, V280, P28989, DOI 10.1074/jbc.M503594200; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Davies AE, 2010, J CELL BIOL, V189, P261, DOI 10.1083/jcb.200910036; Eckert K, 2010, J BIOL CHEM, V285, P31304, DOI 10.1074/jbc.M110.138263; Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Gong CX, 2004, J NEUROCHEM, V88, P298, DOI 10.1046/j.1471-4159.2003.02147.x; Hahn JS, 2009, BMB REP, V42, P623, DOI 10.5483/BMBRep.2009.42.10.623; Hahn JS, 2005, FEBS LETT, V579, P4513, DOI 10.1016/j.febslet.2005.07.024; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Marcussen M, 1996, CELL MOTIL CYTOSKEL, V35, P94, DOI 10.1002/(SICI)1097-0169(1996)35:2<94::AID-CM2>3.0.CO;2-I; Martins T, 2009, EMBO J, V28, P234, DOI 10.1038/emboj.2008.283; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Michowski W, 2010, BBA-MOL CELL RES, V1803, P1043, DOI 10.1016/j.bbamcr.2010.05.005; Picard D, 2008, EMBO REP, V9, P1193, DOI 10.1038/embor.2008.208; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Ramsey AJ, 2002, BIOCHEMISTRY-US, V41, P5625, DOI 10.1021/bi016090h; Rodrigo-Brenni MC, 2004, MOL BIOL CELL, V15, P3366, DOI 10.1091/mbc.E03-12-0887; Sbroggio M, 2008, FEBS LETT, V582, P1788, DOI 10.1016/j.febslet.2008.04.058; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tretter L, 1997, J NEUROCHEM, V69, P2529; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wang YL, 2008, MOL PLANT MICROBE IN, V21, P294, DOI 10.1094/MPMI-21-3-0294; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Wu JC, 2005, FEBS LETT, V579, P421, DOI 10.1016/j.febslet.2004.12.005; Zhang MH, 2010, MOL CELL, V39, P269, DOI 10.1016/j.molcel.2010.05.010	43	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					215	222		10.1074/jbc.M112.398636	http://dx.doi.org/10.1074/jbc.M112.398636			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23184943	Green Published, hybrid			2022-12-25	WOS:000313197200021
J	Ferreira, GCA; Batista, BC; Varela, H				Ferreira, Graziela C. A.; Batista, Bruno C.; Varela, Hamilton			Experimental Assessment of the Sensitiveness of an Electrochemical Oscillator towards Chemical Perturbations	PLOS ONE			English	Article							FORMIC-ACID; ANION ADSORPTION; CO ELECTROOXIDATION; PLATINUM-ELECTRODES; METHANOL OXIDATION; MIXED-MODE; EXPERIMENTAL STRATEGY; CHAOTIC OSCILLATIONS; MECHANISTIC ASPECTS; CYCLIC-VOLTAMMETRY	In this study we address the problem of the response of a (electro)chemical oscillator towards chemical perturbations of different magnitudes. The chemical perturbation was achieved by addition of distinct amounts of trifluoromethanesulfonate (TFMSA), a rather stable and non-specifically adsorbing anion, and the system under investigation was the methanol electro-oxidation reaction under both stationary and oscillatory regimes. Increasing the anion concentration resulted in a decrease in the reaction rates of methanol oxidation and a general decrease in the parameter window where oscillations occurred. Furthermore, the addition of TFMSA was found to decrease the induction period and the total duration of oscillations. The mechanism underlying these observations was derived mathematically and revealed that inhibition in the methanol oxidation through blockage of active sites was found to further accelerate the intrinsic non-stationarity of the unperturbed system. Altogether, the presented results are among the few concerning the experimental assessment of the sensitiveness of an oscillator towards chemical perturbations. The universal nature of the complex chemical oscillator investigated here might be used for reference when studying the dynamics of other less accessible perturbed networks of (bio)chemical reactions.	[Ferreira, Graziela C. A.; Batista, Bruno C.; Varela, Hamilton] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil; [Varela, Hamilton] Gwangju Inst Sci & Technol, Ertl Ctr Electrochem & Catalysis, Kwangju, South Korea	Universidade de Sao Paulo; Gwangju Institute of Science & Technology (GIST)	Varela, H (corresponding author), Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil.	varela@iqsc.usp.br	Varela, Hamilton/AAJ-2735-2021; Batista, Bruno C/G-2837-2015; Ferreira, Graziela/D-8029-2018; Varela, Hamilton/C-3901-2012	Varela, Hamilton/0000-0002-6237-6068; Batista, Bruno C/0000-0003-0629-1737; Ferreira, Graziela/0000-0002-4047-3270; Varela, Hamilton/0000-0002-6237-6068	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/07629-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306151/2010-3, 146790/2011-1, 160495/2011-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, HV grant no. 2009/07629-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, HV grant no. 306151/2010-3, GF grant no. 146790/2011-1, and BCB grant no. 160495/2011-3) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsabet M, 2006, J ELECTROANAL CHEM, V589, P120, DOI 10.1016/j.jelechem.2006.01.022; Apri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009865; Balazs AC, 2009, SCIENCE, V325, P1632, DOI 10.1126/science.1178323; Batista BC, 2011, J PHYS CONF SER, V285, DOI 10.1088/1742-6596/285/1/012003; Batista EA, 2004, J ELECTROANAL CHEM, V571, P273, DOI 10.1016/j.jelechem.2004.05.016; Bauer PR, 2010, CHEMPHYSCHEM, V11, P3002, DOI 10.1002/cphc.201000301; Berna A, 2008, ELECTROCHEM COMMUN, V10, P1695, DOI 10.1016/j.elecom.2008.08.042; Bockris J.O.M., 2000, MODERN ELECTROCHEMIS, V2nd; Boscheto E, 2010, J ELECTROANAL CHEM, V642, P17, DOI 10.1016/j.jelechem.2010.01.026; Carbonio EA, 2009, PHYS CHEM CHEM PHYS, V11, P665, DOI 10.1039/b811636a; Chen QS, 2010, ELECTROCHIM ACTA, V55, P7982, DOI 10.1016/j.electacta.2010.03.050; Chen SL, 2000, J PHYS CHEM A, V104, P6791, DOI 10.1021/jp001066j; Chen SL, 2000, ELECTROCHEM COMMUN, V2, P171, DOI 10.1016/S1388-2481(99)00163-0; Chen SL, 2001, J ELECTROANAL CHEM, V504, P78, DOI 10.1016/S0022-0728(01)00415-6; Chen SL, 2001, ELECTROCHIM ACTA, V46, P3481, DOI 10.1016/S0013-4686(01)00635-1; Christoph J, 2009, SURF SCI, V603, P1652, DOI 10.1016/j.susc.2008.11.054; Cuesta A, 2009, LANGMUIR, V25, P6500, DOI 10.1021/la8041154; Epstein I.R., 1998, INTRO NONLINEAR CHEM; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; Grzybowski B.A., 2009, CHEM MOTION REACTION; Housmans THM, 2006, J PHYS CHEM B, V110, P10021, DOI 10.1021/jp055949s; HUDSON JL, 1994, CHEM ENG SCI, V49, P1493, DOI 10.1016/0009-2509(94)85063-1; HYNNE F, 1990, J CHEM PHYS, V92, P1747, DOI 10.1063/1.458056; Jerkiewicz G, 2004, ELECTROCHIM ACTA, V49, P1451, DOI 10.1016/j.electacta.2003.11.008; Jerkiewicz G, 2009, J ELECTROANAL CHEM, V625, P172, DOI 10.1016/j.jelechem.2008.10.015; Kikuchi M, 2008, ELECTROCHIM ACTA, V53, P7817, DOI 10.1016/j.electacta.2008.05.056; Kiss IZ, 2012, J PHYS CHEM C, V116, P9561, DOI 10.1021/jp300714w; Kiss IZ, 2009, PHYS CHEM CHEM PHYS, V11, P5720, DOI 10.1039/b904650j; Kiss IZ, 2009, PHYS CHEM CHEM PHYS, V11, P7669, DOI 10.1039/b905295j; Kiss IZ, 2005, J PHYS CHEM A, V109, P9521, DOI 10.1021/jp053656t; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KOPER MTM, 1991, J PHYS CHEM-US, V95, P4945, DOI 10.1021/j100166a009; KOPER MTM, 1992, J CHEM PHYS, V96, P7797, DOI 10.1063/1.462377; KOPER MTM, 1992, J CHEM PHYS, V97, P8250, DOI 10.1063/1.463396; Koper MTM, 1996, ADV CHEM PHYS, V92, P161, DOI DOI 10.1002/9780470141519.CH2; Krausa M, 1995, J ELECTROANAL CHEM, V399, P7, DOI 10.1016/0022-0728(95)04249-0; Krischer K., 2002, ADV ELECTROCHEMICAL, P89; LAMPERSKI S, 1994, J ELECTROANAL CHEM, V379, P445, DOI 10.1016/0022-0728(94)87169-8; Lee J, 2002, ELECTROCHIM ACTA, V47, P2297, DOI 10.1016/S0013-4686(02)00075-0; Malkhandi S, 2005, ELECTROCHEM COMMUN, V7, P710, DOI 10.1016/j.elecom.2005.04.022; Malkhandi S, 2013, CATAL TODAY, V202, P144, DOI 10.1016/j.cattod.2012.05.018; Martins AL, 2008, J BRAZIL CHEM SOC, V19, P679, DOI 10.1590/S0103-50532008000400011; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Nagao R, 2008, J PHYS CHEM A, V112, P4617, DOI 10.1021/jp801361j; Nagao R, 2012, PHYS CHEM CHEM PHYS, V14, P8294, DOI 10.1039/c2cp00037g; Nagao R, 2010, J PHYS CHEM C, V114, P22262, DOI 10.1021/jp109554r; Okamoto H, 2008, J ELECTROANAL CHEM, V622, P1, DOI 10.1016/j.jelechem.2008.04.031; Sazou D, 2000, ELECTROCHIM ACTA, V45, P2753, DOI 10.1016/S0013-4686(00)00390-X; SCHELL M, 1994, J PHYS CHEM-US, V98, P12768, DOI 10.1021/j100099a047; Sitta E, 2008, J SOLID STATE ELECTR, V12, P559, DOI 10.1007/s10008-007-0349-6; Sitta E, 2011, CHEM COMMUN, V47, P3775, DOI 10.1039/c0cc05353h; Sitta E, 2010, PHYS CHEM CHEM PHYS, V12, P15195, DOI 10.1039/c002574g; SORENSEN PG, 1990, J CHEM PHYS, V92, P4778, DOI 10.1063/1.457695; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Strasser P, 1999, J ELECTROANAL CHEM, V478, P50, DOI 10.1016/S0022-0728(99)00412-X; Strmcnik D, 2009, NAT CHEM, V1, P466, DOI [10.1038/nchem.330, 10.1038/NCHEM.330]; Tripkovic DV, 2008, FARADAY DISCUSS, V140, P25, DOI 10.1039/b803714k; Vanag VK, 2009, PHYS CHEM CHEM PHYS, V11, P897, DOI 10.1039/b813825g; Wickramasinghe M, 2010, CHAOS, V20, DOI 10.1063/1.3439209; Wolf J, 2005, SYSTEMS BIOL, V2, P35, DOI 10.1049/sb:20045035; Yang W, 2005, ANAL CHIM ACTA, V554, P218, DOI 10.1016/j.aca.2005.08.052; Zolfaghari A, 2002, ELECTROCHIM ACTA, V47, P1173, DOI 10.1016/S0013-4686(01)00841-6; Zolfaghari A, 1997, J ELECTROCHEM SOC, V144, P3034, DOI 10.1149/1.1837955	65	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50145	10.1371/journal.pone.0050145	http://dx.doi.org/10.1371/journal.pone.0050145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185559	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000190
J	Koban, L; Brass, M; Lynn, MT; Pourtois, G				Koban, Leonie; Brass, Marcel; Lynn, Margaret T.; Pourtois, Gilles			Placebo Analgesia Affects Brain Correlates of Error Processing	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FUNCTIONAL-SIGNIFICANCE; COGNITIVE CONTROL; ERP COMPONENTS; NEURAL SYSTEM; TIME-COURSE; PAIN; ANTICIPATION; POTENTIALS; MECHANISMS	Placebo analgesia (PA) is accompanied by decreased activity in pain-related brain regions, but also by greater prefrontal cortex (PFC) activation, which has been suggested to reflect increases in top-down cognitive control and regulation of pain. Here we test whether PA is associated with altered prefrontal monitoring functions that could adjust nociceptive processing to a mismatch between expected and experienced pain. We recorded event-related potentials to response errors in a go/nogo task during placebo vs. a matched control condition. Error commission was associated with two well-described components, the error-related negativity (ERN) and the error positivity (Pe). Results show that the Pe, but not the ERN, was amplified during placebo analgesia compared to the control condition, with neural sources in the lateral and medial PFC. This Pe increase was driven by participants showing a placebo-induced change in pain tolerance, but was absent in the group of non-responders. Our results shed new light on the possible functional mechanisms underlying PA, suggesting a placebo-induced transient change in prefrontal error monitoring and control functions.	[Koban, Leonie] Univ Geneva, Dept Neurosci, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland; [Koban, Leonie] Univ Geneva, Swiss Ctr Affect Sci, CH-1211 Geneva 4, Switzerland; [Brass, Marcel; Lynn, Margaret T.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	University of Geneva; University of Geneva; Ghent University; Ghent University	Koban, L (corresponding author), Univ Geneva, Dept Neurosci, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland.	leonie.koban@unige.ch	Brass, Marcel/J-7082-2012; Lynn, Margaret T/O-8723-2016; Koban, Leonie/AAG-5783-2019	Brass, Marcel/0000-0002-3364-4019; Lynn, Margaret T/0000-0003-2741-2067; KOBAN, LEONIE/0000-0002-3121-6491; Pourtois, Gilles/0000-0002-5109-2801	Swiss National Science Foundation [51NF40-104897]; Network of European Neuroscience Schools (NENS); European Research Council [200758]; Ghent University (BOF) [05Z01708]; NCCR Affective Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Network of European Neuroscience Schools (NENS); European Research Council(European Research Council (ERC)European Commission); Ghent University (BOF)(Ghent University); NCCR Affective Sciences	LK was supported by the NCCR Affective Sciences financed by the Swiss National Science Foundation (no 51NF40-104897) and hosted by the University of Geneva, as well as a travel stipend from the Network of European Neuroscience Schools (NENS). GP is supported by grants from the European Research Council (Starting Grant #200758) and Ghent University (BOF Grant #05Z01708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts K, 2010, COGN AFFECT BEHAV NE, V10, P479, DOI 10.3758/CABN.10.4.479; Allan LG, 2002, EVAL HEALTH PROF, V25, P410, DOI 10.1177/0163278702238054; Amanzio M, 2012, HUMAN BRAIN MAPPING; Benedetti F, 2006, PAIN, V121, P133, DOI 10.1016/j.pain.2005.12.016; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buhle JT, 2012, PSYCHOL SCI; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chang LJ, SOCIAL COGN IN PRESS; Cohen JD, 2004, SYSTEMS LEVEL PERSPE; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Dhar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019578; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hajcak G, 2003, BIOL PSYCHOL, V64, P77, DOI 10.1016/S0301-0511(03)00103-0; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Koban L, J COGNITIVE IN PRESS; Koban L, 2012, COGN AFFECT BEHAV NE, V12, P460, DOI 10.3758/s13415-012-0091-0; Koban L, 2010, SOC NEUROSCI-UK, V5, P360, DOI 10.1080/17470911003651547; Krummenacher P, 2010, PAIN, V148, P368, DOI 10.1016/j.pain.2009.09.033; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Meissner K, 2011, J NEUROSCI, V31, P16117, DOI 10.1523/JNEUROSCI.4099-11.2011; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; Morton DL, 2010, BRAIN RES, V1359, P137, DOI 10.1016/j.brainres.2010.08.046; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2010, PAIN, V150, P59, DOI 10.1016/j.pain.2010.03.011; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Price DD, 2007, PAIN, V127, P63, DOI 10.1016/j.pain.2006.08.001; Ridderinkhof KR, 2009, PSYCHOPHYSIOLOGY, V46, P531, DOI 10.1111/j.1469-8986.2009.00790.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shackman AJ, 2011, J NEUROSCI, V31, P1156, DOI 10.1523/JNEUROSCI.3384-10.2011; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vocat R, 2008, NEUROPSYCHOLOGIA, V46, P2545, DOI 10.1016/j.neuropsychologia.2008.04.006; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003; Zhang WC, 2009, PSYCHOPHYSIOLOGY, V46, P626, DOI 10.1111/j.1469-8986.2009.00786.x	55	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49784	10.1371/journal.pone.0049784	http://dx.doi.org/10.1371/journal.pone.0049784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185436	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000108
J	Lim, W; Kim, HS; Jeong, W; Ahn, SE; Kim, J; Kim, YB; Kim, MA; Kim, MK; Chung, HH; Song, YS; Bazer, FW; Han, JY; Song, G				Lim, Whasun; Kim, Hee Seung; Jeong, Wooyoung; Ahn, Suzie E.; Kim, Jinyoung; Kim, Yong Beom; Kim, Min A.; Kim, Mi-Kyung; Chung, Hyun Hoon; Song, Yong Sang; Bazer, Fuller W.; Han, Jae Yong; Song, Gwonhwa			SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer	PLOS ONE			English	Article							CELL CARCINOMA ANTIGEN; INCREASED EXPRESSION; INHIBITION; BIOGENESIS; CATHEPSINS; MECHANISM; TUMORS; HEN	Serine protease inhibitors (SERPINs) appear to be ubiquitously expressed in a variety of species and play important roles in pivotal physiological processes such as angiogenesis, immune responses, blood coagulation and fibronolysis. Of these, squamous cell carcinoma antigen 1 (SCCA1), also known as a SERPINB3, was first identified in squamous cell carcinoma tissue from the cervix of women. However, there is little known about the SERPINB3 expression in human epithelial ovarian cancer (EOC). Therefore, in the present study, we investigated the functional role of SERPINB3 gene in human EOC using chickens, the most relevant animal model. In 136 chickens, EOC was found in 10 (7.4%). SERPINB3 mRNA was induced in cancerous, but not normal ovaries of chickens (P<0.01), and it was abundant only in the glandular epithelium of cancerous ovaries of chickens. Further, several microRNAs, specifically miR-101, miR-1668 and miR-1681 were discovered to influence SERPINB3 expression via its 3'-UTR which suggests that post-transcriptional regulation influences SERPINB3 expression in chickens. SERPINB3 protein was localized predominantly to the glandular epithelium in cancerous ovaries of chickens, and it was abundant in the nucleus of both chicken and human ovarian cancer cell lines. In 109 human patients with EOC, 15 (13.8%), 66 (60.6%) and 28 (25.7%) patients showed weak, moderate and strong expression of SERPINB3 protein, respectively. Strong expression of SERPINB3 protein was a prognostic factor for platinum resistance (adjusted OR; odds ratio, 5.94; 95% Confidence Limits, 1.21-29.15), and for poor progression-free survival (PFS; adjusted HR; hazard ratio, 2.07; 95% CI; confidence interval, 1.03-4.41). Therefore, SERPINB3 may play an important role in ovarian carcinogenesis and be a novel biomarker for predicting platinum resistance and a poor prognosis for survival in patients with EOC.	[Lim, Whasun; Jeong, Wooyoung; Ahn, Suzie E.; Kim, Jinyoung; Song, Yong Sang; Bazer, Fuller W.; Han, Jae Yong; Song, Gwonhwa] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Kim, Hee Seung; Kim, Mi-Kyung; Chung, Hyun Hoon; Song, Yong Sang] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Yong Beom] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Soungnam, South Korea; [Kim, Min A.] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Song, Yong Sang] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Song, G (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea.	ghsong@snu.ac.kr	Lim, Whasun/AAP-3156-2020; Song, Yong Sang/E-7824-2012; gwonhwa, song/H-3208-2015; Song, Gwonhwa/H-3647-2015; Lim, Whasun/F-2060-2013; Bazer, Fuller/AAF-4317-2021	Lim, Whasun/0000-0002-1328-0465; Bazer, Fuller/0000-0002-5823-5086; SONG, YONGSANG/0000-0001-7115-4021	World Class University (WCU) program [R31-10056]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2010-0013078]; Ministry of Education, Science, and Technology; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008142]	World Class University (WCU) program; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was funded by the World Class University (WCU) program (R31-10056) and by Basic Science Research Program (2010-0013078) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-100; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Castino R, 2009, J CELL MOL MED, V13, P1096, DOI 10.1111/j.1582-4934.2008.00435.x; Chechlinska M, 2010, TUMOR BIOL, V31, P559, DOI 10.1007/s13277-010-0069-x; Collie-Duguid ES, 2011, BREAST CANC RES TREA; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Giles JR, 2006, EXP BIOL MED, V231, P1718, DOI 10.1177/153537020623101108; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Hsu KF, 2007, INT J GYNECOL CANCER, V17, P174, DOI 10.1111/j.1525-1438.2006.00663.x; Jackson E, 2007, GYNECOL ONCOL, V104, P192, DOI 10.1016/j.ygyno.2006.07.024; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kato H, 1996, ANTICANCER RES, V16, P2149; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Kim HS, 2009, EJSO-EUR J SURG ONC, V35, P870, DOI 10.1016/j.ejso.2009.01.005; Lim W, 2011, GEN COMP EN IN PRESS; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakashima T, 2006, HEAD NECK-J SCI SPEC, V28, P24, DOI 10.1002/hed.20293; Petty RD, 2006, J CLIN ONCOL, V24, P1729, DOI 10.1200/JCO.2005.03.3399; Pignata S, 2011, CANCER LETT, V303, P73, DOI 10.1016/j.canlet.2011.01.026; Quarta S, 2010, J PATHOL, V221, P343, DOI 10.1002/path.2708; Rodriguez-Burford C, 2001, GYNECOL ONCOL, V81, P373, DOI 10.1006/gyno.2001.6191; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Shepherd TG, 2006, NAT PROTOC, V1, P2643, DOI 10.1038/nprot.2006.328; Shiiba M, 2010, ONCOL REP, V24, P241, DOI 10.3892/or_00000852; Song G, 2007, REPRODUCTION, V133, P285, DOI 10.1530/REP-06-0092; Song GH, 2006, ENDOCRINOLOGY, V147, P3478, DOI 10.1210/en.2006-0122; Stakleff KDS, 2003, INT J GYNECOL CANCER, V13, P405, DOI 10.1046/j.1525-1438.2003.13317.x; Stammer K, 2008, GYNECOL ONCOL, V109, P115, DOI 10.1016/j.ygyno.2007.12.030; Suh DH, 2012, J GYNECOL ONCOL, V23, P53, DOI 10.3802/jgo.2012.23.1.53; Suminami Y, 2000, BRIT J CANCER, V82, P981, DOI 10.1054/bjoc.1999.1028; SUMINAMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P51, DOI 10.1016/S0006-291X(05)81380-4; Suminami Y, 2001, CANCER RES, V61, P1776; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; Vidalino L, 2009, AUTOIMMUN REV, V9, P108, DOI 10.1016/j.autrev.2009.03.011	37	29	29	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49869	10.1371/journal.pone.0049869	http://dx.doi.org/10.1371/journal.pone.0049869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185467	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000129
J	Liu, LJ; Wang, H; Shi, LJ; Almuklass, A; He, TT; Aiken, S; Bance, M; Yin, SK; Wang, J				Liu, Lijie; Wang, Hui; Shi, Lijuan; Almuklass, Awad; He, Tingting; Aiken, Steve; Bance, Manohar; Yin, Shankai; Wang, Jian			Silent Damage of Noise on Cochlear Afferent Innervation in Guinea Pigs and the Impact on Temporal Processing	PLOS ONE			English	Article							SURFACE AMPA RECEPTORS; INDUCED HEARING-LOSS; CELL RIBBON SYNAPSE; HAIR-CELLS; MAMMALIAN COCHLEA; AGE; EXCITOTOXICITY; NEURONS; EXPRESSION; REPAIR	Noise-exposure at levels low enough to avoid a permanent threshold shift has been found to cause a massive, delayed degeneration of spiral ganglion neurons (SGNs) in mouse cochleae. Damage to the afferent innervation was initiated by a loss of synaptic ribbons, which is largely irreversible in mice. A similar delayed loss of SGNs has been found in guinea pig cochleae, but at a reduced level, suggesting a cross-species difference in SGN sensitivity to noise. Ribbon synapse damage occurs "silently" in that it does not affect hearing thresholds as conventionally measured, and the functional consequence of this damage is not clear. In the present study, we further explored the effect of noise on cochlear afferent innervation in guinea pigs by focusing on the dynamic changes in ribbon counts over time, and resultant changes in temporal processing. It was found that (1) contrary to reports in mice, the initial loss of ribbons largely recovered within a month after the noise exposure, although a significant amount of residual damage existed; (2) while the response threshold fully recovered in a month, the temporal processing continued to be deteriorated during this period.	[Wang, Hui; Yin, Shankai] Jiaotong Univ, Affiliated Hosp 6, Dept Otolaryngol, Shanghai, Peoples R China; [Liu, Lijie; Shi, Lijuan; He, Tingting; Wang, Jian] Southeast Univ, Coll Med, Dept Physiol & Pharmacol, Nanjing, Jiangsu, Peoples R China; [Almuklass, Awad] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS, Canada; [Aiken, Steve; Bance, Manohar; Wang, Jian] Dalhousie Univ, Sch Human Commun Disorders, Halifax, NS, Canada; [Bance, Manohar] Dalhousie Univ, Dept Surg, Div Otolaryngol Head & Neck Surg, Halifax, NS B3H 4H2, Canada	Shanghai Jiao Tong University; Southeast University - China; Dalhousie University; Dalhousie University; Dalhousie University	Yin, SK (corresponding author), Jiaotong Univ, Affiliated Hosp 6, Dept Otolaryngol, Shanghai, Peoples R China.	shankaiyin@china.com; Jian.Wang@dal.ca	石, 丽娟/M-8204-2016; wang, JP/AGG-5573-2022; liu, lijie/AAG-9041-2021	石, 丽娟/0000-0002-3350-303X; liu, lijie/0000-0002-8309-609X; Wang, Jian/0000-0003-3633-6799; Aiken, Steven/0000-0003-4180-8519	Canadian Institute of Health Research [MOP79452]; National Natural Science Foundation of China [30925035, 81100710]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is supported by a grant from Canadian Institute of Health Research (URL: http://www.cihr-irsc.gc.ca/e/193.html, grant#: MOP79452) and two grants from National Natural Science Foundation of China (URL: http://www.nsfc.gov.cn/Portal0/default152.htm, grant#s: 30925035 and 81100710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao JX, 2010, HEARING RES, V264, P93, DOI 10.1016/j.heares.2009.10.009; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Chen Z, 2007, NAT NEUROSCI, V10, P1238, DOI 10.1038/nn1974; Chen ZQ, 2009, J NEUROPHYSIOL, V102, P1152, DOI 10.1152/jn.00288.2009; Francis HW, 2004, BRAIN RES, V1016, P182, DOI 10.1016/j.brainres.2004.05.016; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; GELFAND S, 2001, ESSENTIALS AUDIOLOGY; Gordon-Salant S, 2005, J REHABIL RES DEV, V42, P9, DOI 10.1682/JRRD.2005.01.0006; Grose JH, 2010, EAR HEARING, V31, P755, DOI 10.1097/AUD.0b013e3181e627e7; Grose JH, 2009, EAR HEARING, V30, P568, DOI 10.1097/AUD.0b013e3181ac128f; Iguchi F, 2003, NEUROREPORT, V14, P77, DOI 10.1097/00001756-200301200-00015; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lawner BE, 1997, INT J DEV NEUROSCI, V15, P601, DOI 10.1016/S0736-5748(96)00115-3; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Moser T, 2006, CELL TISSUE RES, V326, P347, DOI 10.1007/s00441-006-0276-3; NIDCD, 1995, RES HUM COMM; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Parthasarathy A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00152; Perez P, 2011, AGING DIS, V2, P231; Puel JL, 1998, NEUROREPORT, V9, P2109, DOI 10.1097/00001756-199806220-00037; Pujol R, 1999, ANN NY ACAD SCI, V884, P249, DOI 10.1111/j.1749-6632.1999.tb08646.x; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Simon H, 2004, J ACOUST SOC AM, V116, P469, DOI 10.1121/1.1760796; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Walton JP, 2010, HEARING RES, V264, P63, DOI 10.1016/j.heares.2010.03.002; Wang J, 2011, GENE THER	28	55	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49550	10.1371/journal.pone.0049550	http://dx.doi.org/10.1371/journal.pone.0049550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185359	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000064
J	Lustenberger, C; Maric, A; Durr, R; Achermann, P; Huber, R				Lustenberger, Caroline; Maric, Angelina; Duerr, Roland; Achermann, Peter; Huber, Reto			Triangular Relationship between Sleep Spindle Activity, General Cognitive Ability and the Efficiency of Declarative Learning	PLOS ONE			English	Article							MEMORY CONSOLIDATION; SCHIZOPHRENIA; EEG; INTELLIGENCE; ENHANCEMENT; PERFORMANCE; RETENTION; ATTENTION; CHILDREN	EEG sleep spindle activity (SpA) during non-rapid eye movement (NREM) sleep has been reported to be associated with measures of intelligence and overnight performance improvements. The reticular nucleus of the thalamus is generating sleep spindles in interaction with thalamocortical connections. The same system enables efficient encoding and processing during wakefulness. Thus, we examined if the triangular relationship between SpA, measures of intelligence and declarative learning reflect the efficiency of the thalamocortical system. As expected, SpA was associated with general cognitive ability, e. g. information processing speed. SpA was also associated with learning efficiency, however, not with overnight performance improvement in a declarative memory task. SpA might therefore reflect the efficiency of the thalamocortical network and can be seen as a marker for learning during encoding in wakefulness, i.e. learning efficiency.	[Lustenberger, Caroline; Maric, Angelina; Huber, Reto] Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland; [Duerr, Roland; Achermann, Peter] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Lustenberger, Caroline; Achermann, Peter; Huber, Reto] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Lustenberger, Caroline; Achermann, Peter; Huber, Reto] Swiss Fed Inst Technol, Zurich, Switzerland; [Achermann, Peter; Huber, Reto] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Huber, R (corresponding author), Univ Childrens Hosp Zurich, Child Dev Ctr, Zurich, Switzerland.	reto.huber@kispi.uzh.ch	Lustenberger, Caroline/AAT-1264-2021; Achermann, Peter/N-1215-2014	Lustenberger, Caroline/0000-0001-6243-8831; Achermann, Peter/0000-0002-0208-3511; Maric, Angelina/0000-0002-1416-6728	Swiss Research Foundation on Mobile Communication [A2008-08]; Swiss National Science Foundation (SNF) [P00A-114923]	Swiss Research Foundation on Mobile Communication; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss Research Foundation on Mobile Communication (FSM-Project Nr. A2008-08 to R. H.; www.mobile-research.ethz.ch) and the Swiss National Science Foundation (SNF; P00A-114923 to R. H.; www.snf.ch). The SNF is the independent national non-profit funding organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus J, 2006, SLEEP MED, V7, P508, DOI 10.1016/j.sleep.2006.04.002; Bader R, 2010, NEUROIMAGE, V50, P772, DOI 10.1016/j.neuroimage.2009.12.100; Bodizs R, 2005, J SLEEP RES, V14, P285, DOI 10.1111/j.1365-2869.2005.00472.x; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; Brebion G, 1997, PSYCHOL MED, V27, P383, DOI 10.1017/S0033291796004448; Cairo TA, 2006, BIOL PSYCHIAT, V59, P740, DOI 10.1016/j.biopsych.2005.08.009; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Diwadkar VA, 2008, COGN NEURODYNAMICS, V2, P207, DOI 10.1007/s11571-008-9054-0; Driver HS, 1996, J CLIN ENDOCR METAB, V81, P728, DOI 10.1210/jc.81.2.728; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Finelli LA, 2001, NEUROPSYCHOPHARMACOL, V25, pS57, DOI 10.1016/S0893-133X(01)00320-7; Fogel SM, 2007, BEHAV NEUROSCI, V121, P1, DOI 10.1037/0735-7044.121.1.1; Forest G, 2007, PSYCHIAT RES, V149, P33, DOI 10.1016/j.psychres.2005.11.005; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; Geiger A, 2011, SLEEP, V34, P181, DOI 10.1093/sleep/34.2.181; Hoedlmoser K, 2008, SLEEP, V31, P1401; HOWARD L, 1985, DEV PSYCHOL, V21, P283, DOI 10.1037/0012-1649.21.2.283; Huber R, 2000, NEUROREPORT, V11, P3321, DOI 10.1097/00001756-200010200-00012; Iber C., 2007, AASM MANUAL SCORING; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Keshavan MS, 2011, SCHIZOPHR RES, V131, P231, DOI 10.1016/j.schres.2011.05.027; Lubar JF, 1997, APPL PSYCHOPHYS BIOF, V22, P111, DOI 10.1023/A:1026276228832; Matzel LD, 2009, LEARN MEMORY, V16, P590, DOI 10.1101/lm.1503209; MILLER EM, 1994, PERS INDIV DIFFER, V17, P803, DOI 10.1016/0191-8869(94)90049-3; Oswald W., 1987, ZAHLENVERBINDUNGSTES; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rauchs G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002949; Schabus M, 2006, EUR J NEUROSCI, V23, P1738, DOI 10.1111/j.1460-9568.2006.04694.x; Schabus M, 2008, BRAIN RES, V1191, P127, DOI 10.1016/j.brainres.2007.10.106; Schmidt C, 2006, J NEUROSCI, V26, P8976, DOI 10.1523/JNEUROSCI.2464-06.2006; STERIADE M, 1984, BRAIN RES REV, V8, P1, DOI 10.1016/0165-0173(84)90017-1; Steriade M, 1988, CELLULAR THALAMIC ME, P37; Tucker MA, 2008, SLEEP, V31, P197, DOI 10.1093/sleep/31.2.197; VERNON PA, 1993, PERS INDIV DIFFER, V14, P35, DOI 10.1016/0191-8869(93)90172-Y; Walker MP, 2008, SLEEP MED, V9, pS29, DOI 10.1016/S1389-9457(08)70014-5; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708	40	51	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49561	10.1371/journal.pone.0049561	http://dx.doi.org/10.1371/journal.pone.0049561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185361	Green Published, Green Accepted, gold			2022-12-25	WOS:000311821000065
J	Mandak, B; Zakravsky, P; Mahelka, V; Plackova, I				Mandak, Bohumil; Zakravsky, Petr; Mahelka, Vaclav; Plackova, Ivana			Can Soil Seed Banks Serve as Genetic Memory? A Study of Three Species with Contrasting Life History Strategies	PLOS ONE			English	Article							OPTIMIZING REPRODUCTION; AMARANTHUS-RETROFLEXUS; CANADIAN WEEDS; DESERT MUSTARD; POPULATIONS; PLANT; CONSEQUENCES; BIOLOGY; DISPERSAL; DIVERSITY	We attempted to confirm that seed banks can be viewed as an important genetic reservoir by testing the hypothesis that standing (aboveground) plants represent a nonrandom sample of the seed bank. We sampled multilocus allozyme genotypes from three species with different life history strategies: Amaranthus retroflexus, Carduus acanthoides, Pastinaca sativa. In four populations of each species we analysed the extent to which allele and genotype frequencies vary in consecutive life history stages including the summer seed bank, which has been overlooked up to now. We compared the winter seed bank (i.e., seeds collected before the spring germination peak), seedlings, rosettes, the summer seed bank (i.e., seeds collected after the spring germination peak) and fruiting plants. We found that: (1) All three species partitioned most of their genetic diversity within life history stages and less among stages within populations and among populations. (2) All genetic diversity parameters, except for allele frequencies, were similar among all life history stages across all populations in different species. (3) There were differences in allele frequencies among life history stages at all localities in Amaranthus retroflexus and at three localities in both Carduus acanthoides and Pastinaca sativa. (4) Allele frequencies did not differ between the winter and summer seed bank in most Carduus acanthoides and Pastinaca sativa populations, but there was a marked difference in Amaranthus retroflexus. In conclusion, we have shown that the summer seed bank is not genetically depleted by spring germination and that a majority of genetic diversity remains in the soil through summer. We suggest that seed banks in the species investigated play an important role by maintaining genetic diversity sufficient for recovery rather than by accumulating new genetic diversity at each locality.	[Mandak, Bohumil; Zakravsky, Petr; Mahelka, Vaclav; Plackova, Ivana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Mandak, Bohumil] Czech Univ Life Sci Prague, Fac Environm Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Mandak, B (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	bohumil.mandak@ibot.cas.cz	Mandak, Bohumil/A-3348-2009; Mahelka, Václav/H-1608-2014; Zákravský, Petr/H-1639-2014	Mahelka, Václav/0000-0003-1922-0540; Mandak, Bohumil/0000-0002-9545-7497	Grant Agency of the Academy of Sciences of the Czech Republic [IAA600050707]; Grant Agency of the Czech Republic [P504/11/0402]; Academy of Sciences of the Czech Republic [AV0Z60050516]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This study was supported by grant No. IAA600050707 from the Grant Agency of the Academy of Sciences of the Czech Republic, grant No. P504/11/0402 from the Grant Agency of the Czech Republic and by grant No. AV0Z60050516 from the Academy of Sciences of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlvarezBuylla ER, 1996, EVOLUTION, V50, P1155, DOI 10.1111/j.1558-5646.1996.tb02356.x; [Anonymous], 1997, TFPGA TOOLS POPULATI; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BASKIN JM, 1979, J ECOL, V67, P601, DOI 10.2307/2259115; Cabin RJ, 1996, EVOLUTION, V50, P1830, DOI 10.1111/j.1558-5646.1996.tb03569.x; Cabin RJ, 1998, AM J BOT, V85, P1098, DOI 10.2307/2446343; Cain N, 2010, CAN J PLANT SCI, V90, P217, DOI 10.4141/CJPS09110; CASWELL H, 1980, THEOR POPUL BIOL, V17, P71, DOI 10.1016/0040-5809(80)90015-5; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COHEN D, 1967, J THEOR BIOL, V16, P1, DOI 10.1016/0022-5193(67)90050-1; Costea M, 2004, CAN J PLANT SCI, V84, P631, DOI 10.4141/P02-183; DESROCHERS AM, 1988, CAN J PLANT SCI, V68, P1053, DOI 10.4141/cjps88-126; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falahati-Anbaran M, 2011, AM J BOT, V98, P1475, DOI 10.3732/ajb.1100021; Fenner M, 1985, SEED ECOLOGY; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HAIRSTON NG, 1988, NATURE, V336, P239, DOI 10.1038/336239a0; HENDRIX SD, 1992, AM J BOT, V79, P365, DOI 10.2307/2445148; HENDRIX SD, 1984, AM J BOT, V71, P795, DOI 10.1002/j.1537-2197.1984.tb14144.x; Hock Z, 2008, AM J BOT, V95, P542, DOI 10.3732/ajb.2007283; Honnay O, 2008, OIKOS, V117, P1, DOI 10.1111/j.2007.0030-1299.16188.x; KALISZ S, 1989, EVOLUTION, V43, P1263, DOI 10.1111/j.1558-5646.1989.tb02573.x; Koch M, 2003, BASIC APPL ECOL, V4, P339, DOI 10.1078/1439-1791-00165; Leck AS, 1989, ECOLOGY SOIL SEED BA; Lundemo S, 2009, MOL ECOL, V18, P2798, DOI 10.1111/j.1365-294X.2009.04236.x; Mahy G, 1999, HEREDITY, V82, P432, DOI 10.1038/sj.hdy.6884990; Mandak B, 2006, MOL ECOL, V15, P2653, DOI 10.1111/j.1365-294X.2006.02953.x; Mandak B, 2001, J ECOL, V89, P149, DOI 10.1046/j.1365-2745.2001.00537.x; Mandak B, 2001, J ECOL, V89, P159, DOI 10.1046/j.1365-2745.2001.00536.x; Mandak B, 2006, AM J BOT, V93, P1640, DOI 10.3732/ajb.93.11.1640; Mandak B, 2011, FLORA, V206, P697, DOI 10.1016/j.flora.2011.01.010; Mandak B, 2009, BIOL J LINN SOC, V98, P596, DOI 10.1111/j.1095-8312.2009.01304.x; Mandak B, 2009, FLORA, V204, P423, DOI 10.1016/j.flora.2008.05.005; McCue KA, 1998, AM J BOT, V85, P30, DOI 10.2307/2446551; Morris AB, 2002, AM J BOT, V89, P29, DOI 10.3732/ajb.89.1.29; Nunney L, 2002, AM NAT, V160, P195, DOI 10.1086/341017; PACALA SW, 1986, THEOR POPUL BIOL, V29, P262, DOI 10.1016/0040-5809(86)90011-0; Pysek Petr, 2002, Preslia (Prague), V74, P97; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rees M, 1996, PHILOS T R SOC B, V351, P1299, DOI 10.1098/rstb.1996.0113; Roberts H. A., 1981, Advances in Applied Biology, V6, P1; Telewski FW, 2002, AM J BOT, V89, P1285, DOI 10.3732/ajb.89.8.1285; TEMPLETON AR, 1979, AM NAT, V114, P232, DOI 10.1086/283471; THOMPSON K, 1979, J ECOL, V67, P893, DOI 10.2307/2259220; Thompson K., 1997, SOIL SEED BANKS N W; THRALL PH, 1989, J ECOL, V77, P1135, DOI 10.2307/2260828; TONSOR SJ, 1993, EVOLUTION, V47, P833, DOI [10.2307/2410187, 10.1111/j.1558-5646.1993.tb01237.x]; Venable D.L., 1989, ECOLOGY SOIL SEED BA, P67; VENABLE DL, 1988, AM NAT, V131, P360, DOI 10.1086/284795; Vitalis R, 2004, AM NAT, V163, P295, DOI 10.1086/381041; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	52	16	18	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49471	10.1371/journal.pone.0049471	http://dx.doi.org/10.1371/journal.pone.0049471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185340	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000053
J	Motomura, K; Fujita, T; Tsutsumi, M; Kikuzato, S; Nakamura, M; Otaki, JM				Motomura, Kenta; Fujita, Tomohiro; Tsutsumi, Motosuke; Kikuzato, Satsuki; Nakamura, Morikazu; Otaki, Joji M.			Word Decoding of Protein Amino Acid Sequences with Availability Analysis: A Linguistic Approach	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; N-GRAM PATTERNS; ZIPFS LAW; SECONDARY STRUCTURE; BIOLOGICAL SEQUENCES; RANDOM TEXTS; LANGUAGE; DATABASE; TOPOLOGY; EXHIBIT	The amino acid sequences of proteins determine their three-dimensional structures and functions. However, how sequence information is related to structures and functions is still enigmatic. In this study, we show that at least a part of the sequence information can be extracted by treating amino acid sequences of proteins as a collection of English words, based on a working hypothesis that amino acid sequences of proteins are composed of short constituent amino acid sequences (SCSs) or "words". We first confirmed that the English language highly likely follows Zipf's law, a special case of power law. We found that the rank-frequency plot of SCSs in proteins exhibits a similar distribution when low-rank tails are excluded. In comparison with natural English and "compressed" English without spaces between words, amino acid sequences of proteins show larger linear ranges and smaller exponents with heavier low-rank tails, demonstrating that the SCS distribution in proteins is largely scale-free. A distribution pattern of SCSs in proteins is similar among species, but species-specific features are also present. Based on the availability scores of SCSs, we found that sequence motifs are enriched in high-availability sites (i.e., "key words") and vice versa. In fact, the highest availability peak within a given protein sequence often directly corresponds to a sequence motif. The amino acid composition of high-availability sites within motifs is different from that of entire motifs and all protein sequences, suggesting the possible functional importance of specific SCSs and their compositional amino acids within motifs. We anticipate that our availability-based word decoding approach is complementary to sequence alignment approaches in predicting functionally important sites of unknown proteins from their amino acid sequences.	[Motomura, Kenta; Fujita, Tomohiro; Tsutsumi, Motosuke; Kikuzato, Satsuki; Otaki, Joji M.] Univ Ryukyus, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Nishihara, Okinawa 90301, Japan; [Motomura, Kenta; Nakamura, Morikazu] Univ Ryukyus, Dept Informat Sci, Nishihara, Okinawa 90301, Japan	University of the Ryukyus; University of the Ryukyus	Otaki, JM (corresponding author), Univ Ryukyus, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Nishihara, Okinawa 90301, Japan.	otaki@sci.u-ryukyu.ac.jp		Tsutsumi, Motosuke/0000-0002-5832-3828	University of the Ryukyus, Okinawa, Japan	University of the Ryukyus, Okinawa, Japan	This work was supported by funds from University of the Ryukyus, Okinawa, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 1997, MACH LEARN, V29, P275, DOI 10.1023/A:1007477814995; Aita T, 2011, BIOSYSTEMS, V106, P67, DOI 10.1016/j.biosystems.2011.06.009; Alstott J, 2012, POWERLAW PYTHON PACK; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baek SK, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043004; Bauke H, 2007, EUR PHYS J B, V58, P167, DOI 10.1140/epjb/e2007-00219-y; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Chiang D, 2006, J COMPUT BIOL, V13, P1077, DOI 10.1089/cmb.2006.13.1077; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CLAVERIE JM, 1986, NUCLEIC ACIDS RES, V14, P179, DOI 10.1093/nar/14.1.179; Ferrer-i-Cancho R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009411; Furusawa C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088102; Illich I., 1988, ABC ALPHABETIZATION; Kalankesh LR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-127; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LI WT, 1992, IEEE T INFORM THEORY, V38, P1842, DOI 10.1109/18.165464; Li WT, 2002, J THEOR BIOL, V219, P539, DOI 10.1006/jtbi.2002.3145; Lin HN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S4; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Noguchi T, 2001, NUCLEIC ACIDS RES, V29, P219, DOI 10.1093/nar/29.1.219; Ogasawara O, 2003, CR BIOL, V326, P1097, DOI 10.1016/j.crvi.2003.09.031; Osmanbeyoglu HU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-12; Otaki JM, 2005, PROTEIN SCI, V14, P617, DOI 10.1110/ps.041092605; Otaki JM, 2003, J JPN SOC INF KNOWLE, V13, P25; Otaki JM, 2008, BIOTECHNOL ANN REV, V14, P109, DOI 10.1016/S1387-2656(08)00004-5; Otaki JM, 2010, J CHEM INF MODEL, V50, P690, DOI 10.1021/ci900452z; Masucci AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017333; Popov O, 1996, BIOSYSTEMS, V38, P65, DOI 10.1016/0303-2647(95)01568-X; Przytycka T, 2002, PROTEIN SCI, V11, P409, DOI 10.1110/ps.24701; Radomski JP, 2007, CR BIOL, V330, P33, DOI 10.1016/j.crvi.2006.11.001; Sawada Y, 2006, BIOPHYS J, V91, P1213, DOI 10.1529/biophysj.105.076661; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Searls DB, 1997, COMPUT APPL BIOSCI, V13, P333; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Singh NK, 2011, BBA-PROTEINS PROTEOM, V1814, P664, DOI 10.1016/j.bbapap.2011.03.004; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Tsutsumi M, 2011, J CHEM INF MODEL, V51, P1457, DOI 10.1021/ci200027d; Vinga S, 2004, BIOINFORMATICS, V20, P206, DOI 10.1093/bioinformatics/btg392; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Vries JK, 2007, PROTEINS, V68, P830, DOI 10.1002/prot.21480; Vries JK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-72; Zhang LQ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-191; Zipf G. K., 1935, PSYCHOBIOLOGY LANGUA; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	49	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50039	10.1371/journal.pone.0050039	http://dx.doi.org/10.1371/journal.pone.0050039			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185527	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000171
J	Price, BA; Sandoval, IM; Chan, F; Nichols, R; Roman-Sanchez, R; Wensel, TG; Wilson, JH				Price, Brandee A.; Sandoval, Ivette M.; Chan, Fung; Nichols, Ralph; Roman-Sanchez, Ramon; Wensel, Theodore G.; Wilson, John H.			Rhodopsin Gene Expression Determines Rod Outer Segment Size and Rod Cell Resistance to a Dominant-Negative Neurodegeneration Mutant	PLOS ONE			English	Article							TRANSGENIC MICE; RETINITIS-PIGMENTOSA; MOUSE MODEL; OPSIN; MUTATION; TRANSPORT; OVEREXPRESSION; PHOTORECEPTORS; DEGRADATION; SUPPRESSION	Two outstanding unknowns in the biology of photoreceptors are the molecular determinants of cell size, which is remarkably uniform among mammalian species, and the mechanisms of rod cell death associated with inherited neurodegenerative blinding diseases such as retinitis pigmentosa. We have addressed both questions by performing an in vivo titration with rhodopsin gene copies in genetically engineered mice that express only normal rhodopsin or an autosomal dominant allele, encoding rhodopsin with a disease-causing P23H substitution. The results reveal that the volume of the rod outer segment is proportional to rhodopsin gene expression; that P23H-rhodopsin, the most common rhodopsin gene disease allele, causes cell death via a dominant-negative mechanism; and that long term survival of rod cells carrying P23H-rhodopsin can be achieved by increasing the levels of wild type rhodopsin. These results point to promising directions in gene therapy for autosomal dominant neurodegenerative diseases caused by dominant-negative mutations.	[Price, Brandee A.; Sandoval, Ivette M.; Chan, Fung; Roman-Sanchez, Ramon; Wensel, Theodore G.; Wilson, John H.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Price, Brandee A.; Wilson, John H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Nichols, Ralph; Wensel, Theodore G.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Roman-Sanchez, Ramon; Wensel, Theodore G.; Wilson, John H.] Baylor Coll Med, Grad Program Cellular & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wilson, JH (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	jwilson@bcm.edu		Wensel, Theodore/0000-0003-3518-9352	National Institutes of Health [RO1EY11731, RO1EY07981]; NIH Vision Research Core Grant [EY002520]; NIH Training [T32 EY007102, R25 GM56929]; Robert A. Welch Foundation Grant [Q0035]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007102, R01EY007981, P30EY002520, R01EY011731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Vision Research Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation Grant(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health RO1EY11731 to J.H.W. and RO1EY07981 to T.G.W., the NIH Vision Research Core Grant EY002520, and NIH Training Grants T32 EY007102 to B.A.P. and R25 GM56929 to I.M.S.(http://www.nih.gov/). Additional support was provided by The Robert A. Welch Foundation Grant Q0035 to T.G.W. (http://www.welch1.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Barr MM, 2007, VISION RES, V47, P3394, DOI 10.1016/j.visres.2007.09.016; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Brachmann RK, 1996, P NATL ACAD SCI USA, V93, P4091, DOI 10.1073/pnas.93.9.4091; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Chan F, 2011, NUCLEIC ACIDS RES, V39, P5955, DOI 10.1093/nar/gkr196; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; GLUCKSMANN A., 1965, AFCH BIOL, V76, P419; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Gorbatyuk MS, 2005, MOL VIS, V11, P648; GOTO Y, 1995, INVEST OPHTH VIS SCI, V36, P62; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HONG K, 1972, P NATL ACAD SCI USA, V69, P2617, DOI 10.1073/pnas.69.9.2617; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu XR, 1997, J CELL SCI, V110, P2589; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037832; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; McNally N, 1999, HUM MOL GENET, V8, P1309, DOI 10.1093/hmg/8.7.1309; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Mervin K, 2002, EXP EYE RES, V75, P703, DOI 10.1006/exer.2002.2063; Millington-Ward S, 2011, MOL THER, V19, P642, DOI 10.1038/mt.2010.293; MillingtonWard S, 1997, HUM MOL GENET, V6, P1415, DOI 10.1093/hmg/6.9.1415; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Price BA, 2011, INVEST OPHTH VIS SCI, V52, P9728, DOI 10.1167/iovs.11-8654; Rajan RS, 2005, J BIOL CHEM, V280, P1284, DOI 10.1074/jbc.M406448200; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saliba RS, 2002, J CELL SCI, V115, P2907; Sullivan JM, 2002, MOL VIS, V8, P102; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; Wilson JH, 2003, MOL NEUROBIOL, V28, P149, DOI 10.1385/MN:28:2:149; Wu TP, 1998, NEUROSCIENCE, V87, P709, DOI 10.1016/S0306-4522(98)00173-0	49	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49889	10.1371/journal.pone.0049889	http://dx.doi.org/10.1371/journal.pone.0049889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185477	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000137
J	Ratzinger, F; Bruckschwaiger, H; Wischenbart, M; Parschalk, B; Fernandez-Reyes, D; Lagler, H; Indra, A; Graninger, W; Winkler, S; Krishna, S; Ramharter, M				Ratzinger, Franz; Bruckschwaiger, Harald; Wischenbart, Martin; Parschalk, Bernhard; Fernandez-Reyes, Delmiro; Lagler, Heimo; Indra, Alexandra; Graninger, Wolfgang; Winkler, Stefan; Krishna, Sanjeev; Ramharter, Michael			Rapid Diagnostic Algorithms as a Screening Tool for Tuberculosis: An Assessor Blinded Cross-Sectional Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; ACTIVE TUBERCULOSIS; ASSAY	Background: A major obstacle to effectively treat and control tuberculosis is the absence of an accurate, rapid, and low-cost diagnostic tool. A new approach for the screening of patients for tuberculosis is the use of rapid diagnostic classification algorithms. Methods: We tested a previously published diagnostic algorithm based on four biomarkers as a screening tool for tuberculosis in a Central European patient population using an assessor-blinded cross-sectional study design. In addition, we developed an improved diagnostic classification algorithm based on a study population at a tertiary hospital in Vienna, Austria, by supervised computational statistics. Results: The diagnostic accuracy of the previously published diagnostic algorithm for our patient population consisting of 206 patients was 54% (CI: 47%-61%). An improved model was constructed using inflammation parameters and clinical information. A diagnostic accuracy of 86% (CI: 80%-90%) was demonstrated by 10-fold cross validation. An alternative model relying solely on clinical parameters exhibited a diagnostic accuracy of 85% (CI: 79%-89%). Conclusion: Here we show that a rapid diagnostic algorithm based on clinical parameters is only slightly improved by inclusion of inflammation markers in our cohort. Our results also emphasize the need for validation of new diagnostic algorithms in different settings and patient populations.	[Ratzinger, Franz; Parschalk, Bernhard; Lagler, Heimo; Graninger, Wolfgang; Winkler, Stefan; Ramharter, Michael] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Ratzinger, Franz] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bruckschwaiger, Harald] Krankenhaus Barmherzigen Bruder, Dept Internal Med, Vienna, Austria; [Wischenbart, Martin] Johannes Kepler Univ Linz, Inst Bioinformat, Informat Syst Grp, A-4040 Linz, Austria; [Fernandez-Reyes, Delmiro] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Indra, Alexandra] Austrian Agcy Hlth & Food Safety, Vienna, Austria; [Krishna, Sanjeev] St Georges Univ London, Ctr Infect, London, England; [Ramharter, Michael] Univ Tubingen, Inst Trop Med, Tubingen, Germany	Medical University of Vienna; Medical University of Vienna; Konventhospital Der Barmherzigen Bruder; Johannes Kepler University Linz; MRC National Institute for Medical Research; St Georges University London; Eberhard Karls University of Tubingen	Ramharter, M (corresponding author), Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria.	michael.ramharter@meduniwien.ac.at	; Ramharter, Michael/C-5273-2013	Ratzinger, Franz/0000-0002-1910-1018; Fernandez-Reyes, Delmiro/0000-0001-5070-9198; Lagler, Heimo/0000-0003-3240-7385; Ramharter, Michael/0000-0002-9259-1885; Krishna, Sanjeev/0000-0003-0066-0634	Landsteiner Gesellschaft; Medical Research Council [MC_U117585869] Funding Source: researchfish; MRC [MC_U117585869] Funding Source: UKRI	Landsteiner Gesellschaft; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was in part supported by the Landsteiner Gesellschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Ali-Gombe A, 1997, Afr J Med Med Sci, V26, P67; Alpaydin E, 2010, INTRO MACHINE LEARNI, P220; Balasingham SV, 2009, MOL DIAGN THER, V13, P137, DOI 10.2165/01250444-200913030-00001; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; FASSBENDER K, 1995, CLIN CHEM, V41, P472; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Glennon M, 2001, Expert Rev Mol Diagn, V1, P163; Guyon I, 2006, STUD FUZZ SOFT COMP, V207, P1; HARJU E, 1989, CLIN PHARMACOKINET, V17, P69, DOI 10.2165/00003088-198917020-00002; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Jolliffe IT, 2002, INTRO PRINCIPAL COMP, P1, DOI DOI 10.1007/0-387-22440-8_1; Kohavi R., 1995, INT JOINT C ART INT, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; Kotsiantis SB, 2006, ARTIF INTELL REV, V26, P159, DOI 10.1007/S10462-007-9052-3; Lange C, 2007, Pneumologie, V61, P518, DOI 10.1055/s-2007-980060; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Liam CK, 1998, INT J TUBERC LUNG D, V2, P818; Marais BJ, 2006, PEDIATRICS, V118, pE1350, DOI 10.1542/peds.2006-0519; McNerney R, 2011, NAT REV MICROBIOL, V9, P204, DOI 10.1038/nrmicro2521; Miller MB, 2011, J CLIN MICROBIOL, V49, P3458, DOI 10.1128/JCM.05212-11; Mitchell TM, 1997, MACH LEARN, P154; Nemeth J, 2009, J INTERN MED, V265, P163, DOI 10.1111/j.1365-2796.2008.02012.x; Papay P, 2011, INFLAMM BOWEL DIS, V17, P84, DOI 10.1002/ibd.21427; Perkins MD, 2002, B WORLD HEALTH ORGAN, V80, P512; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, DOI [10.1007/978-1-4899-7993-3_565-2, DOI 10.1007/978-1-4899-7993-3_565-2]; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sharma O P, 2000, Curr Opin Pulm Med, V6, P442, DOI 10.1097/00063198-200009000-00010; Sita-Lumsden A, 2007, THORAX, V62, P1003, DOI 10.1136/thx.2006.070060; Tanaka T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-71; Thiede B, 2005, METHODS, V35, P237, DOI 10.1016/j.ymeth.2004.08.015; Ustianowski A, 2005, J INFECTION, V50, P432, DOI 10.1016/j.jinf.2004.07.006; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wilson DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027826; WITTEN IH, 2005, DATA MINING PRACTICA; World Health Organization, 2010, GLOB TUB CONTR WHO R; Zhang JX, 2012, CLIN CHIM ACTA, V413, P883, DOI 10.1016/j.cca.2012.01.036	44	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49658	10.1371/journal.pone.0049658	http://dx.doi.org/10.1371/journal.pone.0049658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185397	gold, Green Accepted, Green Published			2022-12-25	WOS:000311821000077
J	Winking, M; Hoffmann, DC; Kuhn, C; Hilgers, RD; Luckhoff, A; Kuhn, FJP				Winking, Mathis; Hoffmann, Daniel C.; Kuehn, Cornelia; Hilgers, Ralf-Dieter; Lueckhoff, Andreas; Kuehn, Frank J. P.			Importance of a Conserved Sequence Motif in Transmembrane Segment S3 for the Gating of Human TRPM8 and TRPM2	PLOS ONE			English	Article							SHAKER K+ CHANNEL; VOLTAGE SENSOR; ELECTROSTATIC INTERACTIONS; COLD; MENTHOL; ACTIVATION; MECHANISM; REVEALS; DOMAIN; STIMULI	For mammalian TRPM8, the amino acid residues asparagine-799 and aspartate-802 are essential for the stimulation of the channel by the synthetic agonist icilin. Both residues belong to the short sequence motif N-x-x-D within the transmembrane segment S3 highly conserved in the entire superfamily of voltage-dependent cation channels, among them TRPM8. Moreover, they are also conserved in the closely related TRPM2 channel, which is essentially voltage-independent. To analyze the differential roles of the motif for the voltage-dependent and voltage-independent gating, we performed reciprocal replacements of the asparagine and aspartate within the S3 motif in both channels, following the proposed idea that specific electrostatic interactions with other domains take place during gating. Wild-type and mutant channels were heterologeously expressed in HEK-293 cells and channel function was analyzed by whole-cell patch-clamp analysis as well as by Ca2+-imaging. Additionally, the expression of the channels in the plasma membrane was tested by Western blot analysis, in part after biotinylation. For the mutations of TRPM8, responses to menthol were only compromised if also the expression of the glycosylated channel isoform was prevented. In contrast, responses to cold were consistently and significantly attenuated but not completely abolished. For TRPM2, surface expression was not significantly affected by any of the mutations but channel function was only retained in one variant. Remarkably, this was the variant of which the corresponding mutation in TRPM8 exerted the most negative effects both on channel function and expression. Furthermore, we performed an exchange of the inner pair of residues of the N-x-x-D motif between the two channels, which proved deleterious for the functional expression of TRPM8 but ineffective on TRPM2. In conclusion, the N-x-x-D motif plays specific roles in TRPM8 and TRPM2, reflecting different requirements for voltage-dependent and voltage-independent channel gating.	[Winking, Mathis; Hoffmann, Daniel C.; Kuehn, Cornelia; Lueckhoff, Andreas; Kuehn, Frank J. P.] Rhein Westfal TH Aachen, Fac Med, Inst Physiol, Aachen, Germany; [Hilgers, Ralf-Dieter] Rhein Westfal TH Aachen, Dept Med Stat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Kuhn, FJP (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Physiol, Aachen, Germany.	fkuehn@physiology.rwth-aachen.de	Hilgers, Ralf-Dieter/C-7090-2013; Kuehn, Frank JP/H-5889-2018	Hilgers, Ralf-Dieter/0000-0002-5945-1119; 	Deutsche Forschungsgemeinschaft [DFG KU-2271/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG KU-2271/1-1), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Kuhn FJP, 2010, J BIOL CHEM, V285, P26806, DOI 10.1074/jbc.M110.109975; Kumanovics A, 2002, FASEB J, V16, P1623, DOI 10.1096/fj.02-0238hyp; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pedretti A, 2011, BIOCHEM BIOPH RES CO, V414, P14, DOI 10.1016/j.bbrc.2011.08.134; Pedretti A, 2009, BBA-BIOMEMBRANES, V1788, P973, DOI 10.1016/j.bbamem.2009.02.007; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pertusa M, 2012, J BIOL CHEM, V287, P18218, DOI 10.1074/jbc.M111.312645; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Toth B, 2012, P NATL ACAD SCI USA, V109, P13440, DOI 10.1073/pnas.1204702109; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Zhang LY, 2007, P NATL ACAD SCI USA, V104, P8263, DOI 10.1073/pnas.0611007104	19	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49877	10.1371/journal.pone.0049877	http://dx.doi.org/10.1371/journal.pone.0049877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185472	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000134
J	Bai, JR; Liu, HB; Li, DH; Cui, LH; Wu, XZ				Bai, Jingrui; Liu, Hongbin; Li, Donghua; Cui, Lihua; Wu, Xianzhong			Duodenum Clamping Trauma Induces Significant Postoperative Intraperitoneal Adhesions on a Rat Model	PLOS ONE			English	Article							ABDOMINAL ADHESIONS; PERITONEAL ADHESIONS; PREVENTION; PATHOPHYSIOLOGY; FIBROSIS; REDUCTION; HYDROGEL; MATRIX; INJURY; REPAIR	Objective: The purpose of this study was to investigate the histological and morphological changes in the first two postoperative weeks on a rat intraperitoneal adhesion model induced by duodenum clamping trauma. Method: The rat model of postoperative intraperitoneal adhesions was established in 48 male Wistar rats by laparotomy, followed by the duodenum clamping trauma. Rats were sacrificed respectively on 1st, 3rd, 5th, 7th and 14th day after the operation. The control rats were sacrificed immediately after the operation (0 day). Then the intraperitoneal adhesions were assessed macroscopically. Histopathology and immunohistochemistry were performed to evaluate the fibrosis, inflammatory responses, neovascularization, and cells infiltration in adhesion tissues. In addition, the changes of the mesothelium covering the surgical sites were examined by scanning electron microscopy. Results: Our study revealed that duodenum clamping trauma induced by mosquito hemostat can result in significant postoperative intraperitoneal adhesions formation. The extent and tenacity of intraperitoneal adhesions reached their peaks on 3rd and 5th days, respectively. Histopathological examination showed that all rats developed inflammatory responses at the clamped sites of duodenum, which was most prominent on 1st day; the scores of fibrosis and vascular proliferation increased slowly from 3rd to 5th day. Myofibroblasts proliferated significantly in the adhesion tissues from 3rd day, which were examined by immunohistochemical method. And the mesothelium covering the surgical sites and the adhesion tissues healed on 7th day. Conclusion: This study suggests that clamping trauma to the duodenum can result in significant postoperative intraperitoneal adhesions formation, which represents an ideal rat model for intraperitoneal adhesions research and prevention. And myofibroblasts may play an important role in the forming process of intraperitoneal adhesions.	[Bai, Jingrui; Liu, Hongbin; Wu, Xianzhong] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China; [Liu, Hongbin; Li, Donghua; Cui, Lihua; Wu, Xianzhong] Tianjin Nankai Hosp, Dept Pharmacol, Tianjin, Peoples R China	Tianjin Medical University	Wu, XZ (corresponding author), Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China.	wuxianzhongdoctor@hotmail.com		cui, lihua/0000-0002-7921-4225	Innovative Foundation of Tianjin Medical University, Tianjin, China [146 200022]	Innovative Foundation of Tianjin Medical University, Tianjin, China	This investigation was financially supported by the Innovative Foundation of Tianjin Medical University (NO. 146#200022, Tianjin, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arung W, 2011, WORLD J GASTROENTERO, V17, P4545, DOI 10.3748/wjg.v17.i41.4545; Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X; Beckingham IJ, 2001, BRIT MED J, V322, P783, DOI 10.1136/bmj.322.7289.783; BIGATTI G, 1995, HUM REPROD, V10, P2290; Brochhausen C, 2012, J GASTROINTEST SURG, V16, P1256, DOI 10.1007/s11605-011-1819-9; Chegini N, 2002, FRONT BIOSCI-LANDMRK, V7, pE91, DOI 10.2741/chegini; DIAMOND M P, 1987, Microsurgery, V8, P197, DOI 10.1002/micr.1920080406; diZerega GS, 1997, EUR J SURG, V163, P10; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Durmus AS, 2011, REV MED VET-TOULOUSE, V162, P198; Duron JJ, 2007, COLORECTAL DIS, V9, P14, DOI 10.1111/j.1463-1318.2007.01343.x; ELKINS TE, 1987, OBSTET GYNECOL, V70, P225; ELLIS H, 1971, SURG GYNECOL OBSTETR, V133, P497; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; Gaertner WB, 2008, J SURG RES, V146, P241, DOI 10.1016/j.jss.2007.08.012; HANEY AF, 1994, FERTIL STERIL, V61, P767; HARRIS ES, 1995, SURGERY, V117, P663, DOI 10.1016/S0039-6060(95)80010-7; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Herington JL, 2011, FERTIL STERIL, V95, P1295, DOI 10.1016/j.fertnstert.2010.09.017; Irkorucu O, 2009, CLINICS, V64, P143, DOI 10.1590/S1807-59322009000200012; Johns A, 2001, HUM REPROD UPDATE, V7, P577, DOI 10.1093/humupd/7.6.577; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Lalountas M, 2012, BRIT J SURG, V99, P423, DOI 10.1002/bjs.7817; Lauder CIW, 2010, DIGEST SURG, V27, P347, DOI 10.1159/000314805; Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149; Lucas PA, 1996, J SURG RES, V65, P135, DOI 10.1006/jsre.1996.0355; Maciver AH, 2011, SURGERY, V150, P907, DOI 10.1016/j.surg.2011.06.022; Mingsan M, 2007, ANIMAL MODEL COMMONL; NAIR SK, 1974, ARCH SURG-CHICAGO, V108, P849; Ozel H, 2005, WOUND REPAIR REGEN, V13, P358, DOI 10.1111/j.1067-1927.2005.130402.x; Pardo Annie, 2008, P39, DOI 10.1007/978-3-7643-8585-9_3; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Stadlmann S, 2003, VIRCHOWS ARCH, V443, P678, DOI 10.1007/s00428-003-0867-2; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Whang SH, 2011, J SURG RES, V167, P245, DOI 10.1016/j.jss.2009.06.020; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Yang B, 2012, INT J NANOMED, V7, P547, DOI 10.2147/IJN.S26141; Zhou J, 2004, SURGERY, V135, P307, DOI 10.1016/j.surg.2003.07.005; ZUHLKE HV, 1990, LANGENBECK ARCH CHIR, P1009	41	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49673	10.1371/journal.pone.0049673	http://dx.doi.org/10.1371/journal.pone.0049673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185403	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700048
J	Guglani, L; Gopal, R; Rangel-Moreno, J; Junecko, BF; Lin, YY; Berger, T; Mak, TW; Alcorn, JF; Randall, TD; Reinhart, TA; Chan, YR; Khader, SA				Guglani, Lokesh; Gopal, Radha; Rangel-Moreno, Javier; Junecko, Beth Fallert; Lin, Yinyao; Berger, Thorsten; Mak, Tak W.; Alcorn, John F.; Randall, Troy D.; Reinhart, Todd A.; Chan, Yvonne R.; Khader, Shabaana A.			Lipocalin 2 Regulates Inflammation during Pulmonary Mycobacterial Infections	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; IMMUNE-RESPONSE; HOST-DEFENSE; TUBERCULOSIS; EXPRESSION; LUNG; INNATE; CELLS; MICE; RESISTANCE	Pulmonary tuberculosis (TB), caused by the intracellular bacteria Mycobacterium tuberculosis, is a worldwide disease that continues to kill more than 1.5 million people every year worldwide. The accumulation of lymphocytes mediates the formation of the tubercle granuloma in the lung and is crucial for host protection against M. tuberculosis infection. However, paradoxically the tubercle granuloma is also the basis for the immunopathology associated with the disease and very little is known about the regulatory mechanisms that constrain the inflammation associated with the granulomas. Lipocalin 2 (Lcn2) is a member of the lipocalin family of proteins and binds to bacterial siderophores thereby sequestering iron required for bacterial growth. Thus far, it is not known whether Lcn2 plays a role in the inflammatory response to mycobacterial pulmonary infections. In the present study, using models of acute and chronic mycobacterial pulmonary infections, we reveal a novel role for Lcn2 in constraining T cell lymphocytic accumulation and inflammation by inhibiting inflammatory chemokines, such as CXCL9. In contrast, Lcn2 promotes neutrophil recruitment during mycobacterial pulmonary infection, by inducing G-CSF and KC in alveolar macrophages. Importantly, despite a common role for Lcn2 in regulating chemokines during mycobacterial pulmonary infections, Lcn2 deficient mice are more susceptible to acute M. bovis BCG, but not low dose M. tuberculosis pulmonary infection.	[Gopal, Radha; Lin, Yinyao; Khader, Shabaana A.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Infect Dis, Pittsburgh, PA 15261 USA; [Guglani, Lokesh; Alcorn, John F.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Pulm Med, Pittsburgh, PA 15261 USA; [Rangel-Moreno, Javier; Randall, Troy D.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Junecko, Beth Fallert; Reinhart, Todd A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Berger, Thorsten; Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Berger, Thorsten; Mak, Tak W.] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Chan, Yvonne R.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Khader, SA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Div Infect Dis, Pittsburgh, PA 15261 USA.	Shabaana.Khader@chp.edu	Guglani, Lokesh/N-6530-2019; Guglani, Lokesh/A-3159-2011; Berger, Thorsten/J-7632-2012	Guglani, Lokesh/0000-0001-8145-0430; Guglani, Lokesh/0000-0001-8145-0430; Rangel-Moreno, Javier/0000-0002-9738-1182; A Khader, Shabaana/0000-0002-9545-4982	Children's Hospital of Pittsburgh; Research Advisory Committee Grant from Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System; National Institute of Health, USA [A1083541, HL105427-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083541] Funding Source: NIH RePORTER	Children's Hospital of Pittsburgh; Research Advisory Committee Grant from Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System; National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from Children's Hospital of Pittsburgh to SAK, and a Research Advisory Committee Grant from Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System to YL. It was also supported by grants from National Institute of Health, USA, A1083541 and HL105427-01 to SAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Arlinghaus R, 2008, LEUKEMIA LYMPHOMA, V49, P600, DOI 10.1080/10428190701859664; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Fallert BA, 2002, J VIROL METHODS, V99, P23, DOI 10.1016/S0166-0934(01)00378-0; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Flower DR, 1996, BIOCHEM J, V318, P1; Fulton SA, 2002, INFECT IMMUN, V70, P5322, DOI 10.1128/IAI.70.9.5322-5327.2002; Halaas O, 2010, J INFECT DIS, V201, P783, DOI 10.1086/650493; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Johnson EE, 2010, FEMS IMMUNOL MED MIC, V58, P138, DOI 10.1111/j.1574-695X.2009.00622.x; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kipnis A, 2003, IMMUNOLOGY, V109, P547, DOI 10.1046/j.1365-2567.2003.01680.x; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Roberts AD, 2002, METHOD MICROBIOL, V32, P433; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; Sunil VR, 2007, EXP MOL PATHOL, V83, P177, DOI 10.1016/j.yexmp.2007.03.004; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wu H, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-96; Zerega B, 2000, EUR J CELL BIOL, V79, P165, DOI 10.1078/S0171-9335(04)70019-9	36	45	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50052	10.1371/journal.pone.0050052	http://dx.doi.org/10.1371/journal.pone.0050052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185529	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700066
J	Janson, C; Kasahara, N; Prendergast, GC; Colicelli, J				Janson, Christine; Kasahara, Noriyuki; Prendergast, George C.; Colicelli, John			RIN3 Is a Negative Regulator of Mast Cell Responses to SCF	PLOS ONE			English	Article							FC-EPSILON-RI; PROTEIN-TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; NUCLEOTIDE EXCHANGE; SURFACE EXPRESSION; KIT; ENDOCYTOSIS; PATIENT; BAR	Stimulation of the receptor tyrosine kinase KIT by Stem Cell Factor (SCF) triggers activation of RAS and its downstream effectors. Proper KIT activation is essential for the maturation, survival and proliferation of mast cells. In addition, SCF activation of KIT is critical for recruiting mast cells to sites of infection or injury, where they release a mix of pro-inflammatory substances. RIN3, a RAS effector and RAB5-directed guanine nucleotide exchange factor (GEF), is highly expressed and enriched in human mast cells. SCF treatment of mast cells increased the amount of GTP-bound RAB5, and the degree of RAB5 activation correlated with the expression level of RIN3. At the same time, SCF caused the dissociation of a pre-formed complex of RIN3 with BIN2, a membrane bending protein implicated in endocytosis. Silencing of RIN3 increased the rate of SCF-induced KIT internalization, while persistent RIN3 over-expression led to KIT down regulation. These observations strongly support a role for RIN3 in coordinating the early steps of KIT endocytosis. Importantly, RIN3 also functioned as an inhibitor of mast cell migration toward SCF. Finally, we demonstrate that elevated RIN3 levels sensitize mastocytosis cells to treatment with a KIT tyrosine kinase inhibitor, suggesting the value of a two-pronged inhibitor approach for this difficult to treat malignancy. These findings directly connect KIT activation with a mast cell-specific RAS effector that regulates the cellular response to SCF and provide new insight for the development of more effective mastocytosis treatments.	[Janson, Christine; Colicelli, John] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Jonsson Comprehens Canc Ctr,Mol Biol Inst, Los Angeles, CA 90095 USA; [Kasahara, Noriyuki] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Prendergast, George C.] Lankenau Inst Med Res, Wynnewood, PA USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Lankenau Medical Center; Lankenau Institute for Medical Research	Colicelli, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Jonsson Comprehens Canc Ctr,Mol Biol Inst, Los Angeles, CA 90095 USA.	colicelli@mednet.ucla.edu		Janson, Christine/0000-0002-5434-7718; Kasahara, Noriyuki/0000-0002-6069-9082	National Institutes of Health (NIH) [CA136699]; University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center; Ruth L. Kirschstein National Research Service Award [GM007185];  [JCCC/P30 CA016042];  [CURE/P30 DK041301]; NATIONAL CANCER INSTITUTE [P30CA016042, R01CA100123, R01CA136699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grant CA136699 (JC) University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center (JC), JCCC/P30 CA016042 and CURE/P30 DK041301 (NK), and the Ruth L. Kirschstein National Research Service Award GM007185 (CMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2007, BLOOD, V109, P3031, DOI 10.1182/blood-2006-07-032714; Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Balaji K, 2012, J CELL SCI IN PRESS; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Barbieri MA, 1996, BIOCELL, V20, P331; Boissan M, 2000, J LEUKOCYTE BIOL, V67, P135, DOI 10.1002/jlb.67.2.135; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Campbell E, 1999, AM J PATHOL, V154, P1259, DOI 10.1016/S0002-9440(10)65377-1; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Clague MJ, 2001, J CELL SCI, V114, P3075; Deininger K, 2008, P NATL ACAD SCI USA, V105, P12539, DOI 10.1073/pnas.0801174105; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hu HL, 2008, MOL CELL BIOL, V28, P1573, DOI 10.1128/MCB.01087-07; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; Hunker CM, 2006, EXP CELL RES, V312, P1106, DOI 10.1016/j.yexcr.2005.12.021; Hunker CM, 2006, ANTICANCER RES, V26, P905; Jin YL, 2010, MOL CANCER THER, V9, P211, DOI 10.1158/1535-7163.MCT-09-0468; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kageyama-Yahara N, 2011, BIOL PHARM BULL, V34, P760, DOI 10.1248/bpb.34.760; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kajiho H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030575; Kalesnikoff J, 2006, P NATL ACAD SCI USA, V103, P2659, DOI 10.1073/pnas.0511191103; Kalesnikoff J, 2007, BLOOD, V109, P5308, DOI 10.1182/blood-2007-01-067363; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kong C, 2007, J BIOL CHEM, V282, P15294, DOI 10.1074/jbc.M611538200; Laidlaw TM, 2011, J ALLERGY CLIN IMMUN, V127, P815, DOI 10.1016/j.jaci.2010.12.1101; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; Miyachi K, 2003, CLIN RHEUMATOL, V22, P329, DOI 10.1007/s10067-003-0716-3; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Prendergast GC, 2009, BBA-REV CANCER, V1795, P25, DOI 10.1016/j.bbcan.2008.09.001; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Rao YJ, 2011, CELL MOL LIFE SCI, V68, P3983, DOI 10.1007/s00018-011-0768-5; Rodman JS, 2000, J CELL SCI, V113, P183; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tomshine JC, 2009, J BIOL CHEM, V284, P26331, DOI 10.1074/jbc.M109.033514; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453	54	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49615	10.1371/journal.pone.0049615	http://dx.doi.org/10.1371/journal.pone.0049615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185384	Green Submitted, Green Published, gold			2022-12-25	WOS:000311535700044
J	Johansson, MA; Saghafian-Hedengren, S; Haileselassie, Y; Roos, S; Troye-Blomberg, M; Nilsson, C; Sverremark-Ekstrom, E				Johansson, Maria A.; Saghafian-Hedengren, Shanie; Haileselassie, Yeneneh; Roos, Stefan; Troye-Blomberg, Marita; Nilsson, Caroline; Sverremark-Ekstrom, Eva			Early-Life Gut Bacteria Associate with IL-4-, IL-10-and IFN-gamma Production at Two Years of Age	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; LACTIC-ACID BACTERIA; INTESTINAL COLONIZATION; IMMUNE-RESPONSES; DENDRITIC CELLS; T-CELLS; MICROBIOTA; CHILDREN; PROBIOTICS; INFECTION	Microbial exposure early in life influences immune maturation and potentially also the development of immune-mediated disease. Here we studied early-life gut colonization in relation to cytokine responses at two years of age. Fecal samples were collected from infants during the first two months of life. DNA was extracted from the fecal samples and Bifidobacterium (B.) adolescentis, B. breve, B. bifidum, a group of lactobacilli (L. casei, L. paracasei and L. rhamnosus) as well as Staphylococcus (S.) aureus were detected with real time PCR. Peripheral mononuclear cells were stimulated with phytohaemagglutinin (PHA) and numbers of IL-4-, IL-10- and IFN-gamma secreting cells were evaluated using ELISpot. We further stimulated peripheral blood mononuclear cells with bacterial supernatants in vitro and assessed the IL-4-, IL-10- and IFN-gamma inducing capacity by flow cytometry and ELISA. Early S. aureus colonization associated with higher numbers of IL-4- (p = 0.022) and IL-10 (p = 0.016) producing cells at two years of age. In contrast to colonization with S. aureus alone, co-colonization with lactobacilli associated with suppression of IL-4- (p = 0.004), IL-10- (p = 0.004) and IFN-gamma (p = 0.034) secreting cells. In vitro stimulations of mononuclear cells with bacterial supernatants supported a suppressive role of L. rhamnosus GG on S. aureus-induced cytokine responses. We demonstrate that the early gut colonization pattern associates with the PHA-induced cytokine profile at two years of age and our in vitro findings support that specific bacterial species influence the T helper cell subsets. This suggests that dysbiosis in the early microbiota may modulate the risk of developing inflammatory conditions like allergy.	[Johansson, Maria A.; Saghafian-Hedengren, Shanie; Haileselassie, Yeneneh; Troye-Blomberg, Marita; Sverremark-Ekstrom, Eva] Stockholm Univ, Arrhenius Labs Nat Sci, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Nilsson, Caroline] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Nilsson, Caroline] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden	Stockholm University; Swedish University of Agricultural Sciences; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet	Sverremark-Ekstrom, E (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden.	maria.johansson@wgi.su.se	Sverremark-Ekström, Eva/A-2305-2016; Nilsson, Caroline/AAF-9663-2022; Troye-Blomberg, Marita/B-9210-2016; Nilsson, Caroline/AFK-2402-2022	Sverremark-Ekström, Eva/0000-0001-6271-8681; Troye-Blomberg, Marita/0000-0002-2804-0325; Haileselassie, Yeneneh/0000-0003-3726-7393; Roos, Stefan/0000-0002-1606-1794	Swedish Research Council [57X-15160-05-2, 57X-15160-07-3]; Swedish Asthma and Allergy Associations' Research Foundation; Cancer and Allergy foundation; Swedish Association for Allergology; Mjolkdroppen foundation; Ragnar Soderberg- foundation; Magnus Bergvall- foundation; Konsul Th C Bergh foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Asthma and Allergy Associations' Research Foundation; Cancer and Allergy foundation; Swedish Association for Allergology; Mjolkdroppen foundation; Ragnar Soderberg- foundation; Magnus Bergvall- foundation; Konsul Th C Bergh foundation	This work was supported by the Swedish Research Council (grants 57X-15160-05-2 and 57X-15160-07-3), the Swedish Asthma and Allergy Associations' Research Foundation, the Cancer and Allergy foundation, The Swedish Association for Allergology and the Mjolkdroppen, the Ragnar Soderberg-, the Magnus Bergvall-, and the Konsul Th C Bergh foundations. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Chen YS, 2010, PEDIATR PULM, V45, P1111, DOI 10.1002/ppul.21296; Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557; Fink LN, 2007, INT IMMUNOL, V19, P1319, DOI 10.1093/intimm/dxm103; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Gabryszewski SJ, 2011, J IMMUNOL, V186, P1151, DOI 10.4049/jimmunol.1001751; Gronlund MM, 2000, ARCH DIS CHILD-FETAL, V83, pF186, DOI 10.1136/fn.83.3.F186; He F, 2002, MICROBIOL IMMUNOL, V46, P781, DOI 10.1111/j.1348-0421.2002.tb02765.x; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Karlsson H, 2002, INFECT IMMUN, V70, P6688, DOI 10.1128/IAI.70.12.6688-6696.2002; King C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017049; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lindberg E, 2011, CLIN MICROBIOL INFEC, V17, P1209, DOI 10.1111/j.1469-0691.2010.03426.x; Martino DJ, 2008, CLIN EXP ALLERGY, V38, P69, DOI 10.1111/j.1365-2222.2007.02856.x; Maudsdotter L, 2011, ANTIMICROB AGENTS CH, V55, P1622, DOI 10.1128/AAC.00770-10; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Niers LEM, 2005, CLIN EXP ALLERGY, V35, P1481, DOI 10.1111/j.1365-2222.2005.02375.x; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Nilsson C, 2009, CLIN EXP ALLERGY, V39, P509, DOI 10.1111/j.1365-2222.2008.03147.x; PASTACALDI C, 2010, ALLERGY; Penders J, 2010, MICROBIOL-SGM, V156, P3298, DOI 10.1099/mic.0.042069-0; Prescott SL, 2008, ALLERGY, V63, P1481, DOI 10.1111/j.1398-9995.2008.01778.x; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saghafian-Hedengren S, 2010, J ALLERGY CLIN IMMUN, V125, P433, DOI 10.1016/j.jaci.2009.09.033; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P1842, DOI 10.1111/j.1365-2222.2009.03326.x; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036; Williams AM, 2006, IMMUNOLOGY, V119, P470, DOI 10.1111/j.1365-2567.2006.02458.x	36	30	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49315	10.1371/journal.pone.0049315	http://dx.doi.org/10.1371/journal.pone.0049315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185315	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700028
J	Nilsson, S; Angeletti, D; Wahlgren, M; Chen, QJ; Moll, K				Nilsson, Sandra; Angeletti, Davide; Wahlgren, Mats; Chen, Qijun; Moll, Kirsten			Plasmodium falciparum Antigen 332 Is a Resident Peripheral Membrane Protein of Maurer's Clefts	PLOS ONE			English	Article							RING-EXPORTED PROTEIN-1; RED-BLOOD-CELLS; ERYTHROCYTE-MEMBRANE; MEGADALTON PROTEIN; PARASITE PROTEINS; STREPTOLYSIN-O; GIANT PROTEIN; BREFELDIN-A; PF332 GENE; MALARIA	During the intraerythrocytic development of Plasmodium falciparum, the malaria parasite remodels the host cell cytosol by inducing membranous structures termed Maurer's clefts and inserting parasite proteins into the red blood cell cytoskeleton and plasma membrane. Pf332 is the largest known asexual malaria antigen that is exported into the red blood cell cytosol where it associates with Maurer's clefts. In the current work, we have utilized a set of different biochemical assays to analyze the solubility of the endogenous Pf332 molecule during its trafficking from the endoplasmic reticulum within the parasite to the host cell cytosol. Solubilization studies demonstrate that Pf332 is synthesized and trafficked within the parasite as a peripheral membrane protein, which after export into the host cell cytosol associates with the cytoplasmic side of Maurer's clefts in a peripheral manner. By immunofluorescence microscopy and flow cytometry, we show that Pf332 persists in close association with Maurer's clefts throughout trophozoite maturation and schizogony, and does not become exposed at the host cell surface. Our data also indicate that Pf332 interacts with the host cell cytoskeleton, but only in very mature parasite stages. Thus, the present study describes Pf332 as a resident peripheral membrane protein of Maurer's clefts and suggests that the antigen participates in host cytoskeleton modifications at completion of the intraerythrocytic developmental cycle.	[Nilsson, Sandra; Angeletti, Davide; Wahlgren, Mats; Moll, Kirsten] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Chen, Qijun] Chinese Acad Med Sci, Parasitol Lab, Inst Pathogen Biol, Beijing 100730, Peoples R China	Karolinska Institutet; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Nilsson, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	snilsson@hsph.harvard.edu; kirsten.moll@ki.se	Angeletti, Davide/H-7350-2019	Angeletti, Davide/0000-0002-5256-1972	European Malaria Consortium (EVIMalaR) grant [242095]; Swedish Research Council; SIDA/SAREC; Karolinska Institutet [6110/06-225]; National Basic Research Program of China (973 Program) [2007CB513100]; Chinese National Natural Science Foundation of China (NSFC) program [81130033, 81171592]; European Community's Seventh Framework Program (FP7) [242095]	European Malaria Consortium (EVIMalaR) grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); SIDA/SAREC; Karolinska Institutet(Karolinska Institutet); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation of China (NSFC) program(National Natural Science Foundation of China (NSFC)); European Community's Seventh Framework Program (FP7)	This study was carried out with support from a European Malaria Consortium (EVIMalaR) grant (242095), Swedish Research Council, SIDA/SAREC, Karolinska Institutet (6110/06-225), the National Basic Research Program of China (973 Program, number 2007CB513100) and the Chinese National Natural Science Foundation of China (NSFC) program (81130033, 81171592). The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement number 242095. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; [Anonymous], 2008, METHODS MALARIA RES; Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; BARNWELL JW, 1989, EXP PARASITOL, V69, P407, DOI 10.1016/0014-4894(89)90190-2; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baumann E, 2000, ACTA HISTOCHEM, V102, P21, DOI 10.1078/0065-1281-00534; Bennett BJ, 1997, J BIOL CHEM, V272, P15299, DOI 10.1074/jbc.272.24.15299; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; Cooke BM, 2004, SEMIN HEMATOL, V41, P173, DOI 10.1053/j.seminhematol.2004.01.004; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; DASILVA E, 1994, MOL BIOCHEM PARASIT, V66, P59, DOI 10.1016/0166-6851(94)90036-1; Dixon MWA, 2008, TRAFFIC, V9, P1316, DOI 10.1111/j.1600-0854.2008.00768.x; Du C, 2010, VACCINE, V28, P4977, DOI 10.1016/j.vaccine.2010.05.027; ELFORD BC, 1995, BIOCHEM J, V308, P361, DOI 10.1042/bj3080361; Elford BC, 1997, TRENDS MICROBIOL, V5, P463, DOI 10.1016/S0966-842X(97)01169-4; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Glenister FK, 2009, BLOOD, V113, P919, DOI 10.1182/blood-2008-05-157735; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Haeggstrom M, 2004, MOL BIOCHEM PARASIT, V133, P1, DOI 10.1016/j.molbiopara.2003.07.006; Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; HINTERBERG K, 1994, EXP PARASITOL, V79, P279, DOI 10.1006/expr.1994.1091; Hodder AN, 2009, MOL MICROBIOL, V71, P48, DOI 10.1111/j.1365-2958.2008.06508.x; HOWARD RJ, 1988, MOL BIOCHEM PARASIT, V27, P207, DOI 10.1016/0166-6851(88)90040-0; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MATTEI D, 1992, GENE, V110, P71, DOI 10.1016/0378-1119(92)90446-V; MATTEI D, 1992, MEM I OSWALDO CRUZ, V87, P163, DOI 10.1590/S0074-02761992000700026; Moll K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000477; Nilsson Sandra, 2011, Malar Res Treat, V2011, P671439, DOI 10.4061/2011/671439; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Pavithra SR, 2007, PLOS COMPUT BIOL, V3, P1701, DOI 10.1371/journal.pcbi.0030168; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Schon P, 2008, BIOPHYS J, V95, P691, DOI 10.1529/biophysj.108.129981; Silva MD, 2005, MOL MICROBIOL, V56, P990, DOI 10.1111/j.1365-2958.2005.04603.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002; Waller KL, 2007, BBA-BIOMEMBRANES, V1768, P2145, DOI 10.1016/j.bbamem.2007.04.027; Waller KL, 2010, BBA-BIOMEMBRANES, V1798, P861, DOI 10.1016/j.bbamem.2010.01.018; Waller KL, 2003, BLOOD, V102, P1911, DOI 10.1182/blood-2002-11-3513; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636	61	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e46980	10.1371/journal.pone.0046980	http://dx.doi.org/10.1371/journal.pone.0046980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185236	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700003
J	Orr, RJS; Murray, SA; Stuken, A; Rhodes, L; Jakobsen, KS				Orr, Russell J. S.; Murray, Shauna A.; Stuken, Anke; Rhodes, Lesley; Jakobsen, Kjetill S.			When Naked Became Armored: An Eight-Gene Phylogeny Reveals Monophyletic Origin of Theca in Dinoflagellates	PLOS ONE			English	Article							SP-NOV DINOPHYCEAE; SAND-DWELLING DINOFLAGELLATE; SUBUNIT RIBOSOMAL DNA; LSU RDNA SEQUENCES; ALVEOLATE GROUP-I; ELECTRON-MICROSCOPY; MOLECULAR PHYLOGENY; MISSING DATA; GEN. NOV; HETEROTROPHIC DINOFLAGELLATE	The dinoflagellates are a diverse lineage of microbial eukaryotes. Dinoflagellate monophyly and their position within the group Alveolata are well established. However, phylogenetic relationships between dinoflagellate orders remain unresolved. To date, only a limited number of dinoflagellate studies have used a broad taxon sample with more than two concatenated markers. This lack of resolution makes it difficult to determine the evolution of major phenotypic characters such as morphological features or toxin production e.g. saxitoxin. Here we present an improved dinoflagellate phylogeny, based on eight genes, with the broadest taxon sampling to date. Fifty-five sequences for eight phylogenetic markers from nuclear and mitochondrial regions were amplified from 13 species, four orders, and concatenated phylogenetic inferences were conducted with orthologous sequences. Phylogenetic resolution is increased with addition of support for the deepest branches, though can be improved yet further. We show for the first time that the characteristic dinoflagellate thecal plates, cellulosic material that is present within the sub-cuticular alveoli, appears to have had a single origin. In addition, the monophyly of most dinoflagellate orders is confirmed: the Dinophysiales, the Gonyaulacales, the Prorocentrales, the Suessiales, and the Syndiniales. Our improved phylogeny, along with results of PCR to detect the sxtA gene in various lineages, allows us to suggest that this gene was probably acquired separately in Gymnodinium and the common ancestor of Alexandrium and Pyrodinium and subsequently lost in some descendent species of Alexandrium.	[Orr, Russell J. S.; Stuken, Anke; Jakobsen, Kjetill S.] Univ Oslo, MERG, Dept Biol, Oslo, Norway; [Murray, Shauna A.] Univ New S Wales, Ecol & Evolut Res Ctr, Sydney, NSW, Australia; [Murray, Shauna A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Murray, Shauna A.] Sydney Inst Marine Sci, Mosman, NSW, Australia; [Rhodes, Lesley] Cawthron Inst, Nelson, New Zealand; [Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, CEES, Oslo, Norway	University of Oslo; University of New South Wales Sydney; University of New South Wales Sydney; Sydney Institute of Marine Science; Cawthron Institute; University of Oslo	Jakobsen, KS (corresponding author), Univ Oslo, MERG, Dept Biol, Oslo, Norway.	k.s.jakobsen@bio.uio.no	Murray, Shauna/K-5781-2015	Murray, Shauna/0000-0001-7096-1307; Stuken, Anke/0000-0002-7553-9524	Research Council of Norway (RCN) [186292/V40]; Molecular Life Science program (MLS), University of Oslo	Research Council of Norway (RCN)(Research Council of Norway); Molecular Life Science program (MLS), University of Oslo	This study was financially supported by the Research Council of Norway (RCN) grant 186292/V40 to KSJ, and by a PhD grant to RJSO from the Molecular Life Science program (MLS), University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM M, 1973, TOXICON, V11, P65, DOI 10.1016/0041-0101(73)90154-2; Bachvaroff TR, 2006, J MOL EVOL, V62, P42, DOI 10.1007/s00239-004-0365-4; Bachvaroff TR, 2011, J EUKARYOT MICROBIOL, V58, P223, DOI 10.1111/j.1550-7408.2011.00555.x; Bergholtz T, 2006, J PHYCOL, V42, P170, DOI 10.1111/j.1529-8817.2006.00172.x; Blackburn SI, 2001, PHYCOLOGIA, V40, P78, DOI 10.2216/i0031-8884-40-1-78.1; Brate J, 2012, PROTIST, V163, P767, DOI 10.1016/j.protis.2012.04.004; BUJAK JP, 1981, CAN J BOT, V59, P2077, DOI 10.1139/b81-270; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Deeds JR, 2008, MAR DRUGS, V6, P308, DOI [10.3390/md6020308, 10.3390/md20080015]; Dodge J. D., 1968, Protistologica, V4, P231; Dodge J. D., 1987, BIOL DINOFLAGELLATES, P93; Dorhofer G, 1980, EVOLUTION ARCHEOPHYL; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; FAUST MA, 1993, J PHYCOL, V29, P826, DOI 10.1111/j.0022-3646.1993.00826.x; Fensome R. A., 1993, MICROPALEONTOLOGY SP, V7, P1; Fensome R.A., 2008, AM ASS STRATIGRAPHIC, V1; Fensome RA, 1999, GRANA, V38, P66; Fukuda Y, 2008, EUR J PROTISTOL, V44, P27, DOI 10.1016/j.ejop.2007.07.001; Fukuda Y, 2006, EUR J PROTISTOL, V42, P209, DOI 10.1016/j.ejop.2006.05.003; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Gaines G., 1987, Botanical Monographs (Oxford), V21, P224; Gast RJ, 2006, J EUKARYOT MICROBIOL, V53, P43, DOI 10.1111/j.1550-7408.2005.00071.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gottschling M, 2012, PROTIST, V163, P15, DOI 10.1016/j.protis.2011.06.003; Gribble KE, 2006, J PHYCOL, V42, P1081, DOI 10.1111/j.1529-8817.2006.00267.x; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; Hackett JD, 2012, MOL BIOL EVOLUTION; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hansen G, 2011, PHYCOLOGIA, V50, P583, DOI 10.2216/11-11.1; Harada A, 2007, PROTIST, V158, P337, DOI 10.1016/j.protis.2007.03.005; Heath TA, 2008, SYST BIOL, V57, P160, DOI 10.1080/10635150701884640; HENDRIKS L, 1989, SYST APPL MICROBIOL, V12, P223, DOI 10.1016/S0723-2020(89)80066-9; Henrichs DW, 2011, J PHYCOL, V47, P366, DOI 10.1111/j.1529-8817.2011.00960.x; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Hoppenrath M, 2006, PHYCOLOGIA, V45, P260, DOI 10.2216/05-23.1; Hoppenrath M, 2003, EUR J PHYCOL, V38, P385, DOI 10.1080/09670260310001613717; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Hoppenrath M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013220; Horiguchi T, 2000, J PHYCOL, V36, P960, DOI 10.1046/j.1529-8817.2000.00007.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; John U, 2003, MOL BIOL EVOL, V20, P1015, DOI 10.1093/molbev/msg105; Johnson KA, 2012, MOL PHYLOGENET EVOL, V62, P146, DOI 10.1016/j.ympev.2011.09.011; Jorgensen MF, 2004, PHYCOL RES, V52, P284; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Ki JS, 2010, EUR J PROTISTOL, V46, P111, DOI 10.1016/j.ejop.2009.11.001; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kim S, 2011, MOL BIOL EVOL, V28, P1469, DOI 10.1093/molbev/msq332; Kiryu H, 2007, BIOINFORMATICS, V23, P434, DOI 10.1093/bioinformatics/btl636; Kuhn SF, 2005, PROTIST, V156, P393, DOI 10.1016/j.protis.2005.09.002; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lindberg K, 2005, PHYCOLOGIA, V44, P416, DOI 10.2216/0031-8884(2005)44[416:SOWDIW]2.0.CO;2; LOEBLICH AR, 1976, J PROTOZOOL, V23, P13, DOI 10.1111/j.1550-7408.1976.tb05241.x; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; MADDISON WP, 2000, MACCLADE; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Mihali TK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014657; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Minge MA, 2009, P ROY SOC B-BIOL SCI, V276, P597, DOI 10.1098/rspb.2008.1358; Moestrup O, 2009, PHYCOL RES, V57, P203, DOI 10.1111/j.1440-1835.2009.00540.x; Moestrup Ojvind, 2007, Systematics Association Special Volume Series, V75, P215; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moustafa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005758; Murray S, 2005, PROTIST, V156, P269, DOI 10.1016/j.protis.2005.05.003; Murray S, 2004, EUR J PHYCOL, V39, P229, DOI 10.1080/0967026042000202154; Murray S, 2006, J PHYCOL, V42, P934, DOI 10.1111/j.1529-8817.2006.00241.x; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Murray SA, 2011, MOL BIOL EVOL, V28, P1173, DOI 10.1093/molbev/msq295; Okamoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034900; Orr RJS, 2011, HARMFUL ALGAE, V10, P676, DOI 10.1016/j.hal.2011.05.003; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029398; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034340; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Saunders GW, 1997, PLANT SYST EVOL, P237; SCHANTZ EJ, 1966, BIOCHEMISTRY-US, V5, P1191, DOI 10.1021/bi00868a011; Shalchian-Tabrizi K, 2006, J EUKARYOT MICROBIOL, V53, P217, DOI 10.1111/j.1550-7408.2006.00098.x; Shimizu Y, 1996, ANNU REV MICROBIOL, V50, P431, DOI 10.1146/annurev.micro.50.1.431; Siano R, 2010, PROTIST, V161, P385, DOI 10.1016/j.protis.2010.01.002; Skovgaard A, 2007, J PHYCOL, V43, P553, DOI 10.1111/j.1529-8817.2007.00338.x; Skovgaard A, 2009, ENVIRON MICROBIOL, V11, P2030, DOI 10.1111/j.1462-2920.2009.01924.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Stuken A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020096; TAKAYAMA H, 1985, Bulletin of Plankton Society of Japan, V32, P129; Tamura M, 2005, EUR J PHYCOL, V40, P281, DOI 10.1080/09670260500211677; Taylor F.J.R., 1990, P419; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Taylor F.J.R, 1987, BIOL DINOFLAGELLATES, P798; Taylor FJR, 2004, PHYCOL RES, V52, P308, DOI 10.1111/j.1440-1835.2004.tb00341.x; TAYLOR FJR, 1980, BIOSYSTEMS, V13, P65, DOI 10.1016/0303-2647(80)90006-4; Taylor FJR, 2001, DINOFLAGELLATES ELS; Tillmann U, 2012, PROTIST, V163, P701, DOI 10.1016/j.protis.2011.10.005; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2005, SYST BIOL, V54, P731, DOI 10.1080/10635150500234583; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wiese M, 2010, MAR DRUGS, V8, P2185, DOI 10.3390/md8072185; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841; Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x; Zhang H, 2008, J PHYCOL, V44, P703, DOI 10.1111/j.1529-8817.2008.00521.x; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4; [No title captured]	115	68	73	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50004	10.1371/journal.pone.0050004	http://dx.doi.org/10.1371/journal.pone.0050004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185516	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800065
J	Sundelin, JP; Stahlman, M; Lundqvist, A; Levin, M; Parini, P; Johansson, ME; Boren, J				Sundelin, Jeanna Perman; Stahlman, Marcus; Lundqvist, Annika; Levin, Max; Parini, Paolo; Johansson, Martin E.; Boren, Jan			Increased Expression of the Very Low-Density Lipoprotein Receptor Mediates Lipid Accumulation in Clear-Cell Renal Cell Carcinoma	PLOS ONE			English	Article							CHOLESTEROL; QUANTIFICATION; METABOLISM; INVIVO; RABBIT; LIGHT	Clear-cell renal cell carcinoma (RCC) is, in most cases, caused by loss of function of the tumor suppressor gene von Hippel-Lindau, resulting in constitutive activation of hypoxia-inducible factor (HIF)-1 alpha and expression of hypoxia-induced genes in normoxic conditions. Clear-cell RCC cells are characterized histologically by accumulation of cholesterol, mainly in its ester form. The origin of the increased cholesterol remains unclear, but it is likely explained by an HIF-1 alpha-driven imbalance between cholesterol uptake and excretion. Here, we showed that expression of the very low-density lipoprotein receptor (VLDL-R) was significantly increased in clear-cell RCC human biopsies compared with normal kidney tissue. Partial knockdown of HIF-1 alpha in clear-cell RCC cells significantly reduced the VLDL-R expression, and knockdown of either HIF-1 alpha or VLDL-R reduced the increased lipid accumulation observed in these cells. We also showed increased uptake of fluorescently labeled lipoproteins in clear-cell RCC cells, which was significantly reduced by knockdown of HIF-1 alpha or VLDL-R. Taken together, our results support the concept that the pathological increase of HIF-1 alpha in clear-cell RCC cells upregulates VLDL-R, which mediates increased uptake and accumulation of lipids. These results explain the morphological characteristics of clear-cell RCC, and open up novel possibilities for detection and treatment of clear-cell RCC.	[Sundelin, Jeanna Perman; Stahlman, Marcus; Lundqvist, Annika; Levin, Max; Boren, Jan] Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Parini, Paolo] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Chem, Stockholm, Sweden; [Johansson, Martin E.] Lund Univ, Dept Lab Med, Dept Pathol, Ctr Mol Pathol, Malmo, Sweden	University of Gothenburg; Karolinska Institutet; Karolinska University Hospital; Lund University	Sundelin, JP (corresponding author), Univ Gothenburg, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden.	jeanna.perman@wlab.gu.se	StÃhlman, Marcus/M-4597-2019	Henricsson, Marcus/0000-0002-4202-0339	Swedish Research Council [K2011-65X-12563-14-66]; Swedish Heart-Lung Foundation [200090683]; Novo Nordisk Foundation [R177-A14864]; Swedish Foundation for Strategic Research [A3 05:188]; EU [FP7-KBBE-222639]; LipidomicNet [HEALTH-2007-2.1.1-6]; Novo Nordisk Fonden [NNF11OC1014864] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); EU(European Commission); LipidomicNet; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Swedish Research Council (contracts K2011-65X-12563-14-66)(www.vr.se), the Swedish Heart-Lung Foundation (contract 200090683) (www.hjart-lungfonden.se), Novo Nordisk Foundation (contract R177-A14864) (www.novonordiskfonden.dk/en), the Swedish Foundation for Strategic Research (contract A3 05:188) and the EU-funded projects ETHERPATHS (Contract FP7-KBBE-222639) and LipidomicNet (Contract HEALTH-2007-2.1.1-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; CLAYMAN RV, 1986, FEBS LETT, V196, P87, DOI 10.1016/0014-5793(86)80219-8; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; ERICSSON JL, 1966, VIRCHOWS ARCH A, V341, P204, DOI 10.1007/BF00961071; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; FOLCH J, 1957, J BIOL CHEM, V226, P497; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Gleadle JM, 2009, NEPHROLOGY, V14, P86, DOI 10.1111/j.1440-1797.2008.01064.x; GONZALEZ R, 1977, LANCET, V1, P912; Harten SK, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-89; Hiukka A, 2009, DIABETES, V58, P2018, DOI 10.2337/db09-0206; Homan R, 1998, J CHROMATOGR B, V708, P21, DOI 10.1016/S0378-4347(97)00651-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; MUKODANI J, 1990, ARTERIOSCLEROSIS, V10, P106, DOI 10.1161/01.ATV.10.1.106; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Pinthus JH, 2011, CUAJ-CAN UROL ASSOC, V5, P274, DOI 10.5489/cuaj.10196; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Tiebel O, 1999, ATHEROSCLEROSIS, V145, P239, DOI 10.1016/S0021-9150(99)00068-4; WILEY MH, 1977, J BIOL CHEM, V252, P548	22	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e48694	10.1371/journal.pone.0048694	http://dx.doi.org/10.1371/journal.pone.0048694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185271	Green Published, gold			2022-12-25	WOS:000311333800009
J	Law, KKL; Makino, S; Mo, R; Zhang, XY; Puviindran, V; Hui, CC				Law, Kelvin King Lo; Makino, Shigeru; Mo, Rong; Zhang, Xiaoyun; Puviindran, Vijitha; Hui, Chi-chung			Antagonistic and Cooperative Actions of Kif7 and Sufu Define Graded Intracellular Gli Activities in Hedgehog Signaling	PLOS ONE			English	Article							VERTEBRATE NEURAL-TUBE; PROGENITOR-CELL IDENTITY; FLOOR PLATE; SPINAL-CORD; RETINOIC ACID; NEURONAL FATE; SUPPRESSOR; MOUSE; PROTEIN; SHH	Graded Hedgehog (Hh) signaling governs the balance of Gli transcriptional activators and repressors to specify diverse ventral cell fates in the spinal cord. It remains unclear how distinct intracellular Gli activity is generated. Here, we demonstrate that Sufu acts universally as a negative regulator of Hh signaling, whereas Kif7 inhibits Gli activity in cooperation with, and independent of, Sufu. Together, they deter naive precursors from acquiring increasingly ventral identity. We show that Kif7 is also required to establish high intracellular Gli activity by antagonizing the Sufu-inhibition of Gli2. Strikingly, by abolishing the negative regulatory action of Sufu, diverse ventral cell fates can be specified in the absence of extracellular Hh signaling. These data suggest that Sufu is the primary regulator of graded Hh signaling and establish that the antagonistic and cooperative actions of Kif7 and Sufu are responsible for setting up distinct Gli activity in ventral cell fate specification.	[Law, Kelvin King Lo; Mo, Rong; Zhang, Xiaoyun; Puviindran, Vijitha; Hui, Chi-chung] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON, Canada; [Law, Kelvin King Lo; Hui, Chi-chung] Univ Toronto, Dept Med Genet, Toronto, ON, Canada; [Makino, Shigeru] RIKEN, BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki, Japan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; RIKEN	Hui, CC (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto Med Discovery Tower, Toronto, ON, Canada.	cchui@sickkids.ca			University of Toronto; Canadian Cancer Society Research Institute [2010-700320, 2011-700774]	University of Toronto(University of Toronto); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by a University of Toronto Open Fellowship to Kelvin Law and funded by the Canadian Cancer Society Research Institute (2010-700320 and 2011-700774) to Chi-chung Hui (http://www.cancer.ca/Research.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Diez del Corral R, 2003, NEURON, V40, P65; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Ding Q, 1998, DEVELOPMENT, V125, P2533; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hsu SHC, 2011, DEVELOPMENT, V138, P3791, DOI 10.1242/dev.069492; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Mo R, 1997, DEVELOPMENT, V124, P113; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Park HL, 2000, DEVELOPMENT, V127, P1593; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Ribes V, 2010, GENE DEV, V24, P1186, DOI 10.1101/gad.559910; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang H, 2011, DEVELOPMENT, V138, P3711, DOI 10.1242/dev.068270; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Wilson L, 2004, DEV BIOL, V269, P433, DOI 10.1016/j.ydbio.2004.01.034; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	35	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e50193	10.1371/journal.pone.0050193	http://dx.doi.org/10.1371/journal.pone.0050193			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166838	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300094
J	Bassaganya-Riera, J; Dominguez-Bello, MG; Kronsteiner, B; Carbo, A; Lu, PY; Viladomiu, M; Pedragosa, M; Zhang, XY; Sobral, BW; Mane, SP; Mohapatra, SK; Horne, WT; Guri, AJ; Groeschl, M; Lopez-Velasco, G; Hontecillas, R				Bassaganya-Riera, Josep; Dominguez-Bello, Maria Gloria; Kronsteiner, Barbara; Carbo, Adria; Lu, Pinyi; Viladomiu, Monica; Pedragosa, Mireia; Zhang, Xiaoying; Sobral, Bruno W.; Mane, Shrinivasrao P.; Mohapatra, Saroj K.; Horne, William T.; Guri, Amir J.; Groeschl, Michael; Lopez-Velasco, Gabriela; Hontecillas, Raquel			Helicobacter pylori Colonization Ameliorates Glucose Homeostasis in Mice through a PPAR gamma-Dependent Mechanism	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; HOMOTYPIC PHAGOSOME FUSION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CAGA(-) STRAINS; INFECTION; INFLAMMATION; OBESITY; LEPTIN; GHRELIN	Background: There is an inverse secular trend between the incidence of obesity and gastric colonization with Helicobacter pylori, a bacterium that can affect the secretion of gastric hormones that relate to energy homeostasis. H. pylori strains that carry the cag pathogenicity island (PAI) interact more intimately with gastric epithelial cells and trigger more extensive host responses than cag(-) strains. We hypothesized that gastric colonization with H. pylori strains differing in cag PAI status exert distinct effects on metabolic and inflammatory phenotypes. Methodology/Principal Findings: To test this hypothesis, we examined metabolic and inflammatory markers in db/db mice and mice with diet-induced obesity experimentally infected with isogenic forms of H. pylori strain 26695: the cag PAI wild-type and its cag PAI mutant strain 99-305. H. pylori colonization decreased fasting blood glucose levels, increased levels of leptin, improved glucose tolerance, and suppressed weight gain. A response found in both wild-type and mutant H. pylori strain-infected mice included decreased white adipose tissue macrophages (ATM) and increased adipose tissue regulatory T cells (Treg) cells. Gene expression analyses demonstrated upregulation of gastric PPAR gamma-responsive genes (i.e., CD36 and FABP4) in H. pylori-infected mice. The loss of PPAR gamma in immune and epithelial cells in mice impaired the ability of H. pylori to favorably modulate glucose homeostasis and ATM infiltration during high fat feeding. Conclusions/Significance: Gastric infection with some commensal strains of H. pylori ameliorates glucose homeostasis in mice through a PPAR gamma-dependent mechanism and modulates macrophage and Treg cell infiltration into the abdominal white adipose tissue.	[Bassaganya-Riera, Josep; Kronsteiner, Barbara; Carbo, Adria; Lu, Pinyi; Viladomiu, Monica; Pedragosa, Mireia; Zhang, Xiaoying; Sobral, Bruno W.; Mane, Shrinivasrao P.; Mohapatra, Saroj K.; Horne, William T.; Guri, Amir J.; Lopez-Velasco, Gabriela; Hontecillas, Raquel] Virginia Tech, Nutr Immunol & Mol Med Lab, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA USA; [Dominguez-Bello, Maria Gloria] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Groeschl, Michael] Univ Erlangen Nurnberg, D-91054 Erlangen, Germany; [Bassaganya-Riera, Josep] Virginia Tech, Dept Biomed Sci & Pathobiol, VA MD Reg Coll Vet Med, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Erlangen Nuremberg; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Nutr Immunol & Mol Med Lab, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA USA.	jbassaga@vt.edu	Lu, Pinyi/U-4513-2017; Viladomiu, Monica/GNM-6447-2022; Sobral, Bruno/GVU-7637-2022	Sobral, Bruno/0000-0003-3908-577X; Kronsteiner-Dobramysl, Barbara/0000-0003-0867-2867; Mohapatra, Saroj Kant/0000-0003-4723-5109; Mane, Shrinivasrao/0000-0003-4123-624X; LOPEZ-VELASCO, GABRIELA/0000-0002-7840-3091; Lu, Pinyi/0000-0003-1962-5783	National Institutes of Health [5R01AT004308]; National Institute of Allergy and Infectious Diseases [HHSN272201000056C, HHSN272200900040C]; Virginia Bioinformatics Institute (VBI); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Virginia Bioinformatics Institute (VBI); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This study was supported in part by the National Institutes of Health 5R01AT004308 to JB-R, National Institute of Allergy and Infectious Diseases contract number HHSN272201000056C to JB-R, National Institute of Allergy and Infectious Diseases contract number HHSN272200900040C to BWS, Virginia Bioinformatics Institute (VBI) exploratory grant (JB-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Allen LAH, 2000, J EXP MED, V191, P115, DOI 10.1084/jem.191.1.115; Allen LAH, 2007, CELL MICROBIOL, V9, P817, DOI 10.1111/j.1462-5822.2007.00906.x; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; [Anonymous], 2007, GASTROENTEROLOGY, V133, P6; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Azuma T, 2001, GUT, V49, P324, DOI 10.1136/gut.49.3.324; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2003, J NUTR, V133, P3204, DOI 10.1093/jn/133.10.3204; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Bazargani A, 2010, SCAND J GASTROENTERO, V45, P1162, DOI 10.3109/00365521.2010.499959; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blaser MJ, 2008, CANCER PREV RES, V1, P308, DOI 10.1158/1940-6207.CAPR-08-0170; Blaser MJ, 2008, GUT; Bourzac KM, 2005, CELL MICROBIOL, V7, P911, DOI 10.1111/j.1462-5822.2005.00541.x; CDC, 2005, NAT DIAB FACT SHEET, P1; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Chow WH, 1998, CANCER RES, V58, P588; Codolo G, 2008, CELL MICROBIOL, V10, P2355, DOI 10.1111/j.1462-5822.2008.01217.x; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; D'Elios MM, 2009, FEMS IMMUNOL MED MIC, V56, P1, DOI 10.1111/j.1574-695X.2009.00537.x; Danesh J, 1999, ALIMENT PHARM THERAP, V13, P851; Ealey KN, 2008, MOL CARCINOGEN, V47, P667, DOI 10.1002/mc.20419; Ghose C, 2005, J CLIN MICROBIOL, V43, P2635, DOI 10.1128/JCM.43.6.2635-2641.2005; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Hontecillas R, 2002, J NUTR, V132, P2019, DOI 10.1093/jn/132.7.2019; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Kalra SP, 2005, J NUTR, V135, P1331, DOI 10.1093/jn/135.5.1331; Kamada T, 2005, DIGEST LIVER DIS, V37, P39, DOI 10.1016/j.dld.2004.07.017; Kandulski A, 2008, HELICOBACTER, V13, P295, DOI 10.1111/j.1523-5378.2008.00612.x; Kaneko H, 2002, J GASTROENTEROL, V37, P77, DOI 10.1007/s005350200000; Karita M, 1998, J INFECT DIS, V178, P213, DOI 10.1086/515606; Konturek PC, 2006, J PHYSIOL PHARMACOL, V57, P67; Kranzer K, 2005, INFECT IMMUN, V73, P4180, DOI 10.1128/IAI.73.7.4180-4189.2005; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lee IO, 2010, J BIOL CHEM, V285, P16042, DOI 10.1074/jbc.M110.111054; Liew PL, 2006, OBES SURG, V16, P612, DOI 10.1381/096089206776945002; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Matarese G, 2010, TRENDS MOL MED; McColl KEL, 2000, GASTROENTEROL CLIN N, V29, P687, DOI 10.1016/S0889-8553(05)70138-2; McCune A, 2003, EUR J GASTROEN HEPAT, V15, P637, DOI 10.1097/00042737-200306000-00010; Menaker RJ, 2004, INFECT IMMUN, V72, P2889, DOI 10.1128/IAI.72.5.2889-2898.2004; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Nwokolo CU, 2003, GUT, V52, P637, DOI 10.1136/gut.52.5.637; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Peek Richard M Jr, 2005, Sci STKE, V2005, ppe14; Perez-Perez GI, 2002, GUT, V50, P295, DOI 10.1136/gut.50.3.295; Permin H, 2005, HELICOBACTER, V10, P21, DOI 10.1111/j.1523-5378.2005.00337.x; Rittig MG, 2003, CELL MICROBIOL, V5, P887, DOI 10.1046/j.1462-5822.2003.00328.x; Roper J, 2007, J CLIN ENDOCR METAB, V10, P2007; SAS Institute INC, 1988, SAS STAT US GUID REL; Secka O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027954; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Shiotani A, 2005, HELICOBACTER, V10, P373, DOI 10.1111/j.1523-5378.2005.00343.x; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Tsai SH, 2004, J GASTROENTEROL, V39, P821, DOI 10.1007/s00535-004-1396-8; Vaezi MF, 2000, AM J GASTROENTEROL, V95, P2206, DOI 10.1111/j.1572-0241.2000.02305.x; Vieth M, 2000, DIGESTION, V62, P225, DOI 10.1159/000007820; Wang TC, 2002, NAT MED, V8, P1080, DOI 10.1038/nm1002-1080; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wu MS, 2005, ARCH INTERN MED, V165, P1552, DOI 10.1001/archinte.165.13.1552; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yao LP, 2010, HYBRIDOMA, V29, P341, DOI 10.1089/hyb.2010.0013; Zheng PY, 2003, CELL MICROBIOL, V5, P25, DOI 10.1046/j.1462-5822.2003.00250.x	73	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e50069	10.1371/journal.pone.0050069	http://dx.doi.org/10.1371/journal.pone.0050069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166823	Green Published, gold, Green Submitted			2022-12-25	WOS:000311272300086
J	Lin, MZ; Marzec, KA; Martin, JL; Baxter, RC				Lin, M. Z.; Marzec, K. A.; Martin, J. L.; Baxter, R. C.			The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents	ONCOGENE			English	Article						EGFR; IGFBP-3; breast cancer; DNA-PK; DNA-damaging therapy	DOUBLE-STRAND BREAK; FACTOR RECEPTOR; NUCLEAR EGFR; RECURRENT GLIOBLASTOMA; TUMOR SUPPRESSION; EPITHELIAL-CELLS; LIPID RAFTS; PHASE-II; EXPRESSION; KINASE	Following exposure to radiation and chemotherapeutic agents, the epidermal growth factor receptor (EGFR) can modulate the repair of DNA double-strand breaks (DSB) by forming protein complexes that include the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs). This is one of the key mechanism by which tumors become resistant to DNA-damaging therapies. Our previous studies have shown that insulin-like growth factor binding protein-3 (IGFBP-3) is a substrate for DNA-PKcs, and can transactivate EGFR. We therefore questioned whether IGFBP-3 might interact with the EGFR - DNA-PK complex that regulates the DNA damage response. The aim of this study was to delineate the role of IGFBP-3 in the response of breast cancer cells to DSB-inducing chemotherapeutic agents. In the estrogen receptor-negative breast cancer cell lines MDA-MB-468 and Hs578T, which express IGFBP-3 highly, nuclear localization of EGFR and IGFBP-3 was enhanced by treatment with cytotoxic drugs etoposide or doxorubicin and reduced by the EGFR kinase inhibitor gefitinib. Enhanced association among IGFBP-3, EGFR and DNA-PKcs, following the exposure to DNA-damaging drugs was supported by both co-immunoprecipitation analysis and direct visualization by proximity ligation assay. The activation of DNA-PKcs at Ser2056, DNA repair as measured by a nonhomologous end-joining assay, and the increase in EGFR and DNA-PKcs interaction induced by DNA-damaging agents, were all decreased by IGFBP-3 silencing, suggesting that IGFBP-3 has an obligatory role in the DNA repair response to DNA-damaging therapy. In conclusion, IGFBP-3 co-translocation to the nucleus of breast cancer cells and its formation of a complex with DNA-PKcs and EGFR in response to DNA damage shows its potential involvement in the regulation of DNA repair. This suggests the possibility of a therapeutic approach for sensitizing breast cancer to chemo-or radiotherapy by targeting the DNA repair function of IGFBP-3.	[Lin, M. Z.; Marzec, K. A.; Martin, J. L.; Baxter, R. C.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Hormones & Canc Div, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Baxter, RC (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Hormones & Canc Div, St Leonards, NSW 2065, Australia.	robert.baxter@sydney.edu.au	Baxter, Robert C/F-3927-2012	Baxter, Robert C/0000-0001-5061-2142; Marzec, Kamila/0000-0002-3051-2205	RCB from the Australian Research Council [DP0984232]	RCB from the Australian Research Council(Australian Research Council)	This work was supported by Grant Number DP0984232 to RCB from the Australian Research Council.	Abulrob A, 2004, ONCOGENE, V23, P6967, DOI 10.1038/sj.onc.1207911; Andrin C, 2004, J BIOL CHEM, V279, P25017, DOI 10.1074/jbc.M401805200; Andrin C, 2012, NUCLEUS-PHILA, V3, P384, DOI 10.4161/nucl.21055; Arnes JB, 2009, J CLIN PATHOL, V62, P139, DOI 10.1136/jcp.2008.056291; BAXTER RC, 1993, TRENDS ENDOCRIN MET, V4, P91, DOI 10.1016/1043-2760(93)90085-S; Butt AJ, 2004, J CLIN ENDOCR METAB, V89, P1950, DOI 10.1210/jc.2003-030914; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; Chuang ST, 2008, J UROLOGY, V179, P445, DOI 10.1016/j.juro.2007.09.106; Ciardiello F, 2006, BRIT J CANCER, V94, P1604, DOI 10.1038/sj.bjc.6603141; CLEMMONS DR, 1990, ENDOCRINOLOGY, V127, P2679, DOI 10.1210/endo-127-6-2679; Cobb LJ, 2006, CANCER RES, V66, P10878, DOI 10.1158/0008-5472.CAN-06-0585; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Dennison GJ, 2008, BREAST CANCER RES, V10, pS21, DOI 10.1186/bcr1924; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Dittmann K, 2010, STRAHLENTHER ONKOL, V186, P1, DOI 10.1007/s00066-009-2026-4; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Dominguez-Brauer C, 2010, CELL CYCLE, V9, P86, DOI 10.4161/cc.9.1.10350; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; GRKOVIC S, 2012, ONCOGENE, DOI DOI 10.1038/0NC.2012.264; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hasty P, 2008, CELL CYCLE, V7, P1139, DOI 10.4161/cc.7.9.5807; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kinzler KW, 1997, NATURE, V386, P763; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Li ML, 2012, TRENDS BIOCHEM SCI, V37, P418, DOI 10.1016/j.tibs.2012.06.007; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Martin JL, 2007, ENDOCRINOLOGY, V148, P2532, DOI 10.1210/en.2006-1335; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; McIntosh J, 2010, J BIOL CHEM, V285, P38788, DOI 10.1074/jbc.M110.177311; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Micutkova L, 2012, INT J CANCER, V130, P1544, DOI 10.1002/ijc.26149; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Muller C, 1998, BLOOD, V92, P2213, DOI 10.1182/blood.V92.7.2213.2213_2213_2219; O'Han MK, 2009, GROWTH FACTORS, V27, P394, DOI 10.3109/08977190903185032; Paharkova-Vatchkova V, 2010, ENDOCR-RELAT CANCER, V17, P293, DOI 10.1677/ERC-09-0106; Probst-Hensch NM, 2010, CLIN CANCER RES, V16, P1025, DOI 10.1158/1078-0432.CCR-09-0957; Putti TC, 2005, MODERN PATHOL, V18, P26, DOI 10.1038/modpathol.3800255; Reardon DA, 2010, J NEURO-ONCOL, V96, P219, DOI 10.1007/s11060-009-9950-0; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; Santer FR, 2006, CANCER RES, V66, P3024, DOI 10.1158/0008-5472.CAN-05-2013; Schedlich LJ, 2003, ENDOCRINOLOGY, V144, P1984, DOI 10.1210/en.2002-220798; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang XQ, 2006, J INVEST DERMATOL, V126, P951, DOI 10.1038/sj.jid.5700282; Williams AC, 2000, CANCER RES, V60, P22; Xi YG, 2006, MOL CANCER THER, V5, P3078, DOI 10.1158/1535-7163.MCT-06-0424; Xue A, 2008, PANCREAS, V36, P160, DOI 10.1097/MPA.0b013e31815750f0; Yarden RI, 2012, INT J BIOCHEM CELL B, V44, P1761, DOI 10.1016/j.biocel.2012.06.026; Yoon JH, 2012, BIOCHEM PHARMACOL, V83, P747, DOI 10.1016/j.bcp.2011.12.029; Yu H, 1996, BRIT J CANCER, V74, P1242, DOI 10.1038/bjc.1996.523	67	51	53	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					85	96		10.1038/onc.2012.538	http://dx.doi.org/10.1038/onc.2012.538			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23178489	Bronze			2022-12-25	WOS:000329212000010
J	Yun, J; Nagai, T; Furukawa-Hibi, Y; Kuroda, K; Kaibuchi, K; Greenberg, ME; Yamada, K				Yun, Jaesuk; Nagai, Taku; Furukawa-Hibi, Yoko; Kuroda, Keisuke; Kaibuchi, Kozo; Greenberg, Michael E.; Yamada, Kiyofumi			Neuronal Per Arnt Sim (PAS) Domain Protein 4 (NPAS4) Regulates Neurite Outgrowth and Phosphorylation of Synapsin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL NEUROGENESIS; TRANSCRIPTION; KINASE; DIFFERENTIATION; MEMORY; GENE; SPECIFICATION; ACTIVATION; PLASTICITY; CDK5	Neuronal Per Arnt Sim domain protein 4 (NPAS4), a brain-specific basic helix-loop-helix transcription factor, has recently been shown to regulate the development of the GABAergic inhibitory synapses and transcription program for contextual memory formation in the hippocampus. We previously reported that chronic social isolation or restriction stress in mice resulted in an impairment in memory and emotional behavior, which was associated with a decrease in Npas4 mRNA levels. In this study, we investigated the role of NPAS4 in neuronal function in vitro and in vivo. Differentiation medium-induced neurite outgrowth was inhibited in Npas4 knockdown Neuro2a cells, whereas overexpression of NPAS4 accelerated the neurite outgrowth in Neuro2a cells. Furthermore, depolarization-induced neurite outgrowth was abolished in Npas4 KO hippocampal neurons. NPAS4 overexpression increased cyclin-dependent kinase 5 (CDK5)-dependent synapsin I phosphorylation in Neuro2a cells and primary cultured hippocampal neurons. A CDK5 inhibitor, roscovitine, inhibited the neurite outgrowth and the increase in phosphorylated synapsin I (p-SYN I) levels in Npas4-overexpressed Neuro2a cells. Interaction of NPAS4 with promoters of Cdk5 and NeuN genes was demonstrated by a chromatin immunoprecipitation assay. In an in vivo study, pentylenetetrazole-induced convulsions in mice resulted in an increase in NPAS4 and p-SYN I levels in the prefrontal cortex of wild-type mice, although no changes in p-SYN I levels were observed in Npas4 knock-out mice. These results suggest that NPAS4 plays an important role in the structural and functional plasticity of neurons.	[Yun, Jaesuk; Nagai, Taku; Furukawa-Hibi, Yoko; Yamada, Kiyofumi] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4668560, Japan; [Kuroda, Keisuke; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4668560, Japan; [Greenberg, Michael E.] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, Boston, MA 02115 USA; [Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Nagoya University; Nagoya University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yamada, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4668560, Japan.	kyamada@med.nagoya-u.ac.jp	Sokabe, Masahiro/I-1565-2012; Kuroda, Keisuke/K-5255-2013; Yamada, Kiyofumi/I-7487-2014; Kaibuchi, Kozo/M-4887-2014; Nagai, Taku/I-7507-2014	Kuroda, Keisuke/0000-0002-6715-5125; Yamada, Kiyofumi/0000-0002-5280-5180; Kaibuchi, Kozo/0000-0003-0714-1992; Nagai, Taku/0000-0001-5050-7748	Japan Society for the Promotion of Science [22390046, 23659135, 23790081]; Ministry of Education, Culture, Sports, Science and Technology; Global-Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology; CREST from Japan Science and Technology Agency; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry [24-12]; Agriculture, Forestry and Fisheries Research Council Project; Nobiletin Research and Development Consortium; Smoking Research Foundation Grant for Biomedical Research; Uehara Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global-Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology; CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry; Agriculture, Forestry and Fisheries Research Council Project; Nobiletin Research and Development Consortium; Smoking Research Foundation Grant for Biomedical Research; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by Grants-in-aid for Scientific Research 22390046, 23659135, and 23790081, Exploratory Research from Japan Society for the Promotion of Science, "Integrated Research on Neuropsychiatric Disorders" and "Bioinformatics for Brain Sciences" carried out under the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science and Technology, the Global-Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology, CREST from Japan Science and Technology Agency, Intramural Research Grant 24-12 for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry, Agriculture, Forestry and Fisheries Research Council Project, Nobiletin Research and Development Consortium, Smoking Research Foundation Grant for Biomedical Research, and The Uehara Memorial Foundation.	BECKER A, 1995, PHARMACOL BIOCHEM BE, V52, P765, DOI 10.1016/0091-3057(95)00175-V; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Brunskill EW, 1999, MECH DEVELOP, V88, P237, DOI 10.1016/S0925-4773(99)00182-3; Bykhovskaia M, 2011, SEMIN CELL DEV BIOL, V22, P387, DOI 10.1016/j.semcdb.2011.07.003; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Cheung Zelda H., 2007, Biotechnology Journal, V2, P949, DOI 10.1002/biot.200700056; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Evangelopoulos ME, 2009, J NEUROSCI RES, V87, P2138, DOI 10.1002/jnr.22025; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Fornasiero EF, 2010, CELL MOL LIFE SCI, V67, P1383, DOI 10.1007/s00018-009-0227-8; Garcia-Perez J, 1999, J NEUROSCI RES, V57, P261, DOI 10.1002/(SICI)1097-4547(19990715)57:2<261::AID-JNR12>3.0.CO;2-4; Havrda MC, 2008, J NEUROSCI, V28, P14074, DOI 10.1523/JNEUROSCI.3188-08.2008; Ibi D, 2008, J NEUROCHEM, V105, P921, DOI 10.1111/j.1471-4159.2007.05207.x; Ide M, 2005, HUM GENET, V117, P520, DOI 10.1007/s00439-005-1342-8; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, J BIOL CHEM, V284, P1057, DOI 10.1074/jbc.M805196200; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Pickard BS, 2006, ANN MED, V38, P439, DOI 10.1080/07853890600946500; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; SCHRODER H, 1993, J NEUROCHEM, V60, P1007, DOI 10.1111/j.1471-4159.1993.tb03248.x; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Shimizu N, 2009, BIOL PHARM BULL, V32, P999, DOI 10.1248/bpb.32.999; Shupliakov O, 2011, SEMIN CELL DEV BIOL, V22, P393, DOI 10.1016/j.semcdb.2011.07.006; Soylemezoglu F, 2003, PATHOL RES PRACT, V199, P463, DOI 10.1078/0344-0338-00446; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yun J, 2010, J NEUROCHEM, V114, P1840, DOI 10.1111/j.1471-4159.2010.06893.x; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	47	29	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2655	2664		10.1074/jbc.M112.413310	http://dx.doi.org/10.1074/jbc.M112.413310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23172225	Green Published, hybrid			2022-12-25	WOS:000314211500050
J	Park, K; Botelho, SC; Hong, J; Osterberg, M; Kim, H				Park, Kwangjin; Botelho, Salome Calado; Hong, Joonki; Osterberg, Marie; Kim, Hyun			Dissecting Stop Transfer versus Conservative Sorting Pathways for Mitochondrial Inner Membrane Proteins in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-AAA PROTEASE; CYTOCHROME BC(1) COMPLEX; SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; SUCCINATE-DEHYDROGENASE; IMPORT MOTOR; TRANSMEMBRANE DOMAINS; PRECURSOR PROTEINS; YEAST; SUBUNIT	Mitochondrial inner membrane proteins that carry an N-terminal presequence are sorted by one of two pathways: stop transfer or conservative sorting. However, the sorting pathway is known for only a small number of proteins, in part due to the lack of robust experimental tools with which to study. Here we present an approach that facilitates determination of inner membrane protein sorting pathways in vivo by fusing a mitochondrial inner membrane protein to the C-terminal part of Mgm1p containing the rhomboid cleavage region. We validated the Mgm1 fusion approach using a set of proteins for which the sorting pathway is known, and determined sorting pathways of inner membrane proteins for which the sorting mode was previously uncharacterized. For Sdh4p, a multispanning membrane protein, our results suggest that both conservative sorting and stop transfer mechanisms are required for insertion. Furthermore, the sorting process of Mgm1 fusion proteins was analyzed under different growth conditions and yeast mutant strains that were defective in the import motor or the m-AAA protease function. Our results show that the sorting of mitochondrial proteins carrying moderately hydrophobic transmembrane segments is sensitive to cellular conditions, implying that mitochondrial import and membrane sorting in the physiological environment may be dynamically tuned.	[Park, Kwangjin; Hong, Joonki; Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Botelho, Salome Calado; Osterberg, Marie] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Seoul National University (SNU); Stockholm University	Kim, H (corresponding author), Seoul Natl Univ, Sch Biol Sci, Bldg 504-421, Seoul 151747, South Korea.	joy@snu.ac.kr		Osterberg, Marie/0000-0002-7439-3754	National Research Foundation of Korea [2012-0001935, C00048]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/36107/2007]	National Research Foundation of Korea(National Research Foundation of Korea); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Basic Research Grant 2012-0001935 and Global Research Network Grant C00048 from the National Research Foundation of Korea (to H. K.).; Recipient of Graduate Student Fellowship SFRH/BD/36107/2007 from Fundacao para a Ciencia e a Tecnologia, Portugal.	Arnold I, 1998, J BIOL CHEM, V273, P1469, DOI 10.1074/jbc.273.3.1469; Baumann F, 2002, J BIOL CHEM, V277, P21405, DOI 10.1074/jbc.M201670200; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; Bohnert M, 2010, CURR BIOL, V20, P1227, DOI 10.1016/j.cub.2010.05.058; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bonn F, 2011, EMBO J, V30, P2545, DOI 10.1038/emboj.2011.169; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; BRANDT U, 1994, J BIOL CHEM, V269, P12947; BUCHWALD P, 1991, MOL GEN GENET, V229, P413, DOI 10.1007/BF00267464; BULLIS BL, 1994, J BIOL CHEM, V269, P6543; Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; CUMSKY MG, 1987, MOL CELL BIOL, V7, P3511, DOI 10.1128/MCB.7.10.3511; Dibrov E, 1998, J BIOL CHEM, V273, P32042, DOI 10.1074/jbc.273.48.32042; Frazier AE, 2004, NAT STRUCT MOL BIOL, V11, P226, DOI 10.1038/nsmb735; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Funes S, 2004, FEBS LETT, V569, P89, DOI 10.1016/j.febslet.2004.05.055; Gaume B, 1998, EMBO J, V17, P6497, DOI 10.1093/emboj/17.22.6497; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Graef M, 2007, MOL CELL BIOL, V27, P2476, DOI 10.1128/MCB.01721-06; Hanekamp T, 1996, MOL CELL BIOL, V16, P2764; Harner M, 2011, EMBO J, V30, P3232, DOI 10.1038/emboj.2011.235; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Klanner C, 2000, FEBS LETT, V470, P365, DOI 10.1016/S0014-5793(00)01322-3; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lemaire C, 2004, J BIOL CHEM, V279, P47464, DOI 10.1074/jbc.M404861200; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Lode A, 2002, YEAST, V19, P909, DOI 10.1002/yea.883; MAARSE AC, 1987, EUR J BIOCHEM, V165, P419, DOI 10.1111/j.1432-1033.1987.tb11455.x; Meier S, 2005, J CELL BIOL, V170, P881, DOI 10.1083/jcb.200505126; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Messerschmitt M, 2003, J CELL BIOL, V160, P553, DOI 10.1083/jcb.200211113; MILLER BR, 1993, J CELL BIOL, V121, P1021, DOI 10.1083/jcb.121.5.1021; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; ONO H, 1995, J BIOL CHEM, V270, P16932, DOI 10.1074/jbc.270.28.16932; Oyedotun KS, 1997, J BIOL CHEM, V272, P31382, DOI 10.1074/jbc.272.50.31382; Preuss M, 2001, J CELL BIOL, V153, P1085, DOI 10.1083/jcb.153.5.1085; Rojo EE, 1998, J BIOL CHEM, V273, P8040, DOI 10.1074/jbc.273.14.8040; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; Schilke BA, 2012, GENETICS, V190, P1341, DOI 10.1534/genetics.112.138743; Schmidt O, 2011, CELL, V144, P227, DOI 10.1016/j.cell.2010.12.015; SCHWARZ E, 1993, EMBO J, V12, P2295, DOI 10.1002/j.1460-2075.1993.tb05883.x; Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; VANLOON APGM, 1987, EMBO J, V6, P2433, DOI 10.1002/j.1460-2075.1987.tb02522.x; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9; Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013	60	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1521	1532		10.1074/jbc.M112.409748	http://dx.doi.org/10.1074/jbc.M112.409748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23184936	Green Published, hybrid			2022-12-25	WOS:000313751400010
J	Bonifacio, A; Guidetti, R; Altiero, T; Sergo, V; Rebecchi, L				Bonifacio, Alois; Guidetti, Roberto; Altiero, Tiziana; Sergo, Valter; Rebecchi, Lorena			Nature, Source and Function of Pigments in Tardigrades: In Vivo Raman Imaging of Carotenoids in Echiniscus blumi	PLOS ONE			English	Article							LIFE-TARSE MISSION; SPACE; SPECTROSCOPY; TOLERANCE; SURVIVAL; STRESS; QUANTIFICATION; TERRESTRIAL; RESISTANCE	Tardigrades are microscopic aquatic animals with remarkable abilities to withstand harsh physical conditions such as dehydration or exposure to harmful highly energetic radiation. The mechanisms responsible for such robustness are presently little known, but protection against oxidative stresses is thought to play a role. Despite the fact that many tardigrade species are variously pigmented, scarce information is available about this characteristic. By applying Raman micro-spectroscopy on living specimens, pigments in the tardigrade Echiniscus blumi are identified as carotenoids, and their distribution within the animal body is visualized. The dietary origin of these pigments is demonstrated, as well as their presence in the eggs and in eye-spots of these animals, together with their absence in the outer layer of the animal (i.e., cuticle and epidermis). Using in-vivo semi-quantitative Raman micro-spectroscopy, a decrease in carotenoid content is detected after inducing oxidative stress, demonstrating that this approach can be used for studying the role of carotenoids in oxidative stress-related processes in tardigrades. This approach could be thus used in further investigations to test several hypotheses concerning the function of these carotenoids in tardigrades as photo-protective pigments against ionizing radiations or as antioxidants defending these organisms against the oxidative stress occurring during desiccation processes.	[Bonifacio, Alois; Sergo, Valter] Univ Trieste, Ctr Excellence Nanostruct Mat, Trieste, Italy; [Bonifacio, Alois; Sergo, Valter] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [Guidetti, Roberto; Rebecchi, Lorena] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Altiero, Tiziana] Univ Modena & Reggio Emilia, Dept Educ & Human Sci, Modena, Italy	University of Trieste; University of Trieste; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Bonifacio, A (corresponding author), Univ Trieste, Ctr Excellence Nanostruct Mat, Trieste, Italy.	abonifacio@units.it	Bonifacio, Alois/C-6311-2008; Rebecchi, Lorena/E-1653-2015; Guidetti, Roberto/H-2855-2012	Bonifacio, Alois/0000-0002-2251-7786; Rebecchi, Lorena/0000-0001-5610-806X; Guidetti, Roberto/0000-0001-6079-2538; Sergo, Valter/0000-0003-3864-658X	University of Modena; Reggio Emilia	University of Modena; Reggio Emilia	This work was supported by a 50% FAR grant of the University of Modena and Reggio Emilia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; [Anonymous], 2010, R LANG ENV STAT COMP; Bhosale P, 2004, J AGR FOOD CHEM, V52, P3281, DOI 10.1021/jf035345q; Britton George, 2008, V4, P189, DOI 10.1007/978-3-7643-7499-0_10; CZECZUGA B, 1980, BRYOLOGIST, V83, P21, DOI 10.2307/3242390; de Oliveira VE, 2010, J RAMAN SPECTROSC, V41, P642, DOI 10.1002/jrs.2493; Efremov EV, 2008, ANAL CHIM ACTA, V606, P119, DOI 10.1016/j.aca.2007.11.006; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Greven H, 2007, ARTHROPOD STRUCT DEV, V36, P401, DOI 10.1016/j.asd.2007.06.003; Greven Hartmut, 2005, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V102, P11; Guidetti R, 2011, J INSECT PHYSIOL, V57, P567, DOI 10.1016/j.jinsphys.2011.03.003; Guidetti R, 2011, ZOOLOGY, V114, P123, DOI 10.1016/j.zool.2010.11.005; Harrison EH, 2011, BIOCHIM BIOPHYS ACTA, V1821, P70; Hengherr S, 2009, J EXP BIOL, V212, P802, DOI 10.1242/jeb.025973; Heras H, 2007, COMP BIOCHEM PHYS C, V146, P158, DOI 10.1016/j.cbpc.2006.10.013; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Kotake-Nara E, 2011, MAR DRUGS, V9, P1024, DOI 10.3390/md9061024; Krafft C, 2009, ANALYST, V134, P1046, DOI 10.1039/b822354h; Kristensen R. M., 1987, SELECTED S MONOGRAPH, P261; Lasch P., 2008, BIOMEDICAL VIBRATION; Massonneau J., 1950, Bulletin de la Societe Zoologique de France, V75, P187; McCreery R.L., 2005, RAMAN SPECTROSCOPY C, VVolume 225; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; Mihelcic F, 1950, ARCH ZOOL ITAL, V35, P1; Nelson D, 2010, ECOLOGY CLASSIFICATI, V14, P445; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Rebecchi L, 2007, ISJ-INVERT SURVIV J, V4, P65; Rebecchi L, 2009, J EXP BIOL, V212, P4033, DOI 10.1242/jeb.033266; Rebecchi L, 2011, J ZOOL SYST EVOL RES, V49, P98, DOI 10.1111/j.1439-0469.2010.00606.x; Rebecchi L, 2009, ASTROBIOLOGY, V9, P581, DOI 10.1089/ast.2008.0305; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Robert B, 1999, ADV PHOTOSYNTH, V8, P189; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Tao ZH, 2011, FEMS MICROBIOL LETT, V314, P42, DOI 10.1111/j.1574-6968.2010.02139.x; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Withnall R, 2003, SPECTROCHIM ACTA A, V59, P2207, DOI 10.1016/S1386-1425(03)00064-7	37	13	13	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50162	10.1371/journal.pone.0050162	http://dx.doi.org/10.1371/journal.pone.0050162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185564	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000193
J	Li, CZ; Chen, YX; Zhang, S; Lu, L; Chen, YH; Chai, JT; Weng, SP; Chen, YG; He, JG; Xu, XP				Li, Chaozheng; Chen, Yi-Xiao; Zhang, Shuang; Lu, Ling; Chen, Yi-Hong; Chai, Jiaoting; Weng, Shaoping; Chen, Yong-Gui; He, Jianguo; Xu, Xiaopeng			Identification, Characterization, and Function Analysis of the Cactus Gene from Litopenaeus vannamei	PLOS ONE			English	Article							KAPPA-B-ALPHA; WHITE SHRIMP; IMMUNE-RESPONSE; FARMED SHRIMP; PEST DOMAIN; PHOSPHORYLATION; DROSOPHILA; HOMOLOG; FAMILY; PROPHENOLOXIDASE	The nuclear factor-kappa B (NF-kappa B) pathways play important roles in innate immune responses. I kappa B is the main cytoplasmic inhibitor of NF-kappa B. In this study, we identified the LvCactus gene from Litopenaeus vannamei, which is the first cloned I kappa B homologue in subphylum Crustacea. LvCactus contains six predicted ankyrin repeats, which show similarities to those of Cactus proteins from insects. LvCactus localizes in cytoplasm and interacts with LvDorsal, an L. vannamei homologue to Drosophila melanogaster Dorsal belonging to class II NF-kappa B family, to prevent its nuclear translocation. Contrary to that of LvDorsal, over-expression of LvCactus down-regulates the activities of shrimp antimicrobial peptides promoters, suggesting LvCactus is an inhibitor of LvDorsal. The promoter of LvCactus was predicted to contain five putative NF-kappa B binding motifs, among which four were proved to be bound by LvDorsal by chromatin immunoprecipitation assays. Dual-luciferase reporter assays also showed that transcription of LvCactus was promoted by LvDorsal but inhibited by LvCactus itself, indicating a feedback regulatory pathway between LvCactus and LvDorsal. Expression of LvCactus was up-regulated after Lipopolysaccharides, poly (I: C), Vibrio parahaemolyticus, and Staphylococcus aureus injections, suggesting an activation response of LvCactus to bacterial and immune stimulant challenges. Differently, the LvCactus expression levels obviously decreased during white spot syndrome virus (WSSV) infection, indicating the feedback regulatory pathway of LvCactus/LvDorsal could be modified by WSSV.	[Li, Chaozheng; Zhang, Shuang; Lu, Ling; Chai, Jiaoting; Weng, Shaoping; He, Jianguo; Xu, Xiaopeng] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yi-Hong; Chen, Yong-Gui; He, Jianguo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yi-Xiao] Soochow Univ, Sch Med, Suzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Soochow University - China	He, JG (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, MOE Key Lab Aquat Prod Safety, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn; xuxpeng@mail.sysu.edu.cn	Chaozheng, Li/E-4632-2016	Li, Chaozheng/0000-0001-7639-7831	National Natural Science Foundation of China [U1131002]; National High Technology Research and Development Program of China (973 Program) [2012CB114401]; China Agriculture Research System [47]; Special Fund for Agro-scientific Research in the Public Interest [201103034]; Foundation from Science and Technology Bureau of Guangdong Province [2011A020102002, 2009A020102002]; Foundation from Administration of Ocean and Fisheries of Guangdong Province [A201101B02]; Open Project of the State Key Laboratory of Biocontrol [SKLBC09K04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (973 Program)(National Basic Research Program of ChinaNational High Technology Research and Development Program of China); China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; Foundation from Science and Technology Bureau of Guangdong Province; Foundation from Administration of Ocean and Fisheries of Guangdong Province; Open Project of the State Key Laboratory of Biocontrol	This research was supported by National Natural Science Foundation of China under grant No. U1131002; National High Technology Research and Development Program of China (973 Program) 2012CB114401; China Agriculture Research System (47); Special Fund for Agro-scientific Research in the Public Interest 201103034; Foundation from Science and Technology Bureau of Guangdong Province 2011A020102002 and 2009A020102002; Foundation from Administration of Ocean and Fisheries of Guangdong Province A201101B02; and the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HS, 2009, DEV COMP IMMUNOL, V33, P59, DOI 10.1016/j.dci.2008.07.017; Ai HS, 2008, FISH SHELLFISH IMMUN, V25, P28, DOI 10.1016/j.fsi.2007.12.002; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Chen YH, 2011, DEV COMP IMMUNOL, V35, P661, DOI 10.1016/j.dci.2011.01.010; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Gunawardena M, 2005, ENVIRON MANAGE, V36, P535, DOI 10.1007/s00267-003-0286-9; Haas M, 1998, J LEUKOCYTE BIOL, V63, P395, DOI 10.1002/jlb.63.3.395; Ho SH, 2009, FISH SHELLFISH IMMUN, V27, P73, DOI 10.1016/j.fsi.2009.05.001; Huang XD, 2010, VIROLOGY, V406, P176, DOI 10.1016/j.virol.2010.06.046; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Huang XD, 2009, FISH SHELLFISH IMMUN, V27, P230, DOI 10.1016/j.fsi.2009.05.003; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; Kang HY, 2010, BIORESOUR TECHNOL; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; KIDD S, 1992, CELL, V71, P623, DOI 10.1016/0092-8674(92)90596-5; Koyama T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-141; Kretz-Remy C, 1998, J BIOL CHEM, V273, P3180, DOI 10.1074/jbc.273.6.3180; Lahat A, 2008, CLIN EXP IMMUNOL, V152, P320, DOI 10.1111/j.1365-2249.2008.03636.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lebel L, 2002, AMBIO, V31, P311, DOI 10.1639/0044-7447(2002)031[0311:ITASAI]2.0.CO;2; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li F, 2011, FISH SHELLFISH IMMUN, V31, P161, DOI 10.1016/j.fsi.2011.04.002; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lightner DV, 2007, DEV BIOLOGICALS, V129, P137; Lightner DV, 2011, J INVERTEBR PATHOL, V106, P110, DOI 10.1016/j.jip.2010.09.012; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Liu CH, 2004, FISH SHELLFISH IMMUN, V16, P151, DOI 10.1016/S1050-4648(03)00058-5; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Lunz G R Jr, 1935, Science, V81, P436, DOI 10.1126/science.81.2105.436; Maniatsi S, 2011, MOL PHYLOGENET EVOL, V58, P353, DOI 10.1016/j.ympev.2010.11.029; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; Packman LC, 1997, FEBS LETT, V400, P45, DOI 10.1016/S0014-5793(96)01324-5; Rottjakob EM, 1996, J VIROL, V70, P3176, DOI 10.1128/JVI.70.5.3176-3188.1996; Smith PT, 2000, DIS AQUAT ORGAN, V43, P159, DOI 10.3354/dao043159; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Yang LS, 2007, MOL IMMUNOL, V44, P1999, DOI 10.1016/j.molimm.2006.09.021; Zhao ZY, 2009, J VIROL, V83, P347, DOI 10.1128/JVI.00707-08	51	25	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49711	10.1371/journal.pone.0049711	http://dx.doi.org/10.1371/journal.pone.0049711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185415	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000093
J	McKinnon, LR; Nagelkerke, NJ; Kaul, R; Shaw, SY; Capina, R; Luo, M; Kariri, A; Apidi, W; Kimani, M; Wachihi, C; Jaoko, W; Anzala, AO; Kimani, J; Ball, TB; Plummer, FA				McKinnon, Lyle R.; Nagelkerke, Nico J.; Kaul, Rupert; Shaw, Souradet Y.; Capina, Rupert; Luo, Ma; Kariri, Anthony; Apidi, Winnie; Kimani, Makobu; Wachihi, Charles; Jaoko, Walter; Anzala, A. Omu; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.			HIV-1 Clade D Is Associated with Increased Rates of CD4 Decline in a Kenyan Cohort	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DISEASE PROGRESSION; SUBTYPE-A; ESCAPE MUTATIONS; TRANSMISSION; INFECTION; DIVERSITY; UGANDA; RAKAI; STAGE	HIV-1 is grouped phylogenetically into clades, which may impact rates of HIV-1 disease progression. Clade D infection in particular has been shown to be more pathogenic. Here we confirm in a Nairobi-based prospective female sex worker cohort (1985-2004) that Clade D (n = 54) is associated with a more rapid CD4 decline than clade A1 (n = 150, 20.6% vs 13.4% decline per year, 1.53-fold increase, p = 0.015). This was independent of "protective" HLA and country of origin (p = 0.053), which in turn were also independent predictors of the rate of CD4 decline (p = 0.026 and 0.005, respectively). These data confirm that clade D is more pathogenic than clade A1. The precise reason for this difference is currently unclear, and requires further study. This is first study to demonstrate difference in HIV-1 disease progression between clades while controlling for protective HLA alleles.	[McKinnon, Lyle R.; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [McKinnon, Lyle R.; Kaul, Rupert; Kariri, Anthony; Kimani, Makobu; Wachihi, Charles; Jaoko, Walter; Anzala, A. Omu; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Nagelkerke, Nico J.; Luo, Ma; Apidi, Winnie; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol & Immunol 9, Winnipeg, MB, Canada; [Nagelkerke, Nico J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Nagelkerke, Nico J.] United Arab Emirates Univ, Al Ain, U Arab Emirates; [Shaw, Souradet Y.] Univ Manitoba, Ctr Global Publ Hlth, Winnipeg, MB, Canada; [Capina, Rupert; Luo, Ma; Plummer, Francis A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Jaoko, Walter; Anzala, A. Omu] Kenyan AIDS Vaccine Initiat, Nairobi, Kenya; [Ball, T. Blake] Publ Hlth Agcy Canada, Lab HIV Immunol, Winnipeg, MB, Canada	University of Toronto; University of Nairobi; University of Manitoba; Erasmus University Rotterdam; Erasmus MC; United Arab Emirates University; University of Manitoba; Public Health Agency of Canada; Public Health Agency of Canada	McKinnon, LR (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	sijuisijali@gmail.com	Jaoko, Walter/AAN-5048-2020; Kimani, Makobu/V-6369-2019	Kimani, Makobu/0000-0001-9275-4018; Jaoko, Walter/0000-0002-7134-6581; McKinnon, Lyle/0000-0002-7157-0700; Shaw, Souradet/0000-0002-0982-1302; Kaul, Rupert/0000-0002-1586-4093	National Institutes of Health [R01 AI56980 A1]; Canadian Institutes of Health Research [HOP-43135]; Bill and Melinda Gates Foundation; CIHR through the Grand Challenges in Global Health Initiative; CIHR Biomedical/Clinical HIV/AIDS Research Fellowship; International Infectious Diseases and Global Health Training Program (IIDGHTP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CIHR through the Grand Challenges in Global Health Initiative(Canadian Institutes of Health Research (CIHR)); CIHR Biomedical/Clinical HIV/AIDS Research Fellowship(Canadian Institutes of Health Research (CIHR)); International Infectious Diseases and Global Health Training Program (IIDGHTP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the National Institutes of Health (R01 AI56980 A1), the Canadian Institutes of Health Research (HOP-43135), and the Bill and Melinda Gates Foundation and the CIHR through the Grand Challenges in Global Health Initiative to F. P. F. P. and R. K. hold Canada Research Chairs. L. M. is supported by a CIHR Biomedical/Clinical HIV/AIDS Research Fellowship and the International Infectious Diseases and Global Health Training Program (IID&GHTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Fauci AS, 2007, CLIN INFECT DIS, V45, pS206, DOI 10.1086/522540; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kiwanuka N, 2009, AIDS, V23, P2479, DOI 10.1097/QAD.0b013e328330cc08; Kuritzkes DR, 2008, J INFECT DIS, V197, P638, DOI 10.1086/527417; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Lipsitz SR, 2000, J ROY STAT SOC C-APP, V49, P287, DOI 10.1111/1467-9876.00192; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Muller-Trutwin MC, 1999, J ACQ IMMUN DEF SYND, V21, P164; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Peng CY, J INFECT DIS; Peters HO, 2008, J VIROL, V82, P1980, DOI 10.1128/JVI.02742-06; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	21	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49797	10.1371/journal.pone.0049797	http://dx.doi.org/10.1371/journal.pone.0049797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185441	gold, Green Published			2022-12-25	WOS:000311821000112
J	Sun, JJ; Xu, JB; Cairns, NJ; Perlmutter, JS; Mach, RH				Sun, Jianjun; Xu, Jinbin; Cairns, Nigel J.; Perlmutter, Joel S.; Mach, Robert H.			Dopamine D-1, D-2, D-3 Receptors, Vesicular Monoamine Transporter Type-2 (VMAT2) and Dopamine Transporter (DAT) Densities in Aged Human Brain	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; AUTORADIOGRAPHIC LOCALIZATION; MESSENGER-RNA; MONKEY BRAIN; RAT-BRAIN; IN-VIVO; SELECTIVE RADIOLIGAND; NUCLEUS-ACCUMBENS; AFFINITY STATES; HUMAN FOREBRAIN	The dopamine D-1, D-2, D-3 receptors, vesicular monoamine transporter type-2 (VMAT2), and dopamine transporter (DAT) densities were measured in 11 aged human brains (aged 77-107.8, mean: 91 years) by quantitative autoradiography. The density of D-1 receptors, VMAT2, and DAT was measured using [H-3]SCH23390, [H-3]dihydrotetrabenazine, and [H-3]WIN35428, respectively. The density of D-2 and D-3 receptors was calculated using the D-3-preferring radioligand, [H-3] WC-10 and the D-2-preferring radioligand [H-3]raclopride using a mathematical model developed previously by our group. Dopamine D-1, D-2, and D-3 receptors are extensively distributed throughout striatum; the highest density of D-3 receptors occurred in the nucleus accumbens (NAc). The density of the DAT is 10-20-fold lower than that of VMAT2 in striatal regions. Dopamine D-3 receptor density exceeded D-2 receptor densities in extrastriatal regions, and thalamus contained a high level of D-3 receptors with negligible D-2 receptors. The density of dopamine D-1 linearly correlated with D-3 receptor density in the thalamus. The density of the DAT was negligible in the extrastriatal regions whereas the VMAT2 was expressed in moderate density. D-3 receptor and VMAT2 densities were in similar level between the aged human and aged rhesus brain samples, whereas aged human brain samples had lower range of densities of D-1 and D-2 receptors and DAT compared with the aged rhesus monkey brain. The differential density of D-3 and D-2 receptors in human brain will be useful in the interpretation of PET imaging studies in human subjects with existing radiotracers, and assist in the validation of newer PET radiotracers having a higher selectivity for dopamine D-2 or D-3 receptors.	[Sun, Jianjun; Xu, Jinbin; Perlmutter, Joel S.; Mach, Robert H.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Cairns, Nigel J.; Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Occupat Therapy, St Louis, MO 63110 USA; [Perlmutter, Joel S.] Washington Univ, Sch Med, Dept Phys Therapy, St Louis, MO 63110 USA; [Mach, Robert H.] Washington Univ, Sch Med, Dept Cell Biol amd Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Mach, RH (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	rhmach@mir.wustl.edu	Cairns, Nigel/AAB-9713-2020; Xu, Jinbin/ABG-1280-2020	Cairns, Nigel/0000-0001-9858-3344; Xu, Jinbin/0000-0002-2120-8287; Mach, Robert/0000-0002-7645-2869	NIH [MH081281, DA29840, NS075321, P50 AG05681]; American Parkinson Disease Association (APDA); Greater St. Louis Chapter of the APDA; Barnes-Jewish Hospital Foundation; Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Alzheimer's Disease Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH081281, R33MH081281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS090214, R01NS075321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson Disease Association (APDA); Greater St. Louis Chapter of the APDA; Barnes-Jewish Hospital Foundation; Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Alzheimer's Disease Research Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH grants MH081281, DA29840, NS075321 and P50 AG05681, the American Parkinson Disease Association (APDA), the Greater St. Louis Chapter of the APDA, the Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund and Parkinson Disease Research Fund) and the Charles and Joanne Knight Alzheimer's Research Initiative of the Washington University Alzheimer's Disease Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Bancroft GN, 1998, NEUROPSYCHOPHARMACOL, V18, P305; Boileau I, 2012, J NEUROSCI, V32, P1353, DOI 10.1523/JNEUROSCI.4371-11.2012; Bordet R, 2000, EUR J NEUROSCI, V12, P2117, DOI 10.1046/j.1460-9568.2000.00089.x; Braak H, 1996, NEUROSCI LETT, V210, P87, DOI 10.1016/0304-3940(96)12668-9; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Buchsbaum MS, 2006, SCHIZOPHR RES, V85, P232, DOI 10.1016/j.schres.2006.03.042; CANFIELD DR, 1990, SYNAPSE, V6, P189, DOI 10.1002/syn.890060211; Carbon M, 2009, NEUROLOGY, V72, P2097, DOI 10.1212/WNL.0b013e3181aa538f; Chu WH, 2005, BIOORGAN MED CHEM, V13, P77, DOI 10.1016/j.bmc.2004.09.054; CORTES R, 1989, NEUROSCIENCE, V28, P263, DOI 10.1016/0306-4522(89)90178-4; De La Garza R, 1999, SYNAPSE, V34, P20, DOI 10.1002/(SICI)1098-2396(199910)34:1<20::AID-SYN3>3.3.CO;2-W; DEKEYSER J, 1988, NEUROSCI LETT, V91, P142, DOI 10.1016/0304-3940(88)90758-6; EHRIN E, 1985, INT J APPL RADIAT IS, V36, P269, DOI 10.1016/0020-708X(85)90083-3; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Eisenstein SA, 2012, SYNAPSE, V66, P770, DOI 10.1002/syn.21566; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Fiorentini C, 2010, CURR OPIN PHARMACOL, V10, P87, DOI 10.1016/j.coph.2009.09.008; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Graff-Guerrero A, 2010, INT J NEUROPSYCHOPH, V13, P273, DOI 10.1017/S1461145709990642; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; Hall H, 1996, SYNAPSE, V23, P115, DOI 10.1002/(SICI)1098-2396(199606)23:2<115::AID-SYN7>3.0.CO;2-C; Haycock JW, 2003, J NEUROCHEM, V87, P574, DOI 10.1046/j.1471-4159.2003.02017.x; HERROELEN L, 1994, BRAIN RES, V648, P222, DOI 10.1016/0006-8993(94)91121-5; Hurley MJ, 1996, BRAIN RES, V709, P259, DOI 10.1016/0006-8993(95)01309-1; Inoue M, 2001, LIFE SCI, V69, P1079, DOI 10.1016/S0024-3205(01)01205-X; Jucaite A, 2010, NEUROSCIENCE, V167, P104, DOI 10.1016/j.neuroscience.2010.01.034; Kaasinen V, 2000, NEUROLOGY, V54, P1482, DOI 10.1212/WNL.54.7.1482; Karasinska JM, 2005, EUR J NEUROSCI, V22, P1741, DOI 10.1111/j.1460-9568.2005.04353.x; KAUFMAN MJ, 1991, SYNAPSE, V9, P177, DOI 10.1002/syn.890090304; Kegeles LS, 2010, BIOL PSYCHIAT, V68, P634, DOI 10.1016/j.biopsych.2010.05.027; Kessler RM, 2009, BIOL PSYCHIAT, V65, P1024, DOI 10.1016/j.biopsych.2008.12.029; Lahti RA, 1995, NEUROREPORT, V6, P2505, DOI 10.1097/00001756-199512150-00015; LANDWEHRMEYER B, 1993, MOL BRAIN RES, V18, P187, DOI 10.1016/0169-328X(93)90188-U; LeMoine C, 1996, NEUROSCIENCE, V73, P131, DOI 10.1016/0306-4522(96)00029-2; LEVESQUE D, 1992, P NATL ACAD SCI USA, V89, P8155, DOI 10.1073/pnas.89.17.8155; Lim MM, 2011, NEUROREPORT, V22, P489, DOI 10.1097/WNR.0b013e32834846a0; Luedtke RR, 2003, CURR PHARM DESIGN, V9, P643, DOI 10.2174/1381612033391199; Marcellino D, 2008, J BIOL CHEM, V283, P26016, DOI 10.1074/jbc.M710349200; MeadorWoodruff JH, 1996, NEUROPSYCHOPHARMACOL, V15, P17, DOI 10.1016/0893-133X(95)00150-C; MENGOD G, 1992, NEUROCHEM INT, V20, pS33; Micheli F, 2008, BIOORG MED CHEM LETT, V18, P901, DOI 10.1016/j.bmcl.2007.12.066; Morissette M, 1998, EUR J NEUROSCI, V10, P2565, DOI 10.1046/j.1460-9568.1998.00264.x; Mukherjee J, 2004, BIOORGAN MED CHEM, V12, P95, DOI 10.1016/j.bmc.2003.10.020; Mukherjee J, 1999, NUCL MED BIOL, V26, P519, DOI 10.1016/S0969-8051(99)00012-8; MURRAY AM, 1992, EUR J PHARM-MOLEC PH, V227, P443, DOI 10.1016/0922-4106(92)90164-Q; MURRAY AM, 1994, P NATL ACAD SCI USA, V91, P11271, DOI 10.1073/pnas.91.23.11271; Narendran R, 2006, SYNAPSE, V60, P485, DOI 10.1002/syn.20325; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Novick A, 2008, LIFE SCI, V83, P74, DOI 10.1016/j.lfs.2008.05.006; Okubo Y, 1999, NEUROIMAGE, V10, P666, DOI 10.1006/nimg.1999.0502; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; Palacios J M, 1988, J Neural Transm Suppl, V27, P227; Perlmutter JS, 1997, J NEUROSCI, V17, P843; Rabiner EA, 2009, SYNAPSE, V63, P782, DOI 10.1002/syn.20658; Ridray S, 1998, EUR J NEUROSCI, V10, P1676, DOI 10.1046/j.1460-9568.1998.00173.x; Rieck RW, 2004, NEUROPSYCHOPHARMACOL, V29, P362, DOI 10.1038/sj.npp.1300336; RINNE JO, 1993, J CEREBR BLOOD F MET, V13, P310, DOI 10.1038/jcbfm.1993.39; Sanchez-Gonzalez Jorge Manuel, 2005, Cir Cir, V73, P287; SAVASTA M, 1986, BRAIN RES, V375, P291, DOI 10.1016/0006-8993(86)90749-3; SCHERMAN D, 1988, J NEUROCHEM, V50, P1131, DOI 10.1111/j.1471-4159.1988.tb10583.x; Schwartz JC, 1998, BRAIN RES REV, V26, P236, DOI 10.1016/S0165-0173(97)00046-5; Searle G, 2010, BIOL PSYCHIAT, V68, P392, DOI 10.1016/j.biopsych.2010.04.038; SIBLEY DR, 1982, J BIOL CHEM, V257, P6351; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Suzuki M, 1998, BRAIN RES, V779, P58, DOI 10.1016/S0006-8993(97)01078-0; Talvik M, 2003, INT J NEUROPSYCHOPH, V6, P361, DOI 10.1017/S1461145703003699; Te Beek ET, 2012, J PSYCHOPHARMACOL; Tian LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031439; Troiano AR, 2010, SYNAPSE, V64, P146, DOI 10.1002/syn.20708; Tziortzi AC, 2011, NEUROIMAGE, V54, P264, DOI 10.1016/j.neuroimage.2010.06.044; Volkow ND, 1997, AM J PSYCHIAT, V154, P50; Volkow ND, 2002, BEHAV PHARMACOL, V13, P355, DOI 10.1097/00008877-200209000-00008; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; Wang Y, 1998, SYNAPSE, V30, P56, DOI 10.1002/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J; Willeit M, 2006, BIOL PSYCHIAT, V59, P389, DOI 10.1016/j.biopsych.2005.09.017; Xu JB, 2010, SYNAPSE, V64, P449, DOI 10.1002/syn.20748; Xu JB, 2009, SYNAPSE, V63, P717, DOI 10.1002/syn.20652; Yue F, 2012, J NEURAL TRANSM; Zeng CY, 2006, HYPERTENSION, V47, P573, DOI 10.1161/01.HYP.0000199983.24674.83	82	51	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49483	10.1371/journal.pone.0049483	http://dx.doi.org/10.1371/journal.pone.0049483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185343	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000056
J	Tillich, UM; Lehmann, S; Schulze, K; Duhring, U; Frohme, M				Tillich, Ulrich M.; Lehmann, Sandra; Schulze, Katja; Duehring, Ulf; Frohme, Marcus			The Optimal Mutagen Dosage to Induce Point-Mutations in Synechocystis sp PCC6803 and Its Application to Promote Temperature Tolerance	PLOS ONE			English	Article							ESCHERICHIA-COLI; ADAPTIVE RESPONSE; DNA-REPAIR; CYANOBACTERIUM; EXPRESSION; RESISTANCE; ANABAENA; GENE; COMPLEMENTATION; AUXOTROPHS	Random mutagenesis is a useful tool to genetically modify organisms for various purposes, such as adaptation to cultivation conditions, the induction of tolerances, or increased yield of valuable substances. This is especially attractive for systems where it is not obvious which genes require modifications. Random mutagenesis has been extensively used to modify crop plants, but even with the renewed interest in microalgae and cyanobacteria for biofuel applications, there is relatively limited current research available on the application of random mutagenesis for these organisms, especially for cyanobacteria. In the presented work we characterized the lethality and rate of non-lethal point mutations for ultraviolet radiation and methyl methanesulphonate on the model cyanobacteria Synechocystis sp. PCC6803. Based on these results an optimal dosage of 10-50 J/m(2) for UV and either 0.1 or 1 v% for MMS was determined. A Synechocystis wildtype culture was then mutagenized and selected for increased temperature tolerance in vivo. During the second round of mutagenesis the viability of the culture was monitored on a cell by cell level from the treatment of the cells up to the growth at an increased temperature. After four distinct rounds of treatment (two with each mutagen) the temperature tolerance of the strain was effectively raised by about 2 degrees C. Coupled with an appropriate in vivo screening, the described methods should be applicable to induce a variety of desirable characteristics in various strains. Coupling random mutagenesis with high-throughput screening methods would additionally allow to select for important characteristics for biofuel production, which do not yield a higher fitness and can not be selected for in vivo, such as fatty acid concentration. In a combined approach with full genome sequencing random mutagenesis could be used to determine suitable target-genes for more focused methods.	[Tillich, Ulrich M.; Lehmann, Sandra; Schulze, Katja; Frohme, Marcus] Tech Univ Appl Sci Wildau, Mol Biotechnol & Funct Genom, Wildau, Germany; [Tillich, Ulrich M.] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany; [Duehring, Ulf] Cyano Biofuels GmbH, Berlin, Germany	University of Applied Sciences Wildau; Humboldt University of Berlin	Frohme, M (corresponding author), Tech Univ Appl Sci Wildau, Mol Biotechnol & Funct Genom, Wildau, Germany.	mfrohme@th-wildau.de	Frohme, Marcus/HCH-4031-2022		German Federal Ministry of Education and Research [17N0809]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	KS's work is financed through the German Federal Ministry of Education and Research grant 17N0809. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, J MOL BIOL, V410, P1, DOI 10.1016/j.jmb.2011.04.068; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chaturvedi R, 2006, PHYCOL RES, V54, P208, DOI 10.1111/j.1440-1835.2006.00428.x; CURRIER TC, 1977, J BACTERIOL, V129, P1556, DOI 10.1128/JB.129.3.1556-1562.1977; DEMPLE B, 1985, P NATL ACAD SCI USA, V82, P2688, DOI 10.1073/pnas.82.9.2688; FLORIANO B, 1992, MOL MICROBIOL, V6, P2085, DOI 10.1111/j.1365-2958.1992.tb01381.x; Foster PL, 1991, METHODS ENZYMOL, V204, P114; Haag AL, 2007, NATURE, V447, P520, DOI 10.1038/447520a; Jia KZ, 2010, ENG LIFE SCI, V10, P422, DOI 10.1002/elsc.201000076; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; LAMBERT JAM, 1980, J GEN MICROBIOL, V121, P213; LEVINE E, 1987, J BACTERIOL, V169, P3988, DOI 10.1128/jb.169.9.3988-3993.1987; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; Marin K, 2002, J BACTERIOL, V184, P2870, DOI 10.1128/JB.184.11.2870-2877.2002; Mascarelli AL, 2009, NATURE, V461, P460, DOI 10.1038/461460a; McCready Shirley, 2005, Saline Syst, V1, P3, DOI 10.1186/1746-1448-1-3; Meireles LA, 2003, BIOTECHNOL BIOENG, V81, P50, DOI 10.1002/bit.10451; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; MILLER JH, 1985, J MOL BIOL, V182, P45, DOI 10.1016/0022-2836(85)90026-9; Minda R, 2005, MOL GENET GENOMICS, V274, P616, DOI 10.1007/s00438-005-0054-z; Nakamoto H, 2003, FEBS LETT, V549, P57, DOI 10.1016/S0014-5793(03)00768-3; Ong SC, 2010, BIORESOURCE TECHNOL, V101, P2880, DOI 10.1016/j.biortech.2009.10.007; Ries G, 2000, P NATL ACAD SCI USA, V97, P13425, DOI 10.1073/pnas.230251897; Schulze K, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-118; SHEVELL DE, 1990, MUTAT RES, V233, P53, DOI 10.1016/0027-5107(90)90151-S; Springer B, 2001, ANTIMICROB AGENTS CH, V45, P2877, DOI 10.1128/AAC.45.10.2877-2884.2001; Suzuki I, 2005, PLANT PHYSIOL, V138, P1409, DOI 10.1104/pp.104.059097; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; TODD PA, 1979, MUTAT RES, V62, P227, DOI 10.1016/0027-5107(79)90081-2; Waltz E, 2009, NAT BIOTECHNOL, V27, P15, DOI [10.1038/461027a, 10.1038/nbt0109-15]; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976; WOLK CP, 1988, J BACTERIOL, V170, P1239, DOI 10.1128/jb.170.3.1239-1244.1988	33	43	47	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e49467	10.1371/journal.pone.0049467	http://dx.doi.org/10.1371/journal.pone.0049467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185339	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000052
J	Zeng, CL; Wang, GY; Wang, JB; Yan, GX; Chen, BY; Xu, K; Li, J; Gao, GZ; Wu, XM; Zhao, B; Liu, L				Zeng, Chang-Li; Wang, Guang-Yong; Wang, Jian-Bo; Yan, Gui-Xin; Chen, Bi-Yun; Xu, Kun; Li, Jun; Gao, Gui-Zhen; Wu, Xiao-Ming; Zhao, Bo; Liu, Lei			High-Throughput Discovery of Chloroplast and Mitochondrial DNA Polymorphisms in Brassicaceae Species by ORG-EcoTILLING	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE MUTATIONS; GENE; INHERITANCE; SEQUENCE; GENOMES; IDENTIFICATION; MARKERS; PLANTS; PCR; MAP	Background: Information on polymorphic DNA in organelle genomes is essential for evolutionary and ecological studies. However, it is challenging to perform high-throughput investigations of chloroplast and mitochondrial DNA polymorphisms. In recent years, EcoTILLING stands out as one of the most universal, low-cost, and high-throughput reverse genetic methods, and the identification of natural genetic variants can provide much information about gene function, association mapping and linkage disequilibrium analysis and species evolution. Until now, no report exists on whether this method is applicable to organelle genomes and to what extent it can be used. Methodology/Principal Findings: To address this problem, we adapted the CEL I-based heteroduplex cleavage strategy used in Targeting Induced Local Lesions in Genomes (TILLING) for the discovery of nucleotide polymorphisms in organelle genomes. To assess the applicability and accuracy of this technology, designated ORG-EcoTILLING, at different taxonomic levels, we sampled two sets of taxa representing accessions from the Brassicaceae with three chloroplast genes (accD, matK and rbcL) and one mitochondrial gene (atp6). The method successfully detected nine, six and one mutation sites in the accD, matK and rbcL genes, respectively, in 96 Brassica accessions. These mutations were confirmed by DNA sequencing, with 100% accuracy at both inter-and intraspecific levels. We also detected 44 putative mutations in accD in 91 accessions from 45 species and 29 genera of seven tribes. Compared with DNA sequencing results, the false negative rate was 36%. However, 17 SNPs detected in atp6 were completely identical to the sequencing results. Conclusions/Significance: These results suggest that ORG-EcoTILLING is a powerful and cost-effective alternative method for high-throughput genome-wide assessment of inter-and intraspecific chloroplast and mitochondrial DNA polymorphisms. It will play an important role in evolutionary and ecological biology studies, in identification of related genes associated with agronomic importance such as high yield and improved cytoplasmic quality, and for identifying mitochondrial point mutations responsible for diseases in humans and other animals.	[Zeng, Chang-Li; Wang, Guang-Yong; Yan, Gui-Xin; Chen, Bi-Yun; Xu, Kun; Li, Jun; Gao, Gui-Zhen; Wu, Xiao-Ming] Chinese Acad Agr Sci, Oil Crop Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China; [Zeng, Chang-Li] Jianghan Univ, Coll Life Sci, Wuhan, Peoples R China; [Wang, Jian-Bo; Zhao, Bo; Liu, Lei] Wuhan Univ, Coll Life Sci, Key Lab MOE Plant Dev Biol, Wuhan 430072, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Jianghan University; Wuhan University	Wu, XM (corresponding author), Chinese Acad Agr Sci, Oil Crop Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China.	wuxm@oilcrops.cn		Li, Jun/0000-0002-1285-6514	China Postdoctoral Science Foundation [20100470417]; Chinese National Basic Research and Development Program [2011CB109302]; National Natural Science Foundation of China [31100911]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese National Basic Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Postdoctoral Science Foundation (20100470417), the Chinese National Basic Research and Development Program (2011CB109302), and the National Natural Science Foundation of China (31100911). The website is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-54; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Appel O, 2003, FA GE VAS P, V5, P75; Azam A, 1996, GENE, V181, P113, DOI 10.1016/S0378-1119(96)00484-2; Barkley NA, 2008, CURR GENOMICS, V9, P212, DOI 10.2174/138920208784533656; Baum DA, 2005, MOL PHYLOGENET EVOL, V37, P1, DOI 10.1016/j.ympev.2005.07.002; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brown W.M., 1983, P62; BYRNE M, 1993, J HERED, V84, P218, DOI 10.1093/oxfordjournals.jhered.a111322; CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; CHATTERJEE A, 1993, MAMM GENOME, V4, P33, DOI 10.1007/BF00364660; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cubas P, 2005, AM J BOT, V92, P2031, DOI 10.3732/ajb.92.12.2031; Dumolin S, 1995, THEOR APPL GENET, V91, P1253, DOI 10.1007/BF00220937; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Feral JP, 2002, J EXP MAR BIOL ECOL, V268, P121, DOI 10.1016/S0022-0981(01)00382-3; Fernandes CA, 2008, CONSERV GENET, V9, P681, DOI 10.1007/s10592-007-9364-5; Flannery ML, 2006, THEOR APPL GENET, V113, P1221, DOI 10.1007/s00122-006-0377-0; Fukami H, 2000, ZOOL SCI, V17, P689, DOI 10.2108/zsj.15.689; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gilchrist EJ, 2005, CURR OPIN PLANT BIOL, V8, P211, DOI 10.1016/j.pbi.2005.01.004; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Goremykin VV, 2004, MOL BIOL EVOL, V21, P1445, DOI 10.1093/molbev/msh147; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; HALLDEN C, 1993, PLANT BREEDING, V111, P185, DOI 10.1111/j.1439-0523.1993.tb00628.x; Haughn G. W., 2006, Floriculture, ornamental and plant biotechnology, P476; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Henikoff S, 2003, ANNU REV PLANT BIOL, V54, P375, DOI 10.1146/annurev.arplant.54.031902.135009; Hodkinson TR, 2002, AM J BOT, V89, P279, DOI 10.3732/ajb.89.2.279; Hu ZY, 2011, GENET RESOUR CROP EV, V58, P875, DOI 10.1007/s10722-010-9626-9; Jakobsson M, 2007, THEOR APPL GENET, V114, P223, DOI 10.1007/s00122-006-0425-9; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kristensen VN, 2001, BIOTECHNIQUES, V30, P318, DOI 10.2144/01302tt01; Lig YP, 2009, AFR J BIOTECHNOL, V8, P2707; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; Malisa AL, 2006, AFR J BIOTECHNOL, V5, P1588; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NAGANO Y, 1991, CURR GENET, V20, P431, DOI 10.1007/BF00317074; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; PALMER J. D., 1985, MONOGRAPHS EVOLUTION, P131, DOI DOI 10.1007/978-1-4684-4988-4_3; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; RADETZKY R, 1990, CURR GENET, V18, P429, DOI 10.1007/BF00309912; RAJORA OP, 1992, THEOR APPL GENET, V84, P280, DOI 10.1007/BF00229483; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; Ryman N., 1987, POPULATION GENETICS; Schranz ME, 2004, AM J BOT, V91, P174, DOI 10.3732/ajb.91.2.174; Slade AJ, 2005, TRANSGENIC RES, V14, P109, DOI 10.1007/s11248-005-2770-x; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; STEELE KP, 1994, SYST BOT, V19, P126, DOI 10.2307/2419717; Stemple DL, 2004, NAT REV GENET, V5, P145, DOI 10.1038/nrg1273; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Till BJ, 2010, THEOR APPL GENET, V121, P1381, DOI 10.1007/s00122-010-1395-5; Tsai H, 2011, PLANT PHYSIOL, V156, P1257, DOI 10.1104/pp.110.169748; Tsuchihashi Z., 2002, Pharmacogenomics Journal, V2, P103, DOI 10.1038/sj.tpj.6500094; URSIN VM, 1993, PLANT PHYSIOL, V101, P333, DOI 10.1104/pp.101.1.333; VEDEL F, 1978, PLANT SCI LETT, V13, P97, DOI 10.1016/0304-4211(78)90236-5; Wang GX, 2008, PESTIC BIOCHEM PHYS, V92, P24, DOI 10.1016/j.pestbp.2008.05.001; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; WARD BL, 1981, CELL, V25, P793, DOI 10.1016/0092-8674(81)90187-2; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wu FF, 2008, J BIOTECHNOL, V136, pS103, DOI 10.1016/j.jbiotec.2008.07.235; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yeung A, 2005, BIOTECHNIQUES, V38, P749, DOI 10.2144/05385RV01	79	10	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e47284	10.1371/journal.pone.0047284	http://dx.doi.org/10.1371/journal.pone.0047284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185237	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000005
J	Grosso, V; Farina, A; Gennaro, A; Giorgi, D; Lucretti, S				Grosso, Valentina; Farina, Anna; Gennaro, Andrea; Giorgi, Debora; Lucretti, Sergio			Flow Sorting and Molecular Cytogenetic Identification of Individual Chromosomes of Dasypyrum villosum L. (H. villosa) by a Single DNA Probe	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; SIMPLE SEQUENCE REPEATS; TRITICUM-AESTIVUM L.; RIBOSOMAL-RNA GENES; STREAK-MOSAIC-VIRUS; HAYNALDIA-VILLOSA; PLANT CHROMOSOMES; BREAD WHEAT; CONFERRING RESISTANCE; TRANSLOCATION LINES	Dasypyrum villosum (L.) Candargy (sin. Haynaldia villosa) is an annual wild diploid grass species (2n = 2x = 14; genome VV) belonging to the Poaceae family, which is considered to be an important source of biotic and abiotic stress resistance genes for wheat breeding. Enhanced characterization of D. villosum chromosomes can facilitate exploitation of its gene pool and its use in wheat breeding programs. Here we present the cytogenetic identification of D. villosum chromosomes on slide by fluorescent in situ hybridization (FISH), with the GAA simple sequence repeat (SSR) as a probe. We also describe the isolation and the flow cytometric analysis of D. villosum chromosomes in suspension, resulting in a distinguished flow karyotype. Chromosomes were flow sorted into three fractions, according their DNA content, one of which was composed of a single type of chromosome, namely 6 V, sorted with over 85% purity. Chromosome 6 V is known to carry genes to code for important resistance and seed storage characteristics, and its isolation represents a new source of genetic traits and specific markers useful for wheat improvement.	[Grosso, Valentina; Farina, Anna; Giorgi, Debora; Lucretti, Sergio] ENEA, CASACCIA Res Ctr, Rome, Italy; [Gennaro, Andrea] Univ Tuscia, Dept Agr Forestry Nat & Energy DAFNE, Viterbo, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Tuscia University	Lucretti, S (corresponding author), ENEA, CASACCIA Res Ctr, Rome, Italy.	sergio.lucretti@enea.it	Gennaro, Andrea/A-2774-2014; giorgi, debora/AAK-9405-2020	Gennaro, Andrea/0000-0002-3020-2637; 	Italian Ministry of Agriculture "Progetto MAPPA 5A" [D.M. 7398/7303/08]	Italian Ministry of Agriculture "Progetto MAPPA 5A"	This work was supported by the Italian Ministry of Agriculture "Progetto MAPPA 5A" (D.M. 7398/7303/08). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAMTHAWATJONSSON K, 1993, MOL GEN GENET, V240, P151, DOI 10.1007/BF00277052; Babu TEG, 2009, J PURE APPL MICROBIO, V3, P311; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Bhalla PL, 2006, TRENDS BIOTECHNOL, V24, P305, DOI 10.1016/j.tibtech.2006.04.008; BLANCO A, 1991, THEOR APPL GENET, V82, P358, DOI 10.1007/BF02190623; Cao YP, 2009, J GENET GENOMICS, V36, P313, DOI 10.1016/S1673-8527(08)60120-4; CHEN PD, 1995, THEOR APPL GENET, V91, P1125, DOI 10.1007/BF00223930; Contento A, 2005, CYTOGENET GENOME RES, V109, P34, DOI 10.1159/000082379; Cuadrado A, 2008, CYTOGENET GENOME RES, V120, P210, DOI 10.1159/000121069; Cuadrado A, 1995, GENOME, V38, P1061, DOI 10.1139/g95-142; Cuadrado A, 1998, CHROMOSOMA, V107, P587, DOI 10.1007/s004120050345; Cuadrado A, 2008, GENOME, V51, P809, DOI 10.1139/G08-065; Cuadrado A, 2010, CHROMOSOMA, V119, P495, DOI 10.1007/s00412-010-0273-x; Cuadrado A, 2009, CHROMOSOME RES, V17, P755, DOI 10.1007/s10577-009-9060-z; De Pace C, 2001, EUPHYTICA, V117, P67, DOI 10.1023/A:1004095705460; De Pace C, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P185, DOI 10.1007/978-3-642-14228-4_4; DENNIS ES, 1980, HEREDITY, V44, P349, DOI 10.1038/hdy.1980.33; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; DOLEZEL J, 1992, PLANTA, V188, P93, DOI 10.1007/BF00198944; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Dolezel J, 2012, FUNCT INTEGR GENOMIC, V12, P397, DOI 10.1007/s10142-012-0293-0; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Gamborg O.L., 1975, PLANT TISSUE CULT; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Giorgi D, 2003, GENOME, V46, P478, DOI 10.1139/g03-022; Gradzielewska A, 2006, EUPHYTICA, V152, P441, DOI 10.1007/s10681-006-9245-x; Gualberti G, 1996, THEOR APPL GENET, V92, P744, DOI 10.1007/BF00226097; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; Hospital F, 2001, GENETICS, V158, P1363; Jauhar PP, 2006, CROP SCI, V46, P1841, DOI 10.2135/cropsci2005.07-0223; Kato Seiji, 2009, Chromosome Science, V12, P43; Ksiazczyk T, 2011, J APPL GENET, V52, P305, DOI 10.1007/s13353-011-0048-y; Kubalakova M, 2000, CYTOMETRY, V41, P102, DOI 10.1002/1097-0320(20001001)41:2&lt;102::AID-CYTO4&gt;3.0.CO;2-H; Kubalakova M, 1997, THEOR APPL GENET, V94, P758, DOI 10.1007/s001220050475; Kubalakova M, 2005, GENETICS, V170, P823, DOI 10.1534/genetics.104.039180; Kubalakova M, 2002, THEOR APPL GENET, V104, P1362, DOI 10.1007/s00122-002-0888-2; Li HJ, 2005, THEOR APPL GENET, V111, P932, DOI 10.1007/s00122-005-0025-0; Li HJ, 2002, PLANT DIS, V86, P423, DOI 10.1094/PDIS.2002.86.4.423; LI WL, 1995, THEOR APPL GENET, V90, P526, DOI 10.1007/BF00221999; Liu C, 2011, GENOME, V54, P836, DOI [10.1139/G11-051, 10.1139/g11-051]; Liu D, 1988, TRANSFER HAYNALDIA V; Molnar I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027708; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Pedersen C, 1996, GENOME, V39, P93, DOI 10.1139/g96-013; Qi LL, 2011, THEOR APPL GENET, V123, P159, DOI 10.1007/s00122-011-1574-z; Qi LL, 1998, THEOR APPL GENET, V97, P1042, DOI 10.1007/s001220050989; Schneider A, 2003, PLANT BREEDING, V122, P396, DOI 10.1046/j.1439-0523.2003.00891.x; SCHUBERT I, 1993, CHROMOSOMA, V102, P96, DOI 10.1007/BF00356026; Schwarzacher T, 2003, GENOME, V46, P953, DOI 10.1139/G03-119; Schwarzacher T, 2000, PRATICAL SITU HYBRID; SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204; SEARS ER, 1953, AM J BOT, V40, P168, DOI 10.2307/2438774; Sharma S, 2005, CYTOGENET GENOME RES, V109, P15, DOI 10.1159/000082377; Song W, 2009, MOL BREEDING, V23, P357, DOI 10.1007/s11032-008-9235-x; Uslu E, 1999, HEREDITAS, V131, P129, DOI 10.1111/j.1601-5223.1999.00129.x; Vrana J, 2000, GENETICS, V156, P2033; Wenzl P, 2010, THEOR APPL GENET, V121, P465, DOI 10.1007/s00122-010-1323-8; Yildirim A, 1998, GENOME, V41, P1, DOI 10.1139/gen-41-1-1; Yu MQ, 2001, EUPHYTICA, V121, P157, DOI 10.1023/A:1012078821397; Yuan WY, 2009, HEREDITAS, V146, P58, DOI 10.1111/j.1601-5223.2009.02110.x; Zamir D, 2008, NAT GENET, V40, P269, DOI 10.1038/ng0308-269; Zhang QP, 2005, EUPHYTICA, V145, P317, DOI 10.1007/s10681-005-1743-8; ZHONG GY, 1995, PLANT BREEDING, V114, P297, DOI 10.1111/j.1439-0523.1995.tb01237.x	65	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50151	10.1371/journal.pone.0050151	http://dx.doi.org/10.1371/journal.pone.0050151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185561	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700074
J	Ituarte, S; Dreon, MS; Ceolin, M; Heras, H				Ituarte, Santiago; Sebastian Dreon, Marcos; Ceolin, Marcelo; Heras, Horacio			Agglutinating Activity and Structural Characterization of Scalarin, the Major Egg Protein of the Snail Pomacea scalaris (d'Orbigny, 1832)	PLOS ONE			English	Article							HELIX-POMATIA AGGLUTININ; APPLE-SNAIL; LECTIN; AMPULLARIIDAE; GASTROPODA; STABILITY; TRYPSIN	Apple snail perivitellins are emerging as ecologically important reproductive proteins. To elucidate if the protective functions of the egg proteins of Pomacea canaliculata (Caenogastropoda, Ampullariidae), involved in embryo defenses, are present in other Pomacea species we studied scalarin (PsSC), the major perivitellin of Pomacea scalaris. Using small angle X-ray scattering, fluorescence and absorption spectroscopy and biochemical methods, we analyzed PsSC structural stability, agglutinating activity, sugar specificity and protease resistance. PsSC aggluttinated rabbit, and, to a lesser extent, human B and A erythrocytes independently of divalent metals Ca2+ and Mg2+ were strongly inhibited by galactosamine and glucosamine. The protein was structurally stable between pH 2.0 to 10.0, though agglutination occurred only between pH 4.0 to 8.0 (maximum activity at pH 7.0). The agglutinating activity was conserved up to 60 degrees C and completely lost above 80 degrees C, in agreement with the structural thermal stability of the protein (up to 60 degrees C). PsSC was able to withstand in vitro gastrointestinal digestion, and showed no trypsin inhibition activity. The presence of lectin activity has been reported in eggs of other Pomacea snails, but here we link for the first time, this activity to an apple snail multifunctional perivitellin. This novel role for a snail egg storage protein is different from closely related P. canaliculata defensive proteins.	[Ituarte, Santiago; Sebastian Dreon, Marcos; Heras, Horacio] Univ Nacl La Plata UNLP, Inst Invest Bioquim La Plata INIBIOLP, CONICET CCT La Plata, La Plata, Buenos Aires, Argentina; [Sebastian Dreon, Marcos] Univ Nacl La Plata UNLP, Fac Cs Med, Catedra Bioquim & Biol Mol, La Plata, Buenos Aires, Argentina; [Ceolin, Marcelo] Univ Nacl La Plata UNLP, Inst Invest Fis Teor & Aplicadas INIFTA, CONICET CCT La Plata, La Plata, Buenos Aires, Argentina; [Heras, Horacio] Univ Nacl La Plata UNLP, Fac Cs Nat & Museo, Catedra Quim Biol, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; INIFTA; National University of La Plata; Museo La Plata	Dreon, MS (corresponding author), Univ Nacl La Plata UNLP, Inst Invest Bioquim La Plata INIBIOLP, CONICET CCT La Plata, La Plata, Buenos Aires, Argentina.	msdreon@gmail.com	Ceolin, Marcelo/T-9405-2017; Heras, Horacio/R-9555-2018	Ituarte, Santiago/0000-0002-3670-2843; Ceolin, Marcelo/0000-0002-2385-7803; Heras, Horacio/0000-0003-3379-0216	Comision de Investigaciones Cientificas de la Provincia de Buenos Aires (CICBA); Agencia Nacional de Promocion Cientifica, Argentina [PICT 2166]	Comision de Investigaciones Cientificas de la Provincia de Buenos Aires (CICBA); Agencia Nacional de Promocion Cientifica, Argentina(ANPCyT)	This work was supported by grants from the Comision de Investigaciones Cientificas de la Provincia de Buenos Aires (CICBA) and Agencia Nacional de Promocion Cientifica (PICT 2166), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht EA, 1996, VELIGER, V39, P142; Alpuche J, 2010, COMP BIOCHEM PHYS B, V156, P1, DOI 10.1016/j.cbpb.2010.01.006; Arreguin-Espinosa R, 1997, BIOCHEM MOL BIOL INT, V43, P1241; Arreguin-Espinosa R, 2001, ARCH BIOCHEM BIOPHYS, V394, P151, DOI 10.1006/abbi.2001.2521; BALDO BA, 1974, VOX SANG, V27, P67, DOI 10.1111/j.1423-0410.1974.tb02390.x; Burgardt NI, 2009, BBA-PROTEINS PROTEOM, V1794, P1115, DOI 10.1016/j.bbapap.2009.04.006; Dreon MS, 2008, FEBS J, V275, P4522, DOI 10.1111/j.1742-4658.2008.06595.x; Dreon MS, 2007, ARCH BIOCHEM BIOPHYS, V460, P107, DOI 10.1016/j.abb.2006.12.033; Dreon MS, 2004, ARCH BIOCHEM BIOPHYS, V422, P1, DOI 10.1016/j.abb.2003.11.018; Estebenet AL, 2002, BIOCELL, V26, P83; Estebenet Alejandra L., 1993, Apex (Brussels), V8, P129; HAJOS G, 1995, J AGR FOOD CHEM, V43, P165, DOI 10.1021/jf00049a030; Hammersley AP, 1997, J SYNCHROTRON RADIAT, V4, P67, DOI 10.1107/S0909049596015087; Hathaway JJM, 2010, DEV COMP IMMUNOL, V34, P425, DOI 10.1016/j.dci.2009.12.001; Heras H, 2007, COMP BIOCHEM PHYS C, V146, P158, DOI 10.1016/j.cbpc.2006.10.013; Heras H, 2008, TOXICON, V52, P481, DOI 10.1016/j.toxicon.2008.06.022; Ito S, 2011, BIOSCI BIOTECH BIOCH, V75, P20, DOI 10.1271/bbb.100389; Ituarte S, 2008, MOL REPROD DEV, V75, P1441, DOI 10.1002/mrd.20880; Ituarte S, 2010, COMP BIOCHEM PHYS B, V157, P66, DOI 10.1016/j.cbpb.2010.05.004; Kamerling J. P., 2007, COMPREHENSIVE GLYCOS; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MERRIL CR, 1990, METHOD ENZYMOL, V182, P477; *NAT RES COUNC, 1996, GUID CAR US LAB AN; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; PROKOP O, 1967, Z IMMUNITATSFORSCH, V133, P176; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Schumacher U, 2005, ANTICANCER RES, V25, P1829; SCHWERT GW, 1955, BIOCHIM BIOPHYS ACTA, V16, P570, DOI 10.1016/0006-3002(55)90280-8; Dreon MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015059; Sun J, 2012, J PROTEOME RES, V11, P4240, DOI 10.1021/pr3003613; Thom I, 2007, LUNG CANCER, V56, P391, DOI 10.1016/j.lungcan.2007.01.003; UHLENBRU.G, 1973, EXPERIENTIA, V29, P1139, DOI 10.1007/BF01946768; Frassa MV, 2010, BBA-PROTEINS PROTEOM, V1804, P1492, DOI 10.1016/j.bbapap.2010.02.013	35	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50115	10.1371/journal.pone.0050115	http://dx.doi.org/10.1371/journal.pone.0050115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185551	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700072
J	Rosenblum, EB; Poorten, TJ; Joneson, S; Settles, M				Rosenblum, Erica Bree; Poorten, Thomas J.; Joneson, Suzanne; Settles, Matthew			Substrate-Specific Gene Expression in Batrachochytrium dendrobatidis, the Chytrid Pathogen of Amphibians	PLOS ONE			English	Article							CANDIDA-ALBICANS; VIRULENCE FACTORS; GENOME SEQUENCE; CHYTRIDIOMYCOSIS; PROTEASES; FLOCCULATION; EFFECTORS; PROTEINS; ADHESION; ALLELES	Determining the mechanisms of host-pathogen interaction is critical for understanding and mitigating infectious disease. Mechanisms of fungal pathogenicity are of particular interest given the recent outbreaks of fungal diseases in wildlife populations. Our study focuses on Batrachochytrium dendrobatidis (Bd), the chytrid pathogen responsible for amphibian declines around the world. Previous studies have hypothesized a role for several specific families of secreted proteases as pathogenicity factors in Bd, but the expression of these genes has only been evaluated in laboratory growth conditions. Here we conduct a genome-wide study of Bd gene expression under two different nutrient conditions. We compare Bd gene expression profiles in standard laboratory growth media and in pulverized host tissue (i.e., frog skin). A large proportion of genes in the Bd genome show increased expression when grown in host tissue, indicating the importance of studying pathogens on host substrate. A number of gene classes show particularly high levels of expression in host tissue, including three families of secreted proteases (metallo-, serine- and aspartyl-proteases), adhesion genes, lipase-3 encoding genes, and a group of phylogenetically unusual crinkler-like effectors. We discuss the roles of these different genes as putative pathogenicity factors and discuss what they can teach us about Bd's metabolic targets, host invasion, and pathogenesis.	[Rosenblum, Erica Bree; Poorten, Thomas J.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Joneson, Suzanne; Settles, Matthew] Univ Idaho, Initiat Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA	University of California System; University of California Berkeley; Idaho; University of Idaho	Rosenblum, EB (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	rosenblum@berkeley.edu	Joneson, Suzanne/AAE-9377-2019; Settles, Matthew L/F-2031-2011	Settles, Matthew L/0000-0002-3424-1086	NSF [EF-0723871]; NIH [P20RR0116454]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NSF (EF-0723871) and NIH (#P20RR0116454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, HDB HYDROCARBON LIPI, DOI [DOI 10.1007/978-3-540-77587-4_247, 10.1007/978-3-540-77587-4_247]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2009, ECOHEALTH, V6, P27, DOI 10.1007/s10393-009-0232-2; Bjornsdottir B, 2009, VET MICROBIOL, V136, P326, DOI 10.1016/j.vetmic.2008.11.020; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Braga-Silva LA, 2011, CURR MED CHEM, V18, P2401; Brunke S, 2006, MICROBIOL-SGM, V152, P547, DOI 10.1099/mic.0.28501-0; da Silva BA, 2006, CURR MICROBIOL, V53, P18, DOI 10.1007/s00284-005-0156-1; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; Duellman W. E., 1986, BIOL AMPHIBIANS; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Fox H., 1986, P78; Fugier Emilie, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000543; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joneson S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002338; Jousson O, 2004, MICROBIOL-SGM, V150, P301, DOI 10.1099/mic.0.26690-0; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; Monod M, 2002, BIOL CHEM, V383, P1087, DOI 10.1515/BC.2002.117; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Monod M, 2008, MYCOPATHOLOGIA, V166, P285, DOI 10.1007/s11046-008-9105-4; Moss AS, 2010, DIS AQUAT ORGAN, V92, P149, DOI 10.3354/dao02223; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Nishikawa K, 2011, ARCH IMMUNOL THER EX, V59, P239, DOI 10.1007/s00005-011-0130-5; Oehmcke S, 2010, CLIN CHIM ACTA, V411, P1172, DOI 10.1016/j.cca.2010.04.032; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rosenblum EB, 2012, MOL ECOL, DOI [10.1111/j.1365-1294X.2012.05481.x, DOI 10.1111/J.1365-1294X.2012.05481.X]; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Ryan MJ, 2008, BIOL CONSERV, V141, P1636, DOI 10.1016/j.biocon.2008.04.014; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Stavrinides J, 2008, CELL MICROBIOL, V10, P285, DOI 10.1111/j.1462-5822.2007.01078.x; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun GL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-195; Symonds EP, 2008, MYCOPATHOLOGIA, V166, P143, DOI 10.1007/s11046-008-9135-y; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Van Rooij P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041481; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2003, APPL MICROBIOL BIOT, V61, P197, DOI 10.1007/s00253-002-1200-8; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wong W, 2011, J BIOL CHEM, V286, P42180, DOI 10.1074/jbc.M111.298711; Zhao XM, 2007, MICROBIOL-SGM, V153, P2342, DOI 10.1099/mic.0.2006/005017-0	57	35	35	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49924	10.1371/journal.pone.0049924	http://dx.doi.org/10.1371/journal.pone.0049924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185485	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700056
J	Steinman, RA; Robinson, AR; Feghali-Bostwick, CA				Steinman, Richard A.; Robinson, Andria Rasile; Feghali-Bostwick, Carol A.			Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DEPENDENT KINASE INHIBITORS; CYC202 R-ROSCOVITINE; SYSTEMIC-SCLEROSIS; TGF-BETA; CELL-CYCLE; SIGNALING PATHWAY; THYMIDINE KINASE; EXPRESSION; TRANSCRIPTION	Heightened production of collagen and other matrix proteins underlies the fibrotic phenotype of systemic sclerosis (SSc). Roscovitine is an inhibitor of cyclin-dependent kinases that promote cell cycling (CDK1, 2), neuronal development (CDK5) and control transcription (CDK7,9). In an in vivo glomerulonephritis model, roscovitine treatment decreased mesangial cell proliferation and matrix proteins [1]. We investigated whether roscovitine could regulate fibrotic protein production directly rather than through cell cycling. Our investigations revealed that roscovitine coordinately inhibited the expression of collagen, fibronectin, and connective tissue growth factor (CTGF) in normal and SSc fibroblasts. This effect occurred on a transcriptional basis and did not result from roscovitine-mediated cell cycle inhibition. Roscovitine-mediated suppression of matrix proteins could not be reversed by the exogenous profibrotic cytokines TGF-beta or IL-6. To our knowledge, we are the first to report that roscovitine modulates matrix protein transcription. Roscovitine may thus be a viable treatment option for SSc and other fibrosing diseases.	[Steinman, Richard A.; Robinson, Andria Rasile; Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Steinman, Richard A.] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Steinman, RA (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.	steinman@pitt.edu			United States National Institutes of Health [R21RR032118]; Scleroderma Foundation; Arthritis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR032118] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD011125] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; Arthritis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by United States National Institutes of Health R21RR032118 to RAS and CFB, by a divisional research fund grant to RAS and a research grant from the Scleroderma Foundation and an Arthritis Investigator Award from the Arthritis Foundation to CFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aldoss IT, 2009, EXPERT OPIN INV DRUG, V18, P1957, DOI 10.1517/13543780903418445; Alessi F, 1998, EXP CELL RES, V245, P8, DOI 10.1006/excr.1998.4216; Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Balomenos D, 2000, NAT MED, V6, P171, DOI 10.1038/72272; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Bhattacharyya S, 2012, NAT REV RHEUMATOL, V8, P42, DOI 10.1038/nrrheum.2011.149; Chang ZF, 2001, J BIOMED SCI, V8, P176; Chang ZF, 1999, J CELL BIOCHEM, V75, P300, DOI 10.1002/(SICI)1097-4644(19991101)75:2<300::AID-JCB12>3.0.CO;2-Z; Collins M, 1997, BIOCHEM J, V322, P199, DOI 10.1042/bj3220199; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; FEGHALI CA, 1994, AUTOIMMUNITY, V17, P309, DOI 10.3109/08916939409010671; FEGHALI CA, 1992, J RHEUMATOL, V19, P1207; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Ghazizadeh M, 2007, J INVEST DERMATOL, V127, P98, DOI 10.1038/sj.jid.5700564; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; GREENWEL P, 1995, LAB INVEST, V72, P83; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; GRUSCHWITZ M, 1990, J INVEST DERMATOL, V94, P197, DOI 10.1111/1523-1747.ep12874503; Haidweger E, 2001, J MOL BIOL, V306, P201, DOI 10.1006/jmbi.2000.4406; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Hein N, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-9; Hou T, 2007, J BIOL CHEM, V282, P37091, DOI 10.1074/jbc.M706458200; HOUGLUM K, 1994, J CLIN INVEST, V94, P808, DOI 10.1172/JCI117400; Hu QH, 2000, J BIOL CHEM, V275, P4435, DOI 10.1074/jbc.275.6.4435; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; JordanSciutto KL, 1997, EXP CELL RES, V236, P527, DOI 10.1006/excr.1997.3762; Katula KS, 1997, CELL GROWTH DIFFER, V8, P811; Kawaguchi Y, 1999, J CLIN INVEST, V103, P1253, DOI 10.1172/JCI4304; Krystof V, 2010, CURR DRUG TARGETS, V11, P291, DOI 10.2174/138945010790711950; Lam LT, 2001, GENOME BIOL, V2; Lania L, 1999, J CELL PHYSIOL, V179, P134, DOI 10.1002/(SICI)1097-4652(199905)179:2<134::AID-JCP3>3.0.CO;2-O; Le Tourneau C, 2010, EUR J CANCER, V46, P3243, DOI 10.1016/j.ejca.2010.08.001; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Medsger TA, 2003, RHEUM DIS CLIN N AM, V29, P255, DOI 10.1016/S0889-857X(03)00023-1; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; Milovanceva-Popovska M, 2005, KIDNEY INT, V67, P1362, DOI 10.1111/j.1523-1755.2005.00213.x; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Pippin JW, 1997, J CLIN INVEST, V100, P2512, DOI 10.1172/JCI119793; Rossert J, 2000, NEPHROL DIAL TRANSPL, V15, P66, DOI 10.1093/ndt/15.suppl_6.66; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; Shima Y, 2010, RHEUMATOLOGY, V49, P2408, DOI 10.1093/rheumatology/keq275; Shinozaki M, 1997, BIOCHEM BIOPH RES CO, V237, P292, DOI 10.1006/bbrc.1997.7134; Steinman RA, 2003, ONCOGENE, V22, P3608, DOI 10.1038/sj.onc.1206523; Sysa P, 2009, DNA CELL BIOL, V28, P425, DOI 10.1089/dna.2009.0884; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Wesierska-Gadek J, 2007, J CELL BIOCHEM, V100, P865, DOI 10.1002/jcb.21211; Wesierska-Gadek J, 2009, ANN NY ACAD SCI, V1171, P228, DOI 10.1111/j.1749-6632.2009.04726.x; Whittaker SR, 2004, CANCER RES, V64, P262, DOI 10.1158/0008-5472.CAN-03-0110; Yamamoto T, 1999, CLIN IMMUNOL, V92, P6, DOI 10.1006/clim.1999.4720; Zhang XH, 2000, MOL BIOL CELL, V11, P2117, DOI 10.1091/mbc.11.6.2117; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	59	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e48560	10.1371/journal.pone.0048560	http://dx.doi.org/10.1371/journal.pone.0048560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185265	gold, Green Submitted, Green Published			2022-12-25	WOS:000311535700014
J	Storer, CG; Pascal, CE; Roberts, SB; Templin, WD; Seeb, LW; Seeb, JE				Storer, Caroline G.; Pascal, Carita E.; Roberts, Steven B.; Templin, William D.; Seeb, Lisa W.; Seeb, James E.			Rank and Order: Evaluating the Performance of SNPs for Individual Assignment in a Non-Model Organism	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RESOLUTION MELTING ANALYSIS; SOCKEYE-SALMON; POPULATION-STRUCTURE; ATLANTIC SALMON; NONMODEL ORGANISMS; JUVENILE MIGRATION; ASCERTAINMENT BIAS; MOLECULAR MARKERS; GENETIC DIVERSITY	Single nucleotide polymorphisms (SNPs) are valuable tools for ecological and evolutionary studies. In non-model species, the use of SNPs has been limited by the number of markers available. However, new technologies and decreasing technology costs have facilitated the discovery of a constantly increasing number of SNPs. With hundreds or thousands of SNPs potentially available, there is interest in comparing and developing methods for evaluating SNPs to create panels of high-throughput assays that are customized for performance, research questions, and resources. Here we use five different methods to rank 43 new SNPs and 71 previously published SNPs for sockeye salmon: F-ST, informativeness (I-n), average contribution to principal components (LC), and the locus-ranking programs BELS and WHICHLOCI. We then tested the performance of these different ranking methods by creating 48- and 96-SNP panels of the top-ranked loci for each method and used empirical and simulated data to obtain the probability of assigning individuals to the correct population using each panel. All 96-SNP panels performed similarly and better than the 48-SNP panels except for the 96-SNP BELS panel. Among the 48-SNP panels, panels created from F-ST, I-n, and LC ranks performed better than panels formed using the topranked loci from the programs BELS and WHICHLOCI. The application of ranking methods to optimize panel performance will become more important as more high-throughput assays become available.	[Storer, Caroline G.; Pascal, Carita E.; Roberts, Steven B.; Seeb, Lisa W.; Seeb, James E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Templin, William D.] Alaska Dept Fish & Game, Gene Conservat Lab, Anchorage, AK 99518 USA	University of Washington; University of Washington Seattle; Alaska Department of Fish & Game	Seeb, JE (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	jseeb@u.washington.edu	Seeb, Lisa W/GSN-3076-2022	Roberts, Steven/0000-0001-8302-1138	Alaska Sustainable Salmon Fund under Study 45908 from the National Oceanic and Atmospheric Administration, United States Department of Commerce; Bristol Bay Regional Seafood Development Association	Alaska Sustainable Salmon Fund under Study 45908 from the National Oceanic and Atmospheric Administration, United States Department of Commerce; Bristol Bay Regional Seafood Development Association	This research was made possible with funding from the Alaska Sustainable Salmon Fund under Study 45908 from the National Oceanic and Atmospheric Administration, United States Department of Commerce, administered by the Alaska Department of Fish and Game. Additional funding was provided by the Bristol Bay Regional Seafood Development Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MW, 2011, T AM FISH SOC, V140, P865, DOI 10.1080/00028487.2011.588137; Anderson EC, 2010, MOL ECOL RESOUR, V10, P701, DOI 10.1111/j.1755-0998.2010.02846.x; Baker Timothy T., 2009, V70, P963; Banks MA, 2003, BIOINFORMATICS, V19, P1436, DOI 10.1093/bioinformatics/btg172; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bromaghin JF, 2008, MOL ECOL RESOUR, V8, P568, DOI 10.1111/j.1471-8286.2007.02010.x; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Campbell NR, 2011, MOL ECOL RESOUR, V11, P20, DOI 10.1111/j.1755-0998.2011.02977.x; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Creelman EK, 2011, T AM FISH SOC, V140, P749, DOI 10.1080/00028487.2011.584494; Dai ZY, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-24; Elfstrom CM, 2006, MOL ECOL NOTES, V6, P1255, DOI 10.1111/j.1471-8286.2006.01507.x; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Everett MV, 2011, MOL ECOL RESOUR, V11, P93, DOI 10.1111/j.1755-0998.2010.02969.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Freamo H, 2011, MOL ECOL RESOUR, V11, P254, DOI 10.1111/j.1755-0998.2010.02952.x; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; Geraldes A, 2011, MOL ECOL RESOUR, V11, P81, DOI 10.1111/j.1755-0998.2010.02960.x; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Gomez-Uchida D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-48; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Habicht C, 2010, T AM FISH SOC, V139, P1171, DOI 10.1577/T09-149.1; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Kalinowski S.T., 2008, ONCOR COMPUTER PROGR; Karlsson S, 2011, MOL ECOL RESOUR, V11, P247, DOI 10.1111/j.1755-0998.2010.02959.x; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; McGlauflin MT, 2011, T AM FISH SOC, V140, P763, DOI 10.1080/00028487.2011.584495; McGlauflin MT, 2010, T AM FISH SOC, V139, P676, DOI 10.1577/T09-103.1; Moazami-Goudarzi K, 2002, GENETICS, V162, P473; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morin PA, 2010, MAR MAMMAL SCI, V26, P716, DOI 10.1111/j.1748-7692.2009.00362.x; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Olsen MT, 2011, MOL ECOL RESOUR, V11, P9, DOI 10.1111/j.1755-0998.2010.02941.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quintela M, 2010, MOL ECOL, V19, P2380, DOI 10.1111/j.1365-294X.2010.04648.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2005, J COMPUT BIOL, V12, P1183, DOI 10.1089/cmb.2005.12.1183; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rosenblum EB, 2007, J HERED, V98, P331, DOI 10.1093/jhered/esm031; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sagarin R, 2009, PLOS BIOL, V7, P426, DOI 10.1371/journal.pbio.1000069; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Seeb JE, 2009, METHODS MOL BIOL, V578, P277, DOI 10.1007/978-1-60327-411-1_18; Seeb LW, 2011, T AM FISH SOC, V140, P734, DOI 10.1080/00028487.2011.584493; Seeb LW, 2000, T AM FISH SOC, V129, P1223, DOI 10.1577/1548-8659(2000)129&lt;1223:GDOSSO&gt;2.0.CO;2; Smith CT, 2007, T AM FISH SOC, V136, P1674, DOI 10.1577/T06-227.1; Smith CT, 2005, MOL ECOL, V14, P4193, DOI 10.1111/j.1365-294X.2005.02731.x; Smith MJ, 2011, MOL ECOL RESOUR, V11, P268, DOI 10.1111/j.1755-0998.2010.02965.x; Topchy A, 2004, MOL ECOL NOTES, V4, P798, DOI 10.1111/j.1471-8286.2004.00781.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Winans GA, 2004, N AM J FISH MANAGE, V24, P672, DOI 10.1577/M03-052.1; Wu SB, 2008, THEOR APPL GENET, V118, P1, DOI 10.1007/s00122-008-0870-8	60	34	37	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e49018	10.1371/journal.pone.0049018	http://dx.doi.org/10.1371/journal.pone.0049018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185290	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700023
J	Pan, C; Gu, YR; Zhang, W; Zheng, YB; Peng, L; Deng, H; Chen, YM; Chen, LB; Chen, S; Zhang, M; Gao, ZL				Pan, Calvin; Gu, Yurong; Zhang, Wei; Zheng, Yubao; Peng, Liang; Deng, Hong; Chen, Youming; Chen, Lubiao; Chen, Sui; Zhang, Min; Gao, Zhiliang			Dynamic Changes of Lipopolysaccharide Levels in Different Phases of Acute on Chronic Hepatitis B Liver Failure	PLOS ONE			English	Article							NF-KAPPA-B; BACTERIAL LIPOPOLYSACCHARIDE; MICROBIAL TRANSLOCATION; SIGNALING PATHWAYS; OXIDATIVE STRESS; VIRUS INFECTION; ENDOTOXIN; ACTIVATION; DISEASE; ETHANOL	Background: High serum levels of lipopolysaccharide (LPS) with LPS-MD-2/TLR4 complex activated NF-kb and cytokine cause hepatic necrosis in animal models. We investigated the dynamic changes of LPS levels in patients with acute on chronic hepatitis B liver failure (ACHBLF). Methods: We enrolled ACHBLF patients for a 12-week study. Patients' LPS levels were measured along with 10 healthy controls. Patients on supportive care and recovered without intervention(s) were analyzed. Patients' LPS levels during the disease progression phase, peak phase, and remission phase were compared with healthy controls. Results: Among 30 patients enrolled, 25 who received interventions or expired during the study period were excluded from the analysis, five patients on supportive care who completed the study were analyzed. Significant abnormal distributions of LPS levels were observed in patients in different phases (0.0168 +/- 0.0101 in progression phase; 0.0960 +/- 0.0680 in peak phase; 0.0249 +/- 0.0365 in remission phase; and 0.0201 +/- 0.0146 in controls; respectively, p<0.05). The highest level of LPS was in the peak phase and significantly elevated when compared to controls (0.0201 +/- 0.0146 vs. 0.0960 +/- 0.0680, p = 0.007). There were no statistically significant differences in LPS levels between healthy controls and subjects in the progression phase or remission phase. Dynamic changes of LPS were correlated with MELD-Na in the progression phase (p = 0.01, R = 0.876) and in the peak phase (p = 0.000, R = 21.00). Conclusions: Significant abnormal distributions of LPS levels were observed in ACHBLF with the highest level in the peak phase. The dynamic changes of LPS were correlated with disease severity and suggested LPS causing secondary hepatic injury.	[Gu, Yurong; Zheng, Yubao; Peng, Liang; Deng, Hong; Chen, Youming; Chen, Lubiao; Chen, Sui; Zhang, Min; Gao, Zhiliang] Sun Yet Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Pan, Calvin] Mt Sinai Med Ctr, Mt Sinai Sch Med, Dept Med, Div Liver Dis, New York, NY 10029 USA; [Zhang, Wei] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China	Sun Yat Sen University; Icahn School of Medicine at Mount Sinai; Capital Medical University	Gao, ZL (corresponding author), Sun Yet Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	zlgao99@hotmail.com	gu, yu/GSD-4507-2022		Natural Science Fund of Guangdong Province [10451008901004818]; National Natural Science Foundation of China [30971356]; National Grant Program on Key Infectious Disease in the Treatment and Prevention of Infectious Diseases of AIDS and Viral Hepatitis [2012ZX10002007]	Natural Science Fund of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grant Program on Key Infectious Disease in the Treatment and Prevention of Infectious Diseases of AIDS and Viral Hepatitis	This study was funded by the Natural Science Fund of Guangdong Province (No. 10451008901004818), the National Natural Science Foundation of China (No. 30971356), and the National Grant Program on Key Infectious Disease in the Treatment and Prevention of Infectious Diseases of AIDS and Viral Hepatitis (No. 2012ZX10002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Backhed F, 2003, MICROBES INFECT, V5, P951, DOI 10.1016/S1286-4579(03)00189-8; Barclay G R, 1995, Prog Clin Biol Res, V392, P263; Bhonchal Sonia, 2007, Trop Gastroenterol, V28, P64; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Garg H, 2011, HEPATOLOGY, V53, P774, DOI 10.1002/hep.24109; Han DW, 2002, WORLD J GASTROENTERO, V8, P961, DOI 10.3748/wjg.v8.i6.961; Hessel FP, 2010, EUR J GASTROEN HEPAT, V22, P213, DOI 10.1097/MEG.0b013e3283314e48; Hoek JB, 1999, HEPATOLOGY, V29, P1602, DOI 10.1002/hep.510290536; Karaa A, 2008, SHOCK, V30, P197, DOI [10.1097/SHK.0b013e318160f417, 10.1097/shk.0b013e318160f417]; Katoonizadeh A, 2010, GUT, V59, P1561, DOI 10.1136/gut.2009.189639; Koh C, 2011, GASTROENTEROLOGY, V140, pS897; Lange CM, 2009, HEPATOLOGY, V50, P2001, DOI 10.1002/hep.23346; Li LJ, 2004, WORLD J GASTROENTERO, V10, P2087, DOI 10.3748/wjg.v10.i14.2087; Li LJ, 2001, CHINESE MED J-PEKING, V114, P869; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Merion RM, 2011, TRANSPL INT, V24, P965, DOI 10.1111/j.1432-2277.2011.01274.x; NAKAO A, 1994, HEPATOLOGY, V19, P1251, DOI 10.1002/hep.1840190525; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Quiroz SC, 2001, J GASTROEN HEPATOL, V16, P1267, DOI 10.1046/j.1440-1746.2001.02619.x; ROTH J, 1994, J PHYSIOL-LONDON, V477, P177, DOI 10.1113/jphysiol.1994.sp020182; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Sen S, 2004, LIVER TRANSPLANT, V10, P1109, DOI 10.1002/lt.20236; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Sozinov AS, 2002, B EXP BIOL MED+, V133, P153, DOI 10.1023/A:1015546821875; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tsung A, 2007, SHOCK, V27, P364, DOI 10.1097/01.shk.0000239773.95280.2c; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Yu H, 2008, HEPATOB PANCREAT DIS, V7, P185; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zheng MH, 2011, CLIN GASTROENTEROL H, V9, P351, DOI 10.1016/j.cgh.2010.12.027	37	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49460	10.1371/journal.pone.0049460	http://dx.doi.org/10.1371/journal.pone.0049460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185336	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800025
J	Corcoran, AA; Boeing, WJ				Corcoran, Alina A.; Boeing, Wiebke J.			Biodiversity Increases the Productivity and Stability of Phytoplankton Communities	PLOS ONE			English	Article							TEMPORAL VARIABILITY; FUNCTIONAL DIVERSITY; INSURANCE HYPOTHESIS; SPECIES-DIVERSITY; ECOSYSTEM; CYANOBACTERIA; ECOLOGY; WATER; COMPLEMENTARITY; CONSEQUENCES	Global biodiversity losses provide an immediate impetus to elucidate the relationships between biodiversity, productivity and stability. In this study, we quantified the effects of species richness and species combination on the productivity and stability of phytoplankton communities subject to predation by a single rotifer species. We also tested one mechanism of the insurance hypothesis: whether large, slow-growing, potentially-defended cells would compensate for the loss of small, fast-growing, poorly-defended cells after predation. There were significant effects of species richness and species combination on the productivity, relative yield, and stability of phytoplankton cultures, but the relative importance of species richness and combination varied with the response variables. Species combination drove patterns of productivity, whereas species richness was more important for stability. Polycultures containing the most productive single species, Dunaliella, were consistently the most productive. Yet, the most species rich cultures were the most stable, having low temporal variability in measures of biomass. Polycultures recovered from short-term negative grazing effects, but this recovery was not due to the compensation of large, slow-growing cells for the loss of small, fast-growing cells. Instead, polyculture recovery was the result of reduced rotifer grazing rates and persisting small species within the polycultures. Therefore, although an insurance effect in polycultures was found, this effect was indirect and unrelated to grazing tolerance. We hypothesize that diverse phytoplankton assemblages interfered with efficient rotifer grazing and that this "interference effect" facilitated the recovery of the most productive species, Dunaliella. In summary, we demonstrate that both species composition and species richness are important in driving patterns of productivity and stability, respectively, and that stability in biodiverse communities can result from an alteration in consumer functioning. Our findings underscore the importance of predator-prey dynamics in determining the relationships between biodiversity, productivity and stability in producer communities.	[Corcoran, Alina A.; Boeing, Wiebke J.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA	New Mexico State University	Corcoran, AA (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Tallahassee, FL USA.	alina.corcoran@myfwc.com			U.S. Department of Energy [DE-EE0003046]; U.S. Hatch Act	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Hatch Act	This work was supported by the U.S. Department of Energy under contract DE-EE0003046 awarded to the National Alliance for Advanced Biofuels and Bioproducts and is also a New Mexico Agricultural Experiment Station publication, supported by state funds and the U.S. Hatch Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Andersen R. A., 2005, ALGAL CULTURING TECH; ARNDT H, 1993, HYDROBIOLOGIA, V255, P231, DOI 10.1007/BF00025844; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Behl S, 2011, LIMNOL OCEANOGR, V56, P683, DOI 10.4319/lo.2011.56.2.0683; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; Bidigare RR, 2009, AMYOTROPH LATERAL SC, V10, P71, DOI 10.3109/17482960903273056; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CONDEPORCUNA JM, 1995, FRESHWATER BIOL, V33, P341, DOI 10.1111/j.1365-2427.1995.tb00396.x; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Douglass JG, 2008, ECOL LETT, V11, P598, DOI 10.1111/j.1461-0248.2008.01175.x; Downing AL, 2010, FRESHWATER BIOL, V55, P2123, DOI 10.1111/j.1365-2427.2010.02472.x; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; GULATI RD, 1993, HYDROBIOLOGIA, V255, P269, DOI 10.1007/BF00025848; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hamm Christian, 2007, P311, DOI 10.1016/B978-012370518-1/50015-1; Hansen B, 1997, J EXP MAR BIOL ECOL, V215, P217, DOI 10.1016/S0022-0981(97)00053-1; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hotos GN, 2002, AQUAC RES, V33, P949, DOI 10.1046/j.1365-2109.2002.00746.x; Leary DJ, 2009, J ANIM ECOL, V78, P1143, DOI 10.1111/j.1365-2656.2009.01586.x; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCLACHLAN J, 1964, CAN J MICROBIOL, V10, P769, DOI 10.1139/m64-098; Metcalf JS, 2009, AMYOTROPH LATERAL SC, V10, P74, DOI 10.3109/17482960903272942; Mohr S, 2000, LIMNOL OCEANOGR, V45, P1175, DOI 10.4319/lo.2000.45.5.1175; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Narwani A, 2010, ECOLOGY, V91, P3441, DOI 10.1890/10-0850.1; Pagano M, 1998, HYDROBIOLOGIA, V390, P83, DOI 10.1023/A:1003561821745; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pondaven P, 2007, PROTIST, V158, P21, DOI 10.1016/j.protis.2006.09.002; Power LD, 2009, OIKOS, V118, P1703, DOI 10.1111/j.1600-0706.2009.17585.x; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; Quinn GP, 2003, EXPT DESIGN DATA ANA; Savas S, 2006, ISR J AQUACULT-BAMID, V58, P39; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; Schmidtke A, 2010, ECOLOGY, V91, P212, DOI 10.1890/08-2370.1; Sokal R. R., 2012, BIOMETRY; STARKWEATHER PL, 1980, HYDROBIOLOGIA, V73, P63, DOI 10.1007/BF00019427; Striebel M, 2009, AM NAT, V174, P141, DOI 10.1086/599294; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; VADSTEIN O, 1993, HYDROBIOLOGIA, V255, P261, DOI 10.1007/BF00025847; Valone TJ, 2008, ECOLOGY, V89, P522, DOI 10.1890/07-0153.1; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yin XW, 2008, AQUAT ECOL, V42, P165, DOI 10.1007/s10452-007-9092-4; Zhang QG, 2006, OIKOS, V112, P218, DOI 10.1111/j.0030-1299.2006.14220.x; Zhang QG, 2006, OIKOS, V114, P385, DOI 10.1111/j.2006.0030-1299.14723.x	58	52	53	1	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49397	10.1371/journal.pone.0049397	http://dx.doi.org/10.1371/journal.pone.0049397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23173059	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885300036
J	Lawrence-Dewar, JM; Baugh, LA; Marotta, JJ				Lawrence-Dewar, Jane M.; Baugh, Lee A.; Marotta, Jonathan J.			Behavioural Distinction between Strategic Control and Spatial Realignment during Visuomotor Adaptation in a Viewing Window Task	PLOS ONE			English	Article							PRISM ADAPTATION; WEDGE PRISMS; TRANSFORMATIONS; NEGLECT; LESIONS; CORTEX; SCENE	We must frequently adapt our movements in order to successfully perform motor tasks. These visuomotor adaptations can occur with or without our awareness and so, have generally been described by two mechanisms: strategic control and spatial realignment. Strategic control is a conscious modification used when discordance between an intended and actual movement is observed. Spatial realignment is an unconscious recalibration in response to subtle differences between an intended and efferent movement. Traditional methods of investigating visuomotor adaptation often involve simplistic, repetitive motor goals and so may be vulnerable to subject boredom or expectation. Our laboratory has recently developed a novel, engaging computer-based task, the Viewing Window, to investigate visuomotor adaptation to large, apparent distortions. Here, we contrast behavioural measures of visuomotor adaptation during the Viewing Window task when either gradual progressive rotations or large, sudden rotations are introduced in order to demonstrate that this paradigm can be utilized to investigate both strategic control and spatial realignment. The gradual rotation group demonstrated significantly faster mean velocities and spent significantly less time off the object compared to the sudden rotation group. These differences demonstrate adaptation to the distortion using spatial realignment. Scan paths revealed greater after-effects in the gradual rotation group reflected by greater time spent scanning areas off of the object. These results demonstrate the ability to investigate both strategic control and spatial realignment. Thus, the Viewing Window provides a powerful engaging tool for investigating the neural basis of visuomotor adaptation and impairment following injury and disease.	[Lawrence-Dewar, Jane M.; Baugh, Lee A.; Marotta, Jonathan J.] Univ Manitoba, Dept Psychol, Percept & Act Lab, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Lawrence-Dewar, JM (corresponding author), Univ Manitoba, Dept Psychol, Percept & Act Lab, Winnipeg, MB R3T 2N2, Canada.	dewarja@tbh.net		Lawrence-Dewar, Jane/0000-0003-1529-5748; Baugh, Lee/0000-0001-6227-497X; Marotta, Jonathan/0000-0001-6635-4694	Natural Sciences and Engineering Research Council of Canada (NSERC); Riverview Health Centre Research Grant; Manitoba Health Research Council (MHRC); MHRC	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Riverview Health Centre Research Grant; Manitoba Health Research Council (MHRC); MHRC	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to JJM and Riverview Health Centre Research Grant to JMLD and JJM. JMLD is supported by a Manitoba Health Research Council (MHRC) postdoctoral research fellowship. LAB was a recipient of a MHRC graduate studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; Baugh LA, 2011, BEHAV BRAIN RES; Baugh LA, 2007, J NEUROSCI METH, V160, P128, DOI 10.1016/j.jneumeth.2006.09.002; Baugh LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005484; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; Chapman HL, 2010, NEUROPSYCHOLOGIA, V48, P2595, DOI 10.1016/j.neuropsychologia.2010.05.006; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Danckert J, 2008, EUR J NEUROSCI, V28, P1696, DOI 10.1111/j.1460-9568.2008.06460.x; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Ito Masao, 1993, Canadian Journal of Neurological Sciences, V20, pS70; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kagerer FA, 2006, HUM MOVEMENT SCI, V25, P622, DOI 10.1016/j.humov.2006.06.003; Kagerer FA, 1997, EXP BRAIN RES, V115, P557, DOI 10.1007/PL00005727; Keisler A, 2010, J NEUROSCI, V30, P14817, DOI 10.1523/JNEUROSCI.4160-10.2010; Klassen J, 2005, EXP BRAIN RES, V164, P250, DOI 10.1007/s00221-005-2247-4; Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Michel C, 2007, J COGNITIVE NEUROSCI, V19, P341, DOI 10.1162/jocn.2007.19.2.341; Newport R, 2012, NEUROPSYCHOLOGIA, V50, P1080, DOI 10.1016/j.neuropsychologia.2012.01.023; OSAKA N, 1994, BEHAV RES METH INSTR, V26, P49, DOI 10.3758/BF03204563; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Redding GM, 2006, J EXP PSYCHOL HUMAN, V32, P1006, DOI 10.1037/0096-1523.32.4.1006; ROBYBRAMI A, 1995, COGNITIVE BRAIN RES, V2, P229, DOI 10.1016/0926-6410(95)90014-4; ROCK I, 1966, PERCEPT PSYCHOPHYS, V1, P351, DOI 10.3758/BF03215803; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; van Diepen PMJ, 1998, PERCEPTION, V27, P1141, DOI 10.1068/p271141; WEINER MJ, 1983, NEUROLOGY, V33, P766, DOI 10.1212/WNL.33.6.766	29	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e48759	10.1371/journal.pone.0048759	http://dx.doi.org/10.1371/journal.pone.0048759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048BN	23173038	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885300008
J	Palavesam, A; Guerrero, FD; Heekin, AM; Wang, J; Dowd, SE; Sun, Y; Foil, LD; de Leon, AAP				Palavesam, Azhahianambi; Guerrero, Felix D.; Heekin, Andrew M.; Wang, Ju; Dowd, Scot E.; Sun, Yan; Foil, Lane D.; de Leon, Adalberto A. Perez			Pyrosequencing-Based Analysis of the Microbiome Associated with the Horn Fly, Haematobia irritans	PLOS ONE			English	Article							BACTERIAL DIVERSITY; STAPHYLOCOCCUS-SAPROPHYTICUS; WOLBACHIA INFECTION; BITING FLIES; L DIPTERA; DNA; EXPRESSION; MUSCIDAE; TRACT; PARATRANSGENESIS	The horn fly, Haematobia irritans, is one of the most economically important pests of cattle. Insecticides have been a major element of horn fly management programs. Growing concerns with insecticide resistance, insecticide residues on farm products, and non-availability of new generation insecticides, are serious issues for the livestock industry. Alternative horn fly control methods offer the promise to decrease the use of insecticides and reduce the amount of insecticide residues on livestock products and give an impetus to the organic livestock farming segment. The horn fly, an obligatory blood feeder, requires the help of microflora to supply additional nutrients and metabolize the blood meal. Recent advancements in DNA sequencing methodologies enable researchers to examine the microflora diversity independent of culture methods. We used the bacterial 16S tag-encoded FLX-titanium amplicon pyrosequencing (bTEFAP) method to carry out the classification analysis of bacterial flora in adult female and male horn flies and horn fly eggs. The bTEFAP method identified 16S rDNA sequences in our samples which allowed the identification of various prokaryotic taxa associated with the life stage examined. This is the first comprehensive report of bacterial flora associated with the horn fly using a culture-independent method. Several rumen, environmental, symbiotic and pathogenic bacteria associated with the horn fly were identified and quantified. This is the first report of the presence of Wolbachia in horn flies of USA origin and is the first report of the presence of Rikenella in an obligatory blood feeding insect.	[Palavesam, Azhahianambi; Guerrero, Felix D.; Heekin, Andrew M.; Wang, Ju; de Leon, Adalberto A. Perez] ARS, USDA, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA; [Palavesam, Azhahianambi] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Dowd, Scot E.] Mol Res LP, Shallowater, TX USA; [Sun, Yan] Res & Testing Lab, Lubbock, TX USA; [Foil, Lane D.] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA; [Palavesam, Azhahianambi] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Parasitol, Madras, Tamil Nadu, India	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; Louisiana State University System; Louisiana State University; Tamil Nadu Veterinary & Animal Sciences University	Palavesam, A (corresponding author), ARS, USDA, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA.	nambibio@gmail.com	Palavesam, Azhahianambi/H-3307-2019; Dowd, Scot E/M-5386-2017; Palavesam, Azhahianambi/K-7606-2015; Garcia-Vallve, Santiago/A-4226-2008; Pujadas, Gerard/B-1457-2010; Arola, Lluis/C-6074-2011; Muguerza, Begona/C-6704-2015	Palavesam, Azhahianambi/0000-0002-7108-6767; Dowd, Scot E/0000-0002-6296-1427; Palavesam, Azhahianambi/0000-0002-7108-6767; Quinones, Mar/0000-0003-0180-2147; Garcia-Vallve, Santiago/0000-0002-0348-7497; Pujadas, Gerard/0000-0003-2598-8089; Arola, Lluis/0000-0003-2767-1974; Muguerza, Begona/0000-0001-7384-8588	U.S. Department of Agriculture APHIS-IS [34-WT-10-5000-1992-IA]; University of Maryland; U.S. Department of Agriculture-APHIS Cooperative Agreement Fund [58-6205-0-038]; Agricultural Research Service	U.S. Department of Agriculture APHIS-IS; University of Maryland; U.S. Department of Agriculture-APHIS Cooperative Agreement Fund; Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors thank the U.S. Department of Agriculture APHIS-IS for support provided to this study through the cooperative agreement 34-WT-10-5000-1992-IA with the University of Maryland and U.S. Department of Agriculture-APHIS Cooperative Agreement Fund 58-6205-0-038 with the Agricultural Research Service. This article reports the results of research only. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation of endorsement by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril C, 2008, VET MICROBIOL, V127, P203, DOI 10.1016/j.vetmic.2007.08.006; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ai H, 2008, CARBOHYD POLYM, V72, P419, DOI 10.1016/j.carbpol.2007.09.010; Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bomar L, 2011, MBIO, V2, DOI 10.1128/mBio.00012-11; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; BRUCE W. G., 1938, JOUR KANSAS ENT SOC, V11, P88; BYFORD RL, 1992, J ANIM SCI, V70, P597, DOI 10.2527/1992.702597x; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CANO RJ, 1994, APPL ENVIRON MICROB, V60, P2164, DOI 10.1128/AEM.60.6.2164-2167.1994; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cheng Q, 1999, INSECT MOL BIOL, V8, P125, DOI 10.1046/j.1365-2583.1999.810125.x; Chung CY, 2004, EMERG INFECT DIS, V10, P1311; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; Cupp EW, 1998, J MED ENTOMOL, V35, P591, DOI 10.1093/jmedent/35.4.591; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dugas JE, 2001, ARCH MICROBIOL, V175, P259, DOI 10.1007/s002030000243; Durvasula RV, 1999, MED VET ENTOMOL, V13, P115, DOI 10.1046/j.1365-2915.1999.00175.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Floate KD, 2006, BIOCONTROL SCI TECHN, V16, P767, DOI 10.1080/09583150600699606; FOIL LD, 1994, REV SCI TECH OIE, V13, P1125, DOI 10.20506/rst.13.4.821; FRANKEL H, 1978, BRIT J HIST SCI, V11, P130, DOI 10.1017/S0007087400016551; Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; GARGALLO D, 1987, APPL ENVIRON MICROB, V53, P1983, DOI 10.1128/AEM.53.8.1983-1986.1987; GARGALLOVIOLA D, 1989, J CLIN MICROBIOL, V27, P860, DOI 10.1128/JCM.27.5.860-868.1989; Gilbert DG, 1989, IUBIO ARCH MOL GEN B; Gillespie BE, 1999, J DAIRY SCI, V82, P1581, DOI 10.3168/jds.S0022-0302(99)75386-5; Glaser RW, 1923, AM J HYG, V3, P469, DOI 10.1093/oxfordjournals.aje.a118948; Grisi L., 2002, A Hora Veterinaria, V21, P8; Hammer O., 1941, Videnskabelige Meddelelser fra Dansk Naturhistorisk Forening i Kjobenhavn, V105, P141; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HEDMAN P, 1990, J INFECTION, V21, P11, DOI 10.1016/0163-4453(90)90554-L; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hornok S, 2008, VET PARASITOL, V154, P354, DOI 10.1016/j.vetpar.2008.03.019; HOVELIUS B, 1984, REV INFECT DIS, V6, P328; Jaklic D, 2008, J MED MICROBIOL, V57, P617, DOI 10.1099/jmm.0.47515-0; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; JUKES T H, 1969, P21; Kunz S. E., 1991, CRC HDB PEST MANAGEM, P68; Leite RC, 1998, MEM I OSWALDO CRUZ, V93, P761, DOI 10.1590/S0074-02761998000600012; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; LYSYK TJ, 1991, CAN ENTOMOL, V123, P1199, DOI 10.4039/Ent1231199-6; Maillard R, 2007, EMERG INFECT DIS, V13, P1383, DOI 10.3201/eid1309.070236; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0; Mrazek J, 2008, FOLIA MICROBIOL, V53, P229, DOI 10.1007/s12223-008-0032-z; O'Hara CM, 2000, CLIN MICROBIOL REV, V13, P534, DOI 10.1128/CMR.13.4.534-546.2000; Owens WE, 1998, AM J VET RES, V59, P1122; Oyarzun MP, 2008, MED VET ENTOMOL, V22, P188, DOI 10.1111/j.1365-2915.2008.00733.x; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Perotti MA, 2001, J MED ENTOMOL, V38, P180, DOI 10.1603/0022-2585-38.2.180; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Rodriguez SD, 2009, INFECT GENET EVOL, V9, P1092, DOI 10.1016/j.meegid.2009.09.007; Ruang-areerate T, 2004, CURR MICROBIOL, V49, P10, DOI 10.1007/s00284-003-4245-8; Sinshaw A, 2006, VET PARASITOL, V142, P35, DOI 10.1016/j.vetpar.2006.06.032; Spier SJ, 2004, AM J VET RES, V65, P829, DOI 10.2460/ajvr.2004.65.829; STEINHAUS EA, 1960, BACTERIOL REV, V24, P365, DOI 10.1128/MMBR.24.4.365-373.1960; STIRRAT JH, 1955, J PARASITOL, V41, P398, DOI 10.2307/3274240; Torres L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-105; Velasco R., 2001, INF AGROPECU BIOLECH, V14, P4; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Watrelot-Virieux D, 2006, J VET MED B, V53, P150, DOI 10.1111/j.1439-0450.2006.00923.x; Weiss BL, 2006, APPL ENVIRON MICROB, V72, P7013, DOI 10.1128/AEM.01507-06; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WILLIAMS JD, 1985, AUST VET J, V62, P367, DOI 10.1111/j.1751-0813.1985.tb14210.x; Worthen PL, 2006, APPL ENVIRON MICROB, V72, P4775, DOI 10.1128/AEM.00356-06; Yanti S. D., 2009, Asian Journal of Food and Agro-Industry, V2, pS241; Zhang B, 2009, VET PARASITOL, V162, P350, DOI 10.1016/j.vetpar.2009.03.012; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	80	98	101	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44390	10.1371/journal.pone.0044390	http://dx.doi.org/10.1371/journal.pone.0044390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23185345	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700011
J	Shen, K; Rice, SD; Gingrich, DA; Wang, DK; Mi, ZB; Tian, CQ; Ding, ZY; Brower, SL; Ervin, PR; Gabrin, MJ; Tseng, G; Song, N				Shen, Kui; Rice, Shara D.; Gingrich, David A.; Wang, Dakun; Mi, Zhibao; Tian, Chunqiao; Ding, Zhenyu; Brower, Stacey L.; Ervin, Paul R., Jr.; Gabrin, Michael J.; Tseng, George; Song, Nan			Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; ANTICANCER DRUGS; NEOADJUVANT CHEMOTHERAPY; EXPRESSION PROFILES; MOLECULAR PORTRAITS; SUBTYPES; SENSITIVITY; DOXORUBICIN; CYCLOPHOSPHAMIDE; CHEMOSENSITIVITY	Breast cancer patients have different responses to chemotherapeutic treatments. Genes associated with drug response can provide insight to understand the mechanisms of drug resistance, identify promising therapeutic opportunities, and facilitate personalized treatment. Estrogen receptor (ER) positive and ER negative breast cancer have distinct clinical behavior and molecular properties. However, to date, few studies have rigorously assessed drug response genes in them. In this study, our goal was to systematically identify genes associated with multidrug response in ER positive and ER negative breast cancer cell lines. We tested 27 human breast cell lines for response to seven chemotherapeutic agents (cyclophosphamide, docetaxel, doxorubicin, epirubicin, fluorouracil, gemcitabine, and paclitaxel). We integrated publicly available gene expression profiles of these cell lines with their in vitro drug response patterns, then applied meta-analysis to identify genes related to multidrug response in ER positive and ER negative cells separately. One hundred eighty-eight genes were identified as related to multidrug response in ER positive and 32 genes in ER negative breast cell lines. Of these, only three genes (DBI, TOP2A, and PMVK) were common to both cell types. TOP2A was positively associated with drug response, and DBI was negatively associated with drug response. Interestingly, PMVK was positively associated with drug response in ER positive cells and negatively in ER negative cells. Functional analysis showed that while cell cycle affects drug response in both ER positive and negative cells, most biological processes that are involved in drug response are distinct. A number of signaling pathways that are uniquely enriched in ER positive cells have complex cross talk with ER signaling, while in ER negative cells, enriched pathways are related to metabolic functions. Taken together, our analysis indicates that distinct mechanisms are involved in multidrug response in ER positive and ER negative breast cells.	[Shen, Kui; Rice, Shara D.; Gingrich, David A.; Wang, Dakun; Tian, Chunqiao; Ding, Zhenyu; Brower, Stacey L.; Ervin, Paul R., Jr.; Gabrin, Michael J.; Song, Nan] Precis Therapeut Inc, Pittsburgh, PA USA; [Tseng, George] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Mi, Zhibao] VA Maryland Hlth Care Syst, Cooperat Studies Program Coordinating Ctr, Perry Point, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shen, K (corresponding author), Precis Therapeut Inc, Pittsburgh, PA USA.	nsong@ptilabs.com	Shen, Kui/E-2764-2015		Precision Therapeutics, Inc.	Precision Therapeutics, Inc.	KS, SR, CT, DG, DW, ZD, SB, PE, MG and NS were employees of Precision Therapeutics, Inc., and received salary from Precision Therapeutics, Inc. Zhibao Mi and George Tseng are consultants of Precision Therapeutics, Inc. A provisional patent application (# 61/265,588) related to the content of the manuscript has been filed. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andre F, 2008, J CLIN ONCOL, V26, P2636, DOI 10.1200/JCO.2007.14.9146; Andre F, 2006, NAT CLIN PRACT ONCOL, V3, P621, DOI 10.1038/ncponc0636; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Council NR, 1992, COMB INF STAT ISS OP; Dan S, 2002, CANCER RES, V62, P1139; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Iwamoto T, 2011, BREAST CANC RES TREA; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Jarvinen TAH, 2000, AM J PATHOL, V156, P839, DOI 10.1016/S0002-9440(10)64952-8; Knoop AS, 2005, J CLIN ONCOL, V23, P7483, DOI 10.1200/JCO.2005.11.007; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Liedtke C, 2009, J CLIN ONCOL, V27, P3185, DOI 10.1200/JCO.2008.18.5934; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Mi ZB, 2008, ANTICANCER RES, V28, P1733; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Pollard C, 2009, AM J PATHOL, V175, P1824, DOI 10.2353/ajpath.2009.090155; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Rustici G. R., 2008, CURR PROTOC BIOINFOR; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spataro V, 1997, J BIOL CHEM, V272, P30470, DOI 10.1074/jbc.272.48.30470; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Takata R, 2005, CLIN CANCER RES, V11, P2625, DOI 10.1158/1078-0432.CCR-04-1988; Tanner M, 2006, J CLIN ONCOL, V24, P2428, DOI 10.1200/JCO.2005.02.9264; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WERMUTH B, 1986, BIOCHEM PHARMACOL, V35, P1277, DOI 10.1016/0006-2952(86)90271-6; Zembutsu H, 2002, CANCER RES, V62, P518	38	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2012	7	7							e40900	10.1371/journal.pone.0040900	http://dx.doi.org/10.1371/journal.pone.0040900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	974VS	22815861	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000306466100092
J	Wang, F; Bobrow, L; Liu, J; Spencer, L; Blumberg, HP				Wang, Fei; Bobrow, Laurel; Liu, Jie; Spencer, Linda; Blumberg, Hilary P.			Corticolimbic Functional Connectivity in Adolescents with Bipolar Disorder	PLOS ONE			English	Article							EMOTIONAL FACES; ANTERIOR CINGULATE; PREFRONTAL CORTEX; RESTING STATE; FACIAL EXPRESSIONS; NEURAL SYSTEMS; AMYGDALA; TRAIT; CHILDREN; ABNORMALITIES	Convergent evidence supports regional dysfunction within a corticolimbic neural system that subserves emotional processing and regulation in adolescents and adults with bipolar disorder (BD), with abnormalities prominent within the amygdala and its major anterior paralimbic cortical connection sites including ventral anterior cingulate, orbitofrontal, insular and temporopolar cortices. Recent studies of adults with BD demonstrate abnormalities in the functional connectivity between the amygdala and anterior paralimbic regions suggesting an important role for the connections between these regions in the development of the disorder. This study tests the hypothesis that these functional connectivity abnormalities are present in adolescents with BD. Fifty-seven adolescents, twenty-one with BD and thirty-six healthy comparison (HC) adolescents, participated in functional magnetic resonance imaging while processing emotional face stimuli. The BD and HC groups were compared in the strength of functional connectivity from amygdala to the anterior paralimbic cortical regions, and explored in remaining brain regions. Functional connectivity was decreased in the BD group, compared to the HC group, during processing of emotional faces in ventral anterior cingulate (VACC), orbitofrontal, insular and temporopolar cortices (p<0.005). Orbitofrontal and VACC findings for the happy condition, and additionally right insula for the neutral condition, survived multiple comparison correction. Exploratory analyses did not reveal additional regions of group differences. This study provides evidence for decreased functional connectivity between the amygdala and anterior paralimbic cortices in adolescents with BD. This suggests that amygdala-anterior paralimbic connectivity abnormalities are early features of BD that emerge at least by adolescence in the disorder.	[Wang, Fei; Bobrow, Laurel; Liu, Jie; Spencer, Linda; Blumberg, Hilary P.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Blumberg, Hilary P.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Blumberg, Hilary P.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Blumberg, HP (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Hilary.blumberg@yale.edu	Liu, Jie/K-3142-2015	Blumberg, Hilary/0000-0002-6363-4698	National Institute of Health (NIH) [R01MH69747, RC1MH088366, R01MH070902, RL1DA024856, K01MH086621]; CTSA from the NIH National Center for Research Resources [UL1RR0249139]; National Alliance for Research on Schizophrenia and Depression (Great Neck, New York); Attias Family Foundation; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut); Klingenstein Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069747, K01MH086621, RC1MH088366, R01MH070902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RL1DA024856] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA from the NIH National Center for Research Resources; National Alliance for Research on Schizophrenia and Depression (Great Neck, New York)(NARSAD); Attias Family Foundation; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut); Klingenstein Foundation(Klingenstein Philanthropies); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute of Health (NIH) R01MH69747 [HPB], RC1MH088366 [HPB], R01MH070902 [HPB], RL1DA024856 [HPB, FW], K01MH086621 [FW]; CTSA UL1RR0249139 from the NIH National Center for Research Resources [HPB, FW] the National Alliance for Research on Schizophrenia and Depression (Great Neck, New York) [FW, HPB]; The Attias Family Foundation [HPB]; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut) [HPB]; and the Klingenstein Foundation [FW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cerullo MA, 2012, BIPOLAR DISORD, V14, P175, DOI 10.1111/j.1399-5618.2012.01002.x; Chang K, 2005, J AM ACAD CHILD PSY, V44, P565, DOI 10.1097/01.chi.0000159948.75136.0d; Chang K, 2004, ARCH GEN PSYCHIAT, V61, P781, DOI 10.1001/archpsyc.61.8.781; Chen BK, 2004, BIOL PSYCHIAT, V56, P399, DOI 10.1016/j.biopsych.2004.06.024; Chen CH, 2006, BIOL PSYCHIAT, V59, P31, DOI 10.1016/j.biopsych.2005.06.008; Chepenik LG, 2010, PSYCHIAT RES-NEUROIM, V182, P207, DOI 10.1016/j.pscychresns.2010.04.002; Chiu S, 2008, J AFFECT DISORDERS, V105, P93, DOI 10.1016/j.jad.2007.04.019; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; DelBello MP, 2004, BIPOLAR DISORD, V6, P43, DOI 10.1046/j.1399-5618.2003.00087.x; Dickstein DP, 2007, BIPOLAR DISORD, V9, P679, DOI 10.1111/j.1399-5618.2007.00418.x; Dickstein DP, 2010, BIOL PSYCHIAT, V68, P839, DOI 10.1016/j.biopsych.2010.06.029; Dickstein DP, 2005, ARCH GEN PSYCHIAT, V62, P734, DOI 10.1001/archpsyc.62.7.734; Farrow TFD, 2005, BIOL PSYCHIAT, V58, P713, DOI 10.1016/j.biopsych.2005.04.033; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Frazier JA, 2005, BIPOLAR DISORD, V7, P555, DOI 10.1111/j.1399-5618.2005.00258.x; Gogtay N, 2007, J CHILD PSYCHOL PSYC, V48, P852, DOI 10.1111/j.1469-7610.2007.01747.x; Kalmar JH, 2009, J AM ACAD CHILD PSY, V48, P636, DOI 10.1097/CHI.0b013e31819f6fbc; Kaur S, 2005, AM J PSYCHIAT, V162, P1637, DOI 10.1176/appi.ajp.162.9.1637; Kim E, 2009, PROG NEURO-PSYCHOPH, V33, P1409, DOI 10.1016/j.pnpbp.2009.07.019; Ladouceur CD, 2011, J AM ACAD CHILD PSY, V50, P1275, DOI 10.1016/j.jaac.2011.09.023; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Liu J, 2012, BIPOLAR DISORD, V14, P432, DOI 10.1111/j.1399-5618.2012.01018.x; Liu J, 2012, J AM ACAD CHILD PSY, V51, P304, DOI 10.1016/j.jaac.2011.12.014; Mesulam MM, 1985, CEREBRAL CORTEX; Najt P, 2007, NEUROSCI LETT, V413, P183, DOI 10.1016/j.neulet.2006.10.016; Passarotti AM, 2010, J INT NEUROPSYCH SOC, V16, P106, DOI 10.1017/S1355617709991019; Pavuluri MN, 2007, BIOL PSYCHIAT, V62, P158, DOI 10.1016/j.biopsych.2006.07.011; Pavuluri MN, 2009, J AM ACAD CHILD PSY, V48, P308, DOI 10.1097/CHI.0b013e3181948fc7; Perlman SB, 2012, BIPOLAR DISORD, V14, P162, DOI 10.1111/j.1399-5618.2012.00999.x; Rich BA, 2008, J CHILD PSYCHOL PSYC, V49, P88, DOI 10.1111/j.1469-7610.2007.01819.x; Rich BA, 2006, P NATL ACAD SCI USA, V103, P8900, DOI 10.1073/pnas.0603246103; Shah MP, 2009, NEUROPSYCHOPHARMACOL, V34, P1301, DOI 10.1038/npp.2008.204; Van der Schot A, 2010, PSYCHIAT RES-NEUROIM, V184, P135, DOI 10.1016/j.pscychresns.2010.07.009; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Wang F, 2011, BRAIN, V134, P2005, DOI 10.1093/brain/awr124; Wang F, 2009, BIOL PSYCHIAT, V66, P516, DOI 10.1016/j.biopsych.2009.03.023; Wilke M, 2004, PSYCHIAT RES-NEUROIM, V131, P57, DOI 10.1016/j.pscychresns.2004.01.004; Womer FY, 2009, ACTA NEUROPSYCHIATR, V21, P228, DOI 10.1111/j.1601-5215.2009.00414.x	45	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50177	10.1371/journal.pone.0050177	http://dx.doi.org/10.1371/journal.pone.0050177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185566	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000194
J	Song, XF; Ren, H; Andreasen, A; Thomsen, JS; Zhai, XY				Song, Xiao-Feng; Ren, Hao; Andreasen, Arne; Thomsen, Jesper Skovhus; Zhai, Xiao-Yue			Expression of Bcl-2 and Bax in Mouse Renal Tubules during Kidney Development	PLOS ONE			English	Article							CYTOCHROME-C; PROXIMAL TUBULE; APOPTOSIS; DEATH; FAMILY; CELLS; MITOCHONDRIA; PROTEINS; RELEASE; MEMBERS	Bcl-2 and Bax play an important role in apoptosis regulation, as well as in cell adhesion and migration during kidney morphogenesis, which is structurally and functionally related to mitochondria. In order to elucidate the role of Bcl-2 and Bax during kidney development, it is essential to establish the exact location of their expression in the kidney. The present study localized their expression during kidney development. Kidneys from embryonic (E) 16-, 17-, 18-day-old mouse fetuses, and postnatal (P) 1-, 3-, 5-, 7-, 14-, 21-day-old pups were embedded in Epon. Semi-thin serial sections from two E17 kidneys underwent computer assisted 3D tubule tracing. The tracing was combined with a newly developed immunohistochemical technique, which enables immunohistochemistry on glutaraldehyde fixated plastic embedded sections. Thereby, the microstructure could be described in detail, and the immunochemistry can be performed using exactly the same sections. The study showed that Bcl-2 and Bax were strongly expressed in mature proximal convoluted tubules at all time points, less strongly expressed in proximal straight tubules, and only weakly in immature proximal tubules and distal tubules. No expression was detected in ureteric bud and other earlier developing structures, such as comma bodies, S shaped bodies, glomeruli, etc. Tubules expressing Bcl-2 only were occasionally observed. The present study showed that, during kidney development, Bcl-2 and Bax are expressed differently in the proximal and distal tubules, although these two tubule segments are almost equally equipped with mitochondria. The functional significance of the different expression of Bcl-2 and Bax in proximal and distal tubules is unknown. However, the findings of the present study suggest that the mitochondrial function differs between mature proximal tubules and in the rest of the tubules. The function of Bcl-2 and Bax during tubulogenesis still needs to be investigated.	[Song, Xiao-Feng; Ren, Hao; Zhai, Xiao-Yue] China Med Univ, Dept Histol & Embryol, Inst Pathol & Pathophysiol, Shenyang, Liao Ning, Peoples R China; [Andreasen, Arne; Thomsen, Jesper Skovhus] Aarhus Univ, Dept Anat, Dept Biomed, Aarhus, Denmark; [Song, Xiao-Feng] Liao Ning Med Coll, Dept Histol & Embryol, Jin Zhou, Liao Ning, Peoples R China; [Zhai, Xiao-Yue] China Med Univ, Inst Nephropathol, Shenyang, Liao Ning, Peoples R China	China Medical University; Aarhus University; China Medical University	Song, XF (corresponding author), China Med Univ, Dept Histol & Embryol, Inst Pathol & Pathophysiol, Shenyang, Liao Ning, Peoples R China.	zhaixy@mail.cmu.edu.cn		Thomsen, Jesper Skovhus/0000-0001-9386-6679	National Natural Science Foundation of China [30871313, 31171400]; China Postdoctoral Science Special Foundation [200801399]; Research Fund for the Doctoral Program of Higher Education of China [200801590016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Special Foundation; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported mainly by grants of National Natural Science Foundation of China (contract no. 30871313 and 31171400, http://isisn.nsfc.gov.cn/egrantweb), in part by China Postdoctoral Science Special Foundation (contract no. 200801399) and Research Fund for the Doctoral Program of Higher Education of China (contract no. 200801590016). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen A, 2003, J NEUROSCI METH, V122, P157, DOI 10.1016/S0165-0270(02)00317-5; Arany I, 2008, KIDNEY INT, V74, P261, DOI 10.1038/ki.2008.221; Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Basile DP, 1997, AM J PHYSIOL-RENAL, V272, pF640, DOI 10.1152/ajprenal.1997.272.5.F640; Carev D, 2006, PEDIATR NEPHROL, V21, P627, DOI 10.1007/s00467-006-0057-y; CHEN BY, 1994, TERATOLOGY, V50, P1, DOI 10.1002/tera.1420500102; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; Erkan E, 2007, J AM SOC NEPHROL, V18, P1199, DOI 10.1681/ASN.2006040407; Fedorov LM, 2006, MECH AGEING DEV, V127, P600, DOI 10.1016/j.mad.2006.02.009; Foley JGD, 2002, J ANAT, V201, P477, DOI 10.1046/j.1469-7580.2002.00114.x; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Hammerman MR, 1998, CURR OPIN NEPHROL HY, V7, P419, DOI 10.1097/00041552-199807000-00012; Hayashi M, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_9.8; KELLENBERGER E, 1987, J HISTOCHEM CYTOCHEM, V35, P959, DOI 10.1177/35.9.3302020; Kim YJ, 2009, J AGR FOOD CHEM, V57, P8793, DOI 10.1021/jf9019745; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Messaris E, 2008, SURG INFECT, V9, P377, DOI 10.1089/sur.2006.018; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; NOVACK DV, 1994, AM J PATHOL, V145, P61; Patschan D, 2007, KIDNEY INT, V71, P744, DOI 10.1038/sj.ki.5002102; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; RUEGG CE, 1990, AM J PHYSIOL, V259, pF176, DOI 10.1152/ajprenal.1990.259.1.F176; Saikumar P, 1998, ONCOGENE, V17, P3401, DOI 10.1038/sj.onc.1202590; Sheibani N, 2007, J CELL PHYSIOL, V210, P616, DOI 10.1002/jcp.20858; Sorenson CM, 2004, BBA-MOL CELL RES, V1644, P169, DOI 10.1016/j.bbamcr.2003.08.010; Torchinsky A, 1995, TERATOGEN CARCIN MUT, V15, P179, DOI 10.1002/tcm.1770150404; UCHIDA S, 1988, AM J PHYSIOL, V255, pF977, DOI 10.1152/ajprenal.1988.255.5.F977; Walker KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018723; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhai XY, 2007, KIDNEY INT, V72, P731, DOI 10.1038/sj.ki.5002403; Zhai XY, 2006, J AM SOC NEPHROL, V17, P77, DOI 10.1681/ASN.2005080796; Ziehr J, 2004, AM J PHYSIOL-RENAL, V287, pF1154, DOI 10.1152/ajprenal.00129.2004	39	28	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2012	7	2							e32771	10.1371/journal.pone.0032771	http://dx.doi.org/10.1371/journal.pone.0032771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928RC	22389723	gold, Green Published			2022-12-25	WOS:000302999600062
